PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Troncale, S; Barbet, A; Coulibaly, L; Henry, E; He, BL; Barillot, E; Dubois, T; Hupe, P; de Koning, L				Troncale, Sylvie; Barbet, Aurelie; Coulibaly, Lamine; Henry, Emilie; He, Beilei; Barillot, Emmanuel; Dubois, Thierry; Hupe, Philippe; de Koning, Leanne			NormaCurve: A SuperCurve-Based Method That Simultaneously Quantifies and Normalizes Reverse Phase Protein Array Data	PLOS ONE			English	Article							SPATIAL NORMALIZATION; MICROARRAYS; CANCER; TECHNOLOGY; ACTIVATION	Motivation: Reverse phase protein array (RPPA) is a powerful dot-blot technology that allows studying protein expression levels as well as post-translational modifications in a large number of samples simultaneously. Yet, correct interpretation of RPPA data has remained a major challenge for its broad-scale application and its translation into clinical research. Satisfying quantification tools are available to assess a relative protein expression level from a serial dilution curve. However, appropriate tools allowing the normalization of the data for external sources of variation are currently missing. Results: Here we propose a new method, called NormaCurve, that allows simultaneous quantification and normalization of RPPA data. For this, we modified the quantification method SuperCurve in order to include normalization for (i) background fluorescence, (ii) variation in the total amount of spotted protein and (iii) spatial bias on the arrays. Using a spike-in design with a purified protein, we test the capacity of different models to properly estimate normalized relative expression levels. The best performing model, NormaCurve, takes into account a negative control array without primary antibody, an array stained with a total protein stain and spatial covariates. We show that this normalization is reproducible and we discuss the number of serial dilutions and the number of replicates that are required to obtain robust data. We thus provide a ready-to-use method for reliable and reproducible normalization of RPPA data, which should facilitate the interpretation and the development of this promising technology. Availability: The raw data, the scripts and the NormaCurve package are available at the following web site: http://microarrays.curie.fr.	[Troncale, Sylvie; Barbet, Aurelie; Coulibaly, Lamine; Henry, Emilie; He, Beilei; Dubois, Thierry; de Koning, Leanne] Inst Curie, Dept Translat Res, Paris, France; [Troncale, Sylvie; Hupe, Philippe] INSERM, U900, Paris, France; [Troncale, Sylvie; Hupe, Philippe] Mines ParisTech, Fontainebleau, France; [Hupe, Philippe] CNRS UMR144, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Troncale, S (corresponding author), Inst Curie, Dept Translat Res, Paris, France.	normacurve@curie.fr	JOB, Sylvie/AAH-2734-2019; Hupe, Philippe/T-8793-2017; Dubois, Thierry/D-2852-2017	Hupe, Philippe/0000-0001-8468-3424; JOB, Sylvie/0000-0002-3899-7606; BARILLOT, Emmanuel/0000-0003-2724-2002; Dubois, Thierry/0000-0003-4739-6164				Anderson T, 2009, PROTEOMICS, V9, P5562, DOI 10.1002/pmic.200900505; Carey MS, 2010, CLIN CANCER RES, V16, P2852, DOI 10.1158/1078-0432.CCR-09-2502; Coombes K, 2009, PACKAGE SUPERCURVE V; Creighton CJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2594; Davies MA, 2009, CLIN CANCER RES, V15, P7538, DOI 10.1158/1078-0432.CCR-09-1985; Dupuy L, 2009, PROTEOMICS, V9, P5446, DOI 10.1002/pmic.200900209; Hennessy B, 2010, CLIN PROTEOMICS; Hu J, 2007, BIOINFORMATICS, V23, P1986, DOI 10.1093/bioinformatics/btm283; Marty B, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2204; Mircean C, 2005, BIOINFORMATICS, V21, P1935, DOI 10.1093/bioinformatics/bti258; Neeley E, 2009, BIOINFORMATICS; Neuvial P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-264; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Pierobon M, 2009, CLIN COLORECTAL CANC, V8, P110, DOI 10.3816/CCC.2009.n.018; Pinheiro J, 2001, MIXED EFFECTS MODELS; Sabbah C, 2011, BIOINFORMATICS, V27, P1693, DOI 10.1093/bioinformatics/btr187; Speer Runa, 2007, Cancer Genomics & Proteomics, V4, P157; Spurrier B, 2008, NAT PROTOC, V3, P1796, DOI 10.1038/nprot.2008.179; Tabus I, 2006, IEEE T SIGNAL PROCES, V54, P2394, DOI 10.1109/TSP.2006.873719; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Tsavachidou-Fenner D, 2010, ANN ONCOL, V21, P1599, DOI 10.1093/annonc/mdp600; Wingren C, 2006, ANTIBODY MICROARRAYS; Wood S, 2009, PACKAGE MGCV; Wulfkuhle JD, 2006, NAT CLIN PRACT ONCOL, V3, P256, DOI 10.1038/ncponc0485; Zhang L, 2009, BIOINFORMATICS, V25, P650, DOI 10.1093/bioinformatics/btn663	25	52	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e38686	10.1371/journal.pone.0038686	http://dx.doi.org/10.1371/journal.pone.0038686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761696	Green Submitted, Green Published, gold			2022-12-27	WOS:000305826400004
J	Ren, J; Wang, F; Wei, GQ; Yang, Y; Liu, Y; Wei, MQ; Huan, Y; Larson, AC; Zhang, ZL				Ren, Jing; Wang, Fang; Wei, Guangquan; Yang, Yong; Liu, Ying; Wei, Mengqi; Huan, Yi; Larson, Andrew C.; Zhang, Zhuoli			MRI of Prostate Cancer Antigen Expression for Diagnosis and Immunotherapy	PLOS ONE			English	Article							STEM-CELL ANTIGEN; MONOCLONAL-ANTIBODY; MESSENGER-RNA; NANOPARTICLES; THERAPY; PARTICLES	Background: Tumor antigen (TA)-targeted monoclonal antibody (mAb) immunotherapy can be effective for the treatment of a broad range of cancer etiologies; however, these approaches have demonstrated variable clinical efficacy for the treatment of patients with prostate cancer (PCa). An obstacle currently impeding translational progress has been the inability to quantify the mAb dose that reaches the tumor site and binds to the targeted TAs. The coupling of mAb to nanoparticle-based magnetic resonance imaging (MRI) probes should permit in vivo measurement of patient-specific biodistributions; these measurements could facilitate future development of novel dosimetry paradigms wherein mAb dose is titrated to optimize outcomes for individual patients. Methods: The prostate stem cell antigen (PSCA) is broadly expressed on the surface of prostate cancer (PCa) cells. Antihuman PSCA monoclonal antibodies (mAb 7F5) were bound to Au/Fe3O4 (GoldMag) nanoparticles (mAb 7F5@GoldMag) to serve as PSCA-specific theragnostic MRI probe permitting visualization of mAb biodistribution in vivo. First, the antibody immobilization efficiency of the GoldMag particles and the efficacy for PSCA-specific binding was assessed. Next, PC-3 (prostate cancer with PSCA over-expression) and SMMC-7721 (hepatoma cells without PSCA expression) tumor-bearing mice were injected with mAb 7F5@GoldMag for MRI. MRI probe biodistributions were assessed at increasing time intervals post-infusion; therapy response was evaluated with serial tumor volume measurements. Results: Targeted binding of the mAb 7F5@GoldMag probes to PC-3 cells was verified using optical images and MRI; selective binding was not observed for SMMC-7721 tumors. The immunotherapeutic efficacy of the mAb 7F5@GoldMag in PC-3 tumor-bearing mice was verified with significant inhibition of tumor growth compared to untreated control animals. Conclusion: Our promising results suggest the feasibility of using mAb 7F5@GoldMag probes as a novel paradigm for the detection and immunotherapeutic treatment of PCa. We optimistically anticipate that the approaches have the potential to be translated into the clinical settings.	[Ren, Jing; Wei, Guangquan; Yang, Yong; Liu, Ying; Wei, Mengqi; Huan, Yi; Zhang, Zhuoli] Fourth Mil Med Univ, Xijing Hosp, Dept Radiol, Xian 710032, Peoples R China; [Wang, Fang] Fourth Mil Med Univ, Dept Microbiol, Xian 710032, Peoples R China; [Larson, Andrew C.; Zhang, Zhuoli] Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA; [Larson, Andrew C.; Zhang, Zhuoli] Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA	Air Force Military Medical University; Air Force Military Medical University; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Robert H. Lurie Comprehensive Cancer Center	Ren, J (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Radiol, Xian 710032, Peoples R China.	huanyi3000@163.com; zhuoli-zhang@northwestern.edu			National Natural Science Foundation of China (NSFC) [30973408]; NSFC [81000627, 81001015]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC))	This study was supported by Grants from the National Natural Science Foundation of China (NSFC) 30973408, NSFC 81000627, and NSFC 81001015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bander NH, 2003, SEMIN ONCOL, V30, P667, DOI 10.1016/S0093-7754(03)00358-0; Beissert M, 2008, UROLOGE, V47, P1405, DOI 10.1007/s00120-008-1720-7; Bouchelouche K, 2010, CURR OPIN ONCOL, V22, P274, DOI 10.1097/CCO.0b013e3283373d5c; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Campoli M, 2010, CLIN CANCER RES, V16, P11, DOI 10.1158/1078-0432.CCR-09-2345; Chao X, 2010, J DRUG TARGET, V13, P13; Chao X, 2010, PHARMAZIE, V65, P500, DOI 10.1691/ph.2010.9362; Cui YL, 2005, BIOMED MICRODEVICES, V7, P153, DOI 10.1007/s10544-005-1596-x; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; Eyal E, 2010, INVEST RADIOL, V45, P174, DOI 10.1097/RLI.0b013e3181d0a02f; Farrell E, 2009, OSTEOARTHR CARTILAGE, V17, P961, DOI 10.1016/j.joca.2008.11.016; Ferris RL, 2010, J CLIN ONCOL, V28, P4390, DOI 10.1200/JCO.2009.27.6360; Giovacchini G, 2010, EUR J NUCL MED MOL I, V37, P1106, DOI 10.1007/s00259-010-1403-7; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Huang HC, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-86; Islam T, 2009, CANCER BIOMARK, V5, P99, DOI 10.3233/CBM-2009-0615; Jakobovits A., 2008, V181, P237; Jani AB, 2003, LANCET, V361, P1045, DOI 10.1016/S0140-6736(03)12833-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jin HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021307; Joung JY, 2010, J SURG ONCOL, V101, P145, DOI 10.1002/jso.21445; Kiessling A, 2008, EUR UROL, V53, P694, DOI 10.1016/j.eururo.2007.11.043; Lapi SE, 2009, J NUCL MED, V50, P2042, DOI 10.2967/jnumed.109.066589; Lepin EJ, 2010, EUR J NUCL MED MOL I, V37, P1529, DOI 10.1007/s00259-010-1433-1; Li ZF, 2007, FOOD ADDIT CONTAM A, V24, P21, DOI 10.1080/02652030600949592; Long CM, 2009, CANCER RES, V69, P3180, DOI 10.1158/0008-5472.CAN-08-3691; Mandal M, 2005, J COLLOID INTERF SCI, V286, P187, DOI 10.1016/j.jcis.2005.01.013; MELDRUM FC, 1992, SCIENCE, V257, P522, DOI 10.1126/science.1636086; Olafsen T, 2007, J IMMUNOTHER, V30, P396, DOI 10.1097/CJI.0b013e318031b53b; Raff AB, 2009, CANCER LETT, V277, P126, DOI 10.1016/j.canlet.2008.08.034; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Saad F, 2004, J NATL CANCER I, V96, P879, DOI 10.1093/jnci/djh141; Schoffelen R, 2010, J NUCL MED, V51, P1780, DOI 10.2967/jnumed.110.079376; Sternberg CN, 2009, J CLIN ONCOL, V27, P5431, DOI 10.1200/JCO.2008.20.1228; Thorek DLJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010655; Turkbey B, 2009, AM J ROENTGENOL, V192, P1471, DOI 10.2214/AJR.09.2527; Turkbey B, 2009, NAT REV UROL, V6, P191, DOI 10.1038/nrurol.2009.27; Wang JA, 2010, COLLOID SURFACE B, V81, P600, DOI 10.1016/j.colsurfb.2010.08.007; Wang XL, 2009, ANAL SCI, V25, P1409, DOI 10.2116/analsci.25.1409; Zhao ZG, 2009, PROSTATE, V69, P1292, DOI 10.1002/pros.20973	40	12	14	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e38350	10.1371/journal.pone.0038350	http://dx.doi.org/10.1371/journal.pone.0038350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761679	Green Submitted, Green Published, gold			2022-12-27	WOS:000305825800011
J	White, MA; Cook, AG; Hocknull, SA; Sloan, T; Sinapius, GHK; Elliott, DA				White, Matt A.; Cook, Alex G.; Hocknull, Scott A.; Sloan, Trish; Sinapius, George H. K.; Elliott, David A.			New Forearm Elements Discovered of Holotype Specimen Australovenator wintonensis from Winton, Queensland, Australia	PLOS ONE			English	Article							MEGARAPTOR-NAMUNHUAIQUII; THEROPOD; GEN.; PATAGONIA; NOV.; SP.	New skeletal elements are reported of the holotype specimen Australovenator wintonensis, from the type locality, near Winton, central western Queensland. New elements include left and right humeri, right radius, right radiale, right distal carpal 1, near complete right metacarpal I, left manual phalanx II-1, left manual phalanx II-2, near complete left manual phalanx II-3 and a left manual phalanx III-3. These new elements combined with those previously described are compared against other neovenatorids.	[White, Matt A.] Univ Newcastle, Sch Engn, Callaghan, NSW 2308, Australia; [White, Matt A.; Hocknull, Scott A.; Sloan, Trish; Sinapius, George H. K.; Elliott, David A.] Jump Up, Australian Age Dinosaurs Museum Nat Hist, Winton, Qld, Australia; [Cook, Alex G.; Hocknull, Scott A.] Queensland Museum, Hendra, Qld, Australia	University of Newcastle; Queensland Museum	White, MA (corresponding author), Univ Newcastle, Sch Engn, Callaghan, NSW 2308, Australia.	fossilised@hotmail.com		Hocknull, Scott/0000-0003-4157-8434; White, Matt/0000-0002-4765-0356	Australian Research Council [LP100100339]; Queensland Xray Mackay; Australian Age of Dinosaurs Natural History Museum; Queensland Museum; University of Newcastle	Australian Research Council(Australian Research Council); Queensland Xray Mackay; Australian Age of Dinosaurs Natural History Museum; Queensland Museum; University of Newcastle	We acknowledge University of Newcastle for providing computer software for specimen analysis. We acknowledge funding to the Australian Age of Dinosaurs Museum and Queensland Museum from the Australian Research Council Linkage Grant (LP100100339). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the following people for the help and preparatory work of Australovenator specimens; N. Skelly, R. Proefke, K. Durack, F. Hill, A. Milson, M. Sloan, D. O'Boyle, M. Macmillan, J. Rasmussen, D. Brow, L. Young, L. Clark. We thank S. Woolridge and I. Pengelly for their assistance at Queensland Xray Mackay. We thank P. Clausen, C. McHenry, M. Quayle, M. McCurry, C. Oldfield, C. Warmsley, B. McBride for their help with computer software. We thank the following people for their help, encouragement and support; J. Elliott, B. Bassam, R. Elliott, H. Elliott, N. Markey, T. Tischler. We thank the two anonymous reviewers and PloS ONE editor P. Dodson for their assistance in reviewing this manuscript. We thank the following organisations for their help and support; Queensland Xray Mackay, Australian Age of Dinosaurs Natural History Museum, Queensland Museum and the University of Newcastle.	Azuma Y, 2000, CAN J EARTH SCI, V37, P1735, DOI 10.1139/e00-064; Benson RBJ, 2008, GEOL MAG, V145, P778, DOI 10.1017/S0016756808005475; Benson RBJ, 2010, NATURWISSENSCHAFTEN, V97, P71, DOI 10.1007/s00114-009-0614-x; Calvo JO, 2004, AMEGHINIANA, V41, P565; Clifford HT, 2005, REV PALAEOBOT PALYNO, V134, P71, DOI 10.1016/j.revpalbo.2004.12.001; COOMBS W P JR, 1981, Memoirs of the Queensland Museum, V20, P351; Currie Philip J., 2000, Geodiversitas, V22, P207; Dettmann ME, 2009, CRETACEOUS RES, V30, P339, DOI 10.1016/j.cretres.2008.07.015; Dettmann Mary E., 2000, Memoirs of the Queensland Museum, V45, P285; Hocknull S. A., 2009, PLOS ONE, V4, P1, DOI DOI 10.1371/J0URNAL.P0NE; Hu S. y., 1964, Vertebrata Palasiatica, V8, P42; Hutt Steve, 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V10, P635; Madsen JH., 1976, UTAH GEOLOGICAL MINI, V109, P1; McLoughlin S., 2010, ALCHERINGA, V35, P1; McLoughlin Stephen, 1995, Memoirs of the Queensland Museum, V38, P273; Novas FE, 1998, J VERTEBR PALEONTOL, V18, P4, DOI 10.1080/02724634.1998.10011030; Novas FE, 2008, CRETACEOUS RES, V29, P468, DOI 10.1016/j.cretres.2008.01.001; Pole M, 1999, BOT J LINN SOC, V129, P177, DOI 10.1006/bojl.1998.0222; Pole MS, 1999, CRETACEOUS RES, V20, P523, DOI 10.1006/cres.1999.0164; Reig O. A., 1963, Ameghiniana, V3, P3; Sereno P. C., 2008, PLOS ONE, V3, P1, DOI DOI 10.1371/JOURNAL.PONE.0003303; Sereno PC., 1994, J VERTEBR PALEONTOL, V13, P425, DOI DOI 10.1080/02724634.1994.10011524; STOVALL JW, 1950, AM MIDL NAT, V43, P696, DOI 10.2307/2421859	23	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39364	10.1371/journal.pone.0039364	http://dx.doi.org/10.1371/journal.pone.0039364			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761772	Green Published, gold			2022-12-27	WOS:000305825800029
J	Wittmann, M; Doble, R; Bachmann, M; Pfeilschifter, J; Werfel, T; Muhl, H				Wittmann, Miriam; Doble, Rosella; Bachmann, Malte; Pfeilschifter, Josef; Werfel, Thomas; Muehl, Heiko			IL-27 Regulates IL-18 Binding Protein in Skin Resident Cells	PLOS ONE			English	Article							CD4(+) T-CELLS; IFN-GAMMA; DIASTOLIC DYSFUNCTION; RHEUMATOID-ARTHRITIS; CHRONIC INFLAMMATION; CARDIAC FIBROSIS; INTERLEUKIN-18; EXPRESSION; INDUCTION; CYTOKINE	IL-18 is an important mediator involved in chronic inflammatory conditions such as cutaneous lupus erythematosus, psoriasis and chronic eczema. An imbalance between IL-18 and its endogenous antagonist IL-18 binding protein (BP) may account for increased IL-18 activity. IL-27 is a cytokine with dual function displaying pro- and anti-inflammatory properties. Here we provide evidence for a yet not described anti-inflammatory mode of action on skin resident cells. Human keratinocytes and surprisingly also fibroblasts (which do not produce any IL-18) show a robust, dose-dependent and highly inducible mRNA expression and secretion of IL-18BP upon IL-27 stimulation. Other IL-12 family members failed to induce IL-18BP. The production of IL-18BP peaked between 48-72 h after stimulation and was sustained for up to 96 h. Investigation of the signalling pathway showed that IL-27 activates STAT1 in human keratinocytes and that a proximal GAS site at the IL-18BP promoter is of importance for the functional activity of IL-27. The data are in support of a significant anti-inflammatory effect of IL-27 on skin resident cells. An important novel property of IL-27 in skin pathobiology may be to counter-regulate IL-18 activities by acting on keratinocytes and importantly also on dermal fibroblasts.	[Wittmann, Miriam] Univ Leeds, Leeds Inst Mol Med, LMBRU LTHT, Div Rheumat & Musculoskeletal Dis, Leeds, W Yorkshire, England; [Wittmann, Miriam] Univ Bradford, Ctr Skin Sci, Sch Life Sci, Bradford BD7 1DP, W Yorkshire, England; [Doble, Rosella] Univ Leeds, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds, W Yorkshire, England; [Bachmann, Malte; Pfeilschifter, Josef; Muehl, Heiko] Univ Hosp Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany; [Werfel, Thomas] Hannover Med Sch, Dept Dermatol, Div Immunodermatol & Allergy Res, D-3000 Hannover, Germany	University of Leeds; University of Bradford; University of Leeds; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Hannover Medical School	Wittmann, M (corresponding author), Univ Leeds, Leeds Inst Mol Med, LMBRU LTHT, Div Rheumat & Musculoskeletal Dis, Leeds, W Yorkshire, England.	M.Wittmann@leeds.ac.uk	Werfel, Thomas/B-6921-2012	Wittmann, Miriam/0000-0003-2328-4926	Royal Society [JP081045]; Leeds Foundation for Dermatological Research	Royal Society(Royal Society of London); Leeds Foundation for Dermatological Research	This study was supported by Royal Society Joint grant JP081045 and the Leeds Foundation for Dermatological Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2000, CURR OPIN IMMUNOL, V12, P59, DOI 10.1016/S0952-7915(99)00051-5; Antonopoulos C, 2008, J LEUKOCYTE BIOL, V83, P361, DOI 10.1189/jlb.0604352; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Bachmann M, 2009, J CELL MOL MED, V13, P1987, DOI 10.1111/j.1582-4934.2008.00604.x; Bani-Hani AH, 2009, KIDNEY INT, V76, P500, DOI 10.1038/ki.2009.216; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Boraschi D, 2011, EUR CYTOKINE NETW, V22, P127, DOI 10.1684/ecn.2011.0288; Calvani N, 2005, AUTOIMMUN REV, V4, P542, DOI 10.1016/j.autrev.2005.04.009; Companjen A, 2004, EUR CYTOKINE NETW, V15, P210; Companjen AR, 2000, J INVEST DERMATOL, V114, P598, DOI 10.1046/j.1523-1747.2000.02003.x; Corsini E, 2009, TOXICOL IN VITRO, V23, P789, DOI 10.1016/j.tiv.2009.04.005; Dinarello CA, 2007, SEMIN NEPHROL, V27, P98, DOI 10.1016/j.semnephrol.2006.09.013; Esteban DJ, 2004, VIROLOGY, V323, P197, DOI 10.1016/j.virol.2004.02.027; Favilli F, 2009, ANN NY ACAD SCI, V1173, P301, DOI 10.1111/j.1749-6632.2009.04742.x; Gangemi S, 2003, J EUR ACAD DERMATOL, V17, P42, DOI 10.1046/j.1468-3083.2003.00647.x; Gutzmer R, 2003, J IMMUNOL, V171, P6363, DOI 10.4049/jimmunol.171.12.6363; Hayashi N, 2007, P NATL ACAD SCI USA, V104, P14765, DOI 10.1073/pnas.0706378104; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Hu DW, 2010, CLIN RHEUMATOL, V29, P717, DOI 10.1007/s10067-010-1386-6; Hurgin V, 2002, P NATL ACAD SCI USA, V99, P16957, DOI 10.1073/pnas.262663399; Iannello A, 2010, J INFECT DIS, V201, P608, DOI 10.1086/650314; Johansen C, 2007, J INVEST DERMATOL, V127, P2857, DOI 10.1038/sj.jid.5700922; Kalliolias GD, 2008, J IMMUNOL, V180, P6325, DOI 10.4049/jimmunol.180.9.6325; Kampfer H, 2000, EUR CYTOKINE NETW, V11, P626; Kanda N, 2007, EUR J IMMUNOL, V37, P338, DOI 10.1002/eji.200636420; Kaser A, 2002, CLIN EXP IMMUNOL, V129, P332, DOI 10.1046/j.1365-2249.2002.01911.x; Kim SH, 2000, P NATL ACAD SCI USA, V97, P1190, DOI 10.1073/pnas.97.3.1190; Lee SJ, 2001, J IMMUNOL, V167, P497, DOI 10.4049/jimmunol.167.1.497; Lotito APN, 2007, AUTOIMMUN REV, V6, P253, DOI 10.1016/j.autrev.2006.08.010; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; Ludwiczek O, 2002, J CLIN IMMUNOL, V22, P331, DOI 10.1023/A:1020600230977; Mallat Z, 2004, FASEB J, V18, P1752, DOI 10.1096/fj.04-2426fje; McInnes IB, 2005, ARTHRITIS RES THER, V7, P38, DOI 10.1186/ar1497; Moller B, 2003, RHEUMATOLOGY, V42, P442, DOI 10.1093/rheumatology/keg146; Muhl H, 2004, EUR J PHARMACOL, V500, P63, DOI 10.1016/j.ejphar.2004.07.012; Muhl H, 2000, BIOCHEM BIOPH RES CO, V267, P960, DOI 10.1006/bbrc.1999.2064; Murray DR, 2012, J MOL CELL CARDIOL, V52, P206, DOI 10.1016/j.yjmcc.2011.09.022; Naik SM, 1999, J INVEST DERMATOL, V113, P766, DOI 10.1046/j.1523-1747.1999.00750.x; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Novick D, 2010, J AUTOIMMUN, V34, P121, DOI 10.1016/j.jaut.2009.08.002; Ohta Y, 2001, ARCH DERMATOL RES, V293, P334, DOI 10.1007/s004030100240; Park HJ, 2004, IMMUNOL LETT, V95, P57, DOI 10.1016/j.imlet.2004.06.011; Paulukat J, 2001, J IMMUNOL, V167, P7038, DOI 10.4049/jimmunol.167.12.7038; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Reading PC, 2003, J VIROL, V77, P9960, DOI 10.1128/JVI.77.18.9960-9968.2003; Sadik CD, 2009, NUCLEIC ACIDS RES, V37, P5041, DOI 10.1093/nar/gkp525; Shibata S, 2010, J INVEST DERMATOL, V130, P1034, DOI 10.1038/jid.2009.349; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sugiyama N, 2008, ANN RHEUM DIS, V67, P1461, DOI 10.1136/ard.2007.077537; Tak PP, 2006, EUR J DRUG METAB PH, V31, P109; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Wang D, 2008, ARTHRITIS RHEUM, V58, P3205, DOI 10.1002/art.23868; Wittmann M, 2005, J INVEST DERMATOL, V124, P1225, DOI 10.1111/j.0022-202X.2005.23715.x; Wittmann M, 2009, AUTOIMMUN REV, V9, P45, DOI 10.1016/j.autrev.2009.03.003; Wittmann M, 2009, J ALLERGY CLIN IMMUN, V124, P81, DOI 10.1016/j.jaci.2009.04.026; Xiang Y, 2003, J VIROL, V77, P2623, DOI 10.1128/JVI.77.4.2623-2630.2003; Xiang Y, 1999, P NATL ACAD SCI USA, V96, P11537, DOI 10.1073/pnas.96.20.11537; Xing SS, 2010, MOL MED, V16, P465, DOI 10.2119/molmed.2010.00028; Yamagata S, 2008, CLIN EXP IMMUNOL, V154, P295, DOI 10.1111/j.1365-2249.2008.03772.x; Yoshimura T, 2006, J IMMUNOL, V177, P5377, DOI 10.4049/jimmunol.177.8.5377; Yu QL, 2009, AM J PHYSIOL-HEART C, V297, pH76, DOI 10.1152/ajpheart.01285.2008; Zeitvogel J, IL 27 ACTS PRI UNPUB; Ziesche E, 2007, J BIOL CHEM, V282, P16006, DOI 10.1074/jbc.M611040200	66	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e38751	10.1371/journal.pone.0038751	http://dx.doi.org/10.1371/journal.pone.0038751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761702	Green Published, gold			2022-12-27	WOS:000305825800014
J	Saunders, I; Vijayakumar, S				Saunders, Ian; Vijayakumar, Sethu			Continuous Evolution of Statistical Estimators for Optimal Decision-Making	PLOS ONE			English	Article							OPTIMAL INTEGRATION; CUE COMBINATION; INFORMATION; TEXTURE; VISION; UNCERTAINTY; DISCRIMINATION; CONFIDENCE; DETERMINES; PERCEPTION	In many everyday situations, humans must make precise decisions in the presence of uncertain sensory information. For example, when asked to combine information from multiple sources we often assign greater weight to the more reliable information. It has been proposed that statistical-optimality often observed in human perception and decision-making requires that humans have access to the uncertainty of both their senses and their decisions. However, the mechanisms underlying the processes of uncertainty estimation remain largely unexplored. In this paper we introduce a novel visual tracking experiment that requires subjects to continuously report their evolving perception of the mean and uncertainty of noisy visual cues over time. We show that subjects accumulate sensory information over the course of a trial to form a continuous estimate of the mean, hindered only by natural kinematic constraints (sensorimotor latency etc.). Furthermore, subjects have access to a measure of their continuous objective uncertainty, rapidly acquired from sensory information available within a trial, but limited by natural kinematic constraints and a conservative margin for error. Our results provide the first direct evidence of the continuous mean and uncertainty estimation mechanisms in humans that may underlie optimal decision making.	[Saunders, Ian; Vijayakumar, Sethu] Univ Edinburgh, Inst Percept Act & Behav, Sch Informat, Edinburgh, Midlothian, Scotland	University of Edinburgh	Saunders, I (corresponding author), Univ Edinburgh, Inst Percept Act & Behav, Sch Informat, Edinburgh, Midlothian, Scotland.	i.saunders@sms.ed.ac.uk			Engineering and Physical Sciences Research Council/Medical Research Council from the Neuroinformatics and Computational Neuroscience Doctoral Training Centre at the University of Edinburgh; Microsoft Research Royal Academy of Engineering	Engineering and Physical Sciences Research Council/Medical Research Council from the Neuroinformatics and Computational Neuroscience Doctoral Training Centre at the University of Edinburgh(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Microsoft Research Royal Academy of Engineering(Microsoft)	This work was supported by an Engineering and Physical Sciences Research Council/Medical Research Council scholarship from the Neuroinformatics and Computational Neuroscience Doctoral Training Centre at the University of Edinburgh. Prof. S. Vijayakumar is supported through a Microsoft Research Royal Academy of Engineering senior research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Barthelme S, 2010, P NATL ACAD SCI USA, V107, P20834, DOI 10.1073/pnas.1007704107; Barthelme S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000504; BJORKMAN M, 1993, PERCEPT PSYCHOPHYS, V54, P75, DOI 10.3758/BF03206939; Brenner E, 2011, HUM MOVEMENT SCI, V30, P475, DOI 10.1016/j.humov.2010.12.007; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Coleman T.F., 1994, MATH PROGRAM, V67, P189, DOI DOI 10.1007/BF01582221; Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Faisal AA, 2009, J NEUROPHYSIOL, V101, P1901, DOI 10.1152/jn.90974.2008; Gepshtein S, 2003, CURR BIOL, V13, P483, DOI 10.1016/S0960-9822(03)00133-7; Gepshtein S, 2005, J VISION, V5, P1013, DOI 10.1167/5.11.7; Graf EW, 2005, VISION RES, V45, P3050, DOI 10.1016/j.visres.2005.08.007; Helbig HB, 2007, EXP BRAIN RES, V179, P595, DOI 10.1007/s00221-006-0814-y; Helbig HB, 2008, J VISION, V8, DOI 10.1167/8.1.21; Heron J, 2004, VISION RES, V44, P2875, DOI 10.1016/j.visres.2004.07.001; Hillis JM, 2004, J VISION, V4, P967, DOI 10.1167/4.12.1; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Jacobs RA, 2002, TRENDS COGN SCI, V6, P345, DOI 10.1016/S1364-6613(02)01948-4; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Lawson C, 1974, SOLVING LEAST SQUARE, P161; Nassar MR, 2010, J NEUROSCI, V30, P12366, DOI 10.1523/JNEUROSCI.0822-10.2010; Oruc I, 2003, VISION RES, V43, P2451, DOI 10.1016/S0042-6989(03)00435-8; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; Rosas P, 2005, J OPT SOC AM A, V22, P801, DOI 10.1364/JOSAA.22.000801; Saunders I, 2012, THESIS U EDINBURGH; Schot WD, 2011, EXP BRAIN RES, V212, P487, DOI 10.1007/s00221-011-2756-2; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; Trommershauser J, 2003, J OPT SOC AM A, V20, P1419, DOI 10.1364/JOSAA.20.001419; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Wallace MT, 2004, EXP BRAIN RES, V158, P252, DOI 10.1007/s00221-004-1899-9	36	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e37547	10.1371/journal.pone.0037547	http://dx.doi.org/10.1371/journal.pone.0037547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761657	Green Published, gold, Green Submitted			2022-12-27	WOS:000305781700003
J	Simiakakis, M; Kapsimalis, F; Chaligiannis, E; Loukides, S; Sitaras, N; Alchanatis, M				Simiakakis, M.; Kapsimalis, F.; Chaligiannis, E.; Loukides, S.; Sitaras, N.; Alchanatis, M.			Lack of Effect of Sleep Apnea on Oxidative Stress in Obstructive Sleep Apnea Syndrome (OSAS) Patients	PLOS ONE			English	Article							LIPID-PEROXIDATION; CARDIOVASCULAR-DISEASE; IMPACT; MECHANISMS; OBESITY; BLOOD	Purpose: The aim of this study was to evaluate markers of systemic oxidative stress and antioxidant capacity in subjects with and without OSAS in order to investigate the most important factors that determine the oxidant-antioxidant status. Methods: A total of 66 subjects referred to our Sleep laboratory were examined by full polysomnography. Oxidative stress and antioxidant activity were assessed by measurement of the derivatives of reactive oxygen metabolites (d-ROMs) and the biological antioxidant capacity (BAP) in blood samples taken in the morning after the sleep study. Known risk factors for oxidative stress, such as age, sex, obesity, smoking, hypelipidemia, and hypertension, were investigated as possible confounding factors. Results: 42 patients with OSAS (Apnea-Hypopnea index >15 events/hour) were compared with 24 controls (AHI < 5). The levels of d-ROMS were significantly higher (p = 0.005) in the control group but the levels of antioxidant capacity were significantly lower (p = 0.004) in OSAS patients. The most important factors predicting the variance of oxidative stress were obesity, smoking habit, and sex. Parameters of sleep apnea severity were not associated with oxidative stress. Minimal oxygen desaturation and smoking habit were the most important predicting factors of BAP levels. Conclusion: Obesity, smoking, and sex are the most important determinants of oxidative stress in OSAS subjects. Sleep apnea might enhance oxidative stress by the reduction of antioxidant capacity of blood due to nocturnal hypoxia.	[Simiakakis, M.; Kapsimalis, F.; Alchanatis, M.] Univ Athens, Sch Med, Dept Resp Med 1, Sotiria Hosp Chest Dis, GR-11527 Athens, Greece; [Chaligiannis, E.; Sitaras, N.] Univ Athens, Sch Med, Dept Pharmacol, GR-11527 Athens, Greece; [Loukides, S.] Univ Athens, Sch Med, Dept Resp Med 2, GR-11527 Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens	Simiakakis, M (corresponding author), Univ Athens, Sch Med, Dept Resp Med 1, Sotiria Hosp Chest Dis, GR-11527 Athens, Greece.	fogeka@otenet.gr						Alzoghaibi Mohammed A, 2005, Sleep Breath, V9, P119, DOI 10.1007/s11325-005-0022-1; Barcelo A, 2006, EUR RESPIR J, V27, P756, DOI 10.1183/09031936.06.00067605; Barcelo A, 2000, EUR RESPIR J, V16, P644, DOI 10.1034/j.1399-3003.2000.16d13.x; Cesarone MR, 1999, INT ANGIOL, V18, P127; Christou Kostas, 2003, Sleep Breath, V7, P105, DOI 10.1007/s11325-003-0105-9; DEAN RT, 1993, SLEEP, V16, pS15, DOI 10.1093/sleep/16.suppl_8.S15; Dyugovskaya L, 2002, AM J RESP CRIT CARE, V165, P934, DOI 10.1164/ajrccm.165.7.2104126; Faure P, 2008, EUR RESPIR J, V31, P1046, DOI 10.1183/09031936.00062707; Iber C., 2007, AASM MANUAL SCORING; Kanaoka Y, 2010, ACTA MED OKAYAMA, V64, P323; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; Lavie L, 2004, SLEEP, V27, P123; Lavie L, 2009, EUR RESPIR J, V33, P1467, DOI 10.1183/09031936.00086608; Lavie L, 2003, SLEEP MED REV, V7, P35, DOI 10.1053/smrv.2002.0261; Mehra R, 2008, J ALLERGY CLIN IMMUN, V121, P1096, DOI 10.1016/j.jaci.2008.04.002; Mugge A, 1998, Z KARDIOL, V87, P851, DOI 10.1007/s003920050241; Ozturk L, 2003, CLIN CHIM ACTA, V332, P83, DOI 10.1016/S0009-8981(03)00126-8; Schulz R, 2000, AM J RESP CRIT CARE, V162, P566, DOI 10.1164/ajrccm.162.2.9908091; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Svatikova A, 2005, EUR HEART J, V26, P2435, DOI 10.1093/eurheartj/ehi440; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Vassalle C, 2011, CLIN CHEM LAB MED, V49, P1509, DOI 10.1515/CCLM.2011.622; Vincent HK, 2006, INT J OBESITY, V30, P400, DOI 10.1038/sj.ijo.0803177; Wali SO, 1998, SLEEP, V21, P290; Wysocka E, 2008, J PHYSIOL PHARMACOL, V59, P761; Yamauchi M, 2005, CHEST, V127, P1674, DOI 10.1378/chest.127.5.1674	27	37	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39172	10.1371/journal.pone.0039172	http://dx.doi.org/10.1371/journal.pone.0039172			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761732	gold, Green Submitted, Green Published			2022-12-27	WOS:000305781700019
J	Palmqvist, S; Hertze, J; Minthon, L; Wattmo, C; Zetterberg, H; Blennow, K; Londos, E; Hansson, O				Palmqvist, Sebastian; Hertze, Joakim; Minthon, Lennart; Wattmo, Carina; Zetterberg, Henrik; Blennow, Kaj; Londos, Elisabet; Hansson, Oskar			Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer's Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study	PLOS ONE			English	Article							MINI-MENTAL-STATE; VASCULAR DEMENTIA; CEREBROSPINAL-FLUID; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; PHOSPHORYLATED TAU; NATIONAL INSTITUTE; PREVALENCE; RECOMMENDATIONS; COMMUNITY	Introduction: Early identification of Alzheimer's disease (AD) is needed both for clinical trials and in clinical practice. In this study, we compared brief cognitive tests and cerebrospinal fluid (CSF) biomarkers in predicting conversion from mild cognitive impairment (MCI) to AD. Methods: At a memory clinic, 133 patients with MCI were followed until development of dementia or until they had been stable over a mean period of 5.9 years (range 3.2-8.8 years). The Mini-Mental State Examination (MMSE), the clock drawing test, total tau, tau phosphorylated at Thr(181) (P-tau) and amyloid-beta(1-42) (A beta(42)) were assessed at baseline. Results: During clinical follow-up, 47% remained cognitively stable and 53% developed dementia, with an incidence of 13.8%/year. In the group that developed dementia the prevalence of AD was 73.2%, vascular dementia 14.1%, dementia with Lewy bodies (DLB) 5.6%, progressive supranuclear palsy (PSP) 4.2%, semantic dementia 1.4% and dementia due to brain tumour 1.4%. When predicting subsequent development of AD among patients with MCI, the cognitive tests classified 81% of the cases correctly (AUC, 0.85; 95% CI, 0.77-0.90) and CSF biomarkers 83% (AUC, 0.89; 95% CI, 0.82-0.94). The combination of cognitive tests and CSF (AUC, 0.93; 95% CI 0.87 to 0.96) was significantly better than the cognitive tests (p = 0.01) and the CSF biomarkers (p = 0.04) alone when predicting AD. Conclusions: The MMSE and the clock drawing test were as accurate as CSF biomarkers in predicting future development of AD in patients with MCI. Combining both instruments provided significantly greater accuracy than cognitive tests or CSF biomarkers alone in predicting AD.	[Palmqvist, Sebastian; Hertze, Joakim; Minthon, Lennart; Wattmo, Carina; Londos, Elisabet; Hansson, Oskar] Lund Univ, Clin Memory Res Unit, Dept Clin Sci, Malmo, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Sahlgrenska Acad, Molndal, Sweden	Lund University; University of Gothenburg	Palmqvist, S (corresponding author), Lund Univ, Clin Memory Res Unit, Dept Clin Sci, Malmo, Sweden.	sebastian.palmqvist@med.lu.se	Hansson, Oskar/A-7134-2013; Palmqvist, Sebastian/AAU-1148-2021; Palmqvist, Sebastian/AFQ-9019-2022	Hansson, Oskar/0000-0001-8467-7286; Palmqvist, Sebastian/0000-0002-9267-1930	Swedish Research Council [14002, 523-2010-520, 2006-6227]; Swedish Brain Power; Alzheimer's Association [NIRG-08-90356]; Regional Agreement on Medical Training and Clinical Research (ALF); Royal Swedish Academy of Sciences and the Torsten and Ragnar Soderberg Foundation; Stiftelsen for Gamla Tjanarinnor; Swedish Society of Medicine; Skane County Council's Research and Development Foundation; Trolle-Wachtmeister Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Power; Alzheimer's Association(Alzheimer's Association); Regional Agreement on Medical Training and Clinical Research (ALF); Royal Swedish Academy of Sciences and the Torsten and Ragnar Soderberg Foundation; Stiftelsen for Gamla Tjanarinnor; Swedish Society of Medicine; Skane County Council's Research and Development Foundation; Trolle-Wachtmeister Foundation	This study was supported by the Swedish Research Council (grant numbers: 14002, 523-2010-520 and 2006-6227); Swedish Brain Power; the Alzheimer's Association (grant number NIRG-08-90356); the Regional Agreement on Medical Training and Clinical Research (ALF) between Skane County Council and Lund University; the Royal Swedish Academy of Sciences and the Torsten and Ragnar Soderberg Foundation; Stiftelsen for Gamla Tjanarinnor; The Swedish Society of Medicine; Skane County Council's Research and Development Foundation and the Trolle-Wachtmeister Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bennett DA, 2005, NEUROLOGY, V64, P834, DOI 10.1212/01.WNL.0000152982.47274.9E; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Buchhave P, 2008, DEMENT GERIATR COGN, V25, P544, DOI 10.1159/000137379; Buchhave P, 2012, ARCH GEN PSYCHIAT, V69, P98, DOI 10.1001/archgenpsychiatry.2011.155; Carter MD, 2010, CLIN PHARMACOL THER, V88, P475, DOI 10.1038/clpt.2010.165; Chen P, 2000, NEUROLOGY, V55, P1847, DOI 10.1212/WNL.55.12.1847; Chen PJ, 2001, ARCH GEN PSYCHIAT, V58, P853, DOI 10.1001/archpsyc.58.9.853; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ehreke L, 2010, INT PSYCHOGERIATR, V22, P56, DOI 10.1017/S1041610209990676; Erkinjuntti T, 2000, J NEURAL TRANSM-SUPP, P23; Ewers M, 2010, NEUROBIOL AGING; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gnanalingham KK, 1996, LANCET, V347, P696, DOI 10.1016/S0140-6736(96)91254-4; Griffith HR, 2006, J INT NEUROPSYCH SOC, V12, P166, DOI 10.1017/S1355617706060267; Hampel H, 2008, ALZHEIMERS DEMENT, V4, P38, DOI 10.1016/j.jalz.2007.08.006; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hertze J, 2010, J ALZHEIMERS DIS; Hodges JR, 2007, LANCET NEUROL, V6, P1004, DOI 10.1016/S1474-4422(07)70266-1; Ismail Z, 2010, INT J GERIATR PSYCH, V25, P111, DOI 10.1002/gps.2306; Jefferson AL, 2002, J NEUROPSYCH CLIN N, V14, P311, DOI 10.1176/appi.neuropsych.14.3.311; Jicha GA, 2006, ARCH NEUROL-CHICAGO, V63, P674, DOI 10.1001/archneur.63.5.674; Jungwirth S, 2009, J NEURAL TRANSM, V116, P1513, DOI 10.1007/s00702-009-0318-6; Leifer BP, 2003, J AM GERIATR SOC, V51, pS281, DOI 10.1046/j.1532-5415.5153.x; LIBON DJ, 1993, ARCH CLIN NEUROPSYCH, V8, P405, DOI 10.1016/0887-6177(93)90004-K; Libon DJ, 1996, ARCH CLIN NEUROPSYCH, V11, P193; Llano DA, 2011, ALZ DIS ASSOC DIS, V25, P73, DOI 10.1097/WAD.0b013e3181f5b8d8; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT; Mitchell AJ, 2009, J NEUROL NEUROSUR PS, V80, P966, DOI 10.1136/jnnp.2008.167791; Modrego Pedro J., 2006, Current Alzheimer Research, V3, P161, DOI 10.2174/156720506776383103; Nath U, 2001, BRAIN, V124, P1438, DOI 10.1093/brain/124.7.1438; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; OTT A, 1995, BRIT MED J, V310, P970, DOI 10.1136/bmj.310.6985.970; Palmqvist S, 2009, INT J GERIATR PSYCH, V24, P1405, DOI 10.1002/gps.2277; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2007, SEMIN NEUROL, V27, P22, DOI 10.1055/s-2006-956752; Petersen RC, 2011, NEW ENGL J MED, V364, P2227, DOI 10.1056/NEJMcp0910237; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; SHULMAN KI, 1993, INT J GERIATR PSYCH, V8, P487, DOI 10.1002/gps.930080606; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Small BJ, 1997, J GERONTOL A-BIOL, V52, pM299, DOI 10.1093/gerona/52A.5.M299; Small BJ, 2000, ARCH NEUROL-CHICAGO, V57, P839, DOI 10.1001/archneur.57.6.839; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Tierney MC, 2003, J AM GERIATR SOC, V51, P813, DOI 10.1046/j.1365-2389.2003.51262.x; Zaccai J, 2005, AGE AGEING, V34, P561, DOI 10.1093/ageing/afi190; Zanetti M, 2006, J AM GERIATR SOC, V54, P580, DOI 10.1111/j.1532-5415.2006.00658.x	53	61	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38639	10.1371/journal.pone.0038639	http://dx.doi.org/10.1371/journal.pone.0038639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761691	Green Submitted, Green Published, gold			2022-12-27	WOS:000305730900015
J	Kim, BM; Thier, MC; Oh, S; Sherwood, R; Kanellopoulou, C; Edenhofer, F; Choi, MY				Kim, Byeong-Moo; Thier, Marc-Christian; Oh, Sangnam; Sherwood, Richard; Kanellopoulou, Chryssa; Edenhofer, Frank; Choi, Michael Y.			MicroRNAs Are Indispensable for Reprogramming Mouse Embryonic Fibroblasts into Induced Stem Cell-Like Cells	PLOS ONE			English	Article							MICROPROCESSOR COMPLEX; RNA INTERFERENCE; NUCLEAR EXPORT; ENZYME DICER; BIOGENESIS; PLURIPOTENCY; EXPRESSION; GENERATION; DIFFERENTIATION; MIR-302	MicroRNAs play a pivotal role in cellular maintenance, proliferation, and differentiation. They have also been implicated to play a key role in disease pathogenesis, and more recently, cellular reprogramming. Certain microRNA clusters can enhance or even directly induce reprogramming, while repressing key proteins involved in microRNA processing decreases reprogramming efficiency. Although microRNAs clearly play important roles in cellular reprogramming, it remains unknown whether microRNAs are absolutely necessary. We endeavored to answer this fundamental question by attempting to reprogram Dicer-null mouse embryonic fibroblasts (MEFs) that lack almost all functional microRNAs using a defined set of transcription factors. Transduction of reprogramming factors using either lentiviral or piggyBac transposon vector into two, independently derived lines of Dicer-null MEFs failed to produce cells resembling embryonic stem cells (ESCs). However, expression of human Dicer in the Dicer-null MEFs restored their reprogramming potential. Our study demonstrates for the first time that microRNAs are indispensable for dedifferentiation reprogramming.	[Kim, Byeong-Moo; Oh, Sangnam; Choi, Michael Y.] Massachusetts Gen Hosp, Dept Med, GI Unit, Boston, MA 02114 USA; [Kim, Byeong-Moo; Oh, Sangnam; Sherwood, Richard; Choi, Michael Y.] Harvard Univ, Sch Med, Boston, MA USA; [Thier, Marc-Christian; Edenhofer, Frank] Univ Bonn, Life & Brain Ctr, Inst Reconstruct Neurobiol, Bonn, Germany; [Sherwood, Richard] Brigham & Womens Hosp, Boston, MA 02115 USA; [Kanellopoulou, Chryssa] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Bonn; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kim, BM (corresponding author), Massachusetts Gen Hosp, Dept Med, GI Unit, Boston, MA 02114 USA.	mchoi@partners.org	Edenhofer, Frank/ABG-9458-2020	Edenhofer, Frank/0000-0002-6489-714X	NIH [K08 DK078641]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, K08DK078641] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research was supported by NIH grants to M.Y.C. (K08 DK078641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Babiarz JE, 2011, RNA, V17, P1489, DOI 10.1261/rna.2442211; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Havens MA, 2012, NUCL ACIDS RES; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Sherwood RI, 2011, MECH DEVELOP, V128, P387, DOI 10.1016/j.mod.2011.07.005; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]	39	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39239	10.1371/journal.pone.0039239	http://dx.doi.org/10.1371/journal.pone.0039239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737231	Green Submitted, Green Published, gold			2022-12-27	WOS:000305695100029
J	Nishida, N; Sawai, H; Matsuura, K; Sugiyama, M; Ahn, SH; Park, JY; Hige, S; Kang, JH; Suzuki, K; Kurosaki, M; Asahina, Y; Mochida, S; Watanabe, M; Tanaka, E; Honda, M; Kaneko, S; Orito, E; Itoh, Y; Mita, E; Tamori, A; Murawaki, Y; Hiasa, Y; Sakaida, I; Korenaga, M; Hino, K; Ide, T; Kawashima, M; Mawatari, Y; Sageshima, M; Ogasawara, Y; Koike, A; Izumi, N; Han, KH; Tanaka, Y; Tokunaga, K; Mizokami, M				Nishida, Nao; Sawai, Hiromi; Matsuura, Kentaro; Sugiyama, Masaya; Ahn, Sang Hoon; Park, Jun Yong; Hige, Shuhei; Kang, Jong-Hon; Suzuki, Kazuyuki; Kurosaki, Masayuki; Asahina, Yasuhiro; Mochida, Satoshi; Watanabe, Masaaki; Tanaka, Eiji; Honda, Masao; Kaneko, Shuichi; Orito, Etsuro; Itoh, Yoshito; Mita, Eiji; Tamori, Akihiro; Murawaki, Yoshikazu; Hiasa, Yoichi; Sakaida, Isao; Korenaga, Masaaki; Hino, Keisuke; Ide, Tatsuya; Kawashima, Minae; Mawatari, Yoriko; Sageshima, Megumi; Ogasawara, Yuko; Koike, Asako; Izumi, Namiki; Han, Kwang-Hyub; Tanaka, Yasuhito; Tokunaga, Katsushi; Mizokami, Masashi			Genome-Wide Association Study Confirming Association of HLA-DP with Protection against Chronic Hepatitis B and Viral Clearance in Japanese and Korean	PLOS ONE			English	Article							VIRUS CLEARANCE; MANAGEMENT; LOCUS	Hepatitis B virus (HBV) infection can lead to serious liver diseases, including liver cirrhosis (LC) and hepatocellular carcinoma (HCC); however, about 85-90% of infected individuals become inactive carriers with sustained biochemical remission and very low risk of LC or HCC. To identify host genetic factors contributing to HBV clearance, we conducted genome-wide association studies (GWAS) and replication analysis using samples from HBV carriers and spontaneously HBV-resolved Japanese and Korean individuals. Association analysis in the Japanese and Korean data identified the HLA-DPA1 and HLA-DPB1 genes with P-meta = 1.89 x 10(-12) for rs3077 and P-meta = 9.69 x 10(-10) for rs9277542. We also found that the HLA-DPA1 and HLA-DPB1 genes were significantly associated with protective effects against chronic hepatitis B (CHB) in Japanese, Korean and other Asian populations, including Chinese and Thai individuals (P-meta = 4.40 x 10(-19) for rs3077 and P-meta = 1.28 x 10(-15) for rs9277542). These results suggest that the associations between the HLA-DP locus and the protective effects against persistent HBV infection and with clearance of HBV were replicated widely in East Asian populations; however, there are no reports of GWAS in Caucasian or African populations. Based on the GWAS in this study, there were no significant SNPs associated with HCC development. To clarify the pathogenesis of CHB and the mechanisms of HBV clearance, further studies are necessary, including functional analyses of the HLA-DP molecule.	[Nishida, Nao; Sugiyama, Masaya; Mawatari, Yoriko; Mizokami, Masashi] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Chiba, Japan; [Nishida, Nao; Sawai, Hiromi; Kawashima, Minae; Mawatari, Yoriko; Sageshima, Megumi; Ogasawara, Yuko; Tokunaga, Katsushi] Univ Tokyo, Dept Human Genet, Bunkyo Ku, Tokyo, Japan; [Matsuura, Kentaro; Tanaka, Yasuhito] Nagoya City Univ, Dept Virol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Matsuura, Kentaro; Tanaka, Yasuhito] Nagoya City Univ, Liver Unit, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Ahn, Sang Hoon; Park, Jun Yong; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Hige, Shuhei] Hokkaido Univ, Dept Internal Med, Grad Sch Med, Sapporo, Hokkaido, Japan; [Kang, Jong-Hon] Teine Keijinkai Hosp, Dept Internal Med, Sapporo, Hokkaido, Japan; [Suzuki, Kazuyuki] Iwate Med Univ, Dept Gastroenterol & Hepatol, Morioka, Iwate 020, Japan; [Kurosaki, Masayuki; Asahina, Yasuhiro; Izumi, Namiki] Musashino Red Cross Hosp, Div Gastroenterol & Hepatol, Tokyo, Japan; [Mochida, Satoshi] Saitama Med Univ, Div Gastroenterol & Hepatol, Saitama, Japan; [Watanabe, Masaaki] Kitasato Univ, Sch Med, Dept Gastroenterol, Sagamihara, Kanagawa 228, Japan; [Tanaka, Eiji] Shinshu Univ, Sch Med, Dept Med, Matsumoto, Nagano 390, Japan; [Honda, Masao; Kaneko, Shuichi] Kanazawa Univ, Dept Gastroenterol, Grad Sch Med, Kanazawa, Ishikawa, Japan; [Orito, Etsuro] Nagoya Daini Red Cross Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan; [Itoh, Yoshito] Kyoto Prefectural Univ Med, Kyoto, Japan; [Mita, Eiji] Osaka Natl Hosp, Natl Hosp Org, Dept Gastroenterol & Hepatol, Osaka, Japan; [Tamori, Akihiro] Osaka City Univ, Dept Hepatol, Grad Sch Med, Osaka 558, Japan; [Murawaki, Yoshikazu] Tottori Univ, Fac Med, Dept Internal Med 2, Yonago, Tottori 683, Japan; [Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Matsuyama, Ehime 790, Japan; [Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Yamaguchi, Japan; [Korenaga, Masaaki; Hino, Keisuke] Kawasaki Med Coll, Div Hepatol & Pancreatol, Kurashiki, Okayama, Japan; [Ide, Tatsuya] Kurume Univ, Sch Med, Dept Med, Div Gastroenterol, Fukuoka, Japan; [Koike, Asako] Hitachi Ltd, Cent Res Lab, Kokubunji, Tokyo 185, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; Nagoya City University; Nagoya City University; Yonsei University; Yonsei University Health System; Hokkaido University; Teine Keijinkai Hospital; Iwate Medical University; Saitama Medical University; Kitasato University; Shinshu University; Kanazawa University; Japanese Red Cross Nagoya Daini Hospital; Kyoto Prefectural University of Medicine; Osaka National Hospital; Osaka Metropolitan University; Tottori University; Ehime University; Yamaguchi University; Kawasaki Medical School; Kurume University; Hitachi Limited	Nishida, N (corresponding author), Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Chiba, Japan.	nishida-75@umin.ac.jp	Hiasa, Yoichi/ABD-2759-2021; Park, Jun Yong/H-7127-2019; Korenaga, Masaaki/AAE-7479-2020	Hiasa, Yoichi/0000-0003-4117-339X; Han, Kwang-Hyub/0000-0003-3960-6539; Park, Jun Yong/0000-0001-6324-2224; Tanaka, Yasuhito/0000-0002-2473-6966; Ahn, Sang Hoon/0000-0002-3629-4624	Ministry of Health, Labour, and Welfare of Japan [H22-kanen-005, H23-kanen-005]; Japan Science and Technology Agency [09038024]; Miyakawa Memorial Research Foundation; Ministry of Education, Culture, Sports, Science, and Technology [22710191]; Grants-in-Aid for Scientific Research [22133008, 23590985, 24790728, 24590960] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Miyakawa Memorial Research Foundation; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from the Ministry of Health, Labour, and Welfare of Japan (H22-kanen-005, H23-kanen-005), the Japan Science and Technology Agency (09038024), and the Miyakawa Memorial Research Foundation. Partial support by Grant-in-Aid for Young Scientists (B) (22710191) from the Ministry of Education, Culture, Sports, Science, and Technology is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2011, J INFECT DIS, V203, P943, DOI 10.1093/infdis/jiq154; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; Godkin A, 2005, HEPATOLOGY, V41, P1383, DOI 10.1002/hep.20716; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Hu L, 2011, HEPATOLOGY IN PRESS; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kobayashi M, 2008, J MED VIROL, V80, P1880, DOI 10.1002/jmv.21309; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024221; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Miyagawa T, 2008, J HUM GENET, V53, P886, DOI 10.1007/s10038-008-0322-y; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029967; Nishida N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-431; STEVENS CE, 1992, PEDIATRICS, V90, P170; SZMUNESS W, 1979, J MED VIROL, V4, P327, DOI 10.1002/jmv.1890040411; Tada Hiroshi, 1992, Acta Paediatrica Japonica, V34, P656; THURSZ MR, 1995, NEW ENGL J MED, V332, P1065, DOI 10.1056/NEJM199504203321604; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608; Yano K, 2010, INTERVIROLOGY, V53, P70, DOI 10.1159/000252788; Yokosuka O, 2011, HEPATOL RES, V41, P1, DOI 10.1111/j.1872-034X.2010.00739.x	22	114	122	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39175	10.1371/journal.pone.0039175	http://dx.doi.org/10.1371/journal.pone.0039175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737229	Green Published, Green Submitted, gold			2022-12-27	WOS:000305695100027
J	Edmondson, D; Richardson, S; Falzon, L; Davidson, KW; Mills, MA; Neria, Y				Edmondson, Donald; Richardson, Safiya; Falzon, Louise; Davidson, Karina W.; Mills, Mary Alice; Neria, Yuval			Posttraumatic Stress Disorder Prevalence and Risk of Recurrence in Acute Coronary Syndrome Patients: A Meta-analytic Review	PLOS ONE			English	Review							MYOCARDIAL-INFARCTION; HEART-DISEASE; SYMPTOMS; DEPRESSION; MORTALITY; PTSD; PREDICTORS; SURVIVORS; NONADHERENCE; PERSONALITY	Background: Acute coronary syndromes (ACS; myocardial infarction or unstable angina) can induce posttraumatic stress disorder (PTSD), and ACS-induced PTSD may increase patients' risk for subsequent cardiac events and mortality. Objective: To determine the prevalence of PTSD induced by ACS and to quantify the association between ACS-induced PTSD and adverse clinical outcomes using systematic review and meta-analysis. Data Sources: Articles were identified by searching Ovid MEDLINE, PsycINFO, and Scopus, and through manual search of reference lists. Methodology/Principal Findings: Observational cohort studies that assessed PTSD with specific reference to an ACS event at least 1 month prior. We extracted estimates of the prevalence of ACS-induced PTSD and associations with clinical outcomes, as well as study characteristics. We identified 56 potentially relevant articles, 24 of which met our criteria (N = 2383). Meta-analysis yielded an aggregated prevalence estimate of 12% (95% confidence interval [CI], 9%-16%) for clinically significant symptoms of ACS-induced PTSD in a random effects model. Individual study prevalence estimates varied widely (0%-32%), with significant heterogeneity in estimates explained by the use of a screening instrument (prevalence estimate was 16% [95% CI, 13%-20%] in 16 studies) vs a clinical diagnostic interview (prevalence estimate was 4% [95% CI, 3%-5%] in 8 studies). The aggregated point estimate for the magnitude of the relationship between ACS-induced PTSD and clinical outcomes (ie, mortality and/or ACS recurrence) across the 3 studies that met our criteria (N = 609) suggested a doubling of risk (risk ratio, 2.00; 95% CI, 1.69-2.37) in ACS patients with clinically significant PTSD symptoms relative to patients without PTSD symptoms. Conclusions/Significance: This meta-analysis suggests that clinically significant PTSD symptoms induced by ACS are moderately prevalent and are associated with increased risk for recurrent cardiac events and mortality. Further tests of the association of ACS-induced PTSD and clinical outcomes are needed.	[Edmondson, Donald; Falzon, Louise; Davidson, Karina W.] Columbia Univ, Med Ctr, Ctr Behav Cardiovasc Hlth, New York, NY 10027 USA; [Richardson, Safiya] Columbia Univ, Coll Phys & Surg, Med Ctr, New York, NY USA; [Mills, Mary Alice] Vet Affairs Boston Healthcare Syst, Boston, MA USA; [Neria, Yuval] Columbia Univ, Med Ctr, New York State Psychiat Inst, New York, NY USA; [Neria, Yuval] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Neria, Yuval] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Columbia University; Columbia University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University	Edmondson, D (corresponding author), Columbia Univ, Med Ctr, Ctr Behav Cardiovasc Hlth, New York, NY 10027 USA.	dee2109@columbia.edu	Edmondson, Donald/G-7486-2016; Falzon, Louise/HCI-2175-2022; Davidson, Karina/AAG-2388-2019; Falzon, Louise/AAG-2404-2019; Davidson, Karina/GWC-0996-2022	Davidson, Karina/0000-0002-9162-477X; Falzon, Louise/0000-0002-9449-6056; Davidson, Karina/0000-0002-9162-477X; Edmondson, Donald/0000-0002-4518-8196	National Institutes of Health, Bethesda, MD [HL-088117, CA-156709]; NIH [KM1CA156709]; Columbia University's CTSA from NCRR/NIH [UL1RR024156]; NATIONAL CANCER INSTITUTE [KM1CA156709] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088117] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University's CTSA from NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants HL-088117 and CA-156709 from the National Institutes of Health, Bethesda, MD. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the National Center for Research Resources or the National Institutes of Health. Dr Edmondson is supported by NIH grant KM1CA156709. Supported in part by Columbia University's CTSA grant No. UL1RR024156 from NCRR/NIH. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 1985, POST TRAUMATIC STRES; Awaida JPS, 2006, CAN J CARDIOL, V22, P121, DOI 10.1016/S0828-282X(06)70250-1; Ayers S, 2009, BRIT J HEALTH PSYCH, V14, P459, DOI 10.1348/135910708X349343; Bennett P, 2002, PSYCHOL HEALTH, V17, P489, DOI 10.1080/0887044022000004966; Bennett P, 2001, HEART LUNG, V30, P458, DOI 10.1067/mhl.2001.118296; Bennett P, 1999, BRIT J CLIN PSYCHOL, V38, P411, DOI 10.1348/014466599163015; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Boscarino JA, 2008, PSYCHOSOM MED, V70, P668, DOI 10.1097/PSY.0b013e31817bccaf; Chung MC, 2007, PSYCHIAT RES, V152, P243, DOI 10.1016/j.psychres.2007.02.008; Damen NL, 2013, EUR J PREV CARDIOL, V20, P127, DOI 10.1177/2047487312436452; Davidson JRT, 1997, PSYCHOL MED, V27, P153, DOI 10.1017/S0033291796004229; DAVIDSON JRT, 1990, J TRAUMA STRESS, V3, P459; Doerfler L.A., 1997, INT J REHAB HLTH, V3, P89, DOI DOI 10.1007/BF02806722; DOERFLER LA, 1994, GEN HOSP PSYCHIAT, V16, P193, DOI 10.1016/0163-8343(94)90101-5; Doerfler Leonard A, 2005, J Cardiopulm Rehabil, V25, P166, DOI 10.1097/00008483-200505000-00008; Edmondson D, 2011, J PSYCHIAT IN PRESS; Edmondson D, 2011, J PSYCHIAT RES; Egger M, 2001, SYSTEMATIC REV HLTH; First M.B., 2014, STRUCTURED CLIN INTE; Foa E., 1996, POSTTRAUMATIC STRESS; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Gander ML, 2006, EUR J CARDIOV PREV R, V13, P165, DOI 10.1097/01.hjr.0000214606.60995.46; Ginzburg K, 2003, J CLIN PSYCHIAT, V64, P1217, DOI 10.4088/JCP.v64n1012; Glassman AH, 2006, ARCH GEN PSYCHIAT, V63, P283, DOI 10.1001/archpsyc.63.3.283; Glassman AH, 2009, ARCH GEN PSYCHIAT, V66, P1022, DOI 10.1001/archgenpsychiatry.2009.121; Grace SL, 2005, AM J CARDIOL, V96, P1179, DOI 10.1016/j.amjcard.2005.06.052; Griffiths J, 2007, INTENS CARE MED, V33, P1506, DOI 10.1007/s00134-007-0730-z; Guler E, 2009, CLIN CARDIOL, V32, P125, DOI 10.1002/clc.20384; Hanssen TA, 2009, EUR J CARDIOV PREV R, V16, P651, DOI 10.1097/HJR.0b013e32832e4206; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Kubzansky LD, 2007, ARCH GEN PSYCHIAT, V64, P109, DOI 10.1001/archpsyc.64.1.109; Kubzansky Laura D, 2009, Cleve Clin J Med, V76 Suppl 2, pS60, DOI 10.3949/ccjm.76.s2.12; KUTZ I, 1994, ISRAEL J PSYCHIAT, V31, P48; Lukach BM, 1996, DISS ABSTR INT B, V56, P6398; Menzin J, 2008, CURR MED RES OPIN, V24, P461, DOI [10.1185/030079908X261096, 10.1185/030079908X261096 ]; Neumann JK, 1991, MED PSYCHOTHER, V4, P105; Newman JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027640; O'Reilly SM, 2004, BRIT J CLIN PSYCHOL, V43, P83, DOI 10.1348/014466504772812986; Pedersen SS, 2003, HEART LUNG, V32, P300, DOI 10.1016/S0147-9563(03)00097-9; Pedersen SS, 2001, SCAND J PSYCHOL, V42, P445, DOI 10.1111/1467-9450.00257; Roberge Marie-Anne, 2010, Can J Cardiol, V26, pe170; Rocha LP, 2008, INT J PSYCHIAT MED, V38, P297, DOI 10.2190/PM.38.3.f; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rutledge T, 2006, J AM COLL CARDIOL, V48, P1527, DOI 10.1016/j.jacc.2006.06.055; Sheldrick R, 2006, BRIT J HEALTH PSYCH, V11, P387, DOI 10.1348/135910705X71434; Shemesh E, 2006, PSYCHOSOMATICS, V47, P231, DOI 10.1176/appi.psy.47.3.231; Shemesh E, 2004, PSYCHOSOM MED, V66, P521, DOI 10.1097/01.psy.0000126199.05189.86; Shemesh E, 2001, GEN HOSP PSYCHIAT, V23, P215, DOI 10.1016/S0163-8343(01)00150-5; Shemesh E, 2011, J CLIN PSYCHIAT, V72, P168, DOI 10.4088/JCP.09m05116blu; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Simpson RJ, 2006, JAMA-J AM MED ASSOC, V296, P2614, DOI 10.1001/jama.296.21.jed60074; Sullivan GM, 2009, CURR OPIN INVEST DR, V10, P35; Switzer GE, 1999, J TRAUMA STRESS, V12, P25, DOI 10.1023/A:1024738114428; Theroux P, 2000, CIRCULATION, V102; Thompson RN, 1999, DISS ABSTR INT B, V60, P2965; Tomlinson LA, 2011, EUR HEART J, V32, P668, DOI 10.1093/eurheartj/ehq404; VANDRIEL RC, 1995, J TRAUMA STRESS, V8, P151, DOI 10.1002/jts.2490080111; von Kanel R, 2007, J PSYCHIATR RES, V41, P744, DOI 10.1016/j.jpsychires.2006.06.009; von Kanel R, 2011, J CARDIOL; Weiss D. S., 2007, ASSESSING PSYCHOL TR, P219, DOI [10.1007/978-0-387-70990-1_10, DOI 10.1007/978-0-387-70990-1_10]; Wiedemar L, 2008, HEART LUNG, V37, P113, DOI 10.1016/j.hrtlng.2007.03.005; Wikman A, 2008, PSYCHOSOM MED, V70, P764, DOI 10.1097/PSY.0b013e3181835c07; Yehuda R, 2006, ANN NY ACAD SCI, V1071, P137, DOI 10.1196/annals.1364.012	65	229	232	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38915	10.1371/journal.pone.0038915	http://dx.doi.org/10.1371/journal.pone.0038915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	964KK	22745687	gold, Green Published			2022-12-27	WOS:000305693200028
J	Honda, A; Valogne, Y; Nader, MB; Brechot, C; Faivre, J				Honda, Arata; Valogne, Yannick; Nader, Myriam Bou; Brechot, Christian; Faivre, Jamila			An Intron-Retaining Splice Variant of Human Cyclin A2, Expressed in Adult Differentiated Tissues, Induces a G1/S Cell Cycle Arrest In Vitro	PLOS ONE			English	Article							RAT-LIVER CELLS; S-PHASE; ENDOPLASMIC-RETICULUM; BREAST-CANCER; HUMAN GENES; LOCALIZATION; MITOSIS; KINASE; TRANSFORMATION; REGENERATION	Background: Human cyclin A2 is a key regulator of S phase progression and entry into mitosis. Alternative splice variants of the G1 and mitotic cyclins have been shown to interfere with full-length cyclin functions to modulate cell cycle progression and are therefore likely to play a role in differentiation or oncogenesis. The alternative splicing of human cyclin A2 has not yet been studied. Methodology/Principal Findings: Sequence-specific primers were designed to amplify various exon-intron regions of cyclin A2 mRNA in cell lines and human tissues. Intron retaining PCR products were cloned and sequenced and then overexpressed in HeLa cells. The subcellular localization of the splice variants was studied using confocal and time-lapse microscopy, and their impact on the cell cycle by flow cytometry, immunoblotting and histone H1 kinase activity. We found a splice variant of cyclin A2 mRNA called A2V6 that partly retains Intron 6. The gene expression pattern of A2V6 mRNA in human tissues was noticeably different from that of wild-type cyclin A2 (A2WT) mRNA. It was lower in proliferating fetal tissues and stronger in some differentiated adult tissues, especially, heart. In transfected HeLa cells, A2V6 localized exclusively in the cytoplasm whereas A2WT accumulated in the nucleus. We show that A2V6 induced a clear G1/S cell cycle arrest associated with a p21 and p27 upregulation and an inhibition of retinoblastoma protein phosphorylation. Like A2WT, A2V6 bound CDK2, but the A2V6/CDK2 complex did not phosphorylate histone H1. Conclusion/Significance: This study has revealed that some highly differentiated human tissues express an intron-retaining cyclin A2 mRNA that induced a G1/S block in vitro. Contrary to full-length cyclin A2, which regulates cell proliferation, the A2V6 splice variant might play a role in regulating nondividing cell states such as terminal differentiation or senescence.	[Honda, Arata] Ebara Hosp, Tokyo Metropolitan Hlth & Med Treatment Corp, Tokyo, Japan; [Honda, Arata; Valogne, Yannick; Nader, Myriam Bou; Brechot, Christian; Faivre, Jamila] Ctr Hepatobiliaire, INSERM, U785, Villejuif, France; [Honda, Arata; Valogne, Yannick; Nader, Myriam Bou; Brechot, Christian; Faivre, Jamila] Univ Paris 11, Fac Med, Villejuif, France	Tokyo Metropolitan Health & Medical Treatment Corporation; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Honda, A (corresponding author), Ebara Hosp, Tokyo Metropolitan Hlth & Med Treatment Corp, Tokyo, Japan.	jamila.faivre@inserm.fr			National Institute of Health and Medical Research (INSERM); Association for Research on Cancer (ARC) [4866]; National Cancer Institute (INCa) [PL027, 2009-PAIR-CHC]	National Institute of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association for Research on Cancer (ARC); National Cancer Institute (INCa)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)Institut National du Cancer (INCA) France)	This work was supported by grants from The National Institute of Health and Medical Research (INSERM), The Association for Research on Cancer (ARC, Grant 4866 to JF) and The National Cancer Institute (INCa, Grants PL027 and 2009-PAIR-CHC to JF). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILLY E, 1992, J CELL SCI, V101, P529; Bendris N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022879; Berasain C, 1998, ONCOGENE, V16, P1277, DOI 10.1038/sj.onc.1201893; CARBONAROHALL D, 1993, ONCOGENE, V8, P1649; CASTRO A, 1994, BIOCHEM BIOPH RES CO, V201, P1072, DOI 10.1006/bbrc.1994.1814; Chaudhry HW, 2004, J BIOL CHEM, V279, P35858, DOI 10.1074/jbc.M404975200; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; DEVOTO SH, 1992, CELL, V68, P167, DOI 10.1016/0092-8674(92)90215-X; Faivre J, 2002, ONCOGENE, V21, P1493, DOI 10.1038/sj.onc.1205215; Faivre J, 2001, FEBS LETT, V506, P243, DOI 10.1016/S0014-5793(01)02920-9; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Hanke J, 1999, TRENDS GENET, V15, P389, DOI 10.1016/S0168-9525(99)01830-2; Harwell RM, 2000, CANCER RES, V60, P481; Hengst L, 1998, CURR TOP MICROBIOL, V227, P25; Hui-Ching Wang L, 2011, CARCINOGENESIS  1209; Jackman M, 2002, MOL BIOL CELL, V13, P1030, DOI 10.1091/mbc.01-07-0361; Jacobs HW, 2001, EMBO J, V20, P2376, DOI 10.1093/emboj/20.10.2376; Kaufmann H, 2001, J BIOL CHEM, V276, P29987, DOI 10.1074/jbc.M005452200; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; KEYOMARSI K, 1995, ONCOGENE, V11, P941; LEES E, 1992, GENE DEV, V6, P1874, DOI 10.1101/gad.6.10.1874; Lozano JC, 1998, J CELL BIOL, V140, P283, DOI 10.1083/jcb.140.2.283; Lozano JC, 2002, BIOCHEM BIOPH RES CO, V291, P406, DOI 10.1006/bbrc.2002.6458; LU XP, 1992, J BIOL CHEM, V267, P2841; Mateo F, 2009, ONCOGENE, V28, P2654, DOI 10.1038/onc.2009.127; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Mumberg D, 1997, NUCLEIC ACIDS RES, V25, P2098, DOI 10.1093/nar/25.11.2098; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Pagliuca FW, 2011, MOL CELL, V43, P406, DOI 10.1016/j.molcel.2011.05.031; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Porter DC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.23.e101; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; ROSENBERG AR, 1995, ONCOGENE, V10, P1501; SEWING A, 1994, J CELL SCI, V107, P581; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Solomon DA, 2003, J BIOL CHEM, V278, P30339, DOI 10.1074/jbc.M303969200; Sun A, 2007, J CELL BIOCHEM, V102, P1400, DOI 10.1002/jcb.21609; Verges M, 1997, BIOCHEM BIOPH RES CO, V230, P49, DOI 10.1006/bbrc.1996.5851; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Winston N, 2000, DEV BIOL, V223, P139, DOI 10.1006/dbio.2000.9721; YOSHIZUMI M, 1995, J CLIN INVEST, V95, P2275, DOI 10.1172/JCI117918	44	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39249	10.1371/journal.pone.0039249	http://dx.doi.org/10.1371/journal.pone.0039249			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745723	gold, Green Submitted, Green Published			2022-12-27	WOS:000305693200053
J	Knippenberg, S; Thau, N; Dengler, R; Brinker, T; Petri, S				Knippenberg, Sarah; Thau, Nadine; Dengler, Reinhard; Brinker, Thomas; Petri, Susanne			Intracerebroventricular Injection of Encapsulated Human Mesenchymal Cells Producing Glucagon-Like Peptide 1 Prolongs Survival in a Mouse Model of ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MARROW STROMAL CELLS; STEM-CELLS; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; ALZHEIMERS-DISEASE; XENOGENEIC CELLS; MOTOR-NEURONS; ANIMAL-MODEL; FAMILIAL ALS	Background: As pharmacological therapies have largely failed so far, stem cell therapy has recently come into the focus of ALS research. Neuroprotective potential was shown for several types of stem and progenitor cells, mainly due to release of trophic factors. In the present study, we assessed the effects of intracerebroventricular injection of glucagon-like peptide 1 (GLP-1) releasing mesenchymal stromal cells (MSC) in mutant SOD1 (G93A) transgenic mice. Methodology/Principal Findings: To improve the neuroprotective effects of native MSC, they had been transfected with a plasmid vector encoding a GLP-1 fusion gene prior to the injection, as GLP-1 was shown to exhibit neuroprotective properties before. Cells were encapsulated and therefore protected against rejection. After intracerebroventricular injection of these GLP-1 MSC capsules in presymptomatic SOD1 (G93A) mice, we assessed possible protective effects by survival analysis, measurement of body weight, daily monitoring and evaluation of motor performance by rotarod and footprint analyses. Motor neuron numbers in the spinal cord as well as the amount of astrocytosis, microglial activation, heat shock response and neuronal nitric oxide synthase (nNOS) expression were analyzed by immunohistological methods. Treatment with GLP-1 producing MSC capsules significantly prolonged survival by 13 days, delayed symptom onset by 15 days and weight loss by 14 days and led to significant improvements in motor performance tests compared to vehicle treated controls. Histological data are mainly in favour of anti-inflammatory effects of GLP-1 producing MSC capsules with reduced detection of inflammatory markers and a significant heat shock protein increase. Conclusion/Significance: Intracerebroventricular injection of GLP-1 MSC capsules shows neuroprotective potential in the SOD1 (G93A) mouse model.	[Knippenberg, Sarah; Thau, Nadine; Dengler, Reinhard; Petri, Susanne] Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany; [Brinker, Thomas] Neurosurg Fdn Providence, Providence, RI USA; [Thau, Nadine; Dengler, Reinhard; Petri, Susanne] Ctr Syst Neurosci, Hannover, Germany	Hannover Medical School	Knippenberg, S (corresponding author), Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany.	Knippenberg.Sarah@mh-hannover.de	Petri, Susanne/AID-7665-2022		Deutsche Gesellschaft fur Muskelkranke; Deutsche Forschungsgemeinschaft [Pe 924/2-2]	Deutsche Gesellschaft fur Muskelkranke; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by a grant from Deutsche Gesellschaft fur Muskelkranke to SP and by a grant from Deutsche Forschungsgemeinschaft (Pe 924/2-2) to SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696; Alvarez E, 1996, J NEUROCHEM, V66, P920; Appel S H, 2011, Acta Myol, V30, P4; Banks WA, 2004, J PHARMACOL EXP THER, V309, P469, DOI 10.1124/jpet.103.063222; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen L, 1997, J NEUROBIOL, V32, P202, DOI 10.1002/(SICI)1097-4695(199702)32:2<202::AID-NEU5>3.0.CO;2-C; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Garbuzova-Davis S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002494; Glage S, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-18; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hargitai J, 2003, BIOCHEM BIOPH RES CO, V307, P689, DOI 10.1016/S0006-291X(03)01254-3; Hedlund E, 2007, EUR J NEUROSCI, V26, P1721, DOI 10.1111/j.1460-9568.2007.05780.x; Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071; Hunt DPJ, 2008, CELL TRANSPLANT, V17, P865, DOI 10.3727/096368908786516738; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; JIN SLC, 1988, J COMP NEUROL, V271, P519, DOI 10.1002/cne.902710405; Kastin AJ, 2002, J MOL NEUROSCI, V18, P7, DOI 10.1385/JMN:18:1-2:07; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Kim S, 2009, J ENDOCRINOL, V202, P431, DOI 10.1677/JOE-09-0132; Klapdor K, 1997, J NEUROSCI METH, V75, P49, DOI 10.1016/S0165-0270(97)00042-3; Klinge P, 2011, NEUROSCI LETT; Klinge PM, 2011, NEUROSCI LETT, V497, P6, DOI 10.1016/j.neulet.2011.03.092; Knippenberg S, 2011, NEURODEGENER DIS; Knippenberg S, 2010, BEHAV BRAIN RES, V213, P82, DOI 10.1016/j.bbr.2010.04.042; Kunst CB, 2004, AM J HUM GENET, V75, P933, DOI 10.1086/426001; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031394; Li YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032008; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Lindvall O, 2008, EXP NEUROL, V209, P82, DOI 10.1016/j.expneurol.2007.08.019; Lu Z, 2008, J NEUROIMMUNOL; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; NATHAN DM, 1992, ENDOCRIN METAB CLIN, V21, P221, DOI 10.1016/S0889-8529(18)30216-0; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Perry T, 2003, J NEUROSCI RES, V72, P603, DOI 10.1002/jnr.10611; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Suzuki M, 2008, MOL THER, V16, P2002, DOI 10.1038/mt.2008.197; Svennerholm L, 2002, DEMENT GERIATR COGN, V14, P128, DOI 10.1159/000063604; Vercelli A, 2008, NEUROBIOL DIS, V31, P395, DOI 10.1016/j.nbd.2008.05.016; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307; Zhang C, 2009, CYTOTHERAPY, V11, P299, DOI 10.1080/14653240902806986; Zhao CP, 2007, CYTOTHERAPY, V9, P414, DOI 10.1080/14653240701376413; Zurn AD, 2000, CELL TRANSPLANT, V9, P471, DOI 10.1177/096368970000900404	55	48	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e36857	10.1371/journal.pone.0036857	http://dx.doi.org/10.1371/journal.pone.0036857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745655	Green Submitted, gold, Green Published			2022-12-27	WOS:000305693200003
J	Ademuyiwa, FO; Bshara, W; Attwood, K; Morrison, C; Edge, SB; Ambrosone, CB; O'Connor, TL; Levine, EG; Miliotto, A; Ritter, E; Ritter, G; Gnjatic, S; Odunsi, K				Ademuyiwa, Foluso O.; Bshara, Wiam; Attwood, Kristopher; Morrison, Carl; Edge, Stephen B.; Ambrosone, Christine B.; O'Connor, Tracey L.; Levine, Ellis G.; Miliotto, Anthony; Ritter, Erika; Ritter, Gerd; Gnjatic, Sacha; Odunsi, Kunle			NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer	PLOS ONE			English	Article							T-CELL RESPONSES; TUMOR-INFILTRATING LYMPHOCYTES; IMMUNE-RESPONSE; EXPRESSION; OVARIAN; ANTIBODY; MELANOMA; GENE; RECURRENCE; CD8+T-CELL	Purpose: NY-ESO-1 cancer testis (CT) antigen is an attractive candidate for immunotherapy as a result of its high immunogenicity. The aim of this study was to explore the potential for NY-ESO-1 antigen directed immunotherapy in triple negative breast cancer (TNBC) by determining the frequency of expression by immunohistochemistry (IHC) and the degree of inherent immunogenicity to NY-ESO-1. Experimental Design: 168 TNBC and 47 ER+/HER2- primary breast cancer specimens were used to determine NY-ESO-1 frequency by IHC. As previous studies have shown that patients with a robust innate humoral immune response to CT antigens are more likely to develop CD8 T-cell responses to NY-ESO-1 peptides, we evaluated the degree to which patients with NY-ESO-1 expression had inherent immunogenicity by measuring antibodies. The relationship between NY-ESO-1 expression and CD8+ T lymphocytes was also examined. Results: The frequency of NY-ESO-1 expression in the TNBC cohort was 16% versus 2% in ER+/HER2- patients. A higher NY-ESO-1 score was associated with a younger age at diagnosis in the TNBC patients with NY-ESO-1 expression (p = 0.026). No differences in OS (p = 0.278) or PFS (p = 0.238) by NY-ESO-1 expression status were detected. Antibody responses to NY-ESO-1 were found in 73% of TNBC patients whose tumors were NY-ESO-1 positive. NY-ESO-1 positive patients had higher CD8 counts than negative patients (p = 0.018). Conclusion: NY-ESO-1 is expressed in a substantial subset of TNBC patients and leads to a high humoral immune response in a large proportion of these individuals. Given these observations, patients with TNBC may benefit from targeted therapies directed against NY-ESO-1.	[Ademuyiwa, Foluso O.; O'Connor, Tracey L.; Levine, Ellis G.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Bshara, Wiam; Morrison, Carl] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Attwood, Kristopher] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA; [Edge, Stephen B.] Roswell Pk Canc Inst, Dept Surg Oncol, Buffalo, NY 14263 USA; [Ambrosone, Christine B.] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Miliotto, Anthony; Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Ritter, Erika; Ritter, Gerd; Gnjatic, Sacha] Mem Sloan Kettering Canc Ctr, New York Branch Human Canc Immunol, Ludwig Inst Canc Res Ltd, New York, NY 10021 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center	Ademuyiwa, FO (corresponding author), Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA.	foluso.ademuyiwa@roswellpark.org		Gnjatic, Sacha/0000-0001-5643-9520; ADEMUYIWA, FOLUSO/0000-0002-6766-2258; Ritter, Erika/0000-0002-5161-7874	American Cancer Society [62-2465-01]; AVON Foundation for Women [02-2010-080]; Cancer Research Institute; NCI [P30 CA016056-32]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); AVON Foundation for Women; Cancer Research Institute; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the American Cancer Society Institutional Research Grant 62-2465-01 (FOA), the AVON Foundation for Women Grant 02-2010-080 (to FA), and the Cancer Research Institute. Biospecimens and research pathology services were provided by the Pathology Resource Network and the Data Bank and BioRepository, which are Roswell Park Cancer Institute Cancer Center Support Grant shared resources, supported by NCI P30 CA016056-32. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Ambrosone CB, 2006, CANCER EPIDEM BIOMAR, V15, P1575, DOI 10.1158/1055-9965.EPI-06-0628; Bender Armin, 2007, Cancer Immun, V7, P16; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Curigliano G, 2011, ANN ONCOL, V22, P98, DOI 10.1093/annonc/mdq325; del Rio ML, 2005, EUR J IMMUNOL, V35, P3545, DOI 10.1002/eji.200535232; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; Fang F, 2010, CANCER-AM CANCER SOC, V116, P4043, DOI 10.1002/cncr.25204; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Gnjatic S, 2003, P NATL ACAD SCI USA, V100, P8862, DOI 10.1073/pnas.1133324100; Gnjatic S, 2010, P NATL ACAD SCI USA, V107, P5088, DOI 10.1073/pnas.0914213107; Gnjatic S, 2009, CLIN CANCER RES, V15, P2130, DOI 10.1158/1078-0432.CCR-08-2632; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Grigoriadis A, 2009, P NATL ACAD SCI USA, V106, P13493, DOI 10.1073/pnas.0906840106; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Hamai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021129; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Horne ZD, 2011, J SURG RES, V171, P1, DOI 10.1016/j.jss.2011.03.068; HOUGHTON AN, 1994, J EXP MED, V180, P1, DOI 10.1084/jem.180.1.1; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Jager E, 2000, P NATL ACAD SCI USA, V97, P4760, DOI 10.1073/pnas.97.9.4760; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Kakimi K, 2011, INT J CANC; Lethe B, 1998, INT J CANCER, V76, P903, DOI 10.1002/(SICI)1097-0215(19980610)76:6<903::AID-IJC22>3.0.CO;2-1; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Mashino K, 2001, BRIT J CANCER, V85, P713, DOI 10.1054/bjoc.2001.1974; Mischo A, 2006, INT J CANCER, V118, P696, DOI 10.1002/ijc.21352; NAKAYAMA E, 1985, J EXP MED, V161, P345, DOI 10.1084/jem.161.2.345; Nicholaou T, 2011, CANC IMMUNOL IMMUNOT; Nosho K, 2010, J PATHOL, V222, P350, DOI 10.1002/path.2774; Odunsi K, 2003, CANCER RES, V63, P6076; Odunsi K, 2007, P NATL ACAD SCI USA, V104, P12837, DOI 10.1073/pnas.0703342104; Sahin U, 1998, INT J CANCER, V78, P387, DOI 10.1002/(SICI)1097-0215(19981029)78:3<387::AID-IJC22>3.0.CO;2-2; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shin T, 2005, J EXP MED, V201, P1531, DOI 10.1084/jem.20050072; Stockert E, 1998, J EXP MED, V187, P1349, DOI 10.1084/jem.187.8.1349; Sugita Y, 2004, CANCER RES, V64, P2199, DOI 10.1158/0008-5472.CAN-03-3070; Tanja BC, 2011, MED ONCOL; Taylor RC, 2007, J CLIN ONCOL, V25, P869, DOI 10.1200/JCO.2006.08.9755; Theurillat JP, 2007, INT J CANCER, V120, P2411, DOI 10.1002/ijc.22376; URBAN JL, 1992, ANNU REV IMMUNOL, V10, P617, DOI 10.1146/annurev.iy.10.040192.003153; Valmori D, 2000, CANCER RES, V60, P4499; West NR, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3072; Woloszynska-Read A, 2008, CLIN CANCER RES, V14, P3283, DOI 10.1158/1078-0432.CCR-07-5279; Yuan JD, 2011, P NATL ACAD SCI USA, V108, P16723, DOI 10.1073/pnas.1110814108; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	48	66	75	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e38783	10.1371/journal.pone.0038783	http://dx.doi.org/10.1371/journal.pone.0038783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761704	Green Published, gold, Green Submitted			2022-12-27	WOS:000305826400006
J	Gustafsson, PE; Janlert, U; Theorell, T; Westerlund, H; Hammarstrom, A				Gustafsson, Per E.; Janlert, Urban; Theorell, Tores; Westerlund, Hugo; Hammarstrom, Anne			Do Peer Relations in Adolescence Influence Health in Adulthood? Peer Problems in the School Setting and the Metabolic Syndrome in Middle-Age	PLOS ONE			English	Article							LIFE-COURSE ORIGINS; RISK-FACTORS; SOCIOECONOMIC-STATUS; LOGISTIC-REGRESSION; MEN; POPULARITY; FRIENDSHIPS; WOMEN; NEUROENDOCRINE; HETEROGENEITY	While the importance of social relations for health has been demonstrated in childhood, adolescence and adulthood, few studies have examined the prospective importance of peer relations for adult health. The aim of this study was to examine whether peer problems in the school setting in adolescence relates to the metabolic syndrome in middle-age. Participants came from the Northern Swedish Cohort, a 27-year cohort study of school leavers (effective n = 881, 82% of the original cohort). A score of peer problems was operationalized through form teachers' assessment of each student's isolation and popularity among school peers at age 16 years, and the metabolic syndrome was measured by clinical measures at age 43 according to established criteria. Additional information on health, health behaviors, achievement and social circumstances were collected from teacher interviews, school records, clinical measurements and self-administered questionnaires. Logistic regression was used as the main statistical method. Results showed a dose-response relationship between peer problems in adolescence and metabolic syndrome in middle-age, corresponding to 36% higher odds for the metabolic syndrome at age 43 for each SD higher peer problems score at age 16. The association remained significant after adjustment for health, health behaviors, school adjustment or family circumstances in adolescence, and for psychological distress, health behaviors or social circumstances in adulthood. In analyses stratified by sex, the results were significant only in women after adjustment for covariates. Peer problems were significantly related to all individual components of the metabolic syndrome. These results suggest that unsuccessful adaption to the school peer group can have enduring consequences for metabolic health.	[Gustafsson, Per E.; Janlert, Urban; Hammarstrom, Anne] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Theorell, Tores; Westerlund, Hugo] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden	Umea University; Stockholm University	Gustafsson, PE (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.	Per.E.Gustafsson@fammed.umu.se	Westerlund, Hugo/A-3049-2012; Gustafsson, Per/AAY-5068-2021	Westerlund, Hugo/0000-0002-8806-5698; Hammarstrom, Anne/0000-0002-4095-7961; Theorell, Tores/0000-0003-1956-7931	County Council of Vasterbotten (ALF) [147931]; Swedish Research Council (VR) [521-2005-4084]; Swedish Council for Working Life and Social Research (FAS) [2006-0950]; Umea University [223-514-09]; Stockholm Stress Center, a FAS (Swedish Council for Working Life and Social Research) Centre of Excellence (FAS) [2009-1758]	County Council of Vasterbotten (ALF); Swedish Research Council (VR)(Swedish Research Council); Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Umea University; Stockholm Stress Center, a FAS (Swedish Council for Working Life and Social Research) Centre of Excellence (FAS)	The study was funded by the County Council of Vasterbotten (www.vll.se, ALF, grant number 147931), The Swedish Research Council (www.vr.se, VR, grant number 521-2005-4084), the Swedish Council for Working Life and Social Research (www.fas.se, FAS, grant number 2006-0950), and PEG by Umea University (www.umu.se, Young Researcher Award, grant number 223-514-09). The study was in part also funded by the Stockholm Stress Center, a FAS (Swedish Council for Working Life and Social Research) Centre of Excellence (FAS, grant #2009-1758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Ali MM, 2012, ECON HUM BIOL, V10, P20, DOI 10.1016/j.ehb.2011.10.001; Almquist Y, 2009, J EPIDEMIOL COMMUN H, V63, P1028, DOI 10.1136/jech.2009.088377; Almquist Y, 2011, ADV LIFE COURSE RES, V16, P1, DOI 10.1016/j.alcr.2010.11.001; Almquist YM, 2011, EUR J PUBLI IN PRESS; Batty GD, 2008, J EPIDEMIOL COMMUN H, V62, P522, DOI 10.1136/jech.2007.064881; Batty GD, 2008, EUR J CARDIOV PREV R, V15, P359, DOI 10.1097/HJR.0b013e3282f738a6; Bukowski WM, 2010, DEV PSYCHOPATHOL, V22, P749, DOI 10.1017/S095457941000043X; Burns TL, 2009, J PEDIAT, V155, p[S5, e17]; CAIRNS RB, 1995, BEHAV RES THER, V33, P725, DOI 10.1016/0005-7967(95)00004-H; Caspi A, 2006, ARCH PEDIAT ADOL MED, V160, P805, DOI 10.1001/archpedi.160.8.805; Cillessen AHN, 2004, CHILD DEV, V75, P147, DOI 10.1111/j.1467-8624.2004.00660.x; Cillessen AHN, 2006, J ADOLESCENCE, V29, P935, DOI 10.1016/j.adolescence.2006.05.005; de Bruyn EH, 2006, J ADOLESCENT RES, V21, P607, DOI 10.1177/0743558406293966; de Bruyn EH, 2006, J YOUTH ADOLESCENCE, V35, P435, DOI 10.1007/s10964-005-9023-4; Deater-Deckard K, 2001, J CHILD PSYCHOL PSYC, V42, P565, DOI 10.1017/S0021963001007272; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Elwell-Sutton TM, 2011, SOC SCI MED, V72, P1884, DOI 10.1016/j.socscimed.2011.03.041; Faith MS, 2011, OBES REV, V12, pe438, DOI 10.1111/j.1467-789X.2010.00843.x; GAVIN LA, 1989, DEV PSYCHOL, V25, P827, DOI 10.1037/0012-1649.25.5.827; Gest SD, 2001, SOC DEV, V10, P23, DOI 10.1111/1467-9507.00146; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Gustafsson PE, 2011, EUR J PUBLI IN PRESS; Gustafsson PE, 2012, SOC SCI MED, V74, P1630, DOI 10.1016/j.socscimed.2012.01.044; Gustafsson PE, 2012, ANN BEHAV MED, V43, P117, DOI 10.1007/s12160-011-9309-6; Gustafsson PE, 2011, ANN EPIDEMIOL, V21, P103, DOI 10.1016/j.annepidem.2010.08.012; Hall-Lande JA, 2007, ADOLESCENCE, V42, P265; Hammarstrom A, 2011, INT J EPIDE IN PRESS; Hartup WW, 1996, CHILD DEV, V67, P1, DOI 10.2307/1131681; Hay DF, 2004, J CHILD PSYCHOL PSYC, V45, P84, DOI 10.1046/j.0021-9630.2003.00308.x; HENDERSON S, 1980, PSYCHOL MED, V10, P723, DOI 10.1017/S003329170005501X; Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778; Laftman SB, 2006, SOC SCI MED, V63, P611, DOI 10.1016/j.socscimed.2006.02.005; Langenberg C, 2006, AM J PUBLIC HEALTH, V96, P2216, DOI 10.2105/AJPH.2004.049429; Lehman BJ, 2005, PSYCHOSOM MED, V67, P846, DOI 10.1097/01.psy.0000188443.48405.eb; Mattsson N, 2008, ANN MED, V40, P542, DOI 10.1080/07853890802307709; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Modin B, 2011, J ABNORM CHILD PSYCH, V39, P187, DOI 10.1007/s10802-010-9462-6; Muthen BO, 1995, SOCIOL METHODOL, V25, P267, DOI 10.2307/271070; Ostberg V, 2008, SOC SCI MED, V66, P835, DOI 10.1016/j.socscimed.2007.10.018; Parkhurst JT, 1998, J EARLY ADOLESCENCE, V18, P125, DOI 10.1177/0272431698018002001; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pollitt RA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-7; Richardson LP, 2003, ARCH PEDIAT ADOL MED, V157, P739, DOI 10.1001/archpedi.157.8.739; Rodkin PC, 2000, DEV PSYCHOL, V36, P14, DOI 10.1037/0012-1649.36.1.14; Rosmond R, 2005, PSYCHONEUROENDOCRINO, V30, P1, DOI 10.1016/j.psyneuen.2004.05.007; Rubin KH, 2009, ANNU REV PSYCHOL, V60, P141, DOI 10.1146/annurev.psych.60.110707.163642; RUTTER M, 1967, J CHILD PSYCHOL PSYC, V8, P1, DOI 10.1111/j.1469-7610.1967.tb02175.x; Seeman TE, 1996, ANN EPIDEMIOL, V6, P442, DOI 10.1016/S1047-2797(96)00095-6; Seeman TE, 1996, PSYCHOSOM MED, V58, P459, DOI 10.1097/00006842-199609000-00008; Seeman T, 2010, ANN NY ACAD SCI, V1186, P223, DOI 10.1111/j.1749-6632.2009.05341.x; Senese LC, 2009, EPIDEMIOL REV, V31, P21, DOI 10.1093/epirev/mxp006; Sentse M, 2010, J ABNORM CHILD PSYCH, V38, P119, DOI 10.1007/s10802-009-9351-z; Shomaker LB, 2011, DIABETES CARE, V34, P2458, DOI 10.2337/dc11-1131; Statistics Sweden, 1984, STAT SWED REP STAT C; Steptoe A, 2004, PSYCHONEUROENDOCRINO, V29, P593, DOI 10.1016/S0306-4530(03)00086-6; Strauss RS, 2003, ARCH PEDIAT ADOL MED, V157, P746, DOI 10.1001/archpedi.157.8.746; Topitzes J, 2009, PREV SCI, V10, P175, DOI 10.1007/s11121-009-0121-5; Wentzel KR, 1997, CHILD DEV, V68, P1198, DOI 10.2307/1132301; WENTZEL KR, 1995, CHILD DEV, V66, P754, DOI 10.2307/1131948; Whisman MA, 2010, HEALTH PSYCHOL, V29, P550, DOI 10.1037/a0020760; Woodward LJ, 2000, J CHILD PSYCHOL PSYC, V41, P191, DOI 10.1017/S002196309900520X; World Health Organization. Cardiovascular Diseases Unit, 1990, MONICA MAN WHO MONIC	64	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39385	10.1371/journal.pone.0039385	http://dx.doi.org/10.1371/journal.pone.0039385			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966GL	22761778	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800030
J	Peng, CC; Chen, KC; Hsieh, CL; Peng, RY				Peng, Chiung-Chi; Chen, Kuan-Chou; Hsieh, Chiu-Lan; Peng, Robert Y.			Swimming Exercise Prevents Fibrogenesis in Chronic Kidney Disease by Inhibiting the Myofibroblast Transdifferentiation	PLOS ONE			English	Article							SMOOTH-MUSCLE ACTIN; CHRONIC-RENAL-FAILURE; MESANGIAL CELLS; GROWTH-FACTOR; TNF-ALPHA; PHYSICAL-ACTIVITY; CD34 EXPRESSION; GENE-EXPRESSION; PROTEIN-KINASE; NITRIC-OXIDE	Background: The renal function of chronic kidney disease (CKD) patients may be improved by a number of rehabilitative mechanisms. Swimming exercise training was supposed to be beneficial to its recovery. Methodology/Principal Findings: Doxorubicin-induced CKD (DRCKD) rat model was performed. Swimming training was programmed three days per week, 30 or 60 min per day for a total period of 11 weeks. Serum biochemical and pathological parameters were examined. In DRCKD, hyperlipidemia was observed. Active mesangial cell activation was evidenced by overexpression of PDGFR, P-PDGFR, MMP-2, MMP-9, alpha-SMA, and CD34 with a huge amount collagen deposition. Apparent myofibroblast transdifferentiation implicating fibrogenesis in the glomerular mesangium, glomerulonephritis and glomeruloscelorosis was observed with highly elevated proteinuria and urinary BUN excretion. The 60-min swimming exercise but not the 30 min equivalent rescued most of the symptoms. To quantify the effectiveness of exercise training, a physical parameter, i.e. "the strenuosity coefficient" or "the myokine releasing coefficient", was estimated to be 7.154 x 10(-23) pg/mL-J. Conclusions: The 60-min swimming exercise may ameliorate DRCKD by inhibiting the transdifferentiation of myofibroblasts in the glomerular mesangium. Moreover, rehabilitative exercise training to rescue CKD is a personalized remedy. Benefits depend on the duration and strength of exercise, and more importantly, on the individual physiological condition.	[Peng, Chiung-Chi] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Peng, Chiung-Chi] China Med Univ, Grad Inst Rehabil Sci, Dept Phys Therapy, Taichung, Taiwan; [Chen, Kuan-Chou] Taipei Med Univ, Coll Med, Sch Med, Dept Urol, Taipei, Taiwan; [Chen, Kuan-Chou] Taipei Med Univ, Shuang Ho Hosp, Dept Urol, Taipei, Taiwan; [Hsieh, Chiu-Lan] Natl Changhua Univ Educ, Grad Inst Biotechnol, Changhua, Taiwan; [Peng, Robert Y.] Hungkuang Univ, Biotechnol Res Inst, Taichung, Shalu County, Taiwan	Taipei Medical University; China Medical University Taiwan; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; National Changhua University of Education; Hungkuang University	Peng, CC (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.	misspeng@ms2.hinet.net			National Science Council (NSC) [99-2320-B-038-011-MY3, 99-2320-B-039-034]; Chinese Medical University [CMU99-N1-09, CMU100-TS-07]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Chinese Medical University(China Medical University)	The authors want to show their gratitude to the financial supports issued by the National Science Council (NSC 99-2320-B-038-011-MY3 and 99-2320-B-039-034) and those offered by Chinese Medical University (CMU99-N1-09 & CMU100-TS-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo LM, 2008, J HISTOCHEM CYTOCHEM, V56, P605, DOI 10.1369/jhc.7A7354.2008; Adams GR, 2006, AM J PHYSIOL-RENAL, V290, pF753, DOI 10.1152/ajprenal.00296.2005; Aresu L, 2011, HISTOL HISTOPATHOL, V26, P307, DOI 10.14670/HH-26.307; Aslan R, 1998, T J MED SCI, V28, P411; Bauheter S, 2003, SCIENCE, V262, P436; BELCASTRO AN, 1985, CAN J PHYSIOL PHARM, V63, P1202, DOI 10.1139/y85-198; Bergamaschi CT, 1997, MED SCI SPORT EXER, V29, P169, DOI 10.1097/00005768-199702000-00001; Berk BC, 2011, ANN NY ACAD SCI, V947, P93; BERTANI T, 1982, LAB INVEST, V46, P16; Bloomfield SA, 1993, RESOURCE MANUAL GUID, P115; Bonegio RGB, 2005, J AM SOC NEPHROL, V16, P2063, DOI 10.1681/ASN.2004030180; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Bruunsgaard H, 2005, J LEUKOCYTE BIOL, V78, P819, DOI 10.1189/jlb.0505247; Carrero JJ, 2008, BLOOD PURIFICAT, V26, P291, DOI 10.1159/000126926; Chebotareva NV, 2002, TERAPEVT ARKH, V74, P27; Coelho BLP, 2010, J RENAL NUTR, V20, P169, DOI 10.1053/j.jrn.2009.10.007; de Gonzalo-Calvo D, 2012, AGE DORDR       0104; De Moraes R, 2004, J APPL PHYSIOL, V97, P683, DOI 10.1152/japplphysiol.00923.2003; Duzova H, 2009, J SPORT SCI MED, V8, P219; FACKLER MJ, 1995, BLOOD, V85, P3040, DOI 10.1182/blood.V85.11.3040.bloodjournal85113040; Fasshauer M, 2003, DIABETOLOGIA, V46, P1594, DOI 10.1007/s00125-003-1228-z; Fasshauer M, 2003, BIOCHEM BIOPH RES CO, V301, P1045, DOI 10.1016/S0006-291X(03)00090-1; Fock RA, 2007, CYTOKINE, V40, P105, DOI 10.1016/j.cyto.2007.08.007; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; GHAHARY A, 1993, J LAB CLIN MED, V122, P465; Gluhovschi C, 2008, VIRCHOWS ARCH, V453, P321, DOI 10.1007/s00428-008-0647-0; HARRI M, 1986, ACTA PHYSIOL SCAND, V126, P189, DOI 10.1111/j.1748-1716.1986.tb07805.x; Hasegawa M, 2005, J DERMATOL SCI, V39, P1, DOI 10.1016/j.jdermsci.2005.03.013; HEIFETS M, 1987, KIDNEY INT, V32, P815, DOI 10.1038/ki.1987.281; Ichimura K, 2006, J HISTOCHEM CYTOCHEM, V54, P1291, DOI 10.1369/jhc.6A7000.2006; Jeansson M, 2009, J AM SOC NEPHROL, V20, P114, DOI 10.1681/ASN.2007111205; Jia B, 2012, CLIN HEMORHEOL  0103; Johansen KL, 2007, J AM SOC NEPHROL, V18, P1845, DOI 10.1681/ASN.2007010009; JOHNSON RJ, 1991, J CLIN INVEST, V87, P847, DOI 10.1172/JCI115089; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KULOZIK M, 1990, J CLIN INVEST, V86, P917, DOI 10.1172/JCI114793; Leber TM, 1997, ANAL BIOCHEM, V249, P24, DOI 10.1006/abio.1997.2170; Li KW, 2009, J OCCUP SAFETY HLTH, V17, P18; Liang YJ, 2009, PEDIATR NEPHROL, V24, P1661, DOI 10.1007/s00467-009-1163-4; MARTINET Y, 1987, NEW ENGL J MED, V317, P202, DOI 10.1056/NEJM198707233170404; Mastorakos George, 2005, Hormones (Athens), V4, P73; Naruse K, 1999, J PATHOL, V189, P105; Nemet D, 2002, PEDIATRICS, V110, P681, DOI 10.1542/peds.110.4.681; Olszanecka-Gliniaowicz M, 2006, ENDOKRYNOL POL, V57, P87; OSATO S, 1990, NEPHRON, V55, P306, DOI 10.1159/000185980; Ostendorf T, 2001, J AM SOC NEPHROL, V12, P909, DOI 10.1681/ASN.V125909; Painter P, 2008, EXERCISE SPORT SCI R, P83; Pedersen BK, 2007, TRENDS PHARMACOL SCI, V28, P152, DOI 10.1016/j.tips.2007.02.002; PELTONEN J, 1991, J INVEST DERMATOL, V97, P240, DOI 10.1111/1523-1747.ep12480289; Peng CC, 2012, J BIOL REGU IN PRESS; Platel D, 1996, CYTOKINE, V8, P895, DOI 10.1006/cyto.1996.0120; POORTMANS JR, 1995, NEPHROLOGIE, V16, P317; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Ranieri E, 2001, J NEPHROL, V14, P253; Rankin CA, 1999, J AM SOC NEPHROL, V10, P210; RUBIN K, 1988, LANCET, V1, P1353; Silveira EMS, 2007, CELL BIOCHEM FUNCT, V25, P63, DOI 10.1002/cbf.1365; Steensberg A, 2002, AM J PHYSIOL-ENDOC M, V283, pE1272, DOI 10.1152/ajpendo.00255.2002; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Stump CS, 2011, CARDIORENAL MED, V1, P164, DOI 10.1159/000329929; Tang WW, 1996, AM J PATHOL, V148, P1169; Tschakovsky ME, 2008, APPL PHYSIOL NUTR ME, V33, P151, DOI 10.1139/H07-148; Vierck HB, 2012, EUR J APPL PHYS 0122; Vouldoukis I, 2004, J ETHNOPHARMACOL, V94, P67, DOI 10.1016/j.jep.2004.04.023; Weibel ER, 1979, PRACTICAL METHODS BI, P51; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513	68	33	34	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e37388	10.1371/journal.pone.0037388	http://dx.doi.org/10.1371/journal.pone.0037388			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761655	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800005
J	Baek, SK; Choi, JK; Kim, BJ				Baek, Seung Ki; Choi, Jung-Kyoo; Kim, Beom Jun			Dworkin's Paradox	PLOS ONE			English	Article							EQUALITY	How to distribute welfare in a society is a key issue in the subject of distributional justice, which is deeply involved with notions of fairness. Following a thought experiment by Dworkin, this work considers a society of individuals with different preferences on the welfare distribution and an official to mediate the coordination among them. Based on a simple assumption that an individual's welfare is proportional to how her preference is fulfilled by the actual distribution, we show that an egalitarian preference is a strict Nash equilibrium and can be favorable even in certain inhomogeneous situations. These suggest how communication can encourage and secure a notion of fairness.	[Baek, Seung Ki] Umea Univ, Integrated Sci Lab, Umea, Sweden; [Choi, Jung-Kyoo] Kyungpook Natl Univ, Sch Econ & Trade, Taegu, South Korea; [Kim, Beom Jun] Sungkyunkwan Univ, Phys Res Div BK21, Suwon, South Korea; [Kim, Beom Jun] Sungkyunkwan Univ, Dept Phys, Suwon, South Korea	Umea University; Kyungpook National University; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU)	Baek, SK (corresponding author), Korea Inst Adv Study, Sch Phys, Seoul, South Korea.	beomjun@skku.edu	Kim, Beom Jun/C-2380-2008; Baek, Seung Ki/B-7835-2014	Kim, Beom Jun/0000-0003-0854-8647; Baek, Seung Ki/0000-0002-4143-1187	Swedish Research Council [621-2008-4449]; Korea Research Foundation; Korean Government [NRF-2010-330-B00077]; National Research Foundation of Korea (NRF); Korean government (MEST) [2010-0008758]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Korea Research Foundation(National Research Foundation of Korea); Korean Government(Korean Government); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	S.K.B. acknowledges the support from the Swedish Research Council with Grant No. 621-2008-4449. J.K.C. was supported by a Korea Research Foundation Grant funded by the Korean Government (NRF-2010-330-B00077). B.J.K. was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2010-0008758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya A., 1943, B CALCUTTA MATH SOC, V35, P99; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Davis MD, 1970, GAME THEORY NONTECHN, P19; DWORKIN R, 1981, PHILOS PUBLIC AFF, V10, P185; DWORKIN R, 1981, PHILOS PUBLIC AFF, V10, P283; Dworkin R, 2000, SOVEREIGN VIRTUE THE, P21; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fleurbaey M, 1996, MATH SOC SCI, V32, P71, DOI 10.1016/0165-4896(96)00811-6; Hausman DM, 2006, EC ANAL MORAL PHILOS, P185; MATHAI AM, 1972, ANN I STAT MATH, V24, P473, DOI 10.1007/BF02479776; Meye C.D., 2000, MATRIX ANAL APPL LIN, P661; Mongin P, 2001, ECON PHILOS, V17, P147; Moreno-Ternero JD, 2008, ECON PHILOS, V24, P233, DOI 10.1017/S026626710800182X; Moreno-Ternero JD, 2006, ECONOMETRICA, V74, P1419, DOI 10.1111/j.1468-0262.2006.00710.x; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Rawls J., 1999, THEORY JUSTICE; ROEMER JE, 1986, Q J ECON, V101, P751, DOI 10.2307/1884177; Sen A., 1980, TANNER LECT HUMAN VA, VI, P197; Sen A, 1997, EC INEQUALITY, P1; Singer P, 1993, PRACTICAL ETHICS, P83	21	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e38529	10.1371/journal.pone.0038529	http://dx.doi.org/10.1371/journal.pone.0038529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966AK	22745666	Green Submitted, gold, Green Published			2022-12-27	WOS:000305808700004
J	Rao, SP; Sancho, J; Campos-Rivera, J; Boutin, PM; Severy, PB; Weeden, T; Shankara, S; Roberts, BL; Kaplan, JM				Rao, Sambasiva P.; Sancho, Jose; Campos-Rivera, Juanita; Boutin, Paula M.; Severy, Peter B.; Weeden, Timothy; Shankara, Srinivas; Roberts, Bruce L.; Kaplan, Johanne M.			Human Peripheral Blood Mononuclear Cells Exhibit Heterogeneous CD52 Expression Levels and Show Differential Sensitivity to Alemtuzumab Mediated Cytolysis	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MONOCLONAL-ANTIBODY CAMPATH-1H; QUANTITATIVE FLUORESCENCE CYTOMETRY; PHASE-II MULTICENTER; CD8(+) T-CELLS; RHEUMATOID-ARTHRITIS; IN-VITRO; DENDRITIC CELLS; ANTIGEN CDW52; B-CELLS	Alemtuzumab is a monoclonal antibody that targets cell surface CD52 and is effective in depleting lymphocytes by cytolytic effects in vivo. Although the cytolytic effects of alemtuzumab are dependent on the density of CD52 antigen on cells, there is scant information regarding the expression levels of CD52 on different cell types. In this study, CD52 expression was assessed on phenotypically distinct subsets of lymphoid and myeloid cells in peripheral blood mononuclear cells (PBMCs) from normal donors. Results demonstrate that subsets of PBMCs express differing levels of CD52. Quantitative analysis showed that memory B cells and myeloid dendritic cells (mDCs) display the highest number while natural killer (NK) cells, plasmacytoid dendritic cells (pDCs) and basophils have the lowest number of CD52 molecules per cell amongst lymphoid and myeloid cell populations respectively. Results of complement dependent cytolysis (CDC) studies indicated that alemtuzumab mediated profound cytolytic effects on B and T cells with minimal effect on NK cells, basophils and pDCs, correlating with the density of CD52 on these cells. Interestingly, despite high CD52 levels, mDCs and monocytes were less susceptible to alemtuzumab-mediated CDC indicating that antigen density alone does not define susceptibility. Additional studies indicated that higher expression levels of complement inhibitory proteins (CIPs) on these cells partially contributes to their resistance to alemtuzumab mediated CDC. These results indicate that alemtuzumab is most effective in depleting cells of the adaptive immune system while leaving innate immune cells relatively intact.	[Rao, Sambasiva P.; Sancho, Jose; Campos-Rivera, Juanita; Boutin, Paula M.; Severy, Peter B.; Shankara, Srinivas; Roberts, Bruce L.; Kaplan, Johanne M.] Genzyme Corp, Neuroimmunol Res, Framingham, MA 01701 USA; [Weeden, Timothy; Roberts, Bruce L.] Genzyme Corp, Immune Mediated Dis Biol Res, Framingham, MA 01701 USA	Sanofi-Aventis; Genzyme Corporation; Sanofi-Aventis; Genzyme Corporation	Rao, SP (corresponding author), Genzyme Corp, Neuroimmunol Res, Framingham, MA 01701 USA.	Sambasiva.rao@genzyme.com						Agematsu K, 2000, IMMUNOL TODAY, V21, P204, DOI 10.1016/S0167-5699(00)01605-4; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Auffermann-Gretzinger S, 2007, TRANSPLANTATION, V83, P1268, DOI 10.1097/01.tp.0000260433.86776.ec; BINDON CI, 1988, EUR J IMMUNOL, V18, P1507, DOI 10.1002/eji.1830181006; Boyd PN, 1995, MOL IMMUNOL, V32, P1311, DOI 10.1016/0161-5890(95)00118-2; Brett SJ, 1996, INT IMMUNOL, V8, P325, DOI 10.1093/intimm/8.3.325; Buggins AGS, 2002, BLOOD, V100, P1715, DOI 10.1182/blood.V100.5.1715.h81702001715_1715_1720; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; CROWE JS, 1992, CLIN EXP IMMUNOL, V87, P105; DYER MJS, 1990, LEUKEMIA LYMPHOMA, V2, P179, DOI 10.3109/10428199009053522; GILLEECE MH, 1993, BLOOD, V82, P807; Ginaldi L, 1998, LEUKEMIA RES, V22, P185, DOI 10.1016/S0145-2126(97)00158-6; Golay J, 2004, HAEMATOLOGICA, V89, P1476; Golay J, 2001, BLOOD, V98, P3383, DOI 10.1182/blood.V98.12.3383; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Gratama JW, 1998, CYTOMETRY, V33, P166, DOI 10.1002/(SICI)1097-0320(19981001)33:2<166::AID-CYTO11>3.0.CO;2-S; Hale C, 1996, IMMUNOLOGY, V88, P183, DOI 10.1111/j.1365-2567.1996.tb00003.x; HALE G, 1990, TISSUE ANTIGENS, V35, P118, DOI 10.1111/j.1399-0039.1990.tb01767.x; Hale G, 2001, CYTOTHERAPY, V3, P137, DOI 10.1080/146532401753174098; HALE G, 1993, J REPROD IMMUNOL, V23, P189, DOI 10.1016/0165-0378(93)90007-5; Hale G, 2001, J BIOL REG HOMEOS AG, V15, P386; Hale G, 1995, IMMUNOTECHNOLOGY, V1, P175, DOI 10.1016/1380-2933(95)00017-8; Henderson LO, 1998, CYTOMETRY, V33, P97, DOI 10.1002/(SICI)1097-0320(19981001)33:2<97::AID-CYTO3>3.0.CO;2-H; Hu YP, 2009, IMMUNOLOGY, V128, P260, DOI 10.1111/j.1365-2567.2009.03115.x; ISAACS JD, 1992, LANCET, V340, P748, DOI 10.1016/0140-6736(92)92294-P; Klabusay M, 2007, CYTOM PART B-CLIN CY, V72B, P363, DOI 10.1002/cyto.b.20181; Liszewski MK, 1996, ADV IMMUNOL, V61, P201; Liszewski MK, 1996, J IMMUNOL, V156, P4415; Lowenstein H, 2006, TRANSPLANT INT, V19, P927, DOI 10.1111/j.1432-2277.2006.00382.x; Lundin J, 1998, J CLIN ONCOL, V16, P3257, DOI 10.1200/JCO.1998.16.10.3257; MATTESON EL, 1995, ARTHRITIS RHEUM, V38, P1187, DOI 10.1002/art.1780380903; Mone AP, 2006, LEUKEMIA, V20, P272, DOI 10.1038/sj.leu.2404014; Nuckel H, 2005, EUR J PHARMACOL, V514, P217, DOI 10.1016/j.ejphar.2005.03.024; Osterborg A, 1996, BRIT J HAEMATOL, V93, P151, DOI 10.1046/j.1365-2141.1996.450989.x; Osterborg A, 1997, J CLIN ONCOL, V15, P1567, DOI 10.1200/JCO.1997.15.4.1567; Osterborg A, 1997, EUR J HAEMATOL, V58, P5; Pangalis GA, 2000, MED ONCOL, V17, P70, DOI 10.1007/BF02826220; Pawson R, 1997, J CLIN ONCOL, V15, P2667, DOI 10.1200/JCO.1997.15.7.2667; Ratzinger G, 2003, BLOOD, V101, P1422, DOI 10.1182/blood-2002-04-1093; Rawstron AC, 2001, BLOOD, V98, P29, DOI 10.1182/blood.V98.1.29; Rebello P, 2002, J IMMUNOL METHODS, V260, P285, DOI 10.1016/S0022-1759(01)00556-7; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; Rossmann E D, 2001, Hematol J, V2, P300, DOI 10.1038/sj.thj.6200119; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Stanglmaier M, 2004, ANN HEMATOL, V83, P634, DOI 10.1007/s00277-004-0917-0	45	136	137	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39416	10.1371/journal.pone.0039416	http://dx.doi.org/10.1371/journal.pone.0039416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761788	Green Published, Green Submitted, gold			2022-12-27	WOS:000305781700036
J	Jutras-Aswad, D; Jacobs, MM; Yiannoulos, G; Roussos, P; Bitsios, P; Nomura, Y; Liu, X; Hurd, YL				Jutras-Aswad, Didier; Jacobs, Michelle M.; Yiannoulos, Georgia; Roussos, Panos; Bitsios, Panos; Nomura, Yoko; Liu, Xun; Hurd, Yasmin L.			Cannabis-Dependence Risk Relates to Synergism between Neuroticism and Proenkephalin SNPs Associated with Amygdala Gene Expression: Case-Control Study	PLOS ONE			English	Article							POPULATION-BASED SAMPLE; STOP SIGNAL INHIBITION; D2 RECEPTOR GENE; ENVIRONMENTAL-INFLUENCES; PRE-PROENKEPHALIN; NEGATIVE AFFECT; WORKING-MEMORY; SUBSTANCE USE; FEMALE TWINS; DRUG-USE	Background: Many young people experiment with cannabis, yet only a subgroup progress to dependence suggesting individual differences that could relate to factors such as genetics and behavioral traits. Dopamine receptor D2 (DRD2) and proenkephalin (PENK) genes have been implicated in animal studies with cannabis exposure. Whether polymorphisms of these genes are associated with cannabis dependence and related behavioral traits is unknown. Methodology/Principal Findings: Healthy young adults (18-27 years) with cannabis dependence and without a dependence diagnosis were studied (N = 50/group) in relation to a priori-determined single nucleotide polymorphisms (SNPs) of the DRD2 and PENK genes. Negative affect, Impulsive Risk Taking and Neuroticism-Anxiety temperamental traits, positive and negative reward-learning performance and stop-signal reaction times were examined. The findings replicated the known association between the rs6277 DRD2 SNP and decisions associated with negative reinforcement outcomes. Moreover, PENK variants (rs2576573 and rs2609997) significantly related to Neuroticism and cannabis dependence. Cigarette smoking is common in cannabis users, but it was not associated to PENK SNPs as also validated in another cohort (N = 247 smokers, N = 312 non-smokers). Neuroticism mediated (15.3%-19.5%) the genetic risk to cannabis dependence and interacted with risk SNPs, resulting in a 9-fold increase risk for cannabis dependence. Molecular characterization of the postmortem human brain in a different population revealed an association between PENK SNPs and PENK mRNA expression in the central amygdala nucleus emphasizing the functional relevance of the SNPs in a brain region strongly linked to negative affect. Conclusions/Significance: Overall, the findings suggest an important role for Neuroticism as an endophenotype linking PENK polymorphisms to cannabis-dependence vulnerability synergistically amplifying the apparent genetic risk.	[Jutras-Aswad, Didier; Jacobs, Michelle M.; Yiannoulos, Georgia; Roussos, Panos; Nomura, Yoko; Liu, Xun; Hurd, Yasmin L.] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Jacobs, Michelle M.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY USA; [Bitsios, Panos; Hurd, Yasmin L.] Univ Crete, Fac Med, Dept Psychiat & Behav Sci, Iraklion, Crete, Greece; [Liu, Xun] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Nomura, Yoko] Queens Coll, Dept Psychol, Queens, NY USA; [Hurd, Yasmin L.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Hurd, Yasmin L.] James J Peters VA Med Ctr, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Crete; Chinese Academy of Sciences; Institute of Psychology, CAS; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Jutras-Aswad, D (corresponding author), Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada.	Yasmin.hurd@mssm.edu	Liu, Xun/C-2400-2009	Liu, Xun/0000-0003-1366-8926	Mount Sinai School of Medicine Fund; Centre Hospitalier de l'Universite de Montreal Research Fellowship Award; National Institutes of Health [DA15446, T32 DA007135]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH080062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015446, T32DA007135] Funding Source: NIH RePORTER	Mount Sinai School of Medicine Fund; Centre Hospitalier de l'Universite de Montreal Research Fellowship Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by Mount Sinai School of Medicine Fund (YLH), Centre Hospitalier de l'Universite de Montreal Research Fellowship Award (DJA) and National Institutes of Health [DA15446 (YLH), T32 DA007135 (MMJ)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2009, ADDICTION, V104, P518, DOI 10.1111/j.1360-0443.2009.02504.x; [Anonymous], 2005, CANADIAN ADDICTION S; Arendt M, 2007, PSYCHOL MED, V37, P935, DOI 10.1017/S0033291706009688; Berman SM, 2003, ALCOHOL, V30, P201, DOI 10.1016/j.alcohol.2003.06.002; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; DiNieri JA, 2011, BIOL PSYCHIAT, V70, P763, DOI 10.1016/j.biopsych.2011.06.027; Drakenberg K, 2006, P NATL ACAD SCI USA, V103, P7883, DOI 10.1073/pnas.0600871103; EMCDDA EMCfDaDA, 2009, ANN REP 2009 STAT DR; Fagergren P, 2003, EUR J NEUROSCI, V17, P2212, DOI 10.1046/j.1460-9568.2003.02636.x; Frank MJ, 2009, NEUROSCIENCE, V164, P131, DOI 10.1016/j.neuroscience.2009.04.048; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Hyman SM, 2009, J SUBST ABUSE TREAT, V36, P400, DOI 10.1016/j.jsat.2008.08.005; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Kang W, 2000, NEUROPSYCHOPHARMACOL, V22, P77, DOI 10.1016/S0893-133X(99)00090-1; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P261, DOI 10.1001/archpsyc.57.3.261; Kendler KS, 1998, AM J PSYCHIAT, V155, P1016, DOI 10.1176/ajp.155.8.1016; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Konig M, 1996, NATURE, V383, P535, DOI 10.1038/383535a0; Kung JC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-29; Le Foll B, 2009, BEHAV PHARMACOL, V20, P1, DOI 10.1097/FBP.0b013e3283242f05; Li CSR, 2008, NEUROPSYCHOPHARMACOL, V33, P1798, DOI 10.1038/sj.npp.1301568; Li CSR, 2006, DRUG ALCOHOL DEPEN, V85, P205, DOI 10.1016/j.drugalcdep.2006.04.008; Lobbestael J, 2011, CLIN PSYCHOL PSYCHOT, V18, P75, DOI 10.1002/cpp.693; Maes HH, 1999, J STUD ALCOHOL, V60, P293, DOI 10.15288/jsa.1999.60.293; McGue M, 2000, AM J MED GENET, V96, P671, DOI 10.1002/1096-8628(20001009)96:5<671::AID-AJMG14>3.0.CO;2-W; Miles DR, 2001, DRUG ALCOHOL DEPEN, V62, P57, DOI 10.1016/S0376-8716(00)00165-4; Munafo MR, 2007, NICOTINE TOB RES, V9, P405, DOI 10.1080/14622200701188851; NODA M, 1982, NATURE, V297, P431, DOI 10.1038/297431a0; Rhee SH, 2003, ARCH GEN PSYCHIAT, V60, P1256, DOI 10.1001/archpsyc.60.12.1256; Ridenour TA, 2005, DRUG ALCOHOL DEPEN, V80, P1, DOI 10.1016/j.drugalcdep.2005.02.005; Roussos P, 2011, NEUROPSYCHOPHARMACOL, V36, P1677, DOI 10.1038/npp.2011.49; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Substance Abuse and Mental Health Services Administration (SAMHSA), 2011, RES 2010 NAT SURV DR, VH-41; Tsuang MT, 1998, ARCH GEN PSYCHIAT, V55, P967, DOI 10.1001/archpsyc.55.11.967; van den Bree MBM, 1998, DRUG ALCOHOL DEPEN, V52, P231, DOI 10.1016/S0376-8716(98)00101-X; Wang XY, 2004, BIOL PSYCHIAT, V56, P909, DOI 10.1016/j.biopsych.2004.10.015; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104; Zuckerman M, 2002, BIG FIVE ASSESSMENT, P377	40	27	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39243	10.1371/journal.pone.0039243	http://dx.doi.org/10.1371/journal.pone.0039243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745721	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900038
J	Klauke, B; Winter, B; Gajewska, A; Zwanzger, P; Reif, A; Herrmann, MJ; Dlugos, A; Warrings, B; Jacob, C; Muhlberger, A; Arolt, V; Pauli, P; Deckert, J; Domschke, K				Klauke, Benedikt; Winter, Bernward; Gajewska, Agnes; Zwanzger, Peter; Reif, Andreas; Herrmann, Martin J.; Dlugos, Andrea; Warrings, Bodo; Jacob, Christian; Muehlberger, Andreas; Arolt, Volker; Pauli, Paul; Deckert, Juergen; Domschke, Katharina			Affect-Modulated Startle: Interactive Influence of Catechol-O-Methyltransferase Val158Met Genotype and Childhood Trauma	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; COMT VAL(158)MET POLYMORPHISM; POSTTRAUMATIC-STRESS-DISORDER; FEAR-POTENTIATED STARTLE; CAFFEINE-INDUCED ANXIETY; PANIC DISORDER; PREPULSE INHIBITION; ACOUSTIC STARTLE; COMMUNITY SAMPLE; LIFE EVENTS	The etiology of emotion-related disorders such as anxiety or affective disorders is considered to be complex with an interaction of biological and environmental factors. Particular evidence has accumulated for alterations in the dopaminergic and noradrenergic system - partly conferred by catechol-O-methyltransferase (COMT) gene variation - for the adenosinergic system as well as for early life trauma to constitute risk factors for those conditions. Applying a multi-level approach, in a sample of 95 healthy adults, we investigated effects of the functional COMT Val158Met polymorphism, caffeine as an adenosine A2A receptor antagonist (300 mg in a placebo-controlled intervention design) and childhood maltreatment (CTQ) as well as their interaction on the affect-modulated startle response as a neurobiologically founded defensive reflex potentially related to fear- and distress-related disorders. COMT val/val genotype significantly increased startle magnitude in response to unpleasant stimuli, while met/met homozygotes showed a blunted startle response to aversive pictures. Furthermore, significant gene-environment interaction of COMT Val158Met genotype with CTQ was discerned with more maltreatment being associated with higher startle potentiation in val/val subjects but not in met carriers. No main effect of or interaction effects with caffeine were observed. Results indicate a main as well as a GxE effect of the COMT Val158Met variant and childhood maltreatment on the affect-modulated startle reflex, supporting a complex pathogenetic model of the affect-modulated startle reflex as a basic neurobiological defensive reflex potentially related to anxiety and affective disorders.	[Klauke, Benedikt; Winter, Bernward; Zwanzger, Peter; Dlugos, Andrea; Arolt, Volker; Domschke, Katharina] Univ Munster, Dept Psychiat & Psychotherapy, Munster, Germany; [Klauke, Benedikt] Christoph Dornier Clin Psychotherapy, Munster, Germany; [Gajewska, Agnes; Reif, Andreas; Herrmann, Martin J.; Warrings, Bodo; Jacob, Christian; Deckert, Juergen; Domschke, Katharina] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany; [Muehlberger, Andreas; Pauli, Paul] Univ Wurzburg, Dept Psychol, Wurzburg, Germany	University of Munster; University of Wurzburg; University of Wurzburg	Klauke, B (corresponding author), Univ Munster, Dept Psychiat & Psychotherapy, Munster, Germany.	Domschke_K@klinik.uni-wuerzburg.de	Herrmann, Martin J./C-9904-2009; herrmann, martin/AAT-9836-2020; Domschke, Katharina/I-7921-2013	Herrmann, Martin J./0000-0001-9970-2122; Pauli, Paul/0000-0003-0692-6720	Deutsche Forschungsgemeinschaft [SFB-TRR-58]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a scientific grant from the Deutsche Forschungsgemeinschaft (SFB-TRR-58, projects B1 to PP and AM, C1 to PZ, C2 to KD and JD and Z2 to JD, AR and PP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky Hamid Mostafavi, 2008, V448, P187, DOI 10.1007/978-1-59745-205-2_9; Allen NB, 1999, BIOL PSYCHIAT, V46, P542, DOI 10.1016/S0006-3223(99)00025-6; Alsene K, 2003, NEUROPSYCHOPHARMACOL, V28, P1694, DOI 10.1038/sj.npp.1300232; Andrews SE, 1998, PHARMACOL BIOCHEM BE, V59, P39, DOI 10.1016/S0091-3057(97)00331-6; Anokhin AP, 2007, PSYCHOPHYSIOLOGY, V44, P106, DOI 10.1111/j.1469-8986.2006.004863x; Anokhin AP, 2003, NEUROSCI LETT, V353, P45, DOI 10.1016/j.neulet.2003.09.014; [Anonymous], 2004, PRACTICAL ASSESSMENT; Armbruster D, 2011, J NEURAL TRANSM, V118, P1281, DOI 10.1007/s00702-011-0625-6; Armbruster D, 2009, INT J NEUROPSYCHOPH, V12, P393, DOI 10.1017/S1461145708009565; Bader K, 2009, Z KL PSYCH PSYCHOTH, V38, P223, DOI 10.1026/1616-3443.38.4.223; Baekken PM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-48; Baffa A, 2010, NEUROPSYCHOBIOLOGY, V62, P121, DOI 10.1159/000317285; Bandelow B, 2002, COMPR PSYCHIAT, V43, P269, DOI 10.1053/comp.2002.33492; Bandelow B, 2001, CAN J PSYCHIAT, V46, P948, DOI 10.1177/070674370104601007; Baune BT, 2008, NEUROSCI LETT, V436, P111, DOI 10.1016/j.neulet.2008.03.001; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; BRADLEY MM, 1993, PSYCHOPHYSIOLOGY, V30, P541, DOI 10.1111/j.1469-8986.1993.tb02079.x; BROWN GW, 1993, PSYCHOL MED, V23, P143, DOI 10.1017/S0033291700038939; BUTLER RW, 1990, AM J PSYCHIAT, V147, P1308; Carlson SR, 1997, BIOL PSYCHOL, V46, P235, DOI 10.1016/S0301-0511(97)00014-8; CHARNEY DS, 1985, ARCH GEN PSYCHIAT, V42, P233; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Childs E, 2008, NEUROPSYCHOPHARMACOL, V33, P2791, DOI 10.1038/npp.2008.17; Comasco E, 2011, PSYCHIAT GENET, V21, P19, DOI 10.1097/YPG.0b013e328341a3c1; Conway CC, 2010, DEPRESS ANXIETY, V27, P737, DOI 10.1002/da.20715; Davis M, 1997, ANN NY ACAD SCI, V821, P305, DOI 10.1111/j.1749-6632.1997.tb48289.x; Deckert J, 1998, MOL PSYCHIATR, V3, P81, DOI 10.1038/sj.mp.4000345; Dichter GS, 2004, PSYCHOPHYSIOLOGY, V41, P433, DOI 10.1111/j.1469-8986.00162.x; Domschke K, 2004, INT J NEUROPSYCHOPH, V7, P183, DOI 10.1017/s146114570400416X; Domschke K, 2008, PSYCHIAT RES-NEUROIM, V163, P13, DOI 10.1016/j.pscychresns.2007.04.016; Domschke K, 2007, AM J MED GENET B, V144B, P667, DOI 10.1002/ajmg.b.30494; Domschke K, 2012, NEUROIMAGE, V60, P2222, DOI 10.1016/j.neuroimage.2012.02.039; Domschke K, 2012, NEUROPSYCHOPHARMACOL, V37, P759, DOI 10.1038/npp.2011.253; Domschke K, 2010, NEUROIMAGE, V53, P822, DOI 10.1016/j.neuroimage.2009.11.042; Eley TC, 2003, AM J MED GENET B, V120B, P90, DOI 10.1002/ajmg.b.20046; Enoch MA, 2003, PSYCHIAT GENET, V13, P33, DOI 10.1097/00041444-200303000-00006; Enoch MA, 2008, DEPRESS ANXIETY, V25, P383, DOI 10.1002/da.20378; Epperson CN, 2007, NEUROPSYCHOPHARMACOL, V32, P2190, DOI 10.1038/sj.npp.1301351; Evans J, 2009, AM J MED GENET B, V150B, P209, DOI 10.1002/ajmg.b.30789; Filion DL, 1998, BIOL PSYCHOL, V47, P1, DOI 10.1016/S0301-0511(97)00020-3; Forbes EE, 2005, PSYCHIAT RES, V134, P11, DOI 10.1016/j.psychres.2005.01.001; Fredrickson BL, 1998, COGNITION EMOTION, V12, P191; Fredrickson BL, 2003, J PERS SOC PSYCHOL, V84, P365, DOI 10.1037/0022-3514.84.2.365; Fredrickson BL, 1998, REV GEN PSYCHOL, V2, P300, DOI DOI 10.1037/1089-2680.2.3.300; Funke B, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-19; Fuxe K, 2007, PHYSIOL BEHAV, V92, P210, DOI 10.1016/j.physbeh.2007.05.034; Gast U, 2001, DTSCH BEARBEITUNG CH; Giakoumaki SG, 2008, NEUROPSYCHOPHARMACOL, V33, P3058, DOI 10.1038/npp.2008.82; Grabe HJ, 2009, AM J PSYCHIAT, V166, P926, DOI 10.1176/appi.ajp.2009.08101542; Greenwood TA, 2007, ARCH GEN PSYCHIAT, V64, P1242, DOI 10.1001/archpsyc.64.11.1242; GRILLON C, 1994, BIOL PSYCHIAT, V35, P431, DOI 10.1016/0006-3223(94)90040-X; Grillon C, 2003, CLIN NEUROPHYSIOL, V114, P1557, DOI 10.1016/S1388-2457(03)00202-5; Grillon C, 2002, BIOL PSYCHIAT, V52, P958, DOI 10.1016/S0006-3223(02)01665-7; Grillon C, 1998, BIOL PSYCHIAT, V44, P1027, DOI 10.1016/S0006-3223(98)00034-1; Hamilton SP, 2004, NEUROPSYCHOPHARMACOL, V29, P558, DOI 10.1038/sj.npp.1300311; Hamilton SP, 2002, BIOL PSYCHIAT, V51, P591, DOI 10.1016/S0006-3223(01)01322-1; HAMM A, 1991, Integrative Physiological and Behavioral Science, V26, P119, DOI 10.1007/BF02691034; Hamm AO, 1997, PSYCHOPHYSIOLOGY, V34, P97, DOI 10.1111/j.1469-8986.1997.tb02420.x; Hariri AR, 2002, NEUROPSYCHOPHARMACOL, V27, P1036, DOI 10.1016/S0893-133X(02)00373-1; Harmer CJ, 2004, AM J PSYCHIAT, V161, P1256, DOI 10.1176/appi.ajp.161.7.1256; Hasenkamp W, 2010, PSYCHIAT RES, V178, P236, DOI 10.1016/j.psychres.2009.11.012; Hawk LW, 2000, PSYCHOPHYSIOLOGY, V37, P5, DOI 10.1017/S0048577200980855; Henderson AS, 2000, AM J MED GENET, V96, P102, DOI 10.1002/(SICI)1096-8628(20000207)96:1<102::AID-AJMG20>3.0.CO;2-3; Henry B., 1994, PSYCHOL ASSESSMENT, V6, P92, DOI [10.1037/1040-3590.6.2.92, DOI 10.1037/1040-3590.6.2.92]; Hettema JM, 2005, ARCH GEN PSYCHIAT, V62, P182, DOI 10.1001/archpsyc.62.2.182; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Hettema JM, 2008, BIOL PSYCHIAT, V64, P302, DOI 10.1016/j.biopsych.2008.03.014; Hohoff C, 2009, J NEURAL TRANSM, V116, P659, DOI 10.1007/s00702-008-0089-5; Hohoff C, 2010, J PSYCHIATR RES, V44, P930, DOI 10.1016/j.jpsychires.2010.02.006; Hoth Karin F, 2006, Neuropsychiatr Dis Treat, V2, P219, DOI 10.2147/nedt.2006.2.2.219; Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491; Jovanovic T, 2009, DEPRESS ANXIETY, V26, P1018, DOI 10.1002/da.20599; Kang EH, 2010, J AFFECT DISORDERS, V123, P337, DOI 10.1016/j.jad.2009.10.008; Kempton MJ, 2009, INT J NEUROPSYCHOPH, V12, P371, DOI 10.1017/S1461145708009395; Kendler KS, 1999, PSYCHOL MED, V29, P539, DOI 10.1017/S0033291799008429; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P109; Kim SJ, 2006, NEUROSCI LETT, V401, P154, DOI 10.1016/j.neulet.2006.03.006; Klauke B, 2011, DEPRESS ANXIETY, V28, P1048, DOI 10.1002/da.20840; Klauke B, 2010, DEPRESS ANXIETY, V27, P716, DOI 10.1002/da.20667; Klumpers F, 2012, BIOL PSYCHOL, V89, P277, DOI 10.1016/j.biopsycho.2011.10.018; Kolassa IT, 2010, BIOL PSYCHIAT, V67, P304, DOI 10.1016/j.biopsych.2009.10.009; Kraemer HC, 2004, INT J METH PSYCH RES, V13, P141, DOI 10.1002/mpr.170; Kroner S, 2005, J NEUROPHYSIOL, V93, P1598, DOI 10.1152/jn.00843.2004; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lam P, 2005, NEUROSCI LETT, V378, P98, DOI 10.1016/j.neulet.2004.12.012; Lang A, 2005, INT AFFECTIVE PICTUR; Lang PJ, 2009, ANXIETY STRESS COPIN, V22, P5, DOI 10.1080/10615800802478247; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Laucht M, 2009, INT J NEUROPSYCHOPH, V12, P737, DOI 10.1017/S1461145708009875; Lelli-Chiesa G, 2011, PSYCHOL MED, V41, P779, DOI 10.1017/S0033291710001431; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Lonsdorf TB, 2011, BIOL PSYCHOL, V87, P106, DOI 10.1016/j.biopsycho.2011.02.014; Lonsdorf TB, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-99; Lonsdorf TB, 2009, PSYCHOL SCI, V20, P198, DOI 10.1111/j.1467-9280.2009.02280.x; Ludewig S, 2005, J PSYCHIATR NEUROSCI, V30, P37; Mandelli L, 2007, INT J NEUROPSYCHOPH, V10, P437, DOI 10.1017/S1461145706006882; Maslova LN, 2002, PHYSIOL BEHAV, V75, P217, DOI 10.1016/S0031-9384(01)00648-5; Massat I, 2005, MOL PSYCHIATR, V10, P598, DOI 10.1038/sj.mp.4001615; McGrath M, 2004, AM J PSYCHIAT, V161, P1703, DOI 10.1176/appi.ajp.161.9.1703; McTeague LM, 2009, BIOL PSYCHIAT, V65, P374, DOI 10.1016/j.biopsych.2008.09.023; Medina AM, 2001, PSYCHIAT RES, V101, P157, DOI 10.1016/S0165-1781(01)00221-9; Melzig CA, 2007, PSYCHOPHYSIOLOGY, V44, P846, DOI 10.1111/j.1469-8986.2007.00560.x; Melzig CA, 2009, INT J PSYCHOPHYSIOL, V71, P109, DOI 10.1016/j.ijpsycho.2008.07.013; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Michalowski JM, 2009, EMOTION, V9, P306, DOI 10.1037/a0015550; Montag C, 2008, BEHAV NEUROSCI, V122, P901, DOI 10.1037/0735-7044.122.4.901; Niwa M, 2010, INT J NEUROPSYCHOPHA, P1; Norbury R, 2007, BRIT J PSYCHIAT, V190, P531, DOI 10.1192/bjp.bp.106.031393; Ohara K, 1998, NEUROREPORT, V9, P1305, DOI 10.1097/00001756-199805110-00009; Ohara K, 1998, PSYCHIAT RES, V80, P145, DOI 10.1016/S0165-1781(98)00062-6; Olsson CA, 2007, GENES BRAIN BEHAV, V6, P647, DOI 10.1111/j.1601-183X.2007.00313.x; Olsson CA, 2005, PSYCHIAT GENET, V15, P109, DOI 10.1097/00041444-200506000-00007; Osborne J. W., 2002, PRACTICAL ASSESSMENT, V8, P2, DOI [10.7275/R222-HV23, DOI 10.7275/R222-HV23]; Pauli P, 2010, PSYCHOPHYSIOLOGY, V47, P25, DOI 10.1111/j.1469-8986.2009.00923.x; de la Mora MP, 2010, PROG NEUROBIOL, V90, P198, DOI 10.1016/j.pneurobio.2009.10.010; Powell KR, 1999, BEHAV PHARMACOL, V10, P707, DOI 10.1097/00008877-199912000-00001; Quednow BB, 2009, BIOL PSYCHIAT, V66, P614, DOI 10.1016/j.biopsych.2009.05.007; Richard IH, 1996, J NEUROPSYCH CLIN N, V8, P383; Rogers PJ, 2010, NEUROPSYCHOPHARMACOL, V35, P1973, DOI 10.1038/npp.2010.71; Rothe C, 2006, NEUROPSYCHOPHARMACOL, V31, P2237, DOI 10.1038/sj.npp.1301048; Roussos P, 2008, PSYCHOL MED, V38, P1651, DOI 10.1017/S0033291708002912; Ruffman T, 2008, NEUROSCI BIOBEHAV R, V32, P863, DOI 10.1016/j.neubiorev.2008.01.001; Sabatinelli D, 2001, PSYCHOPHYSIOLOGY, V38, P719, DOI 10.1111/1469-8986.3840719; Samochowiec J, 2004, PSYCHIAT RES, V128, P21, DOI 10.1016/j.psychres.2004.05.012; Scher CD, 2001, J TRAUMA STRESS, V14, P843, DOI 10.1023/A:1013058625719; SCHICATANO EJ, 1995, PHARMACOL BIOCHEM BE, V52, P231, DOI 10.1016/0091-3057(95)00110-I; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SHULMAN R, 1978, BRIT J PSYCHIAT, V132, P133, DOI 10.1192/bjp.132.2.133; Sloan DM, 2010, BIOL PSYCHOL, V84, P368, DOI 10.1016/j.biopsycho.2010.04.004; Smith DP, 2005, J GERONTOL B-PSYCHOL, V60, pP49, DOI 10.1093/geronb/60.1.P49; Smolka MN, 2005, J NEUROSCI, V25, P836, DOI 10.1523/JNEUROSCI.1792-04.2005; Spatola CAM, 2011, AM J MED GENET B, V156B, P79, DOI 10.1002/ajmg.b.31144; Stein MB, 2005, NEUROPSYCHOPHARMACOL, V30, P2092, DOI 10.1038/sj.npp.1300787; Stein MB, 1996, AM J PSYCHIAT, V153, P275; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Taylor-Clift A, 2011, PSYCHOL MED, V41, P129, DOI 10.1017/S003329171000036X; Vaidyanathan U, 2009, PSYCHOL BULL, V135, P909, DOI 10.1037/a0017222; VRANA SR, 1988, J ABNORM PSYCHOL, V97, P487, DOI 10.1037/0021-843X.97.4.487; Wingenfeld K, 2010, PSYCHOTHER PSYCH MED, V60, P442, DOI 10.1055/s-0030-1247564; WINQVIST R, 1992, CYTOGENET CELL GENET, V59, P253, DOI 10.1159/000133262; Woo JM, 2004, J PSYCHIATR RES, V38, P365, DOI 10.1016/j.jpsychires.2004.01.001; Woo JM, 2002, AM J PSYCHIAT, V159, P1785, DOI 10.1176/appi.ajp.159.10.1785; Wray NR, 2008, AM J MED GENET B, V147B, P1314, DOI 10.1002/ajmg.b.30744; Xie T, 1999, MOL PHARMACOL, V56, P31, DOI 10.1124/mol.56.1.31; Yang A, 2010, PSYCHOPHARMACOLOGY, V211, P245, DOI 10.1007/s00213-010-1900-1	147	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39709	10.1371/journal.pone.0039709	http://dx.doi.org/10.1371/journal.pone.0039709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745815	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900103
J	Nemmar, A; Subramaniyan, D; Ali, BH				Nemmar, Abderrahim; Subramaniyan, Deepa; Ali, Badreldin H.			Protective Effect of Curcumin on Pulmonary and Cardiovascular Effects Induced by Repeated Exposure to Diesel Exhaust Particles in Mice	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; TUMOR-NECROSIS-FACTOR; AIR-POLLUTION; PARTICULATE MATTER; INFLAMMATORY RESPONSES; MYOCARDIAL-INFARCTION; FACTOR-ALPHA; TNF-ALPHA; D-DIMER; RISK	Particulate air pollution has been associated with increased risk of cardiopulmonary diseases. However, the underlying mechanisms are not fully understood. We have previously demonstrated that single dose exposure to diesel exhaust particle (DEP) causes lung inflammation and peripheral thrombotic events. Here, we exposed mice with repeated doses of DEP (15 mu g/animal) every 2nd day for 6 days (a total of 4 exposures), and measured several cardiopulmonary endpoints 48 h after the end of the treatments. Moreover, the potential protective effect of curcumin (the yellow pigment isolated from turmeric) on DEP-induced cardiopulmonary toxicity was assessed. DEP exposure increased macrophage and neutrophil numbers, tumor necrosis factor a (TNF alpha) in the bronchoalveolar lavage (BAL) fluid, and enhanced airway resistance to methacoline measured invasively using Flexivent. DEP also significantly increased plasma C-reactive protein (CRP) and TNF alpha concentrations, systolic blood pressure (SBP) as well as the pial arteriolar thrombosis. It also significantly enhanced the plasma D-dimer and plasminogen activator inhibitor-1 (PAI-1). Pretreatment with curcumin by oral gavage (45 mg/kg) 1h before exposure to DEP significantly prevented the influx of inflammatory cells and the increase of TNF alpha in BAL, and the increased airway resistance caused by DEP. Likewise, curcumin prevented the increase of SBP, CRP, TNF alpha, D-dimer and PAI-1. The thrombosis was partially but significantly mitigated. In conclusion, repeated exposure to DEP induced lung and systemic inflammation characterized by TNF alpha release, increased SBP, and accelerated coagulation. Our findings indicate that curcumin is a potent anti-inflammatory agent that prevents the release of TNF alpha and protects against the pulmonary and cardiovascular effects of DEP.	[Nemmar, Abderrahim; Subramaniyan, Deepa] United Arab Emirates Univ, Dept Physiol, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Ali, Badreldin H.] Sultan Qaboos Univ, Dept Pharmacol & Clin Pharm, Coll Med & Hlth Sci, Al Khoud, Oman	United Arab Emirates University; Sultan Qaboos University	Nemmar, A (corresponding author), United Arab Emirates Univ, Dept Physiol, Fac Med & Hlth Sci, Al Ain, U Arab Emirates.	anemmar@uaeu.ac.ae			Emirates Foundation [2009-045]; United Arab Emirates University, Faculty of Medicine and Health Sciences	Emirates Foundation; United Arab Emirates University, Faculty of Medicine and Health Sciences	This work was supported by the Emirates Foundation grant Grant #: 2009-045 and United Arab Emirates University, Faculty of Medicine and Health Sciences Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BH, 2006, NAT PROD COMMUN, V1, P509; BARRY CC, 1994, ENVIRONMENT, V36, P5; Behndig AF, 2006, EUR RESPIR J, V27, P359, DOI 10.1183/09031936.06.00136904; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brook RD, 2009, J AM SOC HYPERTENS, V3, P332, DOI 10.1016/j.jash.2009.08.005; Brook RD, 2009, HYPERTENSION, V54, P659, DOI 10.1161/HYPERTENSIONAHA.109.130237; Budinger GRS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018525; Cesari M, 2010, CARDIOVASC THER, V28, pe72, DOI 10.1111/j.1755-5922.2010.00171.x; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Delfino RJ, 2008, ENVIRON HEALTH PERSP, V116, P898, DOI 10.1289/ehp.11189; Delfino RJ, 2009, ENVIRON HEALTH PERSP, V117, P1232, DOI [10.1289/journla.ehp.0800194, 10.1289/ehp.0800194]; Driscoll KE, 2000, TOXICOL SCI, V55, P24, DOI 10.1093/toxsci/55.1.24; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Epstein JA, 2008, J CLIN INVEST, V118, P850, DOI 10.1172/JCI34650; Franchini M, 2011, BLOOD, V118, P2405, DOI 10.1182/blood-2011-04-343111; Ghosh SS, 2009, AM J PHYSIOL-RENAL, V296, pF1146, DOI 10.1152/ajprenal.90732.2008; Gruber F, 2003, BLOOD, V101, P3042, DOI 10.1182/blood-2002-07-2331; Hou BD, 2004, J BIOL CHEM, V279, P18127, DOI 10.1074/jbc.M310438200; KIDO T, 2010, AM J RESP CELL MOL B; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lowe GDO, 1999, THROMB HAEMOSTASIS, V82, P667; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314; Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639; Nemmar A, 2004, CIRCULATION, V110, P1670, DOI 10.1161/01.CIR.0000142053.13921.21; Nemmar A, 2003, CIRCULATION, V107, P1202, DOI 10.1161/01.CIR.0000053568.13058.67; Nemmar A, 2008, EXP BIOL MED, V233, P610, DOI 10.3181/0706-RM-165; Nemmar A, 2007, AM J PHYSIOL-LUNG C, V292, pL664, DOI 10.1152/ajplung.00240.2006; Nemmar A, 2011, BRIT J PHARMACOL, V164, P1871, DOI 10.1111/j.1476-5381.2011.01442.x; Nemmar A, 2010, TOXICOL LETT, V194, P58, DOI 10.1016/j.toxlet.2010.02.001; Nemmar A, 2010, TOXICOL SCI, V113, P267, DOI 10.1093/toxsci/kfp222; Nemmar A, 2009, TOXICOLOGY, V263, P84, DOI 10.1016/j.tox.2009.06.017; Nordenhall C, 2001, EUR RESPIR J, V17, P909, DOI 10.1183/09031936.01.17509090; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Park NY, 2011, BRIT J NUTR, V106, P1514, DOI 10.1017/S0007114511001929; Plomgaard P, 2005, J APPL PHYSIOL, V98, P2019, DOI 10.1152/japplphysiol.01220.2004; Punithavathi D, 2000, BRIT J PHARMACOL, V131, P169, DOI 10.1038/sj.bjp.0703578; RIDKER PM, 1994, CIRCULATION, V90, P2236, DOI 10.1161/01.CIR.90.5.2236; Ruckerl R, 2006, AM J RESP CRIT CARE, V173, P432, DOI 10.1164/rccm.200507-1123OC; Ruckerl Regina, 2007, Part Fibre Toxicol, V4, P1, DOI 10.1186/1743-8977-4-1; Saber AT, 2005, ARCH TOXICOL, V79, P177, DOI 10.1007/s00204-004-0613-9; Salam MT, 2008, CURR OPIN PULM MED, V14, P3, DOI 10.1097/MCP.0b013e3282f1987a; Sallam N, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/149678; Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083; Shishodia S, 2003, CARCINOGENESIS, V24, P1269, DOI 10.1093/carcin/bgg078; Su CC, 2010, PHYTOTHER RES, V24, P189, DOI 10.1002/ptr.2905; Sun QH, 2010, CIRCULATION, V121, P2755, DOI 10.1161/CIRCULATIONAHA.109.893461; Suresh MV, 2012, AM J RESP CELL MOL, V47, P280, DOI 10.1165/rcmb.2011-0175OC; Suzuki M, 2009, AM J PHYSIOL-LUNG C, V296, pL614, DOI 10.1152/ajplung.90443.2008; Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241; Vanoirbeek JAJ, 2004, TOXICOL SCI, V80, P310, DOI 10.1093/toxsci/kfh155; Vermylen J, 2005, J THROMB HAEMOST, V3, P1955, DOI 10.1111/j.1538-7836.2005.01471.x; Yamashita M, 1997, THROMB RES, V87, P165, DOI 10.1016/S0049-3848(97)00116-3; Yeh ETH, 2004, CIRCULATION, V109, P11, DOI 10.1161/01.CIR.0000129507.12719.80; Ying ZK, 2009, AM J PHYSIOL-HEART C, V296, pH1540, DOI 10.1152/ajpheart.01270.2008	59	61	63	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39554	10.1371/journal.pone.0039554	http://dx.doi.org/10.1371/journal.pone.0039554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745783	gold, Green Published, Green Submitted			2022-12-27	WOS:000305730900076
J	Sanchez, G; Besada, C; Badenes, ML; Monforte, AJ; Granell, A				Sanchez, Gerardo; Besada, Cristina; Luisa Badenes, Maria; Jose Monforte, Antonio; Granell, Antonio			A Non-Targeted Approach Unravels the Volatile Network in Peach Fruit	PLOS ONE			English	Article							METABOLOMIC NETWORKS; NECTARINES; IDENTIFICATION; QUALITY; BIOSYNTHESIS; CONSTITUENTS; SPECTROMETRY; METABOLITES; MATURATION; CONSUMER	Volatile compounds represent an important part of the plant metabolome and are of particular agronomic and biological interest due to their contribution to fruit aroma and flavor and therefore to fruit quality. By using a non-targeted approach based on HS-SPME-GC-MS, the volatile-compound complement of peach fruit was described. A total of 110 volatile compounds (including alcohols, ketones, aldehydes, esters, lactones, carboxylic acids, phenolics and terpenoids) were identified and quantified in peach fruit samples from different genetic backgrounds, locations, maturity stages and physiological responses. By using a combination of hierarchical cluster analysis and metabolomic correlation network analysis we found that previously known peach fruit volatiles are clustered according to their chemical nature or known biosynthetic pathways. Moreover, novel volatiles that had not yet been described in peach were identified and assigned to co-regulated groups. In addition, our analyses showed that most of the co-regulated groups showed good intergroup correlations that are therefore consistent with the existence of a higher level of regulation orchestrating volatile production under different conditions and/or developmental stages. In addition, this volatile network of interactions provides the ground information for future biochemical studies as well as a useful route map for breeding or biotechnological purposes.	[Sanchez, Gerardo; Besada, Cristina; Jose Monforte, Antonio; Granell, Antonio] CSIC UPV, IBMCP, Valencia, Spain; [Sanchez, Gerardo] INTA, Buenos Aires, DF, Argentina; [Luisa Badenes, Maria] Inst Valenciano Invest Agr, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Valenciano de Investigaciones Agrarias (IVIA)	Sanchez, G (corresponding author), CSIC UPV, IBMCP, Valencia, Spain.	agranell@ibmcp.upv.es	Granell, Antonio/G-3664-2010; Besada, Cristina/J-8767-2014; MONFORTE, Antonio José/B-4784-2009; Badenes, Maria Luisa/C-6606-2014	MONFORTE, Antonio José/0000-0003-3461-3094; Badenes, Maria Luisa/0000-0001-9722-6783; Besada, Cristina/0000-0003-0017-7271	INTA (Instituto Nacional de Tecnologia Agropecuaria)	INTA (Instituto Nacional de Tecnologia Agropecuaria)	GS has financial support from INTA (Instituto Nacional de Tecnologia Agropecuaria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert C, 2003, J AGR FOOD CHEM, V51, P3083, DOI 10.1021/jf026153i; Aubert C, 2007, FOOD CHEM, V102, P375, DOI 10.1016/j.foodchem.2006.05.030; BRUHN CM, 1995, J FOOD QUALITY, V18, P241, DOI 10.1111/j.1745-4557.1995.tb00378.x; BRUHN CM, 1991, J FOOD QUALITY, V14, P187, DOI 10.1111/j.1745-4557.1991.tb00060.x; Camacho D, 2005, METABOLOMICS, V1, P53, DOI 10.1007/s11306-005-1107-3; Gonzalez-Mas MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022016; CHAPMAN GW, 1991, J AGR FOOD CHEM, V39, P867, DOI 10.1021/jf00005a010; CRISOSTO CH, 2006, COMPACT FRUIT TREE, V39, P11; Derail C, 1999, J AGR FOOD CHEM, V47, P4742, DOI 10.1021/jf990459g; Eduardo I, 2010, J SCI FOOD AGR, V90, P1146, DOI 10.1002/jsfa.3932; GOMEZ E, 1993, J AGR FOOD CHEM, V41, P1669, DOI 10.1021/jf00034a029; Guillot S, 2006, FOOD CHEM, V96, P147, DOI 10.1016/j.foodchem.2005.04.016; Hall RD, 2006, NEW PHYTOL, V169, P453, DOI 10.1111/j.1469-8137.2005.01632.x; HORVAT RJ, 1990, J AGR FOOD CHEM, V38, P234, DOI 10.1021/jf00091a051; Jia HJ, 2005, POSTHARVEST BIOL TEC, V35, P61, DOI 10.1016/j.postharvbio.2004.06.004; Mencarelli F., 2005, Acta Horticulturae, P263; Meng XiangMin, 2007, Journal of Northwest A & F University - Natural Science Edition, V35, P125; Moing A, 2011, NEW PHYTOL, V190, P683, DOI 10.1111/j.1469-8137.2010.03626.x; Morgenthal K, 2006, BIOSYSTEMS, V83, P108, DOI 10.1016/j.biosystems.2005.05.017; Muller-Linow M, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-44; Ogundiwin EA, 2008, PLANT MOL BIOL, V68, P379, DOI 10.1007/s11103-008-9378-5; Pesis E, 2005, POSTHARVEST BIOL TEC, V37, P1, DOI 10.1016/j.postharvbio.2005.03.001; ROBERTSON JA, 1990, J AGR FOOD CHEM, V38, P620, DOI 10.1021/jf00093a008; Schottler M, 1996, HELV CHIM ACTA, V79, P1488, DOI 10.1002/hlca.19960790521; Schwab W, 2008, PLANT J, V54, P712, DOI 10.1111/j.1365-313X.2008.03446.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spolaore S, 2001, J EXP BOT, V52, P845, DOI 10.1093/jexbot/52.357.845; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Steuer R, 2003, BIOINFORMATICS, V19, P1019, DOI 10.1093/bioinformatics/btg120; Steuer R, 2006, BRIEF BIOINFORM, V7, P151, DOI 10.1093/bib/bbl009; SUMITANI H, 1994, J AGR FOOD CHEM, V42, P785, DOI 10.1021/jf00039a037; Tikunov Y, 2005, PLANT PHYSIOL, V139, P1125, DOI 10.1104/pp.105.068130; Ursem R, 2008, EUPHYTICA, V161, P181, DOI 10.1007/s10681-008-9672-y; Visai C, 1997, SCI HORTIC-AMSTERDAM, V70, P15, DOI 10.1016/S0304-4238(97)00032-0; Wang YJ, 2009, FOOD CHEM, V116, P356, DOI 10.1016/j.foodchem.2009.02.004; Xi WP, 2012, PLANT CELL ENVIRON, V35, P534, DOI 10.1111/j.1365-3040.2011.02433.x; Zanor MI, 2009, J EXP BOT, V60, P2139, DOI 10.1093/jxb/erp086; Zhang B, 2010, J AGR FOOD CHEM, V58, P6157, DOI 10.1021/jf100172e	38	47	51	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38992	10.1371/journal.pone.0038992	http://dx.doi.org/10.1371/journal.pone.0038992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761719	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900027
J	Skovstrup, S; David, L; Taboureau, O; Jorgensen, FS				Skovstrup, Soren; David, Laurent; Taboureau, Olivier; Jorgensen, Flemming Steen			A Steered Molecular Dynamics Study of Binding and Translocation Processes in the GABA Transporter	PLOS ONE			English	Article							AMINOBUTYRIC-ACID TRANSPORTER; TRANSMEMBRANE DOMAIN-I; FREE-ENERGY DIFFERENCES; NEUROTRANSMITTER TRANSPORTERS; BACTERIAL HOMOLOG; HIGH-AFFINITY; RAT-BRAIN; SUBSTRATE-BINDING; DRUG TARGETS; ION-BINDING	The entire substrate translocation pathway in the human GABA transporter (GAT-1) was explored for the endogenous substrate GABA and the anti-convulsive drug tiagabine. Following a steered molecular dynamics (SMD) approach, in which a harmonic restraining potential is applied to the ligand, dissociation and re-association of ligands were simulated revealing events leading to substrate (GABA) translocation and inhibitor (tiagabine) mechanism of action. We succeeded in turning the transporter from the outward facing occluded to the open-to-out conformation, and also to reorient the transporter to the open-to-in conformation. The simulations are validated by literature data and provide a substrate pathway fingerprint in terms of which, how, and in which sequence specific residues are interacted with. They reveal the essential functional roles of specific residues, e.g. the role of charged residues in the extracellular vestibule including two lysines (K76 (TM1) and K448 (TM10)) and a TM6-triad (D281, E283, and D287) in attracting and relocating substrates towards the secondary/interim substrate-binding site (S2). Likewise, E101 is highlighted as essential for the relocation of the substrate from the primary substrate-binding site (S1) towards the cytoplasm.	[Skovstrup, Soren; Jorgensen, Flemming Steen] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Skovstrup, Soren; David, Laurent] H Lundbeck & Co AS, Dept Computat Chem, Valby, Denmark; [Taboureau, Olivier] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark	University of Copenhagen; Lundbeck Corporation; Technical University of Denmark	Skovstrup, S (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Copenhagen, Denmark.	fsj@farma.ku.dk		Jorgensen, Flemming Steen/0000-0001-8040-2998	Lundbeck Foundation	Lundbeck Foundation(Lundbeckfonden)	The work was supported by a grant to Soren Skovstrup from the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro RE, 2007, BIOCHEMISTRY-US, V46, P2156, DOI 10.1021/bi061708e; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; BENDAHAN A, 1993, FEBS LETT, V318, P41, DOI 10.1016/0014-5793(93)81323-R; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Mai BK, 2010, J CHEM INF MODEL, V50, P2236, DOI 10.1021/ci100346s; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Bowers KJ, 2006, SC06, P4343; BRAESTRUP C, 1990, J NEUROCHEM, V54, P639, DOI 10.1111/j.1471-4159.1990.tb01919.x; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Cherubino F, 2009, CELL MOL LIFE SCI, V66, P3797, DOI 10.1007/s00018-009-0153-9; Clausen RP, 2006, ADV PHARMACOL, V54, P265, DOI 10.1016/S1054-3589(06)54011-6; Clausen RP, 2006, NEUROCHEM INT, V48, P637, DOI 10.1016/j.neuint.2005.12.031; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; *DE SHAW RES, 2009, DESM MOL DYN SYST VE; Deken SL, 2000, NAT NEUROSCI, V3, P998, DOI 10.1038/79939; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; Forlani G, 2001, J PHYSIOL-LONDON, V536, P479, DOI 10.1111/j.1469-7793.2001.0479c.xd; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Genchev GZ, 2009, CELL BIOCHEM BIOPHYS, V55, P141, DOI 10.1007/s12013-009-9064-5; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; Hansra N, 2004, J NEUROSCI, V24, P4082, DOI 10.1523/JNEUROSCI.0664-04.2004; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jarzynski C, 1997, PHYS REV E, V56, P5018, DOI 10.1103/PhysRevE.56.5018; Jensen MO, 2007, BIOPHYS J, V93, P92, DOI 10.1529/biophysj.107.103994; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; KESHET GI, 1995, FEBS LETT, V371, P39, DOI 10.1016/0014-5793(95)00859-8; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; MacAulay N, 2003, J BIOL CHEM, V278, P28771, DOI 10.1074/jbc.M213023200; Madsen KK, 2010, PHARMACOL THERAPEUT, V125, P394, DOI 10.1016/j.pharmthera.2009.11.007; Madsen KK, 2009, J NEUROCHEM, V109, P139, DOI 10.1111/j.1471-4159.2009.05982.x; Maestro, 2009, MAESTR VERS 9 0; Mager S, 1996, J NEUROSCI, V16, P5405; Meinild AK, 2009, J BIOL CHEM, V284, P16226, DOI 10.1074/jbc.M109.003137; Melamed N, 2004, MOL PHARMACOL, V65, P1452, DOI 10.1124/mol.65.6.1452; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Schousboe A, 2004, BIOCHEM PHARMACOL, V68, P1557, DOI 10.1016/j.bcp.2004.06.041; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Shan JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016350; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Skovstrup S, 2010, CHEMMEDCHEM, V5, P986, DOI 10.1002/cmdc.201000100; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; TAMURA S, 1995, J BIOL CHEM, V270, P28712, DOI 10.1074/jbc.270.48.28712; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yu N, 1998, FEBS LETT, V426, P174, DOI 10.1016/S0014-5793(98)00333-0; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhou YG, 2004, J BIOL CHEM, V279, P13800, DOI 10.1074/jbc.M311579200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zomot E, 2003, J BIOL CHEM, V278, P42950, DOI 10.1074/jbc.M209307200	58	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39360	10.1371/journal.pone.0039360	http://dx.doi.org/10.1371/journal.pone.0039360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737235	Green Published, Green Submitted, gold			2022-12-27	WOS:000305695100033
J	Bellander, T; Wichmann, J; Lind, T				Bellander, Tom; Wichmann, Janine; Lind, Tomas			Individual Exposure to NO2 in Relation to Spatial and Temporal Exposure Indices in Stockholm, Sweden: The INDEX Study	PLOS ONE			English	Article							NITROGEN-DIOXIDE; AIR-POLLUTION; PERSONAL EXPOSURE; OUTDOOR; INDOOR; URBAN; PM2.5	Epidemiology studies of health effects from air pollution, as well as impact assessments, typically rely on ambient monitoring data or modelled residential levels. The relationship between these and personal exposure is not clear. To investigate personal exposure to NO2 and its relationship with other exposure metrics and time-activity patterns in a randomly selected sample of healthy working adults (20-59 years) living and working in Stockholm. Personal exposure to NO2 was measured with diffusive samplers in sample of 247 individuals. The 7-day average personal exposure was 14.3 mu g/m(3) and 12.5 mu g/m(3) for the study population and the inhabitants of Stockholm County, respectively. The personal exposure was significantly lower than the urban background level (20.3 mu g/m(3)). In the univariate analyses the most influential determinants of individual exposure were long-term high-resolution dispersion-modelled levels of NO2 outdoors at home and work, and concurrent NO2 levels measured at a rural location, difference between those measured at an urban background and rural location and difference between those measured in busy street and at an urban background location, explaining 20, 16, 1, 2 and 4% (R-2) of the 7-day personal NO2 variation, respectively. A regression model including these variables explained 38% of the variation in personal NO2 exposure. We found a small improvement by adding time-activity variables to the latter model (R-2 = 0.44). The results adds credibility primarily to long-term epidemiology studies that utilise long-term indices of NO2 exposure at home or work, but also indicates that such studies may still suffer from exposure misclassification and dilution of any true effects. In contrast, urban background levels of NO2 are poorly related to individual exposure.	[Bellander, Tom; Lind, Tomas] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Bellander, Tom; Lind, Tomas] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden; [Wichmann, Janine] Univ Pretoria, Fac Hlth Sci, Sch Hlth Syst & Publ Hlth, ZA-0002 Pretoria, South Africa; [Wichmann, Janine] Univ Copenhagen, Inst Publ Hlth, Environm Hlth Sect, Copenhagen, Denmark	Karolinska Institutet; Stockholm County Council; University of Pretoria; University of Copenhagen	Bellander, T (corresponding author), Karolinska Inst, Inst Environm Med, Stockholm, Sweden.	tom.bellander@ki.se			Swedish National Road Administration; South African National Research Foundation	Swedish National Road Administration; South African National Research Foundation(National Research Foundation - South Africa)	Funding for the study was provided by a grant from the Swedish National Road Administration. Janine Wichmann received a postdoctoral fellowship from the South African National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellander T, 2001, ENVIRON HEALTH PERSP, V109, P633, DOI 10.2307/3455039; Chen Y, 2008, J TOXICOL ENV HEAL A, V71, P24, DOI 10.1080/15287390701557479; Ferm M, 1998, ATMOS ENVIRON, V32, P1377, DOI 10.1016/S1352-2310(97)00170-2; Ferm M, 1994, KEM TIDSKR, V1, P30; Kousa A, 2001, ATMOS ENVIRON, V35, P3405, DOI 10.1016/S1352-2310(01)00131-5; Lai HK, 2004, ATMOS ENVIRON, V38, P6399, DOI 10.1016/j.atmosenv.2004.07.013; Latza U, 2009, INT J HYG ENVIR HEAL, V212, P271, DOI 10.1016/j.ijheh.2008.06.003; Levy JI, 1998, J AIR WASTE MANAGE, V48, P553, DOI 10.1080/10473289.1998.10463704; Miller L, 2010, ATMOS ENVIRON, V44, P1162, DOI 10.1016/j.atmosenv.2009.12.030; Monn C, 1998, SCI TOTAL ENVIRON, V215, P243, DOI 10.1016/S0048-9697(98)00124-7; Monn C, 2001, ATMOS ENVIRON, V35, P1, DOI 10.1016/S1352-2310(00)00330-7; Nordling E, 2008, EPIDEMIOLOGY, V19, P401, DOI 10.1097/EDE.0b013e31816a1ce3; Nyberg F, 2000, EPIDEMIOLOGY, V11, P487, DOI 10.1097/00001648-200009000-00002; Rosenlund M, 2009, EPIDEMIOLOGY, V20, P265, DOI 10.1097/EDE.0b013e318190ea68; Sarnat JA, 2007, J EXPO SCI ENV EPID, V17, pS75, DOI 10.1038/sj.jes.7500621; SLB-analys vid Miljoforvaltningen i Stockholm, 2003, SLB ARSR 2002; SPENGLER J, 1994, J AIR WASTE MANAGE, V44, P39, DOI 10.1080/1073161X.1994.10467236; Wichmann J, 2010, ATMOS ENVIRON, V44, P4536, DOI 10.1016/j.atmosenv.2010.08.023; Williams Ross P, 2011, J EXP SCI ENV EPIDEM, P1; World Health Organization, 2006, AIR QUAL GUID GLOB U	20	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39536	10.1371/journal.pone.0039536	http://dx.doi.org/10.1371/journal.pone.0039536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745780	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200088
J	He, K; Chen, JH; Gould, GC; Yamaguchi, N; Ai, HS; Wang, YX; Zhang, YP; Jiang, XL				He, Kai; Chen, Jian-Hai; Gould, Gina C.; Yamaguchi, Nobuyuki; Ai, Huai-Sen; Wang, Ying-Xiang; Zhang, Ya-Ping; Jiang, Xue-Long			An Estimation of Erinaceidae Phylogeny: A Combined Analysis Approach	PLOS ONE			English	Article							MORPHOLOGICAL DATA; MAMMALS; INSECTIVORA; LIKELIHOOD; MOLECULES; CAPTURE; HYLOMYS; TREES; ASIA; PCR	Background: Erinaceidae is a family of small mammals that include the spiny hedgehogs (Erinaceinae) and the silky-furred moonrats and gymnures (Galericinae). These animals are widely distributed across Eurasia and Africa, from the tundra to the tropics and the deserts to damp forests. The importance of these animals lies in the fact that they are the oldest known living placental mammals, which are well represented in the fossil record, a rarity fact given their size and vulnerability to destruction during fossilization. Although the Family has been well studied, their phylogenetic relationships remain controversial. To test previous phylogenetic hypotheses, we combined molecular and morphological data sets, including representatives of all the genera. Methodology and Principal Findings: We included in the analyses 3,218 bp mitochondrial genes, one hundred and thirty-five morphological characters, twenty-two extant erinaceid taxa, and five outgroup taxa. Phylogenetic relationships were reconstructed using both partitioned and combined data sets. As in previous analyses, our results strongly support the monophyly of both subfamilies (Galericinae and Erinaceinae), the Hylomys group (to include Neotetracus and Neohylomys), and a sister-relationship of Atelerix and Erinaceus. As well, we verified that the extremely long branch lengths within the Galericinae are consistent with their fossil records. Not surprisingly, we found significant incongruence between the phylogenetic signals of the genes and the morphological characters, specifically in the case of Hylomys parvus, Mesechinus, and relationships between Hemiechinus and Paraechinus. Conclusions: Although we discovered new clues to understanding the evolutionary relationships within the Erinaceidae, our results nonetheless, strongly suggest that more robust analyses employing more complete taxon sampling (to include fossils) and multiple unlinked genes would greatly enhance our understanding of the Erinaceidae. Until then, we have left the nomenclature of the taxa unchanged; hence it does not yet precisely reflect their phylogenetic relationships or the depth of their genetic diversity.	[He, Kai; Chen, Jian-Hai; Wang, Ying-Xiang; Zhang, Ya-Ping; Jiang, Xue-Long] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [He, Kai; Chen, Jian-Hai] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Gould, Gina C.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Stamford, CT USA; [Gould, Gina C.] Bruce Museum, Greenwich, CT USA; [Yamaguchi, Nobuyuki] Qatar Univ, Dept Biol & Environm Sci, Doha, Qatar; [Ai, Huai-Sen] Baoshan Adm Bur, Gaoligong Natl Nat Reserve, Baoshan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Connecticut; Qatar University	He, K (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	jiangxl@mail.kiz.ac.cn	Yamaguchi, Nobuyuki/AAN-4884-2020; He, Kai/H-3164-2019	Yamaguchi, Nobuyuki/0000-0002-6492-6588; He, Kai/0000-0002-6234-2589	National Basic Research Program of China [2007CB411600]; National Natural Science Foundation of China [30770251]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (2007CB411600), the National Natural Science Foundation of China (30770251). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnason U, 2008, GENE, V421, P37, DOI 10.1016/j.gene.2008.05.024; Asher RJ, 2006, SYST BIOL, V55, P181, DOI 10.1080/10635150500433649; Asher RJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-69; Bannikova AA, 2002, RUSS J GENET+, V38, P714, DOI 10.1023/A:1016056304555; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Choate JR, 1998, J MAMMAL, V79, P1416; CORBET GB, 1988, MAMMAL REV, V18, P117, DOI 10.1111/j.1365-2907.1988.tb00082.x; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Dobigny G, 2002, BIOL J LINN SOC, V77, P319, DOI 10.1046/j.1095-8312.2002.00074.x; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Douady Christophe J., 2009, P495; Doyle JJ, 1997, SYST BIOL, V46, P537, DOI 10.2307/2413695; Flynn LJ, 2003, B AM MUS NAT HIST, P603, DOI 10.1206/0003-0090(2003)279<0603:C>2.0.CO;2; Freudenthal M., 1972, Scripta geol, V14, P1; Frost DR, 1991, PHYLOGENETIC RELATIO; Genoud M, 1996, J ZOOL, V240, P309, DOI 10.1111/j.1469-7998.1996.tb05287.x; Goloboff PA, 2008, CLADISTICS, V24, P758, DOI 10.1111/j.1096-0031.2008.00209.x; Good JM, 2008, MOL ECOL, V17, P1313, DOI 10.1111/j.1365-294X.2007.03640.x; Gould GC, 1997, SYSTEMATIC REVISION; Gould Gina C., 2001, American Museum Novitates, V3340, P1, DOI 10.1206/0003-0082(2001)340<0001:TPRPOD>2.0.CO;2; Gould Gina C., 1995, American Museum Novitates, V3131, P1; Grenyer R, 2003, J ZOOL, V260, P245, DOI 10.1017/S0952836903003716; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; He K, ERINACEIDAE PH UNPUB; He K, 2010, MOL PHYLOGENET EVOL, V56, P734, DOI 10.1016/j.ympev.2010.03.039; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Hutterer R, 2005, MAMMAL SPECIES WORLD, P212; Jenkins Paulina D., 2002, Bulletin of the Natural History Museum Zoology Series, V68, P1; Lee MSY, 2009, J EVOLUTION BIOL, V22, P2243, DOI 10.1111/j.1420-9101.2009.01843.x; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Lopatin AV, 2006, PALEONTOL J+, V40, pS205, DOI 10.1134/S0031030106090012; Luo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-242; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; McKenna Malcolm C., 1997, pi; Mein Pierre, 1997, Geodiversitas, V19, P783; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Miller M.A., 2010, P GAT COMP ENV WORKS; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; NOVACEK MJ, 1986, B AM MUS NAT HIST, V183, P1; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2009, TRACER V1 5; Reeve N., 1994, HEDGEHOGS T AD POYSE; Rich T.H.V., 1981, Bulletin of the American Museum of Natural History, V171, P1; Roca AL, 2004, NATURE, V429, P649, DOI 10.1038/nature02597; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruedi M, 1996, J ZOOL SYST EVOL RES, V34, P153; Sambrook J, 1989, MOL CLONING LAB MANU, V267, P9289; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHAW T. H., 1959, ACTA ZOOL SINICA, V11, P422; Sorenson M., 2007, TREEROT; Springer MS, 2007, SYST BIOL, V56, P673, DOI 10.1080/10635150701491149; Springer MS, 1996, J MOL EVOL, V43, P357; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Valen L., 1967, Bulletin of the American Museum of Natural History, V135, P217; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Wiens JJ, 2004, SYST BIOL, V53, P653, DOI 10.1080/10635150490472959; Wiens JJ, 2005, SYST BIOL, V54, P731, DOI 10.1080/10635150500234583	61	22	26	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39304	10.1371/journal.pone.0039304	http://dx.doi.org/10.1371/journal.pone.0039304			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745729	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693200059
J	Liu, XR; Gai, ZH; Tao, F; Tang, HZ; Xu, P				Liu, Xiaorui; Gai, Zhonghui; Tao, Fei; Tang, Hongzhi; Xu, Ping			Carotenoids Play a Positive Role in the Degradation of Heterocycles by Sphingobium yanoikuyae	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; BIOSYNTHETIC-PATHWAY; GENOME SEQUENCE; BETA-CAROTENE; CANTHAXANTHIN BIOSYNTHESIS; DEINOCOCCUS-RADIODURANS; PARTITION-COEFFICIENTS; PHYTOENE DESATURASE; MEMBRANE-FLUIDITY; OXIDATIVE STRESS	Background: Microbial oxidative degradation is a potential way of removing pollutants such as heterocycles from the environment. During this process, reactive oxygen species or other oxidants are inevitably produced, and may cause damage to DNA, proteins, and membranes, thereby decreasing the degradation rate. Carotenoids can serve as membrane-integrated antioxidants, protecting cells from oxidative stress. Findings: Several genes involved in the carotenoid biosynthetic pathway were cloned and characterized from a carbazole-degrading bacterium Sphingobium yanoikuyae XLDN2-5. In addition, a yellow-pigmented carotenoid synthesized by strain XLDN2-5 was identified as zeaxanthin that was synthesized from beta-carotene through beta-cryptoxanthin. The amounts of zeaxanthin and hydrogen peroxide produced were significantly and simultaneously enhanced during the biodegradation of heterocycles (carbazole < carbazole + benzothiophene < carbazole + dibenzothiophene). These higher production levels were consistent with the transcriptional increase of the gene encoding phytoene desaturase, one of the key enzymes for carotenoid biosynthesis. Conclusions/Significance: Sphingobium yanoikuyae XLDN2-5 can enhance the synthesis of zeaxanthin, one of the carotenoids, which may modulate membrane fluidity and defense against intracellular oxidative stress. To our knowledge, this is the first report on the positive role of carotenoids in the biodegradation of heterocycles, while elucidating the carotenoid biosynthetic pathway in the Sphingobium genus.	[Liu, Xiaorui] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, XR (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	pingxu@sjtu.edu.cn	Tao, Fei/E-5891-2010	Tao, Fei/0000-0002-5997-8770	National Natural Science Foundation of China [30821005, 20977061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by grants from National Natural Science Foundation of China (30821005 and 20977061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asker D, 2007, INT J SYST EVOL MICR, V57, P1435, DOI 10.1099/ijs.0.64828-0; Asker D, 2007, FEMS MICROBIOL LETT, V273, P140, DOI 10.1111/j.1574-6968.2007.00760.x; BARTLEY GE, 1990, J BIOL CHEM, V265, P16020; Busse HJ, 1999, J IND MICROBIOL BIOT, V23, P242, DOI 10.1038/sj.jim.2900745; Cavicchioli R, 1999, J IND MICROBIOL BIOT, V23, P268, DOI 10.1038/sj.jim.2900732; Chattopadhyay MK, 2001, POLAR BIOL, V24, P386; Chavez FP, 2004, APPL ENVIRON MICROB, V70, P3064, DOI 10.1128/AEM.70.5.3064-3072.2004; Christie LJ, 1979, CURR MICROBIOL, V3, P1; Copley SD, 2012, GENOME BIOL EVOL, V4, P184, DOI 10.1093/gbe/evr137; Das A, 2007, APPL MICROBIOL BIOT, V77, P505, DOI 10.1007/s00253-007-1206-3; Deby-Dupont G, 1998, BBA-GEN SUBJECTS, V1379, P61, DOI 10.1016/S0304-4165(97)00083-4; Denich TJ, 2003, J MICROBIOL METH, V52, P149, DOI 10.1016/S0167-7012(02)00155-0; Donato MM, 1997, B ENVIRON CONTAM TOX, V59, P696, DOI 10.1007/s001289900536; Fridovich I, 2004, AGING CELL, V3, P13, DOI 10.1046/j.1474-9728.2003.00075.x; Gai ZH, 2007, APPL ENVIRON MICROB, V73, P2832, DOI 10.1128/AEM.02704-06; Gai ZH, 2011, J BACTERIOL, V193, P6404, DOI 10.1128/JB.06050-11; Gai ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010018; Gai ZH, 2008, MICROBIOL-SGM, V154, P3804, DOI 10.1099/mic.0.2008/023176-0; Gregory DD, 1997, J AM CHEM SOC, V119, P94, DOI 10.1021/ja962975i; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; Guardado P, 1997, J PHARM SCI-US, V86, P106, DOI 10.1021/js960111p; Hannibal L, 2000, J BACTERIOL, V182, P3850, DOI 10.1128/JB.182.13.3850-3853.2000; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; KAJIWARA S, 1995, PLANT MOL BIOL, V29, P343, DOI 10.1007/BF00043657; KESTON AS, 1965, ANAL BIOCHEM, V11, P1, DOI 10.1016/0003-2697(65)90034-5; KILBANE JJ, 1989, TRENDS BIOTECHNOL, V7, P97, DOI 10.1016/0167-7799(89)90007-3; Klassen JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011257; KODAMA K, 1970, AGR BIOL CHEM TOKYO, V34, P1320, DOI 10.1080/00021369.1970.10859781; KRINSKY NI, 1989, FREE RADICAL BIO MED, V7, P617, DOI 10.1016/0891-5849(89)90143-3; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meier S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-77; MISAWA N, 1995, BIOCHEM BIOPH RES CO, V209, P867, DOI 10.1006/bbrc.1995.1579; MISAWA N, 1990, J BACTERIOL, V172, P6704, DOI 10.1128/jb.172.12.6704-6712.1990; MISAWA N, 1995, J BACTERIOL, V177, P6575, DOI 10.1128/jb.177.22.6575-6584.1995; Mykytczuk NCS, 2007, PROG BIOPHYS MOL BIO, V95, P60, DOI 10.1016/j.pbiomolbio.2007.05.001; Nagata Y, 2010, J BACTERIOL, V192, P5852, DOI 10.1128/JB.00961-10; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramos JL, 2002, ANNU REV MICROBIOL, V56, P743, DOI 10.1146/annurev.micro.56.012302.161038; Ritter S, 1995, ENVIRON SCI POLLUT R, V2, P153, DOI 10.1007/BF02987528; Sambrook J., 2001, MOL CLONING LAB MANU; Silva C, 2004, BIOTECHNOL LETT, V26, P257, DOI 10.1023/B:BILE.0000013716.20116.dc; Strobel I, 2009, CURR GENET, V55, P175, DOI 10.1007/s00294-009-0235-0; SUBCZYNSKI WK, 1991, BIOCHIM BIOPHYS ACTA, V1068, P68, DOI 10.1016/0005-2736(91)90061-C; Takeuchi M, 2001, INT J SYST EVOL MICR, V51, P1405, DOI 10.1099/00207713-51-4-1405; Thomas JC, 1996, J BACTERIOL, V178, P6049, DOI 10.1128/jb.178.20.6049-6055.1996; Tian B, 2007, BBA-GEN SUBJECTS, V1770, P902, DOI 10.1016/j.bbagen.2007.01.016; Tian B, 2008, MICROBIOL-SGM, V154, P3697, DOI 10.1099/mic.0.2008/021071-0; TO KY, 1994, MICROBIOL-SGM, V140, P331, DOI 10.1099/13500872-140-2-331; Tuan PA, 2011, J AGR FOOD CHEM, V59, P5412, DOI 10.1021/jf2009827; Woodall AA, 1997, BBA-GEN SUBJECTS, V1336, P575, DOI 10.1016/S0304-4165(97)00007-X; Wu XC, 2011, CARBOHYD POLYM, V84, P1201, DOI 10.1016/j.carbpol.2011.01.018; Xu P, 2006, TRENDS MICROBIOL, V14, P398, DOI 10.1016/j.tim.2006.07.002; Xu ZJ, 2007, MICROBIOL-SGM, V153, P1642, DOI 10.1099/mic.0.2006/002857-0; YABUUCHI E, 1990, MICROBIOL IMMUNOL, V34, P99, DOI 10.1111/j.1348-0421.1990.tb00996.x; Yamada T, 2006, APPL MICROBIOL BIOT, V73, P452, DOI 10.1007/s00253-006-0472-9; Ye RW, 2006, APPL ENVIRON MICROB, V72, P5829, DOI 10.1128/AEM.00918-06; Zhang L, 2007, ARCH MICROBIOL, V188, P411, DOI 10.1007/s00203-007-0262-5; Ziegelhoffer EC, 2009, NAT REV MICROBIOL, V7, P856, DOI 10.1038/nrmicro2237	59	15	16	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39522	10.1371/journal.pone.0039522	http://dx.doi.org/10.1371/journal.pone.0039522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745775	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200086
J	Osanto, S; Qin, YJ; Buermans, HP; Berkers, J; Lerut, E; Goeman, JJ; van Poppel, H				Osanto, Susanne; Qin, Yongjun; Buermans, Henk P.; Berkers, Johannes; Lerut, Evelyne; Goeman, Jelle J.; van Poppel, Hendrik			Genome-Wide MicroRNA Expression Analysis of Clear Cell Renal Cell Carcinoma by Next Generation Deep Sequencing	PLOS ONE			English	Article							MDR1/P-GLYCOPROTEIN EXPRESSION; PROGNOSTIC-FACTOR; CANCER; HYPOXIA; PROLIFERATION; DYSREGULATION; HSA-MIR-210; PREDICTION; MIR-27A	MicroRNAs (miRNAs), non-coding RNAs regulating gene expression, are frequently aberrantly expressed in human cancers. Next-generation deep sequencing technology enables genome-wide expression profiling of known miRNAs and discovery of novel miRNAs at unprecedented quantitative and qualitative accuracy. Deep sequencing was performed on 11 fresh frozen clear cell renal cell carcinoma (ccRCC) and adjacent non-tumoral renal cortex (NRC) pairs, 11 additional frozen ccRCC tissues, and 2 ccRCC cell lines (n = 35). The 22 ccRCCs patients belonged to 3 prognostic sub-groups, i.e. those without disease recurrence, with recurrence and with metastatic disease at diagnosis. Thirty-two consecutive samples (16 ccRCC/NRC pairs) were used for stem-loop PCR validation. Novel miRNAs were predicted using 2 distinct bioinformatic pipelines. In total, 463 known miRNAs (expression frequency 1-150,000/million) were identified. We found that 100 miRNA were significantly differentially expressed between ccRCC and NRC. Differential expression of 5 miRNAs was confirmed by stem-loop PCR in the 32 ccRCC/NRC samples. With respect to RCC subgroups, 5 miRNAs discriminated between non-recurrent versus recurrent and metastatic disease, whereas 12 uniquely distinguished non-recurrent versus metastatic disease. Blocking overexpressed miR-210 or miR-27a in cell line SKCR-7 by transfecting specific antagomirs did not result in significant changes in proliferation or apoptosis. Twenty-three previously unknown miRNAs were predicted in silico. Quantitative genome-wide miRNA profiling accurately separated ccRCC from (benign) NRC. Individual differentially expressed miRNAs may potentially serve as diagnostic or prognostic markers or future therapeutic targets in ccRCC. The biological relevance of candidate novel miRNAs is unknown at present.	[Osanto, Susanne; Qin, Yongjun] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands; [Buermans, Henk P.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Goeman, Jelle J.] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands; [Berkers, Johannes; van Poppel, Hendrik] Katholieke Univ Leuven, Dept Urol, Louvain, Belgium; [Lerut, Evelyne] Katholieke Univ Leuven, Dept Pathol, Louvain, Belgium	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; KU Leuven; KU Leuven	Osanto, S (corresponding author), Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands.	s.osanto@lumc.nl	Goeman, Jelle/AAT-1300-2020	Goeman, Jelle/0000-0003-4283-0259				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Buermans HPJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-716; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chow TFF, 2010, J UROLOGY, V183, P743, DOI 10.1016/j.juro.2009.09.086; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; Coppin C, 2011, BJU INT, V108, P1556, DOI 10.1111/j.1464-410X.2011.10629.x; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Fridman E, 2010, J MOL DIAGN, V12, P687, DOI 10.2353/jmoldx.2010.090187; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gee HE, 2010, CANCER-AM CANCER SOC, V116, P2148, DOI 10.1002/cncr.25009; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Huang Y, 2009, EJSO-EUR J SURG ONC, V35, P1119, DOI 10.1016/j.ejso.2009.04.010; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Kadri S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S35; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lai KW, 2010, EUR J CANCER, V46, P1456, DOI 10.1016/j.ejca.2010.01.036; Lee Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000730; Leibovich BC, 2003, CANCER-AM CANCER SOC, V97, P1663, DOI 10.1002/cncr.11234; Li ZM, 2010, GYNECOL ONCOL, V119, P125, DOI 10.1016/j.ygyno.2010.06.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Petillo D, 2009, INT J ONCOL, V35, P109, DOI 10.3892/ijo_00000318; Qin Y, 2011, PIGM CELL MELANOMA R, V24, P207, DOI 10.1111/j.1755-148X.2010.00781.x; Rini BI, 2008, CURR OPIN ONCOL, V20, P300, DOI 10.1097/CCO.0b013e3282f9782b; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Tsuchiya S, 2011, J BIOL CHEM, V286, P420, DOI 10.1074/jbc.M110.170852; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; White NM, 2010, BIOL CHEM, V391, P411, DOI 10.1515/BC.2010.041; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004; Zhu H, 2008, BIOCHEM PHARMACOL, V76, P582, DOI 10.1016/j.bcp.2008.06.007	38	94	97	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38298	10.1371/journal.pone.0038298	http://dx.doi.org/10.1371/journal.pone.0038298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745662	gold, Green Published, Green Submitted			2022-12-27	WOS:000305693200009
J	Pearce, MS; Basterfield, L; Mann, KD; Parkinson, KN; Adamson, AJ; Reilly, JJ				Pearce, Mark S.; Basterfield, Laura; Mann, Kay D.; Parkinson, Kathryn N.; Adamson, Ashley J.; Reilly, John J.		Gateshead Millennium Study	Early Predictors of Objectively Measured Physical Activity and Sedentary Behaviour in 8-10 Year Old Children: The Gateshead Millennium Study	PLOS ONE			English	Article							ENERGY-EXPENDITURE; BODY FATNESS; TIME SPENT; FAT MASS; ADOLESCENTS; SCHOOL; YOUTH; INTERVENTIONS; ADIPOSITY; WEIGHT	Background: With a number of studies suggesting associations between early life influences and later chronic disease risk, it is suggested that associations between early growth and later physical activity (PA) may be a mediator. However, conflicting evidence exists for association between birth weight and childhood PA. In addition, it is important to know what other, potentially modifiable, factors may influence PA in children given its' association with childhood and later adiposity. We used the Gateshead Millennium Study (GMS) to identify predictors of childhood PA levels. Methods: The GMS is a cohort of 1029 infants born in 1999-2000 in Gateshead in northern England. Throughout infancy and early childhood, detailed information was collected. Assessments at age 9 years included body composition, objective measures of habitual PA and a range of lifestyle factors. Mean total volumes of PA (accelerometer count per minute, cpm) and moderate-vigorous intensity PA (MVPA), and the percentage of time spent in sedentary behaviour (%SB) were quantified and related to potential predictors using linear regression and path analysis. Results: Children aged 8-10 years were included. Significant differences were seen in all three outcome variables between sexes and season of measurement (p<0.001). Restricting children's access to television was associated with decreased MVPA. Increased paternal age was associated with significant increases in %SB (p = 0.02), but not MVPA or total PA. Increased time spent in out of school sports clubs was significantly associated with decreased %SB (p = 0.02). No significant associations were seen with birth weight. Conclusion: A range of factors, directly or indirectly, influenced PA and sedentary behaviour. However, associations differed between the different constructs of PA and %SB. Exploring further the sex differences in PA would appear to be useful, as would encouraging children to join out of school sports clubs.	[Pearce, Mark S.; Basterfield, Laura; Mann, Kay D.; Parkinson, Kathryn N.; Adamson, Ashley J.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Basterfield, Laura; Parkinson, Kathryn N.; Adamson, Ashley J.] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Reilly, John J.; Gateshead Millennium Study] Univ Strathclyde, Sch Psychol Sci & Hlth, Glasgow, Lanark, Scotland	Newcastle University - UK; Newcastle University - UK; University of Strathclyde	Pearce, MS (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	mark.pearce@ncl.ac.uk	Mann, Kay/T-4406-2019	Mann, Kay/0000-0003-0115-5293; Adamson, Ashley/0000-0003-3735-2846; Basterfield, Laura/0000-0003-3245-7622; Pearce, Mark/0000-0002-0583-3779	National Prevention Research Initiative; British Heart Foundation; Cancer Research United Kingdom; Department of Health; Diabetes United Kingdom; Economic and Social Research Council; Food Standards Agency; Medical Research Council; Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office, Scottish Government Health Directorates [CZH/4/484]; Welsh Assembly Government; World Cancer Research Fund; Sport Aiding Research in Kids (SPARKS); Gateshead National Health Service Trust Research & Development (NHS R D); Northern and Yorkshire NHS R D; Northumberland, Tyne and Wear NHS Trust; Henry Smith Charity; Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish; Medical Research Council [G0900686, G0501306] Funding Source: researchfish; National Institute for Health Research [PHCS/C4/4/008] Funding Source: researchfish; Chief Scientist Office [CZH/4/484] Funding Source: researchfish; ESRC [ES/G007470/1] Funding Source: UKRI; MRC [G0900686, G0501306] Funding Source: UKRI	National Prevention Research Initiative(Diabetes UK); British Heart Foundation(British Heart Foundation); Cancer Research United Kingdom(Cancer Research UK); Department of Health; Diabetes United Kingdom(Diabetes UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Food Standards Agency; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office, Scottish Government Health Directorates; Welsh Assembly Government; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Sport Aiding Research in Kids (SPARKS); Gateshead National Health Service Trust Research & Development (NHS R D); Northern and Yorkshire NHS R D; Northumberland, Tyne and Wear NHS Trust; Henry Smith Charity; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Gateshead Millennium Study was supported by a grant from the National Prevention Research Initiative (incorporating funding from British Heart Foundation; Cancer Research United Kingdom; Department of Health; Diabetes United Kingdom; Economic and Social Research Council; Food Standards Agency; Medical Research Council; Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office, Scottish Government Health Directorates; Welsh Assembly Government and World Cancer Research Fund) and further funding from the Chief Scientist Office, Scottish Government Health Directorates, grant number CZH/4/484. The cohort was first established with funding from the Henry Smith Charity and Sport Aiding Research in Kids (SPARKS) and followed up with grants from Gateshead National Health Service Trust Research & Development (NHS R & D), Northern and Yorkshire NHS R & D, and Northumberland, Tyne and Wear NHS Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basterfield L, 2011, J PHYS ACT HEALTH, V8, P543, DOI 10.1123/jpah.8.4.543; Biddle SJH, 2010, PREV MED, V51, P345, DOI 10.1016/j.ypmed.2010.07.018; Brockman R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-461; Campbell CP, 2010, EUR J CLIN NUTR, V64, P1093, DOI 10.1038/ejcn.2010.128; Chief medical officers of England Scotland Wales and Northern Island, 2011, START ACT STAY ACT R; Cleland V, 2008, INT J OBESITY, V32, P1685, DOI 10.1038/ijo.2008.171; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Corder K, 2007, J SPORT SCI, V25, P1607, DOI 10.1080/02640410701283841; Daley AJ, 2006, PEDIATRICS, V118, P2126, DOI 10.1542/peds.2006-1285; de Vries SI, 2006, J CLIN EPIDEMIOL, V59, P670, DOI 10.1016/j.jclinepi.2005.11.020; Ekelund U, 2008, AM J CLIN NUTR, V88, P612, DOI 10.1093/ajcn/88.3.612; Fisher A, 2005, PEDIATR EXERC SCI, V17, P31, DOI 10.1123/pes.17.1.31; Hallal PC, 2006, SPORTS MED, V36, P1019, DOI 10.2165/00007256-200636120-00003; Jackson DM, 2009, AM J CLIN NUTR, V89, P1031, DOI 10.3945/ajcn.2008.26746; Jackson DM, 2003, OBES RES, V11, P420, DOI 10.1038/oby.2003.57; Janz KF, 2009, AM J PREV MED, V37, P35, DOI 10.1016/j.amepre.2009.03.012; Jimenez-Pavon D, 2010, INT J PEDIATR OBES, V5, P3, DOI 10.3109/17477160903067601; Kajantie E, 2010, J PEDIATR-US, V157, P610, DOI 10.1016/j.jpeds.2010.04.002; King AC, 2011, EUR J PUBLIC HEALTH, V21, P424, DOI 10.1093/eurpub/ckq104; Maniccia DM, 2011, PEDIATRICS, V128, pE193, DOI 10.1542/peds.2010-2353; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Mattocks C, 2008, BMJ-BRIT MED J, V336, P26, DOI 10.1136/bmj.39385.443565.BE; Mattocks C, 2007, MED SCI SPORT EXER, V39, P622, DOI 10.1249/mss.0b013e318030631b; McMinn AM, 2008, PEDIATR EXERC SCI, V20, P319, DOI 10.1123/pes.20.3.319; Mendoza JA, 2011, J PHYS ACT HEALTH, V8, P488, DOI 10.1123/jpah.8.4.488; Metcalf BS, 2011, ARCH DIS CHILD, V96, P942, DOI 10.1136/adc.2009.175927; Ness AR, 2007, PLOS MED, V4, P476, DOI 10.1371/journal.pmed.0040097; Parkinson KN, 2011, INT J EPIDEMIOL, V40, P308, DOI 10.1093/ije/dyq015; Pate RR, 2009, BRIT J SPORT MED, V43, P14, DOI 10.1136/bjsm.2008.055517; Penpraze V, 2006, PEDIATR EXERC SCI, V18, P483, DOI 10.1123/pes.18.4.483; Purslow LR, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-67; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Reilly JJ, 2003, OBES RES, V11, P1155, DOI 10.1038/oby.2003.158; Rey-Lopez JP, 2008, NUTR METAB CARDIOVAS, V18, P242, DOI 10.1016/j.numecd.2007.07.008; Sirard JR, 2005, J PHYS ACT HEALTH, V2, P345, DOI DOI 10.1123/JPAH.2.3.345; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Townsend PP., 1988, HLTH DEPRIVATION INE; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Wijga AH, 2010, J OBES, V2010, DOI 10.1155/2010/423296; Wright CM, 2004, ARCH DIS CHILD-FETAL, V89, pF254, DOI 10.1136/adc.2003.026906	41	52	54	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e37975	10.1371/journal.pone.0037975	http://dx.doi.org/10.1371/journal.pone.0037975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745660	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000305693200008
J	Wang, F; Sun, GP; Zou, YF; Fan, LL; Song, B				Wang, Fang; Sun, Guoping; Zou, Yanfeng; Fan, Lulu; Song, Bing			Lack of Association of miR-146a rs2910164 Polymorphism with Gastrointestinal Cancers: Evidence from 10206 Subjects	PLOS ONE			English	Article							COMMON GENETIC-VARIANTS; HEPATOCELLULAR-CARCINOMA; PRE-MICRORNAS; RISK; EXPRESSION; SUSCEPTIBILITY; METAANALYSIS	Background: Recent studies on the association between miR-146a rs2910164 polymorphism and risk of gastrointestinal (GI) cancers showed inconclusive results. Accordingly, we conducted a comprehensive literature search and a meta-analysis to clarify the association. Methodology/Principal Findings: Data were collected from the following electronic databases: Pubmed, Excerpta Medica Database (Embase), and Chinese Biomedical Literature Database (CBM), with the last report up to February 24, 2012. The odds ratio (OR) and its 95% confidence interval (95%CI) were used to assess the strength of association. Ultimately, a total of 12 studies (4,817 cases and 5,389 controls) were found to be eligible for meta-analysis. We summarized the data on the association between miR-146a rs2910164 polymorphism and risk of GI cancers in the overall population, and performed subgroup analyses by ethnicity, cancer types, and quality of studies. In the overall analysis, there was no evidence of association between miR-146a rs2910164 polymorphism and the risk of GI cancers (G versus C: OR = 1.07, 95%CI 0.98-1.16, P = 0.14; GG+GC versus CC: OR = 1.14, 95%CI 1.00-1.31, P = 0.05; GG versus GC+CC: OR = 1.06, 95%CI 0.91-1.23, P = 0.47; GG versus CC: OR = 1.17, 95%CI 0.95-1.44, P = 0.13; GC versus CC: OR = 1.14, 95%CI 1.00-1.31, P = 0.05). Similar results were found in the subgroup analyses by ethnicity, cancer types, and quality of studies. Conclusions/Significance: This meta-analysis demonstrates that miR-146a rs2910164 polymorphism is not associated with GI cancers susceptibility. More well-designed studies based on larger sample sizes and homogeneous cancer patients are needed.	[Wang, Fang; Sun, Guoping; Fan, Lulu] Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei, Anhui, Peoples R China; [Zou, Yanfeng] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China; [Song, Bing] Anhui Med Univ, Affiliated Hosp 1, Dept Cardiol, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Wang, F (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei, Anhui, Peoples R China.	sunguoping@ahmu.edu.cn			National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiz H, 2011, GENE, V486, P104, DOI 10.1016/j.gene.2011.07.006; Babashah S, 2011, EUR J CANCER, V47, P1127, DOI 10.1016/j.ejca.2011.02.008; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cai Yimei, 2009, Genomics Proteomics & Bioinformatics, V7, P147, DOI 10.1016/S1672-0229(08)60044-3; Chen SG, 2010, BIOCHEM BIOPH RES CO, V391, P552, DOI 10.1016/j.bbrc.2009.11.096; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; de la Chapelle A, 2011, J CLIN ENDOCR METAB, V96, P3326, DOI 10.1210/jc.2011-1004; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; Guo H, 2010, FAM CANCER, V9, P599, DOI 10.1007/s10689-010-9370-5; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hishida A, 2011, DIGEST DIS SCI, V56, P1131, DOI 10.1007/s10620-010-1376-1; Hou ZB, 2012, MED ONCOL, V29, P886, DOI 10.1007/s12032-011-9862-7; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hui A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-500; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jiang DK, 2011, J INVEST DERMATOL, V131, P220, DOI 10.1038/jid.2010.270; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; Labbaye C, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-13; Landi D, 2011, MUTAT RES-FUND MOL M, V717, P109, DOI 10.1016/j.mrfmmm.2010.10.002; MANTEL N, 1959, J NATL CANCER I, V22, P719; Min KT, 2012, MOL CARCINOGEN, V51, pE65, DOI 10.1002/mc.21849; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; Oshima H, 2012, J GASTROENTEROL, V47, P97, DOI 10.1007/s00535-011-0523-6; Peng S, 2010, DIGEST DIS SCI, V55, P2288, DOI 10.1007/s10620-009-1007-x; Qiu LX, 2011, CYTOKINE, V56, P695, DOI 10.1016/j.cyto.2011.09.001; Qu KZ, 2011, J CLIN GASTROENTEROL, V45, P355, DOI 10.1097/MCG.0b013e3181f18ac2; Srivastava K, 2010, J HUM GENET, V55, P495, DOI 10.1038/jhg.2010.54; Wang J, 2011, MOL BIOL REP, DOI [10.1089/dna.2011.1340, DOI 10.1089/DNA.2011.1340]; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Xiang Y, 2012, MOL BIOL REP, V39, P7019, DOI 10.1007/s11033-012-1532-0; Xu T, 2008, CARCINOGENESIS, V29, P2126, DOI 10.1093/carcin/bgn195; Xu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020471; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135; Yoon SO, 2011, HUM PATHOL, V42, P1391, DOI 10.1016/j.humpath.2010.12.010; Yu HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030566; Yu J, 2012, CLIN CANCER RES, V18, P981, DOI 10.1158/1078-0432.CCR-11-2347; Zeng Y, 2010, WORLD J GASTROENTERO, V16, P3578, DOI 10.3748/wjg.v16.i28.3578; [张新伟 Zhang Xinwei], 2011, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V45, P239; Zhou J, 2012, DNA CELL BIOL, V31, P524, DOI 10.1089/dna.2011.1340; Zou YF, 2011, J INVEST DERMATOL, V131, P781, DOI 10.1038/jid.2010.367	46	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39623	10.1371/journal.pone.0039623	http://dx.doi.org/10.1371/journal.pone.0039623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761848	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800052
J	Feiglin, A; Moult, J; Lee, B; Ofran, Y; Unger, R				Feiglin, Ariel; Moult, John; Lee, Byungkook; Ofran, Yanay; Unger, Ron			Neighbor Overlap Is Enriched in the Yeast Interaction Network: Analysis and Implications	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; SACCHAROMYCES-CEREVISIAE; COMPLEX NETWORKS; GENETIC INTERACTIONS; MATING PHEROMONE; INVASIVE GROWTH; MAP; PATHWAY; ORGANIZATION; MKK2	The yeast protein-protein interaction network has been shown to have distinct topological features such as a scale free degree distribution and a high level of clustering. Here we analyze an additional feature which is called Neighbor Overlap. This feature reflects the number of shared neighbors between a pair of proteins. We show that Neighbor Overlap is enriched in the yeast protein-protein interaction network compared with control networks carefully designed to match the characteristics of the yeast network in terms of degree distribution and clustering coefficient. Our analysis also reveals that pairs of proteins with high Neighbor Overlap have higher sequence similarity, more similar GO annotations and stronger genetic interactions than pairs with low ones. Finally, we demonstrate that pairs of proteins with redundant functions tend to have high Neighbor Overlap. We suggest that a combination of three mechanisms is the basis for this feature: The abundance of protein complexes, selection for backup of function, and the need to allow functional variation.	[Feiglin, Ariel; Ofran, Yanay; Unger, Ron] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Moult, John] Univ Maryland, Inst Biosci & Biotechnol, Rockville, MD USA; [Lee, Byungkook] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Bar Ilan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Feiglin, A (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	ron@biomodel.os.biu.ac.il		Moult, John/0000-0002-3012-2282	National Institutes of Health, National Cancer Institute, Center for Cancer Research; National Institute of Health [LM007174]; Israeli Science Foundation [1339/08]; NATIONAL CANCER INSTITUTE [ZIABC011233] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM007174] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israeli Science Foundation(Israel Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, by National Institute of Health grant LM007174 to JM and Israeli Science Foundation grant 1339/08 to RU. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Artzy-Randrup Y, 2004, SCIENCE, V305; Bardwell L, 2004, PEPTIDES, V25, P1465, DOI 10.1016/j.peptides.2003.10.022; Cherkasova V, 1999, GENETICS, V151, P989; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Cook JG, 1996, GENE DEV, V10, P2831, DOI 10.1101/gad.10.22.2831; ERREDE B, 1995, MOL REPROD DEV, V42, P477, DOI 10.1002/mrd.1080420416; Frohlich H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-166; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Grassi L, 2010, MOL BIOSYST, V6, P2305, DOI 10.1039/c003507f; Guan YF, 2007, GENETICS, V175, P933, DOI 10.1534/genetics.106.064329; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; IRIE K, 1993, MOL CELL BIOL, V13, P3076, DOI 10.1128/MCB.13.5.3076; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jimenez-Sanchez M, 2007, J BIOL CHEM, V282, P31174, DOI 10.1074/jbc.M706270200; Kafri R, 2008, P NATL ACAD SCI USA, V105, P1243, DOI 10.1073/pnas.0711043105; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kupiec M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100146; LEVIN DE, 1994, CELL MOL BIOL RES, V40, P229; Lin C, 2006, BIBE 2006: SIXTH IEEE SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, PROCEEDINGS, P251; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Ohkuni K, 2003, GENETICS, V165, P517; Olson KA, 2000, MOL CELL BIOL, V20, P4199, DOI 10.1128/MCB.20.12.4199-4209.2000; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Roemer T, 1998, J CELL SCI, V111, P479; Samanta MP, 2003, P NATL ACAD SCI USA, V100, P12579, DOI 10.1073/pnas.2132527100; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; SOLER M, 1995, MOL MICROBIOL, V17, P833, DOI 10.1111/j.1365-2958.1995.mmi_17050833.x; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Sun SW, 2006, FEBS LETT, V580, P1891, DOI 10.1016/j.febslet.2006.02.053; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Ulitsky I, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100144; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Xiang J, 2008, PHYSICA A, V387, P3327, DOI 10.1016/j.physa.2008.01.105; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	49	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39662	10.1371/journal.pone.0039662	http://dx.doi.org/10.1371/journal.pone.0039662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761860	Green Submitted, gold, Green Published			2022-12-27	WOS:000305808700044
J	Atkinson, SC; Dogovski, C; Downton, MT; Pearce, FG; Reboul, CF; Buckle, AM; Gerrard, JA; Dobson, RCJ; Wagner, J; Perugini, MA				Atkinson, Sarah C.; Dogovski, Con; Downton, Matthew T.; Pearce, F. Grant; Reboul, Cyril F.; Buckle, Ashley M.; Gerrard, Juliet A.; Dobson, Renwick C. J.; Wagner, John; Perugini, Matthew A.			Crystal, Solution and In silico Structural Studies of Dihydrodipicolinate Synthase from the Common Grapevine	PLOS ONE			English	Article							ESCHERICHIA-COLI; SCATTERING; PURIFICATION; INHIBITION; MECHANISM; EVOLUTION; CATALYSIS; DYNAMICS; PROGRAM; CLONING	Dihydrodipicolinate synthase (DHDPS) catalyzes the rate limiting step in lysine biosynthesis in bacteria and plants. The structure of DHDPS has been determined from several bacterial species and shown in most cases to form a homotetramer or dimer of dimers. However, only one plant DHDPS structure has been determined to date from the wild tobacco species, Nicotiana sylvestris (Blickling et al. (1997) J. Mol. Biol. 274, 608-621). Whilst N. sylvestris DHDPS also forms a homotetramer, the plant enzyme adopts a 'back-to-back' dimer of dimers compared to the 'head-to-head' architecture observed for bacterial DHDPS tetramers. This raises the question of whether the alternative quaternary architecture observed for N. sylvestris DHDPS is common to all plant DHDPS enzymes. Here, we describe the structure of DHDPS from the grapevine plant, Vitis vinifera, and show using analytical ultracentrifugation, small-angle X-ray scattering and X-ray crystallography that V. vinifera DHDPS forms a 'back-to-back' homotetramer, consistent with N. sylvestris DHDPS. This study is the first to demonstrate using both crystal and solution state measurements that DHDPS from the grapevine plant adopts an alternative tetrameric architecture to the bacterial form, which is important for optimizing protein dynamics as suggested by molecular dynamics simulations reported in this study.	[Atkinson, Sarah C.; Dogovski, Con; Perugini, Matthew A.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic, Australia; [Atkinson, Sarah C.; Dogovski, Con; Dobson, Renwick C. J.; Perugini, Matthew A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Downton, Matthew T.; Wagner, John] IBM Res Collaboratory Life Sci Melbourne, Victorian Life Sci Computat Initiat, Carlton, Vic, Australia; [Pearce, F. Grant; Gerrard, Juliet A.; Dobson, Renwick C. J.] Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand; [Pearce, F. Grant; Gerrard, Juliet A.; Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Reboul, Cyril F.; Buckle, Ashley M.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Reboul, Cyril F.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic, Australia	La Trobe University; University of Melbourne; University of Canterbury; University of Canterbury; Monash University; Monash University	Atkinson, SC (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic, Australia.	M.Perugini@latrobe.edu.au	Dobson, Renwick/AAZ-7020-2021; Buckle, Ashley/P-8366-2016	Dobson, Renwick/0000-0002-5506-4939; Buckle, Ashley/0000-0003-2943-9044; Pearce, Frederick/0000-0002-2683-0331; Atkinson, Sarah/0000-0002-3518-9785; Perugini, Matthew/0000-0001-8052-5584; Reboul, Cyril/0000-0002-6258-2697	Australian Research Council; University of Melbourne; University of Melbourne (FRGSS); U.S. Defense Threat Reduction Agency (DTRA) [AB07CBT004]	Australian Research Council(Australian Research Council); University of Melbourne(University of Melbourne); University of Melbourne (FRGSS); U.S. Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	Funding was provided by: (1) Australian Research Council for providing a Future Fellowship for Matthew A. Perugini; (2) University of Melbourne for providing a CR Roper Fellowship for Renwick CJ Dobson; (3) University of Melbourne (FRGSS 2011 Project grant) for project funding (in part); and (4) U.S. Defense Threat Reduction Agency (DTRA Project AB07CBT004) for project funding (in part). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Atkinson SC, 2011, ACTA CRYSTALLOGR F, V67, P1537, DOI 10.1107/S1744309111038395; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blagova E, 2006, PROTEINS, V62, P297, DOI 10.1002/prot.20684; Blickling S, 1997, BIOCHEMISTRY-US, V36, P24, DOI 10.1021/bi962272d; Blickling S, 1997, J MOL BIOL, V274, P608, DOI 10.1006/jmbi.1997.1393; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; Burgess BR, 2008, J BIOL CHEM, V283, P27598, DOI 10.1074/jbc.M804231200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Davis AJ, 2004, J BIOL CHEM, V279, P12462, DOI 10.1074/jbc.M312365200; Demeler B., 2005, BIOINFORMATICS BASIC, P226; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; DEREPPE C, 1992, PLANT PHYSIOL, V98, P813, DOI 10.1104/pp.98.3.813; Devenish SRA, 2009, BBA-PROTEINS PROTEOM, V1794, P1168, DOI 10.1016/j.bbapap.2009.02.003; Dobson RCJ, 2005, BIOCHEMISTRY-US, V44, P13007, DOI 10.1021/bi051281w; Dobson RCJ, 2005, ACTA CRYSTALLOGR D, V61, P1116, DOI 10.1107/S0907444905016318; Dobson RCJ, 2004, J MOL BIOL, V338, P329, DOI 10.1016/j.jmb.2004.02.060; Dobson RCJ, 2008, PROTEIN SCI, V17, P2080, DOI 10.1110/ps.037440.108; Dogovski C, 2012, BIOCHEMISTR IN PRESS; Dogovski C, 2009, BIOTECHNOLOGY MED 1, V11, P116; Domigan LJ, 2009, BBA-PROTEINS PROTEOM, V1794, P1510, DOI 10.1016/j.bbapap.2009.06.020; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FRISCH DA, 1991, PLANT PHYSIOL, V96, P444, DOI 10.1104/pp.96.2.444; Girish TS, 2008, FEBS LETT, V582, P2923, DOI 10.1016/j.febslet.2008.07.035; Griffin MDW, 2008, J MOL BIOL, V380, P691, DOI 10.1016/j.jmb.2008.05.038; Griffin MDW, 2010, ARCH BIOCHEM BIOPHYS, V494, P58, DOI 10.1016/j.abb.2009.11.014; Hutton CA, 2007, MOL BIOSYST, V3, P458, DOI 10.1039/b705624a; Kang BS, 2010, INT J BIOL MACROMOL, V46, P512, DOI 10.1016/j.ijbiomac.2010.03.005; Karsten WE, 1997, BIOCHEMISTRY-US, V36, P1730, DOI 10.1021/bi962264x; Kaur N, 2011, INT J BIOL MACROMOL, V48, P779, DOI 10.1016/j.ijbiomac.2011.03.002; Kefala G, 2008, BIOCHEM J, V411, P351, DOI 10.1042/BJ20071360; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUMPAISAL R, 1987, PLANT PHYSIOL, V85, P145, DOI 10.1104/pp.85.1.145; LABER B, 1992, BIOCHEM J, V288, P691, DOI 10.1042/bj2880691; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mills RD, 2009, J MOL BIOL, V388, P1043, DOI 10.1016/j.jmb.2009.03.070; MIRWALDT C, 1995, J MOL BIOL, V246, P227, DOI 10.1006/jmbi.1994.0078; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Padmanabhan B, 2009, ACTA CRYSTALLOGR F, V65, P1222, DOI 10.1107/S174430910904651X; Pearce FG, 2006, BIOCHEM J, V400, P359, DOI 10.1042/BJ20060771; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rai N, 2005, STRUCTURE, V13, P723, DOI 10.1016/j.str.2005.02.012; Reboul CF, 2012, PLOS COMP BIOL; Rice EA, 2008, ARCH BIOCHEM BIOPHYS, V480, P111, DOI 10.1016/j.abb.2008.09.018; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Voss JE, 2010, J BIOL CHEM, V285, P5188, DOI 10.1074/jbc.M109.038166	57	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e38318	10.1371/journal.pone.0038318	http://dx.doi.org/10.1371/journal.pone.0038318			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761676	Green Published, gold, Green Submitted			2022-12-27	WOS:000305781700007
J	Inoue, K; Koketsu, D; Kato, S; Kobayashi, K; Nambu, A; Takada, M				Inoue, Ken-ichi; Koketsu, Daisuke; Kato, Shigeki; Kobayashi, Kazuto; Nambu, Atsushi; Takada, Masahiko			Immunotoxin-Mediated Tract Targeting in the Primate Brain: Selective Elimination of the Cortico-Subthalamic "Hyperdirect" Pathway	PLOS ONE			English	Article							SUPPLEMENTARY MOTOR AREA; BASAL GANGLIA FUNCTION; RESPONSE-INHIBITION; FUNCTIONAL-ANATOMY; NUCLEUS; NEURONS; CORTEX; MONKEY; INPUTS; REPRESENTATIONS	Using a neuron-specific retrograde gene-transfer vector (NeuRet vector), we established immunotoxin (IT)-mediated tract targeting in the primate brain that allows ablation of a neuronal population constituting a particular pathway. Here, we attempted selective removal of the cortico-subthalamic "hyperdirect" pathway. In conjunction with the direct and indirect pathways, the hyperdirect pathway plays a crucial role in motor information processing in the basal ganglia. This pathway links the motor-related areas of the frontal lobe directly to the subthalamic nucleus (STN) without relay at the striatum. After electrical stimulation in the motor-related areas such as the supplementary motor area (SMA), triphasic responses consisting of an early excitation, an inhibition, and a late excitation are usually detected in the internal segment of the globus pallidus (GPi). Several lines of pharmacophysiological evidence suggest that the early excitation may be derived from the hyperdirect pathway. In the present study, the NeuRet vector expressing human interleukin-2 receptor a-subunit was injected into the STN of macaque monkeys. Then, IT injections were made into the SMA. In these monkeys, single-neuron activity in the GPi was recorded in response to the SMA stimulation. We found that the early excitation was largely reduced, with neither the inhibition nor the late excitation affected. The spontaneous firing rate and pattern of GPi neurons remained unchanged. This indicates that IT-mediated tract targeting successfully eliminated the hyperdirect pathway selectively from the basal ganglia circuitry without affecting spontaneous activity of STN neurons. The electrophysiological finding was confirmed with anatomical data obtained from retrograde and anterograde neural tracings. The present results define that the cortically-driven early excitation in GPi neurons is mediated by the hyperdirect pathway. The IT-mediated tract targeting technique will provide us with novel strategies for elucidating various neural network functions.	[Inoue, Ken-ichi; Takada, Masahiko] Kyoto Univ, Primate Res Inst, Syst Neurosci Sect, Inuyama, Aichi 484, Japan; [Koketsu, Daisuke; Nambu, Atsushi] Grad Univ Adv Studies, Div Syst Neurophysiol, Natl Inst Physiol Sci, Okazaki, Aichi, Japan; [Koketsu, Daisuke; Nambu, Atsushi] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi, Japan; [Kato, Shigeki; Kobayashi, Kazuto] Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Mol Genet, Fukushima, Japan	Kyoto University; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Fukushima Medical University	Inoue, K (corresponding author), Kyoto Univ, Primate Res Inst, Syst Neurosci Sect, Inuyama, Aichi 484, Japan.	nambu@nips.ac.jp; takada@pri.kyoto-u.ac.jp	Inoue, Ken-ichi/K-4103-2015; Kato, Shigeki/S-8016-2018	Inoue, Ken-ichi/0000-0002-5683-5280; Kato, Shigeki/0000-0002-8792-7591; Kobayashi, Kazuto/0000-0002-7617-2939; Nambu, Atsushi/0000-0003-2153-5445	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study is the result of "Highly creative animal model development for brain sciences" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; CARPENTER MB, 1950, J COMP NEUROL, V92, P293, DOI 10.1002/cne.900920303; HAMADA I, 1992, J NEUROPHYSIOL, V68, P1850, DOI 10.1152/jn.1992.68.5.1850; HARTMANNVONMONAKOW K, 1978, EXP BRAIN RES, V33, P395; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Hutchison WD, 1998, ANN NEUROL, V44, P622, DOI 10.1002/ana.410440407; Inoue K, 2010, SOC NEUR ABSTR, V36, P61415; Isoda M, 2008, J NEUROSCI, V28, P7209, DOI 10.1523/JNEUROSCI.0487-08.2008; Jahfari S, 2011, J NEUROSCI, V31, P6891, DOI 10.1523/JNEUROSCI.5253-10.2011; Kaneda K, 2002, J NEUROPHYSIOL, V88, P1420, DOI 10.1152/jn.2002.88.3.1420; Kato S, 2007, HUM GENE THER, V18, P1141, DOI 10.1089/hum.2007.082; Kato S, 2011, HUM GENE THER, V22, P1511, DOI 10.1089/hum.2011.111; Kato S, 2011, J NEUROSCI, V31, P17169, DOI 10.1523/JNEUROSCI.4005-11.2011; Kato S, 2011, HUM GENE THER, V22, P197, DOI 10.1089/hum.2009.179; KOBAYASHI K, 1995, P NATL ACAD SCI USA, V92, P1132, DOI 10.1073/pnas.92.4.1132; KREITMAN RJ, 1994, BLOOD, V83, P426; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; Mink J W, 1993, Curr Opin Neurobiol, V3, P950, DOI 10.1016/0959-4388(93)90167-W; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Nambu A, 2000, J NEUROPHYSIOL, V84, P289, DOI 10.1152/jn.2000.84.1.289; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Nambu A, 2002, J NEUROPHYSIOL, V88, P1830, DOI 10.1152/jn.2002.88.4.1830; Nambu A, 1997, NEUROSCI LETT, V239, P13, DOI 10.1016/S0304-3940(97)00877-X; Nambu A, 1996, J NEUROSCI, V16, P2671; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Sano H, 2003, J NEUROSCI, V23, P9078; Tachibana Y, 2008, EUR J NEUROSCI, V27, P238, DOI 10.1111/j.1460-9568.2007.05990.x; Tachibana Y, 2011, EUR J NEUROSCI, V34, P1470, DOI 10.1111/j.1460-9568.2011.07865.x; Yasoshima Y, 2005, J NEUROSCI, V25, P7743, DOI 10.1523/JNEUROSCI.1904-05.2005	31	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39149	10.1371/journal.pone.0039149	http://dx.doi.org/10.1371/journal.pone.0039149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761729	Green Published, gold, Green Submitted			2022-12-27	WOS:000305781700018
J	Philipp, U; Vollmar, A; Haggstrom, J; Thomas, A; Distl, O				Philipp, Ute; Vollmar, Andrea; Haeggstroem, Jens; Thomas, Anne; Distl, Ottmar			Multiple Loci Are Associated with Dilated Cardiomyopathy in Irish Wolfhounds	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DOBERMAN-PINSCHERS; CANDIDATE GENES; DOGS; MODEL	Dilated cardiomyopathy (DCM) is a highly prevalent and often lethal disease in Irish wolfhounds. Complex segregation analysis indicated different loci involved in pathogenesis. Linear fixed and mixed models were used for the genome-wide association study. Using 106 DCM cases and 84 controls we identified one SNP significantly associated with DCM on CFA37 and five SNPs suggestively associated with DCM on CFA1, 10, 15, 21 and 17. On CFA37 MOGAT1 and ACSL3 two enzymes of the lipid metabolism were located near the identified SNP.	[Philipp, Ute; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Vollmar, Andrea] Vet Clin Small Anim, Wissen, Germany; [Haeggstroem, Jens] Swedish Univ Agr Sci, Dept Clin Sci, Fac Vet Med & Anim Sci, Uppsala, Sweden; [Thomas, Anne] ANTAGENE, Anim Genet Lab, Limonest, France	University of Veterinary Medicine Hannover, Foundation; Swedish University of Agricultural Sciences	Philipp, U (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany.	ute.philipp@tiho-hannover.de	Melzner, Frank/X-4339-2018	Melzner, Frank/0000-0002-5884-1318; Haggstrom, Jens/0000-0003-3402-023X	Deutsche Forschungsgemeinschaft [PH188_1/1]; European Commission [LUPA-GA.201270]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded thanks to grants from Deutsche Forschungsgemeinschaft (PH188_1/1) and European Commission (LUPA-GA.201270. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bharadwaj KG, 2010, J BIOL CHEM, V285, P37976, DOI 10.1074/jbc.M110.174458; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brownlie SE, 1999, J SMALL ANIM PRACT, V40, P371, DOI 10.1111/j.1748-5827.1999.tb03102.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Caubit X, 2010, J NEUROSCI, V30, P9465, DOI 10.1523/JNEUROSCI.1765-10.2010; Cheng YX, 2011, INFLAMMATION, V34, P698, DOI 10.1007/s10753-010-9281-5; Choi YH, 2006, J CLIN INVEST, V116, P3240, DOI 10.1172/JCI24867; Distl O, 2007, HEREDITY, V99, P460, DOI 10.1038/sj.hdy.6801024; Egenvall A, 2006, J VET INTERN MED, V20, P894, DOI 10.1892/0891-6640(2006)20[894:HDAACO]2.0.CO;2; Flammang D., 2005, Annales de Cardiologie et d'Angeiologie, V54, P144, DOI 10.1016/j.ancard.2004.09.005; Hershberger RE, 2009, CIRC-HEART FAIL, V2, P253, DOI 10.1161/CIRCHEARTFAILURE.108.817346; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Mausberg TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020042; Mestroni L, 1999, J AM COLL CARDIOL, V34, P181, DOI 10.1016/S0735-1097(99)00172-2; Meurs KM, 2008, AM J VET RES, V69, P1050, DOI 10.2460/ajvr.69.8.1050; Meurs KM, 2010, HUM GENET, V128, P315, DOI 10.1007/s00439-010-0855-y; Meurs KM, 2001, AM J VET RES, V62, P33, DOI 10.2460/ajvr.2001.62.33; Meurs KM, 2001, J AM VET MED ASSOC, V218, P729, DOI 10.2460/javma.2001.218.729; Meurs KR, 1998, VET CLIN N AM-SMALL, V28, P1449, DOI 10.1016/S0195-5616(98)50131-3; Morimoto S, 2008, CARDIOVASC RES, V77, P659, DOI 10.1093/cvr/cvm084; Noh HL, 2006, CARDIOVASC DRUG THER, V20, P441, DOI 10.1007/s10557-006-0633-1; O'Sullivan ML, 2011, AM J VET RES, V72, P932, DOI 10.2460/ajvr.72.7.932; Philipp U, 2008, ANIM BIOTECHNOL, V19, P231, DOI 10.1080/10495390802281952; Philipp U, 2008, ANIM GENET, V39, P88, DOI 10.1111/j.1365-2052.2007.01684.x; Philipp U, 2007, J HERED, V98, P506, DOI 10.1093/jhered/esm045; Rampersaud E, 2010, ANN HUM GENET, V74, P110, DOI 10.1111/j.1469-1809.2010.00566.x; Remke M, 2011, J CLIN ONCOL, V29, P3852, DOI 10.1200/JCO.2011.36.2798; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; Schatzberg S, 1999, AM J VET RES, V60, P1040; Stabej P, 2005, CYTOGENET GENOME RES, V111, P140, DOI 10.1159/000086383; Stabej P, 2005, AM J VET RES, V66, P432, DOI 10.2460/ajvr.2005.66.432; Stabej P, 2004, GENE, V340, P241, DOI 10.1016/j.gene.2004.06.050; Stark K, 2011, PLOS GENET, V6; Teyssedre S, 2012, J ANIM SCI, V90, P45, DOI 10.2527/jas.2011-4031; Vollmar AC, 1999, J AM ANIM HOSP ASSOC, V35, P271, DOI 10.5326/15473317-35-4-271; Vollmar AC, 1999, J AM ANIM HOSP ASSOC, V35, P279, DOI 10.5326/15473317-35-4-279; Vollmar AC, 2000, J AM ANIM HOSP ASSOC, V36, P125, DOI 10.5326/15473317-36-2-125; Werner P, 2008, GENOMICS, V91, P517, DOI 10.1016/j.ygeno.2008.03.007; Wiersma AC, 2008, J HERED, V99, P73, DOI 10.1093/jhered/esm090; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	41	26	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e36691	10.1371/journal.pone.0036691	http://dx.doi.org/10.1371/journal.pone.0036691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761652	Green Published, Green Submitted, gold			2022-12-27	WOS:000305781700001
J	Derks, EM; Vorstman, JAS; Ripke, S; Kahn, RS; Ophoff, RA				Derks, Eske M.; Vorstman, Jacob A. S.; Ripke, Stephan; Kahn, Rene S.; Ophoff, Roel A.		Schizophrenia Psychiat Genomic Con	Investigation of the Genetic Association between Quantitative Measures of Psychosis and Schizophrenia: A Polygenic Risk Score Analysis	PLOS ONE			English	Article							SYMPTOM DIMENSIONS; METAANALYSIS; POPULATION; CONTINUUM; DISORDER; COMMON	The presence of subclinical levels of psychosis in the general population may imply that schizophrenia is the extreme expression of more or less continuously distributed traits in the population. In a previous study, we identified five quantitative measures of schizophrenia (positive, negative, disorganisation, mania, and depression scores). The aim of this study is to examine the association between a direct measure of genetic risk of schizophrenia and the five quantitative measures of psychosis. Estimates of the log of the odds ratios of case/control allelic association tests were obtained from the Psychiatric GWAS Consortium (PGC) (minus our sample) which included genome-wide genotype data of 8,690 schizophrenia cases and 11,831 controls. These data were used to calculate genetic risk scores in 314 schizophrenia cases and 148 controls from the Netherlands for whom genotype data and quantitative symptom scores were available. The genetic risk score of schizophrenia was significantly associated with case-control status (p<0.0001). In the case-control sample, the five psychosis dimensions were found to be significantly associated with genetic risk scores; the correlations ranged between. 15 and. 27 (all p<.001). However, these correlations were not significant in schizophrenia cases or controls separately. While this study confirms the presence of a genetic risk for schizophrenia as categorical diagnostic trait, we did not find evidence for the genetic risk underlying quantitative schizophrenia symptom dimensions. This does not necessarily imply that a genetic basis is nonexistent, but does suggest that it is distinct from the polygenic risk score for schizophrenia.	[Derks, Eske M.; Vorstman, Jacob A. S.; Kahn, Rene S.; Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Derks, Eske M.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Ripke, Stephan] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Ophoff, Roel A.] UCLA Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Massachusetts General Hospital; Utrecht University; Utrecht University Medical Center	Derks, EM (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands.	e.m.derks@amc.uva.nl	van Os, Jim/C-2113-2014; Derks, Eske M/A-1652-2017; Mattheisen, Manuel/B-4949-2012; Ripke, Stephan/AAK-5486-2021; Williams, Hywel/AAL-2440-2021; Hartmann, Annette/AAS-6331-2021; Cichon, Sven/H-8803-2013; Fanous, Ayman H/O-1263-2017; Bergen, Sarah/I-8313-2012; Mattingsdal, Morten/Q-9367-2016; Hansen, Thomas Folkmann/O-5965-2014; Cichon, Sven/B-9618-2014; Mattheisen, Manuel/S-3725-2019; Muglia, Pierandrea/ABD-9235-2020; McQuillin, Andrew/C-1623-2008; O'Donovan, Michael C/P-7005-2018; Melle, Ingrid S/B-4858-2011; Rosengren, Anders/AAA-4300-2021; McIntosh, Andrew M/B-9379-2008; Ruderfer, Douglas M/M-5795-2016; Myin-Germeys, Inez/L-5106-2014; Konte, Bettina/AAT-1142-2021; Mowry, Bryan/G-5046-2010	Derks, Eske M/0000-0002-6292-6883; Mattheisen, Manuel/0000-0002-8442-493X; Williams, Hywel/0000-0001-7758-0312; Cichon, Sven/0000-0002-9475-086X; Bergen, Sarah/0000-0002-5888-0034; Mattingsdal, Morten/0000-0003-4440-0324; Hansen, Thomas Folkmann/0000-0001-6703-7762; Cichon, Sven/0000-0002-9475-086X; Mattheisen, Manuel/0000-0002-8442-493X; Muglia, Pierandrea/0000-0002-3973-8606; McQuillin, Andrew/0000-0003-1567-2240; O'Donovan, Michael C/0000-0001-7073-2379; Melle, Ingrid S/0000-0002-9783-548X; Rosengren, Anders/0000-0002-6682-1288; McIntosh, Andrew M/0000-0002-0198-4588; Ruderfer, Douglas M/0000-0002-2365-386X; Konte, Bettina/0000-0001-5287-308X; Andreassen, Ole A./0000-0002-4461-3568; Agartz, Ingrid/0000-0002-9839-5391; Toncheva, Draga/0000-0002-7451-6363; Bruggeman, Richard/0000-0002-3238-8471; Posthuma, Danielle/0000-0001-7582-2365; Mowry, Bryan/0000-0002-4115-5645; Nothen, Markus/0000-0002-8770-2464; Myin-Germeys, Inez/0000-0002-3731-4930; Djurovic, Srdjan/0000-0002-8140-8061; ripke, stephan/0000-0003-3622-835X; Black, Donald/0000-0001-8038-1971; Walters, James/0000-0002-6980-4053; lichtenstein, paul/0000-0003-3037-5287; Buccola, Nancy/0000-0003-1378-4636; Zammit, Stanley/0000-0002-2647-9211; Freedman, Robert/0000-0002-2181-2898	Netherlands Scientific Organization (NWO) [451-080-010, 480-05-003]; Eli Lilly; Janssen Pharmaceutica; GlaxoSmithKline; Bristol-Myers Squibb; AstraZeneca Pharmaceuticals; Pfizer; Forest Pharmaceuticals; Novartis; Solvay; Generation Scotland; Genetics Health Initiative; Organon; Foundation for the National Institutes of Health; Shire; Forest; H. Lundbeck A/S; Eli Lilly Company; Merck; Bristol-Meyers Squibb; PGxHealth (a division of Clinical Data, Inc.); Roche Diagnostics; Vanda Pharmaceuticals; Golden Helix, Inc.; InforMed Insights; Johnson Johnson; Schering-Plough; Hospira (Mayne); AstraZeneca; Hospira; Janssen Cilag; MRC [G1000718] Funding Source: UKRI; Medical Research Council [G0801418B, G1000718] Funding Source: researchfish	Netherlands Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); Eli Lilly(Eli Lilly); Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); GlaxoSmithKline(GlaxoSmithKline); Bristol-Myers Squibb(Bristol-Myers Squibb); AstraZeneca Pharmaceuticals(AstraZeneca); Pfizer(Pfizer); Forest Pharmaceuticals; Novartis(Novartis); Solvay(Solvay SA); Generation Scotland; Genetics Health Initiative; Organon; Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shire; Forest; H. Lundbeck A/S; Eli Lilly Company(Eli Lilly); Merck(Merck & Company); Bristol-Meyers Squibb(Bristol-Myers Squibb); PGxHealth (a division of Clinical Data, Inc.); Roche Diagnostics; Vanda Pharmaceuticals; Golden Helix, Inc.; InforMed Insights; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Schering-Plough(Merck & CompanySchering Plough Corporation); Hospira (Mayne); AstraZeneca(AstraZeneca); Hospira; Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Over 40 United States National Institutes of Health grants and similar numbers of government grants from other countries, along with substantial private and foundation support, enabled this work. We greatly appreciate the sustained efforts of T. Lehner (National Institute of Mental Health) on behalf of the Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (PGC). Dr. E. M. Derks is supported by the Netherlands Scientific Organization (NWO; project number 451-080-010). Statistical analyses were carried out on the Genetic Cluster Computer (http://www.geneticcluster.org) which is financially supported by the Netherlands Scientific Organization (NWO 480-05-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare the following interests: Eli Lilly funded portions of the genotyping for CATIE and TOP. P. F. S. received research funding from Eli Lilly in connection with CATIE. T. S. S. received research funding from Eli Lilly and consulting fees from Janssen Pharmaceutica, GlaxoSmithKline and Bristol-Myers Squibb. J.A.L. received research funding from AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKline, Janssen Pharmaceutica and Pfizer and consulting and educational fees from AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly, Forest Pharmaceuticals, GlaxoSmithKline, Janssen Pharmaceutica, Novartis, Pfizer and Solvay. D.St.C. received research funding from GlaxoSmithKline and Generation Scotland, Genetics Health Initiative. F. A. received funds from Pfizer, Organon and the Foundation for the National Institutes of Health. D. W. B. has received research support from Shire and Forest, has been on the speakers' bureau for Pfizer and has received consulting honoraria from Forest and Jazz. T. W. has received consulting and lecture fees from H. Lundbeck A/S. O.A.A. has received Speaker's honorarium from AstraZeneca, Janssen, Bristol-Myers Squibb and GlaxoSmithKline. I. M. has received a Speaker's honorarium from Janssen and AstraZeneca. A. K. M. has received consulting fees or honoraria from Eli Lilly & Company, Janssen Pharmaceutica, Merck, Bristol-Meyers Squibb, Pfizer, PGxHealth (a division of Clinical Data, Inc.), Roche Diagnostics and Vanda Pharmaceuticals and has received research support from Eli Lilly & Company. T. L. has received consulting fees or honoraria from Merck, Eli Lilly & Company, Golden Helix, Inc., InforMed Insights and PGxHealth (a division of Clinical Data, Inc.). I. B. has been an advisory board member, consultant and lecturer for AstraZeneca, Bristol-Myers Squibb, Eli Lilly, EGIS, Janssen, H. Lundbeck A/S, Novartis, Pfizer, Richter and Schering-Plough and received a grant for an investigator-initiated study from H. Lundbeck A/S. J.J.M. has received consulting and speaker's fees from Johnson & Johnson, Schering-Plough and Eli Lilly. C. P. has received grant support from Janssen-Cilag, Eli Lilly, Hospira (Mayne) and AstraZeneca, provided consultancy to Janssen-Cilag, Eli Lilly, Hospira (Mayne), AstraZeneca, Pfizer and Schering-Plough and has undertaken investigator-initiated studies supported by Eli Lilly, Hospira, Janssen Cilag and AstraZeneca. The Denmark-Aarhus group (The GEMS Stud with principal investigators A. D. B., O.M. and P. B. M.) received research funding from H. Lundbeck A/S. E.G.J. has served as an unpaid consultant for Eli Lilly. H. S., S. S., and K. S. are employed at deCODE Genetics, Reykjavik, Iceland. MH is employed at Illumina, Inc., La Jolla, California, USA. PM is employed at NeuroSearch A/S, Ballerup, Denmark. TFO is employed at ARoS Applied Biotechnology A/S, Skejby, Denmark. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Binbay T, SCHIZOPHR B IN PRESS; Cardno AG, 2001, BRIT J PSYCHIAT, V179, P39, DOI 10.1192/bjp.179.1.39; Derks EM, SCHIZOPHR B IN PRESS; Fanous AH, 2005, MOL PSYCHIATR, V10, P6, DOI 10.1038/sj.mp.4001571; Fanous Ayman H, 2008, Curr Psychiatry Rep, V10, P164, DOI 10.1007/s11920-008-0028-z; Hamshere ML, 2011, BRIT J PSYCHIAT, V198, P284, DOI 10.1192/bjp.bp.110.087866; Peralta V, 2001, SCHIZOPHR RES, V49, P269, DOI 10.1016/S0920-9964(00)00071-2; PLOMIN R, 1994, SCIENCE, V264, P1733, DOI 10.1126/science.8209254; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; R Core Team, 2018, R LANG ENV STAT COMP; Rietkerk T, 2008, SCHIZOPHR RES, V102, P197, DOI 10.1016/j.schres.2008.01.023; Rietschel M, 2011, MOL PSYCHIAT; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Torgersen S, 2002, SCHIZOPHR RES, V54, P33, DOI 10.1016/S0920-9964(01)00349-8; van Os J, 2000, SCHIZOPHR RES, V45, P11, DOI 10.1016/S0920-9964(99)00224-8; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]	22	48	49	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e37852	10.1371/journal.pone.0037852	http://dx.doi.org/10.1371/journal.pone.0037852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761660	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000305730900005
J	Kumar, A; Bhandari, A; Sinha, R; Sardar, P; Sushma; Goyal, P; Goswami, C; Grapputo, A				Kumar, Abhishek; Bhandari, Anita; Sinha, Rahul; Sardar, Puspendu; Miss Sushma; Goyal, Pankaj; Goswami, Chandan; Grapputo, Alessandro			Molecular Phylogeny of OVOL Genes Illustrates a Conserved C2H2 Zinc Finger Domain Coupled by Hypervariable Unstructured Regions	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NATIVELY UNFOLDED PROTEINS; INTRINSIC DISORDER; DROSOPHILA-OVO; GENOME SEQUENCE; TRANSCRIPTION; DUPLICATION; PREDICTION; DATABASE; REVEALS	OVO-like proteins (OVOL) are members of the zinc finger protein family and serve as transcription factors to regulate gene expression in various differentiation processes. Recent studies have shown that OVOL genes are involved in epithelial development and differentiation in a wide variety of organisms; yet there is a lack of comprehensive studies that describe OVOL proteins from an evolutionary perspective. Using comparative genomic analysis, we traced three different OVOL genes (OVOL1-3) in vertebrates. One gene, OVOL3, was duplicated during a whole-genome-duplication event in fish, but only the copy (OVOL3b) was retained. From early-branching metazoa to humans, we found that a core domain, comprising a tetrad of C2H2 zinc fingers, is conserved. By domain comparison of the OVOL proteins, we found that they evolved in different metazoan lineages by attaching intrinsically-disordered (ID) segments of N/C-terminal extensions of 100 to 1000 amino acids to this conserved core. These ID regions originated independently across different animal lineages giving rise to different types of OVOL genes over the course of metazoan evolution. We illustrated the molecular evolution of metazoan OVOL genes over a period of 700 million years (MY). This study both extends our current understanding of the structure/function relationship of metazoan OVOL genes, and assembles a good platform for further characterization of OVOL genes from diverged organisms.	[Kumar, Abhishek; Grapputo, Alessandro] Univ Padua, Dept Biol, Padua, Italy; [Kumar, Abhishek] Univ Kiel, Abt Bot Genet & Mol Biol, Bot Inst & Bot Garten, Kiel, Germany; [Bhandari, Anita] Univ Kiel, Lehrstuhl Mol Phytopathol, Kiel, Germany; [Sinha, Rahul] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Sardar, Puspendu; Goswami, Chandan] Natl Inst Sci Educ & Res, Inst Phys Campus, Bhubaneswar, Orissa, India; [Miss Sushma] Indian Inst Toxicol Res, Lucknow, Uttar Pradesh, India; [Goyal, Pankaj] Univ Greifswald, Klin & Poliklin Frauenheilkunde & Geburtshilfe, Univ Klinikum, Greifswald, Germany	University of Padua; University of Kiel; University of Kiel; Cold Spring Harbor Laboratory; Institute of Physics Bhubaneswar (IOPB); National Institute of Science Education & Research (NISER); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Ernst Moritz Arndt Universitat Greifswald; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kumar, A (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	abhishek.abhishekkumar@gmail.com	Sardar, Puspendu/W-6727-2019; Kumar, Abhishek/A-8727-2012; Grapputo, Alessandro/AAR-1252-2020	Sardar, Puspendu/0000-0001-8011-2915; Kumar, Abhishek/0000-0003-4172-4059; Grapputo, Alessandro/0000-0001-9255-4294				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews J, 1998, DEV GENES EVOL, V207, P482, DOI 10.1007/s004270050139; Andrews J, 2000, DEVELOPMENT, V127, P881; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Conrad B, 2007, ANNU REV GENOM HUM G, V8, P17, DOI 10.1146/annurev.genom.8.021307.110233; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Delon I, 2003, MECH DEVELOP, V120, P747, DOI 10.1016/S0925-4773(03)00081-9; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flicek Paul, 2010, Nucleic Acids Res, V38, pD557, DOI 10.1093/nar/gkp972; Garza AS, 2009, LIFE SCI, V84, P189, DOI 10.1016/j.lfs.2008.12.002; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Guerzoni D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002381; Hedges SB, 2003, TRENDS GENET, V19, P200, DOI 10.1016/S0168-9525(03)00053-2; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Johnson AD, 2001, DEVELOPMENT, V128, P2857; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Knowles DG, 2009, GENOME RES, V19, P1752, DOI 10.1101/gr.095026.109; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Li B, 2002, GENOMICS, V80, P319, DOI 10.1006/geno.2002.6831; Li BA, 2005, DEVELOPMENT, V132, P1463, DOI 10.1242/dev.01658; Li BA, 2002, P NATL ACAD SCI USA, V99, P6064, DOI 10.1073/pnas.092137099; Lu JN, 1998, DEV GENES EVOL, V208, P213, DOI 10.1007/s004270050175; Masel J, 2006, GENETICS, V172, P1985, DOI 10.1534/genetics.105.051649; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MEVELNINIO M, 1991, EMBO J, V10, P2259, DOI 10.1002/j.1460-2075.1991.tb07762.x; MEVELNINIO M, 1995, MECH DEVELOP, V49, P83, DOI 10.1016/0925-4773(94)00305-7; MevelNinio M, 1996, DEVELOPMENT, V122, P4131; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Nair M, 2006, J CELL BIOL, V173, P253, DOI 10.1083/jcb.200508196; Nair M, 2007, NUCLEIC ACIDS RES, V35, P1687, DOI 10.1093/nar/gkl1141; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Ohno S, 1999, SEMIN CELL DEV BIOL, V10, P517, DOI 10.1006/scdb.1999.0332; Ohno S., 1970, P1; OLIVER B, 1987, GENE DEV, V1, P913, DOI 10.1101/gad.1.9.913; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Sardar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031448; Schwarz R, 1979, ATLAS PROTEIN SEQUEN, P353, DOI DOI 10.2307/2408678; Siltberg-Liberles J, 2011, MOL BIOL EVOL, V28, P59, DOI 10.1093/molbev/msq291; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Szilagyi A, 2008, BIOPHYS J, V95, P1612, DOI 10.1529/biophysj.108.131151; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Team RDC, 2011, R STAT PACK; Teng A, 2007, BBA-MOL BASIS DIS, V1772, P89, DOI 10.1016/j.bbadis.2006.08.012; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Williams R M, 2001, Pac Symp Biocomput, P89; Wolfsberg Tyra G, 2010, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0105s29	82	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39399	10.1371/journal.pone.0039399	http://dx.doi.org/10.1371/journal.pone.0039399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737237	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000305695100036
J	Siu, E; Campitelli, MA; Kwong, JC				Siu, Eric; Campitelli, Michael A.; Kwong, Jeffrey C.			Physical Activity and Influenza-Coded Outpatient Visits, a Population-Based Cohort Study	PLOS ONE			English	Article							METABOLIC EQUIVALENT; ANTIBODY-RESPONSES; IMMUNE FUNCTION; EXERCISE; RISK; RELIABILITY; VIRUS; SERUM; DIAGNOSES; COMMUNITY	Background: Although the benefits of physical activity in preventing chronic medical conditions are well established, its impacts on infectious diseases, and seasonal influenza in particular, are less clearly defined. We examined the association between physical activity and influenza-coded outpatient visits, as a proxy for influenza infection. Methodology/Principal Findings: We conducted a cohort study of Ontario respondents to Statistics Canada's population health surveys over 12 influenza seasons. We assessed physical activity levels through survey responses, and influenza-coded physician office and emergency department visits through physician billing claims. We used logistic regression to estimate the risk of influenza-coded outpatient visits during influenza seasons. The cohort comprised 114,364 survey respondents who contributed 357,466 person-influenza seasons of observation. Compared to inactive individuals, moderately active (OR 0.83; 95% CI 0.74-0.94) and active (OR 0.87; 95% CI 0.77-0.98) individuals were less likely to experience an influenza-coded visit. Stratifying by age, the protective effect of physical activity remained significant for individuals <65 years (active OR 0.86; 95% CI 0.75-0.98, moderately active: OR 0.85; 95% CI 0.74-0.97) but not for individuals >= 65 years. The main limitations of this study were the use of influenza-coded outpatient visits rather than laboratory-confirmed influenza as the outcome measure, the reliance on self-report for assessing physical activity and various covariates, and the observational study design. Conclusion/Significance: Moderate to high amounts of physical activity may be associated with reduced risk of influenza for individuals <65 years. Future research should use laboratory-confirmed influenza outcomes to confirm the association between physical activity and influenza.	[Siu, Eric; Campitelli, Michael A.; Kwong, Jeffrey C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kwong, Jeffrey C.] Publ Hlth Ontario, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Siu, E (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	jeff.kwong@utoronto.ca			Canadian Institutes of Health Research [XIN 82408]; University of Toronto Department of Family and Community Medicine; Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care (MOHLTC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Toronto Department of Family and Community Medicine; Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This study was supported by an operating grant from the Canadian Institutes of Health Research (XIN 82408). JCK was supported by a Clinician Scientist Award from the University of Toronto Department of Family and Community Medicine. JCK and MAC receive salary support from the Institute for Clinical Evaluative Sciences (ICES). This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKHTARDANESH N, 2008, OPEN MED, V2, P14; Beland Yves, 2002, Health Rep, V13, P9; Ben-Yehuda A, 1992, Clin Geriatr Med, V8, P701; Byrne NM, 2005, J APPL PHYSIOL, V99, P1112, DOI 10.1152/japplphysiol.00023.2004; Chan B, 1999, Hosp Q, V3, P17; Chen Y, 2006, PREV MED, V42, P261, DOI 10.1016/j.ypmed.2006.01.006; Craig CL, 2002, MED SCI SPORT EXER, V34, P1462, DOI 10.1097/00005768-200209000-00010; deJong A, 2010, ACSMS HEALTH FIT J, V14, P43, DOI 10.1249/FIT.0b013e3181e438f9; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; FOLSOM AR, 1986, J CHRON DIS, V39, P505, DOI 10.1016/0021-9681(86)90195-5; Fondell E, 2011, MED SCI SPORT EXER, V43, P272, DOI 10.1249/MSS.0b013e3181edf108; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; HEATH GW, 1991, MED SCI SPORT EXER, V23, P152; Hemila H, 2003, MED SCI SPORT EXER, V35, P1815, DOI 10.1249/01.MSS.0000093616.60899.92; HOFFMANGOETZ L, 1994, IMMUNOL TODAY, V15, P382, DOI 10.1016/0167-5699(94)90177-5; Holvoet P, 2008, JAMA-J AM MED ASSOC, V299, P2287, DOI 10.1001/jama.299.19.2287; Iron K, 2008, LIVING DYING ONTARIO; Kwan M, 2004, INT J FOOD SCI NUTR, V55, P179, DOI 10.1080/09637480410001725201; LAKKA TA, 1994, NEW ENGL J MED, V330, P1549, DOI 10.1056/NEJM199406023302201; LEON AS, 1987, JAMA-J AM MED ASSOC, V258, P2388, DOI 10.1001/jama.258.17.2388; MACNEIL B, 1991, J APPL PHYSIOL, V70, P179, DOI 10.1152/jappl.1991.70.1.179; Marsden-Haug N, 2007, EMERG INFECT DIS, V13, P207, DOI 10.3201/eid1302.060557; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1242, DOI 10.1097/00005768-200208000-00003; Merchant AT, 2007, CAN J PUBLIC HEALTH, V98, P203, DOI 10.1007/BF03403713; National Advisory Committee on Immunization (NACI), 2008, Can Commun Dis Rep, V34, P1; Naylor CD, 1999, CARDIOVASCULAR HLTH; Nieman David C, 2003, Curr Sports Med Rep, V2, P239; Nieman DC, 2000, IMMUNOL CELL BIOL, V78, P496, DOI 10.1046/j.1440-1711.2000.00950.x; NIEMAN DC, 1990, J SPORT MED PHYS FIT, V30, P316; NIEMAN DC, 1990, INT J SPORTS MED, V11, P467, DOI 10.1055/s-2007-1024839; NIEMAN DC, 1993, MED SCI SPORT EXER, V25, P823, DOI 10.1249/00005768-199307000-00011; NIEMAN DC, 1994, SEMIN HEMATOL, V31, P166; NIEMAN DC, 1994, INT J SPORTS MED, V15, pS131, DOI 10.1055/s-2007-1021128; NIEMAN DC, 1991, SPORTS MED, V11, P183, DOI 10.2165/00007256-199111030-00003; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; PEDERSEN BK, 1995, SPORTS MED, V19, P393, DOI 10.2165/00007256-199519060-00003; POWERS DC, 1994, J MED VIROL, V43, P57, DOI 10.1002/jmv.1890430111; POWERS DC, 1993, J INFECT DIS, V167, P584, DOI 10.1093/infdis/167.3.584; RICHARDSON MT, 1994, J CLIN EPIDEMIOL, V47, P271, DOI 10.1016/0895-4356(94)90008-6; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; SISCOVICK DS, 1982, JAMA-J AM MED ASSOC, V248, P3113, DOI 10.1001/jama.248.23.3113; STARFIELD B, 1991, HEALTH SERV RES, V26, P53; Tambay J L, 1995, Health Rep, V7, P29; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Vartiainen E, 2002, J EPIDEMIOL COMMUN H, V56, P167, DOI 10.1136/jech.56.3.167; Wilkins R., 2004, AUTOMATED GEOGRAPHIC; Wong CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002108; Yung RL, 2000, RHEUM DIS CLIN N AM, V26, P455, DOI 10.1016/S0889-857X(05)70151-4; Zheng W, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-250	50	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39518	10.1371/journal.pone.0039518	http://dx.doi.org/10.1371/journal.pone.0039518			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	964KY	22737242	gold, Green Published, Green Submitted			2022-12-27	WOS:000305695100041
J	de Paz, GA; Cubas, P; Crespo, A; Elix, JA; Lumbsch, HT				Amo de Paz, Guillermo; Cubas, Paloma; Crespo, Ana; Elix, John A.; Lumbsch, H. Thorsten			Transoceanic Dispersal and Subsequent Diversification on Separate Continents Shaped Diversity of the Xanthoparmelia pulla Group (Ascomycota)	PLOS ONE			English	Article							SPECIES DELIMITATION; MOLECULAR PHYLOGENY; LICHENS PARMELIACEAE; PARMELIOID LICHENS; EVOLUTION; FUNGI; BIOGEOGRAPHY; LECANORALES; CHARACTERS; NUCLEAR	In traditional morphology-based concepts many species of lichenized fungi have world-wide distributions. Molecular data have revolutionized the species delimitation in lichens and have demonstrated that we underestimated the diversity of these organisms. The aim of this study is to explore the phylogeography and the evolutionary patterns of the Xanthoparmelia pulla group, a widespread group of one of largest genera of macrolichens. We used a dated phylogeny based on nuITS and nuLSU rDNA sequences and performed an ancestral range reconstruction to understand the processes and explain their current distribution, dating the divergence of the major lineages in the group. An inferred age of radiation of parmelioid lichens and the age of a Parmelia fossil were used as the calibration points for the phylogeny. The results show that many species of the X. pulla group as currently delimited are polyphyletic and five major lineages correlate with their geographical distribution and the biosynthetic pathways of secondary metabolites. South Africa is the area where the X. pulla group radiated during the Miocene times, and currently is the region with the highest genetic, morphological and chemical diversity. From this center of radiation the different lineages migrated by long-distance dispersal to others areas, where secondary radiations developed. The ancestral range reconstruction also detected that a secondary lineage migrated from Australia to South America via long-distance dispersal and subsequent continental radiation.	[Amo de Paz, Guillermo; Cubas, Paloma; Crespo, Ana] Univ Complutense Madrid, Fac Farm, Dept Biol Vegetal 2, E-28040 Madrid, Spain; [Elix, John A.] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia; [Lumbsch, H. Thorsten] Field Museum Nat Hist, Dept Bot, Chicago, IL 60605 USA	Complutense University of Madrid; Australian National University; Field Museum of Natural History (Chicago)	de Paz, GA (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Biol Vegetal 2, E-28040 Madrid, Spain.	tlumbsch@fieldmuseum.org	Crespo, Ana/N-6236-2014; de Paz, Guillermo Amo/Z-4650-2019	Crespo, Ana/0000-0002-5271-0157; Amo de Paz, Guillermo/0000-0002-1374-3124	Spanish Ministerio de Ciencia e Innovacion [CGL2010-21646]; National Science Foundation (USA) [DEB-0949147]; The Universidad Complutense de Madrid (SYSTEMOL research group UCM-BSCH) [GR35/10A]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); National Science Foundation (USA)(National Science Foundation (NSF)); The Universidad Complutense de Madrid (SYSTEMOL research group UCM-BSCH)	This study was supported by a grant from the Spanish Ministerio de Ciencia e Innovacion (CGL2010-21646) and a grant by the National Science Foundation (USA) (DEB-0949147). The Universidad Complutense de Madrid is thanked for providing all complementary facilities and funds (SYSTEMOL research group UCM-BSCH GR35/10A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Paz GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028161; de Paz GA, 2010, BRYOLOGIST, V113, P376, DOI 10.1639/0007-2745-113.2.376; de Paz GA, 2010, AUST SYST BOT, V23, P173, DOI 10.1071/SB09055; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Arguello A, 2007, BIOL J LINN SOC, V91, P455, DOI 10.1111/j.1095-8312.2007.00810.x; Baloch E, 2009, MOL ECOL, V18, P2185, DOI 10.1111/j.1365-294X.2009.04183.x; Blanco O, 2006, MOL PHYLOGENET EVOL, V39, P52, DOI 10.1016/j.ympev.2005.12.015; Blanco O, 2004, TAXON, V53, P959, DOI 10.2307/4135563; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Cracraft J., 1983, Current Ornithology, V1, P159; Crespo A, 2002, MYCOL RES, V106, P788, DOI 10.1017/S095375620200610X; Crespo A, 2001, TAXON, V50, P807, DOI 10.2307/1223708; Crespo A, 2007, MOL PHYLOGENET EVOL, V44, P812, DOI 10.1016/j.ympev.2006.11.029; Crespo A, 2010, IMA FUNGUS, V1, P167, DOI 10.5598/imafungus.2010.01.02.09; Crespo A, 2010, TAXON, V59, P1735, DOI 10.1002/tax.596008; Crespo A, 2009, AN JARDIN BOT MADRID, V66, P71, DOI 10.3989/ajbm.2225; Cubero OF, 2004, MYCOL RES, V108, P498, DOI 10.1017/s095375620400975x; CULBERSON CF, 1977, BRYOLOGIST, V80, P125, DOI 10.2307/3242518; CULBERSON CF, 1982, J CHROMATOGR, V238, P483, DOI 10.1016/S0021-9673(00)81336-9; CULBERSON CF, 1972, J CHROMATOGR, V72, P113, DOI 10.1016/0021-9673(72)80013-X; CULBERSON CF, 1981, BRYOLOGIST, V84, P16, DOI 10.2307/3242974; Del Prado R, 2007, MYCOL RES, V111, P685, DOI 10.1016/j.mycres.2007.04.002; Divakar PK, 2005, LICHENOLOGIST, V37, P37, DOI 10.1017/S0024282904014641; Divakar PK, 2010, FUNGAL DIVERS, V42, P47, DOI 10.1007/s13225-010-0027-3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elix J. A., 2002, AUSTRALASIAN LICHENO, V51, P7; Elix JA, 1999, MYCOTAXON, V71, P431; Elix JA, 2003, MYCOTAXON, V87, P395; Elix JA, 1994, FLORA AUSTR, V55, P68; Elix JA, 2009, SYST BIODIVERS, V7, P479, DOI 10.1017/S1477200009990223; Esslinger T.L., 1977, J HATTORI BOT LAB, V42, P1; ESSLINGER TL, 1978, MYCOTAXON, V7, P45; Esslinger TL, 2000, BRYOLOGIST, V103, P568, DOI 10.1639/0007-2745(2000)103[0568:NOTBCS]2.0.CO;2; FEIGE GB, 1993, J CHROMATOGR, V646, P417, DOI 10.1016/0021-9673(93)83356-W; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Hale BW, 1999, BRYOLOGIST, V102, P462, DOI 10.2307/3244234; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hodkinson BP, 2011, BIBL LICHENOL, V106, P115; Hognabba F, 2003, CLADISTICS, V19, P224, DOI 10.1016/S0748-3007(03)00028-8; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Kroken S, 2001, MYCOLOGIA, V93, P38, DOI 10.2307/3761604; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V60, P317, DOI 10.1016/j.ympev.2011.05.012; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V59, P587, DOI 10.1016/j.ympev.2011.03.020; Leavitt SD, 2011, AM J BOT, V98, P175, DOI 10.3732/ajb.1000230; Lohtander K, 1998, BRYOLOGIST, V101, P404; Lopez-Vaamonde C, 2009, MOL PHYLOGENET EVOL, V52, P715, DOI 10.1016/j.ympev.2009.05.028; Lumbsch HT, 2008, MYCOL RES, V112, P423, DOI 10.1016/j.mycres.2008.02.002; Lumbsch HT, 2006, BIOL J LINN SOC, V89, P615, DOI 10.1111/j.1095-8312.2006.00696.x; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; Lumbsch HT, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-257; Lumbsch HT, 2002, LICHENOLOGY, V1, P37; Molina MD, 2004, LICHENOLOGIST, V36, P37, DOI 10.1017/S0024282904013933; Myllys L, 1999, MOL PHYLOGENET EVOL, V12, P295, DOI 10.1006/mpev.1999.0620; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Orange A., 2001, MICROCHEMICAL METHOD; Otalora MAG, 2008, TAXON, V57, P907, DOI 10.1002/tax.573019; Otalora MAG, 2010, AM J BOT, V97, P216, DOI 10.3732/ajb.0900064; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Plata ER, 2011, MOL PHYLOGENET EVOL, V61, P45, DOI 10.1016/j.ympev.2011.04.025; Poinar GO, 2000, LICHENOLOGIST, V32, P263, DOI 10.1006/lich.1999.0258; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Rambaut A., 2007, TRACER V1 4; Rambaut A., 2009, FIGTREE 1 2 2; Rambaut A, 2007, TREEEDIT V 1 0A10; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Richardson JE, 2001, NATURE, V412, P181, DOI 10.1038/35084067; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Sanmartin I, 2007, J BIOGEOGR, V34, P398, DOI 10.1111/j.1365-2699.2006.01655.x; Schmitt I, 2004, MOL PHYLOGENET EVOL, V33, P43, DOI 10.1016/j.ympev.2004.04.014; Serusiaux E, 2011, J BIOGEOGR; Thell A, 2006, J HATTORI BOT LAB, P797; Thell A., 2009, BIBLIOTHECA LICHENOL, V99, P393; Velmala S, 2009, LICHENOLOGIST, V41, P231, DOI 10.1017/S0024282909008573; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Wedin M, 2009, CLADISTICS, V25, P161, DOI 10.1111/j.1096-0031.2009.00240.x; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Wirtz N, 2008, MYCOL RES, V112, P472, DOI 10.1016/j.mycres.2007.05.006; Wirtz N, 2012, ORG DIVERS EVOL, V12, P17, DOI 10.1007/s13127-011-0066-y; Zwickl D. J, 2006, GENETIC ALGORITHM AP	84	43	44	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39683	10.1371/journal.pone.0039683	http://dx.doi.org/10.1371/journal.pone.0039683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745810	Green Submitted, Green Published, gold			2022-12-27	WOS:000305693200095
J	Krousel-Wood, M; He, J; Booth, M; Chen, CS; Rice, J; Kahn, MJ; Maeshiro, R; Whelton, PK				Krousel-Wood, Marie; He, Jiang; Booth, Meredith; Chen, Chung-Shiuan; Rice, Janet; Kahn, Marc J.; Maeshiro, Rika; Whelton, Paul K.			Formal Public Health Education and Career Outcomes of Medical School Graduates	PLOS ONE			English	Article							UNITED-KINGDOM; ACADEMIC MEDICINE; MD-PHD; STUDENTS; CHOICES; POPULATION; PHYSICIANS; EXPERIENCE; ATTITUDES; PROGRAM	Background: Few data are available evaluating the associations of formal public health education with long-term career choice and professional outcomes among medical school graduates. The objective of this study was to determine if formal public health education via completion of a masters of public health (MPH) degree among US medical school graduates was associated with early and long-term career choice, professional satisfaction, or research productivity. Methods: We conducted a retrospective cohort study in 1108 physicians (17.1% completed a MPH degree) who had 10-20 years of follow-up post medical school graduation. Multivariable logistic regression analyses were conducted. Results: Compared to their counterparts with no MPH, medical school graduates with a MPH were more likely to have completed a generalist primary care residency only [relative risk (RR) 1.79, 95% confidence interval (CI) 1.35-2.29], obtain employment in an academic institution (RR 1.81; 95% CI 1.33-2.37) or government agency (RR 3.26; 95% CI 1.89-5.38), and practice public health (RR 39.84; 95% CI 12.13-107.38) or primary care (RR 1.59; 95% CI 1.18-2.05). Furthermore, medical school graduates with a MPH were more likely to conduct public health research (RR 8.79; 95% CI: 5.20-13.82), receive NIH or other federal funding (RR 3.11, 95% CI 1.74-5.33), have four or more peer-reviewed publications (RR 2.07; 95% CI 1.56-2.60), and have five or more scientific presentations (RR 2.31, 95% CI 1.70-2.98). Conclusion: Formal public health education via a MPH was associated with career choice and professional outcomes among physicians.	[Krousel-Wood, Marie; He, Jiang; Chen, Chung-Shiuan; Whelton, Paul K.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA; [Krousel-Wood, Marie] Tulane Univ, Sch Med, Dept Family & Community Med, New Orleans, LA 70112 USA; [Krousel-Wood, Marie] Ochsner Clin Fdn, Ctr Hlth Res, New Orleans, LA USA; [Booth, Meredith] Louisiana State Univ, Hlth Sci Ctr, Comprehens Alcohol Res Ctr, New Orleans, LA USA; [Rice, Janet] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat, New Orleans, LA USA; [Kahn, Marc J.] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Maeshiro, Rika] Assoc Acad Med Coll, Publ Hlth Project, Washington, DC USA; [Maeshiro, Rika] Assoc Acad Med Coll, Prevent Project, Washington, DC USA	Tulane University; Tulane University; Ochsner Health System; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tulane University; Tulane University	Krousel-Wood, M (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA.	mawood@tulane.edu	Kahn, Marc/AAF-7547-2021; Krousel-Wood, Marie Antoinette/D-4718-2011; Kahn, Marc J/G-1682-2011; He, Jiang/AAF-5303-2020	He, Jiang/0000-0002-8286-9652; KAHN, MARC/0000-0002-9781-9316	Tulane University	Tulane University	This work was supported by a grant from Tulane University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAMC, 1984, PHYS 21 CENT REP PAN; AAMC, 2011, US MCAT DAT 2011 STU; AAMC, 2012, DIR MD MPH ED OPP; AAMC, 2010, DAT WAR APPL MATR FI; AAMC, 1998, MED SCH OBJ PROJ REP; Borges NJ, 2010, ACAD MED, V85, P680, DOI 10.1097/ACM.0b013e3181d29cb9; Boyer MH, 1997, ACAD MED, V72, P269, DOI 10.1097/00001888-199704000-00010; Committee of Inquiry into Medical Education and Medical Workforce, 1988, AUSTR MED ED WORKF 2; Dillman D. A., 2014, INTERNET PHONE MAIL; Eckhert NL, 2000, ACAD MED, V75, pS85, DOI 10.1097/00001888-200007001-00013; Edwards R, 1999, J PUBLIC HEALTH MED, V21, P150, DOI 10.1093/pubmed/21.2.150; EWAN C, 1988, MED EDUC, V22, P375, DOI 10.1111/j.1365-2923.1988.tb00770.x; Gebbie K., 2003, WHO WILL KEEP PUBL H; General Medical Council, 2009, TOM DOCT OUTC STAND; General Medical Council, 2003, TOM DOCT REC UND MED; GENSHEIMER KF, 1994, AM J PREV MED, V10, P238, DOI 10.1016/S0749-3797(18)30598-1; Gillam S, 2006, MED EDUC, V40, P430, DOI 10.1111/j.1365-2929.2006.02444.x; Gillam S, 2010, J PUBLIC HEALTH-UK, V32, P125, DOI 10.1093/pubmed/fdp108; Goldacre MJ, 2011, J PUBLIC HEALTH-UK, V33, P616, DOI 10.1093/pubmed/fdr067; Goldacre MJ, 2004, MED EDUC, V38, P249, DOI 10.1046/j.1365-2923.2004.01763.x; Harris R, 2008, ACAD MED, V83, P371, DOI 10.1097/ACM.0b013e318166a848; Institute of Medicine, 2007, ENTRY REQUIREMENTS T; Jeffe DB, 2010, ACAD MED, V85, P947, DOI 10.1097/ACM.0b013e3181dbe77d; Johnson I, 2008, ACAD MED, V83, P414, DOI 10.1097/ACM.0b013e318166a8e4; Lambert TW, 2006, MED EDUC, V40, P514, DOI 10.1111/j.1365-2929.2006.02480.x; Lambert TW, 2003, BRIT MED J, V326, P194, DOI 10.1136/bmj.326.7382.194; Lambert TW, 2002, MED EDUC, V36, P193, DOI 10.1046/j.1365-2923.2002.01073.x; Littlewood S, 2005, BMJ-BRIT MED J, V331, P387, DOI 10.1136/bmj.331.7513.387; Maeshiro R, 2010, ACAD MED, V85, P211, DOI 10.1097/ACM.0b013e3181c885d8; Maeshiro R, 2008, ACAD MED, V83, P319, DOI 10.1097/ACM.0b013e318166ae9f; MCCLELLAN DA, 1992, ACAD MED, V67, P36, DOI 10.1097/00001888-199201000-00008; Nguyen-Van-Tam JS, 2001, MED EDUC, V35, P134, DOI 10.1046/j.1365-2923.2001.00774.x; Phillips RL, 2009, SPECIALTY GEOGRAPHIC; Price J, 1998, J MED ETHICS, V24, P110, DOI 10.1136/jme.24.2.110; Rego PM, 2005, MED EDUC, V39, P202, DOI 10.1111/j.1365-2929.2004.02058.x; Rosenberg SN, 1998, AM J PREV MED, V14, P184, DOI 10.1016/S0749-3797(97)00065-2; Ruis AR, 2008, ACAD MED, V83, P1153, DOI 10.1097/ACM.0b013e31818c6583; Schwartz P, 1999, JAMA-J AM MED ASSOC, V281, P96, DOI 10.1001/jama.281.1.96; Schwartz P, 1999, JAMA-J AM MED ASSOC, V281, P99; Smith SR, 1996, ACAD MED, V71, P1024, DOI 10.1097/00001888-199610000-00002; Stellman JM, 2008, ACAD MED, V83, P365, DOI 10.1097/01.ACM.0b013e318166af00; Straus SE, 2006, J GEN INTERN MED, V21, P1222, DOI 10.1111/j.1525-1497.2006.00599.x; The AAMC Section for Medical School and Faculty Studies, 2009, MED SCH ADM MAN TOOL; Whitcomb ME, 2004, NEW ENGL J MED, V351, P710, DOI 10.1056/NEJMsb045003; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	45	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39020	10.1371/journal.pone.0039020	http://dx.doi.org/10.1371/journal.pone.0039020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745699	Green Published, gold			2022-12-27	WOS:000305693200037
J	Skeldon, AC; Chaffey, G; Lloyd, DJB; Mohan, V; Bradley, DA; Nisbet, A				Skeldon, Anne C.; Chaffey, Gary; Lloyd, David J. B.; Mohan, Vineet; Bradley, David A.; Nisbet, Andrew			Modelling and Detecting Tumour Oxygenation Levels	PLOS ONE			English	Article							PET DATA; HYPOXIA; TRANSPORT; TISSUE; SIMULATION; CAPILLARIES; DIFFUSION; NETWORKS	Tumours that are low in oxygen (hypoxic) tend to be more aggressive and respond less well to treatment. Knowing the spatial distribution of oxygen within a tumour could therefore play an important role in treatment planning, enabling treatment to be targeted in such a way that higher doses of radiation are given to the more radioresistant tissue. Mapping the spatial distribution of oxygen in vivo is difficult. Radioactive tracers that are sensitive to different levels of oxygen are under development and in the early stages of clinical use. The concentration of these tracer chemicals can be detected via positron emission tomography resulting in a time dependent concentration profile known as a tissue activity curve (TAC). Pharmaco-kinetic models have then been used to deduce oxygen concentration from TACs. Some such models have included the fact that the spatial distribution of oxygen is often highly inhomogeneous and some have not. We show that the oxygen distribution has little impact on the form of a TAC; it is only the mean oxygen concentration that matters. This has significant consequences both in terms of the computational power needed, and in the amount of information that can be deduced from TACs.	[Skeldon, Anne C.; Chaffey, Gary; Lloyd, David J. B.] Univ Surrey, Dept Math, Guildford GU2 5XH, Surrey, England; [Mohan, Vineet] ETH, Dept Math, CH-8092 Zurich, Switzerland; [Bradley, David A.; Nisbet, Andrew] Univ Surrey, Dept Phys, Guildford GU2 5XH, Surrey, England; [Nisbet, Andrew] Royal Surrey Cty Hosp, Dept Med Phys, Guildford, Surrey, England	University of Surrey; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Surrey; Royal Surrey County Hospital	Skeldon, AC (corresponding author), Univ Surrey, Dept Math, Guildford GU2 5XH, Surrey, England.	a.skeldon@surrey.ac.uk	Nisbet, Andrew/A-9651-2013; Nisbet, Andrew/AAK-9799-2021	Nisbet, Andrew/0000-0002-0652-808X; Nisbet, Andrew/0000-0002-0652-808X; Skeldon, Anne/0000-0001-6387-4766; Lloyd, David/0000-0002-1902-0007	Engineering and Physical Sciences Research Council (EPSRC) [EP/P505755/1]; Engineering and Physical Sciences Research Council [1003347] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	GC's contribution was funded by an Engineering and Physical Sciences Research Council (EPSRC) supported Doctoral Training Centre, funded through EP/P505755/1. There was no other external funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAXTER LT, 1991, MICROVASC RES, V41, P5, DOI 10.1016/0026-2862(91)90003-T; Beard DA, 2001, ANN BIOMED ENG, V29, P298, DOI 10.1114/1.1359450; CASCIARI JJ, 1995, MED PHYS, V22, P1127, DOI 10.1118/1.597506; Dasu A, 2003, PHYS MED BIOL, V48, P2829, DOI 10.1088/0031-9155/48/17/307; Goldman D, 2008, MICROCIRCULATION, V15, P795, DOI 10.1080/10739680801938289; Hall E, 2000, RADIOBIOLOGY RADIOLO; HELLUMS JD, 1977, MICROVASC RES, V13, P131, DOI 10.1016/0026-2862(77)90122-4; Hellums JD, 1996, ANN BIOMED ENG, V24, P1, DOI 10.1007/BF02770991; Kelly CJ, 2006, PHYS MED BIOL, V51, P5859, DOI 10.1088/0031-9155/51/22/009; Krogh A, 1919, J PHYSIOL-LONDON, V52, P409, DOI 10.1113/jphysiol.1919.sp001839; Monnich D, 2011, PHYS MED BIOL, V56, P2045, DOI 10.1088/0031-9155/56/7/009; Owen MR, 2009, J MATH BIOL, V58, P689, DOI 10.1007/s00285-008-0213-z; Padhani AR, 2007, EUR RADIOL, V17, P861, DOI 10.1007/s00330-006-0431-y; Pogue BW, 2001, RADIAT RES, V155, P15, DOI 10.1667/0033-7587(2001)155[0015:EOODIR]2.0.CO;2; Secomb TW, 2004, ANN BIOMED ENG, V32, P1519, DOI 10.1114/B:ABME.0000049036.08817.44; Thorwarth D, 2005, PHYS MED BIOL, V50, P2209, DOI 10.1088/0031-9155/50/10/002; Titz B, 2008, PHYS MED BIOL, V53, P4471, DOI 10.1088/0031-9155/53/17/001; Wang WL, 2010, J NUCL MED, V51, P37, DOI 10.2967/jnumed.109.067009; Wang WL, 2009, PHYS MED BIOL, V54, P3083, DOI 10.1088/0031-9155/54/10/008	19	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e38597	10.1371/journal.pone.0038597	http://dx.doi.org/10.1371/journal.pone.0038597			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761687	Green Published, Green Submitted, gold			2022-12-27	WOS:000305826400003
J	Dapat, IC; Dapat, C; Baranovich, T; Suzuki, Y; Kondo, H; Shobugawa, Y; Saito, R; Suzuki, H				Dapat, Isolde C.; Dapat, Clyde; Baranovich, Tatiana; Suzuki, Yasushi; Kondo, Hiroki; Shobugawa, Yugo; Saito, Reiko; Suzuki, Hiroshi		Japanese Influenza Collaborative S	Genetic Characterization of Human Influenza Viruses in the Pandemic (2009-2010) and Post-Pandemic (2010-2011) Periods in Japan	PLOS ONE			English	Article							A H1N1 VIRUS; HEMAGGLUTININ; NEURAMINIDASE; EMERGENCE; H3N2	Background: Pandemic influenza A(H1N1) 2009 virus was first detected in Japan in May 2009 and continued to circulate in the 2010-2011 season. This study aims to characterize human influenza viruses circulating in Japan in the pandemic and post-pandemic periods and to determine the prevalence of antiviral-resistant viruses. Methods: Respiratory specimens were collected from patients with influenza-like illness on their first visit at outpatient clinics during the 2009-2010 and 2010-2011 influenza seasons. Cycling probe real-time PCR assays were performed to screen for antiviral-resistant strains. Sequencing and phylogenetic analysis of the HA and NA genes were done to characterize circulating strains. Results and Conclusion: In the pandemic period (2009-2010), the pandemic influenza A(H1N1) 2009 virus was the only circulating strain isolated. None of the 601 A(H1N1) pdm09 virus isolates had the H275Y substitution in NA (oseltamivir resistance) while 599/601 isolates (99.7%) had the S31N substitution in M2 (amantadine resistance). In the post-pandemic period (2010-2011), cocirculation of different types and subtypes of influenza viruses was observed. Of the 1,278 samples analyzed, 414 (42.6%) were A(H1N1) pdm09, 525 (54.0%) were A(H3N2) and 33 (3.4%) were type-B viruses. Among A(H1N1) pdm09 isolates, 2 (0.5%) were oseltamivir-resistant and all were amantadine-resistant. Among A(H3N2) viruses, 520 (99.0%) were amantadine-resistant. Sequence and phylogenetic analyses of A(H1N1) pdm09 viruses from the post-pandemic period showed further evolution from the pandemic period viruses. For viruses that circulated in 2010-2011, strain predominance varied among prefectures. In Hokkaido, Niigata, Gunma and Nagasaki, A(H3N2) viruses (A/Perth/16/2009-like) were predominant whereas, in Kyoto, Hyogo and Osaka, A(H1N1) pdm09 viruses (A/New_York/10/2009-like) were predominant. Influenza B Victoria(HA)-Yamagata(NA) reassortant viruses (B/Brisbane/60/2008-like) were predominant while a small proportion was in Yamagata lineage. Genetic variants with mutations at antigenic sites were identified in A(H1N1) pdm09, A(H3N2) and type-B viruses in the 2010-2011 season but did not show a change in antigenicity when compared with respective vaccine strains.	[Dapat, Isolde C.; Dapat, Clyde; Baranovich, Tatiana; Suzuki, Yasushi; Kondo, Hiroki; Shobugawa, Yugo; Saito, Reiko] Niigata Univ, Grad Sch Med & Dent Sci, Div Int Hlth Publ Hlth, Niigata, Japan; [Suzuki, Hiroshi] Niigata Seiryo Univ, Sch Nursing, Niigata, Japan	Niigata University	Dapat, IC (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Int Hlth Publ Hlth, Niigata, Japan.	sol@med.niigata-u.ac.jp	Dapat, Clyde/B-4196-2009	Dapat, Clyde/0000-0002-7616-4680; Shobugawa, Yugo/0000-0003-2851-0101; KONDO, HIROKI/0000-0002-8336-3995	Ministry of Health, Welfare and Labour, Japan	Ministry of Health, Welfare and Labour, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Health Labour Sciences Research Grant, Research on Emerging and Re-emerging Infectious Diseases (Ministry of Health, Welfare and Labour, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P81; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P453; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P86; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P249; Baranovich T, 2010, J CLIN VIROL, V47, P23, DOI 10.1016/j.jcv.2009.11.003; Barr IG, 2003, VIRUS RES, V98, P35, DOI 10.1016/j.virusres.2003.08.011; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERTON MT, 1984, J VIROL, V52, P919, DOI 10.1128/JVI.52.3.919-927.1984; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P435; Chen HL, 2009, EMERG INFECT DIS, V15, P1970, DOI 10.3201/eid1512.091057; Dapat C, 2011, JPN J INFECT DIS, V64, P237; Dapat C, 2009, INTERVIROLOGY, V52, P310, DOI 10.1159/000237738; Fanning TG, 2000, VIROLOGY, V276, P417, DOI 10.1006/viro.2000.0578; Fereidouni SR, 2009, EUROSURVEILLANCE, V14; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gubareva LV, 2010, ANTIVIR THER, V15, P1151, DOI 10.3851/IMP1678; Gulati U, 2002, J VIROL, V76, P12274, DOI 10.1128/JVI.76.23.12274-12280.2002; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hurt AC, 2011, EUROSURVEILLANCE, V16, P24; Ikonen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013329; Infectious Disease Surveillance Center (IDSC), 2009, PAND H1N1 2009 JAP M; Infectious Disease Surveillance Center (IDSC), 2010, 2009 10 INFL SEAS JA; Iwatsuki-Horimoto K, 2011, CLIN VACCINE IMMUNOL, V18, P860, DOI 10.1128/CVI.00428-10; Kilander A, 2010, EUROSURVEILLANCE, V15, P6; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Mai LQ, 2010, NEW ENGL J MED, V362, P86, DOI 10.1056/NEJMc0910448; Morlighem JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018956; Mustaquim D., 2010, Morbidity and Mortality Weekly Report, V59, P901; National Institute for Medical Research (NIMR), 2011, FEBR 2011 INT REP; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shiino T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011057; Shimada T, 2009, EUROSURVEILLANCE, V14; Suzuki Y, 2011, J CLIN MICROBIOL, V49, P125, DOI 10.1128/JCM.01401-10; Suzuki Y, 2010, J CLIN MICROBIOL, V48, P57, DOI 10.1128/JCM.00698-09; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Toyokawa T, 2011, J INFECTION, V63, P281, DOI 10.1016/j.jinf.2011.05.001; Ujike M, 2011, EMERG INFECT DIS, V17, P470, DOI 10.3201/eid1703.101188; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Zaraket H, 2010, ANTIVIR THER, V15, P307, DOI 10.3851/IMP1538	45	36	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e36455	10.1371/journal.pone.0036455	http://dx.doi.org/10.1371/journal.pone.0036455			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761651	Green Submitted, gold, Green Published			2022-12-27	WOS:000305825800003
J	Gao, F; Zhou, HF; Li, W; Zhang, XR				Gao, Feng; Zhou, Huafu; Li, Wei; Zhang, Xuerong			Detection of Ligation Products of DNA Linkers with 5 '-OH Ends by Denaturing PAGE Silver Stain	PLOS ONE			English	Article							LIGASE; MECHANISM; REPAIR	To explore if DNA linkers with 5'-hydroxyl (OH) ends could be joined by commercial T4 and E. coli DNA ligase, these linkers were synthesized by using the solid-phase phosphoramidite method and joined by using commercial T4 and E. coli DNA ligases. The ligation products were detected by using denaturing PAGE silver stain and PCR method. About 0.5-1% of linkers A-B and E-F, and 0.13-0.5% of linkers C-D could be joined by T4 DNA ligases. About 0.25-0.77% of linkers A-B and E-F, and 0.06-0.39% of linkers C-D could be joined by E. coli DNA ligases. A 1-base deletion (-G) and a 5-base deletion (-GGAGC) could be found at the ligation junctions of the linkers. But about 80% of the ligation products purified with a PCR product purification kit did not contain these base deletions, meaning that some linkers had been correctly joined by T4 and E. coli DNA ligases. In addition, about 0.025-0.1% of oligo 11 could be phosphorylated by commercial T4 DNA ligase. The phosphorylation products could be increased when the phosphorylation reaction was extended from 1 hr to 2 hrs. We speculated that perhaps the linkers with 5'-OH ends could be joined by T4 or E. coli DNA ligase in 2 different manners: (i) about 0.025-0.1% of linkers could be phosphorylated by commercial T4 DNA ligase, and then these phosphorylated linkers could be joined to the 3'-OH ends of other linkers; and (ii) the linkers could delete one or more nucleotide(s) at their 5'-ends and thereby generated some 5'-phosphate ends, and then these 5'-phosphate ends could be joined to the 3'-OH ends of other linkers at a low efficiency. Our findings may probably indicate that some DNA nicks with 5'-OH ends can be joined by commercial T4 or E. coli DNA ligase even in the absence of PNK.	[Gao, Feng] Guangxi Med Univ, Affiliated Hosp 1, Dept Anal & Colorectal Surg, Nanning, Guangxi, Peoples R China; [Zhou, Huafu] Guangxi Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Nanning, Guangxi, Peoples R China; [Li, Wei; Zhang, Xuerong] Guangxi Med Univ, Med Sci Res Ctr, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Gao, F (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Anal & Colorectal Surg, Nanning, Guangxi, Peoples R China.	liwei60@yahoo.com			Guangxi Natural Science Foundation [GuiKeJi0575063]	Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This research was supported by Guangxi Natural Science Foundation (GuiKeJi0575063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Cheng CH, 1997, NUCLEIC ACIDS RES, V25, P1369, DOI 10.1093/nar/25.7.1369; Cherepanov AV, 2001, BIOPHYS J, V81, P3545, DOI 10.1016/S0006-3495(01)75985-1; Doherty AJ, 2000, NUCLEIC ACIDS RES, V28, P4051, DOI 10.1093/nar/28.21.4051; LEHMAN IR, 1974, SCIENCE, V186, P790; Magnet S, 2004, BIOCHEMISTRY-US, V43, P710, DOI 10.1021/bi0355387; Oliver M., 2006, NUCLEIC ACIDS RES, V34, P3523; Rossi R, 1997, NUCLEIC ACIDS RES, V25, P2106, DOI 10.1093/nar/25.11.2106; Timson DJ, 2000, MUTAT RES-DNA REPAIR, V460, P301, DOI 10.1016/S0921-8777(00)00033-1; Wei L, 2007, APPL MICROBIOL BIOT, V75, P703; Wei L, 2006, CLIN BIOCHEM, V39, P833; Weller GR, 2002, SCIENCE, V297, P1686, DOI 10.1126/science.1074584; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Wilkinson A, 2001, MOL MICROBIOL, V40, P1241, DOI 10.1046/j.1365-2958.2001.02479.x; ZIMMERMAN SB, 1983, P NATL ACAD SCI-BIOL, V80, P5852, DOI 10.1073/pnas.80.19.5852	15	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39251	10.1371/journal.pone.0039251	http://dx.doi.org/10.1371/journal.pone.0039251			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761747	gold, Green Published, Green Submitted			2022-12-27	WOS:000305825800027
J	Malvezzi, A; Higa, PM; Amaral, ATD; Silva, GM; Gozzo, FC; Ferro, ES; Castro, LM; de Rezende, L; Monteiro, G; Demasi, M				Malvezzi, Alberto; Higa, Patricia M.; Amaral, Antonia T. -do; Silva, Gustavo M.; Gozzo, Fabio C.; Ferro, Emer S.; Castro, Leandro M.; de Rezende, Leandro; Monteiro, Gisele; Demasi, Marilene			The Cysteine-Rich Protein Thimet Oligopeptidase as a Model of the Structural Requirements for S-glutathiolation and Oxidative Oligomerization	PLOS ONE			English	Article							I ANTIGEN PRESENTATION; 20S PROTEASOME; EC 3.4.24.15; REDOX REGULATION; SULFENIC ACIDS; MECHANISM; CATALYSIS; GLUTATHIONYLATION; ENDOPEPTIDASE; PEPTIDES	Thimet oligopeptidase (EP24.15) is a cysteine-rich metallopeptidase containing fifteen Cys residues and no intra-protein disulfide bonds. Previous work on this enzyme revealed that the oxidative oligomerization of EP24.15 is triggered by S-glutathiolation at physiological GSSG levels (10-50 mu M) via a mechanism based on thiol-disulfide exchange. In the present work, our aim was to identify EP24.15 Cys residues that are prone to S-glutathiolation and to determine which structural features in the cysteinyl bulk are responsible for the formation of mixed disulfides through the reaction with GSSG and, in this particular case, the Cys residues within EP24.15 that favor either S-glutathiolation or inter-protein thiol-disulfide exchange. These studies were conducted by in silico structural analyses and simulations as well as site-specific mutation. S-glutathiolation was determined by mass spectrometric analyses and western blotting with anti-glutathione antibody. The results indicated that the stabilization of a thiolate sulfhydryl and the solvent accessibility of the cysteines are necessary for S-thiolation. The Solvent Access Surface analysis of the Cys residues prone to glutathione modification showed that the S-glutathiolated Cys residues are located inside pockets where the sulfur atom comes into contact with the solvent and that the positively charged amino acids are directed toward these Cys residues. The simulation of a covalent glutathione docking onto the same Cys residues allowed for perfect glutathione posing. A mutation of the Arg residue 263 that forms a saline bridge to the Cys residue 175 significantly decreased the overall S-glutathiolation and oligomerization of EP24.15. The present results show for the first time the structural requirements for protein S-glutathiolation by GSSG and are consistent with our previous hypothesis that EP24.15 oligomerization is dependent on the electron transfer from specific protonated Cys residues of one molecule to previously S-glutathionylated Cys residues of another one.	[Malvezzi, Alberto; Amaral, Antonia T. -do; de Rezende, Leandro] Univ Sao Paulo, Inst Quim, Sao Paulo, Brazil; [Higa, Patricia M.; Silva, Gustavo M.; Demasi, Marilene] Inst Butantan, Sao Paulo, Brazil; [Gozzo, Fabio C.] Univ Estadual Campinas, Inst Quim, Campinas, SP, Brazil; [Higa, Patricia M.; Ferro, Emer S.; Castro, Leandro M.] Univ Sao Paulo, Inst Ciencias Biomed, BR-05508 Sao Paulo, Brazil; [Monteiro, Gisele] Univ Sao Paulo, Fac Ciencias Farmaceut, Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto Butantan; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo	Malvezzi, A (corresponding author), Univ Sao Paulo, Inst Quim, Sao Paulo, Brazil.	marimasi@butantan.gov.br	Amaral, Antonia/C-4423-2012; Castro, Leandro/ABI-5520-2020; Gozzo, Fabio/F-8123-2010; Monteiro, Gisele/E-5897-2012; Demasi, Marilene/E-5873-2012; Ferro, Emer S/D-3908-2012; Castro, Leandro/O-6762-2019; Castro, Leandro M/E-5654-2014	Amaral, Antonia/0000-0003-2937-5255; Castro, Leandro/0000-0002-7156-2006; Monteiro, Gisele/0000-0002-3385-047X; Ferro, Emer S/0000-0003-1651-9192; Castro, Leandro/0000-0002-7156-2006; Demasi, Marilene/0000-0002-3749-1160	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/06731-9, 07/58147-6]; Instituto Nacional de Ciencia, Tecnologia e Inovacao de Processos Redox em BioMedicina (Redoxoma); CNPq - Conselho Nacional de Ciencia e Tecnologia; CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Ciencia, Tecnologia e Inovacao de Processos Redox em BioMedicina (Redoxoma); CNPq - Conselho Nacional de Ciencia e Tecnologia(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Processes 08/06731-9 and 07/58147-6) and Instituto Nacional de Ciencia, Tecnologia e Inovacao de Processos Redox em BioMedicina (Redoxoma, supported by CNPq - Conselho Nacional de Ciencia e Tecnologia, FAPESP and CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berti DA, 2009, J BIOL CHEM, V284, P14105, DOI 10.1074/jbc.M807916200; CHU TG, 1985, ENDOCRINOLOGY, V116, P1418, DOI 10.1210/endo-116-4-1418; Claiborne A, 2001, ADV PROTEIN CHEM, V58, P215; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Copley SD, 2004, BIOCHEMISTRY-US, V43, P13981, DOI 10.1021/bi048947r; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Demasi M, 2003, J BIOL CHEM, V278, P679, DOI 10.1074/jbc.M209282200; Demasi M, 2008, FREE RADICAL BIO MED, V44, P1180, DOI 10.1016/j.freeradbiomed.2007.12.012; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Ferrer-Sueta G, 2011, CHEM RES TOXICOL, V24, P434, DOI 10.1021/tx100413v; Fricker LD, 2012, J PROTEOME IN PRESS; Ghezzi P, 2005, ANTIOXID REDOX SIGN, V7, P964, DOI 10.1089/ars.2005.7.964; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; HALLYWELL B, 2007, FREE RADICALS BIOL M; Hill BG, 2007, IUBMB LIFE, V59, P21, DOI 10.1080/15216540701196944; Kessler JH, 2011, NAT IMMUNOL, V12, P45, DOI 10.1038/ni.1974; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Malvezzi A, 2008, BIOORG MED CHEM LETT, V18, P350, DOI 10.1016/j.bmcl.2007.10.068; Marino SM, 2012, J BIOL CHEM, V287, P4419, DOI 10.1074/jbc.R111.275578; Orlowski M, 1983, EUR J BIOCHEM, V135, P80; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Shrimpton CN, 1997, J BIOL CHEM, V272, P17395, DOI 10.1074/jbc.272.28.17395; Sigman JA, 2003, FEBS LETT, V545, P224, DOI 10.1016/S0014-5793(03)00548-9; Silva CL, 1999, BIOCHEM BIOPH RES CO, V255, P591, DOI 10.1006/bbrc.1999.0250; Silva GM, 2012, ANTIOXID RE IN PRESS; Silva GM, 2008, FEBS J, V275, P2942, DOI 10.1111/j.1742-4658.2008.06441.x; Silva GM, 2012, ANTIOXID REDOX SIGN, V16, P1183, DOI 10.1089/ars.2011.4210; Wang J, 2003, P NATL ACAD SCI USA, V100, P5103, DOI 10.1073/pnas.0931345100; West MB, 2006, FASEB J, V20, P1715, DOI 10.1096/fj.06-5843fje; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; York IA, 2003, IMMUNITY, V18, P429, DOI 10.1016/S1074-7613(03)00058-X	32	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39408	10.1371/journal.pone.0039408	http://dx.doi.org/10.1371/journal.pone.0039408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761783	Green Submitted, Green Published, gold			2022-12-27	WOS:000305781700034
J	Vohnik, M; Sadowsky, JJ; Kohout, P; Lhotakova, Z; Nestby, R; Kolarik, M				Vohnik, Martin; Sadowsky, Jesse J.; Kohout, Petr; Lhotakova, Zuzana; Nestby, Rolf; Kolarik, Miroslav			Novel Root-Fungus Symbiosis in Ericaceae: Sheathed Ericoid Mycorrhiza Formed by a Hitherto Undescribed Basidiomycete with Affinities to Trechisporales	PLOS ONE			English	Article							DIRECT DNA EXTRACTION; ECTOMYCORRHIZAL FUNGI; HYMENOSCYPHUS-ERICAE; COMMUNITY STRUCTURE; VACCINIUM ROOTS; NO EVIDENCE; HAIR ROOTS; BIOLOGY; DEGRADATION; PHYLOGENIES	Ericaceae (the heath family) are widely distributed calcifuges inhabiting soils with inherently poor nutrient status. Ericaceae overcome nutrient limitation through symbiosis with ericoid mycorrhizal (ErM) fungi that mobilize nutrients complexed in recalcitrant organic matter. At present, recognized ErM fungi include a narrow taxonomic range within the Ascomycota, and the Sebacinales, basal Hymenomycetes with unclamped hyphae and imperforate parenthesomes. Here we describe a novel type of basidiomycetous ErM symbiosis, termed 'sheathed ericoid mycorrhiza', discovered in two habitats in mid-Norway as a co-dominant mycorrhizal symbiosis in Vaccinium spp. The basidiomycete forming sheathed ErM possesses clamped hyphae with perforate parenthesomes, produces 1- to 3-layer sheaths around terminal parts of hair roots and colonizes their rhizodermis intracellularly forming hyphal coils typical for ErM symbiosis. Two basidiomycetous isolates were obtained from sheathed ErM and molecular and phylogenetic tools were used to determine their identity; they were also examined for the ability to form sheathed ErM and lignocellulolytic potential. Surprisingly, ITS rDNA of both conspecific isolates failed to amplify with the most commonly used primer pairs, including ITS1 and ITS1F + ITS4. Phylogenetic analysis of nuclear LSU, SSU and 5.8S rDNA indicates that the basidiomycete occupies a long branch residing in the proximity of Trechisporales and Hymenochaetales, but lacks a clear sequence relationship (>90% similarity) to fungi currently placed in these orders. The basidiomycete formed the characteristic sheathed ErM symbiosis and enhanced growth of Vaccinium spp. in vitro, and degraded a recalcitrant aromatic substrate that was left unaltered by common ErM ascomycetes. Our findings provide coherent evidence that this hitherto undescribed basidiomycete forms a morphologically distinct ErM symbiosis that may occur at significant levels under natural conditions, yet remain undetected when subject to amplification by 'universal' primers. The lignocellulolytic assay suggests the basidiomycete may confer host adaptations distinct from those provisioned by the so far investigated ascomycetous ErM fungi.	[Vohnik, Martin; Sadowsky, Jesse J.; Kohout, Petr] Acad Sci Czech Republ, Inst Bot, Dept Mycorrhizal Symbioses, CS-25243 Pruhonice, Czech Republic; [Vohnik, Martin; Kohout, Petr; Lhotakova, Zuzana] Charles Univ Prague, Fac Sci, Dept Expt Plant Biol, Prague, Czech Republic; [Nestby, Rolf] Norwegian Inst Agr & Environm Res, Bioforsk Grassland & Landscape Div, Stjordal, Norway; [Kolarik, Miroslav] Acad Sci Czech Republ, Inst Microbiol, Lab Genet Physiol & Bioengn Fungi, Prague, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague; Bioforsk; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Vohnik, M (corresponding author), Acad Sci Czech Republ, Inst Bot, Dept Mycorrhizal Symbioses, CS-25243 Pruhonice, Czech Republic.	martin.vohnik@ibot.cas.cz	Kohout, Petr/B-4975-2011; Vohník, Martin/H-1636-2014; Vohnik, Martin/I-1736-2017; Nestby, Rolf/I-6004-2019; Kolařík, Miroslav/A-1680-2008; Lhotakova, Zuzana/I-4612-2017	Kohout, Petr/0000-0002-3985-2310; Vohník, Martin/0000-0002-8655-2708; Vohnik, Martin/0000-0002-8655-2708; Nestby, Rolf/0000-0001-8581-1301; Kolařík, Miroslav/0000-0003-4016-0335; Lhotakova, Zuzana/0000-0003-3060-641X	Grant Agency of the Czech Republic [GACR 206/09/P340]; Academy of Sciences of the Czech Republic [RVO 67985939, MSM 6007665801]; Charles University in Prague [SVV 265203/2012]; Czech Ministry of Education, Youth and Sports [OC10058]; J.W. Fulbright Commission	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Charles University in Prague; Czech Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); J.W. Fulbright Commission	This study was supported by the Grant Agency of the Czech Republic (GACR 206/09/P340). Additional support was provided by Academy of Sciences of the Czech Republic (RVO 67985939 and MSM 6007665801) and Charles University in Prague (SVV 265203/2012). Field sampling in Norway was partially funded by Czech Ministry of Education, Youth and Sports (OC10058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Erik Joner stimulated the research at its beginning, Drahomira Bartakova prepared root permanent slides, Jiri Machac took SEM pictures, and Franz Oberwinkler and Roland Kirschner provided valuable clues on capitate cystidia. J.J.S. is grateful for a scholarship from the J.W. Fulbright Commission.	Allen TR, 2003, NEW PHYTOL, V160, P255, DOI 10.1046/j.1469-8137.2003.00885.x; ARORA DS, 1984, FOLIA MICROBIOL, V29, P310, DOI 10.1007/BF02875963; BAJWA R, 1985, NEW PHYTOL, V101, P469, DOI 10.1111/j.1469-8137.1985.tb02853.x; Bending GD, 1997, MYCOL RES, V101, P1348, DOI 10.1017/S0953756297004140; Berch SM, 2002, PLANT SOIL, V244, P55, DOI 10.1023/A:1020291516884; Binder M, 2005, SYST BIODIVERS, V3, P113, DOI 10.1017/S1477200005001623; Binder M, 2010, MYCOLOGIA, V102, P865, DOI 10.3852/09-288; Bodeker ITM, 2009, ISME J, V3, P1387, DOI 10.1038/ismej.2009.77; BONFANTEFASOLO P, 1980, T BRIT MYCOL SOC, V75, P320, DOI 10.1016/S0007-1536(80)80097-0; Bougoure DS, 2007, MOL ECOL, V16, P4624, DOI 10.1111/j.1365-294X.2007.03540.x; Bougoure DS, 2005, ENVIRON MICROBIOL, V7, P819, DOI 10.1111/j.1462-2920.2005.00755.x; Burke RM, 1998, NEW PHYTOL, V139, P637, DOI 10.1046/j.1469-8137.1998.00235.x; Casieri L, 2010, ANTON LEEUW INT J G, V98, P483, DOI 10.1007/s10482-010-9466-9; Deslippe JR, 2011, NEW PHYTOL, V192, P689, DOI 10.1111/j.1469-8137.2011.03835.x; ENGLANDER L, 1980, NEW PHYTOL, V84, P661, DOI 10.1111/j.1469-8137.1980.tb04779.x; Garcia-Sandoval R, 2011, MYCOLOGIA, V103, P510, DOI 10.3852/10-209; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GIMINGHAM CH, 1960, J ECOL, V48, P455, DOI 10.2307/2257528; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HAMBLETON S, 2005, STUD MYCOL, V53, P1, DOI DOI 10.3114/SIM.53.1.1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ishida TA, 2010, SOIL BIOL BIOCHEM, V42, P234, DOI 10.1016/j.soilbio.2009.10.021; Kemp BM, 2005, FORENSIC SCI INT, V154, P53, DOI 10.1016/j.forsciint.2004.11.017; Kerley SJ, 1998, NEW PHYTOL, V139, P353, DOI 10.1046/j.1469-8137.1998.00189.x; KERLEY SJ, 1995, NEW PHYTOL, V131, P369, DOI 10.1111/j.1469-8137.1995.tb03073.x; Kerley SJ, 1997, NEW PHYTOL, V136, P691, DOI 10.1046/j.1469-8137.1997.00778.x; Kjoller R, 2010, FUNGAL ECOL, V3, P205, DOI 10.1016/j.funeco.2009.10.005; Kohout P, 2011, MYCORRHIZA, V21, P403, DOI 10.1007/s00572-010-0350-2; Kron KA, 2002, BOT REV, V68, P335, DOI 10.1663/0006-8101(2002)068[0335:PCOEMA]2.0.CO;2; Larsson KH, 2007, MYCOL RES, V111, P186, DOI 10.1016/j.mycres.2006.10.002; LEAKE JR, 1991, METHOD MICROBIOL, V23, P435; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; Massicotte HB, 2005, CAN J BOT, V83, P1057, DOI [10.1139/b05-046, 10.1139/B05-046]; Matheny PB, 2007, MOL PHYLOGENET EVOL, V43, P430, DOI 10.1016/j.ympev.2006.08.024; Matheny PB, 2006, CAN J BOT, V84, P1794, DOI 10.1139/B06-128; Mrnka L, 2009, TREES-STRUCT FUNCT, V23, P887, DOI 10.1007/s00468-009-0330-3; MUELLER WC, 1986, CAN J BOT, V64, P718, DOI 10.1139/b86-091; Novakova A, 2012, INT J SYST EVOL MICR, V62, P2778, DOI 10.1099/ijs.0.041004-0; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Palfner G, 1998, COLOUR ATLAS ECTOMYC, P116; Pazourkova Z., 1986, BOT MIKROTECHNIKA; PEARSON V, 1973, NEW PHYTOL, V72, P371, DOI 10.1111/j.1469-8137.1973.tb02044.x; PEARSON V, 1973, NEW PHYTOL, V72, P1325, DOI 10.1111/j.1469-8137.1973.tb02110.x; Perotto S, 2002, PLANT SOIL, V244, P41, DOI 10.1023/A:1020289401610; PETERSON TA, 1980, CAN J BOT, V58, P2421, DOI 10.1139/b80-281; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rains KC, 2003, MYCORRHIZA, V13, P257, DOI 10.1007/s00572-003-0224-y; Rambaut A., 2007, TRACER V1 4; Rayner MC, 1915, ANN BOT-LONDON, V29, P97, DOI 10.1093/oxfordjournals.aob.a089540; READ DJ, 1983, CAN J BOT, V61, P985, DOI 10.1139/b83-107; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; Read DJ, 1996, ANN BOT-LONDON, V77, P365, DOI 10.1006/anbo.1996.0044; Rice AV, 2006, MICROBIAL ROOT ENDOP, P227; Robertson SJ, 2011, PLANT SOIL, V346, P121, DOI 10.1007/s11104-011-0802-2; Rosling A, 2011, SCIENCE, V333, P876, DOI 10.1126/science.1206958; Selosse MA, 2007, NEW PHYTOL, V174, P864, DOI 10.1111/j.1469-8137.2007.02064.x; Setaro S, 2006, NEW PHYTOL, V169, P355, DOI 10.1111/j.1469-8137.2005.01583.x; SEVIOUR RJ, 1973, NEW PHYTOL, V72, P381, DOI 10.1111/j.1469-8137.1973.tb02045.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tedersoo L, 2003, NEW PHYTOL, V159, P153, DOI 10.1046/j.1469-8137.2003.00792.x; Tedersoo L, 2009, ENVIRON MICROBIOL, V11, P3166, DOI 10.1111/j.1462-2920.2009.02020.x; Ternetz C, 1907, JB WISS BOT, V44, P353; THORN RG, 1993, P JPN ACAD B-PHYS, V69, P29, DOI 10.2183/pjab.69.29; Vohnik M, 2009, MICROB ECOL, V57, P203, DOI 10.1007/s00248-008-9402-y; Vohnik M, 2007, FOLIA MICROBIOL, V52, P407, DOI 10.1007/BF02932096; Vohnik M, 2012, PLANT SOIL, V355, P341, DOI 10.1007/s11104-011-1106-2; Vohnik M, 2011, FOLIA GEOBOT, V46, P373, DOI 10.1007/s12224-011-9098-5; Vralstad T, 2004, NEW PHYTOL, V164, P7, DOI 10.1111/j.1469-8137.2004.01180.x; Walker JF, 2011, NEW PHYTOL, V191, P515, DOI 10.1111/j.1469-8137.2011.03703.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Withington JM, 2006, ECOL MONOGR, V76, P381, DOI 10.1890/0012-9615(2006)076[0381:COSALS]2.0.CO;2; XIAO GP, 1992, MYCOLOGIA, V84, P470, DOI 10.2307/3760201; Zhang C, 2009, MYCORRHIZA, V19, P417, DOI 10.1007/s00572-009-0246-1	77	57	58	1	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39524	10.1371/journal.pone.0039524	http://dx.doi.org/10.1371/journal.pone.0039524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761814	Green Published, Green Submitted, gold			2022-12-27	WOS:000305781700042
J	Dalm, S; de Kloet, ER; Oitzl, MS				Dalm, Sergiu; de Kloet, E. Ron; Oitzl, Melly S.			Post-Training Reward Partially Restores Chronic Stress Induced Effects in Mice	PLOS ONE			English	Article							APOLIPOPROTEIN-E KNOCKOUT; CHRONIC MILD STRESS; MALE C57BL/6J MICE; NOVELTY EXPLORATION; REPEATED EXPOSURE; MOOD DISORDERS; MEMORY; BRAIN; GLUCOCORTICOIDS; MODULATION	Reduced responsiveness to positive stimuli is a core symptom of depression, known as anhedonia. In the present study, we assessed the expression of anhedonia in our chronic stress mouse model using a subset of read-out parameters. In line with this, we investigated in how far chronic stress would affect the facilitating effect of post-training self-administration of sugar, as we previously observed in naive mice. Male C57BL/6J mice were repeatedly and at unpredictable times exposed to rats (no physical contact) over the course of two weeks. Following novelty exploration, (non-) spatial learning and memory processes with and without post-training sugar acting as reinforcer, emotionality, reward sensitivity and corticosterone levels were determined. We found that (1) the effects of chronic stress persisted beyond the period of the actual rat exposure. (2) Post-training self-administration of sugar as reinforcer improved spatial performance in naive mice, whereas (3) in stressed mice sugar partially "normalized'' the impaired performance to the level of controls without sugar. Chronic stress (4) increased behavioral inhibition in response to novelty; (5) induced dynamic changes in the pattern of circadian corticosterone secretion during the first week after rat stress and (6) increased the intake of sucrose and water. (7) Chronic stress and sugar consumed during spatial training facilitated the memory for the location of the sucrose bottle weeks later. Concluding, our chronic stress paradigm induces the expression of anhedonia in mice, at different levels of behavior. The behavioral inhibition appears to be long lasting in stressed mice. Interestingly, sugar consumed in close context with spatial learning partially rescued the stress-induced emotional and cognitive impairments. This suggests that reward can ameliorate part of the negative consequences of chronic stress on memory.	[Dalm, Sergiu; de Kloet, E. Ron; Oitzl, Melly S.] Leiden Univ, Med Ctr, Leiden & Amsterdam Ctr Drug Res, Div Med Pharmacol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Dalm, S (corresponding author), Leiden Univ, Med Ctr, Leiden & Amsterdam Ctr Drug Res, Div Med Pharmacol, Leiden, Netherlands.	sdalm@yahoo.com		de Kloet, Ron/0000-0001-9176-1830	Netherlands Organization for Scientific Research NWO [015.01.076, NWO-DN 95-420]	Netherlands Organization for Scientific Research NWO(Netherlands Organization for Scientific Research (NWO))	This project was supported by the Netherlands Organization for Scientific Research NWO #015.01.076 and NWO-DN 95-420. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisman H, 2005, NEUROSCI BIOBEHAV R, V29, P525, DOI 10.1016/j.neubiorev.2005.03.007; [Anonymous], 2000, DIAGNOSTIC STAT MANU, V4th; Bevins RA, 2005, NEUROSCI BIOBEHAV R, V29, P707, DOI 10.1016/j.neubiorev.2005.03.013; Conrad CD, 2010, PROG NEURO-PSYCHOPH, V34, P742, DOI 10.1016/j.pnpbp.2009.11.003; Dallman MF, 2007, J PHYSIOL-LONDON, V583, P431, DOI 10.1113/jphysiol.2007.136051; Dallman MF, 2007, EXP NEUROL, V206, P179, DOI 10.1016/j.expneurol.2007.06.002; Dalm S, 2005, NEUROENDOCRINOLOGY, V81, P372, DOI 10.1159/000089555; Dalm S, 2008, J NEUROSCI METH, V170, P77, DOI 10.1016/j.jneumeth.2007.12.021; Dalm S, 2009, BEHAV BRAIN RES, V198, P98, DOI 10.1016/j.bbr.2008.10.016; Dalm S, 2009, BEHAV BRAIN RES, V196, P84, DOI 10.1016/j.bbr.2008.07.035; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; File SE, 2001, BEHAV BRAIN RES, V125, P151, DOI 10.1016/S0166-4328(01)00292-3; Grootendorst J, 2001, NEUROSCIENCE, V108, P237, DOI 10.1016/S0306-4522(01)00412-2; Grootendorst J, 2001, BEHAV BRAIN RES, V125, P249, DOI 10.1016/S0166-4328(01)00294-7; HUSTON JP, 1977, ACTIV NERV SUPER, V19, P17; HUSTON JP, 1989, NEUROSCI BIOBEHAV R, V13, P171, DOI 10.1016/S0149-7634(89)80027-2; Kalueff AV, 2006, BEHAV PROCESS, V72, P104, DOI 10.1016/j.beproc.2005.12.011; Krebs RM, 2009, NEUROPSYCHOLOGIA, V47, P2272, DOI 10.1016/j.neuropsychologia.2009.01.015; Leppanen JM, 2006, CURR OPIN PSYCHIATR, V19, P34, DOI 10.1097/01.yco.0000191500.46411.00; Linthorst ACE, 2000, EUR J NEUROSCI, V12, P283, DOI 10.1046/j.1460-9568.2000.00878.x; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Messier C, 2004, EUR J PHARMACOL, V490, P33, DOI 10.1016/j.ejphar.2004.02.043; Mizoguchi K, 2000, J NEUROSCI, V20, P1568; O'Carroll CM, 2006, LEARN MEMORY, V13, P760, DOI 10.1101/lm.321006; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Powell SB, 2004, BEHAV BRAIN RES, V152, P341, DOI 10.1016/j.bbr.2003.10.020; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Schwabe L, 2008, NEUROBIOL LEARN MEM, V90, P495, DOI 10.1016/j.nlm.2008.07.015; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097	34	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39033	10.1371/journal.pone.0039033	http://dx.doi.org/10.1371/journal.pone.0039033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745700	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900029
J	Hollmen, M; Liu, P; Kurppa, K; Wildiers, H; Reinvall, I; Vandorpe, T; Smeets, A; Deraedt, K; Vahlberg, T; Joensuu, H; Leahy, DJ; Schoffski, P; Elenius, K				Hollmen, Maija; Liu, Ping; Kurppa, Kari; Wildiers, Hans; Reinvall, Irene; Vandorpe, Thijs; Smeets, Ann; Deraedt, Karen; Vahlberg, Tero; Joensuu, Heikki; Leahy, Daniel J.; Schoffski, Patrick; Elenius, Klaus			Proteolytic Processing of ErbB4 in Breast Cancer	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; ESTROGEN-RECEPTOR; EXTRACELLULAR REGION; CELL-GROWTH; CLEAVAGE; EXPRESSION; SURVIVAL; ISOFORM; PROLIFERATION; CARCINOMA	ErbB4 is a receptor tyrosine kinase that can signal by a mechanism involving proteolytic release of intracellular and extracellular receptor fragments. Proteolysis-dependent signaling of ErbB4 has been proposed to be enhanced in breast cancer, mainly based on immunohistochemical localization of intracellular epitopes in the nuclei. To more directly address the processing of ErbB4 in vivo, an ELISA was developed to quantify cleaved ErbB4 ectodomain from serum samples. Analysis of 238 breast cancer patients demonstrated elevated quantities of ErbB4 ectodomain in the serum (>= 40 ng/mL) in 21% of the patients, as compared to 0% of 30 healthy controls (P = 0.002). Significantly, the elevated serum ectodomain concentration did not correlate with the presence of nuclear ErbB4 immunoreactivity in matched breast cancer tissue samples. However, elevated serum ectodomain concentration was associated with the premenopausal status at diagnosis (P = 0.04), and estradiol enhanced ErbB4 cleavage in vitro. A 3.4 angstrom X-ray crystal structure of a complex of ErbB4 ectodomain and the Fab fragment of anti-ErbB4 mAb 1479 localized the binding site of mAb 1479 on ErbB4 to a region on subdomain IV encompassing the residues necessary for ErbB4 cleavage. mAb 1479 also significantly blocked ErbB4 cleavage in breast cancer cell xenografts in vivo, and the inhibition of cleavage was associated with suppression of xenograft growth. These data indicate that ErbB4 processing is enhanced in breast cancer tissue in vivo, and that ErbB4 cleavage can be stimulated by estradiol and targeted with mAb 1479.	[Hollmen, Maija; Kurppa, Kari; Reinvall, Irene; Elenius, Klaus] Univ Turku, Dept Med Biochem & Genet, Medic Res Labs, Turku, Finland; [Hollmen, Maija; Kurppa, Kari] Turku Doctoral Programme Biomed Sci, Turku, Finland; [Liu, Ping; Leahy, Daniel J.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Wildiers, Hans; Vandorpe, Thijs; Schoffski, Patrick] Univ Hosp Leuven, Dept Gen Med Oncol, Louvain, Belgium; [Smeets, Ann] Univ Hosp Leuven, Dept Surg, Louvain, Belgium; [Deraedt, Karen] Univ Hosp Leuven, Dept Pathol, Louvain, Belgium; [Vahlberg, Tero] Univ Turku, Dept Stat, Turku, Finland; [Joensuu, Heikki] Helsinki Univ Hosp, Dept Oncol, Helsinki, Finland; [Schoffski, Patrick] Leuven Canc Inst, Louvain, Belgium; [Elenius, Klaus] Turku Univ Hosp, Dept Oncol, FIN-20520 Turku, Finland	University of Turku; Johns Hopkins University; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Turku	Hollmen, M (corresponding author), Univ Turku, Dept Med Biochem & Genet, Medic Res Labs, Turku, Finland.	klaus.elenius@utu.fi	smeets, ann/AAP-9191-2020; Elenius, Klaus/AAI-7594-2021; wildiers, hans/AAV-8158-2021; Hollmén, Maija/B-5831-2017	Elenius, Klaus/0000-0001-5700-0827; Hollmén, Maija/0000-0002-3250-7653; Joensuu, Heikki/0000-0003-0281-2507; Kurppa, Kari/0000-0001-8286-2429	Finnish Cultural Foundation; Finnish Cancer Organizations; Ida Montin Foundation; Orion-Farmos Research Foundation; Helsinki University; Academy of Finland; Cancer Society of Finland; Sigrid Juselius Foundation; National Institutes of Health [R01CA090466]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; Turku University Hospital; NATIONAL CANCER INSTITUTE [R01CA090466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099321] Funding Source: NIH RePORTER; Cancer Foundation Finland sr [120084, 110071] Funding Source: researchfish	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Cancer Organizations; Ida Montin Foundation; Orion-Farmos Research Foundation; Helsinki University; Academy of Finland(Academy of Finland); Cancer Society of Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Turku University Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Foundation Finland sr	MH was supported by the Finnish Cultural Foundation, Finnish Cancer Organizations, Ida Montin Foundation, and Orion-Farmos Research Foundation. HJ is supported by Helsinki University Research Funds, Academy of Finland, Cancer Society of Finland, and Sigrid Juselius Foundation. DJL is supported by National Institutes of Health R01CA090466. GM/CA CAT was funded in whole or in part with federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract No. DE-AC02-06CH11357. KE is supported by the Academy of Finland, Finnish Cancer Organizations, Sigrid Juselius Foundation, and Turku University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacus SS, 1996, AM J PATHOL, V148, P549; Barnes NLP, 2005, CLIN CANCER RES, V11, P2163, DOI 10.1158/1078-0432.CCR-04-1633; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Brouckaert O, 2009, BREAST CANCER RES TR, V115, P349, DOI 10.1007/s10549-008-0110-6; Cheng QC, 2003, J BIOL CHEM, V278, P38421, DOI 10.1074/jbc.M302111200; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; Gao YH, 2001, P NATL ACAD SCI USA, V98, P14979, DOI 10.1073/pnas.261463298; Gardberg AS, 2007, P NATL ACAD SCI USA, V104, P15659, DOI 10.1073/pnas.0705888104; Hollmen M, 2009, ONCOGENE, V28, P1309, DOI 10.1038/onc.2008.481; Hollmen M, 2010, FUTURE ONCOL, V6, P37, DOI 10.2217/fon.09.144; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Kainulainen V, 2000, J BIOL CHEM, V275, P8641, DOI 10.1074/jbc.275.12.8641; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Linggi B, 2006, J BIOL CHEM, V281, P25373, DOI 10.1074/jbc.M603998200; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; McCarthy JV, 2009, CELL MOL LIFE SCI, V66, P1534, DOI 10.1007/s00018-009-8435-9; Muraoka-Cook R, 2009, MOL CELL BIOL; Naresh A, 2008, CANCER RES, V68, P6387, DOI 10.1158/0008-5472.CAN-08-0538; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Salfeld JG, 2007, NAT BIOTECHNOL, V25, P1369, DOI 10.1038/nbt1207-1369; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; SeppLorenzino L, 1996, ONCOGENE, V12, P1679; Srinivasan R, 2000, CANCER RES, V60, P1483; Sundvall M, 2008, J MAMMARY GLAND BIOL, V13, P259, DOI 10.1007/s10911-008-9079-3; Sundvall M, 2010, MOL BIOL CELL, V21, P4275, DOI 10.1091/mbc.E10-04-0332; Suo Z, 2002, J PATHOL, V196, P17, DOI 10.1002/path.1003; Tang CK, 1999, CANCER RES, V59, P5315; Thor AD, 2009, AM J PATHOL, V175, P1802, DOI 10.2353/ajpath.2009.090204; Veikkolainen V, 2011, CELL CYCLE, V10, P2647, DOI 10.4161/cc.10.16.17194; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Zeng F, 2007, MOL BIOL CELL, V18, P4446, DOI 10.1091/mbc.E07-03-0223; Zhu Y, 2006, CANCER RES, V66, P7991, DOI 10.1158/0008-5472.CAN-05-4397	36	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39413	10.1371/journal.pone.0039413	http://dx.doi.org/10.1371/journal.pone.0039413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761786	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900057
J	Mahon, RJ; Downes, SJ; James, B				Mahon, Rod J.; Downes, Sharon J.; James, Bill			Vip3A Resistance Alleles Exist at High Levels in Australian Targets before Release of Cotton Expressing This Toxin	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; BACILLUS-THURINGIENSIS; INSECT RESISTANCE; CONFERRING RESISTANCE; TRANSGENIC COTTON; BT CROPS; NOCTUIDAE; FREQUENCY; CRY2AB; POPULATIONS	Crops engineered to produce insecticidal crystal (Cry) proteins from the soil bacterium Bacillus thuringiensis (Bt) have revolutionised pest control in agriculture. However field-level resistance to Bt has developed in some targets. Utilising novel vegetative insecticidal proteins (Vips), also derived from Bt but genetically distinct from Cry toxins, is a possible solution that biotechnical companies intend to employ. Using data collected over two seasons we determined that, before deployment of Vip-expressing plants in Australia, resistance alleles exist in key targets as polymorphisms at frequencies of 0.027 (n = 273 lines, 95% CI = 0.019-0.038) in H. armigera and 0.008 (n = 248 lines, 0.004-0.015) in H. punctigera. These frequencies are above mutation rates normally encountered. Homozygous resistant neonates survived doses of Vip3A higher than those estimated in field-grown plants. Fortunately the resistance is largely, if not completely, recessive and does not confer resistance to the Bt toxins Cry1Ac or Cry2Ab already deployed in cotton crops. These later characteristics are favourable for resistance management; however the robustness of Vip3A inclusive varieties will depend on resistance frequencies to the Cry toxins when it is released (anticipated 2016) and the efficacy of Vip3A throughout the season. It is appropriate to pre-emptively screen key targets of Bt crops elsewhere, especially those such as H. zea in the USA, which is not only closely related to H. armigera but also will be exposed to Vip in several varieties of cotton and corn.	[Mahon, Rod J.; James, Bill] Commonwealth Sci & Ind Res Org, Ecosyst Sci Div, Black Mt Labs, Canberra, ACT, Australia; [Downes, Sharon J.] Commonwealth Sci & Ind Res Org, Ecosyst Sci Div, Australian Cotton Res Inst, Narrabri, NSW, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Mahon, RJ (corresponding author), Commonwealth Sci & Ind Res Org, Ecosyst Sci Div, Black Mt Labs, Canberra, ACT, Australia.	rod.mahon@csiro.au	Downes, Sharon Joy/C-1770-2008; James, Bill J/C-8908-2012	Downes, Sharon Joy/0000-0002-3729-1732; 	Commonwealth Scientific and Industrial Research Organisation; Cotton Research and Development Corporation	Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Cotton Research and Development Corporation(Cotton R&D Corp)	The authors received financial support from the Commonwealth Scientific and Industrial Research Organisation and the Cotton Research and Development Corporation to conduct this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk JJ, 2001, J ECON ENTOMOL, V94, P1589, DOI 10.1603/0022-0493-94.6.1589; Andow DA, 1998, J ECON ENTOMOL, V91, P572, DOI 10.1093/jee/91.3.572; [Anonymous], 2010, SYNGENTA DOW AGROSCI; [Anonymous], 2010, SYNGENTA BAYER CROPS; Artim L, 2003, PETITION 03 155 01P; Caccia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009975; Clark AG, 1998, GENETICA, V102-3, P41, DOI 10.1023/A:1017074523395; Downes S, 2009, J ECON ENTOMOL, V102, P733, DOI 10.1603/029.102.0234; Downes S, 2012, GM CROPS IN PRESS; Downes S, 2012, J INVERTEBR IN PRESS; Downes S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012567; Estruch JJ, 1996, P NATL ACAD SCI USA, V93, P5389, DOI 10.1073/pnas.93.11.5389; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Fitt G, 1998, PEST MANAGEMENT - FUTURE CHALLENGES, VOLS 1 AND 2, PROCEEDINGS, P189; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Genissel A, 2003, P ROY SOC B-BIOL SCI, V270, P791, DOI 10.1098/rspb.2002.2317; Hartley CJ, 2006, P NATL ACAD SCI USA, V103, P8757, DOI 10.1073/pnas.0509590103; Laws F, 2010, VIPCOT NEARING END I; Llewellyn DJ, 2007, AGR FOREST ENTOMOL, V9, P93, DOI 10.1111/j.1461-9563.2007.00332.x; Lu BQ, 2011, ENTOMOL EXP APPL, V140, P17, DOI 10.1111/j.1570-7458.2011.01135.x; Mahon RJ, 2007, J ECON ENTOMOL, V100, P1844, DOI 10.1603/0022-0493(2007)100[1844:FOACRT]2.0.CO;2; Mahon RJ, 2007, J ECON ENTOMOL, V100, P894, DOI 10.1603/0022-0493(2007)100[894:RTBTTC]2.0.CO;2; Mahon RJ, 2010, J ECON ENTOMOL, V103, P472, DOI 10.1603/EC09225; Mahon RJ, 2009, J ECON ENTOMOL, V102, P708, DOI 10.1603/029.102.0232; McKenzie J., 1996, ECOLOGICAL EVOLUTION; Rochester IJ, 2006, J COTTON SCI, V10, P252; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Sena JAD, 2009, APPL ENVIRON MICROB, V75, P2236, DOI 10.1128/AEM.02342-08; Tabashnik BE, 2000, P NATL ACAD SCI USA, V97, P12980, DOI 10.1073/pnas.97.24.12980; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Zhao JZ, 2003, NAT BIOTECHNOL, V21, P1493, DOI 10.1038/nbt907	34	79	81	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39192	10.1371/journal.pone.0039192	http://dx.doi.org/10.1371/journal.pone.0039192			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761737	gold, Green Submitted, Green Published			2022-12-27	WOS:000305730900035
J	Postel, R; Sonnenberg, A				Postel, Ruben; Sonnenberg, Arnoud			Carbonic Anhydrase 5 Regulates Acid-Base Homeostasis in Zebrafish	PLOS ONE			English	Article							MITOCHONDRIAL ISOFORMS VA; CA-IX; EXPRESSION; VB; INHIBITION; TRANSPORT; EVOLUTION; GENE; XIV	The regulation of the acid-base balance in cells is essential for proper cellular homeostasis. Disturbed acid-base balance directly affects cellular physiology, which often results in various pathological conditions. In every living organism, the protein family of carbonic anhydrases regulate a broad variety of homeostatic processes. Here we describe the identification, mapping and cloning of a zebrafish carbonic anhydrase 5 (ca5) mutation, collapse of fins (cof), which causes initially a collapse of the medial fins followed by necrosis and rapid degeneration of the embryo. These phenotypical characteristics can be mimicked in wild-type embryos by acetazolamide treatment, suggesting that CA5 activity in zebrafish is essential for a proper development. In addition we show that CA5 regulates acid-base balance during embryonic development, since lowering the pH can compensate for the loss of CA5 activity. Identification of selective modulators of CA5 activity could have a major impact on the development of new therapeutics involved in the treatment of a variety of disorders.	[Postel, Ruben; Sonnenberg, Arnoud] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands	Netherlands Cancer Institute	Postel, R (corresponding author), Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands.	a.sonnenberg@nki.nl			Dystrophic Epidermolysis Bullosa Research Association (UK)	Dystrophic Epidermolysis Bullosa Research Association (UK)	This research was supported by a grant from the Dystrophic Epidermolysis Bullosa Research Association (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chegwidden WR, 2000, EXS, V90, P13; Davis RA, 2010, BIOORGAN MED CHEM, V18, P14, DOI 10.1016/j.bmc.2009.11.021; De Simone G, 2007, CURR TOP MED CHEM, V7, P879, DOI 10.2174/156802607780636762; DODGSON SJ, 1980, P NATL ACAD SCI-BIOL, V77, P5562, DOI 10.1073/pnas.77.9.5562; Geers C, 2000, PHYSIOL REV, V80, P681, DOI 10.1152/physrev.2000.80.2.681; Gilmour KM, 2009, J EXP BIOL, V212, P3837, DOI 10.1242/jeb.034116; Gilmour KM, 2009, J EXP BIOL, V212, P1647, DOI 10.1242/jeb.029181; Hewett-Emmett D, 2000, EXS, V90, P29; Hilvo M, 2008, J BIOL CHEM, V283, P27799, DOI 10.1074/jbc.M800938200; Hilvo M, 2007, CURR TOP MED CHEM, V7, P893, DOI 10.2174/156802607780636672; Kim HJ, 2006, MOL ENDOCRINOL, V20, P194, DOI 10.1210/me.2005-0189; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; NAGAO Y, 1994, P NATL ACAD SCI USA, V91, P10330, DOI 10.1073/pnas.91.22.10330; Nishimori I, 2007, BIOORGAN MED CHEM, V15, P6742, DOI 10.1016/j.bmc.2007.08.008; Parkkila AK, 1998, J BIOL CHEM, V273, P24620, DOI 10.1074/jbc.273.38.24620; Purkerson JM, 2005, AM J PHYSIOL-REG I, V288, pR1256, DOI 10.1152/ajpregu.00735.2004; Schwartz GJ, 2002, J NEPHROL, V15, pS61; Shah GN, 2000, P NATL ACAD SCI USA, V97, P1677, DOI 10.1073/pnas.97.4.1677; Sly WS, 2000, EXS, V90, P95; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Tashian RE, 2000, EXS, V90, P569; THISSE C, 1993, DEVELOPMENT, V119, P1203; Vullo D, 2007, BIOORG MED CHEM LETT, V17, P1336, DOI 10.1016/j.bmcl.2006.11.075; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103	26	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39881	10.1371/journal.pone.0039881	http://dx.doi.org/10.1371/journal.pone.0039881			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745834	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900119
J	Rayment, M; Thornton, A; Mandalia, S; Elam, G; Atkins, M; Jones, R; Nardone, A; Roberts, P; Tenant-Flowers, M; Anderson, J; Sullivan, AK				Rayment, Michael; Thornton, Alicia; Mandalia, Sundhiya; Elam, Gillian; Atkins, Mark; Jones, Rachael; Nardone, Anthony; Roberts, Patrick; Tenant-Flowers, Melinda; Anderson, Jane; Sullivan, Ann K.		HINTS Study Grp	HIV Testing in Non-Traditional Settings - The HINTS Study: A Multi-Centre Observational Study of Feasibility and Acceptability	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; PERSONS AWARE; UNITED-STATES; CARE; TRANSMISSION; ATTITUDES; BEHAVIOR; UNAWARE; CENTERS; ADULTS	Background: UK guidelines recommend routine HIV testing in healthcare settings if the local diagnosed HIV prevalence >2/1000 persons. This prospective study assessed the feasibility and acceptability, to patients and staff, of routinely offering HIV tests in four settings: Emergency Department, Acute Care Unit, Dermatology Outpatients and Primary Care. Modelling suggested the estimated prevalence of undiagnosed HIV infection in attendees would exceed 1/1000 persons. The prevalence identified prospectively was not a primary outcome. Methods: Permanent staff completed questionnaires assessing attitudes towards routine HIV testing in their workplace before testing began. Subsequently, over a three-month period, patients aged 16-65 were offered an HIV test by study staff. Demographics, uptake, results, and departmental activity were collected. Subsets of patients completed questionnaires. Analyses were conducted to identify factors associated with test uptake. Findings: Questionnaires were received from 144 staff. 96% supported the expansion of HIV testing, but only 54% stated that they would feel comfortable delivering testing themselves, with 72% identifying a need for training. Of 6194 patients offered a test, 4105 (66.8%) accepted (61.8-75.4% across sites). Eight individuals were diagnosed with HIV (0-10/1000 across sites) and all transferred to care. Younger people, and males, were more likely to accept an HIV test. No significant associations were found between uptake and ethnicity, or clinical site. Questionnaires were returned from 1003 patients. The offer of an HIV test was acceptable to 92%. Of respondents, individuals who had never tested for HIV before were more likely to accept a test, but no association was found between test uptake and sexual orientation. Conclusions: HIV testing in these settings is acceptable, and operationally feasible. The strategy successfully identified, and transferred to care, HIV-positive individuals. However, if HIV testing is to be included as a routine part of patients' care, additional staff training and infrastructural resources will be required.	[Rayment, Michael; Jones, Rachael; Sullivan, Ann K.; HINTS Study Grp] Chelsea & Westminster Hosp NHS Fdn Trust, Directorate HIV GU Med, London, England; [Thornton, Alicia; Nardone, Anthony] Hlth Protect Agcy, Ctr Infect, London, England; [Mandalia, Sundhiya] Chelsea & Westminster Hosp NHS Fdn Trust, St Stephens AIDS Trust, London, England; [Elam, Gillian] UCL, Ctr Sexual Hlth & HIV Res, Res Dept Infect & Populat Hlth, London, England; [Atkins, Mark] Univ London Imperial Coll Sci Technol & Med, Dept Clin Virol, London, England; [Roberts, Patrick] Chelsea & Westminster Hosp NHS Fdn Trust, Dept Emergency Med, London, England; [Tenant-Flowers, Melinda] Kings Coll Hosp NHS Fdn Trust, Caldecot Ctr, Dept Sexual Hlth & HIV, London, England; [Anderson, Jane] Homerton Univ Hosp NHS Fdn Trust, Ctr Study Sexual Hlth & HIV, London, England	Imperial College London; Health Protection Agency; Imperial College London; University of London; University College London; Imperial College London; Imperial College London; King's College Hospital NHS Foundation Trust	Rayment, M (corresponding author), Chelsea & Westminster Hosp NHS Fdn Trust, Directorate HIV GU Med, London, England.	michaelrayment@nhs.net	Anderson, Jane/A-1632-2012	Anderson, Jane/0000-0001-5294-8707; Nardone, Anthony/0000-0003-1138-0937; Phekoo, Karen/0000-0002-4755-8437	Department of Health; NIHR CLAHRC for North West London; NHS Kensington and Chelsea; NHS Hammersmith and Fulham	Department of Health; NIHR CLAHRC for North West London; NHS Kensington and Chelsea; NHS Hammersmith and Fulham	This study was funded with the support of the Department of Health, NIHR CLAHRC for North West London, NHS Kensington and Chelsea, and NHS Hammersmith and Fulham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, IMPROVING DETECTION; [Anonymous], TIM TEST HIV EXP HEA; Arbelaez C, 2012, J EMERG MED, V42, P7, DOI 10.1016/j.jemermed.2009.07.038; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; British Association for Sexual Health and HIV (BASHH) the British HIV Association (BHIVA) and the British Infection Society (BIS), 2008, GUID HIV TEST; Brown J, 2007, JAIDS-J ACQ IMM DEF, V46, P395, DOI 10.1097/QAI.0b013e3181582d82; Burke RC, 2007, AIDS, V21, P1617, DOI 10.1097/QAD.0b013e32823f91ff; Calderon Y, 2009, AIDS PATIENT CARE ST, V23, P749, DOI 10.1089/apc.2008.0270; Castel A, 2010, C RETR OPP INF SAN F; Cremieux A. C., 2010, Bulletin Epidemiologique Hebdomadaire, P460; Drayton R, 2010, INT J STD AIDS, V21, P563, DOI 10.1258/ijsa.2010.010085; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Health Protection Agency, 2010, HIV UK 2010; Jain CL, 2008, AIDS PATIENT CARE ST, V22, P657, DOI 10.1089/apc.2007.0189; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Leider J, 2011, AIDS PATIENT CARE ST, V25, P89, DOI 10.1089/apc.2010.0205; Lucas SB, 2008, CLIN MED, V8, P250, DOI 10.7861/clinmedicine.8-3-250; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; National Institute for Health and Clinical Excellence, 2011, INCR UPT HIV TEST ME; National Institute for Health and Clinical Excellence, 2011, INCR UPT HIV TEST BL; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Price H, 2009, INT J STD AIDS, V20, P56, DOI 10.1258/ijsa.2008.008326; Rayment M, 2011, HIV MED S, V12, P63; Siegel M, 2011, J ACQ IMMUN DEF SYND, V55, P205; Simpson WM, 1998, BRIT MED J, V316, P262, DOI 10.1136/bmj.316.7127.262; Stohr W, 2007, HIV MED, V8, P135, DOI 10.1111/j.1468-1293.2007.00443.x; Sullivan AK, 2005, BRIT MED J, V330, P1301, DOI 10.1136/bmj.38398.590602.E0; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397	29	76	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39530	10.1371/journal.pone.0039530	http://dx.doi.org/10.1371/journal.pone.0039530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	964XV	22745777	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900070
J	Jacquet, PO; Chambon, V; Borghi, AM; Tessari, A				Jacquet, Pierre O.; Chambon, Valerian; Borghi, Anna M.; Tessari, Alessia			Object Affordances Tune Observers' Prior Expectations about Tool-Use Behaviors	PLOS ONE			English	Article							LATERAL PREFRONTAL CORTEX; COGNITIVE CONTROL; MOTOR ACTIVATION; IMITATION; MEMORY; PERCEPTION; MECHANISMS; SELECTION; MODELS; GOALS	Learning about the function and use of tools through observation requires the ability to exploit one's own knowledge derived from past experience. It also depends on the detection of low-level local cues that are rooted in the tool's perceptual properties. Best known as 'affordances', these cues generate biomechanical priors that constrain the number of possible motor acts that are likely to be performed on tools. The contribution of these biomechanical priors to the learning of tool-use behaviors is well supported. However, it is not yet clear if, and how, affordances interact with higher-order expectations that are generated from past experience - i.e. probabilistic exposure - to enable observational learning of tool use. To address this question we designed an action observation task in which participants were required to infer, under various conditions of visual uncertainty, the intentions of a demonstrator performing tool-use behaviors. Both the probability of observing the demonstrator achieving a particular tool function and the biomechanical optimality of the observed movement were varied. We demonstrate that biomechanical priors modulate the extent to which participants' predictions are influenced by probabilistically-induced prior expectations. Biomechanical and probabilistic priors have a cumulative effect when they 'converge' (in the case of a probabilistic bias assigned to optimal behaviors), or a mutually inhibitory effect when they actively 'diverge' (in the case of probabilistic bias assigned to suboptimal behaviors).	[Jacquet, Pierre O.; Borghi, Anna M.; Tessari, Alessia] Univ Bologna, Dept Psychol, Bologna, Italy; [Jacquet, Pierre O.] ImpAct Team, Lyon Neurosci Res Ctr, Ctr Natl Rech Sci UMR 5292, Inst Natl Sante & Rech Med Unite 1028, Bron, France; [Chambon, Valerian] Univ Lyon, Ctr Neurosci Cognit, UMR 5229, Ctr Natl Rech Sci, Bron, France; [Borghi, Anna M.] CNR, Inst Cognit Sci & Technol, Rome, Italy	University of Bologna; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Jacquet, PO (corresponding author), Univ Bologna, Dept Psychol, Bologna, Italy.	pierre.jacquet3@unibo.it	Chambon, Valerian/AAF-5482-2019; Jacquet, Pierre/GXF-8514-2022; Tessari, Alessia/K-3457-2013	Chambon, Valerian/0000-0002-2401-1906; Tessari, Alessia/0000-0002-6616-2454; Borghi, Anna M./0000-0001-9455-8408	European Commission [216125]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the FP7 project ROSSI, Emergence of communication in RObots through Sensorimotor and Social Interaction, European Commission grant agreement no. 216125. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi A, 2012, CURR ZOOL, V58, P307, DOI 10.1093/czoolo/58.2.307; Acerbi A, 2011, LEARN BEHAV, V39, P104, DOI 10.3758/s13420-010-0009-z; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Baker CL, 2009, COGNITION, V113, P329, DOI 10.1016/j.cognition.2009.07.005; Barbalat G, 2011, BIOL PSYCHIAT, V70, P73, DOI 10.1016/j.biopsych.2011.02.009; Barbalat G, 2009, ARCH GEN PSYCHIAT, V66, P377, DOI 10.1001/archgenpsychiatry.2009.10; Borghi AM, 2007, NEUROSCI LETT, V411, P17, DOI 10.1016/j.neulet.2006.10.003; Buchsbaum D, 2011, COGNITION, V120, P331, DOI 10.1016/j.cognition.2010.12.001; Casler K, 2007, COGNITION, V103, P120, DOI 10.1016/j.cognition.2006.02.006; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Chambon V, 2011, BRAIN, V134, P3725, DOI 10.1093/brain/awr306; Chambon V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017133; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Claidiere N, 2010, P R SOC B, V277, P651, DOI 10.1098/rspb.2009.1615; Clark A, 1998, BEING THERE PUTTING; Csibra G, 1999, COGNITION, V72, P237, DOI 10.1016/S0010-0277(99)00039-6; Csibra G, 2007, ACTA PSYCHOL, V124, P60, DOI 10.1016/j.actpsy.2006.09.007; Dennett Daniel C., 1995, DARWINS DANGEROUS ID; DENNETT DC, 1982, THOUGHT OBJECT, P1; DESMURGET M, 1995, J NEUROPHYSIOL, V74, P905, DOI 10.1152/jn.1995.74.2.905; Ellis R, 2000, BRIT J PSYCHOL, V91, P451, DOI 10.1348/000712600161934; Franz M, 2010, P ROY SOC B-BIOL SCI, V277, P3363, DOI 10.1098/rspb.2010.0705; Gergely G, 2002, NATURE, V415, P755, DOI 10.1038/415755a; Gergely G, 2003, TRENDS COGN SCI, V7, P287, DOI 10.1016/S1364-6613(03)00128-1; GERGELY G, 1995, COGNITION, V56, P165, DOI 10.1016/0010-0277(95)00661-H; Gergely G, 2007, INNATE MIND, V3, P170; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gregory R.L., 1981, MIND SCI HIST EXPLAN; Grezes J, 2003, EUR J NEUROSCI, V17, P2735, DOI 10.1046/j.1460-9568.2003.02695.x; Griffiths TL, 2008, CAMB HANDB PSYCHOL, P59; Griffiths TL, 2010, TRENDS COGN SCI, V14, P357, DOI 10.1016/j.tics.2010.05.004; Hernik M, 2009, CURR OPIN NEUROBIOL, V19, P34, DOI 10.1016/j.conb.2009.05.003; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Jacquet PO, 2012, BEHAV BRAIN IN PRESS; Johnson-Frey SH, 2003, NEURON, V39, P201, DOI 10.1016/S0896-6273(03)00424-0; Kilner JM, 2011, TRENDS COGN SCI, V15, P352, DOI 10.1016/j.tics.2011.06.005; Kilner JM, 2004, NAT NEUROSCI, V7, P1299, DOI 10.1038/nn1355; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Norman D., 1988, PSYCHOL EVERYDAY THI; Onishi KH, 2007, ACTA PSYCHOL, V124, P106, DOI 10.1016/j.actpsy.2006.09.009; Osiurak F, 2010, PSYCHOL REV, V117, P517, DOI 10.1037/a0019004; Paulignan Y, 1997, EXP BRAIN RES, V114, P226, DOI 10.1007/PL00005631; ROSENBAUM DA, 1992, J EXP PSYCHOL LEARN, V18, P1058, DOI 10.1037/0278-7393.18.5.1058; Rosenbaum DA, 1996, ACTA PSYCHOL, V94, P59, DOI 10.1016/0001-6918(95)00062-3; Sartori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025203; Seed A, 2010, CURR BIOL, V20, pR1032, DOI 10.1016/j.cub.2010.09.042; Southgate V, 2008, COGNITION, V107, P1059, DOI 10.1016/j.cognition.2007.10.002; Southgate V, 2010, PSYCHOL SCI, V21, P355, DOI 10.1177/0956797610362058; Southgate V, 2009, BIOL LETTERS, V5, P769, DOI 10.1098/rsbl.2009.0474; St Amant R, 2008, ANIM BEHAV, V75, P1199, DOI 10.1016/j.anbehav.2007.09.028; Stefan K, 2008, EUR J NEUROSCI, V27, P730, DOI 10.1111/j.1460-9568.2008.06035.x; Stefan K, 2005, J NEUROSCI, V25, P9339, DOI 10.1523/JNEUROSCI.2282-05.2005; Sterelny K, 2003, INNATE MIND, V2, P218; Sterelny K, 2003, THOUGHT HOSTILE WORL; Tennie C, 2008, AM J PRIMATOL, V70, P584, DOI 10.1002/ajp.20532; Tessari A, 2006, EXP BRAIN RES, V173, P507, DOI 10.1007/s00221-006-0395-9; Vaesen K, 2012, BEHAV BRAIN IN PRESS; Weiss DJ, 2007, PSYCHOL SCI, V18, P1063, DOI 10.1111/j.1467-9280.2007.02026.x; World Medical Association, 2008, WORLD MED ASS DECL H	60	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39629	10.1371/journal.pone.0039629	http://dx.doi.org/10.1371/journal.pone.0039629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	964KY	22737249	Green Published, gold, Green Submitted			2022-12-27	WOS:000305695100048
J	Achterberg, EJM; Trezza, V; Vanderschuren, LJMJ				Achterberg, E. J. Marijke; Trezza, Viviana; Vanderschuren, Louk J. M. J.			beta-Adrenoreceptor Stimulation Mediates Reconsolidation of Social Reward-Related Memories	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; ADRENERGIC-RECEPTORS; PROTEIN-SYNTHESIS; FEAR MEMORY; RETRIEVAL; CONSOLIDATION; RATS; EXTINCTION; BLOCKADE; AMYGDALA	Background: In recent years, the notion that consolidated memories become transiently unstable after retrieval and require reconsolidation to persist for later use has received strong experimental support. To date, the majority of studies on reconsolidation have focused on memories of negative emotions, while the dynamics of positive memories have been less well studied. Social play, the most characteristic social behavior displayed by young mammals, is important for social and cognitive development. It has strong rewarding properties, illustrated by the fact that it can induce conditioned place preference (CPP). In order to understand the dynamics of positive social memories, we evaluated the effect of propranolol, a b-adrenoreceptor antagonist known to influence a variety of memory processes, on acquisition, consolidation, retrieval and reconsolidation of social play-induced CPP in adolescent rats. Methodology/Principal Findings: Systemic treatment with propranolol, immediately before or after a CPP test (i.e. retrieval session), attenuated CPP 24 h later. Following extinction, CPP could be reinstated in saline-but not in propranolol-treated rats, indicating that propranolol treatment had persistently disrupted the CPP memory trace. Propranolol did not affect social play-induced CPP in the absence of memory retrieval or when administered 1 h or 6 h after retrieval. Furthermore, propranolol did not affect acquisition, consolidation or retrieval of social play-induced CPP. Conclusions/Significance: We conclude that beta-adrenergic neurotransmission selectively mediates the reconsolidation, but not other processes involved in the storage and stability of social reward-related memories in adolescent rats. These data support the notion that consolidation and reconsolidation of social reward-related memories in adolescent rats rely on distinct neural mechanisms.	[Achterberg, E. J. Marijke; Vanderschuren, Louk J. M. J.] Univ Utrecht, Fac Vet Med, Dept Anim Sci & Soc, Div Behav Neurosci, Utrecht, Netherlands; [Trezza, Viviana; Vanderschuren, Louk J. M. J.] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Trezza, Viviana] Univ Roma Tre, Dept Biol, Rome, Italy	Utrecht University; Utrecht University; Utrecht University Medical Center; Roma Tre University	Achterberg, EJM (corresponding author), Univ Utrecht, Fac Vet Med, Dept Anim Sci & Soc, Div Behav Neurosci, Utrecht, Netherlands.	vtrezza@uniroma3.it; l.j.m.j.vanderschuren@uu.nl	Vanderschuren, Louk/AAS-4391-2020; Trezza, Viviana/K-4418-2016	Achterberg, Marijke/0000-0002-7991-1514; Vanderschuren, Louk/0000-0002-5379-0363	Netherlands Organization for Scientific Research (NWO) Veni grant [91611052]; Marie Curie Career Reintegration Grant [PCIG09-GA-2011-293589]; National Institute on Drug Abuse Grant [R01 DA022628]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022628] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO) Veni grant(Netherlands Organization for Scientific Research (NWO)); Marie Curie Career Reintegration Grant; National Institute on Drug Abuse Grant; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Netherlands Organization for Scientific Research (NWO) Veni grant 91611052 (VT), Marie Curie Career Reintegration Grant PCIG09-GA-2011-293589 (VT) and National Institute on Drug Abuse Grant R01 DA022628 (LJMJV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes P, 2012, HIPPOCAMPUS, V22, P149, DOI 10.1002/hipo.20879; BEATTY WW, 1983, PHARMACOL BIOCHEM BE, V18, P7, DOI 10.1016/0091-3057(83)90242-3; Bernardi RE, 2006, NEUROREPORT, V17, P1443, DOI 10.1097/01.wnr.0000233098.20655.26; BOUTON ME, 1993, PSYCHOL BULL, V114, P80, DOI 10.1037/0033-2909.114.1.80; Cahill L, 2000, NEUROBIOL LEARN MEM, V74, P259, DOI 10.1006/nlme.1999.3950; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cain CK, 2004, LEARN MEMORY, V11, P179, DOI 10.1101/lm.71504; CALCAGNETTI DJ, 1992, PHYSIOL BEHAV, V51, P667, DOI 10.1016/0031-9384(92)90101-7; Cohen J, 2011, NEUROBIOL LEARN MEM, V95, P484, DOI 10.1016/j.nlm.2011.02.011; CROWDER WF, 1992, PHARMACOL BIOCHEM BE, V41, P817, DOI 10.1016/0091-3057(92)90233-6; de Quervain DJF, 2007, AM J PSYCHIAT, V164, P967, DOI 10.1176/appi.ajp.164.6.967; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; Diergaarde L, 2006, BEHAV BRAIN RES, V170, P333, DOI 10.1016/j.bbr.2006.02.014; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Fricks-Gleason AN, 2008, LEARN MEMORY, V15, P643, DOI 10.1101/lm.1054608; Inda MC, 2011, J NEUROSCI, V31, P1635, DOI 10.1523/JNEUROSCI.4736-10.2011; Kim J, 2010, J NEUROSCI, V30, P9631, DOI 10.1523/JNEUROSCI.0940-10.2010; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Kroon JAV, 2009, NEUROBIOL LEARN MEM, V91, P32, DOI 10.1016/j.nlm.2008.10.007; Languille S, 2009, EUR J NEUROSCI, V30, P1923, DOI 10.1111/j.1460-9568.2009.06971.x; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milton AL, 2008, LEARN MEMORY, V15, P88, DOI 10.1101/lm.825008; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Moll GH, 2000, DEV BRAIN RES, V119, P251, DOI 10.1016/S0165-3806(99)00182-0; Murchison CF, 2004, CELL, V117, P131, DOI 10.1016/S0092-8674(04)00259-4; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Otis JM, 2011, NEUROPSYCHOPHARMACOL, V36, P1912, DOI 10.1038/npp.2011.77; PANKSEPP J, 1984, NEUROSCI BIOBEHAV R, V8, P465, DOI 10.1016/0149-7634(84)90005-8; Pellis S. M., 2009, PLAYFUL BRAIN VENTUR; Perrin G, 2007, BEHAV NEUROSCI, V121, P148, DOI 10.1037/0735-7044.121.1.148; PITTMAN RN, 1980, BRAIN RES, V188, P357, DOI 10.1016/0006-8993(80)90037-2; Robinson MJF, 2007, BEHAV BRAIN RES, V182, P129, DOI 10.1016/j.bbr.2007.05.023; Sadler R, 2007, BEHAV PHARMACOL, V18, P699, DOI 10.1097/FBP.0b013e3282effb81; Sanders JD, 2005, NEUROSCIENCE, V130, P107, DOI 10.1016/j.neuroscience.2004.09.014; Sara SJ, 1999, LEARN MEMORY, V6, P88; SARA SJ, 1995, COGNITIVE BRAIN RES, V2, P181, DOI 10.1016/0926-6410(95)90007-1; Spinka M, 2001, Q REV BIOL, V76, P141, DOI 10.1086/393866; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Thiel KJ, 2008, DRUG ALCOHOL DEPEN, V96, P202, DOI 10.1016/j.drugalcdep.2008.02.013; Tollenaar MS, 2009, NEUROBIOL LEARN MEM, V91, P23, DOI 10.1016/j.nlm.2008.08.002; Trezza V, 2011, DEV COGN NEUROS-NETH, V1, P444, DOI 10.1016/j.dcn.2011.05.007; Trezza V, 2010, TRENDS PHARMACOL SCI, V31, P463, DOI 10.1016/j.tips.2010.06.008; Trezza V, 2009, EUR NEUROPSYCHOPHARM, V19, P659, DOI 10.1016/j.euroneuro.2009.03.006; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Vanderschuren LJMJ, 1997, NEUROSCI BIOBEHAV R, V21, P309, DOI 10.1016/S0149-7634(96)00020-6; Vanderschuren LJMJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2946, DOI 10.1038/npp.2008.10; Veeneman MMJ, 2011, PSYCHOPHARMACOLOGY, V214, P863, DOI 10.1007/s00213-010-2095-1	52	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39639	10.1371/journal.pone.0039639	http://dx.doi.org/10.1371/journal.pone.0039639			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745800	Green Submitted, Green Published, gold			2022-12-27	WOS:000305693200093
J	Costantini, S; Capone, F; Guerriero, E; Marfella, R; Sorice, A; Maio, P; Di Stasio, M; Paolisso, G; Castello, G; Colonna, G				Costantini, Susan; Capone, Francesca; Guerriero, Eliana; Marfella, Raffaele; Sorice, Angela; Maio, Patrizia; Di Stasio, Michele; Paolisso, Giuseppe; Castello, Giuseppe; Colonna, Giovanni			Cytokinome Profile of Patients with Type 2 Diabetes and/or Chronic Hepatitis C Infection	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; HEPATOCELLULAR-CARCINOMA; INSULIN-RESISTANCE; LIVER-CIRRHOSIS; VIRUS-INFECTION; GROWTH-FACTOR; GLUCOSE; ASSOCIATION; RESPONSES; FIBROSIS	Both type 2 diabetes (T2D) and chronic hepatitis C (CHC) infection are associated with increased risk of developing hepatocellular carcinoma (HCC). Cytokines are known to play an important role not only in the mechanisms of insulin resistance and glucose disposal defects but also in the pathological processes occurring in the liver during viral infection. We evaluated the serum levels of many cytokines, chemokines, adipokines and growth factors in patients with type 2 diabetes, CHC, CHC-related cirrhosis, CHC and type 2 diabetes and CHC-related cirrhosis and type 2 diabetes by BioPlex assay. The obtained data evidenced that the serum levels of some proteins are significantly up-regulated in all the patients or in those with only one disease and are often higher, even if in different amounts, when both diseases are associated. In particular, our results can be useful for the clinical monitoring of patients because they give specific information in regard to the progression from CHC to LC and CHD to LCD. Moreover, some molecules have shown significant correlations with clinical/biochemical data, suggesting the possibility to define mini-panels that can be used as specific markers for the different disease staging. However, our observations demonstrate that an integrated approach is much more powerful than isolated measurements to evaluate specific stages of these two complex pathologies (type 2 diabetes and chronic CHC hepatitis) alone or when they are concomitant in a patient. In fact it has emerged as an accurate, simple, specific, noninvasive, reproducible and less expensive method that, in future, could be included in routine clinical practice to monitor the association of type 2 diabetes and/or CHC to liver cirrhosis and, possibly, to cancer, and to improve the prognosis of these diseases.	[Costantini, Susan; Capone, Francesca; Guerriero, Eliana; Sorice, Angela; Castello, Giuseppe] INT G Pascale Oncol Res Ctr Mercogliano, Mercogliano, Italy; [Marfella, Raffaele; Paolisso, Giuseppe] Univ Naples 2, Dept Geriatr & Metab Dis, Naples, Italy; [Maio, Patrizia] Azienda Osped Rilievo Nazl San Giuseppe Moscati, Unita Operativa Malattie Infett, Avellino, Italy; [Di Stasio, Michele] CNR, Inst Food Sci, Avellino, Italy; [Colonna, Giovanni] Univ Naples 2, Dept Biochem & Biophys, Naples, Italy; [Colonna, Giovanni] Univ Naples 2, Interdept Res Ctr Computat & Biotechnol Sci, Naples, Italy	Universita della Campania Vanvitelli; San Giuseppe Moscati Hospital; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Costantini, S (corresponding author), INT G Pascale Oncol Res Ctr Mercogliano, Mercogliano, Italy.	susan.costantini@unina2.it	paolisso, giuseppe/AAP-8516-2020; Costantini, Susan/J-9914-2018; Marfella, Raffaele/AAH-2595-2019; Di Stasio, Michele/E-3417-2012; Capone, Francesca/AAS-7458-2021; Colonna, Giovanni/AAY-3568-2021	paolisso, giuseppe/0000-0002-2137-455X; Marfella, Raffaele/0000-0003-3960-9270; Di Stasio, Michele/0000-0002-9778-7633; Capone, Francesca/0000-0002-5402-6228; Colonna, Giovanni/0000-0002-0473-1455; Castello, Giuseppe/0000-0002-0924-6248; Costantini, Susan/0000-0002-7538-4657; Sorice, Angela/0000-0003-4900-6107				Alfadda AA, 2008, SAUDI MED J, V29, P584; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Anan F, 2010, EUR J CLIN INVEST, V40, P585, DOI 10.1111/j.1365-2362.2010.02301.x; Bahr MJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE199, DOI 10.1152/ajpendo.00291.2005; Bobbert P, 2011, CYTOKINE; Capone F, 2010, EUR CYTOKINE NETW, V21, P99, DOI 10.1684/ecn.2010.0192; Carvalheira JBC, 2001, FEBS LETT, V500, P119, DOI 10.1016/S0014-5793(01)02591-1; Castello G, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-109; Chao PC, 2010, EUR J NUTR, V49, P429, DOI 10.1007/s00394-010-0101-3; Chen CL, 2008, GASTROENTEROLOGY, V135, P111, DOI 10.1053/j.gastro.2008.03.073; Classen JB, 2011, J PEDIATR ENDOCR MET, V24, P455, DOI 10.1515/JPEM.2011.023; Coma G, 2006, CLIN EXP IMMUNOL, V145, P535, DOI 10.1111/j.1365-2249.2006.03145.x; Costantini S, 2010, BIOINFORMATION, V5, P166, DOI 10.6026/97320630005166; Costantini S, 2010, EUR CYTOKINE NETW, V21, P251, DOI 10.1684/ecn.2010.0214; Costantini S, 2008, BIOINFORMATION, V3, P238, DOI 10.6026/97320630003238; D'Alessio D, 2011, DIABETES OBES METAB, V13, P126, DOI 10.1111/j.1463-1326.2011.01449.x; Divella R, 2008, ANTICANCER RES, V28, P223; Evangelista D, 2010, PEDS, V123, P899; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Fusco M, 2008, EUR J CANCER, V44, P847, DOI 10.1016/j.ejca.2008.01.025; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; Huang JF, 2007, AM J GASTROENTEROL, V102, P1237, DOI 10.1111/j.1572-0241.2007.01181.x; Hui JM, 2003, GASTROENTEROLOGY, V125, P1695, DOI 10.1053/j.gastro.2003.08.032; Hung CH, 2011, INT J CANCER, V128, P2344, DOI 10.1002/ijc.25585; Hung CH, 2009, LIVER INT, V29, P1086, DOI 10.1111/j.1478-3231.2009.01991.x; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kalaitzakis E, 2007, AM J CLIN NUTR, V85, P808, DOI 10.1093/ajcn/85.3.808; Kim ST, 2011, DIABETES METAB J, V35, P41, DOI 10.4093/dmj.2011.35.1.41; Konya H, 2010, METABOLISM, V59, P1294, DOI 10.1016/j.metabol.2009.12.004; KRUSZYNSKA YT, 1995, HEPATOLOGY, V21, P933; Lai MS, 2006, HEPATOLOGY, V43, P1295, DOI 10.1002/hep.21208; Marra F, 2009, HEPATOLOGY, V50, P957, DOI 10.1002/hep.23046; Montoliu C, 2009, J CLIN GASTROENTEROL, V43, P272, DOI 10.1097/MCG.0b013e31815e7f58; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; OSEI K, 1986, J CLIN ENDOCR METAB, V62, P325, DOI 10.1210/jcem-62-2-325; Paradis V, 2009, HEPATOLOGY, V49, P851, DOI 10.1002/hep.22734; Park KS, 2008, AM J OPHTHALMOL, V145, P432, DOI 10.1016/j.ajo.2007.11.011; Raya-Sanchez JM, 1998, ALCOHOL, V15, P19, DOI 10.1016/S0741-8329(97)00082-7; Schuppan D, 2003, CELL DEATH DIFFER, V10, pS59, DOI 10.1038/sj.cdd.4401163; Sharma A, 2009, IMMUNOLOGY, V128, pe514, DOI 10.1111/j.1365-2567.2008.03021.x; Takahara Y, 2008, WORLD J GASTROENTERO, V14, P2010, DOI 10.3748/wjg.14.2010; Thorens B, 1995, DIABETES METAB, V21, P311; Tietge UJF, 2004, AM J PHYSIOL-ENDOC M, V287, pE82, DOI 10.1152/ajpendo.00494.2003; Veldt BJ, 2008, HEPATOLOGY, V47, P1856, DOI 10.1002/hep.22251; Wong CK, 2007, CLIN EXP IMMUNOL, V149, P123, DOI 10.1111/j.1365-2249.2007.03389.x; Yao K, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-50; Yu XY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016239, 10.1371/journal.pone.0028397]	49	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39486	10.1371/journal.pone.0039486	http://dx.doi.org/10.1371/journal.pone.0039486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745767	Green Submitted, Green Published, gold			2022-12-27	WOS:000305693200081
J	Laiolo, P; Obeso, JR				Laiolo, Paola; Ramon Obeso, Jose			Multilevel Selection and Neighbourhood Effects from Individual to Metapopulation in a Wild Passerine	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; SEXUAL SELECTION; INTERACTING PHENOTYPES; SOFT SELECTION; MATE CHOICE; SONG; BIRD; EVOLUTION; POPULATION; REPRODUCTION	Multilevel selection has rarely been studied in the ecological context of animal populations, in which neighbourhood effects range from competition among territorial neighbours to source-sink effects among local populations. By studying a Dupont's lark Chersophilus duponti metapopulation, we analyze neighbourhood effects mediated by song repertoires on fitness components at the individual level (life-span) and population level (growth rate). As a sexual/aggressive signal with strong effects on fitness, birdsong creates an opportunity for group selection via neighbour interactions, but may also have population-wide effects by conveying information on habitat suitability to dispersing individuals. Within populations, we found a disruptive pattern of selection at the individual level and an opposite, stabilizing pattern at the group level. Males singing the most complex songs had the longest life-span, but individuals with the poorest repertoires lived longer than 'average' males, a finding that likely reflects two male strategies with respect to fitness and sexual trait expression. Individuals from groups with intermediate repertoires had the longest life-span, likely benefitting from conspecific signalling to attract females up to the detrimental spread of competitive interactions in groups with superior vocal skills. Within the metapopulation selection was directional but again followed opposite patterns at the two levels: Populations had the highest growth rate when inhabiting local patches with complex repertoires surrounded by patches with simple repertoires. Here the song may impact metapopulation dynamics by guiding prospecting individuals towards populations advertising habitat quality. Two fitness components linked to viability were therefore influenced by the properties of the group, and birdsong was the target of selection, contributing to linking social/sexual processes at the local scale with regional population dynamics.	[Laiolo, Paola; Ramon Obeso, Jose] Univ Oviedo, Res Unit Biodivers, CSIC, UO,PA, Mieres, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo	Laiolo, P (corresponding author), Univ Oviedo, Res Unit Biodivers, CSIC, UO,PA, Mieres, Spain.	paola.laiolo@csic.es	Laiolo, Paola/B-6566-2014; Laiolo, Paola/Q-3747-2019	Laiolo, Paola/0000-0002-2009-6797; Laiolo, Paola/0000-0002-2009-6797; Obeso-Suarez, Jose Ramon/0000-0001-7157-6478	Spanish Ministry of Education and Science [CGL2008-02749]	Spanish Ministry of Education and Science(Spanish Government)	Funding for this study was provided by project CGL2008-02749 of the Spanish Ministry of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspi J, 2003, EVOLUTION, V57, P509; BELL G, 1987, NATURE, V328, P66, DOI 10.1038/328066a0; Bijma P, 2008, J EVOLUTION BIOL, V21, P1175, DOI 10.1111/j.1420-9101.2008.01550.x; Bleay C, 2007, BEHAV ECOL, V18, P304, DOI 10.1093/beheco/arl101; Bolger DT, 2005, OECOLOGIA, V142, P398, DOI 10.1007/s00442-004-1734-9; Clegg SM, 2008, EVOLUTION, V62, P2393, DOI 10.1111/j.1558-5646.2008.00437.x; Collins S., 2004, NATURES MUSIC SCI BI; CRAWFORD TJ, 1984, HEREDITY, V52, P273, DOI 10.1038/hdy.1984.29; Delgado MD, 2011, BIOL REV, V86, P717, DOI 10.1111/j.1469-185X.2010.00167.x; Dibattista JD, 2007, J EVOLUTION BIOL, V20, P201, DOI 10.1111/j.1420-9101.2006.01210.x; Donohue K, 2004, ECOLOGY, V85, P180, DOI 10.1890/02-0767; Fisher RA, 1930, GENETICAL THEORY NAT; Fletcher RJ, 2007, J ANIM ECOL, V76, P598, DOI 10.1111/j.1365-2656.2007.01230.x; Galef B.G., 1976, ADV STUDY BEHAV VOL, V6, P77, DOI DOI 10.1016/S0065-3454(08)60082-0; GOODNIGHT CJ, 1992, AM NAT, V140, P743, DOI 10.1086/285438; Goodnight CJ, 1997, AM NAT, V150, pS59, DOI 10.1086/286050; Hancox D, 2010, ANIM BEHAV, V80, P845, DOI 10.1016/j.anbehav.2010.08.004; HEISLER IL, 1987, AM NAT, V130, P582, DOI 10.1086/284732; Hereford J, 2004, EVOLUTION, V58, P2133; Hutchinson JMC, 2008, IBIS, V150, P90, DOI 10.1111/j.1474-919X.2007.00744.x; Janzen FJ, 2000, ECOLOGY, V81, P2290; Jennions MD, 2001, Q REV BIOL, V76, P3, DOI 10.1086/393743; KINGSOLVER JG, 1995, EVOLUTION, V49, P384, DOI 10.1111/j.1558-5646.1995.tb02252.x; Knape J, 2011, ECOLOGY, V92, P813, DOI 10.1890/10-0183.1; KODRICBROWN A, 1990, BIOL J LINN SOC, V40, P113, DOI 10.1111/j.1095-8312.1990.tb01972.x; Laiolo P, 2008, ANIM CONSERV, V11, P433, DOI 10.1111/j.1469-1795.2008.00202.x; Laiolo P, 2005, J APPL ECOL, V42, P1183, DOI 10.1111/j.1365-2664.2005.01093.x; Laiolo P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001822; Laiolo P, 2007, FRONT ECOL ENVIRON, V5, P68, DOI 10.1890/1540-9295(2007)5[68:EOACIF]2.0.CO;2; Laiolo P, 2007, J AVIAN BIOL, V38, P672, DOI 10.1111/j.2007.0908-8857.04006.x; Laiolo P, 2007, FRONT ECOL ENVIRON, V5, P406, DOI 10.1890/1540-9295(2007)5[406b:TAR]2.0.CO;2; Laiolo P, 2006, ENVIRON CONSERV, V33, P223, DOI 10.1017/S0376892906003146; Laiolo P, 2011, P ROY SOC B-BIOL SCI, V278, P1072, DOI 10.1098/rspb.2010.1653; Laiolo P, 2010, BIOL CONSERV, V143, P1635, DOI 10.1016/j.biocon.2010.03.025; LAMPE HM, 1994, ANIM BEHAV, V47, P869, DOI 10.1006/anbe.1994.1118; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; LINDEN M, 1989, TRENDS ECOL EVOL, V4, P367, DOI 10.1016/0169-5347(89)90101-8; MacDougall-Shackleton SA, 1997, CURR ORNITHOL, V14, P81; Maclean RC, 2008, J EVOLUTION BIOL, V21, P1836, DOI 10.1111/j.1420-9101.2008.01579.x; Marshall RC, 2007, ANIM BEHAV, V73, P629, DOI 10.1016/j.anbehav.2006.06.011; McGlothlin JW, 2010, EVOLUTION, V64, P2558, DOI 10.1111/j.1558-5646.2010.01012.x; Mendez M, 2011, BIOL CONSERV, V144, P2615, DOI 10.1016/j.biocon.2011.07.011; Moeller DA, 2004, ECOLOGY, V85, P3289, DOI 10.1890/03-0810; Moller AP, 1999, J ANIM ECOL, V68, P163, DOI 10.1046/j.1365-2656.1999.00274.x; MOLLER AP, 1992, ETHOLOGY, V90, P315; Nichols J., 2001, DISPERSAL; Nowicki S, 2004, ANN NY ACAD SCI, V1016, P704, DOI 10.1196/annals.1298.012; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Olivieri I, 1995, TRENDS ECOL EVOL, V5, P2007; Olivieri Isabelle, 1997, P293, DOI 10.1016/B978-012323445-2/50017-1; R Core Team, 2020, R LANG ENV STAT COMP; Rankin DJ, 2005, OIKOS, V111, P616; READ AF, 1992, PHILOS T R SOC B, V338, P165, DOI 10.1098/rstb.1992.0137; Reid JM, 2005, AM NAT, V165, P299, DOI 10.1086/428299; Richardson C, 2010, P ROY SOC B-BIOL SCI, V277, P1247, DOI 10.1098/rspb.2009.1836; Ronce Ophelie, 2004, P227, DOI 10.1016/B978-012323448-3/50012-X; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; Saccheri I, 2006, TRENDS ECOL EVOL, V21, P341, DOI 10.1016/j.tree.2006.03.018; Sanchez AM, 2004, BIRD STUDY, V51, P278, DOI 10.1080/00063650409461364; Seehausen O, 1998, BEHAV ECOL SOCIOBIOL, V42, P1, DOI 10.1007/s002650050405; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; Soma M, 2011, BEHAV ECOL, V22, P363, DOI 10.1093/beheco/arq219; Stelkens RB, 2008, PHILOS T R SOC B, V363, P2861, DOI 10.1098/rstb.2008.0049; Tieleman BI, 2003, FUNCT ECOL, V17, P869, DOI 10.1046/j.0269-8463.2003.00801.x; Vogeli M, 2011, BIOL LETTERS, V7, P954, DOI 10.1098/rsbl.2011.0241; Vogeli M, 2010, BIOL CONSERV, V143, P1057, DOI 10.1016/j.biocon.2009.12.040; Vogeli M, 2008, OIKOS, V117, P1816, DOI 10.1111/j.1600-0706.2008.17225.x; WADE MJ, 1977, EVOLUTION, V31, P134, DOI 10.1111/j.1558-5646.1977.tb00991.x; WALLACE B, 1975, EVOLUTION, V29, P465, DOI [10.2307/2407259, 10.1111/j.1558-5646.1975.tb00836.x]; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; Williams JB, 2005, BIOSCIENCE, V55, P416, DOI 10.1641/0006-3568(2005)055[0416:PAIDB]2.0.CO;2; Wolf JB, 1999, AM NAT, V153, P254, DOI 10.1086/303168; Yanes M, 1996, CONSERV BIOL, V10, P881, DOI 10.1046/j.1523-1739.1996.10030881.x	73	17	17	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38526	10.1371/journal.pone.0038526	http://dx.doi.org/10.1371/journal.pone.0038526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745665	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693200012
J	Aabye, MG; Eugen-Olsen, J; Werlinrud, AM; Holm, LL; Tuuminen, T; Ravn, P; Ruhwald, M				Aabye, Martine G.; Eugen-Olsen, Jesper; Werlinrud, Anne Marie; Holm, Line Lindebo; Tuuminen, Tamara; Ravn, Pernille; Ruhwald, Morten			A Simple Method to Quantitate IP-10 in Dried Blood and Plasma Spots	PLOS ONE			English	Article							GAMMA-INDUCIBLE PROTEIN-10; T-CELL RESPONSES; TUBERCULOSIS INFECTION; INTERFERON-GAMMA; WHOLE-BLOOD; IFN-GAMMA; INFLAMMATORY MARKERS; CXC CHEMOKINES; FILTER-PAPER; RELEASE	Background: Antigen specific release of IP-10 is an established marker for infection with M. tuberculosis. Compared to IFN-gamma, IP-10 is released in 100-fold higher concentrations enabling the development of novel assays for detection. Dried blood spots are a convenient sample for high throughput newborn screening. Aim: To develop a robust and sensitive ELISA-based assay for IP-10 detection in plasma, dried blood spots (DBS) and dried plasma spots (DPS); to validate the ELISA in clinically relevant samples; and to assess the performance of the assay for detection of Cytomegalovirus (CMV) and M. tuberculosis specific immune responses. Method: We raised mice and rat monoclonal antibodies against human IP-10 and developed an ELISA. The assay was validated and applied to the detection of CMV and M. tuberculosis specific responses in 18 patients with immune reactivity towards M. tuberculosis and 32 healthy controls of which 22 had immune reactivity towards CMV and none towards M. tuberculosis. We compared the performance of this new assay to IFN-gamma. Results: The ELISA was reliable for IP-10 detection in both plasma and filter paper samples. The linear range of the ELISA was 2.5-600 pg/ml. IFN-gamma was not readily detectable in DPS samples. IP-10 was stabile in filter paper samples for at least 4 weeks at 37 degrees C. The correlation between IP-10 detected in plasma, DPS and DBS samples was excellent (r(2)>0.97). Conclusions: This newly developed assay is reliable for IP-10 quantification in plasma, DBS and DPS samples from antigen stimulated and non-stimulated whole blood. The filter paper assays enable easy sample acquisition and transport at ambient temperature e.g. via the postal system. The system can potentially simplify diagnostic assays for M. tuberculosis and CMV infection.	[Aabye, Martine G.; Eugen-Olsen, Jesper; Holm, Line Lindebo; Ravn, Pernille; Ruhwald, Morten] Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark; [Werlinrud, Anne Marie] Herlev Univ Hosp, Dept Internal Med, Infect Dis Unit, Copenhagen, Denmark; [Tuuminen, Tamara] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Ravn, Pernille] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark	University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Helsinki; University of Southern Denmark; Odense University Hospital	Aabye, MG (corresponding author), Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark.	mruhwald@gmail.com	Ruhwald, Morten/E-5757-2012; Tuuminen, Tamara/AAF-9723-2020	Eugen-Olsen, Jesper/0000-0002-4630-4275	Danish National Advanced Technology Foundation; Capital Region of Copenhagen; Danish Lung Association; Copenhagen University; Danish Ministry of Science and Innovation; Clinical Research Centre at Hvidovre Hospital; Lundbeck-Foundation (Denmark)	Danish National Advanced Technology Foundation; Capital Region of Copenhagen; Danish Lung Association; Copenhagen University; Danish Ministry of Science and Innovation; Clinical Research Centre at Hvidovre Hospital; Lundbeck-Foundation (Denmark)(Lundbeckfonden)	This work was supported by the Danish National Advanced Technology Foundation, Capital Region of Copenhagen, The Danish Lung Association, Copenhagen University, The Danish Ministry of Science and Innovation, The Clinical Research Centre at Hvidovre Hospital, and The Lundbeck-Foundation (Denmark). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabye MG, 2010, EUR RESPIR J, V36, P1488, DOI 10.1183/09031936.00039010; Aabye MG, 2011, CLIN VACCINE IMMUNOL; Alsleben N, 2012, SCAND J INFECT DIS, V44, P256, DOI 10.3109/00365548.2011.632644; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Cannas A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-333; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Chen DY, 2011, INT J TUBERC LUNG D, V15, P192; Chen YC, 2011, DIS MARKERS, V31, P101, DOI [10.3233/DMA-2011-0808, 10.1155/2011/938794]; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; de Steenwinkel JEM, 2011, EUR J CLIN MICROBIOL; Eising S, 2007, PAEDIATR PERINAT EP, V21, P507, DOI 10.1111/j.1365-3016.2007.00846.x; Eloranta ML, 2010, ANN RHEUM DIS, V69, P1396, DOI 10.1136/ard.2009.121400; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Frahm M, 2011, TUBERCULOSIS EDINB; Groom JR, 2011, IMMUNOL CELL BIOL; Guzzo C, 2010, J BIOL CHEM, V285, P24404, DOI 10.1074/jbc.M110.112599; Hamers RL, 2009, ANTIVIR THER, V14, P619; Hasan Z, 2012, SCAND J IMMUNOL, V75, P220, DOI 10.1111/j.1365-3083.2011.02642.x; Kabeer BSA, 2010, AIDS, V24, P323, DOI 10.1097/QAD.0b013e328334895e; Kabeer BSA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-135; Karonitsch T, 2011, ARTHRITIS RHEUMATISM; Kasprowicz VO, 2012, BIOMARK MED, V6, P177, DOI 10.2217/BMM.12.13; Kasprowicz VO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020606; Kellar KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026545; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; KROUWER JS, 1984, CLIN CHEM, V30, P290; Lee JW, 2006, PHARM RES, V23, P312, DOI 10.1007/s11095-005-9045-3; Levy HL, 2010, GENET MED, V12, pS213, DOI 10.1097/GIM.0b013e3181fe5d77; Levy PA, 2010, J DEV BEHAV PEDIATR, V31, P622, DOI 10.1097/DBP.0b013e3181eedf01; Lighter J, 2009, INT J TUBERC LUNG D, V13, P731; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Maritz J, 2012, J CLIN VIROL, V53, P106, DOI 10.1016/j.jcv.2011.12.002; Mcdade TW, 2007, DEMOGRAPHY, V44, P899, DOI 10.1353/dem.2007.0038; Mei JV, 2010, BIOANALYSIS, V2, P1397, DOI 10.4155/BIO.10.73; Mei JV, 2001, J NUTR, V131, p1631S, DOI 10.1093/jn/131.5.1631S; Monleau M, 2010, J ANTIMICROB CHEMOTH, V65, P1562, DOI 10.1093/jac/dkq205; NARUMI S, 1990, J BIOL CHEM, V265, P7036; Nie CQ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000369; OHMORI Y, 1993, AM J PATHOL, V142, P861; Qi XF, 2009, J CELL PHYSIOL, V220, P690, DOI 10.1002/jcp.21815; Qian C, 2007, BLOOD, V109, P3308, DOI 10.1182/blood-2006-08-040337; Riou C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036886; Rudner XL, 2007, INFECT IMMUN, V75, P3055, DOI 10.1128/IAI.01329-06; Ruhwald M, 2007, MICROBES INFECT, V9, P806, DOI 10.1016/j.micinf.2007.02.021; Ruhwald M, 2012, EXPERT REV MOL DIAGN, V12, P175, DOI [10.1586/ERM.11.97, 10.1586/erm.11.97]; Ruhwald Morten, 2009, BMC Res Notes, V2, P19, DOI 10.1186/1756-0500-2-19; Sauty A, 1999, J IMMUNOL, V162, P3549; Skogstrand K, 2005, CLIN CHEM, V51, P1854, DOI 10.1373/clinchem.2005.052241; Skogstrand K, 2011, METHODS; Skogstrand K, 2008, J IMMUNOL METHODS, V336, P78, DOI 10.1016/j.jim.2008.04.006; Skogstrand K, 2012, SCAND J CLIN LAB INV, V72, P204, DOI 10.3109/00365513.2011.649014; Snijdewind IJM, 2012, ANTIVIRAL RES; Sutherland JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012365; Vanini V, 2012, J INFECT; Vu DH, 2011, CURR PHARM DESIGN, V17, P2931, DOI 10.2174/138161211797470174; Walker S, 2007, TRANSPL INFECT DIS, V9, P165, DOI 10.1111/j.1399-3062.2006.00199.x; Zeremski M, 2007, J VIRAL HEPATITIS, V14, P675, DOI 10.1111/j.1365-2893.2006.00838.x; Zeremski M, 2011, J HEPATOL; Zeremski M, 2011, J INFECT DIS, V204, P832, DOI 10.1093/infdis/jir424	59	37	37	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39228	10.1371/journal.pone.0039228	http://dx.doi.org/10.1371/journal.pone.0039228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761744	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800025
J	de Jong, S; Boks, MPM; Fuller, TF; Strengman, E; Janson, E; de Kovel, CGF; Ori, APS; Vi, N; Mulder, F; Blom, JD; Glenthoj, B; Schubart, CD; Cahn, W; Kahn, RS; Horvath, S; Ophoff, RA				de Jong, Simone; Boks, Marco P. M.; Fuller, Tova F.; Strengman, Eric; Janson, Esther; de Kovel, Carolien G. F.; Ori, Anil P. S.; Vi, Nancy; Mulder, Flip; Blom, Jan Dirk; Glenthoj, Birte; Schubart, Chris D.; Cahn, Wiepke; Kahn, Rene S.; Horvath, Steve; Ophoff, Roel A.			A Gene Co-Expression Network in Whole Blood of Schizophrenia Patients Is Independent of Antipsychotic-Use and Enriched for Brain-Expressed Genes	PLOS ONE			English	Article							MYELINATION-RELATED GENES; 22Q11.2 DELETION SYNDROME; GENOME-WIDE ASSOCIATION; PSYCHIATRIC-DISORDERS; PERIPHERAL-BLOOD; BIPOLAR DISORDER; PREFRONTAL CORTEX; CHROMOSOME 22Q11; COMPLEX DISEASES; PATHWAY ANALYSIS	Despite large-scale genome-wide association studies (GWAS), the underlying genes for schizophrenia are largely unknown. Additional approaches are therefore required to identify the genetic background of this disorder. Here we report findings from a large gene expression study in peripheral blood of schizophrenia patients and controls. We applied a systems biology approach to genome-wide expression data from whole blood of 92 medicated and 29 antipsychotic-free schizophrenia patients and 118 healthy controls. We show that gene expression profiling in whole blood can identify twelve large gene co-expression modules associated with schizophrenia. Several of these disease related modules are likely to reflect expression changes due to antipsychotic medication. However, two of the disease modules could be replicated in an independent second data set involving antipsychotic-free patients and controls. One of these robustly defined disease modules is significantly enriched with brain-expressed genes and with genetic variants that were implicated in a GWAS study, which could imply a causal role in schizophrenia etiology. The most highly connected intramodular hub gene in this module (ABCF1), is located in, and regulated by the major histocompatibility (MHC) complex, which is intriguing in light of the fact that common allelic variants from the MHC region have been implicated in schizophrenia. This suggests that the MHC increases schizophrenia susceptibility via altered gene expression of regulatory genes in this network.	[de Jong, Simone; Strengman, Eric; Ori, Anil P. S.; Vi, Nancy; Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [de Jong, Simone; Strengman, Eric; Janson, Esther; de Kovel, Carolien G. F.; Mulder, Flip] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [de Jong, Simone; Boks, Marco P. M.; Schubart, Chris D.; Cahn, Wiepke; Kahn, Rene S.; Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Boks, Marco P. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Fuller, Tova F.; Horvath, Steve; Ophoff, Roel A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Blom, Jan Dirk] Parnassia Bravo Grp, The Hague, Netherlands; [Blom, Jan Dirk] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Glenthoj, Birte] Univ Copenhagen, Psychiat Univ Ctr Glostrup, Ctr Clin Intervent & Neuropsychiat Schizophrenia, Glostrup, Denmark; [Horvath, Steve] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Parnassia Psychiatric Institute; University of Groningen; University of Copenhagen; University of California System; University of California Los Angeles	de Jong, S (corresponding author), Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA.	ROphoff@mednet.ucla.edu	Fuller, Tova/GVU-2066-2022; de Kovel, Carolien/AAI-3531-2021; Glenthøj, Birte Y/G-3391-2012; Cahn, W/B-5743-2013	de Kovel, Carolien/0000-0002-7818-1396; Glenthoj, Birte/0000-0003-3056-7262; de Jong, Simone/0000-0002-8002-7195; Boks, Marco/0000-0001-6163-7484; Ori, Anil/0000-0003-0579-0905	TI-pharma project [T5-203]; U.S. National Institutes of Health [MH078075, NS058980]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058980] Funding Source: NIH RePORTER	TI-pharma project; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by TI-pharma project T5-203 and funding from the U.S. National Institutes of Health MH078075 and NS058980 (RAO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arion D, 2007, BIOL PSYCHIAT, V62, P711, DOI 10.1016/j.biopsych.2006.12.021; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Bousman CA, 2010, AM J MED GENET B, V153B, P1336, DOI 10.1002/ajmg.b.31106; Bousman CA, 2010, AM J MED GENET B, V153B, P494, DOI 10.1002/ajmg.b.31006; Bowden NA, 2006, SCHIZOPHR RES, V82, P175, DOI 10.1016/j.schres.2005.11.012; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cai CC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-589; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Fan JB, 2005, BIOL PSYCHIAT, V57, P139, DOI 10.1016/j.biopsych.2004.10.018; Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbp.2004.01.009; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; Glatt SJ, 2003, AM J PSYCHIAT, V160, P469, DOI 10.1176/appi.ajp.160.3.469; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Inouye M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001113; Iwamoto K, 2004, MOL PSYCHIATR, V9, P406, DOI 10.1038/sj.mp.4001437; Jasinska AJ, 2009, HUM MOL GENET, V18, P4415, DOI 10.1093/hmg/ddp397; Jungerius BJ, 2008, MOL PSYCHIATR, V13, P1060, DOI 10.1038/sj.mp.4002080; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Konradi C, 2005, BRAIN RES REV, V50, P142, DOI 10.1016/j.brainresrev.2005.05.004; Kurian SM, MOL PSYCHIAT, V16, P37; Kuzman MR, 2009, J PSYCHIATR RES, V43, P1073, DOI 10.1016/j.jpsychires.2009.03.005; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Li T, 2000, MOL PSYCHIATR, V5, P77, DOI 10.1038/sj.mp.4000638; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Maycox PR, 2009, MOL PSYCHIATR, V14, P1083, DOI 10.1038/mp.2009.18; McCullumsmith RE, 2007, SCHIZOPHR RES, V90, P15, DOI 10.1016/j.schres.2006.11.017; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Mitkus SN, 2008, SCHIZOPHR RES, V98, P129, DOI 10.1016/j.schres.2007.09.032; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nica AC, 2008, HUM MOL GENET, V17, pR129, DOI 10.1093/hmg/ddn285; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Okochi T, 2009, SCHIZOPHR RES, V110, P140, DOI 10.1016/j.schres.2009.02.019; Oldham MC, 2011, SAMPLE NETWORKS ENHA; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Prasad SE, 2008, DEV DISABIL RES REV, V14, P26, DOI 10.1002/ddrr.5; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rollins B, 2010, AM J MED GENET B, V153B, P919, DOI 10.1002/ajmg.b.31062; Rosen EY, 2011, NEURON, V71, P1030, DOI 10.1016/j.neuron.2011.07.021; Saba LM, 2011, NEUROPHARMACOLOGY, V60, P1269, DOI 10.1016/j.neuropharm.2010.12.019; Saito T, 2003, AM J MED GENET B, V116B, P77, DOI 10.1002/ajmg.b.10042; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Takahashi M, 2010, SCHIZOPHR RES, V119, P210, DOI 10.1016/j.schres.2009.12.024; Torkamani A, 2010, GENOME RES, V20, P403, DOI 10.1101/gr.101956.109; Tsuang MT, 2005, AM J MED GENET B, V133B, P1, DOI 10.1002/ajmg.b.30161; Vawter MP, 2004, SCHIZOPHR RES, V67, P41, DOI 10.1016/S0920-9964(03)00151-8; Venables WN, 2002, MODERN APPPLIED STAT; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Vorstman JAS, 2009, AM J MED GENET B, V150B, P430, DOI 10.1002/ajmg.b.30827; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yao YR, 2008, J PSYCHIATR RES, V42, P639, DOI 10.1016/j.jpsychires.2007.07.011; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	69	89	90	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39498	10.1371/journal.pone.0039498	http://dx.doi.org/10.1371/journal.pone.0039498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761806	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800038
J	Claerhout, S; Dutta, B; Bossuyt, W; Zhang, F; Nguyen-Charles, C; Dennison, JB; Yu, QH; Yu, SX; Balazsi, G; Lu, YL; Mills, GB				Claerhout, Sofie; Dutta, Bhaskar; Bossuyt, Wouter; Zhang, Fan; Nguyen-Charles, Catherine; Dennison, Jennifer B.; Yu, Qinghua; Yu, Shuangxing; Balazsi, Gabor; Lu, Yiling; Mills, Gordon B.			Abortive Autophagy Induces Endoplasmic Reticulum Stress and Cell Death in Cancer Cells	PLOS ONE			English	Article							PHASE PROTEIN ARRAY; MAMMALIAN-CELLS; OVARIAN CANCERS; GENE-EXPRESSION; BETA-COP; COATOMER; GOLGI; TRANSPORT; APOPTOSIS; OVEREXPRESSION	Autophagic cell death or abortive autophagy has been proposed to eliminate damaged as well as cancer cells, but there remains a critical gap in our knowledge in how this process is regulated. The goal of this study was to identify modulators of the autophagic cell death pathway and elucidate their effects on cellular signaling and function. The result of our siRNA library screenings show that an intact coatomer complex I (COPI) is obligatory for productive autophagy. Depletion of COPI complex members decreased cell survival and impaired productive autophagy which preceded endoplasmic reticulum stress. Further, abortive autophagy provoked by COPI depletion significantly altered growth factor signaling in multiple cancer cell lines. Finally, we show that COPI complex members are overexpressed in an array of cancer cell lines and several types of cancer tissues as compared to normal cell lines or tissues. In cancer tissues, overexpression of COPI members is associated with poor prognosis. Our results demonstrate that the coatomer complex is essential for productive autophagy and cellular survival, and thus inhibition of COPI members may promote cell death of cancer cells when apoptosis is compromised.	[Claerhout, Sofie; Dutta, Bhaskar; Zhang, Fan; Nguyen-Charles, Catherine; Dennison, Jennifer B.; Yu, Qinghua; Yu, Shuangxing; Balazsi, Gabor; Lu, Yiling; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Bossuyt, Wouter] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Claerhout, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	SAClaerhout@mdanderson.org		Claerhout, Sofie/0000-0003-0857-0211; Balazsi, Gabor/0000-0002-6865-5818	Komen Foundation [KG 081694, FAS0703849]; Cancer Prevention and Research Institute of Texas; Ovarian Cancer Research Fund; MD Anderson Cancer Center [CA016672]; Odyssey Program; Theodore N. Law Endowment for Scientific Achievement at The University of Texas MD Anderson Cancer Center; MD Anderson GlaxoSmithKline TRIUMPH fellowship program; National Institutes of Health siRNA consortium for therapeutics; NATIONAL CANCER INSTITUTE [P50CA098258, P30CA016672] Funding Source: NIH RePORTER	Komen Foundation(Susan G. Komen Breast Cancer Foundation); Cancer Prevention and Research Institute of Texas; Ovarian Cancer Research Fund; MD Anderson Cancer Center; Odyssey Program; Theodore N. Law Endowment for Scientific Achievement at The University of Texas MD Anderson Cancer Center; MD Anderson GlaxoSmithKline TRIUMPH fellowship program; National Institutes of Health siRNA consortium for therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by grants from the Komen Foundation (KG 081694 and FAS0703849), the Cancer Prevention and Research Institute of Texas, and Ovarian Cancer Research Fund to GBM, and by the MD Anderson Cancer Center Support Grant CA016672. SC is supported by the Odyssey Program and the Theodore N. Law Endowment for Scientific Achievement at The University of Texas MD Anderson Cancer Center. JBD is supported by the MD Anderson GlaxoSmithKline TRIUMPH fellowship program and BD by National Institutes of Health siRNA consortium for therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Beck R, 2009, TRAFFIC, V10, P307, DOI 10.1111/j.1600-0854.2008.00865.x; Berchuck A, 2005, CLIN CANCER RES, V11, P3686, DOI 10.1158/1078-0432.CCR-04-2398; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Claerhout S., 2010, INT J CANC; Duden R, 1998, EMBO J, V17, P985, DOI 10.1093/emboj/17.4.985; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Erdogan E, 2009, CLIN CANCER RES, V15, P1527, DOI 10.1158/1078-0432.CCR-08-2459; Fernandez PM, 2000, BREAST CANCER RES TR, V59, P15, DOI 10.1023/A:1006332011207; Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396; Gaynor EC, 1998, BBA-MOL CELL RES, V1404, P33, DOI 10.1016/S0167-4889(98)00045-7; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Langer JD, 2008, TRAFFIC, V9, P597, DOI 10.1111/j.1600-0854.2007.00697.x; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Li L, 2010, J BIOL CHEM, V285, P19705, DOI 10.1074/jbc.C110.102483; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lindquist RA, 2011, GENOME RES, V21, P433, DOI 10.1101/gr.111492.110; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moelleken J, 2007, P NATL ACAD SCI USA, V104, P4425, DOI 10.1073/pnas.0611360104; Nanjundan M, 2008, MOL ONCOL, V2, P164, DOI 10.1016/j.molonc.2008.05.001; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; PETER F, 1993, J CELL BIOL, V122, P1155, DOI 10.1083/jcb.122.6.1155; Platini F, 2010, CURR PHARM DESIGN, V16, P101, DOI 10.2174/138161210789941810; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Romano P, 2009, NUCLEIC ACIDS RES, V37, pD925, DOI 10.1093/nar/gkn730; Roy S, 2010, SEMIN IMMUNOPATHOL, V32, P383, DOI 10.1007/s00281-010-0213-0; Schleicher SM, 2010, DRUG RESIST UPDATE, V13, P79, DOI 10.1016/j.drup.2010.04.002; Schonthal AH, 2009, CANCER LETT, V275, P163, DOI 10.1016/j.canlet.2008.07.005; Shy G, 2001, J EXP BOT, V52, P2387, DOI 10.1093/jexbot/52.365.2387; Sudo H, 2010, GENOMICS, V95, P210, DOI 10.1016/j.ygeno.2010.02.002; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Van Cruchten S, 2002, ANAT HISTOL EMBRYOL, V31, P214, DOI 10.1046/j.1439-0264.2002.00398.x; van der Vaart A, 2010, MOL BIOL CELL, V21, P2270, DOI 10.1091/mbc.E09-04-0345; Wegmann D, 2004, MOL CELL BIOL, V24, P1070, DOI 10.1128/MCB.24.3.1070-1080.2004; Wojtkowiak JW, 2011, J PHARMACOL EXP THER, V337, P65, DOI 10.1124/jpet.110.174573; Xu ZX, 2007, CELL DEATH DIFFER, V14, P1948, DOI 10.1038/sj.cdd.4402207; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang L, 2009, BIOINFORMATICS, V25, P650, DOI 10.1093/bioinformatics/btn663	60	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39400	10.1371/journal.pone.0039400	http://dx.doi.org/10.1371/journal.pone.0039400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22745748	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000305808700025
J	Weitz, S; Blanco, S; Fournier, R; Gautrais, J; Jost, C; Theraulaz, G				Weitz, Sebastian; Blanco, Stephane; Fournier, Richard; Gautrais, Jacques; Jost, Christian; Theraulaz, Guy			Modeling Collective Animal Behavior with a Cognitive Perspective: A Methodological Framework	PLOS ONE			English	Article							DIVISION-OF-LABOR; SELF-ORGANIZATION; NEST CONSTRUCTION; WASTE MANAGEMENT; SPATIAL-PATTERNS; ANTS; AGGREGATION; HIERARCHIES; SIMULATION; SOCIETIES	The last decades have seen an increasing interest in modeling collective animal behavior. Some studies try to reproduce as accurately as possible the collective dynamics and patterns observed in several animal groups with biologically plausible, individual behavioral rules. The objective is then essentially to demonstrate that the observed collective features may be the result of self-organizing processes involving quite simple individual behaviors. Other studies concentrate on the objective of establishing or enriching links between collective behavior researches and cognitive or physiological ones, which then requires that each individual rule be carefully validated. Here we discuss the methodological consequences of this additional requirement. Using the example of corpse clustering in ants, we first illustrate that it may be impossible to discriminate among alternative individual rules by considering only observational data collected at the group level. Six individual behavioral models are described: They are clearly distinct in terms of individual behaviors, they all reproduce satisfactorily the collective dynamics and distribution patterns observed in experiments, and we show theoretically that it is strictly impossible to discriminate two of these models even in the limit of an infinite amount of data whatever the accuracy level. A set of methodological steps are then listed and discussed as practical ways to partially overcome this problem. They involve complementary experimental protocols specifically designed to address the behavioral rules successively, conserving group-level data for the overall model validation. In this context, we highlight the importance of maintaining a sharp distinction between model enunciation, with explicit references to validated biological concepts, and formal translation of these concepts in terms of quantitative state variables and fittable functional dependences. Illustrative examples are provided of the benefits expected during the often long and difficult process of refining a behavioral model, designing adapted experimental protocols and inversing model parameters.	[Weitz, Sebastian; Blanco, Stephane; Fournier, Richard] Univ Toulouse, UPS INPT, INPT, LAPLACE Lab Plasma & Convers Energie, Toulouse, France; [Weitz, Sebastian; Blanco, Stephane; Fournier, Richard] CNRS, LAPLACE, Toulouse, France; [Gautrais, Jacques; Jost, Christian; Theraulaz, Guy] Univ Toulouse 3, Ctr Rech Cognit Anim, CNRS, UMR 5169, F-31062 Toulouse, France	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Weitz, S (corresponding author), Univ Toulouse, UPS INPT, INPT, LAPLACE Lab Plasma & Convers Energie, Toulouse, France.	weitz@laplace.univ-tlse.fr	Theraulaz, Guy/H-8464-2016; Gautrais, Jacques/B-4523-2008	Theraulaz, Guy/0000-0002-3062-4215; Gautrais, Jacques/0000-0002-7002-9920; Jost, Christian/0000-0003-3121-3001	French Ministry of Education, Research and Technology	French Ministry of Education, Research and Technology	SW is supported by a research grant from the French Ministry of Education, Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksiev AS, 2007, ANIM BEHAV, V74, P559, DOI 10.1016/j.anbehav.2006.12.019; Anderson C, 2002, BIOL BULL-US, V202, P247, DOI 10.2307/1543475; [Anonymous], 1971, INSECT SOC; AOKI I, 1982, B JPN SOC SCI FISH, V48, P1081; Ball P., 2004, CRITICAL MASS ONE TH; Ballari S, 2007, J INSECT BEHAV, V20, P87, DOI 10.1007/s10905-006-9065-9; Ben-Jacob E, 2003, PHILOS T R SOC A, V361, P1283, DOI 10.1098/rsta.2003.1199; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; Bonabeau E, 1998, PHILOS T R SOC B, V353, P1561, DOI 10.1098/rstb.1998.0310; Bonabeau E, 1999, B MATH BIOL, V61, P727, DOI 10.1006/bulm.1999.0108; Bonabeau E, 1996, B MATH BIOL, V58, P661, DOI 10.1007/BF02459478; Bonabeau E, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P141; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Buhl J, 2005, BEHAV ECOL SOCIOBIOL, V58, P9, DOI 10.1007/s00265-004-0906-2; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Conradt L, 2000, P ROY SOC B-BIOL SCI, V267, P2213, DOI 10.1098/rspb.2000.1271; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Crosland MWJ, 1997, ANIM BEHAV, V54, P999, DOI 10.1006/anbe.1997.0509; Deneubourg J.-L., 1991, P 1 INT C SIM AD BEH, P356; Diez L, 2011, ANIM BEHAV, V81, P1171, DOI 10.1016/j.anbehav.2011.02.026; Dornhaus A, 2008, PLOS BIOL, V6, P2368, DOI 10.1371/journal.pbio.0060285; Dufresne JL, 1999, J QUANT SPECTROSC RA, V61, P433, DOI 10.1016/S0022-4073(97)00214-8; Dussutour A, 2004, NATURE, V428, P70, DOI 10.1038/nature02345; Eckstein MP, 2012, NEUROIMAGE, V59, P94, DOI 10.1016/j.neuroimage.2011.07.009; EMLEN J. T., 1952, AUK, V69, P160; FRANKS NR, 1992, BEHAV ECOL SOCIOBIOL, V30, P109; Franks NR, 1997, ANIM BEHAV, V54, P779, DOI 10.1006/anbe.1996.0496; Garnier Simon, 2007, Swarm Intelligence, V1, P3, DOI 10.1007/s11721-007-0004-y; Gautrais J, 2009, J MATH BIOL, V58, P429, DOI 10.1007/s00285-008-0198-7; Gautrais J, 2007, ANIM BEHAV, V74, P1443, DOI 10.1016/j.anbehav.2007.02.020; Giardina I, 2008, HFSP J, V2, P205, DOI 10.2976/1.2961038; Goldenfeld N., 1992, LECT PHASE TRANSITIO, DOI DOI 10.1201/9780429493492; Gorb E, 2000, ECOL RES, V15, P187, DOI 10.1046/j.1440-1703.2000.00338.x; GRAD H, 1963, PHYS FLUIDS, V6, P147, DOI 10.1063/1.1706716; Grasse P. P., 1959, Insectes Sociaux Paris, V6, P41, DOI 10.1007/BF02223791; Haccou P., 1992, STAT ANAL BEHAV DATA; Hart AG, 2000, ANIM BEHAV, V59, P587, DOI 10.1006/anbe.1999.1332; HEILIGENBERG W, 1991, ANNU REV NEUROSCI, V14, P247; Holldobler B., 1990, pi; Hughes WOH, 2003, P NATL ACAD SCI USA, V100, P9394, DOI 10.1073/pnas.1633701100; HUTH A, 1992, J THEOR BIOL, V156, P365, DOI 10.1016/S0022-5193(05)80681-2; Jeanson R, 2005, ANIM BEHAV, V69, P169, DOI 10.1016/j.anbehav.2004.02.009; Johnson BR, 2010, BEHAV ECOL SOCIOBIOL, V64, P305, DOI 10.1007/s00265-009-0874-7; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; Martin M, 2002, FUTURE GENER COMP SY, V18, P951, DOI 10.1016/S0167-739X(02)00074-2; Moussaid M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002442; Moussaid M, 2011, P NATL ACAD SCI USA, V108, P6884, DOI 10.1073/pnas.1016507108; Moussaid M, 2009, TOP COGN SCI, V1, P469, DOI 10.1111/j.1756-8765.2009.01028.x; Moussaid M, 2009, P ROY SOC B-BIOL SCI, V276, P2755, DOI 10.1098/rspb.2009.0405; Oster G.F., 1978, Monographs in Population Biology, pi; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Pillot MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014487; Radakov D. V., 1973, SCH ECOLOGY FISH; Ravary F, 2007, CURR BIOL, V17, P1308, DOI 10.1016/j.cub.2007.06.047; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Theraulaz G, 2003, PHILOS T R SOC A, V361, P1263, DOI 10.1098/rsta.2003.1198; Theraulaz G, 2002, P NATL ACAD SCI USA, V99, P9645, DOI 10.1073/pnas.152302199; THERAULAZ G, 1995, J THEOR BIOL, V174, P313, DOI 10.1006/jtbi.1995.0101; Toner J, 1998, PHYS REV E, V58, P4828, DOI 10.1103/PhysRevE.58.4828; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Waddington SJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P1219, DOI 10.1007/s00265-010-0936-x; Weidenmuller A, 2004, BEHAV ECOL, V15, P120, DOI 10.1093/beheco/arg101; WILSON EO, 1985, SCIENCE, V228, P1489, DOI 10.1126/science.228.4707.1489; WILSON EO, 1987, J ANIM ECOL, V56, P1, DOI 10.2307/4795	72	29	30	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e38588	10.1371/journal.pone.0038588	http://dx.doi.org/10.1371/journal.pone.0038588			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761685	Green Published, Green Submitted, gold			2022-12-27	WOS:000305808700005
J	Chien, LC; Wu, JC; Chen, YC; Liu, L; Huang, WC; Chen, TJ; Thien, PF; Lo, SS; Cheng, H				Chien, Li-Chien; Wu, Jau-Ching; Chen, Yu-Chun; Liu, Laura; Huang, Wen-Cheng; Chen, Tzeng-Ji; Thien, Peck-Foong; Lo, Su-Shun; Cheng, Henrich			Age, Sex, and Socio-Economic Status Affect the Incidence of Pediatric Spinal Cord Injury: An Eleven-Year National Cohort Study	PLOS ONE			English	Article							LONG-TERM SURVIVAL; RADIOGRAPHIC ABNORMALITY; CHILDREN; TRAUMA; POPULATION; FEATURES; DEATH	Background: Few studies focus on pediatric spinal cord injury (SCI) and there is little information regarding the cause, anatomic level, and high risk population of SCI in children. This study aims to investigate the incidence and risk factors of pediatric SCI. Methods: A nationwide cohort of 8.7 million children aged<18 years in an 11-year period was analyzed for causes, age at injury, anatomic sites, disability, and familial socio-economic factors. Incidence rates and Cox regression analysis were conducted. Results: A total of 4949 SCI patients were analyzed. The incidence rates of cervical, thoracic, lumbar, and other SCI were 4.06, 0.34, 0.75, and 0.85 per 100,000 person-years, respectively. The proportional composition of gender, age, and socioeconomic status of SCI patients were significantly different than those of non-SCI patients (all p<0.001). Male children were significantly more likely to have SCI than females in both the cervical and the other SCI groups [Incidence rate ratio (IRR) = 2.03 and 1.52; both p<0.001]. Young adults and teenagers were also significantly more likely to have SCI than preschool age children in the cervical SCI (IRR = 28.55 and 10.50, both p<0.001) and other SCI groups (IRR = 18.8 and 7.47, both p<0.001). Children in families of lower socio-economic status were also significantly more likely to have SCI (p<0.05). Conclusions: In the pediatric population, the overall SCI incidence rate is 5.99 per 100,000 person-years, with traumatic cervical SCI accounting for the majority. The incidence rate increases abruptly in male teenagers. Gender, age, and socioeconomic status are independent risk factors that should be considered.	[Chien, Li-Chien] Natl Yang Ming Univ Hosp, Dept Surg, Ilan, Taiwan; [Chien, Li-Chien; Lo, Su-Shun] Natl Yang Ming Univ, Sch Med, Dept Surg, Taipei 112, Taiwan; [Wu, Jau-Ching; Cheng, Henrich] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Wu, Jau-Ching; Huang, Wen-Cheng; Cheng, Henrich] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Taipei, Taiwan; [Chen, Yu-Chun; Thien, Peck-Foong] Natl Yang Ming Univ Hosp, Dept Med Res & Educ, Ilan, Taiwan; [Chen, Yu-Chun; Chen, Tzeng-Ji] Natl Yang Ming Univ, Sch Med, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan; [Liu, Laura] Chang Gung Mem Hosp, Dept Ophthalmol, Tao Yuan, Taiwan; [Liu, Laura] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Thien, Peck-Foong] Natl Yang Ming Univ Hosp, Dept Pediat, Ilan, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University	Chien, LC (corresponding author), Natl Yang Ming Univ Hosp, Dept Surg, Ilan, Taiwan.	yuchn.chen@googlemail.com	Chen, YuChun/L-1052-2019; Wu, Jau-Ching/AAU-4009-2021; Chen, Yu Chun/K-6635-2019; Chen, TJ/AAH-8430-2021; Chen, Yu-Chun/B-1227-2012	Chen, YuChun/0000-0002-4124-1949; Wu, Jau-Ching/0000-0002-6996-3409; Chen, Yu-Chun/0000-0002-4124-1949; Huang, Wen-Cheng/0000-0003-4249-710X				APPLE DF, 1995, CLIN PEDIATR, V34, P90, DOI 10.1177/000992289503400205; Augutis M, 2003, SPINAL CORD, V41, P328, DOI 10.1038/sj.sc.3101478; Brown RL, 2001, J PEDIATR SURG, V36, P1107, DOI 10.1053/jpsu.2001.25665; DEVIVO MJ, 1993, ARCH PHYS MED REHAB, V74, P248; Di Martino A, 2004, NEUROSURG QUART, V14, P184, DOI 10.1097/00013414-200412000-00002; Frankel HL, 1998, SPINAL CORD, V36, P266, DOI 10.1038/sj.sc.3100638; HADLEY MN, 1988, J NEUROSURG, V68, P18, DOI 10.3171/jns.1988.68.1.0018; HAMILTON MG, 1992, J NEUROSURG, V77, P700, DOI 10.3171/jns.1992.77.5.0700; Ho JD, 2009, STROKE, V40, P2685, DOI 10.1161/STROKEAHA.109.554642; Kang JH, 2011, STROKE, V42, P336, DOI 10.1161/STROKEAHA.110.595538; KEWALRAMANI LS, 1980, SPINE, V5, P11, DOI 10.1097/00007632-198001000-00003; KEWALRAMANI LS, 1980, PARAPLEGIA, V18, P206, DOI 10.1038/sc.1980.36; Kokoska ER, 2001, J PEDIATR SURG, V36, P100, DOI 10.1053/jpsu.2001.20022; Kriss VM, 1996, CLIN PEDIATR, V35, P119, DOI 10.1177/000992289603500302; Launay F, 2005, CLIN ORTHOP RELAT R, P166, DOI 10.1097/01.blo.0000151876.90256.bf; McCall Todd, 2006, Neurosurg Focus, V20, pE5; Mortazavi MM, 2010, PEDIAT MULTILEVEL SP; OSENBACH RK, 1992, NEUROSURGERY, V30, P385, DOI 10.1227/00006123-199203000-00012; PANG D, 1989, J TRAUMA, V29, P654, DOI 10.1097/00005373-198905000-00021; Parent S, 2011, J NEUROTRAUMA; Parent S, 2010, SPINE, V35, pS202, DOI 10.1097/BRS.0b013e3181f35acb; Platzer P, 2007, J TRAUMA, V62, P389, DOI 10.1097/01.ta.0000221802.83549.46; Polk-Williams A, 2008, J PEDIATR SURG, V43, P1718, DOI 10.1016/j.jpedsurg.2008.06.002; Puisto V, 2010, SPINE, V35, P104, DOI 10.1097/BRS.0b013e3181c64423; Reilly CW, 2007, J BONE JOINT SURG AM, V89A, P98, DOI 10.2106/JBJS.F.00244; Shavelle RM, 2007, J SPINAL CORD MED, V30, pS48, DOI 10.1080/10790268.2007.11753969; Shavelle RM, 2006, J SPINAL CORD MED, V29, P511, DOI 10.1080/10790268.2006.11753901; Soden RJ, 2000, SPINAL CORD, V38, P604, DOI 10.1038/sj.sc.3101080; Trigylidas T, 2010, PEDIATR NEUROSURG, V46, P283, DOI 10.1159/000320134; Vitale MG, 2006, J PEDIATR ORTHOPED, V26, P745, DOI 10.1097/01.bpo.0000235400.49536.83; Wu JC, 2011, J NEUROTRAUMA	31	22	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39264	10.1371/journal.pone.0039264	http://dx.doi.org/10.1371/journal.pone.0039264			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761749	gold, Green Published, Green Submitted			2022-12-27	WOS:000305730900039
J	Gui, DK; Guo, YP; Wang, F; Liu, W; Chen, JG; Chen, YF; Huang, JH; Wang, NS				Gui, Dingkun; Guo, Yongping; Wang, Feng; Liu, Wei; Chen, Jianguo; Chen, Yifang; Huang, Jianhua; Wang, Niansong			Astragaloside IV, a Novel Antioxidant, Prevents Glucose-Induced Podocyte Apoptosis In Vitro and In Vivo	PLOS ONE			English	Article							PROGRESSIVE GLOMERULAR INJURY; FEMALE ANALBUMINEMIC RATS; DIABETIC-NEPHROPATHY; DISEASE; HYPERTROPHY; DYSFUNCTION; GENDER; NUMBER; BETA; AGE	Glucose-induced reactive oxygen species (ROS) production initiates podocyte apoptosis, which represents a novel early mechanism leading to diabetic nephropathy (DN). Here, we tested the hypothesis that Astragaloside IV(AS-IV) exerts antioxidant and antiapoptotic effects on podocytes under diabetic conditions. Apoptosis, albuminuria, ROS generation, caspase-3 activity and cleavage, as well as Bax and Bcl-2 mRNA and protein expression were measured in vitro and in vivo. Cultured podocytes were exposed to high glucose (HG) with 50, 100 and 200 mu g/ml of AS-IV for 24 h. AS-IV significantly attenuated HG-induced podocyte apoptosis and ROS production. This antiapoptotic effect was associated with restoration of Bax and Bcl-2 expression, as well as inhibition of caspase-3 activation and overexpression. In streptozotocin (STZ)-induced diabetic rats, severe hyperglycemia and albuminuria were developed. Increased apoptosis, Bax expression, caspase-3 activity and cleavage while decreased Bcl-2 expression were detected in diabetic rats. However, pretreatment with AS-IV (2.5, 5, 10 mg.kg(-1).d(-1)) for 14 weeks ameliorated podocyte apoptosis, caspase-3 activation, renal histopathology, podocyte foot process effacement, albuminuria and oxidative stress. Expression of Bax and Bcl-2 mRNA and protein in kidney cortex was partially restored by AS-IV pretreatment. These findings suggested AS-IV, a novel antioxidant, to prevent Glucose-Induced podocyte apoptosis partly through restoring the balance of Bax and Bcl-2 expression and inhibiting caspase-3 activation.	[Gui, Dingkun; Chen, Jianguo; Chen, Yifang] Zhejiang Hosp, Dept Nephrol, Hangzhou, Zhejiang, Peoples R China; [Gui, Dingkun; Guo, Yongping; Wang, Feng; Wang, Niansong] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Nephrol & Rheumatol, Shanghai 200030, Peoples R China; [Liu, Wei] 1 Hosp Chenzhou, Dept Gastroenterol, Chenzhou, Peoples R China; [Huang, Jianhua] Fudan Univ, Inst Integrated Chinese & Western Med, Huashan Hosp, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Fudan University	Gui, DK (corresponding author), Zhejiang Hosp, Dept Nephrol, Hangzhou, Zhejiang, Peoples R China.	hjhzyj@yahoo.com.cn; wangniansong@yahoo.com.cn			National Natural Science Foundation of China [81000305, 30901888]; Traditional Chinese Medicine Foundation in Zhejiang Province [2010ZA001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Traditional Chinese Medicine Foundation in Zhejiang Province	This work was supported by research grants from National Natural Science Foundation of China (NO. 81000305 to Dingkun Gui and NO. 30901888 to Jianhua Huang) and Traditional Chinese Medicine Foundation in Zhejiang Province (NO. 2010ZA001 to Dingkun Gui). The website of National Natural Science Foundation of China is http://www.nsfc.gov.cn/Portal0/default152.htm The website of Traditional Chinese Medicine Foundation in Zhejiang Province is http://www.zjtcm.gov.cn/public/Default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLIS C, 1994, J CLIN INVEST, V94, P1823, DOI 10.1172/JCI117531; Chen JG, 2008, BIOCHEM PHARMACOL, V76, P796, DOI 10.1016/j.bcp.2008.06.020; Chen YQ, 2011, AM J NEPHROL, V34, P549, DOI 10.1159/000333809; Drummond K, 2002, DIABETES, V51, P1580, DOI 10.2337/diabetes.51.5.1580; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; JOLES JA, 1995, KIDNEY INT, V47, P442, DOI 10.1038/ki.1995.57; Joles JA, 1996, J AM SOC NEPHROL, V7, P1189; Kim NH, 2006, AM J PHYSIOL-RENAL, V290, pF741, DOI 10.1152/ajprenal.00313.2005; Kummer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027457; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Peng A, 2008, J ETHNOPHARMACOL, V116, P413, DOI 10.1016/j.jep.2007.12.005; Piwkowska A, 2011, J CELL BIOCHEM, V112, P1661, DOI 10.1002/jcb.23088; Qiu LQ, 2004, J AM SOC NEPHROL, V15, P79, DOI 10.1097/01.ASN.0000104573.54132.2E; Qu YZ, 2009, EUR J PHARMACOL, V606, P137, DOI 10.1016/j.ejphar.2009.01.022; Reiser J, 2010, KIDNEY INT, V77, P662, DOI 10.1038/ki.2009.559; Riedl E, 2011, CELL PHYSIOL BIOCHEM, V28, P279, DOI 10.1159/000331740; Rios JL, 1997, PHYTOTHER RES, V11, P411, DOI 10.1002/(SICI)1099-1573(199709)11:6<411::AID-PTR132>3.0.CO;2-6; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Siu Brian, 2006, BMC Nephrol, V7, P6, DOI 10.1186/1471-2369-7-6; Sohn E, 2010, BIOCHEM BIOPH RES CO, V391, P733, DOI 10.1016/j.bbrc.2009.11.129; Steffes MW, 2001, KIDNEY INT, V59, P2104, DOI 10.1046/j.1523-1755.2001.0590062104.x; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Tuncdemir M, 2011, ACTA HISTOCHEM, V113, P826, DOI 10.1016/j.acthis.2010.12.003; Wang H, 2011, BLOOD, V117, P5231, DOI 10.1182/blood-2010-10-314773; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Xu J, 2012, CELL STRESS CHA 0122; Zhang N, 2011, MOLECULES, V16, P3896, DOI 10.3390/molecules16053896; Zhang WD, 2006, PLANTA MED, V72, P4, DOI 10.1055/s-2005-873126	35	125	141	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39824	10.1371/journal.pone.0039824	http://dx.doi.org/10.1371/journal.pone.0039824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745830	gold, Green Published, Green Submitted			2022-12-27	WOS:000305730900116
J	Nardelli, M; Scalzo, PM; Ramirez, MS; Quiroga, MP; Cassini, MH; Centron, D				Nardelli, Maximiliano; Marina Scalzo, Paula; Soledad Ramirez, Maria; Paula Quiroga, Maria; Hernan Cassini, Marcelo; Centron, Daniela			Class 1 Integrons in Environments with Different Degrees of Urbanization	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE GENES; SPECTRUM BETA-LACTAMASES; FECAL ESCHERICHIA-COLI; GRAM-NEGATIVE BACTERIA; SULFONAMIDE RESISTANCE; MULTIDRUG-RESISTANCE; SALMONELLA; ELEMENTS; DISSEMINATION; INTEGRASES	Background: Class 1 integrons are one of the most successful elements in the acquisition, expression and spread of antimicrobial resistance genes (ARG) among clinical isolates. Little is known about the gene flow of the components of the genetic platforms of class 1 integrons within and between bacterial communities. Thus it is important to better understand the interactions among "environmental'' intI1, its genetic platforms and its distribution with human activities. Methodology/Principal Findings: An evaluation of two types of genetic determinants, ARG (sul1 and qacE1/qacE Delta 1 genes) and lateral genetic elements (LGE) (intI1, ISCR1 and tniC genes) in a model of a culture-based method without antibiotic selection was conducted in a gradient of anthropogenic disturbances in a Patagonian island recognized as being one of the last regions containing wild areas. The intI1, ISCR1 genes and intI1 pseudogenes that were found widespread throughout natural communities were not associated with urbanization (p>0.05). Each ARG that is embedded in the most common genetic platform of clinical class 1 integrons, showed different ecological and molecular behaviours in environmental samples. While the sul1 gene frequency was associated with urbanization, the qacE1/qacE Delta 1 gene showed an adaptive role to several habitats. Conclusions/Significance: The high frequency of intI1 pseudogenes suggests that, although intI1 has a deleterious impact within several genomes, it can easily be disseminated among natural bacterial communities. The widespread occurrence of ISCR1 and intI1 throughout Patagonian sites with different degree of urbanization, and within different taxa, could be one of the causes of the increasing frequency of multidrug-resistant isolates that have characterized Argentina for decades. The flow of ARG and LGE between natural and clinical communities cannot be explained with a single general process but is a direct consequence of the interaction of multiple factors operating at molecular, ecological, phylogenetic and historical levels.	[Nardelli, Maximiliano; Marina Scalzo, Paula; Soledad Ramirez, Maria; Paula Quiroga, Maria; Centron, Daniela] Univ Buenos Aires, Fac Med, UBA CONICET, Lab Invest Mecanismos Resistencia Antibiot,IMPaM, Buenos Aires, DF, Argentina; [Hernan Cassini, Marcelo] Univ Nacl Lujan, Dept Ciencias Basicas, Grp GEMA, Buenos Aires, DF, Argentina; [Hernan Cassini, Marcelo] IBYME, Lab Biol Comportamiento, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidad Nacional de Lujan; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Nardelli, M (corresponding author), Univ Buenos Aires, Fac Med, UBA CONICET, Lab Invest Mecanismos Resistencia Antibiot,IMPaM, Buenos Aires, DF, Argentina.	dcentron@gmail.com		Centron, Daniela/0000-0001-9308-3762; Quiroga, Maria Paula/0000-0002-8896-1513	Agencia Nacional de Promocion de Ciencia y Tecnica (A.N.P.C.Y.T.) [BID/OC 1723 ANPCyT 0690]; C.O.N.I.C.E.T.	Agencia Nacional de Promocion de Ciencia y Tecnica (A.N.P.C.Y.T.)(ANPCyT); C.O.N.I.C.E.T.(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was supported by grant BID/OC 1723 ANPCyT 0690 from the Agencia Nacional de Promocion de Ciencia y Tecnica (A.N.P.C.Y.T.), which was given to Dr. Centron. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Sofia Piekar for assisting with the sample collection in Patagonia. M.N. is a recipient of an A.N.P.C.Y.T. fellowship and M. P. Q. is a recipient of a C.O.N.I.C.E.T. fellowship. D. C., M. H. C. and M. S. R. are members of the Carrera del Investigador Cientifico, C.O.N.I.C.E.T., Argentina.	Amin O, 1996, ENVIRON MONIT ASSESS, V41, P219, DOI 10.1007/BF00419743; Amin O, 2011, ENVIRON MONIT ASSESS, V175, P63, DOI 10.1007/s10661-010-1493-5; Antunes P, 2005, ANTIMICROB AGENTS CH, V49, P836, DOI 10.1128/AAC.49.2.836-839.2005; Antunes P, 2007, ANTIMICROB AGENTS CH, V51, P1545, DOI 10.1128/AAC.01275-06; Arduino SM, 2003, ANTIMICROB AGENTS CH, V47, P3945, DOI 10.1128/AAC.47.12.3945-3949.2003; Arduino SM, 2002, ANTIMICROB AGENTS CH, V46, P2303, DOI 10.1128/AAC.46.7.2303-2306.2002; Askar M, 2011, EURO SURVEILL, V16; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Barbolla R, 2004, ANTIMICROB AGENTS CH, V48, P666, DOI 10.1128/AAC.48.2.666-669.2004; Barlow RS, 2004, ANTIMICROB AGENTS CH, V48, P838, DOI 10.1128/AAC.48.3.838-842.2004; Barraud O, 2011, EMERG INFECT DIS, V17, P2078, DOI 10.3201/eid1711.110282; Bartoloni A, 2009, INT J ANTIMICROB AG, V33, P125, DOI 10.1016/j.ijantimicag.2008.07.029; BAUERNFEIND A, 1992, INFECTION, V20, P158, DOI 10.1007/BF01704610; Bonnedahl J, 2008, POLAR BIOL, V31, P759, DOI 10.1007/s00300-008-0430-3; Brown HJ, 1996, J BACTERIOL, V178, P4429, DOI 10.1128/jb.178.15.4429-4437.1996; Chowdhury PR, 2011, ANTIMICROB AGENTS CH, V55, P3140, DOI 10.1128/AAC.01529-10; Chowdhury PR, 2009, ANTIMICROB AGENTS CH, V53, P5294, DOI 10.1128/AAC.00687-09; Dawes FE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012754; Diaz-Mejia JJ, 2008, MICROBIOL-SGM, V154, P94, DOI 10.1099/mic.0.2007/008649-0; Dolejska M, 2009, J APPL MICROBIOL, V106, P1941, DOI 10.1111/j.1365-2672.2009.04155.x; Fluit AC, 2004, CLIN MICROBIOL INFEC, V10, P272, DOI 10.1111/j.1198-743X.2004.00858.x; Franklin K, 2001, ANTIMICROB AGENTS CH, V45, P2238, DOI 10.1128/AAC.45.8.2238-2244.2001; Gaze WH, 2005, ANTIMICROB AGENTS CH, V49, P1802, DOI 10.1128/AAC.49.5.1802-1807.2005; Gillings M, 2008, J BACTERIOL, V190, P5095, DOI 10.1128/JB.00152-08; Gillings MR, 2008, FEMS MICROBIOL LETT, V287, P56, DOI 10.1111/j.1574-6968.2008.01291.x; Gillings MR, 2009, FEMS MICROBIOL LETT, V296, P282, DOI 10.1111/j.1574-6968.2009.01646.x; Gillings MR, 2009, ISME J, V3, P209, DOI 10.1038/ismej.2008.98; Gillings MR, 2005, P NATL ACAD SCI USA, V102, P4419, DOI 10.1073/pnas.0406620102; Goldstein C, 2001, ANTIMICROB AGENTS CH, V45, P723, DOI 10.1128/AAC.45.3.723-726.2001; Gravel A, 1998, J BACTERIOL, V180, P5437, DOI 10.1128/JB.180.20.5437-5442.1998; Gutiurrez E., 1991, OECOLOGIA AQUATICA, V10, P351; Hall RM, 1998, DRUG RESIST UPDATE, V1, P109, DOI 10.1016/S1368-7646(98)80026-5; HALL RM, 1994, J BACTERIOL, V176, P6286, DOI 10.1128/jb.176.20.6286-6294.1994; HALL RM, 1993, GENETICA, V90, P115, DOI 10.1007/BF01435034; Hardwick SA, 2008, FEMS MICROBIOL LETT, V278, P207, DOI 10.1111/j.1574-6968.2007.00992.x; Holmes AJ, 2003, ENVIRON MICROBIOL, V5, P383, DOI 10.1046/j.1462-2920.2003.00429.x; Hoyle D, 2006, VET MICROBIOL, V115, P250, DOI 10.1016/j.vetmic.2006.01.006; Kazama H, 1998, FEMS MICROBIOL LETT, V159, P173; KHOLODII GY, 1995, MOL MICROBIOL, V17, P1189, DOI 10.1111/j.1365-2958.1995.mmi_17061189.x; Laroche E, 2010, J HYDROL, V392, P12, DOI 10.1016/j.jhydrol.2010.07.022; Laroche E, 2009, FEMS MICROBIOL ECOL, V68, P118, DOI 10.1111/j.1574-6941.2009.00655.x; Liebert CA, 1999, MICROBIOL MOL BIOL R, V63, P507, DOI 10.1128/MMBR.63.3.507-522.1999; Literak I, 2010, J APPL MICROBIOL, V108, P1702, DOI 10.1111/j.1365-2672.2009.04572.x; Macinga David R., 1999, Frontiers in Bioscience, V4, pD132, DOI 10.2741/Macinga; Marchiaro P, 2010, J INFECT DEV COUNTR, V4, P412, DOI 10.3855/jidc.1012; Marquez C, 2008, J CLIN MICROBIOL, V46, P3417, DOI 10.1128/JCM.00835-08; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Messier N, 2001, J BACTERIOL, V183, P6699, DOI 10.1128/JB.183.22.6699-6706.2001; Michael CA, 2004, AM NAT, V164, P1, DOI 10.1086/421733; MITTERMEIER RA, 2002, WILDERNESS EARTHS LA; Nandi S, 2004, P NATL ACAD SCI USA, V101, P7118, DOI 10.1073/pnas.0306466101; Nemergut DR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-261; Nemergut DR, 2004, APPL ENVIRON MICROB, V70, P1160, DOI 10.1128/AEM.70.2.1160-1168.2004; Nield BS, 2001, FEMS MICROBIOL LETT, V195, P59, DOI 10.1016/S0378-1097(00)00546-2; Orman BE, 2002, ANTIMICROB AGENTS CH, V46, P3963, DOI 10.1128/AAC.46.12.3963-3970.2002; PAULSEN IT, 1993, ANTIMICROB AGENTS CH, V37, P761, DOI 10.1128/AAC.37.4.761; Petrova M, 2011, RES MICROBIOL, V162, P337, DOI 10.1016/j.resmic.2011.01.003; Pinilla Gladys, 2009, Infect., V13, P196; Quiroga MP, 2007, ANTIMICROB AGENTS CH, V51, P4466, DOI 10.1128/AAC.00726-07; RADSTROM P, 1991, ANTIMICROB AGENTS CH, V35, P1840, DOI 10.1128/AAC.35.9.1840; Ragan MA, 2009, PHILOS T R SOC B, V364, P2241, DOI 10.1098/rstb.2009.0031; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Rosewarne CP, 2010, FEMS MICROBIOL ECOL, V72, P35, DOI 10.1111/j.1574-6941.2009.00823.x; Rosser SJ, 1999, J ANTIMICROB CHEMOTH, V44, P11, DOI 10.1093/jac/44.1.11; Saenz Y, 2010, VET MICROBIOL, V144, P493, DOI 10.1016/j.vetmic.2010.01.026; Schluter A, 2007, APPL ENVIRON MICROB, V73, P1952, DOI 10.1128/AEM.02159-06; Shi L, 2006, MICROBIOL IMMUNOL, V50, P463, DOI 10.1111/j.1348-0421.2006.tb03815.x; Singer RS, 2006, AVIAN DIS, V50, P161, DOI 10.1637/7569-033106R.1; Skurnik D, 2006, J ANTIMICROB CHEMOTH, V57, P1215, DOI 10.1093/jac/dkl122; Stokes HW, 2006, J BACTERIOL, V188, P5722, DOI 10.1128/JB.01950-05; Stokes HW, 2011, FEMS MICROBIOL REV, V35, P790, DOI 10.1111/j.1574-6976.2011.00273.x; Stokes HW, 2001, APPL ENVIRON MICROB, V67, P5240, DOI 10.1128/AEM.67.11.5240-5246.2001; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tauch A, 2002, PLASMID, V48, P117, DOI 10.1016/S0147-619X(02)00120-8; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Valverde A, 2006, ANTIMICROB AGENTS CH, V50, P799, DOI 10.1128/AAC.50.2.799-802.2006; Vinue L, 2010, INT J ANTIMICROB AG, V35, P492, DOI 10.1016/j.ijantimicag.2010.01.012; Walsh TR, 2006, CURR OPIN MICROBIOL, V9, P476, DOI 10.1016/j.mib.2006.08.009; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wright MS, 2008, ISME J, V2, P417, DOI 10.1038/ismej.2008.8; Xu ZB, 2008, CURR MICROBIOL, V57, P264, DOI 10.1007/s00284-008-9187-8	82	46	46	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39223	10.1371/journal.pone.0039223	http://dx.doi.org/10.1371/journal.pone.0039223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761743	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900036
J	Higuchi, S; Irie, K; Yamaguchi, R; Katsuki, M; Araki, M; Ohji, M; Hayakawa, K; Mishima, S; Akitake, Y; Matsuyama, K; Mishima, K; Mishima, K; Iwasaki, K; Fujiwara, M				Higuchi, Sei; Irie, Keiichi; Yamaguchi, Ryuji; Katsuki, Mai; Araki, Maiko; Ohji, Makiko; Hayakawa, Kazuhide; Mishima, Shohei; Akitake, Yoshiharu; Matsuyama, Kiyoshi; Mishima, Kenji; Mishima, Kenichi; Iwasaki, Katsunori; Fujiwara, Michihiro			Hypothalamic 2-Arachidonoylglycerol Regulates Multistage Process of High-Fat Diet Preferences	PLOS ONE			English	Article							CANNABINOID CB1 RECEPTORS; GLIAL-CELL METABOLISM; ENDOCANNABINOID SYSTEM; GLUTAMATE TRANSPORTERS; ENERGY-BALANCE; RAT-BRAIN; CORN-OIL; NEURONS; ASTROCYTES; MORPHINE	Background: In this study, we examined alterations in the hypothalamic reward system related to high-fat diet (HFD) preferences. We previously reported that hypothalamic 2-arachidonoylglycerol (2-AG) and glial fibrillary acid protein (GFAP) were increased after conditioning to the rewarding properties of a HFD. Here, we hypothesized that increased 2-AG influences the hypothalamic reward system. Methods: The conditioned place preference test (CPP test) was used to evaluate HFD preferences. Hypothalamic 2-AG was quantified by gas chromatography-mass spectrometry. The expression of GFAP was examined by immunostaining and western blotting. Results: Consumption of a HFD over either 3 or 7 days increased HFD preferences and transiently increased hypothalamic 2-AG levels. HFD consumption over 14 days similarly increased HFD preferences but elicited a long-lasting increase in hypothalamic 2-AG and GFAP levels. The cannabinoid 1 receptor antagonist O-2050 reduced preferences for HFDs after 3, 7, or 14 days of HFD consumption and reduced expression of GFAP after 14 days of HFD consumption. The astrocyte metabolic inhibitor Fluorocitrate blocked HFD preferences after 14 days of HFD consumption. Conclusions: High levels of 2-AG appear to induce HFD preferences, and activate hypothalamic astrocytes via the cannabinoid system. We propose that there may be two distinct stages in the development of HFD preferences. The induction stage involves a transient increase in 2-AG, whereas the maintenance stage involves a long lasting increase in 2-AG levels and activation of astrocytes. Accordingly, hypothalamic 2-AG may influence the development of HFD preferences.	[Higuchi, Sei; Irie, Keiichi; Yamaguchi, Ryuji; Katsuki, Mai; Araki, Maiko; Ohji, Makiko; Hayakawa, Kazuhide; Mishima, Shohei; Akitake, Yoshiharu; Mishima, Kenichi; Iwasaki, Katsunori; Fujiwara, Michihiro] Fukuoka Univ, Fac Pharmaceut Sci, Dept Neuropharmacol, Fukuoka 81401, Japan; [Irie, Keiichi; Akitake, Yoshiharu; Mishima, Kenichi; Iwasaki, Katsunori] Fukuoka Univ, Inst Aging & Brain Sci, Fukuoka 81401, Japan; [Matsuyama, Kiyoshi; Mishima, Kenji] Fukuoka Univ, Fac Engn, Dept Chem Engn, Fukuoka 81401, Japan	Fukuoka University; Fukuoka University; Fukuoka University	Higuchi, S (corresponding author), Fukuoka Univ, Fac Pharmaceut Sci, Dept Neuropharmacol, 8-19-1 Nanakuma, Fukuoka 81401, Japan.	kenichi@fukuoka-u.ac.jp		Higuchi, Sei/0000-0002-5134-8619; Matsuyama, Kiyoshi/0000-0002-9037-4908				Aguado T, 2006, J NEUROSCI, V26, P1551, DOI 10.1523/JNEUROSCI.3101-05.2006; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Bellocchio L, 2010, NAT NEUROSCI, V13, P281, DOI 10.1038/nn.2494; Bisogno T, 2009, CHEMMEDCHEM, V4, P946, DOI 10.1002/cmdc.200800442; Chouker A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010752; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cota D, 2006, BRAIN RES REV, V51, P85, DOI 10.1016/j.brainresrev.2005.10.004; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 2009, INT J OBESITY, V33, pS18, DOI 10.1038/ijo.2009.67; Di Marzo V, 2011, P NATL ACAD SCI USA, V108, P12567, DOI 10.1073/pnas.1109567108; Di Marzo V, 2009, EUR J ENDOCRINOL, V161, P715, DOI 10.1530/EJE-09-0643; DiPatrizio NV, 2008, J NEUROSCI, V28, P9702, DOI 10.1523/JNEUROSCI.1171-08.2008; ELIZALDE G, 1990, APPETITE, V15, P189, DOI 10.1016/0195-6663(90)90019-5; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; Fellin T, 2009, J NEUROCHEM, V108, P533, DOI 10.1111/j.1471-4159.2008.05830.x; Figlewicz DP, 2004, BEHAV NEUROSCI, V118, P479, DOI 10.1037/0735-7044.118.3.479; Gardner EL, 2005, PHARMACOL BIOCHEM BE, V81, P263, DOI 10.1016/j.pbb.2005.01.032; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8; HASSEL B, 1992, BRAIN RES, V576, P120, DOI 10.1016/0006-8993(92)90616-H; Hayakawa K, 2010, J CEREBR BLOOD F MET, V30, P871, DOI 10.1038/jcbfm.2009.257; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Higuchi S, 2010, ANAL SCI, V26, P1199, DOI 10.2116/analsci.26.1199; Higuchi S, 2011, BEHAV BRAIN RES, V216, P477, DOI 10.1016/j.bbr.2010.08.042; Higuchi S, 2010, J PHARMACOL SCI, V112, P369, DOI 10.1254/jphs.09326SC; Imaizumi M, 2000, BRAIN RES, V870, P150, DOI 10.1016/S0006-8993(00)02416-1; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Kola B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001797; Le Foll B, 2008, NEUROSCI LETT, V443, P236, DOI 10.1016/j.neulet.2008.07.074; Le Foll B, 2008, ADDICT BIOL, V13, P239, DOI 10.1111/j.1369-1600.2008.00113.x; LEPORE M, 1995, LIFE SCI, V56, P2073, DOI 10.1016/0024-3205(95)00191-8; Meng ZQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007742; Miyatake M, 2005, EUR J NEUROSCI, V22, P1476, DOI 10.1111/j.1460-9568.2005.04325.x; Mizushige T, 2006, BIOMED RES-TOKYO, V27, P227, DOI 10.2220/biomedres.27.227; Mizushige T, 2009, LIFE SCI, V84, P760, DOI 10.1016/j.lfs.2009.03.003; Nakagawa T, 2001, EUR J PHARMACOL, V419, P39, DOI 10.1016/S0014-2999(01)00965-7; Narita M, 2005, J NEUROCHEM, V93, P1383, DOI 10.1111/j.1471-4159.2005.03097.x; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; Ozawa T, 2001, BRAIN RES, V905, P254, DOI 10.1016/S0006-8993(01)02536-7; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; PAULSEN RE, 1987, J NEUROCHEM, V48, P1377, DOI 10.1111/j.1471-4159.1987.tb05674.x; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Peyron C, 1998, J NEUROSCI, V18, P9996; Quarta C, 2010, CELL METAB, V11, P273, DOI 10.1016/j.cmet.2010.02.015; Rosin DL, 2003, J COMP NEUROL, V465, P593, DOI 10.1002/cne.10860; South T, 2007, BEHAV BRAIN RES, V181, P153, DOI 10.1016/j.bbr.2007.03.028; Stella N, 2004, GLIA, V48, P267, DOI 10.1002/glia.20084; Takeda M, 2001, LIFE SCI, V69, P847, DOI 10.1016/S0024-3205(01)01180-8; TOWER DB, 1973, J NEUROCHEM, V20, P269, DOI 10.1111/j.1471-4159.1973.tb12126.x; Verkhratsky A, 1996, TRENDS NEUROSCI, V19, P346, DOI 10.1016/0166-2236(96)10048-5; Verty ANA, 2005, NEUROPHARMACOLOGY, V49, P1101, DOI 10.1016/j.neuropharm.2005.03.025; Wiskerke J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025856	56	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38609	10.1371/journal.pone.0038609	http://dx.doi.org/10.1371/journal.pone.0038609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737214	Green Published, Green Submitted, gold			2022-12-27	WOS:000305695100011
J	Kim, H; Phung, Y; Ho, M				Kim, Heungnam; Phung, Yen; Ho, Mitchell			Changes in Global Gene Expression Associated with 3D Structure of Tumors: An Ex Vivo Matrix-Free Mesothelioma Spheroid Model	PLOS ONE			English	Article							MULTICELLULAR SPHEROIDS; APOPTOTIC RESISTANCE; SOLID TUMORS; LUNG-CANCER; CELL-LINES; INHIBITORS; CYTOKINES; PATHWAY; KINASE; APRIL	Tumor microenvironments present significant barriers to anti-tumor agents. Molecules involved in multicellular tumor microenvironments, however, are difficult to study ex vivo. Here, we generated a matrix-free tumor spheroid model using the NCI-H226 mesothelioma cell line and compared the gene expression profiles of spheroids and monolayers using microarray analysis. Microarray analysis revealed that 142 probe sets were differentially expressed between tumor spheroids and monolayers. Gene ontology analysis revealed that upregulated genes were primarily related to immune response, wound response, lymphocyte stimulation and response to cytokine stimulation, whereas downregulated genes were primarily associated with apoptosis. Among the 142 genes, 27 are located in the membrane and related to biologic processes of cellular movement, cell-to-cell signaling, cellular growth and proliferation and morphology. Western blot analysis validated elevation of MMP2, BAFF/BLyS/TNFSF13B, RANTES/CCL5 and TNFAIP6/TSG-6 protein expression in spheroids as compared to monolayers. Thus, we have reported the first large scale comparison of the transcriptional profiles using an ex vivo matrix-free spheroid model to identify genes specific to the three-dimensional biological structure of tumors. The method described here can be used for gene expression profiling of tumors other than mesothelioma.	[Kim, Heungnam; Phung, Yen; Ho, Mitchell] NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kim, H (corresponding author), NCI, Mol Biol Lab, NIH, Bldg 37, Bethesda, MD 20892 USA.	homi@mail.nih.gov	Ho, Mitchell/F-5059-2015	Ho, Mitchell/0000-0002-9152-5405	National Institutes of Health (NIH), National Cancer Institute (NCI); Center for Cancer Research; NCI; Mesothelioma Applied Research Foundation; NATIONAL CANCER INSTITUTE [ZIABC010891] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mesothelioma Applied Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute (NCI), and Center for Cancer Research and by a NCI Director's Intramural Innovation Principal Investigator Award to MH. This work was also possible because of a Mesothelioma Applied Research Foundation Craig Kozicki Memorial Grant to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbone D, 2008, J BIOL CHEM, V283, P13021, DOI 10.1074/jbc.M709698200; Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107; Benton G, 2011, INT J CANCER, V128, P1751, DOI 10.1002/ijc.25781; Carbone M, 2012, CLIN CANCER RES, V18, P598, DOI 10.1158/1078-0432.CCR-11-2259; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cukierman E, 2010, SEMIN CANCER BIOL, V20, P139, DOI 10.1016/j.semcancer.2010.04.004; Engbring JA, 2003, J PATHOL, V200, P465, DOI 10.1002/path.1396; Feng MQ, 2011, J CANCER, V2, P123, DOI 10.7150/jca.2.123; Hegmans JPJJ, 2006, EUR RESPIR J, V27, P1086, DOI 10.1183/09031936.06.00135305; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Jain RK, 1999, ANNU REV BIOMED ENG, V1, P241, DOI 10.1146/annurev.bioeng.1.1.241; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kern C, 2004, BLOOD, V103, P679, DOI 10.1182/blood-2003-02-0540; Kumagai-Takei N, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/481439; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Nishio M, 2005, BLOOD, V106, P1012, DOI 10.1182/blood-2004-03-0889; Phung YT, 2011, J CANCER, V2, P507, DOI 10.7150/jca.2.507; Richmond CS, 1999, NUCLEIC ACIDS RES, V27, P3821, DOI 10.1093/nar/27.19.3821; Roomi MW, 2009, ONCOL REP, V22, P1283, DOI 10.3892/or_00000566; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xiang XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014640; Yang TM, 2009, AM J RESP CELL MOL, V41, P14, DOI 10.1165/rcmb.2008-0320OC; Zhong J, 2006, J CELL PHYSIOL, V207, P540, DOI 10.1002/jcp.20605	25	35	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39556	10.1371/journal.pone.0039556	http://dx.doi.org/10.1371/journal.pone.0039556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737246	gold, Green Published, Green Submitted			2022-12-27	WOS:000305695100045
J	Bao, PP; Lu, W; Cui, Y; Zheng, Y; Gu, K; Chen, Z; Zheng, W; Shu, XO				Bao, Ping-Ping; Lu, Wei; Cui, Yong; Zheng, Ying; Gu, Kai; Chen, Zhi; Zheng, Wei; Shu, Xiao Ou			Ginseng and Ganoderma lucidum Use after Breast Cancer Diagnosis and Quality of Life: A Report from the Shanghai Breast Cancer Survival Study	PLOS ONE			English	Article							ALTERNATIVE MEDICINE; CHINESE WOMEN; PANAX-GINSENG; COMPLEMENTARY; CELLS; INHIBITION; EFFICACY; GROWTH; IMPACT	Objective: To evaluate associations between quality of life (QOL) and use of ginseng and Ganoderma lucidum (G. lucidum) among breast cancer survivors. Methods: Included in this study were 4,149 women with breast cancer who participated in the Shanghai Breast Cancer Survival Study. Ginseng use was assessed at 6-, 18-, and 36-month post-diagnosis surveys; G. lucidum use was assessed at the 6- and 36-month surveys. QOL was evaluated at the 6- and 36-month surveys. Multiple linear regression models were used to examine associations between ginseng and G. lucidum use and QOL assessed at the 36-month survey, with adjustment for potential confounders and baseline QOL. Results: At 6 months post-diagnosis, 14.2% of participants reported regular use of ginseng and 58.8% reported use of G. lucidum. We found no significant associations between ginseng use at 6, 18, and 36 months post-diagnosis and participants' total QOL score or individual scores for psychological, physical, or social well-being. Post-diagnosis G. lucidum use was positively associated with social well-being (adjusted mean difference: 1.26; 95% CI: 0.66, 1.86), but was inversely associated with physical well-being (adjusted mean difference: -1.16; 95% CI: -1.86, -0.47) with a dose-response pattern observed for cumulative number of times of use (P for trend <0.001 for both). Conclusion: We found no evidence that post-diagnosis ginseng use improved the QOL of breast cancer survivors. Post-diagnosis G. lucidum use was associated with better social well-being scores, but poorer physical well-being scores.	[Bao, Ping-Ping; Lu, Wei; Zheng, Ying; Gu, Kai] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Cui, Yong; Chen, Zhi; Zheng, Wei; Shu, Xiao Ou] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Div Epidemiol,Dept Med, Nashville, TN 37212 USA	Shanghai Center for Disease Control & Prevention; Vanderbilt University	Bao, PP (corresponding author), Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China.	xiao-ou.shu@vanderbilt.edu	zhang, weihua/GXV-1334-2022; Zheng, Wei/O-3351-2013	Zheng, Wei/0000-0003-1226-070X	Department of Defense Breast Cancer Research Program [DAMD 17-02-1-0607]; National Cancer Institute [R01 CA118229]; Fogarty International Center [D43 TW003813]; FOGARTY INTERNATIONAL CENTER [F05TW003813, D43TW008313] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA118229] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Research Program(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the Department of Defense Breast Cancer Research Program (DAMD 17-02-1-0607) and the National Cancer Institute (R01 CA118229). PPB was supported by a training grant from the Fogarty International Center (D43 TW003813; PI: XOS). The content of the information does not necessarily reflect the position or the policy of the United States Government, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, INT CLASSIFICATION D; Boon H, 2004, EXPERT OPIN PHARMACO, V5, P2485, DOI 10.1517/14656566.5.12.2485; Carpenter CL, 2009, BREAST CANCER RES TR, V116, P387, DOI 10.1007/s10549-008-0158-3; Chen XL, 2010, BREAST CANCER RES TR, V122, P823, DOI 10.1007/s10549-009-0708-3; Chen Z, 2008, J ALTERN COMPLEM MED, V14, P1049, DOI 10.1089/acm.2008.0039; Coleman CI, 2003, J CLIN PHARM THER, V28, P5, DOI 10.1046/j.1365-2710.2003.00467.x; Cui Y, 2006, AM J EPIDEMIOL, V163, P645, DOI 10.1093/aje/kwj087; Cui Y, 2004, BREAST CANCER RES TR, V87, P135, DOI 10.1023/B:BREA.0000041620.76871.97; Cui Y, 2004, BREAST CANCER RES TR, V85, P263, DOI 10.1023/B:BREA.0000025422.26148.8d; De Angelis R, 2009, CANCER, V115, P1954, DOI 10.1002/cncr.24217; Dorjgochoo T, 2010, BREAST CANCER RES TR, V119, P725, DOI 10.1007/s10549-009-0434-x; Duda RB, 2001, J KOREAN MED SCI, V16, pS54, DOI 10.3346/jkms.2001.16.S.S54; Efficace F, 2004, J CLIN ONCOL, V22, P3381, DOI 10.1200/JCO.2004.02.060; Ernst E, 2005, FUND CLIN PHARMACOL, V19, P405, DOI 10.1111/j.1472-8206.2005.00335.x; Ernst E, 2004, J FAM PRACTICE, V53, P985; Grunau GL, 2006, J CLIN EPIDEMIOL, V59, P274, DOI 10.1016/j.jclinepi.2005.08.007; Harris PF, 2002, J PAIN SYMPTOM MANAG, V23, P501, DOI 10.1016/S0885-3924(02)00395-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang JH, 2004, NUTR CANCER, V49, P209, DOI 10.1207/s15327914nc4902_13; Jiang JH, 2008, INT J MOL MED, V21, P577; Jiang JH, 2006, INT J ONCOL, V29, P695; Li L, 2003, J EPIDEMIOL COMMUN H, V57, P259, DOI 10.1136/jech.57.4.259; Lu W, 2007, BREAST CANCER RES TR, V102, P201, DOI 10.1007/s10549-006-9318-5; Montazeri A, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-32; Parkin DM, 2006, BREAST J, V12, pS70, DOI 10.1111/j.1075-122X.2006.00205.x; Shu XO, 2009, JAMA-J AM MED ASSOC, V302, P2437, DOI 10.1001/jama.2009.1783; Sliva D, 2006, LEUKEMIA RES, V30, P767, DOI 10.1016/j.leukres.2005.12.015; Sliva D, 2002, BIOCHEM BIOPH RES CO, V298, P603, DOI 10.1016/S0006-291X(02)02496-8; Stanley G, 2005, BIOCHEM BIOPH RES CO, V330, P46, DOI 10.1016/j.bbrc.2005.02.116; Trentham-Dietz A, 2008, BREAST CANCER RES TR, V109, P379, DOI 10.1007/s10549-007-9653-1; Vogler BK, 1999, EUR J CLIN PHARMACOL, V55, P567, DOI 10.1007/s002280050674; Wang Hongwei, 2009, Chin Med, V4, P20, DOI 10.1186/1749-8546-4-20; Yun TK, 2001, J KOREAN MED SCI, V16, pS6, DOI 10.3346/jkms.2001.16.S.S6; Yun TK, 1999, ANN NY ACAD SCI, V889, P157, DOI 10.1111/j.1749-6632.1999.tb08734.x; Zhou Biao, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P1193	35	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39343	10.1371/journal.pone.0039343	http://dx.doi.org/10.1371/journal.pone.0039343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745737	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200064
J	Muller, V; Anokhin, AP				Mueller, Viktor; Anokhin, Andrey P.			Neural Synchrony during Response Production and Inhibition	PLOS ONE			English	Article							PHASE SYNCHRONIZATION; BRAIN; EEG; DYNAMICS; ERPS; ANTERIORIZATION; OSCILLATIONS; POTENTIALS; COMPONENT; MEMORY	Inhibition of irrelevant information (conflict monitoring) and/or of prepotent actions is an essential component of adaptive self-organized behavior. Neural dynamics underlying these functions has been studied in humans using event-related brain potentials (ERPs) elicited in Go/NoGo tasks that require a speeded motor response to the Go stimuli and withholding a prepotent response when a NoGo stimulus is presented. However, averaged ERP waveforms provide only limited information about the neuronal mechanisms underlying stimulus processing, motor preparation, and response production or inhibition. In this study, we examine the cortical representation of conflict monitoring and response inhibition using time-frequency analysis of electroencephalographic (EEG) recordings during continuous performance Go/NoGo task in 50 young adult females. We hypothesized that response inhibition would be associated with a transient boost in both temporal and spatial synchronization of prefrontal cortical activity, consistent with the role of the anterior cingulate and lateral prefrontal cortices in cognitive control. Overall, phase synchronization across trials measured by Phase Locking Index and phase synchronization between electrode sites measured by Phase Coherence were the highest in the Go and NoGo conditions, intermediate in the Warning condition, and the lowest under Neutral condition. The NoGo condition was characterized by significantly higher fronto-central synchronization in the 300-600 ms window, whereas in the Go condition, delta-and theta-band synchronization was higher in centro-parietal regions in the first 300 ms after the stimulus onset. The present findings suggest that response production and inhibition is supported by dynamic functional networks characterized by distinct patterns of temporal and spatial synchronization of brain oscillations.	[Mueller, Viktor] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany; [Anokhin, Andrey P.] Washington Univ, Sch Med, St Louis, MO USA	Max Planck Society; Washington University (WUSTL)	Muller, V (corresponding author), Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany.	vmueller@mpib-berlin.mpg.de	Müller, Viktor/AAX-4429-2021; Anokhin, Andrey/A-5008-2013	Muller, Viktor/0000-0002-3716-5445; Anokhin, Andrey/0000-0001-8158-6346	National Institutes of Health from the National Institute on Drug Abuse, USA [DA00421, DA01889]; Max Planck Society, Germany	National Institutes of Health from the National Institute on Drug Abuse, USA; Max Planck Society, Germany(Max Planck Society)	Supported by the National Institutes of Health grants DA00421 and DA01889 from the National Institute on Drug Abuse, USA and by the Max Planck Society, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokhin AP, 1999, INT J PSYCHOPHYSIOL, V33, P259, DOI 10.1016/S0167-8760(99)00064-1; Anokhin AP, 2004, NEUROSCI LETT, V368, P314, DOI 10.1016/j.neulet.2004.07.036; Bekker EM, 2005, COGNITIVE BRAIN RES, V22, P221, DOI 10.1016/j.cogbrainres.2004.08.011; Burle B, 2004, NEUROSCI LETT, V360, P77, DOI 10.1016/j.neulet.2004.02.034; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Fallgatter AJ, 1999, INT J PSYCHOPHYSIOL, V32, P233, DOI 10.1016/S0167-8760(99)00018-5; Fell J, 2004, J COGNITIVE NEUROSCI, V16, P1595, DOI 10.1162/0898929042568514; Freunberger R, 2007, NEUROSCI LETT, V426, P181, DOI 10.1016/j.neulet.2007.08.062; GEVINS A, 1995, TRENDS NEUROSCI, V18, P429, DOI 10.1016/0166-2236(95)94489-R; Gruber WR, 2005, CEREB CORTEX, V15, P371, DOI 10.1093/cercor/bhh139; Harmony T, 1996, INT J PSYCHOPHYSIOL, V24, P161, DOI 10.1016/S0167-8760(96)00053-0; Jonkman LM, 2007, CLIN NEUROPHYSIOL, V118, P1069, DOI 10.1016/j.clinph.2007.01.017; Jonkman LM, 2006, BRAIN RES, V1097, P181, DOI 10.1016/j.brainres.2006.04.064; Jonkman LM, 2003, PSYCHOPHYSIOLOGY, V40, P752, DOI 10.1111/1469-8986.00075; Klimesch W, 2004, COGNITIVE BRAIN RES, V19, P302, DOI 10.1016/j.cogbrainres.2003.11.016; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Livanov M.N., 1934, CONT NEUROPATHOLOGY, V3, P98; Livanov M.N., 1977, SPATIAL ORG CEREBRAL; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; McEvoy LK, 2001, COGNITIVE BRAIN RES, V11, P363, DOI 10.1016/S0926-6410(01)00009-X; Muller V, 2009, DEVELOPMENTAL SCI, V12, P839, DOI 10.1111/j.1467-7687.2009.00834.x; Nieuwenhuis S, 2004, PSYCHOPHYSIOLOGY, V41, P157, DOI 10.1046/j.1469-8986.2003.00128.x; Onton J, 2006, NEUROSCI BIOBEHAV R, V30, P808, DOI 10.1016/j.neubiorev.2006.06.007; PFEFFERBAUM A, 1988, ELECTROEN CLIN NEURO, V71, P55, DOI 10.1016/0168-5597(88)90019-6; PFEFFERBAUM A, 1985, ELECTROEN CLIN NEURO, V60, P423, DOI 10.1016/0013-4694(85)91017-X; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Roth RM, 2007, BIOL PSYCHIAT, V62, P901, DOI 10.1016/j.biopsych.2006.12.007; Rubia K, 2005, AM J PSYCHIAT, V162, P1067, DOI 10.1176/appi.ajp.162.6.1067; Salisbury DF, 2004, CLIN NEUROPHYSIOL, V115, P1550, DOI 10.1016/j.clinph.2004.01.028; Schmiedt-Fehr C, 2011, CLIN NEUROPHYSIOL, V122, P1156, DOI 10.1016/j.clinph.2010.10.045; Shibata T, 1998, NEUROSCI RES, V31, P265, DOI 10.1016/S0168-0102(98)00046-7; Shibata T, 1999, NEUROSCI RES, V33, P215, DOI 10.1016/S0168-0102(99)00003-6; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Smith JL, 2006, INT J PSYCHOPHYSIOL, V61, P121, DOI 10.1016/j.ijpsycho.2005.07.013; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Yeung N, 2004, PSYCHOPHYSIOLOGY, V41, P822, DOI 10.1111/j.1469-8986.2004.00239.x; Yeung N, 2007, PSYCHOPHYSIOLOGY, V44, P39, DOI 10.1111/j.1469-8986.2006.00482.x; Young SE, 2000, AM J MED GENET, V96, P684, DOI 10.1002/1096-8628(20001009)96:5<684::AID-AJMG16>3.3.CO;2-7	43	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38931	10.1371/journal.pone.0038931	http://dx.doi.org/10.1371/journal.pone.0038931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	964KK	22745691	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693200030
J	Softic, S; Kirby, M; Berger, NG; Shroyer, NF; Woods, SC; Kohli, R				Softic, Samir; Kirby, Michelle; Berger, Nicholas G.; Shroyer, Noah F.; Woods, Stephen C.; Kohli, Rohit			Insulin Concentration Modulates Hepatic Lipid Accumulation in Mice in Part via Transcriptional Regulation of Fatty Acid Transport Proteins	PLOS ONE			English	Article							ACYL-COA SYNTHETASE; LIVER-DISEASE; IN-VIVO; NONALCOHOLIC STEATOHEPATITIS; RECEPTOR SUBSTRATE-2; GENE-EXPRESSION; IRS-2; METABOLISM; STEATOSIS; PATHWAY	Background: Fatty liver disease (FLD) is commonly associated with insulin resistance and obesity, but interestingly it is also observed at low insulin states, such as prolonged fasting. Thus, we asked whether insulin is an independent modulator of hepatic lipid accumulation. Methods/Principal Findings: In mice we induced, hypo- and hyperinsulinemia associated FLD by diet induced obesity and streptozotocin treatment, respectively. The mechanism of free fatty acid induced steatosis was studied in cell culture with mouse liver cells under different insulin concentrations, pharmacological phosphoinositol-3-kinase (PI3K) inhibition and siRNA targeted gene knock-down. We found with in vivo and in vitro models that lipid storage is increased, as expected, in both hypo-and hyperinsulinemic states, and that it is mediated by signaling through either insulin receptor substrate (IRS) 1 or 2. As previously reported, IRS-1 was up-regulated at high insulin concentrations, while IRS-2 was increased at low levels of insulin concentration. Relative increase in either of these insulin substrates, was associated with an increase in liver-specific fatty acid transport proteins (FATP) 2&5, and increased lipid storage. Furthermore, utilizing pharmacological PI3K inhibition we found that the IRS-PI3K pathway was necessary for lipogenesis, while FATP responses were mediated via IRS signaling. Data from additional siRNA experiments showed that knock-down of IRSs impacted FATP levels. Conclusions/Significance: States of perturbed insulin signaling (low-insulin or high-insulin) both lead to increased hepatic lipid storage via FATP and IRS signaling. These novel findings offer a common mechanism of FLD pathogenesis in states of both inadequate (prolonged fasting) and ineffective (obesity) insulin signaling.	[Softic, Samir; Kirby, Michelle; Berger, Nicholas G.; Shroyer, Noah F.; Kohli, Rohit] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH USA; [Softic, Samir] Indiana Univ, James Whitcomb Riley Hosp Children, Dept Pediat, Indianapolis, IN USA; [Shroyer, Noah F.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH USA; [Woods, Stephen C.] Univ Cincinnati Coll Med, Dept Psychiat & Behav Neurosci, Metab Dis Inst, Obes Res Ctr, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Softic, S (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH USA.	rohit.kohli@cchmc.org	Softic, Samir/ABD-4612-2020; kohli, Rohit/H-3020-2013	kohli, Rohit/0000-0002-0198-7703; Shroyer, Noah/0000-0002-5934-2852; Berger, Nicholas/0000-0002-6827-6842; Softic, Samir/0000-0003-1419-9789	NIH/NIDDK [K08 DK084310-01, U01 DK08505, P30 DK078392]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092306, T35DK060444, K08DK084310, P30DK078392] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH/NIDDK K08 DK084310-01, U01 DK08505, and P30 DK078392. Website www.nig.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Auinger A, 2010, HORM METAB RES, V42, P854, DOI 10.1055/s-0030-1267186; Bechmann LP, 2010, LIVER INT, V30, P850, DOI 10.1111/j.1478-3231.2010.02248.x; Canettieri G, 2005, CELL METAB, V2, P331, DOI 10.1016/j.cmet.2005.09.008; Cazanave SC, 2010, CLIN LIPIDOL, V5, P71, DOI 10.2217/CLP.09.85; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; DiRusso CC, 2005, J BIOL CHEM, V280, P16829, DOI 10.1074/jbc.M409598200; Doege H, 2006, GASTROENTEROLOGY, V130, P1245, DOI 10.1053/j.gastro.2006.02.006; Doege H, 2008, J BIOL CHEM, V283, P22186, DOI 10.1074/jbc.M803510200; Falcon A, 2010, AM J PHYSIOL-ENDOC M, V299, pE384, DOI 10.1152/ajpendo.00226.2010; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Guan HP, 2009, J BIOL CHEM, V284, P24644, DOI 10.1074/jbc.M109.034397; Gunton JE, 2003, J CLIN ENDOCR METAB, V88, P1323, DOI 10.1210/jc.2002-021394; Guo S, 2009, MOL CELL BIOL, V29, P5070, DOI 10.1128/MCB.00138-09; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Haeusler RA, 2008, CELL METAB, V8, P7, DOI 10.1016/j.cmet.2008.06.010; Heinzer AK, 2003, HUM MOL GENET, V12, P1145, DOI 10.1093/hmg/ddg126; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Hubbard B, 2006, GASTROENTEROLOGY, V130, P1259, DOI 10.1053/j.gastro.2006.02.012; Hui TY, 1998, J BIOL CHEM, V273, P27420, DOI 10.1074/jbc.273.42.27420; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Jandacek RJ, 2004, GASTROENTEROLOGY, V127, P139, DOI 10.1053/j.gastro.2004.04.007; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kohli R, 2007, J BIOL CHEM, V282, P21327, DOI 10.1074/jbc.M701759200; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Koppe SWP, 2004, J HEPATOL, V41, P592, DOI 10.1016/j.jhep.2004.06.030; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Kusunoki M, 2004, METABOLISM, V53, P260, DOI 10.1016/j.metabol.2003.08.016; Leeds JS, 2009, DIABETIC MED, V26, P1235, DOI 10.1111/j.1464-5491.2009.02839.x; Luiken JJFP, 2002, DIABETES, V51, P3113, DOI 10.2337/diabetes.51.10.3113; Masternak MM, 2005, EXP GERONTOL, V40, P679, DOI 10.1016/j.exger.2005.06.003; METCALFE LD, 1960, NATURE, V188, P142, DOI 10.1038/188142a0; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Mitsuyoshi H, 2009, HEPATOL RES, V39, P366, DOI 10.1111/j.1872-034X.2008.00464.x; Previs SF, 2000, J BIOL CHEM, V275, P38990, DOI 10.1074/jbc.M006490200; Rojas FA, 2001, MOL CELL ENDOCRINOL, V183, P63, DOI 10.1016/S0303-7207(01)00597-4; Ruiz-Alcaraz AJ, 2005, BIOCHEM J, V392, P345, DOI 10.1042/BJ20051194; Sandoval A, 2008, ARCH BIOCHEM BIOPHYS, V477, P363, DOI 10.1016/j.abb.2008.06.010; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Simmgen M, 2006, DIABETOLOGIA, V49, P552, DOI 10.1007/s00125-005-0084-4; Smith U, 2001, FASEB J, V15, P215, DOI 10.1096/fj.00-0020com; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Standaert ML, 2002, ENDOCRINOLOGY, V143, P1705, DOI 10.1210/en.143.5.1705; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Targher G, 2010, J HEPATOL, V53, P713, DOI 10.1016/j.jhep.2010.04.030; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952	50	21	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38952	10.1371/journal.pone.0038952	http://dx.doi.org/10.1371/journal.pone.0038952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745692	Green Submitted, gold, Green Published			2022-12-27	WOS:000305693200031
J	Crittenden, MR; Cottam, B; Savage, T; Nguyen, C; Newell, P; Gough, MJ				Crittenden, Marka R.; Cottam, Benjamin; Savage, Talicia; Cynthia Nguyen; Newell, Pippa; Gough, Michael J.			Expression of NF-kappa B p50 in Tumor Stroma Limits the Control of Tumors by Radiation Therapy	PLOS ONE			English	Article							T-CELL RESPONSES; APOPTOTIC CELLS; IMMUNE-RESPONSE; BREAST-CANCER; INFLAMMATORY RESPONSES; MACROPHAGE ACTIVATION; ANTIGEN; POLARIZATION; RECRUITMENT; RESOLUTION	Radiation therapy aims to kill cancer cells with a minimum of normal tissue toxicity. Dying cancer cells have been proposed to be a source of tumor antigens and may release endogenous immune adjuvants into the tumor environment. For these reasons, radiation therapy may be an effective modality to initiate new anti-tumor adaptive immune responses that can target residual disease and distant metastases. However, tumors engender an environment dominated by M2 differentiated tumor macrophages that support tumor invasion, metastases and escape from immune control. In this study, we demonstrate that following radiation therapy of tumors in mice, there is an influx of tumor macrophages that ultimately polarize towards immune suppression. We demonstrate using in vitro models that this polarization is mediated by transcriptional regulation by NF kappa B p50, and that in mice lacking NF kappa B p50, radiation therapy is more effective. We propose that despite the opportunity for increased antigen-specific adaptive immune responses, the intrinsic processes of repair following radiation therapy may limit the ability to control residual disease.	[Crittenden, Marka R.; Cottam, Benjamin; Savage, Talicia; Cynthia Nguyen; Gough, Michael J.] Providence Portland Med Ctr, Earle A Chiles Res Inst, Portland, OR 97213 USA; [Newell, Pippa] Providence Portland Med Ctr, Providence Hepatobiliary & Pancreat Canc Program, Portland, OR USA; [Crittenden, Marka R.] Oregon Clin, Portland, OR USA	Providence Portland Medical Center; Providence Portland Medical Center	Crittenden, MR (corresponding author), Providence Portland Med Ctr, Earle A Chiles Res Inst, Portland, OR 97213 USA.	michael.gough@providence.org	Gough, Michael/AAY-3419-2020	Gough, Michael/0000-0002-5575-0074	Providence Portland Medical Foundation; Susan G Komen Foundation [KG110131]; Wayne D. Kuni and Joan E. Kuni Foundation	Providence Portland Medical Foundation; Susan G Komen Foundation(Susan G. Komen Breast Cancer Foundation); Wayne D. Kuni and Joan E. Kuni Foundation	This work was funded by new laboratory start-up grants provided by the Providence Portland Medical Foundation (to MC and MG), by a Career Catalyst award (to MG) from the Susan G Komen Foundation (Grant Number KG110131), and a Kuni Scholar award from the Wayne D. Kuni and Joan E. Kuni Foundation (to MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn GO, 2010, P NATL ACAD SCI USA, V107, P8363, DOI 10.1073/pnas.0911378107; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; BURSUKER I, 1984, J EXP MED, V159, P1312, DOI 10.1084/jem.159.5.1312; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Chakraborty M, 2004, CANCER RES, V64, P4328, DOI 10.1158/0008-5472.CAN-04-0073; Colombo MP, 2005, CANCER RES, V65, P9113, DOI 10.1158/0008-5472.CAN-05-2714; Demaria S, 2005, CLIN CANCER RES, V11, P728; Drutman SB, 2012, J IMMUNOLOGY; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Filippi CM, 2008, J PATHOL, V214, P224, DOI 10.1002/path.2272; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Ganss R, 2002, CANCER RES, V62, P1462; Gough MJ, 2008, CANCER RES, V68, P5206, DOI 10.1158/0008-5472.CAN-07-6484; Gough MJ, 2010, J IMMUNOTHER, V33, P798, DOI 10.1097/CJI.0b013e3181ee7095; Gough MJ, 2001, CANCER RES, V61, P7240; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Halak BK, 1999, CANCER RES, V59, P911; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Kozin SV, 2010, CANCER RES, V70, P5679, DOI 10.1158/0008-5472.CAN-09-4446; Kuwata H, 2003, BLOOD, V102, P4123, DOI 10.1182/blood-2003-04-1228; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Lin EY, 2007, MOL ONCOL, V1, P288, DOI 10.1016/j.molonc.2007.10.003; Lu HY, 2011, FASEB J, V25, P3344, DOI 10.1096/fj.10-178939; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Matsumura S, 2008, J IMMUNOL, V181, P3099, DOI 10.4049/jimmunol.181.5.3099; Mauceri HJ, 1996, CANCER RES, V56, P4311; Melcher A, 1998, NAT MED, V4, P581, DOI 10.1038/nm0598-581; Mizgerd JP, 2003, AM J RESP CRIT CARE, V168, P810, DOI 10.1164/rccm.200303-412OC; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nesslinger NJ, 2007, CLIN CANCER RES, V13, P1493, DOI 10.1158/1078-0432.CCR-06-1772; Oakley F, 2005, AM J PATHOL, V166, P695, DOI 10.1016/S0002-9440(10)62291-2; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ohba K, 1998, GUT, V43, P575, DOI 10.1136/gut.43.4.575; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; PRIEBE TS, 1992, CANCER CHEMOTH PHARM, V29, P485, DOI 10.1007/BF00684853; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; RALPH P, 1977, J IMMUNOL, V119, P950; Rodriguez PC, 2004, CANCER RES, V64, P5839, DOI 10.1158/0008-5472.CAN-04-0465; Rodriguez PC, 2003, J IMMUNOL, V171, P1232, DOI 10.4049/jimmunol.171.3.1232; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Wessells J, 2004, J BIOL CHEM, V279, P49995, DOI 10.1074/jbc.M404246200; Yang YF, 1997, CANCER RES, V57, P4036	52	71	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39295	10.1371/journal.pone.0039295	http://dx.doi.org/10.1371/journal.pone.0039295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761754	Green Published, gold, Green Submitted			2022-12-27	WOS:000305826400011
J	Larbi, A; Gombert, JM; Auvray, C; l'Homme, B; Magniez, A; Feraud, O; Coulombel, L; Chapel, A; Mitjavila-Garcia, MT; Turhan, AG; Haddad, R; Bennaceur-Griscelli, A				Larbi, Aniya; Gombert, Jean-Marc; Auvray, Celine; l'Homme, Bruno; Magniez, Aurelie; Feraud, Olivier; Coulombel, Laure; Chapel, Alain; Mitjavila-Garcia, Maria Teresa; Turhan, Ali G.; Haddad, Rima; Bennaceur-Griscelli, Annelise			The HOXB4 Homeoprotein Promotes the Ex Vivo Enrichment of Functional Human Embryonic Stem Cell-Derived NK Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; HEMATOPOIETIC STEM; CD34(+) CELLS; PROGENITOR CELLS; DENDRITIC CELLS; DIFFERENTIATION; EXPRESSION; EXPANSION; LINES; OVEREXPRESSION	Human embryonic stem cells (hESCs) can be induced to differentiate into blood cells using either co-culture with stromal cells or following human embryoid bodies (hEBs) formation. It is now well established that the HOXB4 homeoprotein promotes the expansion of human adult hematopoietic stem cells (HSCs) but also myeloid and lymphoid progenitors. However, the role of HOXB4 in the development of hematopoietic cells from hESCs and particularly in the generation of hESC-derived NK-progenitor cells remains elusive. Based on the ability of HOXB4 to passively enter hematopoietic cells in a system that comprises a co-culture with the MS-5/SP-HOXB4 stromal cells, we provide evidence that HOXB4 delivery promotes the enrichment of hEB-derived precursors that could differentiate into fully mature and functional NK. These hEB-derived NK cells enriched by HOXB4 were characterized according to their CMH class I receptor expression, their cytotoxic arsenal, their expression of IFN gamma and CD107a after stimulation and their lytic activity. Furthermore our study provides new insights into the gene expression profile of hEB-derived cells exposed to HOXB4 and shows the emergence of CD34(+)CD45RA(+) precursors from hEBs indicating the lymphoid specification of hESC-derived hematopoietic precursors. Altogether, our results outline the effects of HOXB4 in combination with stromal cells in the development of NK cells from hESCs and suggest the potential use of HOXB4 protein for NK-cell enrichment from pluripotent stem cells.	[Larbi, Aniya; Magniez, Aurelie; Feraud, Olivier; Coulombel, Laure; Mitjavila-Garcia, Maria Teresa; Turhan, Ali G.; Haddad, Rima; Bennaceur-Griscelli, Annelise] Univ Paris 11, Hop Paul Brousse, INSERM,Inst Andre Lwoff, UMR 935,ESTeam Paris Sud,Stem Cell Core Facil, Villejuif, France; [Gombert, Jean-Marc; Turhan, Ali G.] Univ Poitiers, CHU Poitiers, INSERM, UMR 935, Poitiers, France; [Auvray, Celine] INSERM, U1016, Inst Cochin, Paris, France; [Auvray, Celine] CNRS, UMR 8104, Paris, France; [Auvray, Celine] Univ Paris 05, Sorbonne Paris Cite, France; [l'Homme, Bruno; Chapel, Alain] IRSN, PRP HOM, SRBE, Lab Radiopathol & Expt Therapies, Fontenay Aux Roses, France; [Haddad, Rima; Bennaceur-Griscelli, Annelise] Univ Paris 11, Fac Med, Le Kremlin Bicetre, France; [Bennaceur-Griscelli, Annelise] Hop Paul Brousse, Univ Hosp Paris Sud, AP HP, Hematol Lab, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP	Larbi, A (corresponding author), Univ Paris 11, Hop Paul Brousse, INSERM,Inst Andre Lwoff, UMR 935,ESTeam Paris Sud,Stem Cell Core Facil, Villejuif, France.	rima.haddad@inserm.fr	Mitjavila-Garcia, Maria Teresa/L-8909-2018	MAGNIEZ, Aurelie/0000-0003-3116-1723; TURHAN, Ali/0000-0002-4861-0137; bennaceur griscelli, annelise/0000-0002-3557-4499; chapel, alain/0000-0002-4687-4120; FERAUD, Olivier/0000-0002-5332-600X	Inserm; Universite Paris Sud 11; Medicen-Paris Region Ile de France (IngeCELL); PRES UniverSud; Association NRB vaincre le cancer	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Sud 11; Medicen-Paris Region Ile de France (IngeCELL)(Region Ile-de-France); PRES UniverSud; Association NRB vaincre le cancer	This work was supported by Inserm, Universite Paris Sud 11, Medicen-Paris Region Ile de France (IngeCELL), PRES UniverSud and the Association NRB vaincre le cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsellem S, 2003, NAT MED, V9, P1423, DOI 10.1038/nm953; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Auvray C, HAEMATOLOGICA, V97, P168; Bourgeois E, 2009, EUR J IMMUNOL, V39, P1046, DOI 10.1002/eji.200838575; Bowles KM, 2006, STEM CELLS, V24, P1359, DOI 10.1634/stemcells.2005-0210; Buske C, 2002, BLOOD, V100, P862, DOI 10.1182/blood-2002-01-0220; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chan KM, 2008, BLOOD, V111, P2953, DOI 10.1182/blood-2007-10-117366; Deneault E, 2009, CELL, V137, P369, DOI 10.1016/j.cell.2009.03.026; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Elliott JM, 2010, J EXP MED, V207, P2073, DOI 10.1084/jem.20100986; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Goldman O, 2009, STEM CELLS, V27, P1750, DOI 10.1002/stem.100; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Haddad R, 2007, LEUKEMIA, V21, P1836, DOI 10.1038/sj.leu.2404725; Haddad R, 2004, BLOOD, V104, P3918, DOI 10.1182/blood-2004-05-1845; Haddad R, 2006, IMMUNITY, V24, P217, DOI 10.1016/j.immuni.2006.01.008; Haddad R, 2008, STEM CELLS, V26, P312, DOI 10.1634/stemcells.2007-0721; Helgason CD, 1996, BLOOD, V87, P2740, DOI 10.1182/blood.V87.7.2740.bloodjournal8772740; ISSAAD C, 1993, BLOOD, V81, P2916; ITOH K, 1989, EXP HEMATOL, V17, P145; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; KLEIN E, 1976, INT J CANCER, V18, P421, DOI 10.1002/ijc.2910180405; Knorr DA, 2010, TRANSL RES, V156, P147, DOI 10.1016/j.trsl.2010.07.008; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lee GS, 2008, MOL CELLS, V25, P487; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SJ, 2007, STEM CELLS DEV, V16, P547, DOI 10.1089/scd.2007.0002; Ma F, 2008, P NATL ACAD SCI USA, V105, P13087, DOI 10.1073/pnas.0802220105; Melief CJM, 2000, ADV IMMUNOL, V75, P235, DOI 10.1016/S0065-2776(00)75006-1; Milsom MD, 2009, BLOOD, V113, P5111, DOI 10.1182/blood-2008-09-180224; Nasef A, 2008, CELL IMMUNOL, V253, P16, DOI 10.1016/j.cellimm.2008.06.002; Oshima M, 2011, BLOOD, V117, pE142, DOI 10.1182/blood-2010-12-323212; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pelayo R, 2005, CURR OPIN IMMUNOL, V17, P100, DOI 10.1016/j.coi.2005.01.012; Pilat S, 2005, P NATL ACAD SCI USA, V102, P12101, DOI 10.1073/pnas.0505624102; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Schiedlmeier B, 2003, BLOOD, V101, P1759, DOI 10.1182/blood-2002-03-0767; Schiedlmeier B, 2007, P NATL ACAD SCI USA, V104, P16952, DOI 10.1073/pnas.0703082104; Tashiro K, 2012, STEM CELL RES, V8, P300, DOI 10.1016/j.scr.2011.09.001; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tian XH, 2004, EXP HEMATOL, V32, P1000, DOI 10.1016/j.exphem.2004.06.013; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Woan K, 2007, EXPERT OPIN BIOL TH, V7, P17, DOI 10.1517/14712598.7.1.17; Woll PS, 2005, J IMMUNOL, V175, P5095, DOI 10.4049/jimmunol.175.8.5095; Woll PS, 2009, BLOOD; Yong ASM, 2009, BLOOD, V113, P875, DOI 10.1182/blood-2008-05-158253; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522; Zhan XC, 2004, LANCET, V364, P163, DOI 10.1016/S0140-6736(04)16629-4; Zhang XB, 2006, PLOS MED, V3, P687, DOI 10.1371/journal.pmed.0030173	55	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39514	10.1371/journal.pone.0039514	http://dx.doi.org/10.1371/journal.pone.0039514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761810	gold, Green Published, Green Submitted			2022-12-27	WOS:000305825800040
J	Magar, V; Lefranc, M; Hoyle, RB; Reeve, DE				Magar, Vanesa; Lefranc, Marc; Hoyle, Rebecca B.; Reeve, Dominic E.			Spectral Quantification of Nonlinear Behaviour of the Nearshore Seabed and Correlations with Potential Forcings at Duck, NC, USA	PLOS ONE			English	Article							WAVE CLIMATE; SOUTHERN-OSCILLATION; TEMPORAL VARIABILITY; SHORELINE RESPONSE; BEACH PROFILES; EVOLUTION; BARS; GENERATION; MORPHOLOGY; STABILITY	Local bathymetric, quasi-periodic patterns of oscillation are identified from 26 years of monthly profile surveys taken at two shore-perpendicular transects at Duck, North Carolina, USA. The data cover both the swash and surf zones. Singular Spectrum Analysis (SSA) and Multi-channel Singular Spectrum analysis (MSSA) methods are applied, on the shoreface, to three potential forcings: the monthly wave heights, the monthly mean water levels and the large scale atmospheric index known as the North Atlantic Oscillation. The patterns within these forcings are compared to the local bathymetric patterns; it is found that the patterns extracted using SSA and MSSA agree well with previous patterns identified using wavelets and confirm the highly non-stationary behaviour of beach levels at Duck. This is followed by analysis of potential correlations between the local bathymetry (at the two transects) and hydrodynamic and atmospheric patterns. The study is then extended to all measured bathymetric profiles, covering an area of 1100 m (alongshore) by 440 m (cross-shore). MSSA showed no collective inter-annual patterns of oscillations present in the bathymetry and the three potential forcings. Annual and semi-annual cycles within the bathymetry are found to be strongly correlated with the monthly wave height, in agreement with the SSA findings. Other collective intra-annual cycles besides the semi-annual were identified; they were all correlated with the North Atlantic Oscillation.	[Magar, Vanesa; Reeve, Dominic E.] Univ Plymouth, Coastal Engn Res Grp, Inst Marine, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England; [Lefranc, Marc] Univ Sci & Technol Lille, Lab Phys Lasers Atomes Mol PhLAM, Villeneuve Dascq, France; [Lefranc, Marc] Univ Sci & Technol Lille, CERLA, UFR Phys, Villeneuve Dascq, France; [Hoyle, Rebecca B.] Univ Surrey, Dept Math, Guildford GU2 5XH, Surrey, England	University of Plymouth; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; University of Surrey	Magar, V (corresponding author), Univ Plymouth, Coastal Engn Res Grp, Inst Marine, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England.	vanesa.magar@plymouth.ac.uk	Magar, Vanesa/G-1502-2012; Reeve, Dominic/W-8125-2019; Lefranc, Marc/B-3062-2009; Magar, Vanesa/O-2103-2019; Magar, Vanesa/AEK-2907-2022	Magar, Vanesa/0000-0002-7897-1507; Reeve, Dominic/0000-0003-1293-4743; Lefranc, Marc/0000-0003-2563-7967; Magar, Vanesa/0000-0002-7897-1507; Hoyle, Rebecca/0000-0002-1645-1071	Research Councils United Kingdom (RCUK) Academic Fellowship from the Engineering and Physical Sciences Research Council (EPSRC) [EP/C508750/1]; Plymouth University, UK; EPSRC [EP/I027912/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I027912/1] Funding Source: researchfish	Research Councils United Kingdom (RCUK) Academic Fellowship from the Engineering and Physical Sciences Research Council (EPSRC); Plymouth University, UK; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by a Research Councils United Kingdom (RCUK) Academic Fellowship from the Engineering and Physical Sciences Research Council (EPSRC) (grant number EP/C508750/1) and a Research and Innovation Fellowship award from Plymouth University, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMA H, 1970, J ACM, V17, P589, DOI 10.1145/321607.321609; Birkemeier W. A., 1984, COASTAL ENG 84, P1507; Birkemeier WA, 1999, COASTAL SEDIMENTS '99, VOLS 1-3, P1109; Bowen A., 1980, COASTLINE CANADA, P1; BOWEN AJ, 1978, J GEOPHYS RES-OCEANS, V83, P1913, DOI 10.1029/JC083iC04p01913; Cayocca F, 2001, COAST ENG, V42, P115, DOI 10.1016/S0378-3839(00)00053-3; DEVRIEND HJ, 1993, COAST ENG, V21, P225, DOI 10.1016/0378-3839(93)90051-9; Dodd N, 2003, J COASTAL RES, V19, P849; Dowdy S., 1983, STAT RES; Falques A, 2000, J GEOPHYS RES-OCEANS, V105, P24071, DOI 10.1029/2000JC900100; Gehrels R, 2008, GEOGRAPHY, V93, P11; Gilmore R., 2002, TOPOLOGY CHAOS ALICE; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; GRASSBERGER P, 1986, NATURE, V323, P609, DOI 10.1038/323609a0; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Holman R. A., 1986, EOS, V67, P1369; HOLMAN RA, 1982, J GEOPHYS RES-OCEANS, V87, P457, DOI 10.1029/JC087iC01p00457; Holman RA, 1987, P COAST SED 87, P927; Horrillo-Caraballo JM, 2008, J FLOOD RISK MANAG, V1, P110, DOI 10.1111/j.1753-318X.2008.00013.x; Howd PA, 1987, BEACH NEARSHORE SURV; Kirby JR, 2008, CONT SHELF RES, V28, P2615, DOI 10.1016/j.csr.2008.08.006; Kuriyama Y, 2008, MAR GEOL, V248, P1, DOI 10.1016/j.margeo.2007.10.006; LARSON M, 1994, MAR GEOL, V117, P75, DOI 10.1016/0025-3227(94)90007-8; Lee GH, 1998, MAR GEOL, V148, P163, DOI 10.1016/S0025-3227(98)00010-3; Lee GH, 1993, BEACH NEARSHORE SURV; Li Y, 2005, COAST ENG, V52, P1133, DOI 10.1016/j.coastaleng.2005.07.002; Lippmann T.C., 1993, J COASTAL RES, V15, P49, DOI DOI 10.1175/JP0-D-16-0015.1; LIPPMANN TC, 1990, J GEOPHYS RES-OCEANS, V95, P11575, DOI 10.1029/JC095iC07p11575; Miller JK, 2007, COAST ENG, V54, P111, DOI 10.1016/j.coastaleng.2006.08.013; Mote PW, 2000, J GEOPHYS RES-ATMOS, V105, P17457, DOI 10.1029/2000JD900158; Nicholls RJ, 1998, MAR GEOL, V148, P179, DOI 10.1016/S0025-3227(98)00011-5; Papadopoulos A, 2006, J COASTAL RES, V22, P625, DOI 10.2112/04-0156.1; Pape L, 2008, NONLINEAR PROC GEOPH, V15, P145, DOI 10.5194/npg-15-145-2008; Plant NG, 1999, J GEOPHYS RES-OCEANS, V104, P15755, DOI 10.1029/1999JC900112; PLAUT G, 1994, J ATMOS SCI, V51, P210, DOI 10.1175/1520-0469(1994)051<0210:SOLFOA>2.0.CO;2; Pruszak Z, 1999, COASTAL SEDIMENTS '99, VOLS 1-3, P1081; Ranasinghe R, 2004, MAR GEOL, V204, P273, DOI 10.1016/S0025-3227(04)00002-7; Rattan SSP, 2005, NONLINEAR PROC GEOPH, V12, P661, DOI 10.5194/npg-12-661-2005; Reeve D, 2007, COAST ENG, V54, P401, DOI 10.1016/j.coastaleng.2006.11.008; Reeve DE, 2008, ESTUAR COAST SHELF S, V79, P387, DOI 10.1016/j.ecss.2008.04.016; ROGERS JC, 1984, MON WEATHER REV, V112, P1999, DOI 10.1175/1520-0493(1984)112<1999:TABTNA>2.0.CO;2; Rozynski G, 2005, COAST ENG, V52, P79, DOI 10.1016/j.coastaleng.2004.09.007; Rozynski G, 2003, COAST ENG, V48, P151, DOI 10.1016/S0378-3839(03)00024-3; Rozynski G, 2001, COAST ENG, V43, P41, DOI 10.1016/S0378-3839(01)00005-9; Rozynski G, 2010, OCEAN ENG, V37, P186, DOI 10.1016/j.oceaneng.2009.11.008; RUELLE D, 1990, P ROY SOC LOND A MAT, V427, P241, DOI 10.1098/rspa.1990.0010; RUESSINK BG, 1994, MAR GEOL, V121, P187, DOI 10.1016/0025-3227(94)90030-2; Ruessink BG, 2000, MAR GEOL, V163, P289, DOI 10.1016/S0025-3227(99)00094-8; Shand RD, 2007, J COASTAL RES, P721; Shand RD, 1999, J COASTAL RES, V15, P750; Southgate HN, 2003, J COASTAL RES, V19, P776; Southgate HN, 2000, J GEOPHYS RES-OCEANS, V105, P11489, DOI 10.1029/2000JC900021; VAUTARD R, 1989, PHYSICA D, V35, P395, DOI 10.1016/0167-2789(89)90077-8; WIJNBERG KM, 1995, MAR GEOL, V126, P301, DOI 10.1016/0025-3227(95)00084-C; Wijnberg KM, 2002, GEOMORPHOLOGY, V48, P103, DOI 10.1016/S0169-555X(02)00177-0; WINANT CD, 1975, J GEOPHYS RES, V80, P1979, DOI 10.1029/JC080i015p01979; WRIGHT LD, 1984, MAR GEOL, V56, P93, DOI 10.1016/0025-3227(84)90008-2; Yiou P, 2000, PHYSICA D, V142, P254, DOI 10.1016/S0167-2789(00)00045-2	58	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39196	10.1371/journal.pone.0039196	http://dx.doi.org/10.1371/journal.pone.0039196			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22745714	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000305808700019
J	Zhang, C; Fan, K; Ma, XF; Wei, DZ				Zhang, Chun; Fan, Kai; Ma, Xuefeng; Wei, Dongzhi			Impact of Large Aggregated Uricases and PEG Diol on Accelerated Blood Clearance of PEGylated Canine Uricase	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; URATE OXIDASE; POLY(ETHYLENE GLYCOL); REPEATED INJECTION; BIOPHARMACEUTICAL PROPERTIES; POLYETHYLENE-GLYCOL; PROTEIN PEGYLATION; REFRACTORY GOUT; ABC PHENOMENON; LIPOSOMES	Background: Uricase has proven therapeutic value in treating hyperuricemia but sufficient reduction of its immunogenicity may be the largest obstacle to its chronic use. In this study, canine uricase was modified with 5 kDa mPEG-SPA and the impact of large aggregated uricases and cross-linked conjugates induced by difunctional PEG diol on immunogenicity was investigated. Methods and Findings: Recombinant canine uricase was first expressed and purified to homogeneity. Source 15Q anion-exchange chromatography was used to separate tetrameric and aggregated uricase prior to pegylation, while DEAE anion-exchange chromatography was used to remove Di-acid PEG (precursor of PEG diol) from unfractionated 5 kDa mPEG-propionic acid. Tetrameric and aggregated uricases were separately modified with the purified mPEG-SPA. In addition, tetrameric uricases was modified with unfractionated mPEG-SPA, resulting in three types of 5 kDa mPEG-SPA modified uricase. The conjugate size was evaluated by dynamic light scattering and transmission electron microscope. The influence of differently PEGylated uricases on pharmacokinetics and immunogenicity were evaluated in vivo. The accelerated blood clearance (ABC) phenomenon previously identified for PEGylated liposomes occurred in rats injected with PEGylated uricase aggregates. Anti-PEG IgM antibodies, rather than neutralizing antibodies, were found to mediate the ABC. Conclusions: The size of conjugates is important for triggering such phenomena and we speculate that 40-60 nm is the lower size limit that can trigger ABC. Removal of the uricase aggregates and the PEG diol contaminant and modifying with small PEG reagents enabled ABC to be successfully avoided and sufficient reduction in the immunogenicity of 5 kDa mPEG-modified tetrameric canine uricase.	[Zhang, Chun; Wei, Dongzhi] E China Univ Sci & Technol, Newworld Inst Biotechnol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China; [Fan, Kai; Ma, Xuefeng] Fagen Biomed Inc, Chongqing, Peoples R China; [Zhang, Chun] Linyi Univ, Modern TCM Inst, Linyi, Shandong, Peoples R China	East China University of Science & Technology; Linyi University	Zhang, C (corresponding author), E China Univ Sci & Technol, Newworld Inst Biotechnol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.	dzhwei@ecust.edu.cn	Wei, Dongzhi/AAJ-3404-2021		Key Project of the National High Technology Research and Development Program of China [2009ZX09306-001]	Key Project of the National High Technology Research and Development Program of China	The research is founded by Key Project of the National High Technology Research and Development Program of China (No. 2009ZX09306-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bomalaski JS, 2002, J RHEUMATOL, V29, P1942; Bruno R, 2004, ANTIVIR THER, V9, P491; Caliceti P, 2001, BIOCONJUGATE CHEM, V12, P515, DOI 10.1021/bc000119x; Caliceti P, 1999, BIOCONJUGATE CHEM, V10, P638, DOI 10.1021/bc980155k; CHEN RHL, 1981, BIOCHIM BIOPHYS ACTA, V660, P293, DOI 10.1016/0005-2744(81)90173-X; Colloc'h N, 2000, PROTEINS, V39, P142, DOI 10.1002/(SICI)1097-0134(20000501)39:2<142::AID-PROT4>3.0.CO;2-X; Colloch N, 1997, NAT STRUCT BIOL, V4, P947, DOI 10.1038/nsb1197-947; CONLEY TG, 1980, BIOCHEM J, V187, P727, DOI 10.1042/bj1870727; DAVIS S, 1981, LANCET, V2, P281; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Efremova NV, 2001, LANGMUIR, V17, P7628, DOI 10.1021/la010405c; Freitas DD, 2010, INT J PHARMACEUT, V387, P215, DOI 10.1016/j.ijpharm.2009.11.034; Ganson NJ, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1861; Garay R.P., 2011, OPEN C P J, V2, P104, DOI [10.2174/2210289201102010104, DOI 10.2174/2210289201102010104]; Harris MJ, 1997, POLY ETHYLENE GLYCOL; Hershfield MS, 1998, SEMIN HEMATOL, V35, P291; Ishida T, 2006, J CONTROL RELEASE, V112, P15, DOI 10.1016/j.jconrel.2006.01.005; Ishida T, 2003, J CONTROL RELEASE, V88, P35, DOI 10.1016/S0168-3659(02)00462-5; Ishida T, 2003, INT J PHARMACEUT, V255, P167, DOI 10.1016/S0378-5173(03)00085-1; Ishida T, 2008, INT J PHARM, V354, P56, DOI 10.1016/j.ijpharm.2007.11.005; Ishida T, 2007, J CONTROL RELEASE, V122, P349, DOI 10.1016/j.jconrel.2007.05.015; Ishida T, 2006, J CONTROL RELEASE, V115, P243, DOI 10.1016/j.jconrel.2006.08.001; Ishihara T, 2009, PHARM RES-DORDR, V26, P2270, DOI 10.1007/s11095-009-9943-x; Kahn K, 1998, BIOCHEMISTRY-US, V37, P11651, DOI 10.1021/bi980446g; KISSEL P, 1975, LANCET, V1, P229; Koide H, 2010, INT J PHARMACEUT, V392, P218, DOI 10.1016/j.ijpharm.2010.03.022; Koide H, 2008, INT J PHARMACEUT, V362, P197, DOI 10.1016/j.ijpharm.2008.06.004; Kozlowski A, 2001, BIODRUGS, V15, P419, DOI 10.2165/00063030-200115070-00001; Ma HL, 2010, PHARM RES-DORDR, V27, P296, DOI 10.1007/s11095-009-0018-9; Parkinson C, 2003, ADV DRUG DELIVER REV, V55, P1303, DOI 10.1016/S0169-409X(03)00111-X; Pasut G, 2008, ADV DRUG DELIVER REV, V60, P69, DOI 10.1016/j.addr.2007.04.018; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Safra N, 2005, J HERED, V96, P750, DOI 10.1093/jhered/esi078; Schiavon O, 2000, FARMACO, V55, P264, DOI 10.1016/S0014-827X(00)00031-8; Schlesinger N, 2011, NAT REV DRUG DISCOV, V10, P17, DOI 10.1038/nrd3349; Sherman MR, 2008, ADV DRUG DELIVER REV, V60, P59, DOI 10.1016/j.addr.2007.06.011; SIBONY G, 1984, PRESSE MED, V13, P443; SMYTH CJ, 1975, ARTHRITIS RHEUM-US, V18, P713, DOI 10.1002/art.1780180712; STOCKS SJ, 1986, ANAL BIOCHEM, V154, P232, DOI 10.1016/0003-2697(86)90520-8; Sundy JS, 2007, ARTHRITIS RHEUM-US, V56, P1021, DOI 10.1002/art.22403; TSUKADA H, 1966, J CELL BIOL, V28, P449, DOI 10.1083/jcb.28.3.449; Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9; Wang XY, 2007, J CONTROL RELEASE, V119, P236, DOI 10.1016/j.jconrel.2007.02.010; Wang XY, 2005, J CONTROL RELEASE, V104, P91, DOI 10.1016/j.jconrel.2005.01.008; Zhang C, 2012, INT J PHARMACEUT, V430, P307, DOI 10.1016/j.ijpharm.2012.03.057; Zhang C, 2012, BIOCHIMIE, V94, P1412, DOI 10.1016/j.biochi.2012.03.016	47	25	27	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39659	10.1371/journal.pone.0039659	http://dx.doi.org/10.1371/journal.pone.0039659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22745806	Green Submitted, gold, Green Published			2022-12-27	WOS:000305808700043
J	Huang, JY; Chiang, MT; Yet, SF; Chau, LY				Huang, Jun-Yuan; Chiang, Ming-Tsai; Yet, Shaw-Fang; Chau, Lee-Young			Myeloid Heme Oxygenase-1 Haploinsufficiency Reduces High Fat Diet-Induced Insulin Resistance by Affecting Adipose Macrophage Infiltration in Mice	PLOS ONE			English	Article							FOCAL ADHESION KINASE; CARBON-MONOXIDE; METABOLIC SYNDROME; PPAR-GAMMA; IN-VIVO; OBESITY; TISSUE; SENSITIVITY; ANGIOGENESIS; ACTIVATION	Increased adipose tissue macrophages contribute to obesity-induced metabolic syndrome. Heme oxygenase-1 (HO-1) is a stress-inducible enzyme with potent anti-inflammatory and proangiogenic activities in macrophages. However, the role of macrophage HO-1 on obesity-induced adipose inflammation and metabolic syndrome remains unclear. Here we show that high-fat diet (HFD) feeding in C57BL/6J mice induced HO-1 expression in the visceral adipose tissue, particularly the stromal vascular fraction. When the irradiated C57BL/6J mice reconstituted with wild-type or HO-1(+/-) bone marrow were fed with HFD for over 24 weeks, the HO-1(+/-) chimeras were protected from HFD-induced insulin resistance and this was associated with reduced adipose macrophage infiltration and angiogenesis, suggesting that HO-1 affects myeloid cell migration toward adipose tissue during obesity. In vivo and in vitro migration assays revealed that HO-1(+/-) macrophages exhibited an impaired migration response. Chemoattractant-induced phosphorylation of p38 and focal adhesion kinase (FAK) declined faster in HO-1(+/-) macrophages. Further experiments demonstrated that carbon monoxide and bilirubin, the byproducts derived from heme degradation by HO-1, enhanced macrophage migration by increasing phosphorylation of p38 and FAK, respectively. These data disclose a novel role of hematopoietic cell HO-1 in promoting adipose macrophage infiltration and the development of insulin resistance during obesity.	[Huang, Jun-Yuan; Chau, Lee-Young] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Huang, Jun-Yuan; Chiang, Ming-Tsai; Chau, Lee-Young] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Yet, Shaw-Fang] Natl Hlth Res Inst, Zhunan, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan; National Health Research Institutes - Taiwan	Huang, JY (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	lyc@ibms.sinica.edu.tw	Yet, Shaw-Fang/O-8583-2019; Chau, Lee-Young/N-7659-2018; Yet, Shaw-Fang/B-1067-2010	Chau, Lee-Young/0000-0002-6316-2328; Yet, Shaw-Fang/0000-0001-9097-3962	National Science Council of Taiwan [NSC-97-2320-B-001-010-MY3]; National Research Program for Genomic Medicine at the National Science Council of Taiwan [NSC97-3112-B001-025]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Research Program for Genomic Medicine at the National Science Council of Taiwan	This work was supported by a grant from the National Science Council of Taiwan (NSC-97-2320-B-001-010-MY3) (URL://web1.nsc.gov.tw). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Taiwan Mouse Clinic Core (NSC97-3112-B001-025) funded by the National Research Program for Genomic Medicine at the National Science Council of Taiwan for technical support.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Arefieva TI, 2005, CYTOKINE, V31, P439, DOI 10.1016/j.cyto.2005.06.016; Ashida N, 2001, J BIOL CHEM, V276, P16555, DOI 10.1074/jbc.M009068200; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Bilban M, 2008, J MOL MED, V86, P267, DOI 10.1007/s00109-007-0276-0; Brakenhielm E, 2004, CIRC RES, V94, P1579, DOI 10.1161/01.RES.0000132745.76882.70; Brakenhielm Ebba, 2008, V456, P65, DOI 10.1007/978-1-59745-245-8_5; Bussolati B, 2004, BLOOD, V103, P761, DOI 10.1182/blood-2003-06-1974; Cao CZ, 2005, BLOOD, V106, P3234, DOI 10.1182/blood-2005-03-1288; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Coppack SW, 2001, P NUTR SOC, V60, P349, DOI 10.1079/PNS2001110; Del Rio M, 1998, LIFE SCI, V63, P871, DOI 10.1016/S0024-3205(98)00344-0; Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P881, DOI 10.1189/jlb.0808471; Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Johnson FK, 2006, AM J PHYSIOL-REG I, V290, pR601, DOI 10.1152/ajpregu.00308.2005; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Lijnen HR, 2008, CARDIOVASC RES, V78, P286, DOI 10.1093/cvr/cvm007; Lin HH, 2009, J THROMB HAEMOST, V7, P1401, DOI 10.1111/j.1538-7836.2009.03478.x; Lin PH, 2008, BBA-MOL CELL RES, V1783, P1826, DOI 10.1016/j.bbamcr.2008.05.008; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Matsumoto H, 2006, MOL CELL BIOCHEM, V291, P21, DOI 10.1007/s11010-006-9190-y; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; Ndisang JF, 2009, ENDOCRINOLOGY, V150, P2098, DOI 10.1210/en.2008-0239; Nicolai A, 2009, HYPERTENSION, V53, P508, DOI 10.1161/HYPERTENSIONAHA.108.124701; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Orozco LD, 2007, CIRC RES, V100, P1703, DOI 10.1161/CIRCRESAHA.107.151720; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pittock ST, 2005, KIDNEY INT, V68, P611, DOI 10.1111/j.1523-1755.2005.00439.x; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Rodriguez AI, 2010, ARTERIOSCL THROM VAS, V30, P98, DOI 10.1161/ATVBAHA.109.197822; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Song H, 2010, STEM CELLS, V28, P555, DOI 10.1002/stem.302; Soukas A, 2000, GENE DEV, V14, P963; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Victor VM, 2003, INT IMMUNOPHARMACOL, V3, P97, DOI 10.1016/S1567-5769(02)00232-1; Weis N, 2009, MOL BIOL CELL, V20, P1280, DOI 10.1091/mbc.E08-10-1005; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246	52	23	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38626	10.1371/journal.pone.0038626	http://dx.doi.org/10.1371/journal.pone.0038626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22761690	Green Submitted, Green Published, gold			2022-12-27	WOS:000305695100012
J	Huyghe, A; Horzinski, L; Henaut, A; Gaillard, M; Bertini, E; Schiffmann, R; Rodriguez, D; Dantal, Y; Boespflug-Tanguy, O; Fogli, A				Huyghe, Aurelia; Horzinski, Laetitia; Henaut, Alain; Gaillard, Marina; Bertini, Enrico; Schiffmann, Raphael; Rodriguez, Diana; Dantal, Yann; Boespflug-Tanguy, Odile; Fogli, Anne			Developmental Splicing Deregulation in Leukodystrophies Related to EIF2B Mutations	PLOS ONE			English	Article							VANISHING WHITE-MATTER; CENTRAL-NERVOUS-SYSTEM; ENDOPLASMIC-RETICULUM-STRESS; UNFOLDED PROTEIN RESPONSE; FIBRILLARY ACIDIC PROTEIN; CHILDHOOD ATAXIA; EIF2B-RELATED DISORDERS; GENE-EXPRESSION; PROTEOLIPID PROTEIN; MYELINATING CELLS	Leukodystrophies (LD) are rare inherited disorders that primarily affect the white matter (WM) of the central nervous system. The large heterogeneity of LD results from the diversity of the genetically determined defects that interfere with glial cells functions. Astrocytes have been identified as the primary target of LD with cystic myelin breakdown including those related to mutations in the ubiquitous translation initiation factor eIF2B. EIF2B is involved in global protein synthesis and its regulation under normal and stress conditions. Little is known about how eIF2B mutations have a major effect on WM. We performed a transcriptomic analysis using fibroblasts of 10 eIF2B-mutated patients with a severe phenotype and 10 age matched patients with other types of LD in comparison to control fibroblasts. ANOVA was used to identify genes that were statistically significantly differentially expressed at basal state and after ER-stress. The pattern of differentially expressed genes between basal state and ER-stress did not differ significantly among each of the three conditions. However, 70 genes were specifically differentially expressed in eIF2B-mutated fibroblasts whatever the stress conditions tested compared to controls, 96% being under-expressed. Most of these genes were involved in mRNA regulation and mitochondrial metabolism. The 13 most representative genes, including genes belonging to the Heterogeneous Nuclear Ribonucleoprotein (HNRNP) family, described as regulators of splicing events and stability of mRNA, were dysregulated during the development of eIF2B-mutated brains. HNRNPH1, F and C mRNA were over-expressed in foetus but under-expressed in children and adult brains. The abnormal regulation of HNRNP expression in the brain of eIF2B-mutated patients was concomitant with splicing dysregulation of the main genes involved in glial maturation such as PLP1 for oligodendrocytes and GFAP in astrocytes. These findings demonstrate a developmental deregulation of splicing events in glial cells that is related to abnormal production of HNRNP, in eIF2B-mutated brains.	[Huyghe, Aurelia; Horzinski, Laetitia; Gaillard, Marina; Dantal, Yann; Boespflug-Tanguy, Odile; Fogli, Anne] Soluscience, Fac Med, Clermont Ferrand, France; [Huyghe, Aurelia; Horzinski, Laetitia; Gaillard, Marina; Fogli, Anne] Univ Clermont Ferrand, UFR Med, Clermont Ferrand, France; [Henaut, Alain] Univ Paris 06, CNRS, Paris, France; [Bertini, Enrico] Bambino Gesu Pediat Hosp, Inst Ricovero & Cura Carattere Sci IRCCS, Div Neuromuscular & Neurodegenerat Disorders, Mol Med Lab,Dept Neurosci, Rome, Italy; [Schiffmann, Raphael] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA; [Rodriguez, Diana] Hop Armand Trousseau, AP HP, Serv Neuropediat, Paris, France; [Rodriguez, Diana; Boespflug-Tanguy, Odile] Hop Robert Debre, INSERM, U676, F-75019 Paris, France; [Boespflug-Tanguy, Odile] Hop Robert Debre, AP HP, Serv Neuropediat & Malad Metab, F-75019 Paris, France; [Boespflug-Tanguy, Odile] Univ Paris Diderot, Paris, France; [Fogli, Anne] Ctr Hosp Univ Clermont Ferrand, Serv Biochim Med & Biol Mol, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; IRCCS Bambino Gesu; Baylor Scott & White Health; Baylor University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Clermont Ferrand	Huyghe, A (corresponding author), Soluscience, Fac Med, Clermont Ferrand, France.	anne.fogli@u-clermont1.fr	Rodriguez, Diana/GVR-7668-2022; Bertini, Enrico/A-2284-2014; Huyghe, Aurélia/AAA-5203-2020; Bertini, Enrico/ABG-1278-2020; Fogli, Anne/AAL-6640-2020	Bertini, Enrico/0000-0001-9276-4590; Fogli, Anne/0000-0002-2651-7441	European Leukodystrophy Association (ELA) research foundation; Health European Framework Program 7 (Leukotreat) [241622]; French research Ministry (Ecole Doctorale "Sciences de la Vie et de la Sante", Clermont University, France)	European Leukodystrophy Association (ELA) research foundation; Health European Framework Program 7 (Leukotreat); French research Ministry (Ecole Doctorale "Sciences de la Vie et de la Sante", Clermont University, France)	This work was supported by a grant of the European Leukodystrophy Association (ELA) research foundation and of the Health European Framework Program 7 (Leukotreat, grant number 241622 coordinated by OBT). AuH was supported by a PhD grant from the French research Ministry (Ecole Doctorale "Sciences de la Vie et de la Sante", Clermont University, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARQUINT M, 1987, P NATL ACAD SCI USA, V84, P600, DOI 10.1073/pnas.84.2.600; Bione S, 1998, AM J HUM GENET, V62, P533, DOI 10.1086/301761; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Boespflug-Tanguy O, 2008, CURR NEUROL NEUROSCI, V8, P217, DOI 10.1007/s11910-008-0034-x; Bugiani M, 2011, J NEUROPATH EXP NEUR, V70, P69, DOI 10.1097/NEN.0b013e318203ae74; CAMPAGNONI AT, 1988, J NEUROCHEM, V51, P1, DOI 10.1111/j.1471-4159.1988.tb04827.x; Capello E, 1997, ANN NEUROL, V41, P797, DOI 10.1002/ana.410410616; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; Chesnoy-Marchais D., 1999, PHYSL NEURONE; Didier G, 2002, BIOINFORMATICS, V18, P490, DOI 10.1093/bioinformatics/18.3.490; Dietrich J, 2005, NAT MED, V11, P277, DOI 10.1038/nm1195; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Fichera M, 2004, NEUROLOGY, V63, P1108, DOI 10.1212/01.WNL.0000138731.60693.D2; Fogli A, 2004, NEUROLOGY, V62, P1509, DOI 10.1212/01.WNL.0000123259.67815.DB; Fogli A, 2006, BIOCHEM SOC T, V34, P22, DOI 10.1042/BST0340022; Fogli A, 2004, EUR J HUM GENET, V12, P561, DOI 10.1038/sj.ejhg.5201189; Fogli A, 2003, AM J HUM GENET, V72, P1544, DOI 10.1086/375404; Fogli A, 2002, NEUROLOGY, V59, P1966, DOI 10.1212/01.WNL.0000041666.76863.47; Fogli A, 2002, ANN NEUROL, V52, P506, DOI 10.1002/ana.10339; Geva M, 2010, BRAIN, V133, P2448, DOI 10.1093/brain/awq180; Haak LL, 2000, CELL CALCIUM, V28, P297, DOI 10.1054/ceca.2000.0176; Hobson GM, 2002, ANN NEUROL, V52, P477, DOI 10.1002/ana.10320; Horzinski L, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-94; Horzinski L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008318; Iwata K, 2011, PSYCHIAT RES; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Kantor L, 2005, HUM GENET, V118, P99, DOI 10.1007/s00439-005-0024-x; Kantor L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003783; Kerr MK, 2001, GENET RES, V77, P123; Labauge P, 2009, BRAIN, V132, P2161, DOI 10.1093/brain/awp171; LEVINE SM, 1990, DEV NEUROSCI-BASEL, V12, P235, DOI 10.1159/000111853; Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273; LIU XD, 1995, GENE DEV, V9, P1766, DOI 10.1101/gad.9.14.1766; Lyons DA, 2009, NAT GENET, V41, P854, DOI 10.1038/ng.376; Marom L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026992; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mignot C, 2004, CELL MOL LIFE SCI, V61, P369, DOI 10.1007/s00018-003-3143-3; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Riva A, 2005, COMPUT BIOL CHEM, V29, P319, DOI 10.1016/j.compbiolchem.2005.08.006; Rodriguez D, 1999, ACTA NEUROPATHOL, V97, P469, DOI 10.1007/s004010051016; SCHIFFMANN R, 1994, ANN NEUROL, V35, P331, DOI 10.1002/ana.410350314; Sporkel O, 2002, GLIA, V37, P19, DOI 10.1002/glia.10014; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; van der Knaap MS, 2003, AM J HUM GENET, V73, P1199, DOI 10.1086/379524; van der Voorn JP, 2005, J NEUROPATH EXP NEUR, V64, P770, DOI 10.1097/01.jnen.0000178446.41595.3a; Van Haren K, 2004, J NEUROPATH EXP NEUR, V63, P618, DOI 10.1093/jnen/63.6.618; van Kollenburg B, 2006, J NEUROPATH EXP NEUR, V65, P707, DOI 10.1097/01.jnen.0000228201.27539.50; vanderKnaap MS, 1997, NEUROLOGY, V48, P845, DOI 10.1212/WNL.48.4.845; Vorstman JAS, 2011, MOL PSYCHIATR, V16, P442, DOI 10.1038/mp.2010.26; Wang EM, 2006, J CELL BIOCHEM, V97, P999, DOI 10.1002/jcb.20692; Wang EM, 2007, NUCLEIC ACIDS RES, V35, P4164, DOI 10.1093/nar/gkm387; Wong K, 2000, ACTA NEUROPATHOL, V100, P635, DOI 10.1007/s004010000234; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74	54	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38264	10.1371/journal.pone.0038264	http://dx.doi.org/10.1371/journal.pone.0038264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737209	Green Published, Green Submitted, gold			2022-12-27	WOS:000305695100006
J	Lindfield, R; Griffiths, U; Bozzani, F; Mumba, M; Munsanje, J				Lindfield, Robert; Griffiths, Ulla; Bozzani, Fiammetta; Mumba, Musonda; Munsanje, Joseph			A Rapid Assessment of Avoidable Blindness in Southern Zambia	PLOS ONE			English	Article							KENYA	Introduction: A rapid assessment of avoidable blindness (RAAB) was conducted in Southern Zambia to establish the prevalence and causes of blindness in order to plan effective services and advocate for support for eye care to achieve the goals of VISION 2020: the right to sight. Methods: Cluster randomisation was used to select villages in the survey area. These were further subdivided into segments. One segment was selected randomly and a survey team moved from house to house examining everyone over the age of 50 years. Each individual received a visual acuity assessment and simple ocular examination. Data was recorded on a standard proforma and entered into an established software programme for analysis. Results: 2.29% of people over the age of 50 were found to be blind (VA <3/60 in the better eye with available correction). The major cause of blindness was cataract (47.2%) with posterior segment disease being the next main cause (18.8%). 113 eyes had received cataract surgery with 30.1% having a poor outcome (VA <6/60) following surgery. Cataract surgical coverage showed that men (72%) received more surgery than women (65%). Discussion: The results from the RAAB survey in Zambia were very similar to the results from a similar survey in Malawi, where the main cause of blindness was cataract but posterior segment disease was also a significant contributor. Blindness in this part of Zambia is mainly avoidable and there is a need for comprehensive eye care services that can address both cataract and posterior segment disease in the population if the aim of VISION 2020 is to be achieved. Services should focus on quality and gender equity of cataract surgery.	[Lindfield, Robert] London Sch Hyg & Trop Med, Int Ctr Eye Hlth, London WC1, England; [Griffiths, Ulla; Bozzani, Fiammetta] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Mumba, Musonda] Lusaka Eye Hosp, Lusaka, Zambia; [Munsanje, Joseph] S&S Dev Consultants, Lusaka, Zambia	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Lindfield, R (corresponding author), London Sch Hyg & Trop Med, Int Ctr Eye Hlth, London WC1, England.	Robert.lindfield@lshtm.ac.uk			Sightsavers International	Sightsavers International	The study was funded by Sightsavers International (www.sightsavers.org). Sightsavers paid for the field work costs (equipment, consumables, costs for field staff and transport). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Central Statistical Office, 2003, ZAMB 2000 CENS POP H; Habiyakire C, 2010, OPHTHAL EPIDEMIOL, V17, P90, DOI 10.3109/09286580903453514; Kalua K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019226; Kuper Hannah, 2006, Community Eye Health, V19, P68; Lindfield R, 2009, BRIT J OPHTHALMOL, V93, P875, DOI 10.1136/bjo.2008.152744; Mathenge W, 2007, PLOS MED, V4, P1187, DOI 10.1371/journal.pmed.0040217; Mathenge W, 2007, OPHTHALMOLOGY, V114, P599, DOI 10.1016/j.ophtha.2006.06.057; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Pizzarello L, 2004, ARCH OPHTHALMOL-CHIC, V122, P615, DOI 10.1001/archopht.122.4.615; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; UNDP, 2011, NAT HUM DEV REP ZAMB; WHO, 1998, INF CONS AN BLINDN P; WHO IAPB, 2006, VISION 2020 ACT PLAN; WHO Programme for the Prevention of Blindness, 1988, COD INSTR WHO PBL EY; Zulu F, 2005, SITUATION ANAL EYE C	15	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38483	10.1371/journal.pone.0038483	http://dx.doi.org/10.1371/journal.pone.0038483			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737211	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000305695100008
J	Medugorac, I; Seichter, D; Graf, A; Russ, I; Blum, H; Gopel, KH; Rothammer, S; Forster, M; Krebs, S				Medugorac, Ivica; Seichter, Doris; Graf, Alexander; Russ, Ingolf; Blum, Helmut; Goepel, Karl Heinrich; Rothammer, Sophie; Foerster, Martin; Krebs, Stefan			Bovine Polledness - An Autosomal Dominant Trait with Allelic Heterogeneity	PLOS ONE			English	Article							CATTLE BREEDS; HORN; ASSOCIATION; INHERITANCE; DELETION; ALIGNMENT; INSIGHTS; LOCUS	The persistent horns are an important trait of speciation for the family Bovidae with complex morphogenesis taking place briefly after birth. The polledness is highly favourable in modern cattle breeding systems but serious animal welfare issues urge for a solution in the production of hornless cattle other than dehorning. Although the dominant inhibition of horn morphogenesis was discovered more than 70 years ago, and the causative mutation was mapped almost 20 years ago, its molecular nature remained unknown. Here, we report allelic heterogeneity of the POLLED locus. First, we mapped the POLLED locus to a similar to 381-kb interval in a multi-breed case-control design. Targeted re-sequencing of an enlarged candidate interval (547 kb) in 16 sires with known POLLED genotype did not detect a common allele associated with polled status. In eight sires of Alpine and Scottish origin (four polled versus four horned), we identified a single candidate mutation, a complex 202 bp insertion-deletion event that showed perfect association to the polled phenotype in various European cattle breeds, except Holstein-Friesian. The analysis of the same candidate interval in eight Holsteins identified five candidate variants which segregate as a 260 kb haplotype also perfectly associated with the POLLED gene without recombination or interference with the 202 bp insertion-deletion. We further identified bulls which are progeny tested as homozygous polled but bearing both, 202 bp insertion-deletion and Friesian haplotype. The distribution of genotypes of the two putative POLLED alleles in large semi-random sample (1,261 animals) supports the hypothesis of two independent mutations.	[Medugorac, Ivica; Graf, Alexander; Blum, Helmut; Krebs, Stefan] Univ Munich, Lab Funct Genome Anal LAFUGA, Gene Ctr, Munich, Germany; [Seichter, Doris; Russ, Ingolf] Tierzuchtforsch eV Munchen, Grub, Germany; [Goepel, Karl Heinrich] Gopel Genet GmbH, Herleshausen, Germany	University of Munich	Medugorac, I (corresponding author), Univ Munich, Lab Funct Genome Anal LAFUGA, Gene Ctr, Munich, Germany.	ivica.medjugorac@gen.vetmed.uni-muenchen.de		Rothammer, Sophie/0000-0001-5704-5814; Medugorac, Ivica/0000-0002-6891-3039; Seichter, Doris/0000-0002-0325-1134	German Research Foundation (DFG; Germany) [ME 3404/2-1]; German agriculture network PHANOMICS; Federal Ministry of Education and Research [0315536F]; Chair of Animal Genetics and Husbandry of the Ludwig-Maximilians-University Munich (TierALL, LMU Munich, Germany); Laboratory for Functional Genome Analysis (LAFUGA, Gene Center, LMU Munich, Germany); Tierzuchtforschung e.V. Munchen (TZF Grub, Germany); TierALL; LAFUGA; TZF	German Research Foundation (DFG; Germany)(German Research Foundation (DFG)); German agriculture network PHANOMICS; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Chair of Animal Genetics and Husbandry of the Ludwig-Maximilians-University Munich (TierALL, LMU Munich, Germany); Laboratory for Functional Genome Analysis (LAFUGA, Gene Center, LMU Munich, Germany); Tierzuchtforschung e.V. Munchen (TZF Grub, Germany); TierALL; LAFUGA; TZF	This work was funded by the German Research Foundation (DFG; Germany, ME 3404/2-1) and a grant from the German agriculture network PHANOMICS (funded by Federal Ministry of Education and Research funding reference number 0315536F) as well as by substantial budget funds from the Chair of Animal Genetics and Husbandry of the Ludwig-Maximilians-University Munich (TierALL, LMU Munich, Germany), the Laboratory for Functional Genome Analysis (LAFUGA, Gene Center, LMU Munich, Germany) and the Tierzuchtforschung e.V. Munchen (TZF Grub, Germany). The authors IM, SR, MF, SK, AG, HB, DS and IR are employed by TierALL, LAFUGA and TZF which supported this study by substantial budget funds but only the authors and not the funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai M, 2004, ANIM GENET, V35, P34, DOI 10.1111/j.1365-2052.2003.01079.x; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Capitan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022242; Capitan A, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-33; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Dove WF, 1935, J EXP ZOOL, V69, P347, DOI 10.1002/jez.1400690302; Drogemuller C, 2005, MAMM GENOME, V16, P613, DOI 10.1007/s00335-005-0016-0; Felius M., 1995, CATTLE BREEDS ENCY; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GEORGES M, 1993, NAT GENET, V4, P206, DOI 10.1038/ng0693-206; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Graf B, 1999, APPL ANIM BEHAV SCI, V62, P153, DOI 10.1016/S0168-1591(98)00218-4; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Harris RS, 2007, IMPROVED PAIRWISE AL, DOI DOI 10.1093/molbev/msx116; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Johnston SE, 2011, MOL ECOL, V20, P2555, DOI 10.1111/j.1365-294X.2011.05076.x; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; LONG CR, 1978, J HERED, V69, P395, DOI 10.1093/oxfordjournals.jhered.a108980; Mariasegaram M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-370; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McEvoy B, 2004, AM J HUM GENET, V75, P693, DOI 10.1086/424697; Medugorac I, 2011, ECOL EVOL, V1, P408, DOI 10.1002/ece3.39; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; Prayaga KC, 2007, AUST J AGR RES, V58, P1, DOI 10.1071/AR06044; Ramljak J, 2011, J ANIM BREED GENET, V128, P73, DOI 10.1111/j.1439-0388.2010.00905.x; Seichter D, 2012, ANIM GENET IN PRESS; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; White WT, 1936, J GENET, V32, P33, DOI 10.1007/BF02982500; Wood HM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq510; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108	39	89	100	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39477	10.1371/journal.pone.0039477	http://dx.doi.org/10.1371/journal.pone.0039477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737241	Green Published, gold, Green Submitted			2022-12-27	WOS:000305695100040
J	Pashai, N; Hao, HP; All, A; Gupta, S; Chaerkady, R; De Los Angeles, A; Gearhart, JD; Kerr, CL				Pashai, Nikta; Hao, Haiping; All, Angelo; Gupta, Siddharth; Chaerkady, Raghothama; De Los Angeles, Alejandro; Gearhart, John D.; Kerr, Candace L.			Genome-Wide Profiling of Pluripotent Cells Reveals a Unique Molecular Signature of Human Embryonic Germ Cells	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; GENE-EXPRESSION PROFILES; STEM-CELLS; OVARIAN-CANCER; HOMOLOGOUS RECOMBINATION; EXCISION-REPAIR; DNA-DAMAGE; MOUSE; IDENTIFICATION; CYCLE	Human embryonic germ cells (EGCs) provide a powerful model for identifying molecules involved in the pluripotent state when compared to their progenitors, primordial germ cells (PGCs), and other pluripotent stem cells. Microarray and Principal Component Analysis (PCA) reveals for the first time that human EGCs possess a transcription profile distinct from PGCs and other pluripotent stem cells. Validation with qRT-PCR confirms that human EGCs and PGCs express many pluripotency-associated genes but with quantifiable differences compared to pluripotent embryonic stem cells (ESCs), induced pluripotent stem cells (IPSCs), and embryonal carcinoma cells (ECCs). Analyses also identified a number of target genes that may be potentially associated with their unique pluripotent states. These include IPO7, MED7, RBM26, HSPD1, and KRAS which were upregulated in EGCs along with other pluripotent stem cells when compared to PGCs. Other potential target genes were also found which may contribute toward a primed ESC-like state. These genes were exclusively upregulated in ESCs, IPSCs and ECCs including PARP1, CCNE1, CDK6, AURKA, MAD2L1, CCNG1, and CCNB1 which are involved in cell cycle regulation, cellular metabolism and DNA repair and replication. Gene classification analysis also confirmed that the distinguishing feature of EGCs compared to ESCs, ECCs, and IPSCs lies primarily in their genetic contribution to cellular metabolism, cell cycle, and cell adhesion. In contrast, several genes were found upregulated in PGCs which may help distinguish their unipotent state including HBA1, DMRT1, SPANXA1, and EHD2. Together, these findings provide the first glimpse into a unique genomic signature of human germ cells and pluripotent stem cells and provide genes potentially involved in defining different states of germ-line pluripotency.	[Pashai, Nikta; All, Angelo; Gupta, Siddharth] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Hao, Haiping] Johns Hopkins Univ, High Throughput Biol Ctr, Deep Sequencing & Microarray Core, Baltimore, MD USA; [All, Angelo] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Kerr, Candace L.] Johns Hopkins Univ, Stem Cell Program, Inst Cell Engn, Baltimore, MD USA; [Gearhart, John D.] Univ Penn, Dept Cell & Dev Biol, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Gearhart, John D.] Univ Penn, Dept Anim Biol, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Kerr, Candace L.] Johns Hopkins Univ, Inst Cell Engn, Dept Gynecol & Obstet, Baltimore, MD USA; [Chaerkady, Raghothama] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [De Los Angeles, Alejandro] Childrens Hosp Boston, Div Pediat Hematol Oncol, Stem Cell Transplantat Program, Boston, MA USA; [De Los Angeles, Alejandro] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [De Los Angeles, Alejandro] Harvard Stem Cell Inst, Cambridge, MA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University	Pashai, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	ckerr@jhmi.edu		Hao, Haiping/0000-0002-8826-1568	National Institute of Child Health and Human Development (NICHD) [R21 HD057487]; Maryland Stem Cell Research Funds [2007-MSCRFE-0210-01, 2008-MSCRFE-0129-00]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057487] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Maryland Stem Cell Research Funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was graciously supported by National Institute of Child Health and Human Development (NICHD) R21 HD057487 (CK) and Maryland Stem Cell Research Funds 2007-MSCRFE-0210-01 (CK) and by 2008-MSCRFE-0129-00 (CK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Alagaratnam S, 2011, INT J ANDROL, V34, pE133, DOI 10.1111/j.1365-2605.2011.01169.x; Andrews PW, 1998, APMIS, V106, P158, DOI 10.1111/j.1699-0463.1998.tb01331.x; Aoki K, 2007, ONCOGENE, V26, P3511, DOI 10.1038/sj.onc.1210141; Assou S, 2007, STEM CELLS; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Baharvand H, 2008, J PROTEOME RES, V7, P412, DOI 10.1021/pr700560t; Banito A, 2010, EMBO REP, V11, P353, DOI 10.1038/embor.2010.47; Bignotti E, 2006, GYNECOL ONCOL, V103, P405, DOI 10.1016/j.ygyno.2006.03.056; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cai LY, 2007, LIFE SCI, V80, P1458, DOI 10.1016/j.lfs.2007.01.015; Chaerkady R, 2010, PROTEOMICS; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Choufani S, 2011, GENOME RES, V21, P465, DOI 10.1101/gr.111922.110; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; Corbet SW, 1999, ONCOGENE, V18, P1537, DOI 10.1038/sj.onc.1202436; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; DOLCI S, 1993, MOL REPROD DEV, V35, P134, DOI 10.1002/mrd.1080350206; Filion TM, 2009, J CELL PHYSIOL, V220, P586, DOI 10.1002/jcp.21735; Filipczyk AA, 2007, STEM CELL RES, V1, P45, DOI 10.1016/j.scr.2007.09.002; Gao FR, 2009, J BIOL CHEM, V284, P22263, DOI 10.1074/jbc.M109.033118; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Gopalakrishnan S, 2009, MOL CANCER RES, V7, P1622, DOI 10.1158/1541-7786.MCR-09-0018; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Guo YL, 2010, J MED GENET, V47, P616, DOI 10.1136/jmg.2009.074252; GUY J, 1989, J COMP NEUROL, V287, P446, DOI 10.1002/cne.902870404; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; He ZP, 2005, REPRODUCTION, V130, P333, DOI 10.1530/rep.1.00694; Hiller M, 2010, STEM CELLS DEV; Hiller M, 2011, STEM CELLS DEV; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaiswal AS, 2008, CANCER LETT, V271, P272, DOI 10.1016/j.canlet.2008.06.024; Jaiswal AS, 2011, BIOCHEMISTRY-US, V50, P1901, DOI 10.1021/bi102000q; Juric D, 2005, P NATL ACAD SCI USA, V102, P17763, DOI 10.1073/pnas.0509082102; Kerr CL, 2008, HUM REPROD, V23, P589, DOI 10.1093/humrep/dem411; Kerr CL, 2008, STEM CELLS, V26, P412, DOI 10.1634/stemcells.2007-0605; Kerr CL, 2006, SEMIN REPROD MED, V24, P304, DOI 10.1055/s-2006-952152; Kerr CL, 2006, METHOD ENZYMOL, V419, P400, DOI 10.1016/S0076-6879(06)19016-3; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Kurisaki A, 2005, BIOCHEM BIOPH RES CO, V335, P667, DOI 10.1016/j.bbrc.2005.07.128; Lee NS, 2008, BIOCHEM BIOPH RES CO, V377, P434, DOI 10.1016/j.bbrc.2008.09.159; Leitch HG, 2010, DEVELOPMENT, V137, P2279, DOI 10.1242/dev.050427; Li Xiao Hong, 2002, Shi Yan Sheng Wu Xue Bao, V35, P142; Malki S, 2007, CANCER LETT, V255, P182, DOI 10.1016/j.canlet.2007.04.007; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Maynard S, 2008, STEM CELLS, V26, P2266, DOI 10.1634/stemcells.2007-1041; MCKAY DG, 1953, ANAT REC, V117, P201, DOI 10.1002/ar.1091170206; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mise N, 2008, GENES CELLS, V13, P863, DOI 10.1111/j.1365-2443.2008.01211.x; Nagano K, 2005, PROTEOMICS, V5, P1346, DOI 10.1002/pmic.200400990; NAKAGAWA M, 2007, NAT BIOTECHNOL; Narayan S, 1997, J BIOL CHEM, V272, P30619, DOI 10.1074/jbc.272.49.30619; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okumura-Nakanishi S, 2004, J BIOL CHEM; Onyango P, 2002, P NATL ACAD SCI USA, V99, P10599, DOI 10.1073/pnas.152327599; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Park IH, 2007, NATURE; Park JH, 2004, MOL CELLS, V17, P309; Perrett RM, 2008, BIOL REPROD, V78, P852, DOI 10.1095/biolreprod.107.066175; Prigione A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027352; Quinn MCJ, 2009, MOL CARCINOGEN, V48, P648, DOI 10.1002/mc.20511; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; Rao RR, 2004, BIOTECHNOL BIOENG, V88, P273, DOI 10.1002/bit.20245; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Roos WP, 2007, CELL DEATH DIFFER, V14, P1422, DOI 10.1038/sj.cdd.4402136; Rossant J, 2007, NATURE, V448, P260, DOI 10.1038/448260a; RUOSLAHTI E, 1981, INT J CANCER, V27, P763, DOI 10.1002/ijc.2910270606; Sabour D, 2011, HUM MOL GENET, V20, P115, DOI 10.1093/hmg/ddq450; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Santin AD, 2004, INT J CANCER, V112, P14, DOI 10.1002/ijc.20408; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Schvartzman JM, 2011, CANCER CELL, V19, P701, DOI 10.1016/j.ccr.2011.04.017; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sorrentino E, 2007, GENE EXPR PATTERNS, V7, P714, DOI 10.1016/j.modgep.2007.02.002; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tichy ED, 2010, STEM CELLS DEV, V19, P1699, DOI 10.1089/scd.2010.0058; Tsunoda T, 2010, NEOPLASIA, V12, P397, DOI 10.1593/neo.10170; Turnpenny L, 2003, STEM CELLS, V21, P598, DOI 10.1634/stemcells.21-5-598; Van Hoof D, 2006, MOL CELL PROTEOMICS, V5, P1261, DOI 10.1074/mcp.M500405-MCP200; Van Sloun PPH, 1999, NUCLEIC ACIDS RES, V27, P3276, DOI 10.1093/nar/27.16.3276; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Von Hoof D, 2006, EXPERT REV PROTEOMIC, V3, P427, DOI 10.1586/14789450.3.4.427; Wang L, 2010, TUMOR BIOL, V31, P225, DOI 10.1007/s13277-010-0036-6; WITSCHI E, 1963, OVARY, P1; Witschi Emil, 1948, CONTRIBUTIONS TO EMBRYOLOGY [CARNEGIE INST OF WASHINGTON PUBL], V32, P67; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zeng XM, 2004, STEM CELLS, V22, P292, DOI 10.1634/stemcells.22-3-292; Zhang L, 2007, CLIN CANCER RES, V13, P5314, DOI 10.1158/1078-0432.CCR-06-2660; Zhang Z, 2011, STEM CELLS, V29, P229, DOI 10.1002/stem.578; Zhang ZL, 2011, CHROMOSOMA, V120, P73, DOI 10.1007/s00412-010-0292-7; Zhu XF, 2011, MOL CELL BIOL, V31, P2413, DOI 10.1128/MCB.05242-11; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	112	17	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39088	10.1371/journal.pone.0039088	http://dx.doi.org/10.1371/journal.pone.0039088			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737227	Green Published, Green Submitted, gold			2022-12-27	WOS:000305695100026
J	Boucher, DL; Chen, JQ; Cherry, SR; Borowsky, AD				Boucher, David L.; Chen, Jane Qian; Cherry, Simon R.; Borowsky, Alexander D.			Establishment of Clonal MIN-O Transplant Lines for Molecular Imaging via Lentiviral Transduction & In Vitro Culture	PLOS ONE			English	Article							MAMMARY INTRAEPITHELIAL NEOPLASIA; EMISSION-TOMOGRAPHY; MOUSE MODEL; PROMOTER; SITU; CELL; PROGRESSION; POSITRON; LESIONS; VIRUS	As the field of molecular imaging evolves and increasingly is asked to fill the discovery and validation space between basic science and clinical applications, careful consideration should be given to the models in which studies are conducted. The MIN-O mouse model series is an established in vivo model of human mammary precancer ductal carcinoma in situ with progression to invasive carcinoma. This series of transplant lines is propagated in vivo and experiments utilizing this model can be completed in non-engineered immune intact FVB/n wild type mice thereby modeling the tumor microenvironment with biological relevance superior to traditional tumor cell xenografts. Unfortunately, the same qualities that make this and many other transplant lines more biologically relevant than standard cell lines for molecular imaging studies present a significant obstacle as somatic genetic re-engineering modifications common to many imaging applications can be technically challenging. Here, we describe a protocol for the efficient lentiviral transduction of cell slurries derived from precancerous MIN-O lesions, in vitro culture of "MIN-O-spheres" derived from single cell clones, and the subsequent transplantation of these spheres to produce transduced sublines suitable for optical imaging applications. These lines retain the physiologic and pathologic properties, including multilineage differentiation, and complex microanatomic interaction with the host stroma characteristic of the MIN-O model. We also present the in vivo imaging and immunohistochemical analysis of serial transplantation of one such subline and detail the progressive multifocal loss of the transgene in successive generations.	[Boucher, David L.; Cherry, Simon R.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Chen, Jane Qian; Borowsky, Alexander D.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Boucher, DL (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	adborowsky@ucdavis.edu	Borowsky, Alexander D/S-5404-2017; Cherry, Simon/AAH-1000-2019	Cherry, Simon/0000-0002-0155-5644	United States National Institutes of Health [U01 CA141582, P30 CA093373, RC4 EB012836, K26 RR024037, U01 CA14582]; NATIONAL CANCER INSTITUTE [U01CA141582, P30CA093373] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR024037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [RC4EB012836] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding was provided by United States National Institutes of Health grants (http://grants.nih.gov/grants/oer.htm): U01 CA141582, P30 CA093373, RC4 EB012836, K26 RR024037 and U01 CA14582. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey CK, 2004, P NATL ACAD SCI USA, V101, P11438, DOI 10.1073/pnas.0404396101; Abbey CK, 2006, J MAMMARY GLAND BIOL, V11, P137, DOI 10.1007/s10911-006-9020-6; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; CARDIFF RD, 1984, ADV CANCER RES, V42, P167, DOI 10.1016/S0065-230X(08)60458-3; Damonte P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2104; Jessen KA, 2004, BREAST CANCER RES, V6, pR157, DOI 10.1186/bcr768; Kuerer HM, 2008, J CLIN ONCOL; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Maglione JE, 2004, MOL CANCER THER, V3, P941; Maglione JE, 2001, CANCER RES, V61, P8298; Namba R, 2006, CLIN CANCER RES, V12, P2613, DOI 10.1158/1078-0432.CCR-05-2170; Namba R, 2004, MOL CANCER RES, V2, P453; Namba R, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-275; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sontag L, 2005, J THEOR BIOL, V232, P179, DOI 10.1016/j.jtbi.2004.08.002; Tang P, 2007, CURR OPIN OBSTET GYN, V19, P63, DOI 10.1097/GCO.0b013e3280114a3a; Teschendorf C, 2002, ANTICANCER RES, V22, P3325; Tokushige K, 1997, J VIROL METHODS, V64, P73, DOI 10.1016/S0166-0934(96)02143-X; Xia XF, 2007, STEM CELLS DEV, V16, P167, DOI 10.1089/scd.2006.0057	20	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39350	10.1371/journal.pone.0039350	http://dx.doi.org/10.1371/journal.pone.0039350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745739	Green Submitted, Green Published, gold			2022-12-27	WOS:000305693200066
J	Davidson, FA; Chung, SY; Stanley-Wall, NR				Davidson, Fordyce A.; Chung Seon-Yi; Stanley-Wall, Nicola R.			Selective Heterogeneity in Exoprotease Production by Bacillus subtilis	PLOS ONE			English	Article							RESPONSE REGULATOR DEGU; DEGRADATIVE ENZYME-SYNTHESIS; GENE-EXPRESSION; MASTER REGULATOR; SPO0A REGULON; CELL FATE; SPORULATION; COMPETENCE; APRE; STOCHASTICITY	Bacteria have elaborate signalling mechanisms to ensure a behavioural response that is most likely to enhance survival in a changing environment. It is becoming increasingly apparent that as part of this response, bacteria are capable of cell differentiation and can generate multiple, mutually exclusive co-existing cell states. These cell states are often associated with multicellular processes that bring benefit to the community as a whole but which may be, paradoxically, disadvantageous to an individual subpopulation. How this process of cell differentiation is controlled is intriguing and remains a largely open question. In this paper, we consider an important aspect of cell differentiation that is known to occur in the Gram-positive bacterium Bacillus subtilis: we investigate the role of two master regulators DegU and Spo0A in the control of extra-cellular protease production. Recent work in this area focussed the on role of DegU in this process and suggested that transient effects in protein production were the drivers of cell-response heterogeneity. Here, using a combination of mathematical modelling, analysis and stochastic simulations, we provide a complementary analysis of this regulatory system that investigates the roles of both DegU and Spo0A in extra-cellular protease production. In doing so, we present a mechanism for bimodality, or system heterogeneity, without the need for a bistable switch in the underlying regulatory network. Moreover, our analysis leads us to conclude that this heterogeneity is in fact a persistent, stable feature. Our results suggest that system response is divided into three zones: low and high signal levels induce a unimodal or undifferentiated response from the cell population with all cells OFF and ON, respectively for exoprotease production. However, for intermediate levels of signal, a heterogeneous response is predicted with a spread of activity levels, representing typical "bet-hedging" behaviour.	[Davidson, Fordyce A.; Chung Seon-Yi] Univ Dundee, Div Math, Dundee, Scotland; [Stanley-Wall, Nicola R.] Univ Dundee, Coll Life Sci, Dundee, Scotland	University of Dundee; University of Dundee	Davidson, FA (corresponding author), Univ Dundee, Div Math, Dundee, Scotland.	fdavidson@maths.dundee.ac.uk		Davidson, Fordyce/0000-0002-8377-3863; Stanley-Wall, Nicola/0000-0002-5936-9721	Wellcome Trust VIP [087821/Z/08/Z]; MRC [G0902348]; BBSRC [BB/H002340/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H002340/1] Funding Source: researchfish; Medical Research Council [G0902348] Funding Source: researchfish	Wellcome Trust VIP(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding provided by the Wellcome Trust VIP Award 087821/Z/08/Z (www.wellcome.ac.uk/) MRC grant number G0902348 (www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAI U, 1993, GENE DEV, V7, P139, DOI 10.1101/gad.7.1.139; Bigger JW, 1944, LANCET, V2, P497; Bischofs IB, 2009, P NATL ACAD SCI USA, V106, P6459, DOI 10.1073/pnas.0810878106; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Chai YR, 2008, MOL MICROBIOL, V67, P254, DOI 10.1111/j.1365-2958.2007.06040.x; Chastanet A, 2010, P NATL ACAD SCI USA, V107, P8486, DOI 10.1073/pnas.1002499107; CHUNG JD, 1994, J BACTERIOL, V176, P1977, DOI 10.1128/jb.176.7.1977-1984.1994; DAHL MK, 1992, J BIOL CHEM, V267, P14509; de Jong IG, 2010, J BACTERIOL, V192, P2053, DOI 10.1128/JB.01484-09; DUBNAU D, 1991, MICROBIOL REV, V55, P395, DOI 10.1128/MMBR.55.3.395-424.1991; Erban R., 2007, PRACTICAL GUIDE STOC; Eswaramoorthy P, 2010, MICROBIOL-SGM, V156, P2294, DOI 10.1099/mic.0.038497-0; Fawcett P, 2000, P NATL ACAD SCI USA, V97, P8063, DOI 10.1073/pnas.140209597; Fujita M, 2005, GENE DEV, V19, P2236, DOI 10.1101/gad.1335705; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Gardiner C.W., 2003, HDB STOCHASTIC METHO; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Goryachev AB, 2005, PLOS COMPUT BIOL, V1, P265, DOI 10.1371/journal.pcbi.0010037; Hamoen LW, 2000, P NATL ACAD SCI USA, V97, P9246, DOI 10.1073/pnas.160010597; Hata M, 2001, J BACTERIOL, V183, P4648, DOI 10.1128/JB.183.15.4648-4651.2001; Higgins D, 2012, FEMS MICROBIOL REV, V36, P131, DOI 10.1111/j.1574-6976.2011.00310.x; Jabbari S, 2011, B MATH BIOL, V73, P181, DOI 10.1007/s11538-010-9530-7; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; Keener J., 2009, MATH PHYSL, V1; Koerber AJ, 2005, J MATH BIOL, V50, P440, DOI 10.1007/s00285-004-0296-0; Kuchina A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.88; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Lestas I, 2008, IEEE T AUTOMAT CONTR, V53, P189, DOI 10.1109/TAC.2007.911347; Liebal UW, 2010, MOL MICROBIOL, V77, P1083, DOI 10.1111/j.1365-2958.2010.07283.x; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Mader U, 2002, MOL GENET GENOMICS, V268, P455, DOI 10.1007/s00438-002-0774-2; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; MSADEK T, 1990, J BACTERIOL, V172, P824, DOI 10.1128/jb.172.2.824-834.1990; Murray EJ, 2009, J BACTERIOL, V191, P6822, DOI 10.1128/JB.00618-09; Murray EJ, 2009, MICROBIOL-SGM, V155, P1, DOI 10.1099/mic.0.023903-0; Ochab-Marcinek A, 2010, P NATL ACAD SCI USA, V107, P22096, DOI 10.1073/pnas.1008965107; Ogura M, 2003, MOL MICROBIOL, V49, P1685, DOI 10.1046/j.1365-2958.2003.03665.x; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Ramsey Stephen, 2005, Journal of Bioinformatics and Computational Biology, V3, P415, DOI 10.1142/S0219720005001132; Ruzal SM, 1998, CURR MICROBIOL, V37, P368, DOI 10.1007/s002849900395; Sen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025102; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; SHAPIRO L, 1993, CELL, V73, P835, DOI 10.1016/0092-8674(93)90264-Q; Shimane K, 2004, J BIOCHEM, V136, P387, DOI 10.1093/jb/mvh127; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Tian TH, 2006, P NATL ACAD SCI USA, V103, P8372, DOI 10.1073/pnas.0507818103; Tiwari A, 2011, MATH BIOSCI, V231, P76, DOI 10.1016/j.mbs.2011.03.004; To TL, 2010, SCIENCE, V327, P1142, DOI 10.1126/science.1178962; Tsukahara K, 2008, FEMS MICROBIOL LETT, V280, P8, DOI 10.1111/j.1574-6968.2007.01019.x; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Veening JW, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.18; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; Verhamme DT, 2007, MOL MICROBIOL, V65, P554, DOI 10.1111/j.1365-2958.2007.05810.x; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; Yasumura A, 2008, J BACTERIOL, V190, P5162, DOI 10.1128/JB.00368-08	56	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38574	10.1371/journal.pone.0038574	http://dx.doi.org/10.1371/journal.pone.0038574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745669	Green Submitted, Green Published, gold			2022-12-27	WOS:000305693200015
J	Perdih, A; Choudhury, AR; Zuperl, S; Sikorska, E; Zhukov, I; Solmajer, T; Novic, M				Perdih, Andrej; Choudhury, Amrita Roy; Zuperl, Spela; Sikorska, Emilia; Zhukov, Igor; Solmajer, Tom; Novic, Marjana			Structural Analysis of a Peptide Fragment of Transmembrane Transporter Protein Bilitranslocase	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; SODIUM DODECYL-SULFATE; NMR CHEMICAL-SHIFTS; MEMBRANE-PROTEINS; VASCULAR ENDOTHELIUM; DATA-BANK; SPECTROSCOPY; PREDICTION; BINDING; BILIRUBIN	Using a combination of genomic and post-genomic approaches is rapidly altering the number of identified human influx carriers. A transmembrane protein bilitranslocase (TCDB 2.A.65) has long attracted attention because of its function as an organic anion carrier. It has also been identified as a potential membrane transporter for cellular uptake of several drugs and due to its implication in drug uptake, it is extremely important to advance the knowledge about its structure. However, at present, only the primary structure of bilitranslocase is known. In our work, transmembrane subunits of bilitranslocase were predicted by a previously developed chemometrics model and the stability of these polypeptide chains were studied by molecular dynamics (MD) simulation. Furthermore, sodium dodecyl sulfate (SDS) micelles were used as a model of cell membrane and herein we present a high-resolution 3D structure of an 18 amino acid residues long peptide corresponding to the third transmembrane part of bilitranslocase obtained by use of multidimensional NMR spectroscopy. It has been experimentally confirmed that one of the transmembrane segments of bilitranslocase has alpha helical structure with hydrophilic amino acid residues oriented towards one side, thus capable of forming a channel in the membrane.	[Perdih, Andrej; Choudhury, Amrita Roy; Zuperl, Spela; Zhukov, Igor; Solmajer, Tom; Novic, Marjana] Natl Inst Chem, Lab Chemometr, Ljubljana, Slovenia; [Sikorska, Emilia] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland; [Zhukov, Igor] EN FIST Ctr Excellence, Ljubljana, Slovenia; [Zhukov, Igor] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	National Institute of Chemistry - Slovenia; Fahrenheit Universities; University of Gdansk; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Perdih, A (corresponding author), Natl Inst Chem, Lab Chemometr, Ljubljana, Slovenia.	marjana.novic@ki.si	Perdih, Andrej/T-7029-2018; Zhukov, Igor/J-4069-2015	Perdih, Andrej/0000-0002-6645-9231; Sikorska, Emilia/0000-0001-7851-6371; Zhukov, Igor/0000-0002-9912-1018	Ministry of Higher Education, Science and Technology of the Republic of Slovenia [P1-017, J1-2151, Z1-4111]; European Regional Development Fund	Ministry of Higher Education, Science and Technology of the Republic of Slovenia; European Regional Development Fund(European Commission)	This work was supported by the Ministry of Higher Education, Science and Technology of the Republic of Slovenia (P1-017 and J1-2151 to M.N., Z1-4111 to A.P.), as well as by the European Regional Development Fund (Cross-border Collaboration Italy-Slovenia 2007-2013, TRANS2CARE strategic project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battiston L, 1998, BIOCHEM BIOPH RES CO, V247, P687, DOI 10.1006/bbrc.1998.8868; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brandoni A, 2010, NEPHRON PHYSIOL, V114, pP35, DOI 10.1159/000276588; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bruce CD, 2002, J PHYS CHEM B, V106, P3788, DOI 10.1021/jp013616z; Bu LT, 2008, J AM CHEM SOC, V130, P5384, DOI 10.1021/ja710213p; Case D.A., 2022, AMBER 2020; Choudhury AR, 2009, SAR QSAR ENVIRON RES, V20, P741, DOI 10.1080/10629360903438602; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dobson PD, 2008, NAT REV DRUG DISCOV, V7, P205, DOI 10.1038/nrd2438; Duong TH, 1999, J COMPUT PHYS, V151, P358, DOI 10.1006/jcph.1999.6222; Elofsson A, 2007, ANNU REV BIOCHEM, V76, P125, DOI 10.1146/annurev.biochem.76.052705.163539; Foloppe N., 2004, J COMPUT CHEM, V25, P86; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Goddard T. D., SPARKY 3; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Karawajczyk A, 2007, BIOCHEM PHARMACOL, V73, P308, DOI 10.1016/j.bcp.2006.09.024; Kelly Libusha, 2009, Journal of Structural and Functional Genomics, V10, P269, DOI 10.1007/s10969-009-9069-8; Kim HJ, 2009, PROG NUCL MAG RES SP, V55, P335, DOI 10.1016/j.pnmrs.2009.07.002; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Li CG, 2007, J AM CHEM SOC, V129, P5304, DOI 10.1021/ja068402f; Linser R, 2011, ANGEW CHEM INT EDIT, V50, P4508, DOI 10.1002/anie.201008244; LUNAZZI G, 1982, BIOCHIM BIOPHYS ACTA, V685, P117, DOI 10.1016/0005-2736(82)90087-6; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MacKerell Jr A.D., 2004, J COMPUT CHEM, V25, P105; Maestro A, 2010, CARDIOVASC RES, V85, P175, DOI 10.1093/cvr/cvp290; Nicolin V, 2005, J MOL HISTOL, V36, P45, DOI 10.1007/s10735-004-2920-0; Opella SJ, 2004, CHEM REV, V104, P3587, DOI 10.1021/cr0304121; Passamonti S, 2005, FEBS J, V272, P5522, DOI 10.1111/j.1742-4658.2005.04949.x; Passamonti S, 2005, FEBS J, V272, P3282, DOI 10.1111/j.1742-4658.2005.04751.x; PASSAMONTI S, 1988, BIOCHIM BIOPHYS ACTA, V943, P119, DOI 10.1016/0005-2736(88)90543-3; Passamonti S, 2002, BIOCHEM BIOPH RES CO, V296, P631, DOI 10.1016/S0006-291X(02)00927-0; Passamonti S, 1999, MOL MEMBR BIOL, V16, P167; Passamonti S., 1977, BIOCHIM BIOPHYS ACTA, V1323, P130; Passamonti S, 2009, CURR DRUG METAB, V10, P369, DOI 10.2174/138920009788498950; Perdih A, 2007, PROTEINS, V68, P243, DOI 10.1002/prot.21374; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Rodziewicz-Motowidlo S, 2008, J PEPT SCI, V14, P85, DOI 10.1002/psc.917; Schweighofer KJ, 1997, J PHYS CHEM B, V101, P3793, DOI 10.1021/jp963460g; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; TORRES AM, 1993, P NATL ACAD SCI USA, V90, P8136, DOI 10.1073/pnas.90.17.8136; Tusnady GE, 2004, BIOINFORMATICS, V20, P2964, DOI 10.1093/bioinformatics/bth340; Vanzo A, 2008, MOL NUTR FOOD RES, V52, P1106, DOI 10.1002/mnfr.200700505; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Ziberna L, 2013, NUTR METAB CARDIOVAS, V23, P68, DOI 10.1016/j.numecd.2011.02.005; Ziberna L, 2012, FREE RADICAL BIO MED, V52, P1750, DOI 10.1016/j.freeradbiomed.2012.02.027; Zidar J, 2009, J PHYS CHEM B, V113, P15795, DOI 10.1021/jp907138h; Zuperl S, 2011, ANAL CHIM ACTA, V705, P322, DOI 10.1016/j.aca.2011.07.004	54	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38967	10.1371/journal.pone.0038967	http://dx.doi.org/10.1371/journal.pone.0038967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745694	Green Submitted, Green Published, gold			2022-12-27	WOS:000305693200033
J	Zou, HF; Volonte, D; Galbiati, F				Zou, Huafei; Volonte, Daniela; Galbiati, Ferruccio			Interaction of Caveolin-1 with Ku70 Inhibits Bax-Mediated Apoptosis	PLOS ONE			English	Article							COLORECTAL-CANCER; MUSCULAR-DYSTROPHY; SCAFFOLDING DOMAIN; LIPID RAFTS; DNA-REPAIR; C-TERMINUS; IN-VIVO; EXPRESSION; PROTEIN; COLON	Caveolin-1, the structural protein component of caveolae, acts as a scaffolding protein that functionally regulates signaling molecules. We show that knockdown of caveolin-1 protein expression enhances chemotherapeutic drug-induced apoptosis and inhibits long-term survival of colon cancer cells. In vitro studies demonstrate that caveolin-1 is a novel Ku70-binding protein, as shown by the binding of the scaffolding domain of caveolin-1 (amino acids 82-101) to the caveolin-binding domain (CBD) of Ku70 (amino acids 471-478). Cell culture data show that caveolin-1 binds Ku70 after treatment with chemotherapeutic drugs. Mechanistically, we found that binding of caveolin-1 to Ku70 inhibits the chemotherapeutic drug-induced release of Bax from Ku70, activation of Bax, translocation of Bax to mitochondria and apoptosis. Potentiation of apoptosis by knockdown of caveolin-1 protein expression is greatly reduced in the absence of Bax expression. Finally, we found that overexpression of wild type Ku70, but not a mutant form of Ku70 that cannot bind to caveolin-1 (Ku70 Phi -> A), limits the chemotherapeutic drug-induced Ku70/Bax dissociation and apoptosis. Thus, caveolin-1 acts as an anti-apoptotic protein in colon cancer cells by binding to Ku70 and inhibiting Bax-dependent cell death.	[Zou, Huafei; Volonte, Daniela; Galbiati, Ferruccio] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zou, HF (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	feg5@pitt.edu	Galbiati, Ferruccio/AAF-3527-2020		National Institute on Aging [R01-AG022548, R01-AG030636]; NATIONAL INSTITUTE ON AGING [R01AG022548, R01AG030636] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institute on Aging (R01-AG022548 and R01-AG030636) (to F. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholomew JN, 2009, CANCER RES, V69, P2878, DOI 10.1158/0008-5472.CAN-08-2857; Brito RA, 1999, ONCOLOGY-BASEL, V57, P2, DOI 10.1159/000055262; Chechlacz M, 2001, J NEUROCHEM, V78, P141, DOI 10.1046/j.1471-4159.2001.00380.x; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Featherstone C, 1999, MUTAT RES-DNA REPAIR, V434, P3, DOI 10.1016/S0921-8777(99)00006-3; Fine SW, 2001, AM J CLIN PATHOL, V115, P719; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Galbiati F, 2001, TRENDS MOL MED, V7, P435, DOI 10.1016/S1471-4914(01)02105-0; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Gomez JA, 2007, BIOCHEM SOC T, V35, P797, DOI 10.1042/BST0350797; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Hasenjager A, 2004, ONCOGENE, V23, P4523, DOI 10.1038/sj.onc.1207594; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Jagannadham MV, 2002, BIOCHEM BIOPH RES CO, V298, P203, DOI 10.1016/S0006-291X(02)02426-9; Kim HA, 2006, EXP MOL PATHOL, V80, P165, DOI 10.1016/j.yexmp.2005.09.001; Kim SH, 1999, CANCER RES, V59, P4012; Matveev S, 2001, ADV DRUG DELIVER REV, V49, P237, DOI 10.1016/S0169-409X(01)00138-7; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Ouyang H, 1997, J EXP MED, V186, P921, DOI 10.1084/jem.186.6.921; PALADE GE, 1953, J APPL PHYS, V24, P1424; Parat MO, 2009, INT REV CEL MOL BIO, V273, P117, DOI 10.1016/S1937-6448(08)01804-2; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Patlolla JMR, 2004, ONCOL REP, V11, P957; Razani B, 2000, J CELL SCI, V113, P2103; Ries LAG, 2000, CANCER-AM CANCER SOC, V88, P2398, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2398::AID-CNCR26>3.0.CO;2-I; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Selga E, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-35; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tencer L, 2008, ANTICANCER RES, V28, P895; Tessner TG, 2004, J CLIN INVEST, V114, P1676, DOI 10.1172/JCI200422218; Volonte D, 2009, EMBO REP, V10, P1334, DOI 10.1038/embor.2009.215; Volonte D, 2009, J BIOL CHEM, V284, P5462, DOI 10.1074/jbc.C800225200; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Yoshida T, 2004, BIOCHEM BIOPH RES CO, V321, P961, DOI 10.1016/j.bbrc.2004.07.054; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012055	38	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39379	10.1371/journal.pone.0039379	http://dx.doi.org/10.1371/journal.pone.0039379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745744	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000305693200070
J	Senturker, S; Thomas, JT; Mateshaytis, J; Moos, M				Senturker, Sema; Thomas, John Terrig; Mateshaytis, Jennifer; Moos, Malcolm, Jr.			A Homolog of Subtilisin-Like Proprotein Convertase 7 Is Essential to Anterior Neural Development in Xenopus	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; LENS INDUCTION; PROCESSING REQUIREMENTS; MORPHOGENETIC PROTEIN; GENE-EXPRESSION; CRYSTALLIN GENE; EYE DEVELOPMENT; BMP4; INVOLVEMENT; ACTIVATION	Background: Subtilisin-like Proprotein Convertase 7 (SPC7) is a member of the subtilisin/kexin family of pro-protein convertases. It cleaves many pro-proteins to release their active proteins, including members of the bone morphogenetic protein (BMP) family of signaling molecules. Other SPCs are known to be required during embryonic development but corresponding data regarding SPC7 have not been reported previously. Methodology/Principal Findings: We demonstrated that Xenopus SPC7 (SPC7) was expressed predominantly in the developing brain and eye, throughout the neural plate initially, then more specifically in the lens and retina primordia as development progressed. Since no prior functional information has been reported for SPC7, we used gain-and loss-of-function experiments to investigate the possibility that it may also convey patterning or tissue specification information similarly to Furin, SPC4, and SPC6. Overexpression of SPC7 was without effect. In contrast, injection of SPC7 antisense morpholino oligonucleotides (MO) into a single blastomere at the 2- or 4-cell stage produced marked disruption of head structures; anophthalmia was salient. Bilateral injections suppressed head and eye formation completely. In parallel with suppression of eye and brain development by SPC7 knockdown, expression of early anterior neural markers (Sox2, Otx2, Rx2, and Pax6) and late eye-specific markers (beta-Crystallin and Opsin), and of BMP target genes such as Tbx2 and Tbx3, was reduced or eliminated. Taken together, these findings suggest a critical role for SPC7-perhaps, at least in part, due to activation of one or more BMPs-in early patterning of the anterior neural plate and its derivatives. Conclusion/Significance: SPC7 is required for normal development of the eye and brain, possibly through processing BMPs, though other potential substrates cannot be excluded.	[Senturker, Sema; Thomas, John Terrig; Mateshaytis, Jennifer; Moos, Malcolm, Jr.] US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	Senturker, S (corresponding author), US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	malcolm.moos@fda.hhs.gov	Moos, Malcolm C/F-3673-2011	Moos, Malcolm C/0000-0002-9575-9938				Bailey TJ, 2004, INT J DEV BIOL, V48, P761, DOI 10.1387/ijdb.041878tb; Behesti H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-62; Butler K, 2001, METHODS, V23, P303, DOI 10.1006/meth.2000.1142; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Constam DB, 1996, J CELL BIOL, V134, P181, DOI 10.1083/jcb.134.1.181; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; COOKE J, 1979, J EMBRYOL EXP MORPH, V53, P269; CVEKL A, 1994, MOL CELL BIOL, V14, P7363, DOI 10.1128/MCB.14.11.7363; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Grainger RM, 1996, SEMIN CELL DEV BIOL, V7, P149, DOI 10.1006/scdb.1996.0021; Gurdon JB, 1967, METHODS DEV BIOL; Hanel ML, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-43; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; HOROBIN RW, 1971, STAIN TECHNOL, V46, P53, DOI 10.3109/10520297109067822; Jena N, 1997, EXP CELL RES, V230, P28, DOI 10.1006/excr.1996.3411; KAMACHI Y, 1995, EMBO J, V14, P3510, DOI 10.1002/j.1460-2075.1995.tb07357.x; Keller R, 1991, EARLY EMBRYONIC DEV; Mizuno N, 1999, DIFFERENTIATION, V64, P143, DOI 10.1046/j.1432-0436.1999.6430143.x; Moos M, 1995, DEVELOPMENT, V121, P4293; RICHARDSON J, 1995, P NATL ACAD SCI USA, V92, P4676, DOI 10.1073/pnas.92.10.4676; Rousselet E, 2011, J BIOL CHEM, V286, P9185, DOI 10.1074/jbc.M110.189936; SAHA MS, 1993, MOL BRAIN RES, V17, P307, DOI 10.1016/0169-328X(93)90016-I; Sasagawa S, 2002, GENESIS, V33, P86, DOI 10.1002/gene.10095; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Suzuki T, 2004, DEV CELL, V6, P43, DOI 10.1016/S1534-5807(03)00401-5; Thomas JT, 2006, J BIOL CHEM, V281, P26725, DOI 10.1074/jbc.M603851200; Thomas JT, 2007, DEV BIOL, V310, P129, DOI 10.1016/j.ydbio.2007.07.032; Wawersik S, 1999, DEV BIOL, V207, P176, DOI 10.1006/dbio.1998.9153; Zaghloul NA, 2007, DEV BIOL, V306, P222, DOI 10.1016/j.ydbio.2007.03.017; Zaidi AU, 2000, J HISTOCHEM CYTOCHEM, V48, P1369, DOI 10.1177/002215540004801007; Zygar CA, 1998, DEVELOPMENT, V125, P3509	36	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39380	10.1371/journal.pone.0039380	http://dx.doi.org/10.1371/journal.pone.0039380			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761776	Green Published, Green Submitted			2022-12-27	WOS:000305826400014
J	Bindels, LB; Beck, R; Schakman, O; Martin, JC; De Backer, F; Sohet, FM; Dewulf, EM; Pachikian, BD; Neyrinck, AM; Thissen, JP; Verrax, J; Calderon, PB; Pot, B; Grangette, C; Cani, PD; Scott, KP; Delzenne, NM				Bindels, Laure B.; Beck, Raphael; Schakman, Olivier; Martin, Jennifer C.; De Backer, Fabienne; Sohet, Florence M.; Dewulf, Evelyne M.; Pachikian, Barbara D.; Neyrinck, Audrey M.; Thissen, Jean-Paul; Verrax, Julien; Calderon, Pedro Buc; Pot, Bruno; Grangette, Corinne; Cani, Patrice D.; Scott, Karen P.; Delzenne, Nathalie M.			Restoring Specific Lactobacilli Levels Decreases Inflammation and Muscle Atrophy Markers in an Acute Leukemia Mouse Model	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; E3 LIGASE MURF1; GUT MICROBIOTA; SKELETAL-MUSCLE; IN-VIVO; CANCER CACHEXIA; BCR-ABL; MICE; METABOLISM; CELLS	The gut microbiota has recently been proposed as a novel component in the regulation of host homeostasis and immunity. We have assessed for the first time the role of the gut microbiota in a mouse model of leukemia (transplantation of BaF3 cells containing ectopic expression of Bcr-Abl), characterized at the final stage by a loss of fat mass, muscle atrophy, anorexia and inflammation. The gut microbial 16S rDNA analysis, using PCR-Denaturating Gradient Gel Electrophoresis and quantitative PCR, reveals a dysbiosis and a selective modulation of Lactobacillus spp. (decrease of L. reuteri and L. johnsonii/gasseri in favor of L. murinus/animalis) in the BaF3 mice compared to the controls. The restoration of Lactobacillus species by oral supplementation with L. reuteri 100-23 and L. gasseri 311476 reduced the expression of atrophy markers (Atrogin-1, MuRF1, LC3, Cathepsin L) in the gastrocnemius and in the tibialis, a phenomenon correlated with a decrease of inflammatory cytokines (interleukin-6, monocyte chemoattractant protein-1, interleukin-4, granulocyte colony-stimulating factor, quantified by multiplex immuno-assay). These positive effects are strain- and/or species-specific since L. acidophilus NCFM supplementation does not impact on muscle atrophy markers and systemic inflammation. Altogether, these results suggest that the gut microbiota could constitute a novel therapeutic target in the management of leukemia-associated inflammation and related disorders in the muscle.	[Bindels, Laure B.; De Backer, Fabienne; Sohet, Florence M.; Dewulf, Evelyne M.; Pachikian, Barbara D.; Neyrinck, Audrey M.; Cani, Patrice D.; Delzenne, Nathalie M.] Catholic Univ Louvain, Metab & Nutr Res Grp, Louvain Drug Res Inst, B-1200 Brussels, Belgium; [Beck, Raphael; Verrax, Julien; Calderon, Pedro Buc] Catholic Univ Louvain, Toxicol & Canc Biol Res Grp, Louvain Drug Res Inst, B-1200 Brussels, Belgium; [Schakman, Olivier] Catholic Univ Louvain, Lab Cell Physiol, Inst Neurosci, B-1200 Brussels, Belgium; [Martin, Jennifer C.; Scott, Karen P.] Univ Aberdeen, Gut Hlth Div, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Thissen, Jean-Paul] Catholic Univ Louvain, Dept Diabetol & Nutr, Inst Rech Expt & Clin, B-1200 Brussels, Belgium; [Pot, Bruno; Grangette, Corinne] Univ Lille Nord France, Ctr Infect & Immun Lille, Inst Pasteur Lille, INSERM CNRS UMR 8204 U1019, Lille, France	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; University of Aberdeen; Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Bindels, LB (corresponding author), Catholic Univ Louvain, Metab & Nutr Res Grp, Louvain Drug Res Inst, B-1200 Brussels, Belgium.	nathalie.delzenne@uclouvain.be	Delzenne, Nathalie/AAC-4628-2019; D., Cani Patrice/M-8055-2016; Neyrinck, Audrey/AAE-7929-2019; Pot, Bruno DF/I-6645-2012; Scott, Karen/ABD-5484-2021; Bindels, Laure/T-7846-2019	Delzenne, Nathalie/0000-0003-2115-6082; D., Cani Patrice/0000-0003-2040-2448; Neyrinck, Audrey/0000-0002-9435-3338; Scott, Karen/0000-0002-4608-0013; Bindels, Laure/0000-0003-3747-3234; Beck, Raphael/0000-0002-5368-3808	FRS-FNRS; Scottish Government (RESAS)	FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); Scottish Government (RESAS)	LBB is a Research Fellow, JV is a Postdoctoral Researcher and PDC is a Research Associate from the FRS-FNRS (Fond de la Recherche Scientifique) in Belgium, http://www1.frs-fnrs.be/. PDC and NMD are recipients of FRS-FNRS grants. The RINH, University of Aberdeen, receives support from the Scottish Government (RESAS), http://www.abdn.ac.uk/rowett/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Aggarwal BB, 2009, CURR OPIN PHARMACOL, V9, P351, DOI 10.1016/j.coph.2009.06.020; Altermann E, 2005, P NATL ACAD SCI USA, V102, P3906, DOI 10.1073/pnas.0409188102; Attaix D, 2010, CURR OPIN CLIN NUTR, V13, P223, DOI 10.1097/MCO.0b013e328338b9a6; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Cong HL, 2011, HUM GENE THER, V22, P313, DOI 10.1089/hum.2010.057; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; de LeBlanc AD, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-27; Delroisse JM, 2008, MICROBIOL RES, V163, P663, DOI 10.1016/j.micres.2006.09.004; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Dewulf EM, 2011, J NUTR BIOCHEM, V22, P712, DOI 10.1016/j.jnutbio.2010.05.009; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Fernandez EM, 2011, GUT, V60, P1050, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Fiskus W, 2006, CLIN CANCER RES, V12, P5869, DOI 10.1158/1078-0432.CCR-06-0980; Fiskus W, 2006, BLOOD, V108, P645, DOI 10.1182/blood-2005-11-4639; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Han DM, 2007, INT J LAB HEMATOL, V29, P185, DOI 10.1111/j.1751-553X.2006.00839.x; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Livingston M, 2010, IMMUNOL CELL BIOL, V88, P99, DOI 10.1038/icb.2009.71; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2; Moschovi M, 2008, J PEDIAT HEMATOL ONC, V30, P733, DOI 10.1097/MPH.0b013e318179a1d8; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Polge C, 2011, FASEB J, V25, P3790, DOI 10.1096/fj.11-180968; R Development Core Team, 2012, R LANG ENV STAT COMP; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Rollins BJ, 2006, EUR J CANCER, V42, P760, DOI 10.1016/j.ejca.2006.01.002; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sessions J, 2007, J MANAGE CARE PHARM, V13, pS4, DOI 10.18553/jmcp.2007.13.s8-a.4; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Tan BHL, 2008, CURR OPIN CLIN NUTR, V11, P400, DOI 10.1097/MCO.0b013e328300ecc1; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712; Tilg H, 2009, GASTROENTEROLOGY, V136, P1476, DOI 10.1053/j.gastro.2009.03.030; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Trikha M, 2003, CLIN CANCER RES, V9, P4653; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Yao YX, 2005, J EXP MED, V201, P1899, DOI 10.1084/jem.20050324	52	136	148	6	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e37971	10.1371/journal.pone.0037971	http://dx.doi.org/10.1371/journal.pone.0037971			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761662	gold, Green Published			2022-12-27	WOS:000305825800006
J	Bose, A; Teh, MT; Hutchison, IL; Wan, H; Leigh, IM; Waseem, A				Bose, Amrita; Teh, Muy-Teck; Hutchison, Iain L.; Wan, Hong; Leigh, Irene M.; Waseem, Ahmad			Two Mechanisms Regulate Keratin K15 Expression In Keratinocytes: Role of PKC/AP-1 and FOXM1 Mediated Signalling	PLOS ONE			English	Article							PROTEIN-KINASE-C; FOLLICLE STEM-CELLS; HUMAN EPIDERMAL-KERATINOCYTES; CYTOKERATIN 15 EXPRESSION; HAIR FOLLICLE; TERMINAL DIFFERENTIATION; GENE-EXPRESSION; MOUSE KERATINOCYTES; HUMAN SKIN; IN-VITRO	Background: Keratin 15 (K15) is a type I keratin that is used as a marker of stem cells. Its expression is restricted to the basal layer of stratified epithelia, and the bulge in hair follicles. However, in certain clinical situations including oral lichen planus, K15 is induced in suprabasal layers, which is inconsistent with the role of a stem cell marker. This study provides insights into the mechanisms of K15 expression in the basal and differentiating keratinocytes. Methodology/Principal Findings: Human keratinocytes were differentiated by three different methods; suspension in methylcellulose, high cell density and treatment with phorbol ester. The expression of mRNA was determined by quantitative PCR and protein by western blotting and immunostaining. Keratinocytes in suspension suppressed beta 1-integrin expression, induced differentiation-specific markers and K15, whereas FOXM1 (a cell cycle regulated protein) and K14 were downregulated. Rescuing beta 1-integrin by either fibronectin or the arginine-glycine-aspartate peptide suppressed K15 but induced K14 and FOXM1 expression. Specific inhibition of PKC delta, by siRNA, and AP-1 transcription factor, by TAM67 (dominant negative c-Jun), suppressed K15 expression, suggesting that PKC/AP-1 pathway plays a role in the differentiation-specific expression of K15. The basal cell-specific K15 expression may involve FOXM1 because ectopic expression of the latter is known to induce K15. Using chromatin immunoprecipitation, we have identified a single FOXM1 binding motif in the K15 promoter. Conclusions/Significance: The data suggests that K15 is induced during terminal differentiation mediated by the down regulation of beta 1-integrin. However, this cannot be the mechanism of basal/stem cell-specific K15 expression in stratified epithelia, because basal keratinocytes do not undergo terminal differentiation. We propose that there are two mechanisms regulating K15 expression in stratified epithelia; differentiation-specific involving PKC/AP-1 pathway, and basal-specific mediated by FOXM1, and therefore the use of K15 expression as a marker of stem cells must be viewed with caution.	[Bose, Amrita; Teh, Muy-Teck; Hutchison, Iain L.; Wan, Hong; Waseem, Ahmad] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Clin & Diagnost Oral Sci, London, England; [Leigh, Irene M.] Univ Dundee, Med Res Inst, Div Canc, Dundee, Scotland	University of London; Queen Mary University London; University of Dundee	Bose, A (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Clin & Diagnost Oral Sci, London, England.	a.waseem@qmul.ac.uk	Teh, Muy-Teck/B-9284-2016	Teh, Muy-Teck/0000-0002-7725-8355; Hutchison, Iain/0000-0002-4894-4049	Queen Mary University of London; Facial Research Foundation-Saving Faces; Cancer Research UK [13044] Funding Source: researchfish	Queen Mary University of London; Facial Research Foundation-Saving Faces; Cancer Research UK(Cancer Research UK)	The work was partially funded by Queen Mary University of London in the form of an Overseas Research Student award to Amrita Bose and the Facial Research Foundation-Saving Faces. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ADAMS JC, 1990, CELL, V63, P425, DOI 10.1016/0092-8674(90)90175-E; ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0; Adhikary G, 2010, J INVEST DERMATOL, V130, P2017, DOI 10.1038/jid.2010.108; Al-Refu K, 2009, BRIT J DERMATOL, V160, P1188, DOI 10.1111/j.1365-2133.2009.09074.x; Barker N, 2008, COLD SH Q B, V73, P351, DOI 10.1101/sqb.2008.72.003; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Bloor BK, 1998, LAB INVEST, V78, P787; Bloor BK, 2003, AM J PATHOL, V162, P963, DOI 10.1016/S0002-9440(10)63891-6; Bloor BK, 2000, J ORAL PATHOL MED, V29, P376, DOI 10.1034/j.1600-0714.2000.290803.x; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; CROWE DL, 1993, J CELL SCI, V106, P183; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; DLUGOSZ AA, 1992, MOL CARCINOGEN, V5, P286, DOI 10.1002/mc.2940050409; DLUGOSZ AA, 1993, J CELL BIOL, V120, P217, DOI 10.1083/jcb.120.1.217; Eckert RL, 1996, MOL BIOL REP, V23, P59, DOI 10.1007/BF00357073; Efimova T, 2000, J BIOL CHEM, V275, P1601, DOI 10.1074/jbc.275.3.1601; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; FANJUL A, 1994, NATURE, V372, P107, DOI 10.1038/372107a0; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; Gemenetzidis E, 2010, CANCER RES, V70, P9515, DOI 10.1158/0008-5472.CAN-10-2173; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Ghali L, 1999, J INVEST DERMATOL, V113, P595, DOI 10.1046/j.1523-1747.1999.00729.x; Ghazizadeh S, 2005, J INVEST DERMATOL, V124, P367, DOI 10.1111/j.0022-202X.2004.23599.x; GREEN H, 1977, CELL, V11, P405, DOI 10.1016/0092-8674(77)90058-7; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; Hesse M, 2001, J CELL SCI, V114, P2569; Hong JY, 2007, ACS CHEM BIOL, V2, P171, DOI 10.1021/cb600435t; Huynh KM, 2011, J CELL PHYSIOL, V226, P194, DOI 10.1002/jcp.22326; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Janes SM, 2002, J PATHOL, V197, P479, DOI 10.1002/path.1156; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Jih DM, 1999, J CUTAN PATHOL, V26, P113, DOI 10.1111/j.1600-0560.1999.tb01814.x; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Jonkman MF, 1996, J INVEST DERMATOL, V107, P764, DOI 10.1111/1523-1747.ep12365805; Kamioka N, 2010, BIOCHEM BIOPH RES CO, V394, P106, DOI 10.1016/j.bbrc.2010.02.125; Kashiwagi M, 2002, J BIOCHEM, V132, P853, DOI 10.1093/oxfordjournals.jbchem.a003297; Kirfel J, 2003, CELL MOL LIFE SCI, V60, P56, DOI 10.1007/s000180300004; KLEIN CE, 1990, BRIT J DERMATOL, V123, P171, DOI 10.1111/j.1365-2133.1990.tb01844.x; Kose O, 2008, CLIN EXP DERMATOL, V33, P62, DOI 10.1111/j.1365-2230.2007.02558.x; Kose Osman, 2007, J Oral Sci, V49, P133, DOI 10.2334/josnusd.49.133; KULESH DA, 1989, MOL CELL BIOL, V9, P1553, DOI 10.1128/MCB.9.4.1553; LASH JW, 1987, DEV BIOL, V123, P411, DOI 10.1016/0012-1606(87)90399-X; LAVKER RM, 1982, SCIENCE, V215, P1239, DOI 10.1126/science.7058342; Lee YS, 1998, J INVEST DERMATOL, V111, P762, DOI 10.1046/j.1523-1747.1998.00365.x; LEUBE RE, 1988, J CELL BIOL, V106, P1249, DOI 10.1083/jcb.106.4.1249; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329; Lyle S, 1998, J CELL SCI, V111, P3179; Ma SH, 1997, GENE EXPRESSION, V6, P361; Machesney M, 1998, AM J PATHOL, V152, P1133; Matsui M S, 1993, Exp Dermatol, V2, P247, DOI 10.1111/j.1600-0625.1993.tb00041.x; MOLL R, 1983, LAB INVEST, V49, P599; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MORRIS RJ, 1994, CELL PROLIFERAT, V27, P279, DOI 10.1111/j.1365-2184.1994.tb01425.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Papp H, 2003, EXP DERMATOL, V12, P811, DOI 10.1111/j.0906-6705.2003.00097.x; Pontiggia L, 2009, J INVEST DERMATOL, V129, P480, DOI 10.1038/jid.2008.254; Porter RM, 2000, LAB INVEST, V80, P1701, DOI 10.1038/labinvest.3780180; POUMAY Y, 1995, J INVEST DERMATOL, V104, P271, DOI 10.1111/1523-1747.ep12612810; Poumay Y, 1999, Mol Cell Biol Res Commun, V2, P138, DOI 10.1006/mcbr.1999.0165; Radoja N, 2004, MOL CELL BIOL, V24, P3168, DOI 10.1128/MCB.24.8.3168-3179.2004; Roberts NA, 2004, BIOCHEM PHARMACOL, V68, P1923, DOI 10.1016/j.bcp.2004.07.040; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Rutberg SE, 1997, ONCOGENE, V15, P1337, DOI 10.1038/sj.onc.1201293; Rutberg SE, 1996, ONCOGENE, V13, P167; RYLE CM, 1989, DIFFERENTIATION, V40, P42, DOI 10.1111/j.1432-0436.1989.tb00812.x; Sakamoto K, 2011, HISTOPATHOLOGY, V58, P531, DOI 10.1111/j.1365-2559.2011.03759.x; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Sperling LC, 2011, J CUTAN PATHOL, V38, P407, DOI 10.1111/j.1600-0560.2010.01668.x; Swensson O, 1998, BRIT J DERMATOL, V139, P767; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Teh MT, 2002, CANCER RES, V62, P4773; Troy TC, 2011, STEM CELL REV REP, V7, P1041, DOI 10.1007/s12015-011-9264-4; TYNER AL, 1986, J CELL BIOL, V103, P1945, DOI 10.1083/jcb.103.5.1945; Verma AK, 2006, MOL CARCINOGEN, V45, P381, DOI 10.1002/mc.20230; Waseem A, 1999, J INVEST DERMATOL, V112, P362, DOI 10.1046/j.1523-1747.1999.00535.x; Waseem A, 2010, ORAL ONCOL, V46, P536, DOI 10.1016/j.oraloncology.2010.03.022; Webb A, 2004, DIFFERENTIATION, V72, P387, DOI 10.1111/j.1432-0436.2004.07208005.x; Werner S, 2000, EXP CELL RES, V254, P80, DOI 10.1006/excr.1999.4726; Whitbread LA, 1998, EXP CELL RES, V244, P448, DOI 10.1006/excr.1998.4217; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Yoshida S, 2006, INVEST OPHTH VIS SCI, V47, P4780, DOI 10.1167/iovs.06-0574; Zhan Q, 2007, J INVEST DERMATOL, V127, P106, DOI 10.1038/sj.jid.5700583	88	28	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e38599	10.1371/journal.pone.0038599	http://dx.doi.org/10.1371/journal.pone.0038599			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761689	Green Submitted, Green Published, gold			2022-12-27	WOS:000305825800013
J	Ong, JBS; Fu, XJ; Lee, GKK; Chen, MIC				Ong, Jimmy Boon Som; Fu, Xiuju; Lee, Gary Kee Khoon; Chen, Mark I-Cheng			Comparability of Results from Pair and Classical Model Formulations for Different Sexually Transmitted Infections	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; HIV-1 TRANSMISSION; SEX WORKERS; CONDOM USE; GONORRHEA; DISEASE; EPIDEMIOLOGY; DYNAMICS; PARTNERS; WOMEN	The "classical model'' for sexually transmitted infections treats partnerships as instantaneous events summarized by partner change rates, while individual-based and pair models explicitly account for time within partnerships and gaps between partnerships. We compared predictions from the classical and pair models over a range of partnership and gap combinations. While the former predicted similar or marginally higher prevalence at the shortest partnership lengths, the latter predicted self-sustaining transmission for gonorrhoea (GC) and Chlamydia (CT) over much broader partnership and gap combinations. Predictions on the critical level of condom use (C-c) required to prevent transmission also differed substantially when using the same parameters. When calibrated to give the same disease prevalence as the pair model by adjusting the infectious duration for GC and CT, and by adjusting transmission probabilities for HIV, the classical model then predicted much higher C-c values for GC and CT, while C-c predictions for HIV were fairly close. In conclusion, the two approaches give different predictions over potentially important combinations of partnership and gap lengths. Assuming that it is more correct to explicitly model partnerships and gaps, then pair or individual-based models may be needed for GC and CT since model calibration does not resolve the differences.	[Ong, Jimmy Boon Som; Chen, Mark I-Cheng] Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore; [Fu, Xiuju; Lee, Gary Kee Khoon] Agcy Sci Technol & Res, Inst High Performance Comp, Singapore, Singapore; [Chen, Mark I-Cheng] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Chen, Mark I-Cheng] Duke NUS Grad Med Sch, Singapore, Singapore	Tan Tock Seng Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); National University of Singapore; National University of Singapore	Ong, JBS (corresponding author), Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore.	jimmy_ong@ttsh.com.sg	Chen, Mark/CAG-2949-2022; Chen, Mark/AGC-5338-2022	Chen, Mark/0000-0001-9369-5830; Chen, Mark/0000-0001-9369-5830	National Medical Research Council, Singapore [NMRC/NIG/0029/2008, NMRC/CSA/011/2009]	National Medical Research Council, Singapore(National Medical Research Council, Singapore)	JBSO and MIC are funded by the National Medical Research Council, Singapore (under NMRC/NIG/0029/2008 and NMRC/CSA/011/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; Abu-Raddad LJ, 2008, AIDS, V22, P1055, DOI 10.1097/QAD.0b013e3282f8af84; Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; Althaus CL, 2010, EPIDEMICS-NETH, V2, P123, DOI 10.1016/j.epidem.2010.04.002; Baggaley RF, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-9; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; Britton T, 2007, THEOR POPUL BIOL, V72, P389, DOI 10.1016/j.tpb.2007.06.006; BRUNHAM RC, 1990, MED CLIN N AM, V74, P1339, DOI 10.1016/S0025-7125(16)30484-9; Chen MI, 2008, SEX TRANSM DIS, V35, P435, DOI 10.1097/OLQ.0b013e3181612d33; Chen MI, 2010, SEX TRANSM INFECT, V86, P433, DOI 10.1136/sti.2009.040238; Chen MI, 2008, J R SOC INTERFACE; DIETZ K, 1988, J MATH BIOL, V26, P1, DOI 10.1007/BF00280169; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Eames KTD, 2002, P NATL ACAD SCI USA, V99, P13330, DOI 10.1073/pnas.202244299; Elliott LJ, 2002, SEX TRANSM INFECT, V78, pI139, DOI 10.1136/sti.78.suppl_1.i139; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Garnett GP, 2008, SEX TRANSM INFECT, V84, pII4, DOI 10.1136/sti.2008.029850; Garnett GP, 1999, PHILOS T R SOC B, V354, P787, DOI 10.1098/rstb.1999.0431; Garnett GP, 2002, SEX TRANSM INFECT, V78, pI14, DOI 10.1136/sti.78.suppl_1.i14; Ghani AC, 1997, SEX TRANSM DIS, V24, P45, DOI 10.1097/00007435-199701000-00009; Gift TL, 2008, SEX TRANSM DIS, V35, pS66, DOI 10.1097/OLQ.0b013e31818b64ac; Golden MR, 2007, SEX TRANSM DIS, V34, P598, DOI 10.1097/01.olq.0000258319.54316.06; Golden MR, 2005, NEW ENGL J MED, V352, P676, DOI 10.1056/NEJMoa041681; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hethcote H., 1984, LECT NOTES BIOMATHEM; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; HOOPER RR, 1978, AM J EPIDEMIOL, V108, P136, DOI 10.1093/oxfordjournals.aje.a112597; Kerani RP, 2005, AM J PUBLIC HEALTH, V95, P324, DOI 10.2105/AJPH.2003.029413; Kretzschmar M, 2000, SEX TRANSM DIS, V27, P627, DOI 10.1097/00007435-200011000-00011; Kretzschmar M, 1998, MATH BIOSCI, V148, P83, DOI 10.1016/S0025-5564(97)10008-6; Kretzschmar M, 1996, AM J EPIDEMIOL, V144, P306; Lloyd-Smith JO, 2004, P ROY SOC B-BIOL SCI, V271, P625, DOI 10.1098/rspb.2003.2632; LYCKE E, 1980, SEX TRANSM DIS, V7, P6, DOI 10.1097/00007435-198001000-00002; Muller H, 2010, INT J ENV RES PUB HE, V7, P635, DOI 10.3390/ijerph7020635; Nordvik MK, 2006, SEX TRANSM DIS, V33, P342, DOI 10.1097/01.olq.0000194601.25488.b8; Orroth KK, 2007, SEX TRANSM INFECT, V83, pI5, DOI 10.1136/sti.2006.023531; PLATT R, 1983, JAMA-J AM MED ASSOC, V250, P3205, DOI 10.1001/jama.250.23.3205; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Regan DG, 2008, J INFECT DIS, V198, P349, DOI 10.1086/589883; Rietmeijer CA, 2002, SEX TRANSM DIS, V29, P65, DOI 10.1097/00007435-200202000-00001; Rocha LEC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001109; Rocha LEC, 2010, P NATL ACAD SCI USA, V107, P5706, DOI 10.1073/pnas.0914080107; Shahmanesh M, 2000, SEX TRANSM INFECT, V76, P268, DOI 10.1136/sti.76.4.268; Turner KME, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-3; Whittington WLH, 2001, SEX TRANSM DIS, V28, P117, DOI 10.1097/00007435-200102000-00011; Wong ML, 2005, SEX TRANSM DIS, V32, P439, DOI 10.1097/01.olq.0000168279.05452.ad; Wong ML, 1999, SEX TRANSM DIS, V26, P593, DOI 10.1097/00007435-199911000-00010	49	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39575	10.1371/journal.pone.0039575	http://dx.doi.org/10.1371/journal.pone.0039575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761828	gold, Green Published, Green Submitted			2022-12-27	WOS:000305825800044
J	Khong, A; Forestieri, R; Williams, DE; Patrick, BO; Olmstead, A; Svinti, V; Schaeffer, E; Jean, F; Roberge, M; Andersen, RJ; Jan, E				Khong, Anthony; Forestieri, Roberto; Williams, David E.; Patrick, Brian O.; Olmstead, Andrea; Svinti, Victoria; Schaeffer, Emily; Jean, Francois; Roberge, Michel; Andersen, Raymond J.; Jan, Eric			A Daphnane Diterpenoid Isolated from Wikstroemia polyantha Induces an Inflammatory Response and Modulates miRNA Activity	PLOS ONE			English	Article							ENHANCES RNA INTERFERENCE; CAENORHABDITIS-ELEGANS; BINDING PROTEIN; LET-7 MICRORNA; MESSENGER-RNAS; C-ELEGANS; TRANSLATION INITIATION; MAMMALIAN-CELLS; NUCLEAR EXPORT; IN-VITRO	MicroRNAs (miRNAs) are endogenously expressed single-stranded similar to 21-23 nucleotide RNAs that inhibit gene expression post-transcriptionally by binding imperfectly to elements usually within the 3'untranslated region (3'UTR) of mRNAs. Small interfering RNAs (siRNAs) mediate site-specific cleavage by binding with perfect complementarity to RNA. Here, a cell-based miRNA reporter system was developed to screen for compounds from marine and plant extracts that inhibit miRNA or siRNA activity. The daphnane diterpenoid genkwanine M (GENK) isolated from the plant Wikstroemia polyantha induces an early inflammatory response and can moderately inhibit miR-122 activity in the liver Huh-7 cell line. GENK does not alter miR-122 levels nor does it directly inhibit siRNA activity in an in vitro cleavage assay. Finally, we demonstrate that GENK can inhibit HCV infection in Huh-7 cells. In summary, the development of the cell-based miRNA sensor system should prove useful in identifying compounds that affect miRNA/siRNA activity.	[Khong, Anthony; Schaeffer, Emily; Roberge, Michel; Jan, Eric] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Forestieri, Roberto; Williams, David E.; Patrick, Brian O.; Andersen, Raymond J.] Univ British Columbia, Dept Chem, Vancouver, BC, Canada; [Forestieri, Roberto; Williams, David E.; Patrick, Brian O.; Andersen, Raymond J.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V5Z 1M9, Canada; [Olmstead, Andrea; Svinti, Victoria; Jean, Francois] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Khong, A (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada.	ej@mail.ubc.ca	Khong, Anthony/AHD-6446-2022; Jan, Eric/O-1923-2019	Schaeffer, Emily/0000-0002-3263-6586	Canadian Institute of Health Research (CIHR) 376 Grant [MOPS-81244]; Natural Sciences and Engineering Research Council (NSERC); 377 NSERC PGS D fellowship	Canadian Institute of Health Research (CIHR) 376 Grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); 377 NSERC PGS D fellowship	This work was supported by a Canadian Institute of Health Research (CIHR) 376 Grant (E.J. (MOPS-81244) and F.J.) and Natural Sciences and Engineering Research Council (NSERC) (R.J.A.). A. K. is supported by an 377 NSERC PGS D fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2009, ENDOCRINOLOGY, V150, P14, DOI 10.1210/en.2008-0984; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frese M, 2003, J GEN VIROL, V84, P1253, DOI 10.1099/vir.0.18997-0; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Gumireddy K, 2008, ANGEW CHEM INT EDIT, V47, P7482, DOI 10.1002/anie.200801555; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hitti E, 2010, RNA, V16, P1245, DOI 10.1261/rna.2026310; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2004, EUR J BIOCHEM, V271, P1094, DOI 10.1111/j.1432-1033.2004.04011.x; Li LZ, 2010, HELV CHIM ACTA, V93, P1172, DOI 10.1002/hlca.200900359; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Melo S, 2011, P NATL ACAD SCI USA, V108, P4394, DOI 10.1073/pnas.1014720108; Mols J, 2008, BBA-GENE REGUL MECH, V1779, P712, DOI 10.1016/j.bbagrm.2008.03.007; Olmstead AD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002468; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Plaisance V, 2006, J BIOL CHEM, V281, P26932, DOI 10.1074/jbc.M601225200; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Qin XL, 2004, J BIOL CHEM, V279, P13721, DOI 10.1074/jbc.M312854200; Ramanathan M, 2005, INFLAMMATION, V29, P94, DOI 10.1007/s10753-006-9005-z; Reese TA, 2010, J VIROL, V84, P10344, DOI 10.1128/JVI.00707-10; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ricci EP, 2011, NUCLEIC ACIDS RES, V39, P5215, DOI 10.1093/nar/gkr086; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Shan G, 2008, NAT BIOTECHNOL, V26, P933, DOI 10.1038/nbt.1481; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Varallyay E, 2008, NAT PROTOC, V3, P190, DOI 10.1038/nprot.2007.528; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Watashi K, 2010, J BIOL CHEM, V285, P24707, DOI 10.1074/jbc.M109.062976; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017; Yi R, 2005, RNA, V11, P220, DOI 10.1261/rna.7233305; Young DD, 2010, J AM CHEM SOC, V132, P7976, DOI 10.1021/ja910275u; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	68	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39621	10.1371/journal.pone.0039621	http://dx.doi.org/10.1371/journal.pone.0039621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761847	Green Submitted, Green Published, gold			2022-12-27	WOS:000305808700039
J	Maugeri, N; Rovere-Querini, P; Evangelista, V; Godino, C; Demetrio, M; Baldini, M; Figini, F; Coppi, G; Slavich, M; Camera, M; Bartorelli, A; Marenzi, G; Campana, L; Baldissera, E; Sabbadini, MG; Cianflone, D; Tremoli, E; D'Angelo, A; Manfredi, AA; Maseri, A				Maugeri, Norma; Rovere-Querini, Patrizia; Evangelista, Virgilio; Godino, Cosmo; Demetrio, Monica; Baldini, Mattia; Figini, Filippo; Coppi, Giovanni; Slavich, Massimo; Camera, Marina; Bartorelli, Antonio; Marenzi, Giancarlo; Campana, Lara; Baldissera, Elena; Sabbadini, Maria Grazia; Cianflone, Domenico; Tremoli, Elena; D'Angelo, Armando; Manfredi, Angelo A.; Maseri, Attilio			An Intense and Short-Lasting Burst of Neutrophil Activation Differentiates Early Acute Myocardial Infarction from Systemic Inflammatory Syndromes	PLOS ONE			English	Article							GIANT-CELL ARTERITIS; P-SELECTIN; IN-VIVO; PLATELET ACTIVATION; PENTRAXIN 3; LEUKOCYTE; MYELOPEROXIDASE; CLEARANCE; APOPTOSIS; MECHANISMS	Background: Neutrophils are involved in thrombus formation. We investigated whether specific features of neutrophil activation characterize patients with acute coronary syndromes (ACS) compared to stable angina and to systemic inflammatory diseases. Methods and Findings: The myeloperoxidase (MPO) content of circulating neutrophils was determined by flow cytometry in 330 subjects: 69 consecutive patients with acute coronary syndromes (ACS), 69 with chronic stable angina (CSA), 50 with inflammation due to either non-infectious (acute bone fracture), infectious (sepsis) or autoimmune diseases (small and large vessel systemic vasculitis, rheumatoid arthritis). Four patients have also been studied before and after sterile acute injury of the myocardium (septal alcoholization). One hundred thirty-eight healthy donors were studied in parallel. Neutrophils with normal MPO content were 96% in controls, >92% in patients undergoing septal alcoholization, 91% in CSA patients, but only 35 and 30% in unstable angina and AMI (STEMI and NSTEMI) patients, compared to 80%, 75% and 2% of patients with giant cell arteritis, acute bone fracture and severe sepsis. In addition, in 32/33 STEMI and 9/21 NSTEMI patients respectively, 20% and 12% of neutrophils had complete MPO depletion during the first 4 hours after the onset of symptoms, a feature not observed in any other group of patients. MPO depletion was associated with platelet activation, indicated by P-selectin expression, activation and transactivation of leukocyte beta 2-integrins and formation of platelet neutrophil and -monocyte aggregates. The injection of activated platelets in mice produced transient, P-selectin dependent, complete MPO depletion in about 50% of neutrophils. Conclusions: ACS are characterized by intense neutrophil activation, like other systemic inflammatory syndromes. In the very early phase of acute myocardial infarction only a subpopulation of neutrophils is massively activated, possibly via platelet-P selectin interactions. This paroxysmal activation could contribute to occlusive thrombosis.	[Maugeri, Norma; Rovere-Querini, Patrizia; Godino, Cosmo; Baldini, Mattia; Figini, Filippo; Coppi, Giovanni; Slavich, Massimo; Campana, Lara; Baldissera, Elena; Sabbadini, Maria Grazia; Cianflone, Domenico; D'Angelo, Armando; Manfredi, Angelo A.; Maseri, Attilio] Univ Vita Salute San Raffaele, Milan, Italy; [Maugeri, Norma; Rovere-Querini, Patrizia; Godino, Cosmo; Baldini, Mattia; Figini, Filippo; Coppi, Giovanni; Slavich, Massimo; Campana, Lara; Baldissera, Elena; Sabbadini, Maria Grazia; Cianflone, Domenico; D'Angelo, Armando; Manfredi, Angelo A.; Maseri, Attilio] Ist Sci San Raffaele, I-20132 Milan, Italy; [Evangelista, Virgilio] Ist Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy; [Demetrio, Monica; Camera, Marina; Bartorelli, Antonio; Marenzi, Giancarlo; Tremoli, Elena] Ctr Cardiol Monzino, Milan, Italy; [Maseri, Attilio] Heart Care Fdn, Florence, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Centro Cardiologico Monzino	Maugeri, N (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.	maugeri.norma@hsr.it	D'Angelo, Armando/K-2583-2018; Bartorelli, Antonio Luca/ABG-9593-2020; Campana, Lara/AAI-9372-2020; Coppi, Giovanni/AGE-3839-2022; Rovere-Querini, Patrizia/J-2340-2012; Bartorelli, Antonio/K-3955-2018; Slavich, Massimo/AAA-2996-2019; GODINO, COSMO/AAB-5796-2019; Maugeri, Norma/K-2429-2018; Manfredi, Angelo A./C-7018-2014; Camera, Marina/AAC-4741-2022; De Metrio, Monica/ABH-6561-2020; TREMOLI, ELENA/I-8126-2018	D'Angelo, Armando/0000-0002-9857-4509; Campana, Lara/0000-0003-1805-4755; Slavich, Massimo/0000-0002-2129-957X; GODINO, COSMO/0000-0003-1319-0010; Manfredi, Angelo A./0000-0001-8370-6970; Marenzi, Giancarlo/0000-0003-4410-4461; De Metrio, Monica/0000-0002-1955-747X; Maugeri, Norma/0000-0003-3931-0412; TREMOLI, ELENA/0000-0002-0929-6106	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); Ministero della Salute	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ministero della Salute(Ministry of Health, Italy)	This work has been supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) to Attilio Maseri, Patrizia Rovere-Querini, Angelo A. Manfredi and Maria G. Sabbadini and by the Ministero della Salute to Angelo A. Manfredi and Patrizia Rovere-Querini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlbrecht C, 2007, THROMB HAEMOSTASIS, V97, P642, DOI 10.1160/TH06-08-0479; Airoldi F, 2000, Ital Heart J, V1, P200; Apple FS, 2007, CLIN CHEM, V53, P874, DOI 10.1373/clinchem.2006.080192; Apple FS, 2011, CLIN CHEM, V57, P603, DOI 10.1373/clinchem.2010.158014; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baldini M, 2012, ARTHRITIS RHEUM-US, V64, P854, DOI 10.1002/art.33411; Beals CR, 2001, J IMMUNOL, V167, P6113, DOI 10.4049/jimmunol.167.11.6113; Buffon A, 2002, NEW ENGL J MED, V347, P5, DOI 10.1056/NEJMoa012295; Distelmaier K, 2009, THROMB HAEMOSTASIS, V102, P564, DOI 10.1160/TH09-02-0103; Dominguez-Rodriguez A, 2011, EXPERT REV CARDIOVAS, V9, P223, DOI [10.1586/erc.11.2, 10.1586/ERC.11.2]; DRANSFIELD I, 1994, J IMMUNOL, V153, P1254; Dyugovskaya L, 2008, AM J RESP CRIT CARE, V177, P544, DOI 10.1164/rccm.200705-675OC; Evangelista V, 2007, BLOOD, V109, P2461, DOI 10.1182/blood-2006-06-029082; Ferrante G, 2010, CIRCULATION, V122, P2505, DOI 10.1161/CIRCULATIONAHA.110.955302; Ferri LA, 2009, ATHEROSCLEROSIS, V205, P391, DOI 10.1016/j.atherosclerosis.2008.12.042; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Furman MI, 2001, J AM COLL CARDIOL, V38, P1002, DOI 10.1016/S0735-1097(01)01485-1; Gardiner EE, 2001, BLOOD, V98, P1440, DOI 10.1182/blood.V98.5.1440; Garlichs CD, 2004, J LEUKOCYTE BIOL, V75, P828, DOI 10.1189/jlb.0703358; Goldmann BU, 2009, FREE RADICAL BIO MED, V47, P79, DOI 10.1016/j.freeradbiomed.2009.04.004; Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939; Klinke A, 2011, BLOOD, V117, P1350, DOI 10.1182/blood-2010-05-284513; Madsen LH, 2009, CARDIOLOGY, V114, P167, DOI 10.1159/000226596; Manfredi AA, 2010, NEW ENGL J MED, V362, P2132, DOI 10.1056/NEJMcibr1003521; Manfredi AA, 2010, CURR OPIN HEMATOL, V17, P3, DOI 10.1097/MOH.0b013e3283324f97; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Maugeri N, 2009, CLIN EXP IMMUNOL, V156, P395, DOI 10.1111/j.1365-2249.2009.03921.x; Maugeri N, 2005, HAEMATOLOGICA, V90, P833; Maugeri N, 2012, THROMB RES, V129, P267, DOI 10.1016/j.thromres.2011.12.001; Maugeri N, 2011, BLOOD, V118, P3359, DOI 10.1182/blood-2011-02-337337; Maugeri N, 2011, J IMMUNOL, V187, P970, DOI 10.4049/jimmunol.1100261; Maugeri N, 2009, AUTOIMMUNITY, V42, P386, DOI 10.1080/08916930902832629; Maugeri N, 2009, BLOOD, V113, P5254, DOI 10.1182/blood-2008-09-180794; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Michelson AD, 2001, CIRCULATION, V104, P1533, DOI 10.1161/hc3801.095588; PALABRICA T, 1992, NATURE, V359, P848, DOI 10.1038/359848a0; Sakai T, 2011, THROMB RES, V127, P443, DOI 10.1016/j.thromres.2011.02.001; Tang WHW, 2009, AM J CARDIOL, V103, P1269, DOI 10.1016/j.amjcard.2009.01.026; Totani L, 2010, ARTERIOSCL THROM VAS, V30, P2357, DOI 10.1161/ATVBAHA.110.207480; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	41	52	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39484	10.1371/journal.pone.0039484	http://dx.doi.org/10.1371/journal.pone.0039484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761804	Green Submitted, gold, Green Published			2022-12-27	WOS:000305781700039
J	Serelli-Lee, V; Ling, KL; Ho, C; Yeong, LH; Lim, GK; Ho, B; Wong, SBJ				Serelli-Lee, Victoria; Ling, Khoon Lin; Ho, Cassandra; Yeong, Lai Han; Lim, Gek Keow; Ho, Bow; Wong, Soon Boon Justin			Persistent Helicobacter pylori Specific Th17 Responses in Patients with Past H. pylori Infection Are Associated with Elevated Gastric Mucosal IL-1 beta	PLOS ONE			English	Article							PEPTIC-ULCER DISEASE; INFILTRATING LYMPHOCYTES; IL-17-PRODUCING CELLS; UP-REGULATION; T-CELLS; CANCER; IL-17; EXPRESSION; IMMUNITY; GENES	Background: Ongoing Helicobacter pylori (HP) infection triggers a chronic active gastritis. Eradicating HP reduces gastric inflammation, but does not eliminate it. We sought to characterize this persistent gastritis, and demonstrate the persistence of HP-specific Th17 responses in individuals previously infected with HP but who no longer had evidence of ongoing infection. Methodology/Principal Findings: Study subjects were divided into 3 groups 55 individuals had active HP infection (group A), 41 were diagnosed with previous HP infection (group P), and 59 were naive to HP (group N). Blood and gastric tissue were obtained with written informed consent from all subjects, and immune responses were evaluated using flow cytometry, semi-quantitative real time PCR, immunofluorescent staining, ELISA, and multiplex cytometric bead array for cytokine quantification. Elevated IL-17A responses were observed in patients from group A compared to group N. Interestingly, IL-17A responses remained persistently elevated in the blood and gastric mucosa of individuals from group P, despite the absence of ongoing HP infection. Using purified CD4(+) T cells as effectors and antibodies that blocked antigen presentation by MHC Class II, we showed that these persistent IL-17A responses were mediated primarily by HP-specific Th17 cells, rather than other immune cells that have also been described to secrete IL-17A. Gastric mucosal IL-1 beta levels were also persistently elevated in group P, and neutralisation of IL-1 beta reduced the HP-specific IL-17A response of purified CD4+ T cells to autologous HP-pulsed antigen presenting cells in vitro, suggesting a functional association between IL-1 beta and the persistent Th17 response in group P patients. Conclusions/Significance: Despite lack of ongoing HP infection, HP-specific Th17 cells persist in the blood and gastric mucosa of individuals with past HP infection. We speculate that this persistent inflammation might contribute to gastric mucosal pathology, for example, persistent increased gastric cancer risk despite eradication of HP.	[Serelli-Lee, Victoria; Ho, Cassandra; Yeong, Lai Han; Ho, Bow; Wong, Soon Boon Justin] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore; [Ling, Khoon Lin; Lim, Gek Keow] Singapore Gen Hosp, Dept Gastroenterol & Hepatol, Singapore 0316, Singapore; [Wong, Soon Boon Justin] Natl Univ Singapore, Immunol Programme, Singapore 117548, Singapore	National University of Singapore; Singapore General Hospital; National University of Singapore	Serelli-Lee, V (corresponding author), Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore.	micwongj@nus.edu.sg			National Medical Research Council, Singapore [EDG10nov006]; Biomedical Research Council, Singapore [SCS-GCN0101]	National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by funds from the National Medical Research Council, Singapore, to SBJW (grant number EDG10nov006, URL www.nmrc.gov.sg) and funds from the Biomedical Research Council, Singapore, to KLL (grant number SCS-GCN0101, URL http://www.a-star.edu.sg/tabid/64/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Aebischer T, 2010, HELICOBACTER, V15, P21, DOI 10.1111/j.1523-5378.2010.00777.x; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Caruso R, 2008, EUR J IMMUNOL, V38, P470, DOI 10.1002/eji.200737635; Cooper AM, 2009, EUR J IMMUNOL, V39, P649, DOI 10.1002/eji.200839090; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; DElios MM, 1997, J IMMUNOL, V158, P962; Dhar DK, 2005, CLIN CANCER RES, V11, P6472, DOI 10.1158/1078-0432.CCR-05-0671; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Ghannam S, 2011, J IMMUNOL, V186, P1411, DOI 10.4049/jimmunol.1000597; Hoffmann W, 2005, CELL MOL LIFE SCI, V62, P2932, DOI 10.1007/s00018-005-5481-9; Hung LCT, 2005, GASTROENTEROLOGY, V128, P1845, DOI 10.1053/j.gastro.2005.03.026; Iida T, 2011, ONCOL REP, V25, P1271, DOI 10.3892/or.2011.1201; Inoue T, 1999, INT J MOL MED, V4, P73; KARTTUNEN R, 1995, GUT, V36, P341, DOI 10.1136/gut.36.3.341; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Leung WK, 2004, GUT, V53, P1244, DOI 10.1136/gut.2003.034629; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Luzza F, 2000, J IMMUNOL, V165, P5332, DOI 10.4049/jimmunol.165.9.5332; Maruyama T, 2010, CANCER SCI, V101, P1947, DOI 10.1111/j.1349-7006.2010.01624.x; Mera R, 2005, GUT, V54, P1536, DOI 10.1136/gut.2005.072009; Mizuno T, 2005, WORLD J GASTROENTERO, V11, P6305, DOI 10.3748/wjg.v11.i40.6305; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Persson C, 2011, AM J EPIDEMIOL, V173, P259, DOI 10.1093/aje/kwq370; Rao DA, 2007, J IMMUNOL, V179, P6536, DOI 10.4049/jimmunol.179.10.6536; Romero-Gallo J, 2008, LAB INVEST, V88, P328, DOI 10.1038/labinvest.3700719; Shibata T, 2009, HUM IMMUNOL, V70, P547, DOI 10.1016/j.humimm.2009.04.030; Sommer F, 1998, INFECT IMMUN, V66, P5543, DOI 10.1128/IAI.66.11.5543-5546.1998; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Wilson KT, 2007, GASTROENTEROLOGY, V133, P288, DOI 10.1053/j.gastro.2007.05.008; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Wu XAQ, 2010, INT J CANCER, V127, P86, DOI 10.1002/ijc.25027; Wu YY, 2007, INFECT IMMUN, V75, P4357, DOI 10.1128/IAI.01660-06; Xu S, 2010, CELL MOL IMMUNOL, V7, P164, DOI 10.1038/cmi.2010.21; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65; Yamauchi K, 2008, J IMMUNOL, V180, P1207, DOI 10.4049/jimmunol.180.2.1207; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yoshida A, 2009, CLIN IMMUNOL, V130, P290, DOI 10.1016/j.clim.2008.09.016; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhu XW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2195	47	33	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39199	10.1371/journal.pone.0039199	http://dx.doi.org/10.1371/journal.pone.0039199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761739	Green Submitted, Green Published, gold			2022-12-27	WOS:000305781700023
J	Duncan, LM; Timms, RT; Zavodszky, E; Cano, F; Dougan, G; Randow, F; Lehner, PJ				Duncan, Lidia M.; Timms, Richard T.; Zavodszky, Eszter; Cano, Florencia; Dougan, Gordon; Randow, Felix; Lehner, Paul J.			Fluorescence-Based Phenotypic Selection Allows Forward Genetic Screens in Haploid Human Cells	PLOS ONE			English	Article							DERIVATION	The isolation of haploid cell lines has recently allowed the power of forward genetic screens to be applied to mammalian cells. The interest in applying this powerful genetic approach to a mammalian system is only tempered by the limited utility of these screens, if confined to lethal phenotypes. Here we expand the scope of these approaches beyond live/dead screens and show that selection for a cell surface phenotype via fluorescence-activated cell sorting can identify the key molecules in an intracellular pathway, in this case MHC class I antigen presentation. Non-lethal haploid genetic screens are widely applicable to identify genes involved in essentially any cellular pathway.	[Duncan, Lidia M.; Timms, Richard T.; Zavodszky, Eszter; Cano, Florencia; Lehner, Paul J.] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England; [Dougan, Gordon] Wellcome Trust Sanger Inst, Hinxton, England; [Randow, Felix] MRC Lab Mol Biol, Div Prot & Nucle Acid Chem, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; MRC Laboratory Molecular Biology	Duncan, LM (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England.	pjl30@cam.ac.uk		Lehner, Paul Joseph/0000-0001-9383-1054; Zavodszky, Eszter/0000-0002-4123-8758	Wellcome Trust; Medical Research Council; MRC [G9800943, MC_U105170648] Funding Source: UKRI; Medical Research Council [MC_U105170648, G9800943] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Wellcome Trust and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Guimaraes CP, 2011, J CELL BIOL, V195, P751, DOI 10.1083/jcb.201108103; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Koudijs MJ, 2011, GENOME RES, V21, P2181, DOI 10.1101/gr.112763.110; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; PARHAM P, 1979, J IMMUNOL, V123, P342; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Wang ZG, 1999, J EXP MED, V190, P205, DOI 10.1084/jem.190.2.205; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0	16	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39651	10.1371/journal.pone.0039651	http://dx.doi.org/10.1371/journal.pone.0039651			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745803	Green Published, gold			2022-12-27	WOS:000305730900093
J	Grootjans, J; Hameeteman, W; Masclee, AA; van Dam, RM; Buurman, WA; Dejong, CHC				Grootjans, Joep; Hameeteman, Wim; Masclee, Ad A.; van Dam, Ronald M.; Buurman, Wim A.; Dejong, Cornelis H. C.			Real-Time In Vivo Imaging of Early Mucosal Changes during Ischemia-Reperfusion in Human Jejunum	PLOS ONE			English	Article							ACUTE MESENTERIC ISCHEMIA; INTESTINAL ISCHEMIA; CAPSULE ENDOSCOPY; ORGAN DYSFUNCTION; INJURY; DIAGNOSIS; BARRIER; GUT	Background and study aims: Small intestinal ischemia-reperfusion (IR) is a frequent, potentially life threatening phenomenon. There is a lack of non-invasive diagnostic modalities. For many intestinal diseases, visualizing the intestinal mucosa using endoscopy is gold standard. However, limited knowledge exists on small intestinal IR-induced, early mucosal changes. The aims of this study were to investigate endoscopic changes in human jejunum exposed to IR, and to study concordance between endoscopic appearance and histology. Patients and methods: In 23 patients a part of jejunum, to be removed for surgical reasons, was isolated and selectively exposed to ischemia with 0, 30 or 120 minutes of reperfusion. In 3 patients, a videocapsule was inserted in the isolated segment before exposure to IR, to visualize the mucosa. Endoscopic view at several time points was related to histology (Heamatoxylin & Eosin) obtained from 20 patients. Results: Ischemia was characterized by loss of villous structure, mucosal whitening and appearance of punctate lesions. This was related to appearance of subepithelial spaces and breaches in the epithelial lining in the histological view. Early during reperfusion, the lumen filled with IR-damaged, shed cells and VCE showed mucosal erosions, hemorrhage and intraluminal debris. At 60 minutes of reperfusion, the only remaining signs of IR were loss of villous structure and small erosions, indicating rapid mucosal healing. Conclusions: This study shows a unique, real-time in vivo endoscopic view of early mucosal changes during IR of the human small intestine. Future studies should evaluate its usefulness in diagnosis of patients suspected of IR.	[Grootjans, Joep; van Dam, Ronald M.; Buurman, Wim A.; Dejong, Cornelis H. C.] Maastricht Univ, Med Ctr, Dept Surg, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Hameeteman, Wim; Masclee, Ad A.] Maastricht Univ, Med Ctr, Dept Gastroenterol, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Grootjans, J (corresponding author), Maastricht Univ, Med Ctr, Dept Surg, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands.	chc.dejong@maastrichtuniversity.nl		Grootjans, Joep/0000-0002-2805-4831	Dutch Gastroenterology; Hepatology Society (MLDS) [WO10-57]	Dutch Gastroenterology; Hepatology Society (MLDS)	This work was financially supported by the Dutch Gastroenterology and Hepatology Society (MLDS grant WO10-57 to C. H. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMERICAN GASTROENTEROLOGICAL ASSOCIATION MEDICAL POSITION STATEMENT, 2000, GASTROENTEROLOGY, V118, P951, DOI DOI 10.1016/S0016-5085(00)70182-X; Breithaupt-Faloppa AC, 2011, J SURG RES; Chang M, 2012, SHOCK, V37, P297, DOI 10.1097/SHK.0b013e318240b59b; Chen Y, 2004, GUT, V53, P1772, DOI 10.1136/gut.2003.034868; Derikx J. P., 2009, J SURG RES, V166, P222; Derikx JPM, 2007, SHOCK, V28, P544, DOI 10.1097/shk.0b013e3180644e32; Derikx JPM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003428; Feinman R, 2010, AM J PHYSIOL-GASTR L, V299, pG833, DOI 10.1152/ajpgi.00065.2010; Fink MP, 2005, CRIT CARE CLIN, V21, P177, DOI 10.1016/j.ccc.2005.01.005; Grootjans J, 2012, GUT IN PRESS; Grootjans J, 2011, J PATHOL, V224, P411, DOI 10.1002/path.2882; Grootjans J, 2011, GASTROENTEROLOGY, V140, P529, DOI 10.1053/j.gastro.2010.10.040; Grootjans J, 2010, AM J PATHOL, V176, P2283, DOI 10.2353/ajpath.2010.091069; HomerVanniasinkam S, 1997, EUR J VASC ENDOVASC, V14, P195, DOI 10.1016/S1078-5884(97)80191-8; Iddan G, 2000, NATURE, V405, P417, DOI 10.1038/35013140; Kim HM, 2010, GASTROINTEST ENDOSC, V72, P381, DOI 10.1016/j.gie.2009.12.058; Kougias P, 2007, J VASC SURG, V46, P467, DOI 10.1016/j.jvs.2007.04.045; Kozuch PL, 2005, ALIMENT PHARM THER, V21, P201, DOI 10.1111/j.1365-2036.2005.02269.x; KURLAND B, 1992, SURG CLIN N AM, V72, P85; Liatsos C, 2005, GASTROINTEST ENDOSC, V62, P439, DOI 10.1016/j.gie.2005.05.007; Liatsos C, 2010, ENDOSCOPY, V42, pE39, DOI 10.1055/s-0029-1215319; Mensink PBF, 2011, GUT, V60, P722, DOI 10.1136/gut.2009.199695; Oldenburg WA, 2004, ARCH INTERN MED, V164, P1054, DOI 10.1001/archinte.164.10.1054; PARKS DA, 1986, AM J PHYSIOL, V250, pG749, DOI 10.1152/ajpgi.1986.250.6.G749; Qin XF, 2011, SHOCK, V35, P275, DOI 10.1097/SHK.0b013e3181f6aaf1; Reino DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014829; Sharma VK, 2009, GASTROENTEROLOGY, V137, P434, DOI 10.1053/j.gastro.2009.06.029; Swain P, 2010, GASTROINTEST ENDOSC, V71, P1290, DOI 10.1016/j.gie.2010.01.064; Van Noord D, 2011, GASTROINTEST ENDOSC, V73, P291, DOI 10.1016/j.gie.2010.10.025	29	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39638	10.1371/journal.pone.0039638	http://dx.doi.org/10.1371/journal.pone.0039638			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745799	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900089
J	Kroy, DC; Hebing, L; Sander, LE; Gassler, N; Erschfeld, S; Sackett, S; Galm, O; Trautwein, C; Streetz, KL				Kroy, Daniela C.; Hebing, Lisa; Sander, Leif E.; Gassler, Nikolaus; Erschfeld, Stephanie; Sackett, Sara; Galm, Oliver; Trautwein, Christian; Streetz, Konrad L.			Differential Role of gp130-Dependent STAT and Ras Signalling for Haematopoiesis Following Bone-Marrow Transplantation	PLOS ONE			English	Article							CYTOKINE RECEPTOR GP130; MICE; ACTIVATION; CELLS; TRANSDUCER; PHASE	Introduction: Bone marrow transplantation (BMT) is a complex process regulated by different cytokines and growth factors. The pleiotropic cytokine IL-6 (Interleukin-6) and related cytokines of the same family acting on the common signal transducer gp130 are known to play a key role in bone marrow (BM) engraftment. In contrast, the exact signalling events that control IL-6/gp130-driven haematopoietic stem cell development during BMT remain unresolved. Methods: Conditional gp130 knockout and knockin mice were used to delete gp130 expression (gp130(Delta Mx)), or to selectively disrupt gp130-dependent Ras (gp130(Delta MxRas)) or STAT signalling (gp130(Delta MxSTAT)) in BM cells. BM derived from the respective strains was transplanted into irradiated wildtype hosts and repopulation of various haematopoietic lineages was monitored by flow cytometry. Results: BM derived from gp130 deficient donor mice (gp130(Delta Mx)) displayed a delayed engraftment, as evidenced by reduced total white blood cells (WBC), marked thrombocytopenia and anaemia in the early phase after BMT. Lineage analysis unravelled a restricted development of CD4(+) and CD8(+) T-cells, CD19(+) B-cells and CD11b(+) myeloid cells after transplantation of gp130-deficient BM grafts. To further delineate the two major gp130-induced signalling cascades, Ras-MAPK and STAT1/3-signalling respectively, we used gp130(Delta MxRas) and gp130(Delta MxSTAT) donor BM. BMT of gp130(Delta MxSTAT) cells significantly impaired engraftment of CD4(+), CD8(+), CD19(+) and CD11b(+) cells, whereas gp130(Delta MxRas) BM displayed a selective impairment in early thrombopoiesis. Importantly, gp130-STAT1/3 signalling deficiency in BM grafts severely impaired survival of transplanted mice, thus demonstrating a pivotal role for this pathway in BM graft survival and function. Conclusion: Our data unravel a vital function of IL-6/gp130-STAT1/3 signals for BM engraftment and haematopoiesis, as well as for host survival after transplantation. STAT1/3 and ras-dependent pathways thereby exert distinct functions on individual bone-marrow-lineages.	[Kroy, Daniela C.; Hebing, Lisa; Sander, Leif E.; Erschfeld, Stephanie; Sackett, Sara; Trautwein, Christian; Streetz, Konrad L.] Univ Hosp Aachen, Dept Med 3, Aachen, Germany; [Gassler, Nikolaus] Univ Hosp Aachen, Inst Pathol, Aachen, Germany; [Galm, Oliver] Univ Hosp Aachen, Dept Med 4, Aachen, Germany; [Sander, Leif E.] Charite, Dept Infect Dis & Pulm Med, Berlin, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kroy, DC (corresponding author), Univ Hosp Aachen, Dept Med 3, Aachen, Germany.	kstreetz@gmail.com	Sander, Leif Erik/AAI-8619-2020					Audet J, 2001, P NATL ACAD SCI USA, V98, P1757, DOI 10.1073/pnas.98.4.1757; Bernhard H, 2000, EXP HEMATOL, V28, P365, DOI 10.1016/S0301-472X(00)00126-0; Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; Ernst M, 2004, TRENDS GENET, V20, P23, DOI 10.1016/j.tig.2003.11.003; Ernst M, 2001, J EXP MED, V194, P189, DOI 10.1084/jem.194.2.189; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Gerhartz C, 1996, J BIOL CHEM, V271, P12991, DOI 10.1074/jbc.271.22.12991; Jenkins BJ, 2005, BLOOD, V105, P3512, DOI 10.1182/blood-2004-09-3751; Jenkins BJ, 2002, EXP HEMATOL, V30, P1248, DOI 10.1016/S0301-472X(02)00929-3; Jenkins BJ, 2007, BLOOD, V109, P2380, DOI 10.1182/blood-2006-08-040352; Kroy DC, 2010, HEPATOLOGY, V51, P463, DOI 10.1002/hep.23322; Manshouri T, CANC RES, V71, P3831; Mihara M, CLIN SCI LOND, V122, P143; Oh ST, BLOOD, V116, P988; Rellick SL, CYTOKINE, V58, P245; Sander LE, J EXP MED, V207, P1453; Schots R, 2003, LEUKEMIA, V17, P1150, DOI 10.1038/sj.leu.2402946; Siegel AM, IMMUNITY, V35, P806; Streetz KL, 2003, HEPATOLOGY, V38, P218, DOI 10.1053/jhep.2003.50268; SUEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547, DOI 10.1073/pnas.86.19.7547; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Tefferi A, J CLIN ONCOL, V29, P573; Tschaharganeh DF, AM J PATHOL, V176, P2236; TSUJI K, 1992, BLOOD, V79, P2855; Yao LB, 2005, BLOOD, V106, P4093, DOI 10.1182/blood-2005-02-0671	26	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39728	10.1371/journal.pone.0039728	http://dx.doi.org/10.1371/journal.pone.0039728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745821	gold, Green Submitted, Green Published			2022-12-27	WOS:000305730900108
J	Miller, EM; Walton, GM; Dweck, CS; Job, V; Trzesniewski, KH; McClure, SM				Miller, Eric M.; Walton, Gregory M.; Dweck, Carol S.; Job, Veronika; Trzesniewski, Kali H.; McClure, Samuel M.			Theories of Willpower Affect Sustained Learning	PLOS ONE			English	Article							IMPLICIT THEORIES; SELF-REGULATION; EGO DEPLETION; INTELLIGENCE	Building cognitive abilities often requires sustained engagement with effortful tasks. We demonstrate that beliefs about willpower-whether willpower is viewed as a limited or non-limited resource-impact sustained learning on a strenuous mental task. As predicted, beliefs about willpower did not affect accuracy or improvement during the initial phases of learning; however, participants who were led to view willpower as non-limited showed greater sustained learning over the full duration of the task. These findings highlight the interactive nature of motivational and cognitive processes: motivational factors can substantially affect people's ability to recruit their cognitive resources to sustain learning over time.	[Miller, Eric M.; Walton, Gregory M.; Dweck, Carol S.; McClure, Samuel M.] Stanford Univ, Dept Psychol, Stanford, CA USA; [Job, Veronika] Univ Zurich, Dept Psychol, Zurich, Switzerland; [Trzesniewski, Kali H.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	Stanford University; University of Zurich; University of California System; University of California Davis	Miller, EM (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA USA.	ermiller@stanford.edu	Trzesniewski, Kali H/D-3912-2009	Trzesniewski, Kali H/0000-0001-8165-3107; Job, Veronika/0000-0002-4983-1644	Stanford University; Givaudan Corporation (SMM)	Stanford University(Stanford University); Givaudan Corporation (SMM)	The experiment was funded by Stanford University and a grant from the Givaudan Corporation (SMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Baumeister RF, 2011, WILLPOWER REDISCOVER; Blackwell LS, 2007, CHILD DEV, V78, P246, DOI 10.1111/j.1467-8624.2007.00995.x; Colquitt JA, 2000, J APPL PSYCHOL, V85, P678, DOI 10.1037/0021-9010.85.5.678; Eccles JS, 2002, ANNU REV PSYCHOL, V53, P109, DOI 10.1146/annurev.psych.53.100901.135153; Ericsson KA, 1996, ROAD EXCELLENCE ACQU; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Job V, 2010, PSYCHOL SCI, V21, P1686, DOI 10.1177/0956797610384745; Li FZ, 2001, STRUCT EQU MODELING, V8, P175, DOI 10.1207/S15328007SEM0802_2; Molden DC, 2006, AM PSYCHOL, V61, P192, DOI 10.1037/0003-066X.61.3.192; Rydell RJ, 2010, P NATL ACAD SCI USA, V107, P14042, DOI 10.1073/pnas.1002815107; Vohs KD, J EXP SOC P IN PRESS	12	40	42	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38680	10.1371/journal.pone.0038680	http://dx.doi.org/10.1371/journal.pone.0038680			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	964XV	22745675	gold, Green Submitted, Green Published			2022-12-27	WOS:000305730900016
J	Pereira, GC; Pereira, SP; Pereira, CV; Lumini, JA; Magalhaes, J; Ascensao, A; Santos, MS; Moreno, AJ; Oliveira, PJ				Pereira, Goncalo C.; Pereira, Susana P.; Pereira, Claudia V.; Lumini, Jose A.; Magalhaes, Jose; Ascensao, Antonio; Santos, Maria S.; Moreno, Antonio J.; Oliveira, Paulo J.			Mitochondrionopathy Phenotype in Doxorubicin-Treated Wistar Rats Depends on Treatment Protocol and Is Cardiac-Specific	PLOS ONE			English	Article							INDUCED CARDIOTOXICITY; PERMEABILITY TRANSITION; HEART-MITOCHONDRIA; DYSFUNCTION; TOXICITY; ANTHRACYCLINES; CARDIOMYOPATHY; SENSITIVITY; CARVEDILOL; INJURY	Although doxorubicin (DOX) is a very effective antineoplastic agent, its clinical use is limited by a dose-dependent, persistent and cumulative cardiotoxicity, whose mechanism remains to be elucidated. Previous works in animal models have failed to use a multi-organ approach to demonstrate that DOX-associated toxicity is selective to the cardiac tissue. In this context, the present work aims to investigate in vivo DOX cardiac, hepatic and renal toxicity in the same animal model, with special relevance on alterations of mitochondrial bioenergetics. To this end, male Wistar rats were sub-chronically (7 wks, 2 mg/Kg) or acutely (20 mg/Kg) treated with DOX and sacrificed one week or 24 hours after the last injection, respectively. Alterations of mitochondrial bioenergetics showed treatment-dependent differences between tissues. No alterations were observed for cardiac mitochondria in the acute model but decreased ADP-stimulated respiration was detected in the sub-chronic treatment. In the acute treatment model, ADP-stimulated respiration was increased in liver and decreased in kidney mitochondria. Aconitase activity, a marker of oxidative stress, was decreased in renal mitochondria in the acute and in heart in the sub-chronic model. Interestingly, alterations of cardiac mitochondrial bioenergetics co-existed with an absence of echocardiograph, histopathological or ultra-structural alterations. Besides, no plasma markers of cardiac injury were found in any of the time points studied. The results confirm that alterations of mitochondrial function, which are more evident in the heart, are an early marker of DOX-induced toxicity, existing even in the absence of cardiac functional alterations.	[Pereira, Goncalo C.; Pereira, Susana P.; Pereira, Claudia V.; Santos, Maria S.; Oliveira, Paulo J.] Univ Coimbra, Dept Life Sci, Ctr Neurosci & Cell Biol CNC, Coimbra, Portugal; [Lumini, Jose A.; Magalhaes, Jose; Ascensao, Antonio] Univ Porto, Fac Sport Sci, Res Ctr Phys Act Hlth & Leisure, P-4100 Oporto, Portugal; [Lumini, Jose A.] Univ Fernando Pessoa, Fac Hlth Sci, Oporto, Portugal; [Moreno, Antonio J.] Univ Coimbra, Dept Life Sci, Inst Marine Res, Coimbra, Portugal	Universidade de Coimbra; Universidade do Porto; Universidade Fernando Pessoa; Universidade de Coimbra	Pereira, GC (corresponding author), Univ Coimbra, Dept Life Sci, Ctr Neurosci & Cell Biol CNC, Coimbra, Portugal.	pauloliv@ci.uc.pt	Oliveira, Paulo J./AAQ-8943-2020; Magalhães, José/B-6991-2009; Pereira, Susana P./E-7628-2013; Ascensao, Antonio A/I-6171-2013; Pereira, Gonçalo C./C-7954-2009; Lumini-Oliveira, Jose A/L-7522-2013; Oliveira, Paulo J./H-1980-2011	Oliveira, Paulo J./0000-0002-5201-9948; Magalhães, José/0000-0003-4808-8374; Pereira, Susana P./0000-0002-1168-2444; Ascensao, Antonio A/0000-0001-5269-0857; Pereira, Gonçalo C./0000-0001-9638-0615; Lumini-Oliveira, Jose A/0000-0003-1565-7075; Oliveira, Paulo J./0000-0002-5201-9948; Moreno, Antonio/0000-0003-3575-7604; santos, maria sancha/0000-0002-6881-9392	Foundation for Science and Technology (FCT), Portugal through FEDER/COMPETE/National funds [PTDC/SAU-OSM/64084/2006, PTDC/SAU-OSM/104731/2008];  [SFRH/BPD/42525/2007];  [SFRH/BPD/66935/2009];  [SFRH/BD/30906/2006];  [SFRH/BD/36938/2007];  [SFRH/BD/48029/2008];  [SFRH/BD/64247/2009]	Foundation for Science and Technology (FCT), Portugal through FEDER/COMPETE/National funds; ; ; ; ; ; 	The present work was funded by the Foundation for Science and Technology (FCT), Portugal: research grants PTDC/SAU-OSM/64084/2006 and PTDC/SAU-OSM/104731/2008 (PJO), through FEDER/COMPETE/National funds; Post-Doc fellowships SFRH/BPD/42525/2007 to AA and SFRH/BPD/66935/2009 to JM; and, Ph.D. fellowships SFRH/BD/30906/2006 to JAL, SFRH/BD/36938/2007 to GCP, SFRH/BD/48029/2008 to CVP, SFRH/BD/64247/2009 to SPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HH, 2005, BIOORGAN MED CHEM, V13, P1847, DOI 10.1016/j.bmc.2004.10.066; Ascensao A, 2005, AM J PHYSIOL-HEART C, V289, pH722, DOI 10.1152/ajpheart.01249.2004; Ascensao A, 2011, CLIN SCI, V120, P37, DOI 10.1042/CS20100254; Bai P, 2004, ONCOL REP, V11, P505; Berthiaume JM, 2007, CARDIOVASC TOXICOL, V7, P178, DOI 10.1007/s12012-007-0026-0; Berthiaume JM, 2005, CARDIOVASC TOXICOL, V5, P257, DOI 10.1385/CT:5:3:257; Bras C, 2007, EXP PATHOL HLTH SCI, V1, P17; Cardoso S, 2008, FREE RADICAL BIO MED, V45, P1395, DOI 10.1016/j.freeradbiomed.2008.08.008; Carvalho C, 2009, CURR MED CHEM, V16, P3267, DOI 10.2174/092986709788803312; Deng SW, 2007, CARDIOVASC TOXICOL, V7, P129, DOI 10.1007/s12012-007-0024-2; DOROSHOW JH, 1983, CANCER RES, V43, P460; Emanuelov AK, 2010, BIOCHEM PHARMACOL, V79, P180, DOI 10.1016/j.bcp.2009.08.010; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; Huang CQ, 2010, CIRCULATION, V121, P675, DOI 10.1161/CIRCULATIONAHA.109.902221; Kacew S, 1996, J TOXICOL ENV HEALTH, V47, P1; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; Lushnikova EL, 2004, B EXP BIOL MED+, V138, P607, DOI 10.1007/s10517-005-0138-0; Mas M, 2000, BRAIN RES, V866, P109, DOI 10.1016/S0006-8993(00)02255-1; Migrino RQ, 2008, ULTRASOUND MED BIOL, V34, P208, DOI 10.1016/j.ultrasmedbio.2007.07.018; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Neilan TG, 2006, EUR HEART J, V27, P1868, DOI 10.1093/eurheartj/ehl013; Oliveira PJ, 2006, TOXICOLOGY, V220, P160, DOI 10.1016/j.tox.2005.12.009; Oliveira PJ, 2006, BIOCHEMISTRY-MOSCOW+, V71, P194, DOI 10.1134/S000629790602012X; Oliveira PJ, 2004, TOXICOL APPL PHARM, V200, P159, DOI 10.1016/j.taap.2004.04.005; Oliveira PJ, 2004, DIABETES-METAB RES, V20, P131, DOI 10.1002/dmrr.423; Oliveira PJ, 2000, ARCH BIOCHEM BIOPHYS, V374, P279, DOI 10.1006/abbi.1999.1624; Palmeira CM, 1997, BBA-BIOENERGETICS, V1321, P101, DOI 10.1016/S0005-2728(97)00055-8; Pereira GC, 2008, J THEOR EXP PHARM, V1, P39; Pereira GC, 2011, CURR PHARM DESIGN, V17, P2113; Pereira SP, 2009, TOXICOL IN VITRO, V23, P1585, DOI 10.1016/j.tiv.2009.06.032; PETERS JH, 1981, CANCER CHEMOTH PHARM, V7, P65; Riad A, 2009, CANCER RES, V69, P695, DOI 10.1158/0008-5472.CAN-08-3076; Robert J, 2005, CRIT REV ONCOL HEMAT, V54, P171, DOI 10.1016/j.critrevonc.2005.01.005; Sacco G, 2001, EUR J PHARMACOL, V414, P71, DOI 10.1016/S0014-2999(01)00782-8; Sardao VA, 2009, CELL BIOL TOXICOL, V25, P227, DOI 10.1007/s10565-008-9070-1; Schwartz C L, 1999, Oncologist, V4, P45; Shakir Douraid K, 2009, J Clin Med Res, V1, P8, DOI 10.4021/jocmr2009.02.1225; Smibert E, 2004, PEDIATR BLOOD CANCER, V42, P556, DOI 10.1002/pbc.20016; Solem LE, 1996, J MOL CELL CARDIOL, V28, P1023, DOI 10.1006/jmcc.1996.0095; STEINHERZ LJ, 1991, JAMA-J AM MED ASSOC, V266, P1672, DOI 10.1001/jama.266.12.1672; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Todorova VK, 2010, J NUTR, V140, P44, DOI 10.3945/jn.109.113415; Tokarska-Schlattner M, 2006, J MOL CELL CARDIOL, V41, P389, DOI 10.1016/j.yjmcc.2006.06.009; van Leeuwen BL, 2000, ANN ONCOL, V11, P1121, DOI 10.1023/A:1008352620870; VONHOFF DD, 1979, ANN INTERN MED, V91, P710, DOI 10.7326/0003-4819-91-5-710; Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x; WEISS RB, 1992, SEMIN ONCOL, V19, P670; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhou SY, 2001, CANCER RES, V61, P771	50	30	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38867	10.1371/journal.pone.0038867	http://dx.doi.org/10.1371/journal.pone.0038867			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745682	Green Published, gold			2022-12-27	WOS:000305730900021
J	Pierce, A; Williamson, A; Jaworska, E; Griffiths, JR; Taylor, S; Walker, M; O'Dea, MA; Spooncer, E; Unwin, RD; Poolman, T; Ray, D; Whetton, AD				Pierce, Andrew; Williamson, Andrew; Jaworska, Ewa; Griffiths, John R.; Taylor, Sam; Walker, Michael; O'Dea, Mark Aspinall; Spooncer, Elaine; Unwin, Richard D.; Poolman, Toryn; Ray, David; Whetton, Anthony D.			Identification of Nuclear Protein Targets for Six Leukemogenic Tyrosine Kinases Governed by Post-Translational Regulation	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; DNA-DAMAGE; GLUCOCORTICOID RESISTANCE; IMATINIB MESYLATE; ZINC-FINGER; GENE; RECEPTOR; BETA; ACTIVATION; EXPRESSION	Mutated tyrosine kinases are associated with a number of different haematological malignancies including myeloproliferative disorders, lymphoma and acute myeloid leukaemia. The potential commonalities in the action of six of these leukemogenic proteins on nuclear proteins were investigated using systematic proteomic analysis. The effects on over 3600 nuclear proteins and 1500 phosphopeptide sites were relatively quantified in seven isogenic cell lines. The effects of the kinases were diverse although some commonalities were found. Comparison of the nuclear proteomic data with transcriptome data and cytoplasmic proteomic data indicated that the major changes are due to post-translational mechanisms rather than changes in mRNA or protein distribution. Analysis of the promoter regions of genes whose protein levels changed in response to the kinases showed the most common binding site found was that for NF kappa B whilst other sites such as those for the glucocorticoid receptor were also found. Glucocorticoid receptor levels and phosphorylation were decreased by all 6 PTKs. Whilst Glucocorticoid receptor action can potentiate NF kappa B action those proteins where genes have NFkB binding sites were in often regulated post-translationally. However all 6 PTKs showed evidence of NFkB pathway modulation via activation via altered IkB and NFKB levels. Validation of a common change was also undertaken with PMS2, a DNA mismatch repair protein. PMS2 nuclear levels were decreased in response to the expression of all 6 kinases, with no concomitant change in mRNA level or cytosolic protein level. Response to thioguanine, that requires the mismatch repair pathway, was modulated by all 6 oncogenic kinases. In summary common targets for 6 oncogenic PTKs have been found that are regulated by post-translational mechanisms. They represent potential new avenues for therapies but also demonstrate the post-translational regulation is a key target of leukaemogenic kinases.	[Pierce, Andrew; Williamson, Andrew; Jaworska, Ewa; Griffiths, John R.; Taylor, Sam; Walker, Michael; O'Dea, Mark Aspinall; Spooncer, Elaine; Unwin, Richard D.; Whetton, Anthony D.] Univ Manchester, Stem Cell & Leukaemia Prote Lab, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Poolman, Toryn; Ray, David] Univ Manchester, Dev Biomed Res Grp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	University of Manchester; University of Manchester	Pierce, A (corresponding author), Univ Manchester, Stem Cell & Leukaemia Prote Lab, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	tony.whetton@manchester.ac.uk	Unwin, Richard/C-1258-2008	Unwin, Richard/0000-0001-7955-9111; WHETTON, ANTHONY D/0000-0002-1098-3878; Pierce, Andrew/0000-0001-5995-2469; Poolman, Toryn/0000-0002-7427-6603; Aspinall-O'Dea, Mark/0000-0002-5526-974X; Ray, David/0000-0002-4739-6773	Leukaemia; Lymphoma Research UK [08004]; NIHR Manchester Biomedical Research Centre	Leukaemia; Lymphoma Research UK; NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR))	This work was supported by Leukaemia and Lymphoma Research UK (http://leukaemialymphomaresearch.org.uk, grant number: 08004). RDU was in-part funded by NIHR Manchester Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Baldassarre G, 2003, MOL CELL BIOL, V23, P2225, DOI 10.1128/MCB.23.7.2225-2238.2003; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Bhatia R, 2003, BLOOD, V101, P4701, DOI 10.1182/blood-2002-09-2780; Canitrot Y, 1999, ONCOGENE, V18, P2676, DOI 10.1038/sj.onc.1202619; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chen JG, 2005, P NATL ACAD SCI USA, V102, P4813, DOI 10.1073/pnas.0407069102; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Clendenning M, 2008, J MED GENET, V45, P340, DOI 10.1136/jmg.2007.056150; Cools J, 2004, CURR OPIN HEMATOL, V11, P51, DOI 10.1097/00062752-200401000-00008; Costoya JA, 2008, ONCOGENE, V27, P3789, DOI 10.1038/onc.2008.7; De Vos M, 2006, JNCI-J NATL CANCER I, V98, P358, DOI 10.1093/jnci/djj073; Dobbin E, 2009, EXP HEMATOL, V37, P111, DOI 10.1016/j.exphem.2008.09.012; Dobrovolsky VN, 2003, MUTAGENESIS, V18, P365, DOI 10.1093/mutage/geg007; Foti D, 2003, MOL CELL BIOL, V23, P2720, DOI 10.1128/MCB.23.8.2720-2732.2003; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; GREENBERGER JS, 1978, NATURE, V275, P752, DOI 10.1038/275752a0; Hamilton MJ, 2011, EXP HEMATOL, V39, P2, DOI 10.1016/j.exphem.2010.11.002; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Inaba H, 2010, LANCET ONCOL, V11, P1096, DOI 10.1016/S1470-2045(10)70114-5; Karisch R, 2011, CELL, V146, P826, DOI 10.1016/j.cell.2011.07.020; Kim JH, 2005, BLOOD, V105, P1717, DOI 10.1182/blood-2004-03-0849; Kolbus A, 2003, BLOOD, V102, P3136, DOI 10.1182/blood-2003-03-0923; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Lynch HT, 1999, J MED GENET, V36, P801; MacArthur BD, 2010, BIOINFORMATICS, V26, P143, DOI 10.1093/bioinformatics/btp628; Mao GG, 2008, CELL RES, V18, P281, DOI 10.1038/cr.2008.14; MUNKHOLM P, 1994, GUT, V35, P360, DOI 10.1136/gut.35.3.360; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Narayanan L, 1997, P NATL ACAD SCI USA, V94, P3122, DOI 10.1073/pnas.94.7.3122; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pierantoni GM, 2003, BIOCHEM J, V372, P145, DOI 10.1042/BJ20021493; Pierce A, 2008, MOL CELL PROTEOMICS, V7, P853, DOI 10.1074/mcp.M700251-MCP200; Resar LMS, 2010, CANCER RES, V70, P436, DOI 10.1158/0008-5472.CAN-09-1212; Rink L, 2007, BLOOD, V110, P651, DOI 10.1182/blood-2006-08-042630; Sattler M, 2000, J BIOL CHEM, V275, P24273, DOI 10.1074/jbc.M002094200; Shimizu Y, 2003, EMBO J, V22, P164, DOI 10.1093/emboj/cdg016; SHIOTA M, 1995, BLOOD, V86, P1954, DOI 10.1182/blood.V86.5.1954.bloodjournal8651954; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Sionov RV, 2008, ADV CANCER RES, V101, P127, DOI 10.1016/S0065-230X(08)00406-5; Skorski T, 2002, ONCOGENE, V21, P8591, DOI 10.1038/sj.onc.1206087; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; Tissing WJE, 2003, LEUKEMIA, V17, P17, DOI 10.1038/sj.leu.2402733; Treff NR, 2004, ONCOGENE, V23, P8557, DOI 10.1038/sj.onc.1207926; Tsuzuki S, 2002, BLOOD, V99, P3404, DOI 10.1182/blood.V99.9.3404; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Yu YL, 2002, J BIOL CHEM, V277, P27144, DOI 10.1074/jbc.M200924200	53	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38928	10.1371/journal.pone.0038928	http://dx.doi.org/10.1371/journal.pone.0038928			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745689	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900024
J	Tschacher, W; Zorn, P; Ramseyer, F				Tschacher, Wolfgang; Zorn, Peter; Ramseyer, Fabian			Change Mechanisms of Schema-Centered Group Psychotherapy with Personality Disorder Patients	PLOS ONE			English	Article							THERAPEUTIC CHANGE	Background: This study addressed the temporal properties of personality disorders and their treatment by schema-centered group psychotherapy. It investigated the change mechanisms of psychotherapy using a novel method by which psychotherapy can be modeled explicitly in the temporal domain. Methodology and Findings: 69 patients were assigned to a specific schema-centered behavioral group psychotherapy, 26 to social skills training as a control condition. The largest diagnostic subgroups were narcissistic and borderline personality disorder. Both treatments offered 30 group sessions of 100 min duration each, at a frequency of two sessions per week. Therapy process was described by components resulting from principal component analysis of patients' session-reports that were obtained after each session. These patient-assessed components were Clarification, Bond, Rejection, and Emotional Activation. The statistical approach focused on time-lagged associations of components using time-series panel analysis. This method provided a detailed quantitative representation of therapy process. It was found that Clarification played a core role in schema-centered psychotherapy, reducing rejection and regulating the emotion of patients. This was also a change mechanism linked to therapy outcome. Conclusions/Significance: The introduced process-oriented methodology allowed to highlight the mechanisms by which psychotherapeutic treatment became effective. Additionally, process models depicted the actual patterns that differentiated specific diagnostic subgroups. Time-series analysis explores Granger causality, a non-experimental approximation of causality based on temporal sequences. This methodology, resting upon naturalistic data, can explicate mechanisms of action in psychotherapy research and illustrate the temporal patterns underlying personality disorders.	[Tschacher, Wolfgang; Zorn, Peter; Ramseyer, Fabian] Univ Hosp Psychiat, Dept Psychotherapy, Bern, Switzerland	University of Bern; University Hospital of Bern	Tschacher, W (corresponding author), Univ Hosp Psychiat, Dept Psychotherapy, Bern, Switzerland.	tschacher@spk.unibe.ch	Ramseyer, Fabian T/A-6995-2012	Ramseyer, Fabian T/0000-0001-6878-724X; Tschacher, Wolfgang/0000-0001-7357-0280	Swiss National Science Foundation [3200-067932.02]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was partially supported by the Swiss National Science Foundation, grant No. 3200-067932.02 (http://www.snf.ch/D/Seiten/default.aspx). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber JP, 2009, PSYCHOTHER RES, V19, P1, DOI 10.1080/10503300802609680; Beck A. T., 2003, COGNITIVE THERAPY PE; Benjamin L.S., 1996, INTERPERSONAL DIAGNO, V2; Borsboom D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027407; Castonguay LG, 2006, J CLIN PSYCHOL, V62, P631, DOI 10.1002/jclp.20256; Choi-Kain LW, 2010, J PERS DISORD, V24, P365, DOI 10.1521/pedi.2010.24.3.365; Clarkin JF, 2007, AM J PSYCHIAT, V164, P922, DOI 10.1176/appi.ajp.164.6.922; Dinger U, 2010, PSYCHOTHER RES, V20, P22, DOI 10.1080/10503300902855514; EPSTEIN S, 1989, J PERS SOC PSYCHOL, V57, P332, DOI 10.1037/0022-3514.57.2.332; Fluckiger C, 2010, Z KL PSYCH PSYCHOTH, V39, P71, DOI 10.1026/1616-3443/a000015; Franke GH., 2000, BRIEF SYMPTOM INVENT; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grawe K., 2004, PSYCHOL THERAPY; Horowitz L.M., 1994, IIP D INVENTAR ERFAS; KARASU TB, 1986, AM J PSYCHIAT, V143, P687; Kernberg O.F., 1975, BORDERLINE CONDITION; Lambert M.J., 2004, BERGIN GARFIELDS HDB, P139; Leichsenring F, 2003, AM J PSYCHIAT, V160, P1223, DOI 10.1176/appi.ajp.160.7.1223; Linehan M. M., 1993, COGNITIVE BEHAV TREA; Luatkepohl H., 1993, INTRO MULTIPLE TIME, DOI 10.1007/978-3-642-61695-2; Millon T., 2007, MODERATING SEVERE PE; Niedtfeld I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033293; Orlinsky D.E., 2004, BERGIN GARFIELDS HDB, VVolume 5, P307; Pascual-Leone A, 2007, J CONSULT CLIN PSYCH, V75, P875, DOI 10.1037/0022-006X.75.6.875; Pfammatter M, 2012, Z PSYCHIATR PSYCH PS, V60, P67, DOI 10.1024/1661-4747/a000099; Pfingsten U., 2002, GRUPPENTRAINING SOZI; Reisch T, 2008, ACTA PSYCHIAT SCAND, V118, P42, DOI 10.1111/j.1600-0447.2008.01222.x; Sachse R, 2004, PERSONLICHKEITSSTORU; SALKOVSKIS PM, 1985, BEHAV RES THER, V23, P571, DOI 10.1016/0005-7967(85)90105-6; Salvatore S, 2011, INTEGR PSYCHOL BEHAV, V45, P366, DOI 10.1007/s12124-011-9180-9; Skodol AE, 2011, J PERS DISORD, V25, P136, DOI 10.1521/pedi.2011.25.2.136; Strauss B., 2002, KLIN BINDUNGSFORSCHU; Tschacher W, 2007, RES REPORTS; Tschacher W, 2009, PSYCHOTHER RES, V19, P469, DOI 10.1080/10503300802654496; Ullrich R, 1998, ATP 1 EINUBUNG SELBS; Wittchen H.-U., 1997, SKID STRUKTURIERTES; Young J.E., 2006, SCHEMA THERAPY PRACT, DOI DOI 10.1017/; Young J. E. S., 1994, COGNITIVE THERAPY PE; Zeigler-Hill V, 2011, J BEHAV THER EXP PSY, V42, P96, DOI 10.1016/j.jbtep.2010.07.004; Zielke M, 2001, PRAXIS KLINISCHE VER, V14, P7; Znoj H, 2000, CONTROL OF HUMAN BEHAVIOR, MENTAL PROCESSES, AND CONSCIOUSNESS, P263; Zorn P, 2011, SCHEMAZENTRIERTE EMO; Zorn P, 2007, VERHALTENSTHERAPIE, V17, P233, DOI 10.1159/000110129	43	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39687	10.1371/journal.pone.0039687	http://dx.doi.org/10.1371/journal.pone.0039687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	964XV	22745811	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900098
J	Udatha, DBRKG; Mapelli, V; Panagiotou, G; Olsson, L				Udatha, D. B. R. K. Gupta; Mapelli, Valeria; Panagiotou, Gianni; Olsson, Lisbeth			Common and Distant Structural Characteristics of Feruloyl Esterase Families from Aspergillus oryzae	PLOS ONE			English	Article							AUTOMATED PROTEIN-STRUCTURE; SECONDARY-STRUCTURE; ANALOGOUS ENZYMES; SIGNAL PEPTIDES; I-TASSER; PREDICTION; PURIFICATION; SERVER; ACID; CLASSIFICATION	Background: Feruloyl esterases (FAEs) are important biomass degrading accessory enzymes due to their capability of cleaving the ester links between hemicellulose and pectin to aromatic compounds of lignin, thus enhancing the accessibility of plant tissues to cellulolytic and hemicellulolytic enzymes. FAEs have gained increased attention in the area of biocatalytic transformations for the synthesis of value added compounds with medicinal and nutritional applications. Following the increasing attention on these enzymes, a novel descriptor based classification system has been proposed for FAEs resulting into 12 distinct families and pharmacophore models for three FAE sub-families have been developed. Methodology/Principal Findings: The feruloylome of Aspergillus oryzae contains 13 predicted FAEs belonging to six subfamilies based on our recently developed descriptor-based classification system. The three-dimensional structures of the 13 FAEs were modeled for structural analysis of the feruloylome. The three genes coding for three enzymes, viz., A.O.2, A.O.8 and A.O.10 from the feruloylome of A. oryzae, representing sub-families with unknown functional features, were heterologously expressed in Pichia pastoris, characterized for substrate specificity and structural characterization through CD spectroscopy. Common feature-based pharamacophore models were developed according to substrate specificity characteristics of the three enzymes. The active site residues were identified for the three expressed FAEs by determining the titration curves of amino acid residues as a function of the pH by applying molecular simulations. Conclusions/Significance: Our findings on the structure-function relationships and substrate specificity of the FAEs of A. oryzae will be instrumental for further understanding of the FAE families in the novel classification system. The developed pharmacophore models could be applied for virtual screening of compound databases for short listing the putative substrates prior to docking studies or for post-processing docking results to remove false positives. Our study exemplifies how computational predictions can complement to the information obtained through experimental methods.	[Udatha, D. B. R. K. Gupta; Mapelli, Valeria; Panagiotou, Gianni; Olsson, Lisbeth] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Panagiotou, Gianni] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Panagiotou, Gianni] Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, Horsholm, Denmark	Chalmers University of Technology; Technical University of Denmark; Novo Nordisk Foundation; Technical University of Denmark	Udatha, DBRKG (corresponding author), Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.	lisbeth.olsson@chalmers.se	Mapelli, Valeria/E-4434-2014; Panagiotou, Ioannis/B-7083-2013; Udatha, D.B.R.K. Gupta/B-1544-2012	Mapelli, Valeria/0000-0001-8724-3221; Udatha, D.B.R.K. Gupta/0000-0003-0163-9407; /0000-0002-0827-5442	Swedish Research Council (Vetenskapsradet) [2008-2955]; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Novo Nordisk Fonden(Novo Nordisk Foundation)	Financial support for this research was provided by the Swedish Research Council (Vetenskapsradet Grant no: 2008-2955). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MR, 2008, P NATL ACAD SCI USA, V105, P4387, DOI 10.1073/pnas.0709964105; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Barnum D, 1996, J CHEM INF COMP SCI, V36, P563, DOI 10.1021/ci950273r; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benoit I, 2008, BIOTECHNOL LETT, V30, P387, DOI 10.1007/s10529-007-9564-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASTANARES A, 1992, Biochemical Society Transactions, V20, p275S; Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105; Chong L, 2001, SCIENCE, V292, P446, DOI 10.1126/science.1060677; Chou KC, 2004, BIOCHEM BIOPH RES CO, V316, P636, DOI 10.1016/j.bbrc.2004.02.098; Donaghy J, 1997, J APPL MICROBIOL, V83, P718, DOI 10.1046/j.1365-2672.1997.00307.x; Donaghy JA, 2000, J APPL MICROBIOL, V88, P458, DOI 10.1046/j.1365-2672.2000.00983.x; DONAGHY JA, 1995, J APPL BACTERIOL, V79, P657, DOI 10.1111/j.1365-2672.1995.tb00951.x; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Fazary Ahmed Eid, 2008, Biotechnology Journal, V3, P1264, DOI 10.1002/biot.200800101; FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; Galperin MY, 1999, GENETICA, V106, P159, DOI 10.1023/A:1003705601428; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Guo J., 2010, PLOS ONE, V5; Harms MJ, 2009, J MOL BIOL, V389, P34, DOI 10.1016/j.jmb.2009.03.039; Hatamoto O, 1996, GENE, V175, P215, DOI 10.1016/0378-1119(96)00153-9; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Koseki T, 2010, FEBS LETT, V584, P4032, DOI 10.1016/j.febslet.2010.08.021; Koseki T, 2009, APPL MICROBIOL BIOT, V84, P803, DOI 10.1007/s00253-009-2148-8; Koseki T, 2009, APPL MICROBIOL BIOT, V83, P689, DOI 10.1007/s00253-009-1913-z; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P67; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel EB, 2004, ACTA CRYSTALLOGR D, V60, P2250, DOI 10.1107/S0907444904027167; Krissinel EB, 2004, SOFTWARE PRACT EXPER, V34, P591, DOI 10.1002/spe.588; Krissinel E, 2007, BIOINFORMATICS, V23, P717, DOI 10.1093/bioinformatics/btm006; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MERELO JJ, 1994, NEUROCOMPUTING, V6, P443, DOI 10.1016/0925-2312(94)90021-3; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; Omelchenko MV, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-31; Ondrechen MJ, 2001, P NATL ACAD SCI USA, V98, P12473, DOI 10.1073/pnas.211436698; Panagiotou G, 2006, APPL MICROBIOL BIOT, V72, P1117, DOI 10.1007/s00253-006-0394-6; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sankararaman S, 2009, NUCLEIC ACIDS RES, V37, pW390, DOI 10.1093/nar/gkp339; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Spassov VZ, 2008, PROTEIN SCI, V17, P1955, DOI 10.1110/ps.036335.108; Spassov VZ, 2008, PROTEIN ENG DES SEL, V21, P91, DOI 10.1093/protein/gzm083; Spassov VZ, 2007, PROTEIN SCI, V16, P494, DOI 10.1110/ps.062447107; Szwajgier D, 2010, ACTA SCI POLON-TECHN, V9, P45; Tang B, 2010, CHINESE SCI BULL, V55, P1619, DOI 10.1007/s11434-009-3700-8; Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806; Topakas E, 2005, J BIOTECHNOL, V115, P355, DOI 10.1016/j.jbiotec.2004.10.001; Udatha DBRKG, 2011, BIOTECHNOL ADV, V29, P94, DOI 10.1016/j.biotechadv.2010.09.003; Vafiadi C, 2006, J BIOTECHNOL, V125, P210, DOI 10.1016/j.jbiotec.2006.02.009; Wang JF, 2009, PHARMACOGENOMICS, V10, P1213, DOI 10.2217/PGS.09.81; Wang JF, 2007, BIOCHEM BIOPH RES CO, V359, P323, DOI 10.1016/j.bbrc.2007.05.101; Wang Y, 2010, J CHEM INF MODEL, V50, P875, DOI 10.1021/ci900458u; Wong DWS, 2006, APPL BIOCHEM BIOTECH, V133, P87, DOI 10.1385/ABAB:133:2:87; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Yue Q, 2009, ANIM FEED SCI TECH, V153, P263, DOI 10.1016/j.anifeedsci.2009.06.019; Zhang Y, 2004, J COMPUT CHEM, V25, P865, DOI 10.1002/jcc.20011; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	65	12	12	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39473	10.1371/journal.pone.0039473	http://dx.doi.org/10.1371/journal.pone.0039473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745763	Green Published, gold			2022-12-27	WOS:000305730900065
J	El Fatimy, R; Tremblay, S; Dury, AY; Solomon, S; De Koninck, P; Schrader, JW; Khandjian, EW				El Fatimy, Rachid; Tremblay, Sandra; Dury, Alain Y.; Solomon, Samuel; De Koninck, Paul; Schrader, John W.; Khandjian, Edouard W.			Fragile Mental Retardation Protein Interacts with the RNA-Binding Protein Caprin1 in Neuronal RiboNucleoProtein Complexes	PLOS ONE			English	Article							MESSENGER-RNA; NEGATIVE REGULATOR; X PROTEIN; FMRP; IDENTIFICATION; ASSOCIATION; GRANULES; TRANSLATION; KINESIN; POLYRIBOSOMES	Fragile X syndrome is caused by the absence of the Fragile X Mental Retardation Protein (FMRP), an RNA-binding protein. FMRP is associated with messenger RiboNucleoParticles (mRNPs) present in polyribosomes and its absence in neurons leads to alteration in synaptic plasticity as a result of translation regulation defects. The molecular mechanisms by which FMRP plays a role in translation regulation remain elusive. Using immunoprecipitation approaches with monoclonal Ab7G1-1 and a new generation of chicken antibodies, we identified Caprin1 as a novel FMRP-cellular partner. In vivo and in vitro evidence show that Caprin1 interacts with FMRP at the level of the translation machinery as well as in trafficking neuronal granules. As an RNA-binding protein, Caprin1 has in common with FMRP at least two RNA targets that have been identified as CaMKII alpha and Map1b mRNAs. In view of the new concept that FMRP species bind to RNA regardless of known structural motifs, we propose that protein interactors might modulate FMRP functions.	[El Fatimy, Rachid; Tremblay, Sandra; Dury, Alain Y.; De Koninck, Paul; Khandjian, Edouard W.] Inst Univ Sante Mentale, Ctr Rech, Quebec City, PQ, Canada; [El Fatimy, Rachid; Dury, Alain Y.; Khandjian, Edouard W.] Univ Laval, Fac Med, Dept Psychiat & Neurosci, Quebec City, PQ G1K 7P4, Canada; [De Koninck, Paul] Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada; [Solomon, Samuel; Schrader, John W.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada	Laval University; Laval University; Laval University; University of British Columbia	El Fatimy, R (corresponding author), Inst Univ Sante Mentale, Ctr Rech, Quebec City, PQ, Canada.	Edward.khandjian@crulrg.ulaval.ca	Fatimy, Rachid El/K-2822-2019	EL FATIMY, Rachid/0000-0002-7652-5562; Dury, Alain/0000-0002-0240-0441	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Jerome Lejeune Foundation, France	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Jerome Lejeune Foundation, France	EWK was supported by grants from the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Jerome Lejeune Foundation, France; JWS and PDK were supported by CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardoni Barbara, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010751; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bechara E, 2007, NUCLEIC ACIDS RES, V35, P299, DOI 10.1093/nar/gkl1021; Bechara EG, 2009, PLOS BIOL, V7, P133, DOI 10.1371/journal.pbio.1000016; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Ceman S, 1999, MOL CELL BIOL, V19, P7925; Ceman S, 2000, BIOCHEM BIOPH RES CO, V279, P904, DOI 10.1006/bbrc.2000.4035; Ceman Stephanie, 2003, Methods Mol Biol, V217, P345; Chen L, 2003, NEUROSCIENCE, V120, P1005, DOI 10.1016/S0306-4522(03)00406-8; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Costa A, 2005, DEV CELL, V8, P331, DOI 10.1016/j.devcel.2005.01.011; Darnell JC, 2011, CURR OPIN GENET DEV, V21, P465, DOI 10.1016/j.gde.2011.05.002; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Davidovic L, 2006, HUM MOL GENET, V15, P1525, DOI 10.1093/hmg/ddl074; Davidovic L, 2005, MOL BASIS FRAGILE X, P129; Davidovic L, 2007, HUM MOL GENET, V16, P3047, DOI 10.1093/hmg/ddm263; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Fahling M, 2009, J BIOL CHEM, V284, P4255, DOI 10.1074/jbc.M807354200; FALVEY AK, 1970, J MOL BIOL, V53, P1, DOI 10.1016/0022-2836(70)90042-2; Feng Y, 1997, J NEUROSCI, V17, P1539; Forch P, 2002, EMBO J, V21, P6882, DOI 10.1093/emboj/cdf668; Grill B, 2004, J IMMUNOL, V172, P2389, DOI 10.4049/jimmunol.172.4.2389; Grossman AW, 2006, J NEUROSCI, V26, P7151, DOI 10.1523/JNEUROSCI.1790-06.2006; Hensold JO, 1996, J BIOL CHEM, V271, P23246, DOI 10.1074/jbc.271.38.23246; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kao DI, 2010, P NATL ACAD SCI USA, V107, P15601, DOI 10.1073/pnas.1010564107; Khandjian EW, 1999, BIOCHEM CELL BIOL, V77, P331, DOI 10.1139/bcb-77-4-331; KHANDJIAN EW, 1995, HUM MOL GENET, V4, P783, DOI 10.1093/hmg/4.5.783; Khandjian EW, 2005, CURR GENOMICS, V6, P515, DOI 10.2174/138920205775067701; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Khandjian EW, 2009, ENCY NEUROSCIENCE, V8, P389; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; MARTIN TE, 1970, J BIOL CHEM, V245, P1504; Mazroui R, 2003, HUM MOL GENET, V12, P3087, DOI 10.1093/hmg/ddg335; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Menon RP, 2004, J MOL BIOL, V343, P43, DOI 10.1016/j.jmb.2004.08.024; Mientjes EJ, 2006, NEUROBIOL DIS, V21, P549, DOI 10.1016/j.nbd.2005.08.019; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Papoulas O, 2010, DEVELOPMENT, V137, P4201, DOI 10.1242/dev.055046; Piazzon N, 2008, J BIOL CHEM, V283, P5598, DOI 10.1074/jbc.M707304200; Salvetti A, 1998, DEV BIOL, V201, P217, DOI 10.1006/dbio.1998.8996; Shiina N, 2005, J NEUROSCI, V25, P4420, DOI 10.1523/JNEUROSCI.0382-05.2005; Shiina N, 2010, J BIOL CHEM, V285, P24260, DOI 10.1074/jbc.M110.108944; Sofola O, 2008, J NEUROSCI, V28, P10200, DOI 10.1523/JNEUROSCI.2786-08.2008; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Sung YJ, 2000, BIOCHEM BIOPH RES CO, V275, P973, DOI 10.1006/bbrc.2000.3405; Wang B, 2005, J IMMUNOL, V175, P4274, DOI 10.4049/jimmunol.175.7.4274; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; ZYLBER EA, 1970, BIOCHIM BIOPHYS ACTA, V204, P221, DOI 10.1016/0005-2787(70)90505-8	60	42	42	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39338	10.1371/journal.pone.0039338	http://dx.doi.org/10.1371/journal.pone.0039338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737234	Green Submitted, Green Published, gold			2022-12-27	WOS:000305695100032
J	Bhat, S; Polanowski, AM; Double, MC; Jarman, SN; Emslie, KR				Bhat, Somanath; Polanowski, Andrea M.; Double, Mike C.; Jarman, Simon N.; Emslie, Kerry R.			The Effect of Input DNA Copy Number on Genotype Call and Characterising SNP Markers in the Humpback Whale Genome Using a Nanofluidic Array	PLOS ONE			English	Article								Recent advances in nanofluidic technologies have enabled the use of Integrated Fluidic Circuits (IFCs) for high-throughput Single Nucleotide Polymorphism (SNP) genotyping (GT). In this study, we implemented and validated a relatively low cost nanofluidic system for SNP-GT with and without Specific Target Amplification (STA). As proof of principle, we first validated the effect of input DNA copy number on genotype call rate using well characterised, digital PCR (dPCR) quantified human genomic DNA samples and then implemented the validated method to genotype 45 SNPs in the humpback whale, Megaptera novaeangliae, nuclear genome. When STA was not incorporated, for a homozygous human DNA sample, reaction chambers containing, on average 9 to 97 copies, showed 100% call rate and accuracy. Below 9 copies, the call rate decreased, and at one copy it was 40%. For a heterozygous human DNA sample, the call rate decreased from 100% to 21% when predicted copies per reaction chamber decreased from 38 copies to one copy. The tightness of genotype clusters on a scatter plot also decreased. In contrast, when the same samples were subjected to STA prior to genotyping a call rate and a call accuracy of 100% were achieved. Our results demonstrate that low input DNA copy number affects the quality of data generated, in particular for a heterozygous sample. Similar to human genomic DNA, a call rate and a call accuracy of 100% was achieved with whale genomic DNA samples following multiplex STA using either 15 or 45 SNP-GT assays. These calls were 100% concordant with their true genotypes determined by an independent method, suggesting that the nanofluidic system is a reliable platform for executing call rates with high accuracy and concordance in genomic sequences derived from biological tissue.	[Bhat, Somanath; Emslie, Kerry R.] Inst Natl Measurement Stand, Lindfield, NSW, Australia; [Polanowski, Andrea M.; Double, Mike C.; Jarman, Simon N.] Autralian Marine Mammal Ctr, Australian Antarctic Div, Kingston, Tas, Australia	National Measurement Institute Australia - NMI; Australian Antarctic Division	Bhat, S (corresponding author), Inst Natl Measurement Stand, Lindfield, NSW, Australia.	Somanath.Bhat@measurement.gov.au	; Jarman, Simon/H-9265-2016	Polanowski, Andrea/0000-0002-9612-220X; Jarman, Simon/0000-0002-0792-9686	Commonwealth Government of Australia through the National Enabling Technology Strategy; Australian Marine Mammal Centre, Australian Antarctic Division	Commonwealth Government of Australia through the National Enabling Technology Strategy; Australian Marine Mammal Centre, Australian Antarctic Division	This work was supported by the Commonwealth Government of Australia through the National Enabling Technology Strategy (SB, KRE) and the Australian Marine Mammal Centre, Australian Antarctic Division (AMP, MCD, SNJ). All authors are employees of the Commonwealth Government of Australia and had a role in study design, data collection and analysis, preparation of manuscript.	[Anonymous], FLUID SNP GEN AN SOF; [Anonymous], 2010, APPL BIOSYSTEMS; Appleby Nikki, 2009, V513, P19, DOI 10.1007/978-1-59745-427-8_2; Baak-Pablo R, 2010, J MOL DIAGN, V12, P746, DOI 10.2353/jmoldx.2010.100047; Broude NE, 2001, P NATL ACAD SCI USA, V98, P206, DOI 10.1073/pnas.98.1.206; Carlson B, 2008, BIOMARKET TRENDS, V28; Chan M, 2011, J MOL DIAGN, V13, P305, DOI 10.1016/j.jmoldx.2010.12.001; de Alencar SA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/715139; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Hill CR, 2010, SCI ISSUES ANAL LOW; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Mei R, 2000, GENOME RES, V10, P1126, DOI 10.1101/gr.10.8.1126; Mohr P.J., 2006, CODATA RECOMMENDED V; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Pirmohamed M, 2006, AAPS J, V8, pE20, DOI 10.1208/aapsj080103; Polanowski AM, 2011, CONSERVATION GENETIC; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Wang J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-561	21	11	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39181	10.1371/journal.pone.0039181	http://dx.doi.org/10.1371/journal.pone.0039181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745712	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693200046
J	Chakraborty, S				Chakraborty, Sandeep			Enumerating Pathways of Proton Abstraction Based on a Spatial and Electrostatic Analysis of Residues in the Catalytic Site	PLOS ONE			English	Article							A BETA-LACTAMASE; ULTRAHIGH-RESOLUTION STRUCTURE; CRYSTAL-STRUCTURE; SERINE-PROTEASE; ACTIVE-SITE; ACYLATION MECHANISM; SPECIFICITY; ACTIVATION; INSIGHTS; REVEALS	The pathways of proton abstraction (PA), a key aspect of most catalytic reactions, is often controversial and highly debated. Ultrahigh-resolution diffraction studies, molecular dynamics, quantum mechanics and molecular mechanic simulations are often adopted to gain insights in the PA mechanisms in enzymes. These methods require expertise and effort to setup and can be computationally intensive. We present a push button methodology - Proton abstraction Simulation (PRISM) - to enumerate the possible pathways of PA in a protein with known 3D structure based on the spatial and electrostatic properties of residues in the proximity of a given nucleophilic residue. Proton movements are evaluated in the vicinity of this nucleophilic residue based on distances, potential differences, spatial channels and characteristics of the individual residues (polarity, acidic, basic, etc). Modulating these parameters eliminates their empirical nature and also might reveal pathways that originate from conformational changes. We have validated our method using serine proteases and concurred with the dichotomy in PA in Class A beta-lactamases, both of which are hydrolases. The PA mechanism in a transferase has also been corroborated. The source code is made available at www.sanchak.com/prism.	Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Chakraborty, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	sandeepchak@tifr.res.in			Tata Institute of Fundamental Research (Department of Atomic Energy)	Tata Institute of Fundamental Research (Department of Atomic Energy)	This work was funded by the Tata Institute of Fundamental Research (Department of Atomic Energy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BANACKY P, 1981, BIOPHYS CHEM, V13, P39, DOI 10.1016/0301-4622(81)80023-3; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Bjoras M, 2002, J MOL BIOL, V317, P171, DOI 10.1006/jmbi.2002.5400; Brown NG, 2009, J BIOL CHEM, V284, P33703, DOI 10.1074/jbc.M109.053819; Bush K, 1998, CLIN INFECT DIS, V27, pS48, DOI 10.1086/514922; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chakraborty S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032011; Chakraborty S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028470; Chen CC, 1996, BIOCHEMISTRY-US, V35, P12251, DOI 10.1021/bi961153v; Chen Y, 2007, J AM CHEM SOC, V129, P5378, DOI 10.1021/ja0712064; Damblon C, 1996, P NATL ACAD SCI USA, V93, P1747, DOI 10.1073/pnas.93.5.1747; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Fisher JF, 2009, CURR PROTEIN PEPT SC, V10, P401, DOI 10.2174/138920309789351967; Fuhrmann CN, 2006, J AM CHEM SOC, V128, P9086, DOI 10.1021/ja057721o; GALLENI M, 1995, BIOCHEM PHARMACOL, V49, P1171, DOI 10.1016/0006-2952(94)00502-D; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Grochowski P, 2008, BIOPOLYMERS, V89, P93, DOI 10.1002/bip.20877; Hermann JC, 2009, J PHYS CHEM A, V113, P11984, DOI 10.1021/jp9037254; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Ibuka AS, 2003, BIOCHEMISTRY-US, V42, P10634, DOI 10.1021/bi0342822; Ke YY, 2005, BIOPHYS CHEM, V114, P103, DOI 10.1016/j.bpc.2004.11.007; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Kuhn P, 1998, BIOCHEMISTRY-US, V37, P13446, DOI 10.1021/bi9813983; Matagne A, 1999, NAT PROD REP, V16, P1, DOI 10.1039/a705983c; Meroueh SO, 2005, J AM CHEM SOC, V127, P15397, DOI 10.1021/ja051592u; Minasov G, 2002, J AM CHEM SOC, V124, P5333, DOI 10.1021/ja0259640; Nelson D. L., 2008, LEHNINGER PRINCIPLES, V5th, P926; Nukaga M, 2003, J MOL BIOL, V328, P289, DOI 10.1016/S0022-2836(03)00210-9; Page MI, 2008, BIOINORG CHEM APPL, V2008, DOI 10.1155/2008/576297; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Raquet X, 1997, BIOPHYS J, V73, P2416, DOI 10.1016/S0006-3495(97)78270-5; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Reynolds KA, 2006, J BIOL CHEM, V281, P26745, DOI 10.1074/jbc.M603878200; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Scarsdale JN, 1999, BIOCHEMISTRY-US, V38, P8347, DOI 10.1021/bi9904151; Schroder HK, 1998, ACTA CRYSTALLOGR D, V54, P780, DOI 10.1107/S0907444997018611; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Thomas VL, 2010, J MOL BIOL, V396, P47, DOI 10.1016/j.jmb.2009.11.005; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tomanicek SJ, 2011, FEBS LETT, V585, P364, DOI 10.1016/j.febslet.2010.12.017; Tranier S, 2000, J BIOL CHEM, V275, P28075; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wilke MS, 2005, CURR OPIN MICROBIOL, V8, P525, DOI 10.1016/j.mib.2005.08.016; Yap EH, 2010, J CHEM THEORY COMPUT, V6, P2214, DOI 10.1021/ct100145f	48	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39577	10.1371/journal.pone.0039577	http://dx.doi.org/10.1371/journal.pone.0039577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745790	Green Submitted, Green Published, gold			2022-12-27	WOS:000305693200090
J	McDermott, JE; Vartanian, KB; Mitchell, H; Stevens, SL; Sanfilippo, A; Stenzel-Poore, MP				McDermott, Jason E.; Vartanian, Keri B.; Mitchell, Hugh; Stevens, Susan L.; Sanfilippo, Antonio; Stenzel-Poore, Mary P.			Identification and Validation of Ifit1 as an Important Innate Immune Bottleneck	PLOS ONE			English	Article							PROTEIN; NETWORKS; REPLICATION; EXPRESSION; VIRULENCE; P56	The innate immune system plays important roles in a number of disparate processes. Foremost, innate immunity is a first responder to invasion by pathogens and triggers early defensive responses and recruits the adaptive immune system. The innate immune system also responds to endogenous damage signals that arise from tissue injury. Recently it has been found that innate immunity plays an important role in neuroprotection against ischemic stroke through the activation of the primary innate immune receptors, Toll-like receptors (TLRs). Using several large-scale transcriptomic data sets from mouse and mouse macrophage studies we identified targets predicted to be important in controlling innate immune processes initiated by TLR activation. Targets were identified as genes with high betweenness centrality, so-called bottlenecks, in networks inferred from statistical associations between gene expression patterns. A small set of putative bottlenecks were identified in each of the data sets investigated including interferon-stimulated genes (Ifit1, Ifi47, Tgtp and Oasl2) as well as genes uncharacterized in immune responses (Axud1 and Ppp1r15a). We further validated one of these targets, Ifit1, in mouse macrophages by showing that silencing it suppresses induction of predicted downstream genes by lipopolysaccharide (LPS)-mediated TLR4 activation through an unknown direct or indirect mechanism. Our study demonstrates the utility of network analysis for identification of interesting targets related to innate immune function, and highlights that Ifit1 can exert a positive regulatory effect on downstream genes.	[McDermott, Jason E.; Mitchell, Hugh; Sanfilippo, Antonio] Pacific NW Natl Lab, Richland, WA 99352 USA; [Vartanian, Keri B.; Stevens, Susan L.; Stenzel-Poore, Mary P.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Oregon Health & Science University	McDermott, JE (corresponding author), Pacific NW Natl Lab, Richland, WA 99352 USA.	Jason.McDermott@pnl.gov	Sanfilippo, Antonio/B-6743-2016	Sanfilippo, Antonio/0000-0001-7097-4562; Vartanian, Keri/0000-0002-6823-1310; Mitchell, Hugh/0000-0003-0143-8461; McDermott, Jason/0000-0003-2961-2572	National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) [R01NS057484-03]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057484, R01NS050567, R01NS062381] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported under National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) grant R01NS057484-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bahjat FR, 2011, J CEREBR BLOOD F MET, V31, P1229, DOI 10.1038/jcbfm.2011.6; Berchtold S, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-75; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Butte A J, 2000, Pac Symp Biocomput, P418; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carlow DA, 1998, J IMMUNOL, V161, P2348; CSARDI G, 2006, COMPLEX SYSTEMS, V1695; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Glavic A, 2009, MECH DEVELOP, V126, P184, DOI 10.1016/j.mod.2008.11.005; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Hiscott J, 2003, ANN NY ACAD SCI, V1010, P237, DOI 10.1196/annals.1299.042; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hui DJ, 2005, J BIOL CHEM, V280, P3433, DOI 10.1074/jbc.M406700200; IRIZARRY R, 2003, ANAL GENE EXPRESSION; McCabe C, 2008, J CEREBR BLOOD F MET, V28, P747, DOI 10.1038/sj.jcbfm.9600565; McDermott JE, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-28; McDermott JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014673; McDermott JE, 2011, BIOCOMPUT-PAC SYM, P314; McDermott JE, 2010, DIS MARKERS, V28, P253, DOI [10.1155/2010/708932, 10.3233/DMA-2010-0695]; McDermott JE, 2009, J COMPUT BIOL, V16, P169, DOI 10.1089/cmb.2008.04TT; McDermott JE, 2011, MOL BIOSYST; Minami K, 2007, J VIROL, V81, P11106, DOI 10.1128/JVI.01063-07; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Rasmussen AL, 2011, J VIROL, V85, P11646, DOI 10.1128/JVI.05605-11; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stevens SL, 2008, J CEREBR BLOOD F MET, V28, P1040, DOI 10.1038/sj.jcbfm.9600606; Stevens SL, 2011, J NEUROSCI, V31, P8456, DOI 10.1523/JNEUROSCI.0821-11.2011; Tasaki K, 1997, BRAIN RES, V748, P267, DOI 10.1016/S0006-8993(96)01383-2; Team RDC, 2010, R LANG ENV STAT COMP; Terenzi F, 2005, VIROLOGY, V340, P116, DOI 10.1016/j.virol.2005.06.011; Yoon HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000306; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059	36	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e36465	10.1371/journal.pone.0036465	http://dx.doi.org/10.1371/journal.pone.0036465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745654	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200002
J	Roth, S; Franken, P; Sacchetti, A; Kremer, A; Anderson, K; Sansom, O; Fodde, R				Roth, Sabrina; Franken, Patrick; Sacchetti, Andrea; Kremer, Andreas; Anderson, Kurt; Sansom, Owen; Fodde, Riccardo			Paneth Cells in Intestinal Homeostasis and Tissue Injury	PLOS ONE			English	Article							EPITHELIAL STEM-CELL; SELF-RENEWAL; SECRETORY-CELL; CRYPT BASE; MARKER; IDENTIFICATION; COLON; DIFFERENTIATION; EXPRESSION; ENTEROENDOCRINE	Adult stem cell niches are often co-inhabited by cycling and quiescent stem cells. In the intestine, lineage tracing has identified Lgr5(+) cells as frequently cycling stem cells, whereas Bmi1(+), mTert(+), Hopx(+) and Lrig1(+) cells appear to be more quiescent. Here, we have applied a non-mutagenic and cell cycle independent approach to isolate and characterize small intestinal label-retaining cells (LRCs) persisting in the lower third of the crypt of Lieberkuhn for up to 100 days. LRCs do not express markers of proliferation and of enterocyte, goblet or enteroendocrine differentiation, but are positive for Paneth cell markers. While during homeostasis, LR/Paneth cells appear to play a supportive role for Lgr5(+) stem cells as previously shown, upon tissue injury they switch to a proliferating state and in the process activate Bmi1 expression while silencing Paneth-specific genes. Hence, they are likely to contribute to the regenerative process following tissue insults such as chronic inflammation.	[Roth, Sabrina; Franken, Patrick; Sacchetti, Andrea; Fodde, Riccardo] Erasmus MC, Josephine Nefkens Inst, Dept Pathol, Rotterdam, Netherlands; [Anderson, Kurt; Sansom, Owen] Beatson Inst, Glasgow, Lanark, Scotland	Erasmus University Rotterdam; Erasmus MC; Beatson Institute	Roth, S (corresponding author), Erasmus MC, Josephine Nefkens Inst, Dept Pathol, Rotterdam, Netherlands.	r.fodde@erasmusmc.nl	Fodde, Riccardo/AAW-9394-2021; Sacchetti, Andrea/H-8763-2019	Fodde, Riccardo/0000-0001-9839-4324; Kremer, Andreas/0000-0003-1466-0600; Sansom, Owen J./0000-0001-9540-3010; Anderson, Kurt/0000-0002-9324-9598	Dutch Cancer Society [EMCR2007-3740, DDHK 2005-3299]; NWO Vici [016.036.636]; BSIK/NIRM (Netherlands Institute of Regenerative Medicine) of Dutch Government [BSIK 03038]; EU [LSHC-CT-2006-037297]; Cancer Research UK [12481] Funding Source: researchfish	Dutch Cancer Society(KWF Kankerbestrijding); NWO Vici(Netherlands Organization for Scientific Research (NWO)); BSIK/NIRM (Netherlands Institute of Regenerative Medicine) of Dutch Government; EU(European Commission); Cancer Research UK(Cancer Research UK)	These studies were supported by the Dutch Cancer Society (contract grant numbers: EMCR2007-3740 and DDHK 2005-3299); NWO Vici (contract grant number: 016.036.636); the BSIK/NIRM (Netherlands Institute of Regenerative Medicine; www.nirm.nl) program of the Dutch Government (contract grant number: BSIK 03038); EU FP6 "Migrating Cancer Stem Cells'' (MCSCs, contract grant number: LSHC-CT-2006-037297). Additional intramural funding was made available the Erasmus Stem Cell Institute (ESI; http://www.erasmusmc.nl/medical_genetics/esi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu P, 2008, DEV BIOL, V324, P288, DOI 10.1016/j.ydbio.2008.09.027; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; BJERKNES M, 1981, AM J ANAT, V160, P77, DOI 10.1002/aja.1001600107; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Bjerknes M, 2010, DEV BIOL, V345, P49, DOI 10.1016/j.ydbio.2010.06.021; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Kim TH, 2012, P NATL ACAD SCI USA, V109, P3932, DOI 10.1073/pnas.1113890109; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; May R, 2008, STEM CELLS, V26, P630, DOI 10.1634/stemcells.2007-0621; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Pellegrinet L, 2011, GASTROENTEROLOGY; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Potten CS, 2002, J CELL SCI, V115, P2381; POTTEN CS, 1990, INT J RADIAT BIOL, V58, P925, DOI 10.1080/09553009014552281; Potten CS, 1998, BRIT J CANCER, V78, P993, DOI 10.1038/bjc.1998.618; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Qiao XT, 2007, GASTROENTEROLOGY, V133, P1989, DOI 10.1053/j.gastro.2007.09.031; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Roth S, 2009, GENESIS, V47, P7, DOI 10.1002/dvg.20446; Rothenberg ME, 2012, GASTROENTEROLOGY, V142, P1195, DOI 10.1053/j.gastro.2012.02.006; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T., 2010, NATURE; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sei Y, 2011, AM J PHYSIOL-GASTR L, V300, pG345, DOI 10.1152/ajpgi.00278.2010; Shi JS, 2007, INFLAMM BOWEL DIS, V13, P1284, DOI 10.1002/ibd.20197; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; SYMONDS DA, 1974, ARCH PATHOL, V97, P343; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wada Ryo, 2005, J Carcinog, V4, P5, DOI 10.1186/1477-3163-4-5; Wang DH, 2011, P NATL ACAD SCI USA, V108, P10272, DOI 10.1073/pnas.1017668108; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109	54	102	108	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38965	10.1371/journal.pone.0038965	http://dx.doi.org/10.1371/journal.pone.0038965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745693	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200032
J	Valero, JG; Cornut-Thibaut, A; Juge, R; Debaud, AL; Gimenez, D; Gillet, G; Bonnefoy-Berard, N; Salgado, J; Salles, G; Aouacheria, A; Kucharczak, J				Valero, Juan Garcia; Cornut-Thibaut, Aurelie; Juge, Romain; Debaud, Anne-Laure; Gimenez, Diana; Gillet, Germain; Bonnefoy-Berard, Nathalie; Salgado, Jesus; Salles, Gilles; Aouacheria, Abdel; Kucharczak, Jerome			mu-Calpain Conversion of Antiapoptotic Bfl-1 (BCL2A1) into a Prodeath Factor Reveals Two Distinct alpha-Helices Inducing Mitochondria-Mediated Apoptosis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; CYTOCHROME-C RELEASE; BAX-DERIVED PEPTIDE; ANTIMICROBIAL PEPTIDES; BCL-2 PROTEINS; ION-CHANNEL; LIPID-MEMBRANES; HIGH EXPRESSION; PORE FORMATION; B-CELLS	Anti-apoptotic Bfl-1 and pro-apoptotic Bax, two members of the Bcl-2 family sharing a similar structural fold, are classically viewed as antagonist regulators of apoptosis. However, both proteins were reported to be death inducers following cleavage by the cysteine protease mu-calpain. Here we demonstrate that calpain-mediated cleavage of full-length Bfl-1 induces the release of C-terminal membrane active alpha-helices that are responsible for its conversion into a pro-apoptotic factor. A careful comparison of the different membrane-active regions present in the Bfl-1 truncated fragments with homologous domains of Bax show that helix alpha 5, but not alpha 6, of Bfl-1 induces cell death and cytochrome c release from purified mitochondria through a Bax/Bak-dependent mechanism. In contrast, both helices alpha 5 and alpha 6 of Bax permeabilize mitochondria regardless of the presence of Bax or Bak. Moreover, we provide evidence that the alpha 9 helix of Bfl-1 promotes cytochrome c release and apoptosis through a unique membrane-destabilizing action whereas Bax-alpha 9 does not display such activities. Hence, despite a common 3D-structure, C-terminal toxic domains present on Bfl-1 and Bax function in a dissimilar manner to permeabilize mitochondria and induce apoptosis. These findings provide insights for designing therapeutic approaches that could exploit the cleavage of endogenous Bcl-2 family proteins or the use of Bfl-1/Bax-derived peptides to promote tumor cell clearance.	[Valero, Juan Garcia] Univ Lyon 1, IBCP, CNRS UMR 5086, IFR 128, F-69365 Lyon, France; [Cornut-Thibaut, Aurelie; Juge, Romain; Salles, Gilles; Aouacheria, Abdel; Kucharczak, Jerome] Ecole Normale Super Lyon, LBMC, CNRS UMR 5239, SFR Biosci Gerland Lyon Sud US8 UMS3444, F-69364 Lyon, France; [Gimenez, Diana; Salgado, Jesus] Univ Valencia, Inst Ciencia Mol, Paterna, Valencia, Spain; [Salgado, Jesus] Univ Valencia, Dept Bioquim & Biol Mol, E-46100 Burjassot, Valencia, Spain; [Debaud, Anne-Laure; Bonnefoy-Berard, Nathalie] Univ Lyon 1, Inserm U851, IFR128, F-69365 Lyon, France; [Gillet, Germain] Univ Lyon 1, Inserm U1052, UMS3453 CNRS, Ctr Rech Cancerol Lyon,Ctr Leon Berard, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; University of Valencia; University of Valencia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard	Valero, JG (corresponding author), Univ Lyon 1, IBCP, CNRS UMR 5086, IFR 128, F-69365 Lyon, France.	jerome.kucharczak@ens-lyon.fr	Salgado, Jesús/A-7759-2013; Bonnefoy, Nathalie/J-2536-2012; gillet, germain/A-9095-2013; Salles, Gilles/Z-2336-2019	Salgado, Jesús/0000-0002-8537-1550; Bonnefoy, Nathalie/0000-0003-4814-6722; Salles, Gilles/0000-0002-9541-8666; Gimenez, Diana/0000-0003-2842-6989; GILLET, Germain/0000-0002-1514-327X; KUCHARCZAK, Jerome/0000-0001-7722-8490; Mathieu, Anne-Laure/0000-0002-2893-7001	La Region Rhone-Alpes; Silab-Jean Paufique Corporate Foundation (France); La Ligue Contre le Cancer (Comites de la Drome et du Rhone); Spanish MICINN [BFU2010-19118/BMC]; European Regional Development Fund; L'Institut National du Cancer (INCa poro-combo)	La Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Silab-Jean Paufique Corporate Foundation (France); La Ligue Contre le Cancer (Comites de la Drome et du Rhone); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission); L'Institut National du Cancer (INCa poro-combo)	JGV was recipient of doctoral fellowship from La Region Rhone-Alpes. This work was supported by grants from the Silab-Jean Paufique Corporate Foundation (France), La Ligue Contre le Cancer (Comites de la Drome et du Rhone), the Spanish MICINN (BFU2010-19118/BMC, financed in part by the European Regional Development Fund), L'Institut National du Cancer (INCa poro-combo), Complement de dotation from UCBL Lyon 1, Programme CIBLE de la Region Rhone-Alpes and a collaborative French/Spanish project (EGIDE PHC PICASSO 17092SM; MEC, HF2007-0090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Aouacheria A, 2005, MOL BIOL EVOL, V22, P2395, DOI 10.1093/molbev/msi234; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; Blaineau SV, 2009, APOPTOSIS, V14, P923, DOI 10.1007/s10495-009-0376-0; Brien G, 2007, ONCOGENE, V26, P5828, DOI 10.1038/sj.onc.1210363; Brien G, 2009, J BIOL CHEM, V284, P30257, DOI 10.1074/jbc.M109.040824; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cartron PF, 2004, J BIOL CHEM, V279, P11503, DOI 10.1074/jbc.M311922200; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Clem RJ, 1998, P NATL ACAD SCI USA, V95, P554, DOI 10.1073/pnas.95.2.554; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; CRAMER WA, 1995, ANNU REV BIOPH BIOM, V24, P611, DOI 10.1146/annurev.biophys.24.1.611; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; DIVE C, 1992, BIOCHIM BIOPHYS ACTA, V1133, P275, DOI 10.1016/0167-4889(92)90048-G; duVerle David, 2010, V22, P202; Fuertes G, 2010, BIOPHYS J, V99, P2917, DOI 10.1016/j.bpj.2010.08.068; Fujita N, 1998, ONCOGENE, V17, P1295, DOI 10.1038/sj.onc.1202065; Garcia-Saez AJ, 2006, FEBS J, V273, P971, DOI 10.1111/j.1742-4658.2006.05123.x; Garcia-Saez AJ, 2005, BIOPHYS J, V88, P3976, DOI 10.1529/biophysj.104.058008; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Garcia-Saez AJ, 2007, BIOPHYS J, V93, P103, DOI 10.1529/biophysj.106.100370; Garcia-Saez AJ, 2010, ADV EXP MED BIOL, V677, P91; George NM, 2010, J BIOL CHEM, V285, P1384, DOI 10.1074/jbc.M109.049924; Guillemin Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009066; Heimlich G, 2004, BIOCHEM J, V378, P247, DOI 10.1042/BJ20031152; Herman MD, 2008, FEBS LETT, V582, P3590, DOI 10.1016/j.febslet.2008.09.028; Hinz M, 2001, BLOOD, V97, P2798, DOI 10.1182/blood.V97.9.2798; Huang DCS, 1998, EMBO J, V17, P1029, DOI 10.1093/emboj/17.4.1029; Huang HW, 2009, BIOPHYS J, V96, P3263, DOI 10.1016/j.bpj.2009.01.030; Kalaitzidis D, 2002, ONCOGENE, V21, P8759, DOI 10.1038/sj.onc.1206033; Kenny JJ, 1997, ONCOGENE, V14, P997, DOI 10.1038/sj.onc.1200898; Ko JK, 2007, J CELL SCI, V120, P2912, DOI 10.1242/jcs.006197; Kucharczak JF, 2005, CELL DEATH DIFFER, V12, P1225, DOI 10.1038/sj.cdd.4401684; Mangoni ML, 2011, CELL MOL LIFE SCI, V68, P2267, DOI 10.1007/s00018-011-0718-2; Matsuyama S, 1998, J BIOL CHEM, V273, P30995, DOI 10.1074/jbc.273.47.30995; Menoret E, 2010, FEBS LETT, V584, P487, DOI 10.1016/j.febslet.2009.11.094; Michels J, 2004, ONCOGENE, V23, P4818, DOI 10.1038/sj.onc.1207648; Minn AJ, 1999, EMBO J, V18, P632, DOI 10.1093/emboj/18.3.632; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Morales AA, 2005, INT J CANCER, V113, P730, DOI 10.1002/ijc.20614; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nouraini S, 2000, MOL CELL BIOL, V20, P1604, DOI 10.1128/MCB.20.5.1604-1615.2000; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Qian S, 2008, P NATL ACAD SCI USA, V105, P17379, DOI 10.1073/pnas.0807764105; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Schendel SL, 1999, J BIOL CHEM, V274, P21932, DOI 10.1074/jbc.274.31.21932; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; Simmons MJ, 2008, ONCOGENE, V27, P1421, DOI 10.1038/sj.onc.1210771; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tamba Y, 2010, J PHYS CHEM B, V114, P12018, DOI 10.1021/jp104527y; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Valero JG, 2011, J CELL SCI, V124, P556, DOI 10.1242/jcs.076745; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	59	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38620	10.1371/journal.pone.0038620	http://dx.doi.org/10.1371/journal.pone.0038620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745672	Green Submitted, Green Published, gold			2022-12-27	WOS:000305693200018
J	Johansson, R; Ekbladh, S; Hebert, A; Lindstrom, M; Moller, S; Petitt, E; Poysti, S; Larsson, MH; Rousseau, A; Carlbring, P; Cuijpers, P; Andersson, G				Johansson, Robert; Ekbladh, Sigrid; Hebert, Amanda; Lindstrom, Malin; Moller, Sara; Petitt, Eleanor; Poysti, Stephanie; Larsson, Mattias Holmqvist; Rousseau, Andreas; Carlbring, Per; Cuijpers, Pim; Andersson, Gerhard			Psychodynamic Guided Self-Help for Adult Depression through the Internet: A Randomised Controlled Trial	PLOS ONE			English	Article							PSYCHOTHERAPY; ANXIETY; DISORDERS; THERAPY; METAANALYSIS; COMORBIDITY; ATTITUDES; SEVERITY; STATES; PAPER	Background and aims: Psychodynamic psychotherapy (PDT) is an effective treatment for major depressive disorder (MDD), but not all clients with MDD can receive psychotherapy. Using the Internet to provide psychodynamic treatments is one way of improving access to psychological treatments for MDD. The aim of this randomised controlled trial was to investigate the efficacy of an Internet-based psychodynamic guided self-help treatment for MDD. Methods: Ninety-two participants who were diagnosed with MDD according to the Mini-International Neuropsychiatric Interview were randomised to treatment or an active control. The treatment consisted of nine treatment modules based on psychodynamic principles with online therapist contact. The active control condition was a structured support intervention and contained psychoeducation and scheduled weekly contacts online. Both interventions lasted for 10 weeks. The primary outcome measure was the Beck Depression Inventory-II (BDI-II). Results: Mixed-effects model analyses of all randomised participants showed that participants receiving Internet-based PDT made large and superior improvements compared with the active control group on the BDI-II (between-group Cohen's d = 1.11). Treatment effects were maintained at a 10-month follow-up. Conclusions: Internet-based psychodynamic guided self-help is an efficacious treatment for MDD that has the potential to increase accessibility and availability of PDT for MDD.	[Johansson, Robert; Ekbladh, Sigrid; Hebert, Amanda; Lindstrom, Malin; Moller, Sara; Petitt, Eleanor; Poysti, Stephanie; Larsson, Mattias Holmqvist; Andersson, Gerhard] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Rousseau, Andreas] Linkoping Univ Hosp, Psychiat Clin, S-58185 Linkoping, Sweden; [Carlbring, Per] Umea Univ, Dept Psychol, S-90187 Umea, Sweden; [Cuijpers, Pim] Vrije Univ, Dept Clin Psychol, Amsterdam, Netherlands; [Cuijpers, Pim] Vrije Univ, EMGO Inst, Amsterdam, Netherlands; [Andersson, Gerhard] Linkoping Univ, Swedish Inst Disabil Res, Linkoping, Sweden; [Andersson, Gerhard] Karolinska Inst, Psychiat Sect, Dept Clin Neurosci, Stockholm, Sweden	Linkoping University; Linkoping University; Umea University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Linkoping University; Karolinska Institutet	Johansson, R (corresponding author), Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden.	robert.johansson@liu.se	Carlbring, Per/R-1220-2019; Cuijpers, Pim/G-1703-2013; Carlbring, Per/D-3628-2009; Andersson, Gerhard/J-8529-2012	Carlbring, Per/0000-0002-2172-8813; Carlbring, Per/0000-0002-2172-8813; Andersson, Gerhard/0000-0003-4753-6745; Johansson, Robert/0000-0001-5547-3866; Cuijpers, Pim/0000-0001-5497-2743	Swedish council for working and life research; Swedish research council; Linkoping University	Swedish council for working and life research; Swedish research council(Swedish Research CouncilEuropean Commission); Linkoping University	The study was sponsored in part by the Swedish council for working and life research, the Swedish research council, and Linkoping University (Professor contract). The authors report no financial relationships with commercial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 2005, BRIT J PSYCHIAT, V187, P456, DOI 10.1192/bjp.187.5.456; Andersson G, 2009, BEHAV RES THER, V47, P175, DOI 10.1016/j.brat.2009.01.010; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Blagys MD, 2000, CLIN PSYCHOL-SCI PR, V7, P167, DOI 10.1093/clipsy/7.2.167; Blagys MD, 2002, CLIN PSYCHOL REV, V22, P671, DOI 10.1016/S0272-7358(01)00117-9; Borenstein M., 2009, INTRO METAANALYSIS; Busch F.N., 2004, PSYCHODYNAMIC TREATM; Carlbring P, 2007, COMPUT HUM BEHAV, V23, P1421, DOI 10.1016/j.chb.2005.05.002; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cuijpers P, 2010, PSYCHOL MED, V40, P1943, DOI 10.1017/S0033291710000772; Cuijpers P, 2008, PSYCHOTHER RES, V18, P225, DOI 10.1080/10503300701442027; Cuijpers P, 2008, J CONSULT CLIN PSYCH, V76, P909, DOI 10.1037/a0013075; Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658; Driessen E, 2010, CLIN PSYCHOL REV, V30, P25, DOI 10.1016/j.cpr.2009.08.010; Ebmeier KP, 2006, LANCET, V367, P153, DOI 10.1016/S0140-6736(06)67964-6; Frisch M.B., 1992, PSYCHOL ASSESS, V4, P92, DOI [10.1037/1040-3590.4.1.92, DOI 10.1037/1040-3590.4.1.92]; Gerber AJ, 2011, AM J PSYCHIAT, V168, P19, DOI 10.1176/appi.ajp.2010.08060843; Gibbons MBC, 2008, ANNU REV CLIN PSYCHO, V4, P93, DOI 10.1146/annurev.clinpsy.4.022007.141252; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Hollandare F, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1392; Howard KI, 1996, ARCH GEN PSYCHIAT, V53, P696; Kazantzis N, 2005, J CONSULT CLIN PSYCH, V73, P742, DOI 10.1037/0022-006X.73.4.742; Kessler D, 2009, LANCET, V374, P628, DOI 10.1016/S0140-6736(09)61257-5; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kessler RC, 2007, ANNU REV CLIN PSYCHO, V3, P137, DOI 10.1146/annurev.clinpsy.3.022806.091444; Klein Britt, 2009, Cognitive Behaviour Therapy, V38, P100, DOI 10.1080/16506070802561132; Knaevelsrud C, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-13; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Luborsky L., 1984, PRINCIPLES PSYCHOANA; Mora L, 2008, COMPUT HUM BEHAV, V24, P3052, DOI 10.1016/j.chb.2008.05.011; SHAPIRO DA, 1994, J CONSULT CLIN PSYCH, V62, P522, DOI 10.1037/0022-006X.62.3.522; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Silverberg F, 2005, MAKE LEAP PRACTICAL; Smit F, 2006, J MENT HEALTH POLICY, V9, P193; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010939; VESSEY JT, 1993, PSYCHOTHER, V30, P546, DOI 10.1037/0033-3204.30.4.546; Wangberg SC, 2007, CYBERPSYCHOL BEHAV, V10, P418, DOI 10.1089/cpb.2006.9937	42	36	37	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e38021	10.1371/journal.pone.0038021	http://dx.doi.org/10.1371/journal.pone.0038021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WT	22741027	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349600055
J	Gangadharan, B; Bapat, M; Rossa, J; Antrobus, R; Chittenden, D; Kampa, B; Barnes, E; Klenerman, P; Dwek, RA; Zitzmann, N				Gangadharan, Bevin; Bapat, Manisha; Rossa, Jan; Antrobus, Robin; Chittenden, David; Kampa, Bettina; Barnes, Eleanor; Klenerman, Paul; Dwek, Raymond A.; Zitzmann, Nicole			Discovery of Novel Biomarker Candidates for Liver Fibrosis in Hepatitis C Patients: A Preliminary Study	PLOS ONE			English	Article							BIOCHEMICAL MARKERS; III PROCOLLAGEN; DISEASE; GLYCOSYLATION; DECREASE; CANCER; PANEL	Background: Liver biopsy is the reference standard for assessing liver fibrosis and no reliable non-invasive diagnostic approach is available to discriminate between the intermediate stages of fibrosis. Therefore suitable serological biomarkers of liver fibrosis are urgently needed. We used proteomics to identify novel fibrosis biomarkers in hepatitis C patients with different degrees of liver fibrosis. Methodology/Principal Findings: Proteins in plasma samples from healthy control individuals and patients with hepatitis C virus (HCV) induced cirrhosis were analysed using a proteomics technique: two dimensional gel electrophoresis (2-DE). This technique separated the proteins in plasma samples of control and cirrhotic patients and by visualizing the separated proteins we were able to identify proteins which were increasing or decreasing in hepatic cirrhosis. Identified markers were validated across all Ishak fibrosis stages and compared to the markers used in FibroTest, Enhanced Liver Fibrosis (ELF) test, Hepascore and FIBROSpect by Western blotting. Forty four candidate biomarkers for hepatic fibrosis were identified of which 20 were novel biomarkers of liver fibrosis. Western blot validation of all candidate markers using plasma samples from patients across all Ishak fibrosis scores showed that the markers which changed with increasing fibrosis most consistently included lipid transfer inhibitor protein, complement C3d, corticosteroid-binding globulin, apolipoprotein J and apolipoprotein L1. These five novel fibrosis markers which are secreted in blood showed a promising consistent change with increasing fibrosis stage when compared to the markers used for the FibroTest, ELF test, Hepascore and FIBROSpect. These markers will be further validated using a large clinical cohort. Conclusions/Significance: This study identifies 20 novel fibrosis biomarker candidates. The proteins identified may help to assess hepatic fibrosis and eliminate the need for invasive liver biopsies.	[Gangadharan, Bevin; Bapat, Manisha; Rossa, Jan; Antrobus, Robin; Chittenden, David; Kampa, Bettina; Dwek, Raymond A.; Zitzmann, Nicole] Univ Oxford, Dept Biochem, Oxford Antiviral Drug Discovery Unit, Oxford Glycobiol Inst, Oxford OX1 3QU, England; [Barnes, Eleanor; Klenerman, Paul] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Barnes, Eleanor] John Radcliffe Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 9DU, England	University of Oxford; University of Oxford; University of Oxford	Gangadharan, B (corresponding author), Univ Oxford, Dept Biochem, Oxford Antiviral Drug Discovery Unit, Oxford Glycobiol Inst, Oxford OX1 3QU, England.	Bevin.Gangadharan@bioch.ox.ac.uk		klenerman, paul/0000-0003-4307-9161; Barnes, Eleanor/0000-0002-0860-0831; Gangadharan, Bevin/0000-0002-7466-2977	Oxford Glycobiology Endowment; United Therapeutics Corp.; Wellcome Trust; James Martin School; NIHR (Oxford); Scientific Board of United Therapeutics Corp.; MRC [G108/601] Funding Source: UKRI; Medical Research Council [G108/601] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10204] Funding Source: researchfish	Oxford Glycobiology Endowment; United Therapeutics Corp.; Wellcome Trust(Wellcome TrustEuropean Commission); James Martin School; NIHR (Oxford)(National Institute for Health Research (NIHR)); Scientific Board of United Therapeutics Corp.; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Oxford Glycobiology Endowment and a 'Blue Skies' research grant from United Therapeutics Corp. NZ is a Senior Research Fellow of Linacre College, Oxford. PK was supported by the Wellcome Trust, The James Martin School for the 21st Century and the NIHR Biomedical Research Centre Programme (Oxford). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Professor Raymond Dwek is a Director and Member of the Scientific Board of United Therapeutics Corp., which supported this work in part through a "Blue Skies" research grant. A patent covering the biomarkers in this study has been filed. The patent number is 61178334. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; Aggarwal Dimple, 2005, BMC Cardiovasc Disord, V5, P30, DOI 10.1186/1471-2261-5-30; Aigelsreiter A, 2009, HISTOPATHOLOGY, V54, P561, DOI 10.1111/j.1365-2559.2009.03258.x; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Cadranel JF, 2002, EUR J GASTROEN HEPAT, V14, P1057, DOI 10.1097/00042737-200210000-00004; Cheung KJ, 2008, EUR J GASTROEN HEPAT, V20, P450, DOI 10.1097/MEG.0b013e3282f4de92; Gabrielli GB, 1997, CLIN CHIM ACTA, V265, P21, DOI 10.1016/S0009-8981(97)00103-4; Gangadharan B, 2011, NATURE PROTOCOL EXCH, DOI [10.1038/protex.2011.261, DOI 10.1038/PROTEX.2011.261]; Gangadharan B, 2007, CLIN CHEM, V53, P1792, DOI 10.1373/clinchem.2007.089144; Gangadharan B, 2011, J PROTEOME RES, V10, P2643, DOI 10.1021/pr101077c; Garcia A, 2004, BLOOD, V103, P2088, DOI 10.1182/blood-2003-07-2392; Guha IN, 2008, HEPATOLOGY, V47, P455, DOI 10.1002/hep.21984; He ZC, 2006, BIOCHEM BIOPH RES CO, V343, P496, DOI 10.1016/j.bbrc.2006.03.007; HIRAOKA H, 1993, HEPATOLOGY, V18, P103, DOI 10.1016/0270-9139(93)90513-M; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Lagor WR, 2009, ARTERIOSCL THROM VAS, V29, P40, DOI 10.1161/ATVBAHA.108.177105; Marcellin P, 1999, J HEPATOL, V31, P9, DOI 10.1016/S0168-8278(99)80368-7; Matheson LA, 2008, J IMMUNOL METHODS, V339, P82, DOI 10.1016/j.jim.2008.08.003; Pardo M, 2007, J PROTEOME RES, V6, P2802, DOI 10.1021/pr070021t; Parkes J, 2010, J VIRAL HEPAT; Pinzani M, 2010, GUT, V59, P1165, DOI 10.1136/gut.2010.214932; Poordad FF, 2004, EXPERT REV MOL DIAGN, V4, P593, DOI 10.1586/14737159.4.5.593; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Rossi E, 2003, CLIN CHEM, V49, P450, DOI 10.1373/49.3.450; Saldova R, 2008, DIS MARKERS, V25, P219, DOI 10.1155/2008/601583; Sarrats A, 2010, PROTEOM CLIN APPL, V4, P432, DOI 10.1002/prca.200900150; Tolosano E, 2002, BLOOD, V100, P4201, DOI 10.1182/blood-2002-04-1270; White IR, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-33; ZOHRENS G, 1994, DIGEST DIS SCI, V39, P2007, DOI 10.1007/BF02088139	31	34	36	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39603	10.1371/journal.pone.0039603	http://dx.doi.org/10.1371/journal.pone.0039603			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761838	Green Submitted, Green Published, gold			2022-12-27	WOS:000305808700038
J	Xiao, JF; Liu, YM; Li, ZL; Zhou, YC; Lin, H; Wu, XY; Chen, M; Xiao, WF				Xiao, Jianfeng; Liu, Yanmei; Li, Zhiling; Zhou, Yongcui; Lin, Hong; Wu, Xiaoyan; Chen, Man; Xiao, Wanfen			Effects of the Insemination of Hydrogen Peroxide-Treated Epididymal Mouse Spermatozoa on gamma H2AX Repair and Embryo Development	PLOS ONE			English	Article							SPERM DNA-DAMAGE; OXIDATIVE STRESS; LIPID-PEROXIDATION; GENE ACTIVATION; MOTILITY; CRYOPRESERVATION; FRAGMENTATION; EXPRESSION; PARAMETERS; CYTOPLASM	Background: Cryopreservation of human semen for assisted reproduction is complicated by cryodamage to spermatozoa caused by excessive reactive oxygen species (ROS) generation. Methods and Findings: We used exogenous ROS (H2O2) to simulate cryopreservation and examined DNA damage repair in embryos fertilized with sperm with H2O2-induced DNA damage. Sperm samples were collected from epididymis of adult male KM mice and treated with capacitation medium (containing 0, 0.1, 0.5 and 1 mM H2O2) or cryopreservation. The model of DNA-damaged sperm was based on sperm motility, viability and the expression of gamma H2AX, the DNA damage-repair marker. We examined fertility rate, development, cell cleavage, and gamma H2AX level in embryos fertilized with DNA-damaged sperm. Cryopreservation and 1-mM H2O2 treatment produced similar DNA damage. Most of the one-and two-cell embryos fertilized with DNA-damaged sperm showed a delay in cleavage before the blastocyst stage. Immunocytochemistry revealed gamma H2AX in the one-and four-cell embryos. Conclusions: gamma H2AX may be involved in repair of preimplantation embryos fertilized with oxygen-stressed spermatozoa.	[Xiao, Jianfeng; Li, Zhiling; Zhou, Yongcui; Lin, Hong; Wu, Xiaoyan; Chen, Man; Xiao, Wanfen] Shantou Univ, Reprod Ctr, Affiliated Hosp 1, Coll Med, Shantou, Guangdong, Peoples R China; [Liu, Yanmei] Women & Children Healthcare Hosp, Reprod Ctr, Qinzhou, Guangxi, Peoples R China	Shantou University	Xiao, JF (corresponding author), Shantou Univ, Reprod Ctr, Affiliated Hosp 1, Coll Med, Shantou, Guangdong, Peoples R China.	stlizhiling@126.com			National Natural Science Foundation of China [81070542, 30872771]; Natural Science Foundation of Guangdong Province of China [10151503102000020, 81515031102000010]; Medical Scientific Research Foundation of Guangdong Province, China [B2010214]; Foundation for Distinguished Young Talents in Higher Education of Guangdong, China [LYM10076]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Medical Scientific Research Foundation of Guangdong Province, China; Foundation for Distinguished Young Talents in Higher Education of Guangdong, China	This work was supported by the National Natural Science Foundation of China (No. 81070542 and No. 30872771), the Natural Science Foundation of Guangdong Province of China (No. 10151503102000020 and No. 81515031102000010), the Medical Scientific Research Foundation of Guangdong Province, China (B2010214), and the Foundation for Distinguished Young Talents in Higher Education of Guangdong, China (LYM10076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiga SK, 2007, REPRODUCTION, V133, P415, DOI 10.1530/REP-06-0048; AITKEN J, 1994, BIOESSAYS, V16, P259, DOI 10.1002/bies.950160409; Aitken RJ, 1995, REPROD FERT DEVELOP, V7, P659, DOI 10.1071/RD9950659; AITKEN RJ, 1989, INT J ANDROL, V12, P95, DOI 10.1111/j.1365-2605.1989.tb01290.x; ALVAREZ JG, 1993, J ANDROL, V14, P199; ALVAREZ JG, 1995, MOL REPROD DEV, V42, P334, DOI 10.1002/mrd.1080420311; Barroso G, 2000, HUM REPROD, V15, P1338, DOI 10.1093/humrep/15.6.1338; Borini A, 2006, HUM REPROD, V21, P2876, DOI 10.1093/humrep/del251; Bucak MN, 2010, CRYOBIOLOGY, V61, P248, DOI 10.1016/j.cryobiol.2010.09.001; Buffone MG, 2012, FERTIL STERIL, V97, P293, DOI 10.1016/j.fertnstert.2011.11.012; Calamera JC, 2010, FERTIL STERIL, V93, P789, DOI 10.1016/j.fertnstert.2008.10.021; Martinez-Soto JC, 2010, ASIAN J ANDROL, V12, P431, DOI 10.1038/aja.2009.92; Chatterjee S, 2001, MOL REPROD DEV, V59, P451, DOI 10.1002/mrd.1052; Derijck AAHA, 2006, DNA REPAIR, V5, P959, DOI 10.1016/j.dnarep.2006.05.043; du Plessis SS, 2010, ANDROLOGIA, V42, P206, DOI 10.1111/j.1439-0272.2009.00980.x; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Garg A, 2009, REPROD DOMEST ANIM, V44, P907, DOI 10.1111/j.1439-0531.2008.01115.x; Gomez E, 1996, J ANDROL, V17, P276; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hammadeh ME, 2001, J ASSIST REPROD GEN, V18, P364, DOI 10.1023/A:1016666221500; Harrouk W, 2000, MUTAT RES-DNA REPAIR, V461, P229, DOI 10.1016/S0921-8777(00)00053-7; Lewis SEM, 2010, HUM FERTIL, V13, P201, DOI 10.3109/14647273.2010.528823; Li ZL, 2010, J ANDROL, V31, P437, DOI 10.2164/jandrol.109.007849; MACK SR, 1987, GAMETE RES, V18, P375, DOI 10.1002/mrd.1120180411; Mahfouz R, 2008, FERTIL STERIL, V90, pS320; MATSUMOTO K, 1994, MOL REPROD DEV, V39, P136, DOI 10.1002/mrd.1080390203; Morris ID, 2002, HUM REPROD, V17, P990, DOI 10.1093/humrep/17.4.990; Muratori M, 2000, J ANDROL, V21, P903; Nothias JY, 1996, EMBO J, V15, P5715, DOI 10.1002/j.1460-2075.1996.tb00955.x; O'Connell M, 2002, HUM REPROD, V17, P704, DOI 10.1093/humrep/17.3.704; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Sati L, 2008, REPROD BIOMED ONLINE, V16, P570, DOI 10.1016/S1472-6483(10)60464-6; Schiller J, 2000, CHEM PHYS LIPIDS, V106, P145, DOI 10.1016/S0009-3084(00)00148-1; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Shen HM, 2000, FREE RADICAL BIO MED, V28, P529, DOI 10.1016/S0891-5849(99)00234-8; Thomson LK, 2009, HUM REPROD, V24, P2061, DOI 10.1093/humrep/dep214; Watson PF, 2000, ANIM REPROD SCI, V60, P481, DOI 10.1016/S0378-4320(00)00099-3; Zini A, 2006, CAN MED ASSOC J, V175, P495, DOI 10.1503/cmaj.060218	38	17	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e38742	10.1371/journal.pone.0038742	http://dx.doi.org/10.1371/journal.pone.0038742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22745678	Green Published, Green Submitted, gold			2022-12-27	WOS:000305808700010
J	Rinella, ES; Threadgill, DW				Rinella, Erica S.; Threadgill, David W.			Efficacy of EGFR Inhibition Is Modulated by Model, Sex, Genetic Background and Diet: Implications for Preclinical Cancer Prevention and Therapy Trials	PLOS ONE			English	Article							INDUCED COLON TUMORS; INTESTINAL TUMORIGENESIS; MICE; AZOXYMETHANE; AGENTS; CHEMOPREVENTION; CARCINOGENESIS; ACTIVATION; NEOPLASIA; ADENOMAS	Molecule-targeted therapies are being widely developed and deployed, but they are frequently less effective in clinical trials than predicted based upon preclinical studies. Frequently, only a single model or genetic background is utilized using diets that are not relevant to that consumed by most cancer patients, which may contribute to the lack of predictability of many preclinical therapeutic studies. Inhibition of epidermal growth factor receptor (EGFR) in colorectal cancer was used to investigate potential causes for low predictive values of many preclinical studies. The efficacy of the small molecule EGFR inhibitor AG1478 was evaluated using two mouse models, Apc(Min/+) and azoxymethane (AOM), both sexes on three genetic backgrounds, C57BL/6J (B6) and A/J (A) inbred strains and AB6F1 hybrids, and two diets, standard chow (STD) or Western-style diet (WD). AG1478 has significant anti-tumor activity in the B6-Apc(Min/+) model with STD but only moderately on the WD and in the AOM model on an A background with a WD but not STD. On the F1 hybrid background AG1478 is effective in the Apc(Min/+) model with either STD or WD, but has only moderate efficacy in the AOM model with either diet. Sex differences were also observed. Unexpectedly, the level of liver EGFR phosphorylation inhibition by AG1478 was not positively correlated with inhibition of tumor growth in the AOM model. Model-dependent interactions between genetic background and diet can dramatically impact preclinical results, and indicate that low predictive values of preclinical studies can be attributed to study designs that do not account for the heterogeneous patient population or the diets they consume. Better-designed preclinical studies should lead to more accurate predictions of therapeutic response in the clinic.	[Rinella, Erica S.; Threadgill, David W.] Univ N Carolina, Dept Genet, Curriculum Genet & Mol Biol, Lineberger Canc Ctr,Ctr Gastrointestinal Biol & D, Chapel Hill, NC 27515 USA; [Rinella, Erica S.; Threadgill, David W.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Threadgill, David W.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	Rinella, ES (corresponding author), Univ N Carolina, Dept Genet, Curriculum Genet & Mol Biol, Lineberger Canc Ctr,Ctr Gastrointestinal Biol & D, Chapel Hill, NC 27515 USA.	threadgill@ncsu.edu	Threadgill, David W/N-4425-2013	Threadgill, David W/0000-0003-3538-1635	National Institutes of Health [CA106991, CA105417, CA092479, AT002835]; NATIONAL CANCER INSTITUTE [U01CA105417, R01CA092479, P50CA106991] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [F31AT002835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This research was funded in part by grants CA106991, CA105417 and CA092479 from the National Institutes of Health. ESR was supported by fellowship AT002835 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Bissahoyo A, 2005, TOXICOL SCI, V88, P340, DOI 10.1093/toxsci/kfi313; Druckrey H, 1970, COLONIC CARCINOMAS 1; Fichera A, 2007, CANCER RES, V67, P827, DOI 10.1158/0008-5472.CAN-05-3343; Harari PM, 2007, J CLIN ONCOL, V25, P4057, DOI 10.1200/JCO.2007.11.8984; Kwong LN, 2007, GENETICS, V176, P1237, DOI 10.1534/genetics.107.071217; Langreth R, 2002, FORBES, V10, P118; LIPKIN, 1997, J CELL BIOCHEM, V28, P144; MaleckaPanas E, 1996, CARCINOGENESIS, V17, P233, DOI 10.1093/carcin/17.2.233; Moral R, 2003, ONCOL REP, V10, P1417; Moran AE, 2004, J BIOL CHEM, V279, P43261, DOI 10.1074/jbc.M404276200; Nambiar PR, 2003, INT J ONCOL, V22, P145; Newmark HL, 2001, CARCINOGENESIS, V22, P1871, DOI 10.1093/carcin/22.11.1871; Papanikolaou A, 1998, CANCER LETT, V130, P29, DOI 10.1016/S0304-3835(98)00101-3; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Roberts TG, 2004, JAMA-J AM MED ASSOC, V292, P2130, DOI 10.1001/jama.292.17.2130; Ruff SJ, 1997, J BIOL CHEM, V272, P1263, DOI 10.1074/jbc.272.2.1263; STEELE VE, 1994, J CELL BIOCHEM, P32; Steffensen IL, 2006, CANCER LETT, V240, P289, DOI 10.1016/j.canlet.2005.09.015; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Torrance CJ, 2000, NAT MED, V6, P1024, DOI 10.1038/79534; Vacaresse N, 1999, CIRC RES, V85, P892; Xue LX, 1999, JNCI-J NATL CANCER I, V91, P176, DOI 10.1093/jnci/91.2.176; Yang K, 2008, CANCER RES, V68, P7803, DOI 10.1158/0008-5472.CAN-08-1209	24	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39552	10.1371/journal.pone.0039552	http://dx.doi.org/10.1371/journal.pone.0039552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761823	Green Submitted, Green Published, gold			2022-12-27	WOS:000305781700047
J	Feagin, JE; Harrell, MI; Lee, JC; Coe, KJ; Sands, BH; Cannone, JJ; Tami, G; Schnare, MN; Gutell, RR				Feagin, Jean E.; Harrell, Maria Isabel; Lee, Jung C.; Coe, Kevin J.; Sands, Bryan H.; Cannone, Jamie J.; Tami, Germaine; Schnare, Murray N.; Gutell, Robin R.			The Fragmented Mitochondrial Ribosomal RNAs of Plasmodium falciparum	PLOS ONE			English	Article							HUMAN MALARIA PARASITE; TETRAHYMENA-PYRIFORMIS MITOCHONDRIA; PEPTIDE-BOND FORMATION; 6 KB ELEMENT; LARGE SUBUNIT; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; CRITHIDIA-FASCICULATA; LEISHMANIA-TARENTOLAE; EXTRACHROMOSOMAL DNA	Background: The mitochondrial genome in the human malaria parasite Plasmodium falciparum is most unusual. Over half the genome is composed of the genes for three classic mitochondrial proteins: cytochrome oxidase subunits I and III and apocytochrome b. The remainder encodes numerous small RNAs, ranging in size from 23 to 190 nt. Previous analysis revealed that some of these transcripts have significant sequence identity with highly conserved regions of large and small subunit rRNAs, and can form the expected secondary structures. However, these rRNA fragments are not encoded in linear order; instead, they are intermixed with one another and the protein coding genes, and are coded on both strands of the genome. This unorthodox arrangement hindered the identification of transcripts corresponding to other regions of rRNA that are highly conserved and/or are known to participate directly in protein synthesis. Principal Findings: The identification of 14 additional small mitochondrial transcripts from P. falcipaurm and the assignment of 27 small RNAs (12 SSU RNAs totaling 804 nt, 15 LSU RNAs totaling 1233 nt) to specific regions of rRNA are supported by multiple lines of evidence. The regions now represented are highly similar to those of the small but contiguous mitochondrial rRNAs of Caenorhabditis elegans. The P. falciparum rRNA fragments cluster on the interfaces of the two ribosomal subunits in the three-dimensional structure of the ribosome. Significance: All of the rRNA fragments are now presumed to have been identified with experimental methods, and nearly all of these have been mapped onto the SSU and LSU rRNAs. Conversely, all regions of the rRNAs that are known to be directly associated with protein synthesis have been identified in the P. falciparum mitochondrial genome and RNA transcripts. The fragmentation of the rRNA in the P. falciparum mitochondrion is the most extreme example of any rRNA fragmentation discovered.	[Feagin, Jean E.; Harrell, Maria Isabel; Coe, Kevin J.; Sands, Bryan H.; Tami, Germaine] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Lee, Jung C.; Cannone, Jamie J.; Gutell, Robin R.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Lee, Jung C.; Cannone, Jamie J.; Gutell, Robin R.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Schnare, Murray N.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada	Center for Infectious Disease Research; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Dalhousie University	Feagin, JE (corresponding author), Univ Washington, Dept Pharm, Seattle, WA 98195 USA.	feagin@u.washington.edu			National Institutes of Health [R01 AI40368, R01 GM067317]; The M. J. Murdoch Charitable Trust; Canadian Institutes of Health Research; Welch Foundation [F-1427];  [MOP-11212]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The M. J. Murdoch Charitable Trust; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Welch Foundation(The Welch Foundation); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support for these studies was provided by National Institutes of Health R01 AI40368 and The M. J. Murdoch Charitable Trust (JEF), by grant MOP-11212 to Michael W. Gray from the Canadian Institutes of Health Research (MNS), and National Institutes of Health R01 GM067317 and Welch Foundation F-1427 (RRG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; Berg J M, 2001, Science, V291, P203; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Bernstein HJ, 2000, TRENDS BIOCHEM SCI, V25, P453, DOI 10.1016/S0968-0004(00)01606-6; BOER PH, 1988, CELL, V55, P399, DOI 10.1016/0092-8674(88)90026-8; BROSIUS J, 1981, J MOL BIOL, V148, P107, DOI 10.1016/0022-2836(81)90508-8; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Chandramouli P, 2008, STRUCTURE, V16, P535, DOI 10.1016/j.str.2008.01.007; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Conway DJ, 2000, MOL BIOCHEM PARASIT, V111, P163, DOI 10.1016/S0166-6851(00)00313-3; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Dechering KJ, 1999, MOL CELL BIOL, V19, P967; DELACRUZ VF, 1985, NUCLEIC ACIDS RES, V13, P2337, DOI 10.1093/nar/13.7.2337; DELACRUZ VF, 1985, P NATL ACAD SCI USA, V82, P1401, DOI 10.1073/pnas.82.5.1401; DUBIN DT, 1982, J MOL BIOL, V157, P1, DOI 10.1016/0022-2836(82)90510-1; Dubin DT, 1982, MITOCHONDRIAL GENES, P89; Evguenieva-Hackenberg E, 2005, MOL MICROBIOL, V57, P318, DOI 10.1111/j.1365-2958.2005.04662.x; FEAGIN JE, 1992, MOL BIOCHEM PARASIT, V52, P145, DOI 10.1016/0166-6851(92)90046-M; FEAGIN JE, 1992, NUCLEIC ACIDS RES, V20, P879, DOI 10.1093/nar/20.4.879; FEAGIN JE, 1995, EXP PARASITOL, V80, P430, DOI 10.1006/expr.1995.1055; Feagin JE, 1997, NUCLEIC ACIDS RES, V25, P438, DOI 10.1093/nar/25.2.438; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; GARDNER MJ, 1991, MOL BIOCHEM PARASIT, V48, P77, DOI 10.1016/0166-6851(91)90166-4; Gillespie DE, 1999, NUCLEIC ACIDS RES, V27, P2416, DOI 10.1093/nar/27.11.2416; GRAY MW, 1993, CURR OPIN GENET DEV, V3, P884, DOI 10.1016/0959-437X(93)90009-E; Gutell RR, 2002, CURR OPIN STRUC BIOL, V12, P301, DOI 10.1016/S0959-440X(02)00339-1; GUTELL RR, 1986, EMBO J, V5, P1111, DOI 10.1002/j.1460-2075.1986.tb04330.x; GUTELL RR, 1985, PROG NUCLEIC ACID RE, V32, P155, DOI 10.1016/S0079-6603(08)60348-7; Hansen JL, 2002, P NATL ACAD SCI USA, V99, P11670, DOI 10.1073/pnas.172404099; Hansen JL, 2001, COLD SPRING HARB SYM, V66, P33, DOI 10.1101/sqb.2001.66.33; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; HEINONEN TY, 1987, J BIOL CHEM, V262, P2879; Hikosaka K, 2011, PARASITOL INT, V60, P175, DOI 10.1016/j.parint.2011.02.001; Hikosaka K, 2010, MOL BIOL EVOL, V27, P1107, DOI 10.1093/molbev/msp320; Jackson CJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-41; Ji YE, 1996, MOL BIOCHEM PARASIT, V81, P211, DOI 10.1016/0166-6851(96)02712-0; Jongwutiwes S, 2005, MOL BIOL EVOL, V22, P1733, DOI 10.1093/molbev/msi168; JOSEPH JT, 1989, MOL CELL BIOL, V9, P3621, DOI 10.1128/MCB.9.9.3621; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; KAIRO A, 1994, EMBO J, V13, P898, DOI 10.1002/j.1460-2075.1994.tb06333.x; Kamikawa R, 2007, PROTIST, V158, P239, DOI 10.1016/j.protis.2006.12.002; Klein DJ, 2004, RNA, V10, P1366, DOI 10.1261/rna.7390804; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Krief S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000765; KRUNGKRAI J, 1995, BBA-GEN SUBJECTS, V1243, P351, DOI 10.1016/0304-4165(94)00158-T; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Lin RQ, 2011, GENE, V480, P28, DOI 10.1016/j.gene.2011.03.004; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Mears JA, 2006, J MOL BIOL, V358, P193, DOI 10.1016/j.jmb.2006.01.094; Mears JA, 2002, J MOL BIOL, V321, P215, DOI 10.1016/S0022-2836(02)00568-5; Milbury CA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-485; Moore PB, 2002, NATURE, V418, P229, DOI 10.1038/418229a; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; OKIMOTO R, 1992, GENETICS, V130, P471; PAYNE M, 1985, MOL BIOCHEM PARASIT, V15, P159, DOI 10.1016/0166-6851(85)90117-3; Perkins SL, 2009, J PARASITOL, V95, P424, DOI 10.1645/GE-1750.1; POWERS T, 1991, EMBO J, V10, P2203, DOI 10.1002/j.1460-2075.1991.tb07756.x; Raabe CA, 2010, NUCLEIC ACIDS RES, V38, P608, DOI 10.1093/nar/gkp895; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Rehkopf DH, 2000, MOL BIOCHEM PARASIT, V105, P91, DOI 10.1016/S0166-6851(99)00170-X; Rodnina MV, 2007, TRENDS BIOCHEM SCI, V32, P20, DOI 10.1016/j.tibs.2006.11.007; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; SCHNARE MN, 1990, J MOL BIOL, V215, P73, DOI 10.1016/S0022-2836(05)80096-8; SCHNARE MN, 1986, J BIOL CHEM, V261, P5187; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Shukla GC, 1998, MOL BIOCHEM PARASIT, V95, P159, DOI 10.1016/S0166-6851(98)00098-X; Slamovits CH, 2007, J MOL BIOL, V372, P356, DOI 10.1016/j.jmb.2007.06.085; SLOOF P, 1985, NUCLEIC ACIDS RES, V13, P4171, DOI 10.1093/nar/13.11.4171; SPENCER DF, 1987, EMBO J, V6, P1063, DOI 10.1002/j.1460-2075.1987.tb04859.x; Staden R, 2000, Methods Mol Biol, V132, P115; Steitz TA, 2005, FEBS LETT, V579, P955, DOI 10.1016/j.febslet.2004.11.053; SUPLICK K, 1990, MOL CELL BIOL, V10, P6381, DOI 10.1128/MCB.10.12.6381; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0; Tu D, 2005, CELL, V121, P257, DOI 10.1016/j.cell.2005.02.005; TURMEL M, 1991, J MOL BIOL, V218, P293, DOI 10.1016/0022-2836(91)90713-G; VAIDYA AB, 1989, MOL BIOCHEM PARASIT, V35, P97, DOI 10.1016/0166-6851(89)90112-6; VANETTEN RA, 1983, J BIOL CHEM, V258, P104; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; WHITE TC, 1986, NUCLEIC ACIDS RES, V14, P9471, DOI 10.1093/nar/14.23.9471; Wilson RJM, 1997, MICROBIOL MOL BIOL R, V61, P1; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	86	76	77	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38320	10.1371/journal.pone.0038320	http://dx.doi.org/10.1371/journal.pone.0038320			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761677	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900008
J	Goggins, WB; Chan, EYY; Ng, E; Ren, C; Chen, L				Goggins, William B.; Chan, Emily Y. Y.; Ng, Edward; Ren, Chao; Chen, Liang			Effect Modification of the Association between Short-term Meteorological Factors and Mortality by Urban Heat Islands in Hong Kong	PLOS ONE			English	Article							UNITED-STATES; TEMPERATURE; CITIES; WAVES; POLLUTION; WEATHER; MODELS; HEALTH; COLD	Background: Prior studies from around the world have indicated that very high temperatures tend to increase summertime mortality. However possible effect modification by urban micro heat islands has only been examined by a few studies in North America and Europe. This study examined whether daily mortality in micro heat island areas of Hong Kong was more sensitive to short term changes in meteorological conditions than in other areas. Method: An urban heat island index (UHII) was calculated for each of Hong Kong's 248 geographical tertiary planning units (TPU). Daily counts of all natural deaths among Hong Kong residents were stratified according to whether the place of residence of the decedent was in a TPU with high (above the median) or low UHII. Poisson Generalized Additive Models (GAMs) were used to estimate the association between meteorological variables and mortality while adjusting for trend, seasonality, pollutants and flu epidemics. Analyses were restricted to the hot season (June-September). Results: Mean temperatures (lags 0-4) above 29 degrees C and low mean wind speeds (lags 0-4) were significantly associated with higher daily mortality and these associations were stronger in areas with high UHII. A 1 degrees C rise above 29 degrees C was associated with a 4.1% (95% confidence interval (CI): 0.7%, 7.6%) increase in natural mortality in areas with high UHII but only a 0.7% (95% CI: -2.4%, 3.9%) increase in low UHII areas. Lower mean wind speeds (5th percentile vs. 95th percentile) were associated with a 5.7% (95% CI: 2.7, 8.9) mortality increase in high UHII areas vs. a -0.3% (95% CI: -3.2%, 2.6%) change in low UHII areas. Conclusion: The results suggest that urban micro heat islands exacerbate the negative health consequences of high temperatures and low wind speeds. Urban planning measures designed to mitigate heat island effects may lessen the health effects of unfavorable summertime meteorological conditions.	[Goggins, William B.] Chinese Univ Hong Kong, Div Biostat, Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China; [Chan, Emily Y. Y.] Chinese Univ Hong Kong, Div Family Med, Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China; [Ng, Edward; Ren, Chao; Chen, Liang] Chinese Univ Hong Kong, Dept Architecture, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Goggins, WB (corresponding author), Chinese Univ Hong Kong, Div Biostat, Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China.	wgoggins@cuhk.edu.hk	REN, Chao/L-8938-2019; Chan, Emily Ying Yang/H-6849-2017	REN, Chao/0000-0002-8494-2585; Chan, Emily Ying Yang/0000-0002-8854-5093; Ng, Edward Y Y/0000-0002-2483-9922	Planning Department of the Hong Kong S.A.R. Government	Planning Department of the Hong Kong S.A.R. Government	Financial support for this study was provided by the Planning Department of the Hong Kong S.A.R. Government. Their URL is: http://www.pland.gov.hk/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Braga ALF, 2002, ENVIRON HEALTH PERSP, V110, P859, DOI 10.1289/ehp.02110859; Burkart K, 2011, ENVIRON POLLUT, V159, P2035, DOI 10.1016/j.envpol.2011.02.005; Carder M, 2005, OCCUP ENVIRON MED, V62, P702, DOI 10.1136/oem.2004.016394; Chan EYY, 2012, J EPIDEMIOL COMMUN H, V66, P322, DOI 10.1136/jech.2008.085167; Chen L, 2012, INT J CLIMATOL, V32, P121, DOI 10.1002/joc.2243; Cheng V, 2012, INT J BIOMETEOROL, V56, P43, DOI 10.1007/s00484-010-0396-z; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Gabriel KMA, 2011, ENVIRON POLLUT, V159, P2044, DOI 10.1016/j.envpol.2011.01.016; Hoppe P, 1999, INT J BIOMETEOROL, V43, P71, DOI 10.1007/s004840050118; Information Services Department Hong Kong S.A.R. Government, 2011, HONG KONG FACTS; Ishigami A, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-5; Kim YH, 2005, J APPL METEOROL, V44, P591, DOI 10.1175/JAM2226.1; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; Ng E, 2012, ENERG BUILDINGS, V55, P51, DOI 10.1016/j.enbuild.2011.09.025; Ng E, 2012, BUILD ENVIRON, V47, P256, DOI 10.1016/j.buildenv.2011.07.014; Ng E, 2011, LANDSCAPE URBAN PLAN, V101, P59, DOI 10.1016/j.landurbplan.2011.01.004; R Core Team, 2020, R LANG ENV STAT COMP; Smargiassi A, 2009, J EPIDEMIOL COMMUN H, V63, P659, DOI 10.1136/jech.2008.078147; Tan JG, 2010, INT J BIOMETEOROL, V54, P75, DOI 10.1007/s00484-009-0256-x; Vandentorren S, 2006, EUR J PUBLIC HEALTH, V16, P583, DOI 10.1093/eurpub/ckl063; Wong CM, 2008, ENVIRON HEALTH PERSP, V116, P1195, DOI 10.1289/ehp.11257; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	26	128	131	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38551	10.1371/journal.pone.0038551	http://dx.doi.org/10.1371/journal.pone.0038551			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	964XV	22761684	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900013
J	Hazelett, CC; Yeaman, C				Hazelett, C. Clayton; Yeaman, Charles			Sec5 and Exo84 Mediate Distinct Aspects of RalA-Dependent Cell Polarization	PLOS ONE			English	Article							EPITHELIAL-CELLS; TIGHT JUNCTIONS; SEC6/8 COMPLEX; EXOCYST; MIGRATION; MEMBRANE; SUBUNIT; METASTASIS; DELIVERY; GTPASES	Metastasis is a complex process during which several gross cellular changes occur. Cells must dissociate from the tumor mass and gain the ability to degrade extracellular matrix and migrate in order to ultimately attach and form a satellite tumor. Regulation of the actin cytoskeleton is an indispensible aspect of cell migration, and many different factors have been implicated in this process. We identified interactions between RalA and its effectors in the Exocyst complex as directly necessary for migration and invasion of prostate cancer tumor cells. Blocking RalA-Exocyst binding caused significant morphological changes and defects in single and coordinated cell migration.	[Hazelett, C. Clayton; Yeaman, Charles] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Hazelett, CC (corresponding author), Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA 52242 USA.	charles-yeaman@uiowa.edu	Yeaman, Charles A/A-1624-2009	Yeaman, Charles/0000-0001-6149-628X	National Institutes of Health [GM067002]; American Heart Association [11PRE5670009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067002] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM067002 to CY, (http://www.nigms.nih.gov/) and The American Heart Association 11PRE5670009 predoctoral fellowship to CH (http://www.heart.org/HEARTORG/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHTBUEHLER G, 1977, CELL, V11, P395, DOI 10.1016/0092-8674(77)90057-5; Blankenship JT, 2007, J CELL SCI, V120, P3099, DOI 10.1242/jcs.004770; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Chen XW, 2011, NAT CELL BIOL, V13, P580, DOI 10.1038/ncb2226; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Hazelett CC, 2011, MOL BIOL CELL, V22, P4787, DOI 10.1091/mbc.E11-07-0657; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Lalli G, 2009, J CELL SCI, V122, P1499, DOI 10.1242/jcs.044339; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Nelson WJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000513; NUSRAT A, 1995, P NATL ACAD SCI USA, V92, P10629, DOI 10.1073/pnas.92.23.10629; OKA H, 1993, CANCER RES, V53, P1696; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Parrini MC, 2011, MOL CELL, V42, P650, DOI 10.1016/j.molcel.2011.03.032; Ridley AJ, 2001, J CELL SCI, V114, P2713; Rosse C, 2006, MOL CELL BIOL, V26, P727, DOI 10.1128/MCB.26.2.727-734.2006; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Spiczka KS, 2008, J CELL SCI, V121, P2880, DOI 10.1242/jcs.031641; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; van Dam EM, 2006, INT J BIOCHEM CELL B, V38, P1841, DOI 10.1016/j.biocel.2006.04.006; Vega IE, 2001, J NEUROSCI, V21, P3839, DOI 10.1523/JNEUROSCI.21-11-03839.2001; White MA, 1996, J BIOL CHEM, V271, P16439, DOI 10.1074/jbc.271.28.16439	24	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39602	10.1371/journal.pone.0039602	http://dx.doi.org/10.1371/journal.pone.0039602			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761837	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900085
J	Munoz-Pareja, M; Leon-Munoz, LM; Guallar-Castillon, P; Graciani, A; Lopez-Garcia, E; Banegas, JR; Rodriguez-Artalejo, F				Munoz-Pareja, Maritza; Leon-Munoz, Luz M.; Guallar-Castillon, Pilar; Graciani, Auxiliadora; Lopez-Garcia, Esther; Banegas, Jose R.; Rodriguez-Artalejo, Fernando			The Diet of Diabetic Patients in Spain in 2008-2010: Accordance with the Main Dietary Recommendations-A Cross-Sectional Study	PLOS ONE			English	Article							MEDITERRANEAN DIET; US ADULTS; ADHERENCE; POPULATION; MELLITUS; COUNTRIES; HABITS; HEALTH; MEN	Background: No previous study has assessed the diet of the diabetic patients in the general population of an entire country in Europe. This study evaluates accordance of the diet of diabetic adults in Spain with nutritional recommendations of the European Association for the Study of Diabetes (EASD), American Diabetes Association (ADA), and the Mediterranean diet (MD). Methods and Findings: Cross-sectional study conducted in 2008-2010 among 12,948 persons representative of the population aged >= 18 years in Spain. Usual food consumption was assessed with a dietary history. EASD accordance was defined as >= 6 points on a score of 12 nutritional goals, ADA accordance as >= 3 points on a score of 6 goals, and MD accordance as >= 7 points on the Mediterranean Diet Adherence Screener. In the 609 diagnosed diabetic individuals, the diet was rich in saturated fat (11.2% of total energy), but trans fat intake was relatively low (1.1% energy) and monounsaturated fat intake was high (16.1% energy). Carbohydrate intake was relatively low (41.1% energy), but sugar intake was high (16.9% energy). Intake of cholesterol (322 mg/day) and sodium (3.1 g/day) was also high, while fiber intake was insufficient (23.8 g/day). EASD accordance was observed in 48.7% diabetic patients, ADA accordance in 46.3%, and MD accordance in 57.4%. The frequency of EASD, ADA and MD accordance was not statistically different between diagnosed and undiagnosed diabetic individuals. Conclusions: Only about half of diabetic patients in Spain have a diet that is consistent with the major dietary recommendations. The lack of dietary differences between diagnosed and undiagnosed diabetic individuals reflects deficiencies in diabetes management.	[Munoz-Pareja, Maritza; Leon-Munoz, Luz M.; Guallar-Castillon, Pilar; Graciani, Auxiliadora; Lopez-Garcia, Esther; Banegas, Jose R.; Rodriguez-Artalejo, Fernando] Univ Autonoma Madrid, CIBERESP, IdiPaz, Dept Med Prevent & Salud Publ, Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Munoz-Pareja, M (corresponding author), Univ Autonoma Madrid, CIBERESP, IdiPaz, Dept Med Prevent & Salud Publ, Madrid, Spain.	fernando.artalejo@uam.es	Guallar-Castillon, Pilar/F-1533-2016; León-Muñoz, Luz M/H-8275-2017; Lopez-Garcia, Esther/A-8894-2019; Graciani, Auxiliadora/D-8243-2013	Guallar-Castillon, Pilar/0000-0003-4759-6713; Leon-Munoz, Luz Maria/0000-0001-5447-5907; Graciani, Auxiliadora/0000-0002-6211-587X	Sanofi-Aventis; FIS [PI09/1626]; 'Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular'	Sanofi-Aventis(Sanofi-Aventis); FIS(Instituto de Salud Carlos III); 'Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular'	The ENRICA study is funded by Sanofi-Aventis. Additional funding is obtained from FIS grant PI09/1626 and from the 'Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular'. The ENRICA study is being run by an independent academic steering committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Associat, 2008, DIABETES CARE, V31, pS61, DOI 10.2337/dc08-S061; [Anonymous], 1997, Int J Epidemiol, V26 Suppl 1, pS91; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; [Anonymous], 1997, Int J Epidemiol, V26 Suppl 1, pS100; [Anonymous], 2009, STATA SURVEY DATA RE; Aromaa A, 2003, EUR J PUBLIC HEALTH, V13, P67, DOI 10.1093/eurpub/13.suppl_1.67; Banegas JR, 2002, J HYPERTENS, V20, P2157, DOI 10.1097/00004872-200211000-00014; *CAN DIAB ASS, 2008, CAN J DIABETES S1, V32, pS40; Connor H, 2003, DIABETIC MED, V20, P786, DOI 10.1046/j.1464-5491.2003.01104.x; Diez-Espino J, 2011, ANN NUTR METAB, V58, P74, DOI 10.1159/000324718; Eilat-Adar S, 2008, J NUTR, V138, P1699, DOI 10.1093/jn/138.9.1699; Esposito K, 2009, DIABETIC MED, V26, P900, DOI 10.1111/j.1464-5491.2009.02798.x; Esposito K, 2011, METAB SYNDR RELAT D, V9, P1, DOI 10.1089/met.2010.0031; Esposito K, 2010, DIABETES RES CLIN PR, V89, P97, DOI 10.1016/j.diabres.2010.04.019; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Garcia-Closas R, 2006, PUBLIC HEALTH NUTR, V9, P53, DOI 10.1079/PHN2005757; Guallar-Castillon P, 2012, NUTR METAB CARDIOVAS, V22, P192, DOI 10.1016/j.numecd.2010.06.004; Gutierrez-Fisac JL, 2012, OBES REV, V13, P388, DOI 10.1111/j.1467-789X.2011.00964.x; Helmer C, 2008, BRIT J NUTR, V99, P632, DOI 10.1017/S0007114507812050; Mann JI, 2004, NUTR METAB CARDIOVAS, V14, P373, DOI 10.1016/S0939-4753(04)80028-0; Manzano P, 2006, J DIABETES COMPLICAT, V20, P361, DOI 10.1016/j.jdiacomp.2005.09.003; Manzano P, 2004, DIABETES CARE, V27, P984, DOI 10.2337/diacare.27.4.984; Mellen PB, 2008, ARCH INTERN MED, V168, P308, DOI 10.1001/archinternmed.2007.119; Nothlings U, 2011, EUR J CLIN NUTR, V65, P635, DOI 10.1038/ejcn.2011.11; Ortega RM, 2005, BR J NUTR, V105, P787; Pols MA, 1997, INT J EPIDEMIOL, V26, pS181, DOI 10.1093/ije/26.suppl_1.S181; Resnick HE, 2006, DIABETES CARE, V29, P531, DOI 10.2337/diacare.29.03.06.dc05-1254; Rivellese AA, 2008, EUR J CLIN NUTR, V62, P660, DOI 10.1038/sj.ejcn.1602755; Rodriguez-Artalejo F, 2011, REV ESP CARDIOL, V64, P876, DOI 10.1016/j.recesp.2011.05.019; Salas-Salvado J, 2011, DIABETES CARE, V34, P14, DOI 10.2337/dc10-1288; Sayon-Orea C, 2011, NUTR METAB CARDIOVAS; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Serra-Majem L, 2007, PUBLIC HEALTH NUTR, V10, P1406, DOI 10.1017/S1368980007001012; Thanopoulou A, 2004, DIABETOLOGIA, V47, P367, DOI 10.1007/s00125-003-1316-0; Toeller M, 1996, DIABETOLOGIA, V39, P929; Tur JA, 2004, BRIT J NUTR, V92, P341, DOI 10.1079/BJN20041209; United States Departament of Agriculture, 2012, WHAT WE EAT AM; Varela-Moreiras G, 2010, EUR J CLIN NUTR, V64, pS37, DOI 10.1038/ejcn.2010.208; Virtanen SM, 2000, EUR J CLIN NUTR, V54, P181, DOI 10.1038/sj.ejcn.1600916; Willett W., 2012, NUTR EPIDEMIOLOGY	40	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39454	10.1371/journal.pone.0039454	http://dx.doi.org/10.1371/journal.pone.0039454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745757	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900062
J	Zhang, XH; Ma, J; Wu, KN; Chan, AT; Fuchs, CS; Giovannucci, EL				Zhang, Xuehong; Ma, Jing; Wu, Kana; Chan, Andrew T.; Fuchs, Charles S.; Giovannucci, Edward L.			Blood Donation and Colorectal Cancer Incidence and Mortality in Men	PLOS ONE			English	Article							BODY IRON STORES; HEME IRON; ALCOHOL-CONSUMPTION; DIETARY IRON; COLON-CANCER; RISK; HEMOCHROMATOSIS; ASSOCIATION; ZINC; DISEASE	Background: Although blood donations may reduce body iron stores, to date, prospective data on frequent blood donation and colorectal cancer risk are limited. Methodology/Principal Findings: We tested whether frequent blood donation is associated with a lower risk of colorectal cancer in the Health Professionals Follow-up Study. We prospectively followed 35,121 men who provide the information on lifetime number of blood donations in 1992 through 2008. Serum ferritin levels were measured in a random sample of 305 men. Cox proportional hazard regression models were used to calculate the multivariable relative risks (RRs, 95% CIs) after adjusting for age and other established colorectal cancer risk factors. We documented 684 incident colorectal cancer cases and 224 deaths from colorectal cancer. The mean serum ferritin levels varied from 178 mg/L for men who did not donate blood to 98 mg/L for men who had at least 30 donations. Age-adjusted results for both incidence and mortality were essentially the same as the multivariable-adjusted results. Comparing with non-donors, the multivariable RRs (95% CIs) for colorectal cancer incidence were 0.92 (0.77, 1.11) for 1-5 donation, 0.85 (0.64, 1.11) for 6-9 donations, 0.96 (0.73, 1.26) for 10-19 donations, 0.91 (0.63, 1.32) for 20-29 donations, and 0.97 (0.68, 1.38) for at least 30 donations (P-trend = 0.92). The multivariable RRs for colorectal cancer mortality were 0.99 (0.72, 1.36) for 1-5 donation, 0.93 (0.57, 1.51) for 6-9 donations, 0.85 (0.50, 1.42) for 10-19 donations, and 1.14 (0.72, 1.83) for at least 20 donations (P-trend = 0.82). The results did not vary by cancer sub-sites, intake levels of total iron, heme iron, or family history of colorectal cancer. Conclusions/Significance: Frequent blood donations were not associated with colorectal cancer incidence and mortality in men. Our results do not support an important role of body iron stores in colorectal carcinogenesis.	[Zhang, Xuehong; Ma, Jing; Chan, Andrew T.; Fuchs, Charles S.; Giovannucci, Edward L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; [Wu, Kana; Giovannucci, Edward L.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Chan, Andrew T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA USA; [Fuchs, Charles S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Giovannucci, Edward L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Zhang, XH (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA.	xuehong.zhang@channing.harvard.edu	Chan, Andrew T/P-8293-2014	Chan, Andrew T/0000-0001-7284-6767	National Institutes of Health [CA55075]; NATIONAL CANCER INSTITUTE [P01CA055075] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grant CA55075. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MA, 2003, CANCER DETECT PREV, V27, P116, DOI 10.1016/S0361-090X(03)00027-8; Altes A, 1999, HAEMATOLOGICA, V84, P479; Ascherio A, 2001, CIRCULATION, V103, P52; Balder HF, 2006, CANCER EPIDEM BIOMAR, V15, P717, DOI 10.1158/1055-9965.EPI-05-0772; Bastide NM, 2011, CANCER PREV RES, V4, P177, DOI 10.1158/1940-6207.CAPR-10-0113; BRADBEAR RA, 1985, J NATL CANCER I, V75, P81; Chan AT, 2005, JNCI-J NATL CANCER I, V97, P917, DOI 10.1093/jnci/dji165; COX DR, 1972, J R STAT SOC B, V34, P187; Cross AJ, 2006, INT J CANCER, V118, P3147, DOI 10.1002/ijc.21780; Cross AJ, 2003, CANCER RES, V63, P2358; Cross AJ, 2010, CANCER RES, V70, P2406, DOI 10.1158/0008-5472.CAN-09-3929; CUSTER EM, 1995, J LAB CLIN MED, V126, P88; Edgren G, 2008, J NATL CANCER I, V100, P572, DOI 10.1093/jnci/djn084; Edgren G, 2007, TRANSFUSION, V47, P2017, DOI 10.1111/j.1537-2995.2007.01425.x; FINCH CA, 1977, BLOOD, V50, P441; FREUDENHEIM JL, 1990, AM J EPIDEMIOL, V131, P612, DOI 10.1093/oxfordjournals.aje.a115545; HALLIWELL B, 1986, ARCH BIOCHEM BIOPHYS, V246, P501, DOI 10.1016/0003-9861(86)90305-X; HANN HWL, 1988, CANCER RES, V48, P4168; Huang X, 2003, MUTAT RES-FUND MOL M, V533, P153, DOI 10.1016/j.mrfmmm.2003.08.023; Kabat GC, 2007, BRIT J CANCER, V97, P118, DOI 10.1038/sj.bjc.6603837; Kato I, 1999, INT J CANCER, V80, P693, DOI 10.1002/(SICI)1097-0215(19990301)80:5&lt;693::AID-IJC11&gt;3.0.CO;2-G; KNEKT P, 1994, INT J CANCER, V56, P379, DOI 10.1002/ijc.2910560315; Larsson SC, 2005, J NATL CANCER I, V97, P232, DOI 10.1093/jnci/dji032; LASEK W, 1994, TRANSFUSION, V34, P359, DOI 10.1046/j.1537-2995.1994.34494233589.x; Lee DH, 2004, JNCI-J NATL CANCER I, V96, P403, DOI 10.1093/jnci/djh047; Macdonald GA, 1999, J GASTROEN HEPATOL, V14, P1188, DOI 10.1046/j.1440-1746.1999.02027.x; MERK K, 1990, INT J EPIDEMIOL, V19, P505, DOI 10.1093/ije/19.3.505; NELSON RL, 1995, CANCER, V76, P875, DOI 10.1002/1097-0142(19950901)76:5<875::AID-CNCR2820760523>3.0.CO;2-Q; Nelson RL, 2001, NUTR REV, V59, P140, DOI 10.1111/j.1753-4887.2001.tb07002.x; PUCKETT CD, 1986, ED ANNOTATION ICD 9, V1; Sesink ALA, 1999, CANCER RES, V59, P5704; Shaheen NJ, 2003, JNCI-J NATL CANCER I, V95, P154, DOI 10.1093/jnci/95.2.154; VANASPEREN IA, 1995, INT J EPIDEMIOL, V24, P665; Wei EK, 2004, INT J CANCER, V108, P433, DOI 10.1002/ijc.11540; Willett W., 2012, NUTR EPIDEMIOLOGY; Wurzelmann JI, 1996, CANCER EPIDEM BIOMAR, V5, P503; Zacharski LR, 2008, JNCI-J NATL CANCER I, V100, P996, DOI 10.1093/jnci/djn209; Zacharski LR, 2000, AM HEART J, V140, P98, DOI 10.1067/mhj.2000.106646; Zhang XH, 2011, CANCER CAUSE CONTROL, V22, P1627, DOI 10.1007/s10552-011-9839-z	39	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39319	10.1371/journal.pone.0039319	http://dx.doi.org/10.1371/journal.pone.0039319			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761761	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900042
J	Kurth, A; Kohl, C; Brinkmann, A; Ebinger, A; Harper, JA; Wang, LF; Muhldorfer, K; Wibbelt, G				Kurth, Andreas; Kohl, Claudia; Brinkmann, Annika; Ebinger, Arnt; Harper, Jennifer A.; Wang, Lin-Fa; Muehldorfer, Kristin; Wibbelt, Gudrun			Novel Paramyxoviruses in Free-Ranging European Bats	PLOS ONE			English	Article							FRUIT BATS; NIPAH VIRUS; PTEROPID BATS; HENDRA VIRUS; INFECTION; GENOME; RESERVOIRS; INFERENCE; SEQUENCE; MRBAYES	The zoonotic potential of paramyxoviruses is particularly demonstrated by their broad host range like the highly pathogenic Hendra and Nipah viruses originating from bats. But while so far all bat-borne paramyxoviruses have been identified in fruit bats across Africa, Australia, South America, and Asia, we describe the detection and characterization of the first paramyxoviruses in free-ranging European bats. Moreover, we examined the possible impact of paramyxovirus infection on individual animals by comparing histo-pathological findings and virological results. Organs from deceased insectivorous bats of various species were sampled in Germany and tested for paramyxovirus RNA in parallel to a histo-pathological examination. Nucleic acids of three novel paramyxoviruses were detected, two viruses in phylogenetic relationship to the recently proposed genus Jeilongvirus and one closely related to the genus Rubulavirus. Two infected animals revealed subclinical pathological changes within their kidneys, suggestive of a similar pathogenesis as the one described in fruit bats experimentally infected with Hendra virus. Our findings indicate the presence of bat-born paramyxoviruses in geographic areas free of fruit bat species and therefore emphasize a possible virus-host co-evolution in European bats. Since these novel viruses are related to the very distinct genera Rubulavirus and Jeilongvirus, a similarly broad genetic diversity among paramyxoviruses in other Microchiroptera compared to Megachiroptera can be assumed. Given that the infected bats were either found in close proximity to heavily populated human habitation or areas of intensive agricultural use, a potential risk of the emergence of zoonotic paramyxoviruses in Europe needs to be considered.	[Kurth, Andreas; Kohl, Claudia; Brinkmann, Annika; Ebinger, Arnt] Robert Koch Inst, Ctr Biol Secur, Berlin, Germany; [Harper, Jennifer A.; Wang, Lin-Fa] CSIRO Livestock Ind, Australian Anim Hlth Lab, Melbourne, Vic, Australia; [Muehldorfer, Kristin; Wibbelt, Gudrun] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany	Robert Koch Institute; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Leibniz Institut fur Zoo und Wildtierforschung	Kurth, A (corresponding author), Robert Koch Inst, Ctr Biol Secur, Berlin, Germany.	KurthA@rki.de	wang, lin/GSE-3040-2022	kohl, claudia/0000-0002-1480-8911; Wang, Lin-Fa/0000-0003-2752-0535	Konrad Adenauer Foundation; Isler-Stiftung; Clara-Samariter-Stiftung; FAZIT-Stiftung	Konrad Adenauer Foundation; Isler-Stiftung; Clara-Samariter-Stiftung; FAZIT-Stiftung	Funding was provided by the Konrad Adenauer Foundation (fellowship to CK) and by the Isler-Stiftung, Clara-Samariter-Stiftung and FAZIT-Stiftung (KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida FC, 2009, MOL PHYLOGENET EVOL, V53, P772, DOI 10.1016/j.ympev.2009.07.035; Bowden TR, 2012, J GEN VIROL, V93, P1007, DOI 10.1099/vir.0.038448-0; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Chua KB, 2001, VIROLOGY, V283, P215, DOI 10.1006/viro.2000.0882; Cleaveland S, 2007, CURR TOP MICROBIOL, V315, P85; COBB BD, 1994, NUCLEIC ACIDS RES, V22, P3801, DOI 10.1093/nar/22.18.3801; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Halpin K, 1999, VET MICROBIOL, V68, P83, DOI 10.1016/S0378-1135(99)00063-2; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; HENDERSON GW, 1995, J GEN VIROL, V76, P2509, DOI 10.1099/0022-1317-76-10-2509; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jack PJM, 2005, J VIROL, V79, P10690, DOI 10.1128/JVI.79.16.10690-10700.2005; Johara MY, 2001, EMERG INFECT DIS, V7, P439; Lamb RA., 2005, VIRUS TAXONOMY, P655; Lau SKP, 2010, VIROLOGY, V404, P106, DOI 10.1016/j.virol.2010.03.049; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li Z, 2006, VIROLOGY, V346, P219, DOI 10.1016/j.virol.2005.10.039; McCarthy AJ, 2010, INFECT GENET EVOL, V10, P97, DOI 10.1016/j.meegid.2009.11.002; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; Muhldorfer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029773; Muhldorfer K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-61; PAVRI KM, 1971, AM J TROP MED HYG, V20, P125, DOI 10.4269/ajtmh.1971.20.125; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sonntag M, 2009, EMERG INFECT DIS, V15, P2052, DOI 10.3201/eid1512.090646; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Wibbelt Gudrun, 2009, P775; Williamson MM, 2000, J COMP PATHOL, V122, P201, DOI 10.1053/jcpa.1999.0364; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Young PL, 1996, EMERG INFECT DIS, V2, P239, DOI 10.3201/eid0203.960315	36	46	46	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38688	10.1371/journal.pone.0038688	http://dx.doi.org/10.1371/journal.pone.0038688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737217	Green Published, gold			2022-12-27	WOS:000305695100016
J	Paakkanen, R; Vauhkonen, H; Eronen, KT; Jarvinen, A; Seppanen, M; Lokki, ML				Paakkanen, Riitta; Vauhkonen, Hanna; Eronen, Katja T.; Jarvinen, Asko; Seppanen, Mikko; Lokki, Marja-Liisa			Copy Number Analysis of Complement C4A, C4B and C4A Silencing Mutation by Real-Time Quantitative Polymerase Chain Reaction	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; COMPONENTS C4A; RCCX MODULES; NULL ALLELES; RISK-FACTORS; DEFICIENCY; GENE; POLYMORPHISM; DISEASE; POPULATIONS	Low protein levels and copy number variation (CNV) of the fourth component of human complement (C4A and C4B) have been associated with various diseases. High-throughput methods for analysing C4 CNV are available, but they commonly do not detect the most common C4A mutation, a silencing CT insertion (CTins) leading to low protein levels. We developed a SYBR (R) Green labelled real-time quantitative polymerase chain reaction (qPCR) with a novel concentration range approach to address C4 CNV and deficiencies due to CTins. This method was validated in three sample sets and applied to over 1600 patient samples. CTins caused C4A deficiency in more than 70% (76/105) of the carriers. Twenty per cent (76/381) of patients with a C4A deficiency would have been erroneously recorded as having none, if the CTins had not been assessed. C4A deficiency was more common in patients than a healthy reference population, (OR = 1.60, 95%CI = 1.02-2.52, p = 0.039). The number of functional C4 genes can be straightforwardly analyzed by real-time qPCR, also with SYBR (R) Green labelling. Determination of CTins increases the frequency of C4A deficiency and thus helps to elucidate the genotypic versus phenotypic disease associations.	[Paakkanen, Riitta; Vauhkonen, Hanna; Eronen, Katja T.; Lokki, Marja-Liisa] Univ Helsinki, Transplantat Lab, Haartman Inst, Helsinki, Finland; [Paakkanen, Riitta] Univ Helsinki, Cent Hosp, Hosp Dist Helsinki & Uusimaa, Div Cardiol,Dept Med, Helsinki, Finland; [Jarvinen, Asko; Seppanen, Mikko] Univ Helsinki, Cent Hosp, Hosp Dist Helsinki & Uusimaa, Div Infect Dis,Dept Med, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Paakkanen, R (corresponding author), Univ Helsinki, Transplantat Lab, Haartman Inst, Helsinki, Finland.	riitta.paakkanen@helsinki.fi		Seppanen, Mikko/0000-0001-9733-3650	Finnish Foundation for Cardiovascular Research [DW3534297325]; Foundation for Paediatric Research; Maud Kuistila Foundation; Special Finnish Governmental Subsidy for Health Sciences Research [TYH2009307]; Helsinki Biomedical Graduate School	Finnish Foundation for Cardiovascular Research; Foundation for Paediatric Research; Maud Kuistila Foundation; Special Finnish Governmental Subsidy for Health Sciences Research; Helsinki Biomedical Graduate School	RP and MLL are supported by Finnish Foundation for Cardiovascular Research (grant DW3534297325), MLL and MS by Foundation for Paediatric Research, Maud Kuistila Foundation and Special Finnish Governmental Subsidy for Health Sciences Research TYH2009307, and RP by Helsinki Biomedical Graduate School. No commercial sponsors took part in the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBA G, 1993, J CLIN INVEST, V91, P1681, DOI 10.1172/JCI116377; Blanchong CA, 2001, INT IMMUNOPHARMACOL, V1, P365, DOI 10.1016/S1567-5769(01)00019-4; Blanchong CA, 2000, J EXP MED, V191, P2183, DOI 10.1084/jem.191.12.2183; Boteva L, 2012, AM J HUM GENET, V90, P445, DOI 10.1016/j.ajhg.2012.01.012; Boteva L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022128; BRAUN L, 1990, J EXP MED, V171, P129, DOI 10.1084/jem.171.1.129; Chung EK, 2002, AM J HUM GENET, V71, P810, DOI 10.1086/342778; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Fernando MMA, 2010, HUM MUTAT, V31, P866, DOI 10.1002/humu.21259; Gouas L, 2008, PATHOL BIOL, V56, P345, DOI 10.1016/j.patbio.2008.03.010; Hohler T, 2002, J HEPATOL, V37, P387, DOI 10.1016/S0168-8278(02)00205-2; Ittiprasert W, 2005, J AUTOIMMUN, V25, P77, DOI 10.1016/j.jaut.2005.04.004; Kainulainen L, 2012, HUM IMMUNOL, V73, P498, DOI 10.1016/j.humimm.2012.02.015; Lee JH, 2008, CYTOGENET GENOME RES, V123, P333, DOI 10.1159/000184725; Lokki ML, 1999, J IMMUNOL, V162, P3687; Mougey R, 2010, Immunohematology, V26, P30; Paakkanen R, 2012, ATHEROSCLEROSIS, V221, P461, DOI 10.1016/j.atherosclerosis.2012.01.024; Puah SM, 2007, LUPUS, V16, P750, DOI 10.1177/0961203307079454; Samano Eliana Sueco Tibana, 2004, Rev. Hosp. Clin., V59, P138, DOI 10.1590/S0041-87812004000300009; Scheurer Michael E, 2007, Infect Agent Cancer, V2, P8, DOI 10.1186/1750-9378-2-8; Senbagavalli P, 2011, HUM IMMUNOL, V72, P173, DOI 10.1016/j.humimm.2010.11.002; Seppanen M, 2007, SCAND J IMMUNOL, V65, P176, DOI 10.1111/j.1365-3083.2006.01886.x; SIM E, 1986, BIOCHEM J, V239, P763, DOI 10.1042/bj2390763; Sullivan KE, 1999, J RHEUMATOL, V26, P2144; Szilagyi A, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-1; Szilagyi A, 2008, CYTOGENET GENOME RES, V123, P118, DOI 10.1159/000184699; Wennerstrom A, 2012, HUM IMMUNOL, V73, P93, DOI 10.1016/j.humimm.2011.10.016; Wouters D, 2009, MOL IMMUNOL, V46, P592, DOI 10.1016/j.molimm.2008.07.028; Wu YL, 2009, GENES IMMUN, V10, P433, DOI 10.1038/gene.2009.10; Wu YL, 2008, CYTOGENET GENOME RES, V123, P131, DOI 10.1159/000184700; Wu YL, 2007, J IMMUNOL, V179, P3012, DOI 10.4049/jimmunol.179.5.3012; YU CY, 1986, EMBO J, V5, P2873, DOI 10.1002/j.1460-2075.1986.tb04582.x; YU CY, 1991, J IMMUNOL, V146, P1057; Zafar GI, 2009, J UROLOGY, V181, P1028, DOI 10.1016/j.juro.2008.11.013; ZHANG WJ, 1988, HUM IMMUNOL, V21, P165, DOI 10.1016/0198-8859(88)90068-7	35	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38813	10.1371/journal.pone.0038813	http://dx.doi.org/10.1371/journal.pone.0038813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737222	Green Published, gold, Green Submitted			2022-12-27	WOS:000305695100020
J	Halvorsen, MB; Casper, BM; Woodley, CM; Carlson, TJ; Popper, AN				Halvorsen, Michele B.; Casper, Brandon M.; Woodley, Christa M.; Carlson, Thomas J.; Popper, Arthur N.			Threshold for Onset of Injury in Chinook Salmon from Exposure to Impulsive Pile Driving Sounds	PLOS ONE			English	Article							NOISE; BAROTRAUMA; SEVERITY; TRAUMA	The risk of effects to fishes and other aquatic life from impulsive sound produced by activities such as pile driving and seismic exploration is increasing throughout the world, particularly with the increased exploitation of oceans for energy production. At the same time, there are few data that provide insight into the effects of these sounds on fishes. The goal of this study was to provide quantitative data to define the levels of impulsive sound that could result in the onset of barotrauma to fish. A High Intensity Controlled Impedance Fluid filled wave Tube was developed that enabled laboratory simulation of high-energy impulsive sound that were characteristic of aquatic far-field, plane-wave acoustic conditions. The sounds used were based upon the impulsive sounds generated by an impact hammer striking a steel shell pile. Neutrally buoyant juvenile Chinook salmon (Oncorhynchus tshawytscha) were exposed to impulsive sounds and subsequently evaluated for barotrauma injuries. Observed injuries ranged from mild hematomas at the lowest sound exposure levels to organ hemorrhage at the highest sound exposure levels. Frequency of observed injuries were used to compute a biological response weighted index (RWI) to evaluate the physiological impact of injuries at the different exposure levels. As single strike and cumulative sound exposure levels (SELss, SELcum respectively) increased, RWI values increased. Based on the results, tissue damage associated with adverse physiological costs occurred when the RWI was greater than 2. In terms of sound exposure levels a RWI of 2 was achieved for 1920 strikes by 177 dB re 1 mu Pa-2.s SELss yielding a SELcum of 210 dB re 1 mu Pa-2.s, and for 960 strikes by 180 dB re 1 mu Pa-2.s SELss yielding a SELcum of 210 dB re 1 mu Pa-2.s. These metrics define thresholds for onset of injury in juvenile Chinook salmon.	[Halvorsen, Michele B.; Woodley, Christa M.; Carlson, Thomas J.] Pacific NW Natl Lab, Marine Sci Lab, Sequim, WA USA; [Halvorsen, Michele B.; Casper, Brandon M.; Popper, Arthur N.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; University System of Maryland; University of Maryland College Park	Halvorsen, MB (corresponding author), Pacific NW Natl Lab, Marine Sci Lab, Sequim, WA USA.	Michele.halvorsen@pnnl.gov		Woodley, Christa M./0000-0003-1566-0450	Bureau of Ocean Energy Management, (BOEM); California Department of Transportation (Caltrans); National Cooperation of Highway Research Programs/Transportation Research Board (TRB) [NCHRP 25-28]	Bureau of Ocean Energy Management, (BOEM); California Department of Transportation (Caltrans); National Cooperation of Highway Research Programs/Transportation Research Board (TRB)	Funders for this project were: Bureau of Ocean Energy Management, (BOEM -formerly Minerals Management Service), California Department of Transportation (Caltrans), National Cooperation of Highway Research Programs (NCHRP 25-28)/Transportation Research Board (TRB). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2005, FINAL REPORT MONITOR, P1; Bolle LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033052; Brown RS, 2009, T AM FISH SOC, V138, P1285, DOI 10.1577/T08-122.1; Burns K. M., 2008, 1176 MOT MAR LAB; Burns KM, 2009, THESIS U S FLORIDA T, P1; Caltrans, 2010, EFF PIL DRIV SOUND J; Caltrans, 2002, BIOL ASS BEN MART NE, P1; Carlson T.E., 2011, INT C HIGH PERF COMP, V12, P1, DOI DOI 10.1145/2063384.2063454; Carlson TJ, 2007, THESIS CALIFORNIA DE; Champion H R, 2002, Scand J Surg, V91, P12; Chawda MN, 2004, INJURY, V35, P347, DOI 10.1016/S0020-1383(03)00140-2; Davis RI, 2009, EAR HEARING, V30, P628, DOI 10.1097/AUD.0b013e3181b527a8; Gaspin JB, 1975, EXPT INVESTIGATIONS, P1; Halvorsen MB, 2011, NCHRP RES RES DIG NA, P1; Halvorsen MB, 2011, 20787 PNNL USDA, P1; Hamernik RP, 2003, J ACOUST SOC AM, V114, P386, DOI 10.1121/1.1582446; Husum Hans, 2002, Prehosp Disaster Med, V17, P27; Iwama GK, 1997, FISH STRESS HLTH AQU, P13; KRISCHER JP, 1979, HEALTH SERV RES, V14, P56; Lewis TN, 1998, J ACOUST SOC AM, V103, P2756; MacGillivray A, 2005, SOUND PRESSURE PARTI, P1; Marty G. D., 2010, NECR HIST STEELH TRO; Nedwell J, 2005, 633R0115 PMSS, P1; Nedwell JR, 2006, J ACOUST SOC AM, V120, P2550, DOI 10.1121/1.2335573; Oyetunji T, 2010, J SURG RES, V159, P627, DOI 10.1016/j.jss.2009.08.026; Popper AN, 2009, J FISH BIOL, V75, P455, DOI 10.1111/j.1095-8649.2009.02319.x; ROBERTO M, 1985, J ACOUST SOC AM, V77, P1514, DOI 10.1121/1.391993; Rogers PH, 2008, BIOACOUSTICS, V17, P331; Ruggerone G.T., 2008, BEHAV RESPONSE SURVI; Stadler JH, 2009, ASSESSING EFFECTS FI; Stephenson JR, 2010, FISH RES, V106, P271, DOI 10.1016/j.fishres.2010.08.006; Woodbury D, 2008, BIOACOUSTICS, V17, P289, DOI DOI 10.1080/09524622.2008.9753852	32	71	73	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38968	10.1371/journal.pone.0038968	http://dx.doi.org/10.1371/journal.pone.0038968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745695	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693200034
J	Klarer, AC; Stallons, LJ; Burke, TJ; Skaggs, RL; McGregor, WG				Klarer, Alden C.; Stallons, L. Jay; Burke, Tom J.; Skaggs, Robert L.; McGregor, W. Glenn			DNA Polymerase Eta Participates in the Mutagenic Bypass of Adducts Induced by Benzo[a]pyrene Diol Epoxide in Mammalian Cells	PLOS ONE			English	Article							PIGMENTOSUM VARIANT CELLS; XERODERMA-PIGMENTOSUM; ERROR-FREE; INDUCED MUTATIONS; DEOXYGUANOSINE ADDUCTS; TRANSLESION SYNTHESIS; UV PHOTOPRODUCTS; EXCISION REPAIR; HPRT GENE; ZETA	Y-family DNA-polymerases have larger active sites that can accommodate bulky DNA adducts allowing them to bypass these lesions during replication. One member, polymerase eta (pol eta), is specialized for the bypass of UV-induced thymidine-thymidine dimers, correctly inserting two adenines. Loss of pol eta function is the molecular basis for xeroderma pigmentosum (XP) variant where the accumulation of mutations results in a dramatic increase in UV-induced skin cancers. Less is known about the role of pol eta in the bypass of other DNA adducts. A commonly encountered DNA adduct is that caused by benzo[a]pyrene diol epoxide (BPDE), the ultimate carcinogenic metabolite of the environmental chemical benzo[a]pyrene. Here, treatment of pol eta-deficient fibroblasts from humans and mice with BPDE resulted in a significant decrease in Hprt gene mutations. These studies in mammalian cells support a number of in vitro reports that purified pol eta has error-prone activity on plasmids with site-directed BPDE adducts. Sequencing the Hprt gene from this work shows that the majority of mutations are G > T transversions. These data suggest that pol eta has error-prone activity when bypassing BPDE-adducts. Understanding the basis of environmental carcinogen-derived mutations may enable prevention strategies to reduce such mutations with the intent to reduce the number of environmentally relevant cancers.	[Klarer, Alden C.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Klarer, Alden C.; McGregor, W. Glenn] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Burke, Tom J.] Univ Louisville, Dept Med, Div Gastroenterol Hepatol & Nutr, Louisville, KY 40292 USA; [Stallons, L. Jay; Skaggs, Robert L.; McGregor, W. Glenn] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Klarer, AC (corresponding author), Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA.	stallons@musc.edu			USPHS [T32-ES011564];  [F30-ES017730];  [R01-CA112197];  [R03-CA112664]; NATIONAL CANCER INSTITUTE [R03CA112664, R01CA112197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES011564, F30ES017730] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partially supported by USPHS Grant T32-ES011564, by a predoctoral fellowship to LJS, F30-ES017730 to ACK, and by R01-CA112197 and R03-CA112664 to WGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avkin S, 2004, J BIOL CHEM, V279, P53298, DOI 10.1074/jbc.M409155200; Broughton BC, 2002, P NATL ACAD SCI USA, V99, P815, DOI 10.1073/pnas.022473899; Chiapperino D, 2002, J BIOL CHEM, V277, P11765, DOI 10.1074/jbc.M112139200; Chiapperino D, 2005, J BIOL CHEM, V280, P39684, DOI 10.1074/jbc.M508008200; COSMAN M, 1992, P NATL ACAD SCI USA, V89, P1914, DOI 10.1073/pnas.89.5.1914; CROW JF, 1995, EXP CLIN IMMUNOGENET, V12, P121; Diaz M, 2003, MOL CANCER RES, V1, P836; Dreij K, 2005, CHEM RES TOXICOL, V18, P655, DOI 10.1021/tx0497090; Dumstorf CA, 2006, P NATL ACAD SCI USA, V103, P18083, DOI 10.1073/pnas.0605247103; Dumstorf CA, 2009, MOL CANCER RES, V7, P247, DOI 10.1158/1541-7786.MCR-08-0399; Gueranger Q, 2008, DNA REPAIR, V7, P1551, DOI 10.1016/j.dnarep.2008.05.012; Hashimoto K, 2012, J BIOL CHEM, V287, P9613, DOI 10.1074/jbc.M111.331728; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Lin QC, 2006, CANCER RES, V66, P87, DOI 10.1158/0008-5472.CAN-05-1862; MAHER VM, 1976, NATURE, V261, P593, DOI 10.1038/261593a0; McDonald JP, 2003, J EXP MED, V198, P635, DOI 10.1084/jem.20030767; Neal JA, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-97; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Ogi T, 2001, GENES CELLS, V6, P943, DOI 10.1046/j.1365-2443.2001.00478.x; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Ouellette MM, 2000, HUM MOL GENET, V9, P403, DOI 10.1093/hmg/9.3.403; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Rechkoblit O, 2002, J BIOL CHEM, V277, P30488, DOI 10.1074/jbc.M201167200; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Simhadri S, 2002, MUTAT RES-FUND MOL M, V508, P137, DOI 10.1016/S0027-5107(02)00211-7; Tung BS, 1996, MUTAT RES-DNA REPAIR, V362, P65, DOI 10.1016/0921-8777(95)00034-8; Wang Y, 2007, CANCER RES, V67, P3018, DOI 10.1158/0008-5472.CAN-06-3073; Washington MT, 2001, P NATL ACAD SCI USA, V98, P8355, DOI 10.1073/pnas.121007298; WATANABE M, 1985, MUTAT RES, V146, P285, DOI 10.1016/0167-8817(85)90070-7; Xie ZW, 2003, BIOCHEMISTRY-US, V42, P11253, DOI 10.1021/bi0346704; YANG LL, 1980, P NATL ACAD SCI-BIOL, V77, P5933, DOI 10.1073/pnas.77.10.5933; YANG LL, 1982, MUTAT RES, V94, P435, DOI 10.1016/0027-5107(82)90306-2; Zhang YB, 2002, DNA REPAIR, V1, P559, DOI 10.1016/S1568-7864(02)00055-1; Zhao B, 2006, NUCLEIC ACIDS RES, V34, P417, DOI 10.1093/nar/gkj446	34	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39596	10.1371/journal.pone.0039596	http://dx.doi.org/10.1371/journal.pone.0039596			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745795	Green Submitted, gold, Green Published			2022-12-27	WOS:000305693200092
J	Su, YL; Li, JM; Li, M; Luan, JB; Ye, XD; Wang, XW; Liu, SS				Su, Yun-Lin; Li, Jun-Min; Li, Meng; Luan, Jun-Bo; Ye, Xiao-Dong; Wang, Xiao-Wei; Liu, Shu-Sheng			Transcriptomic Analysis of the Salivary Glands of an Invasive Whitefly	PLOS ONE			English	Article							LEAF CURL VIRUS; TABACI HEMIPTERA ALEYRODIDAE; NUCLEOTIDE EXCHANGE FACTOR; PHLOEM-FEEDING INSECTS; BEMISIA-TABACI; GENE-EXPRESSION; BLOODSUCKING BUG; SINGLE-CELL; RNA-SEQ; BEGOMOVIRUS TRANSMISSION	Background: Some species of the whitefly Bemisia tabaci complex cause tremendous losses to crops worldwide through feeding directly and virus transmission indirectly. The primary salivary glands of whiteflies are critical for their feeding and virus transmission. However, partly due to their tiny size, research on whitefly salivary glands is limited and our knowledge on these glands is scarce. Methodology/Principal Findings: We sequenced the transcriptome of the primary salivary glands of the Mediterranean species of B. tabaci complex using an effective cDNA amplification method in combination with short read sequencing (Illumina). In a single run, we obtained 13,615 unigenes. The quantity of the unigenes obtained from the salivary glands of the whitefly is at least four folds of the salivary gland genes from other plant-sucking insects. To reveal the functions of the primary glands, sequence similarity search and comparisons with the whole transcriptome of the whitefly were performed. The results demonstrated that the genes related to metabolism and transport were significantly enriched in the primary salivary glands. Furthermore, we found that a number of highly expressed genes in the salivary glands might be involved in secretory protein processing, secretion and virus transmission. To identify potential proteins of whitefly saliva, the translated unigenes were put into secretory protein prediction. Finally, 295 genes were predicted to encode secretory proteins and some of them might play important roles in whitefly feeding. Conclusions/Significance:: The combined method of cDNA amplification, Illumina sequencing and de novo assembly is suitable for transcriptomic analysis of tiny organs in insects. Through analysis of the transcriptome, genomic features of the primary salivary glands were dissected and biologically important proteins, especially secreted proteins, were predicted. Our findings provide substantial sequence information for the primary salivary glands of whiteflies and will be the basis for future studies on whitefly-plant interactions and virus transmission.	[Su, Yun-Lin; Luan, Jun-Bo; Ye, Xiao-Dong; Wang, Xiao-Wei; Liu, Shu-Sheng] Zhejiang Univ, Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Jun-Min] Zhejiang Acad Agr Sci, Inst Virol & Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Li, Meng] Luoyang Entry Exit Inspect & Quarantine Bur, State Key Lab Identificat & Quarantine Peony Germ, Luoyang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; Zhejiang Academy of Agricultural Sciences	Su, YL (corresponding author), Zhejiang Univ, Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou 310003, Zhejiang, Peoples R China.	xwwang@zju.edu.cn; shshliu@zju.edu.cn	Liu, Shu-Sheng/D-2300-2013	Li, Junmin/0000-0002-8385-8912	National Natural Science Foundation of China [31171848, 31021003]; Zhejiang Provincial Natural Science Foundation [Y3100185]; National Basic Research Program of China [2009CB119203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); National Basic Research Program of China(National Basic Research Program of China)	Financial support for this study was provided by the National Natural Science Foundation of China (Project 31171848, 31021003), the Zhejiang Provincial Natural Science Foundation (Project Y3100185) and the National Basic Research Program of China (Project 2009CB119203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; BAUMANN L, 1995, ENTOMOL EXP APPL, V77, P57, DOI 10.1007/BF02383018; Berdiales B, 1999, EUR J PLANT PATHOL, V105, P211, DOI 10.1023/A:1008713629768; Blanc S, 2011, CURR OPIN MICROBIOL, V14, P483, DOI 10.1016/j.mib.2011.07.008; Blow N, 2009, NATURE, V458, P239, DOI 10.1038/458239a; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Bowman AS, 2004, PARASITOLOGY, V129, pS67, DOI 10.1017/S0031182004006468; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; BYRNE DN, 1991, ANNU REV ENTOMOL, V36, P431, DOI 10.1146/annurev.en.36.010191.002243; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Cherqui A, 2000, J INSECT PHYSIOL, V46, P1177, DOI 10.1016/S0022-1910(00)00037-8; Chung KT, 2002, J BIOL CHEM, V277, P47557, DOI 10.1074/jbc.M208377200; Cicero JM, 2011, ANN ENTOMOL SOC AM, V104, P280, DOI 10.1603/AN10171; Cicero JM, 2011, ANN ENTOMOL SOC AM, V104, P261, DOI 10.1603/AN10075; Cooper WR, 2010, ENVIRON ENTOMOL, V39, P223, DOI 10.1603/EN09079; Coudron TA, 2007, ARCH INSECT BIOCHEM, V66, P76, DOI 10.1002/arch.20200; Couldridge C, 2007, B ENTOMOL RES, V97, P523, DOI 10.1017/S0007485307005160; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Francischetti IMB, 2007, INSECT BIOCHEM MOLEC, V37, P903, DOI 10.1016/j.ibmb.2007.04.007; Francischetti IMB, 2010, J PROTEOME RES, V9, P3820, DOI 10.1021/pr1000169; Funk CJ, 2001, ARCH INSECT BIOCHEM, V46, P165, DOI 10.1002/arch.1026; Garcia-Exposito L, 2011, MOL BIOL CELL, V22, P1148, DOI 10.1091/mbc.E10-08-0722; Ghanim M, 2001, J MORPHOL, V248, P22, DOI 10.1002/jmor.1018; Ghanim M, 2001, PHYTOPATHOLOGY, V91, P188, DOI 10.1094/PHYTO.2001.91.2.188; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Harris KF, 1996, ZOOMORPHOLOGY, V116, P143; Heikkila O, 2010, J VIROL, V84, P3666, DOI 10.1128/JVI.01340-09; Hogenhout SA, 2011, CURR OPIN PLANT BIOL, V14, P422, DOI 10.1016/j.pbi.2011.05.003; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Imai A, 2006, ARCH BIOCHEM BIOPHYS, V455, P127, DOI 10.1016/j.abb.2006.09.021; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Karim S, 2002, INSECT BIOCHEM MOLEC, V32, P1711, DOI 10.1016/S0965-1748(02)00111-X; Kato H, 2010, INFECT GENET EVOL, V10, P184, DOI 10.1016/j.meegid.2009.10.012; Kehr J, 2006, J EXP BOT, V57, P767, DOI 10.1093/jxb/erj087; Kehr J, 1999, PLANTA, V207, P612, DOI 10.1007/s004250050525; Knoblauch M, 2003, NAT MATER, V2, P600, DOI 10.1038/nmat960; Knoblauch M, 1998, PLANT CELL, V10, P35, DOI 10.1105/tpc.10.1.35; Knoblauch M, 2001, PLANT CELL, V13, P1221, DOI 10.1105/tpc.13.5.1221; Langille SE, 1999, J BIOL CHEM, V274, P27099, DOI 10.1074/jbc.274.38.27099; Li JM, 2011, ARCH INSECT BIOCHEM, V77, P118, DOI 10.1002/arch.20428; Li M, 2010, INT J PEST MANAGE, V56, P275, DOI 10.1080/09670871003743428; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lin MK, 2009, MOL CELL PROTEOMICS, V8, P343, DOI 10.1074/mcp.M800420-MCP200; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Macia E, 2001, J BIOL CHEM, V276, P24925, DOI 10.1074/jbc.M103284200; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Martinez-Carrillo JL, 2007, PHYTOPARASITICA, V35, P282, DOI 10.1007/BF02981162; Matsumoto M, 2004, P NATL ACAD SCI USA, V101, P8313, DOI 10.1073/pnas.0306709101; McKenzie CL, 2009, J ECON ENTOMOL, V102, P670, DOI 10.1603/029.102.0227; McSwain JL, 1997, INSECT MOL BIOL, V6, P67, DOI 10.1046/j.1365-2583.1997.00158.x; Medina V, 2006, J PLANT PATHOL, V88, P299; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Moriones E, 2000, VIRUS RES, V71, P123, DOI 10.1016/S0168-1702(00)00193-3; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Orchard I, 2002, PEPTIDES, V23, P693, DOI 10.1016/S0196-9781(01)00663-5; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Ramsey JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-423; Ratzka A, 2002, P NATL ACAD SCI USA, V99, P11223, DOI 10.1073/pnas.172112899; Ray S, 2003, PLANT MOL BIOL, V53, P741, DOI 10.1023/B:PLAN.0000019120.74610.52; Reis MM, 2003, TISSUE CELL, V35, P393, DOI 10.1016/S0040-8166(03)00059-4; Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P61, DOI 10.1016/j.ibmb.2003.09.004; Roux SJ, 2007, TRENDS PLANT SCI, V12, P522, DOI 10.1016/j.tplants.2007.09.003; Santos A, 2007, INSECT BIOCHEM MOLEC, V37, P702, DOI 10.1016/j.ibmb.2007.04.004; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Scrivener AM, 1998, COMP BIOCHEM PHYS B, V119, P273, DOI 10.1016/S0305-0491(97)00325-8; Scrivener AM, 1997, J INSECT PHYSIOL, V43, P1039, DOI 10.1016/S0022-1910(97)00063-2; Serrao JE, 2008, J MED ENTOMOL, V45, P991, DOI 10.1603/0022-2585(2008)45[991:UOTSGI]2.0.CO;2; Shibasaki T, 2005, METHOD ENZYMOL, V403, P408, DOI 10.1016/S0076-6879(05)03036-3; Smith CM, 2007, ENTOMOL EXP APPL, V122, P1, DOI 10.1111/j.1570-7458.2006.00503.x; Subkhankulova T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r18; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tang FC, 2011, NAT METHODS, V8, pS6, DOI [10.1038/NMETH.1557, 10.1038/nmeth.1557]; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Turner RJ, 2002, ORAL DIS, V8, P3, DOI 10.1034/j.1601-0825.2002.10815.x; Ueda S, 2006, PHYTOPARASITICA, V34, P405, DOI 10.1007/BF02981027; Walker Gregory P., 2010, P109; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Walz B, 2006, ARCH INSECT BIOCHEM, V62, P141, DOI 10.1002/arch.20128; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm J, 2006, CLIN CHEM, V52, P1161, DOI 10.1373/clinchem.2005.062406; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Wolf JBW, 2010, MOL ECOL, V19, P162, DOI 10.1111/j.1365-294X.2009.04471.x; Xu J, 2009, THESIS ZHEJIANG U; Yin Y, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000269; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	97	68	74	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39303	10.1371/journal.pone.0039303	http://dx.doi.org/10.1371/journal.pone.0039303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745728	Green Submitted, gold, Green Published			2022-12-27	WOS:000305693200058
J	Risselada, HJ; Marelli, G; Fuhrmans, M; Smirnova, YG; Grubmuller, H; Marrink, SJ; Muller, M				Risselada, Herre Jelger; Marelli, Giovanni; Fuhrmans, Marc; Smirnova, Yuliya G.; Grubmueller, Helmut; Marrink, Siewert Jan; Mueller, Marcus			Line-Tension Controlled Mechanism for Influenza Fusion	PLOS ONE			English	Article							BILAYER-MEMBRANE FUSION; MOLECULAR-DYNAMICS; CONFORMATIONAL-CHANGE; TRANSMEMBRANE DOMAIN; VIRUS HEMAGGLUTININ; CYTOPLASMIC DOMAIN; VESICLE FUSION; AREA EXPANSION; POINT MUTATION; PORE FORMATION	Our molecular simulations reveal that wild-type influenza fusion peptides are able to stabilize a highly fusogenic pre-fusion structure, i.e. a peptide bundle formed by four or more trans-membrane arranged fusion peptides. We rationalize that the lipid rim around such bundle has a non-vanishing rim energy (line-tension), which is essential to (i) stabilize the initial contact point between the fusing bilayers, i. e. the stalk, and (ii) drive its subsequent evolution. Such line-tension controlled fusion event does not proceed along the hypothesized standard stalk-hemifusion pathway. In modeled influenza fusion, single point mutations in the influenza fusion peptide either completely inhibit fusion (mutants G1V and W14A) or, intriguingly, specifically arrest fusion at a hemifusion state (mutant G1S). Our simulations demonstrate that, within a line-tension controlled fusion mechanism, these known point mutations either completely inhibit fusion by impairing the peptide's ability to stabilize the required peptide bundle (G1V and W14A) or stabilize a persistent bundle that leads to a kinetically trapped hemifusion state (G1S). In addition, our results further suggest that the recently discovered leaky fusion mutant G13A, which is known to facilitate a pronounced leakage of the target membrane prior to lipid mixing, reduces the membrane integrity by forming a 'super' bundle. Our simulations offer a new interpretation for a number of experimentally observed features of the fusion reaction mediated by the prototypical fusion protein, influenza hemagglutinin, and might bring new insights into mechanisms of other viral fusion reactions.	[Risselada, Herre Jelger; Grubmueller, Helmut] Max Planck Inst Biophys Chem, Theoret Mol Biophys Grp, D-37077 Gottingen, Germany; [Marelli, Giovanni; Fuhrmans, Marc; Smirnova, Yuliya G.; Mueller, Marcus] Univ Gottingen, Inst Theoret Phys, D-3400 Gottingen, Germany; [Marrink, Siewert Jan] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh, Ag Groningen, Netherlands	Max Planck Society; University of Gottingen; University of Groningen	Risselada, HJ (corresponding author), Max Planck Inst Biophys Chem, Theoret Mol Biophys Grp, D-37077 Gottingen, Germany.	hrissel@gwdg.de	Fuhrmans, Marc/E-2800-2015; Marrink, Siewert J/G-3706-2014; Müller, Marcus/B-9898-2009	Fuhrmans, Marc/0000-0002-9826-018X; Marrink, Siewert J/0000-0001-8423-5277; Müller, Marcus/0000-0002-7472-973X				Aeffner S, 2009, EUR PHYS J E, V30, P205, DOI 10.1140/epje/i2009-10466-x; Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425; Baoukina S, 2010, BIOPHYS J, V99, P2134, DOI 10.1016/j.bpj.2010.07.049; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bonnafous P, 2000, J BIOL CHEM, V275, P6160, DOI 10.1074/jbc.275.9.6160; Brewster R, 2010, BIOPHYS J, V98, pL21, DOI 10.1016/j.bpj.2009.11.027; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Chernomordik LV, 2006, J CELL BIOL, V175, P201, DOI 10.1083/jcb.200607083; Cirac AD, 2011, BIOPHYS J, V100, P2422, DOI 10.1016/j.bpj.2011.03.057; Donald JE, 2011, P NATL ACAD SCI USA, V108, P3958, DOI 10.1073/pnas.1019668108; Engel A, 2008, J CELL BIOL, V183, P181, DOI 10.1083/jcb.200805182; Frolov VA, 2003, BIOPHYS J, V85, P1725, DOI 10.1016/S0006-3495(03)74602-5; Fuhrmans M, 2012, J AM CHEM SOC, V134, P1543, DOI 10.1021/ja207290b; Fuhrmans M, 2009, J AM CHEM SOC, V131, P9166, DOI 10.1021/ja903224q; Haluska CK, 2006, P NATL ACAD SCI USA, V103, P15841, DOI 10.1073/pnas.0602766103; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang HW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198304; Illya G, 2008, BIOPHYS J, V95, P4163, DOI 10.1529/biophysj.108.131300; Kasson PM, 2011, P NATL ACAD SCI USA, V108, P3827, DOI 10.1073/pnas.1101072108; Kasson PM, 2011, J AM CHEM SOC, V133, P3812, DOI 10.1021/ja200310d; Kasson PM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000829; Katsov K, 2006, BIOPHYS J, V90, P915, DOI 10.1529/biophysj.105.071092; Katsov K, 2004, BIOPHYS J, V87, P3277, DOI 10.1529/biophysj.103.038943; Knecht V, 2006, J AM CHEM SOC, V128, P2030, DOI 10.1021/ja056619o; Kozlov MM, 2002, TRAFFIC, V3, P256, DOI 10.1034/j.1600-0854.2002.030403.x; KOZLOV MM, 1983, BIOFIZIKA+, V28, P242; Kozlovsky Y, 2002, BIOPHYS J, V82, P882, DOI 10.1016/S0006-3495(02)75450-7; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; Lai AL, 2006, J BIOL CHEM, V281, P5760, DOI 10.1074/jbc.M512280200; Lai AL, 2010, J BIOL CHEM, V285, P37467, DOI 10.1074/jbc.M110.153700; Laradji M, 1997, MACROMOLECULES, V30, P3242, DOI 10.1021/ma9618437; Lee JY, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2766945; Lee JY, 2008, BIOPHYS J, V94, P1699, DOI 10.1529/biophysj.107.119511; Lee KK, 2010, EMBO J, V29, P1299, DOI 10.1038/emboj.2010.13; Li JY, 2010, J PHYS CHEM B, V114, P8799, DOI 10.1021/jp1029163; Li YL, 2005, J VIROL, V79, P12065, DOI 10.1128/JVI.79.18.12065-12076.2005; LIPOWSKY R, 1992, J PHYS II, V2, P1825, DOI 10.1051/jp2:1992238; Longo ML, 1997, BIOPHYS J, V73, P1430, DOI 10.1016/S0006-3495(97)78175-X; Longo ML, 1998, LANGMUIR, V14, P2385, DOI 10.1021/la970932p; Markin VS, 2002, BIOPHYS J, V82, P693, DOI 10.1016/S0006-3495(02)75432-5; Markosyan RM, 1999, BIOPHYS J, V77, P943, DOI 10.1016/S0006-3495(99)76945-6; Markvoort AJ, 2011, CURR TOP MEMBR, V68, P259, DOI 10.1016/B978-0-12-385891-7.00011-8; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2010, PHYS CHEM CHEM PHYS, V12, P2254, DOI 10.1039/b915293h; Marrink SJ, 2004, BIOPHYS J, V87, P3894, DOI 10.1529/biophysj.104.048710; May S, 2002, BIOPHYS J, V83, P2969, DOI 10.1016/S0006-3495(02)75303-4; Melikyan GB, 2000, MOL BIOL CELL, V11, P3765, DOI 10.1091/mbc.11.11.3765; Melikyan GB, 1999, MOL BIOL CELL, V10, P1821, DOI 10.1091/mbc.10.6.1821; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; MORGAN CG, 1983, BIOCHIM BIOPHYS ACTA, V732, P668, DOI 10.1016/0005-2736(83)90245-6; Muller M, 2003, BIOPHYS J, V85, P1611, DOI 10.1016/S0006-3495(03)74592-5; Qiao H, 1999, MOL BIOL CELL, V10, P2759, DOI 10.1091/mbc.10.8.2759; Risselada HJ, 2008, J PHYS CHEM B, V112, P7438, DOI 10.1021/jp0758519; Risselada HJ, 2012, CURR OPIN STRUC BIOL, V22, P187, DOI 10.1016/j.sbi.2012.01.007; Risselada HJ, 2011, CHEMBIOCHEM, V12, P1049, DOI 10.1002/cbic.201100020; Rowlinson J. S., 1982, MOL THEORY CAPILLARI; Sammalkorpi M, 2007, BIOCHIM BIOPHYS ACTA, V1768, P430; Schafer LV, 2010, BIOPHYS J, V99, pL91, DOI 10.1016/j.bpj.2010.08.072; Schick M, 2005, MOL PHYS, V103, P3055, DOI 10.1080/00268970500151486; Schick M, 2011, J STAT PHYS, V142, P1317, DOI 10.1007/s10955-010-0111-9; SchrothDiez B, 1998, J VIROL, V72, P133, DOI 10.1128/JVI.72.1.133-141.1998; Sengupta D, 2008, BBA-BIOMEMBRANES, V1778, P2308, DOI 10.1016/j.bbamem.2008.06.007; Siegel DP, 2008, BIOPHYS J, V95, P5200, DOI 10.1529/biophysj.108.140152; Siegel DP, 2000, BBA-BIOMEMBRANES, V1468, P87, DOI 10.1016/S0005-2736(00)00246-7; SIEGEL DP, 1993, BIOPHYS J, V65, P2124, DOI 10.1016/S0006-3495(93)81256-6; Smirnova YG, 2010, J AM CHEM SOC, V132, P6710, DOI 10.1021/ja910050x; Soltesz SA, 1997, J COLLOID INTERF SCI, V186, P399, DOI 10.1006/jcis.1996.4670; Stegmann T, 1992, BIOCH MOL BIOL, V268, P1716; Stevens MJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.188102; Tolpekina TV, 2004, J CHEM PHYS, V121, P12060, DOI 10.1063/1.1815296; Tong SG, 1996, BIOCHEMISTRY-US, V35, P4956, DOI 10.1021/bi9526903; Torres O, 2011, BIOCHEMISTRY-US, V50, P5195, DOI 10.1021/bi200696s; Ujike M, 2006, J GEN VIROL, V87, P1669, DOI 10.1099/vir.0.81528-0; Vaidya NK, 2010, ADV APPL MATH MECH, V2, P430, DOI 10.4208/aamm.09-m0987; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810	76	58	58	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e38302	10.1371/journal.pone.0038302	http://dx.doi.org/10.1371/journal.pone.0038302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761674	Green Published, gold			2022-12-27	WOS:000305826400002
J	Via, E; Cardoner, N; Pujol, J; Martinez-Zalacain, I; Hernandez-Ribas, R; Urretavizacaya, M; Lopez-Sola, M; Deus, J; Menchon, JM; Soriano-Mas, C				Via, Esther; Cardoner, Narcis; Pujol, Jesus; Martinez-Zalacain, Ignacio; Hernandez-Ribas, Rosa; Urretavizacaya, Mikel; Lopez-Sola, Marina; Deus, Joan; Manuel Menchon, Jose; Soriano-Mas, Carles			Cerebrospinal Fluid Space Alterations in Melancholic Depression	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GRAY-MATTER REDUCTION; LATE-ONSET DEPRESSION; GERIATRIC DEPRESSION; UNIPOLAR DEPRESSION; MAJOR DEPRESSION; CSF SPACES; ABNORMALITIES; DISORDER; MRI	Melancholic depression is a biologically homogeneous clinical entity in which structural brain alterations have been described. Interestingly, reports of structural alterations in melancholia include volume increases in Cerebro-Spinal Fluid (CSF) spaces. However, there are no previous reports of CSF volume alterations using automated whole-brain voxel-wise approaches, as tissue classification algorithms have been traditionally regarded as less reliable for CSF segmentation. Here we aimed to assess CSF volumetric alterations in melancholic depression and their clinical correlates by means of a novel segmentation algorithm ('new segment', as implemented in the software Statistical Parametric Mapping-SPM8), incorporating specific features that may improve CSF segmentation. A three-dimensional Magnetic Resonance Image (MRI) was obtained from seventy patients with melancholic depression and forty healthy control subjects. Although imaging data were pre-processed with the 'new segment' algorithm, in order to obtain a comparison with previous segmentation approaches, tissue segmentation was also performed with the 'unified segmentation' approach. Melancholic patients showed a CSF volume increase in the region of the left Sylvian fissure, and a CSF volume decrease in the subarachnoid spaces surrounding medial and lateral parietal cortices. Furthermore, CSF increases in the left Sylvian fissure were negatively correlated with the reduction percentage of depressive symptoms at discharge. None of these results were replicated with the 'unified segmentation' approach. By contrast, between-group differences in the left Sylvian fissure were replicated with a non-automated quantification of the CSF content of this region. Left Sylvian fissure alterations reported here are in agreement with previous findings from non-automated CSF assessments, and also with other reports of gray and white matter insular alterations in depressive samples using automated approaches. The reliable characterization of CSF alterations may help in the comprehensive characterization of brain structural abnormalities in psychiatric samples and in the development of etiopathogenic hypotheses relating to the disorders.	[Via, Esther; Cardoner, Narcis; Martinez-Zalacain, Ignacio; Hernandez-Ribas, Rosa; Urretavizacaya, Mikel; Manuel Menchon, Jose; Soriano-Mas, Carles] Bellvitge Univ Hosp IDIBELL, Dept Psychiat, Barcelona, Spain; [Cardoner, Narcis; Hernandez-Ribas, Rosa; Urretavizacaya, Mikel; Manuel Menchon, Jose; Soriano-Mas, Carles] Ctr Invest Biomed Red Salud Mental CIBERSAM, Carlos III Hlth Inst, Barcelona, Spain; [Cardoner, Narcis; Urretavizacaya, Mikel; Manuel Menchon, Jose] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [Pujol, Jesus; Lopez-Sola, Marina; Deus, Joan] CRC Hosp del Mar, Barcelona, Spain; [Deus, Joan] Autonomous Univ Barcelona, Dept Clin & Hlth Psychol, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona	Via, E (corresponding author), Bellvitge Univ Hosp IDIBELL, Dept Psychiat, Barcelona, Spain.	csoriano@idibell.cat	Via, Esther/A-4503-2017; Cardoner, Narcis/AAD-5449-2022; Soriano-Mas, Carles/E-4028-2019; Cardoner, Narcis/H-8436-2015; Yela, Joan Deus/F-3652-2011; Menchon, Jose/A-5242-2009	Via, Esther/0000-0002-2331-3232; Cardoner, Narcis/0000-0001-9633-0888; Soriano-Mas, Carles/0000-0003-4574-6597; LOPEZ SOLA, MARINA/0000-0002-5517-2665; Menchon, Jose/0000-0002-6231-6524; HERNANDEZ-RIBAS, ROSA/0000-0002-0084-6976; Martinez-Zalacain, Ignacio/0000-0002-4036-0284	Carlos III Health Institute [CP10/00604, PI03/0010, PI08/1549, PI09/01961, PI09/01331, PI10/01753]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [2009SGR1554]	Carlos III Health Institute(Instituto de Salud Carlos III); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This study was supported in part by the Carlos III Health Institute (CP10/00604, PI03/0010, PI08/1549, PI09/01961, PI09/01331, PI10/01753,) and by the Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR): 2009SGR1554. Dr. Soriano-Mas is funded by a Miguel Servet contract from the Carlos III Health Institute (CP10/00604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2010, PSYCHIAT RES-NEUROIM, V181, P64, DOI 10.1016/j.pscychresns.2009.07.007; Adolphs R, 2000, J NEUROSCI, V20, P2683; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Antonijevic IA, 2006, PSYCHONEUROENDOCRINO, V31, P1, DOI 10.1016/j.psyneuen.2005.04.004; Armitage R, 2007, ACTA PSYCHIAT SCAND, V115, P104, DOI 10.1111/j.1600-0447.2007.00968.x; Arnone D, 2011, EUR NEUROPS IN PRESS; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Ashburner J, 2011, NEW SEGMENT; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ballmaier M, 2004, AM J PSYCHIAT, V161, P99, DOI 10.1176/appi.ajp.161.1.99; Ballmaier M, 2004, BIOL PSYCHIAT, V55, P382, DOI 10.1016/j.biopsych.2003.09.004; Baumann B, 1997, J AFFECT DISORDERS, V45, P179, DOI 10.1016/S0165-0327(97)00073-6; Cardoner N, 2003, J CLIN PSYCHIAT, V64, P691, DOI 10.4088/JCP.v64n0611; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Davey CG, 2011, BIOL PSYCHIAT, V69, P734, DOI 10.1016/j.biopsych.2010.12.004; Davidson RJ, 2003, AM J PSYCHIAT, V160, P64, DOI 10.1176/appi.ajp.160.1.64; Delaveau P, 2011, J AFFECT DISORDERS, V130, P66, DOI 10.1016/j.jad.2010.09.032; Exner C, 2009, J AFFECT DISORDERS, V119, P156, DOI 10.1016/j.jad.2009.03.015; First MB, 2002, STRUCTURED CLIN INTE; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hickie I, 2005, BRIT J PSYCHIAT, V186, P197, DOI 10.1192/bjp.186.3.197; Hwang JP, 2010, J GERIATR PSYCH NEUR, V23, P171, DOI 10.1177/0891988710363713; Inkster B, 2011, J NEUROIMAGING, V21, P375, DOI 10.1111/j.1552-6569.2010.00515.x; Kaufmann C, 2001, NEUROIMAGE, V13, pS1064; KENDLER KS, 1995, AM J PSYCHIAT, V152, P833; Kennedy SH, 2001, AM J PSYCHIAT, V158, P899, DOI 10.1176/appi.ajp.158.6.899; Kumar A, 1997, ARCH NEUROL-CHICAGO, V54, P613, DOI 10.1001/archneur.1997.00550170085018; Leventhal AM, 2005, CLIN PSYCHOL REV, V25, P25, DOI 10.1016/j.cpr.2004.09.001; Mak AKY, 2009, PROG NEURO-PSYCHOPH, V33, P1184, DOI 10.1016/j.pnpbp.2009.06.025; Maller JJ, 2007, HIPPOCAMPUS, V17, P1023, DOI 10.1002/hipo.20339; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Members & collaborators of the Wellcome Trust Centre for Neuroimaging, SPM SOFTW STAT PAR M; Narr KL, 2006, PSYCHIAT RES-NEUROIM, V146, P21, DOI 10.1016/j.pscychresns.2005.10.005; Nugent NR, 2011, PSYCHOPHARMACOLOGY, V214, P175, DOI 10.1007/s00213-010-2151-x; Pantel J, 1997, J AFFECT DISORDERS, V42, P69, DOI 10.1016/S0165-0327(96)00105-X; Pantel J, 1998, NERVENARZT, V69, P968, DOI 10.1007/s001150050371; Parker G, 2010, AM J PSYCHIAT, V167, P745, DOI 10.1176/appi.ajp.2010.09101525; Peng J, 2011, EUR J RADIOL, V80, P395, DOI 10.1016/j.ejrad.2010.04.006; Pizzagalli DA, 2004, MOL PSYCHIATR, V9, P393, DOI 10.1038/sj.mp.4001469; Pujol J, 2002, NEUROIMAGE, V15, P103, DOI 10.1006/nimg.2001.0928; RABINS PV, 1991, AM J PSYCHIAT, V148, P617; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Salokangas RKR, 2002, BRIT J PSYCHIAT, V181, pS58, DOI 10.1192/bjp.181.43.s58; Savitz J, 2009, NEUROSCI BIOBEHAV R, V33, P699, DOI 10.1016/j.neubiorev.2009.01.004; Shah PJ, 1998, BRIT J PSYCHIAT, V172, P527, DOI 10.1192/bjp.172.6.527; Silberg J, 2001, BRIT J PSYCHIAT, V179, P116, DOI 10.1192/bjp.179.2.116; Soriano-Mas C, 2011, BIOL PSYCHIAT, V69, P318, DOI 10.1016/j.biopsych.2010.07.029; Steingard RJ, 2002, BIOL PSYCHIAT, V52, P413, DOI 10.1016/S0006-3223(02)01393-8; Surguladze SA, 2010, J PSYCHIATR RES, V44, P894, DOI 10.1016/j.jpsychires.2010.02.010; Takahashi T, 2010, J AFFECT DISORDERS, V121, P231, DOI 10.1016/j.jad.2009.06.003; Taylor MA., 2006, MELANCHOLIA DIAGNOSI, DOI [10.1017/CBO9780511544330, DOI 10.1017/CBO9780511544330]; WURTHMANN C, 1995, PSYCHIAT RES-NEUROIM, V61, P103, DOI 10.1016/0925-4927(95)02592-L; ZIMMERMAN M, 1986, ARCH GEN PSYCHIAT, V43, P1090	59	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e38299	10.1371/journal.pone.0038299	http://dx.doi.org/10.1371/journal.pone.0038299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761673	gold, Green Published, Green Submitted			2022-12-27	WOS:000305826400001
J	Kupferberg, A; Huber, M; Helfer, B; Lenz, C; Knoll, A; Glasauer, S				Kupferberg, Aleksandra; Huber, Markus; Helfer, Bartosz; Lenz, Claus; Knoll, Alois; Glasauer, Stefan			Moving Just Like You: Motor Interference Depends on Similar Motility of Agent and Observer	PLOS ONE			English	Article							GOAL-DIRECTED ACTIONS; MOVEMENT INTERFERENCE; PERCEPTION; IMITATION; OTHERS; HUMANS; BRAIN	Recent findings in neuroscience suggest an overlap between brain regions involved in the execution of movement and perception of another's movement. This so-called "action-perception coupling" is supposed to serve our ability to automatically infer the goals and intentions of others by internal simulation of their actions. A consequence of this coupling is motor interference (MI), the effect of movement observation on the trajectory of one's own movement. Previous studies emphasized that various features of the observed agent determine the degree of MI, but could not clarify how human-like an agent has to be for its movements to elicit MI and, more importantly, what 'human-like' means in the context of MI. Thus, we investigated in several experiments how different aspects of appearance and motility of the observed agent influence motor interference (MI). Participants performed arm movements in horizontal and vertical directions while observing videos of a human, a humanoid robot, or an industrial robot arm with either artificial (industrial) or human-like joint configurations. Our results show that, given a human-like joint configuration, MI was elicited by observing arm movements of both humanoid and industrial robots. However, if the joint configuration of the robot did not resemble that of the human arm, MI could longer be demonstrated. Our findings present evidence for the importance of human-like joint configuration rather than other human-like features for perception-action coupling when observing inanimate agents.	[Kupferberg, Aleksandra; Huber, Markus; Helfer, Bartosz; Glasauer, Stefan] Univ Munich, Inst Clin Neurosci, Ctr Sensorimotor Res, D-80539 Munich, Germany; [Kupferberg, Aleksandra; Glasauer, Stefan] Univ Munich, GSN, Grad Sch Syst Neurosci, D-80539 Munich, Germany; [Lenz, Claus; Knoll, Alois] Tech Univ Munich, D-8000 Munich, Germany	University of Munich; University of Munich; Technical University of Munich	Kupferberg, A (corresponding author), Univ Munich, Inst Clin Neurosci, Ctr Sensorimotor Res, D-80539 Munich, Germany.	sglasauer@lmu.de	Knoll, Alois/AAN-8417-2021; Glasauer, Stefan/A-5898-2008; Helfer, Bartosz/AAD-6406-2020	Knoll, Alois/0000-0003-4840-076X; Glasauer, Stefan/0000-0002-4313-6210; Helfer, Bartosz/0000-0001-9863-2871	Graduiertenforderung nach dem Bay. Eliteforderungsgesetz; DFG Cluster of Excellence CoTeSys; Amgen Scholarship	Graduiertenforderung nach dem Bay. Eliteforderungsgesetz; DFG Cluster of Excellence CoTeSys(German Research Foundation (DFG)); Amgen Scholarship	This research was supported by Graduiertenforderung nach dem Bay. Eliteforderungsgesetz (http://www.uni-muenchen.de/einrichtungen/zuv/uebersicht/dez_iii/ref_iii4/bayefg/index.html) and the DFG Cluster of Excellence CoTeSys (http://www.cotesys.de/). BH was funded by an Amgen Scholarship (http://www.amgenscholars.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NB, 2010, J MOTOR BEHAV, V42, P145, DOI 10.1080/00222891003612805; Bouquet CA, 2007, J SPORT SCI, V25, P519, DOI 10.1080/02640410600946803; Bouquet CA, 2011, EXP PSYCHOL, V58, P71, DOI 10.1027/1618-3169/a000069; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Breazeal C, 2005, ARTIF LIFE, V11, P31, DOI 10.1162/1064546053278955; Capa RL, 2011, PSYCHOL RES-PSYCH FO, V75, P152, DOI 10.1007/s00426-010-0303-6; Chaminade T, 2005, INT C DEVEL LEARN, P96; Chaminade T, 2009, J PHYSIOL-PARIS, V103, P286, DOI 10.1016/j.jphysparis.2009.08.011; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; Cross E.S., 2011, HUM BRAIN MAPP; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gowen E, 2008, NEUROPSYCHOLOGIA, V46, P1060, DOI 10.1016/j.neuropsychologia.2007.11.004; Hofer T, 2005, INFANT BEHAV DEV, V28, P466, DOI 10.1016/j.infbeh.2005.04.002; Huber M, 2008, 2008 17TH IEEE INTERNATIONAL SYMPOSIUM ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, VOLS 1 AND 2, P107, DOI 10.1109/ROMAN.2008.4600651; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Kamewari K, 2005, COGNITIVE DEV, V20, P303, DOI 10.1016/j.cogdev.2005.04.004; Kilner J, 2007, SOC NEUROSCI-UK, V2, P158, DOI 10.1080/17470910701428190; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Kupferberg A, 2011, AI SOC, V26, P339, DOI 10.1007/s00146-010-0314-2; Lenz C, 2008, 2008 17TH IEEE INTERNATIONAL SYMPOSIUM ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, VOLS 1 AND 2, P130, DOI 10.1109/ROMAN.2008.4600655; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; Oberman LM, 2007, NEUROCOMPUTING, V70, P2194, DOI 10.1016/j.neucom.2006.02.024; Oztop E., 2005, P 4 IEEE RAS INT C H, V2, P537, DOI [10.1142/S0219843605000582, DOI 10.1142/S0219843605000582]; Peeters R, 2009, J NEUROSCI, V29, P11523, DOI 10.1523/JNEUROSCI.2040-09.2009; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Qiming Shen, 2009, RO-MAN 2009 - The 18th IEEE International Symposium on Robot and Human Interactive Communication, P291, DOI 10.1109/ROMAN.2009.5326342; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Saygin AP, 2012, SOC COGN AFFECT NEUR, V7, P413, DOI 10.1093/scan/nsr025; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Shen QM, 2011, IEEE T AUTON MENT DE, V3, P6, DOI 10.1109/TAMD.2010.2089790; Stanley J, 2007, J EXP PSYCHOL HUMAN, V33, P915, DOI 10.1037/0096-1523.33.4.915; Sturmer B, 2000, J EXP PSYCHOL HUMAN, V26, P1746, DOI 10.1037//0096-1523.26.6.1746; TROUT DL, 1980, J NONVERBAL BEHAV, V4, P176, DOI 10.1007/BF00986818; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4	41	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39637	10.1371/journal.pone.0039637	http://dx.doi.org/10.1371/journal.pone.0039637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966GL	22761853	Green Published, gold			2022-12-27	WOS:000305825800055
J	Smargiassi, M; Daghfous, G; Leroy, B; Legreneur, P; Toubeau, G; Bels, V; Wattiez, R				Smargiassi, Maite; Daghfous, Gheylen; Leroy, Baptiste; Legreneur, Pierre; Toubeau, Gerard; Bels, Vincent; Wattiez, Ruddy			Chemical Basis of Prey Recognition in Thamnophiine Snakes: The Unexpected New Roles of Parvalbumins	PLOS ONE			English	Article							GARTER SNAKES; PROTEINACEOUS CHEMOATTRACTANT; VOMERONASAL SYSTEM; CALCIUM-BINDING; RESPONSES; SKIN; IDENTIFICATION; SENSES; ATTACK; SERUM	Detecting and locating prey are key to predatory success within trophic chains. Predators use various signals through specialized visual, olfactory, auditory or tactile sensory systems to pinpoint their prey. Snakes chemically sense their prey through a highly developed auxiliary olfactory sense organ, the vomeronasal organ (VNO). In natricine snakes that are able to feed on land and water, the VNO plays a critical role in predatory behavior by detecting cues, known as vomodors, which are produced by their potential prey. However, the chemical nature of these cues remains unclear. Recently, we demonstrated that specific proteins-parvalbumins-present in the cutaneous mucus of the common frog (Rana temporaria) may be natural chemoattractive proteins for these snakes. Here, we show that parvalbumins and parvalbumin-like proteins, which are mainly intracellular, are physiologically present in the epidermal mucous cells and mucus of several frog and fish genera from both fresh and salt water. These proteins are located in many tissues and function as Ca2+ buffers. In addition, we clarified the intrinsic role of parvalbumins present in the cutaneous mucus of amphibians and fishes. We demonstrate that these Ca2+-binding proteins participate in innate bacterial defense mechanisms by means of calcium chelation. We show that these parvalbumins are chemoattractive for three different thamnophiine snakes, suggesting that these chemicals play a key role in their prey-recognition mechanism. Therefore, we suggest that recognition of parvalbumin-like proteins or other calcium-binding proteins by the VNO could be a generalized prey-recognition process in snakes. Detecting innate prey defense mechanism compounds may have driven the evolution of this predator-prey interaction.	[Smargiassi, Maite; Leroy, Baptiste; Wattiez, Ruddy] Univ Mons UMONS, Interdisciplinary Ctr Mass Spectrometry CISMa, Dept Prote & Microbiol, Mons, Belgium; [Daghfous, Gheylen; Legreneur, Pierre; Bels, Vincent] Museum Natl Hist Nat, Dept Ecol & Gest Biodivers, F-75231 Paris, France; [Toubeau, Gerard] Univ Mons, Dept Histol, B-7000 Mons, Belgium; [Legreneur, Pierre] Univ Lyon, CRIS, EA 647, Villeurbanne, France	University of Mons; Museum National d'Histoire Naturelle (MNHN); University of Mons	Smargiassi, M (corresponding author), Univ Mons UMONS, Interdisciplinary Ctr Mass Spectrometry CISMa, Dept Prote & Microbiol, Mons, Belgium.	ruddy.wattiez@umons.ac.be		Leroy, Baptiste/0000-0001-7166-4478; wattiez, ruddy/0000-0003-2071-4310	FNRS (National Fund of Scientific Research); FRIA (Fund for Research in the Industry and the Agriculture)	FNRS (National Fund of Scientific Research)(Fonds de la Recherche Scientifique - FNRS); FRIA (Fund for Research in the Industry and the Agriculture)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by FNRS (National Fund of Scientific Research) and FRIA (Fund for Research in the Industry and the Agriculture) (for M. S. and R. W.). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD SJ, 1981, EVOLUTION, V35, P489, DOI 10.1111/j.1558-5646.1981.tb04912.x; Burghardt G. M., 1970, COMMUNICATION CHEM S, P241; Burghardt G. M., 1966, PSYCHON SCI, V4, P37; BURGHARDT GM, 1988, J CHEM ECOL, V14, P855, DOI 10.1007/BF01018779; BURGHARDT GM, 1993, BRAIN BEHAV EVOLUT, V41, P138, DOI 10.1159/000113831; BURGHARDT GM, 1975, PHYSIOL BEHAV, V14, P185, DOI 10.1016/0031-9384(75)90164-X; Caillard O, 2000, P NATL ACAD SCI USA, V97, P13372, DOI 10.1073/pnas.230362997; CATANIA KC, 1995, J COMP NEUROL, V351, P536, DOI 10.1002/cne.903510405; Chiszar D, 2001, J CHEM ECOL, V27, P979, DOI 10.1023/A:1010391121044; Cooper WE, 2008, AMPHIBIA-REPTILIA, V29, P393, DOI 10.1163/156853808785112002; DRUMMOND H, 1983, BEHAVIOUR, V86, P1, DOI 10.1163/156853983X00543; FLIK G, 1984, EUR J BIOCHEM, V138, P651, DOI 10.1111/j.1432-1033.1984.tb07964.x; GOSSELINREY C, 1977, BIOCHIM BIOPHYS ACTA, V492, P53, DOI 10.1016/0005-2795(77)90213-6; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; Halpern M., 1983, CHEM SIGNALS VERTEBR, P45; HEIZMANN CW, 1982, P NATL ACAD SCI-BIOL, V79, P7243, DOI 10.1073/pnas.79.23.7243; HELLER SB, 1982, J COMP PHYSIOL PSYCH, V96, P984, DOI 10.1037/0735-7036.96.6.984; Henzl MT, 2004, BIOCHEMISTRY-US, V43, P2747, DOI 10.1021/bi035890k; JOCKUSCH H, 1990, MUSCLE NERVE, V13, P551, DOI 10.1002/mus.880130613; KALMIJN AJ, 1971, J EXP BIOL, V55, P371; KIRSCHENBAUM DM, 1985, COMP BIOCHEM PHYS B, V82, P447, DOI 10.1016/0305-0491(85)90007-0; KONISHI M, 1973, AM SCI, V61, P414; Leroy B, 2006, MOL CELL PROTEOMICS, V5, P2114, DOI 10.1074/mcp.M600205-MCP200; Liu WM, 1997, J BIOL CHEM, V272, P27378, DOI 10.1074/jbc.272.43.27378; LUO YQ, 1994, J BIOL CHEM, V269, P16867; Pauls TL, 1996, BBA-GENE STRUCT EXPR, V1306, P39, DOI 10.1016/0167-4781(95)00221-9; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Sheffield L. P., 1968, Communications in Behavioral Biology, V2A, P7; Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#; SNYDER AW, 1978, NATURE, V275, P127, DOI 10.1038/275127a0; STIFFLER DF, 1995, J EXP BIOL, V198, P967; WANG D, 1988, ARCH BIOCHEM BIOPHYS, V267, P459, DOI 10.1016/0003-9861(88)90051-3; WATTIEZ R, 1994, J CHEM ECOL, V20, P1143, DOI 10.1007/BF02059750	33	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39560	10.1371/journal.pone.0039560	http://dx.doi.org/10.1371/journal.pone.0039560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761824	gold, Green Published, Green Submitted			2022-12-27	WOS:000305825800042
J	Chang, SC; Koenen, KC; Galea, S; Aiello, AE; Soliven, R; Wildman, DE; Uddin, M				Chang, Shun-Chiao; Koenen, Karestan C.; Galea, Sandro; Aiello, Allison E.; Soliven, Richelo; Wildman, Derek E.; Uddin, Monica			Molecular Variation at the SLC6A3 Locus Predicts Lifetime Risk of PTSD in the Detroit Neighborhood Health Study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DOPAMINE TRANSPORTER GENE; VARIABLE NUMBER; DNA METHYLATION; 3'-UNTRANSLATED REGION; EXPRESSION; VNTR; POLYMORPHISMS; COMMUNITY; HYPOMETHYLATION	Recent work suggests that the 9-repeat (9R) allele located in the 39UTR VNTR of the SLC6A3 gene increases risk of posttraumatic stress disorder (PTSD). However, no study reporting this association to date has been based on population-based samples. Furthermore, no study of which we are aware has assessed the joint action of genetic and DNA methylation variation at SLC6A3 on risk of PTSD. In this study, we assessed whether molecular variation at SLC6A3 locus influences risk of PTSD. Participants (n = 320; 62 cases/258 controls) were drawn from an urban, community-based sample of predominantly African American Detroit adult residents, and included those who had completed a baseline telephone survey, had provided blood specimens, and had a homozygous genotype for either the 9R or 10R allele or a heterozygous 9R/10R genotype. The influence of DNA methylation variation in the SLC6A3 promoter locus was also assessed in a subset of participants with available methylation data (n = 83; 16 cases/67 controls). In the full analytic sample, 9R allele carriers had almost double the risk of lifetime PTSD compared to 10R/10R genotype carriers (OR = 1.98, 95% CI = 1.02-3.86), controlling for age, sex, race, socioeconomic status, number of traumas, smoking, and lifetime depression. In the subsample of participants with available methylation data, a significant (p = 0.008) interaction was observed whereby 9R allele carriers showed an increased risk of lifetime PTSD only in conjunction with high methylation in the SLC6A3 promoter locus, controlling for the same covariates. Our results confirm previous reports supporting a role for the 9R allele in increasing susceptibility to PTSD. They further extend these findings by providing preliminary evidence that a "double hit" model, including both a putatively reduced-function allele and high methylation in the promoter region, may more accurately capture molecular risk of PTSD at the SLC6A3 locus.	[Chang, Shun-Chiao] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Koenen, Karestan C.; Galea, Sandro] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Aiello, Allison E.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Soliven, Richelo; Wildman, Derek E.; Uddin, Monica] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI USA; [Uddin, Monica] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI USA	Harvard University; Harvard T.H. Chan School of Public Health; Columbia University; University of Michigan System; University of Michigan; Wayne State University; Wayne State University	Chang, SC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	monica.uddin@wayne.edu	Galea, Sandro/GLR-6066-2022; Koenen, Karestan/K-5402-2014	Wildman, Derek/0000-0002-6374-5136; Galea, Sandro/0000-0002-7534-0945; Koenen, Karestan/0000-0003-3293-4281	National Institutes of Health [DA022720, DA022720-S1, MH088283]; Robert Wood Johnson Health and Society; University of Michigan Office of the Vice President for Research; Wayne State University; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Health and Society(Robert Wood Johnson Foundation (RWJF)); University of Michigan Office of the Vice President for Research(University of Michigan System); Wayne State University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by National Institutes of Health Grants DA022720, DA022720-S1, and MH088283. Additional support was provided by the Robert Wood Johnson Health and Society Scholars Small Grant Program and the University of Michigan Office of the Vice President for Research Faculty Grants and Awards Program; and by the Wayne State University Research Excellence Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky HM, 2006, HUM MOL GENET, V15, P3132, DOI 10.1093/hmg/ddl253; American Psychiatric Association Task Force on DSM-IV, 1994, DIAGN STAT MAN MENT; Bailey JN, 2010, PSYCHIAT RES, V178, P507, DOI 10.1016/j.psychres.2010.04.043; Bannon MJ, 2001, EUR NEUROPSYCHOPHARM, V11, P449, DOI 10.1016/S0924-977X(01)00122-5; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Breslau N, 1997, ARCH GEN PSYCHIAT, V54, P81; Brookes KJ, 2007, AM J MED GENET B, V144B, P1070, DOI 10.1002/ajmg.b.30572; Drury SS, 2009, J TRAUMA STRESS, V22, P534, DOI 10.1002/jts.20475; Frieling H, 2007, MOL PSYCHIATR, V12, P229, DOI 10.1038/sj.mp.4001931; Fuke S., 2001, Pharmacogenomics Journal, V1, P152; Gelernter J, 1998, GENOMICS, V52, P289, DOI 10.1006/geno.1998.5454; Goldmann E, 2011, J TRAUMA STRESS, V24, P747, DOI 10.1002/jts.20705; HAMNER MB, 1993, BIOL PSYCHIAT, V33, P304, DOI 10.1016/0006-3223(93)90302-T; Hillemacher T, 2007, AM J PSYCHIAT, V164, P1610, DOI 10.1176/appi.ajp.2007.07060881; Inoue-Murayama M, 2002, NEUROSCI LETT, V334, P206, DOI 10.1016/S0304-3940(02)01125-4; Kang AM, 1999, BIOL PSYCHIAT, V46, P151, DOI 10.1016/S0006-3223(99)00101-8; Kolassa IT, 2010, J CLIN PSYCHIAT, V71, P543, DOI 10.4088/JCP.08m04787blu; Kolassa IT, 2010, BIOL PSYCHIAT, V67, P304, DOI 10.1016/j.biopsych.2009.10.009; Valente NLM, 2011, J MOL NEUROSCI, V44, P59, DOI 10.1007/s12031-011-9513-7; Michelhaugh SK, 2001, J NEUROCHEM, V79, P1033, DOI 10.1046/j.1471-4159.2001.00647.x; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; Miller GM, 2002, MOL PSYCHIATR, V7, P44, DOI 10.1038/sj/mp/4000921; Neugebauer R, 2009, INT J EPIDEMIOL, V38, P1033, DOI 10.1093/ije/dyn375; Rogers RG, 2010, BIODEMOGR SOC BIOL, V56, P80, DOI 10.1080/19485561003727372; Sartor CE, 2011, PSYCHOL MED, V41, P1497, DOI 10.1017/S0033291710002072; Segman RH, 2002, MOL PSYCHIATR, V7, P903, DOI 10.1038/sj.mp.4001085; Smith AK, 2011, AM J MED GENET B, V156B, P700, DOI 10.1002/ajmg.b.31212; TRUE WR, 1993, ARCH GEN PSYCHIAT, V50, P257, DOI 10.1001/archpsyc.1993.01820160019002; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Uddin M, 2011, PSYCHOL MED, V41, P997, DOI 10.1017/S0033291710001674; Uddin M, 2011, DIS MARKERS, V30, P111, DOI [10.1155/2011/513659, 10.3233/DMA-2011-0750]; Uddin M, 2010, P NATL ACAD SCI USA, V107, P9470, DOI 10.1073/pnas.0910794107; van Dyck CH, 2005, J NUCL MED, V46, P745; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; VanNess SH, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-55; Weathers FW, 1996, MEASUREMENT STRESS T; Xian H, 2000, DRUG ALCOHOL DEPEN, V61, P95, DOI 10.1016/S0376-8716(00)00127-7; YEHUDA R, 1992, J NERV MENT DIS, V180, P321, DOI 10.1097/00005053-199205000-00006	39	48	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39184	10.1371/journal.pone.0039184	http://dx.doi.org/10.1371/journal.pone.0039184			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22745713	gold, Green Submitted, Green Published			2022-12-27	WOS:000305808700018
J	Pietrzak, RH; Tracy, M; Galea, S; Kilpatrick, DG; Ruggiero, KJ; Hamblen, JL; Southwick, SM; Norris, FH				Pietrzak, Robert H.; Tracy, Melissa; Galea, Sandro; Kilpatrick, Dean G.; Ruggiero, Kenneth J.; Hamblen, Jessica L.; Southwick, Steven M.; Norris, Fran H.			Resilience in the Face of Disaster: Prevalence and Longitudinal Course of Mental Disorders following Hurricane Ike	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; INTIMATE PARTNER VIOLENCE; IV ALCOHOL-ABUSE; PTSD CHECKLIST; PSYCHOLOGICAL RESILIENCE; PSYCHOMETRIC PROPERTIES; TERRORIST ATTACKS; NATURAL DISASTER; IMMUNE FUNCTION; VICTIMS SPEAK	Objectives: Natural disasters may increase risk for a broad range of psychiatric disorders, both in the short-and in the medium-term. We sought to determine the prevalence and longitudinal course of posttraumatic stress disorder (PTSD), generalized anxiety disorder (GAD), panic disorder (PD), depression, and suicidality in the first 18 months after Hurricane Ike. Methods: Six hundred fifty-eight adults representative of Galveston and Chambers Counties, Texas participated in a random, population-based survey. The initial assessment was conducted 2 to 5 months after Hurricane Ike struck Galveston Bay on September 13, 2008. Follow-up assessments were conducted at 5 to 9 and 14 to 18 months after Hurricane Ike. Results: Past-month prevalence of any mental disorder (20.6% to 10.9%) and hurricane-related PTSD (6.9% to 2.5%) decreased over time. Past-month prevalence of PTSD related to a non-disaster traumatic event (5.8% to 7.1%), GAD (3.1% to 1.8%), PD (0.8% to 0.7%), depression (5.0% to 5.6%), and suicidality (2.6% to 4.2%) remained relatively stable over time. Conclusions: PTSD, both due to the hurricane and due to other traumatic events, was the most prevalent psychiatric disorder 2 to 5 months after Hurricane Ike. Prevalence of psychiatric disorders declined rapidly over time, suggesting that the vast majority of individuals exposed to this natural disaster 'bounced back' and were resilient to long-term mental health consequences of this large-scale traumatic event.	[Pietrzak, Robert H.; Southwick, Steven M.] Vet Affairs Connecticut Healthcare Syst, Natl Ctr Posttraumat Stress Disorder, West Haven, CT USA; [Pietrzak, Robert H.; Southwick, Steven M.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Pietrzak, Robert H.; Tracy, Melissa; Galea, Sandro; Kilpatrick, Dean G.; Ruggiero, Kenneth J.; Hamblen, Jessica L.; Southwick, Steven M.; Norris, Fran H.] Natl Ctr Disaster Mental Hlth Res, White River Jct, VT USA; [Tracy, Melissa; Galea, Sandro] Columbia Univ, Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Kilpatrick, Dean G.; Ruggiero, Kenneth J.] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA; [Kilpatrick, Dean G.; Ruggiero, Kenneth J.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA; [Hamblen, Jessica L.; Norris, Fran H.] White River Junct Vet Affairs Med Ctr, Natl Ctr Posttraumat Stress Disorder, White River Jct, VT USA; [Norris, Fran H.] Geisel Sch Med Dartmouth, Hanover, NH USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Columbia University; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Dartmouth College	Pietrzak, RH (corresponding author), Vet Affairs Connecticut Healthcare Syst, Natl Ctr Posttraumat Stress Disorder, West Haven, CT USA.	robert.pietrzak@yale.edu	Galea, Sandro/GLR-6066-2022	Galea, Sandro/0000-0002-7534-0945	National Center for Disaster Mental Health Research (National Institute of Mental Health) [5 P60 MH082598]; National Center for Posttraumatic Stress Disorder; Claude D. Pepper Older Americans Independence Center at Yale University School of Medicine (NIA) [P30AG21342]; NATIONAL INSTITUTE OF MENTAL HEALTH [P60MH082598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021342] Funding Source: NIH RePORTER	National Center for Disaster Mental Health Research (National Institute of Mental Health); National Center for Posttraumatic Stress Disorder; Claude D. Pepper Older Americans Independence Center at Yale University School of Medicine (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Center for Disaster Mental Health Research (National Institute of Mental Health Grant 5 P60 MH082598), Fran H. Norris, Center Director, Sandro Galea, Research Director. Preparation of this report was supported in part by the National Center for Posttraumatic Stress Disorder and a Research Career Development Award to Dr. Pietrzak from the Claude D. Pepper Older Americans Independence Center at Yale University School of Medicine (NIA Grant P30AG21342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acierno Ron, 2007, Am J Public Health, V97 Suppl 1, pS103, DOI 10.2105/AJPH.2006.087007; Acierno R, 2006, AM J GERIAT PSYCHIAT, V14, P1051, DOI 10.1097/01.JGP.0000221327.97904.b0; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amstadter AB, 2009, J TRAUMA STRESS, V22, P180, DOI 10.1002/jts.20404; Andrykowski MA, 1998, J CONSULT CLIN PSYCH, V66, P586, DOI 10.1037/0022-006X.66.3.586; Berg R, 2009, 0123 NAT HURR CTR; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bonanno GA, 2006, PSYCHOL SCI, V17, P181, DOI 10.1111/j.1467-9280.2006.01682.x; Bonanno GA, 2005, CURR DIR PSYCHOL SCI, V14, P135, DOI 10.1111/j.0963-7214.2005.00347.x; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bonanno GA, 2008, HEALTH PSYCHOL, V27, P659, DOI 10.1037/0278-6133.27.5.659; Boscarino JA, 2006, ADDICT BEHAV, V31, P606, DOI 10.1016/j.addbeh.2005.05.035; Boscarino JA, 2009, SOC PSYCH PSYCH EPID, V44, P887, DOI 10.1007/s00127-009-0011-y; Briere J, 2000, J TRAUMA STRESS, V13, P661, DOI 10.1023/A:1007814301369; Carr VJ, 1997, SOC PSYCH PSYCH EPID, V32, P123; Cerda M, 2008, ADDICTION, V103, P1296, DOI 10.1111/j.1360-0443.2008.02247.x; Cerda M, 2011, DRUG ALCOHOL DEPEN, V115, P1, DOI 10.1016/j.drugalcdep.2010.09.011; Chan KL, 2011, VIOLENCE VICTIMS, V26, P364, DOI 10.1891/0886-6708.26.3.364; DeSalvo KB, 2007, J URBAN HEALTH, V84, P142, DOI 10.1007/s11524-006-9147-1; DiGrande L, 2011, AM J EPIDEMIOL, V173, P271, DOI 10.1093/aje/kwq372; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Galea S, 2007, ARCH GEN PSYCHIAT, V64, P1427, DOI 10.1001/archpsyc.64.12.1427; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Ironson G, 1997, PSYCHOSOM MED, V59, P128, DOI 10.1097/00006842-199703000-00003; Kessler RC, 2008, MOL PSYCHIATR, V13, P374, DOI 10.1038/sj.mp.4002119; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 1997, J AFFECT DISORDERS, V45, P19, DOI 10.1016/S0165-0327(97)00056-6; Kilic C, 2011, J NERV MENT DIS, V199, P335, DOI 10.1097/NMD.0b013e3182174ffa; Kim SC, 2008, J CLIN NURS, V17, P2335, DOI 10.1111/j.1365-2702.2008.02317.x; Knight BG, 2000, PSYCHOL AGING, V15, P627, DOI 10.1037/0882-7974.15.4.627; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; NORRIS FH, 1988, AM J COMMUN PSYCHOL, V16, P665, DOI 10.1007/BF00930020; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Norris FH, 2002, PSYCHIATRY, V65, P240, DOI 10.1521/psyc.65.3.240.20169; Norris FH, 2010, REHABIL PSYCHOL, V55, P221, DOI 10.1037/a0020195; Onder E, 2006, SOC PSYCH PSYCH EPID, V41, P868, DOI 10.1007/s00127-006-0107-6; Person C, 2006, J NERV MENT DIS, V194, P659, DOI 10.1097/01.nmd.0000235758.24586.b7; PHIFER JF, 1989, J GERONTOL, V44, pS207, DOI 10.1093/geronj/44.6.S207; Raghunathan T. E., 2002, IVEWARE IMPUTATION V; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Schumacher JA, 2010, VIOLENCE VICTIMS, V25, P588, DOI 10.1891/0886-6708.25.5.588; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SHORE JH, 1986, AM J PSYCHIAT, V143, P590; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; STEINGLASS P, 1990, J APPL SOC PSYCHOL, V20, P1746, DOI 10.1111/j.1559-1816.1990.tb01509.x; Taylor Steven, 2007, Am J Disaster Med, V2, P217; The American Association for Public Opinion Research, 2009, STAND DEF FIN DISP C; THOMPSON MP, 1993, PSYCHOL AGING, V8, P606, DOI 10.1037/0882-7974.8.4.606; Tracy M, 2011, DEPRESS ANXIETY, V28, P666, DOI 10.1002/da.20838; U.S. Census Bureau, 2007, AM COMM SURV 2005 20; Uddin M, 2010, P NATL ACAD SCI USA, V107, P9470, DOI 10.1073/pnas.0910794107; Weathers FW, 1996, MEASUREMENT STRESS T	61	93	94	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e38964	10.1371/journal.pone.0038964	http://dx.doi.org/10.1371/journal.pone.0038964			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966AK	22761716	Green Published, gold			2022-12-27	WOS:000305808700014
J	Baghdadi, M; Chiba, S; Yamashina, T; Yoshiyama, H; Jinushi, M				Baghdadi, Muhammad; Chiba, Shigeki; Yamashina, Tsunaki; Yoshiyama, Hironori; Jinushi, Masahisa			MFG-E8 Regulates the Immunogenic Potential of Dendritic Cells Primed with Necrotic Cell-Mediated Inflammatory Signals	PLOS ONE			English	Article							APOPTOTIC CELLS; DEATH; IDENTIFICATION; PROTEIN; NECROPTOSIS; CLEARANCE; LINKS	Dendritic cells (DC) manipulate tissue homeostasis by recognizing dying cells and controlling immune functions. However, the precise mechanisms by which DC recognize different types of dying cells and devise distinct immunologic consequences remain largely obscure. Herein, we demonstrate that Milk-fat globule-EGF VIII (MFG-E8) is a critical mediator controlling DC immunogenicity in inflammatory microenvironments. MFG-E8 restrains DC-mediated uptake and recognition of necrotic cells. The MFG-E8-mediated suppression of necrotic cell uptake by DC resulted in the decreased proinflammatory cytokines production and activated signal components such as STAT3 and A20, which are critical to maintain tolerogenic properties of DC. Furthermore, the DC-derived MFG-E8 negatively regulates the cross-priming and effector functions of antigen-specific T cells upon recognition of necrotic cells. MFG-E8 deficiency enhances an ability of necrotic cell-primed DC to stimulate antitumor immune responses against established tumors. Our findings define what we believe to a novel mechanism whereby MFG-E8 regulates the immunogenicity of DC by modulating the modes of recognition of dying cells. Manipulating MFG-E8 levels in DC may serve as a useful strategy for controlling inflammatory microenvironments caused by various pathological conditions including cancer and autoimmunity.	[Baghdadi, Muhammad; Chiba, Shigeki; Yamashina, Tsunaki; Yoshiyama, Hironori; Jinushi, Masahisa] Hokkaido Univ, Inst Med Genet, Res Ctr Infect Associated Canc, Sapporo, Hokkaido, Japan	Hokkaido University	Baghdadi, M (corresponding author), Hokkaido Univ, Inst Med Genet, Res Ctr Infect Associated Canc, Sapporo, Hokkaido, Japan.	Jinushi@igm.hokudai.ac.jp	Yoshiyama, Hironori/H-5674-2019	Yoshiyama, Hironori/0000-0001-7588-278X; Baghdadi, Muhammad/0000-0002-2347-8889; Yoshiyama, Hironori/0000-0002-9904-0736	Takeda Science Foundation; Sumitomo Foundation; Akiyama Life Science Foundation	Takeda Science Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Akiyama Life Science Foundation	This study is supported by a Grant-in-Aid for Scientific Research (C), a Grant-in-Aid for Scientific Research for Innovative Areas, Takeda Science Foundation, the Sumitomo Foundation and Akiyama Life Science Foundation (M. J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dong XY, 2005, P NATL ACAD SCI USA, V102, P16007, DOI 10.1073/pnas.0506516102; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Griffith TS, 2011, IMMUNITY, V35, P456, DOI 10.1016/j.immuni.2011.08.011; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Jinushi M, 2008, CANCER RES, V68, P8889, DOI 10.1158/0008-5472.CAN-08-2147; Jinushi M, 2007, J CLIN INVEST, V117, P1902, DOI 10.1172/JCI30966; Jinushi M, 2012, ONCOIMMUNOLOGY, V1, P189, DOI 10.4161/onci.1.2.18495; Jinushi M, 2011, P NATL ACAD SCI USA, V108, P12425, DOI 10.1073/pnas.1106645108; Jinushi M, 2009, J EXP MED, V206, P1317, DOI 10.1084/jem.20082614; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Kuraishy A, 2011, IMMUNITY, V35, P467, DOI 10.1016/j.immuni.2011.09.006; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Onai N, 2008, IMMUNITY, V28, P490, DOI 10.1016/j.immuni.2008.03.006; Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Walsh CM, 2010, IMMUNOL REV, V236, P95, DOI 10.1111/j.1600-065X.2010.00919.x; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273	32	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39607	10.1371/journal.pone.0039607	http://dx.doi.org/10.1371/journal.pone.0039607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761839	Green Published, gold, Green Submitted			2022-12-27	WOS:000305781700050
J	Newick, K; Cunniff, B; Preston, K; Held, P; Arbiser, J; Pass, H; Mossman, B; Shukla, A; Heintz, N				Newick, Kheng; Cunniff, Brian; Preston, Kelsey; Held, Paul; Arbiser, Jack; Pass, Harvey; Mossman, Brooke; Shukla, Arti; Heintz, Nicholas			Peroxiredoxin 3 Is a Redox-Dependent Target of Thiostrepton in Malignant Mesothelioma Cells	PLOS ONE			English	Article							FORKHEAD BOX M1; FLUORESCENT PROTEIN INDICATORS; BREAST-CANCER CELLS; N-TERMINAL-DOMAIN; TRANSCRIPTION FACTOR; PLEURAL MESOTHELIOMA; UP-REGULATION; HEPATOCELLULAR-CARCINOMA; THIAZOLE ANTIBIOTICS; FOXM1 EXPRESSION	Thiostrepton (TS) is a thiazole antibiotic that inhibits expression of FOXM1, an oncogenic transcription factor required for cell cycle progression and resistance to oncogene-induced oxidative stress. The mechanism of action of TS is unclear and strategies that enhance TS activity will improve its therapeutic potential. Analysis of human tumor specimens showed FOXM1 is broadly expressed in malignant mesothelioma (MM), an intractable tumor associated with asbestos exposure. The mechanism of action of TS was investigated in a cell culture model of human MM. As for other tumor cell types, TS inhibited expression of FOXM1 in MM cells in a dose-dependent manner. Suppression of FOXM1 expression and coincidental activation of ERK1/2 by TS were abrogated by pre-incubation of cells with the antioxidant N-acetyl-L-cysteine (NAC), indicating its mechanism of action in MM cells is redox-dependent. Examination of the mitochondrial thioredoxin reductase 2 (TR2)-thioredoxin 2 (TRX2)-peroxiredoxin 3 (PRX3) antioxidant network revealed that TS modifies the electrophoretic mobility of PRX3. Incubation of recombinant human PRX3 with TS in vitro also resulted in PRX3 with altered electrophoretic mobility. The cellular and recombinant species of modified PRX3 were resistant to dithiothreitol and SDS and suppressed by NAC, indicating that TS covalently adducts cysteine residues in PRX3. Reduction of endogenous mitochondrial TRX2 levels by the cationic triphenylmethane gentian violet (GV) promoted modification of PRX3 by TS and significantly enhanced its cytotoxic activity. Our results indicate TS covalently adducts PRX3, thereby disabling a major mitochondrial antioxidant network that counters chronic mitochondrial oxidative stress. Redox-active compounds like GV that modify the TR2/TRX2 network may significantly enhance the efficacy of TS, thereby providing a combinatorial approach for exploiting redox-dependent perturbations in mitochondrial function as a therapeutic approach in mesothelioma.	[Newick, Kheng; Cunniff, Brian; Preston, Kelsey; Mossman, Brooke; Shukla, Arti; Heintz, Nicholas] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Held, Paul] BioTek Instruments, Winooski, VT USA; [Arbiser, Jack] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA; [Pass, Harvey] NYU, Dept Cardiothorac Surg, Langone Med Ctr, New York, NY USA; [Newick, Kheng; Mossman, Brooke; Shukla, Arti; Heintz, Nicholas] Univ Vermont, Vermont Canc Ctr, Burlington, VT USA	University of Vermont; Emory University; New York University; NYU Langone Medical Center; University of Vermont	Newick, K (corresponding author), Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA.	nicholas.heintz@uvm.edu		Pass, Harvey/0000-0003-3222-3471	Mesothelioma Applied Research Foundation; Lake Champlain Cancer Research Organization; Vermont Cancer Center; Vermont Ladies Auxiliary of the Veterans of Foreign Wars; NIEHS [T32 ES007122-29]; MARF; LCCRO; VFW; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007122] Funding Source: NIH RePORTER	Mesothelioma Applied Research Foundation; Lake Champlain Cancer Research Organization; Vermont Cancer Center; Vermont Ladies Auxiliary of the Veterans of Foreign Wars; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); MARF; LCCRO; VFW; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The John Sterling Family Memorial grant from the Mesothelioma Applied Research Foundation, the Lake Champlain Cancer Research Organization, the Vermont Cancer Center, the Vermont Ladies Auxiliary of the Veterans of Foreign Wars, and a training grant in Environmental Pathology from the NIEHS (T32 ES007122-29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The MARF, LCCRO and VFW grants supporting this work do not have federal grant numbers, only internal numbers associated with UVM accounting. The website for the Mesothelioma Applied Research Foundation is curemeso.org. There is no website for the Lake Champlain Cancer Research Organization, a charitable organization that funds cancer research at the Vermont Cancer Center, which has the web address vermontcancer.org. The Vermont Ladies Auxilary of the VFW website is www.ladiesauxvfw.org. The website for the NIEHS in www.niehs.nih.gov.	Basu A, 2011, PROSTATE, V71, P755, DOI 10.1002/pros.21292; Bausch SL, 2005, J BIOL CHEM, V280, P29956, DOI 10.1074/jbc.M504182200; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Brown KK, 2008, FREE RADICAL BIO MED, V45, P494, DOI 10.1016/j.freeradbiomed.2008.04.030; Burch PM, 2004, MOL CELL BIOL, V24, P4696, DOI 10.1128/MCB.24.11.4696-4709.2004; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Calvisi DF, 2009, GUT, V58, P679, DOI 10.1136/gut.2008.152652; Chiu ML, 1996, BIOCHEMISTRY-US, V35, P2332, DOI 10.1021/bi952073e; Chua PJ, 2010, INT J ONCOL, V36, P359, DOI 10.3892/ijo_00000507; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Cox AG, 2009, BIOCHEMISTRY-US, V48, P6495, DOI 10.1021/bi900558g; Cox AG, 2009, BIOCHEM J, V421, P51, DOI 10.1042/BJ20090242; DOCAMPO R, 1990, DRUG METAB REV, V22, P161, DOI 10.3109/03602539009041083; Francis RE, 2009, INT J ONCOL, V35, P57, DOI 10.3892/ijo_00000313; Fried L, 2008, PIGM CELL MELANOMA R, V21, P117, DOI 10.1111/j.1755-148X.2008.00451.x; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Greer EL, 2008, ACTA PHYSIOL, V192, P19, DOI 10.1111/j.1748-1716.2007.01780.x; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Halasi M, 2010, CELL CYCLE, V9, P1214, DOI 10.4161/cc.9.6.10955; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hegde NS, 2011, NAT CHEM, V3, P725, DOI [10.1038/NCHEM.1114, 10.1038/nchem.1114]; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kahlos K, 2001, INT J CANCER, V95, P198, DOI 10.1002/1097-0215(20010520)95:3<198::AID-IJC1034>3.0.CO;2-F; Kim K, 2009, ONCOL REP, V21, P1391, DOI 10.3892/or_00000366; Kinnula VL, 2002, J PATHOL, V196, P316, DOI 10.1002/path.1042; Klaunig JE, 2011, TOXICOL APPL PHARM, V254, P86, DOI 10.1016/j.taap.2009.11.028; Knight JRP, 2012, CURR OPIN ONCOL, V24, P68, DOI 10.1097/CCO.0b013e32834d813b; Koo CY, 1819, BIOCH BIOPHYS ACTA, P28; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Korver W, 1997, GENOMICS, V46, P435, DOI 10.1006/geno.1997.5065; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Kundu K, 2009, ANGEW CHEM INT EDIT, V48, P299, DOI 10.1002/anie.200804851; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Lohman JR, 2008, BIOCHEMISTRY-US, V47, P8678, DOI 10.1021/bi800498g; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; McGovern UB, 2009, MOL CANCER THER, V8, P582, DOI 10.1158/1535-7163.MCT-08-0805; Millour J, 2011, MOL CANCER THER, V10, P1046, DOI 10.1158/1535-7163.MCT-11-0024; Moore AJ, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-34; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Pandit B, 2011, CELL CYCLE, V10, P3269, DOI 10.4161/cc.10.19.17735; Pandit B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017110; Park HJ, 2008, MOL CELL BIOL, V28, P5162, DOI 10.1128/MCB.00387-08; Park HJ, 2009, EMBO J, V28, P2908, DOI 10.1038/emboj.2009.239; PASS HI, 1995, ANN THORAC SURG, V59, P835, DOI 10.1016/0003-4975(95)00045-M; Perry BN, 2006, J INVEST DERMATOL, V126, P2316, DOI 10.1038/sj.jid.5700413; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Qiao BB, 2012, INT J MOL MED, V29, P832, DOI 10.3892/ijmm.2012.916; Qiao SX, 2012, BIOCHEM PHARMACOL, V83, P1229, DOI 10.1016/j.bcp.2012.01.027; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; REALE FR, 1987, CANCER RES, V47, P3199; Reliene R, 2006, CARCINOGENESIS, V27, P240, DOI 10.1093/carcin/bgi222; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Shukla A, 2003, AM J PHYSIOL-LUNG C, V285, pL1018, DOI 10.1152/ajplung.00038.2003; Stahel RA, 2009, FUTURE ONCOL, V5, P391, DOI 10.2217/FON.09.7; Sun XJ, 2000, DIFFERENTIATION, V66, P181, DOI 10.1111/j.1432-0436.2000.660404.x; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; Wenner CE, 2012, J CELL PHYSIOL, V227, P450, DOI 10.1002/jcp.22788; Widmer DS, 2012, PIGM CELL MELANOMA R, V25, P343, DOI 10.1111/j.1755-148X.2012.00986.x; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Yuan ZQ, 2004, CANCER RES, V64, P6530, DOI 10.1158/0008-5472.CAN-04-0946; Zhang X, 2011, FREE RADICAL BIO MED, V50, P811, DOI 10.1016/j.freeradbiomed.2010.12.036; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028	73	37	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39404	10.1371/journal.pone.0039404	http://dx.doi.org/10.1371/journal.pone.0039404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761781	Green Published, gold, Green Submitted			2022-12-27	WOS:000305781700032
J	Rodil, IF; Compton, TJ; Lastra, M				Rodil, Ivan F.; Compton, Tanya J.; Lastra, Mariano			Exploring Macroinvertebrate Species Distributions at Regional and Local Scales across a Sandy Beach Geographic Continuum	PLOS ONE			English	Article							COMMUNITY STRUCTURE; MACROFAUNA; MACROINFAUNA; REGRESSION; GRADIENT; RANGE	Exposed sandy beaches are highly dynamic ecosystems where macroinvertebrate species cope with extremely variable environmental conditions. The majority of the beach ecology studies present exposed beaches as physically dominated ecosystems where abiotic factors largely determine the structure and distribution of macrobenthic communities. However, beach species patterns at different scales can be modified by the interaction between different environmental variables, including biotic interactions. In this study, we examined the role of different environmental variables for describing the regional and local scale distributions of common macrobenthic species across 39 beaches along the North coast of Spain. The analyses were carried out using boosted regression trees, a relatively new technique from the field of machine learning. Our study showed that the macroinvertebrate community on exposed beaches is not structured by a single physical factor, but instead by a complex set of drivers including the biotic compound. Thus, at a regional scale the macrobenthic community, in terms of number of species and abundance, was mainly explained by surrogates of food availability, such as chlorophyll a. The results also revealed that the local scale is a feasible way to construct general predictive species-environmental models, since relationships derived from different beaches showed similar responses for most of the species. However, additional information on aspects of beach species distribution can be obtained with large scale models. This study showed that species-environmental models should be validated against changes in spatial extent, and also illustrates the utility of BRTs as a powerful analysis tool for ecology data insight.	[Rodil, Ivan F.; Lastra, Mariano] Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Spain; [Rodil, Ivan F.; Compton, Tanya J.] Natl Inst Water & Atmospher Res, Hamilton, New Zealand	Universidade de Vigo; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Rodil, IF (corresponding author), Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Spain.	irodil@uvigo.es	Lastra, Mariano/AAH-6289-2021; Compton, Tanya/G-6230-2012; LASTRA, MARIANO/K-9481-2017; Rodil, Iván F./I-5305-2013	Lastra, Mariano/0000-0003-2738-2056; LASTRA, MARIANO/0000-0003-2738-2056; Rodil, Iván F./0000-0001-6375-1598	Xunta Galicia	Xunta Galicia(Xunta de Galicia)	Funding to IFR was provided by a post-doctoral grant (Angeles Alvarino, Xunta Galicia) during the writing of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Salgado XA, 2001, LIMNOL OCEANOGR, V46, P135, DOI 10.4319/lo.2001.46.1.0135; Buston PM, 2011, J ANIM ECOL, V80, P528, DOI 10.1111/j.1365-2656.2011.01803.x; Celentano E, 2006, MAR BIOL, V149, P1453, DOI 10.1007/s00227-006-0309-1; Celentano E, 2010, MAR ECOL PROG SER, V398, P193, DOI 10.3354/meps08342; Cisneros KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023724; Compton TJ, 2010, DIVERS DISTRIB, V16, P243, DOI 10.1111/j.1472-4642.2010.00644.x; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Defeo O, 1997, ESTUAR COAST SHELF S, V45, P453, DOI 10.1006/ecss.1996.0200; Defeo O, 2005, MAR ECOL PROG SER, V295, P1, DOI 10.3354/meps295001; Duarte C, 2010, J SEA RES, V64, P417, DOI 10.1016/j.seares.2010.02.009; Dugan J. E., 2003, ESTUARINE COASTAL SH, V58S, P133, DOI DOI 10.1016/S0272-7714(03)00045-3; Dugan JE, 2004, OECOLOGIA, V139, P630, DOI 10.1007/s00442-004-1547-x; Dugan JE, 2010, SCIENCE, V329, P1146, DOI 10.1126/science.329.5996.1146-a; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Jaramillo E, 2001, MAR ECOL-P S Z N I, V22, P323, DOI 10.1046/j.1439-0485.2001.01752.x; JARAMILLO E, 1993, ESTUAR COAST SHELF S, V37, P615, DOI 10.1006/ecss.1993.1077; Lastra M, 2006, J SEA RES, V55, P128, DOI 10.1016/j.seares.2005.09.001; Lastra M, 2008, MAR BIOL, V154, P163, DOI 10.1007/s00227-008-0913-3; Lastra M, 2010, MAR BIOL, V157, P613, DOI 10.1007/s00227-009-1346-3; Leathwick JR, 2008, J BIOGEOGR, V35, P1481, DOI 10.1111/j.1365-2699.2008.01887.x; Lercari D, 2010, ECOL MODEL, V221, P2751, DOI 10.1016/j.ecolmodel.2010.08.027; MCLACHLAN A, 1980, S AFR J SCI, V76, P137; McLachlan A, 2006, ECOLOGY SANDY SHORES; McLachlan A., 1993, J COASTAL RES, V15, P27, DOI DOI 10.2307/25735721; Olabarria C, 2009, ESTUAR COAST SHELF S, V84, P282, DOI 10.1016/j.ecss.2009.06.021; Orr M, 2005, ECOLOGY, V86, P1496, DOI 10.1890/04-1486; Parviainen M, 2009, ECOL MODEL, V220, P2690, DOI 10.1016/j.ecolmodel.2009.07.017; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ridgeway G, 2009, GEN BOOSTED REGRESSI; Rijkenberg MJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028989; Rodil IF, 2004, ESTUAR COAST SHELF S, V61, P37, DOI 10.1016/j.ecss.2004.03.016; Rodil IF, 2006, ESTUAR COAST SHELF S, V67, P267, DOI 10.1016/j.ecss.2005.11.018; Schlacher TA, 2007, DIVERS DISTRIB, V13, P556, DOI 10.1111/j.1472-4642.2007.00363.x; Thrush SF, 2005, MAR ECOL PROG SER, V302, P13, DOI 10.3354/meps302013; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x	40	26	28	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39609	10.1371/journal.pone.0039609	http://dx.doi.org/10.1371/journal.pone.0039609			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761841	Green Published, Green Submitted, gold			2022-12-27	WOS:000305781700051
J	Helmy, A; Antoniades, CA; Guilfoyle, MR; Carpenter, KLH; Hutchinson, PJ				Helmy, Adel; Antoniades, Chrystalina A.; Guilfoyle, Mathew R.; Carpenter, Keri L. H.; Hutchinson, Peter J.			Principal Component Analysis of the Cytokine and Chemokine Response to Human Traumatic Brain Injury	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INTENSIVE-CARE PATIENTS; HUMAN VENTRICULAR CSF; CLOSED-HEAD INJURY; PROGNOSTIC VALUE; INTRACEREBRAL MICRODIALYSIS; INNATE IMMUNITY; DUAL ROLE; INTERLEUKIN-6; IMPACT	There is a growing realisation that neuro-inflammation plays a fundamental role in the pathology of Traumatic Brain Injury (TBI). This has led to the search for biomarkers that reflect these underlying inflammatory processes using techniques such as cerebral microdialysis. The interpretation of such biomarker data has been limited by the statistical methods used. When analysing data of this sort the multiple putative interactions between mediators need to be considered as well as the timing of production and high degree of statistical co-variance in levels of these mediators. Here we present a cytokine and chemokine dataset from human brain following human traumatic brain injury and use principal component analysis and partial least squares discriminant analysis to demonstrate the pattern of production following TBI, distinct phases of the humoral inflammatory response and the differing patterns of response in brain and in peripheral blood. This technique has the added advantage of making no assumptions about the Relative Recovery (RR) of microdialysis derived parameters. Taken together these techniques can be used in complex microdialysis datasets to summarise the data succinctly and generate hypotheses for future study.	[Helmy, Adel; Guilfoyle, Mathew R.; Carpenter, Keri L. H.; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Antoniades, Chrystalina A.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Dept Clin Neurol, Oxford OX1 2JD, England; [Carpenter, Keri L. H.; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Helmy, A (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge CB2 2QQ, England.	adelhelmy@cantab.net	Helmy, Adel/AAS-3084-2020; Viani, Rafael/V-1196-2018	Helmy, Adel/0000-0002-0531-0556; Antoniades, Chrystalina/0000-0002-1192-3834; Carpenter, Keri/0000-0001-8236-7727	Medical Research Council/Royal College of Surgeons of England Clinical Research Training Fellowship; Raymond and Beverly Sackler Fellowship; Royal College of Surgeons of England; National Institute of Health Research Biomedical Research Centre, Cambridge; Medical Research Council (Acute Brain Injury Programme Grant); Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; Medical Research Council [G9439390, ID 65883, G0600986, ID 79068]; National Institute of Health Research (NIHR) Oxford Biomedical Research Centre; Thames Valley Dementia and Neurodegenerative Disease Research Network (DeNDRoN); MRC [G9439390, G0802251, G1002277, G0600986] Funding Source: UKRI; Medical Research Council [G1002277, G0802251] Funding Source: researchfish; National Institute for Health Research [ACF-2006-14-004] Funding Source: researchfish	Medical Research Council/Royal College of Surgeons of England Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Raymond and Beverly Sackler Fellowship; Royal College of Surgeons of England; National Institute of Health Research Biomedical Research Centre, Cambridge(National Institute for Health Research (NIHR)); Medical Research Council (Acute Brain Injury Programme Grant)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Thames Valley Dementia and Neurodegenerative Disease Research Network (DeNDRoN); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	AH is supported by a joint Medical Research Council/Royal College of Surgeons of England Clinical Research Training Fellowship and a Raymond and Beverly Sackler Fellowship. MRG is supported by the Royal College of Surgeons of England and a Raymond and Beverly Sackler Fellowship. KLHC is supported by the National Institute of Health Research Biomedical Research Centre, Cambridge and by the Medical Research Council (Acute Brain Injury Programme Grant). PJAH is supported by the Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship. Study support was provided by the Medical Research Council (Grant numbers G9439390 ID 65883 and G0600986 ID 79068). CAA is funded by the National Institute of Health Research (NIHR) Oxford Biomedical Research Centre and by the Thames Valley Dementia and Neurodegenerative Disease Research Network (DeNDRoN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre R, 2005, NEUROREPORT, V16, P153, DOI 10.1097/00001756-200502080-00017; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Ceulemans AG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-74; Chao CC, 1995, BRAIN BEHAV IMMUN, V9, P355, DOI 10.1006/brbi.1995.1033; Chiaretti A, 2009, NEUROLOGY, V72, P609, DOI 10.1212/01.wnl.0000342462.51073.06; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Dahlin AP, 2010, ANAL CHEM, V82, P4376, DOI 10.1021/ac1007706; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Downen M, 1999, GLIA, V28, P114, DOI 10.1002/(SICI)1098-1136(199911)28:2<114::AID-GLIA3>3.0.CO;2-O; Eriksson L, 2004, ANAL BIOANAL CHEM, V380, P419, DOI 10.1007/s00216-004-2783-y; Eriksson L., 2001, MULTI MEGAVARIATE DA; Eriksson L., 2006, MULTI MEGAVARIATE DA, V2nd, DOI DOI 10.1016/j.arabjc.2013.10.006; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gasteiger J, 2006, ANAL BIOANAL CHEM, V384, P57, DOI 10.1007/s00216-005-0065-y; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Helmy A, 2011, PROG NEUROBIOL; Helmy A, 2007, CURR MED CHEM, V14, P1525, DOI 10.2174/092986707780831113; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Helmy A, 2010, ACTA NEUROCHIR, V152, P953, DOI 10.1007/s00701-009-0584-y; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hillman J, 2007, J NEUROSURG, V106, P820, DOI 10.3171/jns.2007.106.5.820; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Kirchhoff C, 2008, EUR J MED RES, V13, P464; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Marcus HJ, 2010, J NEURO-ONCOL, V97, P11, DOI 10.1007/s11060-009-9990-5; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mellergard P, 2008, NEUROSURGERY, V62, P151, DOI 10.1227/01.NEU.0000311072.33615.3A; Mellergard P, 2011, NEUROSURGERY, V68, P12, DOI 10.1227/NEU.0b013e3181ef2a40; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Pinteaux E, 2009, CYTOKINE, V45, P1, DOI 10.1016/j.cyto.2008.10.008; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Popovich PG, 2008, NAT REV NEUROSCI, V9, P481, DOI 10.1038/nrn2398; Ramon J, 2007, ADV ENG INFORM, V21, P243, DOI 10.1016/j.aei.2006.12.002; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Semple BD, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-67; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Simi A, 2007, BIOCHEM SOC T, V35, P1122, DOI 10.1042/BST0351122; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; Stein DM, 2011, NEUROCRIT CARE, V14, P200, DOI 10.1007/s12028-010-9496-1; Stenken JA, 2010, AAPS J, V12, P73, DOI 10.1208/s12248-009-9163-7; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Yao HH, 2010, J NEUROIMMUNE PHARM, V5, P489, DOI 10.1007/s11481-010-9211-1	61	74	74	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39677	10.1371/journal.pone.0039677	http://dx.doi.org/10.1371/journal.pone.0039677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745809	Green Published, gold			2022-12-27	WOS:000305730900097
J	Kayali, AG; Lopez, AD; Hao, EG; Hinton, A; Hayek, A; King, CC				Kayali, Ayse G.; Lopez, Ana D.; Hao, Ergeng; Hinton, Andrew; Hayek, Alberto; King, Charles C.			The SDF-1 alpha/CXCR4 Axis is Required for Proliferation and Maturation of Human Fetal Pancreatic Endocrine Progenitor Cells	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; EMBRYONIC STEM-CELLS; DEFINITIVE ENDODERM; NEURONAL APOPTOSIS; TRANSGENIC MICE; GROWTH-FACTOR; HIV-1 ENTRY; BETA-CELLS; DIFFERENTIATION; MIGRATION	The chemokine receptor CXCR4 and ligand SDF-1 alpha are expressed in fetal and adult mouse islets. Neutralization of CXCR4 has previously been shown to diminish ductal cell proliferation and increase apoptosis in the IFN gamma transgenic mouse model in which the adult mouse pancreas displays islet regeneration. Here, we demonstrate that CXCR4 and SDF-1 alpha are expressed in the human fetal pancreas and that during early gestation, CXCR4 colocalizes with neurogenin 3 (ngn3), a key transcription factor for endocrine specification in the pancreas. Treatment of islet like clusters (ICCs) derived from human fetal pancreas with SDF-1 alpha resulted in increased proliferation of epithelial cells in ICCs without a concomitant increase in total insulin expression. Exposure of ICCs in vitro to AMD3100, a pharmacological inhibitor of CXCR4, did not alter expression of endocrine hormones insulin and glucagon, or the pancreatic endocrine transcription factors PDX1, Nkx6.1, Ngn3 and PAX4. However, a strong inhibition of beta cell genesis was observed when in vitro AMD3100 treatment of ICCs was followed by two weeks of in vivo treatment with AMD3100 after ICC transplantation into mice. Analysis of the grafts for human C-peptide found that inhibition of CXCR4 activity profoundly inhibits islet development. Subsequently, a model pancreatic epithelial cell system (CFPAC-1) was employed to study the signals that regulate proliferation and apoptosis by the SDF-1 alpha/CXCR4 axis. From a selected panel of inhibitors tested, both the PI 3-kinase and MAPK pathways were identified as critical regulators of CFPAC-1 proliferation. SDF-1 alpha stimulated Akt phosphorylation, but failed to increase phosphorylation of Erk above the high basal levels observed. Taken together, these results indicate that SDF-1 alpha/CXCR4 axis plays a critical regulatory role in the genesis of human islets.	[Kayali, Ayse G.; Lopez, Ana D.; Hao, Ergeng; Hinton, Andrew; Hayek, Alberto; King, Charles C.] Univ Calif San Diego, Dept Pediat, Pediat Diabet Res Ctr, San Diego, CA 92103 USA	University of California System; University of California San Diego	Kayali, AG (corresponding author), Univ Calif San Diego, Dept Pediat, Pediat Diabet Res Ctr, San Diego, CA 92103 USA.	chking@ucsd.edu			Larry L. Hillblom Foundation; California Institute for Regenerative Medicine (CIRM)	Larry L. Hillblom Foundation; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine)	This work was supported by a grant from the Larry L. Hillblom Foundation and the California Institute for Regenerative Medicine (CIRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bajetto A, 2001, J NEUROCHEM, V77, P1226, DOI 10.1046/j.1471-4159.2001.00350.x; BEATTIE GM, 1993, TRANSPLANTATION, V56, P1340, DOI 10.1097/00007890-199312000-00011; Beattie GM, 1997, DIABETES, V46, P244, DOI 10.2337/diabetes.46.2.244; Biard-Piechaczyk M, 1999, IMMUNOL LETT, V70, P1, DOI 10.1016/S0165-2478(99)00124-8; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Broxmeyer HE, 2003, J IMMUNOL, V170, P421, DOI 10.4049/jimmunol.170.1.421; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Colamussi ML, 2001, J LEUKOCYTE BIOL, V69, P263; Corasaniti MT, 2001, NEUROSCI LETT, V312, P67, DOI 10.1016/S0304-3940(01)02191-7; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Fatrai S, 2006, DIABETES, V55, P318, DOI 10.2337/diabetes.55.02.06.db05-0757; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178; GU DL, 1994, RECENT PROG HORM RES, V49, P161; GU DL, 1994, DEVELOPMENT, V120, P1873; GU DL, 1993, DEVELOPMENT, V118, P33; Hayek A, 1997, J CLIN ENDOCR METAB, V82, P2471, DOI 10.1210/jc.82.8.2471; Herbein G, 1998, NATURE, V395, P189, DOI 10.1038/26026; Hernandez-Lopez C, 2002, BLOOD, V99, P546, DOI 10.1182/blood.V99.2.546; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; Hick AC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-66; Hipfner DR, 2004, NAT REV MOL CELL BIO, V5, P805, DOI 10.1038/nrm1491; Katsumoto K, 2011, DEVELOPMENT, V138, P1947, DOI 10.1242/dev.058719; Kayali AG, 2003, J CELL BIOL, V163, P859, DOI 10.1083/jcb.200304153; Kim CH, 1999, J LEUKOCYTE BIOL, V65, P6, DOI 10.1002/jlb.65.1.6; King CC, 2008, REGEN MED, V3, P175, DOI 10.2217/17460751.3.2.175; Klein RS, 2001, DEVELOPMENT, V128, P1971; Kucia M, 2004, J MOL HISTOL, V35, P233; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Lataillade JJ, 2002, BLOOD, V99, P1117, DOI 10.1182/blood.V99.4.1117; Liu DB, 2000, DIABETES, V49, P1116, DOI 10.2337/diabetes.49.7.1116; Liu Z, 2011, DIABETOLOGIA, V54, P2067, DOI 10.1007/s00125-011-2181-x; Liu Z, 2009, DIABETOLOGIA, V52, P1589, DOI 10.1007/s00125-009-1384-x; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Movassat J, 2003, DIABETOLOGIA, V46, P822, DOI 10.1007/s00125-003-1117-5; Movassat J, 2002, J CLIN ENDOCR METAB, V87, P4775, DOI 10.1210/jc.2002-020137; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Nair S, 2008, SCIENCE, V322, P89, DOI 10.1126/science.1160038; Otonkoski T, 1996, ENDOCRINOLOGY, V137, P3131, DOI 10.1210/en.137.7.3131; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; SARVETNICK N, 1988, CELL, V52, P773, DOI 10.1016/0092-8674(88)90414-X; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Wu YM, 2009, J NEUROCHEM, V109, P1157, DOI 10.1111/j.1471-4159.2009.06043.x; Yano T, 2007, DIABETES, V56, P2946, DOI 10.2337/db07-0291; Yao QZ, 2001, VIROLOGY, V285, P128, DOI 10.1006/viro.2001.0927; Yebra M, 2003, DEV CELL, V5, P695, DOI 10.1016/S1534-5807(03)00330-7; Zakeri Z, 2002, J IMMUNOL METHODS, V265, P3, DOI 10.1016/S0022-1759(02)00067-4; Zhu W, 2007, J BIOL CHEM, V282, P18676, DOI 10.1074/jbc.M610232200; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	55	21	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38721	10.1371/journal.pone.0038721	http://dx.doi.org/10.1371/journal.pone.0038721			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761699	Green Submitted, gold, Green Published			2022-12-27	WOS:000305730900018
J	Sherry, DM; Kanan, Y; Hamilton, R; Hoffhines, A; Arbogast, KL; Fliesler, SJ; Naash, MI; Moore, KL; Al-Ubaidi, MR				Sherry, David M.; Kanan, Yogita; Hamilton, Robert; Hoffhines, Adam; Arbogast, Kelsey L.; Fliesler, Steven J.; Naash, Muna I.; Moore, Kevin L.; Al-Ubaidi, Muayyad R.			Differential Developmental Deficits in Retinal Function in the Absence of either Protein Tyrosine Sulfotransferase-1 or-2	PLOS ONE			English	Article							O-SULFATION; TYROSYLPROTEIN SULFOTRANSFERASE; MONOCLONAL-ANTIBODIES; MOLECULAR-CLONING; PLASMA-MEMBRANE; MOUSE RETINA; CELLS; EXPRESSION; MICE; PURIFICATION	To investigate the role(s) of protein-tyrosine sulfation in the retina and to determine the differential role(s) of tyrosylprotein sulfotransferases (TPST) 1 and 2 in vision, retinal function and structure were examined in mice lacking TPST-1 or TPST-2. Despite the normal histologic retinal appearance in both Tpst1(-/-) and Tpst2(-/-) mice, retinal function was compromised during early development. However, Tpst1(-/-) retinas became electrophysiologically normal by postnatal day 90 while Tpst2(-/-) mice did not functionally normalize with age. Ultrastructurally, the absence of TPST-1 or TPST-2 caused minor reductions in neuronal plexus. These results demonstrate the functional importance of protein-tyrosine sulfation for proper development of the retina and suggest that the different phenotypes resulting from elimination of either TPST-1 or -2 may reflect differential expression patterns or levels of the enzymes. Furthermore, single knock-out mice of either TPST-1 or -2 did not phenocopy mice with double-knockout of both TPSTs, suggesting that the functions of the TPSTs are at least partially redundant, which points to the functional importance of these enzymes in the retina.	[Sherry, David M.; Kanan, Yogita; Hamilton, Robert; Hoffhines, Adam; Arbogast, Kelsey L.; Naash, Muna I.; Moore, Kevin L.; Al-Ubaidi, Muayyad R.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73190 USA; [Sherry, David M.; Naash, Muna I.; Al-Ubaidi, Muayyad R.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Neurosci, Oklahoma City, OK USA; [Sherry, David M.] Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK USA; [Fliesler, Steven J.] SUNY Buffalo, VA Western New York Healthcare Syst, Res Serv, Buffalo, NY 14260 USA; [Fliesler, Steven J.] SUNY Buffalo, Dept Ophthalmol, Buffalo, NY 14260 USA; [Fliesler, Steven J.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Fliesler, Steven J.] SUNY Buffalo, SUNY Eye Inst, Buffalo, NY USA; [Moore, Kevin L.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Al-Ubaidi, MR (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73190 USA.	muayyad-al-ubaidi@ouhsc.edu	Fliesler, Steven J./AAE-9243-2020	Fliesler, Steven/0000-0002-2557-142X	National Center For Research Resources [P20RR017703]; National Eye Institute [P30EY12190]; Oklahoma Center for the Advancement of Science and Technology (OCAST) [R01 EY007361, R01 HD056022, R01 EY018137, R01 EY10609]; Foundation Fighting Blindness; Research to Prevent Blindness; RPB Senior Scientific Investigator Award; NIH-NCRR [P40 RR012546]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056022] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703, P40RR012546] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY007361, R01EY018137, P30EY012190, R01EY010609] Funding Source: NIH RePORTER	National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Oklahoma Center for the Advancement of Science and Technology (OCAST); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); RPB Senior Scientific Investigator Award; NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The project described was partly supported by funds from the National Center For Research Resources (P20RR017703), the National Eye Institute (P30EY12190), Oklahoma Center for the Advancement of Science and Technology (OCAST) (DMS), R01 EY007361 (SJF), R01 HD056022 (KLM), R01 EY018137 (MRA), R01 EY10609 (MIN), the Foundation Fighting Blindness (MRA), and by an Unrestricted Grant from Research to Prevent Blindness (SJF). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources, the National Eye Institute, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SJF is the recipient of an RPB Senior Scientific Investigator Award.; We thank Barbara A. Nagel and Eileen Parks for technical assistance and Drs. Roger Janz and Robert Margolskee for their generous gifts of antisera. The synaptotagmin 2 monoclonal antibody generated by Trevarrow [17] was obtained from the Zebrafish International Resource Center, which is supported by grant P40 RR012546 from the NIH-NCRR. The Islet-1 monoclonal antibody developed by Ericson [18] was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICDH and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.	BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; BLANKS JC, 1984, INVEST OPHTH VIS SCI, V25, P546; Borghei A, 2006, J BIOL CHEM, V281, P9423, DOI 10.1074/jbc.M513768200; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; CHANG YC, 1988, J NEUROSCI, V8, P2123; Danan LM, 2008, J AM SOC MASS SPECTR, V19, P1459, DOI 10.1016/j.jasms.2008.06.021; DEBUS E, 1983, DIFFERENTIATION, V25, P193, DOI 10.1111/j.1432-0436.1984.tb01355.x; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Fox MA, 2007, J COMP NEUROL, V503, P280, DOI 10.1002/cne.21381; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; Hoffhines AJ, 2006, J BIOL CHEM, V281, P37877, DOI 10.1074/jbc.M609398200; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Huang LQ, 2003, J COMP NEUROL, V455, P1, DOI 10.1002/cne.10396; HUBER G, 1984, J NEUROSCI, V4, P151; Janz R, 1999, NEUROSCIENCE, V94, P1279, DOI 10.1016/S0306-4522(99)00370-X; Johnson J, 2004, J COMP NEUROL, V477, P386, DOI 10.1002/cne.20250; Kanan Y, 2012, ADV EXP MED BIOL, V723, P835, DOI 10.1007/978-1-4614-0631-0_107; Kanan Y, 2009, EXP EYE RES, V89, P559, DOI 10.1016/j.exer.2009.05.010; KENTROTI S, 1991, J NEUROSCI RES, V28, P497, DOI 10.1002/jnr.490280406; LEE RWH, 1983, J BIOL CHEM, V258, P1326; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; LI XH, 1995, J NEUROCHEM, V64, P1107; Moore KL, 2009, P NATL ACAD SCI USA, V106, P14741, DOI 10.1073/pnas.0908376106; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Ouyang YB, 1998, J BIOL CHEM, V273, P24770, DOI 10.1074/jbc.273.38.24770; Ouyang YB, 1998, P NATL ACAD SCI USA, V95, P2896, DOI 10.1073/pnas.95.6.2896; Ouyang YB, 2002, J BIOL CHEM, V277, P23781, DOI 10.1074/jbc.M202420200; Sherry DM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-54; Sherry DM, 2010, EUR J NEUROSCI, V32, P1461, DOI 10.1111/j.1460-9568.2010.07431.x; Sherry DM, 2003, J COMP NEUROL, V465, P480, DOI 10.1002/cne.10838; SMITH TW, 1993, CLIN NEUROPATHOL, V12, P335; Stricker HM, 2005, BIOCHEM J, V388, P605, DOI 10.1042/BJ20041960; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; Westmuckett AD, 2008, GEN COMP ENDOCR, V156, P145, DOI 10.1016/j.ygcen.2007.12.006	35	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39702	10.1371/journal.pone.0039702	http://dx.doi.org/10.1371/journal.pone.0039702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745813	gold, Green Published			2022-12-27	WOS:000305730900101
J	Sinner, DI; Kim, GJ; Henderson, GC; Igal, RA				Sinner, Debora I.; Kim, Gretchun J.; Henderson, Gregory C.; Igal, R. Ariel			StearoylCoA Desaturase-5: A Novel Regulator of Neuronal Cell Proliferation and Differentiation	PLOS ONE			English	Article							NEURAL PRECURSOR CELLS; COA DESATURASE; WNT/BETA-CATENIN; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; FATE DETERMINATION; NEURITE OUTGROWTH; CARCINOMA CELLS; CANCER; ACID; INHIBITION	Recent studies have demonstrated that human stearoylCoA desaturase-1 (SCD1), a Delta 9-desaturase that converts saturated fatty acids (SFA) into monounsaturated fatty acids, controls the rate of lipogenesis, cell proliferation and tumorigenic capacity in cancer cells. However, the biological function of stearoylCoA desaturase-5 (SCD5), a second isoform of human SCD that is highly expressed in brain, as well as its potential role in human disease, remains unknown. In this study we report that the constitutive overexpression of human SCD5 in mouse Neuro2a cells, a widely used cell model of neuronal growth and differentiation, displayed a greater n-7 MUFA-to-SFA ratio in cell lipids compared to empty-vector transfected cells (controls). De novo synthesis of phosphatidylcholine and cholesterolesters was increased whereas phosphatidylethanolamine and triacylglycerol formation was reduced in SCD5-expressing cells with respect to their controls, suggesting a differential use of SCD5 products for lipogenic reactions. We also observed that SCD5 expression markedly accelerated the rate of cell proliferation and suppressed the induction of neurite outgrowth, a typical marker of neuronal differentiation, by retinoic acid indicating that the desaturase plays a key role in the mechanisms of cell division and differentiation. Critical signal transduction pathways that are known to modulate these processes, such epidermal growth factor receptor (EGFR) Akt/ERK and Wnt, were affected by SCD5 expression. Epidermal growth factor-induced phosphorylation of EGFR, Akt and ERK was markedly blunted in SCD5-expressing cells. Furthermore, the activity of canonical Wnt was reduced whereas the non-canonical Wnt was increased by the presence of SCD5 activity. Finally, SCD5 expression increased the secretion of recombinant Wnt5a, a non-canonical Wnt, whereas it reduced the cellular and secreted levels of canonical Wnt7b. Our data suggest that, by a coordinated modulation of key lipogenic pathways and transduction signaling cascades, SCD5 participates in the regulation of neuronal cell growth and differentiation.	[Sinner, Debora I.] Cincinnati Childrens Med Ctr, Sect Neonatol Perinatal & Pulm Biol, Cincinnati, OH USA; [Kim, Gretchun J.; Igal, R. Ariel] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08903 USA; [Kim, Gretchun J.; Henderson, Gregory C.; Igal, R. Ariel] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08903 USA; [Henderson, Gregory C.] Rutgers State Univ, Dept Exercise Sci, New Brunswick, NJ 08903 USA	Cincinnati Children's Hospital Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Sinner, DI (corresponding author), Cincinnati Childrens Med Ctr, Sect Neonatol Perinatal & Pulm Biol, Cincinnati, OH USA.	igal@aesop.rutgers.edu	Sinner, Debora/AAL-1761-2021	Sinner, Debora/0000-0002-0704-5223	School of Environmental and Biological Sciences; Charles and Johanna Busch Foundation; Rutgers University; U.S. Department of Agriculture	School of Environmental and Biological Sciences; Charles and Johanna Busch Foundation; Rutgers University; U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported in part by funds from the School of Environmental and Biological Sciences and the Charles and Johanna Busch Foundation, Rutgers University, and a Hatch grant from the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler Elizabeth M, 2006, Sci STKE, V2006, ptr5, DOI 10.1126/stke.3342006tr5; Astarita G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024777; Banchio C, 2004, J BIOL CHEM, V279, P40220, DOI 10.1074/jbc.M406468200; Beiraghi S, 2003, GENE, V309, P11, DOI 10.1016/S0378-1119(03)00461-x; Binczek E, 2007, BIOL CHEM, V388, P405, DOI 10.1515/BC.2007.046; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown JM, 2010, CURR OPIN LIPIDOL, V21, P192, DOI 10.1097/MOL.0b013e32833854ac; Carter JM, 2003, J BIOL CHEM, V278, P44988, DOI 10.1074/jbc.M307336200; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Evangelopoulos ME, 2005, ONCOGENE, V24, P3309, DOI 10.1038/sj.onc.1208494; Farias GG, 2007, J NEUROSCI, V27, P5313, DOI 10.1523/JNEUROSCI.3934-06.2007; Fehrenschild D, 2012, J INVEST DERMATOL, V132, P337, DOI 10.1038/jid.2011.301; Frebel K, 2006, BIOCHEM SOC T, V34, P1287, DOI 10.1042/BST0341287; Freese JL, 2010, NEUROBIOL DIS, V38, P148, DOI 10.1016/j.nbd.2009.09.003; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; Galli LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026636; Henderson GC, 2011, ANAL BIOCHEM, V413, P66, DOI 10.1016/j.ab.2011.02.015; Hess D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011394; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hirabayashi Y, 2005, NEUROSCI RES, V51, P331, DOI 10.1016/j.neures.2005.01.004; Igal R Ariel, 2011, Cancers (Basel), V3, P2462, DOI 10.3390/cancers3022462; Igal RA, 2010, CARCINOGENESIS, V31, P1509, DOI 10.1093/carcin/bgq131; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; Katsetos CD, 2003, CELL MOTIL CYTOSKEL, V55, P77, DOI 10.1002/cm.10116; Lengi AJ, 2008, COMP BIOCHEM PHYS B, V150, P440, DOI 10.1016/j.cbpb.2008.05.001; Ma'ayan A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254cm1; Maeda M, 2009, LIFE SCI, V84, P119, DOI 10.1016/j.lfs.2008.11.009; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marcucci H, 2010, J BIOL CHEM, V285, P25382, DOI 10.1074/jbc.M110.139477; Mark MD, 1997, J BIOL CHEM, V272, P17238, DOI 10.1074/jbc.272.27.17238; Megason SG, 2002, DEVELOPMENT, V129, P2087; Menna PL, 2003, CANCER RES, V63, P2284; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Minville-Walz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014363; MIWA H, 1991, J CHROMATOGR-BIOMED, V568, P25, DOI 10.1016/0378-4347(91)80337-C; Panchision DM, 2002, CURR OPIN GENET DEV, V12, P478, DOI 10.1016/S0959-437X(02)00329-5; Paoletti L, 2011, IUBMB LIFE, V63, P714, DOI 10.1002/iub.521; Polo-Hernandez E, 2010, J NEUROCHEM, V114, P1756, DOI 10.1111/j.1471-4159.2010.06891.x; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Rodriguez-Rodriguez RA, 2004, J NEUROCHEM, V88, P1041, DOI 10.1046/j.1471-4159.2003.02262.x; Roongta UV, 2011, MOL CANCER RES, V9, P1551, DOI 10.1158/1541-7786.MCR-11-0126; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Scaglia N, 2005, J BIOL CHEM, V280, P25339, DOI 10.1074/jbc.M501159200; Scaglia N, 2008, INT J ONCOL, V33, P839, DOI 10.3892/ijo_00000072; Scaglia N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006812; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Seidensticker MJ, 2000, BBA-MOL CELL RES, V1495, P168, DOI 10.1016/S0167-4889(99)00158-5; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Strakova J, 2011, BBA-MOL CELL BIOL L, V1811, P617, DOI 10.1016/j.bbalip.2011.06.017; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Toledo EM, 2008, PROG NEUROBIOL, V86, P281, DOI 10.1016/j.pneurobio.2008.08.001; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Viti J, 2003, J NEUROSCI, V23, P5919; Wang J, 2005, BIOCHEM BIOPH RES CO, V332, P735, DOI 10.1016/j.bbrc.2005.05.013; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	61	33	34	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39787	10.1371/journal.pone.0039787	http://dx.doi.org/10.1371/journal.pone.0039787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745828	gold, Green Submitted, Green Published			2022-12-27	WOS:000305730900114
J	Wu, YY; Guo, ZK; Wu, HB; Wang, XH; Yang, LX; Shi, XY; Du, J; Tang, B; Li, WZ; Yang, LP; Zhang, Y				Wu, Yongyan; Guo, Zekun; Wu, Haibo; Wang, Xiaohai; Yang, Lixia; Shi, Xiaoyan; Du, Juan; Tang, Bo; Li, Wenzhong; Yang, Liping; Zhang, Yong			SUMOylation Represses Nanog Expression via Modulating Transcription Factors Oct4 and Sox2	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SUBCELLULAR-LOCALIZATION; PROTEIN SUMOYLATION; MOUSE EMBRYOS; DNA-BINDING; SUMO; PLURIPOTENCY; STABILITY; UBIQUITIN; LINEAGES	Nanog is a pivotal transcription factor in embryonic stem (ES) cells and is essential for maintaining the pluripotency and self-renewal of ES cells. SUMOylation has been proved to regulate several stem cell markers' function, such as Oct4 and Sox2. Nanog is strictly regulated by Oct4/Sox2 heterodimer. However, the direct effects of SUMOylation on Nanog expression remain unclear. In this study, we reported that SUMOylation repressed Nanog expression. Depletion of Sumo1 or its conjugating enzyme Ubc9 increased the expression of Nanog, while high SUMOylation reduced its expression. Interestingly, we found that SUMOylation of Oct4 and Sox2 regulated Nanog in an opposing manner. SUMOylation of Oct4 enhanced Nanog expression, while SUMOylated Sox2 inhibited its expression. Moreover, SUMOylation of Oct4 by Pias2 or Sox2 by Pias3 impaired the interaction between Oct4 and Sox2. Taken together, these results indicate that SUMOylation has a negative effect on Nanog expression and provides new insights into the mechanism of SUMO modification involved in ES cells regulation.	NW A&F Univ, Coll life Sci, Yangling, Shaanxi, Peoples R China; [Wu, Yongyan; Zhang, Yong] NW A&F Univ, Coll Vet Med, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Zhang, Y (corresponding author), NW A&F Univ, Coll Vet Med, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China.	zhy1956@263.net	Zhang, Yong/K-7945-2016; Yang, Liping/AAA-9183-2019; Wu, Yongyan/AAH-1471-2019	Zhang, Yong/0000-0001-8642-4071; Wu, Yongyan/0000-0003-1669-3860; Yang, Liping/0000-0001-9527-6015	National Natural Science Foundation of China [30870266]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant (grant number 30870266) from National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default106.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012636; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Chiu SY, 2008, PLOS BIOL, V6, P2801, DOI 10.1371/journal.pbio.0060310; Cox B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011996; Du JX, 2010, J BIOL CHEM, V285, P28298, DOI 10.1074/jbc.M110.101717; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fukuda I, 2009, CHEM BIOL, V16, P133, DOI 10.1016/j.chembiol.2009.01.009; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Georges A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025463; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Gupta P, 2008, P NATL ACAD SCI USA, V105, P11424, DOI 10.1073/pnas.0710561105; Hamard PJ, 2007, NUCLEIC ACIDS RES, V35, P1134, DOI 10.1093/nar/gkl1168; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hong YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023046; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Karantzali E, 2011, J BIOL CHEM, V286, P1037, DOI 10.1074/jbc.M110.170050; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; La Salle S, 2008, DEV BIOL, V321, P227, DOI 10.1016/j.ydbio.2008.06.020; Lavial F, 2007, DEVELOPMENT, V134, P3549, DOI 10.1242/dev.006569; Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031; Liu LB, 2007, DIABETES, V56, P1977, DOI 10.2337/db06-1100; Liu X, 2007, P NATL ACAD SCI USA, V104, P9679, DOI 10.1073/pnas.0701806104; Maderbock K, 2010, SUBCELL BIOCHEM, V54, P158, DOI 10.1007/978-1-4419-6676-6_13; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagai S, 2011, CELL RES, V21, P474, DOI 10.1038/cr.2011.31; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sanchez J, 2010, J BIOL CHEM, V285, P25841, DOI 10.1074/jbc.M110.124024; Seeler JS, 2007, CURR TOP MICROBIOL, V313, P49; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Stefanovic S, 2009, J CELL BIOL, V186, P665, DOI 10.1083/jcb.200901040; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang ZX, 2007, J BIOL CHEM, V282, P12822, DOI 10.1074/jbc.M611814200; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Woo CH, 2010, CURR OPIN PHARMACOL, V10, P146, DOI 10.1016/j.coph.2009.12.001; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yang KL, 2011, GENE DEV, V25, P1847, DOI 10.1101/gad.17020911; Zhang ZH, 2007, FASEB J, V21, P3042, DOI 10.1096/fj.06-6914com	47	30	31	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39606	10.1371/journal.pone.0039606	http://dx.doi.org/10.1371/journal.pone.0039606			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745796	Green Submitted, Green Published, gold			2022-12-27	WOS:000305730900086
J	Awasthi, M; Batra, J; Kateriya, S				Awasthi, Mayanka; Batra, Jyoti; Kateriya, Suneel			Disulphide Bridges of Phospholipase C of Chlamydomonas reinhardtii Modulates Lipid Interaction and Dimer Stability	PLOS ONE			English	Article							PLECKSTRIN-HOMOLOGY-DOMAIN; MEMBRANE; BINDING; ACTIVATION; DIMERIZATION; REQUIRES; MODEL; STATE; BETA	Background: Phospholipase C (PLC) is an enzyme that plays pivotal role in a number of signaling cascades. These are active in the plasma membrane and triggers cellular responses by catalyzing the hydrolysis of membrane phospholipids and thereby generating the secondary messengers. Phosphatidylinositol-PLC (PI-PLC) specifically interacts with phosphoinositide and/or phosphoinositol and catalyzes specific cleavage of sn-3- phosphodiester bond. Several isoforms of PLC are known to form and function as dimer but very little is known about the molecular basis of the dimerization and its importance in the lipid interaction. Principal Findings: We herein report that, the disruption of disulphide bond of a novel PI-specific PLC of C. reinhardtii (CrPLC) can modulate its interaction affinity with a set of phospholipids and also the stability of its dimer. CrPLC was found to form a mixture of higher oligomeric states with monomer and dimer as major species. Dimer adduct of CrPLC disappeared in the presence of DTT, which suggested the involvement of disulphide bond(s) in CrPLC oligomerization. Dimer-monomer equilibrium studies with the isolated fractions of CrPLC monomer and dimer supported the involvement of covalent forces in the dimerization of CrPLC. A disulphide bridge was found to be responsible for the dimerization and Cys7 seems to be involved in the formation of the disulphide bond. This crucial disulphide bond also modulated the lipid affinity of CrPLC. Oligomers of CrPLC were also captured in in vivo condition. CrPLC was mainly found to be localized in the plasma membrane of the cell. The cell surface localization of CrPLC may have significant implication in the downstream regulatory function of CrPLC. Significance: This study helps in establishing the role of CrPLC (or similar proteins) in the quaternary structure of the molecule its affinities during lipid interactions.	[Awasthi, Mayanka; Batra, Jyoti; Kateriya, Suneel] Univ Delhi, Dept Biochem, New Delhi, India	University of Delhi	Awasthi, M (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi, India.	skateriya@south.du.ac.in	Batra, Jyoti/ABI-2086-2020; AWASTHI, MAYANKA/J-1219-2019	AWASTHI, MAYANKA/0000-0002-4395-0589; Kateriya, Suneel/0000-0001-5428-4297	DBT, Govt. of India [BT/PR9090/BRB/10/540/2007]	DBT, Govt. of India(Department of Biotechnology (DBT) India)	This study was carried out with the financial support of the DBT (http://dbtindia.nic.in/index.asp), Govt. of India to SK (BT/PR9090/BRB/10/540/2007) for carrying basic research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthanarayanan B, 2002, J BIOL CHEM, V277, P3568, DOI 10.1074/jbc.M109705200; Arisz SA, 2011, J LIPID RES, V52, P2012, DOI 10.1194/jlr.M016873; BANNO Y, 1994, FEBS LETT, V340, P185, DOI 10.1016/0014-5793(94)80134-7; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; Blazer-Yost BL, 2005, PFLUG ARCH EUR J PHY, V450, P75, DOI 10.1007/s00424-004-1371-5; Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Dabdoub A, 1999, J NEUROSCI, V19, P10262; Dekker N, 1997, J BIOL CHEM, V272, P3179, DOI 10.1074/jbc.272.6.3179; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; EICHWALD C, 1993, BIOPHYS J, V65, P2047, DOI 10.1016/S0006-3495(93)81236-0; Ellis MV, 1998, J BIOL CHEM, V273, P11650, DOI 10.1074/jbc.273.19.11650; Fariselli P, 1999, PROTEINS, V36, P340; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Han JM, 2002, MOL BIOL CELL, V13, P3976, DOI 10.1091/mbc.E02-02-0100; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; HOKIN MR, 1953, J BIOL CHEM, V203, P967; Kaftan EJ, 1997, J GEN PHYSIOL, V110, P529, DOI 10.1085/jgp.110.5.529; Katan Matilda, 2005, Biochem J, V391, pe7; Kingma RL, 2002, EUR J BIOCHEM, V269, P2178, DOI 10.1046/j.1432-1033.2002.02873.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lomasney JW, 1996, J BIOL CHEM, V271, P25316, DOI 10.1074/jbc.271.41.25316; Miao BC, 2010, P NATL ACAD SCI USA, V107, P20126, DOI 10.1073/pnas.1004522107; MORIYAMA T, 1990, J BIOCHEM-TOKYO, V108, P414, DOI 10.1093/oxfordjournals.jbchem.a123215; Nomikos M, 2011, J CELL SCI, V124, P2582, DOI 10.1242/jcs.083485; Paterson HF, 1995, BIOCHEM J, V312, P661, DOI 10.1042/bj3120661; Pu MM, 2009, BIOCHEMISTRY-US, V48, P6835, DOI 10.1021/bi900633p; QUARMBY LM, 1992, J CELL BIOL, V116, P737, DOI 10.1083/jcb.116.3.737; Raussens V, 2003, ANAL BIOCHEM, V319, P114, DOI 10.1016/S0003-2697(03)00285-9; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; ROMERO G, 1987, J BIOL CHEM, V262, P13476; Shao CH, 2007, J BIOL CHEM, V282, P9228, DOI 10.1074/jbc.M610918200; Singer AU, 2002, NAT STRUCT BIOL, V9, P32, DOI 10.1038/nsb731; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Zhang X, 2004, J BIOL CHEM, V279, P20490, DOI 10.1074/jbc.M401016200	37	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39258	10.1371/journal.pone.0039258	http://dx.doi.org/10.1371/journal.pone.0039258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737232	gold, Green Published, Green Submitted			2022-12-27	WOS:000305695100030
J	Coppin, G; Delplanque, S; Porcherot, C; Cayeux, I; Sander, D				Coppin, Geraldine; Delplanque, Sylvain; Porcherot, Christelle; Cayeux, Isabelle; Sander, David			When Flexibility Is Stable: Implicit Long-Term Shaping of Olfactory Preferences	PLOS ONE			English	Article							COGNITIVE-DISSONANCE; CONNECTIONIST MODEL; DECISION-MAKING; FREE-CHOICE; STABILITY; ATTITUDES	Preferences are traditionally assumed to be stable. However, empirical evidence such as preference modulation following choices calls this assumption into question. The evolution of such postchoice preference over long time spans, even when choices have been explicitly forgotten, has so far not been studied. In two experiments, we investigated this question by using a variant of the free choice paradigm: In a first session, participants evaluated the pleasantness of a number of odors. We then formed pairs of similarly rated odors, and asked participants to choose their favorite, for each pair. Participants were then presented with all odors again, and asked for another pleasantness rating. In a second session 1 week later, a third pleasantness rating was obtained, and participants were again asked to choose between the same options. Results suggested postchoice preference modulation immediately and 1 week after choice for both chosen and rejected options, even when choices were not explicitly remembered. A third experiment, using another paradigm, confirmed that choice can have a modulatory impact on preferences, and that this modulation can be long-lasting. Taken together, these findings suggest that although preferences appear to be flexible because they are modulated by choices, this modulation also appears to be stable over time and even without explicit recollection of the choice. These results bring a new argument to the idea that postchoice preference modulation could rely on implicit mechanisms, and are consistent with the recent proposal that cognitive dissonance reduction could to some extent be implicit.	[Coppin, Geraldine; Delplanque, Sylvain; Porcherot, Christelle; Cayeux, Isabelle; Sander, David] Univ Geneva, Dept Psychol, Swiss Ctr Affect Sci, Lab Study Emot Elicitat & Express E3 Lab, Geneva, Switzerland	University of Geneva	Coppin, G (corresponding author), Univ Geneva, Dept Psychol, Swiss Ctr Affect Sci, Lab Study Emot Elicitat & Express E3 Lab, Geneva, Switzerland.	geraldine.coppin@gmail.com		Delplanque, Sylvain/0000-0002-9025-4754; Coppin, Geraldine/0000-0002-7848-3298; Sander, David/0000-0003-1266-9361	National Center of Competence in Research for the Affective Sciences; Swiss National Science Foundation [51NF40-104897]; Firmenich, SA; Firmenich	National Center of Competence in Research for the Affective Sciences; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Firmenich, SA; Firmenich	This research was supported by the National Center of Competence in Research for the Affective Sciences, financed by a grant from the Swiss National Science Foundation (51NF40-104897), hosted by the University of Geneva, and also funded by a research grant from Firmenich, SA, to David Sander and Patrik Vuilleumier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We received funding from Firmenich and have two authors affiliated with Firmenich. This does not alter the authors' adherence to all the PLoS One policies on sharing data and materials.	Aldrovandi S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00291; ALLEN VL, 1965, PSYCHOL REP, V16, P1145, DOI 10.2466/pr0.1965.16.3c.1145; ARONSON E, 1959, J ABNORM SOC PSYCH, V59, P177, DOI 10.1037/h0047195; Betsch T, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00290; BREHM JW, 1956, J ABNORM SOC PSYCH, V52, P384, DOI 10.1037/h0041006; BROCK TC, 1968, J PERS, V36, P49, DOI 10.1111/j.1467-6494.1968.tb01459.x; BROCK TC, 1963, J ABNORM PSYCHOL, V67, P53, DOI 10.1037/h0043313; Chen KM, 2008, 1669 YAL U COWL FDN; Chen MK, 2010, J PERS SOC PSYCHOL, V99, P573, DOI 10.1037/a0020217; Chen MK, 2009, J EXP SOC PSYCHOL, V45, P425, DOI 10.1016/j.jesp.2008.08.026; Chrea C, 2009, CHEM SENSES, V34, P49, DOI 10.1093/chemse/bjn052; Coppin G, 2012, NEUROSCIENCE OF PREFERENCE AND CHOICE: COGNITIVE AND NEURAL MECHANISMS, P257, DOI 10.1016/B978-0-12-381431-9.00021-8; Coppin G, 2010, PSYCHOL SCI, V21, P489, DOI 10.1177/0956797610364115; CORWIN J, 1989, NEUROPSYCHOLOGIA, V27, P513, DOI 10.1016/0028-3932(89)90056-0; Delplanque S, 2008, CHEM SENSES, V33, P469, DOI 10.1093/chemse/bjn014; Egan LC, 2007, PSYCHOL SCI, V18, P978, DOI 10.1111/j.1467-9280.2007.02012.x; Egan LC, 2010, J EXP SOC PSYCHOL, V46, P204, DOI 10.1016/j.jesp.2009.08.014; Engen T., 1988, PERFUMERY PSYCHOL BI, P79; Festinger L., 1964, CONFLICT DECISION DI, P100; Festinger L., 1957, THEORY COGNITIVE DIS, V2; FREY D, 1984, EUR J SOC PSYCHOL, V14, P447, DOI 10.1002/ejsp.2420140410; Gawronski B, 2007, J EXP SOC PSYCHOL, V43, P221, DOI 10.1016/j.jesp.2006.04.001; Gilbert DT, 2002, J PERS SOC PSYCHOL, V82, P503, DOI 10.1037//0022-3514.82.4.503; Harmon-Jones E., 1999, COGNITIVE DISSONANCE; Issanchou S, 2002, OLFACTION, TASTE, AND COGNITION, P211, DOI 10.1017/CBO9780511546389.020; Izuma K, 2010, P NATL ACAD SCI USA, V107, P22014, DOI 10.1073/pnas.1011879108; Jarcho JM, 2011, SOC COGN AFFECT NEUR, V6, P460, DOI 10.1093/scan/nsq054; Kahneman D, 1997, Q J ECON, V112, P375, DOI 10.1162/003355397555235; Lieberman MD, 2001, PSYCHOL SCI, V12, P135, DOI 10.1111/1467-9280.00323; McGregor I, 1999, SCI CON SER, P325, DOI 10.1037/10318-013; MCGUIRE WJ, 1960, J ABNORM SOC PSYCH, V60, P345, DOI 10.1037/h0048563; Monroe BM, 2008, PSYCHOL REV, V115, P733, DOI 10.1037/0033-295X.115.3.733; Payne JW, 1999, J RISK UNCERTAINTY, V19, P243, DOI 10.1023/A:1007843931054; Risen JL, 2010, SOC PERSONAL PSYCHOL, V4, P1151, DOI 10.1111/j.1751-9004.2010.00323.x; Ritov I, 2006, J BEHAV DECIS MAKING, V19, P177, DOI 10.1002/bdm.526; Rosenberg M.J., 1960, ATTITUDE ORGAN CHANG; Sagarin BJ, 2009, J EXP SOC PSYCHOL, V45, P428, DOI 10.1016/j.jesp.2008.08.027; Sagarin BJ, 2009, J EXP SOC PSYCHOL, V45, P421, DOI 10.1016/j.jesp.2008.08.024; Scherer KR, 2005, SOC SCI INFORM, V44, P695, DOI 10.1177/0539018405058216; Sharot T, 2010, PSYCHOL SCI, V21, P1231, DOI 10.1177/0956797610379235; Sharot T, 2010, J NEUROSCI, V30, P9209, DOI 10.1523/JNEUROSCI.4770-09.2010; Sharot T, 2009, J NEUROSCI, V29, P3760, DOI 10.1523/JNEUROSCI.4972-08.2009; Shultz TR, 1999, PERS SOC PSYCHOL B, V25, P40, DOI 10.1177/0146167299025001004; SVENSON O, 1992, ACTA PSYCHOL, V80, P143, DOI 10.1016/0001-6918(92)90044-E; SVENSON O, 1992, J ECON PSYCHOL, V13, P315, DOI 10.1016/0167-4870(92)90036-7; Svenson O., 2003, EMERGING PERSPECTIVE, P287, DOI DOI 10.1017/CB09780511609978.011; TEDESCHI JT, 1971, AM PSYCHOL, V26, P685, DOI 10.1037/h0032110; Van Overwalle F, 2002, PERS SOC PSYCHOL REV, V6, P204, DOI 10.1207/S15327957PSPR0603_6; VROOM VH, 1971, ORGAN BEHAV HUM PERF, V6, P36, DOI 10.1016/0030-5073(71)90004-3; Walster E., 1964, CONFLICT DECIS DISSO, P112; Wicklund R.A., 1976, PERSPECTIVES COGNITI; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848	52	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e37857	10.1371/journal.pone.0037857	http://dx.doi.org/10.1371/journal.pone.0037857			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	964KY	22761661	Green Published, gold, Green Submitted			2022-12-27	WOS:000305695100005
J	Lin, F; Li, R; Pan, ZX; Zhou, B; Yu, DB; Wang, XG; Ma, XS; Han, J; Shen, M; Liu, HL				Lin, Fei; Li, Ran; Pan, Zeng Xiang; Zhou, Bo; Yu, De Bing; Wang, Xu Guang; Ma, Xue Shan; Han, Jing; Shen, Ming; Liu, Hong Lin			miR-26b Promotes Granulosa Cell Apoptosis by Targeting ATM during Follicular Atresia in Porcine Ovary	PLOS ONE			English	Article							PIG OVARIES; SKELETAL-MUSCLE; MICRORNA TRANSCRIPTOME; EXPRESSION; FOLLICLES; CANCER; DEATH; PROTEIN; LIGAND; DNA	More than 99% of ovarian follicles undergo atresia in mammals, but the mechanism of follicular atresia remains to be elucidated. In this study, we explored microRNA (miRNA) regulation of follicular atresia in porcine ovary. A miRNA expression profile was constructed for healthy, early atretic, and progressively atretic follicles, and the differentially expressed miRNAs were selected and analyzed. We found that miR-26b, which was upregulated during follicular atresia, increased the number of DNA breaks and promoted granulosa cell apoptosis by targeting the ataxia telangiectasia mutated gene directly in vitro.	[Lin, Fei; Li, Ran; Pan, Zeng Xiang; Zhou, Bo; Yu, De Bing; Wang, Xu Guang; Ma, Xue Shan; Han, Jing; Shen, Ming; Liu, Hong Lin] Nanjing Agr Univ, Coll Anim Sci & Technol, Dept Anim Genet Breeding & Reprod, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Lin, F (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Dept Anim Genet Breeding & Reprod, Nanjing, Jiangsu, Peoples R China.	liuhonglin@263.net	Zhou, Bo/AFL-8720-2022; Lin, Fei/AEI-9957-2022; liu, honglin/HDN-0409-2022	Zhou, Bo/0000-0003-2857-8536; liu, honglin/0000-0002-1254-3163	Key Project of Chinese National Programs for Fundamental Research and Development (973 Program) [2007CB947403]; Chinese National Natural Science Fund [30901027]; Research Fund for the Doctoral Program of Higher Education of China [20090097120043]	Key Project of Chinese National Programs for Fundamental Research and Development (973 Program)(National Basic Research Program of China); Chinese National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported by the Key Project of Chinese National Programs for Fundamental Research and Development (973 Program No. 2007CB947403). This work was also supported by Chinese National Natural Science Fund (No. 30901027); this activity was funded with a Research Fund for the Doctoral Program of Higher Education of China (No. 20090097120043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2005, SCIENCE, V308, P510, DOI 10.1126/science.1112069; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; ARENDS MJ, 1990, AM J PATHOL, V136, P593; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; BJERSING L, 1967, Z ZELLFORSCH MIK ANA, V82, P173, DOI 10.1007/BF01901700; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bortul R, 2003, LEUKEMIA, V17, P379, DOI 10.1038/sj.leu.2402793; CARSON RS, 1979, BIOL REPROD, V21, P75, DOI 10.1095/biolreprod21.1.75; Cheng Y, 2008, J REPROD DEVELOP, V54, P454, DOI 10.1262/jrd.20088; Chun SY, 1996, SEMIN REPROD ENDOCR, V14, P197, DOI 10.1055/s-2007-1016329; Craig J, 2007, FRONT BIOSCI-LANDMRK, V12, P3628, DOI 10.2741/2339; DAILEY RA, 1975, J ANIM SCI, V41, P835, DOI 10.2527/jas1975.413835x; Gao XL, 2004, BIOPOLYMERS, V73, P579, DOI 10.1002/bip.20005; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; GUTHRIE HD, 1995, BIOL REPROD, V52, P920, DOI 10.1095/biolreprod52.4.920; HAY MF, 1976, CELL TISSUE RES, V169, P515, DOI 10.1007/BF00218150; Hillier SG, 1997, BAILLIERE CLIN OB GY, V11, P249, DOI 10.1016/S0950-3552(97)80036-3; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Hussein MR, 2005, HUM REPROD UPDATE, V11, P162, DOI 10.1093/humupd/dmi001; HUTZ RJ, 1990, J MED PRIMATOL, V19, P553; Inoue N, 2003, J REPROD DEVELOP, V49, P313; Inoue N, 2006, J REPROD DEVELOP, V52, P723, DOI 10.1262/jrd.18043; Ji YH, 2010, FEBS LETT, V584, P961, DOI 10.1016/j.febslet.2010.01.036; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kim J, 2008, MAMM GENOME, V19, P570, DOI 10.1007/s00335-008-9111-3; Kim J, 2010, MOL BIOL REP, V37, P3567, DOI 10.1007/s11033-010-0005-6; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Ma Y. L, 2010, J CELL MOL MED; Maeda A, 2007, J REPROD DEVELOP, V53, P481, DOI 10.1262/jrd.18149; Makrigiannakis A, 2000, ANN NY ACAD SCI, V900, P46; Manabe N, 2008, REPROD DOMEST ANIM, V43, P268, DOI 10.1111/j.1439-0531.2008.01172.x; Manabe N, 1996, EXPERIENTIA, V52, P647, DOI 10.1007/BF01925566; Matsuda-Minehata F, 2006, J REPROD DEVELOP, V52, P695, DOI 10.1262/jrd.18069; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Nakayama M, 2003, BIOL REPROD, V68, P530, DOI 10.1095/biolreprod.102.004820; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rolaki A, 2005, REPROD BIOMED ONLINE, V11, P93, DOI 10.1016/S1472-6483(10)61304-1; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Tsang WP, 2008, APOPTOSIS, V13, P1215, DOI 10.1007/s10495-008-0256-z; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Zhang ZC, 2010, J BIOL CHEM, V285, P34718, DOI 10.1074/jbc.M110.126441; Zhou B, 2010, ANIM GENET, V41, P499, DOI 10.1111/j.1365-2052.2010.02026.x; Zhu Qi, 2007, V382, P287, DOI 10.1007/978-1-59745-304-2_19	52	106	127	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38640	10.1371/journal.pone.0038640	http://dx.doi.org/10.1371/journal.pone.0038640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737216	Green Published, Green Submitted, gold			2022-12-27	WOS:000305695100014
J	Zhang, FJ; Peng, DH; Ye, XB; Yu, ZQ; Hu, ZF; Ruan, LF; Sun, M				Zhang, Fengjuan; Peng, Donghai; Ye, Xiaobo; Yu, Ziquan; Hu, Zhenfei; Ruan, Lifang; Sun, Ming			In Vitro Uptake of 140 kDa Bacillus thuringiensis Nematicidal Crystal Proteins by the Second Stage Juvenile of Meloidogyne hapla	PLOS ONE			English	Article							ROOT-KNOT NEMATODE; GREEN-FLUORESCENT PROTEIN; ARABIDOPSIS-THALIANA; FEEDING CELLS; RESISTANCE; PLANTS; EXPRESSION; TOXICITY; PARASITISM; INCOGNITA	Plant-parasitic nematodes (PPNs) are piercing/sucking pests, which cause severe damage to crops worldwide, and are difficult to control. The cyst and root-knot nematodes (RKN) are sedentary endoparasites that develop specialized multinucleate feeding structures from the plant cells called syncytia or giant cells respectively. Within these structures the nematodes produce feeding tubes, which act as molecular sieves with exclusion limits. For example, Heterodera schachtii is reportedly unable to ingest proteins larger than 28 kDa. However, it is unknown yet what is the molecular exclusion limit of the Meloidogyne hapla. Several types of Bacillus thuringiensis crystal proteins showed toxicity to M. hapla. To monitor the entry pathway of crystal proteins into M. hapla, second-stage juveniles (J2) were treated with NHS-rhodamine labeled nematicidal crystal proteins (Cry55Aa, Cry6Aa, and Cry5Ba). Confocal microscopic observation showed that these crystal proteins were initially detected in the stylet and esophageal lumen, and subsequently in the gut. Western blot analysis revealed that these crystal proteins were modified to different molecular sizes after being ingested. The uptake efficiency of the crystal proteins by the M. hapla J2 decreased with increasing of protein molecular mass, based on enzyme-linked immunosorbent assay analysis. Our discovery revealed 140 kDa nematicidal crystal proteins entered M. hapla J2 via the stylet, and it has important implications in designing a transgenic resistance approach to control RKN.	[Zhang, Fengjuan; Peng, Donghai; Ye, Xiaobo; Yu, Ziquan; Hu, Zhenfei; Ruan, Lifang; Sun, Ming] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China	Huazhong Agricultural University	Zhang, FJ (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	m98sun@mail.hzau.edu.cn	Ming, Sun/Q-1497-2015; Peng, donghai/O-7259-2016	Ming, Sun/0000-0001-5465-5983; Peng, donghai/0000-0002-4918-2357	National High Technology Research and Development Program (863) of China [2011AA10A203, 2006AA02Z174]; National Basic Research Program (973) of China [2009CB118902]; National Natural Science Foundation of China [30870066]; Genetically Modified Organisms Breeding Major Projects of China [2009ZX08009-032B]; China 948 Program of Ministry of Agriculture [2011-G25]; Ministry of Forestry [2006-4-41]; Technology Program of Wuhan [200850731360]	National High Technology Research and Development Program (863) of China(National High Technology Research and Development Program of China); National Basic Research Program (973) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Genetically Modified Organisms Breeding Major Projects of China; China 948 Program of Ministry of Agriculture; Ministry of Forestry; Technology Program of Wuhan	This study was supported by the National High Technology Research and Development Program (863) of China (2011AA10A203 and 2006AA02Z174), the National Basic Research Program (973) of China (2009CB118902), the National Natural Science Foundation of China (30870066), the Genetically Modified Organisms Breeding Major Projects of China (2009ZX08009-032B), China 948 Program of Ministry of Agriculture (2011-G25) and Ministry of Forestry (2006-4-41) and the Technology Program of Wuhan (200850731360). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MH, 1959, BACTERIOPHAGES, P446; Bellafiore S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000192; Betz FS, 2000, REGUL TOXICOL PHARM, V32, P156, DOI 10.1006/rtph.2000.1426; Bird DM, 2009, ANNU REV PHYTOPATHOL, V47, P333, DOI 10.1146/annurev-phyto-080508-081839; Bischof Larry J., 2006, V351, P139; BOCKENHOFF A, 1994, PARASITOLOGY, V109, P249, DOI 10.1017/S003118200007637X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JW, 2009, BIOCHEM J, V424, P191, DOI 10.1042/BJ20090730; Chitwood DJ, 2003, PEST MANAG SCI, V59, P748, DOI 10.1002/ps.684; Curtis RHC, 2008, PARASITE, V15, P310, DOI 10.1051/parasite/2008153310; Davis EL, 2004, TRENDS PARASITOL, V20, P134, DOI 10.1016/j.pt.2004.01.005; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; El-Alfy AT, 2002, TOXICOL SCI, V68, P381, DOI 10.1093/toxsci/68.2.381; Fang SL, 2009, APPL ENVIRON MICROB, V75, P5237, DOI 10.1128/AEM.00532-09; Goverse A, 1998, PHYSIOL MOL PLANT P, V52, P275, DOI 10.1006/pmpp.1998.0154; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Griffitts JS, 2003, J BIOL CHEM, V278, P45594, DOI 10.1074/jbc.M308142200; Guo SX, 2008, APPL ENVIRON MICROB, V74, P6997, DOI 10.1128/AEM.01346-08; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; HUSSEY RS, 1991, PROTOPLASMA, V162, P99, DOI 10.1007/BF02562553; Li XQ, 2008, BIOL CONTROL, V47, P97, DOI 10.1016/j.biocontrol.2008.06.007; Li XQ, 2007, PLANT BIOTECHNOL J, V5, P455, DOI 10.1111/j.1467-7652.2007.00257.x; Niu QH, 2010, P NATL ACAD SCI USA, V107, P16631, DOI 10.1073/pnas.1007276107; Peng DH, 2011, MICROB BIOTECHNOL, V4, P794, DOI 10.1111/j.1751-7915.2011.00295.x; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Tian B, 2007, FEMS MICROBIOL ECOL, V61, P197, DOI 10.1111/j.1574-6941.2007.00349.x; Urwin PE, 1997, MOL PLANT MICROBE IN, V10, P394, DOI 10.1094/MPMI.1997.10.3.394; Urwin PE, 2000, MOL BREEDING, V6, P257, DOI 10.1023/A:1009669325944; Yu ZQ, 2008, J MICROBIOL BIOTECHN, V18, P1033	29	41	44	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38534	10.1371/journal.pone.0038534	http://dx.doi.org/10.1371/journal.pone.0038534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737212	Green Submitted, Green Published, gold			2022-12-27	WOS:000305695100009
J	Ihler, F; Bertlich, M; Sharaf, K; Strieth, S; Strupp, M; Canis, M				Ihler, Fritz; Bertlich, Mattis; Sharaf, Kariem; Strieth, Sebastian; Strupp, Michael; Canis, Martin			Betahistine Exerts a Dose-Dependent Effect on Cochlear Stria Vascularis Blood Flow in Guinea Pigs In Vivo	PLOS ONE			English	Article							LASER-DOPPLER; INNER-EAR; RECEPTORS; VELOCITY; DISEASE; DOSAGE	Objective: Betahistine is a histamine H-1-receptor agonist and H-3-receptor antagonist that is administered to treat Meniere's disease. Despite widespread use, its pharmacological mode of action has not been entirely elucidated. This study investigated the effect of betahistine on guinea pigs at dosages corresponding to clinically used doses for cochlear microcirculation. Methods: Thirty healthy Dunkin-Hartley guinea pigs were randomly assigned to five groups to receive betahistine dihydrochloride in a dose of 1,000 mg/kg b. w. (milligram per kilogram body weight), 0.100 mg/kg b. w., 0.010 mg/kg b. w., 0.001 mg/kg b. w. in NaCl 0.9% or NaCl 0.9% alone as placebo. Cochlear blood flow and mean arterial pressure were continuously monitored by intravital fluorescence microscopy and invasive blood pressure measurements 3 minutes before and 15 minutes after administration of betahistine. Results: When betahistine was administered in a dose of 1.000 mg/kg b. w. cochlear blood flow was increased to a peak value of 1.340 arbitrary units (SD: 0.246; range: 0.933-1.546 arb. units) compared to baseline (p < 0.05; Two Way Repeated Measures ANOVA/Bonferroni t-test). The lowest dosage of 0.001 mg/kg b. w. betahistine or NaCl 0.9% had the same effect as placebo. Nonlinear regression revealed that there was a sigmoid correlation between increase in blood flow and dosages. Conclusions: Betahistine has a dose-dependent effect on the increase of blood flow in cochlear capillaries. The effects of the dosage range of betahistine on cochlear microcirculation corresponded well to clinically used single dosages to treat Meniere's disease. Our data suggest that the improved effects of higher doses of betahistine in the treatment of Meniere's disease might be due to a corresponding increase of cochlear blood flow.	[Ihler, Fritz; Canis, Martin] Goettingen Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Gottingen, Germany; [Ihler, Fritz; Strupp, Michael; Canis, Martin] Univ Munich Hosp, Integrated Ctr Res & Treatment Vertigo Balance &, Munich, Germany; [Ihler, Fritz; Bertlich, Mattis; Sharaf, Kariem; Strieth, Sebastian; Canis, Martin] Univ Munich Hosp, Walter Brendel Ctr Expt Med, Munich, Germany; [Strieth, Sebastian] Goethe Univ Frankfurt, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Frankfurt, Germany; [Strupp, Michael] Univ Munich Hosp, Dept Neurol, Munich, Germany	University of Munich; University of Munich; Goethe University Frankfurt; University of Munich	Ihler, F (corresponding author), Goettingen Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Gottingen, Germany.	martin.canis@med.uni-goettingen.de		Ihler, Friedrich/0000-0001-7066-4994; Bertlich, Mattis/0000-0002-6479-5899	German Federal Ministry of Education and Research [01 EO 0901]; Deutsche Forschungsgemeinschaft; Goettingen University Medical School	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Goettingen University Medical School	This project was supported by funds from the German Federal Ministry of Education and Research to the Integrated Center for Research and Treatment of Vertigo, Balance and Ocular Motor Disorders (University of Munich Hospital; Munich; Germany) under the Grant code 01 EO 0901. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Funds of Goettingen University Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors bear full responsibility for the content of this publication.	ARRANG JM, 1985, EUR J PHARMACOL, V111, P73, DOI 10.1016/0014-2999(85)90115-3; AXELSSON A, 1990, ACTA OTO-LARYNGOL, V109, P263, DOI 10.3109/00016489009107442; BAKER M, 1974, MICROVASC RES, V7, P131, DOI 10.1016/0026-2862(74)90043-0; Canis M, 2010, EUR ARCH OTO-RHINO-L, V267, P197, DOI 10.1007/s00405-009-1036-2; Chen X. Y., 2003, Xenobiotica, V33, P1261, DOI 10.1080/716689336; Claes J, 1997, ACTA OTO-LARYNGOL, P37; Dziadziola JK, 1999, OTOLARYNG HEAD NECK, V120, P400, DOI 10.1016/S0194-5998(99)70283-4; Gbahou F, 2010, J PHARMACOL EXP THER, V334, P945, DOI 10.1124/jpet.110.168633; GOODWIN PC, 1984, ACTA OTO-LARYNGOL, V98, P403, DOI 10.3109/00016488409107581; James Adrian, 2005, Clin Evid, P659; James AL., 2001, COCHRANE DB SYST REV, V2001, DOI [10.1002/14651858.Cd001873, DOI 10.1002/14651858.CD001873]; Lamm K, 2000, HEARING RES, V141, P199, DOI 10.1016/S0378-5955(00)00005-8; LAROUERE MJ, 1989, OTOLARYNG HEAD NECK, V101, P375, DOI 10.1177/019459988910100311; Laurikainen E, 1998, EUR ARCH OTO-RHINO-L, V255, P119, DOI 10.1007/s004050050025; Laurikainen E, 2000, ACTA OTO-LARYNGOL, P5; Lezius F, 2011, EUR ARCH OTO-RHINO-L, V268, P1237, DOI 10.1007/s00405-011-1647-2; Meniere P., 1861, GAZ MED PARIS, V16, P597; Merchant SN, 2005, OTOL NEUROTOL, V26, P74, DOI 10.1097/00129492-200501000-00013; MEYER P, 1994, LARYNGO RHINO OTOL, V73, P153, DOI 10.1055/s-2007-997100; MILLER JM, 1983, HEARING RES, V11, P385, DOI 10.1016/0378-5955(83)90069-2; MILLER JM, 1984, ARCH OTOLARYNGOL, V110, P305; Minor LB, 2004, CURR OPIN NEUROL, V17, P9, DOI 10.1097/00019052-200402000-00004; Nakashima T, 2001, HEARING RES, V162, P85, DOI 10.1016/S0378-5955(01)00372-0; Neuhauser HK, 2007, CURR OPIN NEUROL, V20, P40, DOI 10.1097/WCO.0b013e328013f432; NUTTALL AL, 1987, HEARING RES, V27, P111, DOI 10.1016/0378-5955(87)90012-8; Phillips JS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008514.pub2; PRAZMA J, 1989, HEARING RES, V42, P229, DOI 10.1016/0378-5955(89)90147-0; Pullens B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008234.pub2; Pullens B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005395.pub2; REN TY, 1993, MICROVASC RES, V46, P383, DOI 10.1006/mvre.1993.1061; Strupp M, 2008, ACTA OTO-LARYNGOL, V128, P520, DOI 10.1080/00016480701724912; Thirlwall AS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003599.pub2; Thorp MA, 2005, LANCET, V366, P2137, DOI 10.1016/S0140-6736(05)67144-9; Val L, 2010, ARZNEIMITTEL-FORSCH, V60, P440, DOI 10.1055/s-0031-1296309; Woldbaek PR, 2003, AM J PHYSIOL-HEART C, V285, pH2233, DOI 10.1152/ajpheart.01123.2002; Yeh TH, 1998, AM J PHYSIOL-CELL PH, V274, pC566, DOI 10.1152/ajpcell.1998.274.3.C566; ZEINTL H, 1989, INT J MICROCIRC, V8, P293	37	49	56	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39086	10.1371/journal.pone.0039086	http://dx.doi.org/10.1371/journal.pone.0039086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745706	gold, Green Submitted, Green Published			2022-12-27	WOS:000305693200041
J	Lauks, J; Klemmer, P; Farzana, F; Karupothula, R; Zalm, R; Cooke, NE; Li, KW; Smit, AB; Toonen, R; Verhage, M				Lauks, Juliane; Klemmer, Patricia; Farzana, Fatima; Karupothula, Ramesh; Zalm, Robbert; Cooke, Nancy E.; Li, Ka Wan; Smit, August B.; Toonen, Ruud; Verhage, Matthijs			Synapse Associated Protein 102 (SAP102) Binds the C-Terminal Part of the Scaffolding Protein Neurobeachin	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; GLUTAMATE RECEPTORS; NMDA RECEPTORS; WD-REPEAT; IDENTIFICATION; TRAFFICKING; DOMAIN; GENE; PSD-95; FAMILY	Neurobeachin (Nbea) is a multidomain scaffold protein abundant in the brain, where it is highly expressed during development. Nbea-null mice have severe defects in neuromuscular synaptic transmission resulting in lethal paralysis of the newborns. Recently, it became clear that Nbea is important also for the functioning of central synapses, where it is suggested to play a role in trafficking membrane proteins to both, the pre- and post-synaptic sites. So far, only few binding partners of Nbea have been found and the precise mechanism of their trafficking remains unclear. Here, we used mass spectrometry to identify SAP102, a MAGUK protein implicated in trafficking of the ionotropic glutamate AMPA-and NMDA-type receptors during synaptogenesis, as a novel Nbea interacting protein in mouse brain. Experiments in heterologous cells confirmed this interaction and revealed that SAP102 binds to the C-terminal part of Nbea that contains the DUF, PH, BEACH and WD40 domains. Furthermore, we discovered that introducing a mutation in Nbea's PH domain, which disrupts its interaction with the BEACH domain, abolishes this binding, thereby creating an excellent starting point to further investigate Nbea-SAP102 function in the central nervous system.	[Lauks, Juliane; Farzana, Fatima; Zalm, Robbert; Toonen, Ruud; Verhage, Matthijs] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genom, Amsterdam, Netherlands; [Klemmer, Patricia; Karupothula, Ramesh; Li, Ka Wan; Smit, August B.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Mol & Cellular Neurobiol, Amsterdam, Netherlands; [Verhage, Matthijs] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Clin Genet, Amsterdam, Netherlands; [Verhage, Matthijs] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Cooke, Nancy E.] Univ Penn, Perelman Sch Med, Dept Genet & Med, Philadelphia, PA 19104 USA	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Pennsylvania; Pennsylvania Medicine	Lauks, J (corresponding author), Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genom, Neurosci Campus Amsterdam, Amsterdam, Netherlands.	matthijs.verhage@cncr.vu.nl		verhage, matthijs/0000-0002-6085-7503; li, ka wan/0000-0001-6983-5055; Toonen, Ruud/0000-0002-9900-4233	Neuromics Marie Curie Early stage Training grant [MEST-CT_2005-020919]; EU [242167]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD025147] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, P30DK019525] Funding Source: NIH RePORTER	Neuromics Marie Curie Early stage Training grant; EU(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	JL and PK were supported by the Neuromics Marie Curie Early stage Training grant (MEST-CT_2005-020919), MV, ABS, KWL and RK are supported by the EU FP7-HEALTH-2009-2.1.2-1 SynSys grant (242167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Bottomley MJ, 1998, BBA-MOL CELL BIOL L, V1436, P165, DOI 10.1016/S0005-2760(98)00141-6; Burgess A, 2009, BIOINFORMATICS; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Chen N, 2011, NEUROMETHODS, V57, P159, DOI 10.1007/978-1-61779-111-6_12; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Cousins SL, 2008, J NEUROCHEM, V104, P903, DOI 10.1111/j.1471-4159.2007.05067.x; Crump FT, 2001, J NEUROSCI, V21, P5079, DOI 10.1523/JNEUROSCI.21-14-05079.2001; De Lozanne A, 2003, TRAFFIC, V4, P6, DOI 10.1034/j.1600-0854.2003.40102.x; del Pino I, 2011, BIOCHEM BIOPH RES CO, V412, P435, DOI 10.1016/j.bbrc.2011.07.110; DURONIO RJ, 1992, PROTEINS, V13, P41, DOI 10.1002/prot.340130105; Dyer MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012089; Elias GM, 2008, P NATL ACAD SCI USA, V105, P20953, DOI 10.1073/pnas.0811025106; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; Gardoni F, 2009, NEUROSCIENCE, V158, P324, DOI 10.1016/j.neuroscience.2008.07.068; Han JD, 1997, J BIOL CHEM, V272, P26611, DOI 10.1074/jbc.272.42.26611; HASLAM RJ, 1993, NATURE, V363, P309, DOI 10.1038/363309b0; Hassel S, 2004, PROTEOMICS, V4, P1346, DOI 10.1002/pmic.200300770; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; Jogl G, 2002, EMBO J, V21, P4785, DOI 10.1093/emboj/cdf502; Kaplan J, 2008, CURR OPIN HEMATOL, V15, P22, DOI 10.1097/MOH.0b013e3282f2bcce; Karim MA, 2002, AM J MED GENET, V108, P16, DOI 10.1002/ajmg.10184; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Kohrmann M, 1999, J NEUROSCI RES, V58, P831; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; Medrihan L, 2009, J PHYSIOL-LONDON, V587, P5095, DOI 10.1113/jphysiol.2009.178236; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Nagle DL, 1996, NAT GENET, V14, P307, DOI 10.1038/ng1196-307; NEER EJ, 1993, NAT GENET, V5, P3, DOI 10.1038/ng0993-3; Niesmann K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1565; Rudelius M, 2006, ACTA NEUROPATHOL, V112, P267, DOI 10.1007/s00401-006-0092-6; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Smith FD, 2006, EUR J CELL BIOL, V85, P585, DOI 10.1016/j.ejcb.2006.01.011; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Su YH, 2004, J NEUROSCI, V24, P3627, DOI 10.1523/JNEUROSCI.4644-03.2004; Wang JW, 2001, J IMMUNOL, V166, P4586, DOI 10.4049/jimmunol.166.7.4586; Wang XL, 2000, J NEUROSCI, V20, P8551; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004; Wu CG, 2007, PROTEOMICS, V7, P1775, DOI 10.1002/pmic.200601006; Wu WI, 2004, TRAFFIC, V5, P346, DOI 10.1111/j.1600-0854.2004.00177.x; Zheng CY, 2011, NEUROSCIENTIST, V17, P493, DOI 10.1177/1073858410386384	52	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39420	10.1371/journal.pone.0039420	http://dx.doi.org/10.1371/journal.pone.0039420			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745750	gold, Green Published, Green Submitted			2022-12-27	WOS:000305693200074
J	Ranaker, L; Nilsson, PA; Bronmark, C				Ranaker, Lynn; Nilsson, P. Anders; Bronmark, Christer			Effects of Degraded Optical Conditions on Behavioural Responses to Alarm Cues in a Freshwater Fish	PLOS ONE			English	Article							VISUAL INFORMATION; PERCA-FLUVIATILIS; LATERAL-LINE; HUMIC-ACID; PREDATOR; PREY; TURBIDITY; LIGHT; RISK; COMMUNICATION	Prey organisms often use multiple sensory cues to gain reliable information about imminent predation threat. In this study we test if a freshwater fish increases the reliance on supplementary cues when the reliability of the primary cue is reduced. Fish commonly use vision to evaluate predation threat, but may also use chemical cues from predators or injured conspecifics. Environmental changes, such as increasing turbidity or water colour, may compromise the use of vision through changes in the optical properties of water. In an experiment we tested if changes in optical conditions have any effects on how crucian carp respond to chemical predator cues. In turbidity treatments we added either clay or algae, and in a brown water colour treatment we added water with a high humic content. We found that carp reduced activity in response to predator cues, but only in the turbidity treatments (clay, algae), whereas the response in the brown water treatment was intermediate, and not significantly different from, clear and turbid water treatments. The increased reliance on chemical cues indicates that crucian carp can compensate for the reduced information content from vision in waters where optical conditions are degraded. The lower effect in brown water may be due to the reduction in light intensity, changes in the spectral composition (reduction of UV light) or to a change in chemical properties of the cue in humic waters.	[Ranaker, Lynn; Nilsson, P. Anders; Bronmark, Christer] Lund Univ, Dept Biol, Lund, Sweden	Lund University	Ranaker, L (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	lynn.ranaker@biol.lu.se	Nilsson, Anders/H-6836-2014	Nilsson, Anders/0000-0002-3541-9835	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [223-2005-1393]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	This research was funded by a grant from The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (grant # 223-2005-1393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abjornsson K, 1997, OECOLOGIA, V111, P166, DOI 10.1007/s004420050221; Abrahams M, 1997, BEHAV ECOL SOCIOBIOL, V40, P169, DOI 10.1007/s002650050330; Aksnes DL, 1997, SARSIA, V82, P137, DOI 10.1080/00364827.1997.10413647; Beauchamp DA, 1999, CAN J FISH AQUAT SCI, V56, P128, DOI 10.1139/cjfas-56-S1-128; Bronmark C, 2002, ENVIRON CONSERV, V29, P290, DOI 10.1017/S0376892902000218; Brown C., 2006, FISH COGNITION BEHAV; Brown GE, 2003, ETHOLOGY, V109, P739, DOI 10.1046/j.1439-0310.2003.00919.x; Brown GE, 2001, CAN J ZOOL, V79, P2239, DOI 10.1139/cjz-79-12-2239; Chivers DP, 2012, CHEMICAL ECOLOGY IN AQUATIC SYSTEMS, P127; Chivers DP, 2001, CAN J ZOOL, V79, P867, DOI 10.1139/cjz-79-5-867; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Erlandsson M, 2008, GLOBAL CHANGE BIOL, V14, P1191, DOI 10.1111/j.1365-2486.2008.01551.x; Fabian NJ, 2007, J CHEM ECOL, V33, P2090, DOI 10.1007/s10886-007-9377-z; Fisher HS, 2006, P ROY SOC B-BIOL SCI, V273, P1187, DOI 10.1098/rspb.2005.3406; Guthrie DM, 1993, BEHAV TELEOST FISHES, P89; Hartman EJ, 2000, P ROY SOC B-BIOL SCI, V267, P571, DOI 10.1098/rspb.2000.1039; HAWRYSHYN CW, 1985, VISION RES, V25, P11, DOI 10.1016/0042-6989(85)90075-6; Hubbard PC, 2002, AQUAT TOXICOL, V60, P169, DOI 10.1016/S0166-445X(02)00002-4; Jachner A, 1996, HYDROBIOLOGIA, V325, P151, DOI 10.1007/BF00028275; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Kim JW, 2009, J FISH BIOL, V74, P1280, DOI 10.1111/j.1095-8649.2009.02199.x; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Losey GS, 1999, J FISH BIOL, V54, P921, DOI 10.1111/j.1095-8649.1999.tb00848.x; MATHIS A, 1993, J CHEM ECOL, V19, P1967, DOI 10.1007/BF00983800; Meager JJ, 2010, MAR FRESHW BEHAV PHY, V43, P99, DOI 10.1080/10236241003798910; Mikheev VN, 2006, ECOL FRESHW FISH, V15, P111, DOI 10.1111/j.1600-0633.2006.00140.x; Miner JG, 1996, T AM FISH SOC, V125, P97, DOI 10.1577/1548-8659(1996)125<0097:DOPAHC>2.3.CO;2; Mirza RS, 2003, CAN J ZOOL, V81, P88, DOI 10.1139/Z02-216; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Montgomery JC, 1998, J EXP BIOL, V201, P91; New JG, 2001, J EXP BIOL, V204, P1207; Nurminen L, 2006, LIMNOL OCEANOGR, V51, P1550, DOI 10.4319/lo.2006.51.3.1550; Pettersson LB, 2000, OIKOS, V88, P200, DOI 10.1034/j.1600-0706.2000.880122.x; Roulet N, 2006, NATURE, V444, P283, DOI 10.1038/444283a; Sih A., 1987, P203; SKELLY DK, 1994, ANIM BEHAV, V47, P465, DOI 10.1006/anbe.1994.1063; Smith ME, 2001, BEHAV ECOL SOCIOBIOL, V51, P101, DOI 10.1007/s002650100415; Smith R.J.F., 1992, Reviews in Fish Biology and Fisheries, V2, P33, DOI 10.1007/BF00042916; Utne ACW, 1997, J FISH BIOL, V50, P926, DOI 10.1111/j.1095-8649.1997.tb01619.x; Vogel JL, 1999, CAN J FISH AQUAT SCI, V56, P1293, DOI 10.1139/cjfas-56-7-1293; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537; Wisenden BD, 2003, BEHAV ECOL SOCIOBIOL, V54, P485, DOI 10.1007/s00265-003-0653-9	42	21	22	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38411	10.1371/journal.pone.0038411	http://dx.doi.org/10.1371/journal.pone.0038411			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745663	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693200010
J	Tierney, AL; Gabard-Durnam, L; Vogel-Farley, V; Tager-Flusberg, H; Nelson, CA				Tierney, Adrienne L.; Gabard-Durnam, Laurel; Vogel-Farley, Vanessa; Tager-Flusberg, Helen; Nelson, Charles A.			Developmental Trajectories of Resting EEG Power: An Endophenotype of Autism Spectrum Disorder	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; GAMMA-OSCILLATIONS; JOINT ATTENTION; INTERNEURON DEVELOPMENT; BRAIN ASYMMETRY; FRONTAL-CORTEX; GAP-JUNCTIONS; CHILDREN; RISK; ABNORMALITIES	Current research suggests that autism spectrum disorder (ASD) is characterized by asynchronous neural oscillations. However, it is unclear whether changes in neural oscillations represent an index of the disorder or are shared more broadly among both affected and unaffected family members. Additionally, it remains unclear how early these differences emerge in development and whether they remain constant or change over time. In this study we examined developmental trajectories in spectral power in infants at high-or low-risk for ASD. Spectral power was extracted from resting EEG recorded over frontal regions of the scalp when infants were 6, 9, 12, 18 and 24 months of age. We used multilevel modeling to assess change over time between risk groups in the delta, theta, low alpha, high alpha, beta, and gamma frequency bands. The results indicated that across all bands, spectral power was lower in high-risk infants as compared to low-risk infants at 6-months of age. Furthermore high-risk infants showed different trajectories of change in spectral power in the subsequent developmental window indicating that not only are the patterns of change different, but that group differences are dynamic within the first two years of life. These findings remained the same after removing data from a subset of participants who displayed ASD related behaviors at 24 or 36 months. These differences in the nature of the trajectories of EEG power represent important endophenotypes of ASD.	[Tierney, Adrienne L.] Harvard Univ, Harvard Coll Writing Program, Cambridge, MA 02138 USA; [Tierney, Adrienne L.; Vogel-Farley, Vanessa; Nelson, Charles A.] Childrens Hosp, Dept Dev Biol, Boston, MA 02115 USA; [Gabard-Durnam, Laurel] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Tager-Flusberg, Helen] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [Nelson, Charles A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Harvard University; Boston Children's Hospital; University of California System; University of California Los Angeles; Boston University; Harvard University; Harvard Medical School	Tierney, AL (corresponding author), Harvard Univ, Harvard Coll Writing Program, Cambridge, MA 02138 USA.	adrienne_tierney@mail.harvard.edu		Gabard-Durnam, Laurel/0000-0002-4564-8068; Tager-Flusberg, Helen/0000-0002-8768-5414	NIDCD [R21 DC 08637, RO1 DC 10290]; Autism Speaks; Simon's Foundation; Sackler Scholar Programme in Psychobiology; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010290, R21DC008637] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Autism Speaks; Simon's Foundation; Sackler Scholar Programme in Psychobiology; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding was provided by grants from NIDCD R21 DC 08637 and Autism Speaks to HTF, from NIDCD RO1 DC 10290 and the Simon's Foundation to CAN and HTF, and from the Sackler Scholar Programme in Psychobiology to ALT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bailey DB, 2000, J AUTISM DEV DISORD, V30, P49; Basar E., 1999, BRAIN FUNCTION OSCIL, VII, P978; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Benasich AA, 2008, BEHAV BRAIN RES, V195, P215, DOI 10.1016/j.bbr.2008.08.049; Bosl W, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-18; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Brown C, 2005, CORTEX, V41, P364, DOI 10.1016/S0010-9452(08)70273-9; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carper RA, 2005, BIOL PSYCHIAT, V57, P126, DOI 10.1016/j.biopsych.2004.11.005; Casanova MF, 2006, ACTA NEUROPATHOL, V112, P287, DOI 10.1007/s00401-006-0085-5; Cassel TD, 2007, J AUTISM DEV DISORD, V37, P122, DOI 10.1007/s10803-006-0337-1; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Charman T, 1997, DEV PSYCHOL, V33, P781, DOI 10.1037/0012-1649.33.5.781; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Chez MG, 2004, EPILEPSY BEHAV, V5, P159, DOI 10.1016/j.yebeh.2003.11.019; Clarke AR, 2001, CLIN NEUROPHYSIOL, V112, P806, DOI 10.1016/S1388-2457(01)00488-6; CLEMENTZ BA, 1994, PSYCHOPHYSIOLOGY, V31, P486, DOI 10.1111/j.1469-8986.1994.tb01052.x; Coben R, 2008, CLIN NEUROPHYSIOL, V119, P1002, DOI 10.1016/j.clinph.2008.01.013; Constantino JN, 2010, AM J PSYCHIAT, V167, P1349, DOI 10.1176/appi.ajp.2010.09101470; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Csibra G, 2000, SCIENCE, V290, P1582, DOI 10.1126/science.290.5496.1582; Dalton KM, 2007, BIOL PSYCHIAT, V61, P512, DOI 10.1016/j.biopsych.2006.05.019; Daoust AM, 2004, CLIN NEUROPHYSIOL, V115, P1368, DOI 10.1016/j.clinph.2004.01.011; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dhossche Dirk, 2002, Med Sci Monit, V8, pPR1; Elsabbagh M, 2009, BIOL PSYCHIAT, V65, P31, DOI 10.1016/j.biopsych.2008.09.034; FOX NA, 1990, ANN NY ACAD SCI, V608, P677, DOI 10.1111/j.1749-6632.1990.tb48914.x; Gabard-Durnam L, DEV NEUROPS IN PRESS; GASSER T, 1988, ELECTROEN CLIN NEURO, V69, P91, DOI 10.1016/0013-4694(88)90204-0; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gou ZK, 2011, BEHAV BRAIN RES, V220, P263, DOI 10.1016/j.bbr.2011.01.048; Grice SJ, 2001, NEUROREPORT, V12, P2697, DOI 10.1097/00001756-200108280-00021; Hall MH, 2009, PSYCHOL MED, V39, P1277, DOI 10.1017/S0033291709005261; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Kjelgaard MM, 2006, LANG COGNITIVE PROC, V16, P287; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; Levitt P, 2005, EPILEPSIA, V46, P22, DOI 10.1111/j.1528-1167.2005.00305.x; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LOVELAND KA, 1986, J AUTISM DEV DISORD, V16, P335, DOI 10.1007/BF01531663; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Luyster RJ, 2011, BRAIN TOPOGR, V24, P220, DOI 10.1007/s10548-011-0176-z; Ma DQ, 2005, AM J HUM GENET, V77, P377, DOI 10.1086/433195; McCleery JP, 2009, BIOL PSYCHIAT, V66, P950, DOI 10.1016/j.biopsych.2009.07.031; Milne E, 2009, BIOL PSYCHIAT, V65, P22, DOI 10.1016/j.biopsych.2008.07.017; Mullen E. M, 1995, MULLEN SCALES EARLY; Mundy P, 2000, DEV PSYCHOBIOL, V36, P325, DOI 10.1002/(SICI)1098-2302(200005)36:4<325::AID-DEV7>3.3.CO;2-6; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Orekhova EV, 2008, NEUROSCI LETT, V434, P218, DOI 10.1016/j.neulet.2008.01.066; Ozonoff S, 2010, J AM ACAD CHILD PSY, V49, P256, DOI 10.1016/j.jaac.2009.11.009; Piven J, 1997, AM J PSYCHIAT, V154, P185; Rangaswamy M, 2004, INT J PSYCHOPHYSIOL, V51, P239, DOI 10.1016/j.ijpsycho.2003.09.003; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Rogers SJ, 2009, AUTISM RES, V2, P125, DOI 10.1002/aur.81; Rojas DC, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-66; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rutter M., 2003, SOCIAL COMMUNICATION; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Schmitz N, 2006, BIOL PSYCHIAT, V59, P7, DOI 10.1016/j.biopsych.2005.06.007; Siegler R, 2006, HDB CHILD PSYCHOL, V2, P3; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; Stewart JL, 2010, J ABNORM PSYCHOL, V119, P502, DOI 10.1037/a0019196; Sutton SK, 2005, J CHILD PSYCHOL PSYC, V46, P211, DOI 10.1111/j.1469-7610.2004.00341.x; Sutton SK, 1997, PSYCHOL SCI, V8, P204, DOI 10.1111/j.1467-9280.1997.tb00413.x; Szabadics J, 2001, J NEUROSCI, V21, P5824, DOI 10.1523/JNEUROSCI.21-15-05824.2001; Tager-Flusberg H, 2010, NEURAL NETWORKS, V23, P1072, DOI 10.1016/j.neunet.2010.07.008; Takano T, 1998, ACTA PAEDIATR JAPON, V40, P446; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Traub RD, 2001, J NEUROSCI, V21, P9478, DOI 10.1523/JNEUROSCI.21-23-09478.2001; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uhlhaas PJ, 2009, P NATL ACAD SCI USA, V106, P9866, DOI 10.1073/pnas.0900390106; Viding E, 2007, BEHAV GENET, V37, P51, DOI 10.1007/s10519-006-9105-4; Yasuhara A, 2010, BRAIN DEV-JPN, V32, P791, DOI 10.1016/j.braindev.2010.08.010; Zwaigenbaum L, 2005, INT J DEV NEUROSCI, V23, P143, DOI 10.1016/j.ijdevneu.2004.05.001	80	128	132	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39127	10.1371/journal.pone.0039127	http://dx.doi.org/10.1371/journal.pone.0039127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745707	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693200042
J	Willers, SM; Brunekreef, B; Smit, HA; van der Beek, EM; Gehring, U; de Jongste, JC; Kerkhof, M; Koppelman, GH; Wijga, AH				Willers, Saskia M.; Brunekreef, Bert; Smit, Henriette A.; van der Beek, Eline M.; Gehring, Ulrike; de Jongste, Johan C.; Kerkhof, Marjan; Koppelman, Gerard H.; Wijga, Alet H.			BMI Development of Normal Weight and Overweight Children in the PIAMA Study	PLOS ONE			English	Article							BODY-MASS INDEX; BIRTH COHORT; OBESITY; CHILDHOOD; GROWTH; INFANCY; GAIN; ADOLESCENTS; HEIGHT; AGE	Background: There is evidence that rapid weight gain during the first year of life is associated with overweight later in life. However, results from studies exploring other critical periods for the development of overweight are inconsistent. Objective: The objective was to investigate BMI development to assess at what ages essential differences between normal weight and overweight children occur, and to assess which age intervals the most strongly influence the risk of overweight at 8 years of age. Methods: Longitudinal weight and height data were collected by annual questionnaires in a population of 3963 children participating in the PIAMA birth cohort study. BMI and BMI standard deviation scores (SDS) were calculated for every year from birth until 8 years of age. BMI, BMI SDS and BMI SDS change in each 1-year-age interval were compared between children with and without overweight at 8 years of age, using t-tests, logistic regression analysis and the analysis of response profiles method. Results: At 8 years of age, 10.5% of the children were overweight. Already at the age of 1 year, these children had a significantly higher mean BMI SDS than normal weight 8-year-olds, (0.53 vs 0.04). In each 1-year-age interval the change in BMI SDS was significantly associated with overweight at 8 years with odds ratios increasing from 1.14 (95% CI 1.04-1.24) per 1 SDS increase at 0-1 year to 2.40 (95% CI 2.09-2.76) at 7-8 years. Conclusion: At every age, starting already in the first year of life, a rapid increase in BMI SDS was significantly associated with overweight risk at the age of 8 years. There was no evidence for a specific critical period for the development of overweight. Prevention of overweight should start early in life and be continued with age-specific interventions throughout childhood.	[Willers, Saskia M.; Brunekreef, Bert; Gehring, Ulrike] Univ Utrecht, IRAS, Div Environm Epidemiol, Utrecht, Netherlands; [Brunekreef, Bert; Smit, Henriette A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van der Beek, Eline M.] Danone Res, Ctr Specialised Nutr, Wageningen, Netherlands; [van der Beek, Eline M.] Danone Res, Ctr Specialised Nutr, Singapore, Singapore; [de Jongste, Johan C.] Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Dept Pediat,Div Resp Med, Rotterdam, Netherlands; [Kerkhof, Marjan] Univ Groningen, Dept Epidemiol, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; [Koppelman, Gerard H.] Univ Med Ctr Groningen, GRIAC Res Inst, Dept Pediat Pulmonol & Pediat Allergol, NL-9713 AV Groningen, Netherlands; [Wijga, Alet H.] Natl Inst Publ Hlth & Environm RIVM, Ctr Prevent & Hlth Serv Res, Bilthoven, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; Danone Nutricia; Danone Nutricia; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; University of Groningen; University of Groningen; Netherlands National Institute for Public Health & the Environment	Willers, SM (corresponding author), Univ Utrecht, IRAS, Div Environm Epidemiol, Utrecht, Netherlands.	alet.wijga@rivm.nl	Koppelman, Gerard/AAG-9187-2020	brunekreef, bert/0000-0001-9908-0060; Gehring, Ulrike/0000-0003-3612-5780; Koppelman, Gerard/0000-0001-8567-3252	Netherlands Organization for Health Research and Development; Netherlands Organization for Scientific Research; Netherlands Asthma Fund; Netherlands Ministry of Spatial Planning, Housing, and the Environment; Netherlands Ministry of Health Welfare and Sports; Danone Research, Centre for Specialised Nutrition, Wageningen, Netherlands	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Asthma Fund; Netherlands Ministry of Spatial Planning, Housing, and the Environment; Netherlands Ministry of Health Welfare and Sports; Danone Research, Centre for Specialised Nutrition, Wageningen, Netherlands	The PIAMA study was supported by The Netherlands Organization for Health Research and Development; The Netherlands Organization for Scientific Research; The Netherlands Asthma Fund; The Netherlands Ministry of Spatial Planning, Housing, and the Environment; and The Netherlands Ministry of Health Welfare and Sports. The present study was financially supported by Danone Research, Centre for Specialised Nutrition, Wageningen, The Netherlands. The funders had no role in study design, data collection, data analysis and decision to publish. EvB contributed to the preparation of the manuscript.	Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Balding DJ, 2004, APPL LONGITUDINAL AN; Bekkers MBM, 2011, INT J PEDIATR OBES, V6, pE78, DOI 10.3109/17477166.2010.490266; Botton J, 2008, AM J CLIN NUTR, V87, P1760, DOI 10.1093/ajcn/87.6.1760; Brunekreef B, 2002, PEDIAT ALLERG IMM-UK, V13, P55, DOI 10.1034/j.1399-3038.13.s.15.1.x; Chivers P, 2009, OBESITY FACTS, V2, P302, DOI 10.1159/000235561; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; De Kroon MLA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009155; Dennison BA, 2006, OBESITY, V14, P491, DOI 10.1038/oby.2006.64; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Ekelund U, 2006, AM J CLIN NUTR, V83, P324; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Gardner DSL, 2009, PEDIATRICS, V123, pE67, DOI 10.1542/peds.2008-1292; Goodell LS, 2009, J COMMUN HEALTH, V34, P370, DOI 10.1007/s10900-009-9164-6; Lagstrom H, 2008, PEDIATRICS, V122, pE876, DOI 10.1542/peds.2007-2354; McCarthy A, 2007, AM J CLIN NUTR, V86, P907, DOI 10.1093/ajcn/86.4.907; Mei ZG, 2007, PEDIATRICS, V119, pE1306, DOI 10.1542/peds.2006-2546; Ong KK, 2009, J CLIN ENDOCR METAB, V94, P1527, DOI 10.1210/jc.2008-2489; Peneau S, 2010, INT J PEDIATR OBES, V28, P1; Pietrobelli A, 1998, J PEDIATR-US, V132, P204, DOI 10.1016/S0022-3476(98)70433-0; Reagan PB, 2010, INT J PEDIATR OBES, V5, P80, DOI 10.3109/17477160903055929; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Rubin DB, 2004, MULTIPLE IMPUTATION; Schafer JL., 2000, ANAL INCOMPLETE MULT; Scholtens S, 2007, EUR J PUBLIC HEALTH, V17, P369, DOI 10.1093/eurpub/ckl253; Scholtens S, 2007, AM J EPIDEMIOL, V165, P919, DOI 10.1093/aje/kwk083; Schonbeck Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027608; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Silverwood RJ, 2009, INT J OBESITY, V33, P929, DOI 10.1038/ijo.2009.108; Steur M, 2011, INT J PEDIATR OBES, V6, pE170, DOI 10.3109/17477166.2010.519389; Taveras EM, 2009, PEDIATRICS, V123, P1177, DOI 10.1542/peds.2008-1149; Tzoulaki I, 2010, AM J EPIDEMIOL, V171, P989, DOI 10.1093/aje/kwq027; Vogels N, 2006, AM J CLIN NUTR, V84, P717, DOI 10.1093/ajcn/84.4.717; Wijga AH, 2010, J OBES, V2010, DOI 10.1155/2010/423296	34	18	18	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39517	10.1371/journal.pone.0039517	http://dx.doi.org/10.1371/journal.pone.0039517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761811	Green Published, Green Submitted, gold			2022-12-27	WOS:000305826400019
J	Adams, J; Halligan, J; Watson, DB; Ryan, V; Penn, L; Adamson, AJ; White, M				Adams, Jean; Halligan, Joel; Watson, Duika Burges; Ryan, Vicky; Penn, Linda; Adamson, Ashley J.; White, Martin			The Change4Life Convenience Store Programme to Increase Retail Access to Fresh Fruit and Vegetables: A Mixed Methods Process Evaluation	PLOS ONE			English	Article							QUALITATIVE DATA; HEALTH; INTERVENTIONS	Background: Consumption of fruit and vegetables is important for health, but is often lower than recommended and tends to be socio-economically patterned with lower consumption in more deprived groups. In 2008, the English Department of Health introduced the Change4Life convenience store programme. This aimed to increase retail access to fresh fruit and vegetables in deprived, urban areas by providing existing convenience stores with a range of support and branded point-of-sale materials and equipment. Methods: We undertook a mixed-methods study of the Change4Life convenience store programme in the North East of England around two years after initial implementation. Store mapping (n = 87; 100% stores) and systematic in-store observations (n = 74; 85% stores) provided information on intervention fidelity; the variety, purchase price and quality of fresh fruit and vegetables on sale; and purchase price compared to a major supermarket. Ten qualitative interviews with a purposive sample of retailers and other professionals explored experiences of the intervention and provided further insight on quantitative results. Results: Intervention stores were primarily located in socio-economically disadvantaged areas. Fidelity, in terms of presence of branded materials and equipment, was low and much was not being used as intended. Fresh fruit and vegetables on sale were of high quality and had a purchase price around 10% more than comparable products at a major supermarket. Interviewees were supportive of the health improvement aim of the intervention. Retailers were appreciative of part-funding for chill cabinets and free point-of-sale materials. The intervention suffered from: poor initial and on-going communication between the intervention delivery team and retailers; poor availability of replacement point-of-sale materials; and failure to cement intended links with health workers and community organisations. Conclusions: Overall, intervention fidelity was low and the intervention is unlikely to have had a substantial or long-term effect on customers' consumption of fruit and vegetables.	[Adams, Jean; Halligan, Joel; Ryan, Vicky; Penn, Linda; Adamson, Ashley J.; White, Martin] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Watson, Duika Burges] Univ Durham, Sch Med & Hlth, Stockton On Tees, England; [Adamson, Ashley J.] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Durham University; Newcastle University - UK	Adams, J (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	j.m.adams@ncl.ac.uk	Adams, Jean/G-2402-2010; Burges Watson, Duika/C-4899-2009	Adams, Jean/0000-0002-5733-7830; White, Martin/0000-0002-1861-6757; Burges Watson, Duika/0000-0002-5791-9670; Adamson, Ashley/0000-0003-3735-2846	National Institute for Health Research (NIHR) [09/3001/17]; Fuse - the Centre for Translational Research in Public Health; British Heart Foundation; Cancer Research United Kingdom; Economic and Social Research Council; Medical Research Council; National Institute for Health Research under United Kingdom Clinical Research Collaboration; Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish; Medical Research Council [G0900686] Funding Source: researchfish; ESRC [ES/G007470/1] Funding Source: UKRI; MRC [G0900686] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Fuse - the Centre for Translational Research in Public Health; British Heart Foundation(British Heart Foundation); Cancer Research United Kingdom(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research under United Kingdom Clinical Research Collaboration; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded by the National Institute for Health Research (NIHR) Public Health Research (PHR) programme (grant number 09/3001/17). The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the PHR programme, NIHR, National Health Service or the Department of Health. JA, DBW, MW and AJA receive salary support from Fuse - the Centre for Translational Research in Public Health which is funded by the British Heart Foundation, Cancer Research United Kingdom, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the United Kingdom Clinical Research Collaboration (http://www.esrc.ac.uk/aboutesrc/what-we-do/our-research/ukcrc.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulac J, 2009, PREV CHRONIC DIS, V6; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Cross-Government Obesity Unit Department of Health & Department of Children Schools and Families, 2008, HLTH WEIGHT HLTH LIV; Department of Health, 2010, CHANGE4LIFE CONV STO; Department of Health and Human Services, 2007, HLTH PEOPL 2010 MIDC; Gittelsohn J, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110015; Henderson L, 2002, NATL DIET NUTR SURVE; Innvaer Simon, 2002, J Health Serv Res Policy, V7, P239, DOI 10.1258/135581902320432778; Institute of Grocery Distribution, 2008, CONV RET MARK OV; Kelly B, 2011, HEALTH PLACE, V17, P1284, DOI 10.1016/j.healthplace.2011.08.014; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; Linnan L., 2002, PROCESS EVALUATION P, P1; Mallonee S, 2006, INJURY PREV, V12, P357, DOI 10.1136/ip.2006.014159; McKinnon RA, 2009, AM J PREV MED, V36, pS124, DOI 10.1016/j.amepre.2009.01.012; Moffatt S, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-28; Noble M, 2008, ENGLISH INDICES DEPR; Nutbeam D, 1998, HEALTH PROMOT INT, V13, P27, DOI 10.1093/heapro/13.1.27; Office of the Deputy Prime Minister, 2002, URB RUR AR DEF US GU; Ogilvie D, 2011, MILBANK Q, V89, P206, DOI 10.1111/j.1468-0009.2011.00626.x; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Scottish Grocers Federation, 2007, SGF HLTH LIV PROGR B; Simpson L., 2002, INT J POPULATION GEO, V8, P69, DOI [10.1002/ijpg.235, DOI 10.1002/IJPG.235]; Synovate, 2009, CONV STOR CHANGE4LIF; Van Duyn MS, 2000, J AM DIET ASSOC, V100, P1511, DOI 10.1016/S0002-8223(00)00420-X; White M, 2007, OBES REV, V8, P99, DOI 10.1111/j.1467-789X.2007.00327.x	26	24	24	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39431	10.1371/journal.pone.0039431	http://dx.doi.org/10.1371/journal.pone.0039431			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761795	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305825800034
J	Perez, J; Decouvelaere, AV; Pointecouteau, T; Pissaloux, D; Michot, JP; Besse, A; Blay, JY; Dutour, A				Perez, Jennifer; Decouvelaere, Anne Valerie; Pointecouteau, Thomas; Pissaloux, Daniel; Michot, Jean Philippe; Besse, Anthony; Blay, Jean Yves; Dutour, Aurelie			Inhibition of Chondrosarcoma Growth by mTOR Inhibitor in an In Vivo Syngeneic Rat Model	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; MAMMALIAN TARGET; BREAST-CANCER; RAPAMYCIN; RESISTANCE; THERAPY; EVEROLIMUS; PATHWAY; AKT; COMBINATION	Background: Chondrosarcomas are the second most frequent primary malignant type of bone tumor. No effective systemic treatment has been identified in advanced or adjuvant phases for chondrosarcoma. The aim of the present study was to determine the antitumor effects of doxorubicin and everolimus, an mTOR inhibitor on chondrosarcoma progression. Methods and Findings: Doxorubin and/or everolimus were tested in vivo as single agent or in combination in the rat orthotopic Schwarm chondrosarcoma model, in macroscopic phase, as well as with microscopic residual disease. Response to everolimus and/or doxorubicin was evaluated using chondrosarcoma volume evolution (MRI). Histological response was evaluated with % of tumor necrosis, tumor proliferation index, metabolism quantification analysis between the treated and control groups. Statistical analyses were performed using chi square, Fishers exact test. Doxorubicin single agent has no effect of tumor growth as compared to no treatment; conversely, everolimus single agent significantly inhibited tumor progression in macroscopic tumors with no synergistic additive effect with doxorubicin. Everolimus inhibited chondrosarcoma proliferation as evaluated by Ki67 expression did not induce the apoptosis of tumor cells; everolimus reduced Glut1 and 4EBP1 expression. Importantly when given in rats with microscopic residual diseases, in a pseudo neoadjuvant setting, following R1 resection of the implanted tumor, everolimus significantly delayed or prevented tumor recurrence. Conclusions: MTOR inhibitor everolimus blocks cell proliferation, Glut1 expression and HIF1a expression, and prevents in vivo chondrosarcoma tumor progression in both macroscopic and in adjuvant phase post R1 resection. Taken together, our preclinical data indicate that mTOR inhibitor may be effective as a single agent in treating chondrosarcoma patients. A clinical trial evaluating mTOr inhibitor as neo-adjuvant and adjuvant therapy in chondrosarcoma patients is being constructed.	[Perez, Jennifer; Pointecouteau, Thomas; Besse, Anthony; Dutour, Aurelie] Ctr Rech Cancerol, UMR Inserm U1052, Equipe CLB 11, Dept Clin Sci, Lyon, France; [Decouvelaere, Anne Valerie; Pissaloux, Daniel; Michot, Jean Philippe] Ctr Leon Berard, Dept Biopathol & Cytol, F-69373 Lyon, France; [Blay, Jean Yves] Univ Lyon 1, Ctr Rech Cancerol, Dept Clin Sci, Ctr Leon Berard,Dept Med Oncol, F-69365 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard	Perez, J (corresponding author), Ctr Rech Cancerol, UMR Inserm U1052, Equipe CLB 11, Dept Clin Sci, Lyon, France.	aurelie.dutour@lyon.unicancer.fr	Dutour, Aurelie/D-8527-2014; Blay, Jean-Yves/N-3966-2016	Blay, Jean-Yves/0000-0001-7190-120X; PISSALOUX, Daniel/0000-0003-1118-950X	La Ligue nationale contre le cancer (comite de la Drome); NETSARC; RREPS; LYRIC; CONTICANET; EUROSARC (European Union) [278742]; Rhone Alpes, France	La Ligue nationale contre le cancer (comite de la Drome); NETSARC; RREPS; LYRIC; CONTICANET; EUROSARC (European Union); Rhone Alpes, France(Region Auvergne-Rhone-Alpes)	This work was supported by: La Ligue nationale contre le cancer (comite de la Drome), NETSARC, RREPS, LYRIC, CONTICANET, EUROSARC (European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement no278742). JP was supported by a grant Cible from the region Rhone Alpes, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams SL, 2010, CELL CYCLE, V9, P1781, DOI 10.4161/cc.9.9.11483; Bianco R, 2008, BRIT J CANCER, V98, P923, DOI 10.1038/sj.bjc.6604269; Bovee JVMG, 2005, LANCET ONCOL, V6, P599, DOI 10.1016/S1470-2045(05)70282-5; Dickey ID, 2004, J BONE JOINT SURG AM, V86A, P2412, DOI 10.2106/00004623-200411000-00008; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gelderblom H, 2008, ONCOLOGIST, V13, P320, DOI 10.1634/theoncologist.2007-0237; Gouin F, 2006, INT J CANCER, V119, P980, DOI 10.1002/ijc.21951; Grunwald V, 2002, CANCER RES, V62, P6141; Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249; Hernando E, 2007, NAT MED, V13, P748, DOI 10.1038/nm1560; Holland WS, 2012, CANCER CHEMOTH PHARM, V69, P185, DOI 10.1007/s00280-011-1684-y; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Ito D, 2006, INT J CANCER, V118, P2337, DOI 10.1002/ijc.21532; Kalinski T, 2009, PATHOL RES PRACT, V205, P339, DOI 10.1016/j.prp.2008.12.008; Mabuchi S, 2007, CANCER RES, V67, P2408, DOI 10.1158/0008-5472.CAN-06-4490; Mazzoletti M, 2011, CANCER RES, V71, P4573, DOI 10.1158/0008-5472.CAN-10-4322; McCubrey JA, 2008, LEUKEMIA, V22, P708, DOI 10.1038/leu.2008.27; McCubrey JA, 2008, ADV ENZYME REGUL, V48, P113, DOI 10.1016/j.advenzreg.2008.02.006; Merimsky O, 2008, ANTI-CANCER DRUG, V19, P1019, DOI 10.1097/CAD.0b013e328312c0e5; Mondesire WH, 2004, CLIN CANCER RES, V10, P7031, DOI 10.1158/1078-0432.CCR-04-0361; Moriceau G, 2010, CANCER RES, V70, P10329, DOI 10.1158/0008-5472.CAN-10-0578; Nathan CAO, 2007, CANCER RES, V67, P2160, DOI 10.1158/0008-5472.CAN-06-2449; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; O'Reilly T, 2011, ANTI-CANCER DRUG, V22, P58, DOI 10.1097/CAD.0b013e3283400a20; Perl AE, 2009, CLIN CANCER RES, V15, P6732, DOI 10.1158/1078-0432.CCR-09-0842; Piguet AC, 2008, J HEPATOL, V49, P78, DOI 10.1016/j.jhep.2008.03.024; Quek R, 2011, CLIN CANCER RES, V17, P871, DOI 10.1158/1078-0432.CCR-10-2621; Shelton JG, 2004, CELL CYCLE, V3, P372; Strimpakos AS, 2009, CANCER TREAT REV, V35, P148, DOI 10.1016/j.ctrv.2008.09.006; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Wagner AJ, 2010, J CLIN ONCOL, V28, P835, DOI 10.1200/JCO.2009.25.2981; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wan XL, 2007, ONCOLOGIST, V12, P1007, DOI 10.1634/theoncologist.12-8-1007; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yuan RR, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-45; Zhang WS, 2009, CANCER RES, V69, P7466, DOI 10.1158/0008-5472.CAN-08-4385	37	52	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e32458	10.1371/journal.pone.0032458	http://dx.doi.org/10.1371/journal.pone.0032458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761648	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800001
J	Brett, MT; Arhonditsis, GB; Chandra, S; Kainz, MJ				Brett, Michael T.; Arhonditsis, George B.; Chandra, Sudeep; Kainz, Martin J.			Mass Flux Calculations Show Strong Allochthonous Support of Freshwater Zooplankton Production Is Unlikely	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; HETEROTROPHIC BACTERIA; TERRESTRIAL SUPPORT; HUMIC SUBSTANCES; LAKES; PARADIGM; PATTERNS	Many studies have concluded terrestrial carbon inputs contribute 20-70% of the carbon supporting zooplankton and fish production in lakes. Conversely, it is also known that terrestrial carbon inputs are of very low nutritional quality and phytoplankton are strongly preferentially utilized by zooplankton. Because of its low quality, substantial terrestrial support of zooplankton production in lakes is only conceivable when terrigenous organic matter inputs are much larger than algal production. We conducted a quantitative analysis of terrestrial carbon mass influx and algal primary production estimates for oligo/mesotrophic lakes (i.e., TP <= 20 mu g L 21). In keeping with the principle of mass conservation, only the flux of terrestrial carbon retained within lakes can be utilized by zooplankton. Our field data compilation showed the median (inter-quartile range) terrestrial particulate organic carbon (t-POC), available dissolved organic carbon (t-DOC) inputs, and in-lake bacterial and algal production were 11 (8-17), 34 (11-78), 74 (37-165), and 253 (115-546) mg C m(-2) d(-1), respectively. Despite the widespread view that terrestrial inputs dominate the carbon flux of many lakes, our analysis indicates algal production is a factor 4-7 greater than the available flux of allochthonous basal resources in low productivity lakes. Lakes with high loading of t-DOC also have high hydraulic flushing rates. Because t-DOC is processed, i.e., mineralized or lost to the sediments, in lakes at approximate to 0.1% d(-1), in systems with the highest t-DOC inputs (i.e., 1000 mg m(-2) d(-1)) a median of 98% of the t-DOC flux is advected and therefore is not available to support zooplankton production. Further, advection is the primary fate of t-DOC in lakes with hydraulic retention times <3 years. When taking into account the availability and quality of terrestrial and autochthonous fluxes, this analysis indicates approximate to 95-99% of aquatic herbivore production is supported by in-lake primary production.	[Brett, Michael T.] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA; [Arhonditsis, George B.] Univ Toronto, Ecol Modeling Lab, Toronto, ON, Canada; [Chandra, Sudeep] Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA; [Kainz, Martin J.] Donau Univ Krems, WasserCluster Lunz Biol Stn, Lunz Am See, Austria	University of Washington; University of Washington Seattle; University of Toronto; Nevada System of Higher Education (NSHE); University of Nevada Reno; Danube University Krems	Brett, MT (corresponding author), Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA.	mtbrett@uw.edu	Arhonditsis, George/AAI-7897-2020; Kainz, Martin/AAG-6268-2021; Arhonditsis, George B/C-6980-2009	Arhonditsis, George/0000-0001-5359-8737; 	National Science Foundation [0642834]; Association for the Sciences of Limnology and Oceanography	National Science Foundation(National Science Foundation (NSF)); Association for the Sciences of Limnology and Oceanography	This work was supported by National Science Foundation grant 0642834 to MTB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This manuscript was derived from discussions initiated at the Association for the Sciences of Limnology and Oceanography sponsored Emerging Issues workshop titled "A synthesis of the importance of allochthonous and autochthonous support of consumers in aquatic ecosystems" held June 2010 in Sante Fe, New Mexico. We are grateful for support provided for this workshop and the constructive comments of the Academic Editor Caroline Slomp and five anonymous reviewers.	Algesten G, 2004, GLOBAL CHANGE BIOL, V10, P141, DOI 10.1111/j.1365-2486.2003.00721.x; Berggren M, 2010, ECOL LETT, V13, P870, DOI 10.1111/j.1461-0248.2010.01483.x; Brett MT, 2008, FRESHWATER BIOL, V53, P194, DOI 10.1111/j.1365-2427.2007.01862.x; Brett MT, 2009, P NATL ACAD SCI USA, V106, P21197, DOI 10.1073/pnas.0904129106; Brett MT, 2004, OIKOS, V105, P647, DOI 10.1111/j.0030-1299.2004.12777.x; Carignan R, 2000, LIMNOL OCEANOGR, V45, P189, DOI 10.4319/lo.2000.45.1.0189; Christensen DL, 1996, LIMNOL OCEANOGR, V41, P553, DOI 10.4319/lo.1996.41.3.0553; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cole JJ, 1998, ECOSYSTEMS, V1, P310, DOI 10.1007/s100219900024; Cole JJ, 2006, ECOL LETT, V9, P558, DOI 10.1111/j.1461-0248.2006.00898.x; Cole JJ, 2011, P NATL ACAD SCI USA, V108, P1975, DOI 10.1073/pnas.1012807108; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; DELGIORGIO PA, 1994, LIMNOL OCEANOGR, V39, P772, DOI 10.4319/lo.1994.39.4.0772; Dillon PJ, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2004JG000003; Dillon PJ, 1997, BIOGEOCHEMISTRY, V36, P29, DOI 10.1023/A:1005731828660; Dubois K, 2009, APPL GEOCHEM, V24, P988, DOI 10.1016/j.apgeochem.2009.03.001; ECKHARDT BW, 1990, CAN J FISH AQUAT SCI, V47, P1537, DOI 10.1139/f90-173; Fenchel T, 2008, J EXP MAR BIOL ECOL, V366, P99, DOI 10.1016/j.jembe.2008.07.013; Fouilland E, 2010, FEMS MICROBIOL ECOL, V73, P419, DOI 10.1111/j.1574-6941.2010.00896.x; Francis TB, 2011, ECOL LETT, V14, P364, DOI 10.1111/j.1461-0248.2011.01597.x; Grey J, 2001, LIMNOL OCEANOGR, V46, P505, DOI 10.4319/lo.2001.46.3.0505; Hanson PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021884; Jansson M, 2007, TRENDS ECOL EVOL, V22, P316, DOI 10.1016/j.tree.2007.02.015; JONES RI, 1992, HYDROBIOLOGIA, V229, P73, DOI 10.1007/BF00006992; Karlsson J, 2003, LIMNOL OCEANOGR, V48, P269, DOI 10.4319/lo.2003.48.1.0269; Lewis WM, 2011, INLAND WATERS, V1, P1, DOI 10.5268/IW-1.1.384; Martin-Creuzburg D, 2011, FEMS MICROBIOL ECOL, V76, P592, DOI 10.1111/j.1574-6941.2011.01076.x; Pace ML, 2007, LIMNOL OCEANOGR, V52, P2177, DOI 10.4319/lo.2007.52.5.2177; Pace ML, 2004, NATURE, V427, P240, DOI 10.1038/nature02227; PETERSON BJ, 1980, ANNU REV ECOL SYST, V11, P359, DOI 10.1146/annurev.es.11.110180.002043; Prairie YT, 2008, CAN J FISH AQUAT SCI, V65, P543, DOI 10.1139/F08-011; Preston ND, 2008, AQUAT SCI, V70, P213, DOI 10.1007/s00027-008-8074-5; RASMUSSEN JB, 1989, LIMNOL OCEANOGR, V34, P1336, DOI 10.4319/lo.1989.34.7.1336; Reynolds CS, 2008, INT REV HYDROBIOL, V93, P517, DOI 10.1002/iroh.200711026; Schindler DW, 1997, BIOGEOCHEMISTRY, V36, P9, DOI 10.1023/A:1005792014547; Sobek S, 2007, LIMNOL OCEANOGR, V52, P1208, DOI 10.4319/lo.2007.52.3.1208; Steinberg CEW, 2006, FRESHWATER BIOL, V51, P1189, DOI 10.1111/j.1365-2427.2006.01571.x; Stets EG, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003815; Taipale SJ, 2012, FEMS MICROBIOL ECOL, V82, P50, DOI 10.1111/j.1574-6941.2012.01406.x; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Vadeboncoeur Yvonne, 2002, ScientificWorldJournal, V2, P1449; Vano JA, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000112; VOLLENWEIDER RA, 1980, PROG WATER TECHNOL, V12, P5; Webster KE, 2008, LIMNOL OCEANOGR, V53, P1137, DOI 10.4319/lo.2008.53.3.1137; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Wetzel R.G., 2000, LIMNOLOGICAL ANAL, V3; WETZEL RG, 1995, FRESHWATER BIOL, V33, P83, DOI 10.1111/j.1365-2427.1995.tb00388.x	47	38	40	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39508	10.1371/journal.pone.0039508	http://dx.doi.org/10.1371/journal.pone.0039508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761808	Green Published, Green Submitted, gold			2022-12-27	WOS:000305808700033
J	Wu, Y; Hu, J; van Dijk, E; Leliveld, MC; Zhou, XL				Wu, Yin; Hu, Jie; van Dijk, Eric; Leliveld, Marijke C.; Zhou, Xiaolin			Brain Activity in Fairness Consideration during Asset Distribution: Does the Initial Ownership Play a Role?	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; FEEDBACK NEGATIVITY; REWARD MAGNITUDE; P300; VIOLATIONS; PUNISHMENT; POSSESSION; DOPAMINE; VALENCE; EMPATHY	Previous behavioral studies have shown that initial ownership influences individuals' fairness consideration and other-regarding behavior. However, it is not entirely clear whether initial ownership influences the brain activity when a recipient evaluates the fairness of asset distribution. In this study, we randomly assigned the bargaining property (monetary reward) to either the allocator or the recipient in the ultimatum game and let participants of the study, acting as recipients, receive either disadvantageous unequal, equal, or advantageous unequal offers from allocators while the event-related potentials (ERPs) were recorded. Behavioral results showed that participants were more likely to reject disadvantageous unequal and equal offers when they initially owned the property as compared to when they did not. The two types of unequal offers evoked more negative going ERPs (the MFN) than the equal offers in an early time window and the differences were not modulated by the initial ownership. In a late time window, however, the P300 responses to division schemes were affected not only by the type of unequal offers but also by whom the property was initially assigned to. These findings suggest that while the MFN may function as a general mechanism that evaluates whether the offer is consistent or inconsistent with the equity rule, the P300 is sensitive to top-down controlled processes, into which factors related to the allocation of attentional resources, including initial ownership and personal interests, come to play.	[Wu, Yin] Southeast Univ, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing, Jiangsu, Peoples R China; [Wu, Yin; Hu, Jie; Zhou, Xiaolin] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Wu, Yin; Hu, Jie; Zhou, Xiaolin] Peking Univ, Ctr Brain & Cognit Sci, Beijing 100871, Peoples R China; [van Dijk, Eric] Leiden Univ, Dept Social & Org Psychol, Leiden, Netherlands; [van Dijk, Eric] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Leliveld, Marijke C.] Univ Groningen, Dept Mkt, Groningen, Netherlands; [Zhou, Xiaolin] Peking Univ, Minist Educ, Key Lab Machine Percept, Beijing 100871, Peoples R China	Southeast University - China; Peking University; Peking University; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Peking University	Wu, Y (corresponding author), Southeast Univ, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing, Jiangsu, Peoples R China.	xz104@pku.edu.cn		Leliveld, Marijke/0000-0003-4455-5668	National Basic Research Program (973 Program) [2010CB833904]; National Science and Technology Pillar Program of China [2009BAI77B04]; Natural Science Foundation of China [30110972]	National Basic Research Program (973 Program)(National Basic Research Program of China); National Science and Technology Pillar Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Basic Research Program (973 Program: 2010CB833904) and National Science and Technology Pillar Program (2009BAI77B04) of China and by a grant from Natural Science Foundation of China (30110972). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGGAN JK, 1992, J PERS SOC PSYCHOL, V62, P229, DOI 10.1037/0022-3514.62.2.229; BEGGAN JK, 1994, J PSYCHOL, V128, P365, DOI 10.1080/00223980.1994.9712741; Boksem MAS, 2010, SOC NEUROSCI-UK, V5, P118, DOI 10.1080/17470910903202666; CIALDINI RB, 1989, J PERS SOC PSYCHOL, V57, P626, DOI 10.1037/0022-3514.57.4.626; Cunningham WA, 2003, J PERS SOC PSYCHOL, V85, P639, DOI 10.1037/0022-3514.85.4.639; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Falk A, 2003, ECON INQ, V41, P20, DOI 10.1093/ei/41.1.20; Fan Y, 2008, NEUROPSYCHOLOGIA, V46, P160, DOI 10.1016/j.neuropsychologia.2007.07.023; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; FINCH JF, 1989, PERS SOC PSYCHOL B, V15, P222, DOI 10.1177/0146167289152009; FREY BS, 1995, J INST THEOR ECON, V151, P286; Fukushima H, 2006, SOC COGN AFFECT NEUR, V1, P149, DOI 10.1093/scan/nsl020; Fukushima H, 2009, SOC NEUROSCI-UK, V4, P261, DOI 10.1080/17470910802625009; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gray HM, 2004, J EXP SOC PSYCHOL, V40, P216, DOI 10.1016/S0022-1031(03)00092-1; Guroglu B, 2010, SOC COGN AFFECT NEUR, V5, P414, DOI 10.1093/scan/nsq013; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P161, DOI 10.1111/j.1469-8986.2005.00278.x; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P905, DOI 10.1111/j.1469-8986.2007.00567.x; Handgraaf MJJ, 2008, J PERS SOC PSYCHOL, V95, P1136, DOI 10.1037/0022-3514.95.5.1136; Harris LT, 2010, SOC NEUROSCI-UK, V5, P76, DOI 10.1080/17470910903135825; Hewig J, 2011, PSYCHOPHYSIOLOGY, V48, P507, DOI 10.1111/j.1469-8986.2010.01081.x; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Itagaki S, 2008, NEUROREPORT, V19, P383, DOI 10.1097/WNR.0b013e3282f556e8; Jia SW, 2007, NEUROREPORT, V18, P1385, DOI 10.1097/WNR.0b013e3282c48a90; KAHNEMAN D, 1986, J BUS, V59, pS285, DOI 10.1086/296367; Kang SK, 2010, J EXP SOC PSYCHOL, V46, P229, DOI 10.1016/j.jesp.2009.09.012; Keysar B, 2008, PSYCHOL SCI, V19, P1280, DOI 10.1111/j.1467-9280.2008.02223.x; Klucharev V, 2009, NEURON, V61, P140, DOI 10.1016/j.neuron.2008.11.027; Leliveld MC, 2008, PERS SOC PSYCHOL B, V34, P1214, DOI 10.1177/0146167208318600; Leliveld MC, 2009, J EXP SOC PSYCHOL, V45, P505, DOI 10.1016/j.jesp.2009.02.006; Leng Y, 2010, NEUROPSYCHOLOGIA, V48, P448, DOI 10.1016/j.neuropsychologia.2009.10.002; Li P, 2010, NEUROIMAGE, V52, P1727, DOI 10.1016/j.neuroimage.2010.04.275; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Ma QG, 2011, NEUROIMAGE, V54, P2472, DOI 10.1016/j.neuroimage.2010.10.045; Marco-Pallares J, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-86; Messick D. M., 1983, EQUITY THEORY PSYCHO; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Montague PR, 2007, NEURON, V56, P14, DOI 10.1016/j.neuron.2007.09.020; Nelissen RMA, 2011, EUR J SOC PSYCHOL, V41, P78, DOI 10.1002/ejsp.735; Nesselroade KP, 1999, PSYCHOL MARKET, V16, P21; Nieuwenhuis S, 2004, CEREB CORTEX, V14, P741, DOI 10.1093/cercor/bhh034; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Oxoby RJ, 2008, J ECON BEHAV ORGAN, V65, P703, DOI 10.1016/j.jebo.2005.12.006; Peck J, 2009, J CONSUM RES, V36, P434, DOI 10.1086/598614; Peters SL, 2008, SOC JUSTICE RES, V21, P179, DOI 10.1007/s11211-008-0063-2; Polezzi D, 2008, BEHAV BRAIN RES, V190, P218, DOI 10.1016/j.bbr.2008.03.003; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Sato A, 2005, NEUROREPORT, V16, P407, DOI 10.1097/00001756-200503150-00020; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Sen S, 1997, J CONSUM RES, V24, P105, DOI 10.1086/209497; Turk DJ, 2011, J COGNITIVE NEUROSCI, V23, P3725, DOI 10.1162/jocn_a_00101; van den Bos K, 2006, J EXP SOC PSYCHOL, V42, P273, DOI 10.1016/j.jesp.2005.04.003; Wu Y, 2011, BIOL PSYCHOL; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Wu Y, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00131; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004; Yu RJ, 2007, PROG NAT SCI-MATER, V17, P136; Zhou XL, 2011, J EXP SOC PSYCHOL, V47, P582, DOI 10.1016/j.jesp.2010.12.017; Zhou ZH, 2010, NEUROPSYCHOLOGIA, V48, P3606, DOI 10.1016/j.neuropsychologia.2010.08.010	65	38	44	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39627	10.1371/journal.pone.0039627	http://dx.doi.org/10.1371/journal.pone.0039627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966AK	22761850	Green Published, gold, Green Submitted			2022-12-27	WOS:000305808700040
J	Dhakal, S; Lafontaine, JL; Yu, ZB; Koirala, D; Mao, HB				Dhakal, Soma; Lafontaine, Javonne L.; Yu, Zhongbo; Koirala, Deepak; Mao, Hanbin			Intramolecular Folding in Human ILPR Fragment with Three C-Rich Repeats	PLOS ONE			English	Article							SINGLE DNA-MOLECULES; I-MOTIF; G-QUADRUPLEX; RNA-POLYMERASE; NUCLEIC-ACIDS; CIRCULAR-DICHROISM; TELOMERIC REPEATS; MELTING CURVES; STRANDED-DNA; BASE-PAIRS	Enrichment of four tandem repeats of guanine (G) rich and cytosine (C) rich sequences in functionally important regions of human genome forebodes the biological implications of four-stranded DNA structures, such as G-quadruplex and i-motif, that can form in these sequences. However, there have been few reports on the intramolecular formation of non-B DNA structures in less than four tandem repeats of G or C rich sequences. Here, using mechanical unfolding at the single-molecule level, electrophoretic mobility shift assay (EMSA), circular dichroism (CD), and ultraviolet (UV) spectroscopy, we report an intramolecularly folded non-B DNA structure in three tandem cytosine rich repeats, 5'-TGTC4ACAC4TGTC4ACA (ILPR-I3), in the human insulin linked polymorphic region (ILPR). The thermal denaturation analyses of the sequences with systematic C to T mutations have suggested that the structure is linchpinned by a stack of hemiprotonated cytosine pairs between two terminal C4 tracts. Mechanical unfolding and Br-2 footprinting experiments on a mixture of the ILPR-I3 and a 5'-C4TGT fragment have further indicated that the structure serves as a building block for intermolecular i-motif formation. The existence of such a conformation under acidic or neutral pH complies with the strand-by-strand folding pathway of ILPR i-motif structures.	[Dhakal, Soma; Lafontaine, Javonne L.; Yu, Zhongbo; Koirala, Deepak; Mao, Hanbin] Kent State Univ, Dept Chem & Biochem, Kent, OH 44242 USA	Kent State University; Kent State University Kent; Kent State University Salem	Dhakal, S (corresponding author), Kent State Univ, Dept Chem & Biochem, Kent, OH 44242 USA.	hmao@kent.edu		Dhakal, Soma/0000-0002-3734-139X; Mao, Hanbin/0000-0002-6720-9429				Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; Bloomfield V.A., 2000, NUCL ACIDS STRUCTURE, V1st ed.; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; BROWN F, 1974, NATURE, V251, P342, DOI 10.1038/251342a0; CANTOR CR, 1970, BIOPOLYMERS, V9, P1059, DOI 10.1002/bip.1970.360090909; Catasti P, 1997, J MOL BIOL, V272, P369, DOI 10.1006/jmbi.1997.1248; Dai JX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011647; Dhakal S, 2010, J AM CHEM SOC, V132, P8991, DOI 10.1021/ja100944j; Esmaili N, 2005, NUCLEIC ACIDS RES, V33, P213, DOI 10.1093/nar/gki160; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; GEHRING K, 1993, NATURE, V363, P561, DOI 10.1038/363561a0; GRAY DM, 1984, NUCLEIC ACIDS RES, V12, P7565, DOI 10.1093/nar/12.19.7565; Gueron M, 2000, CURR OPIN STRUC BIOL, V10, P326, DOI 10.1016/S0959-440X(00)00091-9; Han XG, 1998, J MOL BIOL, V278, P949, DOI 10.1006/jmbi.1998.1740; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; KANG CH, 1994, P NATL ACAD SCI USA, V91, P11636, DOI 10.1073/pnas.91.24.11636; Kendrick S, 2009, J AM CHEM SOC, V131, P17667, DOI 10.1021/ja9076292; Koirala D, 2012, CHEM COMMUN, V48, P2006, DOI 10.1039/c2cc16752b; Koirala D, 2011, NAT CHEM, V3, P782, DOI [10.1038/NCHEM.1126, 10.1038/nchem.1126]; Kuhner F, 2007, BIOPHYS J, V92, P2491, DOI 10.1529/biophysj.106.095836; Laurence TA, 2005, P NATL ACAD SCI USA, V102, P17348, DOI 10.1073/pnas.0508584102; Leroy JL, 2009, NUCLEIC ACIDS RES, V37, P4127, DOI 10.1093/nar/gkp340; Luchette P, 2007, SENSOR ACTUAT B-CHEM, V128, P154, DOI 10.1016/j.snb.2007.05.048; MANZINI G, 1994, NUCLEIC ACIDS RES, V22, P4634, DOI 10.1093/nar/22.22.4634; Mao HB, 2008, SENSOR ACTUAT B-CHEM, V129, P764, DOI 10.1016/j.snb.2007.09.052; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; Marsich E, 1996, NUCLEIC ACIDS RES, V24, P4029, DOI 10.1093/nar/24.20.4029; Mashimo T, 2010, J AM CHEM SOC, V132, P14910, DOI 10.1021/ja105806u; Mejia YX, 2008, J MOL BIOL, V382, P628, DOI 10.1016/j.jmb.2008.06.079; Mergny JL, 2006, RSC BIOMOL SCI, P31; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; Palumbo SL, 2009, J AM CHEM SOC, V131, P10878, DOI 10.1021/ja902281d; Phan AT, 2000, J MOL BIOL, V299, P123, DOI 10.1006/jmbi.2000.3613; Rachwal PA, 2007, METHODS, V43, P291, DOI 10.1016/j.ymeth.2007.05.004; Rajendran A, 2010, CHEM COMMUN, V46, P1299, DOI 10.1039/b922050j; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; Rief M, 1999, NAT STRUCT BIOL, V6, P346; Ross SA, 1996, NUCLEIC ACIDS RES, V24, P5062, DOI 10.1093/nar/24.24.5062; Sannohe Y, 2010, J AM CHEM SOC, V132, P16311, DOI 10.1021/ja1058907; SCHROTH GP, 1995, NUCLEIC ACIDS RES, V23, P1977, DOI 10.1093/nar/23.11.1977; Sinden R. R., 1995, DNA STRUCTURE FUNCTI; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Sun D, 2009, J MED CHEM, V52, P2863, DOI 10.1021/jm900055s; TAUTZ D, 1984, J MOL BIOL, V172, P229, DOI 10.1016/S0022-2836(84)80041-8; Tinland B, 1997, MACROMOLECULES, V30, P5763, DOI 10.1021/ma970381+; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Weil J, 1999, ACTA CRYSTALLOGR D, V55, P422, DOI 10.1107/S0907444998012529; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Woodside MT, 2006, P NATL ACAD SCI USA, V103, P6190, DOI 10.1073/pnas.0511048103; Yu HQ, 2006, J AM CHEM SOC, V128, P15461, DOI 10.1021/ja064536h; Yu ZB, 2009, J AM CHEM SOC, V131, P1876, DOI 10.1021/ja806782s; Zhang N, 2005, J AM CHEM SOC, V127, P17277, DOI 10.1021/ja0543090; Zhou J, 2010, MOL BIOSYST, V6, P580, DOI 10.1039/b919600e	55	25	25	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39271	10.1371/journal.pone.0039271	http://dx.doi.org/10.1371/journal.pone.0039271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761750	gold, Green Submitted, Green Published			2022-12-27	WOS:000305781700025
J	Hattersley, JG; Mohlig, M; Roden, M; Arafat, AM; von Loeffelholz, C; Nowotny, P; Machann, J; Hierholzer, J; Osterhoff, M; Khan, M; Pfeiffer, AFH; Weickert, MO				Hattersley, John G.; Moehlig, Matthias; Roden, Michael; Arafat, Ayman M.; v. Loeffelholz, Christian; Nowotny, Peter; Machann, Juergen; Hierholzer, Johannes; Osterhoff, Martin; Khan, Michael; Pfeiffer, Andreas F. H.; Weickert, Martin O.			Quantifying the Improvement of Surrogate Indices of Hepatic Insulin Resistance Using Complex Measurement Techniques	PLOS ONE			English	Article							ENDOGENOUS GLUCOSE-PRODUCTION; MODEL ASSESSMENT; PLASMA-GLUCOSE; CEREAL-FIBER; SENSITIVITY; DISEASE; FAT	We evaluated the ability of simple and complex surrogate-indices to identify individuals from an overweight/obese cohort with hepatic insulin-resistance (HEP-IR). Five indices, one previously defined and four newly generated through step-wise linear regression, were created against a single-cohort sample of 77 extensively characterised participants with the metabolic syndrome (age 55.6+/-1.0 years, BMI 31.5+/-0.4 kg/m(2); 30 males). HEP-IR was defined by measuring endogenous-glucose-production (EGP) with [6-6(2)H(2)] glucose during fasting and euglycemic-hyperinsulinemic clamps and expressed as EGP*fasting plasma insulin. Complex measures were incorporated into the model, including various non-standard biomarkers and the measurement of body-fat distribution and liver-fat, to further improve the predictive capability of the index. Validation was performed against a data set of the same subjects after an isoenergetic dietary intervention (4 arms, diets varying in protein and fiber content versus control). All five indices produced comparable prediction of HEP-IR, explaining 39-56% of the variance, depending on regression variable combination. The validation of the regression equations showed little variation between the different proposed indices (r(2) = 27-32%) on a matched dataset. New complex indices encompassing advanced measurement techniques offered an improved correlation (r = 0.75, P<0.001). However, when validated against the alternative dataset all indices performed comparably with the standard homeostasis model assessment for insulin resistance (HOMA-IR) (r = 0.54, P<0.001). Thus, simple estimates of HEP-IR performed comparable to more complex indices and could be an efficient and cost effective approach in large epidemiological investigations.	[Hattersley, John G.; Khan, Michael; Weickert, Martin O.] Univ Hosp Coventry & Warwickshire NHS Trust, Warwickshire Inst Study Diabet Endocrinol & Metab, Coventry, W Midlands, England; [Hattersley, John G.] Univ Hosp Coventry & Warwickshire NHS Trust, Human Metab Res Unit, Coventry, W Midlands, England; [Moehlig, Matthias; Arafat, Ayman M.; v. Loeffelholz, Christian; Osterhoff, Martin; Pfeiffer, Andreas F. H.; Weickert, Martin O.] German Inst Human Nutr, Dept Clin Nutr, Potsdam, Germany; [Moehlig, Matthias; Arafat, Ayman M.; v. Loeffelholz, Christian; Osterhoff, Martin; Pfeiffer, Andreas F. H.; Weickert, Martin O.] Charite, Dept Endocrinol Diabet & Nutr, D-13353 Berlin, Germany; [Roden, Michael; Nowotny, Peter] Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Roden, Michael; Nowotny, Peter] Univ Clin, Dept Metab Dis, Dusseldorf, Germany; [Roden, Michael; Nowotny, Peter] Univ Dusseldorf, D-40225 Dusseldorf, Germany; [Machann, Juergen] Univ Tubingen, Sect Expt Radiol, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Hierholzer, Johannes] Charite Univ Med Berlin, Klinikum Ernst Von Bergmann, Acad Teaching Hosp, Potsdam, Germany; [Khan, Michael; Weickert, Martin O.] Univ Warwick, Warwick Med Sch, Clin Sci Res Inst, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Klinikum Ernst von Bergmann; University of Warwick	Hattersley, JG (corresponding author), Univ Hosp Coventry & Warwickshire NHS Trust, Warwickshire Inst Study Diabet Endocrinol & Metab, Coventry, W Midlands, England.	m.weickert@warwick.ac.uk	von Loeffelholz, Christian/AAQ-3808-2021; Roden, Michael/AAD-3843-2019; Pfeiffer, Andreas F.H./AAJ-2311-2020	Pfeiffer, Andreas F.H./0000-0002-6887-0016; Khan, Michael/0000-0002-8591-384X; Weickert, Martin O/0000-0002-4070-8164; Arafat, Ayman/0000-0003-3069-8385	German Ministry of Education and Science (BMBF) [0313826A]	German Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF))	Martin O. Weickert was supported by a grant of the German Ministry of Education and Science (BMBF, 0313826A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Campioni M, 2009, AM J PHYSIOL-ENDOC M, V297, pE941, DOI 10.1152/ajpendo.90842.2008; Charlton M, 2008, HEPATOLOGY, V47, P484, DOI 10.1002/hep.22063; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; EIDEMAK I, 1995, DIABETOLOGIA, V38, P565, DOI 10.1007/BF00400725; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; Forster MR, 2000, J MATH PSYCHOL, V44, P205, DOI 10.1006/jmps.1999.1284; Gibbons G, 2005, NAT MED, V11, P722, DOI 10.1038/nm0705-722; Hills SA, 2004, DIABETOLOGIA, V47, P566, DOI 10.1007/s00125-004-1335-5; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Machann J, 2005, J MAGN RESON IMAGING, V21, P455, DOI 10.1002/jmri.20292; Mari A, 2006, IMMUN ENDOC METAB AG, V6, P1; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miyazaki Y, 2002, AM J PHYSIOL-ENDOC M, V283, pE1135, DOI 10.1152/ajpendo.0327.2001; Rigalleau V, 1997, AM J CLIN NUTR, V65, P1512, DOI 10.1093/ajcn/65.5.1512; Stefan N, 2003, DIABETES CARE, V26, P3315, DOI 10.2337/diacare.26.12.3315; Szendroedi J, 2007, PLOS MED, V4, P858, DOI 10.1371/journal.pmed.0040154; Vangipurapu J, 2011, DIABETOLOGIA, V54, P540, DOI 10.1007/s00125-010-1966-7; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603; Weickert MO, 2006, DIABETOLOGIA, V49, P1732, DOI 10.1007/s00125-006-0295-3; Weickert MO, 2007, AM J PHYSIOL-ENDOC M, V293, pE1078, DOI 10.1152/ajpendo.00337.2007; Weickert MO, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-90; Weickert MO, 2011, AM J CLIN NUTR, V94, P459, DOI 10.3945/ajcn.110.004374; Weyer C, 1999, DIABETES, V48, P2197, DOI 10.2337/diabetes.48.11.2197; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Yilmaz Y, 2009, ALIMENT PHARM THER, V30, P1103, DOI 10.1111/j.1365-2036.2009.04148.x	27	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39029	10.1371/journal.pone.0039029	http://dx.doi.org/10.1371/journal.pone.0039029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761721	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900028
J	Huang, Y; Li, YL; Huang, H; Wang, L; Yuan, WM; Li, J				Huang, Yan; Li, Yu-Lin; Huang, He; Wang, Ling; Yuan, Wen-Ming; Li, Jing			Effects of Hyperuricemia on Renal Function of Renal Transplant Recipients: A Systematic Review and Meta-Analysis of Cohort Studies	PLOS ONE			English	Review							SERUM URIC-ACID; MUSCLE-CELL PROLIFERATION; EARLY-ONSET HYPERURICEMIA; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR RISK; ENDOTHELIAL DYSFUNCTION; NITRIC-OXIDE; ALLOPURINOL; ASSOCIATION; INFLAMMATION	Background: Hyperuricemia is an independent risk factor of nephropathy, but its role in renal transplant recipients (RTRs) is controversial. Methods: Based on the methods of Cochrane systematic reviews, we searched MEDLINE (1948-2011.6), EMBASE (1956-2011.6), CBM (Chinese Biomedicine Database) (1978-2011.6) to identify cohort studies assessing the association between uric acid level and kidney allograft. Two authors independently screened the studies, assessed the risk of bias of included studies and extracted data. Unadjusted odds ratio(OR), mean difference (MD), adjusted hazard ratio (aHR) and their corresponding 95%CI were pooled to assess the effects of hyperuricemia on kidney allograft. Results: Twelve cohort studies were included and the quality was moderate to high based on the NEWCASTLE-OTTAWA quality assessment scale. RTRs with hyperuricemia had lower eGFR (P<0.0001, 95%CI-16.34 similar to 6.14) and higher SCr (P<0.00001, 95%CI 0.17 similar to 0.31) than those with normal uric acid level. Meta-analysis showed that hyperuricemia was a risk factor of chronic allograft nephropathy (Unadjusted OR = 2.85, 95%CI 1.84 similar to 4.38, adjusted HR = 1.65, 95%CI 1.02 similar to 2.65) and graft loss (Unadjusted OR = 2.29, 95%CI 1.55 similar to 3.39; adjusted HR = 2.01, 95%CI 1.39 similar to 2.94). Conclusions: Current evidence suggests that hyperuricemia may be an independent risk factor of allograft dysfunction. Hyperuricemia may modestly increase the risk of poor outcomes of RTRs. Future research is needed to verify whether lowering uric acid level could improve the kidney function and prognosis of RTRs with hyperuricemia.	[Huang, Yan; Li, Jing] Sichuan Univ, W China Hosp, Chinese Cochrane Ctr, Chengdu 610064, Peoples R China; [Li, Yu-Lin] Chengdu Univ TCM, Clin Med Coll 2, Chengdu, Peoples R China; [Huang, He] Sichuan Univ, W China Hosp, Dept Cardiol, Chengdu 610064, Peoples R China; [Wang, Ling] Peoples Hosp Mianyang, Dept Cardiol, Mianyang, Peoples R China; [Yuan, Wen-Ming] Zhengzhou Univ, Affiliated Hosp 1, Dept Nephrol, Zhengzhou, Peoples R China	Sichuan University; Chengdu University of Traditional Chinese Medicine; Sichuan University; Zhengzhou University	Huang, Y (corresponding author), Sichuan Univ, W China Hosp, Chinese Cochrane Ctr, Chengdu 610064, Peoples R China.	lijing68@hotmail.com						Abdelrahman M, 2002, RENAL FAILURE, V24, P361, DOI 10.1081/JDI-120005370; Akalin E, 2008, TRANSPLANTATION, V86, P652, DOI 10.1097/TP.0b013e3181814f5b; Akgul A, 2007, TRANSPL P, V39, P1023, DOI 10.1016/j.transproceed.2007.03.028; Bandukwala F, 2009, AM J CARDIOL, V103, P867, DOI 10.1016/j.amjcard.2008.11.042; Chung BH, 2011, NEPHRON CLIN PRACT, V117, pC276, DOI 10.1159/000320743; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Flury W, 1977, J SUISSE MED; Gerhardt U, 1999, CLIN TRANSPLANT, V13, P375, DOI 10.1034/j.1399-0012.1999.130502.x; Gersch C, 2008, NUCLEOS NUCLEOT NUCL, V27, P967, DOI 10.1080/15257770802257952; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Haririan A, 2011, AM J TRANSPLANT, V11, P1943, DOI 10.1111/j.1600-6143.2011.03613.x; Haririan A, 2010, TRANSPLANTATION, V89, P573, DOI 10.1097/TP.0b013e3181c73c18; Hashmi S, 2007, Minerva Med, V98, P713; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kang DH, 2005, AM J NEPHROL, V25, P425, DOI 10.1159/000087713; Karbowska A, 2009, TRANSPL P, V41, P3052, DOI 10.1016/j.transproceed.2009.07.080; Karthikeyan V, 2004, AM J TRANSPLANT, V4, P262, DOI 10.1046/j.1600-6143.2003.00315.x; Kato M, 2005, AM J CARDIOL, V96, P1576, DOI 10.1016/j.amjcard.2005.07.068; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kim KM, 2010, TRANSPL P, V42, P3562, DOI 10.1016/j.transproceed.2010.07.104; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Mazzali M, 2005, SEMIN NEPHROL, V25, P50, DOI 10.1016/j.semnephrol.2004.09.008; Meier-Kriesche HU, 2009, CLIN J AM SOC NEPHRO, V4, P1655, DOI 10.2215/CJN.02700409; Min SI, 2009, NEPHROL DIAL TRANSPL, V24, P2584, DOI 10.1093/ndt/gfp192; Navascues RA, 2002, NEPHRON, V91, P173, DOI 10.1159/000057624; Ruggiero C, 2006, EUR HEART J, V27, P1174, DOI 10.1093/eurheatj/ehi879; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Yu-lin L, 2011, CHINESE J INTERNAL M, V50, P555; [Zou Gui-mian 邹贵勉], 2010, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V14, P923	32	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39457	10.1371/journal.pone.0039457	http://dx.doi.org/10.1371/journal.pone.0039457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745759	Green Submitted, Green Published, gold			2022-12-27	WOS:000305730900063
J	Eswarappa, SM; Estrela, S; Brown, SP				Eswarappa, Sandeepa M.; Estrela, Sylvie; Brown, Sam P.			Within-Host Dynamics of Multi-Species Infections: Facilitation, Competition and Virulence	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TYPHOID-FEVER; PATHOGEN INTERACTIONS; CONCURRENT MALARIA; PARASITE; SUSCEPTIBILITY; COINFECTION; EVOLUTION; CONSEQUENCES; REPLICATION	Host individuals are often infected with more than one parasite species (parasites defined broadly, to include viruses and bacteria). Yet, research in infection biology is dominated by studies on single-parasite infections. A focus on single-parasite infections is justified if the interactions among parasites are additive, however increasing evidence points to non-additive interactions being the norm. Here we review this evidence and theoretically explore the implications of non-additive interactions between co-infecting parasites. We use classic Lotka-Volterra two-species competition equations to investigate the within-host dynamical consequences of various mixes of competition and facilitation between a pair of co-infecting species. We then consider the implications of these dynamics for the virulence (damage to host) of co-infections and consequent evolution of parasite strategies of exploitation. We find that whereas one-way facilitation poses some increased virulence risk, reciprocal facilitation presents a qualitatively distinct destabilization of within-host dynamics and the greatest risk of severe disease.	[Eswarappa, Sandeepa M.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA; [Estrela, Sylvie; Brown, Sam P.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Estrela, Sylvie; Brown, Sam P.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Brown, Sam P.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Cleveland Clinic Foundation; University of Edinburgh; University of Edinburgh; University of Oxford	Eswarappa, SM (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA.	eswaras@ccf.org; sam.brown@ed.ac.uk	Eswarappa, Sandeep/AFG-1997-2022; Brown, Sam/B-5234-2009	Brown, Sam/0000-0003-1892-9275; Estrela, Sylvie/0000-0003-1946-3657; Eswarappa, Sandeep/0000-0002-7903-5198; Muthanegere Eswarappa, Sandeepa/0000-0003-4479-5354	Wellcome Trust [082273/Z/07/Z]; American Heart Association; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/33856/2009]	Wellcome Trust(Wellcome TrustEuropean Commission); American Heart Association(American Heart Association); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	The resarch was supported by Wellcome Trust Grant 082273/Z/07/Z (to S.P.B.), American Heart Association's postdoctoral fellowship (to S.M.E.), and Fundacao para a Ciencia e Tecnologia, Portugal, SFRH/BD/33856/2009 (to S.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyemi KO, 2007, J HEALTH POPUL NUTR, V25, P351; Alizon S, 2005, AM NAT, V165, pE155, DOI 10.1086/430053; Alizon S, 2008, AM NAT, V172, pE244, DOI 10.1086/592404; Ammah A, 1999, T ROY SOC TROP MED H, V93, P127, DOI 10.1016/S0035-9203(99)90282-1; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Bandilla M, 2006, INT J PARASITOL, V36, P987, DOI 10.1016/j.ijpara.2006.05.001; Brown SP, 2008, ECOL LETT, V11, P44, DOI 10.1111/j.1461-0248.2007.01125.x; Brown SP, 2009, EVOL APPL, V2, P32, DOI 10.1111/j.1752-4571.2008.00059.x; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Buckling A, 2008, HEREDITY, V100, P484, DOI 10.1038/sj.hdy.6801093; Chowdhury F, 2010, J HEALTH POPUL NUTR, V28, P529; Collins HL, 2003, IMMUNOL LETT, V85, P193, DOI 10.1016/S0165-2478(02)00229-8; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; Cunha BA, 2006, LANCET INFECT DIS, V6, P318, DOI 10.1016/S1473-3099(06)70472-8; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Egusa H, 2008, CURR HIV RES, V6, P485, DOI 10.2174/157016208786501445; Fenton A, 2010, PARASITOLOGY, V137, P1027, DOI 10.1017/S0031182009991788; Fenton A, 2010, ECOL LETT, V13, P606, DOI 10.1111/j.1461-0248.2010.01458.x; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Gardner A, 2004, P ROY SOC B-BIOL SCI, V271, P1529, DOI 10.1098/rspb.2004.2756; Goletti D, 1996, J IMMUNOL, V157, P1271; Graham AL, 2008, P NATL ACAD SCI USA, V105, P566, DOI 10.1073/pnas.0707221105; Griffiths EC, 2011, J INFECTION, V63, P200, DOI 10.1016/j.jinf.2011.06.005; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Harrison F, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-21; Inglis RF, 2009, P NATL ACAD SCI USA, V106, P5703, DOI 10.1073/pnas.0810850106; Kaplan JE, 1996, AM J TROP MED HYG, V55, P1; KAYE D, 1965, P SOC EXP BIOL MED, V120, P810, DOI 10.3181/00379727-120-30661; KAYE D, 1963, J IMMUNOL, V91, P518; Kuris AM, 2008, NATURE, V454, P515, DOI 10.1038/nature06970; LEDERMAN MM, 1994, J ACQ IMMUN DEF SYND, V7, P727; Lello J, 2008, PARASITOLOGY, V135, P825, DOI 10.1017/S0031182008000383; Lello J, 2004, NATURE, V428, P840, DOI 10.1038/nature02490; Lello J, 2008, AM NAT, V171, P176, DOI 10.1086/525257; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; Lysenko ES, 2010, CURR BIOL, V20, P1222, DOI 10.1016/j.cub.2010.05.051; MABEY DCW, 1987, J INFECT DIS, V155, P1319, DOI 10.1093/infdis/155.6.1319; McCullers JA, 2010, J INFECT DIS, V202, P1287, DOI 10.1086/656333; Murray, 2002, MATH BIOL I INTRO IN; Otto SP, 2007, BIOL GUIDE MATH MODE; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; Reece SE, 2009, EVOL APPL, V2, P11, DOI 10.1111/j.1752-4571.2008.00060.x; SHATTOCK RJ, 1993, RES VIROLOGY, V144, P7, DOI 10.1016/S0923-2516(06)80005-1; SMALL PM, 1993, NEW ENGL J MED, V328, P1137, DOI 10.1056/NEJM199304223281601; Staves PA, 2010, EVOLUTION, V64, P2643, DOI 10.1111/j.1558-5646.2010.00999.x; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Thomas F, 2002, TRENDS PARASITOL, V18, P387, DOI 10.1016/S1471-4922(02)02339-5; Uneke C. J., 2008, Journal of Vector Borne Diseases, V45, P133; ZHANG YH, 1995, J CLIN INVEST, V95, P2324, DOI 10.1172/JCI117924	52	33	33	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38730	10.1371/journal.pone.0038730	http://dx.doi.org/10.1371/journal.pone.0038730			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737220	Green Submitted, Green Published, gold			2022-12-27	WOS:000305695100018
J	Lin, IC; Kuo, HC; Lin, YJ; Wang, FS; Wang, L; Huang, SC; Chien, SJ; Huang, CF; Wang, CL; Yu, HR; Chen, RF; Yang, KD				Lin, I-Chun; Kuo, Ho-Chang; Lin, Ying-Jui; Wang, Feng-Shen; Wang, Lin; Huang, Shun-Chen; Chien, Shao-Ju; Huang, Chien-Fu; Wang, Chih-Lu; Yu, Hong-Ren; Chen, Rong-Fu; Yang, Kuender D.			Augmented TLR2 Expression on Monocytes in both Human Kawasaki Disease and a Mouse Model of Coronary Arteritis	PLOS ONE			English	Article							GAMMA-GLOBULIN TREATMENT; LYMPH-NODE SYNDROME; CASEI CELL-WALLS; TRANSCRIPTIONAL REGULATION; IMMUNOGLOBULIN TREATMENT; SYSTEMIC INJECTION; AQUEOUS SUSPENSION; TREATMENT FAILURE; ANIMAL-MODEL; LESIONS	Background: Kawasaki disease (KD) of unknown immunopathogenesis is an acute febrile systemic vasculitis and the leading cause of acquired heart diseases in childhood. To search for a better strategy for the prevention and treatment of KD, this study compared and validated human KD immunopathogenesis in a mouse model of Lactobacillus casei cell wall extract (LCWE)-induced coronary arteritis. Methods: Recruited subjects fulfilled the criteria of KD and were admitted for intravenous gamma globulin (IVIG) treatment at the Kaohsiung Chang Gung Memorial Hospital from 2001 to 2009. Blood samples from KD patients were collected before and after IVIG treatment, and cardiovascular abnormalities were examined by transthoracic echocardiography. Wild-type male BALB/c mice (4-week-old) were intraperitoneally injected with LCWE (1 mg/mL) to induce coronary arteritis. The induced immune response in mice was examined on days 1, 3, 7, and 14 post injections, and histopathology studies were performed on days 7 and 14. Results: Both human KD patients and LCWE-treated mice developed coronary arteritis, myocarditis, valvulitis, and pericarditis, as well as elevated plasma levels of interleukin (IL)-2, IL-6, IL-10, monocyte chemoattractant protein (MCP)-1, and tumor necrosis factor (TNF)-alpha in acute phase. Most of these proinflammatory cytokines declined to normal levels in mice, whereas normal levels were achieved in patients only after IVIG treatment, with a few exceptions. Toll-like receptor (TLR)-2, but not TLR4 surface enhancement on circulating CD14(+) monocytes, was augmented in KD patients before IVIG treatment and in LCWE-treated mice, which declined in patients after IVIG treatment. Conclusion: This result suggests that that not only TLR2 augmentation on CD14(+) monocytes might be an inflammatory marker for both human KD patients and LCWE-induced CAL mouse model but also this model is feasible for studying therapeutic strategies of coronary arteritis in human KD by modulating TLR2-mediated immune activation on CD14(+) monocytes.	[Lin, I-Chun; Kuo, Ho-Chang; Lin, Ying-Jui; Wang, Lin; Chien, Shao-Ju; Huang, Chien-Fu; Yu, Hong-Ren] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Lin, I-Chun; Kuo, Ho-Chang; Lin, Ying-Jui; Wang, Feng-Shen; Wang, Lin; Huang, Shun-Chen; Chien, Shao-Ju; Huang, Chien-Fu; Yu, Hong-Ren] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Kaohsiung, Taiwan; [Wang, Feng-Shen] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Med Res, Kaohsiung, Taiwan; [Huang, Shun-Chen] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan; [Wang, Chih-Lu] Po Jen Hosp, Dept Pediat, Kaohsiung, Taiwan; [Chen, Rong-Fu; Yang, Kuender D.] Show Chwan Mem Hosp Chang Bing, Dept Med Res, Changhua, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lin, IC (corresponding author), Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan.	wangfs@ms33.hinet.net; yangkd.yeh@hotmail.com	于, 鴻仁/AAW-6827-2021; Kuo, Ho-Chang/AAQ-6644-2020; Chen, Rong-Fu/AAI-8593-2021	于, 鴻仁/0000-0003-1242-8760; Kuo, Ho-Chang/0000-0002-3295-2984; Chen, Rong-Fu/0000-0001-7529-5390; Lin, Ying-Jui/0000-0002-2395-5913; Lin, I-Chun/0000-0001-5425-7619	Kaohsiung Chang Gung Memorial Hospital [CMRPG881041, CMRPG881042]; Cardiac Children's Foundation Taiwan [CCF100-03, CCFT0805]; National Science Council [NSC 97-2314-B-182A-054-MY2, NSC 100-2314-B-182A-048-MY3]	Kaohsiung Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Cardiac Children's Foundation Taiwan; National Science Council(Ministry of Science and Technology, Taiwan)	This study was in part supported by grants CMRPG881041 and CMRPG881042 from Kaohsiung Chang Gung Memorial Hospital (URL: http://www.cgmh.org.tw/), grants CCF100-03 and CCFT0805 from Cardiac Children's Foundation Taiwan (URL: http://www.ccft.org.tw/htm/index.asp), and by grant NSC 97-2314-B-182A-054-MY2 and NSC 100-2314-B-182A-048-MY3 from the National Science Council (URL: http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron Karyl S., 1998, Current Opinion in Rheumatology, V10, P29, DOI 10.1097/00002281-199801000-00005; Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009; CULLEN S, 1989, IRISH J MED SCI, V158, P253, DOI 10.1007/BF02943701; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; DURONGPISITKUL K, 1995, PEDIATRICS, V96, P1057; FELSBURG PJ, 1992, CLIN IMMUNOL IMMUNOP, V65, P110, DOI 10.1016/0090-1229(92)90213-8; FUJIWARA H, 1978, PEDIATRICS, V61, P100; Haehnel V, 2002, J IMMUNOL, V168, P5629, DOI 10.4049/jimmunol.168.11.5629; Hirao J, 1997, INT ARCH ALLERGY IMM, V112, P152, DOI 10.1159/000237447; KATO H, 1986, J PEDIATR-US, V108, P923, DOI 10.1016/S0022-3476(86)80928-3; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Kimura J, 2004, CLIN EXP IMMUNOL, V137, P444, DOI 10.1111/j.1365-2249.2004.02506.x; Kuo HC, 2007, PEDIAT ALLERG IMM-UK, V18, P354, DOI 10.1111/j.1399-3038.2007.00516.x; Kuo HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017370; Kuo Ho-Chang, 2007, Journal of Microbiology Immunology and Infection, V40, P395; Lehman T J, 1987, Prog Clin Biol Res, V250, P149; LEHMAN TJA, 1985, ARTHRITIS RHEUM, V28, P652, DOI 10.1002/art.1780280609; LEHMAN TJA, 1983, ARTHRITIS RHEUM, V26, P1259, DOI 10.1002/art.1780261013; LIN CY, 1992, J PEDIATR-US, V121, P924, DOI 10.1016/S0022-3476(05)80343-9; Lin IC, 2012, IMMUNOBIOLO IN PRESS; MURATA H, 1979, MICROBIOL IMMUNOL, V23, P825, DOI 10.1111/j.1348-0421.1979.tb02815.x; Nakamura Y, 2008, PEDIATR INT, V50, P287, DOI 10.1111/j.1442-200X.2008.02572.x; ONOUCHI Z, 1995, ANGIOLOGY, V46, P679, DOI 10.1177/000331979504600806; Philip S, 2004, PEDIATR RES, V55, P211, DOI 10.1203/01.PDR.0000104151.26375.E5; Rosenkranz ME, 2005, CIRCULATION, V112, P2966, DOI 10.1161/CIRCULATIONAHA.105.537530; Schulte DJ, 2009, J IMMUNOL, V183, P5311, DOI 10.4049/jimmunol.0901395; SUGIMURA T, 1992, J PEDIATR-US, V121, P684, DOI 10.1016/S0022-3476(05)81893-1; SUZUKI A, 1988, AM J CARDIOL, V61, P386, DOI 10.1016/0002-9149(88)90950-2; Suzuki A, 2000, CIRCULATION, V101, P2935, DOI 10.1161/01.CIR.101.25.2935; Takahashi K, 2004, INFLAMM RES, V53, P72, DOI 10.1007/s00011-003-1225-1; TAUBERT KA, 1994, PEDIATR INFECT DIS J, V13, P704, DOI 10.1097/00006454-199408000-00005; Terai M, 1997, J PEDIATR-US, V131, P888, DOI 10.1016/S0022-3476(97)70038-6; Terai M, 1999, J LEUKOCYTE BIOL, V65, P566, DOI 10.1002/jlb.65.5.566; Tsuda E, 2005, CARDIOL YOUNG, V15, P481, DOI 10.1017/S1047951105001344; Wallace CA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e78	36	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38635	10.1371/journal.pone.0038635	http://dx.doi.org/10.1371/journal.pone.0038635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737215	Green Published, Green Submitted, gold			2022-12-27	WOS:000305695100013
J	Paul, A; Jain, AK; Misra, SK; Maji, B; Muniyappa, K; Bhattacharya, S				Paul, Ananya; Jain, Akash K.; Misra, Santosh K.; Maji, Basudeb; Muniyappa, K.; Bhattacharya, Santanu			Binding of Gemini Bisbenzimidazole Drugs with Human Telomeric G-Quadruplex Dimers: Effect of the Spacer in the Design of Potent Telomerase Inhibitors	PLOS ONE			English	Article							INTRAMOLECULAR G-QUADRUPLEX; DNA-BINDING; K+ SOLUTION; DUPLEX-DNA; SEQUENCE; BIOLOGY; REPEAT; CHEMISTRY; INSIGHTS; TARGET	The study of anticancer agents that act via stabilization of telomeric G-quadruplex DNA (G4DNA) is important because such agents often inhibit telomerase activity. Several types of G4DNA binding ligands are known. In these studies, the target structures often involve a single G4 DNA unit formed by short DNA telomeric sequences. However, the 3'-terminal single-stranded human telomeric DNA can form higher-order structures by clustering consecutive quadruplex units (dimers or nmers). Herein, we present new synthetic gemini (twin) bisbenzimidazole ligands, in which the oligo-oxyethylene spacers join the two bisbenzimidazole units for the recognition of both monomeric and dimeric G4DNA, derived from d(T2AG3)4 and d(T2AG3) 8 human telomeric DNA, respectively. The spacer between the two bisbenzimidazoles in the geminis plays a critical role in the G4DNA stability. We report here (i) synthesis of new effective gemini anticancer agents that are selectively more toxic towards the cancer cells than the corresponding normal cells; (ii) formation and characterization of G4DNA dimers in solution as well as computational construction of the dimeric G4DNA structures. The gemini ligands direct the folding of the single-stranded DNA into an unusually stable parallel-stranded G4DNA when it was formed in presence of the ligands in KCl solution and the gemini ligands show spacer length dependent potent telomerase inhibition properties.	[Paul, Ananya; Jain, Akash K.; Misra, Santosh K.; Maji, Basudeb; Bhattacharya, Santanu] Indian Inst Sci, Dept Organ Chem, Bangalore 560012, Karnataka, India; [Muniyappa, K.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Bhattacharya, Santanu] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Chem Biol Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Paul, A (corresponding author), Indian Inst Sci, Dept Organ Chem, Bangalore 560012, Karnataka, India.	sb@orgchem.iisc.ernet.in	BHATTACHARYA, SANTANU/E-9739-2010; Bhattacharya, Santanu/N-6531-2019; Bhattacharya, Santanu/GRS-4780-2022; Mishra, Santosh/S-7516-2017	BHATTACHARYA, SANTANU/0000-0001-9040-8971; Bhattacharya, Santanu/0000-0001-9040-8971; Mishra, Santosh/0000-0001-8616-2606; Paul, Ananya/0000-0003-4592-3442; Misra, Santosh K./0000-0002-3313-4895; Maji, Basudeb/0000-0002-3885-5704	DST (Department of Science and Technology); DST, New Delhi	DST (Department of Science and Technology)(Department of Science & Technology (India)); DST, New Delhi(Department of Science & Technology (India))	This work was supported by a grant from DST (Department of Science and Technology) [J. C. Bose Fellowship (S.B.)]. A.K.J. is thankful to DST for a Fast Track Grant for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SB thanks DST, New Delhi for J. C. Bose Fellowship. Authors are thankful to the NMR Research Centre, IISc Bangalore for recording the NMR spectra of the ligands.	Antonacci C, 2007, BIOCHEMISTRY-US, V46, P4654, DOI 10.1021/bi602511p; Bhattacharjee AJ, 2011, BIOCHIMIE, V93, P1297, DOI 10.1016/j.biochi.2011.05.038; Bhattacharya S, 2008, CURR MED CHEM, V15, P1762, DOI 10.2174/092986708785133013; Bhattacharya S, 2010, BIOCONJUGATE CHEM, V21, P1148, DOI 10.1021/bc9003298; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Burger AM, 2005, CANCER RES, V65, P1489, DOI 10.1158/0008-5472.CAN-04-2910; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cech TR, 2000, ANGEW CHEM INT EDIT, V39, P34, DOI 10.1002/(SICI)1521-3773(20000103)39:1<34::AID-ANIE34>3.0.CO;2-N; Chang CC, 2007, NUCLEIC ACIDS RES, V35, P2846, DOI 10.1093/nar/gkm155; Chaudhuri P, 2007, J MED CHEM, V50, P2536, DOI 10.1021/jm0610604; Corey DR, 2009, CHEM BIOL, V16, P1219, DOI 10.1016/j.chembiol.2009.12.001; Cummaro A, 2011, BIOCHIMIE, V93, P1392, DOI 10.1016/j.biochi.2011.04.005; Dai JX, 2008, BIOCHIMIE, V90, P1172, DOI 10.1016/j.biochi.2008.02.026; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P4927, DOI 10.1093/nar/gkm522; De Cian A, 2007, METHODS, V42, P183, DOI 10.1016/j.ymeth.2006.10.004; Eddy J, 2011, NUCLEIC ACIDS RES, V39, P4975, DOI 10.1093/nar/gkr079; Fu YT, 2009, BIOORGAN MED CHEM, V17, P2030, DOI 10.1016/j.bmc.2009.01.015; Gaynutdinov TI, 2009, BIOCHEMISTRY-US, V48, P11169, DOI 10.1021/bi901063g; Hansel R, 2011, NUCLEIC ACIDS RES, V39, P5768, DOI 10.1093/nar/gkr174; Haider S, 2008, BIOPHYS J, V95, P296, DOI 10.1529/biophysj.107.120501; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iida K, 2009, CHEM COMMUN, P6481, DOI 10.1039/b910242f; Jain AK, 2012, J MED CHEM, V55, P2981, DOI 10.1021/jm200860b; Jain AK, 2012, CURR PHARM DESIGN, V18, P1917; Jain AK, 2011, BIOCONJUGATE CHEM, V22, P2355, DOI 10.1021/bc200268a; Jain AK, 2010, BIOCONJUGATE CHEM, V21, P1389, DOI 10.1021/bc900247s; Jain AK, 2009, BIOCHEMISTRY-US, V48, P10693, DOI 10.1021/bi9003815; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kan ZY, 2007, NUCLEIC ACIDS RES, V35, P3646, DOI 10.1093/nar/gkm203; Kerwin SM, 2000, CURR PHARM DESIGN, V6, P441, DOI 10.2174/1381612003400849; Largy E, 2011, CHEM-EUR J, V17, P13274, DOI 10.1002/chem.201102300; Li GR, 2008, CHEM COMMUN, P4564, DOI 10.1039/b807916a; Liu Y, 2005, J ORG CHEM, V70, P1450, DOI 10.1021/jo047968o; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Martadinata H, 2011, BIOCHEMISTRY-US, V50, P6455, DOI 10.1021/bi200569f; Mergny JL, 1998, NAT MED, V4, P1366, DOI 10.1038/3949; MERGNY JL, 2009, CURR PROTOC NUCL ACI, V17; Misra SK, 2012, SMALL, V8, P131, DOI 10.1002/smll.201101640; Miyoshi D, 2005, ANGEW CHEM INT EDIT, V44, P3740, DOI 10.1002/anie.200462667; Miyoshi D, 2004, J AM CHEM SOC, V126, P165, DOI 10.1021/ja036721q; Monchaud D, 2008, ANGEW CHEM INT EDIT, V47, P4858, DOI 10.1002/anie.200800468; Oganesian L, 2006, EMBO J, V25, P1148, DOI 10.1038/sj.emboj.7601006; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Paul A, 2012, CURR SCI INDIA, V102, P212; Pedroso IA, 2007, BIOPOLYMERS, V87, P74, DOI 10.1002/bip.20790; Petraccone L, 2008, J AM CHEM SOC, V130, P16530, DOI 10.1021/ja8075567; Phan AT, 2006, NUCLEIC ACIDS RES, V34, P5715, DOI 10.1093/nar/gkl726; Read M, 2001, P NATL ACAD SCI USA, V98, P4844, DOI 10.1073/pnas.081560598; Reed J, 2008, ANAL BIOCHEM, V380, P99, DOI 10.1016/j.ab.2008.05.013; Romera C, 2011, BIOCHIMIE, V93, P1310, DOI 10.1016/j.biochi.2011.06.008; Tache S, 2006, SCAND J GASTROENTERO, V41, P730, DOI 10.1080/00365520500380668; Tawar U, 2003, J MED CHEM, V46, P3785, DOI 10.1021/jm030114w; Temime-Smaali N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006919; Uziel O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009132; Verma A, 2009, NUCLEIC ACIDS RES, V37, P4194, DOI 10.1093/nar/gkn1076; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Xu L, 2010, CHEM COMMUN, V46, P743, DOI 10.1039/b918045a; Xue Y, 2007, J AM CHEM SOC, V129, P11185, DOI 10.1021/ja0730462; Yang DZ, 2010, FUTURE MED CHEM, V2, P619, DOI 10.4155/FMC.09.172; Zhang ZJ, 2010, NUCLEIC ACIDS RES, V38, P1009, DOI 10.1093/nar/gkp1029	60	21	21	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39467	10.1371/journal.pone.0039467	http://dx.doi.org/10.1371/journal.pone.0039467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737240	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000305695100039
J	Schulz, EC; Roth, HM; Ankri, S; Ficner, R				Schulz, Eike C.; Roth, Heide M.; Ankri, Serge; Ficner, Ralf			Structure Analysis of Entamoeba histolytica DNMT2 (EhMeth)	PLOS ONE			English	Article							DNA METHYLTRANSFERASE EHMETH; POISSON-BOLTZMANN EQUATION; TRANSFER-RNA; EVOLUTIONARY CONSERVATION; METHYLATION PATTERNS; CATALYTIC MECHANISM; DE-NOVO; PROTEIN; SEQUENCE; CONSURF	In eukaryotes, DNA methylation is an important epigenetic modification that is generally involved in gene regulation. Methyltransferases (MTases) of the DNMT2 family have been shown to have a dual substrate specificity acting on DNA as well as on three specific tRNAs (tRNA(Asp), tRNA(Val), tRNA(Gly)). Entamoeba histolytica is a major human pathogen, and expresses a single DNA MTase (EhMeth) that belongs to the DNMT2 family and shows high homology to the human enzyme as well as to the bacterial DNA MTase M.HhaI. The molecular basis for the recognition of the substrate tRNAs and discrimination of non-cognate tRNAs is unknown. Here we present the crystal structure of the cytosine-5-methyltransferase EhMeth at a resolution of 2.15 angstrom, in complex with its reaction product S-adenosyl-L-homocysteine, revealing all parts of a DNMT2 MTase, including the active site loop. Mobility shift assays show that in vitro the full length tRNA is required for stable complex formation with EhMeth.	[Schulz, Eike C.; Roth, Heide M.; Ficner, Ralf] Univ Gottingen, Inst Mikrobiol & Genet, Abt Mol Strukturbiol, Gottingen, Germany; [Ankri, Serge] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Mol Microbiol, IL-31096 Haifa, Israel	University of Gottingen; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Schulz, EC (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.	rficner@gwdg.de		Resch, Heide Marie/0000-0001-9635-6340	State of Lower-Saxony; Volkswagen Foundation, Hannover, Germany; Deutsche Forschungsgemeinschaft (DFG); University Gottingen, Germany	State of Lower-Saxony; Volkswagen Foundation, Hannover, Germany(Volkswagen); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University Gottingen, Germany	This joint research project was financially supported by the State of Lower-Saxony and the Volkswagen Foundation, Hannover, Germany. The publication was financially supported by the Open-Access funding program of the Deutsche Forschungsgemeinschaft (DFG) and the publication fond of the University Gottingen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; Alian A, 2008, P NATL ACAD SCI USA, V105, P6876, DOI 10.1073/pnas.0802247105; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banerjee S, 2005, MOL BIOCHEM PARASIT, V139, P91, DOI 10.1016/j.molbiopara.2004.10.003; Baxt LA, 2008, CURR OPIN INFECT DIS, V21, P489, DOI 10.1097/QCO.0b013e32830ce75f; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; DERRICK WB, 1993, NUCLEIC ACIDS RES, V21, P4948, DOI 10.1093/nar/21.21.4948; Dong AP, 2001, NUCLEIC ACIDS RES, V29, P439, DOI 10.1093/nar/29.2.439; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher O, 2004, NUCLEIC ACIDS RES, V32, P287, DOI 10.1093/nar/gkh161; Gerasimaite R, 2011, NUCLEIC ACIDS RES, V39, P3771, DOI 10.1093/nar/gkq1329; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Goto-Ito S, 2009, NAT STRUCT MOL BIOL, V16, P1109, DOI 10.1038/nsmb.1653; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; H G, 2009, DNA RNA MODIFICATION; Harony H, 2006, MOL BIOCHEM PARASIT, V147, P55, DOI 10.1016/j.molbiopara.2006.02.005; Hermann A, 2003, J BIOL CHEM, V278, P31717, DOI 10.1074/jbc.M305448200; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; HOLST M, 1993, J COMPUT CHEM, V14, P105, DOI 10.1002/jcc.540140114; HOLST MJ, 1995, J COMPUT CHEM, V16, P337, DOI 10.1002/jcc.540160308; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Ishitani R, 2008, CURR OPIN STRUC BIOL, V18, P330, DOI 10.1016/j.sbi.2008.05.003; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Jurkowski TP, 2008, RNA, V14, P1663, DOI 10.1261/rna.970408; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaminskas E, 2005, ONCOLOGIST, V10, P176, DOI 10.1634/theoncologist.10-3-176; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Kuhlmann M, 2005, NUCLEIC ACIDS RES, V33, P6405, DOI 10.1093/nar/gki952; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Liu YQ, 2000, P NATL ACAD SCI USA, V97, P8263, DOI 10.1073/pnas.97.15.8263; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; Osawa T, 2011, NAT STRUCT MOL BIOL, V18, P1275, DOI 10.1038/nsmb.2144; Rai K, 2007, GENE DEV, V21, P261, DOI 10.1101/gad.1472907; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Schaefer M, 2010, CHROMOSOMA, V119, P35, DOI 10.1007/s00412-009-0240-6; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Tang LY, 2003, J BIOL CHEM, V278, P33613, DOI 10.1074/jbc.C300255200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tovy A, 2010, J VISUALIZED EXPT JO; Tovy A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000775; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WHO, 1997, B WORLD HEALTH ORGAN, V75, P291; WU JC, 1987, J BIOL CHEM, V262, P4778; Yoder JA, 1998, HUM MOL GENET, V7, P279, DOI 10.1093/hmg/7.2.279	64	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38728	10.1371/journal.pone.0038728	http://dx.doi.org/10.1371/journal.pone.0038728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737219	Green Submitted, Green Published, gold			2022-12-27	WOS:000305695100017
J	Prout, AP; Frasch, MG; Veldhuizen, R; Hammond, R; Matushewski, B; Richardson, BS				Prout, Andrew P.; Frasch, Martin G.; Veldhuizen, Ruud; Hammond, Rob; Matushewski, Brad; Richardson, Bryan S.			The Impact of Intermittent Umbilical Cord Occlusions on the Inflammatory Response in Pre-Term Fetal Sheep	PLOS ONE			English	Article							HEART-RATE DECELERATIONS; NECROSIS-FACTOR-ALPHA; METABOLIC-RESPONSES; TERM; BRAIN; INTERLEUKIN-6; GENDER; INJURY; FLUID; RESUSCITATION	Fetal hypoxic episodes may occur antepartum with the potential to induce systemic and cerebral inflammatory responses thereby contributing to brain injury. We hypothesized that intermittent umbilical cord occlusions (UCOs) of sufficient severity but without cumulative acidosis will lead to a fetal inflammatory response. Thirty-one chronically instrumented fetal sheep at similar to 0.85 of gestation underwent four consecutive days of hourly UCOs from one to three minutes duration for six hours each day. Maternal and fetal blood samples were taken for blood gases/pH and plasma interleukin (IL)-1 beta and IL-6 levels. Animals were euthanized at the end of experimental study with brain tissue processed for subsequent counting of microglia and mast cells. Intermittent UCOs resulted in transitory fetal hypoxemia with associated acidemia which progressively worsened the longer umbilical blood flow was occluded, but with no cumulative blood gas or pH changes over the four days of study. Fetal arterial IL-1b and IL-6 values showed no significant change regardless of the severity of the UCOs, nor was there any evident impact on the microglia and mast cell counts for any of the brain regions studied. Accordingly, intermittent UCOs of up to three minutes duration with severe, but limited fetal hypoxemia and no cumulative acidemia, do not result in either a systemic or brain inflammatory response in the pre-term ovine fetus. However, fetal IL-1B and IL-6 values were found to be well correlated with corresponding maternal values supporting the placenta as a primary source for these cytokines with related secretion into both circulations. Female fetuses were also found to have higher IL-1 beta levels than males, indicating that gender may impact on the fetal inflammatory response to various stimuli.	[Prout, Andrew P.; Frasch, Martin G.; Matushewski, Brad; Richardson, Bryan S.] Univ Western Ontario, Dept Obstet & Gynaecol, London, ON, Canada; [Prout, Andrew P.; Veldhuizen, Ruud; Richardson, Bryan S.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Hammond, Rob] Univ Western Ontario, Dept Pathol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Prout, AP (corresponding author), Univ Western Ontario, Dept Obstet & Gynaecol, London, ON, Canada.	brichar1@uwo.ca	Frasch, Martin G/B-3539-2014; Frasch, Martin/AAN-8507-2020; Veldhuizen, Ruud/G-3352-2011	Frasch, Martin G/0000-0003-3159-6321; Frasch, Martin/0000-0003-3159-6321; Veldhuizen, Ruud/0000-0002-8802-1580	Canadian Institute of Health Research [MOP 15265]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institute of Health Research (BSR); CIHR Grant # MOP 15265-'Fetal brain development: the impact of acute and chronic hypoxia'. BSR is the recipient of the Canada Research Chair in Fetal and Neonatal Health and Development. MGF is the recipient of a CIHR funded Strategic Training Initiative in Research in Reproductive Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen R, 2005, OBSTET GYNECOL, V106, P802, DOI 10.1097/01.AOG.0000178750.84837.ed; Ahmed Z, 2007, J HISTOCHEM CYTOCHEM, V55, P687, DOI 10.1369/jhc.6A7156.2007; ANYAEGBUNAM A, 1986, AM J OBSTET GYNECOL, V155, P707, DOI 10.1016/S0002-9378(86)80003-5; Chiesa C, 2003, EUR J CLIN INVEST, V33, P352, DOI 10.1046/j.1365-2362.2003.01136.x; Choudhry MA, 2005, SHOCK, V24, P101, DOI 10.1097/01.shk.0000191341.31530.5e; Christiaens I, 2008, J REPROD IMMUNOL, V79, P50, DOI 10.1016/j.jri.2008.04.002; Clapp JF, 1999, J SOC GYNECOL INVEST, V6, P268, DOI 10.1016/S1071-5576(99)00020-9; DAWES GS, 1993, AM J OBSTET GYNECOL, V168, P105, DOI 10.1016/S0002-9378(12)90895-9; Duncan JR, 2006, J SOC GYNECOL INVEST, V13, P87, DOI 10.1016/j.jsgi.2005.12.003; Falkowski A, 2002, DEV BRAIN RES, V136, P165, DOI 10.1016/S0165-3806(02)00361-9; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Green LR, 1999, J SOC GYNECOL INVEST, V6, P56, DOI 10.1016/S1071-5576(98)00055-0; Hagberg H, 2005, CURR OPIN NEUROL, V18, P117, DOI 10.1097/01.wco.0000162851.44897.8f; Hagberg H, 1996, PEDIATR RES, V40, P603, DOI 10.1203/00006450-199610000-00015; HOSKINS IA, 1991, AM J OBSTET GYNECOL, V165, P1094, DOI 10.1016/0002-9378(91)90478-A; Jin YX, 2007, DEV NEUROSCI-BASEL, V29, P373, DOI 10.1159/000105478; Kaneko M, 2003, AM J OBSTET GYNECOL, V188, P961, DOI 10.1067/mob.2003.219; Keelan JA, 2005, J SOC GYNECOL INVEST, V12, P385, DOI 10.1016/j.jsgi.2005.07.001; Markus T, 2007, PEDIATR RES, V62, P71, DOI 10.1203/PDR.0b013e31811ead6e; Moxley G, 2002, ARTHRITIS RHEUM, V46, P250, DOI 10.1002/1529-0131(200201)46:1<250::AID-ART10064>3.0.CO;2-T; Munkeby BH, 2004, PEDIATR RES, V56, P783, DOI 10.1203/01.PDR.0000141988.89820.E3; Nelson KB, 1998, AM J OBSTET GYNECOL, V179, P507, DOI 10.1016/S0002-9378(98)70387-4; Nitsos I, 2006, J SOC GYNECOL INVEST, V13, P239, DOI 10.1016/j.jsgi.2006.02.011; Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x; Pierce BT, 2000, AM J OBSTET GYNECOL, V183, P863, DOI 10.1067/mob.2000.108887; Prout AP, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.020; Richardson BS, 2006, AM J OBSTET GYNECOL, V195, P1357, DOI 10.1016/j.ajog.2006.03.053; Richardson BS, 1996, AM J OBSTET GYNECOL, V175, P929, DOI 10.1016/S0002-9378(96)80027-5; Rocha E, 2004, AM J OBSTET GYNECOL, V191, P488, DOI 10.1016/j.ajog.2004.01.039; ROMERO R, 1994, AM J OBSTET GYNECOL, V171, P912, DOI 10.1016/S0002-9378(94)70058-3; Silveira RC, 2003, J PEDIATR-US, V143, P625, DOI 10.1067/S0022-3476(03)00531-6; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277	32	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39043	10.1371/journal.pone.0039043	http://dx.doi.org/10.1371/journal.pone.0039043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745702	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693200039
J	De Wever, V; Lloyd, DC; Nasa, I; Nimick, M; Trinkle-Mulcahy, L; Gourlay, R; Morrice, N; Moorhead, GBG				De Wever, Veerle; Lloyd, David C.; Nasa, Isha; Nimick, Mhairi; Trinkle-Mulcahy, Laura; Gourlay, Robert; Morrice, Nick; Moorhead, Greg B. G.			Isolation of Human Mitotic Protein Phosphatase Complexes: Identification of a Complex between Protein Phosphatase 1 and the RNA Helicase Ddx21	PLOS ONE			English	Article							CELL-DIVISION; SERINE/THREONINE PHOSPHATASES; CATALYTIC SUBUNIT; NUCLEAR-PROTEIN; PHOSPHORYLATION; AURORA; 2A; KINASES; SPINDLE; FAMILY	Metazoan mitosis requires remodelling of sub-cellular structures to ensure proper division of cellular and genetic material. Faults often lead to genomic instability, cell cycle arrests and disease onset. These key structural changes are under tight spatial-temporal and post-translational control, with crucial roles for reversible protein phosphorylation. The phosphoprotein phosphatases PP1 and PP2A are paramount for the timely execution of mitotic entry and exit but their interaction partners and substrates are still largely unresolved. High throughput, mass-spectrometry based studies have limited sensitivity for the detection of low-abundance and transient complexes, a typical feature of many protein phosphatase complexes. Moreover, the limited timeframe during which mitosis takes place reduces the likelihood of identifying mitotic phosphatase complexes in asynchronous cells. Hence, numerous mitotic protein phosphatase complexes still await identification. Here we present a strategy to enrich and identify serine/threonine protein phosphatase complexes at the mitotic spindle. We thus identified a nucleolar RNA helicase, Ddx21/Gu, as a novel, direct PP1 interactor. Furthermore, our results place PP1 within the toposome, a Topoisomerase II alpha (TOPOII alpha) containing complex with a key role in mitotic chromatin regulation and cell cycle progression, possibly via regulated protein phosphorylation. This study provides a strategy for the identification of further mitotic PP1 partners and the unravelling of PP1 functions during mitosis.	[De Wever, Veerle; Lloyd, David C.; Nasa, Isha; Nimick, Mhairi; Moorhead, Greg B. G.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Trinkle-Mulcahy, Laura] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Trinkle-Mulcahy, Laura] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Gourlay, Robert; Morrice, Nick] Univ Dundee, Prot Phosphorylat Unit, MRC, Coll Life Sci, Dundee, Scotland	University of Calgary; University of Ottawa; University of Ottawa; University of Dundee	De Wever, V (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	moorhead@ucalgary.ca	Trinkle-Mulcahy, Laura/E-2197-2013; Nimick, Mhairi/HCG-9515-2022	Nimick, Mhairi/0000-0002-3351-0897	National Sciences and Engineering Research Council Canada (NSERC); Alberta Cancer Board [23161]; MRC [G1100713] Funding Source: UKRI; Medical Research Council [G1100713] Funding Source: researchfish	National Sciences and Engineering Research Council Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Cancer Board; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the National Sciences and Engineering Research Council Canada (NSERC http://www.nserc-crsng.gc.ca/) to GM, LTM and by the Alberta Cancer Board (http://albertacancer.ca/) to GM (#23161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chamousset D, 2010, PROTEOMICS, V10, P3045, DOI 10.1002/pmic.201000162; Chen YM, 2006, J BIOL CHEM, V281, P5726, DOI 10.1074/jbc.M510945200; Dancheck B, 2011, BIOCHEMISTRY-US, V50, P1238, DOI 10.1021/bi101774g; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; De Wulf P, 2009, CURR OPIN CELL BIOL, V21, P806, DOI 10.1016/j.ceb.2009.08.003; Delestienne N, 2010, FEBS J, V277, P2496, DOI 10.1111/j.1742-4658.2010.07664.x; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dixon MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003178; Emanuele MJ, 2008, J CELL BIOL, V181, P241, DOI 10.1083/jcb.200710019; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Ferrar T, 2012, BIOL OPEN, V1, P128, DOI 10.1242/bio.2011049; Ferrari S, 2006, CELL MOL LIFE SCI, V63, P781, DOI 10.1007/s00018-005-5515-3; Giannakouros T, 2011, FEBS J, V278, P570, DOI 10.1111/j.1742-4658.2010.07987.x; Guergnon J, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-24; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; HIRANO K, 1995, J BIOL CHEM, V270, P19786, DOI 10.1074/jbc.270.34.19786; Hofmann JC, 2010, NUCLEUS-PHILA, V1, P447, DOI 10.4161/nucl.1.6.13328; Holmstrom TH, 2008, J BIOL CHEM, V283, P7046, DOI 10.1074/jbc.M709613200; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Lee CG, 2004, CELL CYCLE, V3, P638; Lee JH, 2010, J BIOL CHEM, V285, P24466, DOI 10.1074/jbc.M110.109801; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Ma CT, 2010, J MOL BIOL, V403, P386, DOI 10.1016/j.jmb.2010.08.024; MacCallum DE, 2000, J PATHOL, V190, P537; MACKINTOSH C, 1999, PROTEIN PHOSPHORYLAT, P153; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Martin-Granados C, 2008, INT J BIOCHEM CELL B, V40, P2315, DOI 10.1016/j.biocel.2008.03.021; Mialon A, 2008, FEBS LETT, V582, P3145, DOI 10.1016/j.febslet.2008.08.004; MOORHEAD G, 1994, FEBS LETT, V356, P46, DOI 10.1016/0014-5793(94)01232-6; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Moorhead Greg B. G., 2008, BMC Biochemistry, V9, P28, DOI 10.1186/1471-2091-9-28; Nanahoshi M, 1999, FEBS LETT, V446, P108, DOI 10.1016/S0014-5793(99)00189-1; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ou YC, 1999, EXP CELL RES, V247, P389, DOI 10.1006/excr.1998.4365; PEARSON NJ, 1982, MOL CELL BIOL, V2, P571, DOI 10.1128/MCB.2.5.571; Perlaky L, 1997, EXP CELL RES, V235, P413, DOI 10.1006/excr.1997.3686; RIABOWOL K, 1989, CELL, V57, P393, DOI 10.1016/0092-8674(89)90914-8; Sakai H, 2002, J BIOL CHEM, V277, P48714, DOI 10.1074/jbc.M208461200; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Schlaitz AL, 2007, CELL, V128, P115, DOI 10.1016/j.cell.2006.10.050; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Schutz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012791; Smetana JHC, 2007, FEBS J, V274, P5891, DOI 10.1111/j.1742-4658.2007.06112.x; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Tegha-Dunghu J, 2008, J CELL SCI, V121, P1718, DOI 10.1242/jcs.019174; Templeton GW, 2011, BIOCHEM J, V435, P73, DOI 10.1042/BJ20101035; Toyo-oka K, 2008, J CELL BIOL, V180, P1133, DOI 10.1083/jcb.200705148; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Valdez BC, 1996, NUCLEIC ACIDS RES, V24, P1220, DOI 10.1093/nar/24.7.1220; Valdez BC, 1997, EUR J BIOCHEM, V250, P800, DOI 10.1111/j.1432-1033.1997.00800.x; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; VANDRE DD, 1991, J CELL SCI, V98, P577; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Zeng K, 2010, J CELL BIOL, V191, P1315, DOI 10.1083/jcb.201008106	69	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39510	10.1371/journal.pone.0039510	http://dx.doi.org/10.1371/journal.pone.0039510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761809	Green Published, gold			2022-12-27	WOS:000305826400018
J	Elkout, H; Helms, PJ; Simpson, CR; McLay, JS				Elkout, Hajer; Helms, Peter J.; Simpson, Colin R.; McLay, James S.			Adequate Levels of Adherence with Controller Medication Is Associated with Increased Use of Rescue Medication in Asthmatic Children	PLOS ONE			English	Article							FLUTICASONE PROPIONATE/SALMETEROL COMBINATION; INHALED CORTICOSTEROIDS; RESOURCE UTILIZATION; GENERAL-PRACTICE; THERAPY; CARE; PRESCRIPTION; PERSISTENCE; CONCORDANCE; POPULATION	Background: The role of asthma controller medication adherence and the level of asthma control in children is poorly defined. Aims: To assess the association between asthma controller medication adherence and asthma control in children using routinely acquired prescribing data. Methods: A retrospective observational study of children aged 0-18 years prescribed inhaled corticosteroids only (ICS), leukotriene receptors antagonists (LTRA), or long-acting beta 2 agonists (LABA) and ICS prescribed as separate or combined inhalers, between 01/09/2001 and 31/08/2006, registered with primary care practices contributing to the Practice Team Information database. The medication possession ratio (MPR) was calculated and associations with asthma control explored. Poor asthma control was defined as the issue of prescriptions for >= 1 course of oral corticosteroids (OCS) and/or >= 6 short-acting beta 2 agonists (SABA) canisters annually. Results: A total of 3172 children prescribed asthma controller medication were identified. Of these, 15-39% (depending on controller medication) demonstrated adequate MPR. Adequate MPR was associated with male gender, good socioeconomic status, and oral LTRA therapy. Adequate MPR was more likely to be associated with increased use of rescue medication. However logistic regression only identified a significant relationship for ICS only (odds ratio [OR], 1.89; 95% confidence interval [CI], 1.35-2.48; p < 0.001), LTRA (OR, 2.11; 95% CI, 1.27-3.48; p = 0.004) and LABA/ICS (OR, 2.85; 95% CI, 1.62-5.02; p < 0.001). Conclusion: Poor adherence was observed for all asthma controller medications, although was significantly better for oral LRTA. In this study adequate adherence was not associated with the use of less rescue medication, suggesting that adherence is a complex issue.	[Elkout, Hajer; Helms, Peter J.; McLay, James S.] Univ Aberdeen, Sch Med, Div Appl Hlth Sci, Dept Child Hlth, Aberdeen AB9 2ZD, Scotland; [Simpson, Colin R.] Univ Aberdeen, Sch Med, Dept Gen Practice & Primary Care, Div Appl Hlth Sci, Aberdeen AB9 2ZD, Scotland; [Simpson, Colin R.] Univ Edinburgh, Ctr Populat Hlth Sci, Foresterhill Hlth Ctr, Edinburgh, Midlothian, Scotland	University of Aberdeen; University of Aberdeen; University of Edinburgh	Elkout, H (corresponding author), Univ Aberdeen, Sch Med, Div Appl Hlth Sci, Dept Child Hlth, Aberdeen AB9 2ZD, Scotland.	j.mclay@abdn.ac.uk	Simpson, Colin/I-3974-2019; Simpson, Colin R/L-7180-2014	Simpson, Colin/0000-0002-5194-8083; Simpson, Colin R/0000-0002-5194-8083; Elkout, Hajer/0000-0003-3191-3868				Anis AH, 2001, CAN MED ASSOC J, V164, P625; Balkrishnan R, 2005, J ASTHMA, V42, P35, DOI 10.1081/JAS-200044769; Bender B, 2008, J ALLERGY CLIN IMMUN, V122, P490, DOI 10.1016/j.jaci.2008.05.041; Bender BG, 2006, J ALLERGY CLIN IMMUN, V118, P899, DOI 10.1016/j.jaci.2006.07.002; Broder MS, 2010, ALLERGY ASTHMA PROC, V31, P60, DOI 10.2500/aap.2010.31.3302; Bukstein DA, 2001, CLIN THER, V23, P1589, DOI 10.1016/S0149-2918(01)80130-2; Butz AM, 2006, PEDIATRICS, V118, P2504, DOI 10.1542/peds.2006-1630; Camargo CA, 2007, AM J HEALTH-SYST PH, V64, P1054, DOI 10.2146/ajhp060256; Chan J, 2007, J MANAG CARE PHARM, V13, P21, DOI 10.18553/jmcp.2007.13.1.21; Cochrane MG, 2000, CHEST, V117, P542, DOI 10.1378/chest.117.2.542; Delea TE, 2008, CLIN THER, V30, P560, DOI 10.1016/j.clinthera.2008.03.011; Ferrell CW, 2006, J AM BOARD FAM MED, V19, P31, DOI 10.3122/jabfm.19.1.31; Guenette L, 2005, J CLIN EPIDEMIOL, V58, P924, DOI 10.1016/j.jclinepi.2005.02.002; Haupt D, 2009, J CLIN PHARM THER, V34, P507, DOI 10.1111/j.1365-2710.2009.01026.x; Horne R, 2006, CHEST, V130, p65S, DOI 10.1378/chest.130.1_suppl.65S; Hudson M, 2007, AM HEART J, V153, P59, DOI 10.1016/j.ahj.2006.10.018; ISD Scotland, GEN PRACT PRACT TEAM; Jones C, 2003, J ASTHMA, V40, P93, DOI 10.1081/JAS-120017212; Krigsman K, 2007, PHARMACOEPIDEM DR S, V16, P441, DOI 10.1002/pds.1321; Laforest L, 2005, FUND CLIN PHARMACOL, V19, P107, DOI 10.1111/j.1472-8206.2004.00302.x; Lasmar L, 2009, J TROP PEDIATRICS, V55, P20, DOI 10.1093/tropej/fmn067; Latry P, 2008, CLIN THER, V30, P1058, DOI 10.1016/j.clinthera.2008.06.011; Mattke S, 2010, J ASTHMA, V47, P323, DOI 10.3109/02770900903497196; Milgrom H, 1996, J ALLERGY CLIN IMMUN, V98, P1051, DOI 10.1016/S0091-6749(96)80190-4; Osman LM, 1999, J ASTHMA, V36, P449, DOI 10.3109/02770909909087287; Riekert KA, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e214; Rosenhall L, 2003, RESP MED, V97, P702, DOI 10.1053/rmed.2003.1504; Smyth AR, 2010, EUR RESPIR J, V35, P247, DOI 10.1183/09031936.00139508; Stempel DA, 2005, RESP MED, V99, P1263, DOI 10.1016/j.rmed.2005.03.002; Stoloff SW, 2004, J ALLERGY CLIN IMMUN, V113, P245, DOI 10.1016/j.jaci.2003.10.011; Straand J, 1998, ACTA PAEDIATR, V87, P218, DOI 10.1080/08035259850157705; The Scottish Government, 2010, SCOTT HLTH SURV RES; Walders N, 2005, J PEDIATR-US, V146, P177, DOI 10.1016/j.jpeds.2004.10.014; Williams LK, 2007, J ALLERGY CLIN IMMUN, V120, P1153, DOI 10.1016/j.jaci.2007.08.020	34	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39130	10.1371/journal.pone.0039130	http://dx.doi.org/10.1371/journal.pone.0039130			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761728	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800020
J	Zhang, ZS; Lu, YS; Zhai, LG; Deng, RS; Jiang, J; Li, Y; He, ZH; Peng, XX				Zhang, Zhisheng; Lu, Yusheng; Zhai, Liguang; Deng, Rongshu; Jiang, Jun; Li, Yong; He, Zhenghui; Peng, Xinxiang			Glycolate Oxidase Isozymes Are Coordinately Controlled by GLO1 and GLO4 in Rice	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; ARABIDOPSIS; PURIFICATION; EXPRESSION; LEAVES; PLANTS; GENES; SUPPRESSION; DROUGHT; ENZYMES	Glycolate oxidase (GLO) is a key enzyme in photorespiratory metabolism. Four putative GLO genes were identified in the rice genome, but how each gene member contributes to GLO activities, particularly to its isozyme profile, is not well understood. In this study, we analyzed how each gene plays a role in isozyme formation and enzymatic activities in both yeast cells and rice tissues. Five GLO isozymes were detected in rice leaves. GLO1 and GLO4 are predominately expressed in rice leaves, while GLO3 and GLO5 are mainly expressed in the root. Enzymatic assays showed that all yeast-expressed GLO members except GLO5 have enzymatic activities. Further analyses suggested that GLO1, GLO3 and GLO4 interacted with each other, but no interactions were observed for GLO5. GLO1/GLO4 co-expressed in yeast exhibited the same isozyme pattern as that from rice leaves. When either GLO1 or GLO4 was silenced, expressions of both genes were simultaneously suppressed and most of the GLO activities were lost, and consistent with this observation, little GLO isozyme protein was detected in the silenced plants. In contrast, no observable effect was detected when GLO3 was suppressed. Comparative analyses between the GLO isoforms expressed in yeast and the isozymes from rice leaves indicated that two of the five isozymes are homo-oligomers composed of either GLO1 or GLO4, and the other three are hetero-oligomers composed of both GLO1 and GLO4. Our current data suggest that GLO isozymes are coordinately controlled by GLO1 and GLO4 in rice, and the existence of GLO isozymes and GLO molecular and compositional complexities implicate potential novel roles for GLO in plants.	[Zhang, Zhisheng; Lu, Yusheng; Zhai, Liguang; Deng, Rongshu; Jiang, Jun; Li, Yong; Peng, Xinxiang] S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Zhang, Zhisheng; Lu, Yusheng; Zhai, Liguang; Deng, Rongshu; Jiang, Jun; Li, Yong; Peng, Xinxiang] S China Agr Univ, Coll Life Sci, Lab Mol Plant Physiol, Guangzhou, Guangdong, Peoples R China; [He, Zhenghui] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	South China Agricultural University; South China Agricultural University; California State University System; San Francisco State University	Peng, XX (corresponding author), S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China.	zhe@sfsu.edu; xpeng@scau.edu.cn		Zhang, Zhi-Sheng/0000-0002-2127-3134	National Natural Science Foundation of China [30971710]; Natural Science Foundation of China [10251064201000005]; National Institute of General Medical Sciences [SC1GM095462]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM095462] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Natural Science Foundation of China (30971710), Natural Science Foundation of China (10251064201000005). This work was also partly supported by Award Number SC1GM095462 (to Z-HH) from the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bari R, 2004, J EXP BOT, V55, P623, DOI 10.1093/jxb/erh079; BEHRENDS W, 1982, PLANTA, V156, P566, DOI 10.1007/BF00392782; Bohman S, 2002, THEOR APPL GENET, V105, P498, DOI 10.1007/s00122-002-0885-5; Boldt R, 2005, PLANT CELL, V17, P2413, DOI 10.1105/tpc.105.033993; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHOUREY PS, 1991, PLANT PHYSIOL, V96, P485, DOI 10.1104/pp.96.2.485; Devi MT, 1996, PHOTOSYNTH RES, V47, P231, DOI 10.1007/BF02184284; EMES MJ, 1984, INT J BIOCHEM, V16, P1373, DOI 10.1016/0020-711X(84)90243-X; Fahnenstich H, 2008, PLANT PHYSIOL, V148, P719, DOI 10.1104/pp.108.126789; Fontaine JX, 2006, PLANT CELL PHYSIOL, V47, P410, DOI 10.1093/pcp/pcj008; Foyer CH, 2009, ANNU REV PLANT BIOL, V60, P455, DOI 10.1146/annurev.arplant.043008.091948; FRIGERIO NA, 1958, J BIOL CHEM, V231, P135; Goyal A, 1996, P NATL ACAD SCI USA, V93, P3319, DOI 10.1073/pnas.93.8.3319; HALL NP, 1985, PHYTOCHEMISTRY, V24, P1645, DOI 10.1016/S0031-9422(00)82527-3; HAVIR EA, 1983, PLANT PHYSIOL, V71, P874, DOI 10.1104/pp.71.4.874; HOFFMAN NE, 1986, PLANT PHYSIOL, V82, P658, DOI 10.1104/pp.82.3.658; Iwamoto K, 2000, PLANT CELL PHYSIOL, V41, P988, DOI 10.1093/pcp/pcd020; Iwamoto Koji, 1997, Phycological Research, V45, P77, DOI 10.1111/j.1440-1835.1997.tb00066.x; JENKINS CLD, 1982, PHYTOCHEMISTRY, V21, P1849, DOI 10.1016/0031-9422(82)83002-1; KERR MW, 1975, PHYTOCHEMISTRY, V14, P359, DOI 10.1016/0031-9422(75)85090-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDQVIST Y, 1985, P NATL ACAD SCI USA, V82, P6855, DOI 10.1073/pnas.82.20.6855; LUDT C, 1990, PLANT PHYSIOL, V94, P1193, DOI 10.1104/pp.94.3.1193; MCLELLAN T, 1982, ANAL BIOCHEM, V126, P94, DOI 10.1016/0003-2697(82)90113-0; MITTLER R, 1994, PLANT J, V5, P397, DOI 10.1111/j.1365-313X.1994.00397.x; MUKHERJEE SP, 1983, PHYSIOL PLANTARUM, V58, P166, DOI 10.1111/j.1399-3054.1983.tb04162.x; Mullen RT, 1997, PLANT PHYSIOL, V115, P881, DOI 10.1104/pp.115.3.881; NISHIMURA M, 1983, ARCH BIOCHEM BIOPHYS, V222, P397, DOI 10.1016/0003-9861(83)90536-2; Noctor G, 2002, ANN BOT-LONDON, V89, P841, DOI 10.1093/aob/mcf096; Odanaka S, 2002, PLANT PHYSIOL, V129, P1119, DOI 10.1104/pp.000703; Ogawa S, 2012, PLANT CELL ENVIRON, V35, P546, DOI 10.1111/j.1365-3040.2011.02434.x; Popov VN, 2003, J PLANT PHYSIOL, V160, P851, DOI 10.1078/0176-1617-01105; Reumann S, 2004, PLANT PHYSIOL, V135, P783, DOI 10.1104/pp.103.035584; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Rojas CM, 2012, PLANT CELL, V24, P336, DOI 10.1105/tpc.111.093245; Schafer P, 2004, MOL PLANT MICROBE IN, V17, P366, DOI 10.1094/MPMI.2004.17.4.366; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SERVAITES JC, 1977, PLANT PHYSIOL, V60, P461, DOI 10.1104/pp.60.4.461; Somerville CR, 2001, PLANT PHYSIOL, V125, P20, DOI 10.1104/pp.125.1.20; SOMERVILLE CR, 1982, TRENDS BIOCHEM SCI, V7, P171, DOI 10.1016/0968-0004(82)90130-X; Suzuki Y, 2001, PLANT CELL ENVIRON, V24, P1353, DOI 10.1046/j.0016-8025.2001.00789.x; Taler D, 2004, PLANT CELL, V16, P172, DOI 10.1105/tpc.016352; TSUGEKI R, 1993, PLANT CELL PHYSIOL, V34, P51; VOLOKITA M, 1987, J BIOL CHEM, V262, P15825; Xu HW, 2006, J EXP BOT, V57, P1899, DOI 10.1093/jxb/erj131; Xu HW, 2009, J EXP BOT, V60, P1799, DOI 10.1093/jxb/erp056; Yamaguchi K, 2000, PLANT CELL PHYSIOL, V41, P1397, DOI 10.1093/pcp/pcd074; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zelitch I, 2009, PLANT PHYSIOL, V149, P195, DOI 10.1104/pp.108.128439	50	23	25	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39658	10.1371/journal.pone.0039658	http://dx.doi.org/10.1371/journal.pone.0039658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761858	Green Published, gold, Green Submitted			2022-12-27	WOS:000305808700042
J	Kagkli, DM; Folloni, S; Barbau-Piednoir, E; Van den Eede, G; Van den Bulcke, M				Kagkli, Dafni-Maria; Folloni, Silvia; Barbau-Piednoir, Elodie; Van den Eede, Guy; Van den Bulcke, Marc			Towards a Pathogenic Escherichia coli Detection Platform Using Multiplex SYBR (R) Green Real-Time PCR Methods and High Resolution Melting Analysis	PLOS ONE			English	Article							5'-NUCLEASE PCR; ASSOCIATION; VARIANTS; STRAINS; O103	Escherichia coli is a group of bacteria which has raised a lot of safety concerns in recent years. Five major intestinal pathogenic groups have been recognized amongst which the verocytotoxin or shiga-toxin (stx1 and/or stx2) producing E. coli (VTEC or STEC respectively) have received a lot of attention recently. Indeed, due to the high number of outbreaks related to VTEC strains, the European Food Safety Authority (EFSA) has requested the monitoring of the "top-five" serogroups (O26, O103, O111, O145 and O157) most often encountered in food borne diseases and addressed the need for validated VTEC detection methods. Here we report the development of a set of intercalating dye Real-time PCR methods capable of rapidly detecting the presence of the toxin genes together with intimin (eae) in the case of VTEC, or aggregative protein (aggR), in the case of the O104:H4 strain responsible for the outbreak in Germany in 2011. All reactions were optimized to perform at the same annealing temperature permitting the multiplex application in order to minimize the need of material and to allow for high-throughput analysis. In addition, High Resolution Melting (HRM) analysis allowing the discrimination among strains possessing similar virulence traits was established. The development, application to food samples and the flexibility in use of the methods are thoroughly discussed. Together, these Real-time PCR methods facilitate the detection of VTEC in a new highly efficient way and could represent the basis for developing a simple pathogenic E. coli platform.	[Kagkli, Dafni-Maria; Folloni, Silvia; Van den Eede, Guy; Van den Bulcke, Marc] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, Mol Biol & Genom Unit, I-21020 Ispra, VA, Italy; [Barbau-Piednoir, Elodie] Sci Inst Publ Hlth, Brussels, Belgium	European Commission Joint Research Centre; EC JRC ISPRA Site	Kagkli, DM (corresponding author), Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, Mol Biol & Genom Unit, I-21020 Ispra, VA, Italy.	Marc.VAN-DEN-BULCKE@ec.europa.eu	Kagkli, Dafni-Maria/C-5987-2008	Kagkli, Dafni-Maria/0000-0002-7351-135X; Folloni, Silvia/0000-0002-3302-6456				[Anonymous], 2004, V030202 NORM AFNOR X; Boerlin P, 1999, CELL MOL LIFE SCI, V56, P735, DOI 10.1007/s000180050020; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Bugarel M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-142; Chassagne L, 2009, DIAGN MICR INFEC DIS, V64, P98, DOI 10.1016/j.diagmicrobio.2009.01.031; Cheng JC, 2006, CLIN CHEM, V52, P1997, DOI 10.1373/clinchem.2006.069286; DEGRANDIS S, 1987, J BACTERIOL, V169, P4313, DOI 10.1128/jb.169.9.4313-4319.1987; EFSA. European Food Safety Authority, 2009, EFSA J, V7, p[1366, 1366], DOI DOI 10.2903/J.EFSA.2009.1366; European Food Safety Authority, 2007, EFSA J, V5, P579, DOI [10.2903/j.efsa.2007.579, DOI 10.2903/J.EFSA.2007.579]; European Food Safety Authority, 2011, EFSAQ201100779; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Friedrich AW, 2003, J CLIN MICROBIOL, V41, P2448, DOI 10.1128/JCM.41.6.2448-2453.2003; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Guion CE, 2008, J CLIN MICROBIOL, V46, P1752, DOI 10.1128/JCM.02341-07; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Gyles CL, 2011, VET MICROBIOL, V153, P2, DOI 10.1016/j.vetmic.2011.04.020; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kagkli DM, 2011, APPL ENVIRON MICROB, V77, P6954, DOI 10.1128/AEM.05357-11; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; Kaur P, 2010, INTERDISCIP PERSPECT, V2010; KONOWALCHUK J, 1977, INFECT IMMUN, V18, P775, DOI 10.1128/IAI.18.3.775-779.1977; Lee JE, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-109; Levesque S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016167; Martin A, 2011, INT J FOOD MICROBIOL, V146, P99, DOI 10.1016/j.ijfoodmicro.2011.01.041; Mathusa EC, 2010, J FOOD PROTECT, V73, P1721, DOI 10.4315/0362-028X-73.9.1721; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nielsen EM, 2003, J CLIN MICROBIOL, V41, P2884, DOI 10.1128/JCM.41.7.2884-2893.2003; Norambuena PA, 2009, CLIN BIOCHEM, V42, P1308, DOI 10.1016/j.clinbiochem.2009.04.015; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Pennington H, 2011, LANCET INFECT DIS, V11, P652, DOI 10.1016/S1473-3099(11)70166-9; Pennington H, 2010, LANCET, V376, P1428, DOI 10.1016/S0140-6736(10)60963-4; Perelle S, 2005, J APPL MICROBIOL, V98, P1162, DOI 10.1111/j.1365-2672.2005.02545.x; Perelle S, 2004, MOL CELL PROBE, V18, P185, DOI 10.1016/j.mcp.2003.12.004; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Simenc J, 2011, APPL BIOCHEM MICRO+, V47, P256, DOI 10.1134/S0003683811030136; STEIN PE, 1992, NATURE, V355, P748, DOI 10.1038/355748a0; Wu CJ, 2011, J MICROBIOL IMMUNOL, V44, P390, DOI 10.1016/j.jmii.2011.07.001	38	22	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39287	10.1371/journal.pone.0039287	http://dx.doi.org/10.1371/journal.pone.0039287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761753	gold, Green Published, Green Submitted			2022-12-27	WOS:000305781700026
J	Moslemi, JM; Snider, SB; MacNeill, K; Gilliam, JF; Flecker, AS				Moslemi, Jennifer M.; Snider, Sunny B.; MacNeill, Keeley; Gilliam, James F.; Flecker, Alexander S.			Impacts of an Invasive Snail (Tarebia granifera) on Nutrient Cycling in Tropical Streams: The Role of Riparian Deforestation in Trinidad, West Indies	PLOS ONE			English	Article							FRESH-WATER; LIGHT; TERRESTRIAL; PHOSPHORUS; NITROGEN; STOICHIOMETRY; LIMITATION; LINKAGES; GROWTH; RIVER	Non-native species and habitat degradation are two major catalysts of environmental change and often occur simultaneously. In freshwater systems, degradation of adjacent terrestrial vegetation may facilitate introduced species by altering resource availability. Here we examine how the presence of intact riparian cover influences the impact of an invasive herbivorous snail, Tarebia granifera, on nitrogen (N) cycling in aquatic systems on the island of Trinidad. We quantified snail biomass, growth, and N excretion in locations where riparian vegetation was present or removed to determine how snail demographics and excretion were related to the condition of the riparian zone. In three Neotropical streams, we measured snail biomass and N excretion in open and closed canopy habitats to generate estimates of mass- and area-specific N excretion rates. Snail biomass was 2 to 8 times greater and areal N excretion rates ranged from 3 to 9 times greater in open canopy habitats. Snails foraging in open canopy habitat also had access to more abundant food resources and exhibited greater growth and mass-specific N excretion rates. Estimates of ecosystem N demand indicated that snail N excretion in fully closed, partially closed, and open canopy habitats supplied 2%, 11%, and 16% of integrated ecosystem N demand, respectively. We conclude that human-mediated riparian canopy loss can generate hotspots of snail biomass, growth, and N excretion along tropical stream networks, altering the impacts of an invasive snail on the biogeochemical cycling of N.	[Moslemi, Jennifer M.; Flecker, Alexander S.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Snider, Sunny B.; Gilliam, James F.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [MacNeill, Keeley] Univ Nebraska, Sch Nat Resources, Lincoln, NE USA	Cornell University; University of North Carolina; North Carolina State University; University of Nebraska System; University of Nebraska Lincoln	Moslemi, JM (corresponding author), Habitat Seven, Seattle, WA USA.	jmm257@cornell.edu	Gilliam, James F/D-5605-2013; MacNeill, Keeley L/B-7203-2016		NSF; NSF FIBR [EF-0623632-002]	NSF(National Science Foundation (NSF)); NSF FIBR(National Science Foundation (NSF))	NSF Graduate Research Fellowship. NSF FIBR Research Grant (EF-0623632-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arar EJ, 1997, 4450 US EPA; Arnott DL, 1996, CAN J FISH AQUAT SCI, V53, P646, DOI 10.1139/cjfas-53-3-646; Baxter CV, 2004, ECOLOGY, V85, P2656, DOI 10.1890/04-138; Benstead JP, 2010, FRESHWATER BIOL, V55, P2047, DOI 10.1111/j.1365-2427.2010.02461.x; Carlsson NOL, 2004, ECOLOGY, V85, P1575, DOI 10.1890/03-3146; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Downing JA, 1999, BIOGEOCHEMISTRY, V46, P109, DOI 10.1007/BF01007576; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Flecker AS, 2002, ECOLOGY, V83, P1831, DOI 10.2307/3071768; Frost PC, 2002, FRESHWATER BIOL, V47, P173, DOI 10.1046/j.1365-2427.2002.00796.x; Hall R, 2003, FRONT ECOL ENVIRON, V1, P407, DOI 10.1890/1540-9295(2003)001[0407:ESDNAC]2.0.CO;2; Hall Robert O. Jr., 2007, P286, DOI 10.1017/CBO9780511611223.016; Hall RO, 2006, ECOL APPL, V16, P1121, DOI 10.1890/1051-0761(2006)016[1121:EHSPOI]2.0.CO;2; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Hill WR, 2008, FRESHWATER BIOL, V53, P215, DOI 10.1111/j.1365-2427.2007.01885.x; Hill WR, 2010, ECOLOGY, V91, P518, DOI 10.1890/09-0703.1; Liess A, 2009, J ECOL, V97, P326, DOI 10.1111/j.1365-2745.2008.01463.x; LIKENS GE, 1974, BIOSCIENCE, V24, P447, DOI 10.2307/1296852; McIntyre PB, 2008, ECOLOGY, V89, P2335, DOI 10.1890/07-1552.1; McIntyre PB, 2007, P NATL ACAD SCI USA, V104, P4461, DOI 10.1073/pnas.0608148104; Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2; MOULTON MP, 1983, AM NAT, V121, P669, DOI 10.1086/284094; Mulholland PJ, 2002, J N AM BENTHOL SOC, V21, P544, DOI 10.2307/1468429; Nakano S, 1999, ECOLOGY, V80, P2435; NEWBOLD JD, 1981, CAN J FISH AQUAT SCI, V38, P860, DOI 10.1139/f81-114; PETERSON BJ, 1993, ECOLOGY, V74, P653, DOI 10.2307/1940794; POINTIER JP, 1989, ACTA TROP, V46, P147, DOI 10.1016/0001-706X(89)90031-4; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Sanches LF, 2011, HYDROBIOLOGIA, V669, P35, DOI 10.1007/s10750-011-0661-0; Small GE, 2011, ECOLOGY, V92, P386, DOI 10.1890/10-0081.1; Snider SB, 2007, THESIS N CAROLINA ST; Sterner RW, 1997, AM NAT, V150, P663, DOI 10.1086/286088; Strayer DL, 2010, FRESHWATER BIOL, V55, P152, DOI 10.1111/j.1365-2427.2009.02380.x; Tank Jennifer L., 2007, P213, DOI 10.1016/B978-012332908-0.50012-7; Taylor BW, 2007, J N AM BENTHOL SOC, V26, P167, DOI 10.1899/0887-3593(2007)26[167:ITFAMM]2.0.CO;2; Vanni MJ, 2002, ANNU REV ECOL SYST, V33, P341, DOI 10.1146/annurev.ecolsys.33.010802.150519; Vanni MJ, 2002, ECOL LETT, V5, P285, DOI 10.1046/j.1461-0248.2002.00314.x; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wallace J. Bruce, 2007, P249, DOI 10.1016/B978-012332908-0.50014-0; Wallace JB, 1999, ECOL MONOGR, V69, P409, DOI 10.1890/0012-9615(1999)069[0409:EORLOA]2.0.CO;2; Wootton JT, 1996, SCIENCE, V273, P1558, DOI 10.1126/science.273.5281.1558	42	34	36	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e38806	10.1371/journal.pone.0038806	http://dx.doi.org/10.1371/journal.pone.0038806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761706	Green Published, gold			2022-12-27	WOS:000305781700011
J	Tricco, AC; Lillie, E; Soobiah, C; Perrier, L; Straus, SE				Tricco, Andrea C.; Lillie, Erin; Soobiah, Charlene; Perrier, Laure; Straus, Sharon E.			Impact of H1N1 on Socially Disadvantaged Populations: Systematic Review	PLOS ONE			English	Review							INFLUENZA-A H1N1; PANDEMIC INFLUENZA; VIRUS-INFECTION; HOSPITALIZED-PATIENTS; SAURASHTRA REGION; EPIDEMIOLOGIC CHARACTERISTICS; SEASONAL INFLUENZA; PREGNANT-WOMEN; AUSTRALIA; CHILDREN	Background: The burden of H1N1 among socially disadvantaged populations is unclear. We aimed to synthesize hospitalization, severe illness, and mortality data associated with pandemic A/H1N1/2009 among socially disadvantaged populations. Methods/Principal Findings: Studies were identified through searching MEDLINE, EMBASE, scanning reference lists, and contacting experts. Studies reporting hospitalization, severe illness, and mortality attributable to laboratory-confirmed 2009 H1N1 pandemic among socially disadvantaged populations (e. g., ethnic minorities, low-income or lower-middle-income economy countries [LIC/LMIC]) were included. Two independent reviewers conducted screening, data abstraction, and quality appraisal (Newcastle Ottawa Scale). Random effects meta-analysis was conducted using SAS and Review Manager. Conclusions/Significance: Sixty-two studies including 44,777 patients were included after screening 787 citations and 164 full-text articles. The prevalence of hospitalization for H1N1 ranged from 17-87% in high-income economy countries (HIC) and 11-45% in LIC/LMIC. Of those hospitalized, the prevalence of intensive care unit (ICU) admission and mortality was 6-76% and 1-25% in HIC; and 30% and 8-15%, in LIC/LMIC, respectively. There were significantly more hospitalizations among ethnic minorities versus non-ethnic minorities in two studies conducted in North America (1,313 patients, OR 2.26 [95% CI: 1.53-3.32]). There were no differences in ICU admissions (n = 8 studies, 15,352 patients, OR 0.84 [0.69-1.02]) or deaths (n = 6 studies, 14,757 patients, OR 0.85 [95% CI: 0.73-1.01]) among hospitalized patients in HIC. Sub-group analysis indicated that the meta-analysis results were not likely affected by confounding. Overall, the prevalence of hospitalization, severe illness, and mortality due to H1N1 was high for ethnic minorities in HIC and individuals from LIC/LMIC. However, our results suggest that there were little differences in the proportion of hospitalization, severe illness, and mortality between ethnic minorities and non-ethnic minorities living in HIC.	[Tricco, Andrea C.; Lillie, Erin; Soobiah, Charlene; Perrier, Laure; Straus, Sharon E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Soobiah, Charlene] Hosp Sick Children, Child Hlth Evaluat Sci, Toronto, ON M5G 1X8, Canada; [Straus, Sharon E.] Univ Toronto, Fac Med, Div Geriatr, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Tricco, AC (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	sharon.straus@utoronto.ca	Tricco, Andrea/B-9920-2011; Perrier, Laure/D-4638-2011	Tricco, Andrea/0000-0002-4114-8971; Perrier, Laure/0000-0001-9941-7129	World Health Organization (WHO); Tier 1 Canada Research Chair through the Canadian Institutes for Health Research	World Health Organization (WHO)(World Health Organization); Tier 1 Canada Research Chair through the Canadian Institutes for Health Research	This systematic review was partially funded by the World Health Organization (WHO), Global Influenza Programme (http://www.who.int/influenza/about/en/). The funders had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript. Sharon E. Straus is funded by a Tier 1 Canada Research Chair through the Canadian Institutes for Health Research.	[Anonymous], 2009, COCHR HDB SYST REV I; Baker MG, 2009, EURO SURVEILLANCE B, V14; Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Bandaranayake D, 2011, EURO SURVEILLANCE B, V16; Bettinger JA, 2010, VACCINE, V28, P3180, DOI 10.1016/j.vaccine.2010.02.044; Bhopal R, 2004, J EPIDEMIOL COMMUN H, V58, P441, DOI 10.1136/jech.2003.013466; Campbell A, 2010, CAN MED ASSOC J, V182, P349, DOI 10.1503/cmaj.091823; Castrodale L., 2009, Morbidity and Mortality Weekly Report, V58, P1341; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P941; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Centers for Disease Control and Prevention (CDC), 2011, INFL DIAGN TEST ALG; Chacko J, 2010, INDIAN J CRIT CARE M, V14, P77, DOI 10.4103/0972-5229.68220; Chien YS, 2010, J INFECTION, V60, P168, DOI 10.1016/j.jinf.2009.12.012; Chitnis Amit S, 2010, WMJ, V109, P201; Chudasama RK, 2011, LUNG INDIA, V28, P11, DOI 10.4103/0970-2113.76294; Chudasama RK, 2010, J INFECT DEV COUNTR, V4, P834, DOI 10.3855/jidc.1049; Chudasama RK, 2010, INDIAN J CRIT CARE M, V14, P113, DOI 10.4103/0972-5229.74169; Chudasama RK, 2010, J PEDIAT SCI, V4, pe27; Chudasama RK, 2010, ONLINE J HLTH ALLIED, V9, P9; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Cretikos M, 2009, EURO SURVEILL, V14; Dee DL, 2011, ANN EPIDEMIOL, V21, P623, DOI 10.1016/j.annepidem.2011.03.002; Dee S, 2010, NEW ZEAL MED J, V123, P45; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Falagas ME, 2011, EPIDEMIOL INFECT, V139, P27, DOI 10.1017/S0950268810002037; Falagas ME, 2010, EUR J CLIN MICROBIOL, V29, P1327, DOI 10.1007/s10096-010-1002-3; Flint SM, 2010, MED J AUSTRALIA, V192, P617, DOI 10.5694/j.1326-5377.2010.tb03654.x; Flint SM, 2009, NO TERRITORY DIS CON, V16, P1; Galante M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031696; Galarce EM, 2011, VACCINE, V29, P5284, DOI 10.1016/j.vaccine.2011.05.014; Gupta BD, 2011, J TROP PEDIATRICS, V57, P87, DOI 10.1093/tropej/fmq048; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Harris PNA, 2010, COMMUN DIS INTELL, V34, P102; Helferty M, 2010, CAN MED ASSOC J, V182, P1981, DOI 10.1503/cmaj.100746; Higgins AM, 2011, ANAESTH INTENS CARE, V39, P384, DOI 10.1177/0310057X1103900308; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jouvet P, 2010, PEDIATR CRIT CARE ME, V11, P603, DOI 10.1097/PCC.0b013e3181d9c80b; Jung J, 2011, 2009 2010 H1N1 RELAT; Kelly H, 2009, EURO SURVEILLANCE B, V14; Kelly PM, 2011, MED J AUSTRALIA, V194, P169, DOI 10.5694/j.1326-5377.2011.tb03764.x; Knight M, 2011, BJOG-INT J OBSTET GY, V118, P232, DOI 10.1111/j.1471-0528.2010.02736.x; Kumar S, 2010, PEDIATR INFECT DIS J, V29, P591, DOI 10.1097/INF.0b013e3181d73e32; Kwan-Gett TS, 2009, DISASTER MED PUBLIC, V3, pS109, DOI 10.1097/DMP.0b013e3181c6b818; La Ruche G, 2009, EUROSURVEILLANCE, V14, P51; Lahlou Amine I, 2011, EURO SURVEILL, V16; Lai PL, 2011, HUM VACCINES, V7, P217, DOI 10.4161/hv.7.0.14607; Landry ML, 2011, CURR OPIN PEDIATR, V23, P91, DOI 10.1097/MOP.0b013e328341ebd9; LaRussa P, 2011, SEMIN RESP CRIT CARE, V32, P393, DOI 10.1055/s-0031-1283279; Lee EH, 2010, CLIN INFECT DIS, V50, P1498, DOI 10.1086/652446; Louie J, 2011, HOSPITALIZATIONS 200; Louriz M, 2010, INT ARCH MED, V3; Martin SS, 2010, CHEST, V137, P1195, DOI 10.1378/chest.10-0032; Miller RR, 2010, CHEST, V137, P752, DOI 10.1378/chest.09-2517; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Naseem A, 2011, JCPSP-J COLL PHYSICI, V21, P97, DOI 02.2011/JCPSP.97102; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Oluyomi-Obi T, 2010, J OBSTET GYNAECOL CA, V32, P443, DOI 10.1016/S1701-2163(16)34497-8; Paine S, 2010, Euro Surveill, V15; Parakh A, 2010, INDIAN J PEDIATR, V77, P981, DOI 10.1007/s12098-010-0168-0; Pramanick A, 2011, INT J GYNECOL OBSTET, V113, P32, DOI 10.1016/j.ijgo.2010.10.025; Puvanalingam A, 2011, J Assoc Physicians India, V59, P14; Ramakrishna K, 2011, CLIN MICROBIOL INFEC, V17, P1355, DOI 10.1111/j.1469-0691.2011.03584.x; Rao SRJ, 2011, INDIAN J PATHOL MICR, V54, P323, DOI [10.4103/0377-4929.81588, 10.4103/0377-4929.81618]; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Reyes L, 2010, INFLUENZA OTHER RESP, V4, P129, DOI 10.1111/j.1750-2659.2010.00138.x; Ritger K. A., 2009, Morbidity and Mortality Weekly Report, V58, P913; Sachedina N, 2010, LANCET, V376, P1846, DOI 10.1016/S0140-6736(10)61195-6; Satterwhite L, 2010, CRIT CARE MED, V38, P2059, DOI 10.1097/CCM.0b013e3181eb96dc; Schanzer DL, 2007, J OBSTET GYNAECOL CA, V29, P622, DOI 10.1016/S1701-2163(16)32559-2; Scriven J, 2009, CLIN MED, V9, P534, DOI 10.7861/clinmedicine.9-6-534; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; Sharma V, 2010, J INFECT DEV COUNTR, V4, P468, DOI 10.3855/jidc.1007; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Slopen M. E., 2010, Morbidity and Mortality Weekly Report, V58, P1436; Subramony H, 2010, ANN ACAD MED SINGAP, V39, P283; Truelove SA, 2011, J INFECT DIS, V203, P828, DOI 10.1093/infdis/jiq117; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Verrall A, 2010, EMERG INFECT DIS, V16, P100, DOI 10.3201/eid1601.090994; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Wells GA, 2011, NEWCASTLE OTTAWA SCA; Wenger JD, 2011, CLIN INFECT DIS, V52, pS189, DOI 10.1093/cid/ciq037; World Bank, 2011, WORLD BANK CLASS; Zarychanski Ryan, 2010, CMAJ, V182, P257, DOI 10.1503/cmaj.091884	84	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39437	10.1371/journal.pone.0039437	http://dx.doi.org/10.1371/journal.pone.0039437			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761796	Green Published, Green Submitted, gold			2022-12-27	WOS:000305781700038
J	Vincenzi, F; Targa, M; Corciulo, C; Gessi, S; Merighi, S; Setti, S; Cadossi, R; Borea, PA; Varani, K				Vincenzi, Fabrizio; Targa, Martina; Corciulo, Carmen; Gessi, Stefania; Merighi, Stefania; Setti, Stefania; Cadossi, Ruggero; Borea, Pier Andrea; Varani, Katia			The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; MAGNETIC-FIELDS; SYNOVIAL FIBROBLASTS; INDUCED APOPTOSIS; HUMAN NEUTROPHILS; CYCLE ARREST; RAT-LIVER; IB-MECA; GROWTH; AGONIST	A(3) adenosine receptors (ARs) play a pivotal role in the development of cancer and their activation is involved in the inhibition of tumor growth. The effects of pulsed electromagnetic fields (PEMFs) on cancer have been controversially discussed and the detailed mechanisms are not yet fully understood. In the past we have demonstrated that PEMFs increased A(2A) and A(3)AR density and functionality in human neutrophils, human and bovine synoviocytes, and bovine chondrocytes. In the same cells, PEMF exposure increased the anti-inflammatory effect mediated by A(2A) and/or A(3)ARs. The primary aim of the present study was to evaluate if PEMF exposure potentiated the anti-tumor effect of A(3)ARs in PC12 rat adrenal pheochromocytoma and U87MG human glioblastoma cell lines in comparison with rat cortical neurons. Saturation binding assays and mRNA analysis revealed that PEMF exposure up-regulated A(2A) and A(3)ARs that are well coupled to adenylate cyclase activity and cAMP production. The activation of A(2A) and A(3)ARs resulted in the decrease of nuclear factor-kappa B (NF-kB) levels in tumor cells, whilst only A(3)ARs are involved in the increase of p53 expression. A(3)AR stimulation mediated an inhibition of tumor cell proliferation evaluated by thymidine incorporation. An increase of cytotoxicity by lactate dehydrogenase (LDH) release and apoptosis by caspase-3 activation in PC12 and U87MG cells, but not in cortical neurons, was observed following A(3)AR activation. The effect of the A(3)AR agonist in tumor cells was enhanced in the presence of PEMFs and blocked by using a well-known selective antagonist. Together these results demonstrated that PEMF exposure significantly increases the anti-tumor effect modulated by A(3)ARs.	[Vincenzi, Fabrizio; Targa, Martina; Corciulo, Carmen; Gessi, Stefania; Merighi, Stefania; Borea, Pier Andrea; Varani, Katia] Univ Ferrara, Dept Clin & Expt Med, Pharmacol Unit, I-44100 Ferrara, Italy; [Setti, Stefania; Cadossi, Ruggero] Igea Biophys Lab, Carpi, Italy	University of Ferrara	Vincenzi, F (corresponding author), Univ Ferrara, Dept Clin & Expt Med, Pharmacol Unit, I-44100 Ferrara, Italy.	vrk@unife.it	Gessi, Stefania/AAS-3844-2020; Vincenzi, Fabrizio/E-7925-2013	Vincenzi, Fabrizio/0000-0002-5027-1699; Gessi, Stefania/0000-0002-2197-5611; MERIGHI, STEFANIA/0000-0003-0839-6671; CORCIULO, CARMEN/0000-0002-1865-3494				Aghaei M, 2011, J CANCER RES CLIN, V137, P1511, DOI 10.1007/s00432-011-1031-z; Arendash GW, 2010, J ALZHEIMERS DIS, V19, P191, DOI 10.3233/JAD-2010-1228; Bar-Yehuda S, 2008, INT J ONCOL, V33, P287, DOI 10.3892/ijo_00000008; Bar-Yehuda S, 2005, NEOPLASIA, V7, P85, DOI 10.1593/neo.04364; Bar-Yehuda S, 2001, NEOPLASIA, V3, P125, DOI 10.1038/sj.neo.7900138; Barbault A, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-51; Belardo G, 2010, LEUKEMIA, V24, P187, DOI 10.1038/leu.2009.227; Borea P A, 2009, Handb Exp Pharmacol, P297, DOI 10.1007/978-3-540-89615-9_10; Cameron IL, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-23; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chen G, 2000, ENVIRON HEALTH PERSP, V108, P967, DOI 10.1289/ehp.00108967; Cohen S, 2011, J CELL PHYSIOL, V226, P2438, DOI 10.1002/jcp.22593; De Mattei M, 2009, OSTEOARTHR CARTILAGE, V17, P252, DOI 10.1016/j.joca.2008.06.002; Fishman P, 2004, ONCOGENE, V23, P2465, DOI 10.1038/sj.onc.1207355; Fishman P, 2003, ANTICANCER RES, V23, P2077; Fishman P, 2009, Handb Exp Pharmacol, P399, DOI 10.1007/978-3-540-89615-9_14; Fishman P, 2002, ANTI-CANCER DRUG, V13, P437, DOI 10.1097/00001813-200206000-00001; Fishman P, 2001, EXP CELL RES, V269, P230, DOI 10.1006/excr.2001.5327; Fishman P, 2000, EUR J CANCER, V36, P1452, DOI 10.1016/S0959-8049(00)00130-1; Galloni P, 2000, BIOELECTROMAGNETICS, V21, P608, DOI 10.1002/1521-186X(200012)21:8<608::AID-BEM7>3.0.CO;2-Z; Garcia AM, 2008, INT J EPIDEMIOL, V37, P329, DOI 10.1093/ije/dym295; Gartlon J, 2006, TOXICOL IN VITRO, V20, P1569, DOI 10.1016/j.tiv.2006.07.009; Gessi S, 2008, PHARMACOL THERAPEUT, V117, P123, DOI 10.1016/j.pharmthera.2007.09.002; Gessi S, 2011, ADV PHARMACOL, V61, P41, DOI 10.1016/B978-0-12-385526-8.00002-3; Gessi S, 2011, BBA-BIOMEMBRANES, V1808, P1400, DOI 10.1016/j.bbamem.2010.09.020; Girgert R, 2005, BIOCHEM BIOPH RES CO, V336, P1144, DOI 10.1016/j.bbrc.2005.08.243; Hardell L, 2008, BIOMED PHARMACOTHER, V62, P104, DOI 10.1016/j.biopha.2007.12.004; Hirata M, 2001, ANTICANCER RES, V21, P317; Jajoo S, 2009, NEOPLASIA, V11, P1132, DOI 10.1593/neo.09744; Kim SJ, 2008, CANCER LETT, V264, P309, DOI 10.1016/j.canlet.2008.01.037; Kuo PL, 2002, LIFE SCI, V72, P23, DOI 10.1016/S0024-3205(02)02177-X; Massot O, 2000, BRAIN RES, V858, P143, DOI 10.1016/S0006-8993(99)02486-5; Melo JB, 2007, ANN NY ACAD SCI, V1096, P220, DOI 10.1196/annals.1397.088; Merighi S, 2003, PHARMACOL THERAPEUT, V100, P31, DOI 10.1016/S0163-7258(03)00084-6; Merighi S, 2006, BIOCHEM PHARMACOL, V72, P19, DOI 10.1016/j.bcp.2006.03.020; Morello S, 2009, J CELL PHYSIOL, V221, P378, DOI 10.1002/jcp.21863; Jimenez-Garcia MN, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-159; Ongaro A, 2012, J CELL PHYSIOL, V227, P2461, DOI 10.1002/jcp.22981; Panjehpour M, 2007, ONCOL RES, V16, P575, DOI 10.3727/000000007783629981; Radeva M, 2004, BIOELECTROMAGNETICS, V25, P503, DOI 10.1002/bem.20023; RANNUG A, 1993, BIOELECTROMAGNETICS, V14, P17, DOI 10.1002/bem.2250140105; Rohde C, 2010, PLAST RECONSTR SURG, V125, P1620, DOI 10.1097/PRS.0b013e3181c9f6d3; Schneider G, 2010, ONCOGENE, V29, P2795, DOI 10.1038/onc.2010.46; Tebano MT, 2005, J NEUROCHEM, V95, P1188, DOI 10.1111/j.1471-4159.2005.03455.x; Varani K, 2000, MOL PHARMACOL, V57, P968; Varani K, 2008, OSTEOARTHR CARTILAGE, V16, P292, DOI 10.1016/j.joca.2007.07.004; Varani K, 2005, BIOCHEM PHARMACOL, V70, P1601, DOI 10.1016/j.bcp.2005.08.018; Varani K, 2003, BIOCHEM PHARMACOL, V66, P1897, DOI 10.1016/S0006-2952(03)00454-4; Varani K, 2002, BRIT J PHARMACOL, V136, P57, DOI 10.1038/sj.bjp.0704695; Varani K, 2012, BIOELECTROMAGNETICS, V33, P279, DOI 10.1002/bem.20704; Varani K, 2011, AM J RESP CRIT CARE, V183, P522, DOI 10.1164/rccm.201006-0980OC; Varani K, 2010, AUTOIMMUN REV, V10, P61, DOI 10.1016/j.autrev.2010.07.019; Varani K, 2010, FASEB J, V24, P1192, DOI 10.1096/fj.09-139485; Varani K, 2010, FASEB J, V24, P587, DOI 10.1096/fj.09-141044; Wang X, 2010, PLOS ONE, V5; Wen JA, 2011, BIOELECTROMAGNETICS, V32, P322, DOI 10.1002/bem.20646; Williams CD, 2001, ANTICANCER RES, V21, P3887; Yasui M, 1997, BIOELECTROMAGNETICS, V18, P531, DOI 10.1002/(SICI)1521-186X(1997)18:8<531::AID-BEM1>3.0.CO;2-3	58	34	36	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39317	10.1371/journal.pone.0039317	http://dx.doi.org/10.1371/journal.pone.0039317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761760	Green Published, Green Submitted, gold			2022-12-27	WOS:000305781700029
J	Hemminki, K; Houlston, R; Sundquist, J; Sundquist, K; Shu, XC				Hemminki, Kari; Houlston, Richard; Sundquist, Jan; Sundquist, Kristina; Shu, Xiaochen			Co-Morbidity between Early-Onset Leukemia and Type 1 Diabetes - Suggestive of a Shared Viral Etiology?	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHILDHOOD LEUKEMIA; RISK; CANCER; EPIDEMIOLOGY; GENETICS; 14Q11.2; 10Q21.2; COHORT; 7P12.2	Background: Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) are common early-onset malignancies. Their causes are largely unknown but infectious etiology has been implicated. Type 1 diabetes (T1D) is an autoimmune disease for which infectious triggers of disease onset have been sought and increasing pointing to enteroviruses. Based on our previous results on co-morbidity between leukemia and T1D, we updated the Swedish dataset and focused on early onset leukemias in patients who had been hospitalized for T1D, comparing to those not hospitalized for T1D. Methods and Findings: Standardized incidence ratios (SIRs) were calculated for leukemia in 24,052 patients hospitalized for T1D covering years 1964 through 2008. T1D patients were included if hospitalized before age 21 years. Practically all Swedish children and adolescents with T1D are hospitalized at the start of insulin treatment. SIR for ALL was 8.30 (N = 18, 95% confidence interval 4.91-13.14) when diagnosed at age 10 to 20 years after hospitalization for T1D and it was 3.51 (13, 1.86-6.02) before hospitalization for T1D. The SIR for ALL was 19.85 (N = 33, 13.74-27.76) and that for AML was 25.28 (8, 10.80-50.06) when the leukemias were diagnosed within the year of T1D hospitalization. The SIRs increased to 38.97 (26, 25.43-57.18) and 40.11 (8, 17.13-79.42) when T1D was diagnosed between ages 10 to 20 years. No consistent time-dependent changes were found in leukemia risk. Conclusion: A shared infectious etiology could be a plausible explanation to the observed co-morbidity. Other possible contributing factors could be insulin therapy or T1D related metabolic disturbances.	[Hemminki, Kari] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany; [Hemminki, Kari; Sundquist, Jan; Sundquist, Kristina; Shu, Xiaochen] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden; [Houlston, Richard] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Sundquist, Jan] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; University of London; Institute of Cancer Research - UK; Stanford University	Hemminki, K (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany.	k.hemminki@dkfz.de		Houlston, Richard/0000-0002-5268-0242	Swedish Council for Working Life and Social Research; Swedish Research Council; ALF funding of Region Skane; German Krebshilfe	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF funding of Region Skane; German Krebshilfe(Deutsche Krebshilfe)	Supported by The Swedish Council for Working Life and Social Research, the Swedish Research Council, ALF funding of Region Skane and the German Krebshilfe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri A, 2006, CANCER EPIDEM BIOMAR, V15, P1281, DOI 10.1158/1055-9965.EPI-06-0087; CenterforEpidemiology, 2010, CANC INC SWED 2009; Couto E, 2005, BRIT J CANCER, V93, P1307, DOI 10.1038/sj.bjc.6602867; Feltbower RG, 2004, ARCH DIS CHILD, V89, P54; Greaves M, 1999, EUR J CANCER, V35, P1941, DOI 10.1016/S0959-8049(99)00296-8; Hemminki K, 2009, DIABETOLOGIA, V52, P1820, DOI 10.1007/s00125-009-1427-3; Hemminki K, 2010, ONCOLOGIST, V15, P548, DOI 10.1634/theoncologist.2009-0300; Jaffe E.S., 2001, PATHOLOGY GENETICS T, VVolume 3; KINLEN LJ, 1995, BRIT J CANCER, V71, P1, DOI 10.1038/bjc.1995.1; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; LITTLE J, 1999, EPIDEMIOLOGY CHILDHO; Ludvigsson JF, 2006, DIABETES CARE, V29, P2483, DOI 10.2337/dc06-0794; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Manda SOM, 2009, EUR J EPIDEMIOL, V24, P743, DOI 10.1007/s10654-009-9391-2; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Polychronakos C, 2011, NAT REV GENET, V12, P781, DOI 10.1038/nrg3069; Prasad RB, 2010, BLOOD, V115, P1765, DOI 10.1182/blood-2009-09-241513; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Sherborne AL, 2010, NAT GENET, V42, P492, DOI 10.1038/ng.585; Shu X, 2010, DIABETIC MED, V27, P791, DOI 10.1111/j.1464-5491.2010.03011.x; Soltesz G, 2007, PEDIATR DIABETES, V8, P6, DOI 10.1111/j.1399-5448.2007.00280.x; Swafford ADE, 2011, DIABETES, V60, P1041, DOI 10.2337/db10-0446; Tauriainen S, 2011, SEMIN IMMUNOPATHOL, V33, P45, DOI 10.1007/s00281-010-0207-y; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001; zur Hausen H, 2009, INT J CANCER, V125, P1764, DOI 10.1002/ijc.24365	26	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39523	10.1371/journal.pone.0039523	http://dx.doi.org/10.1371/journal.pone.0039523			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745776	Green Published, gold			2022-12-27	WOS:000305730900069
J	Noble, R; Recker, M				Noble, Robert; Recker, Mario			A Statistically Rigorous Method for Determining Antigenic Switching Networks	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; MATHEMATICAL-MODEL; TRYPANOSOMA-BRUCEI; IMMUNE-SELECTION; HOST IMMUNITY; MALARIA; ACQUISITION; ANTIBODIES; VARIANTS; PROGRAM	Many vector-borne pathogens rely on antigenic variation to prolong infections and increase their likelihood of onward transmission. This immune evasion strategy often involves mutually exclusive switching between members of gene families that encode functionally similar but antigenically different variants during the course of a single infection. Studies of different pathogens have suggested that switching between variant genes is non-random and that genes have intrinsic probabilities of being activated or silenced. These factors could create a hierarchy of gene expression with important implications for both infection dynamics and the acquisition of protective immunity. Inferring complete switching networks from gene transcription data is problematic, however, because of the high dimensionality of the system and uncertainty in the data. Here we present a statistically rigorous method for analysing temporal gene transcription data to reconstruct an underlying switching network. Using artificially generated transcription profiles together with in vitro var gene transcript data from two Plasmodium falciparum laboratory strains, we show that instead of relying on data from long-term parasite cultures, accuracy can be greatly improved by using transcription time courses of several parasite populations from the same isolate, each starting with different variant distributions. The method further provides explicit indications about the reliability of the resulting networks and can thus be used to test competing hypotheses with regards to the underlying switching pathways. Our results demonstrate that antigenic switch pathways can be determined reliably from short gene transcription profiles assessing multiple time points, even when subject to moderate levels of experimental error. This should yield important new information about switching patterns in antigenically variable organisms and might help to shed light on the molecular basis of antigenic variation.	[Noble, Robert; Recker, Mario] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Noble, R (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	mario.recker@zoo.ox.ac.uk	Noble, Robert/H-9124-2019	Noble, Robert/0000-0002-8057-4252; Recker, Mario/0000-0001-9489-1315	Biotechnology and Biological Sciences Research Council (BBSRC)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	RN is supported by a Biotechnology and Biological Sciences Research Council (BBSRC) studentship. MR is a Royal Society University Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUR Z, 1989, P NATL ACAD SCI USA, V86, P9626, DOI 10.1073/pnas.86.23.9626; Aitcheson N, 2005, MOL MICROBIOL, V57, P1608, DOI 10.1111/j.1365-2958.2005.04795.x; Barbour AG, 2006, P NATL ACAD SCI USA, V103, P18290, DOI 10.1073/pnas.0605302103; Cham GKK, 2010, INFECT IMMUN, V78, P4653, DOI 10.1128/IAI.00593-10; Cham GKK, 2009, J IMMUNOL, V183, P3356, DOI 10.4049/jimmunol.0901331; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Enderes C, 2011, J INFECT DIS, V204, P1620, DOI 10.1093/infdis/jir594; Frank M, 2007, MOL MICROBIOL, V64, P1486, DOI 10.1111/j.1365-2958.2007.05736.x; Frank SA, 1999, P ROY SOC B-BIOL SCI, V266, P1397, DOI 10.1098/rspb.1999.0793; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Horrocks P, 2004, P NATL ACAD SCI USA, V101, P11129, DOI 10.1073/pnas.0402347101; Howell DPG, 2008, MOL MICROBIOL, V67, P78, DOI 10.1111/j.1365-2958.2007.06019.x; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; KOSINSKI RJ, 1980, PARASITOLOGY, V80, P343, DOI 10.1017/S0031182000000809; Lythgoe KA, 2007, P NATL ACAD SCI USA, V104, P8095, DOI 10.1073/pnas.0606206104; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Molineaux L, 2001, PARASITOLOGY, V122, P379, DOI 10.1017/S0031182001007533; Morrison LJ, 2005, INT J PARASITOL, V35, P961, DOI 10.1016/j.ijpara.2005.05.004; Paget-McNicol S, 2002, PARASITOLOGY, V124, P225, DOI 10.1017/S0031182001001160; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Recker M, 2004, NATURE, V429, P555, DOI 10.1038/nature02486; Recker M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001306; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106	25	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39335	10.1371/journal.pone.0039335	http://dx.doi.org/10.1371/journal.pone.0039335			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761765	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000305730900045
J	Polglase, GR; Miller, SL; Barton, SK; Baburamani, AA; Wong, FY; Aridas, JDS; Gill, AW; Moss, TJM; Tolcos, M; Kluckow, M; Hooper, SB				Polglase, Graeme R.; Miller, Suzanne L.; Barton, Samantha K.; Baburamani, Ana A.; Wong, Flora Y.; Aridas, James D. S.; Gill, Andrew W.; Moss, Timothy J. M.; Tolcos, Mary; Kluckow, Martin; Hooper, Stuart B.			Initiation of Resuscitation with High Tidal Volumes Causes Cerebral Hemodynamic Disturbance, Brain Inflammation and Injury in Preterm Lambs	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; END-EXPIRATORY PRESSURE; BLOOD-FLOW VELOCITY; WHITE-MATTER INJURY; VENA-CAVA FLOW; INTRAVENTRICULAR HEMORRHAGE; INTRAAMNIOTIC ENDOTOXIN; LUNG MATURATION; NEWBORN-INFANT; FETAL SHEEP	Aims: Preterm infants can be inadvertently exposed to high tidal volumes (V-T) in the delivery room, causing lung inflammation and injury, but little is known about their effects on the brain. The aim of this study was to compare an initial 15 min of high V-T resuscitation strategy to a less injurious resuscitation strategy on cerebral haemodynamics, inflammation and injury. Methods: Preterm lambs at 126 d gestation were surgically instrumented prior to receiving resuscitation with either: 1) High V-T targeting 10-12 mL/kg for the first 15 min (n = 6) or 2) a protective resuscitation strategy (Prot V-T), consisting of prophylactic surfactant, a 20 s sustained inflation and a lower initial V-T (7 mL/kg; n = 6). Both groups were subsequently ventilated with a V-T 7 mL/kg. Blood gases, arterial pressures and carotid blood flows were recorded. Cerebral blood volume and oxygenation were assessed using near infrared spectroscopy. The brain was collected for biochemical and histologic assessment of inflammation, injury, vascular extravasation, hemorrhage and oxidative injury. Unventilated controls (UVC; n = 6) were used for comparison. Results: High V-T lambs had worse oxygenation and required greater ventilatory support than Prot V-T lambs. High V-T resulted in cerebral haemodynamic instability during the initial 15 min, adverse cerebral tissue oxygenation index and cerebral vasoparalysis. While both resuscitation strategies increased lung and brain inflammation and oxidative stress, High V-T resuscitation significantly amplified the effect (p = 0.014 and p<0.001). Vascular extravasation was evident in the brains of 60% of High V-T lambs, but not in UVC or Prot V-T lambs. Conclusion: High V-T resulted in greater cerebral haemodynamic instability, increased brain inflammation, oxidative stress and vascular extravasation than a Prot V-T strategy. The initiation of resuscitation targeting Prot V-T may reduce the severity of brain injury in preterm neonates.	[Polglase, Graeme R.; Miller, Suzanne L.; Barton, Samantha K.; Baburamani, Ana A.; Wong, Flora Y.; Aridas, James D. S.; Moss, Timothy J. M.; Tolcos, Mary; Hooper, Stuart B.] Monash Univ, Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Polglase, Graeme R.; Miller, Suzanne L.; Moss, Timothy J. M.; Hooper, Stuart B.] Monash Univ, Dept Obstet & Gynecol, Clayton, Vic, Australia; [Gill, Andrew W.] Univ Western Australia, Sch Womens & Infants Hlth, Ctr Neonatal Res & Educ, Crawley, WA, Australia; [Kluckow, Martin] Royal N Shore Hosp, Dept Neonatal Med, Sydney, NSW, Australia; [Kluckow, Martin] Univ Sydney, Sydney, NSW 2006, Australia	Monash University; Monash University; University of Western Australia; Royal North Shore Hospital; University of Sydney; University of Sydney	Polglase, GR (corresponding author), Monash Univ, Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia.	graeme.polglase@monash.edu	Baburamani, Ana/J-4920-2019; Moss, Timothy/A-6633-2008; Baburamani, Ana/AGD-2259-2022	Moss, Timothy/0000-0002-9408-4027; Baburamani, Ana/0000-0002-7537-6534; Miller, Suzanne/0000-0002-0451-8304; Barton, Samantha/0000-0001-7601-0238; Kluckow, Martin/0000-0003-1875-7530; Polglase, Graeme/0000-0002-8906-614X; Hooper, Stuart/0000-0003-1676-4825; Tolcos, Mary/0000-0001-6105-4553	Cerebral Palsy Alliance of Australia; North Shore Heart Research Foundation; NHMRC [1026890, 545921]; Victorian Government	Cerebral Palsy Alliance of Australia; North Shore Heart Research Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	This research was supported by the Cerebral Palsy Alliance of Australia, North Shore Heart Research Foundation, NH&MRC Research Fellowships (GRP: 1026890) and SBH: 545921) and the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SA, 2001, J NEUROSCI, V21, P1302; Bjorklund LJ, 1997, PEDIATR RES, V42, P348; Chiumello D, 1999, AM J RESP CRIT CARE, V160, P109, DOI 10.1164/ajrccm.160.1.9803046; Dani C, 2002, ACTA PAEDIATR, V91, P938, DOI 10.1080/080352502760272623; de Waal KA, 2007, ARCH DIS CHILD-FETAL, V92, P444, DOI 10.1136/adc.2006.103929; DELTORO J, 1991, PEDIATR NEUROL, V7, P3, DOI 10.1016/0887-8994(91)90098-6; DUNCAN A, 1995, PHYS MED BIOL, V40, P295, DOI 10.1088/0031-9155/40/2/007; Elwell C., 1995, HAMAMATSU PHOTONICS; GLEASON CA, 1988, AM J PHYSIOL, V255, pR1049, DOI 10.1152/ajpregu.1988.255.6.R1049; HAYASHI T, 1992, EUR J PEDIATR, V151, P461, DOI 10.1007/BF01959365; Haynes RL, 2003, J NEUROPATH EXP NEUR, V62, P441, DOI 10.1093/jnen/62.5.441; Hillman NH, 2007, AM J RESP CRIT CARE, V176, P575, DOI 10.1164/rccm.200701-051OC; Hillman NH, 2011, AM J PHYSIOL-LUNG C, V300, pL232, DOI 10.1152/ajplung.00294.2010; Hillman NH, 2010, PEDIATR RES, V67, P60, DOI 10.1203/PDR.0b013e3181c1b09e; Ikegami M, 2004, AM J PHYSIOL-LUNG C, V286, pL573, DOI 10.1152/ajplung.00211.2003; Jobe AH, 2008, NEONATOLOGY, V94, P190, DOI 10.1159/000143721; Kallapur SG, 2001, AM J PHYSIOL-LUNG C, V280, pL527, DOI 10.1152/ajplung.2001.280.3.L527; Kallapur SG, 2011, AM J PHYSL LUNG CELL; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Kluckow M, 2000, ARCH DIS CHILD-FETAL, V82, pF188, DOI 10.1136/fn.82.3.F188; LOU HC, 1979, J PEDIATR-US, V94, P118, DOI 10.1016/S0022-3476(79)80373-X; Meek JH, 1999, ARCH DIS CHILD-FETAL, V81, pF110, DOI 10.1136/fn.81.2.F110; Miletin J, 2008, ARCH DIS CHILD-FETAL, V93, pF368, DOI 10.1136/adc.2007.129304; PERLMAN JM, 1983, NEW ENGL J MED, V309, P204, DOI 10.1056/NEJM198307283090402; Polglase GR, 2008, PEDIATR RES, V64, P517, DOI 10.1203/PDR.0b013e3181841363; Polglase GR, 2008, J APPL PHYSIOL, V105, P603, DOI 10.1152/japplphysiol.00041.2008; Polglase GR, 2012, REPROD FERT DEVELOP, V24, P510, DOI 10.1071/RD11121; Polglase GR, 2012, J APPL PHYSIOL, V112, P481, DOI 10.1152/japplphysiol.00995.2011; Polglase GR, 2010, PEDIATR RES, V67, P630, DOI 10.1203/PDR.0b013e3181dbbd18; Polglase GR, 2009, J APPL PHYSIOL, V106, P1347, DOI 10.1152/japplphysiol.91445.2008; Polglase GR, 2009, PEDIATR RES, V65, P67, DOI 10.1203/PDR.0b013e318189487e; Poulton DA, 2011, RESUSCITATION, V82, P175, DOI 10.1016/j.resuscitation.2010.10.012; RICHARDSON BS, 1989, AM J PHYSIOL, V257, pR1251, DOI 10.1152/ajpregu.1989.257.5.R1251; Rosenbaum JL, 1997, NEUROLOGY, V49, P1035, DOI 10.1212/WNL.49.4.1035; RUDOLPH AM, 1977, AM REV RESPIR DIS, V115, P11; Schmolzer GM, 2010, ARCH DIS CHILD-FETAL, V95, pF393, DOI 10.1136/adc.2009.174003; Schmolzer GM, 2008, J PEDIATR-US, V153, P741, DOI 10.1016/j.jpeds.2008.08.016; Siew ML, 2011, PEDIATR RES, V70, P50, DOI 10.1203/PDR.0b013e31821be094; Sobotka KS, 2011, PEDIAT RES IN PRESS; Stenson BJ, 2006, CLIN PERINATOL, V33, P65, DOI 10.1016/j.clp.2005.11.015; te Pas AB, 2009, PEDIATR RES, V66, P295, DOI 10.1203/PDR.0b013e3181b1bca4; VANBEL F, 1994, PEDIATR RES, V35, P329; Volpe J J, 1998, Semin Pediatr Neurol, V5, P135, DOI 10.1016/S1071-9091(98)80030-2; Wallace MJ, 2010, PED AC SOC ANN M ABS, V4407, P222; WINBERG P, 1990, ACTA PAEDIATR SCAND, V79, P1150; Wong FY, 2010, ANESTHESIOLOGY, V113, P1385, DOI 10.1097/ALN.0b013e3181fc5567; Yanowitz TD, 2002, PEDIATR RES, V51, P310, DOI 10.1203/00006450-200203000-00008	47	91	93	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39535	10.1371/journal.pone.0039535	http://dx.doi.org/10.1371/journal.pone.0039535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761816	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900072
J	Tchaptchet, S; Gumenscheimer, M; Kalis, C; Freudenberg, N; Holscher, C; Kirschning, CJ; Lamers, M; Galanos, C; Freudenberg, MA				Tchaptchet, Sandrine; Gumenscheimer, Marina; Kalis, Christoph; Freudenberg, Nikolaus; Hoelscher, Christoph; Kirschning, Carsten J.; Lamers, Marinus; Galanos, Chris; Freudenberg, Marina A.			TLR9-Dependent and Independent Pathways Drive Activation of the Immune System by Propionibacterium Acnes	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; GALACTOSAMINE-INDUCED SENSITIZATION; GAMMA-INTERFERON; DENDRITIC CELLS; MURINE MACROPHAGES; INNATE IMMUNITY; LIVER-INJURY; LYMPH-NODES; LUNG INJURY; TNF-ALPHA	Propionibacterium acnes is usually a relatively harmless commensal. However, under certain, poorly understood conditions it is implicated in the etiology of specific inflammatory diseases. In mice, P. acnes exhibits strong immunomodulatory activity leading to splenomegaly, intrahepatic granuloma formation, hypersensitivity to TLR ligands and endogenous cytokines, and enhanced resistance to infection. All these activities reach a maximum one week after P. acnes priming and require IFN-gamma and TLR9. We report here the existence of a markedly delayed (1-2 weeks), but phenotypically similar TLR9-independent immunomodulatory response to P. acnes. This alternative immunomodulation is also IFN-gamma dependent and requires functional MyD88. From our experiments, a role for MyD88 in the IFN-gamma-mediated P. acnes effects seems unlikely and the participation of the known MyD88-dependent receptors, including TLR5, Unc93B-dependent TLRs, IL-1R and IL-18R in the development of the alternative response has been excluded. However, the crucial role of MyD88 can partly be attributed to TLR2 and TLR4 involvement. Either of these two TLRs, activated by bacteria and/or endogenously generated ligands, can fulfill the required function. Our findings hint at an innate immune sensitizing mechanism, which is potentially operative in both infectious and sterile inflammatory disorders.	[Tchaptchet, Sandrine; Gumenscheimer, Marina; Kalis, Christoph; Lamers, Marinus; Galanos, Chris; Freudenberg, Marina A.] Max Planck Inst Immunbiol & Epigenet, Dept Dev Immunol, Freiburg, Germany; [Freudenberg, Nikolaus] Univ Med Ctr Freiburg, Inst Pathol, Freiburg, Germany; [Hoelscher, Christoph] Res Ctr Borstel, Div Infect Immunol, Borstel, Germany; [Kirschning, Carsten J.] Univ Duisburg Essen, Inst Med Microbiol, Essen, Germany	Max Planck Society; University of Freiburg; Forschungszentrum Borstel; University of Duisburg Essen	Tchaptchet, S (corresponding author), Max Planck Inst Immunbiol & Epigenet, Dept Dev Immunol, Freiburg, Germany.	freudenberg@ie-freiburg.mpg.de	Hölscher, Christoph/O-1732-2018	Hölscher, Christoph/0000-0002-7520-9146; Freudenberg, Marina Alexandra/0000-0001-5894-1805	Bundesministerium fur Bildung und Forschung, project ''German Network for Diffuse Parenchymal Lung Diseases GOLD.net" [01GM0859]	Bundesministerium fur Bildung und Forschung, project ''German Network for Diffuse Parenchymal Lung Diseases GOLD.net"	The study was supported in part by the Bundesministerium fur Bildung und Forschung, project ''German Network for Diffuse Parenchymal Lung Diseases GOLD.net", grant 01GM0859 to MAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE C, 1984, ZBL BAKT-INT J MED M, V256, P541, DOI 10.1016/S0174-3031(84)80032-3; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cole LE, 2010, J LEUKOCYTE BIOL, V87, P275, DOI 10.1189/jlb.0909619; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; FREUDENBERG MA, 1986, INFECT IMMUN, V51, P891, DOI 10.1128/IAI.51.3.891-895.1986; FREUDENBERG MA, 1980, INFECT IMMUN, V28, P373; Freudenberg MA, 2008, IMMUNOBIOLOGY, V213, P193, DOI 10.1016/j.imbio.2007.11.008; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Gumenscheimer M, 2002, INFECT IMMUN, V70, P5596, DOI 10.1128/IAI.70.10.5596-5603.2002; Haq M, 1998, J AM SOC NEPHROL, V9, P614; HEINZEL FP, 1994, INFECT IMMUN, V62, P4244, DOI 10.1128/IAI.62.10.4244-4249.1994; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; HOMMA JY, 1978, JPN J EXP MED, V48, P251; Hoshino K, 1999, J IMMUNOL, V162, P3749; Ishige I, 1999, LANCET, V354, P120, DOI 10.1016/S0140-6736(98)12310-3; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang DH, 2010, ANAT REC, V293, P982, DOI 10.1002/ar.21102; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kalis C, 2005, J IMMUNOL, V174, P4295, DOI 10.4049/jimmunol.174.7.4295; KATSCHINSKI T, 1992, INFECT IMMUN, V60, P1994, DOI 10.1128/IAI.60.5.1994-2001.1992; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim J, 2002, J IMMUNOL, V169, P1535, DOI 10.4049/jimmunol.169.3.1535; KOBAYASHI F, 1980, INFECT IMMUN, V27, P391, DOI 10.1128/IAI.27.2.391-396.1980; Le Bourhis L, 2007, BIOCHEM SOC T, V35, P1479, DOI 10.1042/BST0351479; Lembo A, 2003, INFECT IMMUN, V71, P6058, DOI 10.1128/IAI.71.10.6058-6062.2003; LOHLER J, 1994, LAB INVEST, V70, P263; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509; Merlin T, 2001, J ENDOTOXIN RES, V7, P157, DOI 10.1177/09680519010070021001; Noble PW, 1996, J EXP MED, V183, P2373, DOI 10.1084/jem.183.5.2373; OKAMURA H, 1995, INFECT IMMUN, V63, P3966, DOI 10.1128/IAI.63.10.3966-3972.1995; Pifer R, 2011, J BIOL CHEM, V286, P3307, DOI 10.1074/jbc.M110.171025; PRINGLE AT, 1982, INFECT IMMUN, V38, P371, DOI 10.1128/IAI.38.1.371-374.1982; SCOTT MT, 1977, CANCER RES, V37, P1673; Shibata T, 2011, INT IMMUNOL, V23, P503, DOI 10.1093/intimm/dxr044; Sing A, 2000, INFECT IMMUN, V68, P1600, DOI 10.1128/IAI.68.3.1600-1607.2000; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Tanaka Y, 1996, INT IMMUNOL, V8, P569, DOI 10.1093/intimm/8.4.569; Tchaptchet S, EUR J IMMUNOL, V40, P2506; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863; Tsuji H, 1999, J IMMUNOL, V162, P1049; Wu CY, 2000, J IMMUNOL, V165, P6221, DOI 10.4049/jimmunol.165.11.6221	51	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39155	10.1371/journal.pone.0039155	http://dx.doi.org/10.1371/journal.pone.0039155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745710	gold, Green Published, Green Submitted			2022-12-27	WOS:000305730900033
J	Yang, ZH; Zhang, YX; Kemper, JK; Wang, L				Yang, Zhihong; Zhang, Yuxia; Kemper, Jongsook Kim; Wang, Li			Cross-Regulation of Protein Stability by p53 and Nuclear Receptor SHP	PLOS ONE			English	Article							SMALL HETERODIMER PARTNER; NEGATIVE FEEDBACK-REGULATION; FATTY-ACID SYNTHASE; DIURNAL REGULATION; GENE-EXPRESSION; LIVER RECEPTOR; X RECEPTOR; ERR-GAMMA; INHIBITION; GROWTH	We report here a novel interplay between tumor suppressor p53 and nuclear receptor SHP that controls p53 and SHP stability. Overexpression of p53 causes rapid SHP protein degradation, which does not require the presence of Mdm2 and is mediated by the proteosome pathway. Overexpressing SHP alone does not affect p53 stability. However, SHP destabilizes p53 by augmentation of Mdm2 ubiquitin ligase activity toward p53. The single amino acid substitution in the SHP protein SHPK170R increases SHP binding to p53 relative to SHP wild-type, whereas SHPG171A variant shows a diminished p53 binding. As a result of the cross-regulation, the tumor suppressor function of p53 and SHP in inhibition of colon cancer growth is compromised. Our findings reveal a unique scenario for a cross-inhibition between two tumor suppressors to keep their expression and function in check.	[Yang, Zhihong; Zhang, Yuxia; Wang, Li] Univ Utah, Sch Med, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Yang, Zhihong; Zhang, Yuxia; Wang, Li] Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT USA; [Kemper, Jongsook Kim] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Illinois System; University of Illinois Urbana-Champaign	Yang, ZH (corresponding author), Univ Utah, Sch Med, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	l.wang@hsc.utah.edu			Multidisciplinary Cancer Research Training Program (MCRTP) [T32CA092347]; NIH [DK080440]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095842, R01DK080440] Funding Source: NIH RePORTER	Multidisciplinary Cancer Research Training Program (MCRTP); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Y.Z. was supported by T32CA092347 Multidisciplinary Cancer Research Training Program (MCRTP). This work was supported in part by NIH Grant DK080440 to L.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Datta S, 2006, J BIOL CHEM, V281, P807, DOI 10.1074/jbc.M511050200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; He N, 2008, GASTROENTEROLOGY, V134, P793, DOI 10.1053/j.gastro.2008.01.006; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Huang JS, 2010, AM J PHYSIOL-GASTR L, V299, pG1211, DOI 10.1152/ajpgi.00322.2010; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; Kim DH, 2011, P NATL ACAD SCI USA, V108, P12266, DOI 10.1073/pnas.1019678108; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Lee J, 2010, J BIOL CHEM, V285, P12604, DOI 10.1074/jbc.M109.094524; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Matsukuma KE, 2007, J BIOL CHEM, V282, P20164, DOI 10.1074/jbc.M702895200; Matsukuma KE, 2006, J LIPID RES, V47, P2754, DOI 10.1194/jlr.M600342-JLR200; Neilsen PM, 2008, J CELL SCI, V121, P3541, DOI 10.1242/jcs.026351; Pan XY, 2010, CELL METAB, V12, P174, DOI 10.1016/j.cmet.2010.05.014; Park KG, 2007, DIABETES, V56, P431, DOI 10.2337/db06-0753; Park YJ, 2008, HEPATOLOGY, V47, P1578, DOI 10.1002/hep.22196; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Song GS, 2009, INT J CLIN EXP PATHO, V2, P275; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007829; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006880; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Song GS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003574; Suh JH, 2006, J BIOL CHEM, V281, P39169, DOI 10.1074/jbc.M605947200; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Tabbi-Anneni I, 2010, AM J PHYSIOL-ENDOC M, V298, pE961, DOI 10.1152/ajpendo.00655.2009; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wang L, 2003, J BIOL CHEM, V278, P44475, DOI 10.1074/jbc.M305258200; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Wang L, 2006, MOL ENDOCRINOL, V20, P2671, DOI 10.1210/me.2006-0224; Yang ZH, 2012, FEBS LETT, V586, P1135, DOI 10.1016/j.febslet.2012.03.022; Yang ZH, 2012, BIOCHEM BIOPH RES CO, V417, P744, DOI 10.1016/j.bbrc.2011.12.027; Yang ZH, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-31; Zhang Y, 2012, NUCL ACIDS RES; Zhang YX, 2008, HEPATOLOGY, V48, P289, DOI 10.1002/hep.22342; Zhang YX, 2011, BIOCHEM BIOPH RES CO, V416, P135, DOI 10.1016/j.bbrc.2011.11.011; Zhang YX, 2011, J BIOL CHEM, V286, P29635, DOI 10.1074/jbc.M111.253039; Zhang YX, 2011, BBA-MOL BASIS DIS, V1812, P893, DOI 10.1016/j.bbadis.2010.10.006; Zhang YX, 2011, FEBS LETT, V585, P1269, DOI 10.1016/j.febslet.2011.03.059; Zhang YX, 2010, MOL CELL BIOL, V30, P1341, DOI 10.1128/MCB.01076-09; Zhao BX, 2006, EMBO J, V25, P5703, DOI 10.1038/sj.emboj.7601435; Zhou TF, 2010, J BIOL CHEM, V285, P24871, DOI 10.1074/jbc.M110.133280	45	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39789	10.1371/journal.pone.0039789	http://dx.doi.org/10.1371/journal.pone.0039789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737255	gold, Green Submitted, Green Published			2022-12-27	WOS:000305695100054
J	Hannouf, MB; Sehgal, C; Cao, JQ; Mocanu, JD; Winquist, E; Zaric, GS				Hannouf, Malek B.; Sehgal, Chander; Cao, Jeffrey Q.; Mocanu, Joseph D.; Winquist, Eric; Zaric, Gregory S.			Cost-Effectiveness of Adding Cetuximab to Platinum-Based Chemotherapy for First-Line Treatment of Recurrent or Metastatic Head and Neck Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR RECEPTOR; QUALITY-OF-LIFE; UNKNOWN PRIMARY; PLUS CETUXIMAB; ORPHAN DRUGS; RADIOTHERAPY; PERSPECTIVE; ANTIBODY; ADOPTION	Purpose: To assess the cost effectiveness of adding cetuximab to platinum-based chemotherapy in first-line treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) from the perspective of the Canadian public healthcare system. Methods: We developed a Markov state transition model to project the lifetime clinical and economic consequences of recurrent or metastatic HNSCC. Transition probabilities were derived from a phase III trial of cetuximab in patients with recurrent or metastatic HNSCC. Cost estimates were obtained from London Health Sciences Centre and the Ontario Case Costing Initiative, and expressed in 2011 CAD. A three year time horizon was used. Future costs and health benefits were discounted at 5%. Results: In the base case, cetuximab plus platinum-based chemotherapy compared to platinum-based chemotherapy alone led to an increase of 0.093 QALY and an increase in cost of $36,000 per person, resulting in an incremental cost effectiveness ratio (ICER) of $386,000 per QALY gained. The cost effectiveness ratio was most sensitive to the cost per mg of cetuximab and the absolute risk of progression among patients receiving cetuximab. Conclusion: The addition of cetuximab to standard platinum-based chemotherapy in first-line treatment of patients with recurrent or metastatic HNSCC has an ICER that exceeds $100,000 per QALY gained. Cetuximab can only be economically attractive in this patient population if the cost of cetuximab is substantially reduced or if future research can identify predictive markers to select patients most likely to benefit from the addition of cetuximab to chemotherapy.	[Hannouf, Malek B.; Zaric, Gregory S.] Univ Western Ontario, Dept Epidemiol & Biostat, Schulich Sch Med & Dent, London, ON, Canada; [Sehgal, Chander; Cao, Jeffrey Q.; Mocanu, Joseph D.; Zaric, Gregory S.] Univ Western Ontario, Richard Ivey Sch Business, London, ON, Canada; [Cao, Jeffrey Q.] London Hlth Sci Ctr, London Reg Canc Program, Dept Radiat Oncol, London, ON, Canada; [Winquist, Eric] Univ Western Ontario, Dept Oncol, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario)	Hannouf, MB (corresponding author), Univ Western Ontario, Dept Epidemiol & Biostat, Schulich Sch Med & Dent, London, ON, Canada.	gzaric@ivey.uwo.ca	Zaric, Gregory/B-7665-2013; Cao, Jeffrey/AAL-3736-2021		Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by the Canadian Institutes of Health Research (CIHR) Strategic Training Program in Cancer Research and Technology Transfer (CaRTT) and the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JA, 1992, J OTOLARYNGOL, V21, P321; Avritscher Elenir B C, 2010, J Support Oncol, V8, P242, DOI 10.1016/j.suponc.2010.09.027; Bank of Canada, 2011, HOM RAT STAT REL INF; BC Cancer Agency, 2010, BCCA PROT SUMM COMB; Bernier J, 2008, NAT CLIN PRACT ONCOL, V5, P705, DOI 10.1038/ncponc1228; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Brown B, 2008, VALUE HEALTH, V11, P791, DOI 10.1111/j.1524-4733.2007.00302.x; Canadian Agency for Drugs and Technologies in Health (CADTH), 2017, GUID EC EV HLTH TECH; Canadian Cancer Society National Cancer Institute of Canada, 2009, CAN CANC STAT; Cancer care Ontario, 2004, 115 CANC CAR ONT; Colevas AD, 2006, J CLIN ONCOL, V24, P2644, DOI 10.1200/JCO.2005.05.3348; Cripps C, 2010, CURR ONCOL, V17, P37; Drummond MF, 2007, INT J TECHNOL ASSESS, V23, P36, DOI 10.1017/S0266462307051550; Drummond MF, 2007, J CLIN ONCOL, V25, P191, DOI 10.1200/JCO.2006.07.8956; Ferte C, 2010, ONCOLOGY-BASEL, V78, P87, DOI 10.1159/000306137; Fryback DG, 1997, MED DECIS MAKING, V17, P276, DOI 10.1177/0272989X9701700303; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Grutters JPC, 2010, THORAX, V65, P903, DOI 10.1136/thx.2010.136390; Ho C, 2010, CURR ONCOL, V17, P174; Hoch J, 2012, COMMUNICATION; Hughes DA, 2005, QJM-INT J MED, V98, P829, DOI 10.1093/qjmed/hci128; Fernandez-Cotarelo MJ, 2010, TUMORI J, V96, P111, DOI 10.1177/030089161009600118; Kimura H, 2007, CANCER SCI, V98, P1275, DOI 10.1111/j.1349-7006.2007.00510.x; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; London Health Sciences Centre: London Regional Cancer Program (LRCP), 2011, FORM; Mavranezouli I, 2010, PHARMACOECONOMICS, V28, P1109, DOI 10.2165/11537300-000000000-00000; McCabe C, 2007, INT J TECHNOL ASSESS, V23, P397; McKenna C, 2011, MED DECIS MAKING, V31, P853, DOI 10.1177/0272989X11399921; Mittmann N, 2010, CURR ONCOL, V17, P7; Mittmann N, 2009, J NATL CANCER I, V101, P1182, DOI 10.1093/jnci/djp232; National Institute for Health and Clinical Excellence (NICE), 2008, NICE TECHN APPR GUID, V145; National institute of health and Clinical Excellence (NICE), 2009, GUID CET TREATM MET; National institute of health and Clinical Excellence (NICE), 2009, MAN SUBM CET TREATM; National Institute of Health and Clinical Excellence (NICE), 2010, GUID CET TREATM REC; Ontario Ministry of Health and Long-Term Care, 2011, ONT CAS COST IN OCCI; Ontario Ministry of Health and Long-Term Care, 2007, ONT HLTH INS OHIP SC; Patented Medicine Prices Review Board, 2009, REP NEW PAT DRUGS ER; Pepper PV, 2000, CLIN INFECT DIS, V30, P157, DOI 10.1086/313601; Pohjolainen V, 2010, INT J EAT DISORDER, V43, P596, DOI 10.1002/eat.20754; Rathcke IO, 1996, LARYNGO RHINO OTOL, V75, P465, DOI 10.1055/s-2007-997616; Sambrook J, 2009, J CLIN ONCOL, V27; Simoens S, 2011, J CLIN PHARM THER, V36, P249, DOI 10.1111/j.1365-2710.2010.01181.x; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Statistics Canada/Health Statistics Division, 2006, MIN IND PUBL; Stenson KM, 2011, OVERVIEW HEAD NECK C; Talmor D, 2008, CRIT CARE MED, V36, P1168, DOI 10.1097/CCM.0b013e318168f649; Van Cutsem E, 2007, J CLIN ONCOL, V25; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; WITTES RE, 1977, CANCER TREAT REP, V61, P359	50	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38557	10.1371/journal.pone.0038557	http://dx.doi.org/10.1371/journal.pone.0038557			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745668	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693200014
J	Wang, Z; O'Shaughnessy, TJ; Soto, CM; Rahbar, AM; Robertson, KL; Lebedev, N; Vora, GJ				Wang, Zheng; O'Shaughnessy, Thomas J.; Soto, Carissa M.; Rahbar, Amir M.; Robertson, Kelly L.; Lebedev, Nikolai; Vora, Gary J.			Function and Regulation of Vibrio campbellii Proteorhodopsin: Acquired Phototrophy in a Classical Organoheterotroph	PLOS ONE			English	Article							BIOSYNTHESIS GENE-CLUSTER; PROTON PUMP; LIGHT; BACTERIA; FLAVOBACTERIA; EXPRESSION; GROWTH; OCEAN; ENHANCEMENT; RHODOPSINS	Proteorhodopsins (PRs) are retinal-binding photoproteins that mediate light-driven proton translocation across prokaryotic cell membranes. Despite their abundance, wide distribution and contribution to the bioenergy budget of the marine photic zone, an understanding of PR function and physiological significance in situ has been hampered as the vast majority of PRs studied to date are from unculturable bacteria or culturable species that lack the tools for genetic manipulation. In this study, we describe the presence and function of a horizontally acquired PR and retinal biosynthesis gene cluster in the culturable and genetically tractable bioluminescent marine bacterium Vibrio campbellii. Pigmentation analysis, absorption spectroscopy and photoinduction assays using a heterologous over-expression system established the V. campbellii PR as a functional green light absorbing proton pump. In situ analyses comparing PR expression and function in wild type (WT) V. campbellii with an isogenic Delta pR deletion mutant revealed a marked absence of PR membrane localization, pigmentation and light-induced proton pumping in the Delta pR mutant. Comparative photoinduction assays demonstrated the distinct upregulation of pR expression in the presence of light and PR-mediated photophosphorylation in WT cells that resulted in the enhancement of cellular survival during respiratory stress. In addition, we demonstrate that the master regulator of adaptive stress response and stationary phase, RpoS1, positively regulates pR expression and PR holoprotein pigmentation. Taken together, the results demonstrate facultative phototrophy in a classical marine organoheterotrophic Vibrio species and provide a salient example of how this organism has exploited lateral gene transfer to further its adaptation to the photic zone.	[Wang, Zheng; O'Shaughnessy, Thomas J.; Soto, Carissa M.; Robertson, Kelly L.; Lebedev, Nikolai; Vora, Gary J.] Naval Res Lab, Ctr Biomol Sci & Engn, Washington, DC USA; [Rahbar, Amir M.] NCI, Bethesda, MD 20892 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wang, Z (corresponding author), Naval Res Lab, Ctr Biomol Sci & Engn, Washington, DC USA.	gary.vora@nrl.navy.mil	Vora, Gary J./AAT-7842-2021	Vora, Gary J./0000-0002-0657-8597	Office of Naval Research via United States Naval Research Laboratory core funds [MA 041-06-4R]	Office of Naval Research via United States Naval Research Laboratory core funds	This work was supported by the Office of Naval Research via United States Naval Research Laboratory core funds [MA 041-06-4R]. The opinions and assertions contained herein are those of the authors and are not to be construed as those of the U. S. Navy, military service at large or U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; de la Torre JR, 2003, P NATL ACAD SCI USA, V100, P12830, DOI 10.1073/pnas.2133554100; Eiler A, 2006, APPL ENVIRON MICROB, V72, P7431, DOI 10.1128/AEM.01559-06; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Fuhrman JA, 2008, NAT REV MICROBIOL, V6, P488, DOI 10.1038/nrmicro1893; Giovannoni SJ, 2005, NATURE, V438, P82, DOI 10.1038/nature04032; Gomez-Consarnau L, 2007, NATURE, V445, P210, DOI 10.1038/nature05381; Gomez-Consarnau L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000358; Gonzalez JM, 2008, P NATL ACAD SCI USA, V105, P8724, DOI 10.1073/pnas.0712027105; Gourdon P, 2008, PROTEIN EXPRES PURIF, V58, P103, DOI 10.1016/j.pep.2007.10.017; Johnson ET, 2010, APPL ENVIRON MICROB, V76, P4123, DOI 10.1128/AEM.02425-09; Kimura H, 2011, ISME J, V5, P1641, DOI 10.1038/ismej.2011.36; Lami R, 2009, ENVIRON MICROBIOL, V11, P3201, DOI 10.1111/j.1462-2920.2009.02028.x; Lin BC, 2010, ENV MICROBIOL REP, V2, P81, DOI 10.1111/j.1758-2229.2009.00100.x; Man DL, 2003, EMBO J, V22, P1725, DOI 10.1093/emboj/cdg183; Martinez A, 2007, P NATL ACAD SCI USA, V104, P5590, DOI 10.1073/pnas.0611470104; McCarren J, 2007, ENVIRON MICROBIOL, V9, P846, DOI 10.1111/j.1462-2920.2006.01203.x; MISAWA N, 1995, J BACTERIOL, V177, P6575, DOI 10.1128/jb.177.22.6575-6584.1995; Morris RM, 2010, ISME J, V4, P673, DOI 10.1038/ismej.2010.4; Polz MF, 2006, PHILOS T R SOC B, V361, P2009, DOI 10.1098/rstb.2006.1928; Riedel T, 2010, APPL ENVIRON MICROB, V76, P3187, DOI 10.1128/AEM.02971-09; Sabehi G, 2005, PLOS BIOL, V3, P1409, DOI 10.1371/journal.pbio.0030273; Sabehi G, 2004, ENVIRON MICROBIOL, V6, P903, DOI 10.1111/j.1462-2920.2004.00676.x; Schwalbach MS, 2005, AQUAT MICROB ECOL, V39, P235, DOI 10.3354/ame039235; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Slamovits CH, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1188; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Steindler L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019725; Stingl U, 2007, APPL ENVIRON MICROB, V73, P2290, DOI 10.1128/AEM.02559-06; Takano H, 2005, J BACTERIOL, V187, P1825, DOI 10.1128/JB.187.5.1825-1832.2005; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; van der Horst MA, 2007, TRENDS MICROBIOL, V15, P554, DOI 10.1016/j.tim.2007.09.009; Walter JM, 2007, P NATL ACAD SCI USA, V104, P2408, DOI 10.1073/pnas.0611035104; Zabala B, 2009, APPL ENVIRON MICROB, V75, P1697, DOI 10.1128/AEM.01995-08; Ziegelhoffer EC, 2009, NAT REV MICROBIOL, V7, P856, DOI 10.1038/nrmicro2237	37	29	30	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e38749	10.1371/journal.pone.0038749	http://dx.doi.org/10.1371/journal.pone.0038749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22741028	Green Submitted, Green Published, gold			2022-12-27	WOS:000305351700067
J	Schmitz, M; Driesch, C; Jansen, L; Runnebaum, IB; Durst, M				Schmitz, Martina; Driesch, Corina; Jansen, Lars; Runnebaum, Ingo B.; Duerst, Matthias			Non-Random Integration of the HPV Genome in Cervical Cancer	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS GENOMES; CELLULAR FUSION TRANSCRIPTS; TUMOR-SUPPRESSOR GENE; MICRORNA EXPRESSION; ANOGENITAL LESIONS; PHYSICAL STATE; GENITAL TUMORS; LUNG-CANCER; MYC LOCUS; CARCINOMA	HPV DNA integration into the host genome is a characteristic but not an exclusive step during cervical carcinogenesis. It is still a matter of debate whether viral integration contributes to the transformation process beyond ensuring the constitutive expression of the viral oncogenes. There is mounting evidence for a non-random distribution of integration loci and the direct involvement of cellular cancer-related genes. In this study we addressed this topic by extending the existing data set by an additional 47 HPV16 and HPV18 positive cervical carcinoma. We provide supportive evidence for previously defined integration hotspots and have revealed another cluster of integration sites within the cytogenetic band 3q28. Moreover, in the vicinity of these hotspots numerous microRNAs (miRNAs) are located and may be influenced by the integrated HPV DNA. By compiling our data and published reports 9 genes could be identified which were affected by HPV integration at least twice in independent tumors. In some tumors the viral-cellular fusion transcripts were even identical with respect to the viral donor and cellular acceptor sites used. However, the exact integration sites are likely to differ since none of the integration sites analysed thus far have shown more than a few nucleotides of homology between viral and host sequences. Therefore, DNA recombination involving large stretches of homology at the integration site can be ruled out. It is however intriguing that by sequence alignment several regions of the HPV16 genome were found to have highly homologous stretches of up to 50 nucleotides to the aforementioned genes and the integration hotspots. One common region of homologies with cellular sequences is between the viral gene E5 and L2 (nucleotides positions 4100 to 4240). We speculate that this and other regions of homology are involved in the integration process. Our observations suggest that targeted disruption, possibly also of critical cellular genes, by HPV integration remains an issue to be fully resolved.	[Schmitz, Martina; Driesch, Corina; Jansen, Lars; Runnebaum, Ingo B.; Duerst, Matthias] Univ Klinikum Jena, Klin Frauenheilkunde & Geburtshilfe, Jena, Germany	Friedrich Schiller University of Jena	Schmitz, M (corresponding author), Univ Klinikum Jena, Klin Frauenheilkunde & Geburtshilfe, Jena, Germany.	matthias.duerst@med.uni-jena.de			Deutsche Forschungsgemeinschaft [DR780/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by funds of the Deutsche Forschungsgemeinschaft (DR780/3-1) granted to CD and MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BAKER CC, 1987, J VIROL, V61, P962, DOI 10.1128/JVI.61.4.962-971.1987; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Choi YW, 2007, INT J GYNECOL CANCER, V17, P687, DOI 10.1111/j.1525-1438.2007.00834.x; Dall KL, 2008, CANCER RES, V68, P8249, DOI 10.1158/0008-5472.CAN-08-1741; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; DURST M, 1985, J GEN VIROL, V66, P1515, DOI 10.1099/0022-1317-66-7-1515; Ferber MJ, 2003, ONCOGENE, V22, P7233, DOI 10.1038/sj.onc.1207006; Hafner N, 2008, ONCOGENE, V27, P1610, DOI 10.1038/sj.onc.1210791; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Kalantari M, 2001, DIAGN MOL PATHOL, V10, P46, DOI 10.1097/00019606-200103000-00008; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Klaes R, 1999, CANCER RES, V59, P6132; Kohno T, 2010, GENE CHROMOSOME CANC, V49, P342, DOI 10.1002/gcc.20746; Koopman LA, 1999, CANCER RES, V59, P5615; Kraus I, 2008, CANCER RES, V68, P2514, DOI 10.1158/0008-5472.CAN-07-2776; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Li YH, 2002, J BIOL CHEM, V277, P42366, DOI 10.1074/jbc.M207705200; Liu CX, 2000, GENOMICS, V69, P271, DOI 10.1006/geno.2000.6331; Liu M, 2009, CELL RES, V19, P828, DOI 10.1038/cr.2009.72; Lu YJ, 2010, GENE CHROMOSOME CANC, V49, P412, DOI 10.1002/gcc.20752; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Matovina M, 2009, GYNECOL ONCOL, V113, P120, DOI 10.1016/j.ygyno.2008.12.004; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nagayama K, 2007, GENE CHROMOSOME CANC, V46, P1000, DOI 10.1002/gcc.20485; Nakagawa T, 2006, CANCER SCI, V97, P1070, DOI 10.1111/j.1349-7006.2006.00283.x; Nishi H, 1999, INT J ONCOL, V15, P1149; Peter M, 2006, ONCOGENE, V25, P5985, DOI 10.1038/sj.onc.1209625; Peter M, 2010, J PATHOL, V221, P320, DOI 10.1002/path.2713; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; POPESCU NC, 1990, CANCER RES, V50, P1316; Prazeres H, 2011, ONCOGENE, V30, P1302, DOI 10.1038/onc.2010.512; Reuter S, 1998, EMBO J, V17, P215, DOI 10.1093/emboj/17.1.215; ROMANCZUK H, 1992, P NATL ACAD SCI USA, V89, P3159, DOI 10.1073/pnas.89.7.3159; Santamarina-Fojo S, 1998, CURR OPIN LIPIDOL, V9, P211, DOI 10.1097/00041433-199806000-00005; Sauermann M, 2008, ONCOGENE, V27, P1320, DOI 10.1038/sj.onc.1210743; Schmitz M, 2012, INT J CANC; Schmitz M, 2009, J CLIN VIROL, V44, P302, DOI 10.1016/j.jcv.2009.01.006; Shah R, 2009, BRIT J CANCER, V100, P1687, DOI 10.1038/sj.bjc.6605042; Sonoda I, 2004, CANCER RES, V64, P3741, DOI 10.1158/0008-5472.CAN-04-0172; Thorland EC, 2003, ONCOGENE, V22, P1225, DOI 10.1038/sj.onc.1206170; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Vasilescu F, 2009, ROM J MORPHOL EMBRYO, V50, P357; Vinokurova S, 2008, CANCER RES, V68, P307, DOI 10.1158/0008-5472.CAN-07-2754; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; Wentzensen N, 2002, ONCOGENE, V21, P419, DOI 10.1038/sj.onc.1205104; You JX, 2010, BBA-GENE REGUL MECH, V1799, P192, DOI 10.1016/j.bbagrm.2009.09.009; Ziegert C, 2003, ONCOGENE, V22, P3977, DOI 10.1038/sj.onc.1206629	55	97	104	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39632	10.1371/journal.pone.0039632	http://dx.doi.org/10.1371/journal.pone.0039632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761851	gold, Green Published, Green Submitted			2022-12-27	WOS:000305825800054
J	Sha, LZ; Xing, XL; Zhang, D; Yao, Y; Dou, WC; Jin, LR; Wu, LW; Xu, Q				Sha, Long-Ze; Xing, Xiao-Liang; Zhang, Dan; Yao, Yuan; Dou, Wan-Chen; Jin, Li-Ri; Wu, Li-Wen; Xu, Qi			Mapping the Spatio-Temporal Pattern of the Mammalian Target of Rapamycin (mTOR) Activation in Temporal Lobe Epilepsy	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; GRANULE CELL DISPERSION; HIPPOCAMPAL SCLEROSIS; SIGNALING PATHWAY; MOUSE MODEL; DENTATE GYRUS; EPILEPTOGENESIS; DOWNSTREAM; INHIBITION; ASTROCYTES	Growing evidence from rodent models of temporal lobe epilepsy (TLE) indicates that dysregulation of the mammalian target of rapamycin (mTOR) pathway is involved in seizures and epileptogenesis. However, the role of the mTOR pathway in the epileptogenic process remains poorly understood. Here, we used an animal model of TLE and sclerotic hippocampus from patients with refractory TLE to determine whether cell-type specific activation of mTOR signaling occurs during each stage of epileptogenesis. In the TLE mouse model, we found that hyperactivation of the mTOR pathway is present in distinct hippocampal subfields at three different stages after kainate-induced seizures, and occurs in neurons of the granular and pyramidal cell layers, in reactive astrocytes, and in dispersed granule cells, respectively. In agreement with the findings in TLE mice, upregulated mTOR was observed in the sclerotic hippocampus of TLE patients. All sclerotic hippocampus (n = 13) exhibited widespread reactive astrocytes with overactivated mTOR, some of which invaded the dispersed granular layer. Moreover, two sclerotic hippocampus exhibited mTOR activation in some of the granule cells, which was accompanied by cell body hypertrophy. Taken together, our results indicate that mTOR activation is most prominent in reactive astrocytes in both an animal model of TLE and the sclerotic hippocampus from patients with drug resistant TLE.	[Sha, Long-Ze; Xing, Xiao-Liang; Xu, Qi] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China; [Yao, Yuan; Dou, Wan-Chen; Jin, Li-Ri; Wu, Li-Wen] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Neurol, Beijing 100730, Peoples R China; [Zhang, Dan] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Zhejiang University	Sha, LZ (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China.	wlw1946@yahoo.com.cn; xuqi@pumc.edu.cn		SHA, Longze/0000-0001-7372-6644	National Basic Research Program of China [2010CB529603, 2012CB517902]; National Natural Science Foundation of China [30971001, 31021091]; Beijing Natural Science Foundation [7102109]; Fok Ying Tong Education Foundation [121024]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Fok Ying Tong Education Foundation(Fok Ying Tung Education Foundation)	This work was supported by the National Basic Research Program of China; Grant number: 2010CB529603, 2012CB517902; Grant sponsor: National Natural Science Foundation of China; Grant number: 30971001, 31021091; Grant sponsor: Beijing Natural Science Foundation; Grant number: 7102109; Grant sponsor: Fok Ying Tong Education Foundation; Grant number: 121024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bothwell S, 2001, J NEUROSCI, V21, P4789, DOI 10.1523/JNEUROSCI.21-13-04789.2001; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; Cho CH, 2011, EXP MOL MED, V43, P231, DOI 10.3858/emm.2011.43.5.032; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; Codeluppi S, 2009, J NEUROSCI, V29, P1093, DOI 10.1523/JNEUROSCI.4103-08.2009; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Feliciano DM, 2011, J CLIN INVEST, V121, P1596, DOI 10.1172/JCI44909; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Gomez-Gonzalo M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000352; Gorter JA, 2010, EPILEPSIA, V51, P1791, DOI 10.1111/j.1528-1167.2010.02678.x; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; HOUSER CR, 1990, BRAIN RES, V535, P195, DOI 10.1016/0006-8993(90)91601-C; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; Loscher W, 2006, EPILEPSY RES, V69, P183, DOI 10.1016/j.eplepsyres.2006.03.014; Lurton D, 1998, J NEUROL SCI, V154, P133, DOI 10.1016/S0022-510X(97)00220-7; McCullumsmith RE, 2011, BIOL PSYCHIAT, V69, P127, DOI 10.1016/j.biopsych.2010.09.035; McDaniel SS, 2011, EPILEPSIA, V52, pe7, DOI 10.1111/j.1528-1167.2011.02981.x; McDaniel SS, 2011, NEUROSCI LETT, V497, P231, DOI 10.1016/j.neulet.2011.02.037; Morita T, 2009, J BIOL CHEM, V284, P27734, DOI 10.1074/jbc.M109.008177; Okamoto OK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-230; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Proper EA, 2002, BRAIN, V125, P32, DOI 10.1093/brain/awf001; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Schuele SU, 2008, LANCET NEUROL, V7, P514, DOI 10.1016/S1474-4422(08)70108-X; Sen A, 2006, J NEUROPATH EXP NEUR, V65, P55, DOI 10.1097/01.jnen.0000195940.48033.a2; Sloviter RS, 2006, J COMP NEUROL, V494, P944, DOI 10.1002/cne.20850; Smit WA, 2001, ANAT EMBRYOL, V203, P129, DOI 10.1007/s004290000149; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sperk G, 2012, HIPPOCAMPUS, V22, P590, DOI 10.1002/hipo.20923; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Thom M, 2002, J NEUROPATH EXP NEUR, V61, P510, DOI 10.1093/jnen/61.6.510; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Vincent P, 2009, NEUROSCIENCE, V158, P309, DOI 10.1016/j.neuroscience.2008.02.066; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009	43	64	65	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39152	10.1371/journal.pone.0039152	http://dx.doi.org/10.1371/journal.pone.0039152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761730	gold, Green Published, Green Submitted			2022-12-27	WOS:000305825800021
J	Simoes, DCM; Psarra, AMG; Mauad, T; Pantou, I; Roussos, C; Sekeris, CE; Gratziou, C				Simoes, Davina C. M.; Psarra, Anna-Maria G.; Mauad, Thais; Pantou, Ioanna; Roussos, Charis; Sekeris, Constantine E.; Gratziou, Christina			Glucocorticoid and Estrogen Receptors Are Reduced in Mitochondria of Lung Epithelial Cells in Asthma	PLOS ONE			English	Article							CORTICOSTEROID-INDUCED APOPTOSIS; NUCLEAR TRANSCRIPTION FACTORS; AIRWAY INFLAMMATION; BRONCHIAL EPITHELIUM; ALLERGIC-ASTHMA; REDOX CONTROL; RNA-SYNTHESIS; KAPPA-B; ER-BETA; ALPHA	Mitochondrial glucocorticoid (mtGR) and estrogen (mtER) receptors participate in the coordination of the cell's energy requirement and in the mitochondrial oxidative phosphorylation enzyme (OXPHOS) biosynthesis, affecting reactive oxygen species (ROS) generation and induction of apoptosis. Although activation of mtGR and mtER is known to trigger anti-inflammatory signals, little information exists on the presence of these receptors in lung tissue and their role in respiratory physiology and disease. Using a mouse model of allergic airway inflammation disease and applying confocal microscopy, subcellular fractionation, and Western blot analysis we showed mitochondrial localization of GR alpha and ER beta in lung tissue. Allergic airway inflammation caused reduction in mtGR alpha, mtER beta, and OXPHOS enzyme biosynthesis in lung cells mitochondria and particularly in bronchial epithelial cells mitochondria, which was accompanied by decrease in lung mitochondrial mass and induction of apoptosis. Confirmation and validation of the reduction of the mitochondrial receptors in lung epithelial cells in human asthma was achieved by analyzing autopsies from fatal asthma cases. The presence of the mitochondrial GR alpha and ER beta in lung tissue cells and especially their reduction in bronchial epithelial cells during allergic airway inflammation suggests a crucial role of these receptors in the regulation of mitochondrial function in asthma, implicating their involvement in the pathophysiology of the disease.	[Simoes, Davina C. M.; Pantou, Ioanna; Roussos, Charis; Gratziou, Christina] Univ Athens, Sch Med, Dept Crit Care & Pulm Serv, GP Livanos & M Simou Labs,Evangelismos Hosp, GR-11527 Athens, Greece; [Psarra, Anna-Maria G.] Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece; [Psarra, Anna-Maria G.] Acad Athens, Biomed Res Fdn, Ctr Basic Res, Biochem Lab, Athens, Greece; [Mauad, Thais] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil; [Sekeris, Constantine E.] Natl Hellen Res Fdn, Inst Biol Res & Biotechnol, Mol Endocrinol Lab, Athens, Greece	Athens Medical School; Evangelismos Hospital; National & Kapodistrian University of Athens; University of Thessaly; Academy of Athens; Universidade de Sao Paulo; National Hellenic Research Foundation	Simoes, DCM (corresponding author), Acad Athens, Biomed Res Fdn, Ctr Basic Res, Cellular Immunol Lab, Athens, Greece.	ampsarra@bio.uth.gr	Mauad, Thais/G-1254-2012	Mauad, Thais/0000-0002-3354-1466; Psarra, Anna-Maria/0000-0002-4787-6515; Simoes, Davina Camargo Madeira/0000-0002-7262-1784	Thorax Foundation (Athens, Greece); Bodosaki Foundation; research committee of the University of Thessaly; Biomedical Research Foundation of the Academy of Athens; CNPq Brazilian Research Council	Thorax Foundation (Athens, Greece); Bodosaki Foundation; research committee of the University of Thessaly; Biomedical Research Foundation of the Academy of Athens; CNPq Brazilian Research Council(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Thorax Foundation (Athens, Greece), the Bodosaki Foundation, the research committee of the University of Thessaly, the Biomedical Research Foundation of the Academy of Athens, and the CNPq Brazilian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 1996, AM J RESP CRIT CARE, V154, P771, DOI 10.1164/ajrccm.154.3.8810618; Alzoghaibi MA, 2007, RESPIROLOGY, V12, P439, DOI 10.1111/j.1440-1843.2007.01034.x; Bailey MT, 2009, PHYSIOL BEHAV, V98, P351, DOI 10.1016/j.physbeh.2009.06.013; Bucchieri F, 2002, AM J RESP CELL MOL, V27, P179, DOI 10.1165/ajrcmb.27.2.4699; Carazo A, 2012, J CELL PHYS IN PRESS, P43; Casas F, 1999, MOL CELL BIOL, V19, P7913; Catley MC, 2008, J PHARMACOL EXP THER, V326, P83, DOI 10.1124/jpet.108.136275; Chen JQ, 2007, BBA-MOL CELL RES, V1773, P1732, DOI 10.1016/j.bbamcr.2007.05.008; Chen JQ, 2009, BBA-MOL CELL RES, V1793, P1540, DOI 10.1016/j.bbamcr.2009.06.001; Chen JQ, 2004, J CELL BIOCHEM, V93, P358, DOI 10.1002/jcb.20178; de Carvalho-Pinto RM, 2012, RESP MED, V106, P47, DOI 10.1016/j.rmed.2011.08.013; DEMONACOS C, 1995, J STEROID BIOCHEM, V55, P43, DOI 10.1016/0960-0760(95)00159-W; Diaz-Sanchez D, 1999, CLIN IMMUNOL, V90, P313, DOI 10.1006/clim.1998.4676; Dorscheid DR, 2003, J ALLERGY CLIN IMMUN, V111, P360, DOI 10.1067/mai.2003.117; Dorscheid DR, 2001, AM J RESP CRIT CARE, V164, P1939, DOI 10.1164/ajrccm.164.10.2103013; Du J, 2009, P NATL ACAD SCI USA, V106, P3543, DOI 10.1073/pnas.0812671106; Enriquez JA, 1999, MOL CELL BIOL, V19, P657; Evans RM, 2005, MOL ENDOCRINOL, V19, P1429, DOI 10.1210/me.2005-0046; Goldenthal MJ, 2004, MOL CELL BIOCHEM, V262, P1, DOI 10.1023/B:MCBI.0000038228.85494.3b; Green FHY, 2010, THORAX, V65, P32, DOI 10.1136/thx.2008.111435; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Hsieh YC, 2006, J MOL CELL CARDIOL, V41, P511, DOI 10.1016/j.yjmcc.2006.06.001; HULSMANN AR, 1994, AM J RESP CRIT CARE, V149, P519, DOI 10.1164/ajrccm.149.2.8306055; Ivanova MM, 2009, MOL CELL ENDOCRINOL, V305, P12, DOI 10.1016/j.mce.2009.01.021; Janssen-Heininger Yvonne M W, 2009, Proc Am Thorac Soc, V6, P249, DOI 10.1513/pats.200806-054RM; Kannan MS, 2003, AM J PHYSIOL-LUNG C, V285, pL29, DOI 10.1152/ajplung.00085.2003; Korn SH, 1997, AM J RESP CRIT CARE, V155, P1117, DOI 10.1164/ajrccm.155.3.9116996; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Lu NZ, 2004, ANN NY ACAD SCI, V1024, P102, DOI 10.1196/annals.1321.008; Mabalirajan U, 2008, J IMMUNOL, V181, P3540, DOI 10.4049/jimmunol.181.5.3540; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Modig L, 2009, EUR RESPIR J, V33, P1261, DOI 10.1183/09031936.00101108; Montoya J, 2006, BBA-BIOENERGETICS, V1757, P1179, DOI 10.1016/j.bbabio.2006.03.023; Otto C, 1997, J BIOL CHEM, V272, P26665, DOI 10.1074/jbc.272.42.26665; Psarra AMG, 2005, INT J BIOCHEM CELL B, V37, P2544, DOI 10.1016/j.biocel.2005.06.015; Psarra AMG, 2008, BBA-MOL CELL RES, V1783, P1, DOI 10.1016/j.bbamcr.2007.10.021; Psarra AMG, 2011, BBA-MOL CELL RES, V1813, P1814, DOI 10.1016/j.bbamcr.2011.05.014; Psarra AMG, 2009, BIOCHEM J, V422, P521, DOI 10.1042/BJ20090107; Psarra AMG, 2009, BBA-BIOENERGETICS, V1787, P431, DOI 10.1016/j.bbabio.2008.11.011; Riedl MA, 2008, CURR OPIN ALLERGY CL, V8, P49, DOI 10.1097/ACI.0b013e3282f3d913; Saffar AS, 2007, J IMMUNOL, V178, P2535, DOI 10.4049/jimmunol.178.4.2535; Sekeris C E, 1990, In Vivo, V4, P317; Simoes DCM, 2008, AM J RESP CRIT CARE, V177, P1314, DOI 10.1164/rccm.200708-1141OC; Simoes DCM, 2009, AM J RESP CRIT CARE, V179, P894, DOI 10.1164/rccm.200807-1081OC; Sionov RV, 2006, J EXP MED, V203, P189, DOI 10.1084/jem.20050433; Solakidi S, 2005, HUM REPROD, V20, P3481, DOI 10.1093/humrep/dei267; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Ueda S, 2002, ANTIOXID REDOX SIGN, V4, P405, DOI 10.1089/15230860260196209; Vignola AM, 1998, AM J RESP CRIT CARE, V157, P403, DOI 10.1164/ajrccm.157.2.96-08040; Walsh GM, 2003, J ENDOCRINOL, V178, P37, DOI 10.1677/joe.0.1780037; White SR, 2002, CHEST, V122, p278S, DOI 10.1378/chest.122.6_suppl.278S; Xanthou G, 2007, NAT MED, V13, P570, DOI 10.1038/nm1580; Yang SH, 2009, J BIOL CHEM, V284, P9540, DOI 10.1074/jbc.M808246200; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	56	33	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39183	10.1371/journal.pone.0039183	http://dx.doi.org/10.1371/journal.pone.0039183			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761735	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000305825800022
J	Tschinkel, WR				Tschinkel, Walter R.			The Life Cycle and Life Span of Namibian Fairy Circles	PLOS ONE			English	Article							VEGETATION PATTERNS; MYSTERIOUS CIRCLES; DESERT; ECOSYSTEMS; KAOKOLAND; PATCHES; TERMITE; ORIGIN; MODEL; RINGS	In Namibia of southwestern Africa, the sparse grasslands that develop on deep sandy soils under rainfall between 50 and 100 mm per annum are punctuated by thousands of quasi-circular bare spots, usually surrounded by a ring of taller grass. The causes of these so-called "fairy circles" are unknown, although a number of hypotheses have been proposed. This paper provides a more complete description of the variation in size, density and attributes of fairy circles in a range of soil types and situations. Circles are not permanent; their vegetative and physical attributes allow them to be arranged into a life history sequence in which circles appear (birth), develop (mature) and become revegetated (die). Occasionally, they also enlarge. The appearance and disappearance of circles was confirmed from satellite images taken 4 years apart (2004, 2008). The frequency of births and deaths as a fraction of the total population of circles allowed the calculation of an approximate turnover rate, and from this, an estimate of circle lifespan. Lifespan appeared to vary with circle size, with small circles averaging about 24 years, and larger ones 43-75 years. Overall lifespan averaged about 41 yr. A second, independent estimate of lifespan was made by revisiting circles 2 to 9 years after their clear status had been confirmed. This resulted in a lifespan estimate of about 60 years. Any causal explanation of fairy circles must include their birth, development and death, their mean lifespan and the variation of their features under different conditions.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Tschinkel, WR (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	tschinkel@bio.fsu.edu						Albrecht CF, 2001, S AFR J SCI, V97, P23; Becker T, 2000, BASIC APPL ECOL, V1, P149, DOI 10.1078/1439-1791-00021; Couteron P, 2001, J ECOL, V89, P616, DOI 10.1046/j.0022-0477.2001.00588.x; EICKER A, 1982, S AFR J BOT, V1, P69, DOI 10.1016/S0022-4618(16)30180-2; Grube S, 2002, BASIC APPL ECOL, V3, P367, DOI 10.1078/1439-1791-00138; Jankowitz WJ, 2008, S AFR J BOT, V74, P332, DOI 10.1016/j.sajb.2007.10.010; Lejeune O, 1999, ACTA OECOL, V20, P171, DOI 10.1016/S1146-609X(99)80030-7; Moll E.J., 1994, P 13 PLENARY M AETFA, P1203; Naude Y, 2011, J ARID ENVIRON, V75, P446, DOI 10.1016/j.jaridenv.2010.12.018; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Sheffer E, 2007, ECOL COMPLEX, V4, P192, DOI 10.1016/j.ecocom.2007.06.008; Theron G.K., 1979, J S AFRICAN BIOL SOC, V20, P43; THIERY JM, 1995, J ECOL, V83, P497, DOI 10.2307/2261602; Tinley KL, 1974, SYNOPSIS OUTST UNPUB; Tlidi M, 2008, LECT NOTE PHYS, V751, P381, DOI DOI 10.1007/978-3-540-78217-9_15; Tschinkel WR, 2010, J INSECT SCI, V10; van Rooyen MW, 2004, J ARID ENVIRON, V57, P467, DOI 10.1016/S0140-1963(03)00111-3	18	51	54	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e38056	10.1371/journal.pone.0038056	http://dx.doi.org/10.1371/journal.pone.0038056			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761663	Green Published, gold			2022-12-27	WOS:000305825800007
J	Gruner, BM; Hahne, H; Mazur, PK; Trajkovic-Arsic, M; Maier, S; Esposito, I; Kalideris, E; Michalski, CW; Kleeff, J; Rauser, S; Schmid, RM; Kuster, B; Walch, A; Siveke, JT				Gruener, Barbara M.; Hahne, Hannes; Mazur, Pawel K.; Trajkovic-Arsic, Marija; Maier, Stefan; Esposito, Irene; Kalideris, Evdokia; Michalski, Christoph W.; Kleeff, Joerg; Rauser, Sandra; Schmid, Roland M.; Kuester, Bernhard; Walch, Axel; Siveke, Jens T.			MALDI Imaging Mass Spectrometry for In Situ Proteomic Analysis of Preneoplastic Lesions in Pancreatic Cancer	PLOS ONE			English	Article							PROTEIN EXPRESSION; DUCTAL ADENOCARCINOMA; THYMOSIN BETA-4; RAT PANCREAS; LUNG-CANCER; TISSUE; MOUSE; CELLS; HISTOLOGY; TUMORS	The identification of new biomarkers for preneoplastic pancreatic lesions (PanINs, IPMNs) and early pancreatic ductal adenocarcinoma (PDAC) is crucial due to the diseases high mortality rate upon late detection. To address this task we used the novel technique of matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry (IMS) on genetically engineered mouse models (GEM) of pancreatic cancer. Various GEM were analyzed with MALDI IMS to investigate the peptide/protein-expression pattern of precursor lesions in comparison to normal pancreas and PDAC with cellular resolution. Statistical analysis revealed several discriminative m/z-species between normal and diseased tissue. Intraepithelial neoplasia (PanIN) and intraductal papillary mucinous neoplasm (IPMN) could be distinguished from normal pancreatic tissue and PDAC by 26 significant m/z-species. Among these m/z-species, we identified Albumin and Thymosinbeta 4 by liquid chromatography and tandem mass spectrometry (LC-MS/MS), which were further validated by immunohistochemistry, western blot, quantitative RT-PCR and ELISA in both murine and human tissue. Thymosin-beta 4 was found significantly increased in sera of mice with PanIN lesions. Upregulated PanIN expression of Albumin was accompanied by increased expression of liver-restricted genes suggesting a hepatic transdifferentiation program of preneoplastic cells. In conclusion we show that GEM of endogenous PDAC are a suitable model system for MALDI-IMS and subsequent LC-MS/MS analysis, allowing in situ analysis of small precursor lesions and identification of differentially expressed peptides and proteins.	[Gruener, Barbara M.; Mazur, Pawel K.; Trajkovic-Arsic, Marija; Kalideris, Evdokia; Schmid, Roland M.; Siveke, Jens T.] Tech Univ Munich, Med Klin 2, Munich, Germany; [Hahne, Hannes; Maier, Stefan; Kuester, Bernhard] Tech Univ Munich, Ctr Life & Food Sci, Chair Prote & Bioanalyt, Munich, Germany; [Maier, Stefan; Esposito, Irene; Rauser, Sandra; Walch, Axel] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Pathol, Neuherberg, Germany; [Esposito, Irene] Tech Univ Munich, Inst Pathol, Munich, Germany; [Michalski, Christoph W.; Kleeff, Joerg] Tech Univ Munich, Dept Surg, Munich, Germany; [Kuester, Bernhard] Ctr Integrated Prot Sci Munich, Munich, Germany	Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; University of Munich	Gruner, BM (corresponding author), Tech Univ Munich, Med Klin 2, Munich, Germany.	jens.siveke@lrz.tum.de	Siveke, Jens/AAQ-6170-2021; Maier, Stefan/V-2883-2019; Kuster, Bernhard/Q-6031-2016; Grüner, Barbara/AAB-9246-2020; Mazur, Pawel K./AAU-6343-2021; Walch, Axel/B-4554-2012; Grüner, Barbara M/T-1298-2018; Kleeff, Jorg/B-2124-2009; Michalski, Christoph/U-9167-2019	Maier, Stefan/0000-0001-9704-7902; Kuster, Bernhard/0000-0002-9094-1677; Grüner, Barbara/0000-0003-0974-4826; Mazur, Pawel K./0000-0002-5820-8344; Walch, Axel/0000-0001-5578-4023; Grüner, Barbara M/0000-0003-0974-4826; Kleeff, Jorg/0000-0003-3432-6669; 	German Research Foundation [SFB824-C4]; German Federal Ministry of Education and Research (BMBF) [01GS08115]; Association of Cancer Research (AICR) [07-0543]	German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Association of Cancer Research (AICR)	This work was supported by the German Research Foundation (SFB824-C4), the German Federal Ministry of Education and Research (BMBF; # 01GS08115) and the Association of Cancer Research (AICR; # 07-0543); all to JTS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canto MI, 2006, CLIN GASTROENTEROL H, V4, P766, DOI 10.1016/j.cgh.2006.02.005; Caprioli RM, 2005, CANCER RES, V65, P10642, DOI 10.1158/0008-5472.CAN-04-3581; Cazares LH, 2009, CLIN CANCER RES, V15, P5541, DOI 10.1158/1078-0432.CCR-08-2892; Cha HJ, 2010, INT J DEV BIOL, V54, P135, DOI 10.1387/ijdb.082735hc; Chaurand P, 2004, ANAL CHEM, V76, P1145, DOI 10.1021/ac0351264; Chaurand P, 2001, PROTEOMICS, V1, P1320, DOI 10.1002/1615-9861(200110)1:10<1320::AID-PROT1320>3.3.CO;2-7; Cingolani N, 2000, HUM PATHOL, V31, P938, DOI 10.1053/hupa.2000.9075; Cornett DS, 2006, MOL CELL PROTEOMICS, V5, P1975, DOI 10.1074/mcp.M600119-MCP200; DABEVA MD, 1995, AM J PATHOL, V147, P1633; Djidja MC, 2009, J PROTEOME RES, V8, P4876, DOI 10.1021/pr900522m; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Jaskolla TW, 2009, J AM SOC MASS SPECTR, V20, P1104, DOI 10.1016/j.jasms.2009.02.010; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kim N, 2009, GUT, V58, P1382, DOI 10.1136/gut.2008.170233; Lardon J, 2004, HEPATOLOGY, V39, P1499, DOI 10.1002/hep.20213; Lemaire R, 2007, J PROTEOME RES, V6, P4127, DOI 10.1021/pr0702722; LUKIE BE, 1986, DIGEST DIS SCI, V31, P73, DOI 10.1007/BF01347912; Masui T, 2010, GASTROENTEROLOGY, V139, P270, DOI 10.1053/j.gastro.2010.04.003; Meistermann H, 2006, MOL CELL PROTEOMICS, V5, P1876, DOI 10.1074/mcp.M500399-MCP200; Nakhai H, 2007, DEVELOPMENT, V134, P1151, DOI 10.1242/dev.02781; Nemolato S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009111; Paciucci R, 1996, FEBS LETT, V385, P72, DOI 10.1016/0014-5793(96)00352-3; Paner GP, 2000, CANCER, V88, P1582, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1582::AID-CNCR12>3.0.CO;2-A; Pierson J, 2004, J PROTEOME RES, V3, P289, DOI 10.1021/pr0499747; REDDY JK, 1984, J CELL BIOL, V98, P2082, DOI 10.1083/jcb.98.6.2082; Reyzer ML, 2004, CANCER RES, V64, P9093, DOI 10.1158/0008-5472.CAN-04-2231; Reyzer ML, 2003, J MASS SPECTROM, V38, P1081, DOI 10.1002/jms.525; SANDGREN EP, 1990, CELL, V61, P1121, DOI 10.1016/0092-8674(90)90075-P; Schneider G, 2005, GASTROENTEROLOGY, V128, P1606, DOI 10.1053/j.gastro.2005.04.001; Schwamborn K, 2010, NAT REV CANCER, V10, P639, DOI 10.1038/nrc2917; Schwartz SA, 2004, CLIN CANCER RES, V10, P981, DOI 10.1158/1078-0432.CCR-0927-3; Schwartz SA, 2005, CANCER RES, V65, P7674, DOI 10.1158/0008-5472.CAN-04-3016; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Shen CN, 2003, BIOCHEM J, V375, P41, DOI 10.1042/BJ20030140; Siveke JT, 2007, CANCER CELL, V12, P266, DOI 10.1016/j.ccr.2007.08.002; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Spurney CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008976; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Stoeckli M, 2002, ANAL BIOCHEM, V311, P33, DOI 10.1016/S0003-2697(02)00386-X; Taguchi A, 2011, CANCER CELL, V20, P289, DOI 10.1016/j.ccr.2011.08.007; Walch A, 2008, HISTOCHEM CELL BIOL, V130, P421, DOI 10.1007/s00418-008-0469-9; Watrous JD, 2011, J MASS SPECTROM, V46, P209, DOI 10.1002/jms.1876; Yanagisawa K, 2003, LANCET, V362, P433, DOI 10.1016/S0140-6736(03)14068-8; Zhang YQ, 2008, CANCER BIOL THER, V7, P419, DOI 10.4161/cbt.7.3.5415	49	38	38	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39424	10.1371/journal.pone.0039424	http://dx.doi.org/10.1371/journal.pone.0039424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761793	Green Published, gold, Green Submitted			2022-12-27	WOS:000305808700027
J	Larrieu-Lahargue, F; Welm, AL; Bouchecareilh, M; Alitalo, K; Li, DY; Bikfalvi, A; Auguste, P				Larrieu-Lahargue, Frederic; Welm, Alana L.; Bouchecareilh, Marion; Alitalo, Kari; Li, Dean Y.; Bikfalvi, Andreas; Auguste, Patrick			Blocking Fibroblast Growth Factor Receptor Signaling Inhibits Tumor Growth, Lymphangiogenesis, and Metastasis	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; VEGF-C; BREAST-CANCER; ENDOTHELIAL-CELLS; MAMMARY-TUMOR; ANGIOGENESIS; EXPRESSION; NETRIN-1; MOUSE; INTEGRINS	Fibroblast Growth Factor receptor (FGFR) activity plays crucial roles in tumor growth and patient survival. However, FGF (Fibroblast Growth Factor) signaling as a target for cancer therapy has been under-investigated compared to other receptor tyrosine kinases. Here, we studied the effect of FGFR signaling inhibition on tumor growth, metastasis and lymphangiogenesis by expressing a dominant negative FGFR (FGFR-2DN) in an orthotopic mouse mammary 66c14 carcinoma model. We show that FGFR-2DN-expressing 66c14 cells proliferate in vitro slower than controls. 66c14 tumor outgrowth and lung metastatic foci are reduced in mice implanted with FGFR-2DN-expressing cells, which also exhibited better overall survival. We found 66c14 cells in the lumen of tumor lymphatic vessels and in lymph nodes. FGFR-2DN-expressing tumors exhibited a decrease in VEGFR-3 (Vascular Endothelial Growth Factor Receptor-3) or podoplanin-positive lymphatic vessels, an increase in isolated intratumoral lymphatic endothelial cells and a reduction in VEGF-C (Vascular Endothelial Growth Factor-C) mRNA expression. FGFs may act in an autocrine manner as the inhibition of FGFR signaling in tumor cells suppresses VEGF-C expression in a COX-2 (cyclooxygenase-2) or HIF1-alpha (hypoxia-inducible factor-1 alpha) independent manner. FGFs may also act in a paracrine manner on tumor lymphatics by inducing expression of pro-lymphangiogenic molecules such as VEGFR-3, integrin alpha 9, prox1 and netrin-1. Finally, in vitro lymphangiogenesis is impeded in the presence of FGFR-2DN 66c14 cells. These data confirm that both FGF and VEGF signaling are necessary for the maintenance of vascular morphogenesis and provide evidence that targeting FGFR signaling may be an interesting approach to inhibit tumor lymphangiogenesis and metastatic spread.	[Larrieu-Lahargue, Frederic; Bouchecareilh, Marion; Bikfalvi, Andreas; Auguste, Patrick] Univ Bordeaux, Lab Angiogenese & Microenvironm Canc, Talence, France; [Larrieu-Lahargue, Frederic; Bouchecareilh, Marion; Bikfalvi, Andreas; Auguste, Patrick] INSERM, U1029, Talence, France; [Larrieu-Lahargue, Frederic; Li, Dean Y.] Univ Utah, Program Mol Med, Salt Lake City, UT USA; [Welm, Alana L.; Li, Dean Y.] Univ Utah, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT USA; [Alitalo, Kari] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Alitalo, Kari] Univ Helsinki, Mol Canc Biol Program, Biomedicum Helsinki, Dept Pathol,Haartman Inst, Helsinki, Finland	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Larrieu-Lahargue, F (corresponding author), INSERM, U1034, Pessac, France.	dean.li@hmbg.utah.edu; a.bikfalvi@angio.u-bordeaux1.fr	Alitalo, Kari K/J-5013-2014; Auguste, Patrick/J-9901-2014	Alitalo, Kari K/0000-0002-7331-0902; Auguste, Patrick/0000-0003-1485-0295	Association pour la Recherche sur le Cancer (ARC); Fondation pour la Recherche Medicale; American Heart Association (AHA); Huntsman Cancer Foundation; U.S. Department of Defense Breast Cancer Research Program; U.S. National Institutes of Health; H.A. and Edna Benning Foundation; Juvenile Diabetes Research Foundation; Burroughs Wellcome Fund; Flight Attendants Medical Research Institute	Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); American Heart Association (AHA)(American Heart Association); Huntsman Cancer Foundation; U.S. Department of Defense Breast Cancer Research Program(United States Department of Defense); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); H.A. and Edna Benning Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Flight Attendants Medical Research Institute	This work was supported by grants from the Association pour la Recherche sur le Cancer (ARC) (F. L. L., A. B.), The Fondation pour la Recherche Medicale (F. L. L.), The American Heart Association (AHA) (F. L. L., D.Y.L.), the Huntsman Cancer Foundation (A. L. W.), the U.S. Department of Defense Breast Cancer Research Program (A. L. W. and D.Y.L.), the U.S. National Institutes of Health, the H.A. and Edna Benning Foundation, the Juvenile Diabetes Research Foundation, the Burroughs Wellcome Fund and the Flight Attendants Medical Research Institute (D.Y.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Auguste P, 2001, CANCER RES, V61, P1717; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Cao RH, 2004, CANCER CELL, V6, P333, DOI 10.1016/j.ccr.2004.08.034; Castets M, 2009, DEV CELL, V16, P614, DOI 10.1016/j.devcel.2009.02.006; Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Chien MH, 2009, CARCINOGENESIS, V30, P2005, DOI 10.1093/carcin/bgp244; Dey JH, 2010, CANCER RES, V70, P4151, DOI 10.1158/0008-5472.CAN-09-4479; Dumartin L, 2010, GASTROENTEROLOGY; Fitamant J, 2008, P NATL ACAD SCI USA, V105, P4850, DOI 10.1073/pnas.0709810105; Garmy-Susini B, 2010, CANCER RES, V70, P3042, DOI 10.1158/0008-5472.CAN-09-3761; Garmy-Susini Barbara, 2008, Lymphatic Research and Biology, V6, P155, DOI 10.1089/lrb.2008.1011; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Huang XZ, 2000, MOL CELL BIOL, V20, P5208, DOI 10.1128/MCB.20.14.5208-5215.2000; Iwata C, 2007, CANCER RES, V67, P10181, DOI 10.1158/0008-5472.CAN-07-2366; Karpanen T, 2001, CANCER RES, V61, P1786; Kobayashi S, 2007, CANCER SCI, V98, P726, DOI 10.1111/j.1349-7006.2007.00439.x; Kubo H, 2002, P NATL ACAD SCI USA, V99, P8868, DOI 10.1073/pnas.062040199; Larrieu-Lahargue F, 2010, BLOOD; LI Y, 1994, MOL CELL BIOL, V14, P7660, DOI 10.1128/MCB.14.11.7660; Lin N, 2011, AM J PHYSIOL-CELL PH, V301, pC469, DOI 10.1152/ajpcell.00452.2010; Lorger M, 2009, P NATL ACAD SCI USA, V106, P10666, DOI 10.1073/pnas.0903035106; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Matsuo M, 2007, EUR J CANCER, V43, P1748, DOI 10.1016/j.ejca.2007.04.024; Mattila MMT, 2002, INT J CANCER, V98, P946, DOI 10.1002/ijc.10283; Mishima K, 2007, MOL BIOL CELL, V18, P1421, DOI 10.1091/mbc.E06-09-0780; Murakami M, 2011, J CLIN INVEST, V121, P2668, DOI 10.1172/JCI44762; Ogawa T, 2002, CANCER GENE THER, V9, P633, DOI 10.1038/sj.cgt.7700478; Onimaru M, 2009, AM J PHYSIOL-HEART C, V297, pH1685, DOI 10.1152/ajpheart.00015.2009; Rousseau B, 2004, CANCER RES, V64, P2490, DOI 10.1158/0008-5472.CAN-03-3623; SAKAMOTO T, 1995, ARCH OPHTHALMOL-CHIC, V113, P512, DOI 10.1001/archopht.1995.01100040134039; Schoppmann SF, 2006, BREAST CANCER RES TR, V99, P135, DOI 10.1007/s10549-006-9190-3; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shin JW, 2006, MOL BIOL CELL, V17, P576, DOI 10.1091/mbc.E05-04-0368; Siironen P, 2006, ENDOCR-RELAT CANCER, V13, P465, DOI 10.1677/erc.1.01114; Simiantonaki N, 2008, INT J ONCOL, V32, P585; Sleeman JP, 2009, INT J CANC; Stratman AN, 2011, BLOOD, V117, P3709, DOI 10.1182/blood-2010-11-316752; Taeger J, 2011, MOL CANC THER; Timoshenko AV, 2006, BRIT J CANCER, V94, P1154, DOI 10.1038/sj.bjc.6603067; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Udayakumar TS, 2004, PROSTATE, V58, P66, DOI 10.1002/pros.10293; Vlahakis NE, 2005, J BIOL CHEM, V280, P4544, DOI 10.1074/jbc.M412816200; Wang YP, 1997, NAT MED, V3, P887, DOI 10.1038/nm0897-887; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Yang Y, 2007, CANCER BIOL THER, V6, P743, DOI 10.4161/cbt.6.5.3976	47	24	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39540	10.1371/journal.pone.0039540	http://dx.doi.org/10.1371/journal.pone.0039540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761819	Green Published, Green Submitted, gold			2022-12-27	WOS:000305781700046
J	Sagaspe, P; Taillard, J; Amieva, H; Beck, A; Rascol, O; Dartigues, JF; Capelli, A; Philip, P				Sagaspe, Patricia; Taillard, Jacques; Amieva, Helene; Beck, Arnaud; Rascol, Olivier; Dartigues, Jean-Francois; Capelli, Aurore; Philip, Pierre			Influence of Age, Circadian and Homeostatic Processes on Inhibitory Motor Control: A Go/Nogo Task Study	PLOS ONE			English	Article							PSYCHOMOTOR VIGILANCE PERFORMANCE; SLEEP-DEPRIVATION; RESPONSE-INHIBITION; SUSTAINED ATTENTION; YOUNG; TEMPERATURE; PRESSURE; RHYTHMS; DECREMENTS; REDUCTION	Introduction: The contribution of circadian system and sleep pressure influences on executive performance as a function of age has never been studied. The aim of our study was to determine the age-related evolution of inhibitory motor control (i.e., ability to suppress a prepotent motor response) and sustained attention under controlled high or low sleep pressure conditions. Methods: 14 healthy young males (mean age = 23 +/- 2.7; 20-29 years) and 11 healthy older males (mean age = 68 +/- 1.4; 66-70 years) were recruited. The volunteers were placed for 40 hours in "constant routine". In the "Sleep Deprivation SD" condition, the volunteer was kept awake for 40 hours to obtain a high sleep pressure condition interacting with the circadian process. In the "NAP" condition, the volunteer adopted a short wake/sleep cycle (150/75 min) resulting in a low sleep pressure condition to counteract the homeostatic pressure and investigate the circadian process. Performances were evaluated by a simple reaction time task and a Go/Nogo task repeated every 3H45. Results: In the SD condition, inhibitory motor control (i.e., ability to inhibit an inappropriate response) was impaired by extended wakefulness equally in both age groups (P<.01). Sustained attention (i.e. ability to respond accurately to appropriate stimuli) on the executive task decreased under sleep deprivation in both groups, and even more in young participants (P<.05). In the NAP condition, age did not influence the time course of inhibitory motor control or sustained attention. In the SD and NAP conditions, older participants had a less fluctuating reaction time performance across time of day than young participants (P<.001). Conclusion: Aging could be a protective factor against the effects of extended wakefulness especially on sustained attention failures due to an attenuation of sleep pressure with duration of time awake.	[Sagaspe, Patricia; Taillard, Jacques; Capelli, Aurore; Philip, Pierre] Univ Bordeaux, CNRS USR SANPSY Sleep Attent & NeuroPSYchiat 3413, Bordeaux, France; [Sagaspe, Patricia; Taillard, Jacques; Capelli, Aurore; Philip, Pierre] Univ Hosp Pellegrin, Bordeaux, France; [Amieva, Helene; Dartigues, Jean-Francois] INSERM, U897, ISPED, Bordeaux, France; [Beck, Arnaud] MEDES Inst Space Med & Physiol, Toulouse, France; [Rascol, Olivier] Hosp & Univ Paul Sabatier Toulouse, France INSERM Clin Investigat Ctr INSERM 9302, Dept Clin Pharmacol, Toulouse, France; [Rascol, Olivier] Hosp & Univ Paul Sabatier Toulouse, France INSERM Clin Investigat Ctr INSERM 9302, Dept Neurosci, Toulouse, France; [Rascol, Olivier] UMR 825, Toulouse, France	UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Sagaspe, P (corresponding author), Univ Bordeaux, CNRS USR SANPSY Sleep Attent & NeuroPSYchiat 3413, Bordeaux, France.	patricia.sagaspe@gmail.com	Amieva, Helene/T-4170-2019; Amieva, Helene/E-4850-2014; Taillard, Jacques/H-5063-2018; DARTIGUES, Jean François/T-4513-2019; PHILIP, Pierre/AAS-8889-2020	Amieva, Helene/0000-0002-0119-7242; Taillard, Jacques/0000-0001-9067-8189; PHILIP, Pierre/0000-0003-3267-634X; SAGASPE, Patricia/0000-0003-2845-1199	ANR (Agence Nationale de la Recherche)	ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR))	This research was supported by a grant from ANR (Agence Nationale de la Recherche). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2006, SLEEP, V29, P55, DOI 10.1093/sleep/29.1.55; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Ayalon L, 2009, J SLEEP RES, V18, P204, DOI 10.1111/j.1365-2869.2008.00707.x; Bauer LO, 2001, DRUG ALCOHOL DEPEN, V63, P87, DOI 10.1016/S0376-8716(00)00195-2; Blatter K, 2006, BEHAV BRAIN RES, V168, P312, DOI 10.1016/j.bbr.2005.11.018; Blatter K, 2005, J SLEEP RES, V14, P409, DOI 10.1111/j.1365-2869.2005.00484.x; Blatter K, 2007, PHYSIOL BEHAV, V90, P196, DOI 10.1016/j.physbeh.2006.09.009; Bliwise DL., 2005, PRINCIPLES PRACTICE, V4th ed., P24; Breimhorst M, 2008, EXP BRAIN RES, V187, P631, DOI 10.1007/s00221-008-1333-9; Cajochen C, 2006, CHRONOBIOL INT, V23, P461, DOI 10.1080/07420520500545813; Cajochen C, 2001, NEUROREPORT, V12, P2277, DOI 10.1097/00001756-200107200-00046; Chuah YML, 2006, J NEUROSCI, V26, P7156, DOI 10.1523/JNEUROSCI.0906-06.2006; Czeisler Charles A, 2009, Trans Am Clin Climatol Assoc, V120, P249; Dijk DJ, 2010, SLEEP, V33, P211, DOI 10.1093/sleep/33.2.211; Dijk DJ, 2001, SLEEP, V24, P565, DOI 10.1093/sleep/24.5.565; Dijk DJ, 1999, J PHYSIOL-LONDON, V516, P611, DOI 10.1111/j.1469-7793.1999.0611v.x; Dinges DF, 1997, SLEEP, V20, P267; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Drummond SPA, 2006, J SLEEP RES, V15, P261, DOI 10.1111/j.1365-2869.2006.00535.x; Duffy JF, 2009, J AM GERIATR SOC, V57, P1245, DOI 10.1111/j.1532-5415.2009.02303.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; Galliaudi E, 2008, J SLEEP RES, V17, P11, DOI 10.1111/j.1365-2869.2008.00629.x; GILLBERG M, 1994, SLEEP, V17, P236, DOI 10.1093/sleep/17.3.236; Graw P, 2004, PHYSIOL BEHAV, V80, P695, DOI 10.1016/j.physbeh.2003.12.004; GROBER E, 1988, NEUROLOGY, V38, P900, DOI 10.1212/WNL.38.6.900; Harrison Y, 2000, J EXP PSYCHOL-APPL, V6, P236, DOI 10.1037//1076-898X.6.3.236; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jones K, 2001, SLEEP MED REV, V5, P463, DOI 10.1053/smrv.2001.0203; Kaladjian A, 2011, PSYCHOL MED, V41, P291, DOI 10.1017/S0033291710000796; Kamarajan C, 2005, BIOL PSYCHOL, V69, P353, DOI 10.1016/j.biopsycho.2004.08.004; Klerman EB, 2008, CURR BIOL, V18, P1118, DOI 10.1016/j.cub.2008.06.047; Landolt HP, 1996, BRAIN RES, V738, P205, DOI 10.1016/S0006-8993(96)00770-6; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Mistlberger RE, 2005, BRAIN RES REV, V49, P429, DOI 10.1016/j.brainresrev.2005.01.005; Monk TH, 2000, CHRONOBIOL INT, V17, P355, DOI 10.1081/CBI-100101051; Mulligan RC, 2011, PSYCHIAT RES; Munch M, 2004, EUR J NEUROSCI, V20, P1402, DOI 10.1111/j.1460-9568.2004.03580.x; Munch M, 2007, SLEEP, V30, P781, DOI 10.1093/sleep/30.6.781; Muzur A, 2002, TRENDS COGN SCI, V6, P475, DOI 10.1016/S1364-6613(02)01992-7; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Page LA, 2009, PSYCHIAT RES-NEUROIM, V174, P202, DOI 10.1016/j.pscychresns.2009.05.002; PARTINEN M, 1995, J SLEEP RES, V4, P150, DOI 10.1111/j.1365-2869.1995.tb00205.x; Peres K, 2008, J AM GERIATR SOC, V56, P37, DOI 10.1111/j.1532-5415.2007.01499.x; Philip P, 2004, J SLEEP RES, V13, P105, DOI 10.1111/j.1365-2869.2004.00399.x; Rush BK, 2006, AGING NEUROPSYCHOL C, V13, P588, DOI 10.1080/13825580600680703; Sagaspe P, 2006, BRAIN COGNITION, V60, P76, DOI 10.1016/j.bandc.2005.10.001; Sagaspe P, 2003, CAN J EXP PSYCHOL, V57, P265, DOI 10.1037/h0087430; Sagaspe P, 2007, SLEEP, V30, P1808, DOI 10.1093/sleep/30.12.1808; Sagaspe P, 2007, J SLEEP RES, V16, P381, DOI 10.1111/j.1365-2869.2007.00607.x; Sagaspe P, 2011, NEUROIMAGE, V55, P1825, DOI 10.1016/j.neuroimage.2011.01.027; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Silva EJ, 2010, SLEEP, V33, P481, DOI 10.1093/sleep/33.4.481; Taillard J, 2006, J SLEEP RES, V15, P41, DOI 10.1111/j.1365-2869.2006.00505.x; Tucker AM, 2010, SLEEP, V33, P47, DOI 10.1093/sleep/33.1.47; Vallesi A, 2011, NEUROSCI LETT, V487, P313, DOI 10.1016/j.neulet.2010.10.046; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2003, J SLEEP RES, V12, P181, DOI 10.1046/j.1365-2869.2003.00357.x; Viola AU, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.024; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152; Yang B, 2009, SCI CHINA SER C, V52, P780, DOI 10.1007/s11427-009-0106-4	61	34	36	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39410	10.1371/journal.pone.0039410	http://dx.doi.org/10.1371/journal.pone.0039410			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761784	gold, Green Published, Green Submitted			2022-12-27	WOS:000305781700035
J	Fink, BD; Herlein, JA; O'Malley, Y; Sivitz, WI				Fink, Brian D.; Herlein, Judy A.; O'Malley, Yunxia; Sivitz, William I.			Endothelial Cell and Platelet Bioenergetics: Effect of Glucose and Nutrient Composition	PLOS ONE			English	Article							REACTIVE OXYGEN; MITOCHONDRIAL SUPEROXIDE; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; ACTIVATION; ACONITASE; TARGET; DAMAGE	It has been suggested that cells that are independent of insulin for glucose uptake, when exposed to high glucose or other nutrient concentrations, manifest enhanced mitochondrial substrate oxidation with consequent enhanced potential and generation of reactive oxygen species (ROS); a paradigm that could predispose to vascular complications of diabetes. Here we exposed bovine aortic endothelial (BAE) cells and human platelets to variable glucose and fatty acid concentrations. We then examined oxygen consumption and acidification rates using recently available technology in the form of an extracellular oxygen and proton flux analyzer. Acute or overnight exposure of confluent BAE cells to glucose concentrations from 5.5 to 25 mM did not enhance or change the rate of oxygen consumption (OCR) under basal conditions, during ATP synthesis, or under uncoupled conditions. Glucose also did not alter OCR in sub-confluent cells, in cells exposed to low serum, or in cells treated with added pyruvate. Likewise, overnight exposure to fatty acids of varying saturation had no such effects. Overnight exposure of BAE cells to low glucose concentration decreased maximal uncoupled respiration, but not basal or ATP related oxygen consumption. Labeled glucose oxidation to CO2 increased, but only marginally after high glucose exposure while oleate oxidation to CO2 decreased. Overnight exposure to linolenic acid, but not oleic or linoleic acid increased extracellular acidification consistent with enhanced glycolytic metabolism. We were unable to detect an increase in production of reactive oxygen species (ROS) from BAE cells exposed to high medium glucose. Like BAE cells, exposure of human platelets to glucose did not increase oxygen consumption. As opposed to BAE cells, platelet mitochondria demonstrate less respiratory reserve capacity (beyond that needed for basal metabolism). Our data do not support the concept that exposure to high glucose or fatty acids accelerates mitochondrial oxidative metabolism in endothelial cells or platelets.	[Fink, Brian D.; Herlein, Judy A.; Sivitz, William I.] Univ Iowa Hosp & Clin, Dept Internal Med Endocrinol & Metab, Iowa City, IA 52242 USA; [Fink, Brian D.; Herlein, Judy A.; O'Malley, Yunxia; Sivitz, William I.] Iowa City VAMC, Iowa City, IA USA; [O'Malley, Yunxia] Univ Iowa Hosp & Clin, Dept Surg, Iowa City, IA 52242 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Fink, BD (corresponding author), Univ Iowa Hosp & Clin, Dept Internal Med Endocrinol & Metab, Iowa City, IA 52242 USA.	william-sivitz@uiowa.edu		Fink, Brian/0000-0002-1149-7935; Sivitz, William/0000-0002-7829-0189	Veterans Affairs Medical Research Funds; National Institutes of Health [5R01HL073166]; Iowa Affiliate Fraternal Order of the Eagles; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073166] Funding Source: NIH RePORTER	Veterans Affairs Medical Research Funds(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iowa Affiliate Fraternal Order of the Eagles; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by Veterans Affairs Medical Research Funds, National Institutes of Health grant 5R01HL073166, and the Iowa Affiliate Fraternal Order of the Eagles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainscow EK, 1999, EUR J BIOCHEM, V263, P671, DOI 10.1046/j.1432-1327.1999.00534.x; AKKERMAN JWN, 1981, BLOOD, V57, P956; Avila C, 2011, EXP CLIN ENDOCRINOL; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brill A, 2009, CARDIOVASC RES, V84, P137, DOI 10.1093/cvr/cvp176; Brown A, 2010, NAT REV CARDIOL, V7, P369, DOI 10.1038/nrcardio.2010.35; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Bulteau AL, 2003, BIOCHEMISTRY-US, V42, P14846, DOI 10.1021/bi0353979; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; Dailey G, 2011, DIABETES TECHNOL THE, V13, DOI 10.1089/dia.2011.0019; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Green K, 2004, DIABETES, V53, pS110, DOI 10.2337/diabetes.53.2007.S110; Guppy M, 1997, EUR J BIOCHEM, V244, P161, DOI 10.1111/j.1432-1033.1997.00161.x; Hong Y, 2001, ENDOCRINOLOGY, V142, P249, DOI 10.1210/en.142.1.249; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Kiritoshi S, 2003, DIABETES, V52, P2570, DOI 10.2337/diabetes.52.10.2570; Liu Y, 2003, J CELL MOL MED, V7, P49, DOI 10.1111/j.1582-4934.2003.tb00202.x; MOSER DR, 1992, MOL ENDOCRINOL, V6, P1805, DOI 10.1210/me.6.11.1805; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200; Paramo B, 2010, NEUROSCIENCE, V167, P1057, DOI 10.1016/j.neuroscience.2010.02.074; Reusch JEB, 2011, J CLIN ENDOCR METAB, V96, P2367, DOI 10.1210/jc.2010-3011; Schrama L., 1983, BIOCHEM J, V10, P145; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; Ueno M, 2011, J ATHEROSCLER THROMB, V18, P431, DOI 10.5551/jat.7633; Yamagishi S, 2001, DIABETES, V50, P1491, DOI 10.2337/diabetes.50.6.1491; Yeboah J, 2009, CIRCULATION, V120, P502, DOI 10.1161/CIRCULATIONAHA.109.864801; Zhang L, 2010, J PROTEOME RES, V9, P458, DOI 10.1021/pr900818g; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031	33	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39430	10.1371/journal.pone.0039430	http://dx.doi.org/10.1371/journal.pone.0039430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745753	Green Submitted, Green Published, gold			2022-12-27	WOS:000305730900060
J	Luter, HM; Whalan, S; Webster, NS				Luter, Heidi M.; Whalan, Steve; Webster, Nicole S.			Thermal and Sedimentation Stress Are Unlikely Causes of Brown Spot Syndrome in the Coral Reef Sponge, lanthella basta	PLOS ONE			English	Article							GREAT-BARRIER-REEF; BACTERIAL COMMUNITIES; MICROBIAL COMMUNITY; CLIMATE-CHANGE; DISEASE; POPULATIONS; PHYSIOLOGY; DIVERSITY; GRADIENT; MICROORGANISMS	Background: Marine diseases are being increasingly linked to anthropogenic factors including global and local stressors. On the Great Barrier Reef, up to 66% of the Ianthella basta population was recently found to be afflicted by a syndrome characterized by brown spot lesions and necrotic tissue. Methodology/Principal Findings: Manipulative experiments were undertaken to ascertain the role of environmental stressors in this syndrome. Specifically, the effects of elevated temperature and sedimentation on sponge health and symbiont stability in I. basta were examined. Neither elevated temperature nor increased sedimentation were responsible for the brown spot lesions, but sponges exposed to 32 degrees C developed substantial discoloration and deterioration of their tissues, resulting in death after eight days and a higher microbial diversity in those samples. No shifts in the microbial community of I. basta were observed across a latitudinal gradient or with increased sedimentation, with three previously described symbionts dominating the community of all sponges (Alphaproteobacteria, Gammaproteobacteria and Thaumarchaea). Conclusions/Significance: Results from this study highlight the stable microbial community of I. basta and indicate that thermal and sedimentation stress are not responsible for the brown spot lesions currently affecting this abundant and ecologically important sponge species.	[Luter, Heidi M.; Webster, Nicole S.] James Cook Univ, Australian Inst Marine Sci, Townsville, Qld 4811, Australia; [Luter, Heidi M.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Luter, Heidi M.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Whalan, Steve] So Cross Univ, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia	Australian Institute of Marine Science; James Cook University; James Cook University; Charles Darwin University; Southern Cross University	Luter, HM (corresponding author), James Cook Univ, Australian Inst Marine Sci, Townsville, Qld 4811, Australia.	heidi.luter@my.jcu.edu.au	Luter, Heidi/N-2139-2013; Luter, Heidi M/E-9519-2016; Webster, Nicole S/G-4980-2011	Luter, Heidi/0000-0001-7810-7076; Luter, Heidi M/0000-0001-7810-7076; Webster, Nicole S/0000-0002-4753-5278; Whalan, Steve/0000-0001-6786-8945	Australian Institute of Marine Science @ James Cook University; Marine and a Tropical Sciences Research Foundation	Australian Institute of Marine Science @ James Cook University; Marine and a Tropical Sciences Research Foundation	This study was supported by an Australian Institute of Marine Science @ James Cook University and Marine and a Tropical Sciences Research Foundation postgraduate award to H.M.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Wahab MA, 2012, AQUACULTURE, V324, P281, DOI 10.1016/j.aquaculture.2011.11.006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bannister RJ, 2012, CONT SHELF RES, V32, P86, DOI 10.1016/j.csr.2011.10.018; Bayer K, 2008, ENVIRON MICROBIOL, V10, P2942, DOI 10.1111/j.1462-2920.2008.01582.x; Bergquist Patricia R., 1995, Beagle, V12, P151; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Cebrian E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020211; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Dalton SJ, 2010, MAR FRESHWATER RES, V61, P342, DOI 10.1071/MF09060; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P340, DOI 10.1128/AEM.62.2.340-346.1996; Flores F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037795; Freckelton ML, 2012, HYDROBIOLOGIA, V687, P191, DOI 10.1007/s10750-011-0818-x; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Friedrich AB, 2001, FEMS MICROBIOL ECOL, V38, P105, DOI 10.1111/j.1574-6941.2001.tb00888.x; GAINO E, 1992, B ZOOL, V59, P79, DOI 10.1080/11250009209386652; Galstoff P. S., 1942, P 8 AM SCI C, V3, P411; GERRODETTE T, 1979, MAR BIOL, V55, P103, DOI 10.1007/BF00397305; Haapkyla J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016893; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Kelman D, 2001, AQUAT MICROB ECOL, V24, P9, DOI 10.3354/ame024009; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lemoine Nathan, 2007, V28, P419; Littman R, 2011, ENV MICROBIOL REP, V3, P651, DOI 10.1111/j.1758-2229.2010.00234.x; Lopez-Legentil S, 2008, MOL ECOL, V17, P1840, DOI 10.1111/j.1365-294X.2008.03667.x; Louden D, 2007, AQUACULTURE, V270, P57, DOI 10.1016/j.aquaculture.2007.02.038; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luter HM, 2010, APPL ENVIRON MICROB, V76, P5736, DOI 10.1128/AEM.00653-10; Luter HM, 2010, MAR FRESHWATER RES, V61, P484, DOI 10.1071/MF09200; Maldonado M, 2008, MAR BIOL, V154, P631, DOI 10.1007/s00227-008-0956-5; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Mohamed NM, 2008, APPL ENVIRON MICROB, V74, P1209, DOI 10.1128/AEM.02047-07; Mohamed NM, 2010, ISME J, V4, P38, DOI 10.1038/ismej.2009.84; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Off S, 2010, APPL ENVIRON MICROB, V76, P4640, DOI 10.1128/AEM.00320-10; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pantos O, 2006, DIS AQUAT ORGAN, V69, P79, DOI 10.3354/dao069079; Pettit GR, 1996, J NAT PROD, V59, P927, DOI 10.1021/np960249n; Philipp E, 2003, J EXP MAR BIOL ECOL, V287, P57, DOI 10.1016/S0022-0981(02)00495-1; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; REISWIG HM, 1971, BIOL BULL, V141, P568, DOI 10.2307/1540270; REISWIG HM, 1971, MAR BIOL, V9, P38, DOI 10.1007/BF00348816; Roberts DE, 2006, MAR ECOL PROG SER, V307, P143, DOI 10.3354/meps307143; Sato Y, 2011, CORAL REEFS, V30, P753, DOI 10.1007/s00338-011-0751-5; Schlappy ML, 2010, MAR BIOL, V157, P593, DOI 10.1007/s00227-009-1344-5; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Selvin J, 2009, MICROBIOL RES, V164, P352, DOI 10.1016/j.micres.2007.05.005; Solomon S., 2007, PHYS SCI BASIS WORKI; Southwell MW, 2008, LIMNOL OCEANOGR, V53, P986, DOI 10.4319/lo.2008.53.3.0986; Southwell MW, 2008, MAR CHEM, V108, P96, DOI 10.1016/j.marchem.2007.10.005; Steger D, 2008, ENVIRON MICROBIOL, V10, P1087, DOI 10.1111/j.1462-2920.2007.01515.x; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x; Taylor MW, 2005, ENVIRON MICROBIOL, V7, P419, DOI 10.1111/j.1462-2920.2004.00711.x; Thoms C, 2003, MAR BIOL, V142, P685, DOI 10.1007/s00227-002-1000-9; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Tompkins-MacDonald GJ, 2008, MAR BIOL, V154, P973, DOI 10.1007/s00227-008-0987-y; Vacelet J., 1994, CONTROL SEVERE SPONG, P39; VICENTE VP, 1989, MAR ECOL-P S Z N I, V10, P179, DOI 10.1111/j.1439-0485.1989.tb00073.x; Weber M, 2006, J EXP MAR BIOL ECOL, V336, P18, DOI 10.1016/j.jembe.2006.04.007; Webster NS, 2008, ENVIRON MICROBIOL, V10, P3366, DOI 10.1111/j.1462-2920.2008.01734.x; Webster NS, 2008, ISME J, V2, P830, DOI 10.1038/ismej.2008.42; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; Webster NS, 2011, ENV MICROBIOL REP, V3, P756, DOI 10.1111/j.1758-2229.2011.00296.x; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Webster NS, 2001, ENVIRON MICROBIOL, V3, P19, DOI 10.1046/j.1462-2920.2001.00155.x; Webster NS, 2004, ENVIRON MICROBIOL, V6, P288, DOI 10.1111/j.1462-2920.2004.00570.x; Whalan S, 2007, MAR BIOL, V153, P163, DOI 10.1007/s00227-007-0792-z	73	28	28	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39779	10.1371/journal.pone.0039779	http://dx.doi.org/10.1371/journal.pone.0039779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745827	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000305730900113
J	Munoz, J; Ruiz, S; Soriguer, R; Alcaide, M; Viana, DS; Roiz, D; Vazquez, A; Figuerola, J				Munoz, Joaquin; Ruiz, Santiago; Soriguer, Ramon; Alcaide, Miguel; Viana, Duarte S.; Roiz, David; Vazquez, Ana; Figuerola, Jordi			Feeding Patterns of Potential West Nile Virus Vectors in South-West Spain	PLOS ONE			English	Article							MOSQUITOS DIPTERA-CULICIDAE; UNIVITTATUS THEOBALD; CULEX-PIPIENS; BLOOD MEALS; IDENTIFICATION; TRANSMISSION; INFECTION; ECOLOGY; BIRDS; EPIDEMIOLOGY	Background: Mosquito feeding behaviour determines the degree of vector-host contact and may have a serious impact on the risk of West Nile virus (WNV) epidemics. Feeding behaviour also interacts with other biotic and abiotic factors that affect virus amplification and transmission. Methodology/Principal Findings: We identified the origin of blood meals in five mosquito species from three different wetlands in SW Spain. All mosquito species analysed fed with different frequencies on birds, mammals and reptiles. Both 'mosquito species' and 'locality' explained a similar amount of variance in the occurrence of avian blood meals. However, 'season of year' was the main factor explaining the presence of human blood meals. The differences in diet resulted in a marked spatial heterogeneity in the estimated WNV transmission risk. Culex perexiguus, Cx. modestus and Cx. pipiens were the main mosquito species involved in WNV enzootic circulation since they feed mainly on birds, were abundant in a number of localities and had high vector competence. Cx. perexiguus may also be important for WNV transmission to horses, as are Cx. pipiens and Cx. theileri in transmission to humans. Estimates of the WNV transmission risk based on mosquito diet, abundance and vector competence matched the results of previous WNV monitoring programs in the area. Our sensitivity analyses suggested that mosquito diet, followed by mosquito abundance and vector competence, are all relevant factors in understanding virus amplification and transmission risk in the studied wild ecosystems. At some of the studied localities, the risk of enzootic circulation of WNV was relatively high, even if the risk of transmission to humans and horses was less. Conclusions/Significance: Our results describe for first time the role of five WNV candidate vectors in SW Spain. Interspecific and local differences in mosquito diet composition has an important effect on the potential transmission risk of WNV to birds, horses and humans.	[Munoz, Joaquin; Soriguer, Ramon; Alcaide, Miguel; Viana, Duarte S.; Roiz, David; Figuerola, Jordi] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Ruiz, Santiago] Diputac Huelva, Serv Control Mosquitos, Huelva, Spain; [Alcaide, Miguel] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Vazquez, Ana] CNM Inst Salud Carlos III, Majadahonda, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Harvard University	Munoz, J (corresponding author), CSIC, Estn Biol Donana, E-41080 Seville, Spain.	quini@ebd.csic.es	Ruíz, Santiago/HGU-6016-2022; Viana, Duarte/AAA-1482-2020; Roiz, David/F-2082-2011; Figuerola, Jordi/B-7917-2008; Soriguer, Ramon/J-1494-2014; Vázquez, Ana/H-4911-2013; Munoz, Joaquin/B-9938-2009	Viana, Duarte/0000-0002-7864-0871; Roiz, David/0000-0002-5819-3648; Figuerola, Jordi/0000-0002-4664-9011; Soriguer, Ramon/0000-0002-9165-7766; Vázquez, Ana/0000-0002-9872-3316; Munoz, Joaquin/0000-0003-3623-2439; Alcaide, Miguel/0000-0001-6945-0972	Junta de Andalucia [RNM118, RNM157, P07-RNM-02511]; European Union [HEALTH.2010.2.3.3-3, 261391 EuroWestNile, HEALTH.2010.Single, 261504 EDENEXT]; Spanish Ministry of Science [CGL2009-11445]	Junta de Andalucia(Junta de Andalucia); European Union(European Commission); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was partially supported by projects RNM118, RNM157 and P07-RNM-02511 of the Junta de Andalucia, the European Union FP7 grants HEALTH.2010.2.3.3-3 Project 261391 EuroWestNile, and HEALTH.2010.Single-stage Project 261504 EDENEXT, and the Spanish Ministry of Science project (CGL2009-11445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092; Almeida APG, 2008, T ROY SOC TROP MED H, V102, P823, DOI 10.1016/j.trstmh.2008.03.011; [Anonymous], 2009, LANG ENV STAT COMP; Apperson CS, 2004, VECTOR-BORNE ZOONOT, V4, P71, DOI 10.1089/153036604773083013; Balenghien T, 2006, J MED ENTOMOL, V43, P936, DOI 10.1603/0022-2585(2006)43[936:HBAHBA]2.0.CO;2; Balenghien T, 2008, VECTOR-BORNE ZOONOT, V8, P589, DOI 10.1089/vbz.2007.0266; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Bernabeu-Wittel M, 2007, ENFERM INFEC MICR CL, V25, P561, DOI 10.1157/13111181; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Carnell R, 2009, 1HS LATIN HYPERCUBE; Chaves LF, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-3; Cupp EW, 2004, AM J TROP MED HYG, V71, P272, DOI 10.4269/ajtmh.2004.71.272; Diaz-Delgado R, 2010, CONSERVATION MONITORING IN FRESHWATER HABITATS: A PRACTICAL GUIDE AND CASE STUDIES, P325, DOI 10.1007/978-1-4020-9278-7_28; Figuerola J, 2008, VET MICROBIOL, V132, P39, DOI 10.1016/j.vetmic.2008.04.023; Figuerola J, 2007, EMERG INFECT DIS, V13, P1915, DOI 10.3201/eid1312.070343; Fyodorova MV, 2006, J MED ENTOMOL, V43, P552, DOI 10.1603/0022-2585(2006)43[552:EOPWNV]2.0.CO;2; Gomez-Diaz E, 2010, TRENDS PARASITOL, V26, P470, DOI 10.1016/j.pt.2010.06.007; Hamer GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023767; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; Harbach Ralph E., 1999, European Mosquito Bulletin, V4, P7; Hofle U, 2008, VET MICROBIOL, V129, P171, DOI 10.1016/j.vetmic.2007.11.006; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Hubalek Z, 2000, VIRAL IMMUNOL, V13, P415, DOI 10.1089/vim.2000.13.415; Jimenez-Clavero MA, 2010, VET REC, V167, P379, DOI 10.1136/vr.c3155; Jourdain E, 2007, VECTOR-BORNE ZOONOT, V7, P15, DOI 10.1089/vbz.2006.0543; Jupp PG, 2001, ANN NY ACAD SCI, V951, P143, DOI 10.1111/j.1749-6632.2001.tb02692.x; JUPP PG, 1970, J MED ENTOMOL, V7, P371, DOI 10.1093/jmedent/7.3.371; Kay BH, 2007, AM J TROP MED HYG, V76, P417, DOI 10.4269/ajtmh.2007.76.417; Kent RJ, 2010, J AM MOSQUITO CONTR, V26, P332, DOI 10.2987/09-5953.1; Kent RJ, 2009, MOL ECOL RESOUR, V9, P4, DOI 10.1111/j.1755-0998.2008.02469.x; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Kilpatrick AM, 2005, EMERG INFECT DIS, V11, P425, DOI 10.3201/eid1103.040364; Kilpatrick MA, 2008, AM J TROP MED HYG, V83, P607; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; MCINTOSH BM, 1976, S AFR J SCI, V72, P295; Miller BR, 2000, AM J TROP MED HYG, V62, P240, DOI 10.4269/ajtmh.2000.62.240; Molaei G, 2009, MED VET ENTOMOL, V23, P350, DOI 10.1111/j.1365-2915.2009.00838.x; Munoz J, 2011, J MED ENTOMOL, V48, P956, DOI 10.1603/ME11016; Murdock CC, 2010, J MED ENTOMOL, V47, P226, DOI 10.1603/ME09137; Orshan L, 2008, J MED ENTOMOL, V45, P939, DOI 10.1603/0022-2585(2008)45[939:MVOWNF]2.0.CO;2; Ostlund EN, 2008, OIE TERR MAN, P377; Platt KB, 2007, EMERG INFECT DIS, V13, P831, DOI 10.3201/eid1306.061008; Pujol G, 2008, SENSITIVITY SENSITIV; Randolph SE, 2010, EUROSURVEILLANCE, V15, P24; Roiz D, 2012, J VECTOR ECOL, V37, P20, DOI 10.1111/j.1948-7134.2012.00196.x; Roiz D, 2012, AM J TROP MED HYG, V86, P642, DOI 10.4269/ajtmh.2012.11-0326; Ruiz MO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-19; Saltelli A, 2002, RISK ANAL, V22, P579, DOI 10.1111/0272-4332.00040; Saltelli A., 2008, GLOBAL SENSITIVITY A; Schaffner F., 2001, MOSQUITOES EUROPE ID; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; Simpson JE, 2012, P ROY SOC B-BIOL SCI, V279, P925, DOI 10.1098/rspb.2011.1282; TAYLOR RM, 1956, AM J TROP MED HYG, V5, P579, DOI 10.4269/ajtmh.1956.5.579; TEMPELIS CH, 1975, J MED ENTOMOL, V11, P635, DOI 10.1093/jmedent/11.6.635; Valerio L, 2010, VECTOR-BORNE ZOONOT, V10, P291, DOI 10.1089/vbz.2009.0007; Vazquez A, 2011, AM J TROP MED HYG, V85, P178, DOI 10.4269/ajtmh.2011.11-0042; Vazquez A, 2010, EMERG INFECT DIS, V16, P549, DOI 10.3201/eid1603.091033; Wheeler SS, 2009, CONDOR, V111, P1, DOI 10.1525/cond.2009.080013	61	77	80	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39549	10.1371/journal.pone.0039549	http://dx.doi.org/10.1371/journal.pone.0039549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745781	Green Published, gold			2022-12-27	WOS:000305730900074
J	Vaquero, MR; Yanez-Gascon, MJ; Villalba, RG; Larrosa, M; Fromentin, E; Ibarra, A; Roller, M; Tomas-Barberan, F; de Gea, JCE; Garcia-Conesa, MT				Romo Vaquero, Maria; Yanez-Gascon, Maria-Josefa; Garcia Villalba, Rocio; Larrosa, Mar; Fromentin, Emilie; Ibarra, Alvin; Roller, Marc; Tomas-Barberan, Francisco; Carlos Espin de Gea, Juan; Garcia-Conesa, Maria-Teresa			Inhibition of Gastric Lipase as a Mechanism for Body Weight and Plasma Lipids Reduction in Zucker Rats Fed a Rosemary Extract Rich in Carnosic Acid	PLOS ONE			English	Article							ROSMARINUS-OFFICINALIS L.; PANCREATIC LIPASE; OXIDATIVE STRESS; LIVER STEATOSIS; RISK-FACTORS; OBESITY; ABSORPTION; MICE; ANTIOXIDANT; ENZYMES	Background: Rosemary (Rosmarinus officinalis L.) extracts (REs) exhibit hepatoprotective, anti-obesity and anti-inflammatory properties and are widely used in the food industry. REs are rich in carnosic acid (CA) and carnosol which may be responsible for some of the biological activities of REs. The aim of this study was to investigate whether inhibition of lipase activity in the gut may be a mechanism by which a RE enriched in CA (40%) modulates body weight and lipids levels in a rat model of metabolic disorders and obesity. Methods and Principal Findings: RE was administered for 64 days to lean (fa/+) and obese (fa/fa) female Zucker rats and body weight, food intake, feces weight and blood biochemical parameters were monitored throughout the study. Lipase activity (hydrolysis of p-nitrophenylbutyrate) was measured in the gastrointestinal tract at the end of the study and the contents of CA, carnosol and methyl carnosate were also determined. Sub-chronic administration of RE moderately reduced body weight gain in both lean and obese animals but did not affect food intake. Serum triglycerides, cholesterol and insulin levels were also markedly decreased in the lean animals supplemented with RE. Importantly, lipase activity was significantly inhibited in the stomach of the RE-supplemented animals where the highest content of intact CA and carnosol was detected. Conclusions: Our results confirm that long-term administration of RE enriched in CA moderates weight gain and improves the plasma lipids profile, primarily in the lean animals. Our data also suggest that these effects may be caused, at least in part, by a significant inhibition of gastric lipase and subsequent reduction in fat absorption.	[Romo Vaquero, Maria; Yanez-Gascon, Maria-Josefa; Garcia Villalba, Rocio; Larrosa, Mar; Tomas-Barberan, Francisco; Carlos Espin de Gea, Juan; Garcia-Conesa, Maria-Teresa] CSIC, Ctr Edafol & Biol Aplicada Segura, Dept Food Sci & Technol, Res Grp Qual Safety & Bioact Plant Foods, Murcia, Spain; [Ibarra, Alvin] Naturex Inc, S Hackensack, NJ USA; [Fromentin, Emilie] Naturex SL, Valencia, Spain; [Roller, Marc] Naturex SA, Avignon, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS)	Vaquero, MR (corresponding author), CSIC, Ctr Edafol & Biol Aplicada Segura, Dept Food Sci & Technol, Res Grp Qual Safety & Bioact Plant Foods, Campus Espinardo, Murcia, Spain.	mtconesa@cebas.csic.es	Villalba, Rocio Garcia/G-7217-2015; Espín, Juan Carlos/G-6231-2011; LARROSA, MAR/H-6012-2012; Vaquero, María Romo/G-6883-2015; Tomás-Barberán, Francisco/D-6686-2011; García-Conesa, María-Teresa/N-4032-2014; Yáñez Gascón, María Josefa/H-5327-2015	Espín, Juan Carlos/0000-0002-1068-8692; LARROSA, MAR/0000-0002-8863-4686; Vaquero, María Romo/0000-0002-0084-6060; Tomás-Barberán, Francisco/0000-0002-0790-1739; García-Conesa, María-Teresa/0000-0002-4125-853X; Yáñez Gascón, María Josefa/0000-0001-8694-6072; Ibarra, Alvin/0000-0003-3952-8489; Garcia Villalba, Rocio/0000-0003-1883-1673	Spanish Centre for the Development of Industrial Technology (CDTI) [CEN-20091006]	Spanish Centre for the Development of Industrial Technology (CDTI)	This project was financed by the Spanish Centre for the Development of Industrial Technology (CDTI) as part of the project SENIFOOD, which belongs to the CENIT subvention program (Ref: CEN-20091006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar F., 2008, EFSA J, V721, P1, DOI DOI 10.2903/J.EFSA.2008.754; Aloulou A, 2008, CELL MOL LIFE SCI, V65, P851, DOI 10.1007/s00018-008-7546-z; Anadon A, 2008, J FOOD PROTECT, V71, P790, DOI 10.4315/0362-028X-71.4.790; Ansari JA, 2012, TOXICOL MECH METHOD, V22, P67, DOI 10.3109/15376516.2011.603391; Bailey D. T., 1999, US Patent, Patent No. [5,859,293, 5859293, 5.859.293]; Beltran-Debon R, 2011, PHYTOMEDICINE, V18, P414, DOI 10.1016/j.phymed.2010.11.008; Bermudez-Soto MJ, 2007, FOOD CHEM, V102, P865, DOI 10.1016/j.foodchem.2006.06.025; Caimari A, 2011, J NUTR BIOCH; Chaudhari HS, 2012, PLANTA MED, DOI 10.1055; Chuang CC, 2011, ANNU REV NUTR, V31, P155, DOI 10.1146/annurev-nutr-072610-145149; Cipriani S, 2010, J LIPID RES, V51, P771, DOI 10.1194/jlr.M001602; Debersac P, 2001, FOOD CHEM TOXICOL, V39, P907, DOI 10.1016/S0278-6915(01)00034-5; Debersac P, 2001, FOOD CHEM TOXICOL, V39, P109, DOI 10.1016/S0278-6915(00)00117-4; Doolaege EHA, 2011, PLANT FOOD HUM NUTR, V66, P196, DOI 10.1007/s11130-011-0233-5; Fakeye TO, 2008, PHYTOTHER RES, V22, P664, DOI 10.1002/ptr.2370; Faulds MH, 2012, J ENDOCRINOL, V212, P3, DOI 10.1530/JOE-11-0044; Fluttert M, 2000, LAB ANIM, V34, P372, DOI 10.1258/002367700780387714; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; GREENWOOD MRC, 1993, ANN NY ACAD SCI, V676, P253; Gu YY, 2011, J AGR FOOD CHEM, V59, P5305, DOI 10.1021/jf200180n; Hamad EM, 2009, BRIT J NUTR, V101, P716, DOI 10.1017/S0007114508043808; Hamden K, 2010, FOOD SCI BIOTECHNOL, V19, P439, DOI 10.1007/s10068-010-0062-6; Harach T, 2010, PLANTA MED, V76, P566, DOI 10.1055/s-0029-1240612; Ibarra A, 2011, BRIT J NUTR, V106, P1182, DOI 10.1017/S0007114511001620; Ikewuchi JC, 2011, J ETHNOPHARMACOL, V137, P1415, DOI 10.1016/j.jep.2011.08.015; Johnson JJ, 2010, CANCER PREV RES, V3, P1112, DOI 10.1158/1940-6207.CAPR-10-0168; Kinsey-Jones JS, 2011, ANN NY ACAD SCI, V1245, P3, DOI 10.1111/j.1749-6632.2011.06343.x; de la Garza AL, 2011, PLANTA MED, V77, P773, DOI 10.1055/s-0030-1270924; Lu H, 2003, DRUG METAB DISPOS, V31, P572, DOI 10.1124/dmd.31.5.572; Ludwig DS, 1999, JAMA-J AM MED ASSOC, V282, P1539, DOI 10.1001/jama.282.16.1539; Lupp A, 2008, ARZNEIMITTELFORSCH, V58, P225, DOI 10.1055/s-0031-1296499; Magkos F, 2010, NUTRITION, V26, P686, DOI 10.1016/j.nut.2009.10.013; Magkos F, 2009, OBSTET GYN CLIN N AM, V36, P245, DOI 10.1016/j.ogc.2009.03.001; Mark Manuel, 2007, Curr Protoc Mol Biol, VChapter 29, DOI 10.1002/0471142727.mb29b04s78; McConnell EL, 2008, J PHARM PHARMACOL, V60, P63, DOI 10.1211/jpp.60.1.0008; Mulinacci N, 2011, TALANTA, V85, P167, DOI 10.1016/j.talanta.2011.03.050; Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+; Ninomiya K, 2004, BIOORG MED CHEM LETT, V14, P1943, DOI 10.1016/j.bmcl.2004.01.091; Noh JR, 2011, J MED FOOD, V14, P209, DOI 10.1089/jmf.2010.1152; Nusier MK, 2007, EXP BIOL MED, V232, P809; Oana F, 2005, METABOLISM, V54, P995, DOI 10.1016/j.metabol.2005.02.016; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sanchez D, 2008, J AGR FOOD CHEM, V56, P3574, DOI 10.1021/jf703598j; Serrano A, 2008, NEUROPHARMACOLOGY, V54, P226, DOI 10.1016/j.neuropharm.2007.03.007; Soler-Rivas C, 2010, J AGR FOOD CHEM, V58, P1144, DOI 10.1021/jf902087q; Titta L, 2010, INT J OBESITY, V34, P578, DOI 10.1038/ijo.2009.266; Ueshima K, 2004, EUR J PHARMACOL, V501, P137, DOI 10.1016/j.ejphar.2004.08.014; Valdes-Ramos R, 2010, P NUTR SOC, V69, P644, DOI 10.1017/S0029665110002533; Vickers SP, 2011, BRIT J PHARMACOL, V164, P1248, DOI 10.1111/j.1476-5381.2011.01245.x; Wang T, 2011, HEPATOL RES, V41, P87, DOI 10.1111/j.1872-034X.2010.00747.x; Wang XW, 2011, J CLIN ENDOCR METAB, V96, P885, DOI 10.1210/jc.2010-2061; Yan Haixia, 2009, Zhongguo Zhong Yao Za Zhi, V34, P766; Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011	53	49	52	12	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39773	10.1371/journal.pone.0039773	http://dx.doi.org/10.1371/journal.pone.0039773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745826	Green Submitted, Green Published, gold			2022-12-27	WOS:000305730900112
J	Vellinger, C; Felten, V; Sornom, P; Rousselle, P; Beisel, JN; Usseglio-Polatera, P				Vellinger, Celine; Felten, Vincent; Sornom, Pascal; Rousselle, Philippe; Beisel, Jean-Nicolas; Usseglio-Polatera, Philippe			Behavioural and Physiological Responses of Gammarus pulex Exposed to Cadmium and Arsenate at Three Temperatures: Individual and Combined Effects	PLOS ONE			English	Article							RAINBOW-TROUT; OSMOREGULATORY CAPACITY; RESPIRATORY RESPONSES; COROPHIUM-VOLUTATOR; WATER-QUALITY; HEMOLYMPH NA+; TRACE-METALS; IN-SITU; TOXICITY; AMPHIPOD	This study aimed at investigating both the individual and combined effects of cadmium (Cd) and arsenate (AsV) on the physiology and behaviour of the Crustacean Gammarus pulex at three temperatures (5, 10 and 15 degrees C). G. pulex was exposed during 96 h to (i) two [Cd] alone, (ii) two [AsV] alone, and (iii) four combinations of [Cd] and [AsV] to obtain a complete factorial plane. After exposure, survival, [AsV] or [Cd] in body tissues, behavioural (ventilatory and locomotor activities) and physiological responses (iono-regulation of [Na+] and [Cl-2] in haemolymph) were examined. The interactive effects (antagonistic, additive or synergistic) of binary mixtures were evaluated for each tested temperature using a predictive model for the theoretically expected interactive effect of chemicals. In single metal exposure, both the internal metal concentration in body tissues and the mortality rate increased along metallic gradient concentration. Cd alone significantly impaired both [Na+] and [Cl-2] while AsV alone had a weak impact only on [Cl-2]. The behavioural responses of G. pulex declined with increasing metal concentration suggesting a reallocation of energy from behavioural responses to maintenance functions. The interaction between AsV and Cd was considered as 'additive' for all the tested binary mixtures and temperatures (except for the lowest combination at 10 degrees C considered as "antagonistic''). In binary mixtures, the decrease in both ventilatory and locomotor activities and the decline in haemolymphatic [Cl-2] were amplified when respectively compared to those observed with the same concentrations of AsV or Cd alone. However, the presence of AsV decreased the haemolymphatic [Na+] loss when G. pulex was exposed to the lowest Cd concentration. Finally, the observed physiological and behavioural effects (except ventilation) in G. pulex exposed to AsV and/or Cd were exacerbated under the highest temperature. The discussion encompasses both the toxicity mechanisms of these metals and their interaction with rising temperature.	[Vellinger, Celine; Felten, Vincent; Sornom, Pascal; Rousselle, Philippe; Beisel, Jean-Nicolas; Usseglio-Polatera, Philippe] Univ Lorraine, CNRS, UMR 7146, Lab Interact,Ecosyst LIEBE, Metz, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Vellinger, C (corresponding author), Univ Lorraine, CNRS, UMR 7146, Lab Interact,Ecosyst LIEBE, Metz, France.	celine.vellinger@umail.univ-metz.fr	Beisel, Jean-Nicolas/H-4392-2011	Beisel, Jean-Nicolas/0000-0002-1935-7689; FELTEN, Vincent/0000-0003-2601-7225; VELLINGER, Celine/0000-0002-5448-8705	French Ministry of Education and Research (Ministere de l'Enseignement Superieur et de la Recherche)	French Ministry of Education and Research (Ministere de l'Enseignement Superieur et de la Recherche)	This work has been supported by the French Ministry of Education and Research (Ministere de l'Enseignement Superieur et de la Recherche). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adam O, 2009, ECOTOX ENVIRON SAFE, V72, P441, DOI 10.1016/j.ecoenv.2008.07.017; Alonso A, 2010, ECOTOXICOLOGY, V19, P133, DOI 10.1007/s10646-009-0398-y; Andrew AS, 2003, ENVIRON HEALTH PERSP, V111, P825, DOI 10.1289/ehp.111-1241504; Bat L, 1998, J EXP MAR BIOL ECOL, V223, P167, DOI 10.1016/S0022-0981(97)00162-7; Bat Levent, 2000, Turkish Journal of Zoology, V24, P409; Bollache L, 2001, BEHAV ECOL SOCIOBIOL, V49, P296, DOI 10.1007/s002650000300; Brooks SJ, 2003, COMP BIOCHEM PHYS A, V135, P527, DOI 10.1016/S1095-6433(03)00111-9; BRYANT V, 1985, MAR ECOL PROG SER, V24, P129, DOI 10.3354/meps024129; CAIRNS J, 1975, HYDROBIOLOGIA, V47, P135, DOI 10.1007/BF00036747; Casini S, 1997, B ENVIRON CONTAM TOX, V59, P500, DOI 10.1007/s001289900506; Devin S, 2003, ARCH HYDROBIOL, V158, P43, DOI 10.1127/0003-9136/2003/0158-0043; Easterling DR, 2000, B AM METEOROL SOC, V81, P417, DOI 10.1175/1520-0477(2000)081<0417:OVATIE>2.3.CO;2; Fattorini D, 2004, ENVIRON TOXICOL CHEM, V23, P1881, DOI 10.1897/03-562; Felten V, 2008, AQUAT TOXICOL, V86, P413, DOI 10.1016/j.aquatox.2007.12.002; Felten V, 2008, COMP BIOCHEM PHYS C, V147, P189, DOI 10.1016/j.cbpc.2007.09.006; Felten V, 2004, DIS AQUAT ORGAN, V61, P113, DOI 10.3354/dao061113; Felten V, 2001, DIS AQUAT ORGAN, V45, P77, DOI 10.3354/dao045077; Fisher SW, 1999, ECOTOX ENVIRON SAFE, V43, P274, DOI 10.1006/eesa.1999.1789; Forrow DM, 2000, ENVIRON TOXICOL CHEM, V19, P2100, DOI 10.1002/etc.5620190820; Gebel T, 2000, TOXICOLOGY, V144, P155, DOI 10.1016/S0300-483X(99)00202-4; Ghosh D, 2007, AQUAT TOXICOL, V81, P79, DOI 10.1016/j.aquatox.2006.11.004; Gismondi E, 2012, ENVIRON POLLUT, V160, P17, DOI 10.1016/j.envpol.2011.09.021; GLYNN AW, 1994, AQUAT TOXICOL, V30, P13; Hadjispyrou S, 2001, ECOTOX ENVIRON SAFE, V49, P179, DOI 10.1006/eesa.2001.2059; HALL LW, 1995, CRIT REV TOXICOL, V25, P281, DOI 10.3109/10408449509021613; HENRY RP, 1992, AM ZOOL, V32, P407; Hervant F, 1997, COMP BIOCHEM PHYS A, V118, P1277, DOI 10.1016/S0300-9629(97)00047-9; Heugens EHW, 2001, CRIT REV TOXICOL, V31, P247, DOI 10.1080/20014091111695; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Isnard P, 2001, CHEMOSPHERE, V45, P659, DOI 10.1016/S0045-6535(00)00600-7; Issartel J, 2005, COMP BIOCHEM PHYS A, V141, P1, DOI 10.1016/j.cbpb.2005.02.013; Issartel J, 2010, CHEMOSPHERE, V81, P701, DOI 10.1016/j.chemosphere.2010.07.063; JOHNSON IT, 1990, OPHELIA, V31, P187, DOI 10.1080/00785326.1990.10430861; Kelly DW, 2002, HYDROBIOLOGIA, V485, P199, DOI 10.1023/A:1021370405349; KOOIJMAN SAL, 2009, ECOTOXICOLOGY MODELI, P2237; Kungolos A, 2009, SCI TOTAL ENVIRON, V407, P4610, DOI 10.1016/j.scitotenv.2009.04.038; Kungolos A, 1999, WATER SCI TECHNOL, V40, P357, DOI 10.1016/S0273-1223(99)00384-4; Kungolos A, 1997, WATER POLLUTION IV, P107; Kungolos A., 2004, WATER AIR SOIL POLL, V4, P101, DOI [10.1023/B:WAFO.0000044790.41200.04, DOI 10.1023/B:WAFO.0000044790.41200.04]; Kunz PY, 2010, REV ENVIRON CONTAM T, V205, P1, DOI 10.1007/978-1-4419-5623-1_1; Lannig G, 2006, MAR ENVIRON RES, V62, pS79, DOI 10.1016/j.marenvres.2006.04.010; Lannig G, 2008, AM J PHYSIOL-REG I, V294, pR1338, DOI 10.1152/ajpregu.00793.2007; Lawrence AJ, 1998, WATER RES, V32, P569, DOI 10.1016/S0043-1354(97)00306-0; Lignot JH, 2000, AQUACULTURE, V191, P209, DOI 10.1016/S0044-8486(00)00429-4; LUOMA SN, 1983, SCI TOTAL ENVIRON, V28, P1, DOI 10.1016/S0048-9697(83)80004-7; MacNeil C, 1997, BIOL REV, V72, P349, DOI 10.1017/S0006323196005038; Maltby L, 2002, ENVIRON TOXICOL CHEM, V21, P361, DOI 10.1897/1551-5028(2002)021<0361:EOTGPI>2.0.CO;2; Mantel L.H., 1983, P53; Markich SJ, 1998, SCI TOTAL ENVIRON, V217, P201, DOI 10.1016/S0048-9697(98)00188-0; Marking L.L., 1985, FUNDAMENTALS AQUATIC, P164; MCCAHON CP, 1990, ARCH ENVIRON CON TOX, V19, P926, DOI 10.1007/BF01055063; McGeer JC, 2000, AQUAT TOXICOL, V50, P231, DOI 10.1016/S0166-445X(99)00105-8; Mills CL, 2006, AQUAT TOXICOL, V77, P197, DOI 10.1016/j.aquatox.2005.12.003; PEQUEUX A, 1995, J CRUSTACEAN BIOL, V15, P1, DOI 10.2307/1549010; PHILLIPS DJH, 1976, MAR BIOL, V38, P59, DOI 10.1007/BF00391486; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; PRATAP HB, 1989, ARCH ENVIRON CON TOX, V18, P568, DOI 10.1007/BF01055024; Rainbow PS, 2007, ENVIRON INT, V33, P576, DOI 10.1016/j.envint.2006.05.007; REID SD, 1988, CAN J FISH AQUAT SCI, V45, P244, DOI 10.1139/f88-029; ROSAS C, 1992, COMP BIOCHEM PHYS A, V101, P323, DOI 10.1016/0300-9629(92)90540-7; Scott GR, 2004, AQUAT TOXICOL, V68, P369, DOI 10.1016/j.aquatox.2004.03.016; Shuhaimi-Othman M, 2007, ECOTOX ENVIRON SAFE, V66, P29, DOI 10.1016/j.ecoenv.2006.03.003; Silvestre F, 2005, COMP BIOCHEM PHYS C, V140, P29, DOI 10.1016/j.cca.2004.12.007; Smit CE, 1997, ECOTOX ENVIRON SAFE, V37, P213, DOI 10.1006/eesa.1997.1558; Sokolova IM, 2008, CLIM RES, V37, P181, DOI 10.3354/cr00764; SPEHAR RL, 1978, ENVIRON POLLUT, V15, P195, DOI 10.1016/0013-9327(78)90065-4; SUTCLIFFE DW, 1984, FRESHWATER BIOL, V14, P443, DOI 10.1111/j.1365-2427.1984.tb00168.x; Thomas DJ, 2001, TOXICOL APPL PHARM, V176, P127, DOI 10.1006/taap.2001.9258; Thomasson MA, 2003, MAR ECOL PROG SER, V250, P205, DOI 10.3354/meps250205; Tseng CH, 2004, TOXICOL APPL PHARM, V197, P67, DOI 10.1016/j.taap.2004.02.009; Vahter M, 2002, TOXICOLOGY, V181, P211, DOI 10.1016/S0300-483X(02)00285-8; Vellinger C, 2012, ECOTOXICOLO IN PRESS; Vellinger C, 2012, ENVIRON POLLUT, V160, P66, DOI 10.1016/j.envpol.2011.09.002; VERBOST PM, 1987, AM J PHYSIOL, V253, pR216, DOI 10.1152/ajpregu.1987.253.2.R216; Vindimian E, 1983, J Appl Biochem, V5, P261; Vindimian E, 1999, ENVIRON TOXICOL CHEM, V18, P2386, DOI 10.1002/etc.5620181037; Wallace WG, 2004, AQUAT TOXICOL, V69, P289, DOI 10.1016/j.aquatox.2004.05.010; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wijnhoven S, 2003, AQUAT ECOL, V37, P151, DOI 10.1023/A:1023982200529; Willmer P., 2000, ENV PHYSL ANIMALS; Worms I, 2006, BIOCHIMIE, V88, P1721, DOI 10.1016/j.biochi.2006.09.008; Wright D. A., 1994, Environmental Reviews, V2, P187; Zhang H, 2008, SCI TOTAL ENVIRON, V399, P113, DOI 10.1016/j.scitotenv.2008.03.036	85	20	20	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39153	10.1371/journal.pone.0039153	http://dx.doi.org/10.1371/journal.pone.0039153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761731	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900032
J	Tannenbaum, SE; Turetsky, TT; Singer, O; Aizenman, E; Kirshberg, S; Ilouz, N; Gil, Y; Berman-Zaken, Y; Perlman, TS; Geva, N; Levy, O; Arbell, D; Simon, A; Ben-Meir, A; Shufaro, Y; Laufer, N; Reubinoff, BE				Tannenbaum, Shelly E.; Turetsky, Tikva Tako; Singer, Orna; Aizenman, Einat; Kirshberg, Sophie; Ilouz, Nili; Gil, Yaniv; Berman-Zaken, Yael; Perlman, Temima Schnitzer; Geva, Nitshia; Levy, Ora; Arbell, Daniel; Simon, Alex; Ben-Meir, Assaf; Shufaro, Yoel; Laufer, Neri; Reubinoff, Benjamin E.			Derivation of Xeno-Free and GMP-Grade Human Embryonic Stem Cells - Platforms for Future Clinical Applications	PLOS ONE			English	Article							TERM SELF-RENEWAL; HUMAN BLASTOCYSTS; CROSS-CONTAMINATION; NEURAL PRECURSORS; HUMAN FEEDERS; LINES; CULTURE; DIFFERENTIATION; QUALITY; PROPAGATION	Clinically compliant human embryonic stem cells (hESCs) should be developed in adherence to ethical standards, without risk of contamination by adventitious agents. Here we developed for the first time animal-component free and good manufacturing practice (GMP)-compliant hESCs. After vendor and raw material qualification, we derived xeno-free, GMP-grade feeders from umbilical cord tissue, and utilized them within a novel, xeno-free hESC culture system. We derived and characterized three hESC lines in adherence to regulations for embryo procurement, and good tissue, manufacturing and laboratory practices. To minimize freezing and thawing, we continuously expanded the lines from initial outgrowths and samples were cryopreserved as early stocks and banks. Batch release criteria included DNA-fingerprinting and HLA-typing for identity, characterization of pluripotency-associated marker expression, proliferation, karyotyping and differentiation in-vitro and in-vivo. These hESCs may be valuable for regenerative therapy. The ethical, scientific and regulatory methodology presented here may serve for development of additional clinical-grade hESCs.	[Tannenbaum, Shelly E.; Turetsky, Tikva Tako; Singer, Orna; Kirshberg, Sophie; Ilouz, Nili; Gil, Yaniv; Berman-Zaken, Yael; Perlman, Temima Schnitzer; Shufaro, Yoel; Reubinoff, Benjamin E.] Hadassah Hebrew Univ, Med Ctr, Hadassah Human Embryon Stem Cell Res Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Aizenman, Einat; Geva, Nitshia; Levy, Ora; Simon, Alex; Ben-Meir, Assaf; Shufaro, Yoel; Laufer, Neri; Reubinoff, Benjamin E.] Hadassah Hebrew Univ, Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel; [Arbell, Daniel] Hadassah Hebrew Univ, Med Ctr, Dept Pediat Surg, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Tannenbaum, SE (corresponding author), Hadassah Hebrew Univ, Med Ctr, Hadassah Human Embryon Stem Cell Res Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	benjaminr@ekmd.huji.ac.il	; Shufaro, Yoel/N-6227-2019	Reubinoff, Benjamin/0000-0003-0353-1299; Shufaro, Yoel/0000-0003-2759-5588	Israeli Genesis Consortium for Cell Therapy; Legacy Heritage Fund Ltd.	Israeli Genesis Consortium for Cell Therapy; Legacy Heritage Fund Ltd.	This work was supported by a gift from Sidney and Judy Swartz, by the Israeli Genesis Consortium for Cell Therapy, and by the Legacy Heritage Fund Ltd. The funding agencies had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Amit M, 2002, J ANAT, V200, P225, DOI 10.1046/j.1469-7580.2002.00032.x; Amps KJ, 2010, CRYOBIOLOGY, V60, P344, DOI 10.1016/j.cryobiol.2010.03.007; [Anonymous], 2004, OFFICIAL GAZETTE; [Anonymous], 2006, OFFICIAL J EURO 0208; [Anonymous], 2006, ANC MAT CELL GEN TIS; [Anonymous], 1985, INSP COMPL ENF CRIM; [Anonymous], 1987, ISRAELI OFFICIA 0611, V5035; Carpenter MK, 2009, NAT BIOTECHNOL, V27, P606, DOI 10.1038/nbt0709-606; CLAUSSEN U, 1984, HUM GENET, V67, P23, DOI 10.1007/BF00270553; Coecke S, 2005, ATLA-ALTERN LAB ANIM, V33, P261, DOI 10.1177/026119290503300313; Cortes JL, 2008, STEM CELLS DEV, V17, P255, DOI 10.1089/scd.2007.0157; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Crook JM, 2007, CELL STEM CELL, V1, P490, DOI 10.1016/j.stem.2007.10.004; Crook JM, 2010, IN VITRO CELL DEV-AN, V46, P169, DOI 10.1007/s11626-010-9301-7; Ellerstrom C, 2007, STEM CELLS, V25, P1690, DOI 10.1634/stemcells.2006-0607; Ellerstrom C, 2006, STEM CELLS, V24, P2170, DOI 10.1634/stemcells.2006-0130; Fink DW, 2009, SCIENCE, V324, P1662, DOI 10.1126/science.1173712; Fong CY, 2006, METH MOL B, V331, P129; Fu X, 2011, TISSUE ENG PART C-ME, V17, P927, DOI [10.1089/ten.tec.2010.0735, 10.1089/ten.TEC.2010.0735]; GILBERT DA, 1990, AM J HUM GENET, V47, P499; Hewitt ZA, 2007, CLIN PHARMACOL THER, V82, P448, DOI 10.1038/sj.clpt.6100321; Hovatta O, 2006, REPROD FERT DEVELOP, V18, P823, DOI 10.1071/RD06075; Ilic D, 2012, CYTOTHERAPY, V14, P122, DOI 10.3109/14653249.2011.623692; International Conference on Harmonization, 1997, Q5D DER CHAR CELL SU; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Klimanskaya I, 2005, LANCET, V365, P1636, DOI 10.1016/S0140-6736(05)66473-2; Liu WQ, 2009, J GENET GENOMICS, V36, P229, DOI 10.1016/S1673-8527(08)60110-1; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Markovic O, 1998, IN VITRO CELL DEV-AN, V34, P1; Murdoch A, 2011, STEM CELL REV; Nasonkin IO, 2006, EXP NEUROL, V201, P525, DOI 10.1016/j.expneurol.2006.05.002; NELSONREES WA, 1981, SCIENCE, V212, P446, DOI 10.1126/science.6451928; Rajala K, 2007, HUM REPROD, V22, P1231, DOI 10.1093/humrep/del523; Reubinoff BE, 2001, HUM REPROD, V16, P2187, DOI 10.1093/humrep/16.10.2187; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Revel Michel, 2003, Med Law, V22, P701; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Simon C, 2005, FERTIL STERIL, V83, P246, DOI 10.1016/j.fertnstert.2004.09.004; Sjogren-Jansson E, 2005, DEV DYNAM, V233, P1304, DOI 10.1002/dvdy.20459; Stacey G, 2003, ENCY CELL TECHNOLOGY; Stacey GN, 2000, NATURE, V403, P356, DOI 10.1038/35000394; Steiner D, 2010, NAT BIOTECHNOL, V28, P361, DOI 10.1038/nbt.1616; Stephenson E, 2010, J R SOC INTERFACE, V7, pS677, DOI 10.1098/rsif.2010.0343.focus; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Strom S, 2010, IN VITRO CELL DEV-AN, V46, P337, DOI 10.1007/s11626-010-9308-0; Thomson A, 2008, CLONING STEM CELLS, V10, P89, DOI 10.1089/clo.2007.0072; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Turetsky T, 2008, HUM REPROD, V23, P46, DOI 10.1093/humrep/dem351; US Food and Drug Administration, 2004, GUID IND STER DRUG P; Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631; Weber DJ, 2006, METHOD ENZYMOL, V420, P410, DOI 10.1016/S0076-6879(06)20020-X; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; 2004, FED REG, V69, P29785; 2001, HUM GENE THER, V12, P303	56	68	75	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e35325	10.1371/journal.pone.0035325	http://dx.doi.org/10.1371/journal.pone.0035325			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745653	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693200001
J	Wilkinson, KA; Kloefkorn, HE; Hochman, S				Wilkinson, Katherine A.; Kloefkorn, Heidi E.; Hochman, Shawn			Characterization of Muscle Spindle Afferents in the Adult Mouse Using an In Vitro Muscle-Nerve Preparation	PLOS ONE			English	Article							GOLGI TENDON ORGANS; RAT SOLEUS MUSCLE; RAMP-AND-HOLD; MAMMALIAN MUSCLE; SECONDARY ENDINGS; DYNAMIC-RESPONSE; SKELETAL-MUSCLE; PHYSIOLOGICAL-PROPERTIES; CONTRACTILE PROPERTIES; ECCENTRIC CONTRACTION	We utilized an in vitro adult mouse extensor digitorum longus (EDL) nerve-attached preparation to characterize the responses of muscle spindle afferents to ramp-and-hold stretch and sinusoidal vibratory stimuli. Responses were measured at both room (24 degrees C) and muscle body temperature (34 degrees C). Muscle spindle afferent static firing frequencies increased linearly in response to increasing stretch lengths to accurately encode the magnitude of muscle stretch (tested at 2.5%, 5% and 7.5% of resting length [Lo]). Peak firing frequency increased with ramp speeds (20% Lo/sec, 40% Lo/sec, and 60% Lo/sec). As a population, muscle spindle afferents could entrain 1: 1 to sinusoidal vibrations throughout the frequency (10-100 Hz) and amplitude ranges tested (5-100 mu m). Most units preferentially entrained to vibration frequencies close to their baseline steady-state firing frequencies. Cooling the muscle to 24 degrees C decreased baseline firing frequency and units correspondingly entrained to slower frequency vibrations. The ramp component of stretch generated dynamic firing responses. These responses and related measures of dynamic sensitivity were not able to categorize units as primary (group Ia) or secondary (group II) even when tested with more extreme length changes (10% Lo). We conclude that the population of spindle afferents combines to encode stretch in a smoothly graded manner over the physiological range of lengths and speeds tested. Overall, spindle afferent response properties were comparable to those seen in other species, supporting subsequent use of the mouse genetic model system for studies on spindle function and dysfunction in an isolated muscle-nerve preparation.	[Wilkinson, Katherine A.; Hochman, Shawn] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA; [Kloefkorn, Heidi E.] Georgia Inst Technol, Atlanta, GA 30332 USA	Emory University; University System of Georgia; Georgia Institute of Technology	Wilkinson, KA (corresponding author), Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA.	katherine.a.wilkinson@gmail.com	Hochman, Shawn/ABG-3875-2020	Wilkinson, Katherine A./0000-0002-2692-5533	Pfizer [WS753098]; United States National Institutes of Health [K12 GM000680]; Pfizer; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000680] Funding Source: NIH RePORTER	Pfizer(Pfizer); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from Pfizer (WS753098; http://www.pfizer.com/home/) to S. Hochman and an individual fellowship from the United States National Institutes of Health (K12 GM000680; http://www.nigms.nih.gov/Training/CareerDev/TWDInstRes.htm) to K. Wilkinson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from Pfizer and S. Hochman served as paid consultant in an RLS advisory board meeting that was organized by Pfizer Inc. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ANGEL A, 1980, ELECTROEN CLIN NEURO, V49, P373, DOI 10.1016/0013-4694(80)90233-3; Banks RW, 2009, J ANAT, V214, P859, DOI 10.1111/j.1469-7580.2009.01072.x; Barclay CJ, 2005, J MUSCLE RES CELL M, V26, P225, DOI 10.1007/s10974-005-9013-x; BEAM KG, 1983, J GEN PHYSIOL, V81, P485, DOI 10.1085/jgp.81.4.485; BELL KR, 1987, ARCH PHYS MED REHAB, V68, P490; BIANCONI R, 1963, J NEUROPHYSIOL, V26, P177, DOI 10.1152/jn.1963.26.1.177; Boada MD, 2008, J NEUROSCI, V28, P2006, DOI 10.1523/JNEUROSCI.5609-07.2008; Boada MD, 2007, J NEUROPHYSIOL, V98, P668, DOI 10.1152/jn.00264.2007; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Bullinger KL, 2011, J NEUROPHYSIOL, V106, P704, DOI 10.1152/jn.00083.2011; CLOSE R, 1965, NATURE, V206, P718, DOI 10.1038/206718a0; CODY FWJ, 1972, J PHYSIOL-LONDON, V226, P249, DOI 10.1113/jphysiol.1972.sp009983; De-Doncker L, 2003, J NEUROPHYSIOL, V89, P442, DOI 10.1152/jn.00153.2002; DUCHEN LW, 1973, J PHYSIOL-LONDON, V228, P157, DOI 10.1113/jphysiol.1973.sp010078; EDIN BB, 1990, J NEUROPHYSIOL, V63, P1297, DOI 10.1152/jn.1990.63.6.1297; EDIN BB, 1991, ACTA PHYSIOL SCAND, V143, P169, DOI 10.1111/j.1748-1716.1991.tb09218.x; Fallon JB, 2007, MUSCLE NERVE, V36, P21, DOI 10.1002/mus.20796; Fang X, 2005, J PHYSIOL-LONDON, V565, P927, DOI 10.1113/jphysiol.2005.086199; Fischer M, 2005, BRAIN RES, V1043, P163, DOI 10.1016/j.brainres.2005.02.059; Fischer M, 1999, BRAIN RES, V840, P1, DOI 10.1016/S0006-8993(99)01607-8; GANGULY DK, 1978, BRIT J PHARMACOL, V64, P47, DOI 10.1111/j.1476-5381.1978.tb08639.x; GRANIT R, 1966, J PHYSIOL-LONDON, V182, P484, DOI 10.1113/jphysiol.1966.sp007833; Haftel VK, 2004, J NEUROPHYSIOL, V91, P2164, DOI 10.1152/jn.01147.2003; HAGBARTH KE, 1967, ACTA SOC MED UPS, V72, P102; HARVEY RJ, 1961, J PHYSIOL-LONDON, V157, P370, DOI 10.1113/jphysiol.1961.sp006729; HOUK J, 1967, J NEUROPHYSIOL, V30, P466, DOI 10.1152/jn.1967.30.3.466; HOUK JC, 1971, J NEUROPHYSIOL, V34, P1051, DOI 10.1152/jn.1971.34.6.1051; HUNT CC, 1977, J NEUROPHYSIOL, V40, P1113, DOI 10.1152/jn.1977.40.5.1113; HUNT CC, 1975, J PHYSIOL-LONDON, V252, P259, DOI 10.1113/jphysiol.1975.sp011143; HUNT CC, 1954, J GEN PHYSIOL, V38, P117, DOI 10.1085/jgp.38.1.117; HUNT CC, 1951, J PHYSIOL-LONDON, V113, P298, DOI 10.1113/jphysiol.1951.sp004573; JANSEN JKS, 1962, J PHYSIOL-LONDON, V161, P357, DOI 10.1113/jphysiol.1962.sp006892; JOHNSON MI, 1986, AM J ANAT, V175, P413, DOI 10.1002/aja.1001750403; Kakuda N, 1998, J PHYSIOL-LONDON, V513, P621, DOI 10.1111/j.1469-7793.1998.621bb.x; Kim GH, 2007, J PHYSIOL-LONDON, V582, P525, DOI 10.1113/jphysiol.2007.130120; Kindig AE, 2006, AM J PHYSIOL-HEART C, V290, pH1214, DOI 10.1152/ajpheart.01051.2005; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; LARSSON L, 1986, J NEUROL SCI, V76, P69, DOI 10.1016/0022-510X(86)90143-7; LEONARD JP, 1979, J CELL BIOL, V82, P811, DOI 10.1083/jcb.82.3.811; LIPPOLD OCJ, 1960, J PHYSIOL-LONDON, V153, P218, DOI 10.1113/jphysiol.1960.sp006530; Lund JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011131; Matthews BHC, 1933, J PHYSIOL-LONDON, V78, P1; MATTHEWS PB, 1963, J PHYSIOL-LONDON, V168, P660, DOI 10.1113/jphysiol.1963.sp007214; MATTHEWS PB, 1964, PHYSIOL REV, V44, P219, DOI 10.1152/physrev.1964.44.2.219; Matthews PB, 1981, MUSCLE SPINDLES THEI, P189; MATTHEWS PBC, 1981, J PHYSIOL-LONDON, V317, P365, DOI 10.1113/jphysiol.1981.sp013830; MCCULLY KK, 1985, J APPL PHYSIOL, V59, P119, DOI 10.1152/jappl.1985.59.1.119; Mense S, 2008, DTSCH ARZTEBL INT, V105, P214, DOI 10.3238/artzebl.2008.0214; MICHALSKI WJ, 1975, J PHYSIOL-LONDON, V253, P341, DOI 10.1113/jphysiol.1975.sp011193; Miwa T, 1995, NEUROSCI LETT, V201, P179, DOI 10.1016/0304-3940(95)12165-X; Muller KA, 2008, DIABETES, V57, P1693, DOI 10.2337/db08-0022; Nakanishi ST, 2012, J NEUROPHYSIOL, V107, P500, DOI 10.1152/jn.00699.2011; OTTOSON D, 1965, J PHYSIOL-LONDON, V180, P636, DOI 10.1113/jphysiol.1965.sp007721; Peloquin JB, 2008, NEUROSCIENCE, V151, P1066, DOI 10.1016/j.neuroscience.2007.11.053; Pickar JG, 2001, J MANIP PHYSIOL THER, V24, P2, DOI 10.1067/mmt.2001.112017; Prochazka, 1981, MUSCLE RECEPTORS MOV, P17, DOI 10.1007/978-1-349-06022-1_3; RACK PMH, 1966, J PHYSIOL-LONDON, V186, P698, DOI 10.1113/jphysiol.1966.sp008063; Ribot-Ciscar E, 2000, J PHYSIOL-LONDON, V523, P271, DOI 10.1111/j.1469-7793.2000.t01-1-00271.x; RICHMOND FJR, 1979, J NEUROPHYSIOL, V42, P604, DOI 10.1152/jn.1979.42.2.604; Rodriguez BM, 1998, J GEN PHYSIOL, V112, P223, DOI 10.1085/jgp.112.2.223; Rosant C, 2007, EXP GERONTOL, V42, P301, DOI 10.1016/j.exger.2006.10.007; Ruffini A, 1898, J Physiol, V23, P190; Simon A, 2010, J PHYSIOL-LONDON, V588, P171, DOI 10.1113/jphysiol.2009.182683; SZUMSKI AJ, 1974, ELECTROEN CLIN NEURO, V37, P589, DOI 10.1016/0013-4694(74)90072-8; Taguchi T, 2005, J NEUROPHYSIOL, V94, P2822, DOI 10.1152/jn.00470.2005; TAYLOR A, 1992, J PHYSIOL-LONDON, V456, P609, DOI 10.1113/jphysiol.1992.sp019356; van Deursen RWM, 1998, EXP BRAIN RES, V120, P1, DOI 10.1007/s002210050371; WARREN GL, 1994, J APPL PHYSIOL, V77, P1421, DOI 10.1152/jappl.1994.77.3.1421; Wenk HN, 2007, J NEUROSCI METH, V159, P244, DOI 10.1016/j.jneumeth.2006.07.021; Winarakwong L, 2004, ARCH HISTOL CYTOL, V67, P227, DOI 10.1679/aohc.67.227	70	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39140	10.1371/journal.pone.0039140	http://dx.doi.org/10.1371/journal.pone.0039140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745708	Green Published, gold			2022-12-27	WOS:000305693200043
J	Altafini, C				Altafini, Claudio			Dynamics of Opinion Forming in Structurally Balanced Social Networks	PLOS ONE			English	Article							MONOTONICITY; LANDSCAPE; ATTITUDES; SYSTEMS	A structurally balanced social network is a social community that splits into two antagonistic factions (typical example being a two-party political system). The process of opinion forming on such a community is most often highly predictable, with polarized opinions reflecting the bipartition of the network. The aim of this paper is to suggest a class of dynamical systems, called monotone systems, as natural models for the dynamics of opinion forming on structurally balanced social networks. The high predictability of the outcome of a decision process is explained in terms of the order-preserving character of the solutions of this class of dynamical systems. If we represent a social network as a signed graph in which individuals are the nodes and the signs of the edges represent friendly or hostile relationships, then the property of structural balance corresponds to the social community being splittable into two antagonistic factions, each containing only friends.	SISSA, Int Sch Adv Studies, I-34014 Trieste, Italy	International School for Advanced Studies (SISSA)	Altafini, C (corresponding author), SISSA, Int Sch Adv Studies, I-34014 Trieste, Italy.	altafini@sissa.it	Altafini, Claudio/AAL-4235-2020	Altafini, Claudio/0000-0003-4142-6502	Ministero Istruzione, Universita' e Ricerca	Ministero Istruzione, Universita' e Ricerca(Ministry of Education, Universities and Research (MIUR))	Research supported by a Progetti di Ricerca di Interesse Nazionale grant from Ministero Istruzione, Universita' e Ricerca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, P 18 INT C WORLD WID, DOI DOI 10.1145/1526709.1526809; [Anonymous], 2010, P 2010 SIAM INT C DA; Antal T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036121; ARONSON E, 1968, J PERS SOC PSYCHOL, V8, P8, DOI 10.1037/h0021234; AXELROD R, 1993, BRIT J POLIT SCI, V23, P211, DOI 10.1017/S000712340000973X; AXELROD R, 1995, MANAGE SCI, V41, P1493, DOI 10.1287/mnsc.41.9.1493; BINDER K, 1986, REV MOD PHYS, V58, P801, DOI 10.1103/RevModPhys.58.801; Bosson JK, 2006, PERS RELATIONSHIP, V13, P135, DOI 10.1111/j.1475-6811.2006.00109.x; CARTWRIGHT D, 1956, PSYCHOL REV, V63, P277, DOI 10.1037/h0046049; DasGupta B, 2007, BIOSYSTEMS, V90, P161, DOI 10.1016/j.biosystems.2006.08.001; Easley D, 2010, NETWORKS CROWDS MARK; Facchetti G, 2011, P NATL ACAD SCI USA, V108, P20953, DOI 10.1073/pnas.1109521108; FRADKIN E, 1978, PHYS REV B, V18, P4789, DOI 10.1103/PhysRevB.18.4789; Galam S, 1996, PHYSICA A, V230, P174, DOI 10.1016/0378-4371(96)00034-9; Hage P., 1984, STRUCTURAL MODELS AN; Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5; Heider F, 1946, J PSYCHOL, V21, P107, DOI 10.1080/00223980.1946.9917275; Iacono G, 2010, IET SYST BIOL, V4, P223, DOI 10.1049/iet-syb.2009.0040; Iacono G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-83; Kulakowski K, 2005, INT J MOD PHYS C, V16, P707, DOI 10.1142/S012918310500742X; Leskovec J., 2010, ACM SIGCHI C HUM FAC; Ma'ayan A, 2008, IET SYST BIOL, V2, P103, DOI 10.1049/iet-syb:20070036; Marvel SA, 2011, P NATL ACAD SCI USA, V108, P1771, DOI 10.1073/pnas.1013213108; Marvel SA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.198701; MATTIS DC, 1976, PHYS LETT A, V56, P421, DOI 10.1016/0375-9601(76)90396-0; Mirtabatabaei A, 2011, AM CONTR C 2011 ACC; Newcomb T, 1969, SOCIAL PSYCHOL STUDY; Riker W.R., 1962, THEORY POLITICAL COA; Smith H. L., 1995, MATH SURVEYS MONOGRA, V41; SMITH HL, 1988, SIAM REV, V30, P87, DOI 10.1137/1030003; Sontag Eduardo D, 2007, Syst Synth Biol, V1, P59, DOI 10.1007/s11693-007-9005-9; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; Ware Alan, 2009, DYNAMICS 2 PARTY POL, DOI [10.1093/acprof:oso/9780199564439.001.0001, DOI 10.1093/ACPROF:OSO/9780199564439.001.0001]; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; ZASLAVSKY T, 1982, DISCRETE APPL MATH, V4, P47, DOI 10.1016/0166-218X(82)90033-6	35	153	154	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38135	10.1371/journal.pone.0038135	http://dx.doi.org/10.1371/journal.pone.0038135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	963VI	22761667	Green Published, gold			2022-12-27	WOS:000305652700012
J	Cao, D; Jiao, XD; Liu, X; Hennis, A; Leske, MC; Nemesure, B; Hejtmancik, JF				Cao, Dan; Jiao, Xiaodong; Liu, Xing; Hennis, Anselm; Leske, M. Cristina; Nemesure, Barbara; Hejtmancik, J. Fielding			CDKN2B Polymorphism Is Associated with Primary Open-Glaucoma (POAG) in the Afro-Caribbean Population of Barbados, West Indies	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; GENOME-WIDE ASSOCIATION; TO-DISC RATIO; COMMON VARIANTS; RISK-FACTORS; OPTIC DISC; SUSCEPTIBILITY LOCI; GENE POLYMORPHISMS; AFRICAN DESCENT; EYE	The purpose of this study was to confirm previously reported associations of common variants in or near CDC7/TGFBR3, ZP4, SRBD1, ELOVL5, CAV1/CAV2, TLR4, CDKN2B, CDKN2B-AS1, ATOH7, PLXDC2, TMTC2, SIX1, and CARD10, with primary open angle glaucoma (POAG) in the Afro-Caribbean population of Barbados, West Indies. A total of 437 unrelated subjects from the Barbados Family Study of Open Angle Glaucoma (BFSG), including 272 with POAG and 165 unaffected individuals were included in this study. Eighteen SNPs were genotyped by using the multiplex SNaPshot method. Allelic, genotypic and model-based (dominant, recessive, and additive) associations of the SNPs with POAG were analyzed using Chi-squared tests and logistic regression. SNP rs1063192 (near CDKN2B) was found to be significantly associated with POAG (allelic P = 0.0008, genotypic P = 0.0029), and the minor allele C of rs1063192 was protective against POAG (OR = 0.39; 95% CI = 0.22-0.69). Suggestive association was also noted for rs7916697 (near ATHO7, allelic P = 0.0096, genotypic P = 0.01) with the minor allele being protective (OR = 0.67; 95% CI = 0.50-0.91), although this finding did not withstand correction for multiple testing. However, a significant interactive effect on POAG risk was identified between rs1063192 and rs7916697 (P-interaction = 2.80x10(-5)). Individuals with the rs1063192 protective genotype CC or CT and also rs7916697 genotypes GG or GA show a significantly decreased risk of POAG (OR = 0.17, 95% CI: 0.07-0.41). Our study confirms the significant association between SNP rs1063192 (CDKN2B, previously shown to influence vertical cup-to-disc ratio and POAG at 9p21) and POAG in the Afro-Caribbean population of Barbados. The minor allele of rs1063192 interacts with that of rs7916697 (ATOH7)) to reduce POAG risk. Our results also suggest that rs1063912 is a common protective variant for POAG in populations of African as well as European descent.	[Cao, Dan; Jiao, Xiaodong; Hejtmancik, J. Fielding] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Cao, Dan; Liu, Xing] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Hennis, Anselm] Univ W Indies, Bridgetown, Barbados; [Hennis, Anselm] Minist Hlth, Bridgetown, Barbados; [Leske, M. Cristina; Nemesure, Barbara] Stony Brook Med, Dept Prevent Med, Stony Brook, NY USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Sun Yat Sen University; University West Indies Mona Jamaica; University of the West Indies Open Campus; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital	Cao, D (corresponding author), NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA.	f3h@helix.nih.gov			National Eye Institute (NEI); NATIONAL EYE INSTITUTE [ZIAEY000272] Funding Source: NIH RePORTER	National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	There are no current external funding sources for this study other than the intramural program of the National Eye Institute (NEI).	Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Charlesworth J, 2010, INVEST OPHTH VIS SCI, V51, P3509, DOI 10.1167/iovs.09-4786; CHYLACK LT, 1989, ARCH OPHTHALMOL-CHIC, V107, P991, DOI 10.1001/archopht.1989.01070020053028; Fan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1788, DOI 10.1167/iovs.10-6339; Ghiasvand NM, 2011, NAT NEUROSCI, V14, P578, DOI 10.1038/nn.2798; Girkin CA, 2010, ARCH OPHTHALMOL-CHIC, V128, P541, DOI 10.1001/archophthalmol.2010.49; Gottfredsdottir MS, 1999, J GLAUCOMA, V8, P134; He MG, 2008, INVEST OPHTH VIS SCI, V49, P1350, DOI 10.1167/iovs.07-1146; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Jiao XD, 2009, P NATL ACAD SCI USA, V106, P17105, DOI 10.1073/pnas.0907564106; Khor CC, 2011, HUM MOL GENET, V20, P1864, DOI 10.1093/hmg/ddr060; Kuehn MH, 2011, MOL VIS, V17, P430; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; LESKE MC, 1994, ARCH OPHTHALMOL-CHIC, V112, P821, DOI 10.1001/archopht.1994.01090180121046; Leske MC, 2001, OPHTHALMOLOGY, V108, P1015, DOI 10.1016/S0161-6420(01)00566-8; Mabuchi F, 2011, INVEST OPHTH VIS SCI, V52, P4626, DOI 10.1167/iovs.11-7382; Macgregor S, 2010, HUM MOL GENET, V19, P2716, DOI 10.1093/hmg/ddq144; MASON RP, 1989, OPHTHALMOLOGY, V96, P1363; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Nakano M, 2009, P NATL ACAD SCI USA, V106, P12838, DOI 10.1073/pnas.0906397106; Nemesure B, 2003, HUM GENET, V112, P600, DOI 10.1007/s00439-003-0910-z; Nemesure B, 2001, AM J MED GENET, V103, P36, DOI 10.1002/ajmg.1498; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Racette L, 2010, ARCH OPHTHALMOL-CHIC, V128, P551, DOI 10.1001/archophthalmol.2010.58; Ramdas WD, 2011, HUM MOL GENET, V20, P2464, DOI 10.1093/hmg/ddr120; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Rao KN, 2009, P NATL ACAD SCI USA, V106, pE125, DOI 10.1073/pnas.0910416106; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Sanfilippo PG, 2010, SURV OPHTHALMOL, V55, P561, DOI 10.1016/j.survophthal.2010.07.003; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shibuya E, 2008, INVEST OPHTH VIS SCI, V49, P4453, DOI 10.1167/iovs.07-1575; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; Wiggs JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P30, DOI 10.1001/archopht.125.1.30; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Wiggs JL, 2011, HUM MOL GENET, V20, P4707, DOI 10.1093/hmg/ddr382; Wiggs JL, 2010, ARCH OPHTHALMOL-CHIC, V128, P934, DOI 10.1001/archophthalmol.2010.108; Wolfs RCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1640, DOI 10.1001/archopht.116.12.1640	41	77	81	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39278	10.1371/journal.pone.0039278	http://dx.doi.org/10.1371/journal.pone.0039278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761751	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800028
J	Kurita, M; Nishino, S; Kato, M; Numata, Y; Sato, T				Kurita, Masatake; Nishino, Satoshi; Kato, Maiko; Numata, Yukio; Sato, Tadahiro			Plasma Brain-Derived Neurotrophic Factor Levels Predict the Clinical Outcome of Depression Treatment in a Naturalistic Study	PLOS ONE			English	Article							BDNF LEVELS; MAJOR DEPRESSION; SERUM; ANTIDEPRESSANTS; MONTGOMERY; DISORDER; WOMEN	Remission is the primary goal of treatment for major depressive disorder (MDD). However, some patients do not respond to treatment. The main purpose of this study was to determine whether brain-derived neurotrophic factor (BDNF) levels are correlated with treatment outcomes. In a naturalistic study, we assessed whether plasma BDNF levels were correlated with clinical outcomes by measuring plasma BDNF in patients with depressive syndrome (MADRS score >= 18), and subsequently comparing levels between the subgroup of patients who underwent remission (MADRS score <= 8) and the subgroup who were refractory to treatment (non-responders). Patients with depressive syndrome who underwent remission had significantly higher plasma BDNF levels (p < 0.001), regardless of age or sex. We also found a significant negative correlation between MADRS scores and plasma BDNF levels within this group (rho = -0.287, p = 0.003). In contrast, non-responders had significantly lower plasma BDNF levels (p = 0.029). Interestingly, plasma BDNF levels in the non-responder group were significantly higher than those in the remission group in the initial stage of depressive syndrome (p = 0.002). Our results show that plasma BDNF levels are associated with clinical outcomes during the treatment of depression. We suggest that plasma BDNF could potentially serve as a prognostic biomarker for depression, predicting clinical outcome.	[Kurita, Masatake; Nishino, Satoshi; Kato, Maiko; Numata, Yukio; Sato, Tadahiro] Sato Hosp, Yamagata, Japan; [Kurita, Masatake; Nishino, Satoshi] Tohoku Univ, Dept Cellular Signaling, Grad Sch Pharmaceut Sci, Sendai, Miyagi 980, Japan	Tohoku University	Kurita, M (corresponding author), Sato Hosp, Yamagata, Japan.	kurita@koutoku.or.jp			Koutokukai Organisation	Koutokukai Organisation	This study was supported by funding from Koutokukai Organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study did not receive funding from pharmaceutical corporations.	Angelucci F, 2009, CEREBELLUM, V8, P499, DOI 10.1007/s12311-009-0129-1; Aydemir C, 2006, PROG NEURO-PSYCHOPH, V30, P1256, DOI 10.1016/j.pnpbp.2006.03.025; Aydemir O, 2005, PROG NEURO-PSYCHOPH, V29, P261, DOI 10.1016/j.pnpbp.2004.11.009; Berlim MT, 2008, ANN MED, V40, P149, DOI 10.1080/07853890701769728; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Dreimuller N, 2011, NEUROPHARMACOLOGY; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Elfving B, 2010, INT J NEUROPSYCHOPH, V13, P563, DOI 10.1017/S1461145709990721; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Gonul AS, 2005, EUR ARCH PSY CLIN N, V255, P381, DOI 10.1007/s00406-005-0578-6; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Karege F, 2005, BIOL PSYCHIAT, V57, P1068, DOI 10.1016/j.biopsych.2005.01.008; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Klein AB, 2011, INT J NEUROPSYCHOPH, V14, P347, DOI 10.1017/S1461145710000738; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; Laske C, 2010, INT J NEUROPSYCHOPH, V13, P595, DOI 10.1017/S1461145709991234; Lee BH, 2007, J AFFECT DISORDERS, V101, P239, DOI 10.1016/j.jad.2006.11.005; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; MacQueen GM, 2009, J PSYCHIATR NEUROSCI, V34, P343; MAIER W, 1988, J PSYCHIAT RES, V22, P3, DOI 10.1016/0022-3956(88)90022-2; Matrisciano F, 2008, J PSYCHIATR RES, V43, P247, DOI 10.1016/j.jpsychires.2008.03.014; Mittmann N, 1997, AM J PSYCHIAT, V154, P1320; Molendijk ML, 2011, MOL PSYCHIATR, V16, P1088, DOI 10.1038/mp.2010.98; MONTGOMERY SA, 1985, ACTA PSYCHIAT SCAND, V72, P38, DOI 10.1111/j.1600-0447.1985.tb08073.x; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; PEYRE F, 1989, ANN MED-PSYCHOL, V147, P762; Piccinni A, 2008, J AFFECT DISORDERS, V105, P279, DOI 10.1016/j.jad.2007.05.005; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1	30	51	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39212	10.1371/journal.pone.0039212	http://dx.doi.org/10.1371/journal.pone.0039212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761741	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800023
J	Verhagen, JH; Munster, VJ; Majoor, F; Lexmond, P; Vuong, O; Stumpel, JBG; Rimmelzwaan, GF; Osterhaus, ADME; Schutten, M; Slaterus, R; Fouchier, RAM				Verhagen, Josanne H.; Munster, Vincent J.; Majoor, Frank; Lexmond, Pascal; Oanh Vuong; Stumpel, Job B. G.; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Schutten, Martin; Slaterus, Roy; Fouchier, Ron A. M.			Avian Influenza A Virus in Wild Birds in Highly Urbanized Areas	PLOS ONE			English	Article							DUCKS; HEMAGGLUTININ; SURVEILLANCE	Avian influenza virus (AIV) surveillance studies in wild birds are usually conducted in rural areas and nature reserves. Less is known of avian influenza virus prevalence in wild birds located in densely populated urban areas, while these birds are more likely to be in close contact with humans. Influenza virus prevalence was investigated in 6059 wild birds sampled in cities in the Netherlands between 2006 and 2009, and compared with parallel AIV surveillance data from low urbanized areas in the Netherlands. Viral prevalence varied with the level of urbanization, with highest prevalence in low urbanized areas. Within cities virus was detected in 0.5% of birds, while seroprevalence exceeded 50%. Ring recoveries of urban wild birds sampled for virus detection demonstrated that most birds were sighted within the same city, while few were sighted in other cities or migrated up to 2659 km away from the sample location in the Netherlands. Here we show that urban birds were infected with AIVs and that urban birds were not separated completely from populations of long-distance migrants. The latter suggests that wild birds in cities may play a role in the introduction of AIVs into cities. Thus, urban bird populations should not be excluded as a human-animal interface for influenza viruses.	[Verhagen, Josanne H.; Lexmond, Pascal; Oanh Vuong; Stumpel, Job B. G.; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Schutten, Martin; Fouchier, Ron A. M.] Erasmus MC, Natl Influenza Ctr, Rotterdam, Netherlands; [Verhagen, Josanne H.; Lexmond, Pascal; Oanh Vuong; Stumpel, Job B. G.; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Schutten, Martin; Fouchier, Ron A. M.] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Munster, Vincent J.] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT USA; [Majoor, Frank; Slaterus, Roy] Sovon Dutch Ctr Field Ornithol, Nijmegen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Verhagen, JH (corresponding author), Erasmus MC, Natl Influenza Ctr, Rotterdam, Netherlands.	r.fouchier@erasmusmc.nl	Fouchier, Ron A/A-1911-2014; Munster, Vincent/I-7607-2018	Fouchier, Ron A/0000-0001-8095-2869; Munster, Vincent/0000-0002-2288-3196; Verhagen, Josanne/0000-0003-3133-5228; Osterhaus, Albert/0000-0002-6074-1172	Dutch Ministry of Agriculture; EU DG; EU [044490]; NIAID NIH [HHSN266200700010C]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001179, ZIAAI001168] Funding Source: NIH RePORTER	Dutch Ministry of Agriculture; EU DG(European Commission); EU(European Commission); NIAID NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was sponsored by grants from the Dutch Ministry of Agriculture, the EU DG Sanco monitoring program, EU Framework six program NewFluBird (044490), and contract NIAID NIH HHSN266200700010C. VJM is currently supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], STAT WORLD POP 2007; BECKER WB, 1966, J HYG-CAMB, V64, P309, DOI 10.1017/S0022172400040596; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gronesova P, 2009, ACTA VIROL, V53, P213, DOI 10.4149/av_2009_03_213; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Munster VJ, 2009, VACCINE, V27, P6340, DOI 10.1016/j.vaccine.2009.02.082; Munster VJ, 2009, J CLIN MICROBIOL, V47, P666, DOI 10.1128/JCM.01625-08; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; SLEMONS RD, 1974, AVIAN DIS, V18, P119, DOI 10.2307/1589250; Smietanka K, 2008, B VET I PULAWY, V52, P491; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; WEBSTER RG, 1976, J GEN VIROL, V32, P217, DOI 10.1099/0022-1317-32-2-217; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	16	19	21	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e38256	10.1371/journal.pone.0038256	http://dx.doi.org/10.1371/journal.pone.0038256			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761671	Green Submitted, gold, Green Published			2022-12-27	WOS:000305825800010
J	Allinson, KR; Lee, HS; Fruttiger, M; McCarty, J; Arthur, HM				Allinson, Kathleen R.; Lee, Hye Shin; Fruttiger, Marcus; McCarty, Joseph; Arthur, Helen M.			Endothelial Expression of TGF beta Type II Receptor Is Required to Maintain Vascular Integrity during Postnatal Development of the Central Nervous System	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GROWTH-FACTOR-BETA; HEREDITARY HEMORRHAGIC TELANGIECTASIA; YOLK-SAC VASCULATURE; ALPHA-V INTEGRINS; ALPHA-V-BETA-8-MEDIATED ACTIVATION; CARDIAC DEVELOPMENT; ANGIOGENESIS; MICE; CELLS	TGF beta signalling in endothelial cells is important for angiogenesis in early embryonic development, but little is known about its role in early postnatal life. To address this we used a tamoxifen inducible Cre-LoxP strategy in neonatal mice to deplete the TypeII TGF beta receptor (Tgfbr2) specifically in endothelial cells. This resulted in multiple micro-haemorrhages, and glomeruloid-like vascular tufts throughout the cerebral cortices and hypothalamus of the brain as well as in retinal tissues. A detailed examination of the retinal defects in these mutants revealed that endothelial adherens and tight junctions were in place, pericytes were recruited and there was no failure of vascular smooth muscle differentiation. However, the deeper retinal plexus failed to form in these mutants and the angiogenic sprouts stalled in their progress towards the inner nuclear layer. Instead the leading endothelial cells formed glomerular tufts with associated smooth muscle cells. This evidence suggests that TGF beta signalling is not required for vessel maturation, but is essential for the organised migration of endothelial cells as they begin to enter the deeper layers of the retina. Thus, TGF beta signalling is essential in vascular endothelial cells for maintaining vascular integrity at the angiogenic front as it migrates into developing neural tissues in early postnatal life.	[Allinson, Kathleen R.; Arthur, Helen M.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Lee, Hye Shin; McCarty, Joseph] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Fruttiger, Marcus] UCL, UCL Inst Ophthalmol, London, England	Newcastle University - UK; University of Texas System; UTMD Anderson Cancer Center; University of London; University College London	Allinson, KR (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	helen.arthur@ncl.ac.uk	Arthur, Helen/C-7808-2009	Fruttiger, Marcus/0000-0002-6962-5485; Arthur, Helen/0000-0001-6522-1363	BHF senior research fellowship; National Institutes of Neurological Disease and Stroke [R01NS059876]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059876] Funding Source: NIH RePORTER; British Heart Foundation [FS/08/001/23666] Funding Source: researchfish	BHF senior research fellowship; National Institutes of Neurological Disease and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); British Heart Foundation(British Heart Foundation)	This work was supported by a BHF senior research fellowship to HMA and the National Institutes of Neurological Disease and Stroke (R01NS059876) to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Anderson KD, 2011, P NATL ACAD SCI USA, V108, P2807, DOI 10.1073/pnas.1019761108; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Arnold TD, 2012, J NEUROSCI, V32, P1197, DOI 10.1523/JNEUROSCI.5648-11.2012; Arthur HM, 2011, BIRTH DEFECTS RES A, V91, P423, DOI 10.1002/bdra.20794; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Cambier S, 2005, AM J PATHOL, V166, P1883, DOI 10.1016/S0002-9440(10)62497-2; Carvalho RLC, 2007, J CELL SCI, V120, P4269, DOI 10.1242/jcs.013169; Carvalho RLC, 2004, DEVELOPMENT, V131, P6237, DOI 10.1242/dev.01529; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Hirota S, 2011, DEVELOPMENT, V138, P5157, DOI 10.1242/dev.069153; Hirschi KK, 2003, CIRC RES, V93, P429, DOI 10.1161/01.RES.0000091259.84556.D5; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jiao K, 2006, DEVELOPMENT, V133, P4585, DOI 10.1242/dev.02597; Kim H, 2011, ACTA NEUROCHIR SUPPL, V111, P83, DOI 10.1007/978-3-7091-0693-8_14; Lebrin F, 2010, NAT MED, V16, P420, DOI 10.1038/nm.2131; Leveen P, 2002, BLOOD, V100, P560, DOI 10.1182/blood.V100.2.560; Li FF, 2011, DEV CELL, V20, P291, DOI 10.1016/j.devcel.2011.01.011; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Mahmoud M, 2011, BIOCHEM SOC T, V39, P1659, DOI 10.1042/BST20110664; Mahmoud M, 2010, CIRC RES, V106, P1425, DOI 10.1161/CIRCRESAHA.109.211037; McCarty JH, 2005, DEVELOPMENT, V132, P165, DOI 10.1242/dev.01551; Mobley AK, 2009, J CELL SCI, V122, P1842, DOI 10.1242/jcs.043257; Mu ZY, 2008, MECH DEVELOP, V125, P508, DOI 10.1016/j.mod.2008.01.003; Nguyen HL, 2011, LAB INVEST, V91, P1554, DOI 10.1038/labinvest.2011.124; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Park SO, 2008, BLOOD, V111, P633, DOI 10.1182/blood-2007-08-107359; Park SO, 2009, J CLIN INVEST, V119, P3487, DOI 10.1172/JCI39482; Proctor JM, 2005, J NEUROSCI, V25, P9940, DOI 10.1523/JNEUROSCI.3467-05.2005; Robson A, 2010, DEV DYNAM, V239, P2435, DOI 10.1002/dvdy.22376; Roland EH, 2003, NEUROL CLIN, V21, P833, DOI 10.1016/S0733-8619(03)00067-7; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sridurongrit S, 2008, DEV BIOL, V322, P208, DOI 10.1016/j.ydbio.2008.07.038; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Zhu JW, 2002, DEVELOPMENT, V129, P2891	46	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39336	10.1371/journal.pone.0039336	http://dx.doi.org/10.1371/journal.pone.0039336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22745736	Green Submitted, gold, Green Published			2022-12-27	WOS:000305808700023
J	Jarmoszewicz, K; Lukasiak, K; Riezman, H; Kaminska, J				Jarmoszewicz, Katarzyna; Lukasiak, Katarzyna; Riezman, Howard; Kaminska, Joanna			Rsp5 Ubiquitin Ligase Is Required for Protein Trafficking in Saccharomyces cerevisiae COPI Mutants	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; ACTIN CYTOSKELETON; MEMBRANE-PROTEINS; DEUBIQUITINATING ENZYME; MULTIVESICULAR BODIES; FUNCTIONAL DISSECTION; GENE ENCODES; IN-VIVO; YEAST; GOLGI	Retrograde trafficking from the Golgi to the endoplasmic reticulum (ER) depends on the formation of vesicles coated with the multiprotein complex COPI. In Saccharomyces cerevisiae ubiquitinated derivatives of several COPI subunits have been identified. The importance of this modification of COPI proteins is unknown. With the exception of the Sec27 protein (beta'COP) neither the ubiquitin ligase responsible for ubiquitination of COPI subunits nor the importance of this modification are known. Here we find that the ubiquitin ligase mutation, rsp5-1, has a negative effect that is additive with ret1-1 and sec28D mutations, in genes encoding alpha- and epsilon-COP, respectively. The double ret1-1 rsp5-1 mutant is also more severely defective in the Golgi-to-ER trafficking compared to the single ret1-1, secreting more of the ER chaperone Kar2p, localizing Rer1p mostly to the vacuole, and increasing sensitivity to neomycin. Overexpression of ubiquitin in ret1-1 rsp5-1 mutant suppresses vacuolar accumulation of Rer1p. We found that the effect of rsp5 mutation on the Golgi-to-ER trafficking is similar to that of sla1 Delta mutation in a gene encoding actin cytoskeleton proteins, an Rsp5p substrate. Additionally, Rsp5 and Sla1 proteins were found by co-immunoprecipitation in a complex containing COPI subunits. Together, our results show that Rsp5 ligase plays a role in regulating retrograde Golgi-to-ER trafficking.	[Jarmoszewicz, Katarzyna; Lukasiak, Katarzyna; Kaminska, Joanna] Polish Acad Sci, Inst Biochem & Biophys, Dept Genet, Warsaw, Poland; [Riezman, Howard] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Geneva	Jarmoszewicz, K (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Dept Genet, Warsaw, Poland.	kaminska@ibb.waw.pl	Kamińska, Joanna/D-1063-2011	Kamińska, Joanna/0000-0002-0168-7882; Riezman, Howard/0000-0003-4680-9422	Ministry of Science and Higher Education of Poland [N303 101 32/3456]; Swiss National Science Foundation	Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Ministry of Science and Higher Education of Poland grant N303 101 32/3456 (J.K., K.J. and K. L.) and by the Swiss National Science Foundation (H. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; Belden WJ, 2001, MOL BIOL CELL, V12, P957, DOI 10.1091/mbc.12.4.957; Bon E, 2000, YEAST, V16, P1229, DOI 10.1002/1097-0061(20000930)16:13<1229::AID-YEA618>3.0.CO;2-Q; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Cohen M, 2003, J BIOL CHEM, V278, P51989, DOI 10.1074/jbc.C300451200; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; DULIC V, 1989, EMBO J, V8, P1349, DOI 10.1002/j.1460-2075.1989.tb03515.x; Eugster A, 2004, MOL BIOL CELL, V15, P1011, DOI 10.1091/mbc.E03-10-0724; Gabriely G, 2007, MOL CELL BIOL, V27, P526, DOI 10.1128/MCB.00577-06; Gajewska B, 2001, GENETICS, V157, P91; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Hitchcock AL, 2003, P NATL ACAD SCI USA, V100, P12735, DOI 10.1073/pnas.2135500100; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hudson RT, 1997, MOL BIOL CELL, V8, P1901, DOI 10.1091/mbc.8.10.1901; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kaliszewski P, 2006, BIOCHEM J, V395, P173, DOI 10.1042/BJ20051726; Kaminska J, 2002, MOL CELL BIOL, V22, P6946, DOI 10.1128/MCB.22.20.6946-6958.2002; Kaminska J, 2011, EUR J CELL BIOL, V90, P1016, DOI 10.1016/j.ejcb.2011.08.002; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Kraft C, 2008, AUTOPHAGY, V4, P838, DOI 10.4161/auto.6603; Krsmanovic T, 2004, FEBS LETT, V577, P215, DOI 10.1016/j.febslet.2004.10.006; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu JY, 2008, MOL CELL PROTEOMICS, V7, P35, DOI 10.1074/mcp.M700353-MCP200; Morvan J, 2004, TRAFFIC, V5, P383, DOI 10.1111/j.1398-9219.2004.00183.x; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Ossareh-Nazari B, 2010, EXP CELL RES, V316, P3351, DOI 10.1016/j.yexcr.2010.09.005; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Pashkova N, 2010, MOL CELL, V40, P433, DOI 10.1016/j.molcel.2010.10.018; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Robinson M, 2006, MOL BIOL CELL, V17, P1845, DOI 10.1091/mbc.E05-09-0832; Sato K, 1997, P NATL ACAD SCI USA, V94, P9693, DOI 10.1073/pnas.94.18.9693; Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Springael JY, 1999, J CELL SCI, V112, P1375; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Sutterlin C, 1997, J CELL SCI, V110, P2703; TOWNSLEY FM, 1994, J CELL BIOL, V127, P21, DOI 10.1083/jcb.127.1.21; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Zoladek T, 1997, GENETICS, V145, P595	54	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39582	10.1371/journal.pone.0039582	http://dx.doi.org/10.1371/journal.pone.0039582			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761830	Green Published, gold			2022-12-27	WOS:000305808700036
J	Vopel, T; Makhatadze, GI				Voepel, Tobias; Makhatadze, George I.			Enzyme Activity in the Crowded Milieu	PLOS ONE			English	Article							ESCHERICHIA-COLI; PHOSPHOGLYCERATE KINASE; PROTEIN STABILITY; SELF-ASSOCIATION; YEAST; ACTIVATION; EFFICIENCY; MEDIA	The cytosol of a cell is a concentrated milieu of a variety of different molecules, including small molecules (salts and metabolites) and macromolecules such as nucleic acids, polysaccharides, proteins and large macromolecular complexes. Macromolecular crowding in the cytosolic environment is proposed to influence various properties of proteins, including substrate binding affinity and enzymatic activity. Here we chose to use the synthetic crowding agent Ficoll, which is commonly used to mimic cytosolic crowding conditions to study the crowding effect on the catalytic properties of glycolytic enzymes, namely phosphoglycerate kinase, glyceraldehyde 3-phosphate dehydrogenase, and acylphosphatase. We determined the kinetic parameters of these enzymes in the absence and in the presence of the crowding agent. We found that the Michaelis constant, K-m, and the catalytic turnover number, k(cat), of these enzymes are not perturbed by the presence of the crowding agent Ficoll. Our results support earlier findings which suggested that the Michaelis constant of certain enzymes evolved in consonance with the substrate concentration in the cell to allow effective enzyme function in bidirectional pathways. This conclusion is further supported by the analysis of nine other enzymes for which the K-m values in the presence and absence of crowding agents have been measured.	[Voepel, Tobias] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Vopel, T (corresponding author), Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA.	makhag@rpi.edu	Vöpel, Tobias/M-7242-2014	Vöpel, Tobias/0000-0003-0844-2375	National Science Foundation [MCB-0818419]; Direct For Biological Sciences [0818419] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the National Science Foundation (MCB-0818419) (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bookchin RM, 1999, J BIOL CHEM, V274, P6689, DOI 10.1074/jbc.274.10.6689; BUCHER T, 1955, METHOD ENZYMOL, V1, P415, DOI 10.1016/0076-6879(55)01068-9; CAMICI G, 1976, EXPERIENTIA, V32, P535, DOI 10.1007/BF01920843; CORNISHBOWDEN A, 1976, J MOL BIOL, V101, P1, DOI 10.1016/0022-2836(76)90062-0; Dhar A, 2010, P NATL ACAD SCI USA, V107, P17586, DOI 10.1073/pnas.1006760107; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.11; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gribenko AV, 2007, J MOL BIOL, V366, P842, DOI 10.1016/j.jmb.2006.11.061; Hurth C, 2007, BIOSENS BIOELECTRON, V22, P2449, DOI 10.1016/j.bios.2006.09.007; Jiang M, 2007, J AM CHEM SOC, V129, P730, DOI 10.1021/ja065064+; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; LAURENT TC, 1971, EUR J BIOCHEM, V21, P498, DOI 10.1111/j.1432-1033.1971.tb01495.x; LIGURI G, 1986, BIOCHEMISTRY-US, V25, P8089, DOI 10.1021/bi00372a044; MAS MT, 1988, BIOCHEMISTRY-US, V27, P1168, DOI 10.1021/bi00404a015; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Miklos AC, 2011, J AM CHEM SOC, V133, P7116, DOI 10.1021/ja200067p; MINTON AP, 1981, BIOCHEMISTRY-US, V20, P4821, DOI 10.1021/bi00520a003; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Moran-Zorzano MT, 2007, FEBS LETT, V581, P1035, DOI 10.1016/j.febslet.2007.02.004; Norris MGS, 2011, BIOCHEM BIOPH RES CO, V405, P388, DOI 10.1016/j.bbrc.2011.01.037; Olsen SN, 2006, THERMOCHIM ACTA, V448, P12, DOI 10.1016/j.tca.2006.06.019; Phillip Y, 2009, BIOPHYS J, V97, P875, DOI 10.1016/j.bpj.2009.05.026; Pozdnyakova I, 2010, BBA-PROTEINS PROTEOM, V1804, P740, DOI 10.1016/j.bbapap.2009.11.013; Rivas G, 2001, P NATL ACAD SCI USA, V98, P3150, DOI 10.1073/pnas.051634398; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Stagg L, 2007, P NATL ACAD SCI USA, V104, P18976, DOI 10.1073/pnas.0705127104; STEADMAN BL, 1989, BIOCHEMISTRY-US, V28, P9653, DOI 10.1021/bi00451a017; Strickler SS, 2006, BIOCHEMISTRY-US, V45, P2761, DOI 10.1021/bi0600143; Weber J, 2005, MICROBIOL-SGM, V151, P707, DOI 10.1099/mic.0.27482-0; WILF J, 1981, BIOCHIM BIOPHYS ACTA, V670, P316, DOI 10.1016/0005-2795(81)90103-3; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V; ZIMMERMAN SB, 1988, NUCLEIC ACIDS RES, V16, P6309, DOI 10.1093/nar/16.14.6309; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	35	46	46	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39418	10.1371/journal.pone.0039418	http://dx.doi.org/10.1371/journal.pone.0039418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761790	Green Submitted, gold, Green Published			2022-12-27	WOS:000305808700026
J	Yin, JY; Huang, Q; Zhao, YC; Zhou, HH; Liu, ZQ				Yin, Ji-Ye; Huang, Qiong; Zhao, Ying-Chun; Zhou, Hong-Hao; Liu, Zhao-Qian			Meta-Analysis on Pharmacogenetics of Platinum-Based Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Patients	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; CISPLATIN-INDUCED CYTOTOXICITY; GENOME-WIDE ASSOCIATION; DNA-REPAIR; GENETIC POLYMORPHISMS; MULTIDRUG-RESISTANCE; SUSCEPTIBILITY LOCUS; ERCC1; SURVIVAL; XPD	Aim: To determine the pharmacogenetics of platinum-based chemotherapy in Non Small Cell Lung Cancer (NSCLC) patients. Methods: Publications were selected from PubMed, Cochrane Library and ISI Web of Knowledge. A meta-analysis was conducted to determine the association between genetic polymorphisms and platinum-based chemotherapy by checking odds ratio (OR) and 95% confidence interval (CI). Results: Data were extracted from 24 publications, which included 11 polymorphisms in 8 genes for meta-analysis. MDR1 C3435T (OR = 1.97, 95% CI: 1.11-3.50, P = 0.02), G2677A/T (OR = 2.61, 95% CI: 1.44-4.74, P = 0.002) and GSTP1 A313G (OR = 0.32, 95% CI: 0.17-0.58, P = 0.0002) were significantly correlated with platinum-based chemotherapy in Asian NSCLC patients. Conclusion: Attention should be paid to MDR1 C3435T, G2677A/T and GSTP1 A313G for personalized chemotherapy treatment for NSCLC patients in Asian population in the future.	[Yin, Ji-Ye; Zhou, Hong-Hao; Liu, Zhao-Qian] Cent S Univ, Inst Clin Pharmacol, Hunan Key Lab Pharmacogenet, Changsha, Hunan, Peoples R China; [Huang, Qiong] Anhui Med Univ, Inst Clin Pharmacol, Key Lab Antiinflammatory & Immunopharmacol Educ M, Hefei, Anhui, Peoples R China; [Zhao, Ying-Chun] Creighton Univ, Osteoporosis Res Ctr, Omaha, NE 68178 USA	Central South University; Anhui Medical University; Creighton University	Yin, JY (corresponding author), Cent S Univ, Inst Clin Pharmacol, Hunan Key Lab Pharmacogenet, Changsha, Hunan, Peoples R China.	liuzhaoqian63@126.com	Zhao, Yingchun/F-3683-2012; Yin, Ji-Ye/AAE-6794-2020; Huang, Qiong/HGC-7895-2022	Zhao, Yingchun/0000-0001-7216-9727; Huang, Qiong/0000-0002-0570-5961; Yin, Ji-Ye/0000-0002-1244-5045; Liu, Zhaoqian/0000-0003-0428-3928	National Natural Science Foundation of China [81173129]; National High-Tech R&D Program of China (863Program) [2009AA022703]; Specialized Research Fund for the Doctoral Program of Higher Education [20113420120006]; BSKY from Anhui Medical University [XJ201021]; Ministry of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech R&D Program of China (863Program)(National High Technology Research and Development Program of China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); BSKY from Anhui Medical University; Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China (81173129) (Z.Q.L.), National High-Tech R&D Program of China (863Program) (2009AA022703) (Z.Q.L. and J.Y.Y.), Specialized Research Fund for the Doctoral Program of Higher Education (20113420120006) (Q. H.) and Grants for Scientific Research of BSKY (XJ201021) from Anhui Medical University (Q.H.). J.Y.Y. was supported in part by Scholarship Award for Excellent Doctoral Student granted by the Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Booten R, 2006, J THORAC ONCOL, V1, P679, DOI 10.1097/01243894-200609000-00013; Booton R, 2006, CANCER-AM CANCER SOC, V106, P2421, DOI 10.1002/cncr.21885; Camps Carlos, 2003, Clin Lung Cancer, V4, P237, DOI 10.3816/CLC.2003.n.004; Chen SJ, 2010, INT J HYG ENVIR HEAL, V213, P140, DOI 10.1016/j.ijheh.2010.01.004; Chen XX, 2012, CLIN TRANSL ONCOL, V14, P207, DOI 10.1007/s12094-012-0785-3; Cheng HY, 2010, ACTA BIOCH BIOPH SIN, V42, P311, DOI 10.1093/abbs/gmq023; Cheng J, 2012, J CANCER RES CLIN, V138, P231, DOI 10.1007/s00432-011-1090-1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Dolan ME, 2004, CANCER RES, V64, P4353, DOI 10.1158/0008-5472.CAN-04-0340; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feng JF, 2009, LUNG CANCER, V66, P344, DOI 10.1016/j.lungcan.2009.02.015; Feng JF, 2009, ACTA BIOCH BIOPH SIN, V41, P429, DOI 10.1093/abbs/gmp027; Garcia-Campelo R, 2005, EXPERT OPIN PHARMACO, V6, P2015, DOI 10.1517/14656566.6.12.2015; Gautschi O, 2006, LUNG CANCER, V51, P303, DOI 10.1016/j.lungcan.2005.10.025; Giachino DF, 2007, CLIN CANCER RES, V13, P2876, DOI 10.1158/1078-0432.CCR-06-2543; Hall MD, 2008, ANNU REV PHARMACOL, V48, P495, DOI 10.1146/annurev.pharmtox.48.080907.180426; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hildebrandt MAT, 2009, EXPERT OPIN DRUG MET, V5, P745, DOI 10.1517/17425250902973711; Huang QO, 2010, EUR J CLIN PHARMACOL, V66, P1207, DOI 10.1007/s00228-010-0882-6; Huang RS, 2008, MOL CANCER THER, V7, P3038, DOI 10.1158/1535-7163.MCT-08-0248; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Ishida S, 2002, P NATL ACAD SCI USA, V99, P14298, DOI 10.1073/pnas.162491399; Isla D, 2004, ANN ONCOL, V15, P1194, DOI 10.1093/annonc/mdh319; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kalikaki A, 2009, CLIN LUNG CANCER, V10, P118, DOI 10.3816/CLC.2009.n.015; Katano K, 2002, CANCER RES, V62, P6559; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kweekel DM, 2005, CANCER TREAT REV, V31, P90, DOI 10.1016/j.ctrv.2004.12.006; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Li F, 2010, AM J CLIN ONCOL-CANC, V33, P489, DOI 10.1097/COC.0b013e3181b9cedc; Li WY, 2012, LUNG, V190, P91, DOI 10.1007/s00408-011-9338-8; Li YF, 2011, CLIN CANCER RES, V17, P3830, DOI 10.1158/1078-0432.CCR-10-2877; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; MANTEL N, 1959, J NATL CANCER I, V22, P719; Pan JH, 2008, RESPIRATION, V75, P380, DOI 10.1159/000108407; Pan JH, 2009, RESPIRATION, V78, P49, DOI 10.1159/000158454; Park DJ, 2001, CANCER RES, V61, P8654; Ryu JS, 2004, LUNG CANCER, V44, P311, DOI 10.1016/j.lungcan.2003.11.019; Safaei R, 2004, J INORG BIOCHEM, V98, P1607, DOI 10.1016/j.jinorgbio.2004.05.006; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shiraishi K, 2010, J CLIN ONCOL, V28, P4945, DOI 10.1200/JCO.2010.30.5334; Shukla SJ, 2008, PHARMACOGENET GENOM, V18, P253, DOI 10.1097/FPC.0b013e3282f5e605; Stewart DJ, 2007, CRIT REV ONCOL HEMAT, V63, P12, DOI 10.1016/j.critrevonc.2007.02.001; Su D, 2007, LUNG CANCER, V56, P281, DOI 10.1016/j.lungcan.2006.12.002; Sun N, 2010, CANCER CHEMOTH PHARM, V65, P437, DOI 10.1007/s00280-009-1046-1; Sun XC, 2009, LUNG CANCER, V65, P230, DOI 10.1016/j.lungcan.2008.11.014; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tan XL, 2011, CLIN CANCER RES, V17, P5801, DOI 10.1158/1078-0432.CCR-11-1133; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tibaldi C, 2008, CLIN CANCER RES, V14, P1797, DOI 10.1158/1078-0432.CCR-07-1364; Vinolas N, 2011, LUNG CANCER, V71, P191, DOI 10.1016/j.lungcan.2010.05.005; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Watson MA, 1998, CARCINOGENESIS, V19, P275, DOI 10.1093/carcin/19.2.275; Wei HB, 2011, ARCH MED RES, V42, P412, DOI 10.1016/j.arcmed.2011.07.008; Wei SZ, 2010, MED ONCOL; Woodahl EL, 2004, CURR DRUG METAB, V5, P11, DOI 10.2174/1389200043489108; Wu XF, 2011, J NATL CANCER I, V103, P817, DOI 10.1093/jnci/djr075; Yao CY, 2009, ASIAN PAC J CANCER P, V10, P859; Yin JY, 2011, CLIN EXP PHARMACOL P, V38, P632, DOI 10.1111/j.1440-1681.2011.05571.x; Yin JY, 2009, PHARMACOGENET GENOM, V19, P206, DOI 10.1097/FPC.0b013e328323f680; Yin Jiye, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P927, DOI 10.3969/j.issn.1672-7347.2011.10.002; Yu D, 2012, TUMOUR BIOL; Yu DK, 2008, CLIN CANCER RES, V14, P2878, DOI 10.1158/1078-0432.CCR-07-1612; Yu JJ, 2000, INT J ONCOL, V16, P555; Yu M, 2010, CLIN PHARMACOL THER, V87, P330, DOI 10.1038/clpt.2009.242; Zhou CC, 2010, JPN J CLIN ONCOL, V40, P954, DOI 10.1093/jjco/hyq071; Zhou F, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13275	72	41	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e38150	10.1371/journal.pone.0038150	http://dx.doi.org/10.1371/journal.pone.0038150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761669	Green Submitted, Green Published, gold			2022-12-27	WOS:000305808700002
J	Ferri-Lagneau, KF; Moshal, KS; Grimes, M; Zahora, B; Lv, LS; Sang, SM; Leung, TC				Ferri-Lagneau, Karine F.; Moshal, Karni S.; Grimes, Matthew; Zahora, Braden; Lv, Lishuang; Sang, Shengmin; Leung, TinChung			Ginger Stimulates Hematopoiesis via Bmp Pathway in Zebrafish	PLOS ONE			English	Article							BLOOD STEM-CELLS; BONE MORPHOGENETIC PROTEINS; ZINGIBER-OFFICINALE ROSCOE; AORTIC ENDOTHELIUM; EXPRESSION; EMBRYO; VEGF; MOUSE; ERYTHROPOIESIS; PROGENITOR	Background: Anemia is a hematologic disorder with decreased number of erythrocytes. Erythropoiesis, the process by which red blood cells differentiate, are conserved in humans, mice and zebrafish. The only known agents available to treat pathological anemia are erythropoietin and its biologic derivatives. However, erythropoietin therapy elicits unwanted side-effects, high cost and intravenous or subcutaneous injection, warranting the development of a more cost effective and non-peptide alternative. Ginger (Zingiber officinale) has been widely used in traditional medicine; however, to date there is no scientific research documenting the potential of ginger to stimulate hematopoiesis. Methodology/Principal Findings: Here, we utilized gata1:dsRed transgenic zebrafish embryos to investigate the effect of ginger extract on hematopoiesis in vivo and we identified its bioactive component, 10-gingerol. We confirmed that ginger and 10-gingerol promote the expression of gata1 in erythroid cells and increase the expression of hematopoietic progenitor markers cmyb and scl. We also demonstrated that ginger and 10-gingerol can promote the hematopoietic recovery from acute hemolytic anemia in zebrafish, by quantifying the number of circulating erythroid cells in the dorsal aorta using video microscopy. We found that ginger and 10-gingerol treatment during gastrulation results in an increase of bmp2b and bmp7a expression, and their downstream effectors, gata2 and eve1. At later stages ginger and 10-gingerol can induce bmp2b/7a, cmyb, scl and lmo2 expression in the caudal hematopoietic tissue area. We further confirmed that Bmp/Smad pathway mediates this hematopoiesis promoting effect of ginger by using the Bmp-activated Bmp type I receptor kinase inhibitors dorsomorphin, LND193189 and DMH1. Conclusions/Significance: Our study provides a strong foundation to further evaluate the molecular mechanism of ginger and its bioactive components during hematopoiesis and to investigate their effects in adults. Our results will provide the basis for future research into the effect of ginger during mammalian hematopoiesis to develop novel erythropoiesis promoting agents.	[Ferri-Lagneau, Karine F.; Moshal, Karni S.; Grimes, Matthew; Zahora, Braden; Leung, TinChung] N Carolina Cent Univ, Biomed Biotechnol Res Inst, Kannapolis, NC USA; [Lv, Lishuang; Sang, Shengmin] N Carolina Cent Univ, Ctr Excellence Postharvest Technol, N Carolina Agr & Tech State Univ, Kannapolis, NC USA; [Leung, TinChung] N Carolina Cent Univ, Dept Biol, Durham, NC USA	University of North Carolina; North Carolina Central University; University of North Carolina; North Carolina A&T State University; North Carolina Central University; University of North Carolina; North Carolina Central University	Ferri-Lagneau, KF (corresponding author), N Carolina Cent Univ, Biomed Biotechnol Res Inst, N Carolina Res Campus, Kannapolis, NC USA.	tleung@nccu.edu			North Carolina Biotechnology Center [2009-BRG-1213]; National Institutes of Health [CA138277, CA138277S1]; NATIONAL CANCER INSTITUTE [R21CA138277] Funding Source: NIH RePORTER	North Carolina Biotechnology Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by the North Carolina Biotechnology Center (2009-BRG-1213 to TCL) and the National Institutes of Health (CA138277 and CA138277S1 to SS). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bertrand JY, 2007, DEVELOPMENT, V134, P4147, DOI 10.1242/dev.012385; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Burns CE, 2002, EXP HEMATOL, V30, P1381, DOI 10.1016/S0301-472X(02)00955-4; Butt MS, 2011, CRIT REV FOOD SCI, V51, P383, DOI 10.1080/10408391003624848; Cannon JE, 2010, BRIT J PHARMACOL, V161, P140, DOI 10.1111/j.1476-5381.2010.00871.x; Chen AT, 2009, J CELL BIOCHEM, V108, P35, DOI 10.1002/jcb.22251; CHESEBRO B, 1978, J NATL CANCER I, V60, P239, DOI 10.1093/jnci/60.1.239; CHESEBRO B, 1976, J IMMUNOL, V117, P1267; Ciau-Uitz A, 2010, DEV CELL, V18, P569, DOI 10.1016/j.devcel.2010.02.009; Collery RF, 2011, DEV DYNAM, V240, P712, DOI 10.1002/dvdy.22567; Dalgin G, 2007, DEV BIOL, V310, P454, DOI 10.1016/j.ydbio.2007.08.012; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Dick A, 2000, DEVELOPMENT, V127, P343; Dooley KA, 2005, DEV BIOL, V277, P522, DOI 10.1016/j.ydbio.2004.09.004; Fibach E, 2005, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.im22f07s69, DOI 10.1002/0471142735.IM22F07S69]; Galloway JL, 2003, CURR TOP DEV BIOL, V53, P139, DOI 10.1016/S0070-2153(03)53004-6; Grassinger J, 2007, CYTOKINE, V40, P165, DOI 10.1016/j.cyto.2007.09.004; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Jin H, 2007, BLOOD, V109, P5208, DOI 10.1182/blood-2007-01-069005; Kalev-Zylinska ML, 2002, DEVELOPMENT, V129, P2015; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Leung AYH, 2005, DEV BIOL, V277, P235, DOI 10.1016/j.ydbio.2004.09.032; Leung TC, 2003, DEVELOPMENT, V130, P3639, DOI 10.1242/dev.00558; Leung T, 2006, BLOOD, V108, P160, DOI 10.1182/blood-2005-09-3706; Long QM, 1997, DEVELOPMENT, V124, P4105; Marshall CJ, 2007, BRIT J HAEMATOL, V139, P321, DOI 10.1111/j.1365-2141.2007.06795.x; Miller-Bertoglio VE, 1997, DEV BIOL, V192, P537, DOI 10.1006/dbio.1997.8788; Monteiro R, 2011, EMBO J, V30, P1093, DOI 10.1038/emboj.2011.34; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Ojewole JAO, 2006, PHYTOTHER RES, V20, P764, DOI 10.1002/ptr.1952; Palis J, 1998, BLOOD REV, V12, P106, DOI 10.1016/S0268-960X(98)90022-4; Palis J, 2001, EXP HEMATOL, V29, P927, DOI 10.1016/S0301-472X(01)00669-5; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P840, DOI 10.1073/pnas.0607196104; Robin C, 2010, INT J DEV BIOL, V54, P1189, DOI 10.1387/ijdb.093040cr; Sang SM, 2009, J AGR FOOD CHEM, V57, P10645, DOI 10.1021/jf9027443; Sbafizadeh E, 2004, COMP BIOCHEM PHYS C, V138, P245, DOI 10.1016/j.cca.2004.05.003; Schmerer M, 2003, BLOOD, V102, P3196, DOI 10.1182/blood-2003-04-1094; Snyder A, 2004, J CELL BIOCHEM, V93, P224, DOI 10.1002/jcb.20191; Tao SJ, 2009, DEVELOPMENT, V136, P2757, DOI 10.1242/dev.034959; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232; Wilkinson JM, 2000, REPROD TOXICOL, V14, P507, DOI 10.1016/S0890-6238(00)00106-4; Wohlmuth H, 2005, J AGR FOOD CHEM, V53, P5772, DOI 10.1021/jf050435b; Xu RH, 1999, DEV BIOL, V208, P352, DOI 10.1006/dbio.1999.9205; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	53	22	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39327	10.1371/journal.pone.0039327	http://dx.doi.org/10.1371/journal.pone.0039327			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761764	gold, Green Published, Green Submitted			2022-12-27	WOS:000305781700030
J	Casper, BM; Popper, AN; Matthews, F; Carlson, TJ; Halvorsen, MB				Casper, Brandon M.; Popper, Arthur N.; Matthews, Frazer; Carlson, Thomas J.; Halvorsen, Michele B.			Recovery of Barotrauma Injuries in Chinook Salmon, Oncorhynchus tshawytscha from Exposure to Pile Driving Sound	PLOS ONE			English	Article								Juvenile Chinook salmon, Oncorhynchus tshawytscha, were exposed to simulated high intensity pile driving signals to evaluate their ability to recover from barotrauma injuries. Fish were exposed to one of two cumulative sound exposure levels for 960 pile strikes (217 or 210 dB re 1 mu Pa-2.s SELcum; single strike sound exposure levels of 187 or 180 dB re 1 mu Pa-2.s SELss respectively). This was followed by an immediate assessment of injuries, or assessment 2, 5, or 10 days post-exposure. There were no observed mortalities from the pile driving sound exposure. Fish exposed to 217 dB re 1 mu Pa-2.s SELcum displayed evidence of healing from injuries as post-exposure time increased. Fish exposed to 210 dB re 1 mu Pa-2.s SELcum sustained minimal injuries that were not significantly different from control fish at days 0, 2, and 10. The exposure to 210 dB re 1 mu Pa-2.s SELcum replicated the findings in a previous study that defined this level as the threshold for onset of injury. Furthermore, these data support the hypothesis that one or two Mild injuries resulting from pile driving exposure are unlikely to affect the survival of the exposed animals, at least in a laboratory environment.	[Casper, Brandon M.; Popper, Arthur N.; Matthews, Frazer] Univ Maryland, Dept Biol, Ctr Comparat & Evolutionary Biol Hearing, College Pk, MD 20742 USA; [Carlson, Thomas J.; Halvorsen, Michele B.] Marine Sci Lab, Pacific NW Natl Lab, Sequim, WA USA	University System of Maryland; University of Maryland College Park; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Casper, BM (corresponding author), Univ Maryland, Dept Biol, Ctr Comparat & Evolutionary Biol Hearing, College Pk, MD 20742 USA.	bcasper@umd.edu			Bureau of Ocean Energy Management (BOEM); National Cooperative Highway Research Program (NCHRP)	Bureau of Ocean Energy Management (BOEM); National Cooperative Highway Research Program (NCHRP)	Most of the work was supported by the Bureau of Ocean Energy Management (BOEM), with additional support from the California Transportation Authority (CALTRANS) and Fisheries and Oceans, Canada. Initial studies and development of the HICI-FT were partially supported by a contract with the National Cooperative Highway Research Program (NCHRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey H, 2010, MAR POLLUT BULL, V60, P888, DOI 10.1016/j.marpolbul.2010.01.003; Bolle LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033052; Carlson T. J., 2007, UPDATE RECOMMENDATIO; Halvorsen MB, 2011, 363 NCHRP TRANSP RES; Hastings Mardi C., 2008, Acoustics Today, V4, P22, DOI 10.1121/1.2961166; Hastings MC, 2008, EFFECTS SEISMIC AIRG; Jorgensen R., 2005, INVESTIGATIONS POTEN; MacGillivray A, 2005, SOUND PRESSURE PARTI, P1; Marty G., 2005, FINAL REPORT MONITOR; Popper AN, 2009, J FISH BIOL, V75, P455, DOI 10.1111/j.1095-8649.2009.02319.x; Popper A.N., 2012, EFFECTS NOISE AQUATI; Popper A. N., 2006, INTERIM CRITERIA INJ; Popper AN, 2009, INTEGR ZOOL, V4, P43, DOI 10.1111/j.1749-4877.2008.00134.x; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; Southall B. L., 2008, AQUAT MAMM, V17, P273, DOI [DOI 10.1578/AM.33.4.2007.411, 10.1578/AM, DOI 10.1578/AM]; Stadler JH, 2009, INT 2009 OTT ONT CAN; Stephenson JR, 2010, FISH RES, V106, P271, DOI 10.1016/j.fishres.2010.08.006; Woodbury D, 2008, BIOACOUSTICS, V17, P289, DOI DOI 10.1080/09524622.2008.9753852	19	29	29	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39593	10.1371/journal.pone.0039593	http://dx.doi.org/10.1371/journal.pone.0039593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745794	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900084
J	English, JA; Manadas, B; Scaife, C; Cotter, DR; Dunn, MJ				English, Jane A.; Manadas, Bruno; Scaife, Caitriona; Cotter, David R.; Dunn, Michael J.			Partitioning the Proteome: Phase Separation for Targeted Analysis of Membrane Proteins in Human Post-Mortem Brain	PLOS ONE			English	Article							MASS-SPECTROMETRY; LC-MS; EXTRACTION; MYELIN; QUANTIFICATION; GENOME	Neuroproteomics is a powerful platform for targeted and hypothesis driven research, providing comprehensive insights into cellular and sub-cellular disease states, Gene x Environmental effects, and cellular response to medication effects in human, animal, and cell culture models. Analysis of sub-proteomes is becoming increasingly important in clinical proteomics, enriching for otherwise undetectable proteins that are possible markers for disease. Membrane proteins are one such sub-proteome class that merit in-depth targeted analysis, particularly in psychiatric disorders. As membrane proteins are notoriously difficult to analyse using traditional proteomics methods, we evaluate a paradigm to enrich for and study membrane proteins from human post-mortem brain tissue. This is the first study to extensively characterise the integral trans-membrane spanning proteins present in human brain. Using Triton X-114 phase separation and LC-MS/MS analysis, we enriched for and identified 494 membrane proteins, with 194 trans-membrane helices present, ranging from 1 to 21 helices per protein. Isolated proteins included glutamate receptors, G proteins, voltage gated and calcium channels, synaptic proteins, and myelin proteins, all of which warrant quantitative proteomic investigation in psychiatric and neurological disorders. Overall, our sub-proteome analysis reduced sample complexity and enriched for integral membrane proteins by 2.3 fold, thus allowing for more manageable, reproducible, and targeted proteomics in case vs. control biomarker studies. This study provides a valuable reference for future neuroproteomic investigations of membrane proteins, and validates the use Triton X-114 detergent phase extraction on human post mortem brain.	[English, Jane A.; Manadas, Bruno; Scaife, Caitriona; Dunn, Michael J.] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Proteome Res Ctr, Dublin 2, Ireland; [English, Jane A.; Cotter, David R.] Royal Coll Surgeons Ireland, Dept Psychiat, Dublin 2, Ireland; [Manadas, Bruno] Univ Coimbra, Ctr Neurosci & Cell Biol, Prote Unit, Coimbra, Portugal	University College Dublin; Royal College of Surgeons - Ireland; Universidade de Coimbra	English, JA (corresponding author), Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Proteome Res Ctr, Dublin 2, Ireland.	janeenglish@rcsi.ie	Manadas, Bruno/A-7667-2012; cotter, david r/D-8249-2012; Manadas, Bruno/ABH-8490-2020; Manadas, Bruno/AAS-5973-2020	Manadas, Bruno/0000-0002-2087-4042; Manadas, Bruno/0000-0002-2087-4042; cotter, david/0000-0003-4308-0648; English, Jane A/0000-0001-9930-7050; scaife, caitriona/0000-0002-7463-0676	Science Foundation Ireland [04/RPI/B499]; Fundacao para a Ciencia e Tecnologia - Portugal [SFRH/BPD/26456/2006]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Fundacao para a Ciencia e Tecnologia - Portugal(Portuguese Foundation for Science and Technology)	Research in MJD's laboratory is funded by Science Foundation Ireland under Grant No. 04/RPI/B499. BM was supported by Fundacao para a Ciencia e Tecnologia - Portugal (grant SFRH/BPD/26456/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	America AHP, 2008, PROTEOMICS, V8, P731, DOI 10.1002/pmic.200700694; Arnold T, 2007, BIOTECHNIQUES, V43, P427, DOI 10.2144/000112566; Behan AT, 2009, MOL PSYCHIATR, V14, P601, DOI 10.1038/mp.2008.7; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Donoghue PM, 2008, PROTEOMICS, V8, P3895, DOI 10.1002/pmic.200800116; English JA, 2009, PROTEOMICS, V9, P3368, DOI 10.1002/pmic.200900015; Everberg Henrik, 2009, V528, P73, DOI 10.1007/978-1-60327-310-7_5; Gilmore JM, 2010, J PROTEOMICS, V73, P2078, DOI 10.1016/j.jprot.2010.08.005; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Gray LJ, 2010, PSYCHIAT RES, V178, P374, DOI 10.1016/j.psychres.2008.07.012; Grunewald TGP, 2007, BMC CANCER, V7, P1, DOI 10.1186/1471-2407-7-198; Hahn CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005251; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Ishii A, 2009, P NATL ACAD SCI USA, V106, P14605, DOI 10.1073/pnas.0905936106; Levin Y, 2010, METHODS MOL BIOL, V658, P217, DOI 10.1007/978-1-60761-780-8_13; Malen H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-132; Manadas B, 2010, EXPERT REV PROTEOMIC, V7, P655, DOI [10.1586/epr.10.46, 10.1586/EPR.10.46]; Manadas B, 2009, PROTEOMICS, V9, P5194, DOI 10.1002/pmic.200900349; Mathias RA, 2011, METHODS; Ming M, 2010, P NATL ACAD SCI USA, V107, P22623, DOI 10.1073/pnas.1010377108; Nally JE, 2007, INFECT IMMUN, V75, P766, DOI 10.1128/IAI.00741-06; Podwojski K, 2010, EXPERT REV PROTEOMIC, V7, P249, DOI 10.1586/EPR.09.107; Rabilloud T, 2009, ELECTROPHORESIS, V30, pS174, DOI 10.1002/elps.200900050; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Shen XC, 2005, P NATL ACAD SCI USA, V102, P5969, DOI 10.1073/pnas.0407928102; Shevchenko G, 2010, J PROTEOME RES, V9, P3903, DOI 10.1021/pr100116k; Siegel GG, 1999, BASIC NEUROCHEMISTRY; Sinha S, 2005, MICROBIOL-SGM, V151, P2411, DOI 10.1099/mic.0.27799-0; Tabb DL, 2010, J PROTEOME RES, V9, P761, DOI 10.1021/pr9006365; Taylor CM, 2004, P NATL ACAD SCI USA, V101, P4643, DOI 10.1073/pnas.0400922101; Treumann A, 2010, EXPERT REV PROTEOMIC, V7, P647, DOI 10.1586/EPR.10.29; Tribl F, 2005, MOL CELL PROTEOMICS, V4, P945, DOI 10.1074/mcp.M400117-MCP200; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zuchero JB, 2011, DEV CELL, V21, P385, DOI 10.1016/j.devcel.2011.08.023	34	9	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39509	10.1371/journal.pone.0039509	http://dx.doi.org/10.1371/journal.pone.0039509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745773	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900067
J	Rosales, EM; Aguilera, MO; Salinas, RP; Carminati, SA; Colombo, MI; Martinez-Quiles, N; Beron, W				Rosales, Eliana M.; Aguilera, Milton O.; Salinas, Romina P.; Carminati, Sergio A.; Colombo, Maria I.; Martinez-Quiles, Narcisa; Beron, Walter			Cortactin Is Involved in the Entry of Coxiella burnetii into Non-Phagocytic Cells	PLOS ONE			English	Article							FILAMENT NETWORK FORMATION; ALDRICH-SYNDROME PROTEIN; FOCAL ADHESION KINASE; ARP2/3 COMPLEX; N-WASP; TYROSINE PHOSPHORYLATION; ACTIN CYTOSKELETON; HELICOBACTER-PYLORI; BACTERIAL PATHOGENS; MEMBRANE PROTRUSION	Background: Cortactin is a key regulator of the actin cytoskeleton and is involved in pathogen-host cell interactions. Numerous pathogens exploit the phagocytic process and actin cytoskeleton to infect host cells. Coxiella burnetii, the etiologic agent of Q fever, is internalized by host cells through a molecular mechanism that is poorly understood. Methodology/Principal Finding: Here we analyzed the role of different cortactin motifs in the internalization of C. burnetii by non-phagocytic cells. C. burnetii internalization into HeLa cells was significantly reduced when the cells expressed GFP-cortactin W525K, which carries a mutation in the SH3 domain that renders the protein unable to bind targets such as N-WASP. However, internalization was unaffected when the cells expressed the W22A mutant, which has a mutation in the N-terminal acidic region that destroys the protein's ability to bind and activate Arp2/3. We also determined whether the phosphorylation status of cortactin is important for internalization. Expression of GFP-cortactin 3F, which lacks phosphorylatable tyrosines, significantly increased internalization of C. burnetii, while expression of GFP-cortactin 3D, a phosphotyrosine mimic, did not affect it. In contrast, expression of GFP-cortactin 2A, which lacks phosphorylatable serines, inhibited C. burnetii internalization, while expression of GFP-cortactin SD, a phosphoserine mimic, did not affect it. Interestingly, inhibitors of Src kinase and the MEK-ERK kinase pathway blocked internalization. In fact, both kinases reached maximal activity at 15 min of C. burnetii infection, after which activity decreased to basal levels. Despite the decrease in kinase activity, cortactin phosphorylation at Tyr421 reached a peak at 1 h of infection. Conclusions/Significance: Our results suggest that the SH3 domain of cortactin is implicated in C. burnetii entry into HeLa cells. Furthermore, cortactin phosphorylation at serine and dephosphorylation at tyrosine favor C. burnetii internalization. We present evidence that ERK and Src kinases play a role early in infection by this pathogen.	[Rosales, Eliana M.; Aguilera, Milton O.; Salinas, Romina P.; Carminati, Sergio A.; Colombo, Maria I.; Beron, Walter] Univ Nacl Cuyo, Fac Ciencias Med, CONICET, Inst Histol & Embriol, RA-5500 Mendoza, Argentina; [Martinez-Quiles, Narcisa] Univ Complutense Madrid, Fac Farm, Madrid, Spain	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; Complutense University of Madrid	Rosales, EM (corresponding author), Univ Nacl Cuyo, Fac Ciencias Med, CONICET, Inst Histol & Embriol, RA-5500 Mendoza, Argentina.	wberon@fcm.uncu.edu	Martinez-Quiles, Narcisa/G-8514-2013	Martinez Quiles, Narcisa/0000-0002-0366-6591	Science and Innovation Ministry of Spain [PS-09/00080]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 5794]; Secretaria de Ciencia, Tecnica y Posgrado (SECTyP) [06/J108]; Universidad Nacional de Cuyo; Agencia Nacional de Promocioen Cientifica y Tecnologica (PICT) [02336]	Science and Innovation Ministry of Spain(Spanish Government); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia, Tecnica y Posgrado (SECTyP); Universidad Nacional de Cuyo; Agencia Nacional de Promocioen Cientifica y Tecnologica (PICT)	This work was partly supported by grants from the Science and Innovation Ministry of Spain (PS-09/00080) to NM-Q and from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP 5794) and Secretaria de Ciencia, Tecnica y Posgrado (SECTyP, 06/J108), Universidad Nacional de Cuyo to WB. This work was also supported by the Agencia Nacional de Promocioen Cientifica y Tecnologica (PICT # 02336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agerer F, 2005, J CELL SCI, V118, P2189, DOI 10.1242/jcs.02328; Aguilera M, 2009, INFECT IMMUN, V77, P4609, DOI 10.1128/IAI.00301-09; Alonso A, 2004, INT MICROBIOL, V7, P181; Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; BACA OG, 1983, MICROBIOL REV, V47, P127, DOI 10.1128/MMBR.47.2.127-149.1983; Beron W, 2002, INFECT IMMUN, V70, P5816, DOI 10.1128/IAI.70.10.5816-5821.2002; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Burton EA, 2003, EMBO J, V22, P5471, DOI 10.1093/emboj/cdg512; Campbell DH, 1999, CANCER RES, V59, P5376; Cantarelli VV, 2007, CELL MICROBIOL, V9, P1782, DOI 10.1111/j.1462-5822.2007.00913.x; Cantarelli VV, 2006, CELL MICROBIOL, V8, P769, DOI 10.1111/j.1462-5822.2005.00664.x; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Crostella L, 2001, ONCOGENE, V20, P3735, DOI 10.1038/sj.onc.1204474; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Disanza A, 2005, CELL MOL LIFE SCI, V62, P955, DOI 10.1007/s00018-004-4472-6; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Duleh SN, 2010, CYTOSKELETON, V67, P193, DOI 10.1002/cm.20437; Elwell CA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000021; Fan LZ, 2004, BIOCHEM J, V380, P581, DOI 10.1042/BJ20040178; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Galletta BJ, 2009, CURR OPIN CELL BIOL, V21, P20, DOI 10.1016/j.ceb.2009.01.006; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Gourlay CW, 2005, BIOCHEM SOC T, V33, P1260, DOI 10.1042/BST0331260; Grassart A, 2010, TRAFFIC, V11, P1079, DOI 10.1111/j.1600-0854.2010.01075.x; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Gutierrez MG, 2005, CELL MICROBIOL, V7, P981, DOI 10.1111/j.1462-5822.2005.00527.x; HEESEMANN J, 1985, J CLIN MICROBIOL, V22, P168, DOI 10.1128/JCM.22.2.168-175.1985; Hinsby AM, 2003, MOL CELL PROTEOMICS, V2, P29, DOI 10.1074/mcp.M200075-MCP200; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Kinley AW, 2003, CURR BIOL, V13, P384, DOI 10.1016/S0960-9822(03)00107-6; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; Martin KH, 2006, J CELL SCI, V119, P2851, DOI 10.1242/jcs03034; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; Meconi S, 1998, INFECT IMMUN, V66, P5527, DOI 10.1128/IAI.66.11.5527-5533.1998; Meconi S, 2001, INFECT IMMUN, V69, P2520, DOI 10.1128/IAI.69.4.2520-2526.2001; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Nieto-Pelegrin E, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-11; Perrin BJ, 2006, MOL BIOL CELL, V17, P239, DOI 10.1091/mbc.e05-06-0488; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; SCHUURING E, 1993, MOL CELL BIOL, V13, P2891, DOI 10.1128/MCB.13.5.2891; Selbach M, 2005, TRENDS MICROBIOL, V13, P181, DOI 10.1016/j.tim.2005.02.007; Selbach M, 2003, EMBO J, V22, P515, DOI 10.1093/emboj/cdg050; Stamnes M, 2002, CURR OPIN CELL BIOL, V14, P428, DOI 10.1016/S0955-0674(02)00349-6; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; Tegtmeyer N, 2011, CELL HOST MICROBE, V9, P520, DOI 10.1016/j.chom.2011.05.007; Tsuboi S, 2007, J BIOL CHEM, V282, P34194, DOI 10.1074/jbc.M705999200; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Uruno T, 2003, J BIOL CHEM, V278, P26086, DOI 10.1074/jbc.M301997200; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Voth DE, 2007, CELL MICROBIOL, V9, P829, DOI 10.1111/j.1462-5822.2007.00901.x; Waag DM, 2007, VACCINE, V25, P7288, DOI 10.1016/j.vaccine.2007.08.002; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Webb BA, 2006, EXP CELL RES, V312, P760, DOI 10.1016/j.yexcr.2005.11.032; Webb BA, 2006, ARCH BIOCHEM BIOPHYS, V456, P183, DOI 10.1016/j.abb.2006.06.011; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670; Woldehiwet Z, 2004, RES VET SCI, V77, P93, DOI 10.1016/j.rvsc.2003.09.001; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; Yang L, 2006, CIRC RES, V98, P394, DOI 10.1161/01.RES.0000201958.59020.1a	69	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39348	10.1371/journal.pone.0039348	http://dx.doi.org/10.1371/journal.pone.0039348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761768	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900048
J	Watanabe, T; Yahata, N; Abe, O; Kuwabara, H; Inoue, H; Takano, Y; Iwashiro, N; Natsubori, T; Aoki, Y; Takao, H; Sasaki, H; Gonoi, W; Murakami, M; Katsura, M; Kunimatsu, A; Kawakubo, Y; Matsuzaki, H; Tsuchiya, KJ; Kato, N; Kano, Y; Miyashita, Y; Kasai, K; Yamasue, H				Watanabe, Takamitsu; Yahata, Noriaki; Abe, Osamu; Kuwabara, Hitoshi; Inoue, Hideyuki; Takano, Yosuke; Iwashiro, Norichika; Natsubori, Tatsunobu; Aoki, Yuta; Takao, Hidemasa; Sasaki, Hiroki; Gonoi, Wataru; Murakami, Mizuho; Katsura, Masaki; Kunimatsu, Akira; Kawakubo, Yuki; Matsuzaki, Hideo; Tsuchiya, Kenji J.; Kato, Nobumasa; Kano, Yukiko; Miyashita, Yasushi; Kasai, Kiyoto; Yamasue, Hidenori			Diminished Medial Prefrontal Activity behind Autistic Social Judgments of Incongruent Information	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; PERVASIVE DEVELOPMENTAL DISORDERS; SPECTRUM QUOTIENT AQ; ASPERGER-SYNDROME; NEURAL BASIS; LANGUAGE COMPREHENSION; DIAGNOSTIC INTERVIEW; COGNITIVE CONTROL; CHILDHOOD AUTISM; RATING-SCALE	Individuals with autism spectrum disorders (ASD) tend to make inadequate social judgments, particularly when the nonverbal and verbal emotional expressions of other people are incongruent. Although previous behavioral studies have suggested that ASD individuals have difficulty in using nonverbal cues when presented with incongruent verbal-nonverbal information, the neural mechanisms underlying this symptom of ASD remain unclear. In the present functional magnetic resonance imaging study, we compared brain activity in 15 non-medicated adult males with high-functioning ASD to that of 17 age-, parental-background-, socioeconomic-, and intelligence-quotient-matched typically-developed (TD) male participants. Brain activity was measured while each participant made friend or foe judgments of realistic movies in which professional actors spoke with conflicting nonverbal facial expressions and voice prosody. We found that the ASD group made significantly less judgments primarily based on the nonverbal information than the TD group, and they exhibited significantly less brain activity in the right inferior frontal gyrus, bilateral anterior insula, anterior cingulate cortex/ventral medial prefrontal cortex (ACC/vmPFC), and dorsal medial prefrontal cortex (dmPFC) than the TD group. Among these five regions, the ACC/vmPFC and dmPFC were most involved in nonverbal-information-biased judgments in the TD group. Furthermore, the degree of decrease of the brain activity in these two brain regions predicted the severity of autistic communication deficits. The findings indicate that diminished activity in the ACC/vmPFC and dmPFC underlies the impaired abilities of individuals with ASD to use nonverbal content when making judgments regarding other people based on incongruent social information.	[Watanabe, Takamitsu; Miyashita, Yasushi] Univ Tokyo, Dept Physiol, Bunkyo Ku, Tokyo, Japan; [Yahata, Noriaki; Inoue, Hideyuki; Takano, Yosuke; Iwashiro, Norichika; Natsubori, Tatsunobu; Aoki, Yuta; Kasai, Kiyoto; Yamasue, Hidenori] Univ Tokyo, Dept Neuropsychiat, Bunkyo Ku, Tokyo, Japan; [Kuwabara, Hitoshi; Kawakubo, Yuki; Kano, Yukiko] Univ Tokyo, Dept Child Neuropsychiat, Bunkyo Ku, Tokyo, Japan; [Abe, Osamu; Takao, Hidemasa; Sasaki, Hiroki; Gonoi, Wataru; Murakami, Mizuho; Katsura, Masaki; Kunimatsu, Akira] Univ Tokyo, Dept Radiol, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Yahata, Noriaki; Kasai, Kiyoto] Univ Tokyo, Global Ctr Excellence COE Program, Bunkyo Ku, Tokyo, Japan; [Abe, Osamu] Nihon Univ, Sch Med, Dept Radiol, Itabashi Ku, Tokyo, Japan; [Matsuzaki, Hideo; Kato, Nobumasa; Yamasue, Hidenori] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo, Japan; [Tsuchiya, Kenji J.] Hamamatsu Univ Sch Med, Osaka Hamamatsu Joint Res Ctr Child Mental Dev, Hamamatsu, Shizuoka 4313192, Japan; [Kato, Nobumasa; Yamasue, Hidenori] Showa Univ, Sch Med, Dept Neuropsychiat, Tokyo 142, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Nihon University; Japan Science & Technology Agency (JST); Hamamatsu University School of Medicine; Showa University	Watanabe, T (corresponding author), Univ Tokyo, Dept Physiol, Bunkyo Ku, Tokyo, Japan.	yamasue-tky@umin.ac.jp	Gonoi, Wataru/AAB-2160-2019; Tsuchiya, Kenji J./I-9123-2019; MATSUZAKI, HIDEO/AAE-5246-2020; Watanabe, Takamitsu/H-7234-2018; Kunimatsu, Akira/AAC-8617-2019; Miyashita, Yasushi/B-7171-2019	Gonoi, Wataru/0000-0002-5018-4683; Tsuchiya, Kenji J./0000-0002-1314-4199; MATSUZAKI, HIDEO/0000-0002-6869-1261; Watanabe, Takamitsu/0000-0002-8104-6873; Kunimatsu, Akira/0000-0002-7141-2585; Kasai, Kiyoto/0000-0002-4443-4535; Abe, Osamu/0000-0002-1180-2629; Takao, Hidemasa/0000-0001-7570-924X; aoki, yuta/0000-0001-5617-4948; Natsubori, Tatsunobu/0000-0002-9401-0415; Miyashita, Yasushi/0000-0003-3496-8637	Ministry of Education, Culture, Sports, Science and Technology; Global Centre of Excellence (COE); Japan Society for the Promotion of Science Research Foundation for Young Scientists [222882];  [22689034];  [20591378]; Grants-in-Aid for Scientific Research [10J02882] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Centre of Excellence (COE); Japan Society for the Promotion of Science Research Foundation for Young Scientists; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Part of this study was a result of the "Development of biomarker candidates for social behavior" project carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology, and was also supported by Grants-in-Aid for Scientific Research (22689034 to HY; 20591378 to NY), the Global Centre of Excellence (COE) Program "Comprehensive Centre of Education and Research for Chemical Biology of the Diseases" (NY) and a grant from the Japan Society for the Promotion of Science Research Foundation for Young Scientists (222882) to TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; [Anonymous], 1999, C1 CTR RES PSYCH, DOI DOI 10.1002/PER.2410010304; Association AP DSM-IV APATFO, 2000, DIAGN STAT MAN MENT; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; BOWLER DM, 1992, J CHILD PSYCHOL PSYC, V33, P877, DOI 10.1111/j.1469-7610.1992.tb01962.x; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Cocosco CA, 1997, NEUROIMAGE; Coricelli G, 2009, P NATL ACAD SCI USA, V106, P9163, DOI 10.1073/pnas.0807721106; Critchley H, 2001, BRAIN; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Davis MH, 2003, J NEUROSCI, V23, P3423; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; First M. B., 1997, STRUCTURED CLIN INTE; Frith U, 2004, J CHILD PSYCHOL PSYC, V45, P672, DOI 10.1111/j.1469-7610.2004.00262.x; FRITH U, 1994, PHILOS T ROY SOC B, V346, P97, DOI 10.1098/rstb.1994.0133; Gilbert SJ, 2009, BRAIN, V132, P869, DOI 10.1093/brain/awn365; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grinband J, 2006, NEURON, V49, P757, DOI 10.1016/j.neuron.2006.01.032; Groen WB, 2010, CEREB CORTEX, V20, P1937, DOI 10.1093/cercor/bhp264; HAPPE FGE, 1993, COGNITION, V48, P101, DOI 10.1016/0010-0277(93)90026-R; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Hollingshead AB., 1957, 2 FACTOR INDEX SOCIA; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Jenkins AC, 2010, CEREB CORTEX, V20, P404, DOI 10.1093/cercor/bhp109; Kana RK, 2009, SOC NEUROSCI-UK, V4, P135, DOI 10.1080/17470910802198510; Kleinhans NM, 2009, AM J PSYCHIAT, V166, P467, DOI 10.1176/appi.ajp.2008.07101681; Klin A, 2002, AM J PSYCHIAT, V159, P895, DOI 10.1176/appi.ajp.159.6.895; Kosaka H, 2010, NEUROIMAGE, V50, P1357, DOI 10.1016/j.neuroimage.2010.01.085; Kuhl BA, 2010, NAT NEUROSCI, V13, P501, DOI 10.1038/nn.2498; Kuzmanovic B, 2010, IMPACT VERBAL NONVER; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; Lombardo MV, 2010, BRAIN, V133, P611, DOI 10.1093/brain/awp306; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Mizuno A, 2011, BRAIN, V134, P2422, DOI 10.1093/brain/awr151; Morishima Y, 2010, CEREB CORTEX, V20, P2675, DOI 10.1093/cercor/bhq013; Nakano T, 2010, P ROY SOC B-BIOL SCI, V277, P2935, DOI 10.1098/rspb.2010.0587; NELSON HE, 1982, NAT AD READ TEST NAR; Neuhaus E, 2010, CLIN PSYCHOL REV, V30, P733, DOI 10.1016/j.cpr.2010.05.007; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otten LJ, 2002, NAT NEUROSCI, V5, P1339, DOI 10.1038/nn967; Ozonoff S, 1996, BRAIN LANG, V52, P411, DOI 10.1006/brln.1996.0022; Pelphrey KA, 2005, BRAIN, V128, P1038, DOI 10.1093/brain/awh404; Peterson CC, 2007, J CHILD PSYCHOL PSYC, V48, P1243, DOI 10.1111/j.1469-7610.2007.01810.x; Pilowsky T, 1998, J AUTISM DEV DISORD, V28, P143, DOI 10.1023/A:1026092632466; Ramachandran R, 2009, J CHILD PSYCHOL PSYC, V50, P871, DOI 10.1111/j.1469-7610.2009.02053.x; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Ruffman T, 2001, J CHILD PSYCHOL PSYC, V42, P1083, DOI 10.1111/1469-7610.00807; Saemundsen E, 2003, J AUTISM DEV DISORD, V33, P319, DOI 10.1023/A:1024410702242; SCHOPLER E, 1980, J AUTISM DEV DISORD, V10, P91, DOI 10.1007/BF02408436; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Schwartz C, 2010, J AUTISM DEV DISORD, V40, P100, DOI 10.1007/s10803-009-0843-z; Senju A, 2009, SCIENCE, V325, P883, DOI 10.1126/science.1176170; Shamay-Tsoory SG, 2008, J AUTISM DEV DISORD, V38, P1451, DOI 10.1007/s10803-007-0515-9; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Suzuki S, 2011, SOC COGN AFFECT NEUR, V6, P338, DOI 10.1093/scan/nsq042; Tager-Flusberg H, 2003, PHILOS T R SOC B, V358, P303, DOI 10.1098/rstb.2002.1198; Tamir DI, 2010, P NATL ACAD SCI USA, V107, P10827, DOI 10.1073/pnas.1003242107; Tesink CMJY, 2009, BRAIN, V132, P1941, DOI 10.1093/brain/awp103; Tesink CMJY, 2011, NEUROPSYCHOLOGIA, V49, P1095, DOI 10.1016/j.neuropsychologia.2011.01.018; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Overwalle F, 2011, NEUROIMAGE, V54, P1589, DOI 10.1016/j.neuroimage.2010.09.043; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Wakabayashi A, 2006, J AUTISM DEV DISORD, V36, P263, DOI 10.1007/s10803-005-0061-2; Wang AT, 2007, ARCH GEN PSYCHIAT, V64, P698, DOI 10.1001/archpsyc.64.6.698; Wang AT, 2006, BRAIN, V129, P932, DOI 10.1093/brain/awl032; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Yamasaki S, 2010, BIOL PSYCHIAT, V68, P1141, DOI 10.1016/j.biopsych.2010.07.012; Yamasue H, 2009, PSYCHIAT CLIN NEUROS, V63, P129, DOI 10.1111/j.1440-1819.2009.01944.x	76	53	54	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39561	10.1371/journal.pone.0039561	http://dx.doi.org/10.1371/journal.pone.0039561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	964XV	22745788	Green Submitted, Green Published, gold			2022-12-27	WOS:000305730900080
J	Weinkauf, B; Rukwied, R; Quiding, H; Dahllund, L; Johansson, P; Schmelz, M				Weinkauf, Benjamin; Rukwied, Roman; Quiding, Hans; Dahllund, Leif; Johansson, Patrick; Schmelz, Martin			Local Gene Expression Changes after UV-Irradiation of Human Skin	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; INFLAMMATORY HYPERALGESIA; NOCICEPTOR SENSITIZATION; AXON REFLEX; MODEL; PAIN; RAT; RECEPTORS; PEPTIDE; BRAIN	UV-irradiation is a well-known translational pain model inducing local inflammation and primary hyperalgesia. The mediators and receptor proteins specifically contributing to mechanical or heat hyperalgesia are still unclear. Therefore, we irradiated buttock skin of humans (n = 16) with 5-fold MED of UV-C and assessed the time course of hyperalgesia and axon reflex erythema. In parallel, we took skin biopsies at 3, 6 and 24 h after UVC irradiation and assessed gene expression levels (RT-PCR) of neurotrophins (e. g. NGF, BDNF, GDNF), ion channels (e. g. NaV1.7, TRPV1), inflammatory mediators (e. g. CCL-2, CCL-3) and enzymes (e. g. PGES, COX2). Hyperalgesia to mechanical impact (12 m/s) and heat (48 degrees C) stimuli was significant at 6 h (p<0.05 and p<0.01) and 24 h (p<0.005 and p<0.01) after irradiation. Axon reflex erythema upon mechanical and thermal stimuli was significantly increased 3 h after irradiation and particularly strong at 6 h. A significant modulation of 9 genes was found post UV-C irradiation, including NGF (3, 6, 24 h), TrkA (6, 24 h), artemin, bradykinin-1 receptor, COX-2, CCL-2 and CCL-3 (3 and 6 h each). A significant down-regulation was observed for TRPV1 and iNOS (6, 24 h). Individual one-to-one correlation analysis of hyperalgesia and gene expression revealed that changes of Nav1.7 (SCN9A) mRNA levels at 6 and 24 h correlated to the intensity of mechanical hyperalgesia recorded at 24 h post UV-irradiation (Pearson r: 0.57, p<0.04 and r: 0.82, p<0.001). Expression of COX-2 and mPGES at 6 h correlated to the intensity of heat-induced erythema 24 h post UV (r: 0.57, p<0.05 for COX-2 and r: 0.83, p<0.001 for PGES). The individual correlation analyses of functional readouts (erythema and pain response) with local expression changes provided evidence for a potential role of Nav1.7 in mechanical hyperalgesia.	[Weinkauf, Benjamin; Rukwied, Roman; Schmelz, Martin] Heidelberg Univ, Med Fac Mannheim, Dept Anesthesiol & Operat Intens Care, D-6800 Mannheim, Germany; [Quiding, Hans; Dahllund, Leif; Johansson, Patrick] AstraZeneca R&D, Sodertalje, Sweden	Ruprecht Karls University Heidelberg; AstraZeneca	Weinkauf, B (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Anesthesiol & Operat Intens Care, D-6800 Mannheim, Germany.	martin.schmelz@medma.uni-heidelberg.de	Schmelz, Martin/A-9327-2013	Schmelz, Martin/0000-0002-9736-7241; Weinkauf, Benjamin/0000-0001-6706-7814	AstraZeneca RD Soedertaelje; Kompetenzzentrum Schmerz Baden-Wurttemberg, Germany; AstraZeneca	AstraZeneca RD Soedertaelje(AstraZeneca); Kompetenzzentrum Schmerz Baden-Wurttemberg, Germany; AstraZeneca(AstraZeneca)	This study was supported by AstraZeneca R&D Soedertaelje, which was involved in study design, data analysis, decision to publish and preparation of the manuscript. The study was also supported by Kompetenzzentrum Schmerz Baden-Wurttemberg, Germany. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Hans Quiding, Leif Dahllund and Patrick Johansson are employees of AstraZeneca which provided funding. Moreover, there is no competing interest concerning consultancy, patents or products in development linked to this study. In contrast, the collaboration was planned with the explicit goal to publish the results. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	BENRATH J, 1995, EUR J PHARM-ENVIRON, V293, P87; Bickel A, 1998, PAIN, V76, P317, DOI 10.1016/S0304-3959(98)00062-1; Bishop T, 2007, PAIN, V131, P70, DOI 10.1016/j.pain.2006.12.014; Bishop T, 2010, PAIN, V150, P141, DOI 10.1016/j.pain.2010.04.018; Bishop T, 2009, EUR J PAIN, V13, P524, DOI 10.1016/j.ejpain.2008.06.006; Bull HA, 1998, BRIT J DERMATOL, V139, P776; Cattaneo A, 2010, CURR OPIN MOL THER, V12, P94; Chizh BA, 2007, PAIN, V132, P132, DOI 10.1016/j.pain.2007.06.006; Clydesdale GJ, 2001, IMMUNOL CELL BIOL, V79, P547, DOI 10.1046/j.1440-1711.2001.01047.x; Dawes JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002193; Donnelly CJ, 2010, TRAFFIC, V11, P1498, DOI 10.1111/j.1600-0854.2010.01118.x; Eisenbarth H, 2004, PAIN, V110, P197, DOI 10.1016/j.pain.2004.03.031; GILLARDON F, 1995, NEUROREPORT, V6, P1322, DOI 10.1097/00001756-199506090-00023; Hoffmann RT, 1999, EUR J PAIN-LONDON, V3, P131, DOI 10.1053/eujp.1998.0106; KOHLLOFFEL LUE, 1991, PAIN, V46, P81, DOI 10.1016/0304-3959(91)90037-X; Koppert W, 2004, EUR J PAIN, V8, P237, DOI 10.1016/j.ejpain.2003.08.007; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; Maihofner C, 2007, EUR J NEUROSCI, V26, P1344, DOI 10.1111/j.1460-9568.2007.05733.x; Obreja O, 2011, PAIN; PERKINS MN, 1993, BRIT J PHARMACOL, V110, P1441, DOI 10.1111/j.1476-5381.1993.tb13982.x; Petho G, 2001, EUR J NEUROSCI, V14, P210, DOI 10.1046/j.0953-816x.2001.01651.x; Qin XM, 2005, J NEUROSCI RES, V82, P51, DOI 10.1002/jnr.20612; Rhodes LE, 2009, FASEB J, V23, P3947, DOI 10.1096/fj.09-136077; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Rukwied R, 2008, EUR J PAIN, V12, P242, DOI 10.1016/j.ejpain.2007.05.007; Rukwied R, 2007, J PAIN, V8, P443, DOI 10.1016/j.jpain.2006.12.004; Rukwied R, 2010, PAIN, V148, P407, DOI 10.1016/j.pain.2009.11.022; Schmelz M, 2000, NEUROREPORT, V11, P645, DOI 10.1097/00001756-200002280-00041; Seifert F, 2008, HUM BRAIN MAPP, V29, P1327, DOI 10.1002/hbm.20470; Stefanato CM, 2003, J CUTAN PATHOL, V30, P351, DOI 10.1034/j.1600-0560.2003.00065.x; Sycha T, 2005, PAIN, V113, P316, DOI 10.1016/j.pain.2004.11.002; TRON VA, 1990, J CLIN INVEST, V85, P1085, DOI 10.1172/JCI114539; Wang XM, 2009, PAIN, V142, P275, DOI 10.1016/j.pain.2009.02.001; Zhao P, 2008, PAIN, V139, P90, DOI 10.1016/j.pain.2008.03.016	34	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39411	10.1371/journal.pone.0039411	http://dx.doi.org/10.1371/journal.pone.0039411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761785	Green Submitted, Green Published, gold			2022-12-27	WOS:000305730900056
J	Wu, F; Huang, D; Wang, LS; Xu, QH; Liu, F; Ye, X; Meng, X; Du, X				Wu, Fei; Huang, Dan; Wang, Lisha; Xu, Qinghua; Liu, Fang; Ye, Xun; Meng, Xia; Du, Xiang			92-Gene Molecular Profiling in Identification of Cancer Origin: A Retrospective Study in Chinese Population and Performance within Different Subgroups	PLOS ONE			English	Article							GENE-EXPRESSION TEST; TISSUE	Background: After cancer diagnosis, therapy for the patient is largely dependent on the tumor origin, especially when a metastatic tumor is being treated. However, cases such as untypical metastasis, poorly differentiated tumors or even a limited number of tumor cells may lead to challenges in identifying the origin. Moreover, approximately 3% to 5% of total solid tumor patients will not have to have their tumor origin identified in their lifetime. The THEROS CancerTYPE ID (R) is designed for identifying the tumor origin with an objective, rapid and standardized procedure. Methodology and Principal Findings: This is a blinded retrospective study to evaluate performance of the THEROS CancerTYPE ID (R) in a Chinese population. In total, 184 formalin-fixed paraffin-embedded (FFPE) samples of 23 tumor origins were collected from the tissue bank of Fudan University Shanghai Cancer Center (FDUSCC). A standard tumor cell enrichment process was used, and the prediction results were compared with reference diagnosis, which was confirmed by two experienced pathologists at FDUSCC. All of the 184 samples were successfully analyzed, and no tumor specimens were excluded because of sample quality issues. In total, 151 samples were correctly predicted. The agreement rate was 82.1%. A Pearson Chi-square test shows that there is no difference between this study and the previous evaluation test performed by bioTheranostics Inc. No statistically significant decrease was observed in either the metastasis group or tumors with high grades. Conclusions: A comparable result with previous work was obtained. Specifically, specimens with a high probability score (>0.85) have a high chance (agreement rate = 95%) of being correctly predicted. No performance difference was observed between primary and metastatic specimens, and no difference was observed among three tumor grades. The use of laser capture micro-dissection (LCM) makes the THEROS CancerTYPE ID (R) accessible to almost all of the cancer patients with different tumor statuses.	[Wu, Fei; Xu, Qinghua; Liu, Fang; Ye, Xun; Meng, Xia] Fudan Univ, Shanghai Canc Ctr, Inst Merieux Lab, Shanghai 200433, Peoples R China; [Huang, Dan; Wang, Lisha; Du, Xiang] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Huang, Dan; Wang, Lisha; Du, Xiang] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Huang, Dan; Wang, Lisha; Du, Xiang] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Wu, F (corresponding author), Fudan Univ, Shanghai Canc Ctr, Inst Merieux Lab, Shanghai 200433, Peoples R China.	dx2008cn@yahoo.com.cn	XU, Qinghua/AAZ-9641-2021	XU, Qinghua/0000-0002-9380-5566				ABBRUZZESE JL, 1993, SEMIN ONCOL, V20, P238; ABBRUZZESE JL, 1995, J CLIN ONCOL, V13, P2094, DOI 10.1200/JCO.1995.13.8.2094; Anderson GG, 2010, APPL IMMUNOHISTO M M, V18, P3, DOI 10.1097/PAI.0b013e3181a75e6d; Bloom G, 2004, AM J PATHOL, V164, P9, DOI 10.1016/S0002-9440(10)63090-8; Dowell JE, 2003, AM J MED SCI, V326, P35, DOI 10.1097/00000441-200307000-00006; Dumur CI, 2008, J MOL DIAGN, V10, P67, DOI 10.2353/jmoldx.2008.070099; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Erlander MG, 2011, J MOL DIAGN, V13, P493, DOI 10.1016/j.jmoldx.2011.04.004; Greco FA, 2010, ONCOLOGIST, V15, P500, DOI 10.1634/theoncologist.2009-0328; Ma XJ, 2006, ARCH PATHOL LAB MED, V130, P465; NYSTROM JS, 1977, SEMIN ONCOL, V4, P53; Pillai R, 2011, J MOL DIAGN, V13, P48, DOI 10.1016/j.jmoldx.2010.11.001; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392	13	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39320	10.1371/journal.pone.0039320	http://dx.doi.org/10.1371/journal.pone.0039320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761762	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900043
J	Dong, M; Zhong, L; Chen, WQ; Ji, XP; Zhang, M; Zhao, YX; Li, L; Yao, GH; Zhang, PF; Zhang, C; Zhang, L; Zhang, Y				Dong, Mei; Zhong, Lin; Chen, Wen Qiang; Ji, Xiao Ping; Zhang, Mei; Zhao, Yu Xia; Li, Li; Yao, Gui Hua; Zhang, Peng Fei; Zhang, Cheng; Zhang, Lei; Zhang, Yun			Doxycycline Stabilizes Vulnerable Plaque via Inhibiting Matrix Metalloproteinases and Attenuating Inflammation in Rabbits	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSMS; ATHEROSCLEROTIC PLAQUES; EXPRESSION; RESTENOSIS; TRIAL; MICE; LDL	Enhanced matrix metalloproteinases (MMPs) activity is implicated in the process of atherosclerotic plaque instability. We hypothesized that doxycycline, a broad MMPs inhibitor, was as effective as simvastatin in reducing the incidence of plaque disruption. Thirty rabbits underwent aortic balloon injury and were fed a high-fat diet for 20 weeks. At the end of week 8, the rabbits were divided into three groups for 12-week treatment: a doxycycline-treated group that received oral doxycycline at a dose of 10 mg/kg/d, a simvastatin-treated group that received oral simvastatin at a dose of 5 mg/kg/d, and a control group that received no treatment. At the end of week 20, pharmacological triggering was performed to induce plaque rupture. Biochemical, ultrasonographic, pathologic, immunohistochemical and mRNA expression studies were performed. The results showed that oral administration of doxycycline resulted in a significant increase in the thickness of the fibrous cap of the aortic plaque whereas there was a substantial reduction of MMPs expression, local and systemic inflammation, and aortic plaque vulnerability. The incidence of plaque rupture with either treatment (0% for both) was significantly lower than that for controls (56.0%, P<0.05). There was no significant difference between doxycycline-treated group and simvastatin-treated group in any serological, ultrasonographic, pathologic, immunohistochemical and mRNA expression measurement except for the serum lipid levels that were higher with doxycycline than with simvastatin treatment. In conclusion, doxycycline at a common antimicrobial dose stabilizes atherosclerotic lesions via inhibiting matrix metalloproteinases and attenuating inflammation in a rabbit model of vulnerable plaque. These effects were similar to a large dose of simvastatin and independent of serum lipid levels.	[Dong, Mei; Chen, Wen Qiang; Ji, Xiao Ping; Zhang, Mei; Zhao, Yu Xia; Li, Li; Yao, Gui Hua; Zhang, Peng Fei; Zhang, Cheng; Zhang, Lei; Zhang, Yun] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Dong, Mei; Chen, Wen Qiang; Ji, Xiao Ping; Zhang, Mei; Zhao, Yu Xia; Li, Li; Yao, Gui Hua; Zhang, Peng Fei; Zhang, Cheng; Zhang, Lei; Zhang, Yun] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250100, Shandong, Peoples R China; [Zhong, Lin] Yu Huang Ding Hosp, Yantai, Shandong, Peoples R China	Shandong University; Shandong University	Dong, M (corresponding author), Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	zhangcheng8003@yahoo.cn; leilybao@163.com; zhangyun@sdu.edu.cn	Zhang, Pengfei/GPP-3564-2022	Zhang, Pengfei/0000-0001-8048-425X	National 973 Basic Research Program of China [2011CB503906, 2012CB518603]; National High-tech Research and Development Program of China [2012AA02A510]; Program of Introducing Talents of Discipline to Universities [B07035]; State Program of National Natural Science Foundation of China for Innovative Research Group [81021001]; State Key Program of National Natural Science of China [60831003]; National Natural Science Foundation of China [60971023, 30900607, 30873325, 30971096, 30972809, 81100206, 81173251]; Natural Science Foundation of Shandong Province [Y2007C064]	National 973 Basic Research Program of China(National Basic Research Program of China); National High-tech Research and Development Program of China(National High Technology Research and Development Program of China); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); State Program of National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by the National 973 Basic Research Program of China (no. 2011CB503906, 2012CB518603), the National High-tech Research and Development Program of China (no. 2012AA02A510), the Program of Introducing Talents of Discipline to Universities (no. B07035), the State Program of National Natural Science Foundation of China for Innovative Research Group (no. 81021001), the State Key Program of National Natural Science of China (no. 60831003), the grants of the National Natural Science Foundation of China (no. 60971023, 30900607, 30873325, 30971096, 30972809, 81100206, 81173251), and the grant of the Natural Science Foundation of Shandong Province (no. Y2007C064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axisa B, 2000, J CHROMATOGR B, V744, P359, DOI 10.1016/S0378-4347(00)00261-9; Axisa B, 2002, STROKE, V33, P2858, DOI 10.1161/01.STR.0000038098.04291.F6; Brown DL, 2004, ARTERIOSCL THROM VAS, V24, P733, DOI 10.1161/01.ATV.0000121571.78696.dc; Chen WQ, 2007, AM J PHYSIOL-HEART C, V293, pH2836, DOI 10.1152/ajpheart.00472.2007; Johnson JL, 2011, ARTERIOSCL THROM VAS, V31, P528, DOI 10.1161/ATVBAHA.110.219147; Kim YS, 2001, J BIOL CHEM, V276, P33736, DOI 10.1074/jbc.M101977200; Kirkwood KL, 1999, ANN NY ACAD SCI, V878, P667, DOI 10.1111/j.1749-6632.1999.tb07757.x; Liu J, 2003, J VASC SURG, V38, P1376, DOI 10.1016/S0741-5214(03)01022-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; Matsumoto M, 2004, J IMMUNOL, V172, P7377, DOI 10.4049/jimmunol.172.12.7377; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Ohshima S, 2010, J AM COLL CARDIOL, V55, P1240, DOI 10.1016/j.jacc.2009.11.056; Prescott MF, 1999, ANN NY ACAD SCI, V878, P179, DOI 10.1111/j.1749-6632.1999.tb07683.x; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Selvendiran K, 2009, J PHARMACOL EXP THER, V329, P959, DOI 10.1124/jpet.108.150367; Shapira L, 1996, INFECT IMMUN, V64, P825, DOI 10.1128/IAI.64.3.825-828.1996; Sheth RA, 2010, ATHEROSCLEROSIS, V212, P181, DOI 10.1016/j.atherosclerosis.2010.05.012; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Teixeira LR, 2002, CHEST, V121, P216, DOI 10.1378/chest.121.1.216; Torzewski M, 1998, ARTERIOSCL THROM VAS, V18, P369, DOI 10.1161/01.ATV.18.3.369; Williams H, 2002, ARTERIOSCL THROM VAS, V22, P788, DOI 10.1161/01.ATV.0000014587.66321.B4; Zhang L, 2009, AM J PHYSIOL-HEART C, V297, pH2004, DOI 10.1152/ajpheart.00208.2009; Zhong L, 2008, J CELL MOL MED, V12, P2362, DOI 10.1111/j.1582-4934.2008.00261.x	24	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39695	10.1371/journal.pone.0039695	http://dx.doi.org/10.1371/journal.pone.0039695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737253	gold, Green Published, Green Submitted			2022-12-27	WOS:000305695100052
J	Falcao, AM; Palha, JA; Ferreira, AC; Marques, F; Sousa, N; Sousa, JC				Falcao, Ana Mendanha; Palha, Joana Almeida; Ferreira, Ana Catarina; Marques, Fernanda; Sousa, Nuno; Sousa, Joao Carlos			Topographical Analysis of the Subependymal Zone Neurogenic Niche	PLOS ONE			English	Article							NEURAL STEM-CELLS; ADULT SUBVENTRICULAR ZONE; CENTRAL-NERVOUS-SYSTEM; OLFACTORY-BULB; SELF-RENEWAL; PROGENITOR CELLS; MAMMALIAN BRAIN; G(1) PHASE; CYCLE; PROLIFERATION	The emerging model for the adult subependymal zone (SEZ) cell population indicates that neuronal diversity is not generated from a uniform pool of stem cells but rather from diverse and spatially confined stem cell populations. Hence, when analysing SEZ proliferation, the topography along the anterior-posterior and dorsal-ventral axes must be taken into account. However, to date, no studies have assessed SEZ proliferation according to topographical specificities and, additionally, SEZ studies in animal models of neurological/psychiatric disorders often fail to clearly specify the SEZ coordinates. This may render difficult the comparison between studies and yield contradictory results. More so, by focusing in a single spatial dimension of the SEZ, relevant findings might pass unnoticed. In this study we characterized the neural stem cell/progenitor population and its proliferation rates throughout the rat SEZ anterior-posterior and dorsal-ventral axes. We found that SEZ proliferation decreases along the anterior-posterior axis and that proliferative rates vary considerably according to the position in the dorsal-ventral axis. These were associated with relevant gradients in the neuroblasts and in the neural stem cell populations throughout the dorsal-ventral axis. In addition, we observed spatially dependent differences in BrdU/Ki67 ratios that suggest a high variability in the proliferation rate and cell cycle length throughout the SEZ; in accordance, estimation of the cell cycle length of the neuroblasts revealed shorter cell cycles at the dorsolateral SEZ. These findings highlight the need to establish standardized procedures of SEZ analysis. Herein we propose an anatomical division of the SEZ that should be considered in future studies addressing proliferation in this neural stem cell niche.	[Falcao, Ana Mendanha; Palha, Joana Almeida; Ferreira, Ana Catarina; Marques, Fernanda; Sousa, Nuno; Sousa, Joao Carlos] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Falcao, Ana Mendanha; Palha, Joana Almeida; Ferreira, Ana Catarina; Marques, Fernanda; Sousa, Nuno; Sousa, Joao Carlos] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal	Universidade do Minho	Falcao, AM (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	jcsousa@ecsaude.uminho.pt	Marques, Fernanda/D-4238-2012; Falcao, Ana Luisa/AAF-8371-2021; Ferreira, Ana Catarina/K-6997-2015; Sousa, Nuno/C-2782-2009; Sousa, João C/C-1048-2009; Palha, Joana Almeida/C-2745-2009; Sousa, João/T-6628-2019; Sousa, Nuno JC/N-9137-2017	Marques, Fernanda/0000-0002-3612-1870; Falcao, Ana Luisa/0000-0003-4356-5936; Ferreira, Ana Catarina/0000-0003-3723-2086; Sousa, João C/0000-0003-3249-0035; Palha, Joana Almeida/0000-0002-8866-368X; Sousa, João/0000-0003-3249-0035; Sousa, Nuno JC/0000-0002-8755-5126	FEDER through the COMPETE program; FCT - Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-OSM/104475/2008, PTDC/SAU-NEU/105180/2008]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-NEU/105180/2008] Funding Source: FCT	FEDER through the COMPETE program; FCT - Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This work has received financial support from FEDER through the COMPETE program and FCT - Fundacao para a Ciencia e a Tecnologia under the projects PTDC/SAU-OSM/104475/2008 and PTDC/SAU-NEU/105180/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Alvarez-Buylla A, 2008, COLD SH Q B, V73, P357, DOI 10.1101/sqb.2008.73.019; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Belluardo N, 2008, BRAIN RES, V1193, P12, DOI 10.1016/j.brainres.2007.11.069; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Caillava C, 2011, J CELL BIOL, V193, P397, DOI 10.1083/jcb.201004146; Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Curtis MA, 2007, NAT REV NEUROSCI, V8, P712, DOI 10.1038/nrn2216; DISALVO CV, 1995, CELL PROLIFERAT, V28, P511, DOI 10.1111/j.1365-2184.1995.tb00089.x; Doetsch F, 1997, J NEUROSCI, V17, P5046; Fischer J, 2011, NAT PROTOC, V6, P1981, DOI 10.1038/nprot.2011.412; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Ghashghaei HT, 2006, P NATL ACAD SCI USA, V103, P1930, DOI 10.1073/pnas.0510410103; Golmohammadi MG, 2008, STEM CELLS, V26, P979, DOI 10.1634/stemcells.2007-0919; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Haskell GT, 2005, J NEUROSCI, V25, P7636, DOI 10.1523/JNEUROSCI.0485-05.2005; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Komitova M, 2009, J COMP NEUROL, V512, P702, DOI 10.1002/cne.21917; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Lu M, 2007, J NEUROSCI METH, V161, P323, DOI 10.1016/j.jneumeth.2006.10.021; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mirzadeh Z., 2010, J VIS EXP; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Nait-Oumesmar B, 2008, J NEUROL SCI, V265, P26, DOI 10.1016/j.jns.2007.09.032; Nasrallah HA, 2010, BRAIN RES, V1354, P23, DOI 10.1016/j.brainres.2010.07.075; Nicoleau C, 2009, STEM CELLS, V27, P408, DOI 10.1634/stemcells.2008-0226; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Paxinos G., 2004, RAT BRAIN STEREOTAXI; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Sajad M, 2011, BRAIN RES, V1371, P140, DOI 10.1016/j.brainres.2010.11.050; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Weinandy F, 2011, EUR J NEUROSCI, V33, P1045, DOI 10.1111/j.1460-9568.2011.07602.x; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Zhang RL, 2006, J CEREBR BLOOD F MET, V26, P857, DOI 10.1038/sj.jcbfm.9600237	43	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38647	10.1371/journal.pone.0038647	http://dx.doi.org/10.1371/journal.pone.0038647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745673	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200019
J	Hanhineva, K; Aura, AM; Rogachev, I; Matero, S; Skov, T; Aharoni, A; Poutanen, K; Mykkanen, H				Hanhineva, Kati; Aura, Anna-Marja; Rogachev, Ilana; Matero, Sanni; Skov, Thomas; Aharoni, Asaph; Poutanen, Kaisa; Mykkanen, Hannu			In Vitro Microbiotic Fermentation Causes an Extensive Metabolite Turnover of Rye Bran Phytochemicals	PLOS ONE			English	Article							GUT MICROBIOME; DIETARY-FIBER; LIGNANS; ENTEROLACTONE; REVEALS; HEALTH; POLYPHENOLS; DERIVATIVES; MICROFLORA; CONVERSION	The human gut hosts a microbial community which actively contributes to the host metabolism and has thus remarkable effect on our health. Intestinal microbiota is known to interact remarkably with the dietary constituents entering the colon, causing major metabolic conversions prior to absorption. To investigate the effect of microbial metabolism on the phytochemical pool of rye bran, we applied an in vitro simulated colonic fermentation where samples were collected with intervals and analyzed by LC-MS based non-targeted metabolite profiling. The analyses revealed extensive metabolic turnover on the phytochemical composition of the bran samples, and showed effects on all the metabolite classes detected. Furthermore, the majority of the metabolites, both the precursors and the conversion products, remained unidentified indicating that there are numerous yet unknown phytochemicals, which can potentially affect on our health. This underlines the importance of comprehensive profiling assays and subsequent detailed molecular investigations in order to clarify the effect of microbiota on phytochemicals present in our everyday diet.	[Hanhineva, Kati; Poutanen, Kaisa; Mykkanen, Hannu] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Aura, Anna-Marja; Poutanen, Kaisa] VTT Tech Res Ctr Finland, Espoo, Finland; [Rogachev, Ilana; Aharoni, Asaph] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Matero, Sanni; Skov, Thomas] Univ Copenhagen, Dept Food Sci, Copenhagen, Denmark; [Matero, Sanni] Univ Copenhagen, Dept Pharmaceut & Analyt Chem, Copenhagen, Denmark	University of Eastern Finland; VTT Technical Research Center Finland; Weizmann Institute of Science; University of Copenhagen; University of Copenhagen	Hanhineva, K (corresponding author), Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.	kati.hanhineva@uef.fi	Hanhineva, Kati/AAH-1699-2019; Skov, Thomas/B-8733-2014	Hanhineva, Kati/0000-0001-6834-7375; Skov, Thomas/0000-0002-5993-3062	Nordforsk Nordic Centre of Excellence project "HELGA - whole grains and health"; Academy of Finland; European Research Council (ERC); Benoziyo Institute	Nordforsk Nordic Centre of Excellence project "HELGA - whole grains and health"; Academy of Finland(Academy of Finland); European Research Council (ERC)(European Research Council (ERC)European Commission); Benoziyo Institute	This work is funded by the Nordforsk Nordic Centre of Excellence project "HELGA - whole grains and health" (KH, HM). Funding from the Academy of Finland is gratefully acknowledged (KP). AA is the incumbent of the Adolpho and Evelyn Blum Career Development Chair. The work in the Aharoni lab was supported by the European Research Council (ERC) project SAMIT (FP7 program) and the Benoziyo Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari KB, 2012, J AGR FOOD CHEM, V60, P2497, DOI 10.1021/jf2048492; Andreasen MF, 2001, FREE RADICAL BIO MED, V31, P304, DOI 10.1016/S0891-5849(01)00585-8; Anson NM, 2011, J NUTR, V141, P137, DOI 10.3945/jn.110.127720; Arora T, 2011, NUTR REV, V69, P99, DOI 10.1111/j.1753-4887.2010.00365.x; Aura AM, 2007, DIETARY FIBRE: COMPONENTS AND FUNCTIONS, P235; Aura AM, 2006, EUR J NUTR, V45, P45, DOI 10.1007/s00394-005-0561-z; Aura AM, 2005, J SCI FOOD AGR, V85, P2085, DOI 10.1002/jsfa.2229; Aura AM, 2002, J AGR FOOD CHEM, V50, P1725, DOI 10.1021/jf0108056; Aura Anna-Marja, 2008, Phytochemistry Reviews, V7, P407, DOI 10.1007/s11101-008-9095-3; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; BARRY JL, 1995, BRIT J NUTR, V74, P303, DOI 10.1079/BJN19950137; Braune A, 2009, J AGR FOOD CHEM, V57, P3356, DOI 10.1021/jf900159h; Clavel T, 2006, NUTR RES REV, V19, P187, DOI 10.1017/S0954422407249704; Davis CD, 2009, J NUTR BIOCHEM, V20, P743, DOI 10.1016/j.jnutbio.2009.06.001; Deprez S, 2000, J NUTR, V130, P2733, DOI 10.1093/jn/130.11.2733; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Hanhineva K, METABOLOMICS, P1; Hanhineva K, 2008, PHYTOCHEMISTRY, V69, P2463, DOI 10.1016/j.phytochem.2008.07.009; Hanhineva K, 2011, J AGR FOOD CHEM, V59, P921, DOI 10.1021/jf103612u; Hanhineva K, 2009, PHYTOCHEM ANALYSIS, V20, P353, DOI 10.1002/pca.1133; Heinonen S, 2001, J AGR FOOD CHEM, V49, P3178, DOI 10.1021/jf010038a; Jacobs DM, 2008, NMR BIOMED, V21, P615, DOI 10.1002/nbm.1233; Jacobs DM, 2009, CURR DRUG METAB, V10, P41, DOI 10.2174/138920009787048383; Jaganath IB, 2009, FREE RADICAL BIO MED, V47, P1180, DOI 10.1016/j.freeradbiomed.2009.07.031; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li P, 2010, NATURE, V464, P1287, DOI 10.1038/4641287a; Licht TR, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-98; Martin FPJ, 2009, J PROTEOME RES, V8, P2090, DOI 10.1021/pr801068x; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Oikarinen S, 2003, BRIT J NUTR, V90, P119, DOI 10.1079/BJN2003883; Pan JY, 2009, NAT PROD REP, V26, P1251, DOI 10.1039/b910940d; Penalvo JL, 2005, J AGR FOOD CHEM, V53, P9342, DOI 10.1021/jf051488w; Penalvo JL, 2005, J NUTR, V135, P1056, DOI 10.1093/jn/135.5.1056; Rechner AR, 2004, FREE RADICAL BIO MED, V36, P212, DOI 10.1016/j.freeradbiomed.2003.09.022; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d; Smeds AI, 2009, J AGR FOOD CHEM, V57, P5837, DOI 10.1021/jf9004274; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9	45	12	12	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39322	10.1371/journal.pone.0039322	http://dx.doi.org/10.1371/journal.pone.0039322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745732	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693200062
J	Menard, A; Turgeon, K; Roche, DG; Binning, SA; Kramer, DL				Menard, Alexandre; Turgeon, Katrine; Roche, Dominique G.; Binning, Sandra A.; Kramer, Donald L.			Shelters and Their Use by Fishes on Fringing Coral Reefs	PLOS ONE			English	Article							HABITAT COMPLEXITY; RESERVE PROTECTION; SPECIES RICHNESS; PREY REFUGES; WEST-INDIES; MORAY EELS; ASSEMBLAGES; DENSITY; BARBADOS; COMMUNITIES	Coral reef fish density and species richness are often higher at sites with more structural complexity. This association may be due to greater availability of shelters, but surprisingly little is known about the size and density of shelters and their use by coral reef fishes. We quantified shelter availability and use by fishes for the first time on a Caribbean coral reef by counting all holes and overhangs with a minimum entrance diameter >= 3 cm in 30 quadrats (25 m(2)) on two fringing reefs in Barbados. Shelter size was highly variable, ranging from 42 cm(3) to over 4,000,000 cm(3), with many more small than large shelters. On average, there were 3.8 shelters m(-2), with a median volume of 1,200 cm(3) and a total volume of 52,000 cm(3) m(-2). The number of fish per occupied shelter ranged from 1 to 35 individual fishes belonging to 66 species, with a median of 1. The proportion of shelters occupied and the number of occupants increased strongly with shelter size. Shelter density and total volume increased with substrate complexity, and this relationship varied among reef zones. The density of shelter-using fish was much more strongly predicted by shelter density and median size than by substrate complexity and increased linearly with shelter density, indicating that shelter availability is a limiting resource for some coral reef fishes. The results demonstrate the importance of large shelters for fish density and support the hypothesis that structural complexity is associated with fish abundance, at least in part, due to its association with shelter availability. This information can help identify critical habitat for coral reef fishes, predict the effects of reductions in structural complexity of natural reefs and improve the design of artificial reefs.	[Menard, Alexandre; Turgeon, Katrine; Roche, Dominique G.; Binning, Sandra A.; Kramer, Donald L.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Turgeon, Katrine] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Roche, Dominique G.; Binning, Sandra A.] Australian Natl Univ, Australian Res Council Ctr Excellence Coral Reef, Res Sch Biol, Canberra, ACT, Australia	McGill University; University of Guelph; Australian National University	Menard, A (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	kturgeon@uoguelph.ca	Kramer, Donald L/E-9058-2011; Roche, Dominique/K-7426-2012; Turgeon, Katrine/K-9980-2019	Binning, Sandra/0000-0002-2804-9979; Roche, Dominique/0000-0002-3326-864X; Turgeon, Katrine/0000-0002-2528-130X	Natural Sciences and Engineering Research Council Canada [NSERC Rgpin 213]	Natural Sciences and Engineering Research Council Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Natural Sciences and Engineering Research Council Canada through a Discovery Grant to DLK (NSERC Rgpin 213) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2004, OECOLOGIA, V141, P105, DOI 10.1007/s00442-004-1617-0; Alvarez-Filip L, 2011, ECOL APPL, V21, P2223, DOI 10.1890/10-1563.1; Alvarez-Filip L, 2011, GLOBAL CHANGE BIOL, V17, P2470, DOI 10.1111/j.1365-2486.2010.02385.x; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Anderson DR, 2001, J WILDLIFE MANAGE, V65, P373, DOI 10.2307/3803088; Ault TR, 1998, OIKOS, V82, P354, DOI 10.2307/3546976; Ault TR, 1998, ECOL MONOGR, V68, P25, DOI 10.1890/0012-9615(1998)068[0025:SATPFO]2.0.CO;2; BARTELS PJ, 1984, BEHAVIOUR, V91, P312, DOI 10.1163/156853984X00137; Bartholomew A, 2008, MAR ECOL PROG SER, V358, P95, DOI 10.3354/meps07334; Bates D., 2011, IME4 LINEAR MIXED EF; Bejarano S, 2011, MAR BIOL, V158, P489, DOI 10.1007/s00227-010-1575-5; Berryman AA, 2004, OIKOS, V105, P667, DOI 10.1111/j.0030-1299.2004.13381.x; Bolker B, 2011, BBMLE PACKAGE TOOLS; Booth DJ, 2002, MAR ECOL PROG SER, V245, P205, DOI 10.3354/meps245205; BUCHHEIM JR, 1992, J EXP MAR BIOL ECOL, V164, P45, DOI 10.1016/0022-0981(92)90135-W; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caley MJ, 1996, J ANIM ECOL, V65, P414, DOI 10.2307/5777; Chapman MR, 1999, MAR ECOL PROG SER, V181, P81, DOI 10.3354/meps181081; CLARKE RD, 1994, COPEIA, P398; EGGLESTON DB, 1992, ECOLOGY, V73, P992, DOI 10.2307/1940175; Forrester GE, 2004, ECOLOGY, V85, P1332, DOI 10.1890/03-0184; Friedlander AM, 2010, MAR ECOL PROG SER, V410, P219, DOI 10.3354/meps08634; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Gilbert M, 2005, ENVIRON BIOL FISH, V73, P415, DOI 10.1007/s10641-005-2228-2; Ginsburg R.N, 1983, PERSPECTIVES CORAL R, P148; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Gratwicke B, 2005, MAR ECOL PROG SER, V292, P301, DOI 10.3354/meps292301; Hastings PA, 2010, CORAL REEFS, V29, P155, DOI 10.1007/s00338-009-0565-x; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; HIXON MA, 1989, B MAR SCI, V44, P666; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; HOBSON ES, 1972, FISH BULL NATL OC AT, V70, P715; HOBSON ES, 1965, COPEIA, P291, DOI DOI 10.2307/1440790; Holbrook SJ, 2002, MAR FRESHWATER RES, V53, P181, DOI 10.1071/MF01137; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Johansen JL, 2008, MAR ECOL PROG SER, V360, P219, DOI 10.3354/meps07482; Krause J, 2002, HDB FISH BIOL FISHER, V1, P285; Lewis JB, 2002, CORAL REEFS, V21, P49, DOI 10.1007/s00338-001-0198-1; LEWIS JOHN B., 1960, CANADIAN JOUR ZOOL, V38, P1133, DOI 10.1139/z60-118; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; Menard A, 2008, ENVIRON BIOL FISH, V82, P59, DOI 10.1007/s10641-007-9253-2; Nagelkerken I, 2000, MAR ECOL PROG SER, V194, P55, DOI 10.3354/meps194055; Nemeth RS, 1998, ENVIRON BIOL FISH, V53, P129, DOI 10.1023/A:1007402104047; Neter J., 1985, APPL LINEAR REGRESSI; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Oksanen J., **DATA OBJECT**; Quinn GP, 2003, EXPT DESIGN DATA ANA; ROBERTS CM, 1987, MAR ECOL PROG SER, V41, P1, DOI 10.3354/meps041001; ROBERTSON DR, 1979, J EXP MAR BIOL ECOL, V40, P285, DOI 10.1016/0022-0981(79)90057-1; ROBERTSON DR, 1984, ECOLOGY, V65, P1121, DOI 10.2307/1938320; Samhouri JF, 2009, OECOLOGIA, V160, P257, DOI 10.1007/s00442-009-1307-z; SHULMAN MJ, 1984, J EXP MAR BIOL ECOL, V74, P85, DOI 10.1016/0022-0981(84)90039-X; Smith C.L., 1975, American Museum Novitates, VNo. 2572, P1; STEARN CW, 1977, B MAR SCI, V27, P479; Talbot F, 1972, P S COR COR REEFS 19, P425; TOMASCIK T, 1987, MAR BIOL, V94, P53, DOI 10.1007/BF00392900; Walker BK, 2009, J COASTAL RES, V25, P39, DOI [10.2112/S153-005.1, 10.2112/SI53-005.1]; White JW, 2010, ECOLOGY, V91, P1949, DOI 10.1890/09-0298.1; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Young RF, 2003, COPEIA, P44	63	29	29	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38450	10.1371/journal.pone.0038450	http://dx.doi.org/10.1371/journal.pone.0038450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745664	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693200011
J	Zhang, YC; Wang, HP; Ren, JY; Tang, XF; Jing, Y; Xing, DH; Zhao, GS; Yao, Z; Yang, X; Bai, H				Zhang, Yongci; Wang, Haiping; Ren, Jianyun; Tang, Xiaofei; Jing, Ye; Xing, Donghong; Zhao, Guosheng; Yao, Zhi; Yang, Xi; Bai, Hong			IL-17A Synergizes with IFN-gamma to Upregulate iNOS and NO Production and Inhibit Chlamydial Growth	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INTERFERON-GAMMA; IMMUNE-RESPONSE; T-CELLS; INFECTION; MACROPHAGES; PNEUMONIAE; MECHANISM; INTERLEUKIN-17; ACTIVATION	IFN-gamma-mediated inducible nitric oxide synthase (iNOS) expression is critical for controlling chlamydial infection through microbicidal nitric oxide (NO) production. Interleukin-17A (IL-17A), as a new proinflammatory cytokine, has been shown to play a protective role in host defense against Chlamydia muridarum (Cm) infection. To define the related mechanism, we investigated, in the present study, the effect of IL-17A on IFN-gamma induced iNOS expression and NO production during Cm infection in vitro and in vivo. Our data showed that IL-17A significantly enhanced IFN-gamma-induced iNOS expression and NO production and inhibited Cm growth in Cm-infected murine lung epithelial (TC-1) cells. The synergistic effect of IL-17A and IFN-gamma on Chlamydia clearance from TC-1 cells correlated with iNOS induction. Since one of the main antimicrobial mechanisms of activated macrophages is the release of NO, we also examined the inhibitory effect of IL-17A and IFN-gamma on Cm growth in peritoneal macrophages. IL-17A (10 ng/ml) synergizes with IFN-gamma (200 U/ml) in macrophages to inhibit Cm growth. This effect was largely reversed by aminoguanidine (AG), an iNOS inhibitor. Finally, neutralization of IL-17A in Cm infected mice resulted in reduced iNOS expression in the lung and higher Cm growth. Taken together, the results indicate that IL-17A and IFN-gamma play a synergistic role in inhibiting chlamydial lung infection, at least partially through enhancing iNOS expression and NO production in epithelial cells and macrophages.	[Zhang, Yongci; Wang, Haiping; Ren, Jianyun; Tang, Xiaofei; Xing, Donghong; Zhao, Guosheng; Yao, Zhi; Yang, Xi; Bai, Hong] Tianjin Med Univ, Sch Basic Med Sci, Minist China, Dept Immunol,Tianjin Key Lab Cellular & Mol Immun, Tianjin, Peoples R China; [Zhang, Yongci; Wang, Haiping; Ren, Jianyun; Tang, Xiaofei; Xing, Donghong; Zhao, Guosheng; Yao, Zhi; Yang, Xi; Bai, Hong] Tianjin Med Univ, Sch Basic Med Sci, Minist China, Key Lab Educ, Tianjin, Peoples R China; [Jing, Ye] Chinese Peoples Liberat Army 464 Hosp, Dept Clin Lab, Tianjin, Peoples R China; [Yang, Xi] Univ Manitoba, Fac Med, Dept Med Microbiol, Lab Infect & Immun, Winnipeg, MB, Canada; [Yang, Xi] Univ Manitoba, Fac Med, Dept Immunol, Lab Infect & Immun, Winnipeg, MB R3E 0W3, Canada	Tianjin Medical University; Tianjin Medical University; University of Manitoba; University of Manitoba	Zhang, YC (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Minist China, Dept Immunol,Tianjin Key Lab Cellular & Mol Immun, Tianjin, Peoples R China.	yangxi@cc.umanitoba.ca; hongbai25@163.com		Yang, Xi/0000-0002-8831-7488	National Natural Science Foundation of China [31070797]; Tianjin Municipal Science and Technology Commission (TSTC) [11JCZDJC16200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission (TSTC)	This work was supported by grant (31070797) from the National Natural Science Foundation of China and grant (the Key Program: 11JCZDJC16200) from the Tianjin Municipal Science and Technology Commission (TSTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Bai H, 2009, J IMMUNOL, V183, P5886, DOI 10.4049/jimmunol.0901584; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; BruchGerharz D, 1996, J EXP MED, V184, P2007, DOI 10.1084/jem.184.5.2007; BYRNE GI, 1986, INFECT IMMUN, V53, P347, DOI 10.1128/IAI.53.2.347-351.1986; Chen BJ, 1996, FEMS IMMUNOL MED MIC, V14, P109, DOI 10.1016/0928-8244(96)00018-1; Chung DR, 2003, J IMMUNOL, V170, P1958, DOI 10.4049/jimmunol.170.4.1958; DELAMAZA LM, 1985, J IMMUNOL, V135, P4198; DING AH, 1988, J IMMUNOL, V141, P2407; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Huang J, 2002, P NATL ACAD SCI USA, V99, P3914, DOI 10.1073/pnas.062578399; Igietseme JU, 1996, IMMUNOLOGY, V87, P1; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Miljkovic D, 2004, CYTOKINE GROWTH F R, V15, P21, DOI 10.1016/j.cytogfr.2003.10.003; Miljkovic D, 2005, CELL MOL LIFE SCI, V62, P2658, DOI 10.1007/s00018-005-5259-0; MURRAY HW, 1989, INFECT IMMUN, V57, P845, DOI 10.1128/IAI.57.3.845-849.1989; NUSSLER AK, 1993, J LEUKOCYTE BIOL, V54, P171, DOI 10.1002/jlb.54.2.171; Qiu HY, 2004, IMMUNOLOGY, V111, P453, DOI 10.1111/j.0019-2805.2004.01835.x; Rodriguez N, 2008, J LEUKOCYTE BIOL, V84, P1585, DOI 10.1189/jlb.0508304; Rottenberg ME, 1999, J IMMUNOL, V162, P2829; Saura M, 1999, J MOL BIOL, V289, P459, DOI 10.1006/jmbi.1999.2752; SCHNEEMANN M, 1993, J INFECT DIS, V167, P1358, DOI 10.1093/infdis/167.6.1358; SCHOEDON G, 1993, EUR J BIOCHEM, V213, P833, DOI 10.1111/j.1432-1033.1993.tb17826.x; Schulz SM, 2008, INT IMMUNOL, V20, P1129, DOI 10.1093/intimm/dxn069; SUMMERSGILL JT, 1995, INFECT IMMUN, V63, P2801, DOI 10.1128/IAI.63.7.2801-2803.1995; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; van der Veen RC, 2001, INT IMMUNOPHARMACOL, V1, P1491, DOI 10.1016/S1567-5769(01)00093-5; Woods M L 2nd, 1994, Immunol Ser, V60, P179; Yang X, 1996, J IMMUNOL, V156, P4338; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424	30	44	44	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39214	10.1371/journal.pone.0039214	http://dx.doi.org/10.1371/journal.pone.0039214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745717	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200049
J	Magi, A; Tattini, L; Benelli, M; Giusti, B; Abbate, R; Ruffo, S				Magi, Alberto; Tattini, Lorenzo; Benelli, Matteo; Giusti, Betti; Abbate, Rosanna; Ruffo, Stefano			WNP: A Novel Algorithm for Gene Products Annotation from Weighted Functional Networks	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; YEAST SACCHAROMYCES-CEREVISIAE; FUNCTION PREDICTION; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; GENOMIC DATA; INTEGRATION; ASSOCIATION; TRANSPORTER; MICROARRAY	Predicting the biological function of all the genes of an organism is one of the fundamental goals of computational system biology. In the last decade, high-throughput experimental methods for studying the functional interactions between gene products (GPs) have been combined with computational approaches based on Bayesian networks for data integration. The result of these computational approaches is an interaction network with weighted links representing connectivity likelihood between two functionally related GPs. The weighted network generated by these computational approaches can be used to predict annotations for functionally uncharacterized GPs. Here we introduce Weighted Network Predictor (WNP), a novel algorithm for function prediction of biologically uncharacterized GPs. Tests conducted on simulated data show that WNP outperforms other 5 state-of-the-art methods in terms of both specificity and sensitivity and that it is able to better exploit and propagate the functional and topological information of the network. We apply our method to Saccharomyces cerevisiae yeast and Arabidopsis thaliana networks and we predict Gene Ontology function for about 500 and 10000 uncharacterized GPs respectively.	[Magi, Alberto; Giusti, Betti; Abbate, Rosanna] Univ Florence, Dipartimento Area Crit Med Chirurg, Florence, Italy; [Tattini, Lorenzo; Benelli, Matteo] Univ Florence, Ctr Interdipartimentale Studio Dinam Complesse CS, Florence, Italy; [Benelli, Matteo] Azienda Osped Univ Careggi, Dipartimento Lab, Unita Diagnost Genet, Florence, Italy; [Ruffo, Stefano] Univ Florence, Dipartimento Energet Sergio Stecco, Florence, Italy	University of Florence; University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence	Magi, A (corresponding author), Univ Florence, Dipartimento Area Crit Med Chirurg, Florence, Italy.	albertomagi@gmail.com	Magi, Alberto/M-6773-2015; Giusti, Betti/K-6978-2016; Benelli, Matteo/I-2497-2018	Magi, Alberto/0000-0001-7393-4283; Giusti, Betti/0000-0002-8708-9444; Benelli, Matteo/0000-0003-1227-356X; Ruffo, Stefano/0000-0003-2911-8718; Tattini, Lorenzo/0000-0002-5477-084X	Italian Ministry of Health; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)	Italian Ministry of Health(Ministry of Health, Italy); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was partially financed by the Italian Ministry of Health (Strategic Project: Transcriptomic and proteomic profiles for identification of novel clinical biomarkers of cardiovascular risk in women). Partial financial support for MB was provided by Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); http://www.istruzione.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Braglia P, 2010, EMBO REP, V11, P758, DOI 10.1038/embor.2010.130; Buck MJ, 2004, GENOMICS, V83, P349, DOI 10.1016/j.ygeno.2003.11.004; Burr CA, 2011, PLANT PHYSIOL, V156, P1837, DOI 10.1104/pp.111.175224; Chua HN, 2007, BIOINFORMATICS, V23, P3364, DOI 10.1093/bioinformatics/btm520; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Efroni I, 2008, PLANT CELL, V20, P2293, DOI 10.1105/tpc.107.057521; Fujiwara S, 2008, J BIOL CHEM, V283, P23073, DOI 10.1074/jbc.M803471200; Gerus M, 2010, MOL CELL BIOL, V30, P1130, DOI 10.1128/MCB.00999-09; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Kile AC, 2010, MOL CELL BIOL, V30, P160, DOI 10.1128/MCB.00612-09; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000988; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Lee WY, 2009, PLANT J, V58, P511, DOI 10.1111/j.1365-313X.2009.03795.x; Li MY, 2011, PLANT CELL, V23, P1107, DOI 10.1105/tpc.110.081240; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Morandini P, 2002, PLANT J, V31, P487, DOI 10.1046/j.1365-313X.2002.01373.x; Morozova N, 2006, NAT CELL BIOL, V8, P1263, DOI 10.1038/ncb1489; Mukai N, 2010, J BIOSCI BIOENG, V109, P564, DOI 10.1016/j.jbiosc.2009.11.011; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Reddy VS, 2008, J BIOL CHEM, V283, P8846, DOI 10.1074/jbc.M706752200; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Teste MA, 2010, J BIOL CHEM, V285, P26815, DOI 10.1074/jbc.M110.145946; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Tsallis C, 1996, PHYSICA A, V233, P395, DOI 10.1016/S0378-4371(96)00271-3; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; van Heusden GPH, 2008, FEMS MICROBIOL LETT, V282, P100, DOI 10.1111/j.1574-6968.2008.01113.x; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Wang YY, 2011, PLANT CELL, V23, P1945, DOI 10.1105/tpc.111.083618; Yang CY, 2011, PLANT PHYSIOL, V156, P202, DOI 10.1104/pp.111.172486; Yuan LX, 2009, PLANT CELL PHYSIOL, V50, P13, DOI 10.1093/pcp/pcn186; Zhu YF, 2010, PLANT J, V61, P223, DOI 10.1111/j.1365-313X.2009.04049.x	44	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e38767	10.1371/journal.pone.0038767	http://dx.doi.org/10.1371/journal.pone.0038767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761703	Green Submitted, Green Published, gold			2022-12-27	WOS:000305826400005
J	Kirby, LA; Schott, JT; Noble, BL; Mendez, DC; Caseley, PS; Peterson, SC; Routledge, TJ; Patel, NV				Kirby, Leslie A.; Schott, Jason T.; Noble, Brenda L.; Mendez, Daniel C.; Caseley, Paul S.; Peterson, Sarah C.; Routledge, Tyler J.; Patel, Nilay V.			Glycogen Synthase Kinase 3 (GSK3) Inhibitor, SB-216763, Promotes Pluripotency in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; BETA-CATENIN; SELF-RENEWAL; REGULATORY CIRCUITRY; WNT; NANOG; STATE; TCF3; ACTIVATION; REPRESSION	Canonical Wnt/beta-catenin signaling has been suggested to promote self-renewal of pluripotent mouse and human embryonic stem cells. Here, we show that SB-216763, a glycogen synthase kinase-3 (GSK3) inhibitor, can maintain mouse embryonic stem cells (mESCs) in a pluripotent state in the absence of exogenous leukemia inhibitory factor (LIF) when cultured on mouse embryonic fibroblasts (MEFs). MESCs maintained with SB-216763 for one month were morphologically indistinguishable from LIF-treated mESCs and expressed pluripotent-specific genes Oct4, Sox2, and Nanog. Furthermore, Nanog immunostaining was more homogenous in SB-216763-treated colonies compared to LIF. Embryoid bodies (EBs) prepared from these mESCs expressed early-stage markers for all three germ layers, and could efficiently differentiate into cardiac-like cells and MAP2-immunoreactive neurons. To our knowledge, SB-216763 is the first GSK3 inhibitor that can promote self-renewal of mESC co-cultured with MEFs for more than two months.	[Kirby, Leslie A.; Schott, Jason T.; Noble, Brenda L.; Mendez, Daniel C.; Caseley, Paul S.; Peterson, Sarah C.; Routledge, Tyler J.; Patel, Nilay V.] Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92634 USA; [Patel, Nilay V.] Calif State Univ Fullerton, Ctr Appl Biotechnol Studies, Fullerton, CA 92634 USA	California State University System; California State University Fullerton; California State University System; California State University Fullerton	Kirby, LA (corresponding author), Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92634 USA.	npatel@fullerton.edu		Kirby, Leslie/0000-0003-4467-2661	NSF CCLI [DUE-0737149]; CSU-Fullerton; CIRM Bridges to Stem Cell Research; HHMI Undergraduate Research Scholars Program	NSF CCLI(National Science Foundation (NSF)); CSU-Fullerton; CIRM Bridges to Stem Cell Research; HHMI Undergraduate Research Scholars Program	This research was funded by NSF CCLI (DUE-0737149), intramural funds from CSU-Fullerton (N.V.P.), CIRM Bridges to Stem Cell Research (L.A.K.), and HHMI Undergraduate Research Scholars Program (D.C.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri S, 2009, ONCOGENE, V28, P3033, DOI 10.1038/onc.2009.159; Alonso M, 2004, CURR MED CHEM, V11, P755, DOI 10.2174/0929867043455738; Asuni AA, 2006, EUR J NEUROSCI, V24, P3387, DOI 10.1111/j.1460-9568.2006.05243.x; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Bone HK, 2009, CHEM BIOL, V16, P15, DOI 10.1016/j.chembiol.2008.11.003; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Croce Jenifer C., 2008, V469, P3, DOI 10.1007/978-1-60327-469-2_1; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.00251.x; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Harwood Adrian J., 2008, V469, P21, DOI 10.1007/978-1-60327-469-2_2; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kim CG, 2011, BIOCHEM BIOPH RES CO, V410, P637, DOI 10.1016/j.bbrc.2011.06.044; Kim EA, 2010, BIOCHEM BIOPH RES CO, V394, P966, DOI 10.1016/j.bbrc.2010.03.099; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lawson MA, 1998, MOL CELL ENDOCRINOL, V140, P157, DOI 10.1016/S0303-7207(98)00044-6; Li WL, 2010, TRENDS PHARMACOL SCI, V31, P36, DOI 10.1016/j.tips.2009.10.002; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Lyssiotis CA, 2011, ANGEW CHEM INT EDIT, V50, P200, DOI 10.1002/anie.201004284; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Niwa H, 2011, NAT CELL BIOL, V13, P1024, DOI 10.1038/ncb2333; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Romero-Lanman EE, 2012, STEM CELLS DEV, V21, P384, DOI 10.1089/scd.2011.0428; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Sineva GS, 2010, BIOL CELL, V102, P549, DOI 10.1042/BC20100016; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Sokol SY, 2011, DEVELOPMENT; Soutar MPM, 2010, J NEUROCHEM, V115, P974, DOI 10.1111/j.1471-4159.2010.06988.x; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takao Y, 2007, BIOCHEM BIOPH RES CO, V353, P699, DOI 10.1016/j.bbrc.2006.12.072; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Tighe A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-34; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Villa-Diaz LG, 2009, STEM CELLS DEV, V18, P641, DOI 10.1089/scd.2008.0010; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Yi F, 2008, STEM CELLS, V26, P1951, DOI 10.1634/stemcells.2008-0229; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	61	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39329	10.1371/journal.pone.0039329	http://dx.doi.org/10.1371/journal.pone.0039329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22745733	gold, Green Published, Green Submitted			2022-12-27	WOS:000305808700021
J	Kotelevets, N; Fabbro, D; Huwiler, A; Zangemeister-Wittke, U				Kotelevets, Nataliya; Fabbro, Doriano; Huwiler, Andrea; Zangemeister-Wittke, Uwe			Targeting Sphingosine Kinase 1 in Carcinoma Cells Decreases Proliferation and Survival by Compromising PKC Activity and Cytokinesis	PLOS ONE			English	Article							RENAL MESANGIAL CELLS; DNA-DAMAGE; CHECKPOINT FUNCTION; PROTEIN-KINASES; HUMAN-PLATELETS; C-ALPHA; CANCER; INHIBITOR; CYCLE; EXPRESSION	Sphingosine kinases (SK) catalyze the phosphorylation of proapoptotic sphingosine to the prosurvival factor sphingosine 1-phosphate (S1P), thereby promoting oncogenic processes. Breast (MDA-MB-231), lung (NCI-H358), and colon (HCT 116) carcinoma cells were transduced with shRNA to downregulate SK-1 expression or treated with a pharmacologic SK-1 inhibitor. The effects of SK-1 targeting were investigated by measuring the level of intracellular sphingosine, the activity of protein kinase C (PKC) and cell cycle regulators, and the mitotic index. Functional assays included measurement of cell proliferation, colony formation, apoptosis, and cell cycle analysis. Downregulation of SK-1 or its pharmacologic inhibition increased intracellular sphingosine and decreased PKC activity as shown by reduced phosphorylation of PKC substrates. In MDA-MB-231 cells this effect was most pronounced and reduced cell proliferation and colony formation, which could be mimicked using exogenous sphingosine or the PKC inhibitor RO 31-8220. SK-1 downregulation in MDA-MB-231 cells increased the number of cells with 4N and 8N DNA content, and similar effects were observed upon treatment with sphingosine or inhibitors of SK-1 or PKC. Examination of cell cycle regulators unveiled decreased cdc2 activity and expression of Chk1, which may compromise spindle checkpoint function and cytokinesis. Indeed, SK-1 kd cells entered mitosis but failed to divide, and in the presence of taxol also failed to sustain mitotic arrest, resulting in further increased endoreduplication and apoptosis. Our findings delineate an intriguing link between SK-1, PKC and components of the cell cycle machinery, which underlines the significance of SK-1 as a target for cancer therapy.	[Kotelevets, Nataliya; Huwiler, Andrea; Zangemeister-Wittke, Uwe] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Fabbro, Doriano] Novartis Pharma AG, NIBR Basel, Basel, Switzerland; [Huwiler, Andrea] Univ Hosp Frankfurt, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany; [Zangemeister-Wittke, Uwe] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland	University of Bern; Novartis; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Zurich	Kotelevets, N (corresponding author), Univ Bern, Inst Pharmacol, Bern, Switzerland.	uwe.zangemeister@pki.unibe.ch			Swiss National Science Foundation [310000_119859, 310030_135619]; German Research Foundation [FOG784, HU 842/5-1]; Krebsliga of the Kanton Bern	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Foundation(German Research Foundation (DFG)); Krebsliga of the Kanton Bern	This work was supported by the Swiss National Science Foundation (310000_119859 and 310030_135619), the German Research Foundation (FOG784, HU 842/5-1) and the Krebsliga of the Kanton Bern. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn EH, 2006, EXP BIOL MED, V231, P1664; BALTUCH GH, 1993, J NEURO-ONCOL, V16, P141, DOI 10.1007/BF01324701; Black JD, 2000, FRONT BIOSCI-LANDMRK, V5, pD406, DOI 10.2741/Black; BLOBE GC, 1994, CANCER METAST REV, V13, P411, DOI 10.1007/BF00666107; Doll F, 2005, BBA-MOL CELL BIOL L, V1738, P72, DOI 10.1016/j.bbalip.2005.12.001; Fabbro D, 2000, ANTI-CANCER DRUG DES, V15, P17; Fabbro D, 1999, PHARMACOL THERAPEUT, V82, P293, DOI 10.1016/S0163-7258(99)00005-4; FAUCHER M, 1988, J BIOL CHEM, V263, P5319; French KJ, 2003, CANCER RES, V63, P5962; Geiges D, 1997, BIOCHEM PHARMACOL, V53, P865, DOI 10.1016/S0006-2952(96)00885-4; Gillies L, 2009, CELL SIGNAL, V21, P675, DOI 10.1016/j.cellsig.2009.01.023; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HANNUN YA, 1987, SCIENCE, V235, P670, DOI 10.1126/science.3101176; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HIDAKA H, 1988, J BIOL CHEM, V263, P4523; Hofmann LP, 2008, BIOL CHEM, V389, P1399, DOI 10.1515/BC.2008.160; Huwiler A, 2000, BBA-MOL CELL BIOL L, V1485, P63, DOI 10.1016/S1388-1981(00)00042-1; HUWILER A, 1991, BIOCHEM J, V279, P441, DOI 10.1042/bj2790441; HUWILER A, 1992, FEBS LETT, V300, P259, DOI 10.1016/0014-5793(92)80858-E; Huwiler A, 2007, CRIT REV ONCOL HEMAT, V63, P150, DOI 10.1016/j.critrevonc.2007.04.010; Huwiler A, 2011, BRIT J PHARMACOL, V162, P532, DOI 10.1111/j.1476-5381.2010.01053.x; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Jones ML, 2004, J BIOL CHEM, V279, P40475, DOI 10.1074/jbc.M402970200; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Klawitter S, 2007, BRIT J PHARMACOL, V150, P271, DOI 10.1038/sj.bjp.0706983; Kohn EA, 2003, CANCER RES, V63, P31; Kozutsumi Y, 2002, BBA-MOL CELL BIOL L, V1582, P138, DOI 10.1016/S1388-1981(02)00148-8; Kumar A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.3; Lee JY, 2000, EXP CELL RES, V261, P303, DOI 10.1006/excr.2000.5028; Livneh E, 1997, EUR J BIOCHEM, V248, P1, DOI 10.1111/j.1432-1033.1997.t01-4-00001.x; Loveridge C, 2010, J BIOL CHEM, V285, P38841, DOI 10.1074/jbc.M110.127993; MARTE BM, 1994, CELL GROWTH DIFFER, V5, P239; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Pchejetski D, 2011, NAT REV UROL, V8, P569, DOI 10.1038/nrurol.2011.117; Peddibhotla S, 2009, P NATL ACAD SCI USA, V106, P5159, DOI 10.1073/pnas.0806671106; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Qiao L, 1996, CANCER LETT, V107, P83, DOI 10.1016/0304-3835(96)04346-7; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; STABEL S, 1991, PHARMACOL THERAPEUT, V51, P71, DOI 10.1016/0163-7258(91)90042-K; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Takai H, 2000, GENE DEV, V14, P1439; Tang JB, 2006, P NATL ACAD SCI USA, V103, P11964, DOI 10.1073/pnas.0604987103; Tasinato A, 1995, P NATL ACAD SCI USA, V92, P12190, DOI 10.1073/pnas.92.26.12190; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Vitale I, 2010, EMBO J, V29, P1272, DOI 10.1038/emboj.2010.11; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Yu BZ, 2004, CELL BIOCHEM FUNCT, V22, P291, DOI 10.1002/cbf.1103; Yu Robert K., 1994, Journal of Biomedical Science, V1, P229, DOI 10.1007/BF02253307; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003	56	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39209	10.1371/journal.pone.0039209	http://dx.doi.org/10.1371/journal.pone.0039209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761740	Green Submitted, Green Published, gold			2022-12-27	WOS:000305781700024
J	Wu, SP; Liu, J; Reedy, MC; Perz-Edwards, RJ; Tregear, RT; Winkler, H; Franzini-Armstrong, C; Sasaki, H; Lucaveche, C; Goldman, YE; Reedy, MK; Taylor, KA				Wu, Shenping; Liu, Jun; Reedy, Mary C.; Perz-Edwards, Robert J.; Tregear, Richard T.; Winkler, Hanspeter; Franzini-Armstrong, Clara; Sasaki, Hiroyuki; Lucaveche, Carmen; Goldman, Yale E.; Reedy, Michael K.; Taylor, Kenneth A.			Structural Changes in Isometrically Contracting Insect Flight Muscle Trapped following a Mechanical Perturbation	PLOS ONE			English	Article							X-RAY-DIFFRACTION; FORCE GENERATION; ELECTRON TOMOGRAPHY; MYOSIN HEADS; LIGHT-CHAIN; FLUORESCENCE POLARIZATION; RHODAMINE ISOMERS; LENGTH CHANGES; UNIFIED THEORY; THIN FILAMENT	The application of rapidly applied length steps to actively contracting muscle is a classic method for synchronizing the response of myosin cross-bridges so that the average response of the ensemble can be measured. Alternatively, electron tomography (ET) is a technique that can report the structure of the individual members of the ensemble. We probed the structure of active myosin motors (cross-bridges) by applying 0.5% changes in length (either a stretch or a release) within 2 ms to isometrically contracting insect flight muscle (IFM) fibers followed after 5-6 ms by rapid freezing against a liquid helium cooled copper mirror. ET of freeze-substituted fibers, embedded and thin-sectioned, provides 3-D cross-bridge images, sorted by multivariate data analysis into similar to 40 classes, distinct in average structure, population size and lattice distribution. Individual actin subunits are resolved facilitating quasi-atomic modeling of each class average to determine its binding strength (weak or strong) to actin. similar to 98% of strong-binding acto-myosin attachments present after a length perturbation are confined to "target zones" of only two actin subunits located exactly midway between successive troponin complexes along each long-pitch helical repeat of actin. Significant changes in the types, distribution and structure of actin-myosin attachments occurred in a manner consistent with the mechanical transients. Most dramatic is near disappearance, after either length perturbation, of a class of weak-binding cross-bridges, attached within the target zone, that are highly likely to be precursors of strong-binding cross-bridges. These weak-binding cross-bridges were originally observed in isometrically contracting IFM. Their disappearance following a quick stretch or release can be explained by a recent kinetic model for muscle contraction, as behaviour consistent with their identification as precursors of strong-binding cross-bridges. The results provide a detailed model for contraction in IFM that may be applicable to contraction in other types of muscle.	[Wu, Shenping; Liu, Jun; Winkler, Hanspeter; Taylor, Kenneth A.] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Reedy, Mary C.; Perz-Edwards, Robert J.; Lucaveche, Carmen; Reedy, Michael K.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Tregear, Richard T.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Franzini-Armstrong, Clara; Goldman, Yale E.] Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Sasaki, Hiroyuki] Jikei Univ, Sch Med, Inst DNA Med, Tokyo, Japan	State University System of Florida; Florida State University; Duke University; MRC Laboratory Molecular Biology; University of Pennsylvania; Jikei University	Wu, SP (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	taylor@bio.fsu.edu		Sasaki, Hiroyuki/0000-0002-5358-5853; Edwards, Robert/0000-0003-4446-1194	National Institutes of Health [GM30598, HL15835, AR14317]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL015835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR014317, R01AR014317, R01AR062135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030598] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22136002] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Institutes of Health grants GM30598 (KAT), HL15835 (YEG and CF-A) and AR14317 (MKR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AL-Khayat HA, 2003, BIOPHYS J, V85, P1063, DOI 10.1016/S0006-3495(03)74545-7; Beausang JF, 2008, BIOPHYS J, V95, P5820, DOI 10.1529/biophysj.108.140319; Berger CL, 1996, BIOPHYS J, V71, P3330, DOI 10.1016/S0006-3495(96)79526-7; BERGER CL, 1994, BIOPHYS J, V67, P250, DOI 10.1016/S0006-3495(94)80476-X; Bershitsky SY, 1997, NATURE, V388, P186, DOI 10.1038/40651; Brunello E, 2007, P NATL ACAD SCI USA, V104, P20114, DOI 10.1073/pnas.0707626104; Chan WP, 1996, J EXP BIOL, V199, P2767; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; FINER JT, 1995, BIOPHYS J, V68, pS291; FORD LE, 1977, J PHYSIOL-LONDON, V269, P441, DOI 10.1113/jphysiol.1977.sp011911; GILMOUR KM, 1993, J EXP BIOL, V183, P101; GILMOUR KM, 1993, J EXP BIOL, V183, P77; HIROSE K, 1994, J CELL BIOL, V127, P763, DOI 10.1083/jcb.127.3.763; HIROSE K, 1993, BIOPHYS J, V65, P397, DOI 10.1016/S0006-3495(93)81061-0; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; HOLMES KC, 1980, PROC R SOC SER B-BIO, V207, P13, DOI 10.1098/rspb.1980.0012; Hopkins SC, 1998, BIOPHYS J, V74, P3093, DOI 10.1016/S0006-3495(98)78016-6; Hopkins SC, 2002, J MOL BIOL, V318, P1275, DOI 10.1016/S0022-2836(02)00189-4; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; HUXLEY HE, 1983, J MOL BIOL, V169, P469, DOI 10.1016/S0022-2836(83)80062-X; HUXLEY HE, 1967, J MOL BIOL, V30, P383, DOI 10.1016/S0022-2836(67)80046-9; Huxley H, 2006, J MOL BIOL, V363, P743, DOI 10.1016/j.jmb.2006.08.075; Huxley H, 2006, J MOL BIOL, V363, P762, DOI 10.1016/j.jmb.2006.08.055; Irving M, 2000, NAT STRUCT BIOL, V7, P482, DOI 10.1038/75890; IRVING M, 1992, NATURE, V357, P156, DOI 10.1038/357156a0; IRVING M, 1995, NATURE, V375, P688, DOI 10.1038/375688a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Littlefield KP, 2008, J MOL BIOL, V381, P519, DOI 10.1016/j.jmb.2008.06.029; Liu J, 2004, J STRUCT BIOL, V147, P268, DOI 10.1016/j.jsb.2004.03.008; Liu J, 2006, J MOL BIOL, V362, P844, DOI 10.1016/j.jmb.2006.07.084; LOMBARDI V, 1995, NATURE, V374, P553, DOI 10.1038/374553a0; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Molloy JE, 1988, ACTIVE INSECT FIBRIL; Perz-Edwards RJ, 2011, P NATL ACAD SCI USA, V108, P120, DOI 10.1073/pnas.1014599107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piazzesi G, 2002, NATURE, V415, P659, DOI 10.1038/415659a; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020; Reedy M, 1998, PFLUG ARCH EUR J PHY, V436, pR20; REEDY MC, 1988, J MOL BIOL, V204, P357, DOI 10.1016/0022-2836(88)90582-7; REEDY MK, 1985, J MOL BIOL, V185, P145, DOI 10.1016/0022-2836(85)90188-3; REEDY MK, 1968, J MOL BIOL, V31, P155, DOI 10.1016/0022-2836(68)90437-3; Schmitz H, 1996, J MOL BIOL, V264, P279, DOI 10.1006/jmbi.1996.0641; Smith DA, 2008, ANN BIOMED ENG, V36, P1624, DOI 10.1007/s10439-008-9536-6; Smith DA, 2008, ANN BIOMED ENG, V36, P1353, DOI 10.1007/s10439-008-9514-z; Taylor KA, 1999, CELL, V99, P421, DOI 10.1016/S0092-8674(00)81528-7; Taylor KA, 2007, METHOD CELL BIOL, V79, P321, DOI 10.1016/S0091-679X(06)79013-6; THOMAS DD, 1995, BIOPHYS J, V68, pS135; Tregear RT, 2004, BIOPHYS J, V86, P3009, DOI 10.1016/S0006-3495(04)74350-7; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; VANBUREN P, 1995, BIOPHYS J, V68, pS256; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; WRAY JS, 1979, NATURE, V280, P325, DOI 10.1038/280325a0; Wu SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012643; Wu SP, 2009, J STRUCT BIOL, V168, P485, DOI 10.1016/j.jsb.2009.08.007	56	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39422	10.1371/journal.pone.0039422	http://dx.doi.org/10.1371/journal.pone.0039422			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761792	Green Submitted, Green Published, gold			2022-12-27	WOS:000305781700037
J	Assou, S; Boumela, I; Haouzi, D; Monzo, C; Dechaud, H; Kadoch, IJ; Hamamah, S				Assou, Said; Boumela, Imene; Haouzi, Delphine; Monzo, Cecile; Dechaud, Herve; Kadoch, Issac-Jacques; Hamamah, Samir			Transcriptome Analysis during Human Trophectoderm Specification Suggests New Roles of Metabolic and Epigenetic Genes	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HUMAN PREIMPLANTATION DEVELOPMENT; DNA-REPAIR GENES; MAMMALIAN DEVELOPMENT; STEROIDOGENIC ENZYME; EXPRESSION PATTERNS; HUMAN BLASTOCYST; GENOME-WIDE; MOUSE; DIFFERENTIATION	In humans, successful pregnancy depends on a cascade of dynamic events during early embryonic development. Unfortunately, molecular data on these critical events is scarce. To improve our understanding of the molecular mechanisms that govern the specification/development of the trophoblast cell lineage, the transcriptome of human trophectoderm (TE) cells from day 5 blastocysts was compared to that of single day 3 embryos from our in vitro fertilization program by using Human Genome U133 Plus 2.0 microarrays. Some of the microarray data were validated by quantitative RT-PCR. The TE molecular signature included 2,196 transcripts, among which were genes already known to be TE-specific (GATA2, GATA3 and GCM1) but also genes involved in trophoblast invasion (MUC15), chromatin remodeling (specifically the DNA methyltransferase DNMT3L) and steroid metabolism (HSD3B1, HSD17B1 and FDX1). In day 3 human embryos 1,714 transcripts were specifically up-regulated. Besides stemness genes such as NANOG and DPPA2, this signature included genes belonging to the NLR family (NALP4, 5, 9, 11 and 13), Ret finger protein-like family (RFPL1, 2 and 3), Melanoma Antigen family (MAGEA1, 2, 3, 5, 6 and 12) and previously unreported transcripts, such as MBD3L2 and ZSCAN4. This study provides a comprehensive outlook of the genes that are expressed during the initial embryo-trophectoderm transition in humans. Further understanding of the biological functions of the key genes involved in steroidogenesis and epigenetic regulation of transcription that are up-regulated in TE cells may clarify their contribution to TE specification and might also provide new biomarkers for the selection of viable and competent blastocysts.	[Assou, Said; Boumela, Imene; Haouzi, Delphine; Monzo, Cecile; Dechaud, Herve; Hamamah, Samir] Hop St Eloi, CHU Montpellier, INSERM, U1040,Inst Res Biotherapy, Montpellier, France; [Assou, Said; Boumela, Imene; Monzo, Cecile; Dechaud, Herve; Hamamah, Samir] Univ Montpellier I, UFR Med, Montpellier, France; [Dechaud, Herve; Hamamah, Samir] Hop Arnaud de Villeneuve, CHU Montpellier, ART PGD Dept, Montpellier, France; [Kadoch, Issac-Jacques] Univ Montreal, Hop St Luc, CHUM, Dept Obstet Gynecol, Montreal, PQ, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montreal	Assou, S (corresponding author), Hop St Eloi, CHU Montpellier, INSERM, U1040,Inst Res Biotherapy, Montpellier, France.	s-hamamah@chu-montpellier.fr		assou, said/0000-0001-6448-7995	Ferring pharmaceutical company; Genevrier pharmaceutical company; University-Hospital of Montpellier; ART/PGD teams	Ferring pharmaceutical company(Ferring Pharmaceuticals); Genevrier pharmaceutical company; University-Hospital of Montpellier; ART/PGD teams	This work was supported by Ferring and Genevrier pharmaceutical companies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; We thank the direction of the University-Hospital of Montpellier and the ART/PGD teams for their support and Dr. Robert Feil for insightful discussions and critical review of the manuscript. We thank Genevrier and Ferring Pharmaceutical Companies for their support.	Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Aghajanova L, 2009, BIOL REPROD, V80, P105, DOI 10.1095/biolreprod.108.070300; Aghajanova L, 2011, BIOL REPROD; Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065; Assou S, 2011, HUM REPROD UPDATE, V17, P272, DOI 10.1093/humupd/dmq036; Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; Bai Q, 2011, STEM CELL REV; Boumela I, 2011, REPRODUCTION, V141, P549, DOI 10.1530/REP-10-0504; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Cayrol C, 2006, ONCOGENE, V25, P4421, DOI 10.1038/sj.onc.1209484; CHAPMAN V, 1984, NATURE, V307, P284, DOI 10.1038/307284a0; Cheng YH, 2004, PHYSIOL GENOMICS, V18, P99, DOI 10.1152/physiolgenomics.00181.2003; Darr H, 2006, HANDB EXP PHARM, V174, P1; Daulhac L, 1999, J BIOL CHEM, V274, P20657, DOI 10.1074/jbc.274.29.20657; Dobson AT, 2004, HUM MOL GENET, V13, P1461, DOI 10.1093/hmg/ddh157; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; Galan A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013615; Gardner DK, 1998, HUM REPROD, V13, P3434, DOI 10.1093/humrep/13.12.3434; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; HANDYSIDE AH, 1984, J EXP ZOOL, V231, P429, DOI 10.1002/jez.1402310317; HARDY K, 1989, DEVELOPMENT, V107, P597; Home P, 2009, J BIOL CHEM, V284, P28729, DOI 10.1074/jbc.M109.016840; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Jaroudi S, 2007, MUTAT RES-REV MUTAT, V635, P53, DOI 10.1016/j.mrrev.2006.09.002; Jaroudi S, 2009, HUM REPROD, V24, P2649, DOI 10.1093/humrep/dep224; Jones GM, 2008, HUM REPROD, V23, P1748, DOI 10.1093/humrep/den123; Jungbluth Achim A, 2007, Cancer Immun, V7, P15; Kayes-Wandover KM, 2000, J CLIN ENDOCR METAB, V85, P2519, DOI 10.1210/jc.85.7.2519; Kokalj-Vokac N, 1998, CHROMOSOME RES, V6, P161, DOI 10.1023/A:1009299331871; Mann MRW, 2004, DEVELOPMENT, V131, P3727, DOI 10.1242/dev.01241; Marchand M, 2011, BIOL REPROD, V84, P1258, DOI 10.1095/biolreprod.110.086413; Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Peng LH, 2002, J BIOL CHEM, V277, P7945, DOI 10.1074/jbc.M106765200; Ponsuksili S, 2006, BIOL REPROD, V74, P577, DOI 10.1095/biolreprod.105.045096; Rossant J, 2004, SEMIN CELL DEV BIOL, V15, P573, DOI 10.1016/j.semcdb.2004.04.003; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Suzuki N, 1999, PLACENTA, V20, P203, DOI 10.1053/plac.1998.0367; Suzumori N, 2003, P NATL ACAD SCI USA, V100, P550, DOI 10.1073/pnas.0234474100; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Todisco A, 1997, AM J PHYSIOL-GASTR L, V273, pG891, DOI 10.1152/ajpgi.1997.273.4.G891; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Wu Z, 2008, J BIOL CHEM, V283, P24991, DOI 10.1074/jbc.M803893200; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zhang P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007844; Zhang P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002755	60	36	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39306	10.1371/journal.pone.0039306	http://dx.doi.org/10.1371/journal.pone.0039306			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761758	gold, Green Submitted, Green Published			2022-12-27	WOS:000305730900041
J	Farmer, S; Hong, EJE; Leung, WK; Argunhan, B; Terentyev, Y; Humphryes, N; Toyoizumi, H; Tsubouchi, H				Farmer, Sarah; Hong, Eun-Jin Erica; Leung, Wing-Kit; Argunhan, Bilge; Terentyev, Yaroslav; Humphryes, Neil; Toyoizumi, Hiroshi; Tsubouchi, Hideo			Budding Yeast Pch2, a Widely Conserved Meiotic Protein, Is Involved in the Initiation of Meiotic Recombination	PLOS ONE			English	Article							DOUBLE-STRAND-BREAK; SURVEILLANCE MECHANISMS; DNA REVEALS; CHECKPOINT; MEIOSIS; KINASE; LANDSCAPE; PACHYTENE; HOTSPOTS; DISTINCT	Budding yeast Pch2 protein is a widely conserved meiosis-specific protein whose role is implicated in the control of formation and displacement of meiotic crossover events. In contrast to previous studies where the function of Pch2 was implicated in the steps after meiotic double-strand breaks (DSBs) are formed, we present evidence that Pch2 is involved in meiotic DSB formation, the initiation step of meiotic recombination. The reduction of DSB formation caused by the pch2 mutation is most prominent in the sae2 mutant background, whereas the impact remains mild in the rad51 dmc1 double mutant background. The DSB reduction is further pronounced when pch2 is combined with a hypomorphic allele of SPO11. Interestingly, the level of DSB reduction is highly variable between chromosomes, with minimal impact on small chromosomes VI and III. We propose a model in which Pch2 ensures efficient formation of meiotic DSBs which is necessary for igniting the subsequent meiotic checkpoint responses that lead to proper differentiation of meiotic recombinants.	[Farmer, Sarah; Leung, Wing-Kit; Argunhan, Bilge; Terentyev, Yaroslav; Humphryes, Neil; Tsubouchi, Hideo] Univ Sussex, MRC Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Toyoizumi, Hiroshi] Waseda Univ, Grad Sch Accounting, Tokyo, Japan; [Toyoizumi, Hiroshi] Waseda Univ, Dept Appl Math, Tokyo, Japan; [Hong, Eun-Jin Erica] ImmunoGen Inc, Waltham, MA USA	University of Sussex; Waseda University; Waseda University; ImmunoGen, Inc.	Farmer, S (corresponding author), UCL, Sch Life & Med Sci, London, England.	h.tsubouchi@sussex.ac.uk		Leung, Wing-Kit/0000-0003-3039-4904; Tsubouchi, Hideo/0000-0003-0814-8432	Marie Curie Cancer Care; Biotechnology and Biological Sciences Research Council; BBSRC [BB/I009159/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I009159/1] Funding Source: researchfish; Medical Research Council [G0801130B, 1094901] Funding Source: researchfish	Marie Curie Cancer Care; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Tsubouchi lab is supported by Marie Curie Cancer Care and Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhalla N, 2005, SCIENCE, V310, P1683, DOI 10.1126/science.1117468; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Blitzblau HG, 2011, METHODS MOL BIOL, V745, P47, DOI 10.1007/978-1-61779-129-1_4; Borner GV, 2008, P NATL ACAD SCI USA, V105, P3327, DOI 10.1073/pnas.0711864105; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Cartagena-Lirola H, 2008, MOL CELL BIOL, V28, P4480, DOI 10.1128/MCB.00375-08; Dresser ME, 1997, GENETICS, V147, P533; Farmer S, 2011, METHODS MOL BIOL, V745, P33, DOI 10.1007/978-1-61779-129-1_3; Gerton JL, 2005, NAT REV GENET, V6, P477, DOI 10.1038/nrg1614; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Ho HC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002351; Hochwagen A, 2006, CURR BIOL, V16, pR217, DOI 10.1016/j.cub.2006.03.009; Hochwagen A, 2005, CELL, V122, P861, DOI 10.1016/j.cell.2005.07.010; Joshi N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000557; Joyce EF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001059; Joyce EF, 2009, GENETICS, V181, P39, DOI 10.1534/genetics.108.093112; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Li HW., 2007, FLORA CHINA, V13, P2; Lichten M, 2011, CELL, V147, P267, DOI 10.1016/j.cell.2011.09.038; Malkova A, 1996, GENETICS, V143, P741; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nishant KT, 2010, PLOS GENET, V6; Niu H, 2007, MOL CELL BIOL, V27, P5456, DOI 10.1128/MCB.00416-07; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Phadnis N, 2011, TRENDS GENET, V27, P411, DOI 10.1016/j.tig.2011.06.007; Roig I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001062; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; San-Segundo PA, 2000, MOL BIOL CELL, V11, P3601, DOI 10.1091/mbc.11.10.3601; Sasanuma H, 2008, GENE DEV, V22, P398, DOI 10.1101/gad.1626608; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; Storlazzi A, 1996, P NATL ACAD SCI USA, V93, P9043, DOI 10.1073/pnas.93.17.9043; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; Tsubouchi H, 2006, GENE DEV, V20, P1766, DOI 10.1101/gad.1422506; Vader G, 2011, NATURE, V477, P115, DOI 10.1038/nature10331; Wan L, 2008, GENE DEV, V22, P386, DOI 10.1101/gad.1626408; Wu HY, 2006, CURR BIOL, V16, P2473, DOI 10.1016/j.cub.2006.10.069; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Zanders S, 2011, GENETICS; Zanders S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000571	45	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39724	10.1371/journal.pone.0039724	http://dx.doi.org/10.1371/journal.pone.0039724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745819	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000305730900107
J	Guo, L; Wang, YY; Zhou, HL; Wu, C; Song, JD; Li, JG; Paranhos-Baccala, G; Vernet, G; Wang, JW; Hung, T				Guo, Li; Wang, Yaying; Zhou, Hongli; Wu, Chao; Song, Jingdong; Li, Jianguo; Paranhos-Baccala, Glaucia; Vernet, Guy; Wang, Jianwei; Hung, Tao			Differential Seroprevalence of Human Bocavirus Species 1-4 in Beijing, China	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; IMMUNE-RESPONSE; YOUNG-CHILDREN; INFECTION; VIRUS; AVIDITY; SEROEPIDEMIOLOGY; ANTIBODIES; FREQUENT; PROTEIN	Background: Four species of human bocaviruses (HBoV1-4) have been identified based on phylogenetic analysis since its first report in 2005. HBoV1 has been associated with respiratory disease, whereas HBoV2-4 are mainly detected in enteric infections. Although the prevalence of HBoVs in humans has been studied in some regions, it has not been well addressed globally. Methodology/Principal Findings: Cross-reactivity of anti-VP2 antibodies was detected between HBoV1, 2, 3, and 4 in mouse and human serum. The prevalence of specific anti-VP2 IgG antibodies against HBoV1-4 was determined in different age groups of healthy individuals aged 0-70 years old in Beijing, China, using a competition ELISA assay based on virus-like particles of HBoV1-4. The seroprevalence of HBoV1-4 was 50%, 36.9%, 28.7%, and 0.8%, respectively, in children aged 0-14 years (n = 244); whereas the seroprevalence of HBoV1-4 was 66.9%, 49.3%, 38.7% and 1.4%, respectively, in healthy adults (>= 15 years old; n = 142). The seropositive rate of HBoV1 was higher than that of HBoV2, HBoV3, and HBoV4 in individuals older than 0.5 years. Furthermore, IgG seroconversion of HBoV1 (10/31, 32.3%), HBoV2 (8/31, 25.8%), and HBoV3 (2/31, 6.5%) was found in paired sera collected from children with respiratory tract infections who were positive for HBoV1 according to PCR analysis. Conclusions/Significance: Our data indicate that HBoV1 is more prevalent than HBoV2, HBoV3, and HBoV4 in the population we sampled in Beijing, China, suggesting that HBoV species may play differential roles in disease.	[Guo, Li; Wang, Yaying; Zhou, Hongli; Wu, Chao; Li, Jianguo; Wang, Jianwei; Hung, Tao] Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Guo, Li; Wang, Yaying; Zhou, Hongli; Wu, Chao; Li, Jianguo; Wang, Jianwei; Hung, Tao] Chinese Acad Med Sci, Christophe Merieux Lab, IPB, CAMS Fdn Merieux, Beijing 100730, Peoples R China; [Guo, Li; Wang, Yaying; Zhou, Hongli; Wu, Chao; Li, Jianguo; Wang, Jianwei; Hung, Tao] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Jianguo; Hung, Tao] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Paranhos-Baccala, Glaucia; Vernet, Guy] Fdn Merieux, Lyon, France	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Guo, L (corresponding author), Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	wangjw28@163.com	Wang, Jianwei/W-5916-2019; Wang, Jianwei/AAW-9499-2020	Wang, Jianwei/0000-0002-1116-4559	International Science and Technology Cooperation Program of China [2010DFB33270]; National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China [2009ZX10004-206]	International Science and Technology Cooperation Program of China; National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China	This study was supported in part by the International Science and Technology Cooperation Program of China (2010DFB33270) (http://www.cistc.gov.cn) and National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China (2009ZX10004-206) (http://www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Albuquerque MCM, 2007, EMERG INFECT DIS, V13, P1756, DOI 10.3201/eid1311.070671; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2008, J CLIN VIROL, V41, P29, DOI 10.1016/j.jcv.2007.10.026; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Blessing K, 2009, PEDIATR INFECT DIS J, V28, P1018, DOI 10.1097/INF.0b013e3181a854ae; Cheng WX, 2008, CLIN INFECT DIS, V47, P161, DOI 10.1086/589244; Chieochansin T, 2008, JPN J INFECT DIS, V61, P479; Chow BDW, 2010, J CLIN VIROL, V47, P143, DOI 10.1016/j.jcv.2009.11.030; Cui SJ, 2011, J VIROL METHODS, V177, P160, DOI 10.1016/j.jviromet.2011.07.014; Dijkman R, 2012, J CLIN VIROL, V53, P135, DOI 10.1016/j.jcv.2011.11.011; Flores JC, 2011, REV CHIL INFECTOL, V28, P504, DOI /S0716-10182011000700001; Guo L, 2011, EMERG INFECT DIS, V17, P1775, DOI 10.3201/eid1709.110078; Han TH, 2009, ARCH VIROL, V154, P1923, DOI 10.1007/s00705-009-0533-3; He YX, 2005, J CLIN MICROBIOL, V43, P3718, DOI 10.1128/JCM.43.8.3718-3726.2005; Hedman L, 2010, J CLIN VIROL, V48, P44, DOI 10.1016/j.jcv.2010.02.003; Jartti T, 2012, REV MED VIROL, V22, P46, DOI 10.1002/rmv.720; Kahn JS, 2008, J INFECT DIS, V198, P41, DOI 10.1086/588674; Kantola K, 2011, J INFECT DIS, V204, P1403, DOI 10.1093/infdis/jir525; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Karalar L, 2010, CLIN MICROBIOL INFEC, V16, P633, DOI 10.1111/j.1469-0691.2009.02889.x; Kesebir D, 2006, J INFECT DIS, V194, P1276, DOI 10.1086/508213; Lau SKP, 2007, J INFECT DIS, V196, P986, DOI 10.1086/521310; Lee JI, 2007, J INFECT DIS, V196, P994, DOI 10.1086/521366; LEHTONEN OPJ, 1986, J VIROL METHODS, V14, P1, DOI 10.1016/0166-0934(86)90002-9; Lin F, 2008, J VIROL METHODS, V149, P110, DOI 10.1016/j.jviromet.2007.12.016; Lindner J, 2008, VIRAL IMMUNOL, V21, P443, DOI 10.1089/vim.2008.0045; Lu GL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-62; Ma XM, 2006, J CLIN MICROBIOL, V44, P1132, DOI 10.1128/JCM.44.3.1132-1134.2006; Martin ET, 2010, J INFECT DIS, V201, P1625, DOI 10.1086/652405; Monath TP, 2003, J INFECT DIS, V188, P1213, DOI 10.1086/378356; Ngan TKP, 2011, J MED VIROL, V83, P286, DOI 10.1002/jmv.21876; Santos N, 2010, J CLIN VIROL, V48, P127, DOI 10.1016/j.jcv.2010.03.014; Soderlund-Venermo M, 2009, EMERG INFECT DIS, V15, P1423, DOI 10.3201/eid1509.090204; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang K, 2010, J CLIN VIROL, V47, P148, DOI 10.1016/j.jcv.2009.11.015; Wang Y, 2011, EUR J CLIN MICROBIOL, V30, P799, DOI 10.1007/s10096-011-1159-4; WEBSTER RG, 1968, IMMUNOLOGY, V14, P39; Weissbrich B, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-109; Zou Xiaohui, 2009, Sheng Wu Gong Cheng Xue Bao, V25, P575	40	18	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39644	10.1371/journal.pone.0039644	http://dx.doi.org/10.1371/journal.pone.0039644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761854	Green Submitted, Green Published, gold			2022-12-27	WOS:000305730900091
J	Ito, H; Uehara, K; Matsumoto, Y; Hashimoto, A; Nagano, C; Niimi, M; Miyakoda, G; Nagano, K				Ito, Hideki; Uehara, Kenji; Matsumoto, Yutaka; Hashimoto, Ayako; Nagano, Chifumi; Niimi, Manabu; Miyakoda, Goro; Nagano, Keisuke			Cilostazol Inhibits Accumulation of Triglyceride in Aorta and Platelet Aggregation in Cholesterol-Fed Rabbits	PLOS ONE			English	Article							INTERMITTENT CLAUDICATION; EXPERIMENTAL THROMBOSIS; TRANSGENIC RABBITS; CAROTID-ARTERY; DOUBLE-BLIND; ATHEROSCLEROSIS; DENSITY; PHOSPHODIESTERASE; ACTIVATION; DISEASE	Cilostazol is clinically used for the treatment of ischemic symptoms in patients with chronic peripheral arterial obstruction and for the secondary prevention of brain infarction. Recently, it has been reported that cilostazol has preventive effects on atherogenesis and decreased serum triglyceride in rodent models. There are, however, few reports on the evaluation of cilostazol using atherosclerotic rabbits, which have similar lipid metabolism to humans, and are used for investigating the lipid content in aorta and platelet aggregation under conditions of hyperlipidemia. Therefore, we evaluated the effect of cilostazol on the atherosclerosis and platelet aggregation in rabbits fed a normal diet or a cholesterol-containing diet supplemented with or without cilostazol. We evaluated the effects of cilostazol on the atherogenesis by measuring serum and aortic lipid content, and the lesion area after a 10-week treatment and the effect on platelet aggregation after 1- and 10-week treatment. From the lipid analyses, cilostazol significantly reduced the total cholesterol, triglyceride and phospholipids in serum, and moreover, the triglyceride content in the atherosclerotic aorta. Cilostazol significantly reduced the intimal atherosclerotic area. Platelet aggregation was enhanced in cholesterol-fed rabbits. Cilostazol significantly inhibited the platelet aggregation in rabbits fed both a normal diet and a high cholesterol diet. Cilostazol showed anti-atherosclerotic and anti-platelet effects in cholesterol-fed rabbits possibly due to the improvement of lipid metabolism and the attenuation of platelet activation. The results suggest that cilostazol is useful for prevention and treatment of atherothrombotic diseases with the lipid abnormalities.	[Ito, Hideki; Uehara, Kenji; Matsumoto, Yutaka; Hashimoto, Ayako; Miyakoda, Goro; Nagano, Keisuke] Otsuka Pharmaceut Co Ltd, Inst New Drug Discovery 1, Tokushima 77101, Japan; [Nagano, Chifumi; Niimi, Manabu] Otsuka Pharmaceut Co Ltd, Free Rad Res Project, Tokushima 77101, Japan	Otsuka Pharmaceutical; Otsuka Pharmaceutical	Ito, H (corresponding author), Otsuka Pharmaceut Co Ltd, Inst New Drug Discovery 1, Tokushima 77101, Japan.	h_ito@research.otsuka.co.jp	Niimi, Manabu/AAU-5428-2020	Niimi, Manabu/0000-0002-3694-5642				Amarenco P, 2009, ATHEROSCLEROSIS, V204, P515, DOI 10.1016/j.atherosclerosis.2008.09.008; Aronis A, 2008, NUTRITION, V24, P167, DOI 10.1016/j.nut.2007.10.017; BORN GVR, 1967, NATURE, V215, P1027, DOI 10.1038/2151027a0; Brousseau ME, 1999, J LIPID RES, V40, P365; CARDINAL DC, 1980, J PHARMACOL METHOD, V3, P135, DOI 10.1016/0160-5402(80)90024-8; DAUGHERTY A, 1989, BRIT J PHARMACOL, V98, P612, DOI 10.1111/j.1476-5381.1989.tb12635.x; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Dawson DL, 1998, CIRCULATION, V98, P678, DOI 10.1161/01.CIR.98.7.678; Elam MB, 1998, ARTERIOSCL THROM VAS, V18, P1942, DOI 10.1161/01.ATV.18.12.1942; Girman CJ, 2004, AM J CARDIOL, V93, P136, DOI 10.1016/j.amjcard.2003.09.028; Gotto AM, 2002, AM HEART J, V144, pS33, DOI 10.1067/mhj.2002.130301; Hirano K, 2008, NEW ENGL J MED, V359, P2396, DOI 10.1056/NEJMc0805305; HOKLAND BM, 1993, J BIOL CHEM, V268, P25343; Iba T, 2006, SHOCK, V26, P522, DOI 10.1097/01.shk.0000228800.56223.db; Ishizaka N, 1999, ATHEROSCLEROSIS, V142, P41, DOI 10.1016/S0021-9150(98)00147-6; Ito H, 2004, PLATELETS, V15, P293, DOI 10.1080/09537100410001715583; Kambayashi J, 2003, CURR PHARM DESIGN, V9, P2289, DOI 10.2174/1381612033453910; KIMURA Y, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1144; Kohda N, 1999, THROMB RES, V96, P261, DOI 10.1016/S0049-3848(99)00109-7; Lee JH, 2005, J PHARMACOL EXP THER, V313, P502, DOI 10.1124/jpet.104.079780; MAEDA E, 1993, CURR THER RES CLIN E, V54, P420, DOI 10.1016/S0011-393X(05)80646-0; Matsumoto M, 2005, ATHEROSCLEROSIS SUPP, V6, P33, DOI 10.1016/j.atherosclerosissup.2005.09.003; Minami N, 1997, LIFE SCI, V61, pPL383, DOI 10.1016/S0024-3205(97)00986-7; Mori D, 2007, J ATHEROSCLER THROMB, V14, P213, DOI 10.5551/jat.E492; Nakamura N, 2003, CLIN EXP MED, V2, P180, DOI 10.1007/s102380300004; Okutsu R, 2009, ATHEROSCLEROSIS, V204, P405, DOI 10.1016/j.atherosclerosis.2008.10.042; Ozeki Y, 2001, THROMB RES, V101, P65, DOI 10.1016/S0049-3848(00)00377-7; Park SY, 2005, J PHARMACOL EXP THER, V312, P1241, DOI 10.1124/jpet.104.077826; Rizzo M, 2004, ARTERIOSCL THROM VAS, V24, P141, DOI 10.1161/01.ATV.0000107027.73816.ce; Rizzo M, 2011, EXPERT OPIN PHARMACO, V12, P647, DOI 10.1517/14656566.2011.557359; ROSS R, 1977, AM J PATHOL, V86, P675; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sener A, 2005, CLIN BIOCHEM, V38, P1081, DOI 10.1016/j.clinbiochem.2005.09.005; Shanmuganayagam D, 2007, ATHEROSCLEROSIS, V190, P135, DOI 10.1016/j.atherosclerosis.2006.03.017; Son DJ, 2008, PROSTAG LEUKOTR ESS, V78, P383, DOI 10.1016/j.plefa.2008.04.010; Sudo T, 2001, BRIT J PHARMACOL, V133, P1396, DOI 10.1038/sj.bjp.0704204; Takase H, 2007, ARZNEIMITTEL-FORSCH, V57, P185; Tani T, 2000, ATHEROSCLEROSIS, V152, P299, DOI 10.1016/S0021-9150(99)00480-3; Toyota T, 2001, CLIN DRUG INVEST, V21, P325, DOI 10.2165/00044011-200121050-00002; Yoshikawa T, 2008, HORM METAB RES, V40, P473, DOI 10.1055/s-2008-1065348	40	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39374	10.1371/journal.pone.0039374	http://dx.doi.org/10.1371/journal.pone.0039374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761774	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900053
J	Meyer, PJ; Lovic, V; Saunders, BT; Yager, LM; Flagel, SB; Morrow, JD; Robinson, TE				Meyer, Paul J.; Lovic, Vedran; Saunders, Benjamin T.; Yager, Lindsay M.; Flagel, Shelly B.; Morrow, Jonathan D.; Robinson, Terry E.			Quantifying Individual Variation in the Propensity to Attribute Incentive Salience to Reward Cues	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS CORE; OUTCOME-SPECIFIC FORMS; PAVLOVIAN-INSTRUMENTAL TRANSFER; ANTERIOR CINGULATE CORTEX; SIGN-TRACKING; CONDITIONED REINFORCEMENT; GOAL-TRACKING; LOCOMOTOR-ACTIVITY; COGNITIVE CONTROL; APPROACH BEHAVIOR	If reward-associated cues acquire the properties of incentive stimuli they can come to powerfully control behavior, and potentially promote maladaptive behavior. Pavlovian incentive stimuli are defined as stimuli that have three fundamental properties: they are attractive, they are themselves desired, and they can spur instrumental actions. We have found, however, that there is considerable individual variation in the extent to which animals attribute Pavlovian incentive motivational properties ("incentive salience'') to reward cues. The purpose of this paper was to develop criteria for identifying and classifying individuals based on their propensity to attribute incentive salience to reward cues. To do this, we conducted a meta-analysis of a large sample of rats (N = 1,878) subjected to a classic Pavlovian conditioning procedure. We then used the propensity of animals to approach a cue predictive of reward (one index of the extent to which the cue was attributed with incentive salience), to characterize two behavioral phenotypes in this population: animals that approached the cue ("sign-trackers'') vs. others that approached the location of reward delivery ("goal-trackers''). This variation in Pavlovian approach behavior predicted other behavioral indices of the propensity to attribute incentive salience to reward cues. Thus, the procedures reported here should be useful for making comparisons across studies and for assessing individual variation in incentive salience attribution in small samples of the population, or even for classifying single animals.	[Meyer, Paul J.; Lovic, Vedran; Saunders, Benjamin T.; Yager, Lindsay M.; Robinson, Terry E.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Flagel, Shelly B.; Morrow, Jonathan D.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Meyer, PJ (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	ter@umich.edu	Morrow, Jonathan D/M-9790-2016; Meyer, Paul/GQJ-8502-2022; Flagel, Shelly B/G-5561-2012	Morrow, Jonathan D/0000-0002-3530-4544; Flagel, Shelly B/0000-0002-7309-9908; Saunders, Benjamin/0000-0002-4733-1101; Lovic, Vedran/0000-0002-7622-2430	National Institute of Drug Abuse (National Institutes of Health) [R37 DA004294, T32 DA007268, F31 DA030801, T31 DA007281]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007268, T32DA007281, F31DA030799, R37DA004294, F31DA030801] Funding Source: NIH RePORTER	National Institute of Drug Abuse (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Research supported by grants from the National Institute of Drug Abuse (National Institutes of Health): R37 DA004294 (TER), T32 DA007268 (PJM), F31 DA030801 (BTS) T31 DA007281 (LMY). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute On Drug Abuse or the National Institutes of Health. The authors declare no financial conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2010, NEUROPSYCHOPHARMACOL, V35, P1943, DOI 10.1038/npp.2010.68; Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Anderson RI, 2011, PHARMACOL BIOCHEM BE, V98, P250, DOI 10.1016/j.pbb.2011.01.004; Angelakos CC, 2011, SOC NEUR ABSTS; Baarendse PJ, 2011, PSYCHOPHARMACOLOGY B, V219, DOI [10.1007/s00213-00011-02576-x, DOI 10.1007/S00213-00011-02576-X]; BALLEINE B, 1991, Q J EXP PSYCHOL-B, V43, P279; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Beckmann JS, 2012, BEHAV BRAIN RES, V226, P331, DOI 10.1016/j.bbr.2011.09.021; Beckmann JS, 2011, BEHAV BRAIN RES, V216, P159, DOI 10.1016/j.bbr.2010.07.022; Berridge KC, 2001, PSYCHOL LEARN MOTIV, V40, P223, DOI 10.1016/s0079-7421(00)80022-5; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; BERRIDGE KC, 1991, APPETITE, V16, P103, DOI 10.1016/0195-6663(91)90036-R; Berridge KC, 2012, EUR J NEUROSCI, V35, P1124, DOI 10.1111/j.1460-9568.2012.07990.x; BINDRA D, 1974, PSYCHOL REV, V81, P199, DOI 10.1037/h0036330; BINDRA D, 1978, BEHAV BRAIN SCI, V1, P41, DOI 10.1017/S0140525X00059380; Blaiss CA, 2009, BEHAV BRAIN RES, V200, P22, DOI 10.1016/j.bbr.2008.12.024; BOAKES RA, 1978, J EXP ANAL BEHAV, V29, P115, DOI 10.1901/jeab.1978.29-115; Boakes RA, 1977, OPERANT PAVLOVIAN IN, V1st, P35; BOLLES RC, 1972, PSYCHOL REV, V79, P394, DOI 10.1037/h0033120; BOUTON ME, 1991, CLIN PSYCHOL REV, V11, P123, DOI 10.1016/0272-7358(91)90091-8; BRELAND K, 1961, AM PSYCHOL, V16, P681, DOI 10.1037/h0040090; BROWN VJ, 1989, J NEUROSCI, V9, P3760; BURNS LH, 1993, BEHAV BRAIN RES, V55, P167, DOI 10.1016/0166-4328(93)90113-5; Burns M, 1996, J EXP PSYCHOL-ANIM B, V22, P297, DOI 10.1037/0097-7403.22.3.297; Caggiula AR, 2001, PHARMACOL BIOCHEM BE, V70, P515, DOI 10.1016/S0091-3057(01)00676-1; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Cardinal RN, 2003, BEHAV NEUROSCI, V117, P566, DOI 10.1037/0735-7044.117.3.566; Carnell S, 2012, OBES REV, V13, P43, DOI 10.1111/j.1467-789X.2011.00927.x; Carpenter KM, 2006, ADDICT BEHAV, V31, P174, DOI 10.1016/j.addbeh.2005.04.012; Childress AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001506; Christiansen P, 2012, PSYCHOPHARMACOLOGY, V219, P501, DOI 10.1007/s00213-011-2396-z; CLELAND GG, 1982, LEARN MOTIV, V13, P343, DOI 10.1016/0023-9690(82)90014-5; CLELAND GG, 1983, J EXP ANAL BEHAV, V40, P47, DOI 10.1901/jeab.1983.40-47; Cole PD, 2005, ANIM COGN, V8, P27, DOI 10.1007/s10071-004-0228-9; Cools R, 2008, NEUROSCIENTIST, V14, P381, DOI 10.1177/1073858408317009; Corbit LH, 2007, EUR J NEUROSCI, V26, P3141, DOI 10.1111/j.1460-9568.2007.05934.x; Corbit LH, 2011, J NEUROSCI, V31, P11786, DOI 10.1523/JNEUROSCI.2711-11.2011; Corbit LH, 2005, J NEUROSCI, V25, P962, DOI 10.1523/JNEUROSCI.4507-04.2005; Cousijn J, 2011, ADDICTION, V106, P1667, DOI 10.1111/j.1360-0443.2011.03475.x; Danna CL, 2010, PHARMACOL BIOCHEM BE, V96, P40, DOI 10.1016/j.pbb.2010.04.004; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Dickinson A, 2000, BEHAV NEUROSCI, V114, P468, DOI 10.1037/0735-7044.114.3.468; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Dickinson A., 1989, CONT LEARNING THEORI, P279; Duka T, 2004, PSYCHOPHARMACOLOGY, V176, P353, DOI 10.1007/s00213-004-1906-7; EHRMAN RN, 1992, PSYCHOPHARMACOLOGY, V107, P523, DOI 10.1007/BF02245266; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Everitt BJ, 2000, PSYCHOPHARMACOLOGY, V153, P17, DOI 10.1007/s002130000566; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Flagel SB, 2011, NEUROSCIENCE, V196, P80, DOI 10.1016/j.neuroscience.2011.09.004; Flagel SB, 2008, BEHAV BRAIN RES, V186, P48, DOI 10.1016/j.bbr.2007.07.022; Flagel SB, 2007, PSYCHOPHARMACOLOGY, V191, P599, DOI 10.1007/s00213-006-0535-8; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Flagel SB, 2009, NEUROPHARMACOLOGY, V56, P139, DOI 10.1016/j.neuropharm.2008.06.027; GAMZU E, 1971, SCIENCE, V171, P923, DOI 10.1126/science.171.3974.923; Goldstein RZ, 2010, P NATL ACAD SCI USA, V107, P16667, DOI 10.1073/pnas.1011455107; Hearst E., 1974, SIGN TRACKING STIMUL; Hickey C, 2012, CURR BIOL, V22, pR219, DOI 10.1016/j.cub.2012.02.007; Hogarth LC, 2003, BEHAV PHARMACOL, V14, P153, DOI 10.1097/00008877-200303000-00007; HOLLAND PC, 1980, J EXP PSYCHOL ANIM B, V6, P155, DOI 10.1037/0097-7403.6.2.155; HOLLAND PC, 1977, J EXP PSYCHOL ANIM B, V3, P77, DOI 10.1037/0097-7403.3.1.77; HOLLAND PC, 1984, PSYCHOL LEARN MOTIV, V18, P129, DOI 10.1016/S0079-7421(08)60361-8; Huys QJM, 2011, PHENOMENOLOGICAL NEU; Jansen A, 1998, BEHAV RES THER, V36, P257, DOI 10.1016/S0005-7967(98)00055-2; Kearns DN, 2004, LEARN BEHAV, V32, P463; Killeen PR, 2003, J EXP PSYCHOL-ANIM B, V29, P49, DOI 10.1037//0097-7403.29.1.49; Koksal F, 2004, BEHAV RES THER, V42, P1421, DOI 10.1016/j.brat.2003.10.001; Kozak R, 2006, CEREB CORTEX, V16, P9, DOI 10.1093/cercor/bhi079; LAJOIE J, 1978, ANIM LEARN BEHAV, V6, P301, DOI 10.3758/BF03209618; Levy A, 2013, ADDICT BIOL, V18, P763, DOI 10.1111/j.1369-1600.2011.00433.x; Leyton M, 2007, PROG NEURO-PSYCHOPH, V31, P1601, DOI 10.1016/j.pnpbp.2007.08.027; Lingawi NW, 2012, J NEUROSCI, V32, P1073, DOI 10.1523/JNEUROSCI.4806-11.2012; Lomanowska AM, 2011, BEHAV BRAIN RES, V220, P91, DOI 10.1016/j.bbr.2011.01.033; LOVIBOND PF, 1983, J EXP PSYCHOL ANIM B, V9, P225, DOI 10.1037/0097-7403.9.3.225; Lovic V, 2011, BEHAV BRAIN RES, V223, P255, DOI 10.1016/j.bbr.2011.04.006; Mahler SV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015475; Mahler SV, 2009, J NEUROSCI, V29, P6500, DOI 10.1523/JNEUROSCI.3875-08.2009; Meyer PJ, 2012, PSYCHOPHARMACOLOGY, V219, P999, DOI 10.1007/s00213-011-2429-7; Meyer PJ, 2010, SOC NEUR ABSTS; Milton AL, 2010, EUR J NEUROSCI, V31, P2308, DOI 10.1111/j.1460-9568.2010.07249.x; Moeller SJ, 2009, BIOL PSYCHIAT, V66, P169, DOI 10.1016/j.biopsych.2009.02.015; Morrow JD, 2011, BEHAV BRAIN RES, V220, P238, DOI 10.1016/j.bbr.2011.02.013; NEWMAN J, 1980, J EXP PSYCHOL-HUM L, V6, P630, DOI 10.1037/0278-7393.6.5.630; Nilsson J, 2008, ANIM COGN, V11, P651, DOI 10.1007/s10071-008-0155-2; OBRIEN CP, 1992, ANN NY ACAD SCI, V654, P400, DOI 10.1111/j.1749-6632.1992.tb25984.x; Panlilio LV, 2005, NEUROPSYCHOPHARMACOL, V30, P433, DOI 10.1038/sj.npp.1300599; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Parkinson JA, 2000, BEHAV NEUROSCI, V114, P42, DOI 10.1037/0735-7044.114.1.42; Pavlov I.P., 1927, CONDITIONED REFLEXES; PETERSON GB, 1972, SCIENCE, V177, P1009, DOI 10.1126/science.177.4053.1009; PHILLIPS AG, 1981, PHARMACOL BIOCHEM BE, V14, P543, DOI 10.1016/0091-3057(81)90315-4; Phillips AG, 2008, PHARMACOL BIOCHEM BE, V90, P236, DOI 10.1016/j.pbb.2007.10.014; Preston KL, 2009, PSYCHOPHARMACOLOGY, V207, P291, DOI 10.1007/s00213-009-1655-8; Purdy JE, 1999, J COMP PSYCHOL, V113, P443, DOI 10.1037/0735-7036.113.4.443; RESCORLA RA, 1988, AM PSYCHOL, V43, P151, DOI 10.1037/0003-066X.43.3.151; ROBBINS TW, 1978, PSYCHOPHARMACOLOGY, V58, P79, DOI 10.1007/BF00426794; Robinson MJ, 2010, SOC NEUR ABSTS; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Robinson TE, 2009, BIOL PSYCHIAT, V65, P869, DOI 10.1016/j.biopsych.2008.09.006; Saunders BT, 2011, NEUROPSYCHOPHARMACOL, V36, P1668, DOI 10.1038/npp.2011.48; Saunders BT, 2010, BIOL PSYCHIAT, V67, P730, DOI 10.1016/j.biopsych.2009.11.015; Saunders BT, 2011, SOC NEUR ABSTS; Schoenmakers T, 2008, PSYCHOPHARMACOLOGY, V197, P169, DOI 10.1007/s00213-007-1023-5; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Simon JJ, 2010, NEUROIMAGE, V49, P1868, DOI 10.1016/j.neuroimage.2009.09.016; Smith KS, 2011, P NATL ACAD SCI USA, V108, pE255, DOI 10.1073/pnas.1101920108; Soussignan R, 2012, APPETITE, V58, P508, DOI 10.1016/j.appet.2011.12.018; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; TIMBERLAKE W, 1993, J EXP ANAL BEHAV, V60, P105, DOI 10.1901/jeab.1993.60-105; Toates F., 1986, MOTIVATIONAL SYSTEMS; Tomie A, 2000, PHARMACOL BIOCHEM BE, V65, P509, DOI 10.1016/S0091-3057(99)00241-5; TOMIE A, 1989, CONT LEARNING THEORI, P191; Tomie A, 2008, BRAIN RES REV, V58, P121, DOI 10.1016/j.brainresrev.2007.12.003; Tomie A, 2012, BEHAV BRAIN RES, V226, P571, DOI 10.1016/j.bbr.2011.10.021; Uslaner JM, 2006, BEHAV BRAIN RES, V169, P320, DOI 10.1016/j.bbr.2006.02.001; Van Gucht D, 2008, BEHAV RES THER, V46, P1160, DOI 10.1016/j.brat.2008.05.010; Volkow ND, 2008, NEUROIMAGE, V39, P1266, DOI 10.1016/j.neuroimage.2007.09.059; Volkow ND, 2007, ARCH NEUROL-CHICAGO, V64, P1575, DOI 10.1001/archneur.64.11.1575; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; WASSERMAN EA, 1981, AUTOSHAPING CONDITIO, P21; Wassum KM, 2011, LEARN MEMORY, V18, P475, DOI 10.1101/lm.2229311; Waters AJ, 2012, PSYCHOPHARMACOLOGY, V219, P909, DOI 10.1007/s00213-011-2424-z; Wiers RW, 2009, GENES BRAIN BEHAV, V8, P101, DOI 10.1111/j.1601-183X.2008.00454.x; Wiers RW, 2007, PHARMACOL BIOCHEM BE, V86, P263, DOI 10.1016/j.pbb.2006.09.021; WILLIAMS DR, 1969, J EXP ANAL BEHAV, V12, P511, DOI 10.1901/jeab.1969.12-511; Wolfling K, 2011, BIOL PSYCHOL, V87, P275, DOI 10.1016/j.biopsycho.2011.03.010; Wyvell CL, 2001, J NEUROSCI, V21, P7831, DOI 10.1523/JNEUROSCI.21-19-07831.2001; Yager LM, 2010, BEHAV BRAIN RES, V214, P30, DOI 10.1016/j.bbr.2010.04.021; Yager LM, 2010, SOC NEUR ABSTS; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x; Zener K, 1937, AM J PSYCHOL, V50, P384, DOI 10.2307/1416644; Zhang J, 2012, SPR SER COMPUT NEURO, V10, P189, DOI 10.1007/978-1-4614-0751-5_7; Zhang J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000437; Zijlstra F, 2009, DRUG ALCOHOL DEPEN, V99, P183, DOI 10.1016/j.drugalcdep.2008.07.012	137	186	186	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38987	10.1371/journal.pone.0038987	http://dx.doi.org/10.1371/journal.pone.0038987			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	964XV	22761718	Green Submitted, Green Published, gold			2022-12-27	WOS:000305730900026
J	Murphy, N; Norat, T; Ferrari, P; Jenab, M; Bueno-De-Mesquita, B; Skeie, G; Dahm, CC; Overvad, K; Olsen, A; Tjonneland, A; Clavel-Chapelon, F; Boutron-Ruault, MC; Racine, A; Kaaks, R; Teucher, B; Boeing, H; Bergmann, MM; Trichopoulou, A; Trichopoulos, D; Lagiou, P; Palli, D; Pala, V; Panico, S; Tumino, R; Vineis, P; Siersema, P; van Duijnhoven, F; Peeters, PHM; Hjartaker, A; Engeset, D; Gonzalez, CA; Sanchez, MJ; Dorronsoro, M; Navarro, C; Ardanaz, E; Quiros, JR; Sonestedt, E; Ericson, U; Nilsson, L; Palmqvist, R; Khaw, KT; Wareham, N; Key, TJ; Crowe, FL; Fedirko, V; Wark, PA; Chuang, SC; Riboli, E				Murphy, Neil; Norat, Teresa; Ferrari, Pietro; Jenab, Mazda; Bueno-de-Mesquita, Bas; Skeie, Guri; Dahm, Christina C.; Overvad, Kim; Olsen, Anja; Tjonneland, Anne; Clavel-Chapelon, Francoise; Boutron-Ruault, Marie Christine; Racine, Antoine; Kaaks, Rudolf; Teucher, Birgit; Boeing, Heiner; Bergmann, Manuela M.; Trichopoulou, Antonia; Trichopoulos, Dimitrios; Lagiou, Pagona; Palli, Domenico; Pala, Valeria; Panico, Salvatore; Tumino, Rosario; Vineis, Paolo; Siersema, Peter; van Duijnhoven, Franzel; Peeters, Petra H. M.; Hjartaker, Anette; Engeset, Dagrun; Gonzalez, Carlos A.; Sanchez, Maria-Jose; Dorronsoro, Miren; Navarro, Carmen; Ardanaz, Eva; Quiros, Jose R.; Sonestedt, Emily; Ericson, Ulrika; Nilsson, Lena; Palmqvist, Richard; Khaw, Kay-Tee; Wareham, Nick; Key, Timothy J.; Crowe, Francesca L.; Fedirko, Veronika; Wark, Petra A.; Chuang, Shu-Chun; Riboli, Elio			Dietary Fibre Intake and Risks of Cancers of the Colon and Rectum in the European Prospective Investigation into Cancer and Nutrition (EPIC)	PLOS ONE			English	Article							COLORECTAL-CANCER; NONSTARCH POLYSACCHARIDES; GLYCEMIC INDEX; PROJECT; CARBOHYDRATE; CALIBRATION; PROTECTION; RATIONALE; STARCH; FOODS	Background: Earlier analyses within the EPIC study showed that dietary fibre intake was inversely associated with colorectal cancer risk, but results from some large cohort studies do not support this finding. We explored whether the association remained after longer follow-up with a near threefold increase in colorectal cancer cases, and if the association varied by gender and tumour location. Methodology/Principal Findings: After a mean follow-up of 11.0 years, 4,517 incident cases of colorectal cancer were documented. Total, cereal, fruit, and vegetable fibre intakes were estimated from dietary questionnaires at baseline. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models stratified by age, sex, and centre, and adjusted for total energy intake, body mass index, physical activity, smoking, education, menopausal status, hormone replacement therapy, oral contraceptive use, and intakes of alcohol, folate, red and processed meats, and calcium. After multivariable adjustments, total dietary fibre was inversely associated with colorectal cancer (HR per 10 g/day increase in fibre 0.87, 95% CI: 0.79-0.96). Similar linear associations were observed for colon and rectal cancers. The association between total dietary fibre and risk of colorectal cancer risk did not differ by age, sex, or anthropometric, lifestyle, and dietary variables. Fibre from cereals and fibre from fruit and vegetables were similarly associated with colon cancer; but for rectal cancer, the inverse association was only evident for fibre from cereals. Conclusions/Significance: Our results strengthen the evidence for the role of high dietary fibre intake in colorectal cancer prevention.	[Murphy, Neil; Norat, Teresa; Vineis, Paolo; Wark, Petra A.; Chuang, Shu-Chun; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Ferrari, Pietro; Jenab, Mazda; Fedirko, Veronika] WHO, IARC, Lyon, France; [Bueno-de-Mesquita, Bas; van Duijnhoven, Franzel] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Bueno-de-Mesquita, Bas; Siersema, Peter] Univ Med Ctr, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Skeie, Guri; Engeset, Dagrun] Univ Tromso, Inst Community Med, Tromso, Norway; [Dahm, Christina C.] Aarhus Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Dahm, Christina C.; Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Olsen, Anja; Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Clavel-Chapelon, Francoise; Boutron-Ruault, Marie Christine; Racine, Antoine] Inst Gustave Roussy, INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, F-94805 Villejuif, France; [Clavel-Chapelon, Francoise; Boutron-Ruault, Marie Christine; Racine, Antoine] Paris S Univ, UMRS 1018, Villejuif, France; [Kaaks, Rudolf; Teucher, Birgit] German Canc Res Ctr, Div Canc Epidemiol, D-6900 Heidelberg, Germany; [Boeing, Heiner; Bergmann, Manuela M.] German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany; [Trichopoulou, Antonia; Lagiou, Pagona] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, WHO Collaborating Ctr Food & Nutr Policies, GR-11527 Athens, Greece; [Trichopoulou, Antonia] Hellen Hlth Fdn, Athens, Greece; [Trichopoulos, Dimitrios; Lagiou, Pagona] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Trichopoulos, Dimitrios; Lagiou, Pagona] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Palli, Domenico] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Pala, Valeria] Fdn IRCCS Ist Nazl Tumori, Nutr Epidemiol Unit, Milan, Italy; [Panico, Salvatore] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, Canc Registry, Ragusa, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, Histopathol Unit, Ragusa, Italy; [Vineis, Paolo] HuGeF Fdn, Turin, Italy; [van Duijnhoven, Franzel] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Peeters, Petra H. M.] Univ Med Ctr Utrecht, Julius Ctr, Utrecht, Netherlands; [Hjartaker, Anette] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Gonzalez, Carlos A.] Catalan Inst Oncol, Canc Epidemiol Res Program, Unit Nutr Environm & Canc, Barcelona, Spain; [Sanchez, Maria-Jose] Andalusian Sch Publ Hlth, Granada, Spain; [Sanchez, Maria-Jose; Navarro, Carmen; Ardanaz, Eva] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Dorronsoro, Miren] Basque Reg Hlth Dept, Publ Hlth Div Gipuzkoa, San Sebastian, Spain; [Dorronsoro, Miren] Ciberesp Biodonostia, San Sebastian, Spain; [Navarro, Carmen] Murcia Reg Hlth Author, Dept Epidemiol, Murcia, Spain; [Ardanaz, Eva] Navarre Publ Hlth Inst, Pamplona, Spain; [Quiros, Jose R.] Publ Hlth & Hlth Planning Directorate, Asturias, Spain; [Sonestedt, Emily; Ericson, Ulrika] Lund Univ, Dept Clin Sci Malmo, S-22100 Lund, Sweden; [Nilsson, Lena] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Khaw, Kay-Tee] Univ Cambridge, Cambridge, England; [Wareham, Nick] MRC Epidemiol Unit, Cambridge, England; [Key, Timothy J.; Crowe, Francesca L.] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England	Imperial College London; World Health Organization; International Agency for Research on Cancer (IARC); Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; UiT The Arctic University of Tromso; Aarhus University; Aarhus University; Danish Cancer Society; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; German Cancer Research Center (DKFZ); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Athens Medical School; National & Kapodistrian University of Athens; World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health; Academy of Athens; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Naples Federico II; Civile M.P. Arezzo Hospital; Civile M.P. Arezzo Hospital; Wageningen University & Research; Utrecht University; Utrecht University Medical Center; University of Oslo; Catalan Institute of Oncology; Escuela Andaluza de Salud Publica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Murcia Regional Health Council; Public Health Institute of Navarra; Lund University; Umea University; University of Cambridge; University of Oxford	Murphy, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.	t.norat@imperial.ac.uk	Boutron-Ruault, Marie-Christine/H-3936-2014; Khaw, Kay-Tee/AAZ-3209-2021; Murphy, Neil/E-1189-2017; van Duijnhoven, Fränzel/GWC-0059-2022; González, Carlos A A/O-4651-2014; Pala, Valeria/K-4738-2016; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Sonestedt, Emily/I-3814-2016; Dahm, Christina C/G-9787-2014; Siersema, Peter/V-1636-2019; Sánchez, Maria-José/D-1087-2011; Chuang, Shu-Chun/N-3358-2013; Clavel-Chapelon, Francoise/G-6733-2014; Teucher, Birgit/J-6380-2015; Wark, Petra/C-1752-2016	Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; Murphy, Neil/0000-0003-3347-8249; González, Carlos A A/0000-0003-2822-9715; Pala, Valeria/0000-0001-5438-970X; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Sonestedt, Emily/0000-0002-0747-4562; Dahm, Christina C/0000-0003-0481-2893; Sánchez, Maria-José/0000-0003-4817-0757; Panico, Salvatore/0000-0002-5498-8312; Tjonneland, Anne/0000-0003-4385-2097; PALLI, Domenico/0000-0002-5558-2437; Wark, Petra/0000-0003-1020-4640; Navarro, Carmen/0000-0001-8896-7483; Riboli, Elio/0000-0001-6795-6080; Overvad, Kim/0000-0001-6429-7921; Skeie, Guri/0000-0003-2476-4251; tumino, rosario/0000-0003-2666-414X; Jenab, Mazda/0000-0002-0573-1852; Nilsson, Lena Maria/0000-0002-2354-7258; Olsen, Anja/0000-0003-4788-503X; Crowe, Francesca/0000-0003-4026-1726	European Commission (DG-SANCO); International Agency for Research on Cancer; European Research Council (ERC) [ERC-2009-AdG 232997]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; Medical Research Council [G0801056B, G0401527, G1000143, MC_U106179471] Funding Source: researchfish	European Commission (DG-SANCO)(European CommissionEuropean Commission Joint Research Centre); International Agency for Research on Cancer; European Research Council (ERC)(European Research Council (ERC)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The coordination of EPIC is financially supported by the European Commission (DG-SANCO); and the International Agency for Research on Cancer. The national cohorts are supported by Danish Cancer Society (Denmark); Ligue Contre le Cancer; Institut Gustave Roussy; Mutuelle Generale de l'Education Nationale; and Institut National de la Sante et de la Recherche Medicale (INSERM) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum; and Federal Ministry of Education and Research (Germany); Hellenic Health Foundation; Stavros Niarchos Foundation; and the Hellenic Ministry of Health and Social Solidarity (Greece); Italian Association for Research on Cancer (AIRC); National Research Council; and Associazione Iblea per la Ricerca Epidemiologica (AIRE-ONLUS) Ragusa, Associazione Volontari Italiani Sangu (AVIS) Ragusa, Sicilian Government (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF); and Statistics Netherlands (the Netherlands); European Research Council (ERC) (grant number ERC-2009-AdG 232997) and Nordforsk; and Nordic Center of Excellence Programme on Food, Nutrition and Health (Norway); Health Research Fund (FIS); Regional Governments of Andalucia, Asturias, Basque Country, Murcia (No. 6236) and Navarra; and the Centro de Investigacion Biomedica en Red en Epidemiologia y Salud Publica and Instituto de Salud Carlos II (ISCIII RETIC) (RD06/0020) (Spain); Swedish Cancer Society; Swedish Scientific Council; and Regional Government of Skane and Vasterbotten (Sweden); Cancer Research UK; Medical Research Council; Stroke Association; British Heart Foundation; Department of Health; Food Standards Agency; and Wellcome Trust (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINGHAM SA, 1990, P NUTR SOC, V49, P153, DOI 10.1079/PNS19900021; Bingham SA, 2005, CANCER EPIDEM BIOMAR, V14, P1552, DOI 10.1158/1055-9965.EPI-04-0891; Bingham SA, 2003, LANCET, V361, P1496, DOI 10.1016/S0140-6736(03)13174-1; BURKITT DP, 1971, CANCER, V28, P3, DOI 10.1002/1097-0142(197107)28:1<3::AID-CNCR2820280104>3.0.CO;2-N; Cust AE, 2009, EUR J CLIN NUTR, V63, pS37, DOI 10.1038/ejcn.2009.74; Dagfinn A, 2011, BMJ, P343; Dahm CC, 2010, J NATL CANC I; DeVries JW, 2005, J AOAC INT, V88, P1349; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; ENGLYST HN, 1992, ANALYST, V117, P1707, DOI 10.1039/an9921701707; Ferrari P, 2008, INT J EPIDEMIOL, V37, P368, DOI 10.1093/ije/dym242; Freedman L. S., 2011, J NATL CANC I; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; HOWE GR, 1992, J NATL CANCER I, V84, P1887, DOI 10.1093/jnci/84.24.1887; Jansen MCJF, 1999, INT J CANCER, V81, P174, DOI 10.1002/(SICI)1097-0215(19990412)81:2&lt;174::AID-IJC2&gt;3.0.CO;2-#; Kaaks R, 1997, INT J EPIDEMIOL, V26, pS26, DOI 10.1093/ije/26.suppl_1.S26; Kabat GC, 2008, CANCER CAUSE CONTROL, V19, P1291, DOI 10.1007/s10552-008-9200-3; Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091; McCarl M, 2006, CANCER EPIDEM BIOMAR, V15, P892, DOI 10.1158/1055-9965.EPI-05-0700; Nomura AMY, 2007, CANCER CAUSE CONTROL, V18, P753, DOI 10.1007/s10552-007-9018-4; Papas MA, 2004, CANCER EPIDEM BIOMAR, V13, P1267; Park Y, 2005, JAMA-J AM MED ASSOC, V294, P2849, DOI 10.1001/jama.294.22.2849; Peters U, 2003, LANCET, V361, P1491, DOI 10.1016/S0140-6736(03)13173-X; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; Schatzkin A, 2007, AM J CLIN NUTR, V85, P1353, DOI 10.1093/ajcn/85.5.1353; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Slavin JL, 2000, J AM COLL NUTR, V19, p300S, DOI 10.1080/07315724.2000.10718964; Slimani N, 2007, EUR J CLIN NUTR, V61, P1037, DOI 10.1038/sj.ejcn.1602679; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395; TROCK B, 1990, JNCI-J NATL CANCER I, V82, P650, DOI 10.1093/jnci/82.8.650; Wakai K, 2007, CANCER EPIDEM BIOMAR, V16, P668, DOI 10.1158/1055-9965.EPI-06-0664; World Cancer Research Fund/American Institute for Cancer Research, 2011, CONT UPD PROJ REP SU; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Young GP, 2005, MOL NUTR FOOD RES, V49, P571, DOI 10.1002/mnfr.200500026	37	169	176	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39361	10.1371/journal.pone.0039361	http://dx.doi.org/10.1371/journal.pone.0039361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761771	gold, Green Published, Green Submitted			2022-12-27	WOS:000305730900051
J	Adams, J; Schott, S; Bern, A; Renz, M; Ikenberg, K; Garbe, C; Busch, C				Adams, Julia; Schott, Sarah; Bern, Arno; Renz, Matthias; Ikenberg, Kristian; Garbe, Claus; Busch, Christian			A Novel Role for Relaxin-2 in the Pathogenesis of Primary Varicosis	PLOS ONE			English	Article							SMOOTH-MUSCLE; VEINS; RECEPTORS; ESTROGEN; DISEASE	Background: Varicose veins affect up to 40% of men and up to 51% of women. The pathophysiology of primary varicosis is poorly understood. Theories ranging from incompetence of the venous valves to structural changes in the vein wall have been proposed. Methodology/Principal Findings: We analyzed the functional state of the intramural smooth muscle cells (n = 14 pairs matched for age and gender) and the expression of relaxin-2 and its receptors RXFP1 and RXFP2 in samples of varicose and healthy great saphenous veins (GSV) (n = 21 healthy GSV; n = 46 varicose GSV). Relaxin-2 and RXFP1 contents were determined in tissue samples (n = 9 samples per group). Pharmacological analyses were performed in a perfusion chamber. Morphometric determination of the nuclear size of the smooth muscle compartment yielded no significant difference in varicose GSV in comparison with the healthy controls. Relaxin-2 and its receptors were expressed in the muscular layer, endothelial cells and in blood vessels contained in the vein wall. Immunohistochemical expression of relaxin-2, RXFP1 and RXFP2 was significantly decreased in varicose GSV. Relaxin-2 and RXFP1 measured by ELISA and Western Blot were decreased in varicose GSV (relaxin-2 ELISA healthy vs. varicose GSV: 12.49 +/- 0.66 pg/mg versus 9.12 +/- 3.39 pg/mg of total protein; p = 0.01; Student's T-test). Contractions of vein samples induced by cholinergic or adrenergic stimulation were antagonized by relaxin-2. Conclusions/Significance: We report that relaxin-2 and its receptors RXFP1 and RXFP2 are expressed in GSV and that their expression is significantly decreased in varicose GSV. Further, we were able to demonstrate a functional pharmacological relaxin-2 system in varicose GSV. Our results suggest a novel role for relaxin-2 in the pathogenesis of primary varicosis, rendering relaxin-2 a novel possible pharmacological agent for the treatment of this widely prevailing venous disease.	[Adams, Julia; Renz, Matthias; Garbe, Claus; Busch, Christian] Univ Tubingen, Dept Dermatol, Tubingen, Germany; [Schott, Sarah] Univ Heidelberg, Dept Gynecol, Heidelberg, Germany; [Bern, Arno] Practice Clin Phlebol, Tubingen, Germany; [Ikenberg, Kristian] Univ Spital, Inst Pathol, Zurich, Switzerland	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg	Adams, J (corresponding author), Univ Tubingen, Dept Dermatol, Tubingen, Germany.	Christian.Busch@med.uni-tuebingen.de	Garbe, Claus/ABH-2128-2021; Schott, Sarah/D-5242-2018	Garbe, Claus/0000-0001-8530-780X; Schott, Sarah/0000-0002-1714-1147	German Phlebological Society	German Phlebological Society	This work was supported by a research grant from the German Phlebological Society to Christian Busch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccari MC, 2004, CURR PROTEIN PEPT SC, V5, P9, DOI 10.2174/1389203043486928; Bathgate RA, 2005, ANN NY ACAD SCI, V1041, P61, DOI 10.1196/annals.1282.010; BOGUTH E, 1951, Med Welt, V20, P408; Elsharawy Mohamed A, 2007, Interact Cardiovasc Thorac Surg, V6, P219; Feldner A, 2011, FASEB J, V25, P3613, DOI 10.1096/fj.11-185975; FETZER S, 1955, Z ZELLFORSCH MIK ANA, V43, P404; Knaapen MWM, 2005, J VASC RES, V42, P8, DOI 10.1159/000082723; Mashiah A, 1999, CARDIOVASC SURG, V7, P327, DOI 10.1016/S0967-2109(98)00132-X; Meissner MH, 2007, J VASC SURG, V46, p4S, DOI 10.1016/j.jvs.2007.09.043; Meissner MH, 2007, J VASC SURG, V46, p54S, DOI 10.1016/j.jvs.2007.08.038; Reisenauer C, 2008, INT UROGYNECOL J, V19, P383, DOI 10.1007/s00192-007-0447-0; Samuel CS, 2007, CELL MOL LIFE SCI, V64, P1539, DOI 10.1007/s00018-007-6543-y; Sherwood OD, 2004, ENDOCR REV, V25, P205, DOI 10.1210/er.2003-0013; Somers P, 2006, ANGIOLOGY, V57, P546, DOI 10.1177/0003319706293115; Teichman Sam L, 2010, Curr Heart Fail Rep, V7, P75, DOI 10.1007/s11897-010-0010-z; Travers JP, 1996, EUR J VASC ENDOVASC, V11, P230, DOI 10.1016/S1078-5884(96)80058-X	16	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39021	10.1371/journal.pone.0039021	http://dx.doi.org/10.1371/journal.pone.0039021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737225	Green Accepted, Green Published, gold			2022-12-27	WOS:000305695100024
J	Flesch, IEA; Hollett, NA; Wong, YC; Tscharke, DC				Flesch, Inge E. A.; Hollett, Natasha A.; Wong, Yik Chun; Tscharke, David C.			Linear Fidelity in Quantification of Anti-Viral CD8(+) T Cells	PLOS ONE			English	Article							FLOW-CYTOMETRIC ASSAY; VACCINIA VIRUS; IN-VIVO; CUTTING EDGE; IFN-GAMMA; RESPONSES; EFFECTOR; CYTOTOXICITY; INFECTION; RECEPTOR	Enumeration of anti-viral CD8(+) T cells to make comparisons between mice, viruses and vaccines is a frequently used approach, but controversy persists as to the most appropriate methods. Use of peptide-MHC tetramers (or variants) and intracellular staining for cytokines, in particular IFN gamma, after a short ex vivo stimulation are now common, as are a variety of cytotoxicity assays, but few direct comparisons have been made. It has been argued that use of tetramers leads to the counting of non-functional T cells and that measurement of single cytokines will fail to identify cells with alternative functions. Further, the linear range of these methods has not been tested and this is required to give confidence that relative quantifications can be compared across samples. Here we show for two acute virus infections and CD8(+) T cells activated in vitro that DimerX (a tetramer variant) and intracellular staining for IFN gamma, alone or in combination with CD107 to detect degranulation, gave comparable results at the peak of the response. Importantly, these methods were highly linear over nearly two orders of magnitude. In contrast, in vitro and in vivo assays for cytotoxicity were not linear, suffering from high background killing, plateaus in maximal killing and substantial underestimation of differences in magnitude of responses.	[Flesch, Inge E. A.; Hollett, Natasha A.; Wong, Yik Chun; Tscharke, David C.] Australian Natl Univ, Div Biomed Sci & Biochem, Res Sch Biol, Canberra, ACT, Australia	Australian National University	Flesch, IEA (corresponding author), Australian Natl Univ, Div Biomed Sci & Biochem, Res Sch Biol, Canberra, ACT, Australia.	David.Tscharke@anu.edu.au	Tscharke, David/C-9133-2009	Tscharke, David/0000-0001-6825-9172	CDA fellowship from the Australian National Health and Medical Research Council (NHMRC) [CDA 418108];  [APP1005846];  [APP1023141]	CDA fellowship from the Australian National Health and Medical Research Council (NHMRC); ; 	This work was funded by Project grants (APP1005846; APP1023141) and a CDA fellowship (CDA 418108) from the Australian National Health and Medical Research Council (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Betts MR, 2004, J IMMUNOL, V172, P6407, DOI 10.4049/jimmunol.172.10.6407; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BONNEAU RH, 1993, VIROLOGY, V195, P62, DOI 10.1006/viro.1993.1346; BRUNNER KT, 1968, IMMUNOLOGY, V14, P181; Burkett MW, 2005, J IMMUNOTHER, V28, P396, DOI 10.1097/01.cji.0000165357.11548.6d; Byers AM, 2003, J IMMUNOL, V171, P17, DOI 10.4049/jimmunol.171.1.17; Coles RM, 2002, J IMMUNOL, V168, P834, DOI 10.4049/jimmunol.168.2.834; Doherty PC, 2000, ANNU REV IMMUNOL, V18, P561, DOI 10.1146/annurev.immunol.18.1.561; Flesch IEA, 2010, J IMMUNOL, V184, P45, DOI 10.4049/jimmunol.0900999; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; JUNG T, 1993, J IMMUNOL METHODS, V159, P197, DOI 10.1016/0022-1759(93)90158-4; Kastenmuller W, 2007, J EXP MED, V204, P2187, DOI 10.1084/jem.20070489; Klenerman P, 2002, NAT REV IMMUNOL, V2, P263, DOI 10.1038/nri777; La Gruta NL, 2004, J IMMUNOL, V172, P5553, DOI 10.4049/jimmunol.172.9.5553; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Mackay LK, 2012, J IMMUNOL, V188, P2173, DOI 10.4049/jimmunol.1102719; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Parish Christopher R, 2009, Curr Protoc Immunol, VChapter 4, DOI 10.1002/0471142735.im0409s84; Regner M, 2009, J IMMUNOL, V183, P37, DOI 10.4049/jimmunol.0900466; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; Rubio-Godoy V, 2001, P NATL ACAD SCI USA, V98, P10302, DOI 10.1073/pnas.181348898; SANDER B, 1991, IMMUNOL REV, V119, P65, DOI 10.1111/j.1600-065X.1991.tb00578.x; Schneck Jonathan P., 2000, Immunological Investigations, V29, P163, DOI 10.3109/08820130009062300; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; SIMMONS A, 1984, J VIROL, V52, P816, DOI 10.1128/JVI.52.3.816-821.1984; St Leger AJ, 2011, J IMMUNOL, V186, P3927, DOI 10.4049/jimmunol.1003735; Sun Y, 2003, J IMMUNOL METHODS, V272, P23, DOI 10.1016/S0022-1759(02)00328-9; Symons JA, 2002, J GEN VIROL, V83, P1953, DOI 10.1099/0022-1317-83-8-1953; TAGUCHI T, 1990, J IMMUNOL METHODS, V128, P65, DOI 10.1016/0022-1759(90)90464-7; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Valitutti S, 1996, J EXP MED, V183, P1917, DOI 10.1084/jem.183.4.1917; Wang Y, 2009, J VIROL, V83, P9008, DOI 10.1128/JVI.00410-09; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Yuen TJ, 2010, J VIROL, V84, P10220, DOI 10.1128/JVI.01281-10; Zinkernagel R M, 1979, Adv Immunol, V27, P51, DOI 10.1016/S0065-2776(08)60262-X	40	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39533	10.1371/journal.pone.0039533	http://dx.doi.org/10.1371/journal.pone.0039533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745779	gold, Green Published, Green Submitted			2022-12-27	WOS:000305693200087
J	Paulus, P; Ockelmann, P; Tacke, S; Karnowski, N; Ellinghaus, P; Scheller, B; Holfeld, J; Urbschat, A; Zacharowski, K				Paulus, Patrick; Ockelmann, Pia; Tacke, Sabine; Karnowski, Nora; Ellinghaus, Peter; Scheller, Bertram; Holfeld, Johannes; Urbschat, Anja; Zacharowski, Kai			Deguelin Attenuates Reperfusion Injury and Improves Outcome after Orthotopic Lung Transplantation in the Rat	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR; DNA-BINDING ACTIVITY; INCREASED VASCULAR-PERMEABILITY; FACTOR-I; KIDNEY-TRANSPLANTATION; ISCHEMIA-REPERFUSION; HUMAN MONOCYTES; FACTOR PLAYS; IFN-GAMMA	The main goal of adequate organ preservation is to avoid further cellular metabolism during the phase of ischemia. However, modern preservation solutions do rarely achieve this target. In donor organs hypoxia and ischemia induce a broad spectrum of pathologic molecular mechanisms favoring primary graft dysfunction (PGD) after transplantation. Increased hypoxia-induced transcriptional activity leads to increased vascular permeability which in turn is the soil of a reperfusion edema and the enhancement of a pro-inflammatory response in the graft after reperfusion. We hypothesize that inhibition of the respiration chain in mitochondria and thus inhibition of the hypoxia induced mechanisms might reduce reperfusion edema and consecutively improve survival in vivo. In this study we demonstrate that the rotenoid Deguelin reduces the expression of hypoxia induced target genes, and especially VEGF-A, dose-dependently in hypoxic human lung derived cells. Furthermore, Deguelin significantly suppresses the mRNA expression of the HIF target genes VEGF-A, the pro-inflammatory CXCR4 and ICAM-1 in ischemic lungs vs. control lungs. After lung transplantation, the VEGF-A induced reperfusion-edema is significantly lower in Deguelin-treated animals than in controls. Deguelin-treated rats exhibit a significantly increased survival-rate after transplantation. Additionally, a downregulation of the pro-inflammatory molecules ICAM-1 and CXCR4 and an increase in the recruitment of immunomodulatory monocytes (CD163+ and CD68+) to the transplanted organ involving the IL4 pathway was observed. Therefore, we conclude that ischemic periods preceding reperfusion are mainly responsible for the increased vascular permeability via upregulation of VEGF. Together with this, the resulting endothelial dysfunction also enhances inflammation and consequently lung dysfunction. Deguelin significantly decreases a VEGF-A induced reperfusion edema, induces the recruitment of immunomodulatory monocytes and thus improves organ function and survival after lung transplantation by interfering with hypoxia induced signaling.	[Paulus, Patrick; Ockelmann, Pia; Scheller, Bertram; Zacharowski, Kai] Goethe Univ Hosp Frankfurt, Clin Anesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany; [Tacke, Sabine] Univ Giessen, Dept Vet Clin Sci, Clin Small Anim Surg, Giessen, Germany; [Karnowski, Nora; Ellinghaus, Peter] Bayer Pharma AG, Clin Pharmacol, Global Biomarker, Wuppertal, Germany; [Holfeld, Johannes] Innsbruck Med Univ, Clin Cardiac Surg, Innsbruck, Austria; [Urbschat, Anja] Goethe Univ Hosp Frankfurt Main, Urol Clin, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Justus Liebig University Giessen; Bayer AG; Bayer Healthcare Pharmaceuticals; Medical University of Innsbruck	Paulus, P (corresponding author), Goethe Univ Hosp Frankfurt, Clin Anesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany.	Patrick.Paulus@kgu.de	Tacke, Sabine/A-3213-2019		Faculty of Medicine of the Goethe-University Frankfurt, Germany [F13/09-R88/2009]	Faculty of Medicine of the Goethe-University Frankfurt, Germany	This work was funded by a junior investigator research grant (F13/09-R88/2009) to P. Paulus by the Faculty of Medicine of the Goethe-University Frankfurt, Germany. One part of the in vitro experiments was conducted at Bayer Pharma AG, Wuppertal, Germany. The funders of this study had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abraham D, 2004, ANN THORAC SURG, V77, P1751, DOI 10.1016/j.athoracsur.2003.10.050; Abraham D, 2002, TRANSPLANTATION, V73, P1703, DOI 10.1097/00007890-200206150-00003; Aharinejad S, 2007, AM J TRANSPLANT, V7, P2012, DOI 10.1111/j.1600-6143.2007.01875.x; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Bindewald K, 2004, AM J PHYSIOL-CELL PH, V287, pC1246, DOI 10.1152/ajpcell.00132.2004; Boucek MM, 2007, J HEART LUNG TRANSPL, V26, P796, DOI 10.1016/j.healun.2007.06.006; Brinkkoetter PT, 2006, TRANSPLANTATION, V82, P534, DOI 10.1097/01.tp.0000229396.34362.e2; Chen Fengshi, 2008, Interact Cardiovasc Thorac Surg, V7, P437, DOI 10.1510/icvts.2007.166355; CLAUSS M, 1990, J EXP MED, V172, P1535, DOI 10.1084/jem.172.6.1535; Cursio R, 2008, TRANSPL P, V40, P2042, DOI 10.1016/j.transproceed.2008.05.037; Dominguez-Soto A, 2011, J IMMUNOL, V186, P2192, DOI 10.4049/jimmunol.1000475; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Eltzschig HK, 2011, ANESTHESIOLOGY, V114, P239, DOI 10.1097/ALN.0b013e3182070c66; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Fang NB, 1998, P NATL ACAD SCI USA, V95, P3380, DOI 10.1073/pnas.95.7.3380; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Flamme I, 1997, MECH DEVELOP, V63, P51, DOI 10.1016/S0925-4773(97)00674-6; Grocott MPW, 2009, NEW ENGL J MED, V360, P140, DOI 10.1056/NEJMoa0801581; Hail N, 2004, APOPTOSIS, V9, P437; Hanusch C, 2008, TRANSPLANTATION, V85, P1449, DOI 10.1097/TP.0b013e31816f220d; Hashimoto S, 1997, BLOOD, V89, P315, DOI 10.1182/blood.V89.1.315.315_315_321; Jiang X, 2011, J CLIN INVEST, V121, P2336, DOI 10.1172/JCI46192; Kannan KB, 2011, AM J PHYSIOL-GASTR L, V300, pG853, DOI 10.1152/ajpgi.00459.2010; Kazi AA, 2000, AM J PHYSIOL-LUNG C, V279, pL460, DOI 10.1152/ajplung.2000.279.3.L460; Koeppen M, 2011, CURR OPIN ANESTHESIO, V24, P363, DOI 10.1097/ACO.0b013e32834873fd; Kosieradzki M, 2008, TRANSPL P, V40, P3279, DOI 10.1016/j.transproceed.2008.10.004; Krebs R, 2006, TRANSPLANT P, V38, P3266, DOI 10.1016/j.transproceed.2006.10.087; Krenn K, 2007, EUR J CARDIO-THORAC, V32, P35, DOI 10.1016/j.ejcts.2007.04.006; Kruger B, 2009, P NATL ACAD SCI USA, V106, P3390, DOI 10.1073/pnas.0810169106; Lassus P, 2001, AM J RESP CRIT CARE, V164, P1981, DOI 10.1164/ajrccm.164.10.2012036; Lee JC, 2011, CLIN CHEST MED, V32, P279, DOI 10.1016/j.ccm.2011.02.007; Linfert Douglas, 2009, Transplant Rev (Orlando), V23, P1, DOI 10.1016/j.trre.2008.08.003; Liu GQ, 2011, ARTERIOSCL THROM VAS, V31, P1342, DOI 10.1161/ATVBAHA.110.222208; Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13; MACKEL AM, 1982, CONNECT TISSUE RES, V10, P333, DOI 10.3109/03008208209008058; MALEFYT RD, 1993, J IMMUNOL, V151, P6370; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Marx J, 2004, SCIENCE, V303, P1454, DOI 10.1126/science.303.5663.1454; Navarro A, 2010, J BIOENERG BIOMEMBR, V42, P405, DOI 10.1007/s10863-010-9309-4; Paulus P, 2006, CANCER RES, V66, P4349, DOI 10.1158/0008-5472.CAN-05-3523; Paulus P, 2011, BIOMARKERS, V16, pS11, DOI 10.3109/1354750X.2011.587893; Peeters P, 2008, TRANSPLANTATION, V85, pS31, DOI 10.1097/TP.0b013e318169c548; Polosukhin VV, 2007, VIRCHOWS ARCH, V451, P793, DOI 10.1007/s00428-007-0469-5; Polosukhin VV, 2011, J PATHOL, V224, P203, DOI 10.1002/path.2863; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Rodeheffer RJ, 1996, CIRCULATION, V94, P2883, DOI 10.1161/01.CIR.94.11.2883; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Semenza Gregg L, 2005, Proc Am Thorac Soc, V2, P68, DOI 10.1513/pats.200404-029MS; Souilamas R, 2009, B ACAD NAT MED PARIS, V193, P1589, DOI 10.1016/S0001-4079(19)32447-1; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Taghavi S, 2002, J HEART LUNG TRANSPL, V21, P600, DOI 10.1016/S1053-2498(01)00346-1; Ten Vadim S, 2002, Curr Opin Crit Care, V8, P242, DOI 10.1097/00075198-200206000-00008; Trulock EP, 2007, J HEART LUNG TRANSPL, V26, P782, DOI 10.1016/j.healun.2007.06.003; Villalta SA, 2011, J IMMUNOL, V187, P5419, DOI 10.4049/jimmunol.1101267; WANG GL, 1993, BLOOD, V82, P3610; WANG GL, 1993, J BIOL CHEM, V268, P21513; Winning S, 2010, J IMMUNOL, V185, P1786, DOI 10.4049/jimmunol.0903244; Wohlschlager J, 2011, PATHOLOGE, V32, P104, DOI 10.1007/s00292-010-1403-1; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yamada M, 2011, CELL MOL IMMUNOL, V8, P305, DOI 10.1038/cmi.2011.8	62	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39265	10.1371/journal.pone.0039265	http://dx.doi.org/10.1371/journal.pone.0039265			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745725	Green Submitted, Green Published, gold			2022-12-27	WOS:000305693200055
J	Sforza, E; Simionato, D; Giacometti, GM; Bertucco, A; Morosinotto, T				Sforza, Eleonora; Simionato, Diana; Giacometti, Giorgio Mario; Bertucco, Alberto; Morosinotto, Tomas			Adjusted Light and Dark Cycles Can Optimize Photosynthetic Efficiency in Algae Growing in Photobioreactors	PLOS ONE			English	Article							FATTY-ACID COMPOSITION; FLASHING LIGHT; NANNOCHLOROPSIS SP; CHLOROPHYLL FLUORESCENCE; HAEMATOCOCCUS-PLUVIALIS; BIOMASS PRODUCTION; PHOTOSYSTEM-II; MICROALGAE; BIOFUELS; DENSITY	Biofuels from algae are highly interesting as renewable energy sources to replace, at least partially, fossil fuels, but great research efforts are still needed to optimize growth parameters to develop competitive large-scale cultivation systems. One factor with a seminal influence on productivity is light availability. Light energy fully supports algal growth, but it leads to oxidative stress if illumination is in excess. In this work, the influence of light intensity on the growth and lipid productivity of Nannochloropsis salina was investigated in a flat-bed photobioreactor designed to minimize cells self-shading. The influence of various light intensities was studied with both continuous illumination and alternation of light and dark cycles at various frequencies, which mimic illumination variations in a photobioreactor due to mixing. Results show that Nannochloropsis can efficiently exploit even very intense light, provided that dark cycles occur to allow for re-oxidation of the electron transporters of the photosynthetic apparatus. If alternation of light and dark is not optimal, algae undergo radiation damage and photosynthetic productivity is greatly reduced. Our results demonstrate that, in a photobioreactor for the cultivation of algae, optimizing mixing is essential in order to ensure that the algae exploit light energy efficiently.	[Sforza, Eleonora; Bertucco, Alberto] Univ Padua, Dipartimento Ingn Ind DII, Padua, Italy; [Simionato, Diana; Giacometti, Giorgio Mario; Morosinotto, Tomas] Univ Padua, Dipartimento Biol, Padua, Italy	University of Padua; University of Padua	Sforza, E (corresponding author), Univ Padua, Dipartimento Ingn Ind DII, Padua, Italy.	tomas.morosinotto@unipd.it	Morosinotto, Tomas/AAC-3188-2019	Morosinotto, Tomas/0000-0002-0803-7591; simionato, diana/0000-0002-2774-6641; Sforza, Eleonora/0000-0002-3930-2941	Universita di Padova [CPDA089403]; CUIA	Universita di Padova; CUIA	TM acknowledges the financial support from Universita di Padova (grant CPDA089403) and CUIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro HM, 2011, APPL ENERG, V88, P3402, DOI 10.1016/j.apenergy.2010.12.014; BOUSSIBA S, 1987, BIOMASS, V12, P37, DOI 10.1016/0144-4565(87)90006-0; Brindley C, 2011, BIORESOURCE TECHNOL, V102, P3138, DOI 10.1016/j.biortech.2010.10.088; Carvalho AP, 2011, APPL MICROBIOL BIOT, V89, P1275, DOI 10.1007/s00253-010-3047-8; Damiani MC, 2010, BIORESOURCE TECHNOL, V101, P3801, DOI 10.1016/j.biortech.2009.12.136; Chen W, 2009, J MICROBIOL METH, V77, P41, DOI 10.1016/j.mimet.2009.01.001; Chisti Y, 2011, APPL ENERG, V88, P3277, DOI 10.1016/j.apenergy.2011.04.038; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Dismukes GC, 2008, CURR OPIN BIOTECH, V19, P235, DOI 10.1016/j.copbio.2008.05.007; DUBINSKY Z, 1986, PLANT CELL PHYSIOL, V27, P1335, DOI 10.1093/oxfordjournals.pcp.a077232; FALKOWSKI PG, 1991, J PHYCOL, V27, P8, DOI 10.1111/j.0022-3646.1991.00008.x; Fisher T, 1996, J PLANKTON RES, V18, P1797, DOI 10.1093/plankt/18.10.1797; Fisher T, 1998, J PHYCOL, V34, P818, DOI 10.1046/j.1529-8817.1998.340818.x; Gordon JM, 2007, APPL MICROBIOL BIOT, V76, P969, DOI 10.1007/s00253-007-1102-x; Gouveia L, 2009, J IND MICROBIOL BIOT, V36, P269, DOI 10.1007/s10295-008-0495-6; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Grobbelaar JU, 2010, PHOTOSYNTH RES, V106, P135, DOI 10.1007/s11120-010-9573-5; Grobbelaar JU, 1996, J APPL PHYCOL, V8, P335, DOI 10.1007/BF02178576; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hannon M, 2010, BIOFUELS-UK, V1, P763, DOI 10.4155/BFS.10.44; HODGSON PA, 1991, J APPL PHYCOL, V3, P169, DOI 10.1007/BF00003699; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Kim ZH, 2006, ENZYME MICROB TECH, V39, P414, DOI 10.1016/j.enzmictec.2005.11.041; Kliphuis AMJ, 2010, BIOTECHNOL PROGR, V26, P687, DOI 10.1002/btpr.379; KOK B, 1956, BIOCHIM BIOPHYS ACTA, V21, P245, DOI 10.1016/0006-3002(56)90004-X; Laurens LML, 2012, ANAL BIOANAL CHEM, V403, P167, DOI 10.1007/s00216-012-5814-0; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Matthijs HCP, 1996, BIOTECHNOL BIOENG, V50, P98; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Meiser A, 2004, J APPL PHYCOL, V16, P215, DOI 10.1023/B:JAPH.0000048507.95878.b5; Molina GE, 1994, J AM OIL CHEM SOC, V71, P955; MORAN R, 1980, PLANT PHYSIOL, V65, P478, DOI 10.1104/pp.65.3.478; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Nedbal L, 1996, J APPL PHYCOL, V8, P325, DOI 10.1007/BF02178575; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Pal D, 2011, APPL MICROBIOL BIOT, V90, P1429, DOI 10.1007/s00253-011-3170-1; PHILLIPS JN, 1954, PLANT PHYSIOL, V29, P152, DOI 10.1104/pp.29.2.152; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Qiang H, 1996, J APPL PHYCOL, V8, P139, DOI 10.1007/BF02186317; Richmond A, 2003, BIOMOL ENG, V20, P229, DOI 10.1016/S1389-0344(03)00060-1; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; Sforza E, 2012, CHEM ENG RE IN PRESS; Simionato D, 2011, BIORESOURCE TECHNOL, V102, P6026, DOI 10.1016/j.biortech.2011.02.100; Singh A, 2011, BIORESOURCE TECHNOL, V102, P10, DOI 10.1016/j.biortech.2010.06.032; Solovchenko A, 2011, MAR BIOTECHNOL, V13, P527, DOI 10.1007/s10126-010-9323-x; Su CH, 2011, J APPL PHYCOL, V23, P903, DOI 10.1007/s10811-010-9609-4; SUKENIK A, 1989, J PHYCOL, V25, P686, DOI 10.1111/j.0022-3646.1989.00686.x; TERRY KL, 1986, BIOTECHNOL BIOENG, V28, P988, DOI 10.1002/bit.260280709; Vejrazka C, 2011, BIOTECHNOL BIOENG, V108, P2905, DOI 10.1002/bit.23270; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Malcata FX, 2011, TRENDS BIOTECHNOL, V29, P542, DOI 10.1016/j.tibtech.2011.05.005; Xue SZ, 2011, J BIOTECHNOL, V151, P271, DOI 10.1016/j.jbiotec.2010.12.012; Zijffers JWF, 2010, MAR BIOTECHNOL, V12, P708, DOI 10.1007/s10126-010-9258-2	53	191	200	3	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38975	10.1371/journal.pone.0038975	http://dx.doi.org/10.1371/journal.pone.0038975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745696	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200035
J	Fan, M; Wong, KC; Ryu, T; Ravasi, T; Gao, X				Fan, Ming; Wong, Ka-Chun; Ryu, Taewoo; Ravasi, Timothy; Gao, Xin			SECOM: A Novel Hash Seed and Community Detection Based-Approach for Genome-Scale Protein Domain Identification	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION	With rapid advances in the development of DNA sequencing technologies, a plethora of high-throughput genome and proteome data from a diverse spectrum of organisms have been generated. The functional annotation and evolutionary history of proteins are usually inferred from domains predicted from the genome sequences. Traditional database-based domain prediction methods cannot identify novel domains, however, and alignment-based methods, which look for recurring segments in the proteome, are computationally demanding. Here, we propose a novel genome-wide domain prediction method, SECOM. Instead of conducting all-against-all sequence alignment, SECOM first indexes all the proteins in the genome by using a hash seed function. Local similarity can thus be detected and encoded into a graph structure, in which each node represents a protein sequence and each edge weight represents the shared hash seeds between the two nodes. SECOM then formulates the domain prediction problem as an overlapping community-finding problem in this graph. A backward graph percolation algorithm that efficiently identifies the domains is proposed. We tested SECOM on five recently sequenced genomes of aquatic animals. Our tests demonstrated that SECOM was able to identify most of the known domains identified by InterProScan. When compared with the alignment-based method, SECOM showed higher sensitivity in detecting putative novel domains, while it was also three orders of magnitude faster. For example, SECOM was able to predict a novel sponge-specific domain in nucleoside-triphosphatase (NTPases). Furthermore, SECOM discovered two novel domains, likely of bacterial origin, that are taxonomically restricted to sea anemone and hydra. SECOM is an open-source program and available at http://sfb.kaust.edu.sa/Pages/Software.aspx.	[Fan, Ming; Ravasi, Timothy; Gao, Xin] KAUST, Math & Comp Sci & Engn Div, Thuwal, Saudi Arabia; [Wong, Ka-Chun] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Wong, Ka-Chun] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Ryu, Taewoo; Ravasi, Timothy] KAUST, Computat Biosci Res Ctr, Div Chem & Life Sci & Engn, Thuwal, Saudi Arabia	King Abdullah University of Science & Technology; University of Toronto; University of Toronto; King Abdullah University of Science & Technology	Fan, M (corresponding author), KAUST, Math & Comp Sci & Engn Div, Thuwal, Saudi Arabia.	xin.gao@kaust.edu.sa	Wong, Ka-Chun/L-7160-2019; Ravasi, Timothy/B-8777-2008; Gao, Xin/D-5487-2013; Ryu, Taewoo/AAN-2634-2020	Wong, Ka-Chun/0000-0001-6062-733X; Gao, Xin/0000-0002-7108-3574; Ravasi, Timothy/0000-0002-9950-465X	Academic Excellence Alliance; King Abdullah University of Science and Technology Office of Competitive Research Funds	Academic Excellence Alliance; King Abdullah University of Science and Technology Office of Competitive Research Funds	This work was supported in part by an Academic Excellence Alliance grant awarded by the King Abdullah University of Science and Technology Office of Competitive Research Funds under the title "Association of genetic variation with phenotype at the network and function level". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Berman HM, 2000, NAT STRUCT BIOL, V7, P957, DOI 10.1038/80734; Blanchard JL, 2000, TRENDS GENET, V16, P315, DOI 10.1016/S0168-9525(00)02053-9; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Cheng JL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-113; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kumpula JM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026109; Li Ming, 2004, J Bioinform Comput Biol, V2, P417, DOI 10.1142/S0219720004000661; Li WM, 2009, LECT N BIOINFORMAT, V5462, P44; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Park J, 1998, BIOINFORMATICS, V14, P144, DOI 10.1093/bioinformatics/14.2.144; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; ROSE GD, 1979, J MOL BIOL, V134, P447, DOI 10.1016/0022-2836(79)90363-2; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; SONNHAMMER ELL, 1994, PROTEIN SCI, V3, P482; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Tress M, 2007, PROTEINS, V69, P137, DOI 10.1002/prot.21675; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Wang YT, 2004, INT IMMUNOL, V16, P777, DOI 10.1093/intimm/dxh081; Ward JJ, 2003, BIOINFORMATICS, V19, P1650, DOI 10.1093/bioinformatics/btg223; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697	32	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39475	10.1371/journal.pone.0039475	http://dx.doi.org/10.1371/journal.pone.0039475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761802	Green Published, gold, Green Submitted			2022-12-27	WOS:000305826400017
J	Fields, DM; Shema, SD; Browman, HI; Browne, TQ; Skiftesvik, AB				Fields, David M.; Shema, Steven D.; Browman, Howard I.; Browne, Thomas Q.; Skiftesvik, Anne Berit			Light Primes the Escape Response of the Calanoid Copepod, Calanus finmarchicus	PLOS ONE			English	Article							TROUT SALVELINUS-NAMAYCUSH; PREDATOR-PREY INTERACTIONS; PLANKTONIC MARINE COPEPOD; DIEL VERTICAL MIGRATION; 1ST ANTENNAE; LEPOMIS-MACROCHIRUS; COMMUNITY STRUCTURE; FORCE PRODUCTION; ACARTIA-TONSA; ZOOPLANKTON	The timing and magnitude of an escape reaction is often the determining factor governing a copepod's success at avoiding predation. Copepods initiate rapid and directed escapes in response to fluid signals created by predators; however little is known about how copepods modulate their behavior in response to additional sensory input. This study investigates the effect of light level on the escape behavior of Calanus finmarchicus. A siphon flow was used to generate a consistent fluid signal and the behavioral threshold and magnitude of the escape response was quantified in the dark and in the light. The results show that C. finmarchicus initiated their escape reaction further from the siphon and traveled with greater speed in the light than in the dark. However, no difference was found in the escape distance. These results suggest that copepods use information derived from multiple sensory inputs to modulate the sensitivity and strength of the escape in response to an increase risk of predation. Population and IBM models that predict optimal vertical distributions of copepods in response to visual predators need to consider changes in the copepod's behavioral thresholds when predicting predation risk within the water column.	[Fields, David M.; Shema, Steven D.; Browne, Thomas Q.] Bigelow Lab Ocean Sci, W Boothbay Harbor, ME USA; [Browman, Howard I.; Skiftesvik, Anne Berit] Inst Marine Res, Austevoll Res Stn, Storebo, Norway	Bigelow Laboratory for Ocean Sciences; Institute of Marine Research - Norway	Fields, DM (corresponding author), Bigelow Lab Ocean Sci, W Boothbay Harbor, ME USA.	dfields@bigelow.org	Skiftesvik, Anne Berit/M-1266-2013; Browman, Howard/CAA-2802-2022; Browman, Howard/B-4441-2009	Skiftesvik, Anne Berit/0000-0002-7754-5661; Browman, Howard/0000-0002-6282-7316; Browman, Howard/0000-0002-6282-7316; Fields, David/0000-0002-8291-912X	NSF [0718823]; Norwegian Institute of Marine Research	NSF(National Science Foundation (NSF)); Norwegian Institute of Marine Research	This research was supported by NSF 0718823 to DMF and the Norwegian Institute of Marine Research (Fine-scale interactions in the plankton project to HIB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MB, 2010, MAR BIOL, V157, P1251, DOI 10.1007/s00227-010-1405-9; AKSNES DL, 1990, MAR ECOL PROG SER, V64, P209, DOI 10.3354/meps064209; Aksnes DL, 1997, SARSIA, V82, P137, DOI 10.1080/00364827.1997.10413647; ALCARAZ M, 1988, HYDROBIOLOGIA, V167, P409, DOI 10.1007/BF00026333; BOLLENS SM, 1992, HYDROBIOLOGIA, V234, P33, DOI 10.1007/BF00010777; Brewer MC, 1995, MAR FRESHW BEHAV PHY, V26, P91, DOI 10.1080/10236249509378931; Brewer MC, 1999, J PLANKTON RES, V21, P1317, DOI 10.1093/plankt/21.7.1317; Browman H. I, 2003, BIG FISH BANG; Browman HI, 2003, BIG FISH BANG, P71; BUSKEY EJ, 1987, J PLANKTON RES, V9, P857, DOI 10.1093/plankt/9.5.857; BUSKEY EJ, 1986, J EXP MAR BIOL ECOL, V103, P65, DOI 10.1016/0022-0981(86)90132-2; Cohen JH, 2002, BIOL BULL-US, V203, P307, DOI 10.2307/1543573; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Day SW, 2005, J EXP BIOL, V208, P2661, DOI 10.1242/jeb.01708; EGGERS DM, 1977, ECOLOGY, V58, P46, DOI 10.2307/1935107; Eiane K, 2004, MAR ECOL PROG SER, V268, P183, DOI 10.3354/meps268183; Fields David M., 1996, P323; Fields DM, 2010, MAR BIOL, V157, P505, DOI 10.1007/s00227-009-1336-5; Fields DM, 1997, J PLANKTON RES, V19, P1289, DOI 10.1093/plankt/19.9.1289; Fields DM, 2004, J COMP PHYSIOL A, V190, P877, DOI 10.1007/s00359-004-0543-2; Fields DM, 2002, MAR ECOL PROG SER, V227, P173, DOI 10.3354/meps227173; Fields DM, 2002, J PLANKTON RES, V24, P747, DOI 10.1093/plankt/24.8.747; Fields DM, 2000, MAR FRESHW BEHAV PHY, V34, P21, DOI 10.1080/10236240009379057; Fiksen O, 2002, MAR ECOL PROG SER, V243, P151, DOI 10.3354/meps243151; Fiksen O, 1998, FISH OCEANOGR, V7, P355, DOI 10.1046/j.1365-2419.1998.00068.x; Fiksen O, 2011, MAR ECOL PROG SER, V432, P207, DOI 10.3354/meps09148; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; FROST BW, 1988, B MAR SCI, V43, P675; GERRITSEN J, 1977, J FISH RES BOARD CAN, V34, P73, DOI 10.1139/f77-008; GLIWICZ MZ, 1986, NATURE, V320, P746, DOI 10.1038/320746a0; Grecay PA, 1996, MAR ECOL PROG SER, V131, P11, DOI 10.3354/meps131011; Grimm V., 2005, INDIVIDUAL BASED MOD, P428; HORRIDGE GA, 1967, PROC R SOC SER B-BIO, V168, P413, DOI 10.1098/rspb.1967.0072; Huse G, 2010, PROG OCEANOGR, V84, P93, DOI 10.1016/j.pocean.2009.09.011; Jiang HS, 2011, J R SOC INTERFACE, V8, P1090, DOI 10.1098/rsif.2010.0481; KETTLE D, 1978, J FISH RES BOARD CAN, V35, P1495, DOI 10.1139/f78-236; Kils U, 1989, COUNC M INT COUNC L, VL15, P1; Kiorboe T, 1999, MAR ECOL PROG SER, V179, P97, DOI 10.3354/meps179097; KURBJEWEIT F, 1991, MEERESFORSCHUNG, V33, P168; Lenz PH, 1999, MAR BIOL, V133, P249, DOI 10.1007/s002270050464; Lenz PH, 2004, J MARINE SYST, V49, P133, DOI 10.1016/j.jmarsys.2003.05.006; LENZ PH, 1993, B MAR SCI, V53, P170; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; MARRASE C, 1990, P NATL ACAD SCI USA, V87, P1653, DOI 10.1073/pnas.87.5.1653; Mazur MM, 2003, ENVIRON BIOL FISH, V67, P397, DOI 10.1023/A:1025807711512; Mellon DF, 2005, J EXP BIOL, V208, P3711, DOI 10.1242/jeb.01827; Moore PA, 1999, LIMNOL OCEANOGR, V44, P166, DOI 10.4319/lo.1999.44.1.0166; Pangle KL, 2007, ECOLOGY, V88, P402, DOI 10.1890/06-0768; Pangle KL, 2009, CAN J FISH AQUAT SCI, V66, P1748, DOI 10.1139/F09-133; Sabates A, 2003, J FISH BIOL, V63, P1476, DOI 10.1111/j.1095-8649.2003.00259.x; Seuront L, 2011, PHYSICA A, V390, P250, DOI 10.1016/j.physa.2010.09.025; STRICKLER JR, 1973, P NATL ACAD SCI USA, V70, P2656, DOI 10.1073/pnas.70.9.2656; Strickler JR, 1975, SWIMMING FLYING NATU, P613; Tiselius P, 1997, LIMNOL OCEANOGR, V42, P164, DOI 10.4319/lo.1997.42.1.0164; TURNER AM, 1990, ECOLOGY, V71, P2241, DOI 10.2307/1938636; Utne-Palm AC, 2002, MAR FRESHW BEHAV PHY, V35, P111, DOI 10.1080/10236240290025644; vanDuren LA, 1996, J PLANKTON RES, V18, P805, DOI 10.1093/plankt/18.5.805; Viitasalo M, 1998, MAR ECOL PROG SER, V175, P129, DOI 10.3354/meps175129; VINYARD GL, 1976, J FISH RES BOARD CAN, V33, P2845, DOI 10.1139/f76-342; Visser AW, 2007, J PLANKTON RES, V29, P447, DOI 10.1093/plankt/fbm029; Vogel JL, 1999, CAN J FISH AQUAT SCI, V56, P1293, DOI 10.1139/cjfas-56-7-1293; Vollset KW, 2011, MAR BIOL, V158, P1125, DOI 10.1007/s00227-011-1635-5; Waggett RJ, 2007, MAR BIOL, V150, P599, DOI 10.1007/s00227-006-0384-3; Waggett RJ, 2008, J EXP MAR BIOL ECOL, V361, P111, DOI 10.1016/j.jembe.2008.05.006; YEN J, 1992, J PLANKTON RES, V14, P495, DOI 10.1093/plankt/14.4.495; Yen J., 1992, ERGEBNISSE LIMNOLOGI, V36, P123; ZARET TM, 1980, EVOLUTION ECOLOGY ZO, P594	67	15	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39594	10.1371/journal.pone.0039594	http://dx.doi.org/10.1371/journal.pone.0039594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761834	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800048
J	Zhu, H; Napravnik, S; Eron, J; Cole, S; Ma, Y; Wohl, D; Dou, ZH; Zhang, Y; Liu, ZF; Zhao, DC; Cohen, M; Zhang, FJ				Zhu, Hao; Napravnik, Sonia; Eron, Joseph; Cole, Stephen; Ma, Ye; Wohl, David; Dou, Zhihui; Zhang, Yao; Liu, Zhongfu; Zhao, Decai; Cohen, Myron; Zhang, Fujie			Attrition among Human Immunodeficiency Virus (HIV)-Infected Patients Initiating Antiretroviral Therapy in China, 2003-2010	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; FOLLOW-UP; PATIENTS LOST; SCALE-UP; HEPATITIS-B; MORTALITY; OUTCOMES; PROGRAMS; AFRICA; LOSSES	Background: Mortality and morbidity from HIV have dramatically decreased in both high-and low-income countries. However, some patients may not benefit from combination antiretroviral therapy (cART) because of inadequate access to HIV care, including attrition after care initiation. Methodology/Principal Findings: The study population included all HIV-infected patients receiving cART through the Chinese National Free Antiretroviral Treatment Program from 1 January 2003 to 31 December 2010 (n = 106,542). We evaluated retention in HIV care and used multivariable Cox proportional hazard models to identify independent factors predictive of attrition. The cumulative probability of attrition from cART initiation was 9% at 12 months, 13% at 18 months, 16% at 24 months and 24% at 60 months. A number of factors were associated with attrition, including younger age, male gender, and being single or divorced. Patients with higher CD4 cell counts at cART initiation were more likely to drop out of HIV care. The proportion of patients remaining in HIV care increased in more recent calendar years and among patients who initiated modern cART regimens. Conclusions/Significance: Retention in HIV care is essential for optimizing individual and public health outcomes. Attrition, even the degree observed in our study, can lead to premature morbidity and mortality, and possibly affect further transmission of HIV and HIV resistant drug variants. Effective strategies to promote retention in HIV care programs are needed. In China these strategies may include focusing particularly on younger male patients and those with higher CD4 cell counts at therapy initiation.	[Zhu, Hao; Napravnik, Sonia; Eron, Joseph; Cole, Stephen; Cohen, Myron] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Napravnik, Sonia; Eron, Joseph; Wohl, David; Cohen, Myron] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA; [Zhu, Hao; Ma, Ye; Dou, Zhihui; Zhang, Yao; Liu, Zhongfu; Zhao, Decai; Zhang, Fujie] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Zhang, Fujie] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Capital Medical University	Zhu, H (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.	myron_cohen@med.unc.edu; zhang.fujie.t@gmail.com			National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention; National Institutes of Health [P30-AI50410]; UNC AIDS International Training and Research Programs from the John E. Fogarty International Center, National Institutes of Health [5 D43 TW001039-13]; Pfizer; Bristol-Myers Squibb; Merck; Tibotec; GlaxoSmithKline; ViiV; Boehringer-Ingelheim; FOGARTY INTERNATIONAL CENTER [D43TW001039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC AIDS International Training and Research Programs from the John E. Fogarty International Center, National Institutes of Health; Pfizer(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb); Merck(Merck & Company); Tibotec; GlaxoSmithKline(GlaxoSmithKline); ViiV; Boehringer-Ingelheim(Boehringer Ingelheim); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grants from National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention; Grants P30-AI50410 from the National Institutes of Health; UNC AIDS International Training and Research Programs grant from the John E. Fogarty International Center, National Institutes of Health [5 D43 TW001039-13]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SN has received grant support from Pfizer, Bristol-Myers Squibb, and Merck. JE has received consulting fees from Tibotec, Bristol-Myers Squibb, Merck, GlaxoSmithKline, ViiV and Pfizer, and grant support from GlaxoSmithKline, Merck, Pfizer, Bristol-Myers Squibb, ViiV and Boehringer-Ingelheim. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; Chasombat S, 2009, JAIDS-J ACQ IMM DEF, V50, P506, DOI 10.1097/QAI.0b013e3181967602; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Dou ZH, 2010, INT J EPIDEMIOL, V39, pII56, DOI 10.1093/ije/dyq215; Dou ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013737; Ekouevi DK, 2010, TROP MED INT HEALTH, V15, P34, DOI 10.1111/j.1365-3156.2010.02505.x; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Lanoy E, 2006, J CLIN EPIDEMIOL, V59, P829, DOI 10.1016/j.jclinepi.2005.11.024; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Ma Y, 2010, INT J EPIDEMIOL, V39, P973, DOI 10.1093/ije/dyp233; MacPherson P, 2009, T ROY SOC TROP MED H, V103, P588, DOI 10.1016/j.trstmh.2008.10.001; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; Matthews G, 2007, CURR OPIN INFECT DIS, V20, P16, DOI 10.1097/QCO.0b013e328012c5aa; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Mocroft A, 2008, HIV MED, V9, P261, DOI 10.1111/j.1468-1293.2008.00557.x; Mugavero MJ, 2011, CLIN INFECT DIS, V52, pS238, DOI 10.1093/cid/ciq048; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; State Council AIDS Working Committee Office and UN Theme Group on AIDS in China, 2007, JOINT ASS HIV AIDS P; UNAIDS, 2010, REP GLOB AIDS EP JOI; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Zachariah R, 2008, T ROY SOC TROP MED H, V102, P288, DOI 10.1016/j.trstmh.2007.12.007; Zhang F., 2008, CHINA FREE ANTIRETRO; Zhang FJ, 2005, CELL RES, V15, P877, DOI 10.1038/sj.cr.7290362; Zhang FJ, 2008, CLIN INFECT DIS, V47, P825, DOI 10.1086/590945; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006	40	22	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39414	10.1371/journal.pone.0039414	http://dx.doi.org/10.1371/journal.pone.0039414			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761787	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800031
J	Peterfia, B; Fule, T; Baghy, K; Szabadkai, K; Fullar, A; Dobos, K; Zong, F; Dobra, K; Hollosi, P; Jeney, A; Paku, S; Kovalszky, I				Peterfia, Balint; Fuele, Tibor; Baghy, Kornelia; Szabadkai, Krisztina; Fullar, Alexandra; Dobos, Katalin; Zong, Fang; Dobra, Katalin; Hollosi, Peter; Jeney, Andras; Paku, Sandor; Kovalszky, Ilona			Syndecan-1 Enhances Proliferation, Migration and Metastasis of HT-1080 Cells in Cooperation with Syndecan-2	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; TRANSCRIPTION FACTOR ETS-1; DIFFERENTIAL EXPRESSION; BREAST-CARCINOMA; CO-RECEPTORS; CANCER; APOPTOSIS; ROLES; OSTEOSARCOMA; MESOTHELIOMA	Syndecans are transmembrane heparan sulphate proteoglycans. Their role in the development of the malignant phenotype is ambiguous and depends upon the particular type of cancer. Nevertheless, syndecans are promising targets in cancer therapy, and it is important to elucidate the mechanisms controlling their various cellular effects. According to earlier studies, both syndecan-1 and syndecan-2 promote malignancy of HT-1080 human fibrosarcoma cells, by increasing the proliferation rate and the metastatic potential and migratory ability, respectively. To better understand their tumour promoter role in this cell line, syndecan expression levels were modulated in HT-1080 cells and the growth rate, chemotaxis and invasion capacity were studied. For in vivo testing, syndecan-1 overexpressing cells were also inoculated into mice. Overexpression of full length or truncated syndecan-1 lacking the entire ectodomain but containing the four juxtamembrane amino acids promoted proliferation and chemotaxis. These effects were accompanied by a marked increase in syndecan-2 protein expression. The pro-migratory and pro-proliferative effects of truncated syndecan-1 were not observable when syndecan-2 was silenced. Antisense silencing of syndecan-2, but not that of syndecan-1, inhibited cell migration. In vivo, both full length and truncated syndecan-1 increased tumour growth and metastatic rate. Based on our in vitro results, we conclude that the tumour promoter role of syndecan-1 observed in HT-1080 cells is independent of its ectodomain; however, in vivo the presence of the ectodomain further increases tumour proliferation. The enhanced migratory ability induced by syndecan-1 overexpression is mediated by syndecan-2. Overexpression of syndecan-1 also leads to activation of IGF1R and increased expression of Ets-1. These changes were not evident when syndecan-2 was overexpressed. These findings suggest the involvement of IGF1R and Ets-1 in the induction of syndecan-2 synthesis and stimulation of proliferation by syndecan-1. This is the first report demonstrating that syndecan-1 enhances malignancy of a mesenchymal tumour cell line, via induction of syndecan-2 expression.	[Peterfia, Balint; Fuele, Tibor; Baghy, Kornelia; Szabadkai, Krisztina; Fullar, Alexandra; Dobos, Katalin; Hollosi, Peter; Jeney, Andras; Paku, Sandor; Kovalszky, Ilona] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Zong, Fang; Dobra, Katalin] Karolinska Inst, Div Pathol, Dept Lab Med, Stockholm, Sweden	Semmelweis University; Karolinska Institutet	Peterfia, B (corresponding author), Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary.	koval@korb1.sote.hu	Baghy, Kornélia/ABH-2549-2020; Kovalszky, Ilona/ABH-2832-2020; zong, fang/GQZ-6104-2022	Baghy, Kornélia/0000-0002-5323-2775; Kovalszky, Ilona/0000-0002-0179-3378; Fullar, Alexandra/0000-0003-4368-1523	Hungarian Scientific Research Fund [K67925, K100904]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Hungarian Scientific Research Fund (http://www.otka.hu/) grant numbers K67925 and K100904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbeck M, 2007, EXP DERMATOL, V16, P580, DOI 10.1111/j.1600-0625.2007.00568.x; BAI XM, 1994, J HISTOCHEM CYTOCHEM, V42, P1043, DOI 10.1177/42.8.8027524; Beauvais DM, 2010, J CELL SCI, V123, P3796, DOI 10.1242/jcs.067645; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burbach BJ, 2003, MATRIX BIOL, V22, P163, DOI 10.1016/S0945-053X(03)00009-X; Carey DJ, 1997, BIOCHEM J, V327, P1; Choi Y, 2011, MATRIX BIOL, V30, P93, DOI 10.1016/j.matbio.2010.10.006; Chu PG, 2003, AM J CLIN PATHOL, V120, P64, DOI 10.1309/48KC17WAU69BTBXQ; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; DAVID G, 1993, DEVELOPMENT, V119, P841; Davies EJ, 2004, CLIN CANCER RES, V10, P5178, DOI 10.1158/1078-0432.CCR-03-0103; Dobra K, 2003, ANTICANCER RES, V23, P2435; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Essner JJ, 2006, INT J BIOCHEM CELL B, V38, P152, DOI 10.1016/j.biocel.2005.08.012; Feldman JP, 2009, J APPL QUANT METHODS, P455; Hahne JC, 2008, MINI-REV MED CHEM, V8, P1095, DOI 10.2174/138955708785909934; Hahne JC, 2009, INT J ONCOL, V35, P989, DOI 10.3892/ijo_00000413; Hanyu A, 2009, CANCER SCI, V100, P2085, DOI 10.1111/j.1349-7006.2009.01305.x; HINKES MT, 1993, J BIOL CHEM, V268, P11440; Hoshino R, 2001, J BIOL CHEM, V276, P2686, DOI 10.1074/jbc.M006132200; Juuti A, 2005, ONCOLOGY-BASEL, V68, P97, DOI 10.1159/000085702; Kumar-Singh S, 1998, J PATHOL, V186, P300, DOI 10.1002/(SICI)1096-9896(1998110)186:3<300::AID-PATH180>3.0.CO;2-Q; Kusano Y, 2004, J BIOCHEM, V135, P129, DOI 10.1093/jb/mvh015; Leivonen M, 2004, ONCOLOGY-BASEL, V67, P11, DOI 10.1159/000080280; Lendorf ME, 2011, J HISTOCHEM CYTOCHEM, V59, P615, DOI 10.1369/0022155411405057; Lents NH, 2006, CELL CYCLE, V5, P1699, DOI 10.4161/cc.5.15.3126; Longley RL, 1999, J CELL SCI, V112, P3421; LORIES V, 1992, J BIOL CHEM, V267, P1116; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; Mathe M, 2006, ORAL ONCOL, V42, P493, DOI 10.1016/j.oraloncology.2005.10.003; Modrowski D, 2005, BONE, V37, P180, DOI 10.1016/j.bone.2005.04.010; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; Orosco A, 2007, CANCER RES, V67, P3708, DOI 10.1158/0008-5472.CAN-06-4164; Orosz Z, 2001, ANTICANCER RES, V21, P733; Park H, 2005, CANCER RES, V65, P9899, DOI 10.1158/0008-5472.CAN-05-1386; Peterfia B, 2006, MAGY ONKOL, P115; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; Saqi A, 2005, DIAGN CYTOPATHOL, V33, P65, DOI 10.1002/dc.20297; SOLURSH M, 1990, DEV BIOL, V140, P83, DOI 10.1016/0012-1606(90)90055-N; Teng YH, 2011, MATRIX BIOL; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Uphoff CC, 2002, LEUKEMIA, V16, P289, DOI 10.1038/sj.leu.2402365; VAINIO S, 1989, J CELL BIOL, V108, P1945, DOI 10.1083/jcb.108.5.1945; Whiteford JR, 2006, J BIOL CHEM, V281, P32156, DOI 10.1074/jbc.M605553200; Whiteford JR, 2011, MOL BIOL CELL, V22, P3609, DOI 10.1091/mbc.E11-02-0099; Wiksten JP, 2001, INT J CANCER, V95, P1, DOI 10.1002/1097-0215(20010120)95:1<1::AID-IJC1000>3.0.CO;2-5; Zong F., 2009, CELL PROLIF; Zong F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014816	49	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39474	10.1371/journal.pone.0039474	http://dx.doi.org/10.1371/journal.pone.0039474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22745764	gold, Green Published, Green Submitted			2022-12-27	WOS:000305808700032
J	Wei, B; Han, XY; Qi, CL; Zhang, S; Zheng, ZH; Huang, Y; Chen, TF; Wei, HB				Wei, Bo; Han, Xiao-Yan; Qi, Cui-Ling; Zhang, Shi; Zheng, Zong-Heng; Huang, Yong; Chen, Tu-Feng; Wei, Hong-Bo			Coaction of Spheroid-Derived Stem-Like Cells and Endothelial Progenitor Cells Promotes Development of Colon Cancer	PLOS ONE			English	Article							SIDE-POPULATION CELLS; CHEMOKINE RECEPTOR CXCR4; HUMAN COLORECTAL-CANCER; IN-VITRO; GASTRIC-CANCER; IDENTIFICATION; TUMOR; CARCINOMA; ANGIOGENESIS; METASTASIS	Although some studies described the characteristics of colon cancer stem cells (CSCs) and the role of endothelial progenitor cells (EPCs) in neovascularization, it is still controversial whether an interaction exists or not between CSCs and EPCs. In the present study, HCT116 and HT29 sphere models, which are known to be the cells enriching CSCs, were established to investigate the roles of this interaction in development and metastasis of colon cancer. Compared with their parental counterparts, spheroid cells demonstrated higher capacity of invasion, higher tumorigenic and metastatic potential. Then the in vitro and in vivo relationship between CSCs and EPCs were studied by using capillary tube formation assay and xenograft models. Our results showed that spheroid cells could promote the proliferation, migration and tube formation of EPCs through secretion of vascular endothelial growth factor (VEGF). Meanwhile, the EPCs could increase tumorigenic capacity of spheroid cells through angiogenesis. Furthermore, higher microvessel density was detected in the area enriching cancer stem cells in human colon cancer tissue. Our findings indicate that spheroid cells possess the characteristics of cancer stem cells, and the coaction of CSCs and EPCs may play an important role in the development of colon cancer.	[Wei, Bo; Zheng, Zong-Heng; Huang, Yong; Chen, Tu-Feng; Wei, Hong-Bo] Sun Yat Sen Univ, Dept Gastrointestinal Surg, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Han, Xiao-Yan] Sun Yat Sen Univ, Cent Lab, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Qi, Cui-Ling] Guangdong Pharmaceut Univ, Inst Vasc Biol, Guangzhou, Guangdong, Peoples R China; [Zhang, Shi] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangdong Pharmaceutical University; University of Hong Kong	Wei, B (corresponding author), Sun Yat Sen Univ, Dept Gastrointestinal Surg, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China.	drweihb@126.com	han, xiao/HDN-9782-2022	Wei, Bo/0000-0002-1058-5888	National Science Foundation of China [30872462, 81000960]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Science Foundation of China (No. 30872462 to Hong-Bo Wei, and No. 81000960 to Bo Wei). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Burkert J, 2008, J PATHOL, V214, P564, DOI 10.1002/path.2307; Calzi SL, 2010, MICROVASC RES, V79, P207, DOI 10.1016/j.mvr.2010.02.011; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Erguen S, 2008, STEM CELL REV, V4, P169, DOI 10.1007/s12015-008-9028-y; Fang DD, 2010, BRIT J CANCER, V102, P1265, DOI 10.1038/sj.bjc.6605610; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Fukuda K, 2009, INT J ONCOL, V34, P1201, DOI 10.3892/ijo_00000248; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Hasan MR, 2011, INT J CANCER, V129, P2115, DOI 10.1002/ijc.26179; Hou Y, 2012, CELL RES, V22, P259, DOI 10.1038/cr.2011.139; Hovinga KE, 2010, STEM CELLS, V28, P1019, DOI 10.1002/stem.429; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim J, 2005, J CLIN ONCOL, V23, P2744, DOI 10.1200/JCO.2005.07.078; Kirkland SC, 2008, J BIOL CHEM, V283, P27612, DOI 10.1074/jbc.M802932200; Klettner A, 2008, INVEST OPHTH VIS SCI, V49, P4523, DOI 10.1167/iovs.08-2055; Kryczek I, 2005, CANCER RES, V65, P465; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Matsusue R, 2009, ANN SURG ONCOL, V16, P2645, DOI 10.1245/s10434-009-0599-x; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nishii T, 2009, CANCER SCI, V100, P1397, DOI 10.1111/j.1349-7006.2009.01211.x; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Oka N, 2007, BIOCHEM BIOPH RES CO, V360, P553, DOI 10.1016/j.bbrc.2007.06.094; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Schatteman GC, 2007, AM J PHYSIOL-HEART C, V292, pH1, DOI 10.1152/ajpheart.00662.2006; Schatton T, 2008, PIGM CELL MELANOMA R, V21, P39, DOI 10.1111/j.1755-148X.2007.00427.x; Schimanski CC, 2005, CLIN CANCER RES, V11, P1743, DOI 10.1158/1078-0432.CCR-04-1195; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Spring H, 2005, P NATL ACAD SCI USA, V102, P18111, DOI 10.1073/pnas.0507158102; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Umemoto T, 2006, STEM CELLS, V24, P86, DOI 10.1634/stemcells.2005-0064; Wakimoto H, 2009, CANCER RES, V69, P3472, DOI 10.1158/0008-5472.CAN-08-3886; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zhang LZ, 2010, PATHOL ONCOL RES, V16, P111, DOI 10.1007/s12253-009-9198-1; Zhong Y, 2010, CANCER LETT, V299, P150, DOI 10.1016/j.canlet.2010.08.013	52	32	40	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39069	10.1371/journal.pone.0039069	http://dx.doi.org/10.1371/journal.pone.0039069			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22745705	Green Published, Green Submitted, gold			2022-12-27	WOS:000305808700017
J	Ma, H; Hostuttler, M; Wei, HR; Rexroad, CE; Yao, JB				Ma, Hao; Hostuttler, Mark; Wei, Hairong; Rexroad, Caird E., III; Yao, Jianbo			Characterization of the Rainbow Trout Egg MicroRNA Transcriptome	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; REAL-TIME PCR; ONCORHYNCHUS-MYKISS; MESSENGER-RNA; EXPRESSION; QUALITY; TARGETS; GENES; MIRNA; IDENTIFICATION	MicroRNAs (miRNAs) are a class of endogenous small non-coding RNA molecules that regulate post-transcriptional expression of target genes and play important roles in animal development. The objectives of this study were to characterize the egg miRNA transcriptome and identify novel egg-predominant miRNAs in rainbow trout. Small RNAs isolated from mature unfertilized rainbow trout eggs were subjected to deep sequencing using an Illumina Genome Analyzer. The massive sequencing produced 24,621,741 quality reads, among which, 266 known miRNAs were identified and 230 putatively novel miRNAs were predicted. The most abundantly known miRNAs are let-7 and miR-21, accounting for 24.06% and 18.71% of the known miRNAs, respectively. Other known miRNAs which are abundantly present in eggs include miR-24, miR-202, miR-148, miR-30, miR-10, miR-146, miR-25, and miR-143. Real time PCR analysis using cDNAs derived from 10 tissues validated 87 out of 90 selected putative miRNAs and identified three novel miRNAs predominantly expressed in rainbow trout eggs. Each of these novel egg-predominant miRNAs is predicted to target a significant number of genes, most of which are significantly down-regulated in naturally ovulated rainbow trout eggs based on analysis of publicly available microarray data sets. Quantitative real time PCR analysis also demonstrated low expression of a selected number of target genes in eggs relative to liver and muscle tissues. This study represents the first complete survey of miRNAs in fish eggs and provides a starting point for future studies aimed at understanding the roles of miRNAs in controlling egg quality and early embryogenesis in rainbow trout.	[Ma, Hao; Yao, Jianbo] W Virginia Univ, Div Anim & Nutr Sci, Morgantown, WV 26506 USA; [Hostuttler, Mark; Rexroad, Caird E., III] Natl Ctr Cool & Cold Water Aquaculture, Kearneysville, WV USA; [Wei, Hairong] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA	West Virginia University; Michigan Technological University	Ma, H (corresponding author), W Virginia Univ, Div Anim & Nutr Sci, Morgantown, WV 26506 USA.	jianbo.yao@mail.wvu.edu	wei, hairong/GNM-7061-2022	wei, hairong/0000-0002-3551-4998; Ma, Hao/0000-0001-9593-4102	USDA-ARS [58-1930-0-059]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported by the USDA-ARS Cooperative Agreement No. 58-1930-0-059. It is published with the approval of the director of the West Virginia Agricultural and Forestry Experiment Station as scientific paper No. 3133. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter S, 2005, MOL REPROD DEV, V72, P377, DOI 10.1002/mrd.20361; Aegerter S, 2003, FISH PHYSIOL BIOCHEM, V28, P317, DOI 10.1023/B:FISH.0000030568.30472.71; Aegerter S, 2004, AQUACULTURE, V231, P59, DOI 10.1016/j.aquaculture.2003.08.019; Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Allendorf F.W., 1984, P1; Amanai M, 2006, BIOL REPROD, V75, P877, DOI 10.1095/biolreprod.106.056499; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Bannister SC, 2009, BIOL REPROD, V81, P165, DOI 10.1095/biolreprod.108.074005; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Blelloch R, 2010, CURR BIOL, V20, P271; Bobe J, 2004, BIOL REPROD, V71, P73, DOI 10.1095/biolreprod.103.025205; Bobe J, 2008, ENDOCRINOLOGY, V149, P2980, DOI 10.1210/en.2007-1652; Bobe J, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-39; Bonnet E, 2007, THERIOGENOLOGY, V67, P786, DOI 10.1016/j.theriogenology.2006.10.008; BROMAGE N, 1992, AQUACULTURE, V100, P141, DOI 10.1016/0044-8486(92)90355-O; Buchold GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015317; Burnside J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-185; Carletti MZ, 2009, J ANIM SCI, V87, pE29, DOI 10.2527/jas.2008-1331; Chandra V, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S2; Chen Y, 2010, MOL CELL BIOL, V30, P3902, DOI 10.1128/MCB.01237-09; Creighton CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009637; Dean J, 2002, J REPROD IMMUNOL, V53, P171, DOI 10.1016/S0165-0378(01)00100-0; ELLIOTT JAK, 1984, AQUACULTURE, V43, P23, DOI 10.1016/0044-8486(84)90006-1; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Glazov EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006349; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; He J, 2010, PLOS ONE, V5; Hicks JA, 2008, POULTRY SCI, V87, P2335, DOI 10.3382/ps.2008-00114; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jin HT, 2010, NEW BIOTECHNOL, V27, P734, DOI 10.1016/j.nbt.2010.09.006; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Lu David P, 2005, J RNAi Gene Silencing, V1, P44; Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Ma F, 2010, J IMMUNOL, V184, P6053, DOI 10.4049/jimmunol.0902308; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McDaneld TG, 2009, J ANIM SCI, V87, pE21, DOI 10.2527/jas.2008-1303; Morin RD, 2009, GENOME RES, V19, P958; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Ramachandra RK, 2007, MOL REPROD DEV, V74, P502, DOI 10.1002/mrd.20628; Ramachandra RK, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-41; Rathjen T, 2009, FEBS LETT, V583, P1422, DOI 10.1016/j.febslet.2009.03.048; Rexroad CE, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-74; Rime Helene, 2004, Reprod Biol Endocrinol, V2, P26, DOI 10.1186/1477-7827-2-26; Salem M, 2010, MAR BIOTECHNOL, V12, P410, DOI 10.1007/s10126-009-9232-z; Serezli R, 2010, J ANIM VET ADV, V9, P576; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; Stahlberg A, 2010, METHODS, V50, P282, DOI 10.1016/j.ymeth.2010.01.002; Su GS, 1997, AQUACULTURE, V154, P115, DOI 10.1016/S0044-8486(97)00050-1; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Thorgaard GH, 2002, COMP BIOCHEM PHYS B, V133, P609, DOI 10.1016/S1096-4959(02)00167-7; Vassallo-Agius R, 2001, FISHERIES SCI, V67, P818, DOI 10.1046/j.1444-2906.2001.00328.x; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vaz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-288; Voinnet O, 2006, SCIENCE, V312, P436; Wang JN, 2011, COMP BIOCHEM PHYS B, V158, P208, DOI 10.1016/j.cbpb.2010.11.010; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zheng P, 2007, SEMIN REPROD MED, V25, P243, DOI 10.1055/s-2007-980218	75	69	71	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39649	10.1371/journal.pone.0039649	http://dx.doi.org/10.1371/journal.pone.0039649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761856	Green Published, gold			2022-12-27	WOS:000305781700056
J	Weeda, WD; Grasman, RPPP; Waldorp, LJ; van de Laar, MC; Van der Molen, MW; Huizenga, HM				Weeda, Wouter D.; Grasman, Raoul P. P. P.; Waldorp, Lourens J.; van de laar, Maria C.; Van der Molen, Maurits W.; Huizenga, Hilde M.			A Fast and Reliable Method for Simultaneous Waveform, Amplitude and Latency Estimation of Single-Trial EEG/MEG Data	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; EVOKED POTENTIALS; P3 LATENCY; VARIABILITY; COMPONENTS; SIGNALS; BRAIN	The amplitude and latency of single-trial EEG/MEG signals may provide valuable information concerning human brain functioning. In this article we propose a new method to reliably estimate single-trial amplitude and latency of EEG/MEG signals. The advantages of the method are fourfold. First, no a-priori specified template function is required. Second, the method allows for multiple signals that may vary independently in amplitude and/or latency. Third, the method is less sensitive to noise as it models data with a parsimonious set of basis functions. Finally, the method is very fast since it is based on an iterative linear least squares algorithm. A simulation study shows that the method yields reliable estimates under different levels of latency variation and signal-to-noise ratioOs. Furthermore, it shows that the existence of multiple signals can be correctly determined. An application to empirical data from a choice reaction time study indicates that the method describes these data accurately.	[Weeda, Wouter D.; Grasman, Raoul P. P. P.; Waldorp, Lourens J.; van de laar, Maria C.; Van der Molen, Maurits W.; Huizenga, Hilde M.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands	University of Amsterdam	Weeda, WD (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	w.d.weeda1@uva.nl	van der Molen, Maurits W/B-7543-2014	Weeda, W. D./0000-0001-8619-2645	Netherlands' Organization for Scientific Research (NWO) VIDI; NWO VENI	Netherlands' Organization for Scientific Research (NWO) VIDI(Netherlands Organization for Scientific Research (NWO)); NWO VENI(Netherlands Organization for Scientific Research (NWO))	This study was funded by a Netherlands' Organization for Scientific Research (NWO) VIDI grant awarded to HMH and a NWO VENI grant awarded to RPG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikake H, 1974, IEEE T AUTOMAT CONTR, V19, P716, DOI 10.1109/TAC.1974.1100705; de Munck JC, 2004, IEEE T BIO-MED ENG, V51, P2123, DOI 10.1109/TBME.2004.836515; De Pascalis V, 2008, INTELLIGENCE, V36, P35, DOI 10.1016/j.intell.2007.01.002; FALKENSTEIN M, 1993, BIOL PSYCHOL, V35, P201, DOI 10.1016/0301-0511(93)90002-P; FALKENSTEIN M, 1994, ELECTROEN CLIN NEURO, V92, P148, DOI 10.1016/0168-5597(94)90055-8; FEIN G, 1989, ELECTROEN CLIN NEURO, V72, P384, DOI 10.1016/0013-4694(89)90044-8; Fjell AM, 2009, NEUROBIOL AGING, V30, P2065, DOI 10.1016/j.neurobiolaging.2008.01.015; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Geurts HM, 2008, NEUROPSYCHOLOGIA, V46, P3030, DOI 10.1016/j.neuropsychologia.2008.06.013; GEVINS AS, 1984, IEEE T BIO-MED ENG, V31, P833, DOI 10.1109/TBME.1984.325246; Handy T.C., 2004, EVENT RELATED POTENT; Jaskowski P, 1999, IEEE T BIO-MED ENG, V46, P987, DOI 10.1109/10.775409; Jaskowski P, 2000, PSYCHOPHYSIOLOGY, V37, P153, DOI 10.1111/1469-8986.3720153; Mayhew SD, 2006, CLIN NEUROPHYSIOL, V117, P1331, DOI 10.1016/j.clinph.2006.02.017; PHAM D T, 1987, Biometrika, V74, P525; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Quiroga RQ, 2003, CLIN NEUROPHYSIOL, V114, P376, DOI 10.1016/S1388-2457(02)00365-6; Quiroga RQ, 2000, PHYSICA D, V145, P278, DOI 10.1016/S0167-2789(00)00116-0; Verleger R, 1997, PSYCHOPHYSIOLOGY, V34, P131, DOI 10.1111/j.1469-8986.1997.tb02125.x; Wang ZS, 2007, COMPUT BIOL MED, V37, P463, DOI 10.1016/j.compbiomed.2006.08.011; WOODY CD, 1967, MED BIOL ENG, V5, P539, DOI 10.1007/BF02474247	21	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e38292	10.1371/journal.pone.0038292	http://dx.doi.org/10.1371/journal.pone.0038292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761672	Green Published, gold, Green Submitted			2022-12-27	WOS:000305781700005
J	Anacker, AMJ; Ahern, TH; Young, LJ; Ryabinin, AE				Anacker, Allison M. J.; Ahern, Todd H.; Young, Larry J.; Ryabinin, Andrey E.			The Role of Early Life Experience and Species Differences in Alcohol Intake in Microtine Rodents	PLOS ONE			English	Article							PARENT-CHILD RELATIONSHIPS; PRAIRIE VOLES; FAMILY-STRUCTURE; MATERNAL SEPARATION; SOCIAL-ORGANIZATION; MEADOW VOLES; PARTNER PREFERENCE; NUCLEUS-ACCUMBENS; LATERAL SEPTUM; SUBSTANCE USE	Social relationships have important effects on alcohol drinking. There are conflicting reports, however, about whether early-life family structure plays an important role in moderating alcohol use in humans. We have previously modeled social facilitation of alcohol drinking in peers in socially monogamous prairie voles. We have also modeled the effects of family structure on the development of adult social and emotional behaviors. Here we assessed whether alcohol intake would differ in prairie voles reared by both parents compared to those reared by a single mother. We also assessed whether meadow voles, a closely related species that do not form lasting reproductive partnerships, would differ in alcohol drinking or in the effect of social influence on drinking. Prairie voles were reared either bi-parentally (BP) or by a single mother (SM). BP-and SM-reared adult prairie voles and BP-reared adult meadow voles were given limited access to a choice between alcohol (10%) and water over four days and assessed for drinking behavior in social and non-social drinking environments. While alcohol preference was not different between species, meadow voles drank significantly lower doses than prairie voles. Meadow voles also had significantly higher blood ethanol concentrations than prairie voles after receiving the same dose, suggesting differences in ethanol metabolism. Both species, regardless of rearing condition, consumed more alcohol in the social drinking condition than the non-social condition. Early life family structure did not significantly affect any measure. Greater drinking in the social condition indicates that alcohol intake is influenced similarly in both species by the presence of a peer. While the ability of prairie voles to model humans may be limited, the lack of differences in alcohol drinking in BP-and SM-reared prairie voles lends biological support to human studies demonstrating no effect of single-parenting on alcohol abuse.	[Anacker, Allison M. J.; Ryabinin, Andrey E.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Ahern, Todd H.] Quinnipiac Univ, Ctr Behav Neurosci, Dept Psychol, Hamden, CT USA; [Young, Larry J.] Emory Univ, Yerkes Natl Primate Res Ctr, Dept Psychiat & Behav Sci, Ctr Translat Social Neurosci, Atlanta, GA 30322 USA	Oregon Health & Science University; Quinnipiac University; Emory University	Anacker, AMJ (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.	ryabinin@ohsu.edu	Young, Larry/HGE-5031-2022	Ryabinin, Andrey/0000-0003-4662-3775	Ginger Ashworth Graduate Training Award [MH64692]; United States National Institutes of Health [RR00165];  [AA019793];  [AA016886];  [AA02013601];  [AA007468]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH064692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019793, R21AA016886, T32AA007468] Funding Source: NIH RePORTER	Ginger Ashworth Graduate Training Award; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by AA019793 and AA016886 to AER, AA02013601, AA007468, and the Ginger Ashworth Graduate Training Award to AMJA, MH64692 to LJY and United States National Institutes of Health RR00165 to Yerkes National Primate Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern TH, 2011, DEV PSYCHOBIOL, V53, P118, DOI 10.1002/dev.20498; Ahern TH, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.017.2009; Ahern TH, 2009, J NEUROSCI METH, V182, P180, DOI 10.1016/j.jneumeth.2009.06.010; Anacker AMJ, 2011, ALCOHOL CLIN EXP RES, V35, P1884, DOI 10.1111/j.1530-0277.2011.01533.x; Anacker AMJ, 2011, ADDICT BIOL, V16, P92, DOI 10.1111/j.1369-1600.2010.00234.x; Anacker AMJ, 2010, INT J ENV RES PUB HE, V7, P473, DOI 10.3390/ijerph7020473; Bachtell RK, 2003, J NEUROSCI, V23, P2477; BARNES G M, 1987, Pediatrician, V14, P13; Beery AK, 2010, NEUROSCIENCE, V169, P665, DOI 10.1016/j.neuroscience.2010.05.023; Beery AK, 2008, HORM BEHAV, V54, P153, DOI 10.1016/j.yhbeh.2008.02.007; Beery AK, 2009, PHYSIOL BEHAV, V97, P52, DOI 10.1016/j.physbeh.2009.01.020; CARTER CS, 1993, SCI AM, V268, P100, DOI 10.1038/scientificamerican0693-100; Cruz FC, 2008, PSYCHOPHARMACOLOGY, V201, P459, DOI 10.1007/s00213-008-1307-4; Dackis CA, 2001, J SUBST ABUSE TREAT, V21, P111, DOI 10.1016/S0740-5472(01)00192-1; Dhaher R, 2008, ALCOHOL CLIN EXP RES, V32, P197, DOI 10.1111/j.1530-0277.2007.00566.x; Esch T, 2004, NEUROENDOCRINOL LETT, V25, P235; Fahlke C, 2000, ALCOHOL CLIN EXP RES, V24, P644, DOI 10.1111/j.1530-0277.2000.tb02035.x; Fahlke C, 1997, ALCOHOL, V14, P175, DOI 10.1016/S0741-8329(96)00141-3; Fisher LB, 2007, ARCH PEDIAT ADOL MED, V161, P959, DOI 10.1001/archpedi.161.10.959; FOXCROFT DR, 1991, J ADOLESCENCE, V14, P255, DOI 10.1016/0140-1971(91)90020-R; GETZ LL, 1993, J MAMMAL, V74, P44, DOI 10.2307/1381904; GETZ LL, 1981, BEHAV ECOL SOCIOBIOL, V8, P189, DOI 10.1007/BF00299829; Getz LL, 1972, J MAMM, V53; Hayes LD, 2004, BEHAV ECOL SOCIOBIOL, V56, P585, DOI 10.1007/s00265-004-0815-4; HIGLEY JD, 1991, P NATL ACAD SCI USA, V88, P7261, DOI 10.1073/pnas.88.16.7261; Huot RL, 2001, PSYCHOPHARMACOLOGY, V158, P366, DOI 10.1007/s002130100701; INSEL TR, 1994, J NEUROSCI, V14, P5381; INSEL TR, 1992, P NATL ACAD SCI USA, V89, P5981, DOI 10.1073/pnas.89.13.5981; ISOHANNI M, 1994, SOC SCI MED, V38, P1565, DOI 10.1016/0277-9536(94)90118-X; Jia R, 2011, BEHAV BRAIN RES, V224, P279, DOI 10.1016/j.bbr.2011.05.042; Jia R, 2009, BEHAV PROCESS, V82, P271, DOI 10.1016/j.beproc.2009.07.006; Keebaugh AC, 2011, HORM BEHAV, V60, P498, DOI 10.1016/j.yhbeh.2011.07.018; Ledoux S, 2002, ALCOHOL ALCOHOLISM, V37, P52, DOI 10.1093/alcalc/37.1.52; Lim MM, 2004, NATURE, V429, P754, DOI 10.1038/nature02539; Liu Y, 2010, P NATL ACAD SCI USA, V107, P1217, DOI 10.1073/pnas.0911998107; Lonstein JS, 1999, PHYSIOL BEHAV, V66, P33, DOI 10.1016/S0031-9384(98)00270-4; MADISON DM, 1984, BEHAV ECOL SOCIOBIOL, V15, P9, DOI 10.1007/BF00310209; MADISON DM, 1987, AM ZOOL, V27, P899; MADISON DM, 1980, BEHAV ECOL SOCIOBIOL, V7, P65, DOI 10.1007/BF00302520; Mak KK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-503; McArdle P, 2002, ADDICTION, V97, P329, DOI 10.1046/j.1360-0443.2002.00066.x; McGraw LA, 2010, TRENDS NEUROSCI, V33, P103, DOI 10.1016/j.tins.2009.11.006; MCGUIRE B, 1995, CAN J ZOOL, V73, P383, DOI 10.1139/z95-042; MCGUIRE B, 1993, BEHAV ECOL SOCIOBIOL, V32, P293; McGuire B, 2007, AM MIDL NAT, V157, P187, DOI 10.1674/0003-0031(2007)157[187:SDEOMP]2.0.CO;2; Moffett MC, 2007, BIOCHEM PHARMACOL, V73, P321, DOI 10.1016/j.bcp.2006.08.003; Nicholson JM, 1999, J CHILD PSYCHOL PSYC, V40, P405; Norton EC, 1998, HEALTH ECON, V7, P439, DOI 10.1002/(SICI)1099-1050(199808)7:5<439::AID-HEC362>3.0.CO;2-9; Parker KJ, 2003, J COMP PSYCHOL, V117, P283, DOI 10.1037/0735-7036.117.3.283; Pitkow LJ, 2001, J NEUROSCI, V21, P7392, DOI 10.1523/JNEUROSCI.21-18-07392.2001; Ploj K, 2003, NEUROSCIENCE, V121, P787, DOI 10.1016/S0306-4522(03)00499-8; RANDALL CL, 1975, SCIENCE, V189, P149, DOI 10.1126/science.1138373; ROCKMAN GE, 1987, PHYSIOL BEHAV, V40, P673, DOI 10.1016/0031-9384(87)90116-8; Ross HE, 2009, J NEUROSCI, V29, P1312, DOI 10.1523/JNEUROSCI.5039-08.2009; Ryabinin AE, 2008, NEUROSCIENCE, V151, P780, DOI 10.1016/j.neuroscience.2007.11.014; Ryabinin AE, 2003, PSYCHOPHARMACOLOGY, V165, P296, DOI 10.1007/s00213-002-1284-y; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SELNOW GW, 1987, J DRUG EDUC, V17, P315, DOI 10.2190/GBYN-HEQ1-23D0-N977; Sluyter F, 2000, PHARMACOL BIOCHEM BE, V67, P801, DOI 10.1016/S0091-3057(00)00425-1; WEBSTER AB, 1981, J MAMMAL, V62, P738, DOI 10.2307/1380595; WILLIAMS JR, 1992, ANN NY ACAD SCI, V652, P487, DOI 10.1111/j.1749-6632.1992.tb34393.x; Wise RA, 1996, CURR OPIN NEUROBIOL, V6, P243, DOI 10.1016/S0959-4388(96)80079-1; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	64	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39753	10.1371/journal.pone.0039753	http://dx.doi.org/10.1371/journal.pone.0039753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745824	gold, Green Submitted, Green Published			2022-12-27	WOS:000305730900110
J	Lim, MSC; Dowdeswell, RJ; Murray, J; Field, N; Glynn, JR; Sonnenberg, P				Lim, Megan S. C.; Dowdeswell, Robert J.; Murray, Jill; Field, Nigel; Glynn, Judith R.; Sonnenberg, Pam			The Impact of HIV, an Antiretroviral Programme and Tuberculosis on Mortality in South African Platinum Miners, 1992-2010	PLOS ONE			English	Article							MISSED OPPORTUNITIES; THERAPY; SEROCONVERSION; PREVALENCE; EPIDEMIC; HIV/AIDS	Background: HIV and tuberculosis (TB) are the most common causes of death in South Africa. Antiretroviral therapy (ART) programmes should have had an impact on mortality rates. This study describes the impact of HIV, a Wellness (HIV/ART) programme and TB on population-wide trends in mortality and causes of death among South African platinum miners, from before the HIV epidemic into the ART era. Methodology/Principal Findings: Retrospective analysis was conducted using routinely-collected data from an open cohort. Mortality and causes of death were determined from multiple sources, including cardiorespiratory autopsy records. All-cause and cause-specific mortality rates were calculated by calendar year. 41,665 male miners were observed for 311,938 person years (py) with 3863 deaths. The all-cause age-standardised mortality rate increased from 5.9/1000py in 1992 to 20.2/1000py in 2002. Following ART rollout in 2003, annual mortality rates fluctuated between 12.4/1000py and 19.3/1000py in the subsequent 7 years. Half of all deaths were HIV-related and 21% were caused by TB. Half (50%) of miners who died of HIV after ART rollout had never been registered on the Wellness programme. TB was the most common cause of death in HIV positive miners, increasing from 28% of deaths in the pre-ART period to 41% in the post-ART period. Conclusions/Significance: This population-based cohort experienced a rapid increase in mortality from 1996 to 2003 due to increases in HIV and TB mortality. Following ART rollout there was a decrease in mortality, but a steady decrease has not been sustained. Possible explanations for these trends include the changing composition of the workforce, maturation of the HIV epidemic, insufficient uptake of ART and an increase in the proportion of deaths due to TB. In order to make a significant and sustained reduction in mortality in this population, expanding and integrating HIV and TB care and treatment is essential.	[Lim, Megan S. C.; Field, Nigel; Sonnenberg, Pam] UCL, Res Dept Infect & Populat Hlth, London, England; [Dowdeswell, Robert J.] Rustenburg Platinum Mines Ltd, Rustenburg, South Africa; [Murray, Jill] Univ Witwatersrand, Natl Inst Occupat Hlth, Natl Hlth Lab Serv, Johannesburg, South Africa; [Murray, Jill] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Glynn, Judith R.] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England	University of London; University College London; National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand; University of London; London School of Hygiene & Tropical Medicine	Lim, MSC (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	p.sonnenberg@ucl.ac.uk	Field, Nigel/ABG-3948-2020	Sonnenberg, Pam/0000-0002-1067-1583; Field, Nigel/0000-0002-2825-6652	Colt Foundation, UK [CF/04/08]; Australian Government NH&MRC Early Career Fellowship [543158]; National Institute for Health Research [CL-2010-18-010] Funding Source: researchfish	Colt Foundation, UK; Australian Government NH&MRC Early Career Fellowship; National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by the Colt Foundation, UK (CF/04/08 www.coltfoundation.org.uk). Megan Lim is supported by an Australian Government NH&MRC Early Career Fellowship (543158, http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MA, 2009, SAMJ S AFR MED J, V99, P661; ANDERSON BA, 2006, 030905 STAT S AFR; Anglo American, 2011, SUST DEV REP 2010 SA; Bradshaw D, 2003, SAMJ S AFR MED J, V93, P682; Bradshaw D., 2010, CAUSE DEATH STAT S A; Brink B, 2007, AIDS, V21, pS79, DOI 10.1097/01.aids.0000279697.40568.fd; Charalambous S, 2007, AIDS CARE, V19, P34, DOI 10.1080/09500340600677872; Charalambous S, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000279696.63438.aa; Dahab M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-63; Evian C, 2004, SAMJ S AFR MED J, V94, P125; Field N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-127; Glynn JR, 2008, AIDS, V22, P1859, DOI 10.1097/QAD.0b013e3283097cfa; Glynn JR, 2007, AIDS, V21, P625, DOI 10.1097/QAD.0b013e328017f857; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Laubscher R, 2009, IUSSP INT POP C MARR; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Lim MSC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022807; Mwagomba B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010452; Nyirenda M, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000299413.82893.2b; Perumal R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-243; Rajaratnam JK, 2010, LANCET, V375, P1704, DOI 10.1016/S0140-6736(10)60517-X; Reniers G, 2009, AIDS, V23, P511, DOI 10.1097/QAD.0b013e32832403d0; Stevens W, 2006, SAMJ S AFR MED J, V96, P134; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; World Health Organization (WHO), 2012, TUB COUNTR PROF S AF	28	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38598	10.1371/journal.pone.0038598	http://dx.doi.org/10.1371/journal.pone.0038598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761688	Green Published, Green Accepted, gold			2022-12-27	WOS:000305730900014
J	Machado, FG; Kuriki, PS; Fujihara, CK; Fanelli, C; Arias, SCA; Malheiros, DMAC; Camara, NOS; Zatz, R				Machado, Flavia G.; Kuriki, Patricia Semedo; Fujihara, Clarice K.; Fanelli, Camilla; Arias, Simone C. A.; Malheiros, Denise M. A. C.; Camara, Niels O. S.; Zatz, Roberto			Chronic VEGF Blockade Worsens Glomerular Injury in the Remnant Kidney Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; THROMBOTIC MICROANGIOPATHY; RENAL INJURY; FACTOR EXPRESSION; SUNITINIB; CELLS; RAT; INHIBITION; HYPOXIA	VEGF inhibition can promote renal vascular and parenchymal injury, causing proteinuria, hypertension and thrombotic microangiopathy. The mechanisms underlying these side effects are unclear. We investigated the renal effects of the administration, during 45 days, of sunitinib (Su), a VEGF receptor inhibitor, to rats with 5/6 renal ablation (Nx). Adult male Munich-Wistar rats were distributed among groups S+V, sham-operated rats receiving vehicle only; S+Su, S rats given Su, 4 mg/kg/day; Nx+V, Nx rats receiving V; and Nx+Su, Nx rats receiving Su. Su caused no change in Group S. Seven and 45 days after renal ablation, renal cortical interstitium was expanded, in association with rarefaction of peritubular capillaries. Su did not worsen hypertension, proteinuria or interstitial expansion, nor did it affect capillary rarefaction, suggesting little angiogenic activity in this model. Nx animals exhibited glomerulosclerosis (GS), which was aggravated by Su. This effect could not be explained by podocyte damage, nor could it be ascribed to tuft hypertrophy or hyperplasia. GS may have derived from organization of capillary microthrombi, frequently observed in Group Nx+Su. Treatment with Su did not reduce the fractional glomerular endothelial area, suggesting functional rather than structural cell injury. Chronic VEGF inhibition has little effect on normal rats, but can affect glomerular endothelium when renal damage is already present.	[Machado, Flavia G.; Fujihara, Clarice K.; Fanelli, Camilla; Arias, Simone C. A.; Malheiros, Denise M. A. C.; Zatz, Roberto] Univ Sao Paulo, Fac Med, Dept Clin Med, Div Renal,Lab Renal Pathophysiol LIM 16, Sao Paulo, Brazil; [Kuriki, Patricia Semedo; Camara, Niels O. S.] Univ Fed Sao Paulo, Fac Med, Immunol Lab, Div Nephrol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Machado, FG (corresponding author), Univ Sao Paulo, Fac Med, Dept Clin Med, Div Renal,Lab Renal Pathophysiol LIM 16, Sao Paulo, Brazil.	roberto@lim16.fm.usp.br	Camara, Niels OS/G-8336-2011; Complexos, INCT Fluidos/H-9172-2013; Semedo-Kuriki, Patricia/D-2429-2010; Zatz, Roberto/D-5716-2012; Fujihara, Clarice/H-9565-2012; MALHEIROS, DENISE MAC/L-7382-2017; Fanelli, Camilla/D-6287-2012; camara, niels olsen saraiva/AAX-3269-2020	Camara, Niels OS/0000-0001-5436-1248; MALHEIROS, DENISE MAC/0000-0002-0409-816X; Fanelli, Camilla/0000-0003-4425-7708; camara, niels olsen saraiva/0000-0001-5436-1248; Semedo-Kuriki, Patricia/0000-0002-2136-3308	State of Sao Paulo Foundation (FAPESP) [2011/10943-4]; Brazilian Council of Scientific and Technologic Development (CNPq) [304657/2007-7]	State of Sao Paulo Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Council of Scientific and Technologic Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grant 2011/10943-4 from the State of Sao Paulo Foundation for Research Support (FAPESP). RZ is the recipient of a Research Award (No. 304657/2007-7) from the Brazilian Council of Scientific and Technologic Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013663; ANDERSON S, 1985, J CLIN INVEST, V76, P612, DOI 10.1172/JCI112013; Bollee G, 2009, NEPHROL DIAL TRANSPL, V24, P682, DOI 10.1093/ndt/gfn657; BROWN LF, 1992, KIDNEY INT, V42, P1457, DOI 10.1038/ki.1992.441; Costero O, 2010, NEPHROL DIAL TRANSPL, V25, P1001, DOI 10.1093/ndt/gfp666; Eardley KS, 2008, KIDNEY INT, V74, P495, DOI 10.1038/ki.2008.183; Eckardt Kai-Uwe, 2005, Kidney Int Suppl, pS46; El Awad B, 2000, KIDNEY INT, V58, P43, DOI 10.1046/j.1523-1755.2000.00139.x; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Eremina V, 2007, NEPHRON PHYSIOL, V106, P32, DOI 10.1159/000101798; Eremina V, 2010, SEMIN NEPHROL, V30, P582, DOI 10.1016/j.semnephrol.2010.09.006; FLOEGE J, 1992, KIDNEY INT, V41, P297, DOI 10.1038/ki.1992.42; Flyvbjerg A, 2002, AM J PHYSIOL-ENDOC M, V283, pE362, DOI 10.1152/ajpendo.00007.2002; Foster RR, 2003, AM J PHYSIOL-RENAL, V284, pF1263, DOI 10.1152/ajprenal.00276.2002; Fujihara CK, 1998, KIDNEY INT, V54, P1510, DOI 10.1046/j.1523-1755.1998.00138.x; Fujihara CK, 2007, AM J PHYSIOL-RENAL, V292, pF1810, DOI 10.1152/ajprenal.00521.2006; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313; Gkountouvas A, 2010, THYROID, V20, P597, DOI 10.1089/thy.2010.0028; Guan FX, 2006, AM J PHYSIOL-RENAL, V291, pF422, DOI 10.1152/ajprenal.00448.2005; HIROSE K, 1982, KIDNEY INT, V21, P689, DOI 10.1038/ki.1982.82; ISAKA Y, 1993, J CLIN INVEST, V92, P2597, DOI 10.1172/JCI116874; Izzedine H, 2007, AM J KIDNEY DIS, V50, P203, DOI 10.1053/j.ajkd.2007.04.025; Izzedine H, 2007, CANCER CHEMOTH PHARM, V60, P357, DOI 10.1007/s00280-006-0376-5; Izzedine H, 2010, EUR J CANCER, V46, P439, DOI 10.1016/j.ejca.2009.11.001; JEPSEN FL, 1979, VIRCHOWS ARCH A, V383, P265, DOI 10.1007/BF00430245; Kang DH, 2001, J AM SOC NEPHROL, V12, P1434, DOI 10.1681/ASN.V1271434; Kappers MHW, 2010, HYPERTENSION, V56, P675, DOI 10.1161/HYPERTENSIONAHA.109.149690; Kappers MHW, 2009, J HYPERTENS, V27, P2297, DOI 10.1097/HJH.0b013e3283309b59; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; Kelly DJ, 2003, NEPHROL DIAL TRANSPL, V18, P1286, DOI 10.1093/ndt/gfg176; Kretzler M, 1998, KIDNEY INT, V54, pS159, DOI 10.1046/j.1523-1755.1998.06733.x; Kubo H, 2003, GENE DEV, V17, P322, DOI 10.1101/gad.1071203; LAX DS, 1992, KIDNEY INT, V41, P1527, DOI 10.1038/ki.1992.222; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Manotham K, 2004, J AM SOC NEPHROL, V15, P1277, DOI 10.1097/01.ASN.0000125614.35046.10; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; NAGATA M, 1992, KIDNEY INT, V42, P148, DOI 10.1038/ki.1992.272; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; PLOUET J, 1989, EMBO J, V8, P3801, DOI 10.1002/j.1460-2075.1989.tb08557.x; Rodriguez-Iturbe B, 2002, AM J PHYSIOL-RENAL, V282, pF191, DOI 10.1152/ajprenal.0197.2001; Schatteman GC, 2004, ANAT REC PART A, V276A, P13, DOI 10.1002/ar.a.10131; Schrijvers BF, 2005, NEPHRON EXP NEPHROL, V101, pE9, DOI 10.1159/000086034; Schrijvers BF, 2004, KIDNEY INT, V65, P2003, DOI 10.1111/j.1523-1755.2004.00621.x; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Spyridopoulos I, 1997, J MOL CELL CARDIOL, V29, P1321, DOI 10.1006/jmcc.1996.0365; Tanaka T, 2010, CURR OPIN NEPHROL HY, V19, P43, DOI 10.1097/MNH.0b013e3283328eed; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Wu QQ, 2006, AM J NEPHROL, V26, P97, DOI 10.1159/000092032; Yang NS, 1998, NEPHROL DIAL TRANSPL, V13, P1967, DOI 10.1093/ndt/13.8.1967; Yu DH, 2005, J AM SOC NEPHROL, V16, P1733, DOI 10.1681/ASN.2005020159	53	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39580	10.1371/journal.pone.0039580	http://dx.doi.org/10.1371/journal.pone.0039580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745791	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900082
J	Soares, AR; Reverendo, M; Pereira, PM; Nivelles, O; Pendeville, H; Bezerra, AR; Moura, GR; Struman, I; Santos, MAS				Soares, Ana R.; Reverendo, Marisa; Pereira, Patricia M.; Nivelles, Olivier; Pendeville, Helene; Bezerra, Ana Rita; Moura, Gabriela R.; Struman, Ingrid; Santos, Manuel A. S.			Dre-miR-2188 Targets Nrp2a and Mediates Proper Intersegmental Vessel Development in Zebrafish Embryos	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VASCULAR DEVELOPMENT; STEM-CELLS; MICRORNAS; ANGIOGENESIS; EXPRESSION; NEUROPILIN-1; VEGF; DIFFERENTIATION; PROLIFERATION	Background: MicroRNAs (miRNAs) are a class of small RNAs that are implicated in the control of eukaryotic gene expression by binding to the 3'UTR of target mRNAs. Several algorithms have been developed for miRNA target prediction however, experimental validation is still essential for the correct identification of miRNA targets. We have recently predicted that Neuropilin2a (Nrp2a), a vascular endothelial growth factor receptor which is essential for normal developmental angiogenesis in zebrafish, is a dre-miR-2188 target. Methodology: Here we show that dre-miR-2188 targets the 3'-untranslated region (3'UTR) of Nrp2a mRNA and is implicated in proper intersegmental vessel development in vivo. Over expression of miR-2188 in zebrafish embryos down regulates Nrp2a expression and results in intersegmental vessel disruption, while its silencing increases Nrp2a expression and intersegmental vessel sprouting. An in vivo GFP sensor assay based on a fusion between the GFP coding region and the Nrp2a 3'UTR confirms that miR-2188 binds to the 3'UTR of Nrp2a and inhibits protein translation. Conclusions: We demonstrate that miR-2188 targets Nrp2a and affects intersegmental vessel development in zebrafish embryos.	[Soares, Ana R.; Reverendo, Marisa; Pereira, Patricia M.; Bezerra, Ana Rita; Moura, Gabriela R.; Santos, Manuel A. S.] Univ Aveiro, Dept Biol, RNA Biol Lab, P-3800 Aveiro, Portugal; [Soares, Ana R.; Reverendo, Marisa; Pereira, Patricia M.; Bezerra, Ana Rita; Moura, Gabriela R.; Santos, Manuel A. S.] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Nivelles, Olivier; Pendeville, Helene; Struman, Ingrid] Univ Liege, GIGA Res, Unit Mol Biol & Genet Engn, Liege, Belgium	Universidade de Aveiro; Universidade de Aveiro; University of Liege	Soares, AR (corresponding author), Univ Aveiro, Dept Biol, RNA Biol Lab, P-3800 Aveiro, Portugal.	msantos@ua.pt	Soares, Ana RSCM/G-7331-2014; Santos, Manuel/E-6704-2010; Bezerra, Ana/G-7380-2014; Reverendo, Marisa/W-5088-2018; Moura, Gabriela R/E-6717-2010; Moura, Gabriela/GPF-9079-2022	Soares, Ana RSCM/0000-0003-4000-7461; Santos, Manuel/0000-0002-0437-1146; Moura, Gabriela R/0000-0003-2243-6123; Moura, Gabriela/0000-0003-2243-6123; Reverendo, Marisa/0000-0001-6999-1816; Pereira, Patricia/0000-0002-4828-7632; struman, ingrid/0000-0003-2550-3707; Bezerra, Ana/0000-0003-4613-1711	Fundacao para a Ciencia e Tecnologia - Portugal; European Regional Development Fund program [PTDC/BIA-BCM/64745/2006, PTDC/BIA-BCM/72251/2006]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/72251/2006, PTDC/BIA-BCM/64745/2006] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia - Portugal(Portuguese Foundation for Science and Technology); European Regional Development Fund program; Fundação para a Ciência e a Tecnologia	This work was supported by Fundacao para a Ciencia e Tecnologia - Portugal and the European Regional Development Fund program through projects PTDC/BIA-BCM/64745/2006 and PTDC/BIA-BCM/72251/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberghina M, 2010, MICROVASC RES, V80, P280, DOI 10.1016/j.mvr.2010.03.013; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bovenkamp DE, 2004, GENE EXPR PATTERNS, V4, P361, DOI 10.1016/j.modgep.2004.01.014; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Evangelisti C, 2009, FASEB J, V23, P4276, DOI 10.1096/fj.09-134965; Favier B, 2006, BLOOD, V108, P1243, DOI 10.1182/blood-2005-11-4447; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Flynt AS, 2009, J CELL BIOL, V185, P115, DOI 10.1083/jcb.200807026; Geretti E, 2007, CELL ADHES MIGR, V1, DOI 10.4161/cam.1.2.4490; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Herbert SP, 2009, J BIOL CHEM, V284, P5784, DOI 10.1074/jbc.M807282200; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim WH, 2009, EXP CELL RES, V315, P2154, DOI 10.1016/j.yexcr.2009.04.018; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lee P, 2002, P NATL ACAD SCI USA, V99, P10470, DOI 10.1073/pnas.162366299; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Li N, 2011, DEVELOPMENT, V138, P1817, DOI 10.1242/dev.056697; Martyn U, 2004, DEV DYNAM, V231, P33, DOI 10.1002/dvdy.20048; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Mishima Y, 2009, GENE DEV, V23, P619, DOI 10.1101/gad.1760209; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Shen JK, 2004, MOL MED, V10, P12, DOI 10.2119/2004-00017.Campochiaro; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Soares AR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-195; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Zhang SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-9; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	42	8	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39417	10.1371/journal.pone.0039417	http://dx.doi.org/10.1371/journal.pone.0039417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761789	Green Published, gold			2022-12-27	WOS:000305730900058
J	Derivery, E; Helfer, E; Henriot, V; Gautreau, A				Derivery, Emmanuel; Helfer, Emmanuele; Henriot, Veronique; Gautreau, Alexis			Actin Polymerization Controls the Organization of WASH Domains at the Surface of Endosomes	PLOS ONE			English	Article							DIAPHANOUS-RELATED FORMIN; N-WASP; MEMBRANE-FUSION; ARP2/3 COMPLEX; RAB5; PROTEIN; RECRUITMENT; DYNAMICS; CURVATURE; ACTIVATOR	Sorting of cargoes in endosomes occurs through their selective enrichment into sorting platforms, where transport intermediates are generated. The WASH complex, which directly binds to lipids, activates the Arp2/3 complex and hence actin polymerization onto such sorting platforms. Here, we analyzed the role of actin polymerization in the physiology of endosomal domains containing WASH using quantitative image analysis. Actin depolymerization is known to enlarge endosomes. Using a novel colocalization method that is insensitive to the heterogeneity of size and shape of endosomes, we further show that preventing the generation of branched actin networks induces endosomal accumulation of the WASH complex. Moreover, we found that actin depolymerization induces a dramatic decrease in the recovery of endosomal WASH after photobleaching. This result suggests a built-in turnover, where the actin network, i.e. the product of the WASH complex, contributes to the dynamic exchange of the WASH complex by promoting its detachment from endosomes. Our experiments also provide evidence for a role of actin polymerization in the lateral compartmentalization of endosomes: several WASH domains exist at the surface of enlarged endosomes, however, the WASH domains coalesce upon actin depolymerization or Arp2/3 depletion. Branched actin networks are thus involved in the regulation of the size of WASH domains. The potential role of this regulation in membrane scission are discussed.	[Derivery, Emmanuel; Helfer, Emmanuele; Henriot, Veronique; Gautreau, Alexis] CNRS, UPR3082, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Derivery, E (corresponding author), Univ Sci II, Dept Biochem, Geneva, Switzerland.	alexis.gautreau@lebs.cnrs-gif.fr	Gautreau, Alexis/AAT-2751-2020	Gautreau, Alexis/0000-0002-2369-4362; Helfer, Emmanuele/0000-0001-8123-0964	Agence Nationale pour la Recherche [ANR-08-BLAN-0012-03, ANR-08-PCVI-0010-03, ANR-09-JCJC-0040]	Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by grants (ANR-08-BLAN-0012-03, ANR-08-PCVI-0010-03, and ANR-09-JCJC-0040) from Agence Nationale pour la Recherche (http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain JM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.158104; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444; Benesch S, 2002, J BIOL CHEM, V277, P37771, DOI 10.1074/jbc.M204145200; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032; CARLIER MF, 1986, J BIOL CHEM, V261, P2041; Carnell M, 2011, J CELL BIOL, V193, P831, DOI 10.1083/jcb.201009119; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Delatour V, 2008, BIOPHYS J, V94, P4890, DOI 10.1529/biophysj.107.118653; Derivery E, 2010, BIOESSAYS, V32, P119, DOI 10.1002/bies.200900123; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Drengk A, 2003, CURR BIOL, V13, P1814, DOI 10.1016/j.cub.2003.09.037; Duleh SN, 2010, CYTOSKELETON, V67, P193, DOI 10.1002/cm.20437; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Gautier JJ, 2011, J CELL SCI, V124, P3414, DOI 10.1242/jcs.081083; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Guerin I, 2000, EUR J CELL BIOL, V79, P735, DOI 10.1078/0171-9335-00092; Harbour ME, 2012, BIOCHEM J, V442, P209, DOI 10.1042/BJ20111761; Harbour ME, 2010, J CELL SCI, V123, P3703, DOI 10.1242/jcs.071472; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Jahraus A, 2001, MOL BIOL CELL, V12, P155, DOI 10.1091/mbc.12.1.155; Jia D, 2010, P NATL ACAD SCI USA, V107, P10442, DOI 10.1073/pnas.0913293107; Kjeken R, 2004, MOL BIOL CELL, V15, P345, DOI 10.1091/mbc.e03-05-0334; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Millius A, 2012, J CELL SCI; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Ohashi E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019942; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Solon J, 2005, J GEN VIROL, V86, P3357, DOI 10.1099/vir.0.81129-0; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Weisswange I, 2009, NATURE, V458, P87, DOI 10.1038/nature07773; Zech T, 2011, J CELL SCI, V124, P3753, DOI 10.1242/jcs.080986; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	55	44	44	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39774	10.1371/journal.pone.0039774	http://dx.doi.org/10.1371/journal.pone.0039774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737254	Green Published, Green Submitted, gold			2022-12-27	WOS:000305695100053
J	Jansen, T; Kristensen, K; Payne, M; Edwards, M; Schrum, C; Pitois, S				Jansen, Teunis; Kristensen, Kasper; Payne, Mark; Edwards, Martin; Schrum, Corinna; Pitois, Sophie			Long-Term Retrospective Analysis of Mackerel Spawning in the North Sea: A New Time Series and Modeling Approach to CPR Data	PLOS ONE			English	Article							CONTINUOUS PLANKTON RECORDER; SCOMBER-SCOMBRUS L; FISH; LARVAE; TEMPERATURE; CONSISTENCY; ABUNDANCE	We present a unique view of mackerel (Scomber scombrus) in the North Sea based on a new time series of larvae caught by the Continuous Plankton Recorder (CPR) survey from 1948-2005, covering the period both before and after the collapse of the North Sea stock. Hydrographic backtrack modelling suggested that the effect of advection is very limited between spawning and larvae capture in the CPR survey. Using a statistical technique not previously applied to CPR data, we then generated a larval index that accounts for both catchability as well as spatial and temporal autocorrelation. The resulting time series documents the significant decrease of spawning from before 1970 to recent depleted levels. Spatial distributions of the larvae, and thus the spawning area, showed a shift from early to recent decades, suggesting that the central North Sea is no longer as important as the areas further west and south. These results provide a consistent and unique perspective on the dynamics of mackerel in this region and can potentially resolve many of the unresolved questions about this stock.	[Jansen, Teunis; Kristensen, Kasper; Payne, Mark] Tech Univ Denmark DTU AQUA, Natl Inst Aquat Resources Charlottenlund, Charlottenlund, Denmark; [Edwards, Martin] Sir Alister Hardy Fdn Ocean Sci SAHFOS, Plymouth, Devon, England; [Schrum, Corinna] Univ Bergen, Inst Geophys, Bergen, Norway	Technical University of Denmark; University of Bergen	Jansen, T (corresponding author), Tech Univ Denmark DTU AQUA, Natl Inst Aquat Resources Charlottenlund, Charlottenlund, Denmark.	Tej@aqua.dtu.dk	Payne, Mark/C-6844-2008	Payne, Mark/0000-0001-5795-2481; Kristensen, Kasper/0000-0003-3425-3762; Jansen, Teunis/0000-0001-8722-4493	EURO-BASIN [264933]; Department of Environment, Fisheries and Rural Affairs (Defra) [MF1101]; EU-MEECE [212085]; Norwegian Research Council; NERC [SAH01001] Funding Source: UKRI; Natural Environment Research Council [SAH01001] Funding Source: researchfish	EURO-BASIN; Department of Environment, Fisheries and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); EU-MEECE; Norwegian Research Council(Research Council of NorwayEuropean Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Research was funded by EURO-BASIN (FP7 #264933) and Department of Environment, Fisheries and Rural Affairs (Defra) who funded the analysis of fish larvae samples from 1979 to 2005 through project MF1101. The long-term ECOSMO model simulation was funded by the projects EU-MEECE (FP7# 212085) and the Norwegian Research Council (MarinEra project ECODRIVE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTSCH J, 1989, NATURE, V340, P632, DOI 10.1038/340632a0; Bartsch J, 2002, FISH OCEANOGR, V11, P310, DOI 10.1046/j.1365-2419.2002.00208.x; Batten SD, 2003, PROG OCEANOGR, V58, P193, DOI 10.1016/j.pocean.2003.08.004; Bazilchuk N, 2010, FRONT ECOL ENVIRON, V8, P397; Cendrowicz L, 2010, TIME MAG        0827, P1; Christensen A, 2008, CAN J FISH AQUAT SCI, V65, P1498, DOI 10.1139/F08-073; Christensen A, 2007, MAR ECOL PROG SER, V347, P221, DOI 10.3354/meps06980; COLEBROOK J M, 1975, Bulletins of Marine Ecology, V8, P123; COOMBS SH, 1981, J MAR BIOL ASSOC UK, V61, P343, DOI 10.1017/S0025315400046993; Dickey-Collas M, 2009, MAR ECOL PROG SER, V390, P183, DOI 10.3354/meps08172; Hamre J., 1978, RAPP P V REUN CONS I, V172, P197; HAYS GC, 1993, J MAR BIOL ASSOC UK, V73, P967, DOI 10.1017/S0025315400034846; Hillgruber N, 2001, HELGOLAND MAR RES, P149; ICES, 2005, 2005ACFM08 ICES CM; ICES, 2008, 2008ACOM13 ICES CM; ICES, 1979, 1979H5 ICES CM; ICES, 2019, ICES SCI REPORTS, V1, DOI 10.17895/ices.pub.4982; ICES, 2008, ICES, P10; Iversen S. A., 1989, 1989H20 ICES CM; Iversen SA, 1983, 1983H46 ICES CM; Jansen T, MIXING METAPOP UNPUB; Jansen T, 2011, CONT SHELF RES, V31, P64, DOI 10.1016/j.csr.2010.11.003; Lewy P, 2009, CAN J FISH AQUAT SCI, V66, P1809, DOI 10.1139/F09-114; Lockwood SJ, 1988, MACKEREL ITS BIOL AS; Mendiola D, 2006, FISH RES, V80, P158, DOI 10.1016/j.fishres.2006.05.004; POSTUMA KH, 1972, J CONSEIL, V34, P455; Richardson AJ, 2006, PROG OCEANOGR, V68, P27, DOI 10.1016/j.pocean.2005.09.011; ROPKE A, 1989, MEERESFORSCHUNG, V32, P192; Schrum C, 1999, TELLUS A, V51, P526, DOI 10.1034/j.1600-0870.1992.00006.x; Schrum C, 2003, ICES MAR SCI S, V219, P121; Schrum C, 2006, J MARINE SYST, V61, P79, DOI 10.1016/j.jmarsys.2006.01.005; Skogen M, 1998, FISKEN HAVET, V18, P1; SKOGEN MD, 1995, ESTUAR COAST SHELF S, V41, P545, DOI 10.1016/0272-7714(95)90026-8; Trenkel VM, 2012, PROG OCEANO IN PRESS; [No title captured]	35	21	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38758	10.1371/journal.pone.0038758	http://dx.doi.org/10.1371/journal.pone.0038758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737221	Green Published, gold, Green Accepted			2022-12-27	WOS:000305695100019
J	Ma, KY; Qiu, GF; Feng, JB; Li, JL				Ma, Keyi; Qiu, Gaofeng; Feng, Jianbin; Li, Jiale			Transcriptome Analysis of the Oriental River Prawn, Macrobrachium nipponense Using 454 Pyrosequencing for Discovery of Genes and Markers	PLOS ONE			English	Article							FRESH-WATER PRAWN; VASA-LIKE GENE; SHRIMP LITOPENAEUS-VANNAMEI; ANDROGENIC GLAND ABLATION; SEX-DETERMINATION; MESSENGER-RNA; DNA MARKER; EXPRESSION; PROTEIN; FTZ-F1	Background: The oriental river prawn, Macrobrachium nipponense, is an economically and nutritionally important species of the Palaemonidae family of decapod crustaceans. To date, the sequencing of its whole genome is unavailable as a nonmodel organism. Transcriptomic information is also scarce for this species. In this study, we performed de novo transcriptome sequencing to produce the first comprehensive expressed sequence tag (EST) dataset for M. nipponense using high-throughput sequencing technologies. Methodology and Principal Findings: Total RNA was isolated from eyestalk, gill, heart, ovary, testis, hepatopancreas, muscle, and embryos at the cleavage, gastrula, nauplius and zoea stages. Equal quantities of RNA from each tissue and stage were pooled to construct a cDNA library. Using 454 pyrosequencing technology, we generated a total of 984,204 high quality reads (338.59Mb) with an average length of 344 bp. Clustering and assembly of these reads produced a non-redundant set of 81,411 unique sequences, comprising 42,551 contigs and 38,860 singletons. All of the unique sequences were involved in the molecular function (30,425), cellular component (44,112) and biological process (67,679) categories by GO analysis. Potential genes and their functions were predicted by KEGG pathway mapping and COG analysis. Based on our sequence analysis and published literature, many putative genes involved in sex determination, including DMRT1, FTZ-F1, FOXL2, FEM1 and other potentially important candidate genes, were identified for the first time in this prawn. Furthermore, 6,689 SSRs and 18,107 high-confidence SNPs were identified in this EST dataset. Conclusions: The transcriptome provides an invaluable new data for a functional genomics resource and future biological research in M. nipponense. The molecular markers identified in this study will provide a material basis for future genetic linkage and quantitative trait loci analyses, and will be essential for accelerating aquaculture breeding programs with this species.	[Ma, Keyi; Qiu, Gaofeng; Feng, Jianbin; Li, Jiale] Shanghai Ocean Univ, Key Lab Freshwater Aquat Genet Resources, Minist Agr, Coll Fisheries & Life Sci, Shanghai, Peoples R China; [Qiu, Gaofeng; Li, Jiale] Shanghai Ocean Univ, E Inst Shanghai Univ, Shanghai, Peoples R China	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; Shanghai Ocean University	Ma, KY (corresponding author), Shanghai Ocean Univ, Key Lab Freshwater Aquat Genet Resources, Minist Agr, Coll Fisheries & Life Sci, Shanghai, Peoples R China.	gfqiu@shou.edu.cn; jlli2009@126.com	li, jia/GVT-7587-2022		Innovation Program of Shanghai Municipal Education Commission [08ZZ80]; Marine Biology Program of Shanghai Leading Academic Discipline [J50701]; Natural Science Foundation of China [31001111]; Aquaculture Engineering and Technology Research Center of Shanghai [09DZ2251300]	Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Marine Biology Program of Shanghai Leading Academic Discipline(Shanghai Leading Academic Discipline Project); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Aquaculture Engineering and Technology Research Center of Shanghai	This research was supported by the Innovation Program of Shanghai Municipal Education Commission (project number 08ZZ80), the Marine Biology Program of Shanghai Leading Academic Discipline (project number J50701), the Natural Science Foundation of China (project number 31001111), and the Aquaculture Engineering and Technology Research Center of Shanghai (project number 09DZ2251300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflalo ED, 2006, AQUACULTURE, V256, P468, DOI 10.1016/j.aquaculture.2006.01.035; Aflalo ED, 2007, MOL REPROD DEV, V74, P172, DOI 10.1002/mrd.20622; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Bouck A, 2007, MOL ECOL, V16, P907, DOI 10.1111/j.1365-294X.2006.03195.x; Cai YX, 2006, RAFFLES B ZOOL, V54, P245; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chang CC, 2002, DEV BIOL, V252, P100, DOI 10.1006/dbio.2002.0840; Chareontawee K, 2007, AQUACULTURE, V271, P121, DOI 10.1016/j.aquaculture.2007.07.001; Clark MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015919; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Conley A, 2001, REPRODUCTION, V121, P685, DOI 10.1530/rep.0.1210685; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; de Grave Sammy, 2006, Aquatic Invasions, V1, P204; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Feng JB, 2008, MOL ECOL RESOUR, V8, P986, DOI 10.1111/j.1755-0998.2008.02129.x; Feng Jian-bin, 2008, Shanghai Shuichan Daxue Xuebao, V17, P371; [冯建彬 FENG Jianbin], 2010, [中国水产科学, Journal of Fishery Sciences of China], V17, P218; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gaudet J, 1996, MOL BIOL CELL, V7, P1107, DOI 10.1091/mbc.7.7.1107; Jan E, 1999, EMBO J, V18, P258, DOI 10.1093/emboj/18.1.258; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kim JM, 2006, DNA RES, V13, P275, DOI 10.1093/dnares/dsl016; Kim WJ, 2011, MAR BIOTECHNOL, V13, P127, DOI 10.1007/s10126-010-9280-4; LALA DS, 1992, MOL ENDOCRINOL, V6, P1249, DOI 10.1210/me.6.8.1249; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; LAVORGNA G, 1991, SCIENCE, V252, P848, DOI 10.1126/science.1709303; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Ma KY, 2010, CONSERV GENET RESOUR, V2, P125, DOI 10.1007/s12686-010-9236-z; Ma Ke-Yi, 2011, Zoological Research, V32, P363, DOI 10.3724/SP.J.1141.2011.04363; Ma KY, 2011, GENE, V487, P160, DOI 10.1016/j.gene.2011.07.017; MALECHA SR, 1992, AQUACULTURE, V105, P201, DOI 10.1016/0044-8486(92)90087-2; Manickavelu A, 2010, DNA RES, V17, P211, DOI 10.1093/dnares/dsq009; Manor R, 2004, INVERTEBR REPROD DEV, V45, P151, DOI 10.1080/07924259.2004.9652584; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mirabdullaev IM, 2005, 2 INT S INVASION ALI, P113; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; NAGAMINE C, 1980, GEN COMP ENDOCR, V41, P423, DOI 10.1016/0016-6480(80)90048-9; Nagamine CM, 1997, GENOMICS, V43, P397, DOI 10.1006/geno.1997.4828; Nakkrasae LI, 2007, MOL REPROD DEV, V74, P835, DOI 10.1002/mrd.20680; NER S S, 1992, Current Biology, V2, P208, DOI 10.1016/0960-9822(92)90541-H; Oba K, 1996, BIOCHEM BIOPH RES CO, V226, P261, DOI 10.1006/bbrc.1996.1343; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Poroyko V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012459; Proespraiwong P, 2010, COMP BIOCHEM PHYS B, V156, P86, DOI 10.1016/j.cbpb.2010.02.007; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Raymond CS, 1999, DEV BIOL, V215, P208, DOI 10.1006/dbio.1999.9461; Rocha J, 2012, AQUACULTURE, V330, P111, DOI 10.1016/j.aquaculture.2011.12.024; Rokas A, 2009, TRENDS ECOL EVOL, V24, P192, DOI 10.1016/j.tree.2008.11.004; SAGI A, 1990, GEN COMP ENDOCR, V77, P15, DOI 10.1016/0016-6480(90)90201-V; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Salman Salman D., 2006, Aquatic Invasions, V1, P109, DOI 10.3391/ai.2006.1.3.2; Shinomiya A, 2000, DEV GROWTH DIFFER, V42, P317; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Srivastava A, 2011, DNA RES, V18, P253, DOI 10.1093/dnares/dsr014; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Ventura T, 2011, HEREDITY, V107, P456, DOI 10.1038/hdy.2011.32; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vilain E, 1998, MOL GENET METAB, V65, P74, DOI 10.1006/mgme.1998.2749; von Hofsten J, 2001, GEN COMP ENDOCR, V121, P146, DOI 10.1006/gcen.2000.7582; Wang Y, 2012, PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION 2010, VOL 11, P1; Wu P, 2009, COMP BIOCHEM PHYS D, V4, P111, DOI 10.1016/j.cbd.2008.12.004; Xia JH, 2011, DNA RES, V18, P513, DOI 10.1093/dnares/dsr036; Yu H-P, 1972, OHMU, V3, P45; Zhang EF, 2010, DEV GENES EVOL, V220, P151, DOI 10.1007/s00427-010-0336-2; Zhang FY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017170; Zhang FY, 2010, COMP BIOCHEM PHYS B, V155, P288, DOI 10.1016/j.cbpb.2009.11.013; Zhang WM, 2007, MOL REPROD DEV, V74, P665, DOI 10.1002/mrd.20642	75	98	100	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39727	10.1371/journal.pone.0039727	http://dx.doi.org/10.1371/journal.pone.0039727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745820	gold, Green Submitted, Green Published			2022-12-27	WOS:000305693200096
J	Wang, W; van Veen, HW				Wang, Wei; van Veen, Hendrik W.			Basic Residues R260 and K357 Affect the Conformational Dynamics of the Major Facilitator Superfamily Multidrug Transporter LmrP	PLOS ONE			English	Article							ABC TRANSPORTER; EFFLUX PUMPS; LACTOCOCCUS-LACTIS; CRYSTAL-STRUCTURE; MEMBRANE-PROTEIN; DRUG TRANSPORT; RESISTANCE; MECHANISM; BINDING; BACTERIA	Secondary-active multidrug transporters can confer resistance on cells to pharmaceuticals by mediating their extrusion away from intracellular targets via substrate/H+(Na+) antiport. While the interactions of catalytic carboxylates in these transporters with coupling ions and substrates (drugs) have been studied in some detail, the functional importance of basic residues has received much less attention. The only two basic residues R260 and K357 in transmembrane helices in the Major Facilitator Superfamily transporter LmrP from Lactococcus lactis are present on the outer surface of the protein, where they are exposed to the phospholipid head group region of the outer leaflet (R260) and inner leaflet (K357) of the cytoplasmic membrane. Although our observations on the proton-motive force dependence and kinetics of substrate transport, and substrate-dependent proton transport demonstrate that K357A and R260A mutants are affected in ethidium-proton and benzalkonium-proton antiport compared to wildtype LmrP, our findings suggest that R260 and K357 are not directly involved in the binding of substrates or the translocation of protons. Secondary-active multidrug transporters are thought to operate by a mechanism in which binding sites for substrates are alternately exposed to each face of the membrane. Disulfide crosslinking experiments were performed with a double cysteine mutant of LmrP that reports the substrate-stimulated transition from the outward-facing state to the inward-facing state with high substrate-binding affinity. In the experiments, the R260A and K357A mutations were found to influence the dynamics of these major protein conformations in the transport cycle, potentially by removing the interactions of R260 and K357 with phospholipids and/or other residues in LmrP. The R260A and K357A mutations therefore modify the maximum rate at which the transport cycle can operate and, as the transitions between conformational states are differently affected by components of the proton-motive force, the mutations also influence the energetics of transport.	[Wang, Wei; van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	University of Cambridge	Wang, W (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	hwv20@cam.ac.uk	van Veen, Hendrik W./A-4162-2008	van Veen, Hendrik W./0000-0002-9658-8077	Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/I002383/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I002383/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	H.W.v.V. is grateful for funding by the Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Balakrishnan L, 2004, J BIOL CHEM, V279, P11273, DOI 10.1074/jbc.M308494200; Bapna A, 2007, J MOL MICROB BIOTECH, V12, P197, DOI 10.1159/000099641; Bolhuis H, 1996, J BIOL CHEM, V271, P24123, DOI 10.1074/jbc.271.39.24123; BOLHUIS H, 1995, J BIOL CHEM, V270, P26092, DOI 10.1074/jbc.270.44.26092; Borges-Walmsley MI, 2003, BIOCHEM J, V376, P313, DOI 10.1042/BJ20020957; Breeuwer P, 1996, APPL ENVIRON MICROB, V62, P178, DOI 10.1128/AEM.62.1.178-183.1996; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Brown MH, 2001, J MOL MICROB BIOTECH, V3, P163; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Doshi R, 2010, PROTEINS, V78, P2867, DOI 10.1002/prot.22813; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Gbaguidi B, 2004, CELL MOL LIFE SCI, V61, P2646, DOI 10.1007/s00018-004-4298-2; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Hakizimana P, 2008, J BIOL CHEM, V283, P9369, DOI 10.1074/jbc.M708427200; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mazurkiewicz P, 2004, J BIOL CHEM, V279, P103, DOI 10.1074/jbc.M306579200; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Putman M, 1999, BIOCHEMISTRY-US, V38, P13900, DOI 10.1021/bi991262k; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Schaedler TA, 2010, FASEB J, V24, P3653, DOI 10.1096/fj.10-156927; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schmidt D, 2009, J MOL BIOL, V390, P902, DOI 10.1016/j.jmb.2009.05.062; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; SHAPIRO AB, 1995, J BIOL CHEM, V270, P16167, DOI 10.1074/jbc.270.27.16167; Shilling R, 2005, FASEB J, V19, P1698, DOI 10.1096/fj.04-3558fje; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Sigal N, 2009, J BIOL CHEM, V284, P6966, DOI 10.1074/jbc.M808877200; Steinfels E, 2004, BIOCHEMISTRY-US, V43, P7491, DOI 10.1021/bi0362018; van Veen HW, 1997, SEMIN CANCER BIOL, V8, P183, DOI 10.1006/scbi.1997.0064; Velamakanni S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006137; Venter H, 2003, NATURE, V426, P866, DOI 10.1038/nature02173; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Woebking B, 2008, BIOCHEMISTRY-US, V47, P10904, DOI 10.1021/bi800778d; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yasufuku T, 2011, J CLIN MICROBIOL, V49, P189, DOI 10.1128/JCM.00827-10; Yokota A, 2000, J BACTERIOL, V182, P5196, DOI 10.1128/JB.182.18.5196-5201.2000; Yu JL, 2002, J BACTERIOL, V184, P1370, DOI 10.1128/JB.184.5.1370-1377.2002; Zhou YG, 2008, P NATL ACAD SCI USA, V105, P3774, DOI 10.1073/pnas.0800825105; Zhou YG, 2009, J MOL BIOL, V394, P219, DOI 10.1016/j.jmb.2009.09.043	51	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38715	10.1371/journal.pone.0038715	http://dx.doi.org/10.1371/journal.pone.0038715			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22761697	Green Submitted, Green Published, gold			2022-12-27	WOS:000305693200022
J	Zhou, YH; Ma, XQ; Wu, C; Lu, J; Zhang, SS; Guo, J; Wu, SQ; Ye, XF; Xu, JF; He, J				Zhou, Yu-Hao; Ma, Xiu-Qiang; Wu, Cheng; Lu, Jian; Zhang, Shan-Shan; Guo, Jia; Wu, Shun-Quan; Ye, Xiao-Fei; Xu, Jin-Fang; He, Jia			Effect of Anti-Obesity Drug on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							WEIGHT-LOSS; OBESE ADOLESCENTS; DOUBLE-BLIND; FOLLOW-UP; ENERGY DIET; ORLISTAT; SIBUTRAMINE; MAINTENANCE; REDUCTION; DISEASE	Background: Anti-obesity drugs are widely used to prevent the complications of obesity, however, the effects of anti-obesity drugs on cardiovascular risk factors are unclear at the present time. We carried out a comprehensively systematic review and meta-analysis to assess the effects of anti-obesity drugs on cardiovascular risk factors. Methodology and Principal Findings: We systematically searched Medline, EmBase, the Cochrane Central Register of Controlled Trials, reference lists of articles and proceedings of major meetings for relevant literatures. We included randomized placebo-controlled trials that reported the effects of anti-obesity drugs on cardiovascular risk factors compared to placebo. Overall, orlistat produced a reduction of 2.39 kg (95% CI-3.34 to -1.45) for weight, a reduction of 0.27 mmol/L (95% CI: -0.36 to -0.17) for total cholesterol, a reduction of 0.21 mmol/L (95% CI: -0.30 to -0.12) for LDL, a reduction of 0.12 mmol/L (95% CI: -0.20 to -0.04) for fasting glucose, 1.85 mmHg reduction (95% CI: -3.30 to -0.40) for SBP, and a reduction of 1.49 mmHg (95% CI: -2.39 to -0.58) for DBP. Sibutramine only showed effects on weight loss and triglycerides reduction with statistical significances. Rimonabant was associated with statistically significant effects on weight loss, SBP reduction and DBP reduction. No other significantly different effects were identified between anti-obesity therapy and placebo. Conclusion/Significance: We identified that anti-obesity therapy was associated with a decrease of weight regardless of the type of the drug. Orlistat and rimonabant could lead to an improvement on cardiovascular risk factors. However, Sibutramine may have a direct effect on cardiovascular risk factors.	[Zhou, Yu-Hao; Ma, Xiu-Qiang; Wu, Cheng; Lu, Jian; Wu, Shun-Quan; Ye, Xiao-Fei; Xu, Jin-Fang; He, Jia] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China; [Zhang, Shan-Shan] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Tumor Immunol & Gene Therapy Ctr, Shanghai, Peoples R China; [Guo, Jia] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Ultrasonog, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Zhou, YH (corresponding author), Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China.	hejia63@yahoo.com		He, Jia/0000-0002-2338-9501; ye, xiaofei/0000-0003-3692-1285	National Nature Science Foundation of China [30872186, 81072388]; leading talents of science in Shanghai [022]; Program of Shanghai Subject Chief Scientist [09XD1405500]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); leading talents of science in Shanghai; Program of Shanghai Subject Chief Scientist	This study was conducted under two grants from the National Nature Science Foundation of China (30872186, 81072388), a grant from the leading talents of science in Shanghai 2010 (022) and a grant sponsored by Program of Shanghai Subject Chief Scientist (09XD1405500). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Anderson JW, 2006, ANN PHARMACOTHER, V40, P1717, DOI 10.1345/aph.1H234; Ayyad C, 2000, Obes Rev, V1, P113, DOI 10.1046/j.1467-789x.2000.00019.x; Berkowitz RI, 2003, JAMA-J AM MED ASSOC, V289, P1805, DOI 10.1001/jama.289.14.1805; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Broom I, 2002, INT J CLIN PRACT, V56, P494; Chanoine JP, 2005, JAMA-J AM MED ASSOC, V293, P2873, DOI 10.1001/jama.293.23.2873; Coutinho WF, 2007, INT J OBESITY, V31, pS26, DOI 10.1038/sj.ijo.0803733; Czernichow S, 2010, OBES REV, V11, P150, DOI 10.1111/j.1467-789X.2009.00620.x; Daniels SR, 2007, PEDIATRICS, V120, pE147, DOI 10.1542/peds.2006-2137; de Simone G, 2005, NUTR METAB CARDIOVAS, V15, P24, DOI 10.1016/j.numecd.2004.07.002; Despres JP, 2009, ARTERIOSCL THROM VAS, V29, P416, DOI 10.1161/ATVBAHA.108.176362; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Doggrell SA, 2009, EXPERT OPIN INV DRUG, V18, P1043, DOI 10.1517/13543780902967632; Finer N, 2000, INT J OBESITY, V24, P306, DOI 10.1038/sj.ijo.0801128; Garcia-Morales LM, 2006, CLIN THER, V28, P770, DOI 10.1016/j.clinthera.2006.05.008; Godoy-Matos A, 2004, J CLIN ENDOCRINOL ME, V0263; GOLDSTEIN DJ, 1994, INT J OBESITY, V18, P129; GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397; Hauner H, 2004, EXP CLIN ENDOCR DIAB, V112, P201, DOI 10.1055/s-2004-817934; Hill JO, 1999, AM J CLIN NUTR, V69, P1108; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; James WPT, 2000, LANCET, V356, P2119, DOI 10.1016/S0140-6736(00)03491-7; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Jousilahti P, 1996, CIRCULATION, V93, P1372, DOI 10.1161/01.CIR.93.7.1372; Julie AP, 2004, AM J MANAG CARE, V10, P369; KRAMER FM, 1989, INT J OBESITY, V13, P123; Krempf M, 2003, INT J OBESITY, V27, P591, DOI 10.1038/sj.ijo.0802281; Lindgarde F, 2000, J INTERN MED, V248, P245, DOI 10.1046/j.1365-2796.2000.00720.x; Michael HD, 1999, JAMA-J AM MED ASSOC, V281, P235; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Poston WSC, 2006, J INTERN MED, V260, P388, DOI 10.1111/j.1365-2796.2006.01702.x; Poston WCS, 2003, INT J OBESITY, V27, P1486, DOI 10.1038/sj.ijo.0802439; Richelsen B, 2007, DIABETES CARE, V30, P27, DOI 10.2337/dc06-0210; Sjostrom L, 1998, LANCET, V352, P167, DOI 10.1016/S0140-6736(97)11509-4; Stephan R, 1998, OBES RES, V8, P49; Swinburn BA, 2005, DIABETES OBES METAB, V7, P254, DOI 10.1111/j.1463-1326.2004.00467.x; Toplak H, 2005, DIABETES OBES METAB, V7, P699, DOI 10.1111/j.1463-1326.2005.00483.x; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Wilding J, 2004, INT J OBESITY, V28, P1399, DOI 10.1038/sj.ijo.0802783; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323; Wirth A, 2001, JAMA-J AM MED ASSOC, V286, P1331, DOI 10.1001/jama.286.11.1331; Yaskin J, 2009, POPUL HEALTH MANAG, V12, P305, DOI 10.1089/pop.2008.0049	48	45	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39062	10.1371/journal.pone.0039062	http://dx.doi.org/10.1371/journal.pone.0039062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745703	gold, Green Published			2022-12-27	WOS:000305693200040
J	Piedrafita, G; Ruiz-Mirazo, K; Monnard, PA; Cornish-Bowden, A; Montero, F				Piedrafita, Gabriel; Ruiz-Mirazo, Kepa; Monnard, Pierre-Alain; Cornish-Bowden, Athel; Montero, Francisco			Viability Conditions for a Compartmentalized Protometabolic System: A Semi-Empirical Approach	PLOS ONE			English	Article							LIPID VESICLES; MODEL; ORIGINS; OLIGOMERIZATION; EVOLUTION; CELLS; SETS	In this work we attempt to find out the extent to which realistic prebiotic compartments, such as fatty acid vesicles, would constrain the chemical network dynamics that could have sustained a minimal form of metabolism. We combine experimental and simulation results to establish the conditions under which a reaction network with a catalytically closed organization (more specifically, an (M, R)-system) would overcome the potential problem of self-suffocation that arises from the limited accessibility of nutrients to its internal reaction domain. The relationship between the permeability of the membrane, the lifetime of the key catalysts and their efficiency (reaction rate enhancement) turns out to be critical. In particular, we show how permeability values constrain the characteristic time scale of the bounded protometabolic processes. From this concrete and illustrative example we finally extend the discussion to a wider evolutionary context.	[Piedrafita, Gabriel; Montero, Francisco] Univ Complutense Madrid, Dept Bioquim & Biol Mol 1, Madrid, Spain; [Ruiz-Mirazo, Kepa] Univ Basque Country, Dept Log & Filosofia Ciencia, Donostia San Sebastian, Spain; [Ruiz-Mirazo, Kepa] Univ Basque Country, Consejo Super Invest Cient, Unidad Biofis, Leioa, Spain; [Monnard, Pierre-Alain] Univ So Denmark, Ctr Fundamental Living Technol, Odense, Denmark; [Cornish-Bowden, Athel] CNRS, Unite Bioenerget & Ingn Prot, Marseille, France	Complutense University of Madrid; University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Southern Denmark; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Piedrafita, G (corresponding author), Univ Complutense Madrid, Dept Bioquim & Biol Mol 1, Madrid, Spain.	framonte@quim.ucm.es	Cornish-Bowden, Athel/G-7362-2019; Montero, Francisco/G-9850-2015; Piedrafita, Gabriel/A-4529-2013; Ruiz-Mirazo, Kepa/GQP-0495-2022	Cornish-Bowden, Athel/0000-0001-6670-3006; Montero, Francisco/0000-0003-2366-3635; Piedrafita, Gabriel/0000-0001-8701-1084; Monnard, Pierre-Alain/0000-0003-4679-3950	Ministerio de Economia y Competitividad, Spain [BFU2009-12895-C02-02, FFI2011-25665]; Gobierno Vasco, Spain [IT 505-10]; Danish National Research Foundation; European Community's Seventh Framework Programme [249032]; Ministerio de Educacion, Cultura y Deporte, Spain	Ministerio de Economia y Competitividad, Spain; Gobierno Vasco, Spain(Basque Government); Danish National Research Foundation(Danmarks Grundforskningsfond); European Community's Seventh Framework Programme; Ministerio de Educacion, Cultura y Deporte, Spain	This work was partially supported by the research projects BFU2009-12895-C02-02 and FFI2011-25665 (Ministerio de Economia y Competitividad, Spain). KRM also acknowledges support by grant IT 505-10 (Gobierno Vasco, Spain). PAM acknowledges support by the Danish National Research Foundation and by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement 249032. GP holds a FPU PhD scholarship (Ministerio de Educacion, Cultura y Deporte, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Budin I, 2011, P NATL ACAD SCI USA, V108, P5249, DOI 10.1073/pnas.1100498108; Cape JL, 2011, CHEM SCI, V2, P661, DOI 10.1039/c0sc00575d; Cavalier-Smith T, 2001, J MOL EVOL, V53, P555, DOI 10.1007/s002390010245; Cornish-Bowden A, 2007, PROTEOMICS, V7, P839, DOI 10.1002/pmic.200600431; Deamer DW, 2008, NATURE, V454, P37, DOI 10.1038/454037a; Deamer DW, 1997, MICROBIOL MOL BIOL R, V61, P239, DOI 10.1128/.61.2.239-261.1997; DYSON FJ, 1982, J MOL EVOL, V18, P344, DOI 10.1007/BF01733901; Eigen M, 1979, THE HYPERCYCLE, P60; Epstein IR, 2005, CHAOS, P15; Fontana W, 1996, BOUNDARIES BARRIERS, P55; GANTI T, 1975, BIOSYSTEMS, V7, P15, DOI 10.1016/0303-2647(75)90038-6; Gardner PM, 2009, NAT CHEM, V1, P377, DOI [10.1038/NCHEM.296, 10.1038/nchem.296]; Griffiths G, 2007, NAT REV MOL CELL BIO, V8, P1018, DOI 10.1038/nrm2287; HAROLD FM, 1991, BIOSCIENCE REP, V11, P347, DOI 10.1007/BF01130213; Hitz T, 2000, BIOPOLYMERS, V55, P381, DOI 10.1002/1097-0282(2000)55:5<381::AID-BIP1012>3.0.CO;2-Q; Hordijk W, 2004, J THEOR BIOL, V227, P451, DOI 10.1016/j.jtbi.2003.11.020; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; KAUFFMAN SA, 1986, J THEOR BIOL, V119, P1, DOI 10.1016/S0022-5193(86)80047-9; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Letelier JC, 2006, J THEOR BIOL, V238, P949, DOI 10.1016/j.jtbi.2005.07.007; Luisi PL, 1999, CURR OPIN COLLOID IN, V4, P33, DOI 10.1016/S1359-0294(99)00012-6; Mansy S. S, 2010, COLD SPRING HARB PER, V2; Mansy SS, 2008, NATURE, V454, P122, DOI 10.1038/nature07018; Martin W, 2003, PHILOS T R SOC B, V358, P59, DOI 10.1098/rstb.2002.1183; Maturana H.R., 1980, AUTOPOIESIS COGNITIO; Maurer SE, 2009, ASTROBIOLOGY, V9, P979, DOI 10.1089/ast.2009.0384; Monnard PA, 2003, METHOD ENZYMOL, V372, P133; Monnard PA, 2002, ANAT RECORD, V268, P196, DOI 10.1002/ar.10154; Moran F., 1996, ARTIF LIFE, P255; Morowitz H.J., 1992, BEGINNINGS CELLULAR; Olasagasti F, 2011, BIOCHIMIE, V93, P556, DOI 10.1016/j.biochi.2010.11.012; Oparin A.L, 1961, LIFE ITS NATURE ORIG; Piedrafita G, 2012, J THEOR BIOL, V300, P143, DOI 10.1016/j.jtbi.2012.01.013; Piedrafita G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000872; Rajamani S, 2008, ORIGINS LIFE EVOL B, V38, P57, DOI 10.1007/s11084-007-9113-2; Rosen R, 1991, LIFE ITSELF; Ruiz-Mirazo K, 2004, ARTIF LIFE, V10, P235, DOI 10.1162/1064546041255584; Ruiz-Mirazo K, 2011, ADV EXP MED BIOL, V696, P689, DOI 10.1007/978-1-4419-7046-6_70; Segre D, 2001, ORIGINS LIFE EVOL B, V31, P119, DOI 10.1023/A:1006746807104; Szathmary E, 2005, TOP CURR CHEM, V259, P167, DOI 10.1007/tcc001; Szathmary E, 2007, PHILOS T R SOC B, V362, P1781, DOI 10.1098/rstb.2007.2070; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Tsukahara H, 2002, ORIGINS LIFE EVOL B, V32, P13, DOI 10.1023/A:1013962328048; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; VARELA F G, 1974, Biosystems, V5, P187, DOI 10.1016/0303-2647(74)90031-8; Zepik HH, 2007, ORIGINS LIFE EVOL B, V37, P495, DOI 10.1007/s11084-007-9070-9	46	16	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39480	10.1371/journal.pone.0039480	http://dx.doi.org/10.1371/journal.pone.0039480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761803	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305825800037
J	Lee, CY; Jaw, T; Tseng, HC; Chen, IC; Liou, HH				Lee, Chun-Yao; Jaw, Thomas; Tseng, Huan-Chin; Chen, I-Chun; Liou, Horng-Huei			Lovastatin Modulates Glycogen Synthase Kinase-3 beta Pathway and Inhibits Mossy Fiber Sprouting after Pilocarpine-Induced Status Epilepticus	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; GRANULE CELL DISPERSION; TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL SEIZURES; RAT HIPPOCAMPUS; DENTATE GYRUS; STATINS; MODEL; PHOSPHORYLATION; NEUROGENESIS	This study was undertaken to assay the effect of lovastatin on the glycogen synthase kinase-3 beta (GSK-3 beta) and collapsin responsive mediator protein-2 (CRMP-2) signaling pathway and mossy fiber sprouting (MFS) in epileptic rats. MFS in the dentate gyrus (DG) is an important feature of temporal lobe epilepsy (TLE) and is highly related to the severity and the frequency of spontaneous recurrent seizures. However, the molecular mechanism of MFS is mostly unknown. GSK-3 beta and CRMP-2 are the genes responsible for axonal growth and neuronal polarity in the hippocampus, therefore this pathway is a potential target to investigate MFS. Pilocarpine-induced status epilepticus animal model was taken as our researching material. Western blot, histological and electrophysiological techniques were used as the studying tools. The results showed that the expression level of GSK-3 beta and CRMP-2 were elevated after seizure induction, and the administration of lovastatin reversed this effect and significantly reduced the extent of MFS in both DG and CA3 region in the hippocampus. The alteration of expression level of GSK-3 beta and CRMP-2 after seizure induction proposes that GSK-3 beta and CRMP-2 are crucial for MFS and epiletogenesis. The fact that lovastatin reversed the expression level of GSK-3 beta and CRMP-2 indicated that GSK-3 beta and CRMP-2 are possible to be a novel mechanism of lovatstain to suppress MFS and revealed a new therapeutic target and researching direction for studying the mechanism of MFS and epileptogenesis.	[Liou, Horng-Huei] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lee, Chun-Yao; Jaw, Thomas; Tseng, Huan-Chin; Chen, I-Chun; Liou, Horng-Huei] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lee, CY (corresponding author), Coll France, Ctr Interdisciplinaire Rech Biol, UMR CNRS 7241, INSERM U1050, F-75231 Paris, France.	hhl@ntu.edu.tw		Liou, Horng-Huei/0000-0001-6537-5346	National Science Council Taipei, Taiwan [NSC 96-2323-B-002-014]	National Science Council Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council (NSC 96-2323-B-002-014) Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo JC, 2005, CURR OPIN CELL BIOL, V17, P112, DOI 10.1016/j.ceb.2005.01.004; Bagetta G, 2002, BIOCHEM BIOPH RES CO, V291, P255, DOI 10.1006/bbrc.2002.6424; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; Calabresi P, 2003, ANN NEUROL, V53, P693, DOI 10.1002/ana.10603; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Cilio MR, 2003, EPILEPSIA, V44, P518, DOI 10.1046/j.1528-1157.2003.48802.x; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; Dudek FE, 2011, NEUROSCI LETT, V497, P240, DOI 10.1016/j.neulet.2011.03.071; Fahrner A, 2007, EXP NEUROL, V203, P320, DOI 10.1016/j.expneurol.2006.08.023; George SJ, 2002, AM J CARDIOL, V90, P1237, DOI 10.1016/S0002-9149(02)02841-2; Gobbo OL, 2004, NEUROSCIENCE, V125, P317, DOI 10.1016/j.neuroscience.2004.01.045; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Han Y, 2005, BIOCHEM BIOPH RES CO, V327, P431, DOI 10.1016/j.bbrc.2004.12.028; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Kuo LW, 2008, NEUROIMAGE, V41, P789, DOI 10.1016/j.neuroimage.2008.03.013; Lee CY, 2009, BRIT J PHARMACOL, V158, P1753, DOI 10.1111/j.1476-5381.2009.00463.x; Lee JK, 2008, NEUROSCI LETT, V440, P260, DOI 10.1016/j.neulet.2008.05.112; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; Longo BM, 1999, EPILEPSY RES, V36, P233, DOI 10.1016/S0920-1211(99)00054-6; Lynch M, 2000, J NEUROPHYSIOL, V83, P693, DOI 10.1152/jn.2000.83.2.693; McKenney JM, 2003, ANN PHARMACOTHER, V37, P1063, DOI 10.1345/aph.1C499; Nadler JV, 2003, NEUROCHEM RES, V28, P1649, DOI 10.1023/A:1026004904199; Planavila A, 2008, BBA-MOL CELL BIOL L, V1781, P26, DOI 10.1016/j.bbalip.2007.10.009; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Sironi L, 2003, ARTERIOSCL THROM VAS, V23, P322, DOI 10.1161/01.ATV.0000044458.23905.3B; Sutula T, 1996, J NEUROSCI, V16, P7398; Sutula Thomas, 2002, Epilepsy Curr, V2, P86, DOI 10.1046/j.1535-7597.2002.00032.x; Suzuki F, 2005, EPILEPSIA, V46, P193, DOI 10.1111/j.0013-9580.2005.35504.x; Takei Y, 2001, BRAIN DEV-JPN, V23, P406, DOI 10.1016/S0387-7604(01)00253-4; Takemiya T, 2003, PROSTAG OTH LIPID M, V71, P205, DOI 10.1016/S1098-8823(03)00040-6; Vaughan CJ, 2001, CNS DRUGS, V15, P589, DOI 10.2165/00023210-200115080-00002; Williams PA, 2002, J NEUROPHYSIOL, V88, P2075, DOI 10.1152/jn.2002.88.4.2075; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xie CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024966; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zacco A, 2003, J NEUROSCI, V23, P11104	40	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e38789	10.1371/journal.pone.0038789	http://dx.doi.org/10.1371/journal.pone.0038789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761705	gold, Green Published			2022-12-27	WOS:000305808700011
J	Martinez-Cerdeno, V; Lemen, JM; Chan, V; Wey, A; Lin, WC; Dent, SR; Knoepfler, PS				Martinez-Cerdeno, Veronica; Lemen, Jessica M.; Chan, Vanessa; Wey, Alice; Lin, Wenchu; Dent, Sharon R.; Knoepfler, Paul S.			N-Myc and GCN5 Regulate Significantly Overlapping Transcriptional Programs in Neural Stem Cells	PLOS ONE			English	Article							C-MYC; HISTONE ACETYLTRANSFERASE; ESSENTIAL COFACTOR; REPRESSOR SIN3; MOUSE EMBRYOS; TUBE CLOSURE; GENE; ACETYLATION; EXPRESSION; TRRAP	Here we examine the functions of the Myc cofactor and histone acetyltransferase, GCN5/KAT2A, in neural stem and precursor cells (NSC) using a conditional knockout approach driven by nestin-cre. Mice with GCN5-deficient NSC exhibit a 25% reduction in brain mass with a microcephaly phenotype similar to that observed in nestin-cre driven knockouts of c-or N-myc. In addition, the loss of GCN5 inhibits precursor cell proliferation and reduces their populations in vivo, as does loss of N-myc. Gene expression analysis indicates that about one-sixth of genes whose expression is affected by loss of GCN5 are also affected in the same manner by loss of N-myc. These findings strongly support the notion that GCN5 protein is a key N-Myc transcriptional cofactor in NSC, but are also consistent with recruitment of GCN5 by other transcription factors and the use by N-Myc of other histone acetyltransferases. Putative N-Myc/GCN5 coregulated transcriptional pathways include cell metabolism, cell cycle, chromatin, and neuron projection morphogenesis genes. GCN5 is also required for maintenance of histone acetylation both at its putative specific target genes and at Myc targets. Thus, we have defined an important role for GCN5 in NSC and provided evidence that GCN5 is an important Myc transcriptional cofactor in vivo.	[Martinez-Cerdeno, Veronica; Knoepfler, Paul S.] Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Martinez-Cerdeno, Veronica; Lemen, Jessica M.; Chan, Vanessa; Wey, Alice] Shriners Hosp Children No Calif, Inst Pediat Regenerat Med, Sacramento, CA USA; [Lemen, Jessica M.; Chan, Vanessa; Wey, Alice; Knoepfler, Paul S.] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Lin, Wenchu; Dent, Sharon R.] Univ Texas MD Anderson Canc Ctr Houston, Houston, TX USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Texas System; UTMD Anderson Cancer Center	Martinez-Cerdeno, V (corresponding author), Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Sacramento, CA 95817 USA.	knoepfler@ucdavis.edu	Dent, Sharon YR/F-1746-2011	Dent, Sharon YR/0000-0002-4824-3269; Knoepfler, Paul/0000-0001-5444-334X	National Institutes of Health [01 CA114400]; NATIONAL CANCER INSTITUTE [K01CA114400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100782] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by National Institutes of Health 01 CA114400 Analyzing Myc Function in Neural Cancers and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ard PG, 2002, MOL CELL BIOL, V22, P5650, DOI 10.1128/MCB.22.16.5650-5661.2002; Aruga J, 2003, GENE, V315, P87, DOI 10.1016/S0378-1119(03)00715-7; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; Ben-Porath I, 1999, MOL CELL BIOL, V19, P3529; Bouchard C, 2001, GENE DEV, V15, P2042, DOI 10.1101/gad.907901; Bu P, 2007, MOL CELL BIOL, V27, P3405, DOI 10.1128/MCB.00066-07; Chen YC, 2012, HUM MOL GENET, V21, P394, DOI 10.1093/hmg/ddr474; Ciurciu A, 2006, MOL CELL BIOL, V26, P9413, DOI 10.1128/MCB.01401-06; Cotterman R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005799; Cotterman R, 2008, CANCER RES, V68, P9654, DOI 10.1158/0008-5472.CAN-08-1961; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hatton BA, 2006, CANCER RES, V66, P8655, DOI 10.1158/0008-5472.CAN-06-1621; Hevner RF, 2002, J COMP NEUROL, V447, P8, DOI 10.1002/cne.10219; Imoberdorf RM, 2006, MOL CELL BIOL, V26, P1610, DOI 10.1128/MCB.26.5.1610-1616.2006; Knoepfler PS, 2008, CELL STEM CELL, V2, P18, DOI 10.1016/j.stem.2007.12.004; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Kuo TY, 2009, MOL CELL NEUROSCI, V42, P195, DOI 10.1016/j.mcn.2009.07.006; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; LIN CH, 2009, EMBO J; Lin CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007839; Lin WC, 2008, DEV DYNAM, V237, P928, DOI 10.1002/dvdy.21479; Lin W, 2007, DEV DYNAM, V236, P1547, DOI 10.1002/dvdy.21160; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Soucek L, 2010, CURR OPIN GENET DEV, V20, P91, DOI 10.1016/j.gde.2009.11.001; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van Bokhoven H, 2005, NAT GENET, V37, P465, DOI 10.1038/ng1546; Varlakhanova NV, 2010, DIFFERENTIA IN PRESS; Wey A, 2010, ONCOTARGET, V1, P120, DOI 10.18632/oncotarget.116; Wey A, 2010, CEREBELLUM, V9, P537, DOI 10.1007/s12311-010-0190-9; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703; Zindy F, 2006, P NATL ACAD SCI USA, V103, P11579, DOI 10.1073/pnas.0604727103	45	39	39	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39456	10.1371/journal.pone.0039456	http://dx.doi.org/10.1371/journal.pone.0039456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22745758	Green Published, gold, Green Submitted			2022-12-27	WOS:000305808700030
J	Orlov, M; Vaida, F; Finney, OC; Smith, DM; Talley, AK; Wang, RB; Kappe, SH; Deng, QQ; Schooley, RT; Duffy, PE				Orlov, Marika; Vaida, Florin; Finney, Olivia C.; Smith, David M.; Talley, Angela K.; Wang, Ruobing; Kappe, Stefan H.; Deng, Qianqian; Schooley, Robert T.; Duffy, Patrick E.			P. falciparum Enhances HIV Replication in an Experimental Malaria Challenge System	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; SUB-SAHARAN AFRICA; PLASMODIUM-FALCIPARUM; INTERFERON-GAMMA; IFN-GAMMA; TNF-ALPHA; NK CELLS; INFECTION; BLOOD	Co-infection with HIV and P. falciparum worsens the prognosis of both infections; however, the mechanisms driving this adverse interaction are not fully delineated. To evaluate this, we studied HIV-1 and P. falciparum interactions in vitro using peripheral blood mononuclear cells (PBMCs) from human malaria naive volunteers experimentally infected with P. falciparum in a malaria challenge trial. PBMCs collected before the malaria challenge and at several time points post-infection were infected with HIV-1 and co-cultured with either P. falciparum infected (iRBCs) or uninfected (uRBCs) red blood cells. HIV p24Ag and TNF-alpha, IFN-gamma, IL-4, IL-6, IL-10, IL-17, and MIP-1 alpha were quantified in the co-culture supernatants. In general, iRBCs stimulated more HIV p24Ag production by PBMCs than did uRBCs. HIV p24Ag production by PBMCs in the presence of iRBCs (but not uRBCs) further increased during convalescence (days 35, 56, and 90 post-challenge). In parallel, iRBCs induced higher secretion of pro-inflammatory cytokines (TNF-alpha, IFN-gamma, and MIP-1 alpha) than uRBCs, and production increased further during convalescence. Because the increase in p24Ag production occurred after parasitemia and generalized immune activation had resolved, our results suggest that enhanced HIV production is related to the development of anti-malaria immunity and may be mediated by pro-inflammatory cytokines.	[Orlov, Marika; Finney, Olivia C.; Talley, Angela K.; Wang, Ruobing; Kappe, Stefan H.; Duffy, Patrick E.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Orlov, Marika; Smith, David M.; Deng, Qianqian; Schooley, Robert T.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Vaida, Florin] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Duffy, Patrick E.] NIAID, Lab Malaria Immunol, NIH, Rockville, MD USA	Center for Infectious Disease Research; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Orlov, M (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	rschooley@ucsd.edu		Smith, Davey/0000-0003-3603-1733; Orlov, Marika/0000-0003-1961-0813	Translational Virology Core at the UC San Diego Center for AIDS Research [AI36214]; Gilead Sciences; Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; U.S. National Institutes of Health [U19 AI065664]; Gilead's SAB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI065664, ZIAAI001134, P30AI036214, ZIAAI001056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	Translational Virology Core at the UC San Diego Center for AIDS Research; Gilead Sciences(Gilead Sciences); Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilead's SAB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was performed with the support of the Translational Virology Core at the UC San Diego Center for AIDS Research (AI36214), Gilead Sciences, and funded in part by a Grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative and from the U.S. National Institutes of Health (Grant U19 AI065664). No additional external funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Robert T. Schooley is a member of the Scientific Advisory Board for Gilead Sciences. A consulting fee from Gilead Sciences was sent on to the University of California to be used in an unrestricted fashion for research and educational activities that are not covered by other sources. Ms. Orlov is a graduate student, and Dr. Schooley has used, in part, the funds from his role as a member of Gilead's SAB to pay for her stipend and for some of the laboratory resources used for this work. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Angulo I, 2002, CLIN DIAGN LAB IMMUN, V9, P1145, DOI 10.1128/CDLI.9.6.1145-1152.2002; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Bull M, 2007, J IMMUNOL METHODS, V322, P57, DOI 10.1016/j.jim.2007.02.003; Chandramohan D, 1998, INT J EPIDEMIOL, V27, P296, DOI 10.1093/ije/27.2.296; CHULAY JD, 1986, AM J TROP MED HYG, V35, P66, DOI 10.4269/ajtmh.1986.35.66; Cuadros DF, 2011, INT J EPIDEMIOL, V40, P931, DOI 10.1093/ije/dyq256; Cummings JF, 2010, VACCINE, V28, P5135, DOI 10.1016/j.vaccine.2009.08.046; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Epstein JE, 2007, J INFECT DIS, V196, P145, DOI 10.1086/518510; Grimwade K, 2004, AIDS, V18, P547, DOI 10.1097/00002030-200402200-00023; Hananantachai H, 2007, TISSUE ANTIGENS, V69, P277, DOI 10.1111/j.1399-0039.2006.00756.x; Hoffman SL, 1997, ANN INTERN MED, V127, P233, DOI 10.7326/0003-4819-127-3-199708010-00010; Kalyesubula I, 1997, PEDIATR INFECT DIS J, V16, P876, DOI 10.1097/00006454-199709000-00011; Kapiga SH, 2002, J ACQ IMMUN DEF SYND, V29, P409, DOI 10.1097/00126334-200204010-00013; Kublin JG, 2005, LANCET, V365, P233, DOI 10.1016/S0140-6736(05)17743-5; McCall MBB, 2010, EUR J IMMUNOL, V40, P3472, DOI 10.1002/eji.201040587; Mermin J, 2006, JAIDS-J ACQ IMM DEF, V41, P129, DOI 10.1097/01.qai.0000179427.11789.a7; Murray SM, 2010, J VIROL, V84, P12082, DOI 10.1128/JVI.01466-10; Mwapasa V, 2004, AIDS, V18, P1051, DOI 10.1097/00002030-200404300-00014; Pantaleo G, 1996, ANNU REV MICROBIOL, V50, P825, DOI 10.1146/annurev.micro.50.1.825; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Riddell LA, 2001, AIDS RES HUM RETROV, V17, P789, DOI 10.1089/088922201750251981; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5; Sinha S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-13; Stephens R, 2005, BLOOD, V106, P1676, DOI 10.1182/blood-2004-10-4047; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; Tchinda VHM, 2007, ACTA TROP, V102, P20, DOI 10.1016/j.actatropica.2007.02.011; Urban BC, 2003, J EXP MED, V197, P137, DOI 10.1084/jem.20022003; Walther M, 2006, J IMMUNOL, V177, P5736, DOI 10.4049/jimmunol.177.8.5736; Wipasa J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001281; Xiao LH, 1998, J INFECT DIS, V177, P437, DOI 10.1086/514212; Xu HJ, 2002, J EXP MED, V195, P881, DOI 10.1084/jem.20011174; YAHI N, 1992, EUR J IMMUNOL, V22, P2495, DOI 10.1002/eji.1830221005	35	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39000	10.1371/journal.pone.0039000	http://dx.doi.org/10.1371/journal.pone.0039000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22745697	Green Published, Green Submitted, gold			2022-12-27	WOS:000305808700015
J	Alba, DM; Almecija, S; Casanovas-Vilar, I; Mendez, JM; Moya-Sola, S				Alba, David M.; Almecija, Sergio; Casanovas-Vilar, Isaac; Mendez, Josep M.; Moya-Sola, Salvador			A Partial Skeleton of the Fossil Great Ape Hispanopithecus laietanus from Can Feu and the Mosaic Evolution of Crown-Hominoid Positional Behaviors	PLOS ONE			English	Article							VALLES-PENEDES BASIN; OLD-WORLD MONKEYS; MIDDLE MIOCENE; PIEROLAPITHECUS-CATALAUNICUS; DRYOPITHECUS-BRANCOI; TAXONOMIC AFFINITIES; DIAPHYSEAL STRUCTURE; NACHOLAPITHECUS; QUADRUPEDALISM; RUDABANYA	The extinct dryopithecine Hispanopithecus (Primates: Hominidae), from the Late Miocene of Europe, is the oldest fossil great ape displaying an orthograde body plan coupled with unambiguous suspensory adaptations. On the basis of hand morphology, Hispanopithecus laietanus has been considered to primitively retain adaptations to above-branch quadrupedalism-thus displaying a locomotor repertoire unknown among extant or fossil hominoids, which has been considered unlikely by some researchers. Here we describe a partial skeleton of H. laietanus from the Vallesian (MN9) locality of Can Feu 1 (Valles-Penedes Basin, NE Iberian Peninsula), with an estimated age of 10.0-9.7 Ma. It includes dentognathic and postcranial remains of a single, female adult individual, with an estimated body mass of 22-25 kg. The postcranial remains of the rib cage, shoulder girdle and forelimb show a mixture of monkey-like and modern-hominoid-like features. In turn, the proximal morphology of the ulna-most completely preserved in the Can Feu skeleton than among previously-available remains-indicates the possession of an elbow complex suitable for preserving stability along the full range of flexion/extension and enabling a broad range of pronation/supination. Such features, suitable for suspensory behaviors, are however combined with an olecranon morphology that is functionally related to quadrupedalism. Overall, when all the available postcranial evidence for H. laietanus is considered, it emerges that this taxon displayed a locomotor repertoire currently unknown among other apes (extant or extinct alike), uniquely combining suspensory-related features with primitively-retained adaptations to above-branch palmigrady. Despite phylogenetic uncertainties, Hispanopithecus is invariably considered an extinct member of the great-ape-and-human clade. Therefore, the combination of quadrupedal and suspensory adaptations in this Miocene crown hominoid clearly evidences the mosaic nature of locomotor evolution in the Hominoidea, as well as the impossibility to reconstruct the ancestral locomotor repertoires for crown hominoid subclades on the basis of extant taxa alone.	[Alba, David M.; Moya-Sola, Salvador] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, Inst Catalana Recerca & Estudis Avancats, E-08193 Barcelona, Spain; [Almecija, Sergio] Amer Museum Nat Hist, Dept Vertebrate Paleontol, New York, NY 10024 USA; [Almecija, Sergio] Amer Museum Nat Hist, New York Consortium Evolutionary Primatol, New York, NY 10024 USA; [Moya-Sola, Salvador] Univ Autonoma Barcelona, Dept Biol Anim Biol Vegetal & Ecol, Unitat Antropol Biol, E-08193 Barcelona, Spain	Autonomous University of Barcelona; ICREA; Institut Catala de Paleontologia Miquel Crusafont (ICP); American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); Autonomous University of Barcelona	Alba, DM (corresponding author), Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, Inst Catalana Recerca & Estudis Avancats, E-08193 Barcelona, Spain.	david.alba@icp.cat	Alba, David/G-9716-2015; Almécija, Sergio/ABG-8129-2020; Casanovas-Vilar, Isaac/J-2517-2012	Alba, David/0000-0002-8886-5580; Almécija, Sergio/0000-0003-1373-1497; Casanovas-Vilar, Isaac/0000-0001-7092-9622; Moya-Sola, Salvador/0000-0001-8506-1061	Ministerio de Economia y Competitividad [CGL2011-28681, CGL2011-27343, CGL2010-21672/BTE, RYC-2009-04533, JCI-2010-08241]; Generalitat de Catalunya [2009 SGR 754 GRC, 2009 BP-A 00226]; ICREA Funding Source: Custom	Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); ICREA(ICREA)	Ministerio de Economia y Competitividad, projects (CGL2011-28681, CGL2011-27343, CGL2010-21672/BTE) and research contracts to DMA (RYC-2009-04533) and ICV (JCI-2010-08241 to ICV), as well as Generalitat de Catalunya, project (2009 SGR 754 GRC) and grant to SA (2009 BP-A 00226) supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J, 1997, PALAEOGEOGR PALAEOCL, V133, P149, DOI 10.1016/S0031-0182(97)00084-9; Aiello LC, 1999, AM J PHYS ANTHROPOL, V109, P89, DOI 10.1002/(SICI)1096-8644(199905)109:1<89::AID-AJPA8>3.0.CO;2-4; Alba D. M., EVOL ANTHR IN PRESS; Alba D, 2011, J VERTEBR PALEONTOL, V31, P60; Alba DM, 2011, AM J PHYS ANTHROPOL, V144, P365, DOI 10.1002/ajpa.21417; Alba DM, 2010, J HUM EVOL, V59, P143, DOI 10.1016/j.jhevol.2010.02.002; Alba DM, 2012, AM J PHYS ANTHROPOL, V147, P81; Almecija S, 2007, P ROY SOC B-BIOL SCI, V274, P2375, DOI 10.1098/rspb.2007.0750; Almecija S, 2012, AM J PHYS ANTHROPOL, V148, P436, DOI 10.1002/ajpa.22071; Almecija S, 2009, J HUM EVOL, V57, P284, DOI 10.1016/j.jhevol.2009.02.008; Andrews P., 1996, P168; Begun David R., 1994, Yearbook of Physical Anthropology, V37, P11; Begun DR, 2012, EVOL ANTHROPOL, V21, P10, DOI 10.1002/evan.20329; Begun DR, 2011, AM J PHYS ANTHROPOL, V144, P86; Begun DR, 2009, GEODIVERSITAS, V31, P789, DOI 10.5252/g2009n4a789; BEGUN DR, 1992, AM J PHYS ANTHROPOL, V87, P291, DOI 10.1002/ajpa.1330870306; BEGUN DR, 1990, J HUM EVOL, V19, P255, DOI 10.1016/0047-2484(90)90068-M; Begun DR, 2002, CAM S BIO EVOL ANTHR, V33, P339; BEGUN DR, 1993, J HUM EVOL, V24, P373, DOI 10.1006/jhev.1993.1028; BEGUN DR, 1992, AM J PHYS ANTHROPOL, V87, P311, DOI 10.1002/ajpa.1330870307; BEGUN DR, 1993, J HUM EVOL, V25, P271, DOI 10.1006/jhev.1993.1049; Casanovas-Vilar I, 2012, J VERTEBR PALEONTOL, V32, P225, DOI 10.1080/02724634.2012.633948; Casanovas-Vilar I, 2011, P NATL ACAD SCI USA, V108, P5554, DOI 10.1073/pnas.1018562108; Conroy G.C., 1976, Contributions Primatol, V8, P1; Deane AS, 2008, J HUM EVOL, V55, P691, DOI 10.1016/j.jhevol.2008.05.005; Drapeau MSM, 2008, J HUM EVOL, V55, P86, DOI 10.1016/j.jhevol.2008.01.005; Drapeau MSM, 2004, AM J PHYS ANTHROPOL, V124, P297, DOI 10.1002/ajpa.10359; Garces M, 1996, EARTH PLANET SC LETT, V142, P381, DOI 10.1016/0012-821X(96)00110-0; Golpe Posse J.M, 1993, PALEONTOLOGIA EVOLUC, V26, P151; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HARRISON T, 1991, J HUM EVOL, V20, P515, DOI 10.1016/0047-2484(91)90024-P; Harrison T., 1991, P235; HARRISON T, 1986, J HUM EVOL, V15, P541, DOI 10.1016/S0047-2484(86)80073-2; Ishida H, 2004, J HUM EVOL, V46, P69, DOI 10.1016/j.jhevol.2003.10.001; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Kelley Jay, 1997, P173; Kohler M, 2002, AM J PHYS ANTHROPOL, V119, P297, DOI 10.1002/ajpa.10140; Kordos L, 2001, J HUM EVOL, V41, P689, DOI 10.1006/jhev.2001.0523; Kordos L, 1997, AM J PHYS ANTHROPOL, V103, P277, DOI 10.1002/(SICI)1096-8644(199706)103:2<277::AID-AJPA10>3.0.CO;2-Y; Larson SG, 2006, AM J PHYS ANTHROPOL, V129, P71, DOI 10.1002/ajpa.20236; Larson SG, 1998, EVOL ANTHROPOL, V6, P87, DOI 10.1002/(SICI)1520-6505(1998)6:3<87::AID-EVAN3>3.0.CO;2-T; LEAKEY RE, 1988, AM J PHYS ANTHROPOL, V76, P277, DOI 10.1002/ajpa.1330760302; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175827; Madar SI, 2002, J HUM EVOL, V42, P705, DOI 10.1006/jhev.2002.0554; Morbeck M.E., 1983, P369; MORBECK ME, 1976, J HUM EVOL, V5, P223, DOI 10.1016/0047-2484(76)90025-7; MOSIMANN JE, 1970, J AM STAT ASSOC, V65, P930, DOI 10.2307/2284599; Moya Sola Salvadoor, 1995, Journal of Human Evolution, V29, P101; Moya-Sola S, 2005, SCIENCE, V308, DOI 10.1126/science.1108433; Moya-Sola S, 2004, SCIENCE, V306, P1339, DOI 10.1126/science.1103094; Moya-Sola S, 2009, P NATL ACAD SCI USA, V106, P9601, DOI 10.1073/pnas.0811730106; Moya-Sola S, 2009, AM J PHYS ANTHROPOL, V139, P126, DOI 10.1002/ajpa.20891; MoyaSola S, 1996, NATURE, V379, P156, DOI 10.1038/379156a0; MOYASOLA S, 1993, NATURE, V365, P543, DOI DOI 10.1038/365543A0; Nakatsukasa M, 1998, J HUM EVOL, V34, P657, DOI 10.1006/jhev.1998.0228; Nakatsukasa Masato, 1996, African Study Monographs Supplementary Issue, V24, P57; Nakatsukasa M, 2009, EVOL ANTHROPOL, V18, P103, DOI 10.1002/evan.20208; Pickford M, 2012, ESTUD GEOL-MADRID, V68, P113, DOI 10.3989/egeol.40322.129; Pina M, 2012, AM J PHYS ANTHROPOL, V147, P237; Plavcan JM, 2001, YEARB PHYS ANTHROPOL, V44, P25, DOI 10.1002/ajpa.10011; Preuschoft H., 1973, HUMAN EVOLUTION, VXI, P13; Rein TR, 2011, J HUM EVOL, V61, P564, DOI 10.1016/j.jhevol.2011.07.005; Ribot F, 1996, J HUM EVOL, V31, P129, DOI 10.1006/jhev.1996.0054; Richmond BG, 1998, AM J PHYS ANTHROPOL, V105, P257; Rose M.D., 1983, NEW INTERPRETATIONS, P503; ROSE MD, 1988, J HUM EVOL, V17, P193, DOI 10.1016/0047-2484(88)90054-1; ROSE MD, 1994, J HUM EVOL, V26, P387, DOI 10.1006/jhev.1994.1025; Rose Michael D., 1993, P70; Rose Michael D., 1997, P79; Rose Michael D., 1993, P252; Rose Michael D., 1996, African Study Monographs Supplementary Issue, V24, P3; Ruff CB, 2003, AM J PHYS ANTHROPOL, V120, P16, DOI 10.1002/ajpa.10118; Ruff CB, 2002, AM J PHYS ANTHROPOL, V119, P305, DOI 10.1002/ajpa.10117; SARMIENTO E E, 1987, American Museum Novitates, P1; SARMIENTO EE, 1988, INT J PRIMATOL, V9, P281, DOI 10.1007/BF02737381; Sarmiento EE, 2002, ANAT REC NEW ANAT, V269, P60; Senut B, 2004, PRIMATES, V45, P97, DOI 10.1007/s10329-003-0073-5; Senut B., 1989, CAHIERS PALEOANTHROP; Sherwood RJ, 2002, J HUM EVOL, V42, P63, DOI 10.1006/jhev.2001.0502; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Villalta Comella JFde, 1944, NOT COM I GEOL MIN E, V13, P1; Walker A., 1986, P143; Ward Carol V., 2007, P1011, DOI 10.1007/978-3-540-33761-4_34; ZAPFE HELMUTH, 1960, SCHWEIZ PALAEONTOL ABHANDL, V78, P1	84	32	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39617	10.1371/journal.pone.0039617	http://dx.doi.org/10.1371/journal.pone.0039617			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761844	Green Published, gold			2022-12-27	WOS:000305781700053
J	Ginn, AN; Wiklendt, AM; Gidding, HF; George, N; O'Driscoll, JS; Partridge, SR; O'Toole, BI; Perri, RA; Faoagali, J; Gallagher, JE; Lipman, J; Iredell, JR				Ginn, Andrew N.; Wiklendt, Agnieszka M.; Gidding, Heather F.; George, Narelle; O'Driscoll, James S.; Partridge, Sally R.; O'Toole, Brian I.; Perri, Rita A.; Faoagali, Joan; Gallagher, John E.; Lipman, Jeffrey; Iredell, Jonathan R.			The Ecology of Antibiotic Use in the ICU: Homogeneous Prescribing of Cefepime but Not Tazocin Selects for Antibiotic Resistant Infection	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; STAPHYLOCOCCUS-AUREUS; POSSIBLE SIGNAL; APACHE-II; METAANALYSIS; RESTRICTION; DECONTAMINATION; IDENTIFICATION; CEPHALOSPORIN; COLONIZATION	Background: Antibiotic homogeneity is thought to drive resistance but in vivo data are lacking. In this study, we determined the impact of antibiotic homogeneity per se, and of cefepime versus antipseudomonal penicillin/beta-lactamase inhibitor combinations (APP-beta), on the likelihood of infection or colonisation with antibiotic resistant bacteria and/or two commonly resistant nosocomial pathogens (methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa). A secondary question was whether antibiotic cycling was associated with adverse outcomes including mortality, length of stay, and antibiotic resistance. Methods: We evaluated clinical and microbiological outcomes in two similar metropolitan ICUs, which both alternated cefepime with APP-beta in four-month cycles. All microbiological isolates and commensal samples were analysed for the presence of antibiotic-resistant bacteria including MRSA and P. aeruginosa. Results: Length of stay, mortality and overall antibiotic resistance were unchanged after sixteen months. However, increased colonisation and infection by antibiotic-resistant bacteria were observed in cefepime cycles, returning to baseline in APP-beta cycles. Cefepime was the strongest risk factor for acquisition of antibiotic-resistant infection. Conclusions: Ecological effects of different beta-lactam antibiotics may be more important than specific activity against the causative agents or the effect of antibiotic homogeneity in selection for antibiotic resistance. This has important implications for antibiotic policy.	[Ginn, Andrew N.; Wiklendt, Agnieszka M.; Partridge, Sally R.; O'Toole, Brian I.; Iredell, Jonathan R.] Westmead Hosp, Ctr Infect Dis & Microbiol, Sydney, NSW, Australia; [Ginn, Andrew N.; Wiklendt, Agnieszka M.; Partridge, Sally R.; Iredell, Jonathan R.] Univ Sydney, Ctr Res Excellence Crit Infect, Sydney, NSW 2006, Australia; [Ginn, Andrew N.; Wiklendt, Agnieszka M.; Partridge, Sally R.; Iredell, Jonathan R.] Univ Sydney, Sydney Inst Emerging Infect & Biosecur, Sydney, NSW 2006, Australia; [Ginn, Andrew N.; Partridge, Sally R.; Perri, Rita A.; Iredell, Jonathan R.] Westmead Millennium Inst, Westmead, NSW, Australia; [Gidding, Heather F.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; [George, Narelle; Faoagali, Joan] Royal Brisbane Hosp, Brisbane, Qld 4029, Australia; [O'Driscoll, James S.; Gallagher, John E.] Westmead Hosp, Intens Care Unit, Sydney, NSW, Australia; [Perri, Rita A.] Westmead Hosp, Ludwig Engel Ctr Resp Res, Sydney, NSW, Australia; [Faoagali, Joan] Princess Alexandra Hosp, Dept Microbiol, Brisbane, Qld 4102, Australia; [Lipman, Jeffrey] Univ Queensland, Intens Care Unit, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of New South Wales Sydney; Kirby Institute; Royal Brisbane & Women's Hospital; University of Sydney; University of Sydney; Royal Brisbane & Women's Hospital; University of Queensland	Ginn, AN (corresponding author), Westmead Hosp, Ctr Infect Dis & Microbiol, Sydney, NSW, Australia.	jonathan.iredell@sydney.edu.au	faoagali, joan l/H-6374-2013; Partridge, Sally R/Q-9374-2019; Lipman, Jeffrey/G-2211-2010	faoagali, joan l/0000-0003-4785-7995; Lipman, Jeffrey/0000-0002-5965-9876; Ginn, Andrew/0000-0002-4356-2615; O'Toole, Brian/0000-0002-3825-0772; Gidding, Heather/0000-0001-7595-9281	Australia and New Zealand Intensive Care Foundation; New South Wales Health (CIDM-Public Health Capacity Building grant); National Health and Medical Research Council of Australia [512396, 1001020]	Australia and New Zealand Intensive Care Foundation; New South Wales Health (CIDM-Public Health Capacity Building grant); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australia and New Zealand Intensive Care Foundation; New South Wales Health (CIDM-Public Health Capacity Building grant); and the National Health and Medical Research Council of Australia grant numbers 512396 and 1001020 (Centre for Research Excellence in Critical Infection). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antibiotic Expert Group, 2010, THER GUID ANT; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Beardmore RE, 2010, MATH BIOSCI ENG, V7, P923, DOI 10.3934/mbe.2010.7.923; Bergstrom CT, 2004, P NATL ACAD SCI USA, V101, P13285, DOI 10.1073/pnas.0402298101; Borg MA, 2010, AM J INFECT CONTROL, V38, P212, DOI 10.1016/j.ajic.2009.07.010; Breslow MJ, 2012, CHEST, V141, P245, DOI 10.1378/chest.11-0330; Brown EM, 2005, J ANTIMICROB CHEMOTH, V55, P6, DOI 10.1093/jac/dkh482; Cadena J, 2007, BONE MARROW TRANSPL, V40, P151, DOI 10.1038/sj.bmt.1705704; de Araujo OR, 2007, BRAZ J INFECT DIS, V11, P277, DOI 10.1590/S1413-86702007000200022; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gilbert DN, 2009, SANFORD GUIDE ANTIMI; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Kho ME, 2007, AM J CRIT CARE, V16, P378; Kim PW, 2010, CLIN INFECT DIS, V51, P1351, DOI 10.1086/657248; Kim PW, 2010, CLIN INFECT DIS, V51, P381, DOI 10.1086/655131; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kollef MH, 1997, AM J RESP CRIT CARE, V156, P1040, DOI 10.1164/ajrccm.156.4.9701046; Kumar A, 2006, J INFECT DIS, V193, P251, DOI 10.1086/498909; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Leibovici L, 2010, CLIN INFECT DIS, V51, P1350, DOI 10.1086/657247; Leibovici L, 2010, LANCET INFECT DIS, V10, P293, DOI 10.1016/S1473-3099(10)70070-0; Lepelletier D, 2006, EUR J CLIN MICROBIOL, V25, P600, DOI 10.1007/s10096-006-0184-1; Levin BR, 2004, P NATL ACAD SCI USA, V101, P13101, DOI 10.1073/pnas.0404970101; Malhotra-Kumar S, 2010, J CLIN MICROBIOL, V48, P1040, DOI 10.1128/JCM.01745-09; Martinez JA, 2006, CRIT CARE MED, V34, P329, DOI 10.1097/01.CCM.0000195010.63855.45; Masterton RG, 2005, J ANTIMICROB CHEMOTH, V55, P1, DOI 10.1093/jac/dkh506; Merlino J, 1996, J CLIN MICROBIOL, V34, P1788, DOI 10.1128/JCM.34.7.1788-1793.1996; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Nerandzic MM, 2011, ANTIMICROB AGENTS CH, V55, P2174, DOI 10.1128/AAC.01612-10; Oostdijk EAN, 2010, AM J RESP CRIT CARE, V181, P452, DOI 10.1164/rccm.200908-1210OC; Owens RC, 2008, CLIN INFECT DIS, V46, pS19, DOI 10.1086/521859; Paterson DL, 2004, CLIN INFECT DIS, V38, pS341, DOI 10.1086/382690; Paul M, 2006, J ANTIMICROB CHEMOTH, V57, P176, DOI 10.1093/jac/dki448; Rahal JJ, 1998, JAMA-J AM MED ASSOC, V280, P1233, DOI 10.1001/jama.280.14.1233; Sandiumenge A, 2006, J ANTIMICROB CHEMOTH, V57, P1197, DOI 10.1093/jac/dkl097; Sarraf-Yazdi S, 2012, J SURG RES; Schweizer ML, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-279; Song XY, 2010, INFECT CONT HOSP EP, V31, P177, DOI 10.1086/649797; Sullivan A, 2001, Lancet Infect Dis, V1, P101, DOI 10.1016/S1473-3099(01)00066-4; Summers WC, 1998, DIAGN MICR INFEC DIS, V30, P131, DOI 10.1016/S0732-8893(97)00214-9; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Towne TG, 2009, LANCET INFECT DIS, V9, P4, DOI 10.1016/S1473-3099(08)70288-3; van Loon HJ, 2005, AM J RESP CRIT CARE, V171, P480, DOI 10.1164/rccm.200401-070OC; Villers D, 1998, ANN INTERN MED, V129, P182, DOI 10.7326/0003-4819-129-3-199808010-00003; Warren DK, 2004, CRIT CARE MED, V32, P2450, DOI 10.1097/01.CCM.0000147685.79487.28; Westphal JF, 1997, ANTIMICROB AGENTS CH, V41, P1636, DOI 10.1128/AAC.41.8.1636; Yahav D, 2007, LANCET INFECT DIS, V7, P338, DOI 10.1016/S1473-3099(07)70109-3	49	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e38719	10.1371/journal.pone.0038719	http://dx.doi.org/10.1371/journal.pone.0038719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761698	Green Submitted, Green Published, gold			2022-12-27	WOS:000305781700009
J	Fiole, D; Touvrey, C; Quesnel-Hellmann, A; Douady, J; Tournier, JN				Fiole, Daniel; Touvrey, Cedric; Quesnel-Hellmann, Anne; Douady, Julien; Tournier, Jean-Nicolas			Shape-Based Tracking Allows Functional Discrimination of Two Immune Cell Subsets Expressing the Same Fluorescent Tag in Mouse Lung Explant	PLOS ONE			English	Article							PERIPHERAL LYMPHOID ORGANS; CONVENTIONAL DENDRITIC CELLS; BLOOD MONOCYTE SUBSETS; RESPIRATORY-TRACT; IN-VIVO; IDENTIFICATION; CD103(+); MICE; INFLAMMATION; HOMEOSTASIS	Dendritic Cells (DC) represent a key lung immune cell population, which play a critical role in the antigen presenting process and initiation of the adaptive immune response. The study of DCs has largely benefited from the joint development of fluorescence microscopy and knock- in technology, leading to several mouse strains with constitutively labeled DC subsets. However, in the lung most transgenic mice do express fluorescent protein not only in DCs, but also in closely related cell lineages such as monocytes and macrophages. As an example, in the lungs of CX(3)CR1(+/gfp) mice the green fluorescent protein is expressed mostly by both CD11b conventional DCs and resident monocytes. Despite this non-specific staining, we show that a shape criterion can discriminate these two particular subsets. Implemented in a cell tracking code, this quantified criterion allows us to analyze the specific behavior of DCs under inflammatory conditions mediated by lipopolysaccharide on lung explants. Compared to monocytes, we show that DCs move slower and are more confined, while both populations do not have any chemotactism- associated movement. We could generalize from these results that DCs can be automatically discriminated from other round- shaped cells expressing the same fluorescent protein in various lung inflammation models.	[Fiole, Daniel; Touvrey, Cedric; Quesnel-Hellmann, Anne; Tournier, Jean-Nicolas] Inst Rech Biomed Armees, Dept Microbiol, Unite Interact Hote Agents Pathogenes, La Tronche, France; [Fiole, Daniel; Douady, Julien] Univ Grenoble 1, CNRS, Lab Interdisciplinaire Phys UMR 5588, Grenoble, France; [Tournier, Jean-Nicolas] Ecole Val de Grace, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Fiole, D (corresponding author), Inst Rech Biomed Armees, Dept Microbiol, Unite Interact Hote Agents Pathogenes, La Tronche, France.	jntournier@gmail.com	Quesnel-Hellmann, Anne/M-7696-2014; Tournier, Jean-Nicolas/A-7332-2011	Quesnel-Hellmann, Anne/0000-0002-7589-8834; Tournier, Jean-Nicolas/0000-0002-4542-2421; Fiole, Daniel/0000-0002-1072-6935	Direction Generale de l'Armement (DGA) [09co301-1]; Agence Nationale de la Recherche [ANABio]; DGA	Direction Generale de l'Armement (DGA)(General Electric); Agence Nationale de la Recherche(French National Research Agency (ANR)); DGA	This work was supported by grant 09co301-1 from the Direction Generale de l'Armement (DGA) and by grant ANABio from the Agence Nationale de la Recherche. Daniel Fiole was supported by a fellowship from the DGA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Beaty SR, 2007, J IMMUNOL, V178, P1882, DOI 10.4049/jimmunol.178.3.1882; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Beltman JB, 2009, NAT REV IMMUNOL, V9, P789, DOI 10.1038/nri2638; Benhamou S, 2004, J THEOR BIOL, V229, P209, DOI 10.1016/j.jtbi.2004.03.016; Bhattacharya J, 2011, NAT METHODS, V8, P57, DOI 10.1038/nmeth0111-57; Cleret A, 2007, J IMMUNOL, V178, P7994, DOI 10.4049/jimmunol.178.12.7994; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; Desch AN, 2011, J EXP MED, V208, P1789, DOI 10.1084/jem.20110538; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kessel CHG, 2008, MUCOSAL IMMUNOL, V1, P442, DOI 10.1038/mi.2008.39; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Schneberger D, 2011, CELL TISSUE RES, V343, P97, DOI 10.1007/s00441-010-1032-2; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1974, J EXP MED, V139, P1431, DOI 10.1084/jem.139.6.1431; STEINMAN RM, 1975, J EXP MED, V141, P804; STEINMAN RM, 1974, J EXP MED, V139, P380, DOI 10.1084/jem.139.2.380; Tournier JN, 2010, TRENDS MOL MED, V16, P303, DOI 10.1016/j.molmed.2010.04.006; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Veres TZ, 2011, AM J PATHOL, V179, P603, DOI 10.1016/j.ajpath.2011.04.039; von Garnier C, 2005, J IMMUNOL, V175, P1609, DOI 10.4049/jimmunol.175.3.1609	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39831	10.1371/journal.pone.0039831	http://dx.doi.org/10.1371/journal.pone.0039831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745831	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900117
J	Kaur, N; Ranjan, A; Tiwari, V; Aneja, R; Tandon, V				Kaur, Navrinder; Ranjan, Atul; Tiwari, Vinod; Aneja, Ritu; Tandon, Vibha			DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NF kappa B Transactivation through NIK/IKK in Human Glioma Cells	PLOS ONE			English	Article							MNSOD GENE-EXPRESSION; DOUBLE-STRAND BREAKS; IONIZING-RADIATION; IN-VITRO; TRANSCRIPTION FACTORS; INDUCED APOPTOSIS; PULSE-RADIOLYSIS; GENOTOXIC STRESS; CANCER CELLS; TUMOR-CELLS	Background: Ionizing radiation (IR) exposure often occurs for human beings through occupational, medical, environmental, accidental and/or other sources. Thus, the role of radioprotector is essential to overcome the complex series of overlapping responses to radiation induced DNA damage. Methods and Results: Treatment of human glioma U87 cells with DMA (5- {4-methylpiperazin-1-yl}-2-[2'-(3, 4-dimethoxyphenyl)-5'-benzimidazolyl] in the presence or absence of radiation uncovered differential regulation of an array of genes and proteins using microarray and 2D PAGE techniques. Pathway construction followed by relative quantitation of gene expression of the identified proteins and their interacting partners led to the identification of MAP3K14 (NF kappa B inducing kinase, NIK) as the candidate gene affected in response to DMA. Subsequently, over expression and knock down of NIK suggested that DMA affects NF kappa B inducing kinase mediated phosphorylation of IKK alpha and IKK beta both alone and in the presence of ionizing radiation (IR). The TNF-alpha induced NF kappa B dependent luciferase reporter assay demonstrated 1.65, 2.26 and 3.62 fold increase in NF kappa B activation at 10, 25 and 50 mu M DMA concentrations respectively, compared to control cells. This activation was further increased by 5.8 fold in drug + radiation (50 mu M +8.5 Gy) treated cells in comparison to control. We observed 51% radioprotection in control siRNA transfected cells that attenuated to 15% in siRNA NIK treated U87 cells, irradiated in presence of DMA at 24 h. Conclusions: Our studies show that NIK/IKK mediated NF kappa B activation is more intensified in cells over expressing NIK and treated with DMA, alone or in combination with ionizing radiation, indicating that DMA promotes NIK mediated NF kappa B signaling. This subsequently leads to the radioprotective effect exhibited by DMA.	[Kaur, Navrinder] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India; [Ranjan, Atul; Tiwari, Vinod; Tandon, Vibha] Univ Delhi, Dept Chem, Delhi 110007, India; [Aneja, Ritu] Georgia State Univ, Dept Biol, Atlanta, GA USA	University of Delhi; University of Delhi; University System of Georgia; Georgia State University	Kaur, N (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.	vibhadelhi@hotmail.com	TIWARI, VINOD K/L-9595-2019	TIWARI, VINOD K/0000-0001-9244-8889	Department of Science & Technology, Delhi, India; Department of Biotechnology Delhi, India; Council of Scientific & Industrial Research, Delhi, India	Department of Science & Technology, Delhi, India; Department of Biotechnology Delhi, India; Council of Scientific & Industrial Research, Delhi, India	This work was supported in part by the Department of Science & Technology, Delhi, India, and the Department of Biotechnology Delhi, India. PhD Fellowship was from Council of Scientific & Industrial Research, Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari J S, 2005, J Cancer Res Ther, V1, P151; Adhikary A, 2000, INT J RADIAT BIOL, V76, P1157; Ahmed KM, 2009, FREE RADICAL BIO MED, V46, P1543, DOI 10.1016/j.freeradbiomed.2009.03.012; Amundson SA, 2003, ONCOGENE, V22, P5828, DOI 10.1038/sj.onc.1206681; Amundson SA, 1999, ONCOGENE, V18, P3666, DOI 10.1038/sj.onc.1202676; Andreassen CN, 2003, SEMIN RADIAT ONCOL, V13, P62, DOI 10.1053/srao.2003.50006; AntrasFerry J, 1997, CARCINOGENESIS, V18, P2113, DOI 10.1093/carcin/18.11.2113; Arora R, 2005, MOL CELL BIOCHEM, V273, P209, DOI 10.1007/s11010-005-0822-4; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Brzoska K, 2009, MUTAGENESIS, V24, P1, DOI 10.1093/mutage/gen056; DAS KC, 1995, AM J PHYSIOL-LUNG C, V269, pL588, DOI 10.1152/ajplung.1995.269.5.L588; Egan LJ, 2004, P NATL ACAD SCI USA, V101, P2452, DOI 10.1073/pnas.0306734101; FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gizard F, 2001, J BIOL CHEM, V276, P33881, DOI 10.1074/jbc.M100113200; Grdina D J, 2000, Drug Metabol Drug Interact, V16, P237; Guo GZ, 1998, INT J RADIAT BIOL, V73, P297, DOI 10.1080/095530098142392; Habraken Y, 2006, BIOCHEM PHARMACOL, V72, P1132, DOI 10.1016/j.bcp.2006.07.015; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Jung DJ, 2002, MOL CELL BIOL, V22, P5203, DOI 10.1128/MCB.22.14.5203-5211.2002; Kataoka Y, 2002, INT J RADIAT ONCOL, V53, P180, DOI 10.1016/S0360-3016(01)02820-6; Kataoka Y, 2000, INT J RADIAT BIOL, V76, P633; Martin RF, 1998, INT J RADIAT ONCOL, V42, P827, DOI 10.1016/S0360-3016(98)00316-2; Martin RF, 2004, CANCER RES, V64, P1067, DOI 10.1158/0008-5472.CAN-03-2423; Martin RF, 1996, BRIT J CANCER, V74, pS99; Meyer RG, 2002, EUR J BIOCHEM, V269, P337, DOI 10.1046/j.0014-2956.2001.02658.x; Michiels C, 2002, FREE RADICAL BIO MED, V33, P1231, DOI 10.1016/S0891-5849(02)01045-6; Mori K, 2000, FREE RADICAL RES, V33, P157, DOI 10.1080/10715760000300711; Murley JS, 2004, RADIAT RES, V162, P536, DOI 10.1667/RR3256; Murley JS, 2001, FREE RADICAL BIO MED, V30, P1426, DOI 10.1016/S0891-5849(01)00554-8; Murray D, 2000, RADIAT RES, V154, P159, DOI 10.1667/0033-7587(2000)154[0159:POHTCO]2.0.CO;2; Natoli G, 1998, J BIOL CHEM, V273, P31262, DOI 10.1074/jbc.273.47.31262; Otomo T, 2004, J RADIAT RES, V45, P53, DOI 10.1269/jrr.45.53; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pieri L, 2003, BBA-GEN SUBJECTS, V1621, P76, DOI 10.1016/S0304-4165(03)00048-5; Qutob SS, 2006, RADIAT RES, V165, P636, DOI 10.1667/RR3561.1; Razani B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000778; Romano MF, 1999, BLOOD, V94, P4060, DOI 10.1182/blood.V94.12.4060.424k23_4060_4066; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Shah N, 1999, BIOCHEMISTRY-US, V38, P14763, DOI 10.1021/bi991291v; Shanley TP, 2000, SHOCK, V14, P447, DOI 10.1097/00024382-200014040-00005; Singh M, 2011, EUR J MED CHEM, V46, P659, DOI 10.1016/j.ejmech.2010.11.046; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tawar U, 2003, J MED CHEM, V46, P3785, DOI 10.1021/jm030114w; Tawar U, 2007, MOL CELL BIOCHEM, V305, P221, DOI 10.1007/s11010-007-9546-y; Thu YM, 2012, ONCOGENE, V31, P2580, DOI 10.1038/onc.2011.427; Vogel TW, 2005, CLIN CANCER RES, V11, P3624, DOI 10.1158/1078-0432.CCR-04-2115; Wadgaonkar R, 1999, J BIOL CHEM, V274, P1879, DOI 10.1074/jbc.274.4.1879; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yi J, 2004, CANCER RES, V64, P108, DOI 10.1158/0008-5472.CAN-2820-2; Yoo CG, 2000, J IMMUNOL, V164, P5416, DOI 10.4049/jimmunol.164.10.5416; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zheng M, 2008, CANCER RES, V68, P7570, DOI 10.1158/0008-5472.CAN-08-0632	58	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39426	10.1371/journal.pone.0039426	http://dx.doi.org/10.1371/journal.pone.0039426			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745752	Green Published, gold			2022-12-27	WOS:000305730900059
J	Kolb, C; Nolker, G; Lennerz, C; Jetter, H; Semmler, V; Purner, K; Gutleben, KJ; Reents, T; Lang, K; Lotze, U				Kolb, Christof; Noelker, Georg; Lennerz, Carsten; Jetter, Hansmartin; Semmler, Verena; Puerner, Klaus; Gutleben, Klaus-Juergen; Reents, Tilko; Lang, Klaus; Lotze, Ulrich		AVOID-FFS Investigators	Use of an Atrial Lead with Very Short Tip-To-Ring Spacing Avoids Oversensing of Far-Field R-Wave	PLOS ONE			English	Article							DUAL-CHAMBER PACEMAKERS; INAPPROPRIATE MODE SWITCH; FIBRILLATION; TACHYARRHYTHMIAS; MANAGEMENT; REDUCTION; DISTANCE; CHANNEL	Objective: The AVOID-FFS (Avoidance of Far-Field R-wave Sensing) study aimed to investigate whether an atrial lead with a very short tip-to-ring spacing without optimization of pacemaker settings shows equally low incidence of far-field R-wave sensing (FFS) when compared to a conventional atrial lead in combination with optimization of the programming. Methods: Patients receiving a dual chamber pacemaker were randomly assigned to receive an atrial lead with a tip-to-ring spacing of 1.1 mm or a lead with a conventional tip-to-ring spacing of 10 mm. Postventricular atrial blanking (PVAB) was programmed to the shortest possible value of 60 ms in the study group, and to an individually determined optimized value in the control group. Atrial sensing threshold was programmed to 0.3 mV in both groups. False positive mode switch caused by FFS was evaluated at one and three months post implantation. Results: A total of 204 patients (121 male; age 73 +/- 10 years) were included in the study. False positive mode switch caused by FFS was detected in one (1%) patient of the study group and two (2%) patients of the control group (p = 0.62). Conclusion: The use of an atrial electrode with a very short tip-to-ring spacing avoids inappropriate mode switch caused by FFS without the need for individual PVAB optimization.	[Kolb, Christof; Lennerz, Carsten; Semmler, Verena; Reents, Tilko] Tech Univ Munich, Deutsch Herzzentrum, Munich, Germany; [Kolb, Christof; Lennerz, Carsten; Semmler, Verena; Reents, Tilko] Tech Univ Munich, Med Klin Rechts Isar 1, Fac Med, Munich, Germany; [Noelker, Georg; Gutleben, Klaus-Juergen] Klinikum Coburg, Med Klin 2, Coburg, Germany; [Noelker, Georg; Gutleben, Klaus-Juergen] Ruhr Univ Bochum, Herzzentrum N Rhein Westfalen, Bad Oeynhausen, Germany; [Jetter, Hansmartin] Klinikum Memmingen, Med Klin 1, Memmingen, Germany; [Puerner, Klaus] Kreisklin Ebersberg, Innere Med Abt, Ebersberg, Germany; [Lang, Klaus] Kreiskrankenhaus Ottweiler, Innere Med Abt, Ottweiler, Germany; [Lotze, Ulrich] DRK Krankenhaus Sondershausen, Innere Med Abt, Sondershausen, Germany	German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; Technical University of Munich; Klinikum Coburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruhr University Bochum	Kolb, C (corresponding author), Tech Univ Munich, Deutsch Herzzentrum, Munich, Germany.	kolb@dhm.mhn.de	Nölker, Georg/W-3528-2017	Nölker, Georg/0000-0003-2789-8247	St. Jude Medical, Eschborn, Germany; Biotronik; Boston; Medtronic; Sorin; St. Jude Medical	St. Jude Medical, Eschborn, Germany; Biotronik; Boston; Medtronic(Medtronic); Sorin; St. Jude Medical(St. Jude Medical)	The study was financially supported by St. Jude Medical, Eschborn, Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially supported by St. Jude Medical, Eschborn, Germany. CK has received lecture fees from Biotronik, Boston, Medtronic, Sorin, and St. Jude Medical, and is or was an advisor to Biotronik, Sorin and St. Jude Medical. GN and KG received lecture fees from Biotronik, Medtronic, Sorin and St. Jude Medical. GN received support for travelling when presenting study data from St. Jude Medical. UL has received lecture fees from Medtronic and St. Jude Medical. All other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Botto GL, 2009, J CARDIOVASC ELECTR, V20, P241, DOI 10.1111/j.1540-8167.2008.01320.x; de Groot JR, 2008, PACE, V31, P1554, DOI 10.1111/j.1540-8159.2008.01226.x; De Voogt W, 2005, PACE, V28, P782, DOI 10.1111/j.1540-8159.2005.00175.x; de Voogt WG, 2008, NETH HEART J, V16, P20; de Voogt WG, 2008, NETH HEART J, V16, P201, DOI 10.1007/BF03086146; de Voogt WG, 2005, EUROPACE, V7, P60, DOI 10.1016/j.eupc.2004.10.001; de Voogt WG, 2006, EUROPACE, V8, P950, DOI 10.1093/europace/eul112; Fitts SM, 2000, PACE, V23, P1080, DOI 10.1111/j.1540-8159.2000.tb00905.x; Frohlig G, 1999, PACE, V22, P1604, DOI 10.1111/j.1540-8159.1999.tb00379.x; Fung JWH, 2009, EUROPACE, V11, P618, DOI 10.1093/europace/eup078; Glotzer TV, 2003, CIRCULATION, V107, P1614, DOI 10.1161/01.CIR.0000057981.70380.45; Goethals M, 2003, EUROPACE, V5, P95, DOI 10.1053/eupc.2002.0281; Inama G, 2004, PACE, V27, P1221, DOI 10.1111/j.1540-8159.2004.00613.x; Jastrzebski M, 2011, PACE, V34, P1682, DOI 10.1111/j.1540-8159.2011.03219.x; Kolb C, 2004, J INTERV CARD ELECTR, V10, P231, DOI 10.1023/B:JICE.0000026917.82516.eb; Kolb C, 2006, J CARDIOVASC ELECTR, V17, P992, DOI 10.1111/j.1540-8167.2006.00545.x; Leung SK, 1998, PACE, V21, P2214, DOI 10.1111/j.1540-8159.1998.tb01155.x; Lewicka-Nowak E, 2008, EUROPACE, V10, P138, DOI 10.1093/europace/eum277; Minamiguchi H, 2012, CIRC J, V76, P598, DOI 10.1253/circj.CJ-11-0745; Nash A, 2005, EUROPACE, V7, P67, DOI 10.1016/j.eupc.2004.11.002; Nowak B, 2001, PACE, V24, P496, DOI 10.1046/j.1460-9592.2001.00496.x; Purerfellner H, 2004, PACE, V27, P983, DOI 10.1111/j.1540-8159.2004.00569.x; Silberbauer J, 2010, PACE, V33, P85, DOI 10.1111/j.1540-8159.2009.02576.x; Walfridsson H, 2000, PACE, V23, P1089, DOI 10.1111/j.1540-8159.2000.tb00907.x	24	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38277	10.1371/journal.pone.0038277	http://dx.doi.org/10.1371/journal.pone.0038277			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745661	Green Submitted, Green Published, gold			2022-12-27	WOS:000305730900007
J	Vallejo, MC; Nakayasu, ES; Longo, LVG; Ganiko, L; Lopes, FG; Matsuo, AL; Almeida, IC; Puccia, R				Vallejo, Milene C.; Nakayasu, Ernesto S.; Longo, Larissa V. G.; Ganiko, Luciane; Lopes, Felipe G.; Matsuo, Alisson L.; Almeida, Igor C.; Puccia, Rosana			Lipidomic Analysis of Extracellular Vesicles from the Pathogenic Phase of Paracoccidioides brasiliensis	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; CELL-DERIVED EXOSOMES; CRYPTOCOCCUS-NEOFORMANS; HISTOPLASMA-CAPSULATUM; ASPERGILLUS-FUMIGATUS; VESICULAR TRANSPORT; TRYPANOSOMA-CRUZI; FILAMENTOUS FUNGI; CANDIDA-ALBICANS; VIRULENCE	Background: Fungal extracellular vesicles are able to cross the cell wall and transport molecules that help in nutrient acquisition, cell defense, and modulation of the host defense machinery. Methodology/Principal Findings: Here we present a detailed lipidomic analysis of extracellular vesicles released by Paracoccidioides brasiliensis at the yeast pathogenic phase. We compared data of two representative isolates, Pb3 and Pb18, which have distinct virulence profiles and phylogenetic background. Vesicle lipids were fractionated into different classes and analyzed by either electrospray ionization- or gas chromatography-mass spectrometry. We found two species of monohexosylceramide and 33 phospholipid species, including phosphatidylcholine, phosphatidylethanolamine, phosphatidic acid, phosphatidylserine, phosphatidylinositol, and phosphatidylglycerol. Among the phospholipid-bound fatty acids in extracellular vesicles, C181 predominated in Pb3, whereas C18:2 prevailed in Pb18. The prevalent sterol in Pb3 and Pb18 vesicles was brassicasterol, followed by ergosterol and lanosterol. Inter-isolate differences in sterol composition were observed, and also between extracellular vesicles and whole cells. Conclusions/Significance: The extensive lipidomic analysis of extracellular vesicles from two P. brasiliensis isolates will help to understand the composition of these fungal components/organelles and will hopefully be useful to study their biogenesis and role in host-pathogen interactions.	[Vallejo, Milene C.; Longo, Larissa V. G.; Matsuo, Alisson L.; Puccia, Rosana] Univ Fed Sao Paulo, UNIFESP, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Nakayasu, Ernesto S.; Ganiko, Luciane; Lopes, Felipe G.; Almeida, Igor C.] Univ Texas El Paso, Dept Biol Sci, Border Biomed Res Ctr, El Paso, TX 79968 USA	Universidade Federal de Sao Paulo (UNIFESP); University of Texas System; University of Texas El Paso	Vallejo, MC (corresponding author), Univ Fed Sao Paulo, UNIFESP, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil.	icalmeida@utep.edu; rpuccia@unifesp.br	Nakayasu, Ernesto S./AAJ-8374-2020; Puccia, Rosana/D-7303-2012; Almeida, Igor C./AAF-9409-2019	Nakayasu, Ernesto S./0000-0002-4056-2695; Puccia, Rosana/0000-0002-3332-0487; Almeida, Igor C./0000-0002-2443-8213	FAPESP (The State of Sao Paulo Research Foundation) [06/05095-6, 07/04757-8, 07/59768-4]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [301666/2010-5]; National Institutes of Health (NIH) [5G12RR008124-16A1, 5G12RR008124-16A1S1, G12MD007592]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	FAPESP (The State of Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by FAPESP (The State of Sao Paulo Research Foundation) grant 06/05095-6, and fellowships 07/04757-8 and 07/59768-4; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) research fellowship 301666/2010-5; and National Institutes of Health (NIH) grants 5G12RR008124-16A1, 5G12RR008124-16A1S1, and G12MD007592. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque PC, 2008, CELL MICROBIOL, V10, P1695, DOI 10.1111/j.1462-5822.2008.01160.x; Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; ALVES LMC, 1987, MYCOPATHOLOGIA, V97, P3, DOI 10.1007/BF00437324; Calich VLG, 1998, RES IMMUNOL, V149, P407, DOI 10.1016/S0923-2494(98)80764-5; Carayon K, 2011, J BIOL CHEM, V286, P34426, DOI 10.1074/jbc.M111.257444; Carvalho KC, 2005, MICROBES INFECT, V7, P55, DOI 10.1016/j.micinf.2004.09.008; Casadevall A, 2009, TRENDS MICROBIOL, V17, P158, DOI 10.1016/j.tim.2008.12.005; CERNIGLIA CE, 1974, J BACTERIOL, V118, P844, DOI 10.1128/JB.118.3.844-847.1974; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Eisenman HC, 2009, MICROBIOL-SGM, V155, P3860, DOI 10.1099/mic.0.032854-0; Gehrmann U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021480; HAMDAN JS, 1988, MYCOPATHOLOGIA, V102, P97, DOI 10.1007/BF00437446; Kmetzsch L, 2011, MOL MICROBIOL, V81, P206, DOI 10.1111/j.1365-2958.2011.07686.x; Laulagnier K, 2005, BLOOD CELL MOL DIS, V35, P116, DOI 10.1016/j.bcmd.2005.05.010; Laulagnier K, 2004, BIOCHEM J, V380, P161, DOI 10.1042/BJ20031594; Levery SB, 1998, BIOCHEMISTRY-US, V37, P8764, DOI 10.1021/bi9730083; Levery SB, 2002, FEBS LETT, V525, P59, DOI 10.1016/S0014-5793(02)03067-3; Maldonado RA, 2006, J PARASITOL, V92, P1064, DOI 10.1645/GE-845R.1; MANOCHA MS, 1980, J GEN MICROBIOL, V117, P147; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Nimrichter L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00212; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Oliveira DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011113; Oliveira DL, 2010, INFECT IMMUN, V78, P1601, DOI 10.1128/IAI.01171-09; Oliveira DL, 2009, FUNGAL GENET BIOL, V46, P956, DOI 10.1016/j.fgb.2009.09.001; Oura T, 2008, MICROBIOL-SGM, V154, P3795, DOI 10.1099/mic.0.2008/018788-0; Pereira M, 2010, BBA-MOL CELL BIOL L, V1801, P1163, DOI 10.1016/j.bbalip.2010.06.007; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Rappleye CA, 2004, MOL MICROBIOL, V53, P153, DOI 10.1111/j.1365-2958.2004.04131.x; RAWAT DS, 1984, MICROBIOLOGICA, V7, P299; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06; Rodrigues ML, 2011, FUTURE MICROBIOL, V6, P1371, DOI [10.2217/fmb.11.112, 10.2217/FMB.11.112]; Rodrigues ML, 2000, INFECT IMMUN, V68, P7049, DOI 10.1128/IAI.68.12.7049-7060.2000; San-Blas G, 2002, MED MYCOL, V40, P225, DOI 10.1080/mmy.40.3.225.242; San-Blas G, 1994, PARACOCCIDIOIDOMYCO, P44; SanBlas G, 1997, MICROBIOL-UK, V143, P1583, DOI 10.1099/00221287-143-5-1583; SILVA CL, 1985, T ROY SOC TROP MED H, V79, P70, DOI 10.1016/0035-9203(85)90240-8; Stahl PD, 1996, APPL ENVIRON MICROB, V62, P4136, DOI 10.1128/AEM.62.11.4136-4146.1996; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; Toledo MS, 1999, BIOCHEMISTRY-US, V38, P7294, DOI 10.1021/bi982898z; Vaejo MC, 2012, J PROTEOME RES, V11, P1676, DOI 10.1021/pr200872s; Vallejo MC, 2011, EUKARYOT CELL, V10, P343, DOI 10.1128/EC.00227-10; VIDAL M, 1989, J CELL PHYSIOL, V140, P455, DOI 10.1002/jcp.1041400308; Weete JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010899; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Zarnowski R, 2008, CURR MICROBIOL, V56, P110, DOI 10.1007/s00284-007-9052-1	49	81	81	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39463	10.1371/journal.pone.0039463	http://dx.doi.org/10.1371/journal.pone.0039463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745761	Green Submitted, Green Published, gold			2022-12-27	WOS:000305730900064
J	Yan, QL; Zhu, JJ; Yu, LZ				Yan, Qiao-Ling; Zhu, Jiao-Jun; Yu, Li-Zhong			Seed Regeneration Potential of Canopy Gaps at Early Formation Stage in Temperate Secondary Forests, Northeast China	PLOS ONE			English	Article							BANK DYNAMICS; RAIN-FOREST; GROWTH; ESTABLISHMENT; VEGETATION; LIGHT; DISTURBANCE; PINE; SIZE; TREE	Promoting the seed regeneration potential of secondary forests undergoing gap disturbances is an important approach for achieving forest restoration and sustainable management. Seedling recruitment from seed banks strongly determines the seed regeneration potential, but the process is poorly understood in the gaps of secondary forests. The objectives of the present study were to evaluate the effects of gap size, seed availability, and environmental conditions on the seed regeneration potential in temperate secondary forests. It was found that gap formation could favor the invasion of more varieties of species in seed banks, but it also could speed up the turnover rate of seed banks leading to lower seed densities. Seeds of the dominant species, Fraxinus rhynchophylla, were transient in soil and there was a minor and discontinuous contribution of the seed bank to its seedling emergence. For Quercus mongolica, emerging seedling number was positively correlated with seed density in gaps (R = 0.32, P<0.01), especially in medium and small gaps (<500 m(2)). Furthermore, under canopies, there was a positive correlation between seedling number and seed density of Acer mono (R = 0.43, P<0.01). Gap formation could promote seedling emergence of two gap-dependent species (i.e., Q. mongolica and A. mono), but the contribution of seed banks to seedlings was below 10% after gap creation. Soil moisture and temperature were the restrictive factors controlling the seedling emergence from seeds in gaps and under canopies, respectively. Thus, the regeneration potential from seed banks is limited after gap formation.	[Yan, Qiao-Ling; Zhu, Jiao-Jun; Yu, Li-Zhong] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China; [Yan, Qiao-Ling; Zhu, Jiao-Jun; Yu, Li-Zhong] Chinese Acad Sci, Qingyuan Expt Stn Forest Ecol, Shenyang, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences	Yan, QL (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China.	jiaojunzhu@iae.ac.cn		ZHU, Jiaojun/0000-0002-2512-7900	National Nature Scientific Foundation of China [31070556, 30830085]	National Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Nature Scientific Foundation of China (31070556, 30830085). The funder had a critical role in study design, data collection and analysis, and preparation of the manuscript.	Arriaga L, 2004, J VEG SCI, V15, P661, DOI 10.1111/j.1654-1103.2004.tb02308.x; Bakker JP, 1996, ACTA BOT NEERL, V45, P461; Banal S, 2007, ECOL MODEL, V206, P41, DOI 10.1016/j.ecolmodel.2007.03.026; Barsoum N, 2001, EVOL ECOL, V15, P255, DOI 10.1023/A:1016028730129; Bekker RM, 2000, J ECOL, V88, P594, DOI 10.1046/j.1365-2745.2000.00485.x; Braak Ter C., 1998, CANOCO REFERENCE MAN; Brearley FQ, 2004, FOREST ECOL MANAG, V195, P385, DOI 10.1016/j.foreco.2004.02.048; Busing RT, 1997, OIKOS, V78, P562, DOI 10.2307/3545618; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; Collins BS, 2002, FOREST ECOL MANAG, V155, P279, DOI 10.1016/S0378-1127(01)00565-5; Dupuy JM, 2008, FOREST ECOL MANAG, V255, P3716, DOI 10.1016/j.foreco.2008.03.021; Erefur C, 2008, FOREST ECOL MANAG, V255, P1186, DOI 10.1016/j.foreco.2007.10.024; Fenner M, 1999, HANDBOOK OF FUNCTIONAL PLANT ECOLOGY, P589; Forrester JA, 2006, PLANT ECOL, V183, P349, DOI 10.1007/s11258-005-9045-8; Garwood N.C., 1989, ECOLOGY SOIL SEED BA, V1, P149, DOI DOI 10.1016/B978-0-12-440405-2.50014-2; Grand J, 2003, BIOL CONSERV, V112, P307, DOI 10.1016/S0006-3207(02)00323-3; Grime J. P., 1979, Plant strategies and vegetation processes.; GUNSTER A, 1994, J ARID ENVIRON, V28, P195, DOI 10.1016/S0140-1963(05)80057-6; GUREVITCH J, 1986, ECOLOGY, V67, P251, DOI 10.2307/1938525; Harper J. L., 1977, POPULATION BIOL PLAN; Hirao T, 2008, ECOL RES, V23, P189, DOI 10.1007/s11284-007-0370-3; Hu Li-le, 2007, Shengtaixue Zazhi, V26, P455; [胡理乐 HU LiLe], 2005, [生态学报, Acta Ecologica Sinica], V25, P2848; Hu L, 2009, AGR FOREST METEOROL, V149, P862, DOI 10.1016/j.agrformet.2008.11.008; Hyatt LA, 2000, J ECOL, V88, P516, DOI 10.1046/j.1365-2745.2000.00465.x; Kollmann J, 1996, VEGETATIO, V125, P193, DOI 10.1007/BF00044651; Kyereh B, 1999, J ECOL, V87, P772, DOI 10.1046/j.1365-2745.1999.00386.x; Leck, 1989, ECOLOGY SOIL SEED BA; Lorenzetti F, 2008, FOREST ECOL MANAG, V254, P350, DOI 10.1016/j.foreco.2007.08.010; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Marchante H, 2011, APPL VEG SCI, V14, P107, DOI 10.1111/j.1654-109X.2010.01099.x; Meissner RA, 1999, J ARID ENVIRON, V42, P117, DOI 10.1006/jare.1999.0515; Naaf T, 2007, FOREST ECOL MANAG, V244, P141, DOI 10.1016/j.foreco.2007.04.020; Peng Shan-jiang, 2003, Journal of Tropical and Subtropical Botany, V11, P229; Ritter E, 2005, FOREST ECOL MANAG, V206, P15, DOI 10.1016/j.foreco.2004.08.011; Ruano I, 2009, FOREST ECOL MANAG, V258, P2647, DOI 10.1016/j.foreco.2009.09.027; Sapkota IP, 2009, J PLANT ECOL, V2, P21, DOI 10.1093/jpe/rtp004; SOKAL R. R., 1963, Principles of numerical taxonomy., P359; Suh MH, 1998, FOREST ECOL MANAG, V106, P27, DOI 10.1016/S0378-1127(97)00236-3; THOMPSON K, 1979, J ECOL, V67, P893, DOI 10.2307/2259220; Thompson K, 1992, SEEDS ECOLOGY REGENE, P231; van Kuijk M, 2008, OECOLOGIA, V157, P1, DOI 10.1007/s00442-008-1048-4; Wang J, 2010, FOREST ECOL MANAG, V259, P2390, DOI 10.1016/j.foreco.2010.03.015; White P.S., 1985, ECOLOGY NATURAL DIST, P3, DOI 10.1016/B978-0-12-554520-4.50006-X; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; Yan QL, 2010, PLANT SOIL, V329, P469, DOI 10.1007/s11104-009-0172-1; [闫巧玲 Yan Qiaoling], 2005, [生态学杂志, Chinese Journal of Ecology], V24, P948; YAVITT JB, 1995, J TROP ECOL, V11, P391, DOI 10.1017/S0266467400008853; Yeo US, 2006, FORESTRY, V79, P167, DOI 10.1093/forestry/cpl001; Zang RG, 1998, CHINESE J ECOL, V17, P50; Zang RG, 2008, J INTEGR PLANT BIOL, V50, P513, DOI 10.1111/j.1744-7909.2008.00662.x; Zhu Jiao-jun, 2007, Shengtaixue Zazhi, V26, P1085; Zhu Jiao-jun, 2007, Journal of Forestry Research (Harbin), V18, P167, DOI 10.1007/s11676-007-0035-7; Zhu Jiaojun, 2004, Yingyong Shengtai Xuebao, V15, P1703; Zhu JJ, 2010, J FOREST RES-JPN, V15, P71, DOI 10.1007/s10310-009-0152-6; Zhu JJ, 2003, FOREST ECOL MANAG, V182, P339, DOI 10.1016/S0378-1127(03)00094-X; Zhu N., 1994, NATURAL SECONDARY FO; 谷瑞升, 2005, [林业科学, Scientia Silvae Sinicae], V41, P201	58	19	21	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39502	10.1371/journal.pone.0039502	http://dx.doi.org/10.1371/journal.pone.0039502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745771	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900066
J	Dammer, EB; Fallini, C; Gozal, YM; Duong, DM; Rossoll, W; Xu, P; Lah, JJ; Levey, AI; Peng, JM; Bassell, GJ; Seyfried, NT				Dammer, Eric B.; Fallini, Claudia; Gozal, Yair M.; Duong, Duc M.; Rossoll, Wilfried; Xu, Ping; Lah, James J.; Levey, Allan I.; Peng, Junmin; Bassell, Gary J.; Seyfried, Nicholas T.			Coaggregation of RNA-Binding Proteins in a Model of TDP-43 Proteinopathy with Selective RGG Motif Methylation and a Role for RRM1 Ubiquitination	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEIC-ACID BINDING; STRESS GRANULES; MOTOR-NEURONS; FTLD-U; MUTATIONS; INCLUSIONS; COMPLEXES; LOCALIZATION	TAR DNA-binding protein 43 (TDP-43) is a major component within ubiquitin-positive inclusions of a number of neurodegenerative diseases that increasingly are considered as TDP-43 proteinopathies. Identities of other inclusion proteins associated with TDP-43 aggregation remain poorly defined. In this study, we identify and quantitate 35 coaggregating proteins in the detergent-resistant fraction of HEK-293 cells in which TDP-43 or a particularly aggregate prone variant, TDP-S6, were enriched following overexpression, using stable isotope-labeled (SILAC) internal standards and liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). We also searched for differential post-translational modification (PTM) sites of ubiquitination. Four sites of ubiquitin conjugation to TDP-43 or TDP-S6 were confirmed by dialkylated GST-TDP-43 external reference peptides, occurring on or near RNA binding motif (RRM) 1. RRM-containing proteins co-enriched in cytoplasmic granular structures in HEK-293 cells and primary motor neurons with insoluble TDP-S6, including cytoplasmic stress granule associated proteins G3BP, PABPC1, and eIF4A1. Proteomic evidence for TDP-43 coaggregation with paraspeckle markers RBM14, PSF and NonO was also validated by western blot and by immunocytochemistry in HEK-293 cells. An increase in peptides from methylated arginine-glycine-glycine (RGG) RNA-binding motifs of FUS/TLS and hnRNPs was found in the detergent-insoluble fraction of TDP-overexpressing cells. Finally, TDP-43 and TDP-S6 detergent-insoluble species were reduced by mutagenesis of the identified ubiquitination sites, even following oxidative or proteolytic stress. Together, these findings define some of the aggregation partners of TDP-43, and suggest that TDP-43 ubiquitination influences TDP-43 oligomerization.	[Dammer, Eric B.; Xu, Ping; Peng, Junmin] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Fallini, Claudia; Rossoll, Wilfried; Bassell, Gary J.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA; [Gozal, Yair M.; Lah, James J.; Levey, Allan I.; Bassell, Gary J.; Seyfried, Nicholas T.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Duong, Duc M.; Seyfried, Nicholas T.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Dammer, Eric B.; Fallini, Claudia; Duong, Duc M.; Rossoll, Wilfried; Lah, James J.; Levey, Allan I.; Peng, Junmin; Bassell, Gary J.; Seyfried, Nicholas T.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA USA	Emory University; Emory University; Emory University; Emory University; Emory University	Dammer, EB (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	nseyfri@emory.edu	Dammer, Eric B/V-8652-2019; Peng, Junmin/N-2614-2018; Fallini, Claudia/AAZ-1244-2020; Levey, Allan/F-2104-2011	Dammer, Eric B/0000-0003-2947-7606; Peng, Junmin/0000-0003-0472-7648; Fallini, Claudia/0000-0001-8329-3467; Levey, Allan/0000-0002-3153-502X; Rossoll, Wilfried/0000-0002-9622-541X; Duong, Duc/0000-0001-5880-1888	Proteomics and Confocal Microscopy Core Facilities of the Emory Neuroscience NINDS Core Facilities grant [P30NS055077]; National Institute on Aging [F32AG038259, F32AG032848-02]; National Institutes of Health [NS-007480]; Muscular Dystrophy Association [MDA173851]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007480, P30NS055077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG032848, F32AG038259] Funding Source: NIH RePORTER	Proteomics and Confocal Microscopy Core Facilities of the Emory Neuroscience NINDS Core Facilities grant; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research project was supported in part by the Proteomics and Confocal Microscopy Core Facilities of the Emory Neuroscience NINDS Core Facilities grant, P30NS055077. E.B.D. was supported by a National Institute on Aging grant F32AG038259 and National Institutes of Health T32 grant for translational neuroscience, NS-007480. N.T.S was supported by a National Institute on Aging grant F32AG032848-02. W.R. was supported by Muscular Dystrophy Association grant MDA173851. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Ash PEA, 2010, HUM MOL GENET, V19, P3206, DOI 10.1093/hmg/ddq230; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Cohen TJ, 2011, EMBO J; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Dammer EB, 2007, MOL ENDOCRINOL, V21, P415, DOI 10.1210/me.2006-0361; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Estes PS, 2011, HUM MOL GENET, V20, P2308, DOI 10.1093/hmg/ddr124; Fallini C, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-17; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Giordana MT, 2009, BRAIN PATHOLOGY; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Josephs KA, 2009, ACTA NEUROPATHOL, V118, P349, DOI 10.1007/s00401-009-0547-7; Kadokura A, 2009, NEUROPATHOLOGY, V29, P566, DOI 10.1111/j.1440-1789.2009.01017.x; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim S, 1998, AMINO ACIDS, V15, P291, DOI 10.1007/BF01320895; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; King OD, 2012, BRAIN RES; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Kwong LK, 2007, ACTA NEUROPATHOL, V114, P63, DOI 10.1007/s00401-007-0226-5; Kzhyshkowska J, 2001, BIOCHEM J, V358, P305, DOI 10.1042/0264-6021:3580305; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Mackenzie IR, 2007, NEUROGENETICS; Mackenzie IRA, 2003, ACTA NEUROPATHOL, V105, P98, DOI 10.1007/s00401-002-0620-y; Mackenzie IRA, 2007, BRAIN RES; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Nakashima-Yasuda H, 2007, ACTA NEUROPATHOL, V114, P221, DOI 10.1007/s00401-007-0261-2; Neumann M, 2009, BRAIN; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P177, DOI 10.1097/01.jnen.0000248554.45456.58; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pavlopoulos E, 2011, CELL, V147, P1369, DOI 10.1016/j.cell.2011.09.056; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pesiridis GS, 2011, J BIOL CHEM; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Seyfried NT, 2008, ANAL CHEM, V80, P4161, DOI 10.1021/ac702516a; Seyfried NT, 2010, MOL CELL PROTEOMICS, V9, P705, DOI 10.1074/mcp.M800390-MCP200; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Squatrito M, 2006, BIOCHEM BIOPH RES CO, V344, P859, DOI 10.1016/j.bbrc.2006.03.205; Tan CF, 2009, ACTA NEUROPATHOL, V118, P553, DOI 10.1007/s00401-009-0552-x; Tettweiler G, 2006, TRENDS BIOCHEM SCI, V31, P607, DOI 10.1016/j.tibs.2006.09.008; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Volpicelli LA, 2002, J NEUROSCI, V22, P9776, DOI 10.1523/jneurosci.22-22-09776.2002; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Wooten MW, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/62079; Yokota O, 2010, ACTA NEUROPATHOL, V120, P789, DOI 10.1007/s00401-010-0731-9	73	81	84	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38658	10.1371/journal.pone.0038658	http://dx.doi.org/10.1371/journal.pone.0038658			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22761693	gold, Green Published, Green Submitted			2022-12-27	WOS:000305695100015
J	Capuano, M; Garcia-Herrero, CM; Tinto, N; Carluccio, C; Capobianco, V; Coto, I; Cola, A; Iafusco, D; Franzese, A; Zagari, A; Navas, MA; Sacchetti, L				Capuano, Marina; Maria Garcia-Herrero, Carmen; Tinto, Nadia; Carluccio, Carla; Capobianco, Valentina; Coto, Iolanda; Cola, Arturo; Iafusco, Dario; Franzese, Adriana; Zagari, Adriana; Angeles Navas, Maria; Sacchetti, Lucia			Glucokinase (GCK) Mutations and Their Characterization in MODY2 Children of Southern Italy	PLOS ONE			English	Article							BETA-CELL GLUCOKINASE; PRACTICE GUIDELINES; DIABETES-MELLITUS; GENETIC DIAGNOSIS; YOUNG; HYPOGLYCEMIA; MUTANTS	Type 2 Maturity Onset Diabetes of the Young (MODY2) is a monogenic autosomal disease characterized by a primary defect in insulin secretion and hyperglycemia. It results from GCK gene mutations that impair enzyme activity. Between 2006 and 2010, we investigated GCK mutations in 66 diabetic children from southern Italy with suspected MODY2. Denaturing High Performance Liquid Chromatography (DHPLC) and sequence analysis revealed 19 GCK mutations in 28 children, six of which were novel: p.Glu40Asp, p.Val154Leu, p.Arg447Glyfs, p.Lys458_Cys461del, p.Glu395_Arg397del and c.580-2A>T. We evaluated the effect of these 19 mutations using bioinformatic tools such as Polymorphism Phenotyping (Polyphen), Sorting Intolerant From Tolerant (SIFT) and in silico modelling. We also conducted a functional study to evaluate the pathogenic significance of seven mutations that are among the most severe mutations found in our population, and have never been characterized: p.Glu70Asp, p.His137Asp, p.Phe150Tyr, p.Val154Leu, p.Gly162Asp, p.Arg303Trp and p.Arg392Ser. These seven mutations, by altering one or more kinetic parameters, reduced enzyme catalytic activity by >40%. All mutations except p.Glu70Asp displayed thermal-instability, indeed >50% of enzyme activity was lost at 50 degrees C/30 min. Thus, these seven mutations play a pathogenic role in MODY2 insurgence. In conclusion, this report revealed six novel GCK mutations and sheds some light on the structure-function relationship of human GCK mutations and MODY2.	[Capuano, Marina; Tinto, Nadia; Coto, Iolanda; Cola, Arturo; Sacchetti, Lucia] Univ Naples Federico II, Dept Biochem & Med Biotechnol, Naples, Italy; [Capuano, Marina; Tinto, Nadia; Carluccio, Carla; Coto, Iolanda; Cola, Arturo; Zagari, Adriana; Sacchetti, Lucia] Ctr Ingn Genet CEINGE Adv Biotechnol Scarl, Naples, Italy; [Maria Garcia-Herrero, Carmen; Angeles Navas, Maria] Univ Complutense Madrid, Fac Med, Dept Biochem & Mol Biol 3, Madrid, Spain; [Maria Garcia-Herrero, Carmen; Angeles Navas, Maria] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Carluccio, Carla; Zagari, Adriana] Univ Naples Federico II, Dept Biol Sci, Naples, Italy; [Capobianco, Valentina] Fdn SDN IRCSS, Ist Diagnost Nucl Ist Ric & Cura Carattere Sci, Naples, Italy; [Iafusco, Dario] Univ Naples 2, Dept Pediat, Naples, Italy; [Franzese, Adriana] Univ Naples Federico II, Dept Pediat, Naples, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Naples Federico II; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Universita della Campania Vanvitelli; University of Naples Federico II	Capuano, M (corresponding author), Univ Naples Federico II, Dept Biochem & Med Biotechnol, Naples, Italy.	sacchett@unina.it	capuano, marina/GLT-0659-2022	Navas, Maria Angeles/0000-0001-6858-2172; Iafusco, Dario/0000-0002-9398-3856; Capobianco, Valentina/0000-0002-9161-1581	CEINGE-Regione Campania, Italy [DGRC 1901/2009]; Instituto de Salud Carlos III, Spain [PI1000424]; Direccion General de Universidades e investigacion de la Consejeria de Educacion de la Comunidad de Madrid-Universidad Complutense de Madrid, Spain [CCG10-UCM/BIO-4728]; FPU from the Ministerio de Ciencia e Innovacion of Spain	CEINGE-Regione Campania, Italy; Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Direccion General de Universidades e investigacion de la Consejeria de Educacion de la Comunidad de Madrid-Universidad Complutense de Madrid, Spain; FPU from the Ministerio de Ciencia e Innovacion of Spain	Work was supported by grants from: CEINGE-Regione Campania, Italy (DGRC 1901/2009), the Instituto de Salud Carlos III, Spain (PI1000424) and the Direccion General de Universidades e investigacion de la Consejeria de Educacion de la Comunidad de Madrid-Universidad Complutense de Madrid, Spain (CCG10-UCM/BIO-4728). C.M. Garcia-Herrero was supported by a predoctoral FPU fellowship from the Ministerio de Ciencia e Innovacion of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burke CV, 1999, BIOCHEM J, V342, P345, DOI 10.1042/0264-6021:3420345; Colom C, 2010, BEST PRACT RES CL EN, V24, P605, DOI 10.1016/j.beem.2010.05.008; Davis EA, 1999, DIABETOLOGIA, V42, P1175, DOI 10.1007/s001250051289; Ellard S, 2008, DIABETOLOGIA, V51, P546, DOI 10.1007/s00125-008-0942-y; Estalella I, 2007, CLIN ENDOCRINOL, V67, P538, DOI 10.1111/j.1365-2265.2007.02921.x; Galan M, 2006, BIOCHEM J, V393, P389, DOI 10.1042/BJ20051137; Garcia-Herrero CM, 2007, DIABETOLOGIA, V50, P325, DOI 10.1007/s00125-006-0542-7; GIDHJAIN M, 1993, P NATL ACAD SCI USA, V90, P1932, DOI 10.1073/pnas.90.5.1932; Hussain K, 2010, REV ENDOCR METAB DIS, V11, P179, DOI 10.1007/s11154-010-9147-z; Incani M, 2010, DIABETIC MED, V27, P1332, DOI 10.1111/j.1464-5491.2010.03095.x; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kesavan P, 1997, BIOCHEM J, V322, P57, DOI 10.1042/bj3220057; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; LIANG Y, 1995, BIOCHEM J, V309, P167, DOI 10.1042/bj3090167; Lorini R, 2009, DIABETES CARE, V32, P1864, DOI 10.2337/dc08-2018; Mantovani Vilma, 2003, Hum Mutat, V22, P338, DOI 10.1002/humu.9179; Massa ML, 2011, IUBMB LIFE, V63, P1, DOI 10.1002/iub.411; Massa O, 2001, DIABETOLOGIA, V44, P898; Matyka KA, 1998, ARCH DIS CHILD, V78, P552, DOI 10.1136/adc.78.6.552; Naylor R, 2011, CLIN ENDOCRINOL, V75, P422, DOI 10.1111/j.1365-2265.2011.04049.x; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nyunt Ohn, 2009, Clin Biochem Rev, V30, P67; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Pruhova S, 2010, PEDIATR DIABETES, V11, P529, DOI 10.1111/j.1399-5448.2010.00646.x; SHIMADA F, 1993, DIABETOLOGIA, V36, P433, DOI 10.1007/BF00402280; STOFFEL M, 1992, P NATL ACAD SCI USA, V89, P7698, DOI 10.1073/pnas.89.16.7698; Tinto N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001870; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weng JP, 2002, DIABETES CARE, V25, P68, DOI 10.2337/diacare.25.1.68; Zou MJ, 2011, ENDOCRINE, V40, P14, DOI 10.1007/s12020-011-9489-7	31	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38906	10.1371/journal.pone.0038906	http://dx.doi.org/10.1371/journal.pone.0038906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22761713	gold, Green Published, Green Submitted			2022-12-27	WOS:000305693200027
J	Larsson, T; Morkore, T; Kolstad, K; Ostbye, TK; Afanasyev, S; Krasnov, A				Larsson, Thomas; Morkore, Turid; Kolstad, Kari; Ostbye, Tone-Kari; Afanasyev, Sergey; Krasnov, Aleksei			Gene Expression Profiling of Soft and Firm Atlantic Salmon Fillet	PLOS ONE			English	Article							CONNECTIVE-TISSUE; WHITE MUSCLE; TEXTURE; QUALITY; FISH; IMPROVEMENT; MICROARRAY; BINDING; PROTEIN; HEART	Texture of salmon fillets is an important quality trait for consumer acceptance as well as for the suitability for processing. In the present work we measured fillet firmness in a population of farmed Atlantic salmon with known pedigree and investigated the relationship between this trait and gene expression. Transcriptomic analyses performed with a 21 K oligonucleotide microarray revealed strong correlations between firmness and a large number of genes. Highly similar expression profiles were observed in several functional groups. Positive regression was found between firmness and genes encoding proteasome components (41 genes) and mitochondrial proteins (129 genes), proteins involved in stress responses (12 genes), and lipid metabolism (30 genes). Coefficients of determination (R-2) were in the range of 0.64-0.74. A weaker though highly significant negative regression was seen in sugar metabolism (26 genes, R-2 = 0.66) and myofiber proteins (42 genes, R-2 = 0.54). Among individual genes that showed a strong association with firmness, there were extracellular matrix proteins (negative correlation), immune genes, and intracellular proteases (positive correlation). Several genes can be regarded as candidate markers of flesh quality (coiled-coil transcriptional coactivator b, AMP deaminase 3, and oligopeptide transporter 15) though their functional roles are unclear. To conclude, fillet firmness of Atlantic salmon depends largely on metabolic properties of the skeletal muscle; where aerobic metabolism using lipids as fuel, and the rapid removal of damaged proteins, appear to play a major role.	[Larsson, Thomas; Morkore, Turid; Kolstad, Kari; Ostbye, Tone-Kari; Afanasyev, Sergey; Krasnov, Aleksei] Nofima, As, Norway; [Larsson, Thomas; Morkore, Turid; Kolstad, Kari] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway; [Afanasyev, Sergey] IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia	Nofima; Norwegian University of Life Sciences; North-Western State Medical University named after I.I. Mechnikov; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Larsson, T (corresponding author), Nofima, As, Norway.	thomas.larsson@nofima.no	Krasnov, Aleksei/D-3065-2012; Afanasyev, Sergey V/K-9309-2015	Afanasyev, Sergey V/0000-0002-8393-820X; Ostbye, Tone-Kari Knutsdatter/0000-0001-5173-7115	Norwegian Research Council [173490/130]; Fishery and Aquaculture Industry Research Fund [190479/E40]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Fishery and Aquaculture Industry Research Fund	This work was funded by The Norwegian Research Council (grant no. 173490/130, www.forskningsradet.no) and The Fishery and Aquaculture Industry Research Fund (grant no. 190479/E40, www.fiskerifond.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando M, 1999, EXTRACELLULAR MATRIX OF FISH AND SHELLFISH, P69; Angione AR, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-33; Bahuaud D, 2010, AQUACULTURE, V310, P213, DOI 10.1016/j.aquaculture.2010.10.008; CLEVELAND WS, 1999, STAT MODELS, P309; Douglas SE, 2006, OMICS, V10, P474, DOI 10.1089/omi.2006.10.474; Einen O, 1998, AQUACULTURE, V169, P37, DOI 10.1016/S0044-8486(98)00332-9; Elvevoll EO, 1996, MEAT SCI, V43, pS265, DOI 10.1016/0309-1740(95)00061-5; Folkestad A, 2008, AQUACULTURE, V280, P129, DOI 10.1016/j.aquaculture.2008.04.037; Gjedrem T, 2005, SELECTION AND BREEDING PROGRAMS IN AQUACULTURE, P45, DOI 10.1007/1-4020-3342-7_5; Gjedrem T, 1997, AQUACULT INT, V5, P197, DOI 10.1023/A:1014546816984; Gjoen HM, 1997, ICES J MAR SCI, V54, P1009, DOI 10.1016/S1054-3139(97)80005-7; Hannesson KO, 2007, COMP BIOCHEM PHYS B, V146, P512, DOI 10.1016/j.cbpb.2006.11.024; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; HATAE K, 1986, B JPN SOC SCI FISH, V52, P2001; Hultmann L, 2007, FOOD CHEM, V104, P1687, DOI 10.1016/j.foodchem.2007.03.030; Hyldig G, 2001, J TEXTURE STUD, V32, P219, DOI 10.1111/j.1745-4603.2001.tb01045.x; Johnston IA, 2008, WOODHEAD PUBL FOOD S, P465, DOI 10.1533/9781845694586.5.465; Jun DW, 2011, LIVER INT, V31, P1315, DOI 10.1111/j.1478-3231.2011.02602.x; KESSLER E, 1990, BIOCHEM BIOPH RES CO, V173, P81, DOI 10.1016/S0006-291X(05)81024-1; KRASNOV A, 2005, BMC GENOMICS, V6; Krasnov A, 2011, COMP BIOCHEM PHYS D, V6, P31, DOI 10.1016/j.cbd.2010.04.006; Larsson T, 2012, AQUACULTURE, V330, P82, DOI 10.1016/j.aquaculture.2011.12.016; Lerfall J, 2012, AQUACULTURE, V324, P209, DOI 10.1016/j.aquaculture.2011.11.003; MADSEN P, 2006, USERS GUIDE DMU PACK; Martinez I, 2011, FOOD CHEM, V126, P140, DOI 10.1016/j.foodchem.2010.10.090; Mitchie I., 2001, FARMED FISH QUALITY, V4, P129; Morkore T, 2008, KUNNSKAPSSTATUS FORH; Muoio DM, 2002, DIABETES, V51, P901, DOI 10.2337/diabetes.51.4.901; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Ohno S, 2005, CONNECT TISSUE RES, V46, P227, DOI 10.1080/03008200500346111; Ostbye TK, 2011, AQUACULT NUTR, V17, P177, DOI 10.1111/j.1365-2095.2009.00721.x; Ponsuksili S, 2009, FUNCT INTEGR GENOMIC, V9, P455, DOI 10.1007/s10142-009-0131-1; Reddi AH, 2001, ARTHRITIS RES, V3, P1; Salem M, 2006, PHYSIOL GENOMICS, V28, P33, DOI 10.1152/physiolgenomics.00114.2006; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698; Tingbo MG, 2006, COMP BIOCHEM PHYS B, V143, P441, DOI 10.1016/j.cbpb.2005.12.022; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veland JO, 1999, J SCI FOOD AGR, V79, P1737, DOI 10.1002/(SICI)1097-0010(199909)79:12<1737::AID-JSFA432>3.0.CO;2-Y; Yamawaki H, 2005, CURR OPIN NEPHROL HY, V14, P149, DOI 10.1097/00041552-200503000-00010; Yang CK, 2006, MOL ENDOCRINOL, V20, P3251, DOI 10.1210/me.2006-0200	41	33	35	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39219	10.1371/journal.pone.0039219	http://dx.doi.org/10.1371/journal.pone.0039219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745718	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200050
J	Li, J; Zheng, H; Wang, JF; Yu, F; Morris, RJ; Wang, TC; Huang, SA; Ai, W				Li, Juan; Zheng, Hai; Wang, Junfeng; Yu, Fang; Morris, Rebecca J.; Wang, Timothy C.; Huang, Shiang; Ai, Walden			Expression of Kruppel-Like Factor KLF4 in Mouse Hair Follicle Stem Cells Contributes to Cutaneous Wound Healing	PLOS ONE			English	Article							LABEL-RETAINING CELLS; GENE-EXPRESSION; EPIDERMAL STEM; DIFFERENTIATION; PROLIFERATION; IDENTIFICATION; CYCLE; ADULT; BULGE; KRUPPEL-LIKE-FACTOR-4	Background: Kruppel-like factor KLF4 is a transcription factor critical for the establishment of the barrier function of the skin. Its function in stem cell biology has been recently recognized. Previous studies have revealed that hair follicle stem cells contribute to cutaneous wound healing. However, expression of KLF4 in hair follicle stem cells and the importance of such expression in cutaneous wound healing have not been investigated. Methodology/Principal Findings: Quantitative real time polymerase chain reaction (RT-PCR) analysis showed higher KLF4 expression in hair follicle stem cell-enriched mouse skin keratinocytes than that in control keratinocytes. We generated KLF4 promoter-driven enhanced green fluorescence protein (KLF4/EGFP) transgenic mice and tamoxifen-inducible KLF4 knockout mice by crossing KLF4 promoter-driven Cre recombinase fused with tamoxifen-inducible estrogen receptor (KLF4/CreER (TM)) transgenic mice with KLF4(flox) mice. KLF4/EGFP cells purified from dorsal skin keratinocytes of KLF4/EGFP transgenic mice were co-localized with 5-bromo-2'-deoxyuridine (BrdU)-label retaining cells by flow cytometric analysis and immunohistochemistry. Lineage tracing was performed in the context of cutaneous wound healing, using KLF4/CreER (TM) and Rosa26RLacZ double transgenic mice, to examine the involvement of KLF4 in wound healing. We found that KLF4 expressing cells were likely derived from bulge stem cells. In addition, KLF4 expressing multipotent cells migrated to the wound and contributed to the wound healing. After knocking out KLF4 by tamoxifen induction of KLF4/CreER (TM) and KLF4(flox) double transgenic mice, we found that the population of bulge stem cell-enriched population was decreased, which was accompanied by significantly delayed cutaneous wound healing. Consistently, KLF4 knockdown by KLF4-specific small hairpin RNA in human A431 epidermoid carcinoma cells decreased the stem cell population and was accompanied by compromised cell migration. Conclusions/Significance: KLF4 expression in mouse hair bulge stem cells plays an important role in cutaneous wound healing. These findings may enable future development of KLF4-based therapeutic strategies aimed at accelerating cutaneous wound closure.	[Li, Juan; Wang, Junfeng; Yu, Fang; Ai, Walden] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Li, Juan; Wang, Junfeng; Huang, Shiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Stem Cell Res & Applicat, Union Hosp, Wuhan 430074, Peoples R China; [Zheng, Hai] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Gen Surg, Union Hosp, Wuhan 430074, Peoples R China; [Morris, Rebecca J.] Univ Minnesota, Hormel Inst, Lab Stem Cells & Canc, Austin, MN 55912 USA; [Wang, Timothy C.] Columbia Univ, Dept Med, Div Digest & Liver Dis, New York, NY USA; [Wang, Timothy C.] Columbia Univ, Irving Canc Ctr, New York, NY USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Minnesota System; Columbia University; Columbia University	Li, J (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	shianghuang2000@yahoo.com; Walden.Ai@uscmed.sc.edu	Wang, Junfeng/AAJ-3248-2020	Wang, Timothy/0000-0001-5730-3019	National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health [1RO3AR060987]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR060987] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Grant Number 1RO3AR060987 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health to WA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai WD, 2004, J BIOL CHEM, V279, P8684, DOI 10.1074/jbc.M308278200; Atsumi N, 2008, BIOCHEM BIOPH RES CO, V373, P36, DOI 10.1016/j.bbrc.2008.05.163; BICKENBACH JR, 1981, J DENT RES, V60, P1611, DOI 10.1177/002203458106000311011; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Bruce SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-365; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Chen YJ, 2008, CANCER BIOL THER, V7, P777, DOI 10.4161/cbt.7.5.5768; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Forsberg EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008785; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Georgantas RW, 2004, CANCER RES, V64, P4434, DOI 10.1158/0008-5472.CAN-03-3247; Hermey G, 1999, BIOCHEM BIOPH RES CO, V254, P273, DOI 10.1006/bbrc.1998.9882; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kioka N, 2010, EXP CELL RES, V316, P1728, DOI 10.1016/j.yexcr.2010.03.019; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Li J, 2012, CARCINOGENESIS; Liang XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029999; Mahatan CS, 1999, NUCLEIC ACIDS RES, V27, P4562, DOI 10.1093/nar/27.23.4562; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nickenig G, 2002, FASEB J, V16, P1077, DOI 10.1096/fj.01-0570com; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Schwacha MG, 2010, J SURG RES, V158, P112, DOI 10.1016/j.jss.2008.07.034; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Strachan LR, 2008, STEM CELL REV, V4, P149, DOI 10.1007/s12015-008-9020-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wei DY, 2010, GASTROENTEROLOGY, V139, P2135, DOI 10.1053/j.gastro.2010.08.022; Wong V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/969618; Wu WY, 2004, METH MOL B, V289, P79; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Yu TX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032492; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958; Zheng H, 2009, AM J PHYSIOL-GASTR L, V296, pG490, DOI 10.1152/ajpgi.90393.2008	54	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39663	10.1371/journal.pone.0039663	http://dx.doi.org/10.1371/journal.pone.0039663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745808	gold, Green Submitted, Green Published			2022-12-27	WOS:000305693200094
J	Feng, JF; Yi, DY; Krishna, R; Guo, SX; Buchanan-Wollaston, V				Feng, Jianfeng; Yi, Dongyun; Krishna, Ritesh; Guo, Shuixia; Buchanan-Wollaston, Vicky			Listen to Genes: Dealing with Microarray Data in the Frequency Domain	PLOS ONE			English	Article							EXPRESSION DATA; TIME; ARABIDOPSIS; NORMALIZATION; SYSTEMS; CLOCK; ELF4	Background: We present a novel and systematic approach to analyze temporal microarray data. The approach includes normalization, clustering and network analysis of genes. Methodology: Genes are normalized using an error model based uniform normalization method aimed at identifying and estimating the sources of variations. The model minimizes the correlation among error terms across replicates. The normalized gene expressions are then clustered in terms of their power spectrum density. The method of complex Granger causality is introduced to reveal interactions between sets of genes. Complex Granger causality along with partial Granger causality is applied in both time and frequency domains to selected as well as all the genes to reveal the interesting networks of interactions. The approach is successfully applied to Arabidopsis leaf microarray data generated from 31,000 genes observed over 22 time points over 22 days. Three circuits: a circadian gene circuit, an ethylene circuit and a new global circuit showing a hierarchical structure to determine the initiators of leaf senescence are analyzed in detail. Conclusions: We use a totally data-driven approach to form biological hypothesis. Clustering using the power-spectrum analysis helps us identify genes of potential interest. Their dynamics can be captured accurately in the time and frequency domain using the methods of complex and partial Granger causality. With the rise in availability of temporal microarray data, such methods can be useful tools in uncovering the hidden biological interactions. We show our method in a step by step manner with help of toy models as well as a real biological dataset. We also analyse three distinct gene circuits of potential interest to Arabidopsis researchers.	[Feng, Jianfeng] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Feng, Jianfeng; Krishna, Ritesh] Warsaw Univ, Dept Comp Sci, Coventry, W Midlands, England; [Yi, Dongyun] Natl Univ Defence Technol, Dept Syst Sci & Math, Changsha, Peoples R China; [Guo, Shuixia] Hunan Normal Univ, Dept Math, Changsha, Peoples R China; [Buchanan-Wollaston, Vicky] Univ Warwick, Warwick HRI, Wellesbourne, Warwick, England	Fudan University; University of Warwick; National University of Defense Technology - China; Hunan Normal University; University of Warwick	Feng, JF (corresponding author), Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China.	Jianfeng.Feng@warwick.ac.uk		feng, jianfeng/0000-0002-9328-5732	Department of Computer Science, University of Warwick, UK; EU; EPSRC; RCUK; BBSRC [BB/F005806/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F005806/1] Funding Source: researchfish	Department of Computer Science, University of Warwick, UK; EU(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); RCUK(UK Research & Innovation (UKRI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Ritesh Krishna is supported by Department of Computer Science, University of Warwick, UK. Jianfeng Feng is supported by grants from EU, EPSRC and RCUK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, INTRO SYSTEMS BIOL D; Androulakis IP, 2007, ANNU REV BIOMED ENG, V9, P205, DOI 10.1146/annurev.bioeng.9.060906.151904; Balasubramaniyan R, 2005, BIOINFORMATICS, V21, P1069, DOI 10.1093/bioinformatics/bti095; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; CRISTI R, 2003, MODERN DIGITAL SIGNA; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Dojer N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-249; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Fan JQ, 2005, J AM STAT ASSOC, V100, P781, DOI 10.1198/016214504000001781; Fan JQ, 2004, P NATL ACAD SCI USA, V101, P1135, DOI 10.1073/pnas.0307557100; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Guo SX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000087; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Kim BR, 2006, CURR GENOMICS, V7, P197, DOI 10.2174/138920206777780229; Kim Sun Yong, 2003, Briefings in Bioinformatics, V4, P228, DOI 10.1093/bib/4.3.228; Lim PO, 2007, PLANT J, V52, P1140, DOI 10.1111/j.1365-313X.2007.03317.x; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; McWatters HG, 2007, PLANT PHYSIOL, V144, P391, DOI 10.1104/pp.107.096206; Pan W, 2002, GENOME BIOL, V3; Qian J, 2001, J MOL BIOL, V314, P1053, DOI 10.1006/jmbi.2000.5219; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stepanova A. N., 2005, SCIENCE, V276, P1872; Stepanova AN, 2000, CURR OPIN PLANT BIOL, V3, P353, DOI 10.1016/S1369-5266(00)00096-0; Ueda HR, 2006, MOL SYST BIOL, V2, DOI 10.1038/mbs4100105; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; Wu JH, 2008, J NEUROSCI METH, V167, P367, DOI 10.1016/j.jneumeth.2007.08.022; Yanovsky MJ, 2003, NAT REV MOL CELL BIO, V4, P265, DOI 10.1038/nrm1077	27	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2009	4	4							e5098	10.1371/journal.pone.0005098	http://dx.doi.org/10.1371/journal.pone.0005098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437RS	22745650	Green Published, gold, Green Submitted			2022-12-27	WOS:000265505200006
J	Yang, T; Cai, SY; Zhang, J; Lu, JH; Lin, C; Zhai, J; Wu, MC; Shen, F				Yang, Tian; Cai, Sheng-Yun; Zhang, Jin; Lu, Jun-Hua; Lin, Chuan; Zhai, Jian; Wu, Meng-Chao; Shen, Feng			Kruppel-Like Factor 8 Is a New Wnt/Beta-Catenin Signaling Target Gene and Regulator in Hepatocellular Carcinoma	PLOS ONE			English	Article							KLF8 TRANSCRIPTION; BETA-CATENIN; WNT; ACTIVATION; ADHESION; P300	Kruppel-like factor 8 (KLF8) plays important role in cell cycle and oncogenic transformation. Here we report the mechanisms by which KLF8 crosstalks with Wnt/beta-catenin signaling pathway and regulates hepatocellular carcinoma (HCC) cells proliferation. We show that overexpression of KLF8 and nucleus accumulation of beta-catenin in the human HCC samples are positively correlated. More importantly, KLF8 protein levels plus nucleus accumulation of beta-catenin levels were significantly elevated in high-grade HCC compared to low-grade HCC. Using HCC HepG2 cells we find that, on the one hand both protein and mRNA of KLF8 are up-regulated under Wnt3a stimulation, on the other hand overexpression of KLF8 increases the cytoplasm and nucleus accumulation of beta-catenin, recruits p300 to beta-catenin/T-cell factor 4 (TCF4) transcription complex, enhances TOP flash report gene transcription, and induces Wnt/beta-catenin signaling target genes c-Myc, cyclin D1 and Axin1 expression. Knockdown of KLF8 using shRNA inhibits Wnt3a induced transcription of TOP flash report gene and expression of c-Myc, cyclin D1 and Axin1. Knockdown of beta-catenin by shRNA rescues the enhanced HepG2 and Hep3B cells proliferation ability induced by overexpression of KLF8.	[Yang, Tian; Zhang, Jin; Lu, Jun-Hua; Lin, Chuan; Zhai, Jian; Wu, Meng-Chao; Shen, Feng] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg, Shanghai, Peoples R China; [Cai, Sheng-Yun] Second Mil Med Univ, Dept Obstet & Gynaecol, Changhai Hosp, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Yang, T (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg, Shanghai, Peoples R China.	mengchao_wu@sina.com; fengshensmmu@gmail.com	lin, chuan/HHD-2571-2022; Yang, Tian/W-6668-2019; Yang, Tian/M-5484-2018; Shen, Feng/GSD-2508-2022	Yang, Tian/0000-0003-1544-0976; 	National Natural Science Foundation for Youths of China [81000166]; National Natural Science Foundation of China [81172020]; Shanghai Guiding Program of Science and Technology Development Commission Foundation [10411963300]; Shanghai Program for Excellent Talents in Health System [XYQ2011033]; Shanghai Foundation for Youths of Health Bureau [ab8307000-2010-92]	National Natural Science Foundation for Youths of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Guiding Program of Science and Technology Development Commission Foundation; Shanghai Program for Excellent Talents in Health System; Shanghai Foundation for Youths of Health Bureau	This study was supported by the National Natural Science Foundation for Youths of China (No. 81000166); the National Natural Science Foundation of China (No. 81172020); the Shanghai Guiding Program of Science and Technology Development Commission Foundation (No. 10411963300); the Shanghai Program for Excellent Talents in Health System (No. XYQ2011033); and the Shanghai Foundation for Youths of Health Bureau (No. ab8307000-2010-92). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Cavard C, 2008, FUTURE ONCOL, V4, P647, DOI 10.2217/14796694.4.5.647; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Li JC, 2010, GASTROENTEROLOGY, V139, P2146, DOI 10.1053/j.gastro.2010.08.004; Marrero JA, 2006, CURR OPIN GASTROEN, V22, P248, DOI 10.1097/01.mog.0000218961.86182.8c; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Takigawa Y, 2008, CURR DRUG TARGETS, V9, P1013, DOI 10.2174/138945008786786127; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Urvalek AM, 2010, CELL CYCLE, V9, P601, DOI 10.4161/cc.9.3.10606; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; Wang XH, 2008, J BIOL CHEM, V283, P13934, DOI 10.1074/jbc.M709300200; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5	17	32	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39668	10.1371/journal.pone.0039668	http://dx.doi.org/10.1371/journal.pone.0039668			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761862	Green Submitted, gold, Green Published			2022-12-27	WOS:000305825800058
J	Ducruet, AF; Zacharia, BE; Sosunov, SA; Gigante, PR; Yeh, ML; Gorski, JW; Otten, ML; Hwang, RY; DeRosa, PA; Hickman, ZL; Sergot, P; Connolly, ES				Ducruet, Andrew F.; Zacharia, Brad E.; Sosunov, Sergey A.; Gigante, Paul R.; Yeh, Mason L.; Gorski, Justin W.; Otten, Marc L.; Hwang, Richard Y.; DeRosa, Peter A.; Hickman, Zachary L.; Sergot, Paulina; Connolly, E. Sander, Jr.			Complement Inhibition Promotes Endogenous Neurogenesis and Sustained Anti-Inflammatory Neuroprotection following Reperfused Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; ANAPHYLATOXIN C3A; SUBVENTRICULAR ZONE; PROGENITOR CELLS; C5A RECEPTORS; BRAIN-INJURY; EXPRESSION; INFLAMMATION; ANTAGONIST; COMPONENT	Background and Purpose: The restoration of blood-flow following cerebral ischemia incites a series of deleterious cascades that exacerbate neuronal injury. Pharmacologic inhibition of the C3a-receptor ameliorates cerebral injury by attenuating post-ischemic inflammation. Recent reports also implicate C3a in the modulation of tissue repair, suggesting that complement may influence both injury and recovery at later post-ischemic time-points. Methods: To evaluate the effect of C3a-receptor antagonism on post-ischemic neurogenesis and neurological outcome in the subacute period of stroke, transient focal cerebral ischemia was induced in adult male C57BL/6 mice treated with multiple regimens of a C3a receptor antagonist (C3aRA). Results: Low-dose C3aRA administration during the acute phase of stroke promotes neuroblast proliferation in the subventricular zone at 7 days. Additionally, the C3a receptor is expressed on T-lymphocytes within the ischemic territory at 7 days, and this cellular infiltrate is abrogated by C3aRA administration. Finally, C3aRA treatment confers robust histologic and functional neuroprotection at this delayed time-point. Conclusions: Targeted complement inhibition through low-dose antagonism of the C3a receptor promotes post-ischemic neuroblast proliferation in the SVZ. Furthermore, C3aRA administration suppresses T-lymphocyte infiltration and improves delayed functional and histologic outcome following reperfused stroke. Post-ischemic complement activation may be pharmacologically manipulated to yield an effective therapy for stroke.	[Ducruet, Andrew F.; Zacharia, Brad E.; Sosunov, Sergey A.; Gigante, Paul R.; Yeh, Mason L.; Gorski, Justin W.; Otten, Marc L.; Hwang, Richard Y.; DeRosa, Peter A.; Hickman, Zachary L.; Sergot, Paulina; Connolly, E. Sander, Jr.] Columbia Univ, Dept Neurol Surg, New York, NY 10027 USA	Columbia University	Ducruet, AF (corresponding author), Columbia Univ, Dept Neurol Surg, New York, NY 10027 USA.	afd12@columbia.edu	Zacharia, Brad/P-1726-2019; Hickman, Zachary L./O-6335-2017	Hickman, Zachary L./0000-0001-5535-0268; Zacharia, Brad/0000-0002-2078-7635; Sergot, Paulina/0000-0003-0796-8009	National Institutes of Health [R01 NS040409]; American Heart Association, Heritage Affiliate; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, Heritage Affiliate(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health grant R01 NS040409 (E.S.C.). P.A.D. was supported by a Health Sciences Student Research Grant from the American Heart Association, Heritage Affiliate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames RS, 2001, J IMMUNOL, V166, P6341, DOI 10.4049/jimmunol.166.10.6341; Arumugam TV, 2008, NEUROSCIENCE; Atkinson C, 2006, J IMMUNOL, V177, P7266, DOI 10.4049/jimmunol.177.10.7266; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Bogestal YR, 2007, J NEUROSCI RES, V85, P2892, DOI 10.1002/jnr.21401; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; Connolly ES, 1996, NEUROSURGERY, V38, P523, DOI 10.1097/00006123-199603000-00021; DeAngelis RA, 2006, ADV EXP MED BIOL, V586, P17; Drouin SM, 2001, J IMMUNOL, V166, P2025, DOI 10.4049/jimmunol.166.3.2025; Ducruet AF, 2008, J CEREBR BLOOD F MET, V28, P1048, DOI 10.1038/sj.jcbfm.9600608; Encinas JM, 2008, METHOD CELL BIOL, V85, P243, DOI 10.1016/S0091-679X(08)85011-X; Gasque P, 1998, J IMMUNOL, V160, P3543; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Jean WC, 1998, NEUROSURGERY, V43, P1382, DOI 10.1097/00006123-199812000-00076; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kimura Y, 2003, J IMMUNOL, V170, P2331, DOI 10.4049/jimmunol.170.5.2331; Kuge A, 2009, NEUROL RES, V31, P969, DOI 10.1179/174313209X383312; Markiewski MM, 2004, J IMMUNOL, V173, P747, DOI 10.4049/jimmunol.173.2.747; Mathieu P, 2009, J NEUROCHEM; Mocco J, 2006, ADV EXP MED BIOL, V586, P189; Mocco J, 2006, CIRC RES, V99, P209, DOI 10.1161/01.RES.0000232544.90675.42; Moriyama M, 2011, J NEUROSCI, V31, P3981, DOI 10.1523/JNEUROSCI.3617-10.2011; Proctor LM, 2004, BRIT J PHARMACOL, V142, P756, DOI 10.1038/sj.bjp.0705819; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Rynkowski MA, 2009, J CEREBR BLOOD F MET, V29, P98, DOI 10.1038/jcbfm.2008.95; Saver JL, 2009, STROKE, V40, P2594, DOI 10.1161/STROKEAHA.109.552554; Stevens SL, 2002, BRAIN RES, V932, P110, DOI 10.1016/S0006-8993(02)02292-8; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Ten VS, 2003, BEHAV BRAIN RES, V145, P209, DOI 10.1016/S0166-4328(03)00146-3; Wang TG, 2010, J NEUROSCI, V30, P5020, DOI 10.1523/JNEUROSCI.0311-10.2010; Winter B, 2004, STROKE, V35, P191, DOI 10.1161/01.STR.0000107188.29688.2C; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	33	55	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e38664	10.1371/journal.pone.0038664	http://dx.doi.org/10.1371/journal.pone.0038664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761695	Green Published, gold, Green Submitted			2022-12-27	WOS:000305808700009
J	Shinoda, M; Ando, T; El-Omar, EM; Takashi, H; Suzuki, T; Murayama, M; Morise, K; Goto, H				Shinoda, Masataka; Ando, Takafumi; El-Omar, Emad M.; Takashi, Hitomi; Suzuki, Takahisa; Murayama, Mutsumi; Morise, Kazuhiro; Goto, Hidemi			Programmed Chemotherapy for Patients with Metastatic Unresectable Gastric Cancer	PLOS ONE			English	Article							PHASE-III TRIAL; PLUS CISPLATIN; S-1; PACLITAXEL; 5-FLUOROURACIL; COMBINATION; I/II; IRINOTECAN; INFUSION	Background: Recent advances in the treatment of metastatic unresectable gastric cancers (MGC) include the development of new antitumor drugs and new regimens for their use. However, the selection of individually designed regimens by gastric cancer (GC) subtype remains problematic. Here, we investigated the clinical usefulness of programmed chemotherapy. Methodology/Principal Findings: MGC patients were classified into three groups by clinical condition. We implemented a chemotherapy program consisting of S-1 combination regimens. Median survival time (MST) of level 1 patients was 416 days (95% CI: 313-506 days), with an overall response rate of 47%. MSTs of level 2 and 3 patients were 208 (95% CI: 153-287 days) and 95 days (95% CI: 28-136 days), respectively. Grade 3-4 toxicities were neutropenia in 12% and anorexia in 6%. All treatment-related toxicities were resolved, and no treatment-related deaths occurred. Conclusions/Significance: This program provided reasonable selection of case-matching regimens and may improve the survival of patients with MGC. Further, it may represent the first clinical tool to provide efficient chemotherapy course selection for MGC. Ongoing analysis of newly developed drugs and regimens will allow the efficacy of this chemotherapy program to be improved.	[Shinoda, Masataka; Ando, Takafumi; Morise, Kazuhiro; Goto, Hidemi] Nagoya Univ, Dept Gastroenterol, Grad Sch Med, Nagoya, Aichi, Japan; [Shinoda, Masataka; Takashi, Hitomi; Suzuki, Takahisa; Murayama, Mutsumi] Toyota Mem Hosp, Dept Gastroenterol, Toyota, Japan; [El-Omar, Emad M.] Univ Aberdeen, Dept Med & Therapeut, Aberdeen, Scotland	Nagoya University; University of Aberdeen	Shinoda, M (corresponding author), Nagoya Univ, Dept Gastroenterol, Grad Sch Med, Nagoya, Aichi, Japan.	takafumiando-gi@umin.ac.jp	El-Omar, Emad/AAT-7780-2021	El-Omar, Emad/0000-0002-0011-3924				Arai T, 2003, JPN J CANC CLIN, V49, P621; Fujitani K, 2005, ONCOLOGY-BASEL, V69, P414, DOI 10.1159/000089996; Futatsuki K, 1994, JPN J CANC CHEMOTHER, V21, P1033; HEIDELBERGER C, 1957, NATURE, V179, P663, DOI 10.1038/179663a0; Iwase H, 2005, ANTICANCER RES, V25, P1297; Katsube T, 2007, ANTI-CANCER DRUG, V18, P605, DOI 10.1097/CAD.0b013e3280262460; Koizumi W, 2000, ONCOLOGY-BASEL, V58, P191, DOI 10.1159/000012099; Koizumi W, 2003, BRIT J CANCER, V89, P2207, DOI 10.1038/sj.bjc.6601413; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-2045(08)70035-4; Mochiki E, 2006, BRIT J CANCER, V95, P1642, DOI 10.1038/sj.bjc.6603497; Narahara H, 2008, ONCOLOGY-BASEL, V74, P37, DOI 10.1159/000138978; Ohtsu A, 2003, J CLIN ONCOL, V21, P54, DOI 10.1200/JCO.2003.04.130; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; Sugimachi K, 1999, ONCOLOGY-BASEL, V57, P202, DOI 10.1159/000012032; Sugimoto N, 2009, JPN J CANC CHEMOTHER, V36, P417; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Trotti A, 2000, INT J RADIAT ONCOL, V47, P13, DOI 10.1016/S0360-3016(99)00559-3; Uedo N, 2007, ONCOLOGY-BASEL, V73, P65, DOI 10.1159/000120630; Yamada Y, 2001, ANN ONCOL, V12, P1133, DOI 10.1023/A:1011680507956; Yamada Yasuhide, 2003, Int J Clin Oncol, V8, P374, DOI 10.1007/s10147-003-0359-z; Yano T, 2003, JPN J CANC CLIN, V49, P583; Yoshida K, 2006, CLIN CANCER RES, V12, P3402, DOI 10.1158/1078-0432.CCR-05-2425	22	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e38652	10.1371/journal.pone.0038652	http://dx.doi.org/10.1371/journal.pone.0038652			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761692	Green Published, gold, Green Submitted			2022-12-27	WOS:000305808700007
J	Spindler, SR; Li, R; Dhahbi, JM; Yamakawa, A; Mote, P; Bodmer, R; Ocorr, K; Williams, RT; Wang, YS; Ablao, KP				Spindler, Stephen R.; Li, Rui; Dhahbi, Joseph M.; Yamakawa, Amy; Mote, Patricia; Bodmer, Rolf; Ocorr, Karen; Williams, Renee T.; Wang, Yinsheng; Ablao, Kenneth P.			Statin Treatment Increases Lifespan and Improves Cardiac Health in Drosophila by Decreasing Specific Protein Prenylation	PLOS ONE			English	Article							COENZYME-Q LEVELS; CALORIC RESTRICTION; ATRIAL-FIBRILLATION; PLASMA; SUPPLEMENTATION; ISOPRENOIDS; CHOLESTEROL; REGULATOR; CELLS; Q(10)	Statins such as simvastatin are 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors and standard therapy for the prevention and treatment of cardiovascular diseases in mammals. Here we show that simvastatin significantly increased the mean and maximum lifespan of Drosophila melanogaster (Drosophila) and enhanced cardiac function in aging flies by significantly reducing heart arrhythmias and increasing the contraction proportion of the contraction/relaxation cycle. These results appeared independent of internal changes in ubiquinone or juvenile hormone levels. Rather, they appeared to involve decreased protein prenylation. Simvastatin decreased the membrane association (prenylation) of specific small Ras GTPases in mice. Both farnesyl (L744832) and type 1 geranylgeranyl transferase (GGTI-298) inhibitors increased Drosophila lifespan. These data are the most direct evidence to date that decreased protein prenylation can increase cardiac health and lifespan in any metazoan species, and may explain the pleiotropic (non-cholesterol related) health effects of statins.	[Spindler, Stephen R.; Li, Rui; Dhahbi, Joseph M.; Yamakawa, Amy; Mote, Patricia; Ablao, Kenneth P.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Bodmer, Rolf; Ocorr, Karen] Sanford Burnham Med Res Inst, Dev & Aging Program, La Jolla, CA USA; [Williams, Renee T.; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Riverside	Spindler, SR (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	spindler@ucr.edu			Alva LLC, a private, basic research foundation; ALVA LLC.	Alva LLC, a private, basic research foundation; ALVA LLC.	The research was supported by Alva LLC, a private, basic research foundation. Alva has no web site. Its funder, a high net worth individual, prefers to remain anonymous. The funder has explicitly asked (several times) that nothing commercial be entangled in any way in the funds from ALVA LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Bonetti PO, 2003, EUR HEART J, V24, P225, DOI 10.1016/S0195-668X(02)00419-0; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Chamberlain MD, 2010, CELL SIGNAL, V22, P1562, DOI 10.1016/j.cellsig.2010.05.025; Chen WT, 2010, J THORAC CARDIOV SUR, V140, P364, DOI 10.1016/j.jtcvs.2010.02.042; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; DRIVER CJI, 1986, EXP GERONTOL, V21, P497, DOI 10.1016/0531-5565(86)90002-1; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; Fink M, 2009, BIOTECHNIQUES, V46, P101, DOI 10.2144/000113078; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; FOLKERS K, 1990, P NATL ACAD SCI USA, V87, P8931, DOI 10.1073/pnas.87.22.8931; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; GHIRLANDA G, 1993, J CLIN PHARMACOL, V33, P226, DOI 10.1002/j.1552-4604.1993.tb03948.x; Hinson DD, 1997, J LIPID RES, V38, P2216; Ishii N, 2004, MECH AGEING DEV, V125, P41, DOI 10.1016/j.mad.2003.10.002; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jafari M, 2006, CURR DRUG TARGETS, V7, P1479, DOI 10.2174/1389450110607011479; Kulik A, 2010, AM J CARDIOL, V105, P1655, DOI 10.1016/j.amjcard.2010.01.341; LANG JK, 1986, ANAL BIOCHEM, V157, P106, DOI 10.1016/0003-2697(86)90203-4; Lee CK, 2004, FREE RADICAL BIO MED, V36, P1043, DOI 10.1016/j.freeradbiomed.2004.01.015; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lonnrot K, 1998, BIOCHEM MOL BIOL INT, V44, P727; Ludman A, 2009, PHARMACOL THERAPEUT, V122, P30, DOI 10.1016/j.pharmthera.2009.01.002; Ma S, 2011, CYTOKINE GROWTH F R, V22, P167, DOI 10.1016/j.cytogfr.2011.05.004; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Min KJ, 2006, MECH AGEING DEV, V127, P93, DOI 10.1016/j.mad.2005.09.004; Montecucco F, 2009, SEMIN IMMUNOPATHOL, V31, P127, DOI 10.1007/s00281-009-0150-y; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Palmer MR, 2003, AGING CELL, V2, P335, DOI 10.1046/j.1474-9728.2003.00065.x; Quiles JL, 2004, EXP GERONTOL, V39, P189, DOI 10.1016/j.exger.2003.10.002; Salat David, 2009, Expert Rev Cardiovasc Ther, V7, P1219, DOI 10.1586/erc.09.52; Santos AC, 2004, DEV CELL, V6, P283, DOI 10.1016/S1534-5807(04)00023-1; Saxena N, 2008, CANCER INVEST, V26, P948, DOI 10.1080/07357900802087275; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Sohal RS, 2006, FREE RADICAL BIO MED, V40, P480, DOI 10.1016/j.freeradbiomed.2005.08.037; Spindler SR, 2011, AGE DORDR, V34, P111; Spindler SR, 2007, GERONTOLOGY, V53, P306, DOI 10.1159/000103924; Spindler SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029782; Spindler SR, 2010, AGEING RES REV, V9, P324, DOI 10.1016/j.arr.2009.10.003; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; WILLIS RA, 1990, P NATL ACAD SCI USA, V87, P8928, DOI 10.1073/pnas.87.22.8928; Zhao JJ, 2000, J MASS SPECTROM, V35, P1133, DOI 10.1002/1096-9888(200009)35:9<1133::AID-JMS42>3.0.CO;2-X	47	40	40	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39581	10.1371/journal.pone.0039581	http://dx.doi.org/10.1371/journal.pone.0039581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737247	Green Published, Green Submitted, gold			2022-12-27	WOS:000305695100046
J	Kalinichenko, SV; Itoh, K; Korobko, EV; Sokol, SY; Buchman, VL; Korobko, IV				Kalinichenko, Svetlana V.; Itoh, Keiji; Korobko, Elena V.; Sokol, Sergei Y.; Buchman, Vladimir L.; Korobko, Igor V.			Identification of Nedd4 E3 Ubiquitin Ligase as a Binding Partner and Regulator of MAK-V Protein Kinase	PLOS ONE			English	Article							MOUSE; EXPRESSION; CLONING; DOMAIN; DEGRADATION; METASTASIS; CELLS; HUNK; PHOSPHORYLATION; RECEPTOR	MAK-V/Hunk is a scantily characterized AMPK-like protein kinase. Recent findings identified MAK-V as a pro-survival and anti-apoptotic protein and revealed its role in embryonic development as well as in tumorigenesis and metastasis. However molecular mechanisms of MAK-V action and regulation of its activity remain largely unknown. We identified Nedd4 as an interaction partner for MAK-V protein kinase. However, this HECT-type E3 ubiquitin ligase is not involved in the control of MAK-V degradation by the ubiquitin-proteasome system that regulates MAK-V abundance in cells. However, Nedd4 in an ubiquitin ligase-independent manner rescued developmental defects in Xenopus embryos induced by MAK-V overexpression, suggesting physiological relevance of interaction between MAK-V and Nedd4. This identifies Nedd4 as the first known regulator of MAK-V function.	[Kalinichenko, Svetlana V.; Korobko, Elena V.; Korobko, Igor V.] Russian Acad Sci, Inst Gene Biol, Moscow, Russia; [Itoh, Keiji; Sokol, Sergei Y.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY USA; [Buchman, Vladimir L.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Icahn School of Medicine at Mount Sinai; Cardiff University	Kalinichenko, SV (corresponding author), Russian Acad Sci, Inst Gene Biol, Moscow, Russia.	igorvk@igb.ac.ru	Kalinichenko, Svetlana V./AAY-3344-2020; Buchman, Vladimir L/A-4814-2010; Korobko, Elena/AAP-1193-2021	Buchman, Vladimir L/0000-0002-7631-8352; Sokol, Sergei/0000-0002-3963-9202; Korobko, Elena/0000-0002-9752-9714	Russian Foundation for Basic Research; Molecular and Cell Biology Program of the Presidium of Russian academy of sciences; Wellcome Trust [071269]; INTAS Young Scientist Fellowship	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Molecular and Cell Biology Program of the Presidium of Russian academy of sciences; Wellcome Trust(Wellcome TrustEuropean Commission); INTAS Young Scientist Fellowship(INTAS)	The work was supported by grants from Russian Foundation for Basic Research, Molecular and Cell Biology Program of the Presidium of Russian academy of sciences, and the Wellcome Trust Short Term Travel Grant 071269 and INTAS Young Scientist Fellowship to IVK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchman VL, 2002, GENE, V295, P13, DOI 10.1016/S0378-1119(02)00821-1; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; Fotia AB, 2006, INT J BIOCHEM CELL B, V38, P472, DOI 10.1016/j.biocel.2005.11.006; Gardner HP, 2000, GENOMICS, V63, P46, DOI 10.1006/geno.1999.6078; Guo L, 2007, NEUROSCIENCE, V145, P100, DOI 10.1016/j.neuroscience.2006.11.042; Higashi Y, 2008, AM J PHYSIOL-HEART C, V295, pH1684, DOI 10.1152/ajpheart.00548.2008; Jaleel M, 2006, BIOCHEM J, V394, P545, DOI 10.1042/BJ20051844; Kalinichenko SV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P278, DOI 10.1134/S0006297908030061; Kalinichenko SV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P196, DOI 10.1134/S0006297911020052; Kamynina E, 2001, AM J PHYSIOL-RENAL, V281, pF469, DOI 10.1152/ajprenal.2001.281.3.F469; Kibardin A, 2006, DEVELOPMENT, V133, P2845, DOI 10.1242/dev.02445; Kiselev SL, 1998, J BIOL CHEM, V273, P18633, DOI 10.1074/jbc.273.29.18633; Korobko E, 2005, FEBS J, V272, P37, DOI 10.1111/j.1432-1033.2004.04399.x; Korobko E V, 2000, Dokl Biochem, V370, P1; Korobko IV, 2007, DOKL BIOCHEM BIOPHYS, V412, P37, DOI 10.1134/S1607672907010115; Korobko I. V., 2004, Arkhiv Patologii, V66, P6; Korobko IV, 2010, CELL CYCLE, V9, P4248, DOI 10.4161/cc.9.20.13592; Korobko IV, 2000, MOL GEN GENET, V264, P411, DOI 10.1007/s004380000293; Korobko IV, 1997, DOKL AKAD NAUK+, V354, P554; Kumar S, 1997, GENOMICS, V40, P435, DOI 10.1006/geno.1996.4582; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Murphy JM, 2007, P NATL ACAD SCI USA, V104, P14336, DOI 10.1073/pnas.0703012104; Quintela-Fandino M, 2010, P NATL ACAD SCI USA, V107, P2622, DOI 10.1073/pnas.0914492107; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Sudol M, 1996, TRENDS BIOCHEM SCI, V21, P161, DOI 10.1016/0968-0004(96)30018-2; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Vasilescu J, 2007, J PROTEOME RES, V6, P298, DOI 10.1021/pr060438j; Wertheim GBW, 2009, P NATL ACAD SCI USA, V106, P15855, DOI 10.1073/pnas.0906993106; Xiong HB, 2005, J BIOL CHEM, V280, P23531, DOI 10.1074/jbc.M414296200; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yeh ES, 2011, J CLIN INVEST, V121, P866, DOI 10.1172/JCI42928	31	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39505	10.1371/journal.pone.0039505	http://dx.doi.org/10.1371/journal.pone.0039505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745772	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000305693200085
J	Li, J; Qiu, SJ; She, WM; Wang, FP; Gao, H; Li, L; Tu, CT; Wang, JY; Shen, XZ; Jiang, W				Li, Jing; Qiu, Shuang-Jian; She, Wei-Min; Wang, Fu-Ping; Gao, Hong; Li, Lei; Tu, Chuan-Tao; Wang, Ji-Yao; Shen, Xi-Zhong; Jiang, Wei			Significance of the Balance between Regulatory T (Treg) and T Helper 17 (Th17) Cells during Hepatitis B Virus Related Liver Fibrosis	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; STELLATE CELLS; CONCANAVALIN-A; TGF-BETA; INFLAMMATION	Background: Hepatitis B virus-related liver fibrosis (HBV-LF) always progresses from inflammation to fibrosis. However, the relationship between these two pathological conditions is not fully understood. Here, it is postulated that the balance between regulatory T (Treg) cells and T helper 17 (Th17) cells as an indicator of inflammation may predict fibrosis progression of HBV-LF. Methodology/Principal Findings: The frequencies and phenotypes of peripheral Treg and Th17 cells of seventy-seven HBeAg-positive chronic hepatitis B (CHB) patients who underwent liver biopsies and thirty healthy controls were determined by flow cytometry. In the periphery of CHB patients, both Treg and Th17 frequencies were significantly increased and correlated, and a lower Treg/Th17 ratio always indicated more liver injury and fibrosis progression. To investigate exact effects of Treg and Th17 cells during HBV-LF, a series of in vitro experiments were performed using purified CD4(+), CD4(+)CD25(+), or CD4(+)CD25(-) cells from the periphery, primary human hepatic stellate cells (HSCs) isolated from healthy liver specimens, human recombinant interleukin (IL)-17 cytokine, anti-IL-17 antibody and HBcAg. In response to HBcAg, CD4(+)CD25(+) cells significantly inhibited cell proliferation and cytokine production (especially IL-17 and IL-22) by CD4(+)CD25(-) cells in cell-contact and dose-dependent manners. In addition, CD4(+) cells from CHB patients, compared to those from HC subjects, dramatically promoted proliferation and activation of human HSCs. Moreover, in a dramatically dose-dependent manner, CD4(+)CD25(+) cells from CHB patients inhibited, whereas recombinant IL-17 response promoted the proliferation and activation of HSCs. Finally, in vivo evidence about effects of Treg/Th17 balance during liver fibrosis was obtained in concanavalin A-induced mouse fibrosis models via depletion of CD25(+) or IL-17(+) cells, and it's observed that CD25 depletion promoted, whereas IL-17 depletion, alleviated liver injury and fibrosis progression. Conclusions/Significance: The Treg/Th17 balance might influence fibrosis progression in HBV-LF via increase of liver injury and promotion of HSCs activation.	[Li, Jing; She, Wei-Min; Wang, Fu-Ping; Gao, Hong; Li, Lei; Tu, Chuan-Tao; Wang, Ji-Yao; Shen, Xi-Zhong; Jiang, Wei] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Qiu, Shuang-Jian] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Jiang, W (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China.	jiang.wei@zs-hospital.sh.cn	Tu, Chuantao/AAL-5059-2021; Tu, Chuantao/AAX-2495-2021		National Nature Science Foundation of China [81070341]; Shanghai Nature Science Foundation [09ZR1406000]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Nature Science Foundation	This study was supported by grants from the National Nature Science Foundation of China (No. 81070341 http://www.nsfc.gov.cn) and Shanghai Nature Science Foundation (No. 09ZR1406000 http://www.stcsm.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bissell DM, 2010, SEMIN LIVER DIS, V30, P211, DOI 10.1055/s-0030-1255350; Chen CH, 2006, HEPATOLOGY, V44, P1171, DOI 10.1002/hep.21379; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Fan YH, 2011, VIROL J, V8, DOI [10.1186/1743-422X-8-492, 10.1186/1743-422X-8-17]; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Liu CH, 2003, J BIOL CHEM, V278, P11721, DOI 10.1074/jbc.M207728200; Lo Re S, 2010, J IMMUNOL, V184, P6367, DOI 10.4049/jimmunol.0900459; Lu FM, 2009, CHINESE MED J-PEKING, V122, P3, DOI 10.3760/cma.j.issn.0366-6999.2009.01.001; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Mou ZR, 2010, INFECT IMMUN, V78, P5271, DOI 10.1128/IAI.00168-10; Nan XP, 2010, VIRAL IMMUNOL, V23, P63, DOI 10.1089/vim.2009.0061; Niu YH, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-47; Peng GP, 2008, IMMUNOLOGY, V123, P57, DOI 10.1111/j.1365-2567.2007.02691.x; Rong G, 2009, CLIN EXP IMMUNOL, V156, P217, DOI 10.1111/j.1365-2249.2009.03898.x; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Stephens LA, 2005, P NATL ACAD SCI USA, V102, P17418, DOI 10.1073/pnas.0507454102; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Tanabe J, 2007, IMMUNOLOGY, V122, P562, DOI 10.1111/j.1365-2567.2007.02672.x; Vinas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392; Wang WH, 2012, RHEUMATOL INT, V32, P887, DOI 10.1007/s00296-010-1710-0; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Wei HX, 2008, J IMMUNOL, V181, P7221, DOI 10.4049/jimmunol.181.10.7221; Weng YQ, 2008, J CANCER RES CLIN, V134, P179, DOI 10.1007/s00432-007-0267-0; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011; Yu MC, 2004, HEPATOLOGY, V40, P1312, DOI 10.1002/hep.20488; Zhang JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013869; Zhang JY, 2010, HEPATOLOGY, V51, P81, DOI 10.1002/hep.23273; Zhang YW, 2007, J SURG RES, V142, P175, DOI 10.1016/j.jss.2007.01.024; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	31	85	98	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39307	10.1371/journal.pone.0039307	http://dx.doi.org/10.1371/journal.pone.0039307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745730	gold, Green Published, Green Submitted			2022-12-27	WOS:000305693200060
J	Liu, ZJ; Li, D; Zhao, WJ; Zheng, XL; Wang, J; Wang, EK				Liu, Zuojia; Li, Dan; Zhao, Wenjing; Zheng, Xiliang; Wang, Jin; Wang, Erkang			A Potent Lead Induces Apoptosis in Pancreatic Cancer Cells	PLOS ONE			English	Article							CYTOCHROME-C; INHIBITION; GEMCITABINE; RESISTANCE; CASPASE-3; THERAPY; GROWTH	Pancreatic cancer is considered a lethal and treatment-refractory disease. To obtain a potent anticancer drug, the cytotoxic effect of 2-(benzo[d]oxazol-3(2H)-ylmethyl)-5-((cyclohexylamino) methyl)benzene-1,4-diol, dihydrochloride (NSC48693) on human pancreatic cancer cells CFPAC-1, MiaPaCa-2, and BxPC-3 was assessed in vitro. The proliferation of CFPAC-1, MiaPaCa-2, and BxPC-3 is inhibited with IC50 value of 12.9 +/- 0.2, 20.6 +/- 0.3, and 6.2 +/- 0.6 mu M at 48 h, respectively. This discovery is followed with additional analysis to demonstrate that NSC48693 inhibition is due to induction of apoptosis, including Annexin V staining, chromatins staining, and colony forming assays. It is further revealed that NSC48693 induces the release of cytochrome c, reduces mitochondrial membrane potential, generates reactive oxygen species, and activates caspase. These results collectively indicate that NSC48693 mainly induces apoptosis of CFPAC-1, MiaPaCa-2, and BxPC-3 cells by the mitochondrial-mediated apoptotic pathway. Excitingly, the study highlights an encouraging inhibition effect that human embryonic kidney (HEK-293) and liver (HL-7702) cells are more resistant to the antigrowth effect of NSC48693 compared to the three cancer cell lines. From this perspective, NSC48693 should help to open up a new opportunity for the treatment of patients with pancreatic cancer.	[Liu, Zuojia; Li, Dan; Zhao, Wenjing; Zheng, Xiliang; Wang, Jin; Wang, Erkang] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Wang, Jin] SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Liu, ZJ (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China.	jin.wang.1@stonybrook.edu; ekwang@ciac.jl.cn	, 汪尔康/P-1748-2019; 李, 丹/O-1545-2017	李, 丹/0000-0001-5904-871X	National Natural Science Foundation of China [90713022, 20735003]; National Science Foundation; National Institutes of Health	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Natural Science Foundation of China with the grants of No. 90713022 and 20735003. J. Wang thanks National Science Foundation and National Institutes of Health for financial supports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson R, 2009, SCAND J GASTROENTERO, V44, P782, DOI 10.1080/00365520902745039; Beauparlant P, 2003, CURR OPIN DRUG DISC, V6, P179; Blanc C, 2000, CANCER RES, V60, P4386; Bouchier-Hayes L, 2008, METHODS, V44, P222, DOI 10.1016/j.ymeth.2007.11.007; Evans Douglas B., 1997, P1054; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; Heerdt BG, 1998, CANCER RES, V58, P2869; Hegardt C, 2001, EXP CELL RES, V266, P333, DOI 10.1006/excr.2001.5230; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Karaguni IM, 2002, BIOORG MED CHEM LETT, V12, P709, DOI 10.1016/S0960-894X(01)00839-3; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KOHL NE, 1993, SCIENCE, V260, P1934, DOI 10.1126/science.8316833; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Ma D, 2011, AM J BIOMED SCI, V3, P278, DOI DOI 10.5099/AJ110400278; McCollum AK, 2006, CANCER RES, V66, P10967, DOI 10.1158/0008-5472.CAN-06-1629; Mimeault M, 2008, CLIN PHARMACOL THER, V83, P673, DOI 10.1038/sj.clpt.6100296; Min JK, 2006, BIOCHEM BIOPH RES CO, V349, P987, DOI 10.1016/j.bbrc.2006.08.129; Murtaza I, 2009, CANCER RES, V69, P1156, DOI 10.1158/0008-5472.CAN-08-2917; Nangia-Makker P, 2007, INT J CANCER, V121, P884, DOI 10.1002/ijc.22733; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Oberstein PE, 2011, J PANCREAS, V12, P96; Ren DD, 2006, TOXICOL IN VITRO, V20, P1411, DOI 10.1016/j.tiv.2006.06.011; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Stahnke K, 2004, APOPTOSIS, V9, P457, DOI 10.1023/B:APPT.0000031454.62937.fa; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Taraphdar AK, 2001, CURR SCI INDIA, V80, P1387; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Wang J, 2007, PHYS REV LETT, V99; Xiao D, 2006, CARCINOGENESIS, V27, P2223, DOI 10.1093/carcin/bgl087; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yip-Schneider MT, 2001, J PHARMACOL EXP THER, V298, P976; You BR, 2010, TOXICOL IN VITRO, V24, P1356, DOI 10.1016/j.tiv.2010.04.009; Zou GM, 2008, MOL CANCER THER, V7, P2012, DOI 10.1158/1535-7163.MCT-08-0113	35	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e37841	10.1371/journal.pone.0037841	http://dx.doi.org/10.1371/journal.pone.0037841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745658	gold, Green Submitted, Green Published			2022-12-27	WOS:000305693200006
J	Ritthipichai, K; Nan, YC; Bossis, I; Zhang, YJ				Ritthipichai, Krit; Nan, Yuchen; Bossis, Ioannis; Zhang, Yanjin			Viral FLICE Inhibitory Protein of Rhesus Monkey Rhadinovirus Inhibits Apoptosis by Enhancing Autophagosome Formation	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; SUPEROXIDE-DISMUTASE; MACAQUE RHADINOVIRUS; MORPHOLINO OLIGOMERS; REGULATORY SUBUNIT; DNA-SEQUENCES; VIRUS; CELLS; DEATH; EXPRESSION	Rhesus monkey rhadinovirus (RRV) is a gamma-2 herpesvirus closely related to human herpesvirus 8 (HHV8). RRV encodes viral FLICE inhibitory protein (vFLIP), which has death effector domains. Little is known about RRV vFLIP. This study intended to examine its function in apoptosis. Here we found that RRV vFLIP inhibits apoptosis induced by tumor necrosis factor-alpha (TNF-alpha) and cycloheximide. In HeLa cells with vFLIP expression, the cleavage of poly [ADP-ribose] polymerase 1 (PARP-1) and activities of caspase 3, 7, and 9 were much lower than those in controls. Cell viability of HeLa cells with vFLIP expression was significantly higher than control cells after apoptosis induction. However, RRV vFLIP appears unable to induce NF-kappa B signaling when tested in NF-kappa B reporter assay. RRV vFLIP was able to enhance cell survival under starved conditions or apoptosis induction. At early time points after apoptosis induction, autophagosome formation was enhanced and LC3-II level was elevated in cells with vFLIP and, when autophagy was blocked with chemical inhibitors, these cells underwent apoptosis. Moreover, RRV latent infection of BJAB B-lymphoblastoid cells protects the cells against apoptosis by enhancing autophagy to maintain cell survival. Knockdown of vFLIP expression in the RRV-infected BJAB cells with siRNA abolished the protection against apoptosis. These results indicate that vFLIP protects cells against apoptosis by enhancing autophagosome formation to extend cell survival. The finding of vFLIP's inhibition of apoptosis via the autophagy pathway provides insights of vFLIP in RRV pathogenesis.	[Ritthipichai, Krit; Nan, Yuchen; Zhang, Yanjin] Univ Maryland, VA MD Reg Coll Vet Med, Mol Virol Lab, College Pk, MD 20742 USA; [Ritthipichai, Krit; Nan, Yuchen; Bossis, Ioannis; Zhang, Yanjin] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA; [Bossis, Ioannis] Univ Maryland, VA MD Reg Coll Vet Med, Cell Biol Lab, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Ritthipichai, K (corresponding author), Univ Maryland, VA MD Reg Coll Vet Med, Mol Virol Lab, College Pk, MD 20742 USA.	zhangyj@umd.edu	Nan, Yuchen/F-9917-2014; Nan, Yuchen/ABF-3746-2021; Zhang, Yanjin/H-5035-2019	Nan, Yuchen/0000-0002-4442-8004; Zhang, Yanjin/0000-0002-5847-3260	University of Maryland, College Park, MD	University of Maryland, College Park, MD	This work was supported by funds from University of Maryland, College Park, MD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Alexander L, 2000, J VIROL, V74, P3388, DOI 10.1128/JVI.74.7.3388-3398.2000; Bergquam EP, 1999, J VIROL, V73, P7874, DOI 10.1128/JVI.73.9.7874-7876.1999; Bilello JP, 2006, J VIROL, V80, P3644, DOI 10.1128/JVI.80.7.3644-3649.2006; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Desrosiers RC, 1997, J VIROL, V71, P9764, DOI 10.1128/JVI.71.12.9764-9769.1997; DeWire SM, 2002, J VIROL, V76, P9819, DOI 10.1128/JVI.76.19.9819-9831.2002; Fujimura M, 1999, J NEUROSCI, V19, P3414; Fulda S, 2000, CANCER RES, V60, P3947; Glykofrydes D, 2000, J VIROL, V74, P11919, DOI 10.1128/JVI.74.24.11919-11927.2000; Guasparri I, 2006, EMBO REP, V7, P114, DOI 10.1038/sj.embor.7400580; Hussain SP, 2004, CANCER RES, V64, P2350, DOI 10.1158/0008-5472.CAN-2287-2; Kannan H, 2009, J VIROL, V83, P6375, DOI 10.1128/JVI.02571-08; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; Mansfield KG, 1999, J VIROL, V73, P10320, DOI 10.1128/JVI.73.12.10320-10328.1999; Mavrakis M, 2007, AUTOPHAGY, V3, P151, DOI 10.4161/auto.3632; Mavrakis M, 2006, HUM MOL GENET, V15, P2962, DOI 10.1093/hmg/ddl239; MCCORD JM, 1988, FREE RADICAL BIO MED, V5, P363, DOI 10.1016/0891-5849(88)90109-8; NADOR RG, 1995, NEW ENGL J MED, V333, P943, DOI 10.1056/NEJM199510053331417; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Orzechowska BU, 2008, BLOOD, V112, P4227, DOI 10.1182/blood-2008-04-151498; Parravicini C, 1997, AM J PATHOL, V151, P1517; Patel D, 2008, ANTIVIR RES, V77, P95, DOI 10.1016/j.antiviral.2007.09.002; Rajawat Y, 2011, ANTIOXID REDOX SIGN, V14, P2165, DOI 10.1089/ars.2010.3491; Renne R, 2004, J MED PRIMATOL, V33, P1, DOI 10.1046/j.1600-0684.2003.00043.x; Ruff K, 2003, J MED PRIMATOL, V32, P1, DOI 10.1034/j.1600-0684.2003.00007.x; Sarid R, 2001, CELL DEATH DIFFER, V8, P1224, DOI 10.1038/sj.cdd.4400926; Schmitz I, 2004, J IMMUNOL, V172, P2194, DOI 10.4049/jimmunol.172.4.2194; Searles RP, 1999, J VIROL, V73, P3040, DOI 10.1128/JVI.73.4.3040-3053.1999; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Tanida I, 2010, METHODS MOL BIOL, V648, P193, DOI 10.1007/978-1-60761-756-3_13; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Thurau M, 2009, J VIROL, V83, P598, DOI 10.1128/JVI.00629-08; Wong SW, 1999, J EXP MED, V190, P827, DOI 10.1084/jem.190.6.827; Zhang YJ, 2007, ANTIVIR RES, V73, P12, DOI 10.1016/j.antiviral.2006.05.017	40	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39438	10.1371/journal.pone.0039438	http://dx.doi.org/10.1371/journal.pone.0039438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745754	gold, Green Published			2022-12-27	WOS:000305693200076
J	Tinta, T; Kogovsek, T; Malej, A; Turk, V				Tinta, Tinkara; Kogovsek, Tjasa; Malej, Alenka; Turk, Valentina			Jellyfish Modulate Bacterial Dynamic and Community Structure	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; AURELIA SP SCYPHOZOA; BIOMASS PRODUCTION; MARINE; BLOOMS; DECOMPOSITION; ZOOPLANKTON; POPULATIONS; ECOLOGY; AURITA	Jellyfish blooms have increased in coastal areas around the world and the outbreaks have become longer and more frequent over the past few decades. The Mediterranean Sea is among the heavily affected regions and the common bloom forming taxa are scyphozoans Aurelia aurita s.l., Pelagia noctiluca, and Rhizostoma pulmo. Jellyfish have few natural predators, therefore their carcasses at the termination of a bloom represent an organic-rich substrate that supports rapid bacterial growth, and may have a large impact on the surrounding environment. The focus of this study was to explore whether jellyfish substrate have an impact on bacterial community phylotype selection. We conducted in situ jellyfish enrichment experiment with three different jellyfish species. Bacterial dynamic together with nutrients were monitored to assess decaying jellyfish-bacteria dynamics. Our results show that jellyfish biomass is characterized by protein rich organic matter, which is highly bioavailable to 'jellyfish - associated' and 'free - living' bacteria, and triggers rapid shifts in bacterial population dynamics and composition. Based on 16S rRNA clone libraries and denaturing gradient gel electrophoresis (DGGE) analysis, we observed a rapid shift in community composition from unculturable Alphaproteobacteria to culturable species of Gammaproteobacteria and Flavobacteria. The results of sequence analyses of bacterial isolates and of total bacterial community determined by culture independent genetic analysis showed the dominance of the Pseudoalter-omonadaceae and the Vibrionaceae families. Elevated levels of dissolved proteins, dissolved organic and inorganic nutrient release, bacterial abundance and carbon production as well as ammonium concentrations characterized the degradation process. The biochemical composition of jellyfish species may influence changes in the amount of accumulated dissolved organic and inorganic nutrients. Our results can contribute insights into possible changes in bacterial population dynamics and nutrient pathways following jellyfish blooms which have important implications for ecology of coastal waters.	[Tinta, Tinkara; Kogovsek, Tjasa; Malej, Alenka; Turk, Valentina] Natl Inst Biol, Marine Biol Stn, Piran, Slovenia	National Institute of Biology - Slovenia	Tinta, T (corresponding author), Natl Inst Biol, Marine Biol Stn, Piran, Slovenia.	valentina.turk@mbss.org	Kogovsek, Tjasa/HGD-3803-2022; Kogovšek, Tjaša/AAW-4421-2021; turk, Valentina/AAV-8033-2020; Tinta, Tinkara/L-8912-2016	Kogovsek, Tjasa/0000-0002-0887-4701; Malej, Alenka/0000-0001-6650-4795; Tinta, Tinkara/0000-0001-6740-8973	Slovenian Research Agency, Ministry of Education, Science, Culture and Sport in Slovenia: the project Coastal Ocean Research [P1-0237];  [1000-07-310029]	Slovenian Research Agency, Ministry of Education, Science, Culture and Sport in Slovenia: the project Coastal Ocean Research; 	This research was supported by grants from the Slovenian Research Agency, Ministry of Education, Science, Culture and Sport in Slovenia: the project Coastal Ocean Research (# P1-0237), and Grant #1000-07-310029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colombo GA, 2009, HYDROBIOLOGIA, V616, P99, DOI 10.1007/s10750-008-9587-6; Attrill MJ, 2007, LIMNOL OCEANOGR, V52, P480, DOI 10.4319/lo.2007.52.1.0480; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; Baxter EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018529; BEERS JR, 1966, LIMNOL OCEANOGR, V11, P520; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bickel SL, 2010, MAR BIOL, V157, P1613, DOI 10.1007/s00227-010-1434-4; Bidle KD, 2001, LIMNOL OCEANOGR, V46, P1606, DOI 10.4319/lo.2001.46.7.1606; Billett DSM, 2006, LIMNOL OCEANOGR, V51, P2077, DOI 10.4319/lo.2006.51.5.2077; Bostrom KH, 2004, LIMNOL OCEANOGR-METH, V2, P365, DOI 10.4319/lom.2004.2.365; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brotz L, 2012, HYDROBIOLOGIA, V690, P3, DOI 10.1007/s10750-012-1039-7; Burnett JW, 2001, HYDROBIOLOGIA, V451, P1, DOI 10.1023/A:1011883019506; Clarke K.R., 2006, PRIMER V6 USER MANUA; Condon RH, 2012, BIOSCIENCE, V62, P160, DOI 10.1525/bio.2012.62.2.9; Condon RH, 2011, P NATL ACAD SCI USA, V108, P10225, DOI 10.1073/pnas.1015782108; Cottrell MT, 2003, LIMNOL OCEANOGR, V48, P168, DOI 10.4319/lo.2003.48.1.0168; Delannoy CMJ, 2011, AQUACULTURE, V311, P255, DOI 10.1016/j.aquaculture.2010.11.033; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Dong ZJ, 2010, MAR POLLUT BULL, V60, P954, DOI 10.1016/j.marpolbul.2010.04.022; Eilers H, 2000, APPL ENVIRON MICROB, V66, P4634, DOI 10.1128/AEM.66.11.4634-4640.2000; Elifantz H, 2005, APPL ENVIRON MICROB, V71, P7799, DOI 10.1128/AEM.71.12.7799-7805.2005; Frost JR, 2012, HYDROBIOLOGIA, V690, P247, DOI 10.1007/s10750-012-1042-z; Garren M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007319; HANSSON LJ, 1995, MAR BIOL, V121, P527, DOI 10.1007/BF00349462; Hay S, 2006, CURR BIOL, V16, pR679, DOI 10.1016/j.cub.2006.08.010; Kirchman DL, 2005, LIMNOL OCEANOGR, V50, P1697, DOI 10.4319/lo.2005.50.5.1697; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Kogovsek T., 2012, THESIS U LJUBLJANA L; Kogovsek T, 2010, HYDROBIOLOGIA, V645, P81, DOI 10.1007/s10750-010-0217-8; KROM MD, 1991, LIMNOL OCEANOGR, V36, P424, DOI 10.4319/lo.1991.36.3.0424; Lebrato M, 2011, LIMNOL OCEANOGR, V56, P1917, DOI 10.4319/lo.2011.56.5.1917; Long RA, 2001, APPL ENVIRON MICROB, V67, P4975, DOI 10.1128/AEM.67.11.4975-4983.2001; Malej A, 2007, MAR BIOL, V151, P827, DOI 10.1007/s00227-006-0503-1; Malej A, 2003, J PLANKTON RES, V25, P949, DOI 10.1093/plankt/25.8.949; Malmstrom RR, 2005, APPL ENVIRON MICROB, V71, P2979, DOI 10.1128/AEM.71.6.2979-2986.2005; Martinez J, 1996, AQUAT MICROB ECOL, V10, P223, DOI 10.3354/ame010223; Matsumura K, 2005, J MAR BIOL ASSOC UK, V85, P563, DOI 10.1017/S0025315405011483; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nagata T, 1997, ADV MICROB ECOL, V15, P81; Parsons T.R., 1984, MANUAL CHEM BIOL MET; Pitt KA, 2009, HYDROBIOLOGIA, V616, P133, DOI 10.1007/s10750-008-9584-9; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Purcell JE, 2001, MAR ECOL PROG SER, V210, P67, DOI 10.3354/meps210067; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2012, ANNU REV MAR SCI, V4, P209, DOI 10.1146/annurev-marine-120709-142751; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; REICHENBACH H, 1992, PROKARYOTES, V2, P3631, DOI DOI 10.1007/978-1-4757-2191-1_37; Riemann L, 2006, MAR ECOL PROG SER, V325, P29, DOI 10.3354/meps325029; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; STOECKER DK, 1987, J PLANKTON RES, V9, P901, DOI 10.1093/plankt/9.5.901; Tang KW, 2006, AQUAT MICROB ECOL, V45, P219, DOI 10.3354/ame045219; Tang KW, 2010, AQUAT MICROB ECOL, V61, P261, DOI 10.3354/ame01424; Tang KW, 2009, AQUAT MICROB ECOL, V57, P89, DOI 10.3354/ame01331; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Tinta T, 2010, HYDROBIOLOGIA, V645, P179, DOI 10.1007/s10750-010-0223-x; Titelman J, 2006, MAR ECOL PROG SER, V325, P43, DOI 10.3354/meps325043; Turk V, 2008, MAR ECOL-EVOL PERSP, V29, P495, DOI 10.1111/j.1439-0485.2008.00250.x; West EJ, 2009, HYDROBIOLOGIA, V616, P151, DOI 10.1007/s10750-008-9586-7; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299	65	52	54	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39274	10.1371/journal.pone.0039274	http://dx.doi.org/10.1371/journal.pone.0039274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745726	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200056
J	Darling, KEA; Hugli, O; Mamin, R; Cellerai, C; Martenet, S; Berney, A; Peters, S; Du Pasquier, RA; Bodenmann, P; Cavassini, M				Darling, Katharine E. A.; Hugli, Olivier; Mamin, Rachel; Cellerai, Cristina; Martenet, Sebastien; Berney, Alexandre; Peters, Solange; Du Pasquier, Renaud A.; Bodenmann, Patrick; Cavassini, Matthias			HIV Testing Practices by Clinical Service before and after Revised Testing Guidelines in a Swiss University Hospital	PLOS ONE			English	Article							OPT; UK; TRANSMISSION; ADMISSIONS; INFECTION; DIAGNOSIS; COHORT; ADULTS; HEALTH; IMPACT	Objectives: To determine 1) HIV testing practices in a 1400-bed university hospital where local HIV prevalence is 0.4% and 2) the effect on testing practices of national HIV testing guidelines, revised in March 2010, recommending Physician-Initiated Counselling and Testing (PICT). Methods: Using 2 hospital databases, we determined the number of HIV tests performed by selected clinical services, and the number of patients tested as a percentage of the number seen per service ('testing rate'). To explore the effect of the revised national guidelines, we examined testing rates for two years pre- and two years post-PICT guideline publication. Results: Combining the clinical services, 253,178 patients were seen and 9,183 tests were performed (of which 80 tested positive, 0.9%) in the four-year study period. The emergency department (ED) performed the second highest number of tests, but had the lowest testing rates (0.9-1.1%). Of inpatient services, neurology and psychiatry had higher testing rates than internal medicine (19.7% and 9.6% versus 8%, respectively). There was no significant increase in testing rates, either globally or in the majority of the clinical services examined, and no increase in new HIV diagnoses post-PICT recommendations. Conclusions: Using a simple two-database tool, we observe no global improvement in HIV testing rates in our hospital following new national guidelines but do identify services where testing practices merit improvement. This study may show the limit of PICT strategies based on physician risk assessment, compared to the opt-out approach.	[Darling, Katharine E. A.; Cavassini, Matthias] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland; [Hugli, Olivier] Univ Lausanne Hosp, Emergency Dept, Lausanne, Switzerland; [Mamin, Rachel; Cellerai, Cristina] Univ Lausanne Hosp, Serv Immunol & Allergy, Lausanne, Switzerland; [Berney, Alexandre] Univ Lausanne Hosp, Psychiat Serv, Lausanne, Switzerland; [Peters, Solange] Univ Lausanne Hosp, Serv Oncol, Lausanne, Switzerland; [Du Pasquier, Renaud A.] Univ Lausanne Hosp, Serv Neurol, Lausanne, Switzerland; [Bodenmann, Patrick] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Darling, KEA (corresponding author), Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland.		Hugli, Olivier/AAA-7057-2020; peters, solange/ABF-2187-2020; Du Pasquier, Renaud/O-8588-2016; cavassini, matthias/F-8987-2017	Du Pasquier, Renaud/0000-0002-2786-3434; Hugli, Olivier/0000-0003-2312-1625; Darling, Katharine/0000-0003-1449-3873; Berney, Alexandre/0000-0001-9535-1222; cavassini, matthias/0000-0003-0933-7833; Bodenmann, Patrick/0000-0002-1058-1035				[Anonymous], 2006, MMWR RECOMM REP; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Burke RC, 2007, AIDS, V21, P1617, DOI 10.1097/QAD.0b013e32823f91ff; Cave J, 2009, CLIN MED, V9, P320, DOI 10.7861/clinmedicine.9-4-320; Chadborn TR, 2006, AIDS, V20, P2371, DOI 10.1097/QAD.0b013e32801138f7; Chiao EY, 2010, JAMA-J AM MED ASSOC, V304, P334, DOI 10.1001/jama.2010.752; Federal Office of Public Health website, 2010, FED OFF PUBL HLTH B, V11/10, P364; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Haukoos JS, 2012, ARCH INTERN MED, V172, P20, DOI 10.1001/archinternmed.2011.538; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Kecojevic A, 2011, ANN EMERG MED, V58, pS151, DOI 10.1016/j.annemergmed.2011.03.040; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Mickan S, 2011, POSTGRAD MED J, V87, P670, DOI 10.1136/pgmj.2010.116012; Pavie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011581; Peck L, 2010, QJM-INT J MED, V103, P147, DOI 10.1093/qjmed/hcp185; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Smith RD, 2010, AIDS, V24, P2109, DOI 10.1097/QAD.0b013e32833c7b9c; Sullivan AK, 2005, BRIT MED J, V330, P1301, DOI 10.1136/bmj.38398.590602.E0; Taegtmeyer M, 2008, JICS, V9, P37; Udayaraj UP, 2009, CLIN MED, V9, P333, DOI 10.7861/clinmedicine.9-4-333; UNAIDS, 2009, UNAIDS EP FIG 2009; White DAE, 2011, ANN EMERG MED, V58, pS53, DOI 10.1016/j.annemergmed.2011.03.025; Wolbers M, 2008, HIV MED, V9, P397, DOI 10.1111/j.1468-1293.2008.00566.x	24	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39299	10.1371/journal.pone.0039299	http://dx.doi.org/10.1371/journal.pone.0039299			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761757	Green Submitted, Green Published, gold			2022-12-27	WOS:000305826400013
J	He, YH; Yu, Y; Zhang, Y; Song, JZ; Mitra, A; Zhang, Y; Wang, YC; Sun, DX; Zhang, SL				He, Yanghua; Yu, Ying; Zhang, Yuan; Song, Jiuzhou; Mitra, Apratim; Zhang, Yi; Wang, Yachun; Sun, Dongxiao; Zhang, Shengli			Genome-Wide Bovine H3K27me3 Modifications and the Regulatory Effects on Genes Expressions in Peripheral Blood Lymphocytes	PLOS ONE			English	Article							SOMATIC-CELL COUNTS; HEIFER REARING CONDITIONS; HISTONE MODIFICATIONS; CLINICAL MASTITIS; HOLSTEIN; MILK; PARITY; COWS; H3; TRIMETHYLATION	Background: Gene expression of lymphocytes was found to be influenced by histone methylation in mammals and trimethylation of lysine 27 on histone H3 (H3K27me3) normally represses genes expressions. Peripheral blood lymphocytes are the main source of somatic cells in the milk of dairy cows that vary frequently in response to the infection or injury of mammary gland and number of parities. Methods: The genome-wide status of H3K27me3 modifications on blood lymphocytes in lactating Holsteins was performed via ChIP-Seq approach. Combined with digital gene expression (DGE) technique, the regulation effects of H3K27me3 on genes expressions were analyzed. Results: The ChIP-seq results showed that the peaks of H3K27me3 in cows lymphocytes were mainly enriched in the regions of up20K (similar to 50%), down20K (similar to 30%) and intron (similar to 28%) of the genes. Only similar to 3% peaks were enriched in exon regions. Moreover, the highest H3K27me3 modification levels were mainly around the 2 Kb upstream of transcriptional start sites (TSS) of the genes. Using conjoint analysis with DGE data, we found that H3K27me3 marks tended to repress target genes expressions throughout whole gene regions especially acting on the promoter region. A total of 53 differential expressed genes were detected in third parity cows compared to first parity, and the 25 down-regulated genes (PSEN2 etc.) were negatively correlated with H3K27me3 levels on up2Kb to up1Kb of the genes, while the up-regulated genes were not showed in this relationship. Conclusions: The first blueprint of bovine H3K27me3 marks that mediates gene silencing was generated. H3K27me3 plays its repressed role mainly in the regulatory region in bovine lymphocytes. The up2Kb to up1Kb region of the down-regulated genes in third parity cows could be potential target of H3K27me3 regulation. Further studies are warranted to understand the regulation mechanisms of H3K27me3 on somatic cell count increases and milk losses in latter parities of cows.	[He, Yanghua; Yu, Ying; Zhang, Yuan; Zhang, Yi; Wang, Yachun; Sun, Dongxiao; Zhang, Shengli] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Agr Anim Genet & Breeding, Beijing 100094, Peoples R China; [Song, Jiuzhou; Mitra, Apratim] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	China Agricultural University; University System of Maryland; University of Maryland College Park	He, YH (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Agr Anim Genet & Breeding, Beijing 100094, Peoples R China.	yuying@cau.edu.cn; changy@cau.edu.cn	Song, Jiuzhou/AAD-6440-2020		Ministry of Education of People's Republic of China [2011JS006]; Modern Agro-industry Technology Research System [CARS-37]; National Science and Technology Project in Rural Areas [2011BAD28B02]; National Key Technologies R D Program [2008AA101002, 2008BADB2B03-05]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]	Ministry of Education of People's Republic of China(Ministry of Education, China); Modern Agro-industry Technology Research System; National Science and Technology Project in Rural Areas; National Key Technologies R D Program(National Key Technology R&D Program); Program for Changjiang Scholar and Innovation Research Team in University	This work was supported by Basic Research from the Ministry of Education of the People's Republic of China (2011JS006), Modern Agro-industry Technology Research System (CARS-37), the Twelfth Five-Year plan of National Science and Technology Project in Rural Areas (2011BAD28B02), the National Key Technologies R & D Program (2008AA101002, 2008BADB2B03-05) and the Program for Changjiang Scholar and Innovation Research Team in University (IRT1191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcobia I, 2003, EXP CELL RES, V290, P358, DOI 10.1016/S0014-4827(03)00335-5; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beglopoulos V, 2004, J BIOL CHEM, V279, P46907, DOI 10.1074/jbc.M409544200; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Breton A, 2010, J REPROD DEVELOP, V56, P379, DOI 10.1262/jrd.09-182A; Caraviello DZ, 2005, J DAIRY SCI, V88, P804, DOI 10.3168/jds.S0022-0302(05)72745-4; Crispi KT, 2010, P 9 WORLD C GEN APPL, P1; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Derks S, 2009, CARCINOGENESIS, V30, P1041, DOI 10.1093/carcin/bgp073; Durr JW, 2008, LIVEST SCI, V117, P225, DOI 10.1016/j.livsci.2007.12.004; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Hare E, 2006, J DAIRY SCI, V89, P3713, DOI 10.3168/jds.S0022-0302(06)72412-2; Hultgren J, 2009, J DAIRY SCI, V92, P3274, DOI 10.3168/jds.2008-1678; Hultgren J, 2009, PREV VET MED, V89, P255, DOI 10.1016/j.prevetmed.2009.02.012; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kioussis D, 2007, SCIENCE, V317, P620, DOI 10.1126/science.1143777; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Koc A, 2008, TURK J VET ANIM SCI, V32, P13; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lee CG, 2009, YONSEI MED J, V50, P322, DOI 10.3349/ymj.2009.50.3.322; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Ohtsuka H, 2010, CAN J VET RES, V74, P130; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rivas AL, 2000, CAN J VET RES, V64, P232; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Ross PJ, 2008, REPRODUCTION, V136, P777, DOI 10.1530/REP-08-0045; Rupp R, 2000, PREV VET MED, V46, P99, DOI 10.1016/S0167-5877(00)00142-2; Singh K, 2010, J MAMMARY GLAND BIOL, V15, P101, DOI 10.1007/s10911-010-9164-2; Szalkowski AM, 2010, BRIEF BIOINFORM, P1; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; ten Napel J, 2009, J DAIRY SCI, V92, P1253, DOI 10.3168/jds.2007-0824; Vivier E, 2009, CELL HOST MICROBE, V6, P493, DOI 10.1016/j.chom.2009.12.001; Walsh S, 2007, J DAIRY SCI, V90, P5767, DOI 10.3168/jds.2007-0389; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wei YK, 2008, MOL CARCINOGEN, V47, P701, DOI 10.1002/mc.20413; Woo HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034615; Wu X, 2011, ZYGOTE, V19, P31, DOI 10.1017/S0967199410000328; Xu Min, 2008, Yi Chuan, V30, P463, DOI 10.3724/SP.J.1005.2008.00463; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	51	13	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39094	10.1371/journal.pone.0039094	http://dx.doi.org/10.1371/journal.pone.0039094			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761725	gold, Green Submitted, Green Published			2022-12-27	WOS:000305826400008
J	Snajder, M; Vilfan, T; Cernilec, M; Rupreht, R; Popovic, M; Juntes, P; Serbec, VC; Ulrih, NP				Snajder, Marko; Vilfan, Tanja; Cernilec, Maja; Rupreht, Ruth; Popovic, Mara; Juntes, Polona; Serbec, Vladka Curin; Ulrih, Natasa Poklar			Enzymatic Degradation of PrPSc by a Protease Secreted from Aeropyrum pernix K1	PLOS ONE			English	Article							PRION PROTEIN; CELLULAR PRION; SERINE-PROTEASE; THERMOCOCCUS-KODAKARAENSIS; SPONGIFORM ENCEPHALOPATHY; MONOCLONAL-ANTIBODY; IN-VITRO; SCRAPIE; SUBTILISIN; DECONTAMINATION	Background: An R30 fraction from the growth medium of Aeropyrum pernix was analyzed for the protease that can digest the pathological prion protein isoform (PrPSc) from different species (human, bovine, deer and mouse). Methodology/Principal Findings: Degradation of the PrPSc isoform by the R30 fraction and the purified protease was evaluated using the 6H4 anti-PrP monoclonal antibody. Fragments from the N-terminal and C-terminal of PrPSc were also monitored by Western blotting using the EB8 anti-PrP monoclonal antibody, and by dot blotting using the C7/5 anti-PrP monoclonal antibody, respectively. For detection of smaller peptides from incomplete digestion of PrPSc, the EB8 monoclonal antibody was used after precipitation with sodium phosphotungstate. Characterization of the purified active protease from the R30 fraction was achieved, through purification by fast protein liquid chromatography, and identification by tandem mass spectrometry the serine metalloprotease pernisine. SDS-PAGE and zymography show the purified pernisine plus its proregion with a molecular weight of ca. 45 kDa, and the mature purified pernisine as ca. 23 kDa. The purified pernisine was active between 58 degrees C and 99 degrees C, and between pH 3.5 and 8.0. The temperature and pH optima of the enzymatic activity of the purified pernisine in the presence of 1 mM CaCl2 were 105 degrees C +/- 0.5 degrees C and pH 6.5 +/- 0.2, respectively. Conclusions/Significance: Our study has identified and characterized pernisine as a thermostable serine metalloprotease that is secreted from A. pernix and that can digest the pathological prion protein PrPSc.	[Snajder, Marko; Vilfan, Tanja; Ulrih, Natasa Poklar] Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia; [Cernilec, Maja; Rupreht, Ruth; Serbec, Vladka Curin] Blood Transfus Ctr Slovenia, Ljubljana, Slovenia; [Popovic, Mara] Univ Ljubljana, Fac Med, Ljubljana, Slovenia; [Juntes, Polona] Univ Ljubljana, Fac Vet, Ljubljana, Slovenia; [Ulrih, Natasa Poklar] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana; University of Ljubljana	Snajder, M (corresponding author), Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia.	natasa.poklar@bf.uni-lj.si	Ulrih, Natasa Poklar/B-2015-2008		Ministry of Higher Education, Science and Technology of Slovenia [P4-0121, L3-0206]	Ministry of Higher Education, Science and Technology of Slovenia	This work was funded by the Ministry of Higher Education, Science and Technology of Slovenia under the research program P4-0121 (Biochemical and Biophysical-Chemical Characterization of the Natural Compounds), and project L3-0206 (Prions in Human Medicine: from Structural Studies to Application). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BENDHEIM PE, 1985, P NATL ACAD SCI USA, V82, P997, DOI 10.1073/pnas.82.4.997; Beynon R., 2004, BUFFER SOLUTIONS; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cardone F, 2006, BBA-PROTEINS PROTEOM, V1764, P558, DOI 10.1016/j.bbapap.2006.01.022; Catara G, 2003, EXTREMOPHILES, V7, P391, DOI 10.1007/s00792-003-0337-4; CHARNEY J, 1947, J BIOL CHEM, V171, P501; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; de Almeida CJG, 2005, J LEUKOCYTE BIOL, V77, P238, DOI 10.1189/jlb.1103531; Foophow T, 2010, PROTEIN ENG DES SEL, V23, P347, DOI 10.1093/protein/gzp092; Foophow T, 2010, J MOL BIOL, V400, P865, DOI 10.1016/j.jmb.2010.05.064; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Jackson GS, 2005, J GEN VIROL, V86, P869, DOI 10.1099/vir.0.80484-0; Jamnik P, 2010, WORLD J MICROB BIOT, V26, P1579, DOI 10.1007/s11274-010-0333-7; Johnson CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019836; Jouvin-Marche E, 2006, J IMMUNOL, V176, P3490, DOI 10.4049/jimmunol.176.6.3490; Kanaani J, 2005, J NEUROCHEM, V95, P1373, DOI 10.1111/j.1471-4159.2005.03469.x; Kasermann F, 2003, J GEN VIROL, V84, P3173, DOI 10.1099/vir.0.19355-0; Koma D, 2007, EXTREMOPHILES, V11, P769, DOI 10.1007/s00792-007-0103-0; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langeveld JPM, 2003, J INFECT DIS, V188, P1782, DOI 10.1086/379664; Lemmer K, 2004, J GEN VIROL, V85, P3805, DOI 10.1099/vir.0.80346-0; LOCHT C, 1986, P NATL ACAD SCI USA, V83, P6372, DOI 10.1073/pnas.83.17.6372; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; MATSUZAWA H, 1988, EUR J BIOCHEM, V171, P441, DOI 10.1111/j.1432-1033.1988.tb13809.x; Milek I, 2005, CAN J MICROBIOL, V51, P805, DOI 10.1139/W05-060; Mitsuiki S, 2006, BIOSCI BIOTECH BIOCH, V70, P1246, DOI 10.1271/bbb.70.1246; Moreira LA, 2006, COLLOID SURFACE A, V282, P457, DOI 10.1016/j.colsurfa.2005.11.021; Muller-Hellwig S, 2006, SYST APPL MICROBIOL, V29, P165, DOI 10.1016/j.syapm.2005.07.010; Nechitaylo TY, 2010, SOIL BIOL BIOCHEM, V42, P1168, DOI 10.1016/j.soilbio.2010.03.004; Palmieri G, 2009, MOL CELL PROTEOMICS, V8, P2570, DOI 10.1074/mcp.M900012-MCP200; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRUSINER SB, 1993, J INFECT DIS, V167, P602, DOI 10.1093/infdis/167.3.602; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sako Y, 1997, FEBS LETT, V415, P329, DOI 10.1016/S0014-5793(97)01153-8; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; SCHATZL HM, 1995, J MOL BIOL, V245, P362, DOI 10.1006/jmbi.1994.0030; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Serbec VC, 2004, J BIOL CHEM, V279, P3694, DOI 10.1074/jbc.M310868200; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Tanaka SI, 2007, J MOL BIOL, V372, P1055, DOI 10.1016/j.jmb.2007.07.027; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Tsiroulnikov K, 2004, J AGR FOOD CHEM, V52, P6353, DOI 10.1021/jf0493324; Vranac T, 2006, PEPTIDES, V27, P2695, DOI 10.1016/j.peptides.2006.05.026; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Yoshioka M, 2007, J APPL MICROBIOL, V102, P509, DOI 10.1111/j.165-2672.2006.03080.x	50	6	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39548	10.1371/journal.pone.0039548	http://dx.doi.org/10.1371/journal.pone.0039548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761822	gold, Green Submitted, Green Published			2022-12-27	WOS:000305826400020
J	Kool, A; de Boer, HJ; Kruger, A; Rydberg, A; Abbad, A; Bjork, L; Martin, G				Kool, Anneleen; de Boer, Hugo J.; Kruger, Asa; Rydberg, Anders; Abbad, Abdelaziz; Bjork, Lars; Martin, Gary			Molecular Identification of Commercialized Medicinal Plants in Southern Morocco	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; DNA BARCODES; PHYLOGENETIC ANALYSES; RETICULATE EVOLUTION; LAND PLANTS; SEQUENCE; GENUS; AUTHENTICATION; BIOGEOGRAPHY; PERSPECTIVES	Background: Medicinal plant trade is important for local livelihoods. However, many medicinal plants are difficult to identify when they are sold as roots, powders or bark. DNA barcoding involves using a short, agreed-upon region of a genome as a unique identifier for species-ideally, as a global standard. Research Question: What is the functionality, efficacy and accuracy of the use of barcoding for identifying root material, using medicinal plant roots sold by herbalists in Marrakech, Morocco, as a test dataset. Methodology: In total, 111 root samples were sequenced for four proposed barcode regions rpoC1, psbA-trnH, matK and ITS. Sequences were searched against a tailored reference database of Moroccan medicinal plants and their closest relatives using BLAST and Blastclust, and through inference of RAxML phylograms of the aligned market and reference samples. Principal Findings: Sequencing success was high for rpoC1, psbA-trnH, and ITS, but low for matK. Searches using rpoC1 alone resulted in a number of ambiguous identifications, indicating insufficient DNA variation for accurate species-level identification. Combining rpoC1, psbA-trnH and ITS allowed the majority of the market samples to be identified to genus level. For a minority of the market samples, the barcoding identification differed significantly from previous hypotheses based on the vernacular names. Conclusions/Significance: Endemic plant species are commercialized in Marrakech. Adulteration is common and this may indicate that the products are becoming locally endangered. Nevertheless the majority of the traded roots belong to species that are common and not known to be endangered. A significant conclusion from our results is that unknown samples are more difficult to identify than earlier suggested, especially if the reference sequences were obtained from different populations. A global barcoding database should therefore contain sequences from different populations of the same species to assure the reference sequences characterize the species throughout its distributional range.	[Kool, Anneleen; de Boer, Hugo J.; Rydberg, Anders; Bjork, Lars] Uppsala Univ, Dept Systemat Biol, Evolutionary Biol Ctr, Uppsala, Sweden; [Kruger, Asa] Stockholm Univ, Dept Bot, S-10691 Stockholm, Sweden; [Abbad, Abdelaziz] Cadi Ayyad Univ, Fac Sci Semlalia, Lab Biotechnol Protect & Valorisat Plant Resource, Marrakech, Morocco; [Martin, Gary] Global Divers Fdn, Marrakech, Morocco	Uppsala University; Stockholm University; Cadi Ayyad University of Marrakech	Kool, A (corresponding author), Uppsala Univ, Dept Systemat Biol, Evolutionary Biol Ctr, Uppsala, Sweden.	anneleen.kool@ebc.uu.se	de Boer, Hugo Joris/AAS-7585-2020; de Boer, Hugo/B-5640-2015	de Boer, Hugo Joris/0000-0003-1985-7859; de Boer, Hugo/0000-0003-1985-7859	SRL-MENA from the Swedish Research Council; Sida; Formas	SRL-MENA from the Swedish Research Council(Swedish Research Council); Sida; Formas(Swedish Research Council Formas)	This study was funded through a SRL-MENA grant from the Swedish Research Council, Sida and Formas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARNASON U, 1991, HEREDITAS, V115, P183, DOI 10.1111/j.1601-5223.1991.tb03554.x; Asahina H, 2010, J NAT MED-TOKYO, V64, P133, DOI 10.1007/s11418-009-0379-8; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Barthelson RA, 2006, AM J BOT, V93, P566, DOI 10.3732/ajb.93.4.566; BELLAKHDAR J, 1991, J ETHNOPHARMACOL, V35, P123, DOI 10.1016/0378-8741(91)90064-K; Bellakhdar J, 1997, PHARMACOPEE MAROCAIN; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Boulos L., 1983, Medicinal plants of North Africa.; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Caldeira RL, 1998, MEM I OSWALDO CRUZ, V93, P219, DOI 10.1590/S0074-02761998000700039; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Coghlan ML, 2012, PLOS GENET, V8, P436, DOI 10.1371/journal.pgen.1002657; Collins RA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028381, 10.1371/journal.pone.0030581]; Cotton CM, 1996, ETHNOBOTANY PRINCIPL; Cunningham AB, 1993, PEOPLE PLANTS WORKIN, V1, P1; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Deguilloux MF, 2002, P ROY SOC B-BIOL SCI, V269, P1039, DOI 10.1098/rspb.2002.1982; Devey DS, 2009, TAXON, V58, P7, DOI 10.1002/tax.581003; Dondoshansky I, 2002, BLASTCLUST NCBI SOFT; Downie S. R., 2001, Edinburgh Journal of Botany, V58, P301; Downie SR, 2000, AM J BOT, V87, P273, DOI 10.2307/2656915; El-Hilaly J, 2003, J ETHNOPHARMACOL, V86, P149, DOI 10.1016/S0378-8741(03)00012-6; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fennane M., 1998, BOCCONEA, V8, P1; Fennane M, 2007, FLORE PRATIQUE MAROC, V2; Fennane M, 2005, FLORE VASCULAIRE MAR; Fennane M, 1999, TRAV I SCI RABAT, V1, P1; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GarnockJones PJ, 1996, PLANT SYST EVOL, V202, P211, DOI 10.1007/BF00983383; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Guo ZH, 2010, J CENT SOUTH UNIV T, V17, P770, DOI 10.1007/s11771-010-0555-8; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Ibn Tattou M, 2008, FLORE VASCULAIRE MAR; IUCN Centre for Mediterranean Cooperation, 2005, GUID MED PLANTS N AF; Ize-Ludlow D, 2004, PEDIATRICS, V114, pE653, DOI 10.1542/peds.2004-0058; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Marshall NT, 1998, SEARCHING CURE CONSE; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Milinkovitch MC, 2004, MOL PHYLOGENET EVOL, V31, P1, DOI 10.1016/j.ympev.2004.01.009; Miller M. A., 2010, CIPRES PORTALS; Mirza N, 2010, BIORESOURCE TECHNOL, V101, P5815, DOI 10.1016/j.biortech.2010.03.012; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; Newmaster SG, 2008, MOL ECOL RESOUR, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Nielsen R, 2006, SYST BIOL, V55, P162, DOI 10.1080/10635150500431239; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Piredda R, 2011, MOL ECOL RESOUR, V11, P72, DOI 10.1111/j.1755-0998.2010.02900.x; RBG-K, 2007, DNA BARC; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; SANG T, 1995, P NATL ACAD SCI USA, V92, P6813, DOI 10.1073/pnas.92.15.6813; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Song JY, 2009, J ETHNOPHARMACOL, V124, P434, DOI 10.1016/j.jep.2009.05.042; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Stoeckle MY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00042; Sucher NJ, 2008, PLANTA MED, V74, P603, DOI 10.1055/s-2008-1074517; TANG J, 1995, INSECT MOL BIOL, V4, P79, DOI 10.1111/j.1365-2583.1995.tb00011.x; Valdes B, 2002, CATALOGUE PLANTES VA, V2; Valdes B, 2002, CATALOGUE PLANTES VA, V1; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; YOON CS, 1991, MYCOLOGIA, V83, P835, DOI 10.2307/3760446	86	98	107	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39459	10.1371/journal.pone.0039459	http://dx.doi.org/10.1371/journal.pone.0039459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761800	gold, Green Submitted, Green Published			2022-12-27	WOS:000305825800036
J	Bauer, J; Sporn, JC; Cabral, J; Gomez, J; Jung, B				Bauer, Jessica; Sporn, Judith C.; Cabral, Jennifer; Gomez, Jessica; Jung, Barbara			Effects of Activin and TGF beta on p21 in Colon Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CELL-CYCLE ARREST; RECEPTOR RESTORATION; PROTEIN EXPRESSION; COLORECTAL-CANCER; DEGRADATION; CARCINOMAS; GENE; TRANSFORMATION; PROLIFERATION	Activin and TGF beta share SMAD signaling and colon cancers can inactivate either pathway alone or simultaneously. The differential effects of activin and TGF beta signaling in colon cancer have not been previously dissected. A key downstream target of TGF beta signaling is the cdk2 inhibitor p21 (p21(cip1/waf1)). Here, we evaluate activin-specific effects on p21 regulation and resulting functions. We find that TGF beta is a more potent inducer of growth suppression, while activin is a more potent inducer of apoptosis. Further, growth suppression and apoptosis by both ligands are dependent on SMAD4. However, activin downregulates p21 protein in a SMAD4-independent fashion in conjunction with increased ubiquitination and proteasomal degradation to enhance migration, while TGF beta upregulates p21 in a SMAD4-dependent fashion to affect growth arrest. Activin-induced growth suppression and cell death are dependent on p21, while activin-induced migration is counteracted by p21. Further, primary colon cancers show differential p21 expression consistent with their ACVR2/TGFBR2 receptor status. In summary, we report p21 as a differentially affected activin/TGF beta target and mediator of ligand-specific functions in colon cancer, which may be exploited for future risk stratification and therapeutic intervention.	[Bauer, Jessica; Sporn, Judith C.; Jung, Barbara] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Cabral, Jennifer; Gomez, Jessica] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Northwestern University; Feinberg School of Medicine; University of California System; University of California San Diego	Bauer, J (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA.	bjung@northwestern.edu	Bauer, Jessica/AAT-7399-2020	Bauer, Jessica/0000-0001-9022-9877	U.S. Public Health Service [DK074019]; National Institutes of Health [R01CA141057]; ARRA [P30 CA060553]; UCSD Digestive Diseases Research Development Center [DK080506]; Robert H. Lurie Comprehensive Cancer Center [P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA141057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080506, K08DK074019] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD Digestive Diseases Research Development Center; Robert H. Lurie Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the U.S. Public Health Service DK074019 to BJ, the National Institutes of Health grant R01CA141057 and ARRA P30 CA060553 to BJ, the UCSD Digestive Diseases Research Development Center DK080506 to BJ, and the Robert H. Lurie Comprehensive Cancer Center support grant P30 CA060553 to BJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Barbara JT, 2006, INT J CANCER, V118, P2509, DOI 10.1002/ijc.21710; Beck SE, 2007, CELL SIGNAL, V19, P1465, DOI 10.1016/j.cellsig.2007.01.017; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; BOYD D, 1988, CANCER RES, V48, P3112; Bukholm IK, 2000, VIRCHOWS ARCH, V436, P224, DOI 10.1007/s004280050034; Burdette JE, 2005, CANCER RES, V65, P7968, DOI 10.1158/0008-5472.CAN-04-3553; Chen Y, 1996, P NATL ACAD SCI USA, V93, P12992, DOI 10.1073/pnas.93.23.12992; Chen YG, 2002, EXP BIOL MED, V227, P75, DOI 10.1177/153537020222700201; Chow JYC, 2008, CANCER BIOL THER, V7, P1694, DOI 10.4161/cbt.7.10.6665; Datto M, 2005, CELL, V121, P2, DOI 10.1016/j.cell.2005.03.017; Deacu E, 2004, CANCER RES, V64, P7690, DOI 10.1158/0008-5472.CAN-04-2082; Gong JG, 2003, CANCER RES, V63, P3340; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Grady WM, 1998, CANCER RES, V58, P3101; Grau AM, 2006, CELL SIGNAL, V18, P1041, DOI 10.1016/j.cellsig.2005.08.021; Hempen PM, 2003, CANCER RES, V63, P994; Hwang CY, 2009, MOL CELL BIOL, V29, P3379, DOI 10.1128/MCB.01758-08; Jung B, 2004, GASTROENTEROLOGY, V126, P654, DOI 10.1053/j.gastro.2004.01.008; Jung BH, 2007, GASTROENTEROLOGY, V132, P633, DOI 10.1053/j.gastro.2006.11.018; Lee YJ, 2006, GENESIS, V44, P487, DOI 10.1002/dvg.20238; Mitomi H, 2005, HEPATO-GASTROENTEROL, V52, P1421; Mori Y, 2001, CANCER RES, V61, P6046; Munoz NM, 2006, CANCER RES, V66, P9837, DOI 10.1158/0008-5472.CAN-06-0890; Piek E, 2004, BIOCHEM J, V383, P187, DOI 10.1042/BJ20040774; Polyak K, 1996, AM J PATHOL, V149, P381; Rau B, 2003, J CLIN ONCOL, V21, P3391, DOI 10.1200/JCO.2003.07.077; Satia JA, 2005, CANCER EPIDEM BIOMAR, V14, P429, DOI 10.1158/1055-9965.EPI-04-0486; Satia-Abouta J, 2003, CANCER EPIDEM BIOMAR, V12, P747; Shah MA, 2005, CLIN CANCER RES, V11, P3836, DOI 10.1158/1078-0432.CCR-04-2651; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Yamato K, 1997, MOL ENDOCRINOL, V11, P1044, DOI 10.1210/me.11.8.1044; Zhang BX, 2010, GASTROENTEROLOGY, V138, P969, DOI 10.1053/j.gastro.2009.11.004; Zirbes TK, 2000, INT J CANCER, V89, P14, DOI 10.1002/(SICI)1097-0215(20000120)89:1<14::AID-IJC3>3.0.CO;2-L	35	44	45	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39381	10.1371/journal.pone.0039381	http://dx.doi.org/10.1371/journal.pone.0039381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761777	gold, Green Published, Green Submitted			2022-12-27	WOS:000305808700024
J	Dohgu, S; Ryerse, JS; Robinson, SM; Banks, WA				Dohgu, Shinya; Ryerse, Jan S.; Robinson, Sandra M.; Banks, William A.			Human Immunodeficiency Virus-1 Uses the Mannose-6-Phosphate Receptor to Cross the Blood-Brain Barrier	PLOS ONE			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; ENVELOPE GLYCOPROTEIN GP120; LYSOSOMAL-ENZYME; ADSORPTIVE ENDOCYTOSIS; MEDIATED TRANSPORT; ENDOTHELIAL-CELLS; SURFACE-PROTEINS; HIV-1 GP120; RAT-BRAIN; MOUSE	HIV-1 circulates both as free virus and within immune cells, with the level of free virus being predictive of clinical course. Both forms of HIV-1 cross the blood-brain barrier (BBB) and much progress has been made in understanding the mechanisms by which infected immune cells cross the blood-brain barrier BBB. How HIV-1 as free virus crosses the BBB is less clear as brain endothelial cells are CD4 and galactosylceramide negative. Here, we found that HIV-1 can use the mannose-6 phosphate receptor (M6PR) to cross the BBB. Brain perfusion studies showed that HIV-1 crossed the BBB of all brain regions consistent with the uniform distribution of M6PR. Ultrastructural studies showed HIV-1 crossed by a transcytotic pathway consistent with transport by M6PR. An in vitro model of the BBB was used to show that transport of HIV-1 was inhibited by mannose, mannan, and mannose-6 phosphate and that enzymatic removal of high mannose oligosaccharide residues from HIV-1 reduced transport. Wheatgerm agglutinin and protamine sulfate, substances known to greatly increase transcytosis of HIV-1 across the BBB in vivo, were shown to be active in the in vitro model and to act through a mannose-dependent mechanism. Transport was also cAMP and calcium-dependent, the latter suggesting that the cation-dependent member of the M6PR family mediates HIV-1 transport across the BBB. We conclude that M6PR is an important receptor used by HIV-1 to cross the BBB.	[Dohgu, Shinya] Fukuoka Univ, Fac Pharmaceut Sci, Dept Pharmaceut Care & Hlth Sci, Fukuoka 81401, Japan; [Ryerse, Jan S.] St Louis Univ, Hlth Sci Ctr, Dept Pathol, St Louis, MO 63103 USA; [Robinson, Sandra M.] St Louis Univ, Sch Med, Div Geriatr Med, Dept Internal Med, St Louis, MO 63104 USA; [Banks, William A.] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Banks, William A.] Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA USA	Fukuoka University; Saint Louis University; Saint Louis University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Dohgu, S (corresponding author), Fukuoka Univ, Fac Pharmaceut Sci, Dept Pharmaceut Care & Hlth Sci, 8-19-1 Nanakuma, Fukuoka 81401, Japan.	wabanks1@u.washington.edu	Banks, William A/K-1330-2017; Dohgu, Shinya/AAK-9992-2020	Banks, William A/0000-0002-0496-3619; 	Veterans Affairs merit review; National Institutes of Health [RO-1 AG029839]; NATIONAL INSTITUTE ON AGING [R01AG029839] Funding Source: NIH RePORTER	Veterans Affairs merit review(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The funders were Veterans Affairs merit review (http://www.research.va.gov/programs/csrd/merit_review.cfm) and National Institutes of Health RO-1 AG029839. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur LO, 1998, AIDS RES HUM RETROV, V14, pS311; Banks WA, 2000, AM J PHYSIOL-ENDOC M, V278, pE1158, DOI 10.1152/ajpendo.2000.278.6.E1158; Banks WA, 1998, J CELL SCI, V111, P533; Banks WA, 2005, LIFE SCI, V77, P2361, DOI 10.1016/j.lfs.2004.11.041; Banks WA, 2004, NEUROSCIENCE, V128, P143, DOI 10.1016/j.neuroscience.2004.06.021; Banks WA, 2001, J VIROL, V75, P4681, DOI 10.1128/JVI.75.10.4681-4691.2001; Banks WA, 1998, J NEUROSCI RES, V54, P522, DOI 10.1002/(SICI)1097-4547(19981115)54:4<522::AID-JNR9>3.0.CO;2-O; Banks WA, 1997, LIFE SCI, V61, pPL119, DOI 10.1016/S0024-3205(97)00597-3; Bobardt MD, 2004, J VIROL, V78, P6567, DOI 10.1128/JVI.78.12.6567-6584.2004; BOURINBAIAR AS, 1991, J ACQ IMMUN DEF SYND, V4, P56; Brown RC, 2002, STROKE, V33, P1706, DOI 10.1161/01.STR.0000016405.06729.83; DEHOUCK MP, 1992, J NEUROCHEM, V58, P1790, DOI 10.1111/j.1471-4159.1992.tb10055.x; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; DEZUTTER-DAMBUYANT C, 1991, Journal of Dermatology (Tokyo), V18, P377; FROST EHE, 1977, J GEN VIROL, V35, P181, DOI 10.1099/0022-1317-35-1-181; Gelderblom HR, 1997, FIE STRUCTURE HIV SI; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Hall NC, 1995, NEUROCHEM RES, V20, P1161, DOI 10.1007/BF00995379; Hambleton S, 2005, CURR OPIN INFECT DIS, V18, P235, DOI 10.1097/01.qco.0000168384.31766.89; HANSEN JES, 1989, AIDS, V3, P635, DOI 10.1097/00002030-198910000-00003; Hawkes C, 2003, J COMP NEUROL, V458, P113, DOI 10.1002/cne.10578; HOFLACK B, 1985, P NATL ACAD SCI USA, V82, P4428, DOI 10.1073/pnas.82.13.4428; JOHNSON RT, 1994, ANN NEUROL, V36, pS54, DOI 10.1002/ana.410360715; Kim JJP, 2009, CURR OPIN STRUC BIOL, V19, P534, DOI 10.1016/j.sbi.2009.09.002; KIMURAKURODA J, 1994, ARCH VIROL, V137, P81, DOI 10.1007/BF01311175; LARKIN M, 1989, AIDS, V3, P793, DOI 10.1097/00002030-198912000-00003; LIUZZI GM, 1994, NEUROREPORT, V6, P157, DOI 10.1097/00001756-199412300-00040; Marcus CD, 1998, METAB BRAIN DIS, V13, P123, DOI 10.1023/A:1020609213664; MBEMBA E, 1994, GLYCOBIOLOGY, V4, P13, DOI 10.1093/glycob/4.1.13; McKinnon T, 2001, J CLIN ENDOCR METAB, V86, P3665, DOI 10.1210/jc.86.8.3665; MONTELARO RC, 1975, J GEN VIROL, V29, P127, DOI 10.1099/0022-1317-29-1-127; MOSES AV, 1993, P NATL ACAD SCI USA, V90, P10474, DOI 10.1073/pnas.90.22.10474; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Nottet HSLM, 1996, J IMMUNOL, V156, P1284; OTT DE, 1995, J VIROL, V69, P2443, DOI 10.1128/JVI.69.4.2443-2450.1995; Persidsky Y, 1997, J IMMUNOL, V158, P3499; ROBINSON WE, 1987, AIDS RES HUM RETROV, V3, P265, DOI 10.1089/aid.1987.3.265; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Ryerse J, 1997, BBA-BIOMEMBRANES, V1327, P193, DOI 10.1016/S0005-2736(97)00058-8; Ryerse JS, 2001, HISTOCHEM CELL BIOL, V115, P325; SAAG MS, 1991, J INFECT DIS, V164, P72, DOI 10.1093/infdis/164.1.72; Suh HS, 2010, AM J PATHOL, V177, P2446, DOI 10.2353/ajpath.2010.100399; Szabo C A, 1997, Neurobiology (Bp), V5, P1; Urayama A, 2004, P NATL ACAD SCI USA, V101, P12658, DOI 10.1073/pnas.0405042101; Urayama A, 2008, MOL THER, V16, P1261, DOI 10.1038/mt.2008.84; Urayama A, 2007, P NATL ACAD SCI USA, V104, P12873, DOI 10.1073/pnas.0705611104; Yu ZW, 1996, BBA-BIOMEMBRANES, V1282, P57, DOI 10.1016/0005-2736(96)00037-5; ZHANG LQ, 1991, AIDS, V5, P675, DOI 10.1097/00002030-199106000-00006; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100	49	36	37	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39565	10.1371/journal.pone.0039565	http://dx.doi.org/10.1371/journal.pone.0039565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761827	gold, Green Submitted, Green Published			2022-12-27	WOS:000305781700049
J	Li, LZ; Wang, XH; Banerjee, S; Volsky, B; Williams, C; Virland, D; Nadas, A; Seaman, MS; Chen, XM; Spearman, P; Zolla-Pazner, S; Gorny, MK				Li, Liuzhe; Wang, Xiao-Hong; Banerjee, Sagarika; Volsky, Barbara; Williams, Constance; Virland, Diana; Nadas, Arthur; Seaman, Michael S.; Chen, Xuemin; Spearman, Paul; Zolla-Pazner, Susan; Gorny, Miroslaw K.			Different Pattern of Immunoglobulin Gene Usage by HIV-1 Compared to Non-HIV-1 Antibodies Derived from the Same Infected Subject	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; MEMORY B-CELLS; PBL-SCID MICE; NEUTRALIZING ANTIBODIES; PASSIVE-IMMUNIZATION; FAMILY EXPRESSION; PARTICLES BEARING; ENVELOPE PROTEINS; V3 DOMAIN	A biased usage of immunoglobulin (Ig) genes is observed in human anti-HIV-1 monoclonal antibodies (mAbs) resulting probably from compensation to reduced usage of the VH3 family genes, while the other alternative suggests that this bias usage is due to antigen requirements. If the antigen structure is responsible for the preferential usage of particular Ig genes, it may have certain implications for HIV vaccine development by the targeting of particular Ig gene-encoded B cell receptors to induce neutralizing anti-HIV-1 antibodies. To address this issue, we have produced HIV-1 specific and non-HIV-1 mAbs from an infected individual and analyzed the Ig gene usage. Green-fluorescence labeled virus-like particles (VLP) expressing HIV-1 envelope (Env) proteins of JRFL and BaL and control VLPs (without Env) were used to select single B cells for the production of 68 recombinant mAbs. Ten of these mAbs were HIV-1 Env specific with neutralizing activity against V3 and the CD4 binding site, as well as non-neutralizing mAbs to gp41. The remaining 58 mAbs were non-HIV-1 Env mAbs with undefined specificities. Analysis revealed that biased usage of Ig genes was restricted only to anti-HIV-1 but not to non-HIV-1 mAbs. The VH1 family genes were dominantly used, followed by VH3, VH4, and VH5 among anti-HIV-1 mAbs, while non-HIV-1 specific mAbs preferentially used VH3 family genes, followed by VH4, VH1 and VH5 families in a pattern identical to Abs derived from healthy individuals. This observation suggests that the biased usage of Ig genes by anti-HIV-1 mAbs is driven by structural requirements of the virus antigens rather than by compensation to any depletion of VH3 B cells due to autoreactive mechanisms, according to the gp120 superantigen hypothesis.	[Li, Liuzhe; Banerjee, Sagarika; Volsky, Barbara; Williams, Constance; Zolla-Pazner, Susan; Gorny, Miroslaw K.] NYU, Sch Med, Dept Pathol, New York, NY 10003 USA; [Wang, Xiao-Hong; Virland, Diana; Zolla-Pazner, Susan] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA; [Nadas, Arthur] NYU, Sch Med, Inst Environm Med, New York, NY USA; [Seaman, Michael S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Chen, Xuemin; Spearman, Paul] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA	New York University; New York University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Emory University	Li, LZ (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10003 USA.	mirek.gorny@nyumc.org	Zolla-Pazner, Susan/S-1864-2019; Banerjee, Sagarika/AAR-2682-2020	Zolla-Pazner, Susan/0000-0002-0750-2666; Banerjee, Sagarika/0000-0002-4549-3342; Gorny, Miroslaw/0000-0002-2714-8780	NIH [AI091543, AI077451]; Department of Veterans Affairs [HL59725]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI077451, R56AI091543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by NIH grants AI091543 and AI077451 to MKG, and by HL59725 and research funds from the Department of Veterans Affairs to SZP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrus L, 1998, J INFECT DIS, V177, P889, DOI 10.1086/515251; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; BERBERIAN L, 1991, BLOOD, V78, P175; BERBERIAN L, 1993, SCIENCE, V261, P1588, DOI 10.1126/science.7690497; BOUHABIB DC, 1994, J VIROL, V68, P6006, DOI 10.1128/JVI.68.9.6006-6013.1994; Breden F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016857; Crooks ET, 2007, VIROLOGY, V366, P245, DOI 10.1016/j.virol.2007.04.033; DAVID D, 1995, IMMUNOL LETT, V47, P107, DOI 10.1016/0165-2478(95)00078-J; DAVID D, 1995, EUR J IMMUNOL, V25, P1524, DOI 10.1002/eji.1830250608; Dennison SM, 2011, J VIROL, V85, P1340, DOI 10.1128/JVI.01680-10; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; Gauduin MC, 1997, NAT MED, V3, P1389, DOI 10.1038/nm1297-1389; Gigler A, 1999, J VIROL, V73, P1974, DOI 10.1128/JVI.73.3.1974-1979.1999; Gorny MK, 2009, MOL IMMUNOL, V46, P917, DOI 10.1016/j.molimm.2008.09.005; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Gorny MK, 1997, J IMMUNOL, V159, P5114; GORNY MK, 1989, P NATL ACAD SCI USA, V86, P1624, DOI 10.1073/pnas.86.5.1624; Haigwood NL, 2004, J VIROL, V78, P5983, DOI 10.1128/JVI.78.11.5983-5995.2004; Hammonds J, 2007, VACCINE, V25, P8036, DOI 10.1016/j.vaccine.2007.09.016; Hicar MD, 2010, JAIDS-J ACQ IMM DEF, V54, P223, DOI 10.1097/QAI.0b013e3181dc98a3; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Kimura Tetsuya, 2009, Human Antibodies, V18, P35, DOI 10.3233/HAB-2009-0200; Li HL, 2009, J IMMUNOL, V182, P6369, DOI 10.4049/jimmunol.0804287; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Margolin DH, 1997, J VIROL, V71, P8582, DOI 10.1128/JVI.71.11.8582-8591.1997; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Nyambi PN, 1998, J VIROL, V72, P9384, DOI 10.1128/JVI.72.11.9384-9391.1998; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Vasiliver-Shamis G, 2008, J VIROL, V82, P9445, DOI 10.1128/JVI.00835-08; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Weitkamp JH, 2003, J IMMUNOL METHODS, V275, P223, DOI 10.1016/S0022-1759(03)00013-9; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	42	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39534	10.1371/journal.pone.0039534	http://dx.doi.org/10.1371/journal.pone.0039534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761815	gold, Green Published, Green Submitted			2022-12-27	WOS:000305781700043
J	Li, SN; Huang, XQ; Wang, GH; Xu, YQ				Li, Sainan; Huang, Xianqing; Wang, Guohao; Xu, Yuquan			Transcriptional Activation of Pyoluteorin Operon Mediated by the LysR-Type Regulator PltR Bound at a 22 bp lys Box in Pseudomonas aeruginosa M18	PLOS ONE			English	Article							FLUORESCENS PF-5; ANTIBIOTIC PRODUCTION; BIOLOGICAL-CONTROL; PHENAZINE-1-CARBOXYLIC ACID; BINDING-SITE; SIGMA-FACTOR; BIOSYNTHESIS; GENE; GENOME; FAMILY	Pseudomonas aeruginosa M18, a rhizosphere-isolated bacterial strain showing strong antifungal activity, can produce secondary metabolites such as phenazine-1-carboxylic acid and pyoluteorin (Plt). The LysR-type transcriptional regulator PltR activates the Plt biosynthesis operon pltLABCDEFG, the expression of which is induced by Plt. Here, we identified and characterized the non-conserved pltL promoter (pltLp) specifically activated by PltR and its upstream neighboring lys box from the complicated pltR-pltL intergenic sequence. The 22 bp palindromic lys box, which consists of two 9 bp complementary inverted repeats interrupted by 4 bp, was found to contain the conserved, GC-rich LysR-binding motif (T-N11-A). Evidence obtained in vivo from mutational and lacZ report analyses and in vitro from electrophoretic mobility shift assays reveals that the PltR protein directly bound to the pltLp region as the indispensable binding motif "lys box", thereby transcriptionally activating the pltLp-driven plt operon expression. Plt, as a potential non-essential coinducer of PltR, specifically induced the pltLp expression and thus strengthened its biosynthetic plt operon expression.	[Li, Sainan; Huang, Xianqing; Wang, Guohao; Xu, Yuquan] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Li, Sainan; Huang, Xianqing; Wang, Guohao; Xu, Yuquan] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Huang, XQ (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	xqhuang11@gmail.com; xuyq@sjtu.edu.cn	Wang, Guohao/AAF-3433-2020	Wang, Guohao/0000-0002-9991-1765; Huang, Xianqing/0000-0001-6649-518X	National Natural Science Foundation of China [30800009]; National High-Tech Research and Development Program (863 Program) of China [2007AA02Z215]; National Key Basic Research Program (973 Program) of China [2009CB118906]; Shanghai Committee of Science and Technology [08391911900]; Shanghai Leading Academic Discipline Project [B203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); National Key Basic Research Program (973 Program) of China(National Basic Research Program of China); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by grants from the National Natural Science Foundation of China (No. 30800009), the National High-Tech Research and Development Program (863 Program) of China (No. 2007AA02Z215), the National Key Basic Research Program (973 Program) of China (No. 2009CB118906), the Key Project of the Shanghai Committee of Science and Technology (No. 08391911900), and the Shanghai Leading Academic Discipline Project (No. B203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2002, J BACTERIOL, V184, P3008, DOI 10.1128/JB.184.11.3008-3016.2002; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bender CL, 1999, ANNU REV PHYTOPATHOL, V37, P175, DOI 10.1146/annurev.phyto.37.1.175; Blumer C, 1999, P NATL ACAD SCI USA, V96, P14073, DOI 10.1073/pnas.96.24.14073; Brodhagen M, 2005, APPL ENVIRON MICROB, V71, P6900, DOI 10.1128/AEM.71.11.6900-6909.2005; Brodhagen M, 2004, APPL ENVIRON MICROB, V70, P1758, DOI 10.1128/AEM.70.3.1758-1766.2004; Chen YF, 2008, OPEN ZOOL J, V1, P1; Ge YH, 2004, FEMS MICROBIOL LETT, V237, P41, DOI [10.1016/j.femsle.2004.06.028, 10.1111/j.1574-6968.2004.tb09676.x]; Ge YH, 2006, BIOL CONTROL, V39, P186, DOI 10.1016/j.biocontrol.2006.07.010; Haas D, 2003, ANNU REV PHYTOPATHOL, V41, P117, DOI 10.1146/annurev.phyto.41.052002.095656; Huang XQ, 2006, GENE, V376, P68, DOI 10.1016/j.gene.2006.02.009; Huang XQ, 2004, FEMS MICROBIOL LETT, V232, P197, DOI 10.1016/S0378-1097(04)00074-6; Kidarsa TA, 2011, MOL MICROBIOL, V81, P395, DOI 10.1111/j.1365-2958.2011.07697.x; KING EO, 1954, J LAB CLIN MED, V44, P301; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lamont IL, 2002, P NATL ACAD SCI USA, V99, P7072, DOI 10.1073/pnas.092016999; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Li YX, 2011, ANIMAL, V5, P18, DOI 10.1017/S1751731110001370; Lu JS, 2009, J BIOTECHNOL, V143, P1, DOI 10.1016/j.jbiotec.2009.06.008; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Nowak-Thompson B, 1999, J BACTERIOL, V181, P2166, DOI 10.1128/JB.181.7.2166-2174.1999; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Porrua O, 2010, MOL MICROBIOL, V76, P331, DOI 10.1111/j.1365-2958.2010.07100.x; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Sambrook J., 2001, MOL CLONING LAB MANU; Sarniguet A, 1995, P NATL ACAD SCI USA, V92, P12255, DOI 10.1073/pnas.92.26.12255; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; SCHNIDER U, 1995, J BACTERIOL, V177, P5387, DOI 10.1128/jb.177.18.5387-5392.1995; Schnider-Keel U, 2000, J BACTERIOL, V182, P1215, DOI 10.1128/JB.182.5.1215-1225.2000; Venturi V, 2006, FEMS MICROBIOL REV, V30, P274, DOI 10.1111/j.1574-6976.2005.00012.x; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108; Wu DQ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-438; Xiao GP, 2006, MOL MICROBIOL, V62, P1689, DOI 10.1111/j.1365-2958.2006.05462.x; Yan A, 2007, MICROBIOL-SGM, V153, P16, DOI 10.1099/mic.0.29211-0; Zhang XH, 2005, WORLD J MICROB BIOT, V21, P883, DOI 10.1007/s11274-004-6358-z; Zhu Donghua, 2003, Weishengwu Xuebao, V43, P315; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; 严安, 2007, [中国科学. C辑, 生命科学, Science in China], V37, P325	39	16	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39538	10.1371/journal.pone.0039538	http://dx.doi.org/10.1371/journal.pone.0039538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761817	gold, Green Published, Green Submitted			2022-12-27	WOS:000305781700044
J	Guo, YC; Bao, YH; Meng, QW; Hu, XX; Meng, QY; Ren, LM; Li, N; Zhao, YF				Guo, Yongchen; Bao, Yonghua; Meng, Qingwen; Hu, Xiaoxiang; Meng, Qingyong; Ren, Liming; Li, Ning; Zhao, Yaofeng			Immunoglobulin Genomics in the Guinea Pig (Cavia porcellus)	PLOS ONE			English	Article							HEAVY-CHAIN GENE; COMPLETE MITOCHONDRIAL GENOME; HUMAN GERMLINE GENES; VARIABLE-REGION; LIGHT-CHAIN; ANTIBODY REPERTOIRE; EVOLUTION; IG; SEQUENCE; FAMILY	In science, the guinea pig is known as one of the gold standards for modeling human disease. It is especially important as a molecular and cellular biology model for studying the human immune system, as its immunological genes are more similar to human genes than are those of mice. The utility of the guinea pig as a model organism can be further enhanced by further characterization of the genes encoding components of the immune system. Here, we report the genomic organization of the guinea pig immunoglobulin (Ig) heavy and light chain genes. The guinea pig IgH locus is located in genomic scaffolds 54 and 75, and spans approximately 6,480 kb. 507 V-H segments (94 potentially functional genes and 413 pseudogenes), 41 D-H segments, six J(H) segments, four constant region genes (mu, gamma, epsilon, and alpha), and one reverse delta remnant fragment were identified within the two scaffolds. Many V-H pseudogenes were found within the guinea pig, and likely constituted a potential donor pool for gene conversion during evolution. The Ig kappa locus mapped to a 4,029 kb region of scaffold 37 and 24 is composed of 349 V-kappa (111 potentially functional genes and 238 pseudogenes), three J(kappa) and one C-kappa genes. The Ig lambda locus spans 1,642 kb in scaffold 4 and consists of 142 V-lambda (58 potentially functional genes and 84 pseudogenes) and 11 J(lambda)-C-lambda clusters. Phylogenetic analysis suggested the guinea pig's large germline V-H gene segments appear to form limited gene families. Therefore, this species may generate antibody diversity via a gene conversion-like mechanism associated with its pseudogene reserves.	[Guo, Yongchen; Hu, Xiaoxiang; Meng, Qingyong; Ren, Liming; Li, Ning; Zhao, Yaofeng] China Agr Univ, Coll Biol Sci, State Key Lab AgroBiotechnol, Beijing 100094, Peoples R China; [Bao, Yonghua] Xinxiang Med Univ, Dept Basic Immunol, Xinxiang, Peoples R China; [Meng, Qingwen] Chinese Acad Agr Sci, Harbin Vet Res Inst, Natl Key Lab Vet Biotechnol, Harbin, Peoples R China; [Zhao, Yaofeng] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao, Peoples R China	China Agricultural University; Xinxiang Medical University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Qingdao Agricultural University	Guo, YC (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab AgroBiotechnol, Beijing 100094, Peoples R China.	baoyonghua2005@yahoo.com.cn; yaofengzhao@cau.edu.cn	Meng, Qingyong/AAS-4335-2021		National Science Fund for Distinguished Young Scholars [30725029]; Tai shan Scholar Foundation of Shan dong Province; National Basic Research Program of China (973 Program) [2010CB945300]; Program for New Century Excellent Talents in University of China; Swedish Research Council	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Tai shan Scholar Foundation of Shan dong Province; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The authors are supported by the National Science Fund for Distinguished Young Scholars (30725029), the Tai shan Scholar Foundation of Shan dong Province, the National Basic Research Program of China (973 Program-2010CB945300), Program for New Century Excellent Talents in University of China and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour I, 2008, J IMMUNOL, V181, P2001, DOI 10.4049/jimmunol.181.3.2001; AIR GM, 1971, AUST J BIOL SCI, V24, P75, DOI 10.1071/BI9710075; Almagro JC, 1998, IMMUNOGENETICS, V47, P355, DOI 10.1007/s002510050370; Almagro JC, 2006, MOL IMMUNOL, V43, P1836, DOI 10.1016/j.molimm.2005.10.017; Andersson KE, 2011, NEUROUROL URODYNAM, V30, P636, DOI 10.1002/nau.21108; Andrianova EP, 2011, BIOCHEMISTRY-MOSCOW+, V76, P339, DOI 10.1134/S0006297911030072; Baker ML, 2010, IMMUNOGENETICS, V62, P173, DOI 10.1007/s00251-010-0425-4; Bao YH, 2010, VET IMMUNOL IMMUNOP, V137, P64, DOI 10.1016/j.vetimm.2010.04.011; Bengten E, 2000, CURR TOP MICROBIOL, V248, P189; BENSMANA M, 1988, NUCLEIC ACIDS RES, V16, P3108, DOI 10.1093/nar/16.7.3108; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Berens SJ, 1997, INT IMMUNOL, V9, P189, DOI 10.1093/intimm/9.1.189; BERMAN JE, 1988, EMBO J, V7, P727, DOI 10.1002/j.1460-2075.1988.tb02869.x; BRODEUR PH, 1984, EUR J IMMUNOL, V14, P922, DOI 10.1002/eji.1830141012; BRUGGEMANN M, 1988, GENE, V74, P473, DOI 10.1016/0378-1119(88)90180-1; Butler JE, 2006, DEV COMP IMMUNOL, V30, P199, DOI 10.1016/j.dci.2005.06.025; Butler JE, 1997, SCAND J IMMUNOL, V45, P455, DOI 10.1046/j.1365-3083.1997.d01-423.x; CAO Y, 1994, MOL BIOL EVOL, V11, P593; Charlton KA, 2000, J IMMUNOL, V164, P6221, DOI 10.4049/jimmunol.164.12.6221; Chevillard C, 2002, J IMMUNOL, V168, P5659, DOI 10.4049/jimmunol.168.11.5659; Churakov G, 2010, MOL BIOL EVOL, V27, P1315, DOI 10.1093/molbev/msq019; Clewley J P, 1997, Methods Mol Biol, V70, P119; CURRIER SJ, 1988, J IMMUNOL, V140, P1651; Das S, 2008, IMMUNOGENETICS, V60, P47, DOI 10.1007/s00251-007-0270-2; DErchia AM, 1996, NATURE, V381, P597, DOI 10.1038/381597a0; Dufour V, 1996, J IMMUNOL, V156, P2163; ELLISON JW, 1982, NUCLEIC ACIDS RES, V10, P4071, DOI 10.1093/nar/10.13.4071; FELSENSTEIN J, 2007, PHYLIP PHYLOGENY INF; FLANAGAN JG, 1984, CELL, V36, P681, DOI 10.1016/0092-8674(84)90348-9; Freedman MH, 1998, P NATL ACAD SCI USA, V95, P95, DOI 10.1073/pnas.95.1.95; Gambon-Deza F, 2009, MOL IMMUNOL, V46, P2515, DOI 10.1016/j.molimm.2009.05.025; GRAUR D, 1991, NATURE, V351, P649, DOI 10.1038/351649a0; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; Guo YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016889; HAINO M, 1994, J BIOL CHEM, V269, P2619; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Helling K, 2011, AURIS NASUS LARYNX, V38, P671, DOI 10.1016/j.anl.2011.02.013; Hendricks J, 2010, IMMUNOGENETICS, V62, P479, DOI 10.1007/s00251-010-0448-x; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HONJO T, 1995, IMMUNOGLOBULIN GENES, P145; Horner DS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-16; Ikeda R, 2011, OTOLARYNG HEAD NECK, V145, P801, DOI 10.1177/0194599811409516; Janke A, 1996, J MOL EVOL, V42, P153, DOI 10.1007/BF02198841; Janke A, 1997, P NATL ACAD SCI USA, V94, P1276, DOI 10.1073/pnas.94.4.1276; Johansson J, 2002, J IMMUNOL, V168, P5155, DOI 10.4049/jimmunol.168.10.5155; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Kajiwara D, 2011, EUR J PHARMACOL, V667, P389, DOI 10.1016/j.ejphar.2011.05.041; KAWAMURA S, 1992, J BIOL CHEM, V267, P7359; KNIGHT KL, 1985, J IMMUNOL, V134, P1245; KNIGHT KL, 1988, J IMMUNOL, V140, P3654; Kullander K, 1997, J MOL EVOL, V45, P311, DOI 10.1007/PL00006235; KUMA K, 1994, JPN J GENET, V69, P555, DOI 10.1266/jjg.69.555; Lanning DK, 2003, GENE, V309, P135, DOI 10.1016/S0378-1119(03)00500-6; LI WH, 1992, J HERED, V83, P174, DOI 10.1093/oxfordjournals.jhered.a111188; Lin YH, 2002, MOL BIOL EVOL, V19, P2060, DOI 10.1093/oxfordjournals.molbev.a004031; Lucier MR, 1998, J IMMUNOL, V161, P5438; Mizutani N, 2012, PHYTOTHER RES, V26, P325, DOI 10.1002/ptr.3557; MORGADO MG, 1989, EMBO J, V8, P3245, DOI 10.1002/j.1460-2075.1989.tb08484.x; Nei M, 2007, P NATL ACAD SCI USA, V104, P12235, DOI 10.1073/pnas.0703349104; Nguyen VK, 1998, J MOL BIOL, V275, P413, DOI 10.1006/jmbi.1997.1477; OSBORNE BA, 1988, GENETICS, V119, P925; Padilla-Carlin DJ, 2008, COMPARATIVE MED, V58, P324; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PHIZACKERLEY RP, 1979, MOL IMMUNOL, V16, P841, DOI 10.1016/0161-5890(79)90083-X; Qin T, 2008, DEV COMP IMMUNOL, V32, P156, DOI 10.1016/j.dci.2007.05.007; RETIEF JD, 1993, EUR J BIOCHEM, V218, P457, DOI 10.1111/j.1432-1033.1993.tb18396.x; Reyes A, 2000, GENE, V259, P177, DOI 10.1016/S0378-1119(00)00438-8; Robinson-Rechavi M, 2000, MOL BIOL EVOL, V17, P1410, DOI 10.1093/oxfordjournals.molbev.a026424; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHROEDER HW, 1990, INT IMMUNOL, V2, P41, DOI 10.1093/intimm/2.1.41; SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5; Sinclair MC, 1997, J IMMUNOL, V159, P3883; Sitnikova T, 1998, MOL BIOL EVOL, V15, P617, DOI 10.1093/oxfordjournals.molbev.a025965; Sturm EM, 2011, J LEUKOCYTE BIOL, V90, P285, DOI 10.1189/jlb.0211087; SUN J, 1994, J IMMUNOL, V153, P5618; Sun Y, 2010, DEV COMP IMMUNOL, V34, P1009, DOI 10.1016/j.dci.2010.05.003; Thomas RK, 2004, LANCET ONCOL, V5, P11, DOI 10.1016/S1470-2045(03)01319-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOMLINSON IM, 1992, J MOL BIOL, V227, P776, DOI 10.1016/0022-2836(92)90223-7; TUCKER PW, 1981, P NATL ACAD SCI-BIOL, V78, P7684, DOI 10.1073/pnas.78.12.7684; TUTTER A, 1989, P NATL ACAD SCI USA, V86, P7460, DOI 10.1073/pnas.86.19.7460; VANDIJK KW, 1993, EUR J IMMUNOL, V23, P832, DOI 10.1002/eji.1830230410; VARGASMADRAZO E, 1995, J MOL BIOL, V246, P74, DOI 10.1006/jmbi.1994.0067; Wagner B, 2004, J IMMUNOL, V173, P3230, DOI 10.4049/jimmunol.173.5.3230; Wang XX, 2009, IMMUNOGENETICS, V61, P581, DOI 10.1007/s00251-009-0385-8; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5; Warr GW, 1997, DEV BIOLOGICALS, V90, P15; Zhang YA, 2003, VET IMMUNOL IMMUNOP, V95, P81, DOI 10.1016/S0165-2427(03)00105-3	89	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39298	10.1371/journal.pone.0039298	http://dx.doi.org/10.1371/journal.pone.0039298			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761756	gold, Green Submitted, Green Published			2022-12-27	WOS:000305730900040
J	Lin, CJ; Lee, CC; Shih, YL; Lin, CH; Wang, SH; Chen, TH; Shih, CM				Lin, Chien-Ju; Lee, Chin-Cheng; Shih, Yung-Luen; Lin, Chien-Huang; Wang, Sheng-Hao; Chen, Thay-Hsiung; Shih, Chwen-Ming			Inhibition of Mitochondria- and Endoplasmic Reticulum Stress-Mediated Autophagy Augments Temozolomide-Induced Apoptosis in Glioma Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; PERMEABILITY TRANSITION; OXIDATIVE STRESS; DYNAMICS; SURVIVAL; DEATH; PORE	Autophagy is a crucial process for cells to maintain homeostasis and survival through degradation of cellular proteins and organelles, including mitochondria and endoplasmic reticula (ER). We previously demonstrated that temozolomide (TMZ), an alkylating agent for brain tumor chemotherapy, induced reactive oxygen species (ROS)/extracellular signal-regulated kinase (ERK)-mediated autophagy to protect glioma cells from apoptosis. In this study, we investigated the role of mitochondrial damage and ER stress in TMZ-induced cytotoxicity. Mitochondrial depolarization and mitochondrial permeability transition pore (MPTP) opening were observed as a prelude to TMZ-induced autophagy, and these were followed by the loss of mitochondrial mass. Electron transport chain (ETC) inhibitors, such as rotenone (a complex I inhibitor), sodium azide (a complex IV inhibitor), and oligomycin (a complex V inhibitor), or the MPTP inhibitor, cyclosporine A, decreased mitochondrial damage-mediated autophagy, and therefore increased TMZ-induced apoptosis. TMZ treatment triggered ER stress with increased expression of GADD153 and GRP78 proteins, and deceased pro-caspase 12 protein. ER stress consequently induced autophagy through c-Jun N-terminal kinases (JNK) and Ca2+ signaling pathways. Combination of TMZ with 4-phenylbutyrate (4-PBA), an ER stress inhibitor, augmented TMZ-induced cytotoxicity by inhibiting autophagy. Taken together, our data indicate that TMZ induced autophagy through mitochondrial damage-and ER stress-dependent mechanisms to protect glioma cells. This study provides evidence that agents targeting mitochondria or ER may be potential anticancer strategies.	[Lin, Chien-Ju; Lin, Chien-Huang; Wang, Sheng-Hao; Shih, Chwen-Ming] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Lin, Chien-Ju; Wang, Sheng-Hao; Shih, Chwen-Ming] Taipei Med Univ, Dept Biochem, Coll Med, Taipei, Taiwan; [Lee, Chin-Cheng; Shih, Yung-Luen] Shin Kong Wu Ho Su Mem Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Shih, Yung-Luen] Taipei Med Univ, Coll Med, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Chen, Thay-Hsiung] Cathay Gen Hosp, Div Cardiovasc Surg, Dept Surg, Taipei, Taiwan; [Shih, Chwen-Ming] Taipei Med Univ Hosp, Tradit Herbal Med Res Ctr, Taipei, Taiwan; [Shih, Chwen-Ming] Taipei Med Univ Hosp, Ctr Reprod Med & Sci, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Shin Kong Wu Ho Su Memorial Hospital; Taipei Medical University; Cathay General Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital	Lin, CJ (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan.	cmshih@tmu.edu.tw		Lin, Chien-Ju/0000-0001-5224-3539; Lin, Chien-Huang/0000-0002-0916-8737	National Science Council of Taiwan [NSC99-2320-B-038-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from National Science Council (NSC99-2320-B-038-MY3) of Taiwan to CMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin RC, 2009, ANTIOXID REDOX SIGN, V11, P2279, DOI [10.1089/ars.2009.2686, 10.1089/ARS.2009.2686]; Bhutia SK, 2010, CANCER RES, V70, P3667, DOI 10.1158/0008-5472.CAN-09-3647; Carreira RS, 2010, AUTOPHAGY, V6, P462, DOI 10.4161/auto.6.4.11553; Chen TC, 2011, CANCER LETT, V302, P100, DOI 10.1016/j.canlet.2010.11.008; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Gao M, 2008, CANCER RES, V68, P9348, DOI 10.1158/0008-5472.CAN-08-1642; Grandemange S, 2009, SEMIN CANCER BIOL, V19, P50, DOI 10.1016/j.semcancer.2008.12.001; Hara H, 2011, NEUROCHEM INT, V58, P35, DOI 10.1016/j.neuint.2010.10.006; Hwang MS, 2010, BIOCHEM BIOPH RES CO, V399, P111, DOI 10.1016/j.bbrc.2010.07.050; Isakovic A, 2007, CELL MOL LIFE SCI, V64, P1290, DOI 10.1007/s00018-007-7080-4; Kanzawa T, 2003, J NEUROSURG, V99, P1047, DOI 10.3171/jns.2003.99.6.1047; Kim EH, 2007, CANCER RES, V67, P6314, DOI 10.1158/0008-5472.CAN-06-4217; Kim KW, 2010, ONCOGENE, V29, P3241, DOI 10.1038/onc.2010.74; Kitamura M, 2008, AM J PHYSIOL-RENAL, V295, pF323, DOI 10.1152/ajprenal.00050.2008; Ko WC, 2012, ACTA PHARMACOL SIN, V33, P49, DOI 10.1038/aps.2011.178; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Krebiehl G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009367; Lena A, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-13; Lin CJ, 2012, FREE RADICAL BIO MED, V52, P377, DOI 10.1016/j.freeradbiomed.2011.10.487; MAFTAH A, 1989, BIOCHEM BIOPH RES CO, V164, P185, DOI 10.1016/0006-291X(89)91700-2; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Oh SH, 2009, J PHARMACOL EXP THER, V329, P112, DOI 10.1124/jpet.108.144113; Oliva CR, 2010, J BIOL CHEM, V285, P39759, DOI 10.1074/jbc.M110.147504; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Pietra G, 2001, CANCER RES, V61, P8218; Pramanik KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020151; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; REIPERT S, 1995, EXP CELL RES, V221, P281, DOI 10.1006/excr.1995.1376; Rickmann M, 2007, GASTROENTEROLOGY, V132, P2518, DOI 10.1053/j.gastro.2007.03.107; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; Rodriguez-Enriquez S, 2009, AUTOPHAGY, V5, P1099, DOI 10.4161/auto.5.8.9825; Schleicher SM, 2010, DRUG RESIST UPDATE, V13, P79, DOI 10.1016/j.drup.2010.04.002; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sy LK, 2008, CANCER RES, V68, P10229, DOI 10.1158/0008-5472.CAN-08-1983; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Thevenod F, 1999, FASEB J, V13, P1751, DOI 10.1096/fasebj.13.13.1751; Vilatoba M, 2005, SURGERY, V138, P342, DOI 10.1016/j.surg.2005.04.019; Villano JL, 2009, CANCER CHEMOTH PHARM, V64, P647, DOI 10.1007/s00280-009-1050-5; Viola G, 2009, CANCER CHEMOTH PHARM, V64, P1235, DOI 10.1007/s00280-009-0994-9; Wang SH, 2008, CELL MOL LIFE SCI, V65, P3640, DOI 10.1007/s00018-008-8383-9; Wang SH, 2009, CHEM-BIOL INTERACT, V181, P45, DOI 10.1016/j.cbi.2009.05.004; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Wu SN, 2009, J CELL PHYSIOL, V218, P603, DOI 10.1002/jcp.21636; Xi HB, 2011, CANCER CHEMOTH PHARM, V67, P899, DOI 10.1007/s00280-010-1391-0; Yang PM, 2010, CANCER RES, V70, P7699, DOI 10.1158/0008-5472.CAN-10-1626; Yang Y, 2010, BIOCHEM BIOPH RES CO, V395, P190, DOI 10.1016/j.bbrc.2010.03.155	49	68	71	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38706	10.1371/journal.pone.0038706	http://dx.doi.org/10.1371/journal.pone.0038706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745676	Green Published, gold			2022-12-27	WOS:000305730900017
J	Skowronski, DM; Hamelin, ME; Janjua, NZ; De Serres, G; Gardy, JL; Rheaume, C; Bouhy, X; Boivin, G				Skowronski, Danuta M.; Hamelin, Marie-Eve; Janjua, Naveed Z.; De Serres, Gaston; Gardy, Jennifer L.; Rheaume, Chantal; Bouhy, Xavier; Boivin, Guy			Cross-Lineage Influenza B and Heterologous Influenza A Antibody Responses in Vaccinated Mice: Immunologic Interactions and B/Yamagata Dominance	PLOS ONE			English	Article							H1N1 2009 VACCINE; ORIGINAL ANTIGENIC SIN; IMMUNE-RESPONSE; VIRUS; CHILDREN; IMMUNOGENICITY; DISQUISITIONS; IMMUNIZATION	The annually reformulated trivalent inactivated influenza vaccine (TIV) includes both influenza A/subtypes (H3N2 (and) under bar H1N1) but only one of two influenza B/lineages (Yamagata (or) under bar Victoria). In a recent series of clinical trials to evaluate prime-boost response across influenza B/lineages, influenza-naive infants and toddlers originally primed with two doses of 2008-09 B/Yamagata-containing TIV were assessed after two doses of B/Victoria-containing TIV administered in the subsequent 200910 and 2010-11 seasons. In these children, the Victoria-containing vaccines strongly recalled antibody to the initiating B/Yamagata antigen but induced only low B/Victoria antibody responses. To further evaluate this unexpected pattern of cross-lineage vaccine responses, we conducted additional immunogenicity assessment in mice. In the current study, mice were primed with two doses of 2008-09 Yamagata-containing TIV and subsequently boosted with two doses of 2010-11 Victoria-containing TIV (Group-Yam/Vic). With the same vaccines, we also assessed the reverse order of two-dose Victoria followed by two-dose Yamagata immunization (Group-Vic/Yam). The Group-Yam/Vic mice showed strong homologous responses to Yamagata antigen. However, as previously reported in children, subsequent doses of Victoria antigen substantially boosted Yamagata but induced only low antibody response to the immunizing Victoria component. The reverse order of Group-Vic/Yam mice also showed low homologous responses to Victoria but subsequent heterologous immunization with even a single dose of Yamagata antigen induced substantial boost response to both lineages. For influenza A/H3N2, homologous responses were comparably robust for the differing TIV variants and even a single follow-up dose of the heterologous strain, regardless of vaccine sequence, substantially boosted antibody to both strains. For H1N1, two doses of 2008-09 seasonal antigen significantly blunted response to two doses of the 2010-11 pandemic H1N1 antigen. Immunologic interactions between influenza viruses considered antigenically distant and in particular the cross-lineage influenza B and dominant Yamagata boost responses we have observed in both human and animal studies warrant further evaluation.	[Skowronski, Danuta M.; Janjua, Naveed Z.; Gardy, Jennifer L.] British Columbia Ctr Dis Control, Communicable Dis Prevent & Control Serv, Vancouver, BC, Canada; [Skowronski, Danuta M.; Janjua, Naveed Z.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Hamelin, Marie-Eve; Boivin, Guy] Univ Laval, Dept Microbiol & Immunol, Quebec City, PQ, Canada; [Hamelin, Marie-Eve; Rheaume, Chantal; Bouhy, Xavier; Boivin, Guy] Ctr Hosp Univ Quebec, Dept Micrbiol & Immunol, Quebec City, PQ, Canada; [De Serres, Gaston] Univ Laval, Fac Med, Dept Social & Prevent Med, Quebec City, PQ G1K 7P4, Canada; [De Serres, Gaston] Inst Natl Sante Publ Quebec, Direct Biol & Occupat Risks, Quebec City, PQ, Canada; [Gardy, Jennifer L.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; Laval University; Laval University; Laval University; Institut national de sante publique du Quebec (INSPQ); University of British Columbia	Skowronski, DM (corresponding author), British Columbia Ctr Dis Control, Communicable Dis Prevent & Control Serv, Vancouver, BC, Canada.	danuta.skowronski@bccdc.ca	Zafar, Naveed/A-2712-2008	Zafar, Naveed/0000-0001-5681-719X; Boivin, Guy/0000-0003-3027-4662	Canadian Institutes of Health Research [229733]; Sanofi Pasteur; GlaxoSmithKline (GSK)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Sanofi Pasteur; GlaxoSmithKline (GSK)(GlaxoSmithKline)	The Canadian Institutes of Health Research funded this study (Grant number: 229733). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts to declare on behalf of co-authors within 5 years of submission: DMS was Principal Investigator on a vaccine trial for which influenza vaccine was provided free by Sanofi Pasteur, GD has received research grants from GlaxoSmithKline (GSK) and Sanofi Pasteur. JLG declares stock options with Becton Dickinson and Pfizer, neither of which had direct or indirect involvement in the current study. GB has received research grant funding from GSK. No other authors have competing interests to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andrews NJ, 2011, VACCINE, V29, P7913, DOI 10.1016/j.vaccine.2011.08.076; ARMERDING D, 1982, J INFECT DIS, V145, P320, DOI 10.1093/infdis/145.3.320; Babiuk S, 2004, J MED VIROL, V72, P138, DOI 10.1002/jmv.10540; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Baz M, 2012, CLIN VACCINE IMMUNOL, V19, P209, DOI 10.1128/CVI.05441-11; Belshe RB, 2010, VACCINE, V28, pD45, DOI 10.1016/j.vaccine.2010.08.028; Choi YS, 2011, CLIN VACCINE IMMUNOL, V18, P1519, DOI 10.1128/CVI.05053-11; D'Aoust MA, 2008, PLANT BIOTECHNOL J, V6, P930, DOI 10.1111/j.1467-7652.2008.00384.x; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Denis J, 2008, VACCINE, V26, P3395, DOI 10.1016/j.vaccine.2008.04.052; DESTGROTH SF, 1966, J EXP MED, V124, P347, DOI 10.1084/jem.124.3.347; DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331; Englund JA, 2006, PEDIATRICS, V118, pE579, DOI 10.1542/peds.2006-0201; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Gilca V, 2011, VACCINE, V30, P35, DOI 10.1016/j.vaccine.2011.10.062; Huang Bao-ying, 2011, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V25, P92; Jones T, 2004, VACCINE, V22, P3691, DOI 10.1016/j.vaccine.2004.03.035; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; KENDAL AP, 1983, J CLIN MICROBIOL, V18, P930, DOI 10.1128/JCM.18.4.930-934.1983; KILBOURNE ED, 1987, J IMMUNOL, V138, P3010; Langley JM, 2012, VACCINE, V30, P3389, DOI 10.1016/j.vaccine.2012.03.046; LEVANDOWSKI RA, 1991, J CLIN MICROBIOL, V29, P1530, DOI 10.1128/JCM.29.7.1530-1532.1991; Loebermann M, 2011, VACCINE, V29, P1228, DOI 10.1016/j.vaccine.2010.11.092; Matsuoka Yumiko, 2009, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g03s13, 10.1002/9780471729259.mc15g02s13]; MONTO AS, 1981, J CLIN MICROBIOL, V13, P54, DOI 10.1128/JCM.13.1.54-57.1981; Morens DM, 2010, EMERG INFECT DIS, V16, P1023, DOI 10.3201/eid1606.100453; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Ohfuji S, 2011, J INFECT DIS, V203, P1301, DOI 10.1093/infdis/jir026; Papenburg J, 2011, CLIN VACCINE IMMUNOL, V18, P520, DOI 10.1128/CVI.00449-10; Qiu C, 2012, CLIN INFECT DIS, V54, P17, DOI 10.1093/cid/cir753; Roman F, 2010, CLIN INFECT DIS, V51, P668, DOI 10.1086/655830; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Savard C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021522; Shaw MW, 2002, VIROLOGY, V303, P1, DOI 10.1006/viro.2002.1719; Siegrist CA, VACCINE IMMUNOLOGY; Skowronski DM, 2011, PEDIATR INFECT DIS J, V30, P833, DOI 10.1097/INF.0b013e31822db4dc; Skowronski DM, 2011, PEDIATRICS, V128, pE276, DOI 10.1542/peds.2010-2777; Uno S, 2011, MICROBIOL IMMUNOL, V55, P783, DOI 10.1111/j.1348-0421.2011.00381.x; van der Laan JW, 2008, EXPERT REV VACCINES, V7, P783, DOI 10.1586/14760584.7.6.783; van Maurik A, 2010, VACCINE, V28, P1778, DOI 10.1016/j.vaccine.2009.12.008; Walter EB, 2006, PEDIATRICS, V118, pE570, DOI 10.1542/peds.2006-0198; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization, 2011, MAN LAB DIAGN VIR SU; World Health Organization, WHO REC COMP INFL VI; Xie H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016650; Zhou C, 2012, VACCINE, V30, P3463, DOI 10.1016/j.vaccine.2012.03.021	47	31	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38929	10.1371/journal.pone.0038929	http://dx.doi.org/10.1371/journal.pone.0038929			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745690	gold, Green Published, Green Submitted			2022-12-27	WOS:000305730900025
J	Sholukh, AM; Mukhtar, MM; Humbert, M; Essono, SS; Watkins, JD; Vyas, HK; Shanmuganathan, V; Hemashettar, G; Kahn, M; Hu, SL; Montefiori, DC; Polonis, VR; Schur, PH; Ruprecht, RM				Sholukh, Anton M.; Mukhtar, Muhammad M.; Humbert, Michael; Essono, Sosthene S.; Watkins, Jennifer D.; Vyas, Hemant K.; Shanmuganathan, Vivekanandan; Hemashettar, Girish; Kahn, Maria; Hu, Shiu-Lok; Montefiori, David C.; Polonis, Victoria R.; Schur, Peter H.; Ruprecht, Ruth M.			Isolation of Monoclonal Antibodies with Predetermined Conformational Epitope Specificity	PLOS ONE			English	Article							HUMAN IMMUNE-RESPONSE; NEUTRALIZING ANTIBODIES; REPLICATION-COMPETENT; RHESUS MACAQUES; B-CELLS; VIRUS; HIV-1; VACCINE; BINDING; BROAD	Existing technologies allow isolating antigen-specific monoclonal antibodies (mAbs) from B cells. We devised a direct approach to isolate mAbs with predetermined conformational epitope specificity, using epitope mimetics (mimotopes) that reflect the three-dimensional structure of given antigen subdomains. We performed differential biopanning using bacteriophages encoding random peptide libraries and polyclonal antibodies (Abs) that had been affinity-purified with either native or denatured antigen. This strategy yielded conformational mimotopes. We then generated mimotope-fluorescent protein fusions, which were used as baits to isolate single memory B cells from rhesus monkeys (RMs). To amplify RM immunoglobulin variable regions, we developed RM-specific PCR primers and generated chimeric simian-human mAbs with predicted epitope specificity. We established proof-of-concept of our strategy by isolating mAbs targeting the conformational V3 loop crown of HIV Env; the new mAbs cross-neutralized viruses of different clades. The novel technology allows isolating mAbs from RMs or other hosts given experimental immunogens or infectious agents.	[Sholukh, Anton M.; Mukhtar, Muhammad M.; Humbert, Michael; Essono, Sosthene S.; Watkins, Jennifer D.; Vyas, Hemant K.; Shanmuganathan, Vivekanandan; Hemashettar, Girish; Ruprecht, Ruth M.] Dana Farber Canc Inst, Dept Canc Immunol, Boston, MA 02115 USA; [Sholukh, Anton M.; Mukhtar, Muhammad M.; Humbert, Michael; Essono, Sosthene S.; Watkins, Jennifer D.; Vyas, Hemant K.; Shanmuganathan, Vivekanandan; Hemashettar, Girish; Ruprecht, Ruth M.] Dana Farber Canc Inst, AIDS, Boston, MA 02115 USA; [Sholukh, Anton M.; Mukhtar, Muhammad M.; Humbert, Michael; Essono, Sosthene S.; Watkins, Jennifer D.; Vyas, Hemant K.; Schur, Peter H.; Ruprecht, Ruth M.] Harvard Univ, Sch Med, Boston, MA USA; [Kahn, Maria; Hu, Shiu-Lok] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; [Hu, Shiu-Lok] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Montefiori, David C.] Duke Univ, Sch Med, Dept Surg, Durham, NC USA; [Polonis, Victoria R.] Walter Reed Army Inst Res, Mil HIV Res Program, Silver Spring, MD USA; [Schur, Peter H.] Brigham & Womens Hosp, Dept Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Duke University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Harvard University; Brigham & Women's Hospital	Sholukh, AM (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol, Boston, MA 02115 USA.	ruth_ruprecht@dfci.harvard.edu	Sholukh, Anton/AAU-2338-2021; Hu, Shiu-Lok/A-3196-2008	Sholukh, Anton/0000-0003-0498-9162; Hu, Shiu-Lok/0000-0003-4336-7964	NIH [P01 AI048240, P01 AI048240-08s1, R37 AI034266, P30 AI060354]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, P01AI048240, R37AI034266, P01AI082282] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants P01 AI048240, P01 AI048240-08s1, R37 AI034266, and P30 AI060354. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayash-Rashkovsky M, 2007, INFECT IMMUN, V75, P1751, DOI 10.1128/IAI.01703-06; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Corti D, 2011, CURR OPIN IMMUNOL, V23, P430, DOI 10.1016/j.coi.2011.04.006; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; FOLKS T, 1985, P NATL ACAD SCI USA, V82, P4539, DOI 10.1073/pnas.82.13.4539; Gorny MK, 2009, MOL IMMUNOL, V46, P917, DOI 10.1016/j.molimm.2008.09.005; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+; Hioe CE, 2011, PLOS ONE, V5; Humbert M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003937; Humbert M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-94; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; JULIUS MH, 1972, P NATL ACAD SCI USA, V69, P1934, DOI 10.1073/pnas.69.7.1934; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KLANIECKI J, 1991, AIDS RES HUM RETROV, V7, P791, DOI 10.1089/aid.1991.7.791; Kwong PD, 2009, CELL HOST MICROBE, V6, P292, DOI 10.1016/j.chom.2009.09.008; Margolin DH, 2006, J IMMUNOL, V177, P1108, DOI 10.4049/jimmunol.177.2.1108; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Parren PWHI, 1996, J VIROL, V70, P9046, DOI 10.1128/JVI.70.12.9046-9050.1996; POSNER MR, 1991, J IMMUNOL, V146, P4325; Rasmussen RA, 2007, AIDS, V21, P1841, DOI 10.1097/QAD.0b013e32828684ea; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Robinson JE, 2010, J VIROL, V84, P3443, DOI 10.1128/JVI.02617-09; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Siddappa NB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011689; Song RJ, 2006, J VIROL, V80, P8729, DOI 10.1128/JVI.00558-06; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Watkins JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018207; Weitkamp JH, 2003, J IMMUNOL METHODS, V275, P223, DOI 10.1016/S0022-1759(03)00013-9; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004; Zielinski CE, 2011, IMMUNOL REV, V240, P40, DOI 10.1111/j.1600-065X.2010.01000.x	37	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38943	10.1371/journal.pone.0038943	http://dx.doi.org/10.1371/journal.pone.0038943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737224	Green Published, Green Submitted, gold			2022-12-27	WOS:000305695100023
J	Asbach, B; Ludwig, C; Saksela, K; Wagner, R				Asbach, Benedikt; Ludwig, Christine; Saksela, Kalle; Wagner, Ralf			Comprehensive Analysis of Interactions between the Src-Associated Protein in Mitosis of 68 kDa and the Human Src-Homology 3 Proteome	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; SAM68 RNA-BINDING; SH3 DOMAIN; TYROSINE PHOSPHORYLATION; ARGININE METHYLATION; INSULIN-RECEPTOR; STRUCTURAL BASIS; KINASE HCK; C-SRC; SPECIFICITY	The protein Sam68 is involved in many cellular processes such as cell-cycle regulation, RNA metabolism, or signal transduction. Sam68 comprises a central RNA-binding domain flanked by unstructured tails containing docking sites for signalling proteins including seven proline-rich sequences (denoted P0 to P6) as potential SH3-domain binding motifs. To comprehensively assess Sam68-SH3-interactions, we applied a phage-display screening of a library containing all approx. 300 human SH3 domains. Thereby we identified five new (from intersectin 2, the osteoclast stimulating factor OSF, nephrocystin, sorting nexin 9, and CIN85) and seven already known high-confidence Sam68-ligands (mainly from the Src-kinase family), as well as several lower-affinity binders. Interaction of the high-affinity Sam68-binders was confirmed in independent assays in vitro (phage-ELISA, GST-pull-down) and in vivo (FACS-based FRET-analysis with CFP- and YFP-tagged proteins). Fine-mapping analyses with peptides established P0, P3, P4, and P5 as exclusive docking-sites for SH3 domains, which showed varying preferences for these motifs. Mutational analyses identified individual residues within the proline-rich motifs being crucial for the interactions. Based on these data, we generated a Sam68-mutant incapable of interacting with SH3 domains any more, as subsequently demonstrated by FRET-analyses. In conclusion, we present a thorough characterization of Sam68's interplay with the SH3 proteome. The observed interaction between Sam68 and OSF complements the known Sam68-Src and OSF-Src interactions. Thus, we propose, that Sam68 functions as a classical scaffold protein in this context, assembling components of an osteoclast-specific signalling pathway.	[Asbach, Benedikt; Ludwig, Christine; Wagner, Ralf] Univ Regensburg, Inst Med Microbiol & Hyg, Regensburg, Germany; [Saksela, Kalle] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland	University of Regensburg; University of Helsinki	Asbach, B (corresponding author), Univ Regensburg, Inst Med Microbiol & Hyg, Regensburg, Germany.	ralf.wagner@klinik.uni-regensburg.de		Saksela, Kalle/0000-0003-0827-122X	German Federal Ministry for Education and Research (BMBF)	German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported in part by a BioChance Plus grant from the German Federal Ministry for Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; Asbach B, 2010, ANAL BIOANAL CHEM, V398, P1937, DOI 10.1007/s00216-010-4202-x; Babic I, 2006, ONCOGENE, V25, P4955, DOI 10.1038/sj.onc.1209504; Babic I, 2004, ONCOGENE, V23, P3781, DOI 10.1038/sj.onc.1207484; Barlat I, 1997, J BIOL CHEM, V272, P3129, DOI 10.1074/jbc.272.6.3129; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; Buday L, 1999, BBA-REV BIOMEMBRANES, V1422, P187, DOI 10.1016/S0304-4157(99)00005-2; Buchse T, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006239; Bunnell SC, 1996, J BIOL CHEM, V271, P25646, DOI 10.1074/jbc.271.41.25646; Busa R, 2007, ONCOGENE, V26, P4372, DOI 10.1038/sj.onc.1210224; Cesareni G, 2002, FEBS LETT, V513, P38, DOI 10.1016/S0014-5793(01)03307-5; Chen TP, 1997, MOL CELL BIOL, V17, P5707, DOI 10.1128/MCB.17.10.5707; Chen TP, 1999, MOL BIOL CELL, V10, P3015, DOI 10.1091/mbc.10.9.3015; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; Derry JJ, 2000, MOL CELL BIOL, V20, P6114, DOI 10.1128/MCB.20.16.6114-6126.2000; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Espejo A, 2002, BIOCHEM J, V367, P697, DOI 10.1042/BJ20020860; Finan PM, 1996, FEBS LETT, V389, P141, DOI 10.1016/0014-5793(96)00552-2; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; Gilbert C, 2001, J IMMUNOL, V166, P4664, DOI 10.4049/jimmunol.166.7.4664; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Guiet R, 2008, EUR J CELL BIOL, V87, P527, DOI 10.1016/j.ejcb.2008.03.008; Guinamard R, 1997, SCAND J IMMUNOL, V45, P587, DOI 10.1046/j.1365-3083.1997.d01-447.x; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Hassaine G, 2001, J BIOL CHEM, V276, P16885, DOI 10.1074/jbc.M009076200; He LS, 2003, CYTOM PART A, V55A, P71, DOI 10.1002/cyto.a.10073; Ishidate T, 1997, FEBS LETT, V409, P237, DOI 10.1016/S0014-5793(97)00455-9; Jia CYH, 2005, MOL CELL PROTEOMICS, V4, P1155, DOI 10.1074/mcp.M500108-MCP200; JONES AR, 1995, GENE DEV, V9, P1491, DOI 10.1101/gad.9.12.1491; KANG AS, 1991, P NATL ACAD SCI USA, V88, P4363, DOI 10.1073/pnas.88.10.4363; Karkkainen S, 2006, EMBO REP, V7, P186, DOI 10.1038/sj.embor.7400596; Kesti T, 2007, J IMMUNOL, V179, P878, DOI 10.4049/jimmunol.179.2.878; Kim Y, 2006, MOL NEUROBIOL, V34, P129, DOI 10.1385/MN:34:2:129; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Lang V, 1997, EUR J IMMUNOL, V27, P3360, DOI 10.1002/eji.1830271235; Lawe DC, 1997, ONCOGENE, V14, P223, DOI 10.1038/sj.onc.1200821; Lazer G, 2007, CELL SIGNAL, V19, P2479, DOI 10.1016/j.cellsig.2007.07.022; LEE CH, 1995, EMBO J, V14, P5006, DOI 10.1002/j.1460-2075.1995.tb00183.x; Li QH, 2002, FEBS LETT, V525, P145, DOI 10.1016/S0014-5793(02)03103-4; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Liu K, 2000, J BIOL CHEM, V275, P40195, DOI 10.1074/jbc.M006194200; Lukong KE, 2005, J BIOL CHEM, V280, P38639, DOI 10.1074/jbc.M505802200; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Lukong KE, 2008, BEHAV BRAIN RES, V189, P357, DOI 10.1016/j.bbr.2008.01.010; Mammen Mathai, 1998, Angew Chem Int Ed Engl, V37, P2754, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Mayer BJ, 2001, J CELL SCI, V114, P1253; Meyer NH, 2010, J BIOL CHEM, V285, P28893, DOI 10.1074/jbc.M110.126185; Najib S, 2002, J CELL BIOCHEM, V86, P99, DOI 10.1002/jcb.10198; O'Bryan JP, 2001, ONCOGENE, V20, P6300, DOI 10.1038/sj.onc.1204773; Oneyama C, 2003, CHEM BIOL, V10, P443, DOI 10.1016/S1074-5521(03)00101-7; Paronetto MP, 2009, J CELL BIOL, V185, P235, DOI 10.1083/jcb.200811138; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Pucharcos C, 2001, BBA-GENE STRUCT EXPR, V1521, P1, DOI 10.1016/S0167-4781(01)00276-7; Qiu HQ, 2004, ONCOGENE, V23, P2216, DOI 10.1038/sj.onc.1207339; Reddy S, 1998, J CELL PHYSIOL, V177, P636, DOI 10.1002/(SICI)1097-4652(199812)177:4<636::AID-JCP14>3.3.CO;2-8; Rho J, 2007, ARCH BIOCHEM BIOPHYS, V466, P49, DOI 10.1016/j.abb.2007.07.017; Richard S, 2005, PLOS GENET, V1, P676, DOI 10.1371/journal.pgen.0010074; RICHARD S, 1995, MOL CELL BIOL, V15, P186, DOI 10.1128/MCB.15.1.186; Sanchez-Margalet V, 1999, FEBS LETT, V455, P307, DOI 10.1016/S0014-5793(99)00887-X; Sanchez-Margalet V, 2001, CELL IMMUNOL, V211, P30, DOI 10.1006/cimm.2001.1815; Sette C, 2010, J ANDROL, V31, P66, DOI 10.2164/jandrol.109.008136; Shen ZW, 1999, ONCOGENE, V18, P4647, DOI 10.1038/sj.onc.1203079; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; TAYLOR SJ, 1995, J BIOL CHEM, V270, P10120, DOI 10.1074/jbc.270.17.10120; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; Tran T, 2005, BIOCHEMISTRY-US, V44, P15042, DOI 10.1021/bi051403k; Trub T, 1997, J BIOL CHEM, V272, P894, DOI 10.1074/jbc.272.2.894; VERONESE FDM, 1994, J MOL BIOL, V243, P167, DOI 10.1006/jmbi.1994.1643; VOGEL LB, 1995, J BIOL CHEM, V270, P2506, DOI 10.1074/jbc.270.6.2506; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; Wunderlich L, 1999, CELL SIGNAL, V11, P253, DOI 10.1016/S0898-6568(98)00054-0; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8; Zeke A, 2009, TRENDS CELL BIOL, V19, P364, DOI 10.1016/j.tcb.2009.05.007	76	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38540	10.1371/journal.pone.0038540	http://dx.doi.org/10.1371/journal.pone.0038540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745667	Green Published, gold			2022-12-27	WOS:000305693200013
J	Balakirev, ES; Krupnova, TN; Ayala, FJ				Balakirev, Evgeniy S.; Krupnova, Tatiana N.; Ayala, Francisco J.			Symbiotic Associations in the Phenotypically-Diverse Brown Alga Saccharina japonica	PLOS ONE			English	Article							URCHIN HELIOCIDARIS-ERYTHROGRAMMA; MULTIPLE SEQUENCE ALIGNMENT; SELFISH GENETIC ELEMENTS; COLOR POLYMORPHISM; DROSOPHILA-MELANOGASTER; REPRODUCTIVE ISOLATION; MICROBIAL COMMUNITIES; PHYLOGENETIC ANALYSIS; LAMINARIA-SACCHARINA; BACTERIAL BIOFILMS	The brown alga Saccharina japonica (Areschoug) Lane, Mayes, Druehl et Saunders is a highly polymorphic representative of the family Laminariaceae, inhabiting the northwest Pacific region. We have obtained 16S rRNA sequence data in symbiont microorganisms of the typical form (TYP) of S. japonica and its common morphological varieties, known as "longipes" (LON) and "shallow-water" (SHA), which show contrasting bathymetric distribution and sharp morphological, life history traits, and ecological differences. Phylogenetic analysis of the 16S rRNA sequences shows that the microbial communities are significantly different in the three forms studied and consist of mosaic sets of common and form-specific bacterial lineages. The divergence in bacterial composition is substantial between the TYP and LON forms in spite of their high genetic similarity. The symbiont distribution in the S. japonica forms and in three other laminarialean species is not related to the depth or locality of the algae settlements. Combined with our previous results on symbiont associations in sea urchins and taking into account the highly specific character of bacteria-algae associations, we propose that the TYP and LON forms may represent incipient species passing through initial steps of reproductive isolation. We suggest that phenotype differences between genetically similar forms may be caused by host-symbiont interactions that may be a general feature of evolution in algae and other eukaryote organisms. Bacterial symbionts could serve as sensitive markers to distinguish genetically similar algae forms and also as possible growth-promoting inductors to increase algae productivity.	[Balakirev, Evgeniy S.; Ayala, Francisco J.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Balakirev, Evgeniy S.] Russian Acad Sci, Far Eastern Branch, AV Zhirmunsky Inst Marine Biol, Vladivostok 690022, Russia; [Krupnova, Tatiana N.] TINRO Ctr, Pacific Res Fisheries Ctr, Vladivostok, Russia	University of California System; University of California Irvine; Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; Research lnstitute of Fisheries & Oceanography	Balakirev, ES (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	balakire@uci.edu	Balakirev, Evgeniy Stanislavovich/O-1462-2017		Bren Professor Funds at the University of California, Irvine	Bren Professor Funds at the University of California, Irvine	This study was supported by Bren Professor Funds at the University of California, Irvine to FJA and ESB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CE, 2007, ECOL FRESHW FISH, V16, P20, DOI 10.1111/j.1600-0633.2006.00179.x; Amser C. D., 2008, P297; Ashen JB, 2000, APPL ENVIRON MICROB, V66, P3024, DOI 10.1128/AEM.66.7.3024-3030.2000; Balakirev ES, 2003, GENETICS, V164, P533; Balakirev ES, 2012, BMC PLANT B IN PRESS; Balakirev ES, 2008, P NATL ACAD SCI USA, V105, P16218, DOI 10.1073/pnas.0807860105; Bartsch I, 2008, EUR J PHYCOL, V43, P1, DOI 10.1080/09670260701711376; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Bordenstein Sr, 2003, CONT T ENT, P283; Butler A, 1998, SCIENCE, V281, P207, DOI 10.1126/science.281.5374.207; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; Delbridge L, 2004, SYMBIOSIS, V37, P335; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Domingo JL, 2011, ENVIRON INT, V37, P734, DOI 10.1016/j.envint.2011.01.003; Druehl LD, 2005, J PHYCOL, V41, P250, DOI 10.1111/j.1529-8817.2005.04143.x; DRUEHL LD, 1992, PROG PHYCOL RES, V8, P47; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Dworjanyn SA, 2008, AQUACULTURE, V274, P268, DOI 10.1016/j.aquaculture.2007.11.030; ETTER RJ, 1988, EVOLUTION, V42, P660, DOI 10.1111/j.1558-5646.1988.tb02485.x; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Goecke F, 2010, MAR ECOL PROG SER, V409, P267, DOI 10.3354/meps08607; Guerrero A, 2010, DEV BIOL, V344, P52, DOI 10.1016/j.ydbio.2010.04.013; GUIRY MD, 1992, PROGR PHYCOLOGICAL R, V8, P251; Gusarova IS, 2006, IZV TINRO, V147, P157; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Harley CDG, 2006, BIOL BULL-US, V211, P248, DOI 10.2307/4134547; HARRISON RG, 1991, ANNU REV ECOL SYST, V22, P281, DOI 10.1146/annurev.ecolsys.22.1.281; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Huggett MJ, 2006, OECOLOGIA, V149, P604, DOI 10.1007/s00442-006-0470-8; Huggett MJ, 2008, AQUAT MICROB ECOL, V53, P161, DOI 10.3354/ame01239; Hunter MS, 2003, P ROY SOC B-BIOL SCI, V270, P2185, DOI 10.1098/rspb.2003.2475; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Hurst GDD, 2001, NAT REV GENET, V2, P597, DOI 10.1038/35084545; Hurst GDD, 1998, HEREDITY, V80, P2, DOI 10.1046/j.1365-2540.1998.00337.x; Jiggins FM, 2011, SCIENCE, V332, P185, DOI 10.1126/science.1205386; Joint I, 2002, SCIENCE, V298, P1207, DOI 10.1126/science.1077075; Joint I, 2007, PHILOS T R SOC B, V362, P1223, DOI 10.1098/rstb.2007.2047; Kaupp UB, 2003, NAT CELL BIOL, V5, P109, DOI 10.1038/ncb915; KESHTACHERLIEBSON E, 1995, APPL ENVIRON MICROB, V61, P2439, DOI 10.1128/AEM.61.6.2439-2441.1995; Kraan S, 2000, J PHYCOL, V36, P190, DOI 10.1046/j.1529-8817.2000.99244.x; Krupnova TN, 2000, BIOTECHNOLOGY MAT CO, V23647, P54; Krupnova TN, 1999, DEV BIOTECHNOLOGY IN, V23285, P38; Lachnit T, 2009, AQUAT BIOL, V5, P181, DOI 10.3354/ab00149; Lane CE, 2006, J PHYCOL, V42, P493, DOI 10.1111/j.1529-8817.2006.00204.x; Leonardo TE, 2006, P ROY SOC B-BIOL SCI, V273, P1079, DOI 10.1098/rspb.2005.3408; Lessios HA, 2007, B MAR SCI, V81, P191; Liptack MK, 2000, EUR J PHYCOL, V35, P135, DOI 10.1017/S0967026200002651; Liu FL, 2010, MAR BIOTECHNOL, V12, P386, DOI 10.1007/s10126-009-9229-7; Lopez-Legentil S, 2005, ZOOL SCR, V34, P3, DOI 10.1111/j.1463-6409.2005.00167.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ma Yuexin, 2009, Acta Ecologica Sinica, V29, P222; Mackenzie JB, 2004, MOL ECOL, V13, P9, DOI 10.1046/j.1365-294X.2003.02019.x; MAIER I, 1986, BIOL BULL, V170, P145, DOI 10.2307/1541801; Mandel MJ, 2010, TRENDS MICROBIOL, V18, P504, DOI 10.1016/j.tim.2010.07.005; MANHART JR, 1992, J PHYCOL, V28, P730, DOI 10.1111/j.0022-3646.1992.00730.x; Marshall K, 2006, MICROB ECOL, V52, P302, DOI 10.1007/s00248-006-9060-x; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Matsuo Y, 2005, SCIENCE, V307, P1598, DOI 10.1126/science.1105486; Medlin LK, 1995, NATO ADV SCI INST SE, V38, P133; Mei Chuansheng, 2010, Recent Pat Biotechnol, V4, P81, DOI 10.2174/187220810790069523; Merilaita S, 2001, EVOL ECOL, V15, P103, DOI 10.1023/A:1013814623311; Meusnier I, 2001, MOL ECOL, V10, P931, DOI 10.1046/j.1365-294X.2001.01245.x; Moran NA, 2005, APPL ENVIRON MICROB, V71, P8802, DOI 10.1128/AEM.71.12.8802-8810.2005; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Nakanishi K, 1996, J PHYCOL, V32, P479, DOI 10.1111/j.0022-3646.1996.00479.x; Niwa K, 2010, J PHYCOL, V46, P693, DOI 10.1111/j.1529-8817.2010.00853.x; PALUMBI SR, 1991, MOL BIOL EVOL, V8, P227; Patel P, 2003, ENVIRON MICROBIOL, V5, P338, DOI 10.1046/j.1462-2920.2003.00407.x; REIMCHEN TE, 1989, BIOL J LINN SOC, V36, P97, DOI 10.1111/j.1095-8312.1989.tb00485.x; Ronald P, 2011, GENETICS, V188, P11, DOI 10.1534/genetics.111.128553; SABBADIN A, 1967, NATURE, V213, P815, DOI 10.1038/213815b0; Selivanova ON, 2007, RUSS J MAR BIOL +, V33, P278, DOI 10.1134/S1063074007050021; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Staufenberger T, 2008, FEMS MICROBIOL ECOL, V64, P65, DOI 10.1111/j.1574-6941.2008.00445.x; Swanson RL, 2006, MAR ECOL PROG SER, V314, P1, DOI 10.3354/meps314001; Tait K, 2005, ENVIRON MICROBIOL, V7, P229, DOI 10.1111/j.1462-2920.2004.00706.x; Telschow A, 2002, AM NAT, V160, pS54, DOI 10.1086/342153; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THOMPSON JN, 1987, BIOL J LINN SOC, V32, P385, DOI 10.1111/j.1095-8312.1987.tb00439.x; Uchida M, 2002, FISHERIES SCI, V68, P703, DOI 10.1046/j.1444-2906.2002.00481.x; Wang G, 2008, J APPL PHYCOL, V20, P403, DOI 10.1007/s10811-007-9274-4; Wang L, 2003, FISHERIES SCI, V22, P9; WARD GE, 1985, J CELL BIOL, V101, P2324, DOI 10.1083/jcb.101.6.2324; Weinberger F, 2007, J PHYCOL, V43, P235, DOI 10.1111/j.1529-8817.2007.00329.x; Werren JH, 1998, ENDLESS FORMS, P245; Weyens N, 2009, TRENDS BIOTECHNOL, V27, P591, DOI 10.1016/j.tibtech.2009.07.006; WICKSTEN MK, 1989, B MAR SCI, V45, P519; Wiese J, 2009, MAR BIOTECHNOL, V11, P287, DOI 10.1007/s10126-008-9143-4; Winkler FM, 2001, J HERED, V92, P521, DOI 10.1093/jhered/92.6.521; Wirth T, 2004, P NATL ACAD SCI USA, V101, P4746, DOI 10.1073/pnas.0306629101; Xu P, 2011, J APPL PHYCOL, V23, P235, DOI 10.1007/s10811-010-9537-3; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57	95	15	19	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39587	10.1371/journal.pone.0039587	http://dx.doi.org/10.1371/journal.pone.0039587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745792	Green Published, gold			2022-12-27	WOS:000305693200091
J	Englander, ZA; Haidt, J; Morris, JP				Englander, Zoe A.; Haidt, Jonathan; Morris, James P.			Neural Basis of Moral Elevation Demonstrated through Inter-Subject Synchronization of Cortical Activity during Free-Viewing	PLOS ONE			English	Article							BRAIN; EMOTIONS; ADMIRATION; IMAGES; ROBUST; MIND	Background: Most research investigating the neural basis of social emotions has examined emotions that give rise to negative evaluations of others (e. g. anger, disgust). Emotions triggered by the virtues and excellences of others have been largely ignored. Using fMRI, we investigated the neural basis of two "other-praising" emotions - Moral Elevation (a response to witnessing acts of moral beauty), and Admiration (which we restricted to admiration for physical skill). Methodology/Principal Findings: Ten participants viewed the same nine video clips. Three clips elicited moral elevation, three elicited admiration, and three were emotionally neutral. We then performed pair-wise voxel-by-voxel correlations of the BOLD signal between individuals for each video clip and a separate resting-state run. We observed a high degree of inter-subject synchronization, regardless of stimulus type, across several brain regions during free-viewing of videos. Videos in the elevation condition evoked significant inter-subject synchronization in brain regions previously implicated in self-referential and interoceptive processes, including the medial prefrontal cortex, precuneus, and insula. The degree of synchronization was highly variable over the course of the videos, with the strongest synchrony occurring during portions of the videos that were independently rated as most emotionally arousing. Synchrony in these same brain regions was not consistently observed during the admiration videos, and was absent for the neutral videos. Conclusions/Significance: Results suggest that the neural systems supporting moral elevation are remarkably consistent across subjects viewing the same emotional content. We demonstrate that model-free techniques such as inter-subject synchronization may be a useful tool for studying complex, context dependent emotions such as self-transcendent emotion.	[Englander, Zoe A.; Haidt, Jonathan; Morris, James P.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA	University of Virginia	Englander, ZA (corresponding author), Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA.	jpmorris@virginia.edu	Haidt, Jonathan/B-2835-2013	Englander, Zoe/0000-0002-0809-8466	National Institute of Mental Health Pathway to Independence Award [R00MH079617]; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH079617] Funding Source: NIH RePORTER	National Institute of Mental Health Pathway to Independence Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	JP Morris was supported by a National Institute of Mental Health Pathway to Independence Award, R00MH079617. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algoe SB, 2009, J POSIT PSYCHOL, V4, P105, DOI 10.1080/17439760802650519; EKMAN P., 1969, SEMIOTICA, V1, P49, DOI DOI 10.1515/SEMI.1969.1.1.49; Ekman Paul, 1994, NATURE EMOTION FUNDA; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Gallagher HL, 2004, NEUROPSYCHOLOGIA, V42, P1725, DOI 10.1016/j.neuropsychologia.2004.05.006; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Haidt J, 2003, SER AFFECTIVE SCI, P852; Haidt J., 2006, HAPPINESS HYPOTHESIS; Haidt J, 2009, P NATL ACAD SCI USA, V106, P7687, DOI 10.1073/pnas.0903076106; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Immordino-Yang MH, 2009, P NATL ACAD SCI USA, V106, P8021, DOI 10.1073/pnas.0810363106; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; LAZARUS RS, 1991, AM PSYCHOL, V46, P819, DOI 10.1037/0003-066X.46.8.819; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ortony A., 1988, COGNITIVE STRUCTURE; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Schnall S, 2010, PSYCHOL SCI, V21, P315, DOI 10.1177/0956797609359882; SMITH CA, 1985, J PERS SOC PSYCHOL, V48, P813, DOI 10.1037/0022-3514.48.4.813; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	21	36	40	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39384	10.1371/journal.pone.0039384	http://dx.doi.org/10.1371/journal.pone.0039384			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	964KK	22745745	Green Submitted, Green Published, gold			2022-12-27	WOS:000305693200071
J	Hager, J; Kamatani, Y; Cazier, JB; Youhanna, S; Ghassibe-Sabbagh, M; Platt, DE; Abchee, AB; Romanos, J; Khazen, G; Othman, R; Badro, DA; Haber, M; Salloum, AK; Douaihy, B; Shasha, N; Kabbani, S; Sbeite, H; Chammas, E; el Bayeh, H; Rousseau, F; Zelenika, D; Gut, I; Lathrop, M; Farrall, M; Gauguier, D; Zalloua, PA				Hager, Joerg; Kamatani, Yoichiro; Cazier, Jean-Baptiste; Youhanna, Sonia; Ghassibe-Sabbagh, Michella; Platt, Daniel E.; Abchee, Antoine B.; Romanos, Jihane; Khazen, Georges; Othman, Raed; Badro, Danielle A.; Haber, Marc; Salloum, Angelique K.; Douaihy, Bouchra; Shasha, Nabil; Kabbani, Samer; Sbeite, Hana; Chammas, Elie; el Bayeh, Hamid; Rousseau, Francis; Zelenika, Diana; Gut, Ivo; Lathrop, Mark; Farrall, Martin; Gauguier, Dominique; Zalloua, Pierre A.		FGENTCARD Consortium	Genome-Wide Association Study in a Lebanese Cohort Confirms PHACTR1 as a Major Determinant of Coronary Artery Stenosis	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; HEART-DISEASE; HISTORY; RISK; LOCI; ATHEROSCLEROSIS; SUSCEPTIBILITY; LIFE; ENOS	The manifestation of coronary artery disease (CAD) follows a well-choreographed series of events that includes damage of arterial endothelial cells and deposition of lipids in the sub-endothelial layers. Genome-wide association studies (GWAS) of multiple populations with distinctive genetic and lifestyle backgrounds are a crucial step in understanding global CAD pathophysiology. In this study, we report a GWAS on the genetic basis of arterial stenosis as measured by cardiac catheterization in a Lebanese population. The locus of the phosphatase and actin regulator 1 gene (PHACTR1) showed association with coronary stenosis in a discovery experiment with genome wide data in 1,949 individuals (rs9349379, OR = 1.37, p = 1.57 x 10(-5)). The association was replicated in an additional 2,547 individuals (OR = 1.31, p = 8.85 x 10(-6)), leading to genome-wide significant association in a combined analysis (OR = 1.34, p = 8.02 x 10(-10)). Results from this GWAS support a central role of PHACTR1 in CAD susceptibility irrespective of lifestyle and ethnic divergences. This association provides a plausible component for understanding molecular mechanisms involved in the formation of stenosis in cardiac vessels and a potential drug target against CAD.	[Hager, Joerg; Zelenika, Diana; Gut, Ivo; Lathrop, Mark] CEA Genom Inst, Ctr Natl Genotypage, Evry, France; [Kamatani, Yoichiro] Ctr Etud Polymorphisme Humain, F-75010 Paris, France; [Cazier, Jean-Baptiste; Farrall, Martin; Gauguier, Dominique] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Youhanna, Sonia; Ghassibe-Sabbagh, Michella; Romanos, Jihane; Khazen, Georges; Badro, Danielle A.; Haber, Marc; Salloum, Angelique K.; Douaihy, Bouchra; Sbeite, Hana; Chammas, Elie; el Bayeh, Hamid; Zalloua, Pierre A.] Lebanese Amer Univ, Sch Med, Beirut, Lebanon; [Platt, Daniel E.] IBM TJ Watson Res Ctr, Bioinformat & Pattern Discovery, New York, NY USA; [Abchee, Antoine B.] Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon; [Othman, Raed; Shasha, Nabil; Kabbani, Samer] Raf Hariri Univ Hosp, Div Cardiol, Beirut, Lebanon; [Rousseau, Francis] IntegraGen SA, Evry, France; [Gauguier, Dominique] Ctr Rech Cordeliers, UMRS872, INSERM, Paris, France; [Zalloua, Pierre A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Oxford; Wellcome Centre for Human Genetics; Lebanese American University; International Business Machines (IBM); American University of Beirut; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Harvard University; Harvard T.H. Chan School of Public Health	Hager, J (corresponding author), CEA Genom Inst, Ctr Natl Genotypage, Evry, France.	pzalloua@lau.edu.lb	Ghassibe-Sabbagh, Michella/AAG-5710-2019; Kamatani, Yoichiro/N-5513-2015; Romanos, Jihane/F-7372-2012; Cazier, Jean-Baptiste/F-2369-2010; Haber, Marc/D-2553-2012; Haber, Marc/Y-5090-2019; Gauguier, Dominique/G-2190-2016; Ghassibe, Michella/A-7256-2011; Khazen, Georges/AAC-2923-2020; Cazier, Jean-Baptiste/GLR-2949-2022; Gut, Ivo/ABF-3188-2020	Ghassibe-Sabbagh, Michella/0000-0003-2107-9929; Cazier, Jean-Baptiste/0000-0001-7581-9051; Haber, Marc/0000-0003-1000-1448; Haber, Marc/0000-0003-1000-1448; Gauguier, Dominique/0000-0001-6156-9530; Cazier, Jean-Baptiste/0000-0001-7581-9051; Gut, Ivo/0000-0001-7219-632X; youhanna, sonia/0000-0002-9376-8478; Badro, Danielle A/0000-0003-4487-9144; zalloua, pierre/0000-0002-8494-5081; Khazen, Geroges/0000-0002-9244-2978; Holy Spirit University of Kaslik (USEK), FACULTY OF MEDICINE AND MEDICAL SCIENCESHoly Spirit University of Kaslik (USEK)/0000-0001-6734-4105	European Commission (FGENTCARD) [LSHG-CT-2006-037683]; Wellcome Trust [075491/Z/04, 057733]; BHF; Qatar National Research Fund (QNRF) [NPRP 09-215-3-049, NPRP 4-230-1-047]; Rafic Hariri University Hospital; Centre Hospitalier du Nord; Saint Georges Hospital, Lebanon	European Commission (FGENTCARD)(European Commission); Wellcome Trust(Wellcome Trust); BHF(British Heart Foundation); Qatar National Research Fund (QNRF)(National Research Foundation of KoreaQatar National Research Fund (QNRF)); Rafic Hariri University Hospital; Centre Hospitalier du Nord; Saint Georges Hospital, Lebanon	This work was supported by a grant from the European Commission (FGENTCARD, LSHG-CT-2006-037683). JBC is supported by the Wellcome Trust core award grant number 075491/Z/04. DG held a Wellcome Trust senior fellowship in basic biomedical science (057733). MF is supported by a BHF Clinical Research Excellence award. MGS and PAZ are partly funded by Qatar National Research Fund (QNRF, NPRP 09-215-3-049), JR is partly funded by QNRF (NPRP 4-230-1-047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the patients for agreeing to participate in the study. We thank Nour Moukalled and Bariaa Khalil for their help with subject recruitment and data collection. We thank the Rafic Hariri University Hospital, "Centre Hospitalier du Nord" and Saint Georges Hospital, Lebanon for their collaboration and support.	Abchee A, 2006, THROMB RES, V117, P631, DOI 10.1016/j.thromres.2005.05.022; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P48, DOI 10.1093/oxfordjournals.aje.a114223; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Gaziano TA, 2005, CIRCULATION, V112, P3547, DOI 10.1161/CIRCULATIONAHA.105.591792; Gaziano TA, 2007, HEALTH AFFAIR, V26, P13, DOI 10.1377/hlthaff.26.1.13; Helgadottir A, 2005, AM J HUM GENET, V76, P505, DOI 10.1086/428066; Hirschhorn JN, 2011, ANNU REV MED, V62, P11, DOI 10.1146/annurev.med.091708.162036; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Lee HY, 2010, CIRC J, V74, P2257, DOI 10.1253/circj.CJ-10-0910; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Lukkarinen H, 1997, J ADV NURS, V26, P73, DOI 10.1046/j.1365-2648.1997.1997026073.x; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Neumann J, 1997, J MOL CELL CARDIOL, V29, P265, DOI 10.1006/jmcc.1996.0271; Nordlie MA, 2005, J MOL CELL CARDIOL, V39, P667, DOI 10.1016/j.yjmcc.2005.06.006; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Saade S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029427; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; SLACK J., 1966, J MED GENET, V3, P239, DOI 10.1136/jmg.3.4.239; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; van Velzen JE, 2010, CIRC-CARDIOVASC IMAG, V3, P718, DOI 10.1161/CIRCIMAGING.109.913541; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Youhanna S, 2010, ATHEROSCLEROSIS, V212, P559, DOI 10.1016/j.atherosclerosis.2010.07.013; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	33	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38663	10.1371/journal.pone.0038663	http://dx.doi.org/10.1371/journal.pone.0038663			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745674	Green Published, gold			2022-12-27	WOS:000305693200020
J	Huie, JR; Baumbauer, KM; Lee, KH; Bresnahan, JC; Beattie, MS; Ferguson, AR; Grau, JW				Huie, J. Russell; Baumbauer, Kyle M.; Lee, Kuan H.; Bresnahan, Jacqueline C.; Beattie, Michael S.; Ferguson, Adam R.; Grau, James W.			Glial Tumor Necrosis Factor Alpha (TNF alpha) Generates Metaplastic Inhibition of Spinal Learning	PLOS ONE			English	Article							CORD-INJURY; SYNAPTIC PLASTICITY; FACTOR RECEPTOR; NEUROPATHIC PAIN; VISUAL-CORTEX; NONCONTINGENT SHOCK; HIPPOCAMPAL-NEURONS; PARKINSONS-DISEASE; LOCOMOTOR NETWORK; PROTEIN-SYNTHESIS	Injury-induced overexpression of tumor necrosis factor alpha (TNF alpha) in the spinal cord can induce chronic neuroinflammation and excitotoxicity that ultimately undermines functional recovery. Here we investigate how TNF alpha might also act to upset spinal function by modulating spinal plasticity. Using a model of instrumental learning in the injured spinal cord, we have previously shown that peripheral intermittent stimulation can produce a plastic change in spinal plasticity (metaplasticity), resulting in the prolonged inhibition of spinal learning. We hypothesized that spinal metaplasticity may be mediated by TNF alpha. We found that intermittent stimulation increased protein levels in the spinal cord. Using intrathecal pharmacological manipulations, we showed TNF alpha to be both necessary and sufficient for the long-term inhibition of a spinal instrumental learning task. These effects were found to be dependent on glial production of TNF alpha and involved downstream alterations in calcium-permeable AMPA receptors. These findings suggest a crucial role for glial TNF alpha in undermining spinal learning, and demonstrate the therapeutic potential of inhibiting TNF alpha activity to rescue and restore adaptive spinal plasticity to the injured spinal cord. TNF alpha modulation represents a novel therapeutic target for improving rehabilitation after spinal cord injury.	[Huie, J. Russell; Baumbauer, Kyle M.; Lee, Kuan H.; Grau, James W.] Texas A&M Univ, Dept Psychol, College Stn, TX 77843 USA; [Huie, J. Russell; Bresnahan, Jacqueline C.; Beattie, Michael S.; Ferguson, Adam R.] Univ Calif San Francisco, Dept Neurol Surg, Brain & Spinal Injury Ctr, San Francisco, CA USA	Texas A&M University System; Texas A&M University College Station; University of California System; University of California San Francisco	Huie, JR (corresponding author), Texas A&M Univ, Dept Psychol, College Stn, TX 77843 USA.	huier@neurosurg.ucsf.edu; adam.ferguson@ucsf.edu	Grau, James/S-2372-2019	Baumbauer, Kyle/0000-0003-0437-9209; Ferguson, Adam/0000-0001-7102-1608	National Institute of Neurological Disorders and Stroke [NS063597, NS067092, NS038079, NS041548]; National Institute of Child Health and Development [HD058412]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038079, R01NS041548, R01NS067092] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute of Neurological Disorders and Stroke (NS063597 & NS067092 to ARF, NS038079 to MSB & JCB, and NS041548 to JWG), as well as a grant from the National Institute of Child Health and Development (HD058412 to JWG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Albensi BC, 2000, SYNAPSE, V35, P151; Aloe L, 1999, BRAIN RES, V840, P125, DOI 10.1016/S0006-8993(99)01748-5; Baumbauer KM, 2009, J NEUROSCI, V29, P14383, DOI 10.1523/JNEUROSCI.3583-09.2009; Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Bethea JR, 2000, PROG BRAIN RES, V128, P33; Bevan S, 2004, J NEUROSCI, V24, P9458, DOI 10.1523/JNEUROSCI.3391-04.2004; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Bigbee AJ, 2007, BEHAV BRAIN RES, V180, P95, DOI 10.1016/j.bbr.2007.02.029; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Choi JI, 2010, PAIN, V149, P243, DOI 10.1016/j.pain.2010.02.008; Cocchiara R, 1999, J NEUROIMMUNOL, V101, P128, DOI 10.1016/S0165-5728(99)00138-1; Crown ED, 2002, BEHAV NEUROSCI, V116, P1032, DOI 10.1037//0735-7044.116.6.1032; Crown ED, 2001, J NEUROPHYSIOL, V86, P845, DOI 10.1152/jn.2001.86.2.845; Czeschik JC, 2008, NEUROSCI LETT, V434, P293, DOI 10.1016/j.neulet.2008.01.070; Edgerton VR, 2004, ANNU REV NEUROSCI, V27, P145, DOI 10.1146/annurev.neuro.27.070203.144308; Elliott MB, 2009, NEUROSCIENCE, V158, P922, DOI 10.1016/j.neuroscience.2008.10.050; Ferguson AR, 2006, NEUROSCIENCE, V141, P421, DOI 10.1016/j.neuroscience.2006.03.029; Ferguson AR, 2008, J NEUROSCI, V28, P11391, DOI 10.1523/JNEUROSCI.3708-08.2008; Ferguson AR, 2008, J NEUROSCI, V28, P11939, DOI 10.1523/JNEUROSCI.3098-08.2008; Furukawa K, 1998, J NEUROCHEM, V70, P1876; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Grau James W, 2006, Behav Cogn Neurosci Rev, V5, P191, DOI 10.1177/1534582306289738; Grau JW, 2004, J NEUROTRAUM, V21, P1795, DOI 10.1089/neu.2004.21.1795; Grau JW, 1998, BEHAV NEUROSCI, V112, P1366, DOI 10.1037/0735-7044.112.6.1366; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; GU Q, 1989, DEV BRAIN RES, V47, P281, DOI 10.1016/0165-3806(89)90183-1; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Hook MA, 2008, BEHAV NEUROSCI, V122, P233, DOI 10.1037/0735-7044.122.1.233; Huie JR, 2012, NEUROSCIENCE, V200, P74, DOI 10.1016/j.neuroscience.2011.10.028; Hwang HJ, 2008, J MICROBIOL BIOTECHN, V18, P1641; Ji RR, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-33; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Joynes RL, 2004, BEHAV BRAIN RES, V154, P431, DOI 10.1016/j.bbr.2004.03.030; Keppel G., 2004, DESIGN ANAL RES HDB; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; Kuno R, 2005, J NEUROIMMUNOL, V162, P89, DOI 10.1016/j.jneuroim.2005.01.015; Leonoudakis D, 2008, J NEUROSCI, V28, P2119, DOI 10.1523/JNEUROSCI.5159-07.2008; Liu GT, 2005, BEHAV NEUROSCI, V119, P538, DOI 10.1037/0735-7044.119.2.538; Marino RJ, 1999, ARCH PHYS MED REHAB, V80, P1391, DOI 10.1016/S0003-9993(99)90249-6; Mccoy MK, 2006, J NEUROSCI, V26, P9365, DOI 10.1523/JNEUROSCI.1504-06.2006; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Park CK, 2011, J NEUROSCI, V31, P15072, DOI 10.1523/JNEUROSCI.2443-11.2011; Parker D, 1999, J NEUROSCI, V19, P1647; Patton BC, 2004, BEHAV NEUROSCI, V118, P653, DOI 10.1037/0735-7044.118.3.653; Reeve AJ, 2000, EUR J PAIN-LONDON, V4, P247, DOI 10.1053/eujp.2000.0177; Santee SM, 1996, J BIOL CHEM, V271, P21151, DOI 10.1074/jbc.271.35.21151; Schafers M, 2008, NEUROSCIENCE, V157, P414, DOI 10.1016/j.neuroscience.2008.08.067; Shen Q, 2008, INFLAMMATION, V31, P336, DOI 10.1007/s10753-008-9083-1; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; Sriram K, 2002, FASEB J, V16, P1474, DOI 10.1096/fj.02-0216fje; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Sweitzer S, 2001, NEUROSCIENCE, V103, P529, DOI 10.1016/S0306-4522(00)00574-1; Tobin AM, 2005, BIODRUGS, V19, P47, DOI 10.2165/00063030-200519010-00006; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vichaya EG, 2009, BRAIN BEHAV IMMUN, V23, P969, DOI 10.1016/j.bbi.2009.05.001; Wang CX, 1996, J NEUROIMMUNOL, V69, P151; Yan P, 2003, EXP NEUROL, V183, P286, DOI 10.1016/S0014-4886(03)00135-3; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Young EE, 2007, BRAIN BEHAV IMMUN, V21, P748, DOI 10.1016/j.bbi.2007.02.001; Zhang L, 2011, PAIN, V152, P419, DOI 10.1016/j.pain.2010.11.014; Zhang QG, 2003, NEUROSCI LETT, V337, P51, DOI 10.1016/S0304-3940(02)01295-8; Zhao XR, 2001, J NEUROSCI RES, V64, P121, DOI 10.1002/jnr.1059	66	45	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39751	10.1371/journal.pone.0039751	http://dx.doi.org/10.1371/journal.pone.0039751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745823	gold, Green Submitted, Green Published			2022-12-27	WOS:000305693200097
J	Ohshima-Hosoyama, S; Simmons, HA; Goecks, N; Joers, V; Swanson, CR; Bondarenko, V; Velotta, R; Brunner, K; Wood, LD; Hruban, RH; Emborg, ME				Ohshima-Hosoyama, Sachiko; Simmons, Heather A.; Goecks, Nichole; Joers, Valerie; Swanson, Christine R.; Bondarenko, Viktoriya; Velotta, Rebecca; Brunner, Kevin; Wood, Laura D.; Hruban, Ralph H.; Emborg, Marina E.			A Monoclonal Antibody-GDNF Fusion Protein Is Not Neuroprotective and Is Associated with Proliferative Pancreatic Lesions in Parkinsonian Monkeys	PLOS ONE			English	Article							NEURAL PROGENITOR CELLS; NEUROTROPHIC FACTOR; INTRAEPITHELIAL NEOPLASIA; FUNCTIONAL RECOVERY; PRIMATE MODELS; MPTP; INFUSION; DELIVERY; EXPRESSION; INVASION	Glial cell line derived neurotrophic factor (GDNF) is a neurotrophic factor that has neuroprotective effects in animal models of Parkinson's disease (PD) and has been proposed as a PD therapy. GDNF does not cross the blood brain barrier (BBB), and requires direct intracerebral delivery to be effective. Trojan horse technology, in which GDNF is coupled to a monoclonal antibody (mAb) against the human insulin receptor (HIR), has been proposed to allow GDNF BBB transport (ArmaGen Technologies Inc.). In this study we tested the feasibility of HIRMAb-GDNF to induce neuroprotection in parkinsonian monkeys, as well as its tolerability and safety. Adult rhesus macaques were assessed throughout the study with a clinical rating scale, a computerized fine motor skills task and general health evaluations. Following baseline measurements, the animals received a unilateral intracarotid artery MPTP injection. Seven days later the animals were evaluated, matched according to disability and blindly assigned to receive twice a week iv. treatments (vehicle, 1 or 5 mg/kg HIRmAb-GDNF) for a period of three months. HIRmAb-GDNF did not improve parkinsonian motor symptoms and induced a dose-dependent hypersensitivity reaction. Quantification of dopaminergic striatal optical density and stereological nigral cell counts did not demonstrate differences between treatment groups. Focal pancreatic acinar to ductular metaplasia (ADM) was noted in four of seven animals treated with 1 mg/kg HIRmAb-GDNF; two of four with ADM also had focal pancreatic intraepithelial neoplasia 1B (PanIN-1B) lesions. Minimal to mild, focal to multifocal, nonsuppurative myocarditis was noted in all animals in the 5 mg/kg treatment group. Our results demonstrate that HIRmAb-GDNF dosing in a monkey model of PD is not an effective neuroprotective strategy and may present serious health risks that should be considered when planning future use of the IR antibody as a carrier, or of any systemic treatment of a GDNF-containing molecule.	[Ohshima-Hosoyama, Sachiko; Joers, Valerie; Swanson, Christine R.; Bondarenko, Viktoriya; Velotta, Rebecca; Emborg, Marina E.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Preclin Parkinsons Res Program, Madison, WI 53706 USA; [Joers, Valerie; Swanson, Christine R.; Emborg, Marina E.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Emborg, Marina E.] Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA; [Wood, Laura D.; Hruban, Ralph H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University	Ohshima-Hosoyama, S (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Preclin Parkinsons Res Program, Madison, WI 53706 USA.	emborg@primate.wisc.edu	Simmons, Heather/U-6081-2019; Joers, Valerie/S-2455-2019; Wood, Laura/ABF-1531-2020	Joers, Valerie/0000-0001-6743-6587; 	Michael J. Fox Foundation for Parkinson's Research; National Institutes of Health/NIA [T32 AG000213]; National Institutes of Health/NCRR (Wisconsin National Primate Research Center, University of Wisconsin-Madison) [P51 RR000167]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; Michael J. Fox Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167, C06RR015459, C06RR020141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000213] Funding Source: NIH RePORTER	Michael J. Fox Foundation for Parkinson's Research; National Institutes of Health/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health/NCRR (Wisconsin National Primate Research Center, University of Wisconsin-Madison); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Michael J. Fox Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support for this study was provided by the Michael J. Fox Foundation for Parkinson's Research (M. E. E.), National Institutes of Health/NIA grant T32 AG000213 (C.R.S.), and National Institutes of Health/NCRR grant P51 RR000167 (Wisconsin National Primate Research Center, University of Wisconsin-Madison). This research was conducted at a facility constructed with support from Research Facilities Improvement Program grants RR15459-01 and RR020141-01. HIRmAb-GDNF (AGT-190) was provided by ArmaGen Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; HIRmAb-GDNF (AGT-190) was provided by ArmaGen Technologies for this study. The Michael J. Fox Foundation awarded to ArmaGen Technologies a grant for a "Program Project" for which Marina E. Emborg designed the efficacy study in monkeys that was proposed to the Foundation. It was then directed by Marina E. Emborg. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	BAR RS, 1988, J CLIN INVEST, V81, P1225, DOI 10.1172/JCI113439; Boado RJ, 2008, BIOTECHNOL BIOENG, V100, P387, DOI 10.1002/bit.21764; Boado RJ, 2009, DRUG METAB DISPOS, V37, P2299, DOI 10.1124/dmd.109.028787; Brat DJ, 1998, AM J SURG PATHOL, V22, P163, DOI 10.1097/00000478-199802000-00003; Capowski EE, 2007, J NEUROSCI METH, V163, P338, DOI 10.1016/j.jneumeth.2007.02.022; Carriere C, 2007, P NATL ACAD SCI USA, V104, P4437, DOI 10.1073/pnas.0701117104; Depner CM, 2010, EUR J APPL PHYSIOL, V109, P1067, DOI 10.1007/s00421-010-1448-0; Eberling JL, 2009, HUM GENE THER, V20, P511, DOI 10.1089/hum.2008.201; Emborg ME, 2006, NEUROBIOL DIS, V23, P281, DOI 10.1016/j.nbd.2006.03.010; Emborg ME, 2009, NEUROBIOL DIS, V36, P303, DOI 10.1016/j.nbd.2009.07.022; Emborg ME, 2008, CELL TRANSPLANT, V17, P383; Emborg ME, 2007, ILAR J, V48, P339, DOI 10.1093/ilar.48.4.339; Emborg ME, 2001, EXP NEUROL, V168, P171, DOI 10.1006/exnr.2000.7592; Emborg ME, 1998, J COMP NEUROL, V401, P253; Emborg ME, 1998, J COMP NEUROL, V401; Emborg-Knott ME, 1998, EXP NEUROL, V152, P214, DOI 10.1006/exnr.1998.6845; Eslamboli A, 2005, J NEUROSCI, V25, P769, DOI 10.1523/JNEUROSCI.4421-04.2005; Fu AL, 2010, BRAIN RES, V1352, P208, DOI 10.1016/j.brainres.2010.06.059; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Gil Z, 2010, J NATL CANCER I, V102, P107, DOI 10.1093/jnci/djp456; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Grondin R, 2002, BRAIN, V125, P2191, DOI 10.1093/brain/awf234; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Hartmann M, 2008, INT J CARDIOL, V127, pE136, DOI 10.1016/j.ijcard.2007.04.136; Hiltunen JO, 2000, DEV DYNAM, V219, P28, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1031>3.0.CO;2-P; Hovland DN, 2007, TOXICOL PATHOL, V35, P1013, DOI 10.1177/01926230701481899; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Hruban RHPM., 2007, TUMORS PANCREAS, V4th ed; Ito Y, 2005, SURGERY, V138, P788, DOI 10.1016/j.surg.2005.07.007; Kimmelman J, 2009, MOVEMENT DISORD, V24, P1893, DOI 10.1002/mds.22712; Kirik D, 2004, NAT NEUROSCI, V7, P105, DOI 10.1038/nn1175; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Moretto G, 1996, CELL TISSUE RES, V286, P257, DOI 10.1007/s004410050695; Okada Y, 1999, INT J CANCER, V81, P67, DOI 10.1002/(SICI)1097-0215(19990331)81:1<67::AID-IJC13>3.0.CO;2-V; Pakkenberg B, 1991, J NEUROL NEUROSURG P, V54; Pardridge WM, 2009, PHARM RES-DORDR, V26, P2227, DOI 10.1007/s11095-009-9939-6; Przedborski S, 2001, J NEUROCHEM, V76, P1265, DOI 10.1046/j.1471-4159.2001.00183.x; SAKAMOTO C, 1984, P SOC EXP BIOL MED, V175, P497; Sawai H, 2005, CANCER RES, V65, P11536, DOI 10.1158/0008-5472.CAN-05-2843; Simmons HA, 2011, ANTIOXID REDOX SIGN, V14, P221, DOI 10.1089/ars.2010.3311; Swanson CR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-91; Vastag B, 2010, NATURE, V466, P916, DOI 10.1038/466916a; Watanabe M, 1998, BRAZ J MED BIOL RES, V31, P243, DOI 10.1590/S0100-879X1998000200008; West MJ, 1996, J COMP NEUROL, V370, P11; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176	48	46	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39036	10.1371/journal.pone.0039036	http://dx.doi.org/10.1371/journal.pone.0039036			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745701	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693200038
J	Sabha, N; Au, K; Agnihotri, S; Singh, S; Mangat, R; Guha, A; Zadeh, G				Sabha, Nesrin; Au, Karolyn; Agnihotri, Sameer; Singh, Sanjay; Mangat, Rupinder; Guha, Abhijit; Zadeh, Gelareh			Investigation of the In Vitro Therapeutic Efficacy of Nilotinib in Immortalized Human NF2-Null Vestibular Schwannoma Cells	PLOS ONE			English	Article							ABL TYROSINE KINASE; CHRONIC MYELOID-LEUKEMIA; BCR-ABL; NEUROFIBROMATOSIS TYPE-2; IMATINIB MESYLATE; PHILADELPHIA-CHROMOSOME; INHIBITOR NILOTINIB; TUMOR-SUPPRESSOR; NF2 GENE; GROWTH	Vestibular schwannomas (VS) are a common posterior fossa brain tumor, and though benign can cause significant morbidity, particularly loss of hearing, tinnitus, vertigo and facial paralysis. The current treatment options for VS include microsurgical resection, stereotactic radiosurgery or close surveillance monitoring, with each treatment option carrying associated complications and morbidities. Most importantly, none of these options can definitively reverse hearing loss or tinnitus. Identification of a novel medical therapy, through the use of targeted molecular inhibition, is therefore a highly desirable treatment strategy that may minimize complications arising from both tumor and treatment and more importantly be suitable for patients whose options are limited with respect to surgical or radiosurgical interventions. In this study we chose to examine the effect of Nilotinib on VS. Nilotinib (Tasigna (R)) is a second-generation receptor tyrosine kinase (RTK) inhibitor with a target profile similar to that of imatinib (Gleevec (R)), but increased potency, decreased toxicity and greater cellular and tissue penetration. Nilotinib targets not only the BCR-ABL oncoprotein, but also platelet-derived growth factor (PDGF) receptor signalling. In this preclinical study, the human NF2-null schwannoma cell line HEI-193 subjected to nilotinib inhibition demonstrated decreased viability, proliferation and anchorage-independent growth, and increased apoptosis. A daily dose of nilotinib for 5 days inhibited HEI-I93 proliferation at a clinically-relevant concentration in a dose-dependent manner (IC50 3-5 mu mol/L) in PDGF-stimulated cells. These anti-tumorigenic effects of nilotinib were correlated to inhibited activation of PDGFR-a and PDGFR-beta and major downstream signalling pathways. These experiments support a therapeutic potential for Nilotinib in VS.	[Sabha, Nesrin; Au, Karolyn; Agnihotri, Sameer; Singh, Sanjay; Mangat, Rupinder; Guha, Abhijit; Zadeh, Gelareh] Univ Toronto, Hosp Sick Children, Res Inst, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Guha, Abhijit; Zadeh, Gelareh] Univ Toronto, Western Hosp, Dept Surg Neurosurg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Sabha, N (corresponding author), Univ Toronto, Hosp Sick Children, Res Inst, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada.	Gelareh.Zadeh@uhn.on.ca	AGNIHOTRI, SAMEER/HHS-2255-2022	AGNIHOTRI, SAMEER/0000-0001-6584-3795; Au, Karolyn/0000-0001-5536-2971; Sabha, Nadeen B./0000-0001-7134-9005	Novartis [MTD 33832]; Cancer Research Society (CRS) of Canada	Novartis(Novartis); Cancer Research Society (CRS) of Canada	Novartis provided Nilotinib and partial funding for this study; grant agreement for academic research - MTA #MTD 33832. Operating funds for AG were provided by the Cancer Research Society (CRS) of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ammoun S, 2008, CANCER RES, V68, P5236, DOI 10.1158/0008-5472.CAN-07-5849; Ammoun S, 2011, NEURO-ONCOLOGY, V13, P759, DOI 10.1093/neuonc/nor056; Apperley JF, 2002, NEW ENGL J MED, V347, P481, DOI 10.1056/NEJMoa020150; Balasubramaniam A, 2007, NEURO-ONCOLOGY, V9, P447, DOI 10.1215/15228517-2007-027; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Fraenzer JT, 2003, INT J ONCOL, V23, P1493; Giovannini M, 2000, GENE DEV, V14, P1617; Hung G, 2002, INT J ONCOL, V20, P475; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; Johnson WD, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/5/E2; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Lepont P, 2008, MUTAT RES-FUND MOL M, V637, P142, DOI 10.1016/j.mrfmmm.2007.07.015; Manley PW, 2010, BBA-PROTEINS PROTEOM, V1804, P445, DOI 10.1016/j.bbapap.2009.11.008; Martin TPC, 2008, CLIN OTOLARYNGOL, V33, P228, DOI 10.1111/j.1749-4486.2008.01715.x; Mukherjee J, 2009, CANCER RES, V69, P5099, DOI 10.1158/0008-5472.CAN-08-4475; Park CS, 2003, J BIOL CHEM, V278, P37064, DOI 10.1074/jbc.M304968200; Rong R, 2004, P NATL ACAD SCI USA, V101, P18200, DOI 10.1073/pnas.0405971102; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Tanaka C, 2010, CLIN PHARMACOL THER, V87, P197, DOI 10.1038/clpt.2009.208; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007	24	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39412	10.1371/journal.pone.0039412	http://dx.doi.org/10.1371/journal.pone.0039412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745749	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693200073
J	Wang, DS; Szyf, M; Benkelfat, C; Provencal, N; Turecki, G; Caramaschi, D; Cote, SM; Vitaro, F; Tremblay, RE; Booij, L				Wang, Dongsha; Szyf, Moshe; Benkelfat, Chawki; Provencal, Nadine; Turecki, Gustavo; Caramaschi, Doretta; Cote, Sylvana M.; Vitaro, Frank; Tremblay, Richard E.; Booij, Linda			Peripheral SLC6A4 DNA Methylation Is Associated with In Vivo Measures of Human Brain Serotonin Synthesis and Childhood Physical Aggression	PLOS ONE			English	Article							TRANSPORTER GENE; MAJOR DEPRESSION; BEHAVIOR; LYMPHOCYTES; EXPRESSION; PROMOTER; POLYMORPHISM; PLATELETS; PATTERNS; TRAITS	The main challenge in addressing the role of DNA methylation in human behaviour is the fact that the brain is inaccessible to epigenetic analysis in living humans. Using positron emission tomography (PET) measures of brain serotonin (5-HT) synthesis, we found in a longitudinal sample that adult males with high childhood-limited aggression (C-LHPA) had lower in vivo 5-HT synthesis in the orbitofrontal cortex (OBFC). Here we hypothesized that 5-HT alterations associated with childhood aggression were linked to differential DNA methylation of critical genes in the 5-HT pathway and these changes were also detectable in peripheral white blood cells. Using pyrosequencing, we determined the state of DNA methylation of SLC6A4 promoter in T cells and monocytes isolated from blood of cohort members (N = 25) who underwent a PET scan, and we examined whether methylation status in the blood is associated with in vivo brain 5-HT synthesis. Higher levels of methylation were observed in both T cells and monocytes at specific CpG sites in the C-LHPA group. DNA methylation of SLC6A4 in monocytes appears to be associated more reliably with group membership than T cells. In both cell types the methylation state of these CpGs was associated with lower in vivo measures of brain 5-HT synthesis in the left and right lateral OBFC (N = 20) where lower 5-HT synthesis in C-LHPA group was observed. Furthermore, in vitro methylation of the SLC6A4 promoter in a luciferase reporter construct suppresses its transcriptional activity supporting a functional role of DNA methylation in SLC6A4 promoter regulation. These findings indicate that state of SLC6A4 promoter methylation is altered in peripheral white blood cells of individuals with physical aggression during childhood. This supports the relevance of peripheral DNA methylation for brain function and suggests that peripheral SLC6A4 DNA methylation could be a marker of central 5-HT function.	[Wang, Dongsha; Caramaschi, Doretta; Cote, Sylvana M.; Vitaro, Frank; Tremblay, Richard E.; Booij, Linda] St Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Wang, Dongsha; Szyf, Moshe; Provencal, Nadine; Caramaschi, Doretta] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Wang, Dongsha; Szyf, Moshe; Provencal, Nadine] McGill Univ, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada; [Benkelfat, Chawki; Turecki, Gustavo; Booij, Linda] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Booij, Linda] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Vitaro, Frank] Univ Montreal, Dept Psychoeduc, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Montreal, Dept Psychol & Pediat, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth Psychotherapy & Populat Sci, Dublin 2, Ireland	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; University College Dublin	Wang, DS (corresponding author), St Justine Hosp, Res Ctr, Montreal, PQ, Canada.	moshe.szyf@mcgill.ca; tremblar@grip.umontreal.ca; linda.booij@umontreal.ca	Tremblay, Richard E./O-1360-2014; Côté, Sylvana M./T-4600-2019; Cote, Silvana Maria/O-1356-2014; Turecki, Gustavo/K-5100-2015	Côté, Sylvana M./0000-0001-7944-0647; Caramaschi, Doretta/0000-0002-9740-871X; Provencal, Nadine/0000-0002-2079-8393; Turecki, Gustavo/0000-0003-4075-2736	Canadian Institutes of Health Research (CIHR) [MOP-106422]; Fonds de la recherche en sante du Quebec (FRSQ); Sackler program for epigenetics and psychobiology; Canadian Institute for Advanced Research; GlaxoSmithKline-Canadian Institutes of Health Research (GSK-CIHR); CIHR [MOP- 57838]; FRSQ; Fonds de recherche sur la societe et la culture (FQRSC); Social Sciences and Humanities Research Council (SSHRC); GlaxoSmithKline-Canadian Institues of Health Research	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Sackler program for epigenetics and psychobiology; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); GlaxoSmithKline-Canadian Institutes of Health Research (GSK-CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec); Fonds de recherche sur la societe et la culture (FQRSC); Social Sciences and Humanities Research Council (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)); GlaxoSmithKline-Canadian Institues of Health Research(Canadian Institutes of Health Research (CIHR))	The data collection and analysis of the methylation data has been funded by an operating grant from Canadian Institutes of Health Research (CIHR, MOP-106422) to Drs. L. Booij, M. Szyf and R. E. Tremblay. L. B. is supported by a chercheur boursier career award from Fonds de la recherche en sante du Quebec (FRSQ). Dr. M. Szyf is supported by the Sackler program for epigenetics and psychobiology, the Canadian Institute for Advanced Research and a GlaxoSmithKline-Canadian Institutes of Health Research (GSK-CIHR) professorship in pharmacology. The brain-imaging data has been collected as part of a CIHR grant awarded to Drs. C. Benkelfat and R. E. Tremblay (MOP- 57838). The longitudinal study was supported by grants to Dr. R. E. Tremblay and collaborators from CIHR, FRSQ, Fonds de recherche sur la societe et la culture (FQRSC) and Social Sciences and Humanities Research Council (SSHRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests to declare. This study was supported by a GlaxoSmithKline-Canadian Institues of Health Research professorship in pharmacology. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Avila L, 2010, PLACENTA, V31, P1070, DOI 10.1016/j.placenta.2010.09.011; Barkan T, 2006, EUR NEUROPSYCHOPHARM, V16, P572, DOI 10.1016/j.euroneuro.2006.03.001; Beitchman JH, 2006, AM J PSYCHIAT, V163, P1103, DOI 10.1176/appi.ajp.163.6.1103; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Booij L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011255; COOL DR, 1991, J BIOL CHEM, V266, P15750; Craig IW, 2009, HUM GENET, V126, P101, DOI 10.1007/s00439-009-0695-9; de Lara CL, 2006, BIOL PSYCHIAT, V59, P114, DOI 10.1016/j.biopsych.2005.06.021; Devlin AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012201; Ferrari PF, 2005, EUR J PHARMACOL, V526, P259, DOI 10.1016/j.ejphar.2005.10.002; First MB, 2002, STRUCTURED CLIN INTE; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Heils A, 1996, J NEUROCHEM, V66, P2621; Heils A, 1995, J NEURAL TRANSM-GEN, V102, P247, DOI 10.1007/BF01281159; Hernandez E, 2002, INT IMMUNOPHARMACOL, V2, P893, DOI 10.1016/S1567-5769(02)00025-5; Kim DK, 2005, NEUROPHARMACOLOGY, V49, P798, DOI 10.1016/j.neuropharm.2005.08.010; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; LINNET K, 1995, BRAIN RES, V697, P251, DOI 10.1016/0006-8993(95)00906-7; Marazziti D, 2006, PHARMACOPSYCHIATRY, V39, P35, DOI 10.1055/s-2006-931477; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Nagin D, 1999, CHILD DEV, V70, P1181, DOI 10.1111/1467-8624.00086; NUR I, 1985, J BACTERIOL, V164, P19, DOI 10.1128/JB.164.1.19-24.1985; Olsson CA, 2010, BIOL PSYCHOL, V83, P159, DOI 10.1016/j.biopsycho.2009.12.003; Philibert R, 2011, BIOL PSYCHIAT, V70, pE27, DOI 10.1016/j.biopsych.2011.02.029; Philibert RA, 2008, AM J MED GENET B, V147B, P543, DOI 10.1002/ajmg.b.30657; RAZIN A, 1984, BIOCHIM BIOPHYS ACTA, V782, P331, DOI 10.1016/0167-4781(84)90043-5; Retz W, 2004, BEHAV SCI LAW, V22, P415, DOI 10.1002/bsl.589; ROULEAU J, 1992, J BIOL CHEM, V267, P7368; Szyf M, 2011, J NEURODEV DISORD, V3, P238, DOI 10.1007/s11689-011-9079-2; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	33	116	119	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39501	10.1371/journal.pone.0039501	http://dx.doi.org/10.1371/journal.pone.0039501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745770	Green Published, gold			2022-12-27	WOS:000305693200084
J	Zaidi, I; Peterson, K; Jeffries, D; Whittle, H; de Silva, T; Rowland-Jones, S; Jaye, A; de Jong, BC				Zaidi, Irfan; Peterson, Kevin; Jeffries, David; Whittle, Hilton; de Silva, Thushan; Rowland-Jones, Sarah; Jaye, Assan; de Jong, Bouke C.			Immune Reconstitution Inflammatory Syndrome and the Influence of T Regulatory Cells: A Cohort Study in the Gambia	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; RESTORATION DISEASE; RISK-FACTORS; INFECTED PATIENTS; TUBERCULOSIS; RESPONSES; PATHOGENESIS; BIOMARKERS; FOXP3	Objective: The factors associated with the development of immune reconstitution inflammatory syndrome in HIV patients commencing antiretroviral therapy have not been fully elucidated. Using a longitudinal study design, this study addressed whether alteration in the levels of T regulatory cells contributed to the development of IRIS in a West African cohort of HIV-1 and HIV-2 patients. Seventy-one HIV infected patients were prospectively recruited to the study and followed up for six months. The patients were categorized as IRIS or non-IRIS cases following published clinical guidelines. The levels of T regulatory cells were measured using flow cytometry at baseline and all follow-up visits. Baseline cytokine levels of IL-2, IL-6, IFN-gamma, TNF-alpha, MIP-1 beta, IL-1, IL-12, IL-13, and IL-10 were measured in all patients. Results: Twenty eight percent of patients (20/71) developed IRIS and were predominantly infected with HIV-1. Patients developing IRIS had lower nadir CD4 T cells at baseline (p = 0.03) and greater CD4 T cell reconstitution (p = 0.01) at six months post-ART. However, the development of IRIS was not influenced by the levels of T regulatory cells. Similarly, baseline cytokine levels did not predict the onset of IRIS. Conclusion: The development of IRIS was not associated with differences in levels of T regulatory cells or baseline pro-inflammatory cytokines.	[Zaidi, Irfan; Peterson, Kevin; Jeffries, David; Whittle, Hilton; de Silva, Thushan; Jaye, Assan; de Jong, Bouke C.] Med Res Council UK Unit, Fajara, Gambia; [Peterson, Kevin; de Jong, Bouke C.] Inst Trop Med, B-2000 Antwerp, Belgium; [de Silva, Thushan; Rowland-Jones, Sarah] John Radcliffe Hosp, Human Immunol Unit, MRC, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [de Jong, Bouke C.] NYU, Div Infect Dis, New York, NY USA	University of London; London School of Hygiene & Tropical Medicine; Institute of Tropical Medicine (ITM); University of Oxford; New York University	Zaidi, I (corresponding author), Med Res Council UK Unit, Fajara, Gambia.	irfan.zaidi@gmail.com	de Silva, Thushan/AAT-4820-2020; de Jong, Bouke/A-3636-2013	de Silva, Thushan/0000-0002-6498-9212; de Jong, Bouke/0000-0002-1017-4675	MRC Unit in The Gambia; MRC [MC_U137884180, MC_U190085854, MC_U190081975, MC_U190085855] Funding Source: UKRI; Medical Research Council [MC_U190085854, MC_U137884180, MC_U190085855, MC_U190081975] Funding Source: researchfish	MRC Unit in The Gambia(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for this study was provided by the MRC Unit in The Gambia. The study was approved by the scientific steering committee and the Gambia goverment ethics board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabi AS, 2003, AIDS, V17, P1513, DOI 10.1097/00002030-200307040-00012; Antonelli LRV, 2010, BLOOD, V116, P3818, DOI 10.1182/blood-2010-05-285080; Barber DL, 2010, BLOOD, V116, P3485, DOI 10.1182/blood-2010-05-286336; Berry N, 1998, J Hum Virol, V1, P457; Bourgarit A, 2006, AIDS, V20, pF1, DOI 10.1097/01.aids.0000202648.18526.bf; Bourgarit A, 2009, J IMMUNOL, V183, P3915, DOI 10.4049/jimmunol.0804020; Elliott JH, 2009, J INFECT DIS, V200, P1736, DOI 10.1086/644784; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; Grant PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011416; Haddow LJ, 2011, AIDS, V25, P1163, DOI 10.1097/QAD.0b013e3283477d67; Haddow LJ, 2009, CLIN INFECT DIS, V49, P1424, DOI 10.1086/630208; Hori S, 2004, MICROBES INFECT, V6, P745, DOI 10.1016/j.micinf.2004.02.020; Jevtovic D, 2005, BIOMED PHARMACOTHER, V59, P446, DOI 10.1016/j.biopha.2005.07.006; Kestens L, 2008, CURR OPIN HIV AIDS, V3, P419, DOI 10.1097/COH.0b013e328302ebbb; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lawn SD, 2011, EXPERT REV ANTI-INFE, V9, P415, DOI [10.1586/eri.11.21, 10.1586/ERI.11.21]; Lawn SD, 2009, AIDS, V23, P143, DOI 10.1097/QAD.0b013e32831d2a98; Letang E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016946; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meintjes G, 2008, AM J RESP CRIT CARE, V178, P1083, DOI 10.1164/rccm.200806-858OC; Montes M, 2011, J INFECT DIS, V203, P496, DOI 10.1093/infdis/jiq073; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Murdoch DA, 2008, AIDS, V22, P601, DOI 10.1097/QAD.0b013e3282f4a607; Murdoch David M, 2007, AIDS Res Ther, V4, P9, DOI 10.1186/1742-6405-4-9; Ratnam I, 2006, CLIN INFECT DIS, V42, P418, DOI 10.1086/499356; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Seddiki N, 2009, EUR J IMMUNOL, V39, P391, DOI 10.1002/eji.200838630; Sereti I, 2010, CURR OPIN HIV AIDS, V5, P504, DOI 10.1097/COH.0b013e32833ed774; Shelburne SA, 2005, CLIN INFECT DIS, V40, P1049, DOI 10.1086/428618; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Tan D, 2008, HIV MED, V9, P307, DOI 10.1111/j.1468-1293.2008.00565.x; Valin N, 2010, AIDS, V24, P1519, DOI 10.1097/QAD.0b013e3283396007	35	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39213	10.1371/journal.pone.0039213	http://dx.doi.org/10.1371/journal.pone.0039213			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745716	Green Published, Green Accepted, gold			2022-12-27	WOS:000305693200048
J	Rodriguez, V; Vasudevan, S; Noma, A; Carlson, BA; Green, JE; Suzuki, T; Chandrasekharappa, SC				Rodriguez, Virginia; Vasudevan, Sona; Noma, Akiko; Carlson, Bradley A.; Green, Jeffrey E.; Suzuki, Tsutomu; Chandrasekharappa, Settara C.			Structure-Function Analysis of Human TYW2 Enzyme Required for the Biosynthesis of a Highly Modified Wybutosine (yW) Base in Phenylalanine-tRNA	PLOS ONE			English	Article							TRANSGENIC MICE; GENE-EXPRESSION; MAMMARY-TUMORS; CANCER; LIVER; RAT; SELENOCYSTEINE; CLASSIFICATION; CHROMOSOME-8; POSITION-37	Posttranscriptional modifications are critical for structure and function of tRNAs. Wybutosine (yW) and its derivatives are hyper-modified guanosines found at the position 37 of eukaryotic and archaeal tRNA(Phe). TYW2 is an enzyme that catalyzes a-amino-a-carboxypropyl transfer activity at the third step of yW biogenesis. Using complementation of a Delta TYW2 strain, we demonstrate here that human TYW2 (hTYW2) is active in yeast and can synthesize the yW of yeast tRNA(Phe). Structure-guided analysis identified several conserved residues in hTYW2 that interact with S-adenosyl-methionine (AdoMet), and mutation studies revealed that K225 and E265 are critical residues for the enzymatic activity. We previously reported that the human TYW2 is overexpressed in breast cancer. However, no difference in the tRNA(Phe) modification status was observed in either normal mouse tissue or a mouse tumor model that overexpresses Tyw2, indicating that hTYW2 may have a role in tumorigenesis unrelated to yW biogenesis.	[Rodriguez, Virginia; Chandrasekharappa, Settara C.] NHGRI, Canc Genet Branch, Bethesda, MD 20892 USA; [Vasudevan, Sona] Georgetown Univ, Med Ctr, Dept Biochem & Mol Cellular Biol, Washington, DC 20007 USA; [Noma, Akiko; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan; [Carlson, Bradley A.] NCI, Lab Canc Prevent, NIH, Bethesda, MD 20892 USA; [Green, Jeffrey E.] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Georgetown University; University of Tokyo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rodriguez, V (corresponding author), NHGRI, Canc Genet Branch, Bethesda, MD 20892 USA.	chandra@mail.nih.gov	Suzuki, Tsutomu/J-1776-2015	Suzuki, Tsutomu/0000-0002-9731-1731	National Human Genome Research Institute; Center for Cancer Research, National Cancer Institute, National Institutes of Health; JSPS; NATIONAL CANCER INSTITUTE [ZIABC005740] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000029] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Intramural Research Programs of the National Human Genome Research Institute, and the Center for Cancer Research, National Cancer Institute, National Institutes of Health. A.N. thanks the JSPS Fellowship for Japanese Junior Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Bienvenu F, 2010, NATURE, V463, P374, DOI 10.1038/nature08684; BLOBSTEIN SH, 1973, BIOCHEMISTRY-US, V12, P188, DOI 10.1021/bi00726a002; BOUCHARD L, 1989, CELL, V57, P931, DOI 10.1016/0092-8674(89)90331-0; Camps J, 2008, CANCER RES, V68, P1284, DOI 10.1158/0008-5472.CAN-07-2864; Carlson BA, 2002, METHOD ENZYMOL, V347, P24; Carlson BA, 2001, VIROLOGY, V279, P130, DOI 10.1006/viro.2000.0692; Carlson BA, 2008, BIOCHEM BIOPH RES CO, V375, P86, DOI 10.1016/j.bbrc.2008.07.118; Flanagan JM, 2004, GENE CHROMOSOME CANC, V40, P247, DOI 10.1002/gcc.20039; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; HATFIELD D, 1979, BIOCHIM BIOPHYS ACTA, V564, P414, DOI 10.1016/0005-2787(79)90032-7; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Hu YB, 1999, BIOCHEMISTRY-US, V38, P8323, DOI 10.1021/bi990332k; Kato T, 2005, CANCER RES, V65, P5638, DOI 10.1158/0008-5472.CAN-05-0600; KELMERS AD, 1971, ANAL BIOCHEM, V44, P486, DOI 10.1016/0003-2697(71)90236-3; Konevega AL, 2004, RNA, V10, P90, DOI 10.1261/rna.5142404; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; KUCHINO Y, 1978, NATURE, V271, P126, DOI 10.1038/271126a0; Kumaraswamy E, 2003, MOL CELL BIOL, V23, P1477, DOI 10.1128/MCB.23.5.1477-1488.2003; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAROULAKOU IG, 1994, P NATL ACAD SCI USA, V91, P11236, DOI 10.1073/pnas.91.23.11236; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; MUSHINSKI JF, 1979, CANCER RES, V39, P1253; Noma A, 2006, EMBO J, V25, P2142, DOI 10.1038/sj.emboj.7601105; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; RAJBHAND.UL, 1967, P NATL ACAD SCI USA, V57, P751, DOI 10.1073/pnas.57.3.751; Rodriguez V, 2007, GENE CHROMOSOME CANC, V46, P694, DOI 10.1002/gcc.20454; Shibata MA, 1999, EMBO J, V18, P2692, DOI 10.1093/emboj/18.10.2692; Umitsu M, 2009, P NATL ACAD SCI USA, V106, P15616, DOI 10.1073/pnas.0905270106; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; Wu CH, 2004, NUCLEIC ACIDS RES, V32, pD112, DOI 10.1093/nar/gkh097	35	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39297	10.1371/journal.pone.0039297	http://dx.doi.org/10.1371/journal.pone.0039297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761755	Green Published, gold, Green Submitted			2022-12-27	WOS:000305826400012
J	Petrovska, I; Kumamoto, CA				Petrovska, Ivana; Kumamoto, Carol A.			Functional Importance of the DNA Binding Activity of Candida albicans Czf1p	PLOS ONE			English	Article							FILAMENTOUS GROWTH; RNA-POLYMERASE; PROTEIN; MORPHOGENESIS; REGULATOR; CLUSTER; EXPRESSION; EFG1P; RECOGNITION; VIRULENCE	The human opportunistic pathogen Candida albicans undergoes a reversible morphological transition between the yeast and hyphal states in response to a variety of signals. One such environmental trigger is growth within a semisolid matrix such as agar medium. This growth condition is of interest because it may mimic the growth of C. albicans in contact with host tissue during infection. During growth within a semisolid matrix, hyphal growth is positively regulated by the transcriptional regulator Czf1p and negatively by a second key transcriptional regulator, Efg1p. Genetic studies indicate that Czf1p, a member of the zinc-cluster family of transcriptional regulators, exerts its function by opposing the inhibitory influence of Efg1p on matrix-induced filamentous growth. We examined the importance of the two known activities of Czf1p, DNA-binding and interaction with Efg1p. We found that the two activities were separable by mutation allowing us to demonstrate that the DNA-binding activity of Czf1p was essential for its role as a positive regulator of morphogenesis. Surprisingly, however, interactions with Efg1p appeared to be largely dispensable. Our studies provide the first evidence of a key role for the DNA-binding activity of Czf1p in the morphological yeast-to-hyphal transition triggered by matrix-embedded growth.	[Petrovska, Ivana] Tufts Univ, Sackler Sch Grad Biomed Sci, Grad Program Genet, Boston, MA 02111 USA; [Kumamoto, Carol A.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Tufts University; Tufts University	Petrovska, I (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Grad Program Genet, Boston, MA 02111 USA.	carol.kumamoto@tufts.edu			National Institute of Allergy and Infectious Diseases [R01AI081794]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081794] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grant R01AI081794 from the National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov) to CAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM, 1988, MOL REPROD DEV; BAI YL, 1991, NUCLEIC ACIDS RES, V19, P5991, DOI 10.1093/nar/19.21.5991; Brown D. H. Jr., 1999, Molecular Microbiology, V34, P651, DOI 10.1046/j.1365-2958.1999.01619.x; CALDERONE R, 2001, CANDIDA CANDIDIASIS; Corton JC, 1998, J BIOL CHEM, V273, P13776, DOI 10.1074/jbc.273.22.13776; Doedt T, 2004, MOL BIOL CELL, V15, P3167, DOI 10.1091/mbc.E03-11-0782; Fitzgerald MX, 2006, STRUCTURE, V14, P725, DOI 10.1016/j.str.2005.11.025; FONZI WA, 1993, GENETICS, V134, P717; Giusani AD, 2002, GENETICS, V160, P1749; GOLEMIS EA, 1996, CURRENT PROTOCOLS MO; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; JOHNSTON M, 1987, P NATL ACAD SCI USA, V84, P2401, DOI 10.1073/pnas.84.8.2401; Kadosh D, 2001, MOL CELL BIOL, V21, P2496, DOI 10.1128/MCB.21.7.2496-2505.2001; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; Lassak T, 2011, MOL MICROBIOL, V82, P602, DOI 10.1111/j.1365-2958.2011.07837.x; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lu Y, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001105; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Noffz CS, 2008, EUKARYOT CELL, V7, P881, DOI 10.1128/EC.00033-08; ODDS FC, 1985, CRC CR REV MICROBIOL, V12, P45, DOI 10.3109/10408418509104425; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Riggle FJ, 1999, INFECT IMMUN, V67, P3649, DOI 10.1128/IAI.67.7.3649-3652.1999; Setiadi ER, 2006, J MOL BIOL, V361, P399, DOI 10.1016/j.jmb.2006.06.040; Sonneborn A, 2000, MOL MICROBIOL, V35, P386, DOI 10.1046/j.1365-2958.2000.01705.x; Stoldt VR, 1997, EMBO J, V16, P1982, DOI 10.1093/emboj/16.8.1982; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Tebarth B, 2003, J MOL BIOL, V329, P949, DOI 10.1016/S0022-2836(03)00505-9; Vinces MD, 2007, MICROBIOL-SGM, V153, P2877, DOI 10.1099/mic.0.2007/005983-0; Vinces MD, 2006, EUKARYOT CELL, V5, P825, DOI 10.1128/EC.5.5.825-835.2006; WHITEWAY M, 1992, P NATL ACAD SCI USA, V89, P9410, DOI 10.1073/pnas.89.20.9410; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Zheng XD, 2004, EMBO J, V23, P1845, DOI 10.1038/sj.emboj.7600195; Zordan RE, 2007, PLOS BIOL, V5, P2166, DOI 10.1371/journal.pbio.0050256	41	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39624	10.1371/journal.pone.0039624	http://dx.doi.org/10.1371/journal.pone.0039624			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761849	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800053
J	Whitworth, H; Bhadel, S; Ivey, M; Conaway, M; Spencer, A; Hernan, R; Holemon, H; Gioeli, D				Whitworth, Hilary; Bhadel, Shriti; Ivey, Melissa; Conaway, Mark; Spencer, Andrea; Hernan, Ronald; Holemon, Heather; Gioeli, Daniel			Identification of Kinases Regulating Prostate Cancer Cell Growth Using an RNAi Phenotypic Screen	PLOS ONE			English	Article							ANDROGEN RECEPTOR; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; TYROSINE KINASE; GENE-EXPRESSION; PHOSPHORYLATION; PROGRESSION; ACTIVATION; PATHWAY; PROLIFERATION	As prostate cancer progresses to castration-resistant disease, there is an increase in signal transduction activity. Most castration-resistant prostate tumors continue to express the androgen receptor (AR) as well as androgen-responsive genes, despite the near absence of circulating androgen in these patients. The AR is regulated not only by its cognate steroid hormone, but also by interactions with a constellation of co-regulatory and signaling molecules. Thus, the elevated signaling activity that occurs during progression to castration resistance can affect prostate cancer cell growth either through the AR or independent of the AR. In order to identify signaling pathways that regulate prostate cancer cell growth, we screened a panel of shRNAs targeting 673 human kinases against LNCaP prostate cancer cells grown in the presence and absence of hormone. The screen identified multiple shRNA clones against known and novel gene targets that regulate prostate cancer cell growth. Based on the magnitude of effect on growth, we selected six kinases for further study: MAP3K11, DGKD, ICK, CIT, GALK2, and PSKH1. Knockdown of these kinases decreased cell growth in both androgen-dependent and castration-resistant prostate cancer cells. However, these kinases had different effects on basal or androgen-induced transcriptional activity of AR target genes. MAP3K11 knockdown most consistently altered transcription of AR target genes, suggesting that MAP3K11 affected its growth inhibitory effect by modulating the AR transcriptional program. Consistent with MAP3K11 acting on the AR, knockdown of MAP3K11 inhibited AR Ser 650 phosphorylation, further supporting stress kinase regulation of AR phosphorylation. This study demonstrates the applicability of lentiviral-based shRNA for conducting phenotypic screens and identifies MAP3K11, DGKD, ICK, CIT, GALK2, and PSKH1 as regulators of prostate cancer cell growth. The thorough evaluation of these kinase targets will pave the way for developing more effective treatments for castration-resistant prostate cancer.	[Whitworth, Hilary; Bhadel, Shriti; Ivey, Melissa; Gioeli, Daniel] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Whitworth, Hilary; Bhadel, Shriti; Ivey, Melissa; Gioeli, Daniel] Univ Virginia, Dept Immunol, Charlottesville, VA USA; [Whitworth, Hilary; Bhadel, Shriti; Ivey, Melissa; Gioeli, Daniel] Univ Virginia, Dept Canc Biol, Charlottesville, VA USA; [Conaway, Mark] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Spencer, Andrea; Hernan, Ronald; Holemon, Heather] Sigma Aldrich Biotechnol, St Louis, MO USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; Merck KGaA; MilliporeSigma	Whitworth, H (corresponding author), Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA.	dgioeli@virginia.edu		Whitworth, Hilary/0000-0002-5323-7023	National Institute of Health [R01 CA124706]; Paul Mellon Urologic Cancer Institute at the University of Virginia; NATIONAL CANCER INSTITUTE [P30CA044579, R01CA124706] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul Mellon Urologic Cancer Institute at the University of Virginia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institute of Health Grant R01 CA124706 to DG and the Paul Mellon Urologic Cancer Institute at the University of Virginia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Brede G, 2002, NUCLEIC ACIDS RES, V30, P5301, DOI 10.1093/nar/gkf648; Burnstein KL, 2005, J CELL BIOCHEM, V95, P657, DOI 10.1002/jcb.20460; Cai JJ, 2010, J BIOL CHEM, V285, P6952, DOI 10.1074/jbc.M109.055731; Clark DE, 2005, CANCER RES, V65, P3108; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; Culig Z, 2002, MOL CELL ENDOCRINOL, V197, P231, DOI 10.1016/S0303-7207(02)00263-0; Culig Z, 1996, PROSTATE, V28, P392, DOI 10.1002/(SICI)1097-0045(199606)28:6<392::AID-PROS9>3.0.CO;2-C; Culig Z, 2000, UROL RES, V28, P211, DOI 10.1007/s002400000111; Cunha GR, 2004, J STEROID BIOCHEM, V92, P221, DOI 10.1016/j.jsbmb.2004.10.017; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Fu Z, 2006, MOL CELL BIOL, V26, P8639, DOI 10.1128/MCB.00816-06; Galliher-Beckley AJ, 2008, MOL CELL BIOL, V28, P7309, DOI 10.1128/MCB.00808-08; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; Gioeli D, 2005, CLIN SCI, V108, P293, DOI 10.1042/CS20040329; Gioeli D, 1999, CANCER RES, V59, P279; Gioeli DG, 2010, CELL CYCLE, V9, P440, DOI 10.4161/cc.9.3.11045; Gordon V, 2010, MOL ENDOCRINOL, V24, P2267, DOI 10.1210/me.2010-0238; IKONEN T, 1994, ENDOCRINOLOGY, V135, P1359, DOI 10.1210/en.135.4.1359; Imai S, 2009, BBA-MOL CELL BIOL L, V1791, P246, DOI 10.1016/j.bbalip.2009.01.024; Kraus S, 2006, CANCER RES, V66, P11047, DOI 10.1158/0008-5472.CAN-06-0596; Luo B, 2004, CELL SIGNAL, V16, P983, DOI 10.1016/j.cellsig.2004.03.016; Ma AH, 2006, CANCER RES, V66, P8439, DOI 10.1158/0008-5472.CAN-06-1636; Mellinghoff IK, 2002, CANCER RES, V62, P5254; Mellinghoff IK, 2004, CANCER CELL, V6, P517, DOI 10.1016/j.ccr.2004.09.031; Nazareth LV, 1996, J BIOL CHEM, V271, P19900, DOI 10.1074/jbc.271.33.19900; Perez CA, 1985, CANCER PRINCIPLES PR, P929; Reinikainen P, 1996, ENDOCRINOLOGY, V137, P4351, DOI 10.1210/en.137.10.4351; Sadar MD, 1999, J BIOL CHEM, V274, P7777, DOI 10.1074/jbc.274.12.7777; Shandala T, 2004, DEVELOPMENT, V131, P5053, DOI 10.1242/dev.01382; SOULE HD, 1990, CANCER RES, V50, P6075; Steiner H, 2003, AM J PATHOL, V162, P655, DOI 10.1016/S0002-9440(10)63859-X; THALMANN GN, 1994, CANCER RES, V54, P2577; Thalmann GN, 2000, PROSTATE, V44, P91; Thoden JB, 2005, J BIOL CHEM, V280, P32784, DOI 10.1074/jbc.M505730200; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Weigel NL, 1998, J MOL MED, V76, P469, DOI 10.1007/s001090050241; Yeh SY, 1999, P NATL ACAD SCI USA, V96, P5458, DOI 10.1073/pnas.96.10.5458; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678	41	41	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e38950	10.1371/journal.pone.0038950	http://dx.doi.org/10.1371/journal.pone.0038950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761715	Green Submitted, Green Published, gold			2022-12-27	WOS:000305825800017
J	Brenner, DS; Golden, JP; Gereau, RW				Brenner, Daniel S.; Golden, Judith P.; Gereau, Robert W.			A Novel Behavioral Assay for Measuring Cold Sensation in Mice	PLOS ONE			English	Article							SPINAL NERVE LIGATION; C-FIBER NOCICEPTORS; ANESTHETIZED MONKEY; EXPERIMENTAL-MODEL; HEAT STIMULI; PAIN; RAT; HYPERALGESIA; ALLODYNIA; TRPM8	Behavioral models of cold responses are important tools for exploring the molecular mechanisms of cold sensation. To complement the currently cold behavioral assays and allow further studies of these mechanisms, we have developed a new technique to measure the cold response threshold, the cold plantar assay. In this assay, animals are acclimated on a glass plate and a cold stimulus is applied to the hindpaw through the glass using a pellet of compressed dry ice. The latency to withdrawal from the cooled glass is used as a measure of the cold response threshold of the rodents, and the dry ice pellet provides a ramping cold stimulus on the glass that allows the correlation of withdrawal latency values to rough estimates of the cold response threshold temperature. The assay is highly sensitive to manipulations including morphine-induced analgesia, Complete Freund's Adjuvant-induced inflammatory allodynia, and Spinal Nerve Ligation-induced neuropathic allodynia.	[Brenner, Daniel S.; Golden, Judith P.; Gereau, Robert W.] Washington Univ, Sch Med, Pain Ctr, St Louis, MO 63130 USA; [Brenner, Daniel S.; Golden, Judith P.; Gereau, Robert W.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Brenner, Daniel S.; Gereau, Robert W.] Washington Univ, Sch Med, Neurosci Program, St Louis, MO USA; [Brenner, Daniel S.] Washington Univ, Sch Med, Med Scientist Training Program, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Brenner, DS (corresponding author), Washington Univ, Sch Med, Pain Ctr, St Louis, MO 63130 USA.	gereaur@wustl.edu		Golden, Judith/0000-0002-5168-8525	NINDS (National Institute of Neurological Disorders and Stroke) [R01NS42595]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042595] Funding Source: NIH RePORTER	NINDS (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NINDS (National Institute of Neurological Disorders and Stroke) grant R01NS42595 to RWG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allchorne AJ, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-36; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Campero M, 2001, J PHYSIOL-LONDON, V535, P855, DOI 10.1111/j.1469-7793.2001.t01-1-00855.x; CARLTON SM, 1994, PAIN, V56, P155, DOI 10.1016/0304-3959(94)90090-6; Cassidy J, 2002, SEMIN ONCOL, V29, P11, DOI 10.1053/sonc.2002.35524; CHOI Y, 1994, PAIN, V59, P369, DOI 10.1016/0304-3959(94)90023-X; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Descoeur J, 2011, EMBO MOL MED, V3, P266, DOI 10.1002/emmm.201100134; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Gamelin E, 2002, SEMIN ONCOL, V29, P21, DOI 10.1053/sonc.2002.35525; Gauchan P, 2009, NEUROSCI LETT, V458, P93, DOI 10.1016/j.neulet.2009.04.029; Golden JP, 2010, J NEUROSCI, V30, P3983, DOI 10.1523/JNEUROSCI.5930-09.2010; Greenspan JD, 2004, PAIN, V109, P357, DOI [10.1016/j.pain.2004.02.002, 10.1016/S0304-3959(04)00068-5]; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Knowlton WM, 2010, PAIN, V150, P340, DOI 10.1016/j.pain.2010.05.021; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lampert A, 2010, PFLUG ARCH EUR J PHY, V460, P249, DOI 10.1007/s00424-009-0779-3; LEEM JW, 1993, J NEUROPHYSIOL, V69, P1684, DOI 10.1152/jn.1993.69.5.1684; Medicine Io, 2011, REL PAIN AM BLUEPR T; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Pinto-Ribeiro F, 2004, NEUROSCI LETT, V359, P73, DOI 10.1016/j.neulet.2004.02.016; PIZZIKETTI RJ, 1985, EUR J PHARMACOL, V119, P23, DOI 10.1016/0014-2999(85)90317-6; Svendsen KB, 2005, PAIN, V114, P473, DOI 10.1016/j.pain.2005.01.015; Tanabe P, 1999, J Emerg Nurs, V25, P171, DOI 10.1016/S0099-1767(99)70200-X; TILLMAN DB, 1995, J PHYSIOL-LONDON, V485, P753, DOI 10.1113/jphysiol.1995.sp020766; TILLMAN DB, 1995, J PHYSIOL-LONDON, V485, P767, DOI 10.1113/jphysiol.1995.sp020767; VERDUGO R, 1992, BRAIN, V115, P893, DOI 10.1093/brain/115.3.893; Vilceanu D, 2010, J PAIN, V11, P588, DOI 10.1016/j.jpain.2009.09.018; Zhao CS, 2011, ANESTHESIOLOGY, V115, P1261, DOI 10.1097/ALN.0b013e3182390788	31	110	111	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39765	10.1371/journal.pone.0039765	http://dx.doi.org/10.1371/journal.pone.0039765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745825	Green Published, gold			2022-12-27	WOS:000305730900111
J	Fitches, EC; Pyati, P; King, GF; Gatehouse, JA				Fitches, Elaine C.; Pyati, Prashant; King, Glenn F.; Gatehouse, John A.			Fusion to Snowdrop Lectin Magnifies the Oral Activity of Insecticidal omega-Hexatoxin-Hv1a Peptide by Enabling Its Delivery to the Central Nervous System	PLOS ONE			English	Article							SPIDER VENOM TOXIN; GALANTHUS-NIVALIS AGGLUTININ; LACANOBIA-OLERACEA; CALCIUM-CHANNELS; PROTEINS; OMEGA-ATRACOTOXIN-HV1A; NEUROTOXIN; INGESTION; AGENTS; LARVAE	Background: The spider-venom peptide omega-hexatoxin-Hv1a (Hv1a) targets insect voltage-gated calcium channels, acting directly at sites within the central nervous system. It is potently insecticidal when injected into a wide variety of insect pests, but it has limited oral toxicity. We examined the ability of snowdrop lectin (GNA), which is capable of traversing the insect gut epithelium, to act as a "carrier" in order to enhance the oral activity of Hv1a. Methodology/Principal Findings: A synthetic Hv1a/GNA fusion protein was produced by recombinant expression in the yeast Pichia pastoris. When injected into Mamestra brassicae larvae, the insecticidal activity of the Hv1a/GNA fusion protein was similar to that of recombinant Hv1a. However, when proteins were delivered orally via droplet feeding assays, Hv1a/GNA, but not Hv1a alone, caused a significant reduction in growth and survival of fifth stadium Mamestra brassicae (cabbage moth) larvae. Feeding second stadium larvae on leaf discs coated with Hv1a/GNA (0.1-0.2% w/v) caused >= 80% larval mortality within 10 days, whereas leaf discs coated with GNA (0.2% w/v) showed no acute effects. Intact Hv1a/GNA fusion protein was delivered to insect haemolymph following ingestion, as shown by Western blotting. Immunoblotting of nerve chords dissected from larvae following injection of GNA or Hv1a/GNA showed high levels of bound proteins. When insects were injected with, or fed on, fluorescently labelled GNA or HV1a/GNA, fluorescence was detected specifically associated with the central nerve chord. Conclusions/Significance: In addition to mediating transport of Hv1a across the gut epithelium in lepidopteran larvae, GNA is also capable of delivering Hv1a to sites of action within the insect central nervous system. We propose that fusion to GNA provides a general mechanism for dramatically enhancing the oral activity of insecticidal peptides and proteins.	[Fitches, Elaine C.] Food & Environm Res Agcy, Dept Environm Food & Rural Affairs, Sand Hutton, N Yorkshire, England; [Pyati, Prashant; Gatehouse, John A.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [King, Glenn F.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia	Food & Environment Research Agency; Durham University; University of Queensland	Fitches, EC (corresponding author), Food & Environm Res Agcy, Dept Environm Food & Rural Affairs, Sand Hutton, N Yorkshire, England.	elaine.fitches@fera.gsi.gov.uk	King, Glenn F/J-5059-2012	King, Glenn F/0000-0002-2308-2200; Gatehouse, John/0000-0002-7192-568X	United Kingdom Department for the Environment, Food, and Rural Affairs; agrochemical company Isagro Ricerca S.r.l. (Novara, Italy) through LINK [09910]; Technology Strategy Board [100865]; Australian Research Council (ARC) [DP1095728]; Isagro Ricerca S.r.l; Engineering and Physical Sciences Research Council [TS/I000690/1] Funding Source: researchfish; EPSRC [TS/I000690/1] Funding Source: UKRI	United Kingdom Department for the Environment, Food, and Rural Affairs; agrochemical company Isagro Ricerca S.r.l. (Novara, Italy) through LINK; Technology Strategy Board; Australian Research Council (ARC)(Australian Research Council); Isagro Ricerca S.r.l; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by funding from the United Kingdom Department for the Environment, Food, and Rural Affairs, the agrochemical company Isagro Ricerca S.r.l. (Novara, Italy) through LINK Project 09910, the Technology Strategy Board (Project 100865), and the Australian Research Council (ARC) (ARC Discovery Grant DP1095728 to GK). The funders had no role in study design, dta collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare that Isagro Ricerca S.r.l have contributed to the funding of this work. In addition the authors declare that a PCT International patent application (covering the inventiveness of the fusion protein described in this manuscript) was filed with the United Kingdom Intellectual Property office on the 29th March 2012, which claims priority from GB1105418.6 filed 31st March 2011. This does not alter the authors' adherence to all PloS ONE policies on sharing data and materials.	[Anonymous], [No title captured]; Atkinson RK., 1998, Patent No. 5763568; Bloomquist JR, 2003, INVERTEBR NEUROSCI, V5, P45, DOI 10.1007/s10158-003-0027-z; Bown DP, 1997, INSECT BIOCHEM MOLEC, V27, P625, DOI 10.1016/S0965-1748(97)00043-X; Chong Y, 2007, BIOCHEM PHARMACOL, V74, P623, DOI 10.1016/j.bcp.2007.05.017; Cino J, 1999, HIGH YIELD PROTEIN P; Down RE, 2006, PEST MANAG SCI, V62, P77, DOI 10.1002/ps.1119; Fitches E, 1998, J INSECT PHYSIOL, V44, P1213, DOI 10.1016/S0022-1910(98)00090-0; Fitches E, 2004, J INSECT PHYSIOL, V50, P61, DOI 10.1016/j.jinsphys.2003.09.010; Fitches E, 2002, INSECT BIOCHEM MOLEC, V32, P1653, DOI 10.1016/S0965-1748(02)00105-4; Fitches E, 2001, J INSECT PHYSIOL, V47, P777, DOI 10.1016/S0022-1910(01)00068-3; Fitches EC, 2010, PEST MANAG SCI, V66, P74, DOI 10.1002/ps.1833; Fletcher JI, 1997, NAT STRUCT BIOL, V4, P559, DOI 10.1038/nsb0797-559; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; Khan SA, 2006, TRANSGENIC RES, V15, P349, DOI 10.1007/s11248-006-0007-2; King GF, 2002, J TOXICOL-TOXIN REV, V21, P359, DOI 10.1081/TXR-120014409; Mukherjee AK, 2006, TOXICON, V47, P182, DOI 10.1016/j.toxicon.2005.10.011; PENCE ROY J., 1965, CALIF AGR, V19, P13; Raemaekers RJM, 1999, EUR J BIOCHEM, V265, P394, DOI 10.1046/j.1432-1327.1999.00749.x; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; Sambrook J., 2001, MOL CLONING LAB MANU; Tedford HW, 2004, J BIOL CHEM, V279, P44133, DOI 10.1074/jbc.M404006200; Tedford HW, 2004, TOXICON, V43, P601, DOI 10.1016/j.toxicon.2004.02.010; Tedford HW, 2001, J BIOL CHEM, V276, P26568, DOI 10.1074/jbc.M102199200; Trung NP, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-18; VANDAMME EJM, 1991, PLANTA, V186, P35, DOI 10.1007/BF00201495; Windley MJ, 2012, TOXINS IN PRESS	27	40	44	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39389	10.1371/journal.pone.0039389	http://dx.doi.org/10.1371/journal.pone.0039389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761779	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900054
J	Shipp, C; Derhovanessian, E; Pawelec, G				Shipp, Christopher; Derhovanessian, Evelyna; Pawelec, Graham			Effect of Culture at Low Oxygen Tension on the Expression of Heat Shock Proteins in a Panel of Melanoma Cell Lines	PLOS ONE			English	Article							HLA-DR EXPRESSION; MALIGNANT-MELANOMA; TUMOR HYPOXIA; METASTATIC MELANOMA; C-MYC; CANCER; HSP90; ANGIOGENESIS; INDUCTION; INVOLVEMENT	Objective: Tumours are commonly hypoxic and this can be associated with aggressive tumour type, metastasis and resistance to therapy. Heat shock proteins (hsps) are induced in response to hypoxia, provide cancer cells with protection against tumour-associated stressors and chaperone oncoproteins that drive tumour proliferation. This study examined the effect of different oxygen concentrations on the expression of hsps in melanoma cell lines. Methods: Melanoma cell lines were cultured in 2% and 20% O-2. Expression of Hsp90, Hsp70, Hsp60, Hsp40 and Hsp32 proteins were determined by flow cytometry. Results: Growth rates and viability were reduced in the majority of cell lines by culture in 2% O-2. Hsp expression was different in 2% compared to 20% O-2 and changes in Hsp90 expression correlated with cell line generation time (P<0.005) and viability (P<0.01). Greater total hsp expression correlated with improved viability in 2% but not 20% O-2 (P<0.05). Relative expression of the different hsps was consistent across cell lines and each correlated with the others (P = 0.0001) but not with Hsp32. Hsp expression was inversely correlated with cell line adhesion to laminin as well as collagen type IV and Breslow depth of the original primary tumour tissue (P<0.05), but not with Clark level or patient survival. All five hsps were identified on the cell surface. Conclusion: Culture in 2% O-2 variably altered hsp expression in a panel of melanoma cell lines. Hsp expression was associated with certain cell line characteristics and clinical parameters of the originating tumour.	[Shipp, Christopher; Derhovanessian, Evelyna; Pawelec, Graham] Univ Tubingen, Tubingen Ageing & Tumour Immunol Grp, Dept Internal Med 2, Med Res Ctr, Tubingen, Baden Wurttembe, Germany; [Shipp, Christopher] Univ New England, Ctr Bioact Discovery Hlth & Ageing, Armidale, NSW, Australia	Eberhard Karls University of Tubingen; University of New England	Shipp, C (corresponding author), Univ Tubingen, Tubingen Ageing & Tumour Immunol Grp, Dept Internal Med 2, Med Res Ctr, Tubingen, Baden Wurttembe, Germany.	mrchristophershipp@gmail.com	Pawelec, Graham/H-2713-2019	Pawelec, Graham/0000-0002-3600-0163	Australian Postgraduate Award; University of New England Strategic Doctoral Scholarship	Australian Postgraduate Award(Australian Government); University of New England Strategic Doctoral Scholarship	We are grateful to Lilly Ottinger for assistance with harvesting cultured cell lines used in this study. The laboratory of Dirk Schadendorf provided the melanoma patient clinical data. Christopher Shipp is the recipient of an Australian Postgraduate Award and a University of New England Strategic Doctoral Scholarship.	Abarzua F, 2007, INT J MOL MED, V20, P37; [Anonymous], 2011, STUD EV SAF ANT ACT; Babchia N, 2008, INVEST OPHTH VIS SCI, V49, P2348, DOI 10.1167/iovs.07-1305; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Baird NA, 2006, J BIOL CHEM, V281, P38675, DOI 10.1074/jbc.M608013200; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; Brown JM, 2007, METHOD ENZYMOL, V435, P297, DOI 10.1016/S0076-6879(07)35015-5; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Deichmann M, 2004, INT J ONCOL, V25, P259; Dong Z, 2004, J BIOL CHEM, V279, P9215, DOI 10.1074/jbc.M312225200; Farkas B, 2003, MELANOMA RES, V13, P147, DOI 10.1097/00008390-200304000-00006; Gibbons NB, 2000, PROSTATE, V45, P58; Goel G, 2010, NEUROSCI LETT, V483, P162, DOI 10.1016/j.neulet.2010.07.069; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; Hammerer-Lercher A, 2001, CARDIOVASC RES, V50, P115, DOI 10.1016/S0008-6363(01)00198-5; Harada M, 1998, BIOTHERAPY, V10, P229, DOI 10.1007/BF02678301; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Kalogeraki A, 2006, ANTICANCER RES, V26, P3551; Katschinski DM, 2005, DTSCH GESELLSCHAFT C, V34, P115; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; Kim CY, 1997, CANCER RES, V57, P4200; Lartigau E, 1997, MELANOMA RES, V7, P400, DOI 10.1097/00008390-199710000-00006; Lee JE, 2010, CELL PROLIFERAT, V43, P378, DOI 10.1111/j.1365-2184.2010.00687.x; Lukacs KV, 1993, J EXP MED, P178; Lukashev D, 2007, CANCER METAST REV, V26, P273, DOI 10.1007/s10555-007-9054-2; McCarthy MM, 2008, ANN ONCOL, V19, P590, DOI 10.1093/annonc/mdm545; Multhoff G, 1997, J IMMUNOL, V158, P4341; Murphy M, 2004, J CUTAN PATHOL, V31, P477, DOI 10.1111/j.0303-6987.2004.00205.x; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Okui T, 2011, ANTICANCER RES, V31, P1197; Pawelec G, 2006, CANCER IMMUNOL IMMUN, V55, P623, DOI 10.1007/s00262-005-0117-3; Ricaniadis N, 2001, EUR J SURG ONCOL, V27, P88, DOI 10.1053/ejso.1999.1018; Rofstad EK, 1999, INT J RADIAT BIOL, V75, P1377; Rofstad EK, 2002, BRIT J CANCER, V86, P301, DOI 10.1038/sj.bjc.6600052; Rofstad EK, 1999, BRIT J CANCER, V80, P1697, DOI 10.1038/sj.bjc.6690586; Rofstad EK, 2002, CANCER RES, V62, P1847; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Semenza GL, 2007, CANCER METAST REV, V26, P223, DOI 10.1007/s10555-007-9058-y; Sun JX, 2004, ARTERIOSCL THROM VAS, V24, P2238, DOI 10.1161/01.ATV.0000147894.22300.4c; Trisciuoglio D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011772; Tsutsumi S, 2009, FUTURE ONCOL, V5, P679, DOI 10.2217/FON.09.30; VAUPEL P, 2004, ONCOLOGIST, V9; Victor N, 2006, CLIN EXP METASTAS, V23, P87, DOI 10.1007/s10585-006-9024-z; Walther MM, 1997, UROLOGY, V50, P295, DOI 10.1016/S0090-4295(97)00220-3; Weinmann M, 2004, ONKOLOGIE, V27, P83, DOI 10.1159/000075611; Wells AD, 1998, INT IMMUNOL, V10, P609, DOI 10.1093/intimm/10.5.609; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Yerlikaya A, 2010, MOL MED REP, V3, P333, DOI 10.3892/mmr_00000262; Zhao RM, 2007, ADV EXP MED BIOL, V594, P27	51	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e37475	10.1371/journal.pone.0037475	http://dx.doi.org/10.1371/journal.pone.0037475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761656	gold, Green Submitted, Green Published			2022-12-27	WOS:000305730900003
J	Tzeng, HT; Tsai, HF; Liao, HJ; Lin, YJ; Chen, LP; Chen, PJ; Hsu, PN				Tzeng, Horng-Tay; Tsai, Hwei-Fang; Liao, Hsiu-Jung; Lin, Yi-Jiun; Chen, Lieping; Chen, Pei-Jer; Hsu, Ping-Ning			PD-1 Blockage Reverses Immune Dysfunction and Hepatitis B Viral Persistence in a Mouse Animal Model	PLOS ONE			English	Article							CHRONIC HBV INFECTION; T-CELL EXHAUSTION; VIRUS-INFECTION; UP-REGULATION; EXPRESSION; LIVER; TOLERANCE; SIGNALS	Persistent hepatitis B viral (HBV) infection results in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). Recent studies in animal models of viral infection indicate that the interaction between the inhibitory receptor, programmed death (PD)-1, on lymphocytes and its ligand (PD-L1) play a critical role in T-cell exhaustion by inducing T-cell inactivation. High PD-1 expression levels by peripheral T-lymphocytes and the possibility of improving T-cell function by blocking PD-1-mediated signaling confirm the importance of this inhibitory pathway in inducing T-cell exhaustion. We studied T-cell exhaustion and the effects of PD-1 and PD-L1 blockade on intrahepatic infiltrating T-cells in our recently developed mouse model of HBV persistence. In this mouse animal model, we demonstrated that there were increased intrahepatic PD-1-expressing CD8+ and CD4+ T cells in mice with HBV persistence, but PD-1 upregulation was resolved in mice which had cleared HBV. The Intrahepatic CD8+ T-cells expressed higher levels of PD-1 and lower levels of CD127 in mice with HBV persistence. Blockade of PD-1/PD-L1 interactions increased HBcAg-specific interferon (IFN)-gamma production in intrahepatic T lymphocytes. Furthermore, blocking the interaction of PD-1 with PD-L1 by an anti-PD-1 monoclonal antibody (mAb) reversed the exhausted phenotype in intrahepatic T lymphocytes and viral persistence to clearance of HBV in vivo. Our results indicated that PD-1 blockage reverses immune dysfunction and viral persistence of HBV infection in a mouse animal model, suggesting that the anti-PD-1 mAb might be a good therapeutic candidate for chronic HBV infection.	[Tzeng, Horng-Tay; Liao, Hsiu-Jung; Hsu, Ping-Ning] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan; [Tsai, Hwei-Fang] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Taipei, Taiwan; [Tsai, Hwei-Fang] Taipei Med Univ, Coll Med, Inst Clin Med, Taipei, Taiwan; [Lin, Yi-Jiun; Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan; [Chen, Lieping] Yale Univ, Sch Med, Yale Canc Ctr, Canc Immunol Program, New Haven, CT USA; [Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Hsu, Ping-Ning] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; National Taiwan University; Yale University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Tzeng, HT (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan.	phsu8635@ntu.edu.tw		HSU, PING-NING/0000-0003-4479-3391; Chen, Pei-Jer/0000-0001-8316-3785	National Health Research Institute [NHRIEX95-9532SI]; National Science Council, Taiwan [NSC096-2811-B-002-043, NSC98-3112-B-002-047, NSC98-2320-B-002-049-MY3]; National Taiwan University Hospital [VN-9801]; NATIONAL CANCER INSTITUTE [R01CA142779] Funding Source: NIH RePORTER	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Health Research Institute (NHRIEX95-9532SI), National Science Council, Taiwan (NSC096-2811-B-002-043, NSC98-3112-B-002-047, and NSC98-2320-B-002-049-MY3), and National Taiwan University Hospital (VN-9801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Boettler T, 2006, J VIROL, V80, P3532, DOI 10.1128/JVI.80.7.3532-3540.2006; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Fisicaro P, 2010, GASTROENTEROLOGY, V138, P682, DOI 10.1053/j.gastro.2009.09.052; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Ha SJ, 2008, J EXP MED, V205, P543, DOI 10.1084/jem.20071949; Hsu PN, 2010, LIVER INT, V30, P1379, DOI 10.1111/j.1478-3231.2010.02323.x; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235; Jung MC, 2002, LANCET INFECT DIS, V2, P43, DOI 10.1016/S1473-3099(01)00172-4; Lin YJ, 2010, P NATL ACAD SCI USA, V107, P9340, DOI 10.1073/pnas.1004762107; Maier H, 2007, J IMMUNOL, V178, P2714, DOI 10.4049/jimmunol.178.5.2714; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Nurieva R, 2006, EMBO J, V25, P2623, DOI 10.1038/sj.emboj.7601146; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Xie ZY, 2009, IMMUNOL INVEST, V38, P624, DOI 10.1080/08820130903062210; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Yang PL, 2010, P NATL ACAD SCI USA, V107, P798, DOI 10.1073/pnas.0913498107; Zhang Z, 2008, GASTROENTEROLOGY, V134, P1938, DOI 10.1053/j.gastro.2008.03.037; Zhang Z, 2009, J HEPATOL, V50, P1163, DOI 10.1016/j.jhep.2009.01.026	25	105	128	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39179	10.1371/journal.pone.0039179	http://dx.doi.org/10.1371/journal.pone.0039179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761734	Green Submitted, Green Published, gold			2022-12-27	WOS:000305730900034
J	Beltrami, M; Medina-Munoz, MC; Del Pino, F; Ferveur, JF; Godoy-Herrera, R				Beltrami, Marcial; Cristina Medina-Munoz, Maria; Del Pino, Francisco; Ferveur, Jean-Francois; Godoy-Herrera, Raul			Chemical Cues Influence Pupation Behavior of Drosophila simulans and Drosophila buzzatii in Nature and in the Laboratory	PLOS ONE			English	Article							MELANOGASTER; LARVAE	In the wild, larvae of several species of Drosophila develop in heterogeneous and rapidly changing environments sharing resources as food and space. In this scenario, sensory systems contribute to detect, localize and recognize congeners and heterospecifics, and provide information about the availability of food and chemical features of environments where animals live. We investigated the behavior of D. simulans and D. buzzatii larvae to chemicals emitted by conspecific and heterospecific larvae. Our goal was to understand the role of these substances in the selection of pupation sites in the two species that cohabit within decaying prickly pear fruits (Opuntia ficus-indica). In these breeding sites, larvae of D. simulans and D. buzzatii detect larvae of the other species changing their pupation site preferences. Larvae of the two species pupated in the part of the fruit containing no or few heterospecifics, and spent a longer time in/on spots marked by conspecifics rather than heterospecifics. In contrast, larvae of the two species reared in isolation from conspecifics pupated randomly over the substrate and spent a similar amount of time on spots marked by conspecifics and by heterospecifics. Our results indicate that early chemically-based experience with conspecific larvae is critical for the selection of the pupation sites in D. simulans and D. buzzatii, and that pupation site preferences of Drosophila larvae depend on species-specific chemical cues. These preferences can be modulate by the presence of larvae of the same or another species.	[Beltrami, Marcial] Univ Metropolitana Ciencias Educ, Fac Ciencias Nat & Exactas, Dept Biol, Santiago, Chile; [Cristina Medina-Munoz, Maria] Univ Playa Ancha Ciencias Educ, Fac Ciencias Nat & Exactas, Dept Biol, Valparaiso, Chile; [Del Pino, Francisco] Univ Chile, Fac Med, Programa Genet Humana, ICBM, Santiago 7, Chile; [Ferveur, Jean-Francois] Univ Bourgogne, Ctr Sci Gout & Alimentat, Unite Mixte Rech 6265, Associee Ctr Natl Rech Sci,Fac Sci, Dijon, France; [Godoy-Herrera, Raul] Univ Bio Bio, Fac Ciencias, Dept Ciencias Basicas, Chillan, Chile	Universidad Metropolitana de Ciencias de la Educacion (UMCE); Universidad de Chile; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Universidad del Bio-Bio	Beltrami, M (corresponding author), Univ Metropolitana Ciencias Educ, Fac Ciencias Nat & Exactas, Dept Biol, Santiago, Chile.	raulgodoy.herrera@gmail.com	Corrêa, Marcio N Nunes/D-1034-2019	Corrêa, Marcio N Nunes/0000-0003-0855-2750	Centre National de la Recherche Scientifique (CNRS); Burgundy Regional Council; Fondo Nacional de Investigacion Cientifica y Tecnologica (FONDECYT) [1100110]; Comite de Evaluacion-Orientacion de la Cooperacion Cientifica Chile-France (ECOS-CONICYT) [08 B03]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Burgundy Regional Council(Region Bourgogne-Franche-Comte); Fondo Nacional de Investigacion Cientifica y Tecnologica (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comite de Evaluacion-Orientacion de la Cooperacion Cientifica Chile-France (ECOS-CONICYT)	JFF's funding was provided in part by the Centre National de la Recherche Scientifique (CNRS) and the Burgundy Regional Council. This work was supported by Fondo Nacional de Investigacion Cientifica y Tecnologica (FONDECYT No1100110) to RG-H and by Comite de Evaluacion-Orientacion de la Cooperacion Cientifica Chile-France (ECOS-CONICYT NoC08 B03) to RG-H and JFF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; Beltrami M, 2010, EVOL ECOL, V24, P347, DOI 10.1007/s10682-009-9310-8; BRNCIC D, 1985, Z ZOOL SYST EVOL, V23, P90; Burdick A. B., 1954, DROSOPH INF SERV, V28, P170; Del Pino F, 2012, BEHAV GENET, V42, P162, DOI 10.1007/s10519-011-9490-1; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Hendel T, 2005, J COMP PHYSIOL A, V191, P265, DOI 10.1007/s00359-004-0574-8; KAMBYSELLIS MP, 1971, AM NAT, V105, P31, DOI 10.1086/282700; LEVINS RICHARD, 1968; Markow T. A., 2006, DROSOPHILA GUIDE SPE; Masuda-Nakagawa LM, 2009, P NATL ACAD SCI USA, V106, P10314, DOI 10.1073/pnas.0900178106; Medina-Munoz MC, 2005, BEHAV ECOL, V16, P316, DOI 10.1093/beheco/arh125; Mery F, 2004, EVOLUTION, V58, P757; POWELL JR, 1997, PROGR PROSPECT EVOLU; Reaume CJ, 2006, CURR BIOL, V16, pR623, DOI 10.1016/j.cub.2006.07.042; Sisodia S, 2005, J GENET, V84, P195, DOI 10.1007/BF02715846; Zar JH, 1999, BIOSTATISTICAL ANAL	17	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39393	10.1371/journal.pone.0039393	http://dx.doi.org/10.1371/journal.pone.0039393			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737236	Green Published, gold, Green Submitted			2022-12-27	WOS:000305695100035
J	Abouzeid, MS; Zumla, AI; Felemban, S; Alotaibi, B; O'Grady, J; Memish, ZA				Abouzeid, Mohammad S.; Zumla, Alimuddin I.; Felemban, Shaza; Alotaibi, Badriah; O'Grady, Justin; Memish, Ziad A.			Tuberculosis Trends in Saudis and Non-Saudis in the Kingdom of Saudi Arabia - A 10 Year Retrospective Study (2000-2009)	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; EPIDEMIOLOGY; SMOKING; ASSOCIATION; POPULATION; INFECTION; GENDER	Background: Tuberculosis (TB) remains a public health problem in the Kingdom of Saudi Arabia (KSA), which has a very large labour force from high TB endemic countries. Understanding the epidemiological and clinical features of the TB problem, and the TB burden in the immigrant workforce, is necessary for improved planning and implementation of TB services and prevention measures. Methods: A 10 year retrospective study of all TB cases reported in KSA covering the period 1st January 2000 to 31st December 2009. Data was obtained from TB reporting forms returned to the Ministry of Health. Data were then organised, tabulated and analysed for annual incidence rates by province, nationality, country of origin and gender. Results: There was an annual increase in the number of TB cases registered from 3,284 in 2000 to 3,964 in 2009. Non-Saudis had nearly twice the TB incidence rate compared to Saudis (P = <0.05). All but four provinces (Najran, Riyadh, Makkah, Tabuk) showed decreasing TB incidence rates. The highest rates were seen in the 65+ age group. In the 15-24 year age group the incidence rate increased from 15.7/100,000 in 2000 to 20.9/100,00 in 2009 (P = <0.05). The incidence of TB in Saudi males was higher than Saudi females. Conversely, for non-Saudis the TB incidence rates were significantly higher in females compared to males. Conclusions: Despite significant investments in TB control over 15 years, TB remains an important public health problem in the KSA affecting all age groups, and Saudis and non-Saudis alike. Identification of the major risk factors associated with the persistently high TB rates in workers migrating to KSA is required. Further studies are warranted to delineate whether such patients re-activate latent Mycobacterium tuberculosis (M.tb) infection or acquire new M.tb infection after arrival in KSA. Appropriate interventions are required to reduce TB incidence rates as have been implemented by other countries.	[Abouzeid, Mohammad S.; Felemban, Shaza; Alotaibi, Badriah; Memish, Ziad A.] Minist Hlth, Prevent Med Directorate, Riyadh, Saudi Arabia; [Zumla, Alimuddin I.; O'Grady, Justin] UCL, Dept Infect, Div Infect & Immun, London, England; [Memish, Ziad A.] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia	Ministry of Health - Saudi Arabia; University of London; University College London; Alfaisal University	Abouzeid, MS (corresponding author), Minist Hlth, Prevent Med Directorate, Riyadh, Saudi Arabia.	zmemish@yahoo.com	Memish, Ziad Ahmed/AEJ-9424-2022; ZUMLA, Alimuddin/ABA-8208-2020; O'Grady, Justin/I-2982-2012	Memish, Ziad Ahmed/0000-0002-5099-0714; ZUMLA, Alimuddin/0000-0002-5111-5735; O'Grady, Justin/0000-0001-5412-7152				Al-Hajoj Sahal Abdulaziz, 2010, J Infect Public Health, V3, P17, DOI 10.1016/j.jiph.2009.12.001; Al-Kahtani NH, 2003, MANUAL NATL TB CONTR; Al-Otaibi F, 2010, INDIAN J PATHOL MICR, V53, P227, DOI 10.4103/0377-4929.64327; Al-Tawfiq JA, 2005, CHEST, V128, P3229, DOI 10.1378/chest.128.5.3229; Alzohairy M. A., 2011, Research Journal of Medical Sciences, V5, P233; Anderson RH, 1997, AM J PREV MED, V13, P175, DOI 10.1016/S0749-3797(18)30190-9; [Anonymous], 576421 MIN HLTH; [Anonymous], WHO REP 2011 GLOB TU; [Anonymous], 363421 MIN HLTH; [Anonymous], 14132519 MIN HLTH; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P123; den Boon S, 2005, THORAX, V60, P555, DOI 10.1136/thx.2004.030924; Heldal E, 2008, INT J TUBERC LUNG D, V12, P878; Hudelson P, 1996, TUBERCLE LUNG DIS, V77, P391, DOI 10.1016/S0962-8479(96)90110-0; Marrero A, 2000, THORAX, V55, P39, DOI 10.1136/thorax.55.1.39; Maurya V, 2002, INT J TUBERC LUNG D, V6, P942; Rapiti E, 1998, INT J TUBERC LUNG D, V2, P479; Samman Y, 2003, CLIN MICROBIOL INFEC, V9, P289, DOI 10.1046/j.1469-0691.2003.00547.x; Scolari C, 1999, INT J TUBERC LUNG D, V3, P18; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; Tornieporth NG, INT J TUBER LUNG DIS, V1, P528; UNITED NATIONS, 2011, MILL DEV GOALS REP 2, P46; Wilder-Smith A, 2005, TROP MED INT HEALTH, V10, P336, DOI 10.1111/j.1365-3156.2005.01395.x; World Health Organization, 1994, WHOEMTUB184EL; ZAMAN R, 1991, TUBERCLE, V72, P43, DOI 10.1016/0041-3879(91)90023-L; Zhang LX, 2000, INT J TUBERC LUNG D, V4, P904	26	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39478	10.1371/journal.pone.0039478	http://dx.doi.org/10.1371/journal.pone.0039478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745765	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200079
J	Tachezy, M; Zander, H; Marx, AH; Stahl, PR; Gebauer, F; Izbicki, JR; Bockhorn, M				Tachezy, Michael; Zander, Hilke; Marx, Andreas H.; Stahl, Phillip R.; Gebauer, Florian; Izbicki, Jakob R.; Bockhorn, Maximilian			ALCAM (CD166) Expression and Serum Levels in Pancreatic Cancer	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; PROSTATE-CANCER; STEM-CELLS; HIGH-GRADE; PHASE-III; ALCAM/CD166; CARCINOMA; BIOMARKER; RECOMMENDATIONS; ADENOCARCINOMA	Background: This study was conducted to evaluate the expression of the activated leukocyte cell adhesion molecule (ALCAM) in pancreatic cancer (PAC) and to determine whether or not the ectodomain shedding of ALCAM (s-ALCAM) could serve as a biomarker in the peripheral blood of PAC patients. Material and Methods: Tissue specimens and blood sera of patients with PAC (n = 264 and n = 116, respectively) and the sera of 115 patients with chronic pancreatitis (CP) were analyzed via ALCAM immunohistochemistry and s-ALCAM ELISA tests. Results were correlated with clinical, histopathological, and patient survival data (Chi-square test, Kaplan-Meier analysis, log-rank test, respectively). Results: ALCAM was expressed in the majority of PAC lesions. Immunohistochemistry and serum ELISA tests revealed no association between ALCAM expression in primary tumors or s-ALCAM and clinical or histopathological data. Neither ALCAM nor s-ALCAM showed a significant impact regarding overall survival (p = 0.261 and p = 0.660, respectively). S-ALCAM serum levels were significantly elevated compared to the sera of CP patients (p < 0.001). The sensitivity of s-ALCAM in detecting PAC was 58.6% at a specificity of 73.9% (AUC = 0.69). Conclusions: ALCAM is expressed in the majority of PAC lesions, but statistical analysis revealed no association with clinical or pathological data. Although significantly elevated in patients with PAC, the sensitivity and specificity of the s-ALCAM serum quantification test was low. Therefore, its potential as a novel diagnostic marker for PAC remains elusive and further investigations are required.	[Tachezy, Michael; Zander, Hilke; Gebauer, Florian; Izbicki, Jakob R.; Bockhorn, Maximilian] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany; [Marx, Andreas H.; Stahl, Phillip R.] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Tachezy, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany.	mtachezy@uke.uni-hamburg.de	Marx, Andreas/I-5676-2012; Tachezy, Michael/AAD-6759-2022	Marx, Andreas/0000-0002-5182-8364; Zander, Hilke/0000-0003-2727-0265	University of Hamburg (Forschungsforderung Medizin - FFM)	University of Hamburg (Forschungsforderung Medizin - FFM)	Financial support for this study was provided by a research grant from the University of Hamburg (Forschungsforderung Medizin - FFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boman BM, 2008, J CLIN ONCOL, V26, P2828, DOI 10.1200/JCO.2008.17.6941; Buhusi M, 2009, J NEUROSCI, V29, P15630, DOI 10.1523/JNEUROSCI.2215-09.2009; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; Goldstein NS, 2007, APPL IMMUNOHISTO M M, V15, P124, DOI 10.1097/PAI.0b013e31804c7283; Hong X, 2010, J SURG ONCOL, V101, P564, DOI 10.1002/jso.21538; Horst D, 2009, CANCER INVEST, V27, P844, DOI 10.1080/07357900902744502; Ihnen M, 2008, BREAST CANCER RES TR, V112, P419, DOI 10.1007/s10549-007-9879-y; Kahlert C, 2009, BRIT J CANCER, V101, P457, DOI 10.1038/sj.bjc.6605136; Kilic M, 2006, CAN J SURG, V49, P241; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Kleeff J, 2008, J CLIN ONCOL, V26, P3100, DOI 10.1200/JCO.2008.16.9326; Kristiansen G, 2003, PROSTATE, V54, P34, DOI 10.1002/pros.10161; Kulasingam V, 2009, INT J CANCER, V125, P9, DOI 10.1002/ijc.24292; Kuuselo R, 2010, GENE CHROMOSOME CANC, V49, P569, DOI 10.1002/gcc.20767; Ladd J, 2009, ANAL BIOANAL CHEM, V393, P1157, DOI 10.1007/s00216-008-2448-3; Levin TG, 2010, GASTROENTEROLOGY, V139, P2072, DOI 10.1053/j.gastro.2010.08.053; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Liu B, 2007, J MOL MED, V85, P1113, DOI 10.1007/s00109-007-0208-z; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Mehta SP, 2010, SURG CLIN N AM, V90, P365, DOI 10.1016/j.suc.2009.12.005; Mezzanzanica D, 2008, CLIN CANCER RES, V14, P1726, DOI 10.1158/1078-0432.CCR-07-0428; Minner S, 2011, HUM PATHOL, V42, P1946, DOI 10.1016/j.humpath.2011.02.017; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ofori-Acquah SF, 2008, TRANSL RES, V151, P122, DOI 10.1016/j.trsl.2007.09.006; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Philip PA, 2010, J CLIN ONCOL, V28, P3605, DOI 10.1200/JCO.2009.25.7550; Piscuoglio S, 2011, J CLIN PATHOL; Reichelt U, 2007, MODERN PATHOL, V20, P120, DOI 10.1038/modpathol.3800712; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rivera F, 2009, CANCER TREAT REV, V35, P335, DOI 10.1016/j.ctrv.2008.11.007; Rosso O, 2007, MOL CANCER RES, V5, P1246, DOI 10.1158/1541-7786.MCR-07-0060; Roth A, 2007, MOL CANCER THER, V6, P2737, DOI 10.1158/1535-7163.MCT-07-0140; Schlomm T, 2008, MODERN PATHOL, V21, P1371, DOI 10.1038/modpathol.2008.104; Simon R, 2010, METHODS MOL BIOL, V664, P113, DOI 10.1007/978-1-60761-806-5_12; STEINBERG WM, 1986, GASTROENTEROLOGY, V90, P343, DOI 10.1016/0016-5085(86)90930-3; Swart GWM, 2002, EUR J CELL BIOL, V81, P313, DOI 10.1078/0171-9335-00256; Tachezy M, 2011, INT J CANC; Tachezy M, 2012, J SURG RES; Tachezy M, 2011, J SURG RES, V170, P226, DOI 10.1016/j.jss.2011.06.002; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Vaisocherova H, 2009, BIOSENS BIOELECTRON, V24, P2143, DOI 10.1016/j.bios.2008.11.015; van Kilsdonk JWJ, 2008, CANCER RES, V68, P3671, DOI 10.1158/0008-5472.CAN-07-5767; Weichert W, 2004, J CLIN PATHOL, V57, P1160, DOI 10.1136/jcp.2004.016238; Weidle Ulrich H., 2010, Cancer Genomics & Proteomics, V7, P231; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	47	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39018	10.1371/journal.pone.0039018	http://dx.doi.org/10.1371/journal.pone.0039018			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745698	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200036
J	Suzuki, H; Shibata, R; Kito, T; Yamamoto, T; Ishii, M; Nishio, N; Ito, S; Isobe, K; Murohara, T				Suzuki, Hirohiko; Shibata, Rei; Kito, Tetsutaro; Yamamoto, Takashi; Ishii, Masakazu; Nishio, Naomi; Ito, Sachiko; Isobe, Ken-ichi; Murohara, Toyoaki			Comparative Angiogenic Activities of Induced Pluripotent Stem Cells Derived from Young and Old Mice	PLOS ONE			English	Article							THERAPEUTIC ANGIOGENESIS; PROGENITOR CELLS; TISSUE ISCHEMIA; LIMB ISCHEMIA; TRANSPLANTATION; AGE	Advanced age is associated with decreased stem cell activity. However, the effect of aging on the differentiation capacity of induced pluripotent stem (iPS) cells into cardiovascular cells has not been fully clarified. We investigated whether iPS cells derived from young and old mice are equally capable of differentiating into vascular progenitor cells, and whether these cells regulate vascular responses in vivo. iPS cells from mouse embryonic fibroblasts (young) or 21 month-old mouse bone marrow (old) were used. Fetal liver kinase-1 positive (Flk-1(+)) cells, as a vascular progenitor marker, were induced after 3 to 4 days of culture from iPS cells derived from young and old mice. These Flk-1(+) cells were sorted and shown to differentiate into VE-cadherin(+) endothelial cells and alpha-SMA(+) smooth muscle cells. Tube-like formation was also successfully induced in both young and old murine Flk-1(+) cells. Next, hindlimb ischemia was surgically induced, and purified Flk-1(+) cells were directly injected into ischemic hindlimbs of nude mice. Revascularization of the ischemic hindlimb was significantly accelerated in mice transplanted with Flk-1(+) cells derived from iPS cells from either young or old mice, as compared to control mice as evaluated by laser Doppler blood flowmetry. The degree of revascularization was similar in the two groups of ischemic mice injected with iPS cell-derived Flk-1(+) cells from young or old mice. Transplantation of Flk-1(+) cells from both young and old murine iPS cells also increased the expression of VEGF, HGF and IGF mRNA in ischemic tissue as compared to controls. iPS cell-derived Flk-1(+) cells differentiated into vascular progenitor cells, and regulated angiogenic vascular responses both in vitro and in vivo. These properties of iPS cells derived from old mice are essentially the same as those of iPS cells from young mice, suggesting the functionality of generated iPS cells themselves to be unaffected by aging.	[Suzuki, Hirohiko; Shibata, Rei; Kito, Tetsutaro; Yamamoto, Takashi; Ishii, Masakazu; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Nishio, Naomi; Ito, Sachiko; Isobe, Ken-ichi] Nagoya Univ, Grad Sch Med, Dept Immunol, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Suzuki, H (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan.	rshibata@med.nagoya-u.ac.jp; murohara@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014; ito, Sachiko/M-4877-2014		Ministry of Education, Culture, Sports, Science and Technology of Japan [20249045]; Japanese Circulation Society; Grants-in-Aid for Scientific Research [22390144] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Circulation Society(Japanese Circulation Society); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants (No. 20249045 to Toyoaki Murohara) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and a grant for advancement of translational research from the Japanese Circulation Society to T. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Devanesan AJ, 2009, EUR J VASC ENDOVASC, V38, P475, DOI 10.1016/j.ejvs.2009.05.019; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Fuller Jennifer, 2002, Sci Aging Knowledge Environ, V2002, ppe11, DOI 10.1126/sageke.2002.25.pe11; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Kajiguchi M, 2007, CIRC J, V71, P196, DOI 10.1253/circj.71.196; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kumar AHS, 2010, ARTERIOSCL THROM VAS, V30, P1080, DOI 10.1161/ATVBAHA.109.198895; Mund JA, 2009, CYTOTHERAPY, V11, P103, DOI 10.1080/14653240802714827; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Piccin D, 2010, DIS MODEL MECH, V3, P421, DOI 10.1242/dmm.003137; Repoli MF, 2009, J CARDIOVASC MED, V10, P624, DOI 10.2459/JCM.0b013e328329ac77; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; SIGAL SH, 1992, AM J PHYSIOL, V263, pG139, DOI 10.1152/ajpgi.1992.263.2.G139; Suzuki H, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-72; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Taura D, 2009, ARTERIOSCL THROM VAS, V29, P1100, DOI 10.1161/ATVBAHA.108.182162; Zhao Cheng SI, 2010, J INEQUAL APPL, V0, P1	25	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39562	10.1371/journal.pone.0039562	http://dx.doi.org/10.1371/journal.pone.0039562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761825	Green Submitted, Green Published, gold			2022-12-27	WOS:000305825800043
J	Yong, ST; Wang, XF				Yong, Sheila T.; Wang, Xiao-Fan			A Novel, Non-Apoptotic Role for Scythe/BAT3: A Functional Switch between the Pro- and Anti-Proliferative Roles of p21 during the Cell Cycle	PLOS ONE			English	Article							UBIQUITIN LIGASE COMPLEX; DNA-DAMAGE; LUNG-CANCER; CYTOPLASMIC LOCALIZATION; INDUCED PHOSPHORYLATION; NUCLEAR ACCUMULATION; MEDIATED DEGRADATION; PROTEASOMAL TURNOVER; BREAST-CANCER; P21(CIP1)	Background: Scythe/BAT3 is a member of the BAG protein family whose role in apoptosis has been extensively studied. However, since the developmental defects observed in Bat3-null mouse embryos cannot be explained solely by defects in apoptosis, we investigated whether BAT3 is also involved in cell-cycle progression. Methods/Principal Findings: Using a stable-inducible Bat3-knockdown cellular system, we demonstrated that reduced BAT3 protein level causes a delay in both G1/S transition and G2/M progression. Concurrent with these changes in cell-cycle progression, we observed a reduction in the turnover and phosphorylation of the CDK inhibitor p21, which is best known as an inhibitor of DNA replication; however, phosphorylated p21 has also been shown to promote G2/M progression. Our findings indicate that in Bat3-knockdown cells, p21 continues to be synthesized during cell-cycle phases that do not normally require p21, resulting in p21 protein accumulation and a subsequent delay in cell-cycle progression. Finally, we showed that BAT3 co-localizes with p21 during the cell cycle and is required for the translocation of p21 from the cytoplasm to the nucleus during the G1/S transition and G2/M progression. Conclusion:: Our study reveals a novel, non-apoptotic role for BAT3 in cell-cycle regulation. By maintaining a low p21 protein level during the G1/S transition, BAT3 counteracts the inhibitory effect of p21 on DNA replication and thus enables the cells to progress from G1 to S phase. Conversely, during G2/M progression, BAT3 facilitates p21 phosphorylation by cyclin A/Cdk2, an event required for G2/M progression. BAT3 modulates these pro- and anti-proliferative roles of p21 at least in part by regulating cyclin A abundance, as well as p21 translocation between the cytoplasm and the nucleus to ensure that it functions in the appropriate intracellular compartment during each phase of the cell cycle.	[Yong, Sheila T.; Wang, Xiao-Fan] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	Duke University	Yong, ST (corresponding author), Natl Inst Environm Hlth Sci, Inositol Signaling Grp, Lab Signal Transduct, NIH, Res Triangle Pk, NC USA.	xiao.fan.wang@duke.edu			National Institutes of Health [CA123250, GM83000]; NATIONAL CANCER INSTITUTE [R01CA151541, R01CA123250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health CA123250 and GM83000 to XFW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Alt JR, 2002, J BIOL CHEM, V277, P8517, DOI 10.1074/jbc.M108867200; Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Blundell R, 2004, EXP MOL PATHOL, V77, P231, DOI 10.1016/j.yexmp.2004.07.003; Blundell R, 2004, EXP LUNG RES, V30, P447, DOI 10.1080/01902140490476373; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carrettiero DC, 2009, J NEUROSCI, V29, P2151, DOI 10.1523/JNEUROSCI.4660-08.2009; Child ES, 2006, CELL CYCLE, V5, P1313, DOI 10.4161/cc.5.12.2863; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Corduan A, 2009, CELL MOL LIFE SCI, V66, P1998, DOI 10.1007/s00018-009-9198-z; Dash BC, 2005, MOL CELL BIOL, V25, P3364, DOI 10.1128/MCB.25.8.3364-3387.2005; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Dong Y, 2004, CELL SIGNAL, V16, P263, DOI 10.1016/S0898-6568(03)00136-0; Dulic V, 1998, MOL CELL BIOL, V18, P546, DOI 10.1128/MCB.18.1.546; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Funk JO, 1997, GENE DEV, V11, P2090, DOI 10.1101/gad.11.16.2090; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Han ZY, 2002, J BIOL CHEM, V277, P17154, DOI 10.1074/jbc.M112401200; Hengst L, 1998, GENE DEV, V12, P3882, DOI 10.1101/gad.12.24.3882; Hwang CY, 2009, MOL CELL BIOL, V29, P3379, DOI 10.1128/MCB.01758-08; Israels ED, 2001, STEM CELLS, V19, P88, DOI 10.1634/stemcells.19-1-88; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kaye FJ, 2000, FEBS LETT, V467, P348, DOI 10.1016/S0014-5793(00)01135-2; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kyratsous CA, 2008, P NATL ACAD SCI USA, V105, P20912, DOI 10.1073/pnas.0810656105; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Li R, 1996, CURR BIOL, V6, P189, DOI 10.1016/S0960-9822(02)00452-9; Manchen ST, 2001, BIOCHEM BIOPH RES CO, V287, P1075, DOI 10.1006/bbrc.2001.5701; Manchen ST, 2002, CHARACTERIZATION SUB; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Preta G, 2012, FEBS LETT, V586, P747, DOI 10.1016/j.febslet.2012.01.034; Rossig L, 2002, J BIOL CHEM, V277, P9684, DOI 10.1074/jbc.M106157200; Rudd MF, 2006, GENOME RES, V16, P693, DOI 10.1101/gr.5120106; Sasaki T, 2008, J CELL BIOL, V182, P449, DOI 10.1083/jcb.200802113; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; te Poele RH, 2002, CANCER RES, V62, P1876; Ter-Minassian M, 2008, CARCINOGENESIS, V29, P2147, DOI 10.1093/carcin/bgn205; Thress K, 1999, EMBO J, V18, P5486, DOI 10.1093/emboj/18.20.5486; Thress K, 1998, EMBO J, V17, P6135, DOI 10.1093/emboj/17.21.6135; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Townsend PA, 2003, CANCER RES, V63, P4150; Tsukahara T, 2009, CANCER SCI, V100, P47, DOI 10.1111/j.1349-7006.2008.00991.x; Van Nguyen T, 2007, J EXP MED, V204, P1453, DOI 10.1084/jem.20062453; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vinayagam A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001699; Waddell DS, 2004, J BIOL CHEM, V279, P29236, DOI 10.1074/jbc.M400880200; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Wakeman TP, 2012, EMBO J, V31, P2169, DOI 10.1038/emboj.2012.50; Wang B, 2010, MOL CELL BIOL, V30, P1508, DOI 10.1128/MCB.01335-09; Wang W, 2005, BIOCHEMISTRY-US, V44, P14553, DOI 10.1021/bi051071j; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Winnefeld M, 2006, EXP CELL RES, V312, P2500, DOI 10.1016/j.yexcr.2006.04.020; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200; Yamada K, 2011, J BIOL CHEM, V286, P44057, DOI 10.1074/jbc.M111.236711; Yamauchi H, 2001, CANCER LETT, V165, P103, DOI 10.1016/S0304-3835(01)00397-4; Zeiner M, 1999, P NATL ACAD SCI USA, V96, P10194, DOI 10.1073/pnas.96.18.10194; Zheng HC, 2010, HUM PATHOL, V41, P724, DOI 10.1016/j.humpath.2009.10.017; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	67	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e38085	10.1371/journal.pone.0038085	http://dx.doi.org/10.1371/journal.pone.0038085			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761665	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800008
J	Qi, ST; Song, Y; Peng, YP; Wang, H; Long, H; Yu, XL; Li, ZY; Fang, LX; Wu, AB; Luo, WR; Zhen, Y; Zhou, Y; Chen, Y; Mai, CP; Liu, Z; Fang, WY				Qi, Songtao; Song, Ye; Peng, Yuping; Wang, Hao; Long, Hao; Yu, Xiaoli; Li, Zhiyong; Fang, Luxiong; Wu, Aibing; Luo, Weiren; Zhen, Yan; Zhou, Ying; Chen, Yan; Mai, Chunping; Liu, Zhen; Fang, Weiyi			ZEB2 Mediates Multiple Pathways Regulating Cell Proliferation, Migration, Invasion, and Apoptosis in Glioma	PLOS ONE			English	Article							SMAD-INTERACTING PROTEIN-1; E-CADHERIN; MESENCHYMAL TRANSITION; C-MYC; EXPRESSION; SIP1; CARCINOMA; MOTILITY; SNAIL; GENE	Background: The aim of the present study was to analyze the expression of Zinc finger E-box Binding homeobox 2 (ZEB2) in glioma and to explore the molecular mechanisms of ZEB2 that regulate cell proliferation, migration, invasion, and apoptosis. Methodology/Principal Findings: Expression of ZEB2 in 90 clinicopathologically characterized glioma patients was analyzed by immunohistochemistry. Furthermore, siRNA targeting ZEB2 was transfected into U251 and U87 glioma cell lines in vitro and proliferation, migration, invasion, and apoptosis were examined separately by MTT assay, Transwell chamber assay, flow cytometry, and western blot. Results: The expression level of ZEB2 protein was significantly increased in glioma tissues compared to normal brain tissues (P<0.001). In addition, high levels of ZEB2 protein were positively correlated with pathology grade classification (P=0.024) of glioma patients. Knockdown of ZEB2 by siRNA suppressed cell proliferation, migration and invasion, as well as induced cell apoptosis in glioma cells. Furthermore, ZEB2 downregulation was accompanied by decreased expression of CDK4/6, Cyclin D1, Cyclin E, E2F1, and c-myc, while p15 and p21 were upregulated. Lowered expression of ZEB2 enhanced E-cadherin levels but also inhibited beta-Catenin, Vimentin, N-cadherin, and Snail expression. Several apoptosis-related regulators such as Caspase-3, Caspase-6, Caspase-9, and Cleaved-PARP were activated while PARP was inhibited after ZEB2 siRNA treatment. Conclusion: Overexpression of ZEB2 is an unfavorable factor that may facilitate glioma progression. Knockdown ZEB2 expression by siRNA suppressed cell proliferation, migration, invasion and promoted cell apoptosis in glioma cells.	[Qi, Songtao; Song, Ye; Peng, Yuping; Long, Hao; Li, Zhiyong; Fang, Luxiong] So Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Song, Ye; Wang, Hao; Yu, Xiaoli; Wu, Aibing; Luo, Weiren; Zhen, Yan; Zhou, Ying; Chen, Yan; Mai, Chunping; Liu, Zhen; Fang, Weiyi] So Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Liu, Zhen] Guangzhou Med Univ, Basic Sch, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Guangzhou Medical University	Qi, ST (corresponding author), So Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China.	qisongtaosjwk@163.com; narcissus_jane@163.com; fangweiyi1975@yahoo.com.cn	Luo, Weiren/AAI-8364-2020; peng, yu/GXW-2071-2022	Luo, Weiren/0000-0002-2762-6332; 	National 973 project [2010CB529401]; Natural Science Fund of Guangdong Province [S2011010005643]; Medical Science Research Fund of Guangdong Province [B2011133]; Medical College of Guangzhou [2010C04]	National 973 project(National Basic Research Program of China); Natural Science Fund of Guangdong Province(National Natural Science Foundation of Guangdong Province); Medical Science Research Fund of Guangdong Province; Medical College of Guangzhou	This study was supported by National 973 project (no. 2010CB529401) (http://www.most.gov.cn), Natural Science Fund of Guangdong Province (no. S2011010005643)(http://www.gdstc.gov.cn), Medical Science Research Fund of Guangdong Province (no. B2011133)(http://www.gdwst.gov.cn), and Doctor Fund of Medical College of Guangzhou (2010C04)(http://www.gzhmc.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen H, 2005, MOL CELL BIOL, V25, P9138, DOI 10.1128/MCB.25.20.9138-9150.2005; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Browne G, 2010, CELL CYCLE, V9, P886, DOI 10.4161/cc.9.5.10839; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Davis JN, 2006, CANCER RES, V66, P11897, DOI 10.1158/0008-5472.CAN-06-2497; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Huang JW, 2010, ACTA BIOCH BIOPH SIN, V42, P274, DOI 10.1093/abbs/gmq016; Hunter JE, 2011, ONCOGENE; Imamichi Y, 2007, ONCOGENE, V26, P2381, DOI 10.1038/sj.onc.1210012; Jansen M, 2010, LANCET NEUROL, V9, P717, DOI 10.1016/S1474-4422(10)70105-8; Liu Z, 2011, INT J CANCER, V128, P2562, DOI 10.1002/ijc.25595; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; Mejlvang J, 2007, MOL BIOL CELL, V18, P4615, DOI 10.1091/mbc.E07-05-0406; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Panicker SP, 2010, ONCOTARGET, V1, P289; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Ponnala S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026191; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Reifenberger G, 2011, INT J CANC; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Saini S, 2011, CANCER RES, V71, P6208, DOI 10.1158/0008-5472.CAN-11-0073; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Sayan AE, 2009, P NATL ACAD SCI USA, V106, P14884, DOI 10.1073/pnas.0902042106; Shin S, 2010, CELL CYCLE, V9, P2483, DOI 10.4161/cc.9.13.12270; Smulson ME, 2000, ADV ENZYME REGUL, V40, P183, DOI 10.1016/S0065-2571(99)00024-2; Stanic G, 2011, COLLEGIUM ANTROPOL, V35, P39; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Stupp R, 2006, ONCOLOGIST, V11, P165, DOI 10.1634/theoncologist.11-2-165; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Wu AB, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-38; Xia M, 2010, J NEURO-ONCOL, V97, P225, DOI 10.1007/s11060-009-0015-1; Yang G, 2011, J MOL MED, V89, P1037, DOI 10.1007/s00109-011-0775-x; Zanotto A, 2011, BIOCHEM PHARMACOL, V81, P412, DOI 10.1016/j.bcp.2010.10.014; Zhou You-xin, 2002, Ai Zheng, V21, P1106; Zhuang WZ, 2009, ACTA BIOCH BIOPH SIN, V41, P341, DOI 10.1093/abbs/gmp028	39	144	152	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e38842	10.1371/journal.pone.0038842	http://dx.doi.org/10.1371/journal.pone.0038842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761708	Green Published, gold			2022-12-27	WOS:000305808700013
J	Ferrer, M; Ghazi, A; Beloqui, A; Vieites, JM; Lopez-Cortes, N; Marin-Navarro, J; Nechitaylo, TY; Guazzaroni, ME; Polaina, J; Waliczek, A; Chernikova, TN; Reva, ON; Golyshina, OV; Golyshin, PN				Ferrer, Manuel; Ghazi, Azam; Beloqui, Ana; Maria Vieites, Jose; Lopez-Cortes, Nieves; Marin-Navarro, Julia; Nechitaylo, Taras Y.; Guazzaroni, Maria-Eugenia; Polaina, Julio; Waliczek, Agnes; Chernikova, Tatyana N.; Reva, Oleg N.; Golyshina, Olga V.; Golyshin, Peter N.			Functional Metagenomics Unveils a Multifunctional Glycosyl Hydrolase from the Family 43 Catalysing the Breakdown of Plant Polymers in the Calf Rumen	PLOS ONE			English	Article							BOVINE RUMEN; GEOBACILLUS-STEAROTHERMOPHILUS; STRUCTURAL-ANALYSIS; IDENTIFICATION; MICROBIOTA; CELLULASE; DATABASE; REVEALS; LIBRARY; GENES	Microbial communities from cow rumen are known for their ability to degrade diverse plant polymers at high rates. In this work, we identified 15 hydrolases through an activity-centred metagenome analysis of a fibre-adherent microbial community from dairy cow rumen. Among them, 7 glycosyl hydrolases (GHs) and 1 feruloyl esterase were successfully cloned, expressed, purified and characterised. The most striking result was a protein of GH family 43 (GHF43), hereinafter designated as R_09-02, which had characteristics very distinct from the other proteins in this family with mono-functional beta-xylosidase, alpha-xylanase, alpha-L-arabinase and alpha-L-arabinofuranosidase activities. R_09-02 is the first multifunctional enzyme to exhibit beta-1,4 xylosidase, alpha-1,5 arabinofur(pyr)anosidase, beta-1,4 lactase, alpha-1,6 raffinase, alpha-1,6 stachyase, alpha-galactosidase and alpha-1,4 glucosidase activities. The R_09-02 protein appears to originate from the chromosome of a member of Clostridia, a class of phylum Firmicutes, members of which are highly abundant in ruminal environment. The evolution of R_09-02 is suggested to be driven from the xylose-and arabinose-specific activities, typical for GHF43 members, toward a broader specificity to the glucose-and galactose-containing components of lignocellulose. The apparent capability of enzymes from the GHF43 family to utilise xylose-, arabinose-, glucose-and galactose-containing oligosaccharides has thus far been neglected by, or could not be predicted from, genome and metagenome sequencing data analyses. Taking into account the abundance of GHF43-encoding gene sequences in the rumen (up to 7% of all GH-genes) and the multifunctional phenotype herein described, our findings suggest that the ecological role of this GH family in the digestion of ligno-cellulosic matter should be significantly reconsidered.	[Ferrer, Manuel; Ghazi, Azam; Beloqui, Ana; Maria Vieites, Jose; Lopez-Cortes, Nieves; Guazzaroni, Maria-Eugenia] CSIC, Inst Catalysis, Madrid, Spain; [Marin-Navarro, Julia; Polaina, Julio] CSIC, Inst Agroquim & Tecnol Alimentos, E-46010 Valencia, Spain; [Nechitaylo, Taras Y.; Waliczek, Agnes] HZI Helmholtz Ctr Infect Res, Braunschweig, Germany; [Nechitaylo, Taras Y.] Max Planck Inst Chem Ecol, Insect Symbiosis Res Grp, Jena, Germany; [Chernikova, Tatyana N.; Golyshina, Olga V.; Golyshin, Peter N.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Reva, Oleg N.] Univ Pretoria, Dept Biochem, ZA-0002 Pretoria, South Africa; [Golyshin, Peter N.] Aberystwyth Univ Bangor Univ Partnership CIRRE, Ctr Integrated Res Rural Environm, Aberystwyth, Ceredigion, Wales	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Helmholtz Association; Helmholtz-Center for Infection Research; Max Planck Society; Bangor University; University of Pretoria; Aberystwyth University	Ferrer, M (corresponding author), CSIC, Inst Catalysis, Madrid, Spain.	mferrer@icp.csic.es; p.golyshin@bangor.ac.uk	Beloqui, Ana/C-4512-2012; Guazzaroni, María-Eugenia/Y-9268-2019; Reva, Oleg N/A-7316-2009; Guazzaroni, María Eugenia MEG/E-2599-2013; Polaina, Julio/H-4498-2012; , Marín-Navarro/F-7630-2016; Ferrer, Manuel/K-4535-2014	Beloqui, Ana/0000-0002-7693-4163; Guazzaroni, María-Eugenia/0000-0002-4657-3731; Reva, Oleg N/0000-0002-5459-2772; Guazzaroni, María Eugenia MEG/0000-0002-4657-3731; , Marín-Navarro/0000-0001-7893-3423; Chernikova, Tatyana/0000-0001-6684-9099; Golyshina, Olga/0000-0001-5132-6850; Ferrer, Manuel/0000-0003-4962-4714; Polaina, Julio/0000-0001-9912-0640; Golyshin, Peter/0000-0002-5433-0350	Spanish CDTI [CENIT 2007-1031]; Ministry of Economy and Competitiveness; Spanish MEC; CSIC; Federal Ministry for Science and Education (BMBF) within the GenoMikPlus initiative [0313751K]	Spanish CDTI(Spanish Government); Ministry of Economy and Competitiveness; Spanish MEC(Spanish Government); CSIC; Federal Ministry for Science and Education (BMBF) within the GenoMikPlus initiative(Federal Ministry of Education & Research (BMBF))	The authors gratefully acknowledge the financial support provided by the Spanish CDTI (research projects CENIT 2007-1031 and Cenit BioSos, I+DEA). This work has been funded by the Ministry of Economy and Competitiveness "Fondo de inversion local para el empleo-Gobierno de Espana". AB thanks the Spanish MEC for a FPU fellowship. M-EG thanks the CSIC for a JAE-Doc fellowship. TYN, PNG, and OVG acknowledge the support of grant 0313751K from the Federal Ministry for Science and Education (BMBF) within the GenoMikPlus initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhassid A, 2009, BIOCHEM J, V422, P73, DOI 10.1042/BJ20090180; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; Beloqui A, 2006, J BIOL CHEM, V281, P22933, DOI 10.1074/jbc.M600577200; Beloqui A, 2010, APPL ENVIRON MICROB, V76, P5934, DOI 10.1128/AEM.00902-10; Bringhurst RM, 2001, P NATL ACAD SCI USA, V98, P4540, DOI 10.1073/pnas.071375898; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Brunzelle JS, 2008, ARCH BIOCHEM BIOPHYS, V474, P157, DOI 10.1016/j.abb.2008.03.007; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; de Sanctis D, 2010, FEBS J, V277, P4562, DOI 10.1111/j.1742-4658.2010.07870.x; Feng Y, 2007, APPL MICROBIOL BIOT, V75, P319, DOI 10.1007/s00253-006-0820-9; Ferrer M, 2005, ENVIRON MICROBIOL, V7, P1996, DOI 10.1111/j.1462-2920.2005.00920.x; Gloux K, 2011, P NATL ACAD SCI USA, V108, P4539, DOI 10.1073/pnas.1000066107; Graham JE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1373; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hespell Robert B., 1997, P59; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hongoh Y, 2011, CELL MOL LIFE SCI, V68, P1311, DOI 10.1007/s00018-011-0648-z; Jamal-Talabani S, 2004, STRUCTURE, V12, P1177, DOI 10.1016/j.str.2004.04.022; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Kanokratana P, 2011, MICROB ECOL, V61, P518, DOI 10.1007/s00248-010-9766-7; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Li LL, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-10; Li RW, 2012, ENVIRON MICROBIOL, V14, P129, DOI 10.1111/j.1462-2920.2011.02543.x; Vieites JM, 2010, MICROB BIOTECHNOL, V3, P48, DOI 10.1111/j.1751-7915.2009.00135.x; Ohtoko K, 2000, EXTREMOPHILES, V4, P343, DOI 10.1007/s007920070003; Pang H, 2009, CURR MICROBIOL, V58, P404, DOI 10.1007/s00284-008-9346-y; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Vandermarliere E, 2009, BIOCHEM J, V418, P39, DOI 10.1042/BJ20081256; Walter J, 2005, APPL ENVIRON MICROB, V71, P2347, DOI 10.1128/AEM.71.5.2347-2354.2005; Walton J, 2011, JOVE-J VIS EXP, DOI 10.3791/3314; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Xiong JS, 2007, J EXP BOT, V58, P2799, DOI 10.1093/jxb/erm133; ZHANG BG, 1993, EUR J SOIL BIOL, V29, P7; Zhou FF, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-69; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108; Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275	43	52	56	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e38134	10.1371/journal.pone.0038134	http://dx.doi.org/10.1371/journal.pone.0038134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761666	gold, Green Published, Green Submitted			2022-12-27	WOS:000305781700004
J	Fitzpatrick, BM; Harvey, ES; Heyward, AJ; Twiggs, EJ; Colquhoun, J				Fitzpatrick, Ben M.; Harvey, Euan S.; Heyward, Andrew J.; Twiggs, Emily J.; Colquhoun, Jamie			Habitat Specialization in Tropical Continental Shelf Demersal Fish Assemblages	PLOS ONE			English	Article							CORAL-REEF FISH; UNDERWATER VIDEO STATIONS; SYSTEM; COMMUNITIES; DENSITY; AREAS; BIODIVERSITY; EVOLUTION; ACCURACY; ECOLOGY	The implications of shallow water impacts such as fishing and climate change on fish assemblages are generally considered in isolation from the distribution and abundance of these fish assemblages in adjacent deeper waters. We investigate the abundance and length of demersal fish assemblages across a section of tropical continental shelf at Ningaloo Reef, Western Australia, to identify fish and fish habitat relationships across steep gradients in depth and in different benthic habitat types. The assemblage composition of demersal fish were assessed from baited remote underwater stereo-video samples (n = 304) collected from 16 depth and habitat combinations. Samples were collected across a depth range poorly represented in the literature from the fringing reef lagoon (1-10 m depth), down the fore reef slope to the reef base (10-30 m depth) then across the adjacent continental shelf (30-110 m depth). Multivariate analyses showed that there were distinctive fish assemblages and different sized fish were associated with each habitat/depth category. Species richness, MaxN and diversity declined with depth, while average length and trophic level increased. The assemblage structure, diversity, size and trophic structure of demersal fishes changes from shallow inshore habitats to deeper water habitats. More habitat specialists (unique species per habitat/depth category) were associated with the reef slope and reef base than other habitats, but offshore sponge-dominated habitats and inshore coral-dominated reef also supported unique species. This suggests that marine protected areas in shallow coral-dominated reef habitats may not adequately protect those species whose depth distribution extends beyond shallow habitats, or other significant elements of demersal fish biodiversity. The ontogenetic habitat partitioning which is characteristic of many species, suggests that to maintain entire species life histories it is necessary to protect corridors of connected habitats through which fish can migrate.	[Fitzpatrick, Ben M.; Harvey, Euan S.] Univ Western Australia, Fac Nat & Agr Sci, Oceans Inst, Perth, WA 6009, Australia; [Fitzpatrick, Ben M.; Harvey, Euan S.] Univ Western Australia, Fac Nat & Agr Sci, Sch Plant Biol, Perth, WA 6009, Australia; [Fitzpatrick, Ben M.; Twiggs, Emily J.] Oceanwise Environm Scientists, Perth, WA, Australia; [Heyward, Andrew J.; Colquhoun, Jamie] Australian Inst Marine Sci, Oceans Inst, Perth, WA, Australia; [Twiggs, Emily J.] Curtin Univ Technol, Dept Appl Geol, Perth, WA, Australia	University of Western Australia; University of Western Australia; Australian Institute of Marine Science; Curtin University	Fitzpatrick, BM (corresponding author), Univ Western Australia, Fac Nat & Agr Sci, Oceans Inst, Perth, WA 6009, Australia.	ben.fitzpatrick@oceanwise.com.au	Harvey, Euan/B-2896-2011	Harvey, Euan/0000-0002-9069-4581; Fitzpatrick, Benjamin/0000-0003-2700-8195	Western Australian Marine Science Institute; University of Western Australia; Curtin University of Technology	Western Australian Marine Science Institute; University of Western Australia; Curtin University of Technology	The Australian Institute of Marine Science contributed vessels and sampling equipment. The Western Australian Marine Science Institute provided funding to all of the researchers from the Ningaloo Research Program fund. Ben Fitzpatrick was supported by a University of Western Australia post graduate award PhD scholarship, and Emily Twiggs was supported by a Curtin University of Technology scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo D., 2004, SURVEYS BENTHIC REEF; Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Allen GR, 2004, MARINE FISHES TROPIC; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2004, J EXP MAR BIOL ECOL, V305, P191, DOI 10.1016/j.jembe.2003.12.011; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Brokovich E, 2008, MAR ECOL PROG SER, V371, P253, DOI 10.3354/meps07591; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M, 1996, EVALUATION SAMPLING; Cappo M, 2003, AQUATIC PROTECTED AR, P455; Cappo M., 2001, VIDEO SENSING SIZE A, P63; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; CARLETON JH, 1995, CORAL REEFS, V14, P35, DOI 10.1007/BF00304070; Cassata L, 2008, J COASTAL RES, V24, P139, DOI 10.2112/05-0623.1; Cheal AJ, 2007, ECOLOGY, V88, P158, DOI 10.1890/0012-9658(2007)88[158:SSICRF]2.0.CO;2; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Collins LB, 2008, GROWTH HIST GEOMORPH; Colquhoun J., 2007, NINGALOO REEF MARINE; CONNELL JH, 1983, AM NAT, V122, P661, DOI 10.1086/284165; EGGLESTON DB, 1995, MAR ECOL PROG SER, V124, P9, DOI 10.3354/meps124009; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Haedrich RL, 1996, J FISH BIOL, V49, P40, DOI 10.1111/j.1095-8649.1996.tb06066.x; Harvey E, 2004, MAR FRESHWATER RES, V55, P573, DOI 10.1071/MF03130; Harvey E, 2002, MAR TECHNOL SOC J, V36, P38, DOI 10.4031/002533202787914106; Harvey E, 2001, FISH B-NOAA, V99, P72; Harvey E, 1995, MAR TECHNOL SOC J, V29, P10; Harvey ES, 1998, MAR TECHNOL SOC J, V32, P3; Harvey ES, 2003, MARINE TECHNOLOGY SO, V36, P38; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kahng SE, 2007, CORAL REEFS, V26, P679, DOI 10.1007/s00338-007-0253-7; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Langlois TJ, 2010, AQUAT BIOL, V9, P155, DOI 10.3354/ab00235; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Love MS, 2008, ENVIRON BIOL FISH, V82, P195, DOI 10.1007/s10641-007-9290-x; Magurran A.E., 2004, MEASURING BIOL DIVER; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Moore CH, 2010, MAR BIOL, V157, P2717, DOI 10.1007/s00227-010-1531-4; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; MPRA, 2005, NING MAR PARK MAN PL; Munday P. L., 2007, CLIMATE CHANGE GREAT, P357; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Rogers SI, 1999, J ANIM ECOL, V68, P769, DOI 10.1046/j.1365-2656.1999.00327.x; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; Shortis M.R., 1998, INT ARCH PHOTOGRAMM, V32, P792, DOI DOI 10.1017/CB09781107415324.004; Vazquez DP, 2002, AM NAT, V159, P606, DOI 10.1086/339991; Watson DL, 2007, MAR BIOL, V152, P1197, DOI 10.1007/s00227-007-0767-0; Watson DL, 2010, MAR BIOL, V157, P1237, DOI 10.1007/s00227-010-1404-x; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Westera M, 2003, J EXP MAR BIOL ECOL, V294, P145, DOI 10.1016/S0022-0981(03)00268-5; Williams A, 2001, MAR ECOL PROG SER, V212, P247, DOI 10.3354/meps212247; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Wilson SK, 2008, J ANIM ECOL, V77, P220, DOI 10.1111/j.1365-2656.2007.01341.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Young MA, 2010, MAR ECOL PROG SER, V415, P247, DOI 10.3354/meps08760	62	72	72	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39634	10.1371/journal.pone.0039634	http://dx.doi.org/10.1371/journal.pone.0039634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761852	gold, Green Published, Green Submitted			2022-12-27	WOS:000305781700054
J	Miranda, L; de Souza, AJF; Ferreira, FF; Campos, PRA				Miranda, Luciano; de Souza, Adauto J. F.; Ferreira, Fernando F.; Campos, Paulo R. A.			Complex Transition to Cooperative Behavior in a Structured Population Model	PLOS ONE			English	Article							PRISONERS-DILEMMA GAME; EVOLUTIONARY GAMES; MECHANISM	Cooperation plays an important role in the evolution of species and human societies. The understanding of the emergence and persistence of cooperation in those systems is a fascinating and fundamental question. Many mechanisms were extensively studied and proposed as supporting cooperation. The current work addresses the role of migration for the maintenance of cooperation in structured populations. This problem is investigated in an evolutionary perspective through the prisoner's dilemma game paradigm. It is found that migration and structure play an essential role in the evolution of the cooperative behavior. The possible outcomes of the model are extinction of the entire population, dominance of the cooperative strategy and coexistence between cooperators and defectors. The coexistence phase is obtained in the range of large migration rates. It is also verified the existence of a critical level of structuring beyond that cooperation is always likely. In resume, we conclude that the increase in the number of demes as well as in the migration rate favor the fixation of the cooperative behavior.	[Miranda, Luciano; de Souza, Adauto J. F.] Univ Fed Rural Pernambuco, Dept Fis, Recife, PE, Brazil; [Ferreira, Fernando F.] Univ Sao Paulo, GRIFE Escola Artes Ciencias & Humanidades, Sao Paulo, Brazil; [Campos, Paulo R. A.] Univ Fed Pernambuco, Dept Fis, BR-50739 Recife, PE, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade de Sao Paulo; Universidade Federal de Pernambuco	Miranda, L (corresponding author), Univ Fed Rural Pernambuco, Dept Fis, Recife, PE, Brazil.	prac@df.ufpe.br	Campos, Paulo/AAC-7734-2019; Campos, Paulo/G-2459-2012	Campos, Paulo/0000-0002-7823-1998; Campos, Paulo/0000-0002-7823-1998; Miranda Filho, Luciano/0000-0001-6278-3053	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	This work is supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Campos PRA, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/12/L12003; Chaves VL, 2010, PHYSICA A, V389, P5725, DOI 10.1016/j.physa.2010.08.055; Cheng HY, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/123014; Duran O, 2005, PHYSICA D, V208, P257, DOI 10.1016/j.physd.2005.07.005; Economo EP, 2011, AM NAT, V177, pE167, DOI 10.1086/659946; ERDOS P, 1960, B INT STATIST INST, V38, P343; HARLEY CB, 1981, J THEOR BIOL, V89, P611, DOI 10.1016/0022-5193(81)90032-1; Helbing D, 2009, EUR PHYS J B, V67, P345, DOI 10.1140/epjb/e2009-00025-7; Helbing D, 2008, ADV COMPLEX SYST, V11, P641, DOI 10.1142/S0219525908001866; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Hobbes T., 2010, LEVIATHAN; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Jiang LL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036108; KIMURA M, 1964, GENETICS, V49, P561; Laslier JF, 2001, GAME ECON BEHAV, V37, P340, DOI 10.1006/game.2000.0841; Lin H, 2011, CHAOS SOLITON FRACT, V44, P153, DOI 10.1016/j.chaos.2011.01.004; Lin YT, 2011, PHYSICA A, V390, P77, DOI 10.1016/j.physa.2010.07.034; Maynard Smith J., 1982, pi; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Patwa Z, 2008, J R SOC INTERFACE, V5, P1279, DOI 10.1098/rsif.2008.0248; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Santos FC, 2006, P ROY SOC B-BIOL SCI, V273, P51, DOI 10.1098/rspb.2005.3272; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Szabo G, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036107; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Szolnoki A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093033; Szolnoki A, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30007; Tainaka K, 2002, ECOL MODEL, V150, P295, DOI 10.1016/S0304-3800(01)00481-1; Tomochi M, 2004, SOC NETWORKS, V26, P309, DOI 10.1016/j.socnet.2004.08.003; TRACY ND, 1992, J MATH PSYCHOL, V36, P278, DOI 10.1016/0022-2496(92)90040-E; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; Vainstein MH, 2007, J THEOR BIOL, V244, P722, DOI 10.1016/j.jtbi.2006.09.012; Wright S, 1931, GENETICS, V16, P0097; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Wu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027669; Yang DP, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/7/073048; Yang HX, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.065101; Zhang JL, 2010, PHYSICA A, V389, P4081, DOI 10.1016/j.physa.2010.06.005	49	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39188	10.1371/journal.pone.0039188	http://dx.doi.org/10.1371/journal.pone.0039188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761736	Green Published, Green Submitted, gold			2022-12-27	WOS:000305781700021
J	Zhong, JT; Kong, XX; Zhang, HY; Yu, CY; Xu, Y; Kang, JS; Yu, HM; Yi, HW; Yang, XC; Sun, LK				Zhong, Jiateng; Kong, Xiaoxia; Zhang, Hongyu; Yu, Chunyan; Xu, Ye; Kang, Jinsong; Yu, Huimei; Yi, Haowei; Yang, Xiaochun; Sun, Liankun			Inhibition of CLIC4 Enhances Autophagy and Triggers Mitochondrial and ER Stress-Induced Apoptosis in Human Glioma U251 Cells under Starvation	PLOS ONE			English	Article							CHLORIDE CHANNEL PROTEIN; PROTEOMIC ANALYSIS; CANCER CELLS; DEATH; MECHANISM; FAMILY; GROWTH; GENE; MORPHOGENESIS; MTCLIC/CLIC4	CLIC4/mtCLIC, a chloride intracellular channel protein, localizes to mitochondria, endoplasmic reticulum (ER), nucleus and cytoplasm, and participates in the apoptotic response to stress. Apoptosis and autophagy, the main types of the programmed cell death, seem interconnected under certain stress conditions. However, the role of CLIC4 in autophagy regulation has yet to be determined. In this study, we demonstrate upregulation and nuclear translocation of the CLIC4 protein following starvation in U251 cells. CLIC4 siRNA transfection enhanced autophagy with increased LC3-II protein and puncta accumulation in U251 cells under starvation conditions. In that condition, the interaction of the 14-3-3 epsilon isoform with CLIC4 was abolished and resulted in Beclin 1 overactivation, which further activated autophagy. Moreover, inhibiting the expression of CLIC4 triggered both mitochondrial apoptosis involved in Bax/Bcl-2 and cytochrome c release under starvation and endoplasmic reticulum stress-induced apoptosis with CHOP and caspase-4 upregulation. These results demonstrate that CLIC4 nuclear translocation is an integral part of the cellular response to starvation. Inhibiting the expression of CLIC4 enhances autophagy and contributes to mitochondrial and ER stress-induced apoptosis under starvation.	[Zhong, Jiateng; Kang, Jinsong; Yi, Haowei; Yang, Xiaochun; Sun, Liankun] Jilin Univ, Norman Bethune Coll Med, Dept Pathophysiol, Changchun 130023, Jilin, Peoples R China; [Kong, Xiaoxia] Wenzhou Med Coll, Basic Med Sch, Teaching Ctr Funct Expt, Inst Hypoxia Med Res, Wenzhou, Peoples R China; [Zhang, Hongyu] Wenzhou Med Coll, Sch Pharm, Wenzhou, Peoples R China; [Yu, Chunyan] Beihua Univ, Basic Med Coll, Dept Pathol, Jilin, Peoples R China; [Xu, Ye] Jilin Med Coll, Med Res Lab, Jilin, Peoples R China; [Yu, Huimei] Jilin Univ, Norman Bethune Coll Med, Dept Pathogenobiol, Changchun 130023, Jilin, Peoples R China	Jilin University; Wenzhou Medical University; Wenzhou Medical University; Beihua University; Jilin Medical University; Jilin University	Zhong, JT (corresponding author), Jilin Univ, Norman Bethune Coll Med, Dept Pathophysiol, Changchun 130023, Jilin, Peoples R China.	sunlk@jlu.edu.cn	Xu, Ye/E-3639-2018	Xu, Ye/0000-0002-8714-8715; YANG, XIAOCHUN/0000-0002-7026-8809	National Natural Science Foundation of China [30801354, 30970791]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (No. 30801354 and No. 30970791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afra D, 2002, LANCET, V359, P1011; Ando Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023385; Berryman MA, 2003, CELL MOTIL CYTOSKEL, V56, P159, DOI 10.1002/cm.10141; Bhutia SK, 2010, CANCER RES, V70, P3667, DOI 10.1158/0008-5472.CAN-09-3647; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Bohman S, 2005, J BIOL CHEM, V280, P42397, DOI 10.1074/jbc.M506724200; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Carninci P, 2002, BIOTECHNIQUES, V33, P306, DOI 10.2144/02332st01; Chen L, 2004, EXP EYE RES, V79, P239, DOI 10.1016/j.exer.2004.05.002; Chiu HW, 2009, AUTOPHAGY, V5, P472, DOI 10.4161/auto.5.4.7759; Chuang JZ, 2010, MOL BIOL CELL, V21, P3017, DOI 10.1091/mbc.E09-10-0907; Conradt B, 2009, ANNU REV GENET, V43, P493, DOI 10.1146/annurev.genet.42.110807.091533; Elliott A, 2008, TOXICOL APPL PHARM, V232, P169, DOI 10.1016/j.taap.2008.06.017; Fernandez-Salas E, 2002, MOL CELL BIOL, V22, P3610, DOI 10.1128/MCB.22.11.3610-3620.2002; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Gonzalez-Polo RA, 2007, AUTOPHAGY, V3, P366, DOI 10.4161/auto.4194; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Heymann D, 2006, CURR OPIN INVEST DR, V7, P443; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lee CY, 2001, DEVELOPMENT, V128, P1443; Lee M, 2008, CELL BIOCHEM FUNCT, V26, P125, DOI 10.1002/cbf.1428; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Malik M, 2010, J BIOL CHEM, V285, P23818, DOI 10.1074/jbc.M109.091611; Martin DN, 2004, DEVELOPMENT, V131, P275, DOI 10.1242/dev.00933; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Mujumdar N, 2010, AUTOPHAGY, V6, P997, DOI 10.4161/auto.6.7.13334; Nishino TG, 2008, BIOCHEM BIOPH RES CO, V377, P852, DOI 10.1016/j.bbrc.2008.10.079; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Ponsioen B, 2009, MOL BIOL CELL, V20, P4664, DOI 10.1091/mbc.E09-06-0529; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; Ronnov-Jessen L, 2002, AM J PATHOL, V161, P471, DOI 10.1016/S0002-9440(10)64203-4; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Shiio Y, 2006, J BIOL CHEM, V281, P2750, DOI 10.1074/jbc.M509349200; Suginta W, 2001, BIOCHEM J, V359, P55, DOI 10.1042/0264-6021:3590055; Suh KS, 2005, J INVEST DERM SYMP P, V10, P105, DOI 10.1111/j.1087-0024.2005.200402.x; Suh KS, 2005, CANCER RES, V65, P562; Suh KS, 2004, J BIOL CHEM, V279, P4632, DOI 10.1074/jbc.M311632200; Suh KS, 2007, CLIN CANCER RES, V13, P121, DOI 10.1158/1078-0432.CCR-06-1562; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Ulmasov B, 2009, AM J PATHOL, V174, P1084, DOI 10.2353/ajpath.2009.080625; Wang B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010409; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Werstruck GH, 2006, DIABETES, V55, P93, DOI 10.2337/diabetes.55.01.06.db05-0633; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Younce CW, 2010, BIOCHEM J, V426, P43, DOI 10.1042/BJ20090976; Yu H, 2011, EUR J CANCER, V47, P1585, DOI 10.1016/j.ejca.2011.01.019; Zhang HY, 2009, TOXICOL SCI, V110, P376, DOI 10.1093/toxsci/kfp101	53	31	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39378	10.1371/journal.pone.0039378	http://dx.doi.org/10.1371/journal.pone.0039378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761775	gold, Green Published, Green Submitted			2022-12-27	WOS:000305781700031
J	Arbour, VM; Currie, PJ				Arbour, Victoria M.; Currie, Philip J.			Analyzing Taphonomic Deformation of Ankylosaur Skulls Using Retrodeformation and Finite Element Analysis	PLOS ONE			English	Article							ORNITHISCHIA; PHYLOGENY	Taphonomic deformation can make the interpretation of vertebrate fossil morphology difficult. The effects of taphonomic deformation are investigated in two ankylosaurid dinosaur taxa, Euoplocephalus tutus (to investigate effects on our understanding of intraspecific variation) and Minotaurasaurus ramachandrani (to investigate the validity of this genus). The ratio of orbit maximum rostrocaudal length to perpendicular height is used as a strain ellipse, which can be used to determine if ankylosaur skull fossils have been dorsoventrally compacted during fossilization and diagenesis. The software program Geomagic is used to retrodeform three-dimensional (3D) digital models of the ankylosaur skulls. The effects of sediment compaction are modeled using finite element analysis, and the resulting strain distributions are compared with the retrodeformed models as a test of the retrodeformation method. Taphonomic deformation can account for a large amount of intraspecific variation in Euoplocephalus, but finite element analysis and retrodeformation of Minotaurasaurus shows that many of its diagnostic features are unlikely to result from deformation.	[Arbour, Victoria M.; Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Arbour, VM (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	arbour@ualberta.ca	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161	Canada Research Chair; National Sciences and Engineering Research Council Discovery Grant; National Sciences and Engineering Research Council Canada Graduate Scholarship - Doctoral; Alberta Ingenuity Scholarship; Izaak Walton Killam Memorial Scholarship; National Sciences and Engineering Research Council Michael Smith Foreign Study Supplement; University of Alberta China Institute Travel Grant; Dinosaur Research Institute	Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); National Sciences and Engineering Research Council Discovery Grant; National Sciences and Engineering Research Council Canada Graduate Scholarship - Doctoral; Alberta Ingenuity Scholarship; Izaak Walton Killam Memorial Scholarship; National Sciences and Engineering Research Council Michael Smith Foreign Study Supplement; University of Alberta China Institute Travel Grant; Dinosaur Research Institute	Funding to PJC is provided by a Canada Research Chair (http://www.chairs-chaires.gc.ca/), and a National Sciences and Engineering Research Council Discovery Grant (http://www.nserc-crsng.gc.ca/). Funding for this project for VMA was provided by a National Sciences and Engineering Research Council Canada Graduate Scholarship - Doctoral, an Alberta Ingenuity Scholarship (http://albertainnovates.ca/), an Izaak Walton Killam Memorial Scholarship (http://www.killamtrusts.ca/), a National Sciences and Engineering Research Council Michael Smith Foreign Study Supplement, a University of Alberta China Institute Travel Grant (http://www.china.ualberta.ca/), and the Dinosaur Research Institute (http://dinosaurresearch.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbour VM, 2009, J VERTEBR PALEONTOL, V29, P1117, DOI 10.1671/039.029.0405; Arbour VM, 2009, ANAT REC, V292, P1412, DOI 10.1002/ar.20987; Boyd AA, 2008, PALAEONTOL ELECTRON, V11; COOMBS W P JR, 1978, Palaeontology (Oxford), V21, P143; De Leon MSP, 2002, EVOL ANTHROPOL, V11, P68, DOI 10.1002/evan.10060; Degrange FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011856; Geomagic Inc, 2008, GEOM STUD; Gilmore C. W., 1933, American Museum Novitates, V679, P1; Godefroit Pascal, 2000, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V69, P17; Hughes NC, 1999, NUMERICAL PALAEOBIOL, P157; Lambe L.M., 1910, OTTAWA NATURALIST, V14, P149; Lu JC, 2007, ACTA GEOL SIN-ENGL, V81, P883; Maryaska T., 1977, PALAEONTOLOGIA POLON, V37, P85; Miles CA, 2009, CURR SCI INDIA, V96, P65; Motani R, 1997, LETHAIA, V30, P221; Nopcsa F., 1928, GEOLOGICA HUNGARIA S, V1, P3; Pang QQ, 1998, PROG NAT SCI, V8, P326; Parks W. A., 1924, University of Toronto Studies Geological Series, V18, P1; Penkalski P, 2001, LIFE O PAST, P261; Porro LB, 2011, J MORPHOL, V272, P910, DOI 10.1002/jmor.10957; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Rasband WS, 1997, IMAGEJ; Retallack GJ, 2007, ALCHERINGA, V31, P215, DOI 10.1080/03115510701484705; Srivastava DC, 2006, GEOLOGY, V34, P593, DOI 10.1130/G22374.1; Sternberg C. M., 1929, Bulletin Canada Dept Mines Ottawa, V54, P28; Strand7 Pty Ltd, 2008, STRAND7; Sullivan RM, 1999, J VERTEBR PALEONTOL, V19, P126, DOI 10.1080/02724634.1999.10011128; Thompson RS, 2012, J SYST PALAEONTOL, V10, P301, DOI 10.1080/14772019.2011.569091; Tseng ZJ, 2010, ZOOL J LINN SOC-LOND, V158, P683, DOI 10.1111/j.1096-3642.2009.00555.x; Twiss R, 1992, STRUCTURAL GEOLOGY; White T, 2003, SCIENCE, V299, P1994, DOI 10.1126/science.1078294; Witmer LM, 2008, ANAT REC, V291, P1362, DOI 10.1002/ar.20794; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	33	37	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39323	10.1371/journal.pone.0039323	http://dx.doi.org/10.1371/journal.pone.0039323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761763	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900044
J	Coso, S; Zeng, YP; Opeskin, K; Williams, ED				Coso, Sanja; Zeng, Yiping; Opeskin, Kenneth; Williams, Elizabeth D.			Vascular Endothelial Growth Factor Receptor-3 Directly Interacts with Phosphatidylinositol 3-Kinase to Regulate Lymphangiogenesis	PLOS ONE			English	Article							CELL LUNG-CANCER; LYMPH-NODE METASTASIS; PROMOTES TUMOR-METASTASIS; PHOSPHOLIPASE-C-GAMMA; VEGF-C; PROSTATE-CANCER; EXPRESSION; ACTIVATION; CARCINOMA; INVOLVEMENT	Background: Dysfunctional lymphatic vessel formation has been implicated in a number of pathological conditions including cancer metastasis, lymphedema, and impaired wound healing. The vascular endothelial growth factor (VEGF) family is a major regulator of lymphatic endothelial cell (LEC) function and lymphangiogenesis. Indeed, dissemination of malignant cells into the regional lymph nodes, a common occurrence in many cancers, is stimulated by VEGF family members. This effect is generally considered to be mediated via VEGFR-2 and VEGFR-3. However, the role of specific receptors and their downstream signaling pathways is not well understood. Methods and Results: Here we delineate the VEGF-C/VEGF receptor (VEGFR)-3 signaling pathway in LECs and show that VEGF-C induces activation of PI3K/Akt and MEK/Erk. Furthermore, activation of PI3K/Akt by VEGF-C/VEGFR-3 resulted in phosphorylation of P70S6K, eNOS, PLC gamma 1, and Erk1/2. Importantly, a direct interaction between PI3K and VEGFR-3 in LECs was demonstrated both in vitro and in clinical cancer specimens. This interaction was strongly associated with the presence of lymph node metastases in primary small cell carcinoma of the lung in clinical specimens. Blocking PI3K activity abolished VEGF-C-stimulated LEC tube formation and migration. Conclusions: Our findings demonstrate that specific VEGFR-3 signaling pathways are activated in LECs by VEGF-C. The importance of PI3K in VEGF-C/VEGFR-3-mediated lymphangiogenesis provides a potential therapeutic target for the inhibition of lymphatic metastasis.	[Coso, Sanja; Zeng, Yiping; Williams, Elizabeth D.] Monash Univ, Ctr Canc Res, Monash Inst Med Res, Melbourne, Vic 3004, Australia; [Opeskin, Kenneth] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Opeskin, Kenneth] St Vincents Hosp, Dept Anat Pathol, Fitzroy, Vic 3065, Australia	Monash University; University of Melbourne; St Vincent's Hospital Melbourne	Coso, S (corresponding author), Monash Univ, Ctr Canc Res, Monash Inst Med Res, Melbourne, Vic 3004, Australia.	Elizabeth.Williams@monash.edu	Williams, Elizabeth D/B-1538-2008	Williams, Elizabeth D/0000-0002-3364-6655	Cancer Council Victoria; Victorian Government's Operational Infrastructure Support Program; Australian NHMRC Career Development Award [519539]	Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Victorian Government's Operational Infrastructure Support Program; Australian NHMRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia)	This project was supported in part by funding from the Cancer Council Victoria (www.cancervic.org.au/) and the Victorian Government's Operational Infrastructure Support Program. EDW is supported by an Australian NHMRC Career Development Award (#519539; www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 2008, ANN NY ACAD SCI, P225; Arinaga M, 2003, CANCER-AM CANCER SOC, V97, P457, DOI 10.1002/cncr.11073; Dellinger MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028947; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Feng YK, 2010, ANAT REC, V293, P802, DOI 10.1002/ar.21096; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gombos Z, 2005, CLIN CANCER RES, V11, P8364, DOI 10.1158/1078-0432.CCR-05-1238; He YL, 2005, CANCER RES, V65, P4739, DOI 10.1158/0008-5472.CAN-04-4576; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Jia HY, 2004, J BIOL CHEM, V279, P36148, DOI 10.1074/jbc.M401538200; Joukov V, 1996, EMBO J, V15, P290; Kajita T, 2001, BRIT J CANCER, V85, P255, DOI 10.1054/bjoc.2001.1882; Kang J, 2009, ANAL BIOCHEM, V386, P251, DOI 10.1016/j.ab.2008.12.021; KawakamiKimura N, 1997, BRIT J CANCER, V75, P47, DOI 10.1038/bjc.1997.8; Kobayashi S, 2007, CANCER SCI, V98, P726, DOI 10.1111/j.1349-7006.2007.00439.x; Kukk E, 1996, DEVELOPMENT, V122, P3829; Lahdenranta J, 2009, CANCER RES, V69, P2801, DOI 10.1158/0008-5472.CAN-08-4051; Leu AJ, 2000, CANCER RES, V60, P4324; Loges S, 2007, CLIN CANCER RES, V13, P76, DOI 10.1158/1078-0432.CCR-06-1324; Luangdilok S, 2011, EUR J CANCER, V47, P520, DOI 10.1016/j.ejca.2010.10.009; Maffucci T, 2007, BIOCHEM SOC T, V35, P229, DOI 10.1042/BST0350229; Maffucci T, 2005, CANCER RES, V65, P8339, DOI 10.1158/0008-5472.CAN-05-0121; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Matsuo M, 2007, EUR J CANCER, V43, P1748, DOI 10.1016/j.ejca.2007.04.024; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Osaki T, 2004, LUNG CANCER, V43, P151, DOI 10.1016/j.lungcan.2003.08.020; Pegu A, 2008, J IMMUNOL, V180, P3399, DOI 10.4049/jimmunol.180.5.3399; Podgrabinska S, 2002, P NATL ACAD SCI USA, V99, P16069, DOI 10.1073/pnas.242401399; Pomel V, 2006, J MED CHEM, V49, P3857, DOI 10.1021/jm0601598; Renyi-Vamos F, 2005, CLIN CANCER RES, V11, P7344, DOI 10.1158/1078-0432.CCR-05-1077; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; Roberts N, 2006, CANCER RES, V66, P2650, DOI 10.1158/0008-5472.CAN-05-1843; Roma AA, 2006, MODERN PATHOL, V19, P392, DOI 10.1038/modpathol.3800546; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spinella F, 2009, CANCER RES, V69, P2669, DOI 10.1158/0008-5472.CAN-08-1879; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tanno S, 2004, LUNG CANCER, V46, P11, DOI 10.1016/j.lungcan.2004.03.006; Wilde JI, 2001, CELL SIGNAL, V13, P691, DOI 10.1016/S0898-6568(01)00191-7; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; Wissmann C, 2006, CLIN CANCER RES, V12, P6865, DOI 10.1158/1078-0432.CCR-06-1800; Witte MH, 2001, MICROSC RES TECHNIQ, V55, P122, DOI 10.1002/jemt.1163; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8; Zeng YP, 2006, CANCER RES, V66, P9566, DOI 10.1158/0008-5472.CAN-06-1488; Zeng YP, 2004, CLIN CANCER RES, V10, P5137, DOI 10.1158/1078-0432.CCR-03-0434; Zhu CF, 2011, J CANCER RES CLIN, V137, P1587, DOI 10.1007/s00432-011-1049-2	52	61	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39558	10.1371/journal.pone.0039558	http://dx.doi.org/10.1371/journal.pone.0039558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745786	Green Published, gold			2022-12-27	WOS:000305730900079
J	Kern, M; Kloting, N; Niessen, HG; Thomas, L; Stiller, D; Mark, M; Klein, T; Bluher, M				Kern, Matthias; Kloeting, Nora; Niessen, Heiko G.; Thomas, Leo; Stiller, Detlef; Mark, Michael; Klein, Thomas; Blueher, Matthias			Linagliptin Improves Insulin Sensitivity and Hepatic Steatosis in Diet-Induced Obesity	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; DIPEPTIDYL PEPTIDASE-4 INHIBITORS; DIPEPTIDYL-PEPTIDASE-4 INHIBITOR; GLUCOSE RESPONSIVENESS; CLINICAL-IMPLICATIONS; CELL APOPTOSIS; FATTY LIVER; HUMANS; RESISTANCE; RATS	Linagliptin (TRADJENTA (TM)) is a selective dipeptidyl peptidase-4 (DPP-4) inhibitor. DPP-4 inhibition attenuates insulin resistance and improves peripheral glucose utilization in humans. However, the effects of chronic DPP-4 inhibition on insulin sensitivity are not known. The effects of long-term treatment (3-4 weeks) with 3 mg/kg/day or 30 mg/kg/day linagliptin on insulin sensitivity and liver fat content were determined in diet-induced obese C57BL/6 mice. Chow-fed animals served as controls. DPP-4 activity was significantly inhibited (67-89%) by linagliptin (P<0.001). Following an oral glucose tolerance test, blood glucose concentrations (measured as area under the curve) were significantly suppressed after treatment with 3 mg/kg/day (-16.5% to -20.3%; P<0.01) or 30 mg/kg/day (-14.5% to -26.4%; P<0.05) linagliptin (both P<0.01). Liver fat content was significantly reduced by linagliptin in a dose-dependent manner (both doses P<0.001). Diet-induced obese mice treated for 4 weeks with 3 mg/kg/day or 30 mg/kg/day linagliptin had significantly improved glycated hemoglobin compared with vehicle (both P<0.001). Significant dose-dependent improvements in glucose disposal rates were observed during the steady state of the euglycemic-hyperinsulinemic clamp: 27.3 mg/kg/minute and 32.2 mg/kg/minute in the 3 mg/kg/day and 30 mg/kg/day linagliptin groups, respectively; compared with 20.9 mg/kg/minute with vehicle (P<0.001). Hepatic glucose production was significantly suppressed during the clamp: 4.7 mg/kg/minute and 2.1 mg/kg/minute in the 3 mg/kg/day and 30 mg/kg/day linagliptin groups, respectively; compared with 12.5 mg/kg/minute with vehicle (P<0.001). In addition, 30 mg/kg/day linagliptin treatment resulted in a significantly reduced number of macrophages infiltrating adipose tissue (P<0.05). Linagliptin treatment also decreased liver expression of PTP1B, SOCS3, SREBP1c, SCD-1 and FAS (P<0.05). Other tissues like muscle, heart and kidney were not significantly affected by the insulin sensitizing effect of linagliptin. Long-term linagliptin treatment reduced liver fat content in animals with diet-induced hepatic steatosis and insulin resistance, and may account for improved insulin sensitivity.	[Kern, Matthias; Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany; [Kloeting, Nora] Univ Leipzig, IFB Obes Dis, Jr Res Grp Anim Models, Leipzig, Germany; [Niessen, Heiko G.; Thomas, Leo; Stiller, Detlef; Mark, Michael; Klein, Thomas] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany	Leipzig University; Leipzig University; Boehringer Ingelheim	Kern, M (corresponding author), Univ Leipzig, Dept Med, Leipzig, Germany.	bluma@medizin.uni-leipzig.de						Ahren B, 2007, DIABETES CARE, V30, P1344, DOI 10.2337/dc07-0233; Azuma K, 2008, J CLIN ENDOCR METAB, V93, P459, DOI 10.1210/jc.2007-1369; Blech S, 2010, DRUG METAB DISPOS, V38, P667, DOI 10.1124/dmd.109.031476; Brubaker PL, 2004, ENDOCRINOLOGY, V145, P2653, DOI 10.1210/en.2004-0015; Bugianesi E, 2010, CURR PHARM DESIGN, V16, P1941, DOI 10.2174/138161210791208875; Bulotta A, 2002, J MOL ENDOCRINOL, V29, P347, DOI 10.1677/jme.0.0290347; Buteau J, 2004, DIABETOLOGIA, V47, P806, DOI 10.1007/s00125-004-1379-6; Deacon CF, 2010, EXPERT OPIN INV DRUG, V19, P133, DOI 10.1517/13543780903463862; Del Prato S, 2011, DIABETES OBES METAB, V13, P258, DOI 10.1111/j.1463-1326.2010.01350.x; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Farilla L, 2003, ENDOCRINOLOGY, V144, P5149, DOI 10.1210/en.2003-0323; Forst T, 2011, DIABETES OBES METAB, V13, P542, DOI 10.1111/j.1463-1326.2011.01386.x; Fuchs H, 2009, J PHARM PHARMACOL, V61, P55, DOI 10.1211/jpp/61.01.0008; Gomis R, 2011, DIABETES OBES METAB, V13, P653, DOI 10.1111/j.1463-1326.2011.01391.x; Gonzalez-Rodriguez A, 2012, AGING CELL, V11, P284, DOI 10.1111/j.1474-9726.2011.00786.x; Heise T, 2009, DIABETES OBES METAB, V11, P786, DOI 10.1111/j.1463-1326.2009.01046.x; Holst JJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE199, DOI 10.1152/ajpendo.00545.2003; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Maiztegui B, 2011, CLIN SCI, V120, P73, DOI 10.1042/CS20100372; Matthaei S, 2000, ENDOCR REV, V21, P585, DOI 10.1210/er.21.6.585; Mauer J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000938; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; Nauck MA, 2011, AM J MED, V124, pS19, DOI 10.1016/j.amjmed.2010.11.002; Pospisilik JA, 2002, DIABETES, V51, P943, DOI 10.2337/diabetes.51.4.943; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Sachithanandan N, 2010, HEPATOLOGY, V52, P1632, DOI 10.1002/hep.23861; Scheen AJ, 2010, DIABETES OBES METAB, V12, P648, DOI 10.1111/j.1463-1326.2010.01212.x; Scott LJ, 2011, DRUGS, V71, P611, DOI 10.2165/11207400-000000000-00000; Shirakawa J, 2011, DIABETES, V60, P1246, DOI 10.2337/db10-1338; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Taskinen MR, 2011, DIABETES OBES METAB, V13, P65, DOI 10.1111/j.1463-1326.2010.01326.x; Thomas L, 2008, J PHARMACOL EXP THER, V325, P175, DOI 10.1124/jpet.107.135723; Vilsboll T, 2004, DIABETOLOGIA, V47, P357, DOI 10.1007/s00125-004-1342-6; Yki-Jarvinen H, 2009, CURR OPIN LIPIDOL, V20, P477, DOI 10.1097/MOL.0b013e3283321d37	35	92	96	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38744	10.1371/journal.pone.0038744	http://dx.doi.org/10.1371/journal.pone.0038744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761701	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900019
J	McLaren, CE; McLachlan, S; Garner, CP; Vulpe, CD; Gordeuk, VR; Eckfeldt, JH; Adams, PC; Acton, RT; Murray, JA; Leiendecker-Foster, C; Snively, BM; Barcellos, LF; Cook, JD; McLaren, GD				McLaren, Christine E.; McLachlan, Stela; Garner, Chad P.; Vulpe, Chris D.; Gordeuk, Victor R.; Eckfeldt, John H.; Adams, Paul C.; Acton, Ronald T.; Murray, Joseph A.; Leiendecker-Foster, Catherine; Snively, Beverly M.; Barcellos, Lisa F.; Cook, James D.; McLaren, Gordon D.			Associations between Single Nucleotide Polymorphisms in Iron-Related Genes and Iron Status in Multiethnic Populations	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OVERLOAD SCREENING HEIRS; TRANSFERRIN RECEPTOR; TMPRSS6 GENE; HEMOCHROMATOSIS; DEFICIENCY; ANEMIA; MUTATIONS; ASSAY; SNP	The existence of multiple inherited disorders of iron metabolism suggests genetic contributions to iron deficiency. We previously performed a genome-wide association study of iron-related single nucleotide polymorphisms (SNPs) using DNA from white men aged > 25 y and women >50 y in the Hemochromatosis and Iron Overload Screening (HEIRS) Study with serum ferritin (SF) <= 12 mu g/L (cases) and controls (SF > 100 mu g/L in men, SF>50 mu g/L in women). We report a follow-up study of white, African-American, Hispanic, and Asian HEIRS participants, analyzed for association between SNPs and eight iron-related outcomes. Three chromosomal regions showed association across multiple populations, including SNPs in the TF and TMPRSS6 genes, and on chromosome 18q21. A novel SNP rs1421312 in TMPRSS6 was associated with serum iron in whites (p = 3.7x10(-6)) and replicated in African Americans (p = 0.0012). Twenty SNPs in the TF gene region were associated with total iron-binding capacity in whites (p < 4.4x10(-5)); six SNPs replicated in other ethnicities (p<0.01). SNP rs10904850 in the CUBN gene on 10p13 was associated with serum iron in African Americans (P = 1.0x10(-5)). These results confirm known associations with iron measures and give unique evidence of their role in different ethnicities, suggesting origins in a common founder.	[McLaren, Christine E.; Garner, Chad P.] Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92717 USA; [Gordeuk, Victor R.] Univ Illinois, Dept Med, Sickle Cell Ctr, Chicago, IL USA; [Eckfeldt, John H.; Leiendecker-Foster, Catherine] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Adams, Paul C.] London Hlth Sci Ctr, London, ON, Canada; [Acton, Ronald T.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Murray, Joseph A.] Mayo Clin, Coll Med, Div Gastroenterol Hepatol, Rochester, MN USA; [Snively, Beverly M.] Wake Forest Univ, Sch Med, Dept Biostat Sci, Div Publ Hlth Sci, Winston Salem, NC 27109 USA; [Barcellos, Lisa F.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Cook, James D.] Univ Kansas, Med Ctr, Dept Med, Kansas City, KS 66103 USA; [McLaren, Gordon D.] Dept Vet Affairs Long Beach Healthcare Syst, Long Beach, CA USA; [McLaren, Gordon D.] Univ Calif Irvine, Dept Med, Div Hematol Oncol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Minnesota System; University of Minnesota Twin Cities; London Health Sciences Centre; University of Alabama System; University of Alabama Birmingham; Mayo Clinic; Wake Forest University; University of California System; University of California Berkeley; University of Kansas; University of Kansas Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine	McLaren, CE (corresponding author), Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92717 USA.	cmclaren@uci.edu	Adams, Paul/G-2868-2011; Vulpe, Chris/AAF-9170-2020; Gordeuk, Victor/AAG-6577-2019	Vulpe, Chris/0000-0001-5134-8929; murray, joseph/0000-0003-1941-9090; Adams, Paul/0000-0002-9921-2956	National Heart, Lung, and Blood Institute [R01 HL083328]; United States National Institutes of Health [R01DK57892]; Department of Veterans Affairs; NHLBI; University of Minnesota [N01-HC-05185]; Howard University [N01-HC-05186]; University of Alabama at Birmingham [N01-HC-05188]; Kaiser Permanente Center for Health Research [N01-HC-05189]; University of California, Irvine [N01-HC-05190]; London Health Sciences Centre [N01-HC-05191]; Wake Forest University [N01-HC-05192]; University of Alabama at Birmingham General Clinical Research Center [M01-RR00032]; Southern Iron Disorders Center; Howard University GCRC [M01-RR10284]; Howard University Research Scientist Award from National Heart, Lung, and Blood Institute [UH1-HL03679-05]; Office of Research on Minority Health; grant UC Irvine from General Clinical Research Centers Program of the National Center for Research Resources National Institutes of Health [M01RR 00827-29]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC005189, N01HC005191, N01HC005190, N01HC005185, N01HC005186, N01HC005188, N01HC005192] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000032, M01RR010284, M01RR000827] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083328, UH1HL003679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057892] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Minnesota(University of Minnesota System); Howard University; University of Alabama at Birmingham; Kaiser Permanente Center for Health Research; University of California, Irvine(University of California System); London Health Sciences Centre; Wake Forest University; University of Alabama at Birmingham General Clinical Research Center; Southern Iron Disorders Center; Howard University GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Howard University Research Scientist Award from National Heart, Lung, and Blood Institute; Office of Research on Minority Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); grant UC Irvine from General Clinical Research Centers Program of the National Center for Research Resources National Institutes of Health; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support was provided by grant R01 HL083328 from the National Heart, Lung, and Blood Institute (C. E. M.), grant R01DK57892 from the United States National Institutes of Health (J.A.M.), and by a Merit Review award from the Department of Veterans Affairs (G. D. M.). The HEIRS Study was initiated and funded by NHLBI, in conjunction with NHGRI (National Human Genome Research Institute). Data collection for this study was supported by contracts N01-HC-05185 (University of Minnesota), N01-HC-05186 (Howard University), N01-HC-05188 (University of Alabama at Birmingham), N01-HC-05189 (Kaiser Permanente Center for Health Research), N01-HC-05190 (University of California, Irvine), N01-HC-05191 (London Health Sciences Centre), and N01-HC-05192 (Wake Forest University). the University of Alabama at Birmingham General Clinical Research Center (G. C. R. C.) grant M01-RR00032, Southern Iron Disorders Center (J.C.B.), Howard University GCRC grant M01-RR10284, Howard University Research Scientist Award UH1-HL03679-05 from the National Heart, Lung, and Blood Institute and the Office of Research on Minority Health (V. R. G.); and grant UC Irvine M01RR 00827-29 from the General Clinical Research Centers Program of the National Center for Research Resources National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Anderson GJ, 2009, CURR OPIN GASTROEN, V25, P129, DOI 10.1097/MOG.0b013e32831ef1f7; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Benyamin B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/j.ajhg.2008.11.011; Bleackley MR, 2009, TRANSFUS MED REV, V23, P103, DOI 10.1016/j.tmrv.2008.12.001; Boger CA, 2011, J AM SOC NEPHROL, V22, P555, DOI 10.1681/ASN.2010060598; Chambers JC, 2009, NAT GENET, V41, P1170, DOI 10.1038/ng.462; Constantine CC, 2009, BRIT J HAEMATOL, V147, P140, DOI 10.1111/j.1365-2141.2009.07843.x; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Donovan A, 2006, PHYSIOLOGY, V21, P115, DOI 10.1152/physiol.00052.2005; Edwards CQ, 2000, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, P8; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; FISHER KD, 1985, AM J CLIN NUTR, V42, P1318; FLOWERS CA, 1986, AM J HEMATOL, V23, P141, DOI 10.1002/ajh.2830230209; Guillem F, 2008, BLOOD, V112, P2089, DOI 10.1182/blood-2008-05-154740; Kozyraki R, 2001, P NATL ACAD SCI USA, V98, P12491, DOI 10.1073/pnas.211291398; LEBOEUF RC, 1995, J LAB CLIN MED, V126, P128; Lieu Pauline T., 2001, Molecular Aspects of Medicine, V22, P1, DOI 10.1016/S0098-2997(00)00006-6; McLaren CE, 2003, AM J MED SCI, V325, P53, DOI 10.1097/00000441-200302000-00001; McLaren CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017390; McLaren CE, 2010, AM J HEMATOL, V85, P101, DOI 10.1002/ajh.21585; Melis MA, 2008, HAEMATOL-HEMATOL J, V93, P1473, DOI 10.3324/haematol.13342; Morse AC, 1999, P SOC EXP BIOL MED, V220, P147, DOI 10.1046/j.1525-1373.1999.d01-22.x; Pfeiffer CM, 2007, CLIN CHIM ACTA, V382, P112, DOI 10.1016/j.cca.2007.04.008; Pichler I, 2011, HUM MOL GENET, V20, P1232, DOI 10.1093/hmg/ddq552; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Risch N., 2002, GENOME BIOL, V3, pcomm, DOI [10.1186/gb-2002-3-7-comment2007, 10.1186/GB-2002-3-7-COMMENT2007]; Shriver Mark D., 2005, Human Genomics, V2, P81; SKIKNE BS, 1990, BLOOD, V75, P1870; Tanaka T, 2010, BLOOD, V115, P94, DOI 10.1182/blood-2009-07-232496; World Health Organization, 2000, WHONHD007	32	41	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38339	10.1371/journal.pone.0038339	http://dx.doi.org/10.1371/journal.pone.0038339			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761678	Green Published, gold			2022-12-27	WOS:000305730900010
J	Zhang, LC; Li, X; Tai, JX; Li, W; Chen, LN				Zhang, Liangcai; Li, Xu; Tai, Jingxie; Li, Wan; Chen, Lina			Predicting Candidate Genes Based on Combined Network Topological Features: A Case Study in Coronary Artery Disease	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; LEPTIN-MEDIATED ACTIVATION; SUPPORT VECTOR MACHINES; PLASMINOGEN-ACTIVATOR; INTERFERON-GAMMA; HUMAN PLATELETS; EXPRESSION; PRIORITIZATION; POLYMORPHISMS; ASSOCIATION	Predicting candidate genes using gene expression profiles and unbiased protein-protein interactions (PPI) contributes a lot in deciphering the pathogenesis of complex diseases. Recent studies showed that there are significant disparities in network topological features between non-disease and disease genes in protein-protein interaction settings. Integrated methods could consider their characteristics comprehensively in a biological network. In this study, we introduce a novel computational method, based on combined network topological features, to construct a combined classifier and then use it to predict candidate genes for coronary artery diseases (CAD). As a result, 276 novel candidate genes were predicted and were found to share similar functions to known disease genes. The majority of the candidate genes were cross-validated by other three methods. Our method will be useful in the search for candidate genes of other diseases.	[Zhang, Liangcai; Li, Xu; Tai, Jingxie; Li, Wan; Chen, Lina] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University	Zhang, LC (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang Pr, Peoples R China.	zhangliangcai2008@gmail.com; chenlina@ems.hrbmu.edu.cn	Zhang, Liang/GWM-6088-2022; Zhang, Liangcai/AAD-4415-2020	Chen, Lina/0000-0002-4576-6814; Li, Wan/0000-0002-9797-0315	Heilongjiang Ministry of Education [12511271]; Master Innovation Funds of Heilongjiang Province [YJSCX2011-338HLJ]	Heilongjiang Ministry of Education; Master Innovation Funds of Heilongjiang Province	This work was supported in part by the Science & Technology Research Project of the Heilongjiang Ministry of Education (Grant No. 12511271) and the Master Innovation Funds of Heilongjiang Province (Grant No. YJSCX2011-338HLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/bioinformatics/btk031; Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Byvatov Evgeny, 2003, Appl Bioinformatics, V2, P67; Cavusoglu E, 2007, J AM COLL CARDIOL, V50, P1768, DOI 10.1016/j.jacc.2007.05.051; Chen L, 2009, BIOINFORMATICS, V25, P237, DOI 10.1093/bioinformatics/btn613; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; CROWTHER CS, 1995, PSYCHOL REV, V102, P396, DOI 10.1037/0033-295X.102.2.396; Dellas C, 2007, THROMB HAEMOSTASIS, V98, P1063, DOI 10.1160/TH07-03-0213; Elbatarny HS, 2005, AM J PHYSIOL-ENDOC M, V289, pE695, DOI 10.1152/ajpendo.00125.2005; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; George RA, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl707; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hagg D, 2007, ATHEROSCLEROSIS, V190, P291, DOI 10.1016/j.atherosclerosis.2006.03.020; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Hua SJ, 2001, J MOL BIOL, V308, P397, DOI 10.1006/jmbi.2001.4580; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Joseph L, 2002, BLOOD COAGUL FIBRIN, V13, P105, DOI 10.1097/00001721-200203000-00005; KARLSSON JE, 1992, AM HEART J, V124, P1419, DOI 10.1016/0002-8703(92)90052-W; Kim HJ, 2012, MOL BIOL REP, V39, P5425, DOI 10.1007/s11033-011-1342-9; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Liu B, 2006, BIOCHEM BIOPH RES CO, V349, P1308, DOI 10.1016/j.bbrc.2006.08.168; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Martins TB, 2006, AM J CLIN PATHOL, V125, P906, DOI 10.1309/Q3E6KF0QD3U3YL6T; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Ozgur A, 2008, BIOINFORMATICS, V24, pI277, DOI 10.1093/bioinformatics/btn182; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Reilly MP, 2007, J CLIN INVEST, V117, P595, DOI 10.1172/JCI31608; RYDZEWSKI A, 1990, HAEMOSTASIS, V20, P305; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spencer MJ, 2002, P NATL ACAD SCI USA, V99, P8874, DOI 10.1073/pnas.132269299; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Tabata T, 2007, ENDOCR J, V54, P685, DOI 10.1507/endocrj.K05-120; Tang NP, 2008, CLIN CHIM ACTA, V387, P42, DOI 10.1016/j.cca.2007.08.014; Tiroch K, 2005, ATHEROSCLEROSIS, V182, P145, DOI 10.1016/j.atherosclerosis.2005.02.003; Wolf Z, 2007, CYTOM PART A, V71A, P486, DOI 10.1002/cyto.a.20403; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zimmermann O, 2006, J VASC RES, V43, P157, DOI 10.1159/000090945	40	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39542	10.1371/journal.pone.0039542	http://dx.doi.org/10.1371/journal.pone.0039542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761820	Green Submitted, gold, Green Published			2022-12-27	WOS:000305730900073
J	Benesova, K; Spasic, MV; Schaefer, SM; Stolte, J; Baehr-Ivacevic, T; Waldow, K; Zhou, Z; Klingmueller, U; Benes, V; Mall, MA; Muckenthaler, MU				Benesova, Karolina; Spasic, Maja Vujic; Schaefer, Sebastian M.; Stolte, Jens; Baehr-Ivacevic, Tomi; Waldow, Katharina; Zhou, Zhe; Klingmueller, Ursula; Benes, Vladimir; Mall, Marcus A.; Muckenthaler, Martina U.			Hfe Deficiency Impairs Pulmonary Neutrophil Recruitment in Response to Inflammation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HEREDITARY HEMOCHROMATOSIS; HEPCIDIN EXPRESSION; IRON HOMEOSTASIS; EPITHELIAL-CELLS; HUMAN MONOCYTES; IFN-BETA; DIFFERENTIAL REGULATION; LEUKOCYTE MIGRATION; LUNG-DISEASE	Regulation of iron homeostasis and the inflammatory response are tightly linked to protect the host from infection. Here we investigate how imbalanced systemic iron homeostasis in a murine disease model of hereditary hemochromatosis (Hfe(-/-) mice) affects the inflammatory responses of the lung. We induced acute pulmonary inflammation in Hfe(-/-) and wild-type mice by intratracheal instillation of 20 mu g of lipopolysaccharide (LPS) and analyzed local and systemic inflammatory responses and iron-related parameters. We show that in Hfe(-/-) mice neutrophil recruitment to the bronchoalveolar space is attenuated compared to wild-type mice although circulating neutrophil numbers in the bloodstream were elevated to similar levels in Hfe(-/-) and wild-type mice. The underlying molecular mechanisms are likely multifactorial and include elevated systemic iron levels, alveolar macrophage iron deficiency and/or hitherto unexplored functions of Hfe in resident pulmonary cell types. As a consequence, pulmonary cytokine expression is out of balance and neutrophils fail to be recruited efficiently to the bronchoalveolar compartment, a process required to protect the host from infections. In conclusion, our findings suggest a novel role for Hfe and/or imbalanced iron homeostasis in the regulation of the inflammatory response in the lung and hereditary hemochromatosis.	[Benesova, Karolina; Spasic, Maja Vujic; Mall, Marcus A.; Muckenthaler, Martina U.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany; [Benesova, Karolina; Schaefer, Sebastian M.; Stolte, Jens; Baehr-Ivacevic, Tomi; Benes, Vladimir] European Mol Biol Lab, Heidelberg, Germany; [Benesova, Karolina; Spasic, Maja Vujic; Mall, Marcus A.; Muckenthaler, Martina U.] Mol Med Partnership Unit, Heidelberg, Germany; [Waldow, Katharina; Klingmueller, Ursula] DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ, Heidelberg, Germany; [Zhou, Zhe; Mall, Marcus A.] Univ Heidelberg, Dept Translat Pulmonol, Heidelberg, Germany; [Zhou, Zhe; Klingmueller, Ursula; Mall, Marcus A.; Muckenthaler, Martina U.] Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Benesova, K (corresponding author), Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany.	marcus.mall@med.uni-heidelberg.de; martina.muckenthaler@med.uni-heidelberg.de	Klingmüller, Ursula/G-8477-2013; Mall, Marcus A./AAA-1498-2022; Robichon, Katharina/AAC-3257-2020	Klingmüller, Ursula/0000-0001-9845-3099; Mall, Marcus A./0000-0002-4057-2199; Robichon, Katharina/0000-0001-6638-2679; Benes, Vladimir/0000-0002-0352-2547; Muckenthaler, Martina/0000-0002-3778-510X	Deutsche Forschungsgemeinschaft [MU 1108/4-1, MA 2081/3-2, MA 2081/4-1]; EEC Framework 6 [LSHM-CT-2006-037296 EuroIron1]; German Federal Ministry of Education and Research (BMBF) [82DZL00401]; Virtual Liver funding initiatives of the BMBF; University of Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EEC Framework 6; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Virtual Liver funding initiatives of the BMBF; University of Heidelberg	The authors were supported in part by the Deutsche Forschungsgemeinschaft (MU 1108/4-1 to MUM and MA 2081/3-2 and MA 2081/4-1 to MAM), EEC Framework 6 (LSHM-CT-2006-037296 EuroIron1), grant support from the German Federal Ministry of Education and Research (BMBF) (82DZL00401), the Virtual Liver funding initiatives of the BMBF and by the University of Heidelberg Award to MVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andonegui G, 2009, J CLIN INVEST, V119, P1921, DOI 10.1172/JCI36411; Bauer GJ, 2000, SHOCK, V14, P435, DOI 10.1097/00024382-200014040-00003; Bosnar M, 2011, INT IMMUNOPHARMACOL, V11, P424, DOI 10.1016/j.intimp.2010.12.010; BULLEN JJ, 1991, ARCH INTERN MED, V151, P1606, DOI 10.1001/archinte.151.8.1606; Cai SS, 2010, J IMMUNOL, V185, P6214, DOI 10.4049/jimmunol.0903843; Chen Hong, 2010, Expert Rev Respir Med, V4, P773, DOI 10.1586/ers.10.71; Dittrich AM, 2010, CLIN EXP ALLERGY, V40, P1689, DOI 10.1111/j.1365-2222.2010.03508.x; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Frazier MD, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-100; Gamble L, 2009, SHOCK, V31, P212, DOI 10.1097/SHK.0b013e31817c0d7d; Garuti C, 2010, GASTROENTEROLOGY, V139, P315, DOI 10.1053/j.gastro.2010.03.043; Ghio AJ, 2006, BIOL RES, V39, P67, DOI 10.4067/S0716-97602006000100008; Ghio AJ, 2009, BBA-GEN SUBJECTS, V1790, P731, DOI 10.1016/j.bbagen.2008.11.004; GORDEUK VR, 1992, BLOOD, V79, P1855; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Herrmann T, 2004, J MOL MED, V82, P39, DOI 10.1007/s00109-003-0508-x; Hirano S, 1997, IND HEALTH, V35, P353, DOI 10.2486/indhealth.35.353; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Jeyaseelan S, 2007, J IMMUNOL, V178, P3153, DOI 10.4049/jimmunol.178.5.3153; Kartikasari AER, 2009, ATHEROSCLEROSIS, V205, P369, DOI 10.1016/j.atherosclerosis.2008.12.031; Levy JE, 1999, BLOOD, V94, P9, DOI 10.1182/blood.V94.1.9.413a43_9_11; Liu YH, 2011, J IMMUNOL, V186, P3197, DOI 10.4049/jimmunol.1002016; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall MA, 2008, AM J RESP CRIT CARE, V177, P730, DOI 10.1164/rccm.200708-1233OC; Molnarfi N, 2004, J NEUROIMMUNOL, V146, P76, DOI 10.1016/j.jneuroim.2003.10.035; Montosi G, 2000, BLOOD, V96, P1125, DOI 10.1182/blood.V96.3.1125.015k19_1125_1129; Moreau-Marquis S, 2009, AM J RESP CELL MOL, V41, P305, DOI 10.1165/rcmb.2008-0299OC; Muckenthaler M, 2003, BLOOD, V101, P3690, DOI 10.1182/blood-2002-07-2140; Nairz M, 2009, BLOOD, V114, P3642, DOI 10.1182/blood-2009-05-223354; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nguyen NB, 2006, AM J PHYSIOL-LUNG C, V291, pL417, DOI 10.1152/ajplung.00484.2005; Norris S, 2010, INT J IMMUNOGENET, V37, P125, DOI 10.1111/j.1744-313X.2010.00904.x; O'Brien-Ladner AR, 1998, J LAB CLIN MED, V132, P497, DOI 10.1016/S0022-2143(98)90128-7; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Pagani A, 2011, BLOOD, V118, P736, DOI 10.1182/blood-2011-02-337212; Paradkar PN, 2008, BLOOD, V112, P866, DOI 10.1182/blood-2007-12-126854; Peyssonnaux C, 2006, BLOOD, V107, P3727, DOI 10.1182/blood-2005-06-2259; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Roy CN, 2004, NAT GENET, V36, P481, DOI 10.1038/ng1350; Scaccabarozzi A, 2000, BRIT J HAEMATOL, V110, P978, DOI 10.1046/j.1365-2141.2000.02280.x; Sengoelge G, 2003, J AM SOC NEPHROL, V14, P2639, DOI 10.1097/01.ASN.0000087087.61306.4A; Silver BJ, 1997, J LEUKOCYTE BIOL, V62, P547, DOI 10.1002/jlb.62.4.547; Skerrett SJ, 2004, AM J PHYSIOL-LUNG C, V287, pL143, DOI 10.1152/ajplung.00030.2004; Spasic MV, 2008, CELL METAB, V7, P173, DOI 10.1016/j.cmet.2007.11.014; Spasic MV, 2007, BLOOD, V109, P4511, DOI 10.1182/blood-2006-07-036186; Tamagawa E, 2009, INNATE IMMUN-LONDON, V15, P251, DOI 10.1177/1753425909104782; Theurl I, 2008, BLOOD, V111, P2392, DOI 10.1182/blood-2007-05-090019; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; VANASBECK BS, 1984, J INFECTION, V8, P232, DOI 10.1016/S0163-4453(84)93955-0; Vernooy JHJ, 2005, EXP LUNG RES, V31, P855, DOI 10.1080/01902140600611645; Wallace DF, 2011, BLOOD, V117, P2960, DOI 10.1182/blood-2010-08-303859; Wang LJ, 2008, J IMMUNOL, V181, P2723, DOI 10.4049/jimmunol.181.4.2723; Wang LJ, 2009, J CLIN INVEST, V119, P3322, DOI 10.1172/JCI39939; Weiss G, 2002, EUR J CLIN INVEST, V32, P70, DOI 10.1046/j.1365-2362.2002.0320s1070.x; Weiss G, 2009, BBA-GEN SUBJECTS, V1790, P682, DOI 10.1016/j.bbagen.2008.08.006; Wiener Edith, 2003, Hematology, V8, P35, DOI 10.1080/1024533031000081414; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Zhou XY, 1998, P NATL ACAD SCI USA, V95, P2492, DOI 10.1073/pnas.95.5.2492	62	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39363	10.1371/journal.pone.0039363	http://dx.doi.org/10.1371/journal.pone.0039363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22745741	Green Submitted, Green Published, gold			2022-12-27	WOS:000305695100034
J	Reeder, DM; Frank, CL; Turner, GG; Meteyer, CU; Kurta, A; Britzke, ER; Vodzak, ME; Darling, SR; Stihler, CW; Hicks, AC; Jacob, R; Grieneisen, LE; Brownlee, SA; Muller, LK; Blehert, DS				Reeder, DeeAnn M.; Frank, Craig L.; Turner, Gregory G.; Meteyer, Carol U.; Kurta, Allen; Britzke, Eric R.; Vodzak, Megan E.; Darling, Scott R.; Stihler, Craig W.; Hicks, Alan C.; Jacob, Roymon; Grieneisen, Laura E.; Brownlee, Sarah A.; Muller, Laura K.; Blehert, David S.			Frequent Arousal from Hibernation Linked to Severity of Infection and Mortality in Bats with White-Nose Syndrome	PLOS ONE			English	Article							MYOTIS-LUCIFUGUS; VESPERTILIONID BATS; EMERGING DISEASE; METABOLIC-RATE; BROWN BATS; TEMPERATURE; PATTERNS; DURATION; TORPOR; GROWTH	White-nose syndrome (WNS), an emerging infectious disease that has killed over 5.5 million hibernating bats, is named for the causative agent, a white fungus (Geomyces destructans (Gd)) that invades the skin of torpid bats. During hibernation, arousals to warm (euthermic) body temperatures are normal but deplete fat stores. Temperature-sensitive dataloggers were attached to the backs of 504 free-ranging little brown bats (Myotis lucifugus) in hibernacula located throughout the northeastern USA. Dataloggers were retrieved at the end of the hibernation season and complete profiles of skin temperature data were available from 83 bats, which were categorized as: (1) unaffected, (2) WNS-affected but alive at time of datalogger removal, or (3) WNS-affected but found dead at time of datalogger removal. Histological confirmation of WNS severity (as indexed by degree of fungal infection) as well as confirmation of presence/absence of DNA from Gd by PCR was determined for 26 animals. We demonstrated that WNS-affected bats aroused to euthermic body temperatures more frequently than unaffected bats, likely contributing to subsequent mortality. Within the subset of WNS-affected bats that were found dead at the time of datalogger removal, the number of arousal bouts since datalogger attachment significantly predicted date of death. Additionally, the severity of cutaneous Gd infection correlated with the number of arousal episodes from torpor during hibernation. Thus, increased frequency of arousal from torpor likely contributes to WNS-associated mortality, but the question of how Gd infection induces increased arousals remains unanswered.	[Reeder, DeeAnn M.; Vodzak, Megan E.; Jacob, Roymon; Grieneisen, Laura E.; Brownlee, Sarah A.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA; [Frank, Craig L.] Fordham Univ, Dept Biol Sci, Armonk, NY USA; [Turner, Gregory G.] Pennsylvania Game Commiss, Harrisburg, PA USA; [Meteyer, Carol U.; Muller, Laura K.; Blehert, David S.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Kurta, Allen] Eastern Michigan Univ, Dept Biol, Ypsilanti, MI 48197 USA; [Britzke, Eric R.] USA, Engineer Res & Dev Ctr, Vicksburg, MS USA; [Darling, Scott R.] Vermont Fish & Wildlife Dept, Rutland, VT USA; [Stihler, Craig W.] W Virginia Div Nat Resources, Elkins, WV USA; [Hicks, Alan C.] New York State Dept Environm Conservat, Albany, NY USA	Bucknell University; Fordham University; United States Department of the Interior; United States Geological Survey; Eastern Michigan University; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Geospatial Research Laboratory (GRL)	Reeder, DM (corresponding author), Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA.	dreeder@bucknell.edu	Frank, Craig/AFQ-3761-2022	Reeder, DeeAnn/0000-0001-8651-2012; Frank, Craig/0000-0002-4340-4422; Blehert, David/0000-0002-1065-9760	Northeast Association of Fish and Wildlife Agencies (NEAFWA); Pennsylvania Department of Conservation and Natural Resources; Woodtiger Fund; Bucknell University; Direct For Biological Sciences [0818222] Funding Source: National Science Foundation	Northeast Association of Fish and Wildlife Agencies (NEAFWA); Pennsylvania Department of Conservation and Natural Resources; Woodtiger Fund; Bucknell University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The temperature tracking portion of this study was supported by State Wildlife Grant funds awarded through the Northeast Association of Fish and Wildlife Agencies (NEAFWA) Regional Conservation Needs grant program to DMR. (PI), CLF, GGT, ACH, and ERB, by funds from the Pennsylvania Department of Conservation and Natural Resources and the Woodtiger Fund to DMR, and by Graduate Fellowships from Bucknell University to LEG, SAB, and RJ. This grant and its associated conservation activities are done to support implementation of a priority action of the State Wildlife Action Plans from members of the NEAFWA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bouma HR, 2010, J LEUKOCYTE BIOL, V88, P619, DOI 10.1189/jlb.0310174; Boyles JG, 2007, J EXP BIOL, V210, P4345, DOI 10.1242/jeb.007294; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Boyles JG, 2010, FRONT ECOL ENVIRON, V8, P92, DOI 10.1890/080187; BRACK V, 1985, CAN J ZOOL, V63, P2952, DOI 10.1139/z85-442; Britzke ER, 2010, NORTHEAST NAT, V17, P239, DOI 10.1656/045.017.0207; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Dunbar MB, 2006, J MAMMAL, V87, P1096, DOI 10.1644/05-MAMM-A-254R3.1; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Humphries Murray M., 2005, P23; Jonasson KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021061; Kayser C, 1965, PHYSL MAMMALOGY, P180; Kunz TH, 1998, ECOSCIENCE, V5, P8, DOI 10.1080/11956860.1998.11682443; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Lorch JM, 2010, J VET DIAGN INVEST, V22, P224, DOI 10.1177/104063871002200208; Lovegrove BG, 2009, J COMP PHYSIOL B, V179, P451, DOI 10.1007/s00360-008-0329-x; Luis AD, 2006, FUNCT ECOL, V20, P471, DOI 10.1111/j.1365-2435.2006.01119.x; Martinkova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013853; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Puechmaille SJ, 2011, TRENDS ECOL EVOL, V26, P570, DOI 10.1016/j.tree.2011.06.013; Puechmaille SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019167; Reynolds DS, 2000, ECOSCIENCE, V7, P10; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Thomas DW, 1995, SYM ZOOL S, P233; THOMAS DW, 1990, J MAMMAL, V71, P475, DOI 10.2307/1381967; Turner Gregory G., 2011, Bat Research News, V52, P13; TWENTE JW, 1985, CAN J ZOOL, V63, P2955, DOI 10.1139/z85-443; Warnecke L, 2012, INOCULATION BATS EUR; Willis CKR, 2003, J COMP PHYSIOL B, V173, P379, DOI 10.1007/s00360-003-0343-y	36	182	185	3	245	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38920	10.1371/journal.pone.0038920	http://dx.doi.org/10.1371/journal.pone.0038920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745688	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693200029
J	Tracey, DM; Clark, MR; Anderson, OF; Kim, SW				Tracey, Dianne M.; Clark, Malcolm R.; Anderson, Owen F.; Kim, Susan W.			Deep-Sea Fish Distribution Varies between Seamounts: Results from a Seamount Complex off New Zealand	PLOS ONE			English	Article							SPECIES COMPOSITION; ASSEMBLAGES; COMMUNITY; INDICATORS; SLOPE; CLASSIFICATION; DIVERSITY; FAUNA; SHELF; GULF	Fish species data from a complex of seamounts off New Zealand termed the "Graveyard Seamount Complex' were analysed to investigate whether fish species composition varied between seamounts. Five seamount features were included in the study, with summit depths ranging from 748-891 m and elevation from 189-352 m. Measures of fish species dominance, rarity, richness, diversity, and similarity were examined. A number of factors were explored to explain variation in species composition, including latitude, water temperature, summit depth, depth at base, elevation, area, slope, and fishing effort. Depth at base and slope relationships were significant with shallow seamounts having high total species richness, and seamounts with a more gradual slope had high mean species richness. Species similarity was modelled and showed that the explanatory variables were driven primarily by summit depth, as well as by the intensity of fishing effort and elevation. The study showed that fish assemblages on seamounts can vary over very small spatial scales, in the order of several km. However, patterns of species similarity and abundance were inconsistent across the seamounts examined, and these results add to a growing literature suggesting that faunal communities on seamounts may be populated from a broad regional species pool, yet show considerable variation on individual seamounts.	[Tracey, Dianne M.; Clark, Malcolm R.; Anderson, Owen F.] Natl Inst Water & Atmospher Res, Deepwater Grp, Wellington, New Zealand; [Kim, Susan W.] Flinders Univ S Australia, Flinders Ctr Epidemiol & Biostat, Adelaide, SA, Australia	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Flinders University South Australia	Tracey, DM (corresponding author), Natl Inst Water & Atmospher Res, Deepwater Grp, Wellington, New Zealand.	d.tracey@niwa.co.nz	Kim, Susan/D-5144-2015	Kim, Susan/0000-0002-0924-8964	New Zealand Foundation for Research, Science, and Technology [CO1X0028, CO1X0906]; Census of Marine Life on Seamounts; New Zealand Ministry of Science and Innovation	New Zealand Foundation for Research, Science, and Technology(New Zealand Foundation for Research, Science and Technology); Census of Marine Life on Seamounts; New Zealand Ministry of Science and Innovation	The authors (DMT, MRC, OFA) received support from New Zealand Foundation for Research, Science, and Technology, under contracts CO1X0028 (Seamounts: their importance to fisheries and marine ecosystems) and CO1X0906 (Deep-Sea Communities) and the Census of Marine Life on Seamounts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the New Zealand Ministry of Science and Innovation (previously the Foundation for Research, Science, and Technology), for supporting the Seamounts: their importance to fisheries and marine ecosystems programme and the New Zealand Ministry of Primary Industries (previously Ministry of Fisheries) for approving the access to the trawl database and for provision of a subset of commercial fishing data. We acknowledge many NIWA scientific staff for at-sea research survey data collection. Thanks to Andy McKenzie (NIWA) for providing mathematical advice to an earlier draft and to two anonymous reviewers.	Anderson OF, 1998, 42 NIWA; [Anonymous], 1957, KONGELIGE DANSKE VID; Auster PJ, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P93; Beentjes MP, 2002, NEW ZEAL J MAR FRESH, V36, P197, DOI 10.1080/00288330.2002.9517080; Bianchi G, 2000, ICES J MAR SCI, V57, P558, DOI 10.1006/jmsc.2000.0727; Carney R.S., 1983, SEA DEEP SEA BIOL, V8, P97; Clark M, 1999, OCEANOL ACTA, V22, P593, DOI 10.1016/S0399-1784(00)88950-1; Clark M. R., 2010, 46 NZ AQ ENV BIOD; Clark Malcolm, 2003, Journal of Northwest Atlantic Fishery Science, V31, P441; Clark MR, 2010, MAR ECOL-EVOL PERSP, V31, P39, DOI 10.1111/j.1439-0485.2010.00384.x; Clark MR, 2010, OCEANOGRAPHY, V23, P146, DOI 10.5670/oceanog.2010.79; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Clark MR, 2009, DEEP-SEA RES PT I, V56, P1540, DOI 10.1016/j.dsr.2009.04.015; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Costello MJ, 2005, ERLANGEN EARTH C SER, P771, DOI 10.1007/3-540-27673-4_41; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; Francis MP, 2002, ENVIRON BIOL FISH, V65, P215, DOI 10.1023/A:1020046713411; Gage J. D., 1991, DEEP SEA BIOL NATURA; Graham P, 1998, J CLIN EPIDEMIOL, V51, P763, DOI 10.1016/S0895-4356(98)00048-1; Greenstreet SPR, 2006, ICES J MAR SCI, V63, P573, DOI 10.1016/j.icesjms.2005.12.009; Greenstreet SPR, 1999, FISH RES, V40, P153, DOI 10.1016/S0165-7836(98)00210-0; Hall S.J., 1999, EFFECTS FISHING MARI, P274, DOI [10.1002/1099-0755(200005/06)10:3%3C226::AID-AQC411%3E3.0.CO;2-9, DOI 10.1002/1099-0755(200005/06)10:3%3C226::AID-AQC411%3E3.0.CO;2-9]; Howell KL, 2010, BIOL CONSERV, V143, P1041, DOI 10.1016/j.biocon.2010.02.001; Hurst RJ, 2000, 84 NIWA; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; KOSLOW JA, 1994, DEEP-SEA RES PT I, V41, P113; LAMBSHEAD PJD, 1983, J NAT HIST, V17, P859, DOI 10.1080/00222938300770671; Mackay KA, 2005, NIWA MISCELLANEOUS C, V82; McClain CR, 2007, J BIOGEOGR, V34, P2001, DOI 10.1111/j.1365-2699.2007.01783.x; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; MORATO T, 2007, BLACKWELL FISHERIES, V12, P170; Mueter FJ, 2005, ICES J MAR SCI, V62, P344, DOI 10.1016/j.icesjms.2004.11.006; Niklitschek EJ, 2010, MAR ECOL-EVOL PERSP, V31, P168, DOI 10.1111/j.1439-0485.2010.00372.x; O'Driscoll RL, 2005, NEW ZEAL J MAR FRESH, V39, P839, DOI 10.1080/00288330.2005.9517356; Parin NV, 1997, ADV MAR BIOL, V32, P145; Piet GJ, 2005, ICES J MAR SCI, V62, P214, DOI 10.1016/j.icesjms.2004.09.007; Pratt RM, 1967, J HOPKINS OCEANOGRAP, V3, P145; RAYMORE PA, 1982, PAC SCI, V36, P15; Rogers SI, 2000, ICES J MAR SCI, V57, P866, DOI 10.1006/jmsc.2000.0574; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rowden AA, 2005, NEW ZEAL J MAR FRESH, V39, P1039, DOI 10.1080/00288330.2005.9517374; Rowden AA, 2008, 27 AQ ENV BIOD; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P95, DOI 10.1111/j.1439-0485.2010.00369.x; Samadi Sarah, 2007, Fish and Aquatic Resources Series, V12, P119; Shank TM, 2010, OCEANOGRAPHY, V23, P104, DOI 10.5670/oceanog.2010.76; Stocks Karen I., 2007, Fish and Aquatic Resources Series, V12, P255; Tracey D, 2011, MAR ECOL PROG SER, V430; Tracey DM, 2004, NEW ZEAL J MAR FRESH, V38, P163, DOI 10.1080/00288330.2004.9517226; Tuck I., 2009, 42 NZ AQ ENV BIOD; Venables W., 2013, MODERN APPL STAT S, V53, P86; Wilson R. R., 1987, GEOPHYS MONOGR SER, P319; Wright IC, 2001, MAR GEOL, V172, P287, DOI 10.1016/S0025-3227(00)00131-6; Yesson C, 2011, DEEP-SEA RES PT I, V58, P442, DOI 10.1016/j.dsr.2011.02.004	54	16	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e36897	10.1371/journal.pone.0036897	http://dx.doi.org/10.1371/journal.pone.0036897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745656	Green Submitted, Green Published, gold			2022-12-27	WOS:000305693200004
J	Voutilainen, L; Savola, S; Kallio, ER; Laakkonen, J; Vaheri, A; Vapalahti, O; Henttonen, H				Voutilainen, Liina; Savola, Sakeri; Kallio, Eva Riikka; Laakkonen, Juha; Vaheri, Antti; Vapalahti, Olli; Henttonen, Heikki			Environmental Change and Disease Dynamics: Effects of Intensive Forest Management on Puumala Hantavirus Infection in Boreal Bank Vole Populations	PLOS ONE			English	Article							SIN-NOMBRE-VIRUS; CLETHRIONOMYS-GLAREOLUS; NEPHROPATHIA-EPIDEMICA; SPECIES-DIVERSITY; INTERSPECIFIC COMPETITION; MATERNAL ANTIBODIES; TEMPORAL DYNAMICS; NORTHERN SWEDEN; HABITAT FACTORS; SMALL RODENTS	Intensive management of Fennoscandian forests has led to a mosaic of woodlands in different stages of maturity. The main rodent host of the zoonotic Puumala hantavirus (PUUV) is the bank vole (Myodes glareolus), a species that can be found in all woodlands and especially mature forests. We investigated the influence of forest age structure on PUUV infection dynamics in bank voles. Over four years, we trapped small mammals twice a year in a forest network of different succession stages in Northern Finland. Our study sites represented four forest age classes from young (4 to 30 years) to mature (over 100 years) forests. We show that PUUV-infected bank voles occurred commonly in all forest age classes, but peaked in mature forests. The probability of an individual bank vole to be PUUV infected was positively related to concurrent host population density. However, when population density was controlled for, a relatively higher infection rate was observed in voles trapped in younger forests. Furthermore, we found evidence of a "dilution effect" in that the infection probability was negatively associated with the simultaneous density of other small mammals during the breeding season. Our results suggest that younger forests created by intensive management can reduce hantaviral load in the environment, but PUUV is common in woodlands of all ages. As such, the Fennoscandian forest landscape represents a significant reservoir and source of hantaviral infection in humans.	[Voutilainen, Liina; Savola, Sakeri; Henttonen, Heikki] Finnish Forest Res Inst, Vantaa Res Unit, Vantaa, Finland; [Voutilainen, Liina; Vaheri, Antti; Vapalahti, Olli] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Voutilainen, Liina; Vaheri, Antti; Vapalahti, Olli] Univ Helsinki, Haartman Inst, Res Programs Unit, Helsinki, Finland; [Kallio, Eva Riikka] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Kallio, Eva Riikka] Univ Liverpool, Inst Integrat Biol, Dept Evolut Ecol & Behav, Liverpool L69 3BX, Merseyside, England; [Laakkonen, Juha; Vapalahti, Olli] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland; [Vaheri, Antti; Vapalahti, Olli] Univ Helsinki, Cent Hosp, HUSLAB, Helsinki, Finland	Natural Resources Institute Finland (Luke); University of Helsinki; University of Helsinki; University of Jyvaskyla; University of Liverpool; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Voutilainen, L (corresponding author), Finnish Forest Res Inst, Vantaa Res Unit, Vantaa, Finland.	liina.voutilainen@helsinki.fi	Vaheri, Antti/AAV-1523-2020	Vapalahti, Olli/0000-0003-2270-6824; Laakkonen, Juha/0000-0002-4040-6588	Maj and Tor Nessling Foundation; Kone Foundation; Emil Aaltonen Foundation; Jenny and Antti Wihuri Foundation; Finnish Game and Fisheries Research Institute; EU 6th Framework Programme [GOCE-2003-010284 EDEN]; EU [FP7-261504 EDENext]	Maj and Tor Nessling Foundation; Kone Foundation; Emil Aaltonen Foundation; Jenny and Antti Wihuri Foundation; Finnish Game and Fisheries Research Institute; EU 6th Framework Programme(European Commission); EU(European Commission)	This study was financially supported by Maj and Tor Nessling Foundation (www.nessling.fi/en),Kone Foundation (www.koneensaatio.fi/en), Emil Aaltonen Foundation (www.emilaaltonen.fi/eng.htm), Jenny and Antti Wihuri Foundation (www.wihurinrahasto.fi/foundation.html), Finnish Game and Fisheries Research Institute (www.rktl.fi/english), and the EU 6th Framework Programme (GOCE-2003-010284 EDEN, www.eden-fp6project.net). This study was partially funded by EU grant FP7-261504 EDENext and is catalogued by the EDENext Steering Committee as EDENext014 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and don't necessarily reflect the views of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apeldoorn RCv, 1992, OIKOS, V65, P265; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Begon M, 2003, J ANIM ECOL, V72, P343, DOI 10.1046/j.1365-2656.2003.00705.x; Bernshtein AD, 1999, ARCH VIROL, V144, P2415, DOI 10.1007/s007050050654; BRUMMERKORVENKONTIO M, 1980, J INFECT DIS, V141, P131, DOI 10.1093/infdis/141.2.131; BRUMMERKORVENKONTIO M, 1982, SCAND J INFECT DIS, P88; Burnham K.P., 2000, MODEL SELECTION INFE; Calisher CH, 2007, J WILDLIFE DIS, V43, P1, DOI 10.7589/0090-3558-43.1.1; Carver S, 2011, OECOLOGIA, V166, P713, DOI 10.1007/s00442-010-1882-z; Clay CA, 2009, ECOHEALTH, V6, P250, DOI 10.1007/s10393-009-0240-2; Clay CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006467; Dearing MD, 2010, ANN NY ACAD SCI, V1195, P99, DOI 10.1111/j.1749-6632.2010.05452.x; Dizney LJ, 2009, EMERG INFECT DIS, V15, P1012, DOI [10.3201/eid1507.081621, 10.3201/eid1507.081083]; Eccard JA, 2002, OIKOS, V99, P580, DOI 10.1034/j.1600-0706.2002.11833.x; Eccard JA, 2007, J ANIM ECOL, V76, P65, DOI 10.1111/j.1365-2656.2006.01175.x; Ecke F, 2002, J APPL ECOL, V39, P781, DOI 10.1046/j.1365-2664.2002.00759.x; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Escutenaire S, 2000, VIRUS RES, V67, P91, DOI 10.1016/S0168-1702(00)00136-2; Finnish Forest Research Institute, 2010, STAT YB FOR 2010; GAVRILOVSKAYA IN, 1990, ARCH VIROL         S, V1, P57; Guivier E, 2011, MOL ECOL, V20, P3569, DOI 10.1111/j.1365-294X.2011.05199.x; Hanski I, 1996, J ANIM ECOL, V65, P220, DOI 10.2307/5725; HANSKI I, 1991, J ANIM ECOL, V60, P353, DOI 10.2307/5465; HANSSON L, 1988, TRENDS ECOL EVOL, V3, P195, DOI 10.1016/0169-5347(88)90006-7; HANSSON L, 1985, OECOLOGIA, V67, P394, DOI 10.1007/BF00384946; HAUKISALMI V, 1988, J ANIM ECOL, V57, P807, DOI 10.2307/5094; HENTTONEN H, 1989, ANN ZOOL FENN, V26, P349; HENTTONEN H, 1977, OIKOS, V29, P581, DOI 10.2307/3543596; HENTTONEN H, 1984, ACTA ZOOL FENN, V172, P61; Henttonen Heikki, 2000, Polish Journal of Ecology, V48, P87; Heyman P, 2008, Euro Surveill, V13; Heyman P, 2001, VIRUS RES, V77, P71, DOI 10.1016/S0168-1702(01)00267-2; Huitu O, 2004, ECOGRAPHY, V27, P197, DOI 10.1111/j.0906-7590.2003.03684.x; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Kallio ER, 2007, ECOLOGY, V88, P1911, DOI 10.1890/06-1620.1; Kallio ER, 2006, P ROY SOC B-BIOL SCI, V273, P2771, DOI 10.1098/rspb.2006.3645; Kallio ER, 2006, J GEN VIROL, V87, P2127, DOI 10.1099/vir.0.81643-0; Kallio ER, 2010, P ROY SOC B-BIOL SCI, V277, P3783, DOI 10.1098/rspb.2010.1022; Kallio ER, 2009, EPIDEMICS-NETH, V1, P101, DOI 10.1016/j.epidem.2009.03.002; Kallio-Kokko H, 2006, EPIDEMIOL INFECT, V134, P830, DOI 10.1017/S0950268805005431; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Liesenjohann M, 2011, BEHAV ECOL SOCIOBIOL, V65, P2079, DOI 10.1007/s00265-011-1217-z; Linard C, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-55; Linard C, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-15; Makary P, 2010, EPIDEMIOL INFECT, V138, P1484, DOI 10.1017/S0950268810000087; Meyer BJ, 2000, TRENDS MICROBIOL, V8, P61, DOI 10.1016/S0966-842X(99)01658-3; Mills JN, 1998, EMERG INFECT DIS, V4, P529, DOI 10.3201/eid0404.980403; MYLLYMAKI A, 1971, Annales Zoologici Fennici, V8, P177; NIKLASSON B, 1995, AM J TROP MED HYG, V53, P134, DOI 10.4269/ajtmh.1995.53.134; Norman R, 1999, J THEOR BIOL, V200, P111, DOI 10.1006/jtbi.1999.0982; Olsson GE, 2005, VECTOR-BORNE ZOONOT, V5, P315, DOI 10.1089/vbz.2005.5.315; Olsson GE, 2003, EMERG INFECT DIS, V9, P1395, DOI 10.3201/eid0911.030275; Olsson GE, 2002, EMERG INFECT DIS, V8, P924, DOI 10.3201/eid0809.020037; Olsson GE, 2009, EMERG INFECT DIS, V15, P104, DOI 10.3201/eid1501.080502; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sauvage F, 2007, EPIDEMIOL INFECT, V135, P46, DOI 10.1017/S0950268806006595; Suzan G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005461; Tersago K, 2009, EPIDEMIOL INFECT, V137, P250, DOI 10.1017/S0950268808000940; Tersago K, 2008, VECTOR-BORNE ZOONOT, V8, P235, DOI 10.1089/vbz.2007.0160; Tersago K, 2011, VECTOR-BORNE ZOONOT, V11, P715, DOI 10.1089/vbz.2010.0007; Uotila A, 2005, FOREST ECOL MANAG, V215, P113, DOI 10.1016/j.foreco.2005.05.008; Vapalahti K, 2010, EPIDEMIOL INFECT, V138, P576, DOI 10.1017/S095026880999077X; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6; Wood S., 2011, R PACKAGE VERSION, V0, P1; YLONEN H, 1985, ANN ZOOL FENN, V22, P353	66	33	34	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39452	10.1371/journal.pone.0039452	http://dx.doi.org/10.1371/journal.pone.0039452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745755	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693200077
J	Suarez, C; Maglietti, F; Colonna, M; Breitburd, K; Marshall, G				Suarez, Cecilia; Maglietti, Felipe; Colonna, Mario; Breitburd, Karina; Marshall, Guillermo			Mathematical Modeling of Human Glioma Growth Based on Brain Topological Structures: Study of Two Clinical Cases	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; LOW-GRADE GLIOMAS; GLIOBLASTOMA-MULTIFORME; RESECTION; EXTENT; ACTIVATION; FMRI; RADIOTHERAPY; PERCEPTION; SIMULATION	Gliomas are the most common primary brain tumors and yet almost incurable due mainly to their great invasion capability. This represents a challenge to present clinical oncology. Here, we introduce a mathematical model aiming to improve tumor spreading capability definition. The model consists in a time dependent reaction-diffusion equation in a three-dimensional spatial domain that distinguishes between different brain topological structures. The model uses a series of digitized images from brain slices covering the whole human brain. The Talairach atlas included in the model describes brain structures at different levels. Also, the inclusion of the Brodmann areas allows prediction of the brain functions affected during tumor evolution and the estimation of correlated symptoms. The model is solved numerically using patient-specific parametrization and finite differences. Simulations consider an initial state with cellular proliferation alone (benign tumor), and an advanced state when infiltration starts (malign tumor). Survival time is estimated on the basis of tumor size and location. The model is used to predict tumor evolution in two clinical cases. In the first case, predictions show that real infiltrative areas are underestimated by current diagnostic imaging. In the second case, tumor spreading predictions were shown to be more accurate than those derived from previous models in the literature. Our results suggest that the inclusion of differential migration in glioma growth models constitutes another step towards a better prediction of tumor infiltration at the moment of surgical or radiosurgical target definition. Also, the addition of physiological/psychological considerations to classical anatomical models will provide a better and integral understanding of the patient disease at the moment of deciding therapeutic options, taking into account not only survival but also life quality.	[Suarez, Cecilia; Maglietti, Felipe; Marshall, Guillermo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Comp, Lab Sistemas Complejos, Buenos Aires, DF, Argentina; [Colonna, Mario; Breitburd, Karina] Hosp Aleman, Serv Neurocirugia, Buenos Aires, DF, Argentina	University of Buenos Aires; Hospital Aleman; University of Buenos Aires	Suarez, C (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Comp, Lab Sistemas Complejos, Buenos Aires, DF, Argentina.	csuarez@dc.uba.ar	, Cecilia/I-5244-2016	, Cecilia/0000-0003-0134-8618; Maglietti, Felipe Horacio/0000-0002-0860-6854	CONICET [PIP 112-200801-01087/09]; Universidad de Buenos Aires [UBACyT X132/08]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by grants from CONICET (PIP 112-200801-01087/09) and Universidad de Buenos Aires (UBACyT X132/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2003, NEUROLOGY, V60, P1598, DOI 10.1212/01.WNL.0000059865.32155.86; Anderson ARA, 2008, NAT REV CANCER, V8, P227, DOI 10.1038/nrc2329; [Anonymous], 2011, STAT REP PRIM BRAIN; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Burgess PK, 1997, J NEUROPATH EXP NEUR, V56, P704; Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001; Chaichana KL, 2011, ANN SURG ONCOL, V18, P239, DOI 10.1245/s10434-010-1242-6; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; de Araujo IET, 2003, EUR J NEUROSCI, V18, P2059, DOI 10.1046/j.1460-9568.2003.02915.x; Dhermain F, 2010, B CANCER, V97, P753, DOI 10.1684/bdc.2010.1146; Duffau H, 2012, ACTA NEUROCHIR, V154, P575, DOI 10.1007/s00701-011-1216-x; Ewelt C, 2011, J NEURO-ONCOL, V103, P611, DOI 10.1007/s11060-010-0429-9; Faramarz-Allandini, 2010, WORLD NEUROSURG, V73, P128, DOI 10.1016/j.wneu.2009.06.001; Fisher R, 2011, ANN HUM GENET, V7, P355, DOI DOI 10.1111/J.1469-1809.1937.TB02153.X; Francis ST, 2000, NEUROIMAGE, V11, P188, DOI 10.1006/nimg.2000.0541; Gilbertson RJ, 2007, CANCER RES, V67, P5579, DOI 10.1158/0008-5472.CAN-07-0760; Gu S, 2011, MATH MED BIOL; Harpaz Y, 2009, CORTEX, V45, P1097, DOI 10.1016/j.cortex.2009.01.002; Harpold HLP, 2007, J NEUROPATH EXP NEUR, V66, P1, DOI 10.1097/nen.0b013e31802d9000; Hart HC, 2003, HEARING RES, V179, P104, DOI 10.1016/S0378-5955(03)00100-X; Jbabdi S, 2005, MAGN RESON MED, V54, P616, DOI 10.1002/mrm.20625; Katz A, 2009, CASE REP ONCOL, V2, P57, DOI 10.1159/000208378; Kelly PJ, 2010, SURG NEUROLOGY INT, P1; KOHLER S, 1995, NEUROREPORT, V6, P1865, DOI 10.1097/00001756-199510020-00011; Kwan RKS, 1999, IEEE T MED IMAGING, V18, P1085, DOI 10.1109/42.816072; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lasota KJ, 2003, J COMPUT ASSIST TOMO, V27, P213, DOI 10.1097/00004728-200303000-00018; Lathia JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024807; Loukas M, 2011, NEUROSURGERY, V68, P6, DOI 10.1227/NEU.0b013e3181fc5cac; McDermott KB, 1999, MEMORY, V7, P661; Menendez-Colino LM, 2007, ACTA OTO-LARYNGOL, V127, P1283, DOI 10.1080/00016480701258705; Nagarajan RP, 2009, SEMIN CANCER BIOL, V19, P188, DOI 10.1016/j.semcancer.2009.02.005; Ngwenya LB, 2011, J NEUROSURG, V115, P1, DOI 10.3171/2010.9.JNS101437; NINDS, 2006, NIH PUBL; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Rockne R, 2010, PHYS MED BIOL, V55, P3271, DOI 10.1088/0031-9155/55/12/001; Sanai N, 2011, REV NEUROL-FRANCE, V167, P648, DOI 10.1016/j.neurol.2011.07.004; Sanai N, 2011, J NEUROSURG, V115, P948, DOI [10.3171/2011.7.JNS101238, 10.3171/2011.7.JNS10238]; Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998; Schon D, 2002, NEUROREPORT, V13, P2285, DOI 10.1097/01.wnr.0000044224.79663.f5; Siebzehnrubl FA, 2011, GLIA, V59, P1135, DOI 10.1002/glia.21143; Silbergeld DL, 1997, J NEUROSURG, V86, P525, DOI 10.3171/jns.1997.86.3.0525; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Soderfeldt B, 1997, NEUROLOGY, V49, P82, DOI 10.1212/WNL.49.1.82; Stefanatos GA, 2008, NEUROPSYCHOLOGIA, V46, P301, DOI 10.1016/j.neuropsychologia.2007.07.008; Suzuki SO, 2002, J NEUROPATH EXP NEUR, V61, P403, DOI 10.1093/jnen/61.5.403; Swanson K., 1999, THESIS U WASHINGTON; Swanson KR, 2008, CLIN ONCOL-UK, V20, P301, DOI 10.1016/j.clon.2008.01.006; Swanson KR, 2000, CELL PROLIFERAT, V33, P317, DOI 10.1046/j.1365-2184.2000.00177.x; Swanson KR, 2011, CANCER RES, V71, P7366, DOI 10.1158/0008-5472.CAN-11-1399; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor LP, 2010, NEUROLOGY, V75, pS28, DOI 10.1212/WNL.0b013e3181fb3661; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Yamaguchi S, 2012, JPN J CLIN ONCOL, V42, P270, DOI 10.1093/jjco/hys016; Yordanova YN, 2011, J NEUROSURG, V115, P232, DOI 10.3171/2011.3.JNS101333	58	20	20	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39616	10.1371/journal.pone.0039616	http://dx.doi.org/10.1371/journal.pone.0039616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761843	gold, Green Published, Green Submitted			2022-12-27	WOS:000305826400022
J	Drewe, JA; Weber, N; Carter, SP; Bearhop, S; Harrison, XA; Dall, SRX; McDonald, RA; Delahay, RJ				Drewe, Julian A.; Weber, Nicola; Carter, Stephen P.; Bearhop, Stuart; Harrison, Xavier A.; Dall, Sasha R. X.; McDonald, Robbie A.; Delahay, Richard J.			Performance of Proximity Loggers in Recording Intra-and Inter-Species Interactions: A Laboratory and Field-Based Validation Study	PLOS ONE			English	Article							BOVINE TUBERCULOSIS; CONTACT NETWORKS; SOCIAL-BEHAVIOR; TRANSMISSION; POSSUMS; INDIVIDUALS; INFECTION; BADGERS; CATTLE; RATES	Knowledge of the way in which animals interact through social networks can help to address questions surrounding the ecological and evolutionary consequences of social organisation, and to understand and manage the spread of infectious diseases. Automated proximity loggers are increasingly being used to record interactions between animals, but the accuracy and reliability of the collected data remain largely un-assessed. Here we use laboratory and observational field data to assess the performance of these devices fitted to a herd of 32 beef cattle (Bos taurus) and nine groups of badgers (Meles meles, n = 77) living in the surrounding woods. The distances at which loggers detected each other were found to decrease over time, potentially related to diminishing battery power that may be a function of temperature. Loggers were highly accurate in recording the identification of contacted conspecifics, but less reliable at determining contact duration. There was a tendency for extended interactions to be recorded as a series of shorter contacts. We show how data can be manipulated to correct this discrepancy and accurately reflect observed interaction patterns by combining records between any two loggers that occur within a 1 to 2 minute amalgamation window, and then removing any remaining 1 second records. We make universally applicable recommendations for the effective use of proximity loggers, to improve the validity of data arising from future studies.	[Drewe, Julian A.] Royal Vet Coll, N Mymms, Herts, England; [Weber, Nicola; Bearhop, Stuart; Harrison, Xavier A.; Dall, Sasha R. X.] Univ Exeter, Ctr Ecol & Conservat, Coll Life & Environm Sci, Penryn, England; [Weber, Nicola; Carter, Stephen P.; Delahay, Richard J.] Food & Environm Res Agcy, York, N Yorkshire, England; [McDonald, Robbie A.] Univ Exeter, Environm & Sustainabil Inst, Coll Life & Environm Sci, Penryn, England	University of London; University of London Royal Veterinary College; University of Exeter; Food & Environment Research Agency; University of Exeter	Drewe, JA (corresponding author), Royal Vet Coll, Hawkshead Lane, N Mymms, Herts, England.	N.L.Weber@exeter.ac.uk	Carter, Steve P/J-1686-2014; Delahay, Richard/J-2261-2014; McDonald, Robbie A/A-2931-2012; Delahay, Richard/GSI-4663-2022; Bearhop, Stuart/G-3105-2012; Dall, Sasha/B-2642-2010; Drewe, Julian A/A-6562-2009; Harrison, Xavier/F-6420-2011; McDonald, Robbie/AAK-2718-2020	Carter, Steve P/0000-0002-9487-7377; McDonald, Robbie A/0000-0002-6922-3195; Bearhop, Stuart/0000-0002-5864-0129; Dall, Sasha/0000-0001-9873-6507; Harrison, Xavier/0000-0002-2004-3601; McDonald, Robbie/0000-0002-6922-3195; Weber, Nicola/0000-0001-6910-3727	DEFRA [SE3032]; Royal Veterinary College [VCS00203]	DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); Royal Veterinary College	Funding was provided by DEFRA Project SE3032 and the Royal Veterinary College (MS#VCS00203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005016; Bohm M, 2008, J ANIM ECOL, V77, P735, DOI 10.1111/j.1365-2656.2008.01377.x; Bourne F., 2007, BOVINE TUBERCULOSIS; Broster JC, 2010, ANIMAL, V4, P796, DOI 10.1017/S1751731110000030; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Cross Paul C., 2009, P9, DOI 10.1007/978-4-431-77134-0_2; Cross PC, 2004, ANN ZOOL FENN, V41, P879; Delahay RJ, 2000, J ANIM ECOL, V69, P428, DOI 10.1046/j.1365-2656.2000.00406.x; Drewe JA, 2010, P ROY SOC B-BIOL SCI, V277, P633, DOI 10.1098/rspb.2009.1775; Goodman EL, 2007, THESIS U YORK; Guttridge TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009324; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; Hutchings MR, 1999, EPIDEMIOL INFECT, V122, P167, DOI 10.1017/S0950268898001897; Ji WH, 2005, J APPL ECOL, V42, P595, DOI 10.1111/j.1365-2664.2005.01026.x; Krause J., 2010, TRENDS ECOL EVOL, V26, P5; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Marsh MK, 2011, BEHAV ECOL SOCIOBIOL, V65, P183, DOI 10.1007/s00265-010-1024-y; Mullen J, 2004, P IERC IND ENG C MAY; Paterson BM, 1995, NEW ZEAL VET J, V43, P289, DOI 10.1080/00480169./1995.35908; Patison KP, 2010, APPL ANIM BEHAV SCI, V128, P10, DOI 10.1016/j.applanim.2010.10.001; Prange S, 2006, WILDLIFE SOC B, V34, P1333, DOI 10.2193/0091-7648(2006)34[1333:NRFTDO]2.0.CO;2; R Core Team, 2020, R LANG ENV STAT COMP; Sauter CM, 1995, NEW ZEAL VET J, V43, P294, DOI 10.1080/00480169./1995.35909; Schauber EM, 2007, J WILDLIFE MANAGE, V71, P155, DOI 10.2193/2005-546; Swain DL, 2007, APPL ANIM BEHAV SCI, V102, P1, DOI 10.1016/j.applanim.2006.03.008; Walrath R, 2011, WILDLIFE SOC B, V35, P452, DOI 10.1002/wsb.76; White PCL, 2008, TRENDS MICROBIOL, V16, P420, DOI 10.1016/j.tim.2008.06.005; Whitehead H, 2008, ANAL ANIMAL SOC, P1	29	48	48	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39068	10.1371/journal.pone.0039068	http://dx.doi.org/10.1371/journal.pone.0039068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22745704	Green Published, Green Submitted, gold			2022-12-27	WOS:000305808700016
J	Wang, N; Eckert, KA; Zomorrodi, AR; Xin, P; Pan, WH; Shearer, DA; Weisz, J; Maranus, CD; Clawson, GA				Wang, Ning; Eckert, Kristin A.; Zomorrodi, Ali R.; Xin, Ping; Pan, Weihua; Shearer, Debra A.; Weisz, Judith; Maranus, Costas D.; Clawson, Gary A.			Down-Regulation of HtrA1 Activates the Epithelial-Mesenchymal Transition and ATM DNA Damage Response Pathways	PLOS ONE			English	Article							SERINE-PROTEASE HTRA1; OXIDATIVE STRESS; AKT PHOSPHORYLATION; ACCESSIBLE SITES; GENE-EXPRESSION; MESSENGER-RNA; HUMAN BREAST; TUMOR-CELLS; STEM-CELLS; CANCER	Expression of the serine protease HtrA1 is decreased or abrogated in a variety of human primary cancers, and higher levels of HtrA1 expression are directly related to better response to chemotherapeutics. However, the precise mechanisms leading to HtrA1 down regulation during malignant transformation are unclear. To investigate HtrA1 gene regulation in breast cancer, we characterized expression in primary breast tissues and seven human breast epithelial cell lines, including two non-tumorigenic cell lines. In human breast tissues, HtrA1 expression was prominent in normal ductal glands. In DCIS and in invasive cancers, HtrA1 expression was greatly reduced or lost entirely. HtrA1 staining was also reduced in all of the human breast cancer cell lines, compared with the normal tissue and non-tumorigenic cell line controls. Loss of HtrA1 gene expression was attributable primarily to epigenetic silencing mechanisms, with different mechanisms operative in the various cell lines. To mechanistically examine the functional consequences of HtrA1 loss, we stably reduced and/or overexpressed HtrA1 in the non-tumorigenic MCF10A cell line. Reduction of HtrA1 levels resulted in the epithelial-to-mesenchymal transition with acquisition of mesenchymal phenotypic characteristics, including increased growth rate, migration, and invasion, as well as expression of mesenchymal biomarkers. A concomitant decrease in expression of epithelial biomarkers and all microRNA 200 family members was also observed. Moreover, reduction of HtrA1 expression resulted in activation of the ATM and DNA damage response, whereas overexpression of HtrA1 prevented this activation. Collectively, these results suggest that HtrA1 may function as a tumor suppressor by controlling the epithelial-to-mesenchymal transition, and may function in chemotherapeutic responsiveness by mediating DNA damage response pathways.	[Wang, Ning; Eckert, Kristin A.; Xin, Ping; Pan, Weihua; Clawson, Gary A.] Penn State Univ, Gittlen Canc Res Inst, Coll Med, Hershey, PA USA; [Wang, Ning; Eckert, Kristin A.; Xin, Ping; Pan, Weihua; Clawson, Gary A.] Penn State Univ, Dept Pathol, Coll Med, Hershey, PA USA; [Zomorrodi, Ali R.; Maranus, Costas D.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Shearer, Debra A.; Weisz, Judith] Penn State Univ, Dept Obstet & Gynecol, Hershey, PA USA; [Clawson, Gary A.] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wang, N (corresponding author), Penn State Univ, Gittlen Canc Res Inst, Coll Med, Hershey, PA USA.	gac4@psu.edu	Maranas, Costas D/A-4774-2011	Maranas, Costas D/0000-0002-1508-1398	National Institutes of Health [CA40145]; Gittlen Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA040145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gittlen Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funds for this study were obtained from the National Institutes of Health (CA40145; www.nih.gov) and from the Gittlen Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lopez JA, 2011, BIOCHEM BIOPH RES CO, V409, P513, DOI 10.1016/j.bbrc.2011.05.036; Ahmed N, 2010, CURR CANCER DRUG TAR, V10, P268, DOI 10.2174/156800910791190175; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Baldi A, 2002, ONCOGENE, V21, P6684, DOI 10.1038/sj.onc.1205911; Baldi A, 2008, PHARMACOGENOMICS, V9, P1069, DOI 10.2217/14622416.9.8.1069; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biswas S, 2006, CLIN CANCER RES, V12, P4142, DOI 10.1158/1078-0432.CCR-06-0952; Bowden MA, 2006, GYNECOL ONCOL, V103, P253, DOI 10.1016/j.ygyno.2006.03.006; Catalano V, 2011, HISTOPATHOLOGY, V58, P669, DOI 10.1111/j.1365-2559.2011.03818.x; Ceppi P, 2010, MOL CANCER RES, V8, P1207, DOI 10.1158/1541-7786.MCR-10-0052; Chan N, 2008, CANCER RES, V68, P605, DOI 10.1158/0008-5472.CAN-07-5472; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Chien J, 2009, MOL CELL BIOL, V29, P4177, DOI 10.1128/MCB.00035-09; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Chien J, 2009, J CELL BIOCHEM, V107, P253, DOI 10.1002/jcb.22121; Chien J, 2006, J CLIN INVEST, V116, P1994, DOI 10.1172/JCI27698; Cicenas J, 2008, INT J BIOL MARKER, V23, P1, DOI 10.1177/172460080802300101; Clawson GA, 2008, J CELL BIOCHEM, V105, P81, DOI 10.1002/jcb.21804; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; De Luca A, 2003, J HISTOCHEM CYTOCHEM, V51, P1279, DOI 10.1177/002215540305101004; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Folgueira MAAK, 2005, CLIN CANCER RES, V11, P7434; Fukutake T, 2011, J STROKE CEREBROVASC, V20, P85, DOI 10.1016/j.jstrokecerebrovasdis.2010.11.008; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hagman Z, 2010, INT J CANCER, V127, P2768, DOI 10.1002/ijc.25269; He X, 2010, CANC RES, V70; Holian J, 2008, AM J PHYSIOL-RENAL, V295, pF1388, DOI 10.1152/ajprenal.00055.2008; Hubbi ME, 2011, MOL CELL, V42, P700, DOI 10.1016/j.molcel.2011.03.029; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Ivanovic V, 2006, CLIN CHIM ACTA, V371, P191, DOI 10.1016/j.cca.2006.02.027; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Kalyanaraman B, 2002, MOL CELL BIOCHEM, V234, P119, DOI 10.1023/A:1015976430790; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kimbro KS, 2006, ENDOCR-RELAT CANCER, V13, P739, DOI 10.1677/erc.1.00728; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Kotamraju S, 2004, METHOD ENZYMOL, V378, P362; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Loss LA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-305; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Mullany SA, 2011, CLIN CANCER RES, V17, P427, DOI 10.1158/1078-0432.CCR-09-3069; Narkiewicz J, 2009, ONCOL REP, V21, P1529, DOI 10.3892/or_00000385; Narklewicz J, 2008, CLIN BIOCHEM, V41, P561, DOI 10.1016/j.clinbiochem.2008.01.004; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Pan WH, 2006, CURR MED CHEM, V13, P3083, DOI 10.2174/092986706778521788; Pan WH, 2010, J CELL BIOCHEM, V109, P509, DOI 10.1002/jcb.22428; Pan WH, 2004, MOL THER, V9, P596, DOI 10.1016/j.ymthe.2003.12.013; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Radisky DC, 2006, CURR OPIN GENET DEV, V16, P45, DOI 10.1016/j.gde.2005.12.011; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; ROGERS KR, 1989, INT J TISSUE REACT, V11, P309; Saito H, 2000, ANTICANCER RES, V20, P4489; Salkind N., 2007, ENCY MEASUREMENT STA; Shariat SF, 2001, CANCER-AM CANCER SOC, V92, P2985, DOI 10.1002/1097-0142(20011215)92:12<2985::AID-CNCR10175>3.0.CO;2-5; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stinson S, 2011, SCI SIGNAL, V4, P1; Strnad P, 2008, HISTOCHEM CELL BIOL, V129, P735, DOI 10.1007/s00418-008-0431-x; Tang JT, 2011, CARCINOGENESIS, V32, P1207, DOI 10.1093/carcin/bgr114; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Van den Eynden GG, 2007, CLIN EXP METASTAS, V24, P13, DOI 10.1007/s10585-006-9049-3; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wang ZW, 2010, DRUG RESIST UPDATE, V13, P109, DOI 10.1016/j.drup.2010.07.001; Wang ZW, 2010, CURR STEM CELL RES T, V5, P74, DOI 10.2174/157488810790442813; Weisz J, 2012, CANCER BIOL THER, V13, P1; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Yang SX, 2010, J CLIN ONCOL, V28, P2974, DOI 10.1200/JCO.2009.26.1602; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Ye G, 2011, J CELL SCI, V124, P359, DOI 10.1242/jcs.072223; Yoo YG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002072; Yoo YG, 2011, CANCER RES, V71, P1244, DOI 10.1158/0008-5472.CAN-10-2360; Zhu F, 2010, HEPATOB PANCREAT DIS, V9, P508; Zumbrunn J, 1996, FEBS LETT, V398, P187, DOI 10.1016/S0014-5793(96)01229-X; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06; Zurawa-Janicka D, 2008, ACTA BIOCHIM POL, V55, P9, DOI 10.18388/abp.2008_3123; Zurawa-Janicka D, 2010, EXPERT OPIN THER TAR, V14, P665, DOI 10.1517/14728222.2010.487867	89	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39446	10.1371/journal.pone.0039446	http://dx.doi.org/10.1371/journal.pone.0039446			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761798	Green Published, Green Submitted, gold			2022-12-27	WOS:000305808700028
J	Ben-Israel, I; Kilian, B; Nida, H; Fridman, E				Ben-Israel, Imri; Kilian, Benjamin; Nida, Habte; Fridman, Eyal			Heterotic Trait Locus (HTL) Mapping Identifies Intra-Locus Interactions That Underlie Reproductive Hybrid Vigor in Sorghum bicolor	PLOS ONE			English	Article							QUANTITATIVE TRAIT; INBREEDING DEPRESSION; YIELD COMPONENTS; GRAIN-SORGHUM; GENETIC-BASIS; MAIZE; ASSOCIATION; RICE; TOMATO; GENOME	Identifying intra-locus interactions underlying heterotic variation among whole-genome hybrids is a key to understanding mechanisms of heterosis and exploiting it for crop and livestock improvement. In this study, we present the development and first use of the heterotic trait locus (HTL) mapping approach to associate specific intra-locus interactions with an overdominant heterotic mode of inheritance in a diallel population using Sorghum bicolor as the model. This method combines the advantages of ample genetic diversity and the possibility of studying non-additive inheritance. Furthermore, this design enables dissecting the latter to identify specific intra-locus interactions. We identified three HTLs (3.5% of loci tested) with synergistic intra-locus effects on overdominant grain yield heterosis in 2 years of field trials. These loci account for 19.0% of the heterotic variation, including a significant interaction found between two of them. Moreover, analysis of one of these loci (hDPW4.1) in a consecutive F2 population confirmed a significant 21% increase in grain yield of heterozygous vs. homozygous plants in this locus. Notably, two of the three HTLs for grain yield are in synteny with previously reported overdominant quantitative trait loci for grain yield in maize. A mechanism for the reproductive heterosis found in this study is suggested, in which grain yield increase is achieved by releasing the compensatory tradeoffs between biomass and reproductive output, and between seed number and weight. These results highlight the power of analyzing a diverse set of inbreds and their hybrids for unraveling hitherto unknown allelic interactions mediating heterosis.	[Ben-Israel, Imri; Nida, Habte; Fridman, Eyal] Hebrew Univ Jerusalem, Fac Agr Food & Environm, Robert H Smith Inst Plant Sci & Genet Agr, IL-91905 Jerusalem, Israel; [Kilian, Benjamin] Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany	Hebrew University of Jerusalem; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Ben-Israel, I (corresponding author), Hebrew Univ Jerusalem, Fac Agr Food & Environm, Robert H Smith Inst Plant Sci & Genet Agr, IL-91905 Jerusalem, Israel.	fridmane@agri.huji.ac.il		Fridman, Eyal/0000-0003-1275-7791; Kilian, Benjamin/0000-0002-9145-6980	Hebrew University [0346591]; Birk Foundation; BARD [GS-16-2011]	Hebrew University; Birk Foundation; BARD	This research was supported by the Hebrew University Innovative grant no. 0346591. E. F. was supported in part by the Birk Foundation. I.B.-I. was supported by a BARD graduate grant no. GS-16-2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MW, 1967, CROP SCI, V7, P505, DOI 10.2135/cropsci1967.0011183X000700050030x; Ben-Israel I, 2009, PLANT PHYSIOL, V151, P1952, DOI 10.1104/pp.109.146415; Bhattramakki D, 2000, GENOME, V43, P988, DOI 10.1139/gen-43-6-988; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brown PJ, 2006, THEOR APPL GENET, V113, P931, DOI 10.1007/s00122-006-0352-9; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Cho YI, 2004, BREEDING SCI, V54, P389, DOI 10.1270/jsbbs.54.389; CHURCHILL GA, 1994, GENETICS, V138, P963; Clark SA, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-18; Cockerham CC, 1996, GENETICS, V143, P1437; Darwin CR, 1876, EFFECTS CROSS SELF F; Doggett H, 1988, SORGHUM, pxviii; Falconer DS, 1996, INTRO QUANTITATIVE G, Vxiii; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Frascaroli E, 2007, GENETICS, V176, P625, DOI 10.1534/genetics.106.064493; Fridman E, 2004, SCIENCE, V305, P1786, DOI 10.1126/science.1101666; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; Hua JP, 2002, GENETICS, V162, P1885; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Huber S, 2009, MOL ECOL, V18, P1523, DOI 10.1111/j.1365-294X.2009.04106.x; Hubner S, 2012, MOL ECOL, V21, P1115, DOI 10.1111/j.1365-294X.2011.05434.x; Jordan DR, 2003, THEOR APPL GENET, V106, P559, DOI 10.1007/s00122-002-1144-5; KAMBAL AE, 1966, CROP SCI, V6, P513, DOI 10.2135/cropsci1966.0011183X000600060004x; KEARSEY MJ, 1965, HEREDITY, V20, P205, DOI 10.1038/hdy.1965.31; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Lariepe A, 2012, GENETICS, V190, P795, DOI 10.1534/genetics.111.133447; Li LZ, 2008, GENETICS, V180, P1725, DOI 10.1534/genetics.108.091942; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Luo LJ, 2001, GENETICS, V158, P1755; MELCHINGER AE, 1990, THEOR APPL GENET, V80, P488, DOI 10.1007/BF00226750; Meyer RC, 2010, THEOR APPL GENET, V120, P227, DOI 10.1007/s00122-009-1074-6; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pea G, 2009, MOL GENET GENOMICS, V281, P447, DOI 10.1007/s00438-008-0422-6; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; QUINBY JR, 1946, AM J BOT, V33, P716, DOI 10.2307/2437497; Quinby JR, 1958, GRAIN SORGHUM PRODUC; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; SCHERTZ KF, 1967, CROP SCI, V7, P540, DOI 10.2135/cropsci1967.0011183X000700050040x; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Smith LM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002164; Srinivas G, 2009, THEOR APPL GENET, V118, P703, DOI 10.1007/s00122-008-0931-z; Tang JH, 2010, THEOR APPL GENET, V120, P333, DOI 10.1007/s00122-009-1213-0; Tesso T, 2011, HEREDITAS, V148, P98, DOI 10.1111/j.1601-5223.2011.02229.x; WILLIAMS W, 1959, NATURE, V184, P527, DOI 10.1038/184527a0; Xin ZG, 2003, BIOTECHNIQUES, V34, P820, DOI 10.2144/03344rr04; YU J, 2011, GENETICS GENOMICS SA; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Yu JM, 2009, PLANT GENOME-US, V2, P2, DOI 10.3835/plantgenome2009.02.0002let; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	54	22	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e38993	10.1371/journal.pone.0038993	http://dx.doi.org/10.1371/journal.pone.0038993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761720	Green Published, gold			2022-12-27	WOS:000305781700015
J	Han, ML; Liu, MR; Wang, YM; Chen, X; Xu, JL; Sun, Y; Zhao, LY; Qu, HB; Fan, YM; Wu, CY				Han, Mingli; Liu, Manran; Wang, Yimeng; Chen, Xin; Xu, Jianli; Sun, Yan; Zhao, Liuyang; Qu, Hongbo; Fan, Yuanming; Wu, Chengyi			Antagonism of miR-21 Reverses Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotype through AKT/ERK1/2 Inactivation by Targeting PTEN	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; MICRORNA-21 TARGETS; IN-VIVO; INVASION; EXPRESSION; AKT; METASTASIS; ACTIVATION; EMT; IDENTIFICATION	Background: Accumulating evidence suggested that epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) characteristics, both of which contribute to tumor invasion and metastasis, are interrelated with miR-21. MiR-21 is one of the important microRNAs associated with tumor progression and metastasis, but the molecular mechanisms underlying EMT and CSC phenotype during miR-21 contributes to migration and invasion of breast cancer cells remain to be elucidated. Methodology/Principal Findings: In this study, MDA-MB-231/anti-miR-21 cells were established by transfected hsa-miR-21 antagomir into breast cancer MDA-MB-231 cells. EMT was evaluated by the changes of mesenchymal cell markers (N-cadherin, Vimentin, and alpha-SMA), epithelial cell marker (E-cadherin), as well as capacities of cell migration and invasion; CSC phenotype was measured using the changes of CSC surface markers (ALDH1 and CD44), and the capacity of sphereforming (mammospheres). We found that antagonism of miR-21 reversed EMT and CSC phenotype, accompanied with PTEN up-regulation and AKT/ERK1/2 inactivation. Interestingly, down-regulation of PTEN by siPTEN suppressed the effects of miR-21 antagomir on EMT and CSC phenotype, confirming that PTEN is a target of miR-21 in reversing EMT and CSC phenotype. The inhibitors of PI3K-AKT and ERK1/2 pathways, LY294002 and U0126, both significantly suppressed EMT and CSC phenotype, indicating that AKT and ERK1/2 pathways are required for miR-21 mediating EMT and CSC phenotype. Conclusions/Significance: In conclusion, our results demonstrated that antagonism of miR-21 reverses EMT and CSC phenotype through targeting PTEN, via inactivation of AKT and ERK1/2 pathways, and showed a novel mechanism of which might relieve the malignant biological behaviors of breast cancer.	[Han, Mingli; Chen, Xin; Qu, Hongbo; Fan, Yuanming; Wu, Chengyi] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine Surg, Chongqing, Peoples R China; [Han, Mingli; Liu, Manran; Sun, Yan; Zhao, Liuyang] Chongqing Med Univ, Minist Educ, Key Lab Lab Med Diagnost, Chongqing, Peoples R China; [Han, Mingli; Liu, Manran; Sun, Yan; Zhao, Liuyang] Chongqing Med Univ, Dept Clin Biochem, Chongqing, Peoples R China; [Wang, Yimeng] Chongqing Med Univ, Affiliated Hosp 1, Dept Emergency, Chongqing, Peoples R China; [Xu, Jianli] Peoples Hosp Jiangjin City, Dept Gen Surg, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Wu, CY (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine Surg, Chongqing, Peoples R China.	wuchengyi1192@163.com			National Natural Science Foundation of China [NSFC 81072147, NSFC 31171336]; Natural Science Foundation of Chongqing Science & Technology Commission, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing Science & Technology Commission, China	This work was supported in part by National Natural Science Foundation of China (NSFC 81072147, NSFC 31171336), the Natural Science Foundation of Chongqing Science & Technology Commission, China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bao B, 2011, CANCER LETT, V307, P26, DOI 10.1016/j.canlet.2011.03.012; Bao B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017850; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Han ML, 2012, MOL CELL BIOCHEM, V363, P427, DOI 10.1007/s11010-011-1195-5; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Latifi A, 2011, J CELL BIOCHEM, V112, P2850, DOI 10.1002/jcb.23199; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Liu MR, 2009, AM J PATHOL, V174, P1910, DOI 10.2353/ajpath.2009.080706; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Pirozzi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021548; Polakis P, 2000, GENE DEV, V14, P1837; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sigurdsson V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023833; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang YK, 2010, CARCINOGENESIS, V31, P1376, DOI 10.1093/carcin/bgq120; Weng LP, 2001, HUM MOL GENET, V10, P605, DOI 10.1093/hmg/10.6.605; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	40	167	178	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39520	10.1371/journal.pone.0039520	http://dx.doi.org/10.1371/journal.pone.0039520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761812	gold, Green Published, Green Submitted			2022-12-27	WOS:000305781700041
J	Tomchuck, SL; Henkle, SL; Coffelt, SB; Betancourt, AM				Tomchuck, Suzanne L.; Henkle, Sarah L.; Coffelt, Seth B.; Betancourt, Aline M.			Toll-Like Receptor 3 and Suppressor of Cytokine Signaling Proteins Regulate CXCR4 and CXCR7 Expression in Bone Marrow-Derived Human Multipotent Stromal Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; UP-REGULATION; STEM/PROGENITOR CELLS; PROMOTING MIGRATION; NEGATIVE REGULATOR; INNATE IMMUNITY; RESPONSES; ACTIVATION; TRANSPLANTATION; INFLAMMATION	Background: The use of bone marrow-derived human multipotent stromal cells (hMSC) in cell-based therapies has dramatically increased in recent years, as researchers have exploited the ability of these cells to migrate to sites of tissue injury, inflammation, and tumors. Our group established that hMSC respond to "danger" signals - by-products of damaged, infected or inflamed tissues - via activation of Toll-like receptors (TLRs). However, little is known regarding downstream signaling mediated by TLRs in hMSC. Methodology/Principal Findings: We demonstrate that TLR3 stimulation activates a Janus kinase (JAK) 2/signal transducer and activator of transcription (STAT) 1 pathway, and increases expression of suppressor of cytokine signaling (SOCS) 1 and SOCS3 in hMSC. Our studies suggest that each of these SOCS plays a distinct role in negatively regulating TLR3 and JAK/STAT signaling. TLR3-mediated interferon regulatory factor 1 (IRF1) expression was inhibited by SOCS3 overexpression in hMSC while SOCS1 overexpression reduced STAT1 activation. Furthermore, our study is the first to demonstrate that when TLR3 is activated in hMSC, expression of CXCR4 and CXCR7 is downregulated. SOCS3 overexpression inhibited internalization of both CXCR4 and CXCR7 following TLR3 stimulation. In contrast, SOCS1 overexpression only inhibited CXCR7 internalization. Conclusion/Significance: These results demonstrate that SOCS1 and SOCS3 each play a functionally distinct role in modulating TLR3, JAK/STAT, and CXCR4/CXCR7 signaling in hMSC and shed further light on the way hMSC respond to danger signals.	[Tomchuck, Suzanne L.; Henkle, Sarah L.; Betancourt, Aline M.] Tulane Univ, Dept Microbiol & Immunol, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Tomchuck, Suzanne L.; Henkle, Sarah L.; Betancourt, Aline M.] Tulane Univ, Tulane Ctr Stem Cell Res & Regenerat Med, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Coffelt, Seth B.] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands	Tulane University; Tulane University; Netherlands Cancer Institute	Tomchuck, SL (corresponding author), Tulane Univ, Dept Microbiol & Immunol, Hlth Sci Ctr, New Orleans, LA 70118 USA.	alibscan@tulane.edu	Coffelt, Seth/O-9929-2019	Coffelt, Seth/0000-0003-2257-2862	National Institutes of Health [1P20RR20152-01]; Department of Defense [OC073102]; Tulane Cancer Center; Center for Stem Cell Research and Regenerative Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Tulane Cancer Center; Center for Stem Cell Research and Regenerative Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was provided by the National Institutes of Health 1P20RR20152-01, Department of Defense OC073102 Concept Award and research support from the Tulane Cancer Center and the Center for Stem Cell Research and Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EJ, 2004, AM J PATHOL, V164, P817, DOI 10.1016/S0002-9440(10)63170-7; Ahmed CMI, 2010, J IMMUNOL, V185, P1103, DOI 10.4049/jimmunol.0902895; Arminan A, 2010, J AM COLL CARDIOL, V55, P2244, DOI 10.1016/j.jacc.2009.08.092; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cho HH, 2006, STEM CELLS, V24, P2744, DOI 10.1634/stemcells.2006-0189; Coffelt SB, 2009, P NATL ACAD SCI USA, V106, P3806, DOI 10.1073/pnas.0900244106; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Dai XJ, 2006, J INVEST DERMATOL, V126, P1574, DOI 10.1038/sj.jid.5700294; Dalpke A, 2008, IMMUNOBIOLOGY, V213, P225, DOI 10.1016/j.imbio.2007.10.008; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Gao H, 2009, STEM CELLS, V27, P857, DOI 10.1002/stem.23; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Garzon R, 2004, J BIOL CHEM, V279, P44460, DOI 10.1074/jbc.M408010200; Kim HK, 2007, INT J HEMATOL, V85, P390, DOI 10.1532/IJH97.A30613; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Le Blanc K, 2007, J INTERN MED, V262, P509, DOI 10.1111/j.1365-2796.2007.01844.x; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Liang J, 2010, NAT REV RHEUMATOL, V6, P486, DOI 10.1038/nrrheum.2010.80; Lim JH, 2010, INT J HEMATOL, V92, P204, DOI 10.1007/s12185-010-0606-9; Liu HB, 2010, BIOCHEM BIOPH RES CO, V401, P509, DOI 10.1016/j.bbrc.2010.09.076; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Martino G, 2010, NAT REV NEUROL, V6, P247, DOI 10.1038/nrneurol.2010.35; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Niyibizi Christopher, 2009, Int J Clin Rheumtol, V4, P57, DOI 10.2217/17584272.4.1.57; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; Panes J, 2010, EXPERT REV CLIN IMMU, V6, P597, DOI [10.1586/eci.10.27, 10.1586/ECI.10.27]; Pello OM, 2006, BLOOD, V108, P3928, DOI 10.1182/blood-2006-02-006353; Pevsner-Fischer M, 2006, BLOOD; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Schlee M, 2006, MOL THER, V14, P463, DOI 10.1016/j.ymthe.2006.06.001; Sharma M, 2011, STEM CELLS DEV, V20, P933, DOI 10.1089/scd.2010.0263; Sioud M, 2007, ADV DRUG DELIVER REV, V59, P153, DOI 10.1016/j.addr.2007.03.006; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Soriano SF, 2002, J EXP MED, V196, P311, DOI 10.1084/jem.20012041; Spaeth E, 2008, GENE THER, V15, P730, DOI 10.1038/gt.2008.39; Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563; Tyndall A, 2009, BONE MARROW TRANSPL, V43, P821, DOI 10.1038/bmt.2009.63; Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001; Uccelli A, 2008, AUTOIMMUNITY, V41, P592, DOI 10.1080/08916930802200166; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Zanin-Zhorov A, 2005, J IMMUNOL, V175, P276, DOI 10.4049/jimmunol.175.1.276; Zeng B, 2008, CANCER RES, V68, P5397, DOI 10.1158/0008-5472.CAN-07-6792	51	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39592	10.1371/journal.pone.0039592	http://dx.doi.org/10.1371/journal.pone.0039592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745793	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900083
J	You, JHS; Tsui, KKN; Wong, RSM; Cheng, G				You, Joyce H. S.; Tsui, Kia K. N.; Wong, Raymond S. M.; Cheng, Gergory			Cost-Effectiveness of Dabigatran versus Genotype-Guided Management of Warfarin Therapy for Stroke Prevention in Patients with Atrial Fibrillation	PLOS ONE			English	Article							NORMALIZED RATIO CONTROL; RE-LY TRIAL; CHINESE PATIENTS; MYOCARDIAL-INFARCTION; ORAL ANTICOAGULATION; PHARMACOGENETIC DATA; ECONOMIC OUTCOMES; RANDOMIZED-TRIAL; EVENTS; PROPHYLAXIS	Background: Dabigatran is associated with lower rate of stroke comparing to warfarin when anticoagulation control is suboptimal. Genotype-guided warfarin dosing and management may improve patient-time in target range (TTR) and therefore affect the cost-effectiveness of dabigatran compared with warfain. We examined the cost-effectiveness of dabigatran versus warfarin therapy with genotype-guided management in patients with atrial fibrillation (AF). Methodology/Principal Findings: A Markov model was designed to compare life-long economic and treatment outcomes of dabigatran (110 mg and 150 mg twice daily), warfarin usual anticoagulation care (usual AC) with mean TTR 64%, and genotype-guided anticoagulation care (genotype-guided AC) in a hypothetical cohort of AF patients aged 65 years old with CHADS(2) score 2. Model inputs were derived from literature. The genotype-guided AC was assumed to achieve TTR = 78.9%, adopting the reported TTR achieved by warfarin service with good anticoagulation control in literature. Outcome measure was incremental cost per quality-adjusted life-year (QALY) gained (ICER) from perspective of healthcare payers. In base-case analysis, dabigatran 150 mg gained higher QALYs than genotype-guided AC (10.065QALYs versus 9.554QALYs) at higher cost (USD92,684 versus USD85,627) with ICER = USD13,810. Dabigatran 110 mg and usual AC gained less QALYs but cost more than dabigatran 150 mg and genotype-guided AC, respectively. ICER of dabigatran 150 mg versus genotype-guided AC would be. USD50,000 (and genotype-guided AC would be most cost-effective) when TTR in genotype-guided AC was >77% and utility value of warfarin was the same or higher than that of dabigatran. Conclusions/Significance: The likelihood of genotype-guided anticoagulation service to be accepted as cost-effective would increase if the quality of life on warfarin and dabigatran therapy are compatible and genotype-guided service achieves high TTR (>77%).	[You, Joyce H. S.; Tsui, Kia K. N.] Chinese Univ Hong Kong, Fac Med, Sch Pharm, Ctr Pharmacoecon Res, Shatin, Hong Kong, Peoples R China; [Wong, Raymond S. M.; Cheng, Gergory] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Div Hematol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	You, JHS (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Pharm, Ctr Pharmacoecon Res, Shatin, Hong Kong, Peoples R China.	joyceyou@cuhk.edu.hk	Wong, Raymond S. M./H-9644-2016; You, Joyce H. S./C-2984-2008	Wong, Raymond S. M./0000-0002-9011-4268; You, Joyce H. S./0000-0002-5763-7403				Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Chan FWH, 2006, BRIT J CLIN PHARMACO, V62, P601, DOI 10.1111/j.1365-2125.2006.02693.x; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000; Connolly SJ, 2010, NEW ENGL J MED, V363, P1875, DOI 10.1056/NEJMc1007378; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Eckman MH, 2009, ANN INTERN MED, V150, P73, DOI 10.7326/0003-4819-150-2-200901200-00005; Epstein RS, 2010, J AM COLL CARDIOL, V55, P2804, DOI 10.1016/j.jacc.2010.03.009; Freeman JV, 2011, ANN INTERN MED, V154, P1, DOI 10.7326/0003-4819-154-1-201101040-00289; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Mark DB, 2008, AM HEART J, V156, P698, DOI 10.1016/j.ahj.2008.05.032; Maurice CB, 2010, CLIN CHIM ACTA, V411, P947, DOI 10.1016/j.cca.2010.03.005; Menzin J, 2005, ANN PHARMACOTHER, V39, P446, DOI 10.1345/aph.1E169; O'Brien CL, 2005, JAMA-J AM MED ASSOC, V293, P699, DOI 10.1001/jama.293.6.699; Shah SV, 2011, CIRCULATION, V123, P2562, DOI 10.1161/CIRCULATIONAHA.110.985655; Sorensen SV, 2011, THROMB HAEMOSTASIS, V105, P908, DOI 10.1160/TH11-02-0089; Tsevat J, 2001, AM HEART J, V141, P727, DOI 10.1067/mhj.2001.114805; Uchino K., 2012, ARCH INTERN MED; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; You JHS, 2009, CLIN PHARMACOL THER, V86, P540, DOI 10.1038/clpt.2009.104; You JHS, 2005, BRIT J CLIN PHARMACO, V59, P582, DOI 10.1111/j.1365-2125.2005.02361.x; You JHS, 2011, EXPERT OPIN PHARMACO, V12, P435, DOI 10.1517/14656566.2011.521153; You JHS, 2011, J THROMB THROMBOLYS, V31, P113, DOI 10.1007/s11239-010-0497-x	26	43	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39640	10.1371/journal.pone.0039640	http://dx.doi.org/10.1371/journal.pone.0039640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745801	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900090
J	Buerki, S; Jose, S; Yadav, SR; Goldblatt, P; Manning, JC; Forest, F				Buerki, Sven; Jose, Sarah; Yadav, Shrirang R.; Goldblatt, Peter; Manning, John C.; Forest, Felix			Contrasting Biogeographic and Diversification Patterns in Two Mediterranean-Type Ecosystems	PLOS ONE			English	Article							GEOGRAPHIC RANGE EVOLUTION; PLASTID DNA; CAPE FLORA; PLANT DIVERSITY; MOLECULAR PHYLOGENETICS; BIODIVERSITY HOTSPOT; DIVERGENCE TIMES; SPECIES RICHNESS; ABSOLUTE RATES; INFERENCE	The five Mediterranean regions of the world comprise almost 50,000 plant species (ca 20% of the known vascular plants) despite accounting for less than 5% of the world's land surface. The ecology and evolutionary history of two of these regions, the Cape Floristic Region and the Mediterranean Basin, have been extensively investigated, but there have been few studies aimed at understanding the historical relationships between them. Here, we examine the biogeographic and diversification processes that shaped the evolution of plant diversity in the Cape and the Mediterranean Basin using a large plastid data set for the geophyte family Hyacinthaceae (comprising ca. 25% of the total diversity of the group), a group found mainly throughout Africa and Eurasia. Hyacinthaceae is a predominant group in the Cape and the Mediterranean Basin both in terms of number of species and their morphological and ecological variability. Using state-of-the-art methods in biogeography and diversification, we found that the Old World members of the family originated in sub-Saharan Africa at the Paleocene-Eocene boundary and that the two Mediterranean regions both have high diversification rates, but contrasting biogeographic histories. While the Cape diversity has been greatly influenced by its relationship with sub-Saharan Africa throughout the history of the family, the Mediterranean Basin had no connection with the latter after the onset of the Mediterranean climate in the region and the aridification of the Sahara. The Mediterranean Basin subsequently contributed significantly to the diversity of neighbouring areas, especially Northern Europe and the Middle East, whereas the Cape can be seen as a biogeographical cul-de-sac, with only a few dispersals toward sub-Saharan Africa. The understanding of the evolutionary history of these two important repositories of biodiversity would benefit from the application of the framework developed here to other groups of plants present in the two regions.	[Buerki, Sven; Jose, Sarah; Forest, Felix] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England; [Yadav, Shrirang R.] Shivaji Univ, Dept Bot, Kolhapur, Maharashtra, India; [Goldblatt, Peter] Missouri Bot Garden, St Louis, MO 63166 USA; [Manning, John C.] S African Natl Biodivers Inst, Kirstenbosch Res Ctr, Compton Herbarium, Claremont, South Africa	Royal Botanic Gardens, Kew; Shivaji University; Missouri Botanical Gardens; South African National Biodiversity Institute	Buerki, S (corresponding author), Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England.	s.buerki@kew.org; f.forest@kew.org	Buerki, Sven/A-8305-2012	Buerki, Sven/0000-0002-8299-6539; Jose, Sarah/0000-0003-2737-6473	Marie Curie Intra-European Fellowship (CRADLE) [253866]; Royal Botanic Gardens, Kew	Marie Curie Intra-European Fellowship (CRADLE); Royal Botanic Gardens, Kew	This project was funded by a Marie Curie Intra-European Fellowship (CRADLE; no 253866) to SB and FF and the Royal Botanic Gardens, Kew. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ali SS, 2012, ANN BOT-LONDON, V109, P95, DOI 10.1093/aob/mcr274; Anderson CL., 2009, TIMETREE LIFE; Andrus N, 2004, TAXON, V53, P333, DOI 10.2307/4135612; Arrigo N, 2011, MOL PHYLOGENET EVOL, V58, P33, DOI 10.1016/j.ympev.2010.11.009; AXELROD DI, 1975, ANN MO BOT GARD, V62, P280, DOI 10.2307/2395199; Brummitt RK, 2001, WORLD GEOGRAPHICAL S; Buerki S, 2011, J BIOGEOGR, V38, P531, DOI 10.1111/j.1365-2699.2010.02432.x; Chase MW, 2009, BOT J LINN SOC, V161, P132, DOI 10.1111/j.1095-8339.2009.00999.x; Comes Hans Peter, 2004, New Phytol, V164, P11, DOI 10.1111/j.1469-8137.2004.01194.x; Cowling R.M., 1992, ECOLOGY FYNBOS NUTR, P62; Cowling RM, 2009, MOL PHYLOGENET EVOL, V51, P64, DOI 10.1016/j.ympev.2008.05.034; COWLING RM, 1987, S AFR J SCI, V83, P106; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Cowling RM, 2002, DIVERS DISTRIB, V8, P163, DOI 10.1046/j.1472-4642.2002.00143.x; Desamore A, 2011, J BIOGEOGR, V38, P164, DOI 10.1111/j.1365-2699.2010.02387.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duggen S, 2003, NATURE, V422, P602, DOI 10.1038/nature01553; Fay MF, 1998, TAXON, V47, P43, DOI 10.2307/1224017; FitzJohn RG, 2010, SYST BIOL, V59, P619, DOI 10.1093/sysbio/syq053; FitzJohn RG, 2009, SYST BIOL, V58, P595, DOI 10.1093/sysbio/syp067; Forest F, 2007, MOL PHYLOGENET EVOL, V43, P60, DOI 10.1016/j.ympev.2006.08.017; Forest F, 2009, ANN BOT-LONDON, V104, P789, DOI 10.1093/aob/mcp192; Friis E. M., 2011, EARLY FLOWERS ANGIOS; Galley C, 2006, J BIOGEOGR, V33, P236, DOI 10.1111/j.1365-2699.2005.01376.x; Goldberg EE, 2011, SYST BIOL, V60, P451, DOI 10.1093/sysbio/syr046; Goldblatt P, 2002, ANN MO BOT GARD, V89, P281, DOI 10.2307/3298566; GOLDBLATT P, 1978, ANN MO BOT GARD, V65, P369, DOI 10.2307/2398858; Goldblatt P, 2002, MOL PHYLOGENET EVOL, V25, P341, DOI 10.1016/S1055-7903(02)00235-X; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnson SD, 2010, PHILOS T R SOC B, V365, P499, DOI 10.1098/rstb.2009.0243; Kim JH, 2010, ANN BOT-LONDON, V106, P775, DOI 10.1093/aob/mcq167; Linder H. P., 1985, SPECIES SPECIATION, V4, P53; Linder HP, 2003, BIOL REV, V78, P597, DOI 10.1017/S1464793103006171; Linder HP, 2005, TRENDS PLANT SCI, V10, P536, DOI 10.1016/j.tplants.2005.09.006; LINDER HP, 1991, J BIOGEOGR, V18, P509, DOI 10.2307/2845687; Lynch Anna H., 2006, Kew Bulletin, V61, P145; Manning JC, 2009, TAXON, V58, P77, DOI 10.1002/tax.581011; Mansion G, 2009, J BIOGEOGR, V36, P1282, DOI 10.1111/j.1365-2699.2009.02082.x; Martinez-Azorin M, 2011, ANN BOT-LONDON, V107, P1, DOI 10.1093/aob/mcq207; Mittermeier RA., 2005, HOTSPOTS REVISITED E, DOI DOI 10.1111/j.1471-8286.2007.01678.x; Muasya AM, 1998, PLANT SYST EVOL, V211, P257, DOI 10.1007/BF00985363; Mummenhoff K, 2005, ANN MO BOT GARD, V92, P400; Nylander JAA., 2004, MRMODELTEST; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pfosser M, 1999, ANN MO BOT GARD, V86, P852, DOI 10.2307/2666172; Pfosser M, 2003, J PLANT RES, V116, P115, DOI 10.1007/s10265-003-0076-8; Pires J. Chris, 2006, Aliso, V22, P287; Rambaut A, 2009, TRACER; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ree RH, 2009, J BIOGEOGR, V36, P1211, DOI 10.1111/j.1365-2699.2008.02068.x; Reeves G, 2001, AM J BOT, V88, P2074, DOI 10.2307/3558433; Richardson JE, 2001, NATURE, V412, P181, DOI 10.1038/35084067; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Salvo G, 2010, SYST BIOL, V59, P705, DOI 10.1093/sysbio/syq046; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Sauquet H, 2009, P NATL ACAD SCI USA, V106, P221, DOI 10.1073/pnas.0805607106; Schnitzler J, 2011, SYST BIOL, V60, P343, DOI 10.1093/sysbio/syr006; SIESSER WG, 1980, SCIENCE, V208, P283, DOI 10.1126/science.208.4441.283; Speta F., 1998, FAMILIES GENERA VASC, P261, DOI [10.1007/978-3-662-03533-7_35, DOI 10.1007/978-3-662-03533-7_35, DOI 10.1007/978-3-662-03533-7_]; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Thompson JD, 2005, PLANT EVOULTION MEDI; Thuiller W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000938; World Checklist of Selected Plant Families, 2011, WORLD CHECKL SEL PLA; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	73	54	56	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39377	10.1371/journal.pone.0039377	http://dx.doi.org/10.1371/journal.pone.0039377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745743	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200069
J	Quertainmont, R; Cantinieaux, D; Botman, O; Sid, S; Schoenen, J; Franzen, R				Quertainmont, Renaud; Cantinieaux, Dorothee; Botman, Olivier; Sid, Selim; Schoenen, Jean; Franzen, Rachelle			Mesenchymal Stem Cell Graft Improves Recovery after Spinal Cord Injury in Adult Rats through Neurotrophic and Pro-Angiogenic Actions	PLOS ONE			English	Article							MARROW STROMAL CELLS; AUTOLOGOUS BONE-MARROW; NERVE GROWTH-FACTOR; PROMOTE FUNCTIONAL RECOVERY; IN-VITRO; GM-CSF; AXONAL REGENERATION; TRANSPLANTATION; EXPRESSION; NEUROPROTECTION	Numerous strategies have been managed to improve functional recovery after spinal cord injury (SCI) but an optimal strategy doesn't exist yet. Actually, it is the complexity of the injured spinal cord pathophysiology that begets the multifactorial approaches assessed to favour tissue protection, axonal regrowth and functional recovery. In this context, it appears that mesenchymal stem cells (MSCs) could take an interesting part. The aim of this study is to graft MSCs after a spinal cord compression injury in adult rat to assess their effect on functional recovery and to highlight their mechanisms of action. We found that in intravenously grafted animals, MSCs induce, as early as 1 week after the graft, an improvement of their open field and grid navigation scores compared to control animals. At the histological analysis of their dissected spinal cord, no MSCs were found within the host despite their BrdU labelling performed before the graft, whatever the delay observed: 7, 14 or 21 days. However, a cytokine array performed on spinal cord extracts 3 days after MSC graft reveals a significant increase of NGF expression in the injured tissue. Also, a significant tissue sparing effect of MSC graft was observed. Finally, we also show that MSCs promote vascularisation, as the density of blood vessels within the lesioned area was higher in grafted rats. In conclusion, we bring here some new evidences that MSCs most likely act throughout their secretions and not via their own integration/differentiation within the host tissue.	[Quertainmont, Renaud; Cantinieaux, Dorothee; Botman, Olivier; Sid, Selim; Schoenen, Jean; Franzen, Rachelle] Univ Liege, GIGA Neurosci, Axonal Regenerat & Cephal Pain Unit, Liege, Belgium	University of Liege	Quertainmont, R (corresponding author), Univ Liege, GIGA Neurosci, Axonal Regenerat & Cephal Pain Unit, Liege, Belgium.	rfranzen@ulg.ac.be			National Fund for Scientific Research (Belgium) [3.4.563.04]; European Community; "Gunter Verbraeckel Foundation" for scientific research on spinal cord injury (private foundation, Belgium)	National Fund for Scientific Research (Belgium)(Fonds de la Recherche Scientifique - FNRS); European Community(European Commission); "Gunter Verbraeckel Foundation" for scientific research on spinal cord injury (private foundation, Belgium)	This work was supported by grant 3.4.563.04 of the National Fund for Scientific Research (Belgium) to JS, the Specific Targeted Research Project 'RESCUE' from the 6th Framework Program of the European Community and the "Gunter Verbraeckel Foundation" for scientific research on spinal cord injury (private foundation, Belgium). RQ is a Formation a la Recherche dans l'Industrie et dans l'Agriculture research fellow from the National Fund for Scientific Research (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augello A, 2010, EUR CELLS MATER, V20, P121; Bakondi B, 2009, MOL THER, V17, P1938, DOI 10.1038/mt.2009.185; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bouhy D, 2006, FASEB J, V20, P1239, DOI 10.1096/fj.05-4382fje; Cao QL, 2010, J NEUROSCI, V30, P2989, DOI 10.1523/JNEUROSCI.3174-09.2010; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Coutts M, 2008, EXP NEUROL, V209, P368, DOI 10.1016/j.expneurol.2007.09.002; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Franzen R, 1998, J NEUROSCI RES, V51, P316, DOI 10.1002/(SICI)1097-4547(19980201)51:3<316::AID-JNR5>3.0.CO;2-J; Franzen R, 1999, NEUROREPORT, V10, P1551, DOI 10.1097/00001756-199905140-00029; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Greco SJ, 2008, BIOL PROCED ONLINE, V10, P90, DOI 10.1251/bpo147; Honmou O, 1996, J NEUROSCI, V16, P3199; Huang X, 2007, NEUROSCI RES, V58, P50, DOI 10.1016/j.neures.2007.01.015; Huang X, 2009, J NEUROL SCI, V277, P87, DOI 10.1016/j.jns.2008.10.022; Iihoshi S, 2004, BRAIN RES, V1007, P1, DOI 10.1016/j.brainres.2003.09.084; Jain A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016135; Jansen BJH, 2010, STEM CELLS DEV, V19, P481, DOI 10.1089/scd.2009.0288; Jin KL, 2003, EXP NEUROL, V184, P78, DOI 10.1016/S0014-4886(03)00133-X; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kishk NA, 2010, NEUROREHAB NEURAL RE, V24, P702, DOI 10.1177/1545968310369801; Kordower JH, 1999, EXP NEUROL, V159, P4, DOI 10.1006/exnr.1999.7156; Krampera M, 2007, BONE, V40, P382, DOI 10.1016/j.bone.2006.09.006; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Li BC, 2011, J NEUROL SCI, V303, P67, DOI 10.1016/j.jns.2011.01.013; Li ZH, 2011, INT J MED SCI, V8, P74, DOI 10.7150/ijms.8.74; Liuzzo JP, 1999, MOL MED, V5, P334, DOI 10.1007/BF03402069; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Luo J, 2009, ACTA NEUROCHIR, V151, P1483, DOI 10.1007/s00701-009-0402-6; Lutton C, 2011, J NEUROTRAUMA; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Martin D, 1996, J NEUROSCI RES, V45, P588; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Neuhuber B, 2008, EXP HEMATOL, V36, P1176, DOI 10.1016/j.exphem.2008.03.019; Nguyen TLX, 2010, EXP MOL MED, V42, P583, DOI 10.3858/emm.2010.42.8.060; Nishio T, 2009, J NEUROL, V256, pS306, DOI 10.1007/s00415-009-5244-x; Ohta M, 2004, EXP NEUROL, V187, P266, DOI 10.1016/j.expneurol.2004.01.021; Osaka M, 2010, BRAIN RES, V1343, P226, DOI 10.1016/j.brainres.2010.05.011; Ousman SS, 2001, J NEUROSCI, V21, P4649, DOI 10.1523/JNEUROSCI.21-13-04649.2001; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Paul C, 2009, SPINE, V34, P328, DOI 10.1097/BRS.0b013e31819403ce; Pettigrew DB, 2007, EXP NEUROL, V203, P95, DOI 10.1016/j.expneurol.2006.07.026; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Potapova IA, 2007, STEM CELLS, V25, P1761, DOI 10.1634/stemcells.2007-0022; Quirici N, 2002, EXP HEMATOL, V30, P783, DOI 10.1016/S0301-472X(02)00812-3; Ra JC, 2011, STEM CELLS DEV; Rabchevsky AG, 1998, MENT RETARD DEV D R, V4, P187, DOI 10.1002/(SICI)1098-2779(1998)4:3<187::AID-MRDD6>3.0.CO;2-L; Raisman G, 2007, CR BIOL, V330, P557, DOI 10.1016/j.crvi.2007.03.010; Reier Paul J, 2004, NeuroRx, V1, P424, DOI 10.1007/BF03206629; Roussos I, 2005, TRANSPL P, V37, P4127, DOI 10.1016/j.transproceed.2005.09.185; Samdani AF, 2009, SPINE, V34, P2605, DOI 10.1097/BRS.0b013e3181bdca87; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Sauerzweig S, 2009, EXP CELL RES, V315, P50, DOI 10.1016/j.yexcr.2008.10.007; Schultz SS, 2005, CURR DRUG TARGETS, V6, P63, DOI 10.2174/1389450053345046; Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402; Sinescu Crina, 2010, J Med Life, V3, P254; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Sundberg LM, 2011, J NEUROTRAUM, V28, P565, DOI 10.1089/neu.2010.1533; Susaki Y, 1996, BLOOD, V88, P4630, DOI 10.1182/blood.V88.12.4630.bloodjournal88124630; Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381; Takahashi Y, 2010, CELL TRANSPLANTATION; Takeuchi H, 2007, NEUROSCI LETT, V426, P69, DOI 10.1016/j.neulet.2007.08.048; Tarasenko YI, 2007, J NEUROSCI RES, V85, P47, DOI 10.1002/jnr.21098; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Tewarie RDSN, 2009, J NEUROTRAUM, V26, P2313, DOI 10.1089/neu.2009.0987; Tobias CA, 2003, EXP NEUROL, V184, P97, DOI 10.1016/S0014-4886(03)00394-7; Uccelli A, 2011, BEST PRACT RES CL HA, V24, P59, DOI 10.1016/j.beha.2011.01.004; Urdzikova L, 2006, J NEUROTRAUM, V23, P1379, DOI 10.1089/neu.2006.23.1379; van Poll D, 2008, CELL MOL BIOENG, V1, P42, DOI 10.1007/s12195-008-0001-2; Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687; Wang TT, 2007, BIOCHEM BIOPH RES CO, V357, P1021, DOI 10.1016/j.bbrc.2007.04.046; Webb AA, 2010, CAN VET J, V51, P485; Wislet-Gendebien S, 2003, J CELL SCI, V116, P3295, DOI 10.1242/jcs.00639; Wislet-Gendebien S, 2005, STEM CELLS, V23, P392, DOI 10.1634/stemcells.2004-0149; Wislet-Gendebien S, 2012, CELL MOL LIFE SCI, V69, P2593, DOI 10.1007/s00018-012-0937-1; Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570; Xu HY, 2010, J NEUROSCI RES, V88, P3598, DOI 10.1002/jnr.22501; Zurita M, 2004, NEUROREPORT, V15, P1105, DOI 10.1097/00001756-200405190-00004	90	160	174	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39500	10.1371/journal.pone.0039500	http://dx.doi.org/10.1371/journal.pone.0039500			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745769	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200083
J	Ghosh, AP; Klocke, BJ; Ballestas, ME; Roth, KA				Ghosh, Arindam P.; Klocke, Barbara J.; Ballestas, Mary E.; Roth, Kevin A.			CHOP Potentially Co-Operates with FOXO3a in Neuronal Cells to Regulate PUMA and BIM Expression in Response to ER Stress	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR CHOP; BH3-ONLY PROTEINS; INDUCED APOPTOSIS; GENE-EXPRESSION; MITOCHONDRIAL APOPTOSIS; SYMPATHETIC NEURONS; DEATH; KINASE	Endoplasmic reticulum (ER) stress-induced apoptosis has been implicated in various neurodegenerative diseases including Parkinson Disease, Alzheimer Disease and Huntington Disease. PUMA (p53 upregulated modulator of apoptosis) and BIM (BCL2 interacting mediator of cell death), pro-apoptotic BH3 domain-only, BCL2 family members, have previously been shown to regulate ER stress-induced cell death, but the upstream signaling pathways that regulate this response in neuronal cells are incompletely defined. Consistent with previous studies, we show that both PUMA and BIM are induced in response to ER stress in neuronal cells and that transcriptional induction of PUMA regulates ER stress-induced cell death, independent of p53. CHOP (C/EBP homologous protein also known as GADD153; gene name Ddit3), a critical initiator of ER stress-induced apoptosis, was found to regulate both PUMA and BIM expression in response to ER stress. We further show that CHOP knockdown prevents perturbations in the AKT (protein kinase B)/FOXO3a (forkhead box, class O, 3a) pathway in response to ER stress. CHOP co-immunoprecipitated with FOXO3a in tunicamycin treated cells, suggesting that CHOP may also regulate other pro-apoptotic signaling cascades culminating in PUMA and BIM activation and cell death. In summary, CHOP regulates the expression of multiple pro-apoptotic BH3-only molecules through multiple mechanisms, making CHOP an important therapeutic target relevant to a number of neurodegenerative conditions.	[Ghosh, Arindam P.; Klocke, Barbara J.; Roth, Kevin A.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Ghosh, Arindam P.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Ballestas, Mary E.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ghosh, AP (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	karoth@uab.edu		Ballestas, Mary/0000-0003-0660-9477; Roth, Kevin/0000-0002-0643-995X	National Institutes of Health [NS 35107, CA 134773, NS 41962]; NATIONAL CANCER INSTITUTE [R01CA134773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041962, R01NS035107, P30NS047466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (NS 35107, CA 134773 and NS 41962). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Akhtar RS, 2006, J NEUROSCI, V26, P7257, DOI 10.1523/JNEUROSCI.0196-06.2006; Amente S, 2011, NUCLEIC ACIDS RES, V39, P9498, DOI 10.1093/nar/gkr638; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bouillet P, 2002, J CELL SCI, V115, P1567; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Dudgeon C, 2010, MOL CANCER THER, V9, P2893, DOI 10.1158/1535-7163.MCT-10-0635; DUKSIN D, 1982, J BIOL CHEM, V257, P3105; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gonzalez VM, 1999, ONCOGENE, V18, P7328, DOI [10.1038/sj.onc.1203159, DOI 10.1038/SJ.ONC.1203159]; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Ji C, 2005, ALCOHOL CLIN EXP RES, V29, P1496, DOI 10.1097/01.alc.0000174691.03751.11; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Kudo T, 2002, ANN NY ACAD SCI, V977, P349, DOI 10.1111/j.1749-6632.2002.tb04837.x; Li DY, 2009, J CEREBR BLOOD F MET, V29, P1903, DOI 10.1038/jcbfm.2009.102; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Maytin EV, 2001, EXP CELL RES, V267, P193, DOI 10.1006/excr.2001.5248; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Namba T, 2009, AM J PATHOL, V174, P1786, DOI 10.2353/ajpath.2009.080864; Ogawa S, 2007, ANTIOXID REDOX SIGN, V9, P573, DOI 10.1089/ars.2006.1516; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Reijonen S, 2008, EXP CELL RES, V314, P950, DOI 10.1016/j.yexcr.2007.12.025; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Roth KA, 1996, J NEUROSCI, V16, P1753; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Silva RM, 2005, J NEUROCHEM, V95, P974, DOI 10.1111/j.1471-4159.2005.03428.x; Smith MI, 2007, CELL DEATH DIFFER, V14, P1011, DOI 10.1038/sj.cdd.4402089; Ubeda M, 1999, MOL CELL BIOL, V19, P7589; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Volchuk A, 2010, DIABETES OBES METAB, V12, P48, DOI 10.1111/j.1463-1326.2010.01271.x; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wyttenbach A, 2006, J NEUROCHEM, V96, P1213, DOI 10.1111/j.1471-4159.2005.03676.x; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Zhu WW, 2004, MOL BRAIN RES, V126, P45, DOI 10.1016/j.molbrainres.2004.03.019; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	54	149	157	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39586	10.1371/journal.pone.0039586	http://dx.doi.org/10.1371/journal.pone.0039586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761832	gold, Green Published, Green Submitted			2022-12-27	WOS:000305826400021
J	Aitsi-Selmi, A; Chandola, T; Friel, S; Nouraei, R; Shipley, MJ; Marmot, MG				Aitsi-Selmi, Amina; Chandola, Tarani; Friel, Sharon; Nouraei, Reza; Shipley, Martin J.; Marmot, Michael G.			Interaction between Education and Household Wealth on the Risk of Obesity in Women in Egypt	PLOS ONE			English	Article							BODY-MASS INDEX; NUTRITION TRANSITION; SOCIOECONOMIC-STATUS; HEALTH; INCOME; OVERWEIGHT; MORBIDITY	Background: Obesity is a growing problem in lower income countries particularly among women. There are few studies exploring individual socioeconomic status indicators in depth. This study examines the interaction of education and wealth in relation to obesity, hypothesising that education protects against the obesogenic effect of wealth. Methods: Four datasets of women of reproductive age from the Egyptian Demographic and Health Surveys spanning the period 1992-2008 are used to examine two distinct time periods: 1992/95 (N = 11097) and 2005/08 (N = 23178). The association in the two time periods between education level and household wealth in relation to the odds of being obese is examined, and the interaction between the two socioeconomic indicators investigated. Estimates are adjusted for age group and area of residence. Results: An interaction was found between the association of education and wealth with obesity in both time periods (P-value for interaction <0.001). For women with the lowest education level, moving up one wealth quintile was associated with a 78% increase in the odds of obesity in 1992/95 (OR; 95% CI: 1.78; 1.65, 1.91) and a 33% increase in 2005/08 (OR; 95% CI: 1.33; 1.26,1.39). For women with the highest level of education, there was little evidence of an association between wealth and obesity (OR; 95% CI: 0.82; 0.57, 1.16 in 1992/95 and 0.95; 0.84, 1.08 in 2005/08). Obesity levels increased most in women who were in the no/primary education, poorest wealth quintile and rural groups (absolute difference in prevalence percentage points between the two time periods: 20.2, 20.1, and 21.3 respectively). Conclusion: In the present study, wealth appears to be a risk factor for obesity in women with lower education levels, while women with higher education are protected. The findings also suggest that a reversal in the social distribution of obesity risk is occurring which can be explained by the large increase in obesity levels in lower socioeconomic groups between the two time periods.	[Aitsi-Selmi, Amina; Friel, Sharon; Shipley, Martin J.; Marmot, Michael G.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Chandola, Tarani] Univ Manchester, Cathie Marsh Ctr Census & Survey Res, Manchester, Lancs, England; [Friel, Sharon] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Nouraei, Reza] Imperial Coll Healthcare NHS Trust, Dept Surg, London, England	University of London; University College London; University of Manchester; Australian National University; Imperial College London	Aitsi-Selmi, A (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	a.aitsi-selmi@ucl.ac.uk	Marmot, M G/Y-3920-2019; Nouraei, Reza/W-3557-2017; Chandola, Tarani/I-3192-2013	Marmot, M G/0000-0002-2431-6419; Nouraei, Reza/0000-0002-5604-1739; Chandola, Tarani/0000-0002-1864-3413; Friel, Sharon/0000-0002-8345-5435	Wellcome Trust [WT088536MA]; British Heart Foundation; MRC; ESRC [ES/G002452/1, ES/H024972/1] Funding Source: UKRI; MRC [G0902037] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Economic and Social Research Council [ES/G002452/1, ES/H024972/1] Funding Source: researchfish; Medical Research Council [G0902037, G0100222, G19/35, G8802774] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Amina Aitsi-Selmi is funded by a Wellcome Trust clinical Research Training Fellowship (Grant no WT088536MA) to complete a doctoral thesis at University College London on obesity, which includes the analysis presented in this paper. Further information about this grant is available from http://www.wellcome.ac.uk/Funding/. Martin Shipley is supported by the British Heart Foundation. Michael Marmot is supported by a MRC professorship. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitsi-Selmi A, 2009, COMMUNICATION   1102; Asfaw A, 2007, WORLD DEV, V35, P687, DOI 10.1016/j.worlddev.2006.05.005; Austin AM, 2013, MATERN CHILD NUTR, V9, P167, DOI 10.1111/j.1740-8709.2011.00346.x; Bieler GS, 2010, AM J EPIDEMIOL, V171, P618, DOI 10.1093/aje/kwp440; Carbonates in Egypt, 2011, CARBONATES EGYPT; Chen R, 2011, INT J GERIATRIC PSYC; Dahly DL, 2010, J NUTR, V140, P366, DOI 10.3945/jn.109.114207; Dawoud S, 2005, THESIS KIEL U; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Ebrahim S, 2004, BMJ-BRIT MED J, V328, P861, DOI 10.1136/bmj.38034.702836.55; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Fernald LCH, 2008, J NUTR, V138, P2250, DOI 10.3945/jn.108.090506; Galal A., 2002, PARADOX ED UNEMPLOYM; Galal OM, 2002, PUBLIC HEALTH NUTR, V5, P141, DOI 10.1079/PHN2001286; Gluckman PD, 2008, FRONT HORM RES, V36, P61, DOI 10.1159/000115337; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hatt LE, 2006, SOC SCI MED, V62, P375, DOI 10.1016/j.socscimed.2005.06.007; Hou XH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-389; James P, 2006, NUTR REV, V64, pS1, DOI 10.1301/nr.2006.may.S1-S11; Jones-Smith JC, 2012, INT J OBESITY, V36, P1114, DOI 10.1038/ijo.2011.179; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P433, DOI 10.1007/s10654-011-9554-9; Marmot M, 2001, J EPIDEMIOL COMMUN H, V55, P301, DOI 10.1136/jech.55.5.301; Martorell R, 2000, EUR J CLIN NUTR, V54, P247, DOI 10.1038/sj.ejcn.1600931; Mirowsky J., 2003, ED SOCIAL STATUS HLT; Molarius A, 2000, AM J PUBLIC HEALTH, V90, P1260, DOI 10.2105/AJPH.90.8.1260; Monteiro C, 2004, INT J OBESITY, V28, P1181, DOI 10.1038/sj.ijo.0802716; Monteiro CA, 2001, J NUTR, V131, p881S, DOI 10.1093/jn/131.3.881S; Musaiger AO, 2011, J OBES, V2011, DOI 10.1155/2011/407237; Neuman M, 2011, AM J CLIN NUTR, V94, P1348, DOI 10.3945/ajcn.111.018127; Popkin BM, 2002, PUBLIC HEALTH NUTR, V5, P205, DOI 10.1079/PHN2001295; Poterico JA, 2012, OBESITY, V20, P2283, DOI 10.1038/oby.2011.288; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; Rosen S, 2008, OBESITY MIDST UNYIEL; Rutstein SO, 2004, 6 ORC MACR; Sen G, 2009, J HUM DEV CAPABIL, V10, P397, DOI 10.1080/19452820903048894; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Soft drinks in Egypt, 2012, EUR COUNTR REP; Subramanian SV, 2011, AM J CLIN NUTR, V93, P413, DOI 10.3945/ajcn.110.004820; [United Nations Population Division DESA], WORLD MARR DAT; Ziraba AK, 2009, BMC PUBLIC HEALTH, V9, P465, DOI DOI 10.1186/1471-2458-9-465; Zohry G, 2002, THESIS U SUSSEX; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	43	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39507	10.1371/journal.pone.0039507	http://dx.doi.org/10.1371/journal.pone.0039507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966GL	22761807	Green Published, gold			2022-12-27	WOS:000305825800039
J	Stoner, KA; Eitzer, BD				Stoner, Kimberly A.; Eitzer, Brian D.			Movement of Soil-Applied Imidacloprid and Thiamethoxam into Nectar and Pollen of Squash (Cucurbita pepo)	PLOS ONE			English	Article							PEPONAPIS-PRUINOSA HYMENOPTERA; HONEY-BEES; SYSTEMIC INSECTICIDES; APIS-MELLIFERA; BUMBLE BEES; EXPOSURE; PUMPKIN; POLLINATORS; SUNFLOWERS; RESIDUES	There has been recent interest in the threat to bees posed by the use of systemic insecticides. One concern is that systemic insecticides may translocate from the soil into pollen and nectar of plants, where they would be ingested by pollinators. This paper reports on the movement of two such systemic neonicotinoid insecticides, imidacloprid and thiamethoxam, into the pollen and nectar of flowers of squash (Cucurbita pepo cultivars "Multipik," "Sunray" and "Bush Delicata") when applied to soil by two methods: (1) sprayed into soil before seeding, or (2) applied through drip irrigation in a single treatment after transplant. All insecticide treatments were within labeled rates for these compounds. Pollen and nectar samples were analyzed using a standard extraction method widely used for pesticides (QuEChERS) and liquid chromatography mass spectrometric analysis. The concentrations found in nectar, 10 +/- 3 ppb (mean +/- s.d) for imidacloprid and 11 +/- 6 ppb for thiamethoxam, are higher than concentrations of neonicotinoid insecticides in nectar of canola and sunflower grown from treated seed, and similar to those found in a recent study of neonicotinoids applied to pumpkins at transplant and through drip irrigation. The concentrations in pollen, 14 +/- 8 ppb for imidacloprid and 12 +/- 9 ppb for thiamethoxam, are higher than those found for seed treatments in most studies, but at the low end of the range found in the pumpkin study. Our concentrations fall into the range being investigated for sublethal effects on honey bees and bumble bees.	[Stoner, Kimberly A.] Connecticut Agr Expt Stn, Dept Entomol, New Haven, CT 06504 USA; [Eitzer, Brian D.] Connecticut Agr Expt Stn, Dept Analyt Chem, New Haven, CT 06504 USA	Connecticut Agricultural Experiment Station; Connecticut Agricultural Experiment Station	Stoner, KA (corresponding author), Connecticut Agr Expt Stn, Dept Entomol, POB 1106, New Haven, CT 06504 USA.	Kimberly.Stoner@ct.gov	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216; Stoner, Kimberly/0000-0003-1248-7082	Project Apis m	Project Apis m	This study was supported by a grant from Project Apis m. (URL: www.ProjectApism.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Artz DR, 2011, J ECON ENTOMOL, V104, P1153, DOI 10.1603/EC10431; Bonmatin JM, 2005, J AGR FOOD CHEM, V53, P5336, DOI 10.1021/jf0479362; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; Fischer D., 2011, PESTICIDE RISK ASSES; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Halm MP, 2006, ENVIRON SCI TECHNOL, V40, P2448, DOI 10.1021/es051392i; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Julier HE, 2009, J ECON ENTOMOL, V102, P563, DOI 10.1603/029.102.0214; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Laurent FM, 2003, J AGR FOOD CHEM, V51, P8005, DOI 10.1021/jf034310n; Lehotay SJ, 2005, METH BIOTEC, V19, P239; Macintyre AJK, 2001, J VEGET CROP PROD, V7, P83; Maxim L, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014006; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; National Research Council, 2007, STAT POLL N AM; Nepi M, 2001, INT J PLANT SCI, V162, P353, DOI 10.1086/319581; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Schnier Heinz Friedrich, 2003, Bulletin of Insectology, V56, P73; Shuler RE, 2005, J ECON ENTOMOL, V98, P790, DOI 10.1603/0022-0493-98.3.790; SYSTAT, 2009, SYSTAT; Tapparo A, 2011, J ENVIRON MONITOR, V13, P1564, DOI 10.1039/c1em10085h; vanEngelsdorp D, 2011, J APICULT RES, V50, P1, DOI 10.3896/IBRA.1.50.1.01; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; WILLIS DS, 1995, CAN ENTOMOL, V127, P167, DOI 10.4039/Ent127167-2	33	161	175	2	224	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39114	10.1371/journal.pone.0039114	http://dx.doi.org/10.1371/journal.pone.0039114			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761727	Green Published, gold			2022-12-27	WOS:000305825800019
J	Taylor, BM; McIlwain, JL; Kerr, AM				Taylor, Brett M.; McIlwain, Jennifer L.; Kerr, Alexander M.			Marine Reserves and Reproductive Biomass: A Case Study of a Heavily Targeted Reef Fish	PLOS ONE			English	Article							GREAT-BARRIER-REEF; PROTECTED AREAS; LONG-TERM; FISHERIES MANAGEMENT; LIFE-HISTORY; RECOVERY; SIZE; AGE; DEMOGRAPHY; ABUNDANCE	Recruitment overfishing (the reduction of a spawning stock past a point at which the stock can no longer replenish itself) is a common problem which can lead to a rapid and irreversible fishery collapse. Averting this disaster requires maintaining a sufficient spawning population to buffer stochastic fluctuations in recruitment of heavily harvested stocks. Optimal strategies for managing spawner biomass are well developed for temperate systems, yet remain uncertain for tropical fisheries, where the danger of collapse from recruitment overfishing looms largest. In this study, we explored empirically and through modeling, the role of marine reserves in maximizing spawner biomass of a heavily exploited reef fish, Lethrinus harak around Guam, Micronesia. On average, spawner biomass was 16 times higher inside the reserves compared with adjacent fished sites. Adult density and habitat-specific mean fish size were also significantly greater. We used these data in an age-structured population model to explore the effect of several management scenarios on L. harak demography. Under minimum-size limits, unlimited extraction and all rotational-closure scenarios, the model predicts that preferential mortality of larger and older fish prompt dramatic declines in spawner biomass and the proportion of male fish, as well as considerable declines in total abundance. For rotational closures this occurred because of the mismatch between the scales of recovery and extraction. Our results highlight how alternative management scenarios fall short in comparison to marine reserves in preserving reproductively viable fish populations on coral reefs.	[Taylor, Brett M.; Kerr, Alexander M.] Univ Guam, Marine Lab, Mangilao, GU 96923 USA; [Taylor, Brett M.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [McIlwain, Jennifer L.] Curtin Univ Technol, Dept Environm & Agr, Perth, WA, Australia; [Kerr, Alexander M.] Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia	University of Guam; James Cook University; Curtin University	Taylor, BM (corresponding author), Univ Guam, Marine Lab, Mangilao, GU 96923 USA.	brettmtaylor@gmail.com	McIlwain, Jennifer L/J-9179-2012; Taylor, Brett/AAC-6787-2019	McIlwain, Jennifer L/0000-0002-7790-5081; Taylor, Brett/0000-0002-4746-7228	U.S. Fish and Wildlife's Federal Assistance in Sportfish Restoration Program [F-14R-1, F-14R-10]; Western Pacific Coral Reef Institute	U.S. Fish and Wildlife's Federal Assistance in Sportfish Restoration Program; Western Pacific Coral Reef Institute	Financial support was provided by the U.S. Fish and Wildlife's Federal Assistance in Sportfish Restoration Program to the Guam Department of Agriculture, grant numbers F-14R-1 and F-14R-10. Further financial support was provided by the Western Pacific Coral Reef Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala AC, 2005, CAN J FISH AQUAT SCI, V62, P98, DOI 10.1139/F04-176; [Anonymous], 2006, U GUAM MARINE LAB MU; Armsworth PR, 2001, CAN J FISH AQUAT SCI, V58, P568, DOI 10.1139/cjfas-58-3-568; Ault JS, 2005, ICES J MAR SCI, V62, P417, DOI 10.1016/j.icesjms.2004.12.001; BELL JD, 1985, CORAL REEFS, V4, P41, DOI 10.1007/BF00302203; Berkeley SA, 2004, ECOLOGY, V85, P1258, DOI 10.1890/03-0706; Beverton R.J.H., 1957, FISH INVEST SER, P19; Birkeland C, 1997, U HAWAII SEA GRANT P, P91; Bobko SJ, 2004, FISH B-NOAA, V102, P418; Bohnsack JA, 2000, B MAR SCI, V66, P635; Brooks EN, 2008, FISH B-NOAA, V106, P12; Burdick DR, 2008, STATE CORAL REEF ECO, P413; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Claudet J, 2010, ECOL APPL, V20, P830, DOI 10.1890/08-2131.1; Coleman FC, 2000, FISHERIES, V25, P14, DOI 10.1577/1548-8446(2000)025<0014:LRF>2.0.CO;2; DEMARTINI EE, 1993, FISH B-NOAA, V91, P414; Ebisawa A, 2006, ICHTHYOL RES, V53, P269, DOI 10.1007/s10228-006-0345-3; Ebisawa A, 2009, FISHERIES SCI, V75, P553, DOI 10.1007/s12562-009-0061-9; Evans RD, 2004, AQUAT CONSERV, V14, P505, DOI 10.1002/aqc.631; FERREIRA BP, 1995, FISH B-NOAA, V93, P629; Gaines SD, 2003, ECOL APPL, V13, pS32; Galzin R, ATOLL RES B, V305, P21; Grandcourt EM, 2006, FISH B-NOAA, V104, P75; Guenette S, 1999, FISH RES, V39, P295, DOI 10.1016/S0165-7836(98)00173-8; Haddon M., 2011, MODELLING QUANTITATI; Haedrich RL, 1997, FISH RES, V31, P229, DOI 10.1016/S0165-7836(97)00023-4; Halpern BS, 2004, ECOL APPL, V14, P1248, DOI 10.1890/03-5136; Halpern BS, 2003, ECOL APPL, V13, pS117; Hart DR, 2003, FISH B-NOAA, V101, P44; Hawkins JP, 2004, BIOL CONSERV, V115, P213, DOI 10.1016/S0006-3207(03)00119-8; Hensley R.A., 1993, MAR FISH REV, V55, P129; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; Hilborn R, 2004, MAR ECOL PROG SER, V274, P275; Huntsman Gene R., 1994, North American Journal of Fisheries Management, V14, P41, DOI 10.1577/1548-8675(1994)014<0041:SOTIOF>2.3.CO;2; Jennings S, 1996, BIOL CONSERV, V75, P201, DOI 10.1016/0006-3207(95)00081-X; Johannes R.E., 1981, WORDS LAGOON FISHING; Kingsford M.J., 1998, P49; Kleczkowski M, 2008, MAR FRESHWATER RES, V59, P165, DOI 10.1071/MF07093; Mace PM, 2004, MAR ECOL PROG SER, V274, P285; MAN A, 1995, BIOL CONSERV, V71, P197, DOI 10.1016/0006-3207(94)00047-T; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2010, CONSERV BIOL, V24, P1519, DOI 10.1111/j.1523-1739.2010.01530.x; McClanahan TR, 2000, BIOL CONSERV, V94, P191, DOI 10.1016/S0006-3207(99)00176-7; McClanahan TR, 2005, MAR ECOL PROG SER, V294, P241, DOI 10.3354/meps294241; MCCORMICK MI, 1987, MAR BIOL, V96, P469, DOI 10.1007/BF00397964; Meekan MG, 2001, MAR ECOL PROG SER, V212, P223, DOI 10.3354/meps212223; Munro John L., 1996, Fish and Fisheries Series, V20, P1; Murawski SA, 2000, B MAR SCI, V66, P775; Myers RA, 2000, CAN J FISH AQUAT SCI, V57, P2357, DOI 10.1139/cjfas-57-12-2357; Nanami A, 2009, FISHERIES SCI, V75, P1109, DOI 10.1007/s12562-009-0136-7; Neyman J, 1934, J R STAT SOC, V97, P558, DOI 10.2307/2342192; Nowlis JS, 2000, B MAR SCI, V66, P651; Pears RJ, 2006, MAR ECOL PROG SER, V307, P259, DOI 10.3354/meps307259; Pelc RA, 2010, P NATL ACAD SCI USA, V107, P18266, DOI 10.1073/pnas.0907368107; Polacheck T., 1990, NAT RESOUR MODEL, V4, P327; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Quinn GP, 2003, EXPT DESIGN DATA ANA; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Russ GR, 2005, MAR ECOL PROG SER, V292, P1, DOI 10.3354/meps292001; Russ GR, 2004, OECOLOGIA, V138, P622, DOI 10.1007/s00442-003-1456-4; Russ GR, 1996, ECOL APPL, V6, P947, DOI 10.2307/2269497; STAMPS JA, 1987, AM NAT, V129, P533, DOI 10.1086/284656; Taylor BM, 2008, EFFECTS PROTECTED AR; Taylor BM, 2010, MAR ECOL PROG SER, V411, P243, DOI 10.3354/meps08672; Trip EL, 2008, MAR ECOL PROG SER, V373, P97, DOI 10.3354/meps07755; Wantiez L, 1997, CORAL REEFS, V16, P215, DOI 10.1007/s003380050077; Williams ID, 2006, MAR ECOL PROG SER, V310, P139, DOI 10.3354/meps310139; Williamson DH, 2004, ENVIRON CONSERV, V31, P149, DOI 10.1017/S0376892904001262	68	18	18	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39599	10.1371/journal.pone.0039599	http://dx.doi.org/10.1371/journal.pone.0039599			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761836	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000305808700037
J	Tiwari, V; Vashistt, J; Kapil, A; Moganty, RR				Tiwari, Vishvanath; Vashistt, Jitendraa; Kapil, Arti; Moganty, Rajeswari R.			Comparative Proteomics of Inner Membrane Fraction from Carbapenem-Resistant Acinetobacter baumannii with a Reference Strain	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEIN COMPLEXES; BETA-LACTAMASES; OVEREXPRESSION; IDENTIFICATION; MORTALITY; INFECTION; INSERTION; PORINS; GROWTH	Acinetobacter baumannii has been identified by the Infectious Diseases Society of America as one of the six pathogens that cause majority of hospital infections. Increased resistance of A. baumannii even to the latest generation of beta-lactams like carbapenem is an immediate threat to mankind. As inner-membrane fraction plays a significant role in survival of A. baumannii, we investigated the inner-membrane fraction proteome of carbapenem-resistant strain of A. baumannii using Differential In-Gel Electrophoresis (DIGE) followed by DeCyder, Progenesis and LC-MS/MS analysis. We identified 19 over-expressed and 4 down-regulated proteins (fold change>2, p<0.05) in resistant strain as compared to reference strain. Some of the upregulated proteins in resistant strain and their association with carbapenem resistance in A. baumannii are: i) beta-lactamases, AmpC and OXA-51: cleave and inactivate carbapenem ii) metabolic enzymes, ATP synthase, malate dehydrogenase and 2-oxoglutarate dehydrogenase: help in increased energy production for the survival and iii) elongation factor Tu and ribosomal proteins: help in the overall protein production. Further, entry of carbapenem perhaps is limited by controlled production of OmpW and low levels of surface antigen help to evade host defence mechanism in developing resistance in A. baumannii. Present results support a model for the importance of proteins of inner-membrane fraction and their synergistic effect in the mediation of resistance of A. baumannii to carbapenem.	[Tiwari, Vishvanath; Vashistt, Jitendraa; Moganty, Rajeswari R.] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Kapil, Arti] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Tiwari, V (corresponding author), All India Inst Med Sci, Dept Biochem, New Delhi 110029, India.	rajeswari3011@hotmail.com	Tiwari, Vishvanath/W-8175-2018	Tiwari, Vishvanath/0000-0003-1664-3871	Indian Council of Medical Research, New Delhi, India [ICMR-5/3/3/18/2009-ECD-I]; Council of Scientific and Industrial Research, India [09/006(0361)/2006-EMR-1]	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	Present work was funded by Indian Council of Medical Research, New Delhi, India, grant number: ICMR-5/3/3/18/2009-ECD-I. URL of funder's website: http://www.icmr.nic.in/. VT wishes to thank the Council of Scientific and Industrial Research, India, for providing fellowship (09/006(0361)/2006-EMR-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Alteri CJ, 2007, INFECT IMMUN, V75, P2679, DOI 10.1128/IAI.00076-06; Bisle B, 2006, MOL CELL PROTEOMICS, V5, P1543, DOI 10.1074/mcp.M600106-MCP200; Breckau D, 2003, J BIOL CHEM, V278, P46625, DOI 10.1074/jbc.M308553200; Brown S, 2005, CLIN MICROBIOL INFEC, V11, P15, DOI 10.1111/j.1469-0691.2004.01016.x; Cardoso K, 2010, J MED MICROBIOL, V59, P1061, DOI 10.1099/jmm.0.020339-0; Castro ME, 2009, BIOCHEM BIOPH RES CO, V380, P148, DOI 10.1016/j.bbrc.2009.01.078; Chuang YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014133; CONSTANTINIU S, 2004, J PREV MED, V12, P35; Dalla-Costa LM, 2003, J CLIN MICROBIOL, V41, P3403, DOI 10.1128/JCM.41.7.3403-3406.2003; dos Santos KV, 2010, RES MICROBIOL, V161, P268, DOI 10.1016/j.resmic.2010.03.006; Echave P, 2003, J BIOL CHEM, V278, P30193, DOI 10.1074/jbc.M304351200; Falagas ME, 2006, CLIN INFECT DIS, V43, P389, DOI 10.1086/505599; Fan Y, 2011, J PROTEOME RES, V10, P1361, DOI 10.1021/pr1011069; Fernandez-Cuenca F, 2003, J ANTIMICROB CHEMOTH, V51, P565, DOI 10.1093/jac/dkg097; Fernandez-Reyes M, 2009, PROTEOMICS, V9, P1632, DOI 10.1002/pmic.200800434; Figueiredo S, 2009, ANTIMICROB AGENTS CH, V53, P4045, DOI 10.1128/AAC.00292-09; Figueiredo S, 2009, ANTIMICROB AGENTS CH, V53, P2657, DOI 10.1128/AAC.01663-08; FILIP C, 1973, J BACTERIOL, V115, P717, DOI 10.1128/JB.115.3.717-722.1973; Fishbain J, 2010, CLIN INFECT DIS, V51, P79, DOI 10.1086/653120; Garcia-Garmendia JL, 2001, CLIN INFECT DIS, V33, P939, DOI 10.1086/322584; Garcia-Garmendia JL, 1999, CRIT CARE MED, V27, P1794, DOI 10.1097/00003246-199909000-00015; Garduno RA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00122; Gupta E, 2006, INDIAN J MED RES, V124, P95; Harms JM, 2003, J CELL SCI, V116, P1391, DOI 10.1242/jcs.00365; Heritier C, 2006, CLIN MICROBIOL INFEC, V12, P123, DOI 10.1111/j.1469-0691.2005.01320.x; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Kang YY, 2009, J PROTEOME RES, V8, P1077, DOI 10.1021/pr800588f; Karageorgopoulos DE, 2008, LANCET INFECT DIS, V8, P751, DOI 10.1016/S1473-3099(08)70279-2; Kim K, 1998, J BACTERIOL, V180, P3692, DOI 10.1128/JB.180.14.3692-3696.1998; Kohlenberg A, 2009, J MED MICROBIOL, V58, P1499, DOI 10.1099/jmm.0.012302-0; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Lee HY, 2011, INT J ANTIMICROB AG, V37, P302, DOI 10.1016/j.ijantimicag.2010.12.015; Madeira A, 2011, PROTEOMICS, V11, P1313, DOI 10.1002/pmic.201000457; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Marti S, 2006, PROTEOMICS, V6, pS82, DOI 10.1002/pmic.200500323; Martinez-Martinez L, 1999, ANTIMICROB AGENTS CH, V43, P1669, DOI 10.1128/AAC.43.7.1669; Nieves W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014361; Nikaido H, 1999, J BACTERIOL, V181, P4, DOI 10.1128/JB.181.1.4-8.1999; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Pieper R, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-5; Rodriguez-Martinez JM, 2010, ANTIMICROB AGENTS CH, V54, P4930, DOI 10.1128/AAC.00427-10; Santos KV, 2011, J CHEMOTHERAPY, V23, P135, DOI 10.1179/joc.2011.23.3.135; Seneviratne CJ, 2010, PROTEOMICS, V10, P1444, DOI 10.1002/pmic.200900611; Shen CJ, 2010, J APPL MICROBIOL, V108, P1398, DOI 10.1111/j.1365-2672.2009.04544.x; Shin JH, 2009, J MICROBIOL, V47, P728, DOI 10.1007/s12275-009-0158-y; Siroy A, 2005, ANTIMICROB AGENTS CH, V49, P4876, DOI 10.1128/AAC.49.12.4876-4883.2005; Siroy A, 2006, J PROTEOME RES, V5, P3385, DOI 10.1021/pr060372s; Soares NC, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-37; Stenberg F, 2005, J BIOL CHEM, V280, P34409, DOI 10.1074/jbc.M506479200; Suri A, 2000, NATL MED J INDIA, V13, P296; Tiwari V, 2012, MICROB PATHOGENESIS, V53, P81, DOI 10.1016/j.micpath.2012.05.004; Vashist J, 2011, INDIAN J MED RES, V133, P332; Vashist J, 2010, J PROTEOME RES, V9, P1121, DOI 10.1021/pr9011188; Vila J, 2008, EXPERT OPIN PHARMACO, V9, P587, DOI 10.1517/14656566.9.4.587; Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509; Yun SH, 2011, J PROTEOME RES, V10, P459, DOI 10.1021/pr101012s	57	50	51	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39451	10.1371/journal.pone.0039451	http://dx.doi.org/10.1371/journal.pone.0039451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761799	Green Submitted, gold, Green Published			2022-12-27	WOS:000305808700029
J	Auld, SKJR; Hall, SR; Duffy, MA				Auld, Stuart K. J. R.; Hall, Spencer R.; Duffy, Meghan A.			Epidemiology of a Daphnia-Multiparasite System and Its Implications for the Red Queen	PLOS ONE			English	Article							HOST GENETIC DIVERSITY; PASTEURIA-RAMOSA; GENOTYPE INTERACTIONS; POPULATION BIOLOGY; PARASITE FITNESS; RAPID EVOLUTION; MAGNA; VIRULENCE; DISEASE; RESISTANCE	The Red Queen hypothesis can explain the maintenance of host and parasite diversity. However, the Red Queen requires genetic specificity for infection risk (i.e., that infection depends on the exact combination of host and parasite genotypes) and strongly virulent effects of infection on host fitness. A European crustacean (Daphnia magna) - bacterium (Pasteuria ramosa) system typifies such specificity and high virulence. We studied the North American host Daphnia dentifera and its natural parasite Pasteuria ramosa, and also found strong genetic specificity for infection success and high virulence. These results suggest that Pasteuria could promote Red Queen dynamics with D. dentifera populations as well. However, the Red Queen might be undermined in this system by selection from a more common yeast parasite (Metschnikowia bicuspidata). Resistance to the yeast did not correlate with resistance to Pasteuria among host genotypes, suggesting that selection by Metschnikowia should proceed relatively independently of selection by Pasteuria.	[Auld, Stuart K. J. R.; Duffy, Meghan A.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Hall, Spencer R.] Indiana Univ, Dept Biol, Bloomington, IN USA	University System of Georgia; Georgia Institute of Technology; Indiana University System; Indiana University Bloomington	Auld, SKJR (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	stuart.auld@biology.gatech.edu	Duffy, Meghan A/A-9376-2008; Auld, Stuart/J-8217-2012; Duffy, Meghan/AFN-5376-2022; Auld, Stuart KJR/N-1911-2019; Duffy, Meghan A/E-6867-2016	Auld, Stuart/0000-0001-6865-3743; Duffy, Meghan/0000-0002-8142-0802; Auld, Stuart KJR/0000-0001-6691-7442; Duffy, Meghan A/0000-0002-8142-0802	National Science Foundation [DEB-0841679, DEB-1053525, DEB-0841817]; Georgia Institute of Technology	National Science Foundation(National Science Foundation (NSF)); Georgia Institute of Technology	The authors received funding from the National Science Foundation (DEB-0841679 and DEB-1053525 to MAD; DEB-0841817 to SRH) and from the Georgia Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermatt F, 2008, ECOL LETT, V11, P918, DOI 10.1111/j.1461-0248.2008.01203.x; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Auld SKJR, 2012, FUNCT ECOL, V26, P434, DOI 10.1111/j.1365-2435.2011.01959.x; Auld SKJR, 2010, P ROY SOC B-BIOL SCI, V277, P3291, DOI 10.1098/rspb.2010.0772; Ben-Ami F, 2008, EVOLUTION, V62, P1700, DOI 10.1111/j.1558-5646.2008.00391.x; Byers DL, 2005, GENETICA, V123, P107, DOI 10.1007/s10709-003-2721-5; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; Clay K, 1996, ANNU REV PHYTOPATHOL, V34, P29, DOI 10.1146/annurev.phyto.34.1.29; Decaestecker E, 2003, EVOLUTION, V57, P784, DOI 10.1111/j.0014-3820.2003.tb00290.x; Decaestecker E, 2007, NATURE, V450, P870, DOI 10.1038/nature06291; Duffy MA, 2008, AM NAT, V171, P499, DOI 10.1086/528998; Duffy MA, 2007, ECOL LETT, V10, P44, DOI 10.1111/j.1461-0248.2006.00995.x; Duffy MA, 2012, SCIENCE, V335, P1636, DOI 10.1126/science.1215429; Duffy MA, 2010, ECOLOGY, V91, P3322, DOI 10.1890/09-1611.1; Duffy MA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-80; Duncan AB, 2007, EVOLUTION, V61, P796, DOI 10.1111/j.1558-5646.2007.00072.x; Duneau D, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-11; Dwyer G, 1997, AM NAT, V150, P685, DOI 10.1086/286089; Ebert D, 2000, OECOLOGIA, V122, P200, DOI 10.1007/PL00008847; Ebert D, 2000, AM NAT, V156, P459, DOI 10.1086/303404; Ebert D, 2004, AM NAT, V164, pS19, DOI 10.1086/424606; Ebert D, 1996, PHILOS T ROY SOC B, V351, P1689, DOI 10.1098/rstb.1996.0151; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; Edel KH, 2012, EVOLUTION EARLY VIEW; FRITZ RS, 1992, PLANT RESISTANCE HER; Ganz HH, 2010, ECOLOGY, V91, P1263, DOI 10.1890/09-1243.1; GREEN J, 1974, Transactions of the Zoological Society of London, V32, P417; Hall SR, 2007, ECOL LETT, V10, P207, DOI 10.1111/j.1461-0248.2007.01011.x; Hall SR, 2006, ECOLOGY, V87, P1684, DOI 10.1890/0012-9658(2006)87[1684:WDNHTM]2.0.CO;2; Hall SR, 2011, OECOLOGIA, V166, P833, DOI 10.1007/s00442-011-1905-4; Hall SR, 2010, AM NAT, V176, P557, DOI 10.1086/656523; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; Hebert P.D.N., 1995, DAPHNIA N AM ILLUSTR; HOWARD RS, 1994, NATURE, V367, P554, DOI 10.1038/367554a0; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; Labbe P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-355; Lambrechts L, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-3; Lambrechts L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001019; Little TJ, 2000, P ROY SOC B-BIOL SCI, V267, P2037, DOI 10.1098/rspb.2000.1246; Little TJ, 2002, J EVOLUTION BIOL, V15, P1, DOI 10.1046/j.1420-9101.2002.00366.x; Little TJ, 2007, J ANIM ECOL, V76, P1202, DOI 10.1111/j.1365-2656.2007.01290.x; Lively CM, 1999, AM NAT, V153, pS34, DOI 10.1086/303210; Lively CM, 2000, NATURE, V405, P679, DOI 10.1038/35015069; Lively CM, 2010, AM NAT, V175, pE149, DOI 10.1086/652430; Luijckx P, 2011, ECOL LETT, V14, P125, DOI 10.1111/j.1461-0248.2010.01561.x; Meagher S, 1999, EVOLUTION, V53, P1318, DOI 10.1111/j.1558-5646.1999.tb04547.x; Mitchell SE, 2004, ECOL LETT, V7, P848, DOI 10.1111/j.1461-0248.2004.00639.x; MitchellOlds T, 1996, EVOLUTION, V50, P1859, DOI 10.1111/j.1558-5646.1996.tb03572.x; Prior NH, 2011, EVOL ECOL RES, V13, P401; Rigaud T, 2010, P ROY SOC B-BIOL SCI, V277, P3693, DOI 10.1098/rspb.2010.1163; Salvaudon L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-189; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Stirnadel HA, 1997, J ANIM ECOL, V66, P212, DOI 10.2307/6023; Vale PF, 2009, HEREDITY, V103, P102, DOI 10.1038/hdy.2009.54; Wilfert L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-187; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	58	30	30	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39564	10.1371/journal.pone.0039564	http://dx.doi.org/10.1371/journal.pone.0039564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761826	Green Published, gold, Green Submitted			2022-12-27	WOS:000305781700048
J	Guillot, N; Kollins, D; Gilbert, V; Xavier, S; Chen, J; Gentle, M; Reddy, A; Bottinger, E; Jiang, RL; Rastaldi, MP; Corbelli, A; Schlondorff, D				Guillot, Nicolas; Kollins, Dmitrij; Gilbert, Victoria; Xavier, Sandhya; Chen, Jun; Gentle, Madeleine; Reddy, Anand; Bottinger, Erwin; Jiang, Rulang; Rastaldi, Maria Pia; Corbelli, Alessandro; Schlondorff, Detlef			BAMBI Regulates Angiogenesis and Endothelial Homeostasis through Modulation of Alternative TGF beta Signaling	PLOS ONE			English	Article							MEMBRANE-BOUND INHIBITOR; RECEPTOR-LIKE KINASE-1; GROWTH-FACTOR; TRANSCRIPTION FACTORS; COLORECTAL-CANCER; RENAL HYPERTROPHY; AORTIC-ANEURYSM; CELLS; EXPRESSION; PATHWAYS	Background: BAMBI is a type I TGF beta receptor antagonist, whose in vivo function remains unclear, as BAMBI(-/-) mice lack an obvious phenotype. Methodology/Principal Findings: Identifying BAMBI's functions requires identification of cell-specific expression of BAMBI. By immunohistology we found BAMBI expression restricted to endothelial cells and by electron microscopy BAMBI(-/-) mice showed prominent and swollen endothelial cells in myocardial and glomerular capillaries. In endothelial cells overexpression of BAMBI reduced, whereas knock-down enhanced capillary growth and migration in response to TGF beta. In vivo angiogenesis was enhanced in matrigel implants and in glomerular hypertrophy after unilateral nephrectomy in BAMBI(-/-) compared to BAMBI(+/+) mice consistent with an endothelial phenotype for BAMBI(-/-) mice. BAMBI's mechanism of action in endothelial cells was examined by canonical and alternative TGF beta signaling in HUVEC with over-expression or knock-down of BAMBI. BAMBI knockdown enhanced basal and TGF beta stimulated SMAD1/5 and ERK1/2 phosphorylation, while overexpression prevented both. Conclusions/Significance: Thus we provide a first description of a vascular phenotype for BAMBI(-/-) mice, and provide in vitro and in vivo evidence that BAMBI contributes to endothelial and vascular homeostasis. Further, we demonstrate that in endothelial cells BAMBI interferes with alternative TGF beta signaling, most likely through the ALK 1 receptor, which may explain the phenotype observed in BAMBI(-/-) mice. This newly described role for BAMBI in regulating endothelial function has potential implications for understanding and treating vascular disease and tumor neo-angiogenesis.	[Guillot, Nicolas; Kollins, Dmitrij; Gilbert, Victoria; Gentle, Madeleine; Reddy, Anand; Bottinger, Erwin; Schlondorff, Detlef] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Xavier, Sandhya; Chen, Jun] New York Med Coll, Dept Med, Valhalla, NY 10595 USA; [Jiang, Rulang] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Rastaldi, Maria Pia; Corbelli, Alessandro] Fdn Am Ric Malattie Renali, Milan, Italy; [Rastaldi, Maria Pia; Corbelli, Alessandro] Osped Maggior Policlin, Renal Res Lab, Milan, Italy	Icahn School of Medicine at Mount Sinai; New York Medical College; Cincinnati Children's Hospital Medical Center	Guillot, N (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY USA.	detlef.schlondorff@mssm.edu	Corbelli, Alessandro/ABG-3900-2020	Corbelli, Alessandro/0000-0001-8545-8050; Jiang, Rulang/0000-0001-7842-4696; Guillot, Nicolas/0000-0003-1096-6960	National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [R01-DK081420-01, RO1-DK081420-02S1, RO1-DK56077, RO1-DK60043, R01-DE015207]; Westchester Artificial Kidney Foundation; ABN - Associazione Bambino Nefropatico, Milano, Italy; French Foundation for Medical Research;  [DK54602];  [DK052783];  [DK45462]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073960, R01DK054602, R01DK081420, R01DK045462, U01DK060995, R01DK056077, R01DK060043, R01DK052783] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Westchester Artificial Kidney Foundation; ABN - Associazione Bambino Nefropatico, Milano, Italy; French Foundation for Medical Research(Fondation pour la Recherche Medicale); ; ; ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases R01-DK081420-01 and RO1-DK081420-02S1 to DS, RO1-DK56077 and RO1-DK60043 to EB, and R01-DE015207 to RJ, DK54602, DK052783, DK45462 and a Westchester Artificial Kidney Foundation to SX, and by ABN - Associazione Bambino Nefropatico, Milano, Italy, to MPR. NG received support from the French Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akishima Y, 2004, VIRCHOWS ARCH, V444, P153, DOI 10.1007/s00428-003-0950-8; Chang H, 2000, DEV BIOL, V219, P71, DOI 10.1006/dbio.1999.9594; Chen JQ, 2007, GENESIS, V45, P482, DOI 10.1002/dvg.20320; Chen J, 2008, KIDNEY INT, V74, P879, DOI 10.1038/ki.2008.304; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; Deindl E, 2007, THROMB HAEMOSTASIS, V98, P940, DOI 10.1160/TH07-04-0261; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Eitenmuller I, 2006, CIRC RES, V99, P656, DOI 10.1161/01.RES.0000242560.77512.dd; FINE LG, 1992, J AM SOC NEPHROL, V2, P1163; FINE LG, 1986, KIDNEY INT, V29, P619, DOI 10.1038/ki.1986.45; Flyvbjerg A, 2002, AM J PHYSIOL-ENDOC M, V283, pE362, DOI 10.1152/ajpendo.00007.2002; Fritzmann J, 2009, GASTROENTEROLOGY, V137, P165, DOI 10.1053/j.gastro.2009.03.041; Garcia-Cardena G, 2006, Handb Exp Pharmacol, P79; Giardino L, 2009, J AM SOC NEPHROL, V20, P1929, DOI 10.1681/ASN.2008121286; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Grotewold L, 2001, MECH DEVELOP, V100, P327, DOI 10.1016/S0925-4773(00)00524-4; Guedez L, 2003, AM J PATHOL, V162, P1431, DOI 10.1016/S0002-9440(10)64276-9; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Higashihori N, 2008, DEV DYNAM, V237, P1500, DOI 10.1002/dvdy.21529; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Iverson C, 2009, CANCER RES, V69, P6839, DOI 10.1158/0008-5472.CAN-09-0679; Jalali S, 1998, ARTERIOSCL THROM VAS, V18, P227, DOI 10.1161/01.ATV.18.2.227; LAITINEN L, 1987, HISTOCHEM J, V19, P225, DOI 10.1007/BF01680633; Lamouille S, 2002, BLOOD, V100, P4495, DOI 10.1182/blood.V100.13.4495; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Loveland KL, 2003, ENDOCRINOLOGY, V144, P4180, DOI 10.1210/en.2002-0124; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Maynard SE, 2011, SEMIN NEPHROL, V31, P33, DOI 10.1016/j.semnephrol.2010.10.004; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; MULLER WA, 1989, J EXP MED, V170, P399, DOI 10.1084/jem.170.2.399; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Orlova VV, 2011, HISTOL HISTOPATHOL, V26, P1219, DOI 10.14670/HH-26.1219; Pardali E, 2009, FRONT BIOSCI-LANDMRK, V14, P4848, DOI 10.2741/3573; Park SO, 2008, BLOOD, V111, P633, DOI 10.1182/blood-2007-08-107359; Preisig P, 1999, EXP NEPHROL, V7, P273; Ren B, 2010, J CLIN INVEST, V120, P1217, DOI 10.1172/JCI39837; ROBERTS AB, 1981, P NATL ACAD SCI-BIOL, V78, P5339, DOI 10.1073/pnas.78.9.5339; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki T, 2003, CIRC RES, V93, P682, DOI 10.1161/01.RES.0000095246.40391.3B; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Stan RV, 1999, J CELL BIOL, V145, P1189, DOI 10.1083/jcb.145.6.1189; Sumpio BE, 2005, J BIOL CHEM, V280, P11185, DOI 10.1074/jbc.M414631200; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Togo N, 2008, WORLD J GASTROENTERO, V14, P4880, DOI 10.3748/wjg.14.4880; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; Xavier S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012995; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304	55	38	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39406	10.1371/journal.pone.0039406	http://dx.doi.org/10.1371/journal.pone.0039406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761782	Green Published, Green Submitted, gold			2022-12-27	WOS:000305781700033
J	Klose, D; Klare, JP; Grohmann, D; Kay, CWM; Werner, F; Steinhoff, HJ				Klose, Daniel; Klare, Johann P.; Grohmann, Dina; Kay, Christopher W. M.; Werner, Finn; Steinhoff, Heinz-Juergen			Simulation vs. Reality: A Comparison of In Silico Distance Predictions with DEER and FRET Measurements	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; NANO-POSITIONING SYSTEM; SINGLE-MOLECULE FRET; RNA-BINDING; DYNAMICS; PROTEIN; EPR; ORIENTATION; ELONGATION; DENSITY	Site specific incorporation of molecular probes such as fluorescent-and nitroxide spin-labels into biomolecules, and subsequent analysis by Forster resonance energy transfer (FRET) and double electron-electron resonance (DEER) can elucidate the distance and distance-changes between the probes. However, the probes have an intrinsic conformational flexibility due to the linker by which they are conjugated to the biomolecule. This property minimizes the influence of the label side chain on the structure of the target molecule, but complicates the direct correlation of the experimental inter-label distances with the macromolecular structure or changes thereof. Simulation methods that account for the conformational flexibility and orientation of the probe(s) can be helpful in overcoming this problem. We performed distance measurements using FRET and DEER and explored different simulation techniques to predict inter-label distances using the Rpo4/7 stalk module of the M. jannaschii RNA polymerase. This is a suitable model system because it is rigid and a high-resolution X-ray structure is available. The conformations of the fluorescent labels and nitroxide spin labels on Rpo4/7 were modeled using in vacuo molecular dynamics simulations (MD) and a stochastic Monte Carlo sampling approach. For the nitroxide probes we also performed MD simulations with explicit water and carried out a rotamer library analysis. Our results show that the Monte Carlo simulations are in better agreement with experiments than the MD simulations and the rotamer library approach results in plausible distance predictions. Because the latter is the least computationally demanding of the methods we have explored, and is readily available to many researchers, it prevails as the method of choice for the interpretation of DEER distance distributions.	[Klose, Daniel; Klare, Johann P.; Steinhoff, Heinz-Juergen] Univ Osnabruck, Dept Phys, Osnabruck, Germany; [Grohmann, Dina; Werner, Finn] UCL, RNAP Lab, Inst Struct & Mol Biol, Div Biosci, London, England; [Kay, Christopher W. M.] UCL, London Ctr Nanotechnol, London, England	University Osnabruck; University of London; Birkbeck University London; University College London; University of London; University College London	Klose, D (corresponding author), Univ Osnabruck, Dept Phys, Osnabruck, Germany.	jklare@uni-osnabrueck.de; hsteinho@uni-osnabrueck.de	Klare, Johann P./C-1428-2009; Kay, Christopher William Michael/C-2467-2008; Steinhoff, Heinz-Juergen/H-3791-2014	Klare, Johann P./0000-0002-5761-5968; Kay, Christopher William Michael/0000-0002-5200-6004; Steinhoff, Heinz-Juergen/0000-0002-5888-0157; Werner, Finn/0000-0002-3930-3821; Klose, Daniel/0000-0002-3597-0889	Wellcome Trust [079351/Z/06/Z]; BBSRC [BB/E008232/1, BB/H019332/1]; DFG [SFB 431 P18, SFB 944 P10]; Biotechnology and Biological Sciences Research Council [BB/E008232/1, BB/H019332/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); DFG(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work in the RNAP laboratory was supported by Wellcome Trust (www.wellcome.ac.uk) grant 079351/Z/06/Z and BBSRC (www.bbsrc.ac.uk) grants BB/E008232/1 and BB/H019332/1 to FW. DK received support from grants DFG (www.dfg.de) SFB 431 P18 and DFG SFB 944 P10 to H-JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agafonov RV, 2009, P NATL ACAD SCI USA, V106, P21625, DOI 10.1073/pnas.0909757106; Alexander N, 2008, STRUCTURE, V16, P181, DOI 10.1016/j.str.2007.11.015; ALTENBACH C, 1989, BIOCHEMISTRY-US, V28, P7806, DOI 10.1021/bi00445a042; Andrecka J, 2009, NUCLEIC ACIDS RES, V37, P5803, DOI 10.1093/nar/gkp601; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Beier C, 2006, BIOPHYS J, V91, P2647, DOI 10.1529/biophysj.105.080051; Bohme S, 2009, PHYS CHEM CHEM PHYS, V11, P6770, DOI 10.1039/b907117m; Bordignon E, 2007, BIOL MAGN RESON, V27, P129; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER A, 1984, CHEM PHYS LETT, V105, P495, DOI 10.1016/0009-2614(84)80098-6; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Corry B, 2008, BIOPHYS J, V95, P2711, DOI 10.1529/biophysj.107.126243; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dietrich Anja, 2002, J Biotechnol, V82, P211; DOSREMEDIOS CG, 1995, J STRUCT BIOL, V115, P175, DOI 10.1006/jsbi.1995.1042; Edidin Michael, 2003, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1810s52; F?rster, 1967, COMPREHENSIVE BIOCH; Fajer PG, 2007, BIOL MAGN RESON, V27, P95; Fleissner MR, 2009, PROTEIN SCI, V18, P893, DOI 10.1002/pro.96; Forster T, 1959, DISCUSS FARADAY SOC, V27, P7, DOI DOI 10.1039/DF9592700007; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Grohmann D, 2011, MOL CELL, V43, P263, DOI 10.1016/j.molcel.2011.05.030; Grohmann D, 2010, J AM CHEM SOC, V132, P5954, DOI 10.1021/ja101663d; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; HARRISON RW, 1993, J COMPUT CHEM, V14, P1112, DOI 10.1002/jcc.540140912; Hirtreiter A, 2010, NUCLEIC ACIDS RES, V38, P4040, DOI 10.1093/nar/gkq135; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Kay CWM, 2007, J AM CHEM SOC, V129, P4868, DOI 10.1021/ja068966j; Kay CWM, 2006, J AM CHEM SOC, V128, P76, DOI 10.1021/ja057308g; Klare JP, 2009, PHOTOSYNTH RES, V102, P377, DOI 10.1007/s11120-009-9490-7; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, DOI DOI 10.1007/978-0-387-46312-4; Liang BY, 2006, J AM CHEM SOC, V128, P4389, DOI 10.1021/ja0574825; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Majumdar ZK, 2005, J MOL BIOL, V351, P1123, DOI 10.1016/j.jmb.2005.06.027; Marras SAE, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf121; Martin RE, 1998, ANGEW CHEM INT EDIT, V37, P2834, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2833::AID-ANIE2833>3.0.CO;2-7; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Meka H, 2005, NUCLEIC ACIDS RES, V33, P6435, DOI 10.1093/nar/gki945; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Muschielok A, 2008, NAT METHODS, V5, P965, DOI 10.1038/nmeth.1259; Naber N, 2010, J MOL BIOL, V396, P937, DOI 10.1016/j.jmb.2009.12.035; ORCA, 2007, AB IN DENS FUNCT SEM; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Pedretti A, 2002, J MOL GRAPH MODEL, V21, P47, DOI 10.1016/S1093-3263(02)00123-7; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; Schiemann O, 2007, Q REV BIOPHYS, V40, P1, DOI 10.1017/S003358350700460X; Schroder GF, 2005, BIOPHYS J, V89, P3757, DOI 10.1529/biophysj.105.069500; Shah JJ, 2009, ANAL CHEM, V81, P8260, DOI 10.1021/ac901644w; Sisamakis E, 2010, METHOD ENZYMOL, V475, P455, DOI 10.1016/S0076-6879(10)75018-7; SNARE MJ, 1982, J PHOTOCHEM, V18, P335, DOI 10.1016/0047-2670(82)87023-8; Steinhoff HJ, 2004, BIOL CHEM, V385, P913, DOI 10.1515/BC.2004.119; Stone JE, 1998, P 1995 INT SUP US GR; Todone F, 2001, MOL CELL, V8, P1137, DOI 10.1016/S1097-2765(01)00379-3; VAHTRAS O, 1993, CHEM PHYS LETT, V213, P514, DOI 10.1016/0009-2614(93)89151-7; VANGUNSTEREN WF, 1982, MOL PHYS, V45, P637, DOI 10.1080/00268978200100491; Werner F, 2002, MOL CELL, V10, P635, DOI 10.1016/S1097-2765(02)00629-9; Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507; Wozniak AK, 2008, P NATL ACAD SCI USA, V105, P18337, DOI 10.1073/pnas.0800977105; WU PG, 1992, BIOCHEMISTRY-US, V31, P7939, DOI 10.1021/bi00149a027	67	53	53	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39492	10.1371/journal.pone.0039492	http://dx.doi.org/10.1371/journal.pone.0039492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761805	gold, Green Published, Green Submitted			2022-12-27	WOS:000305781700040
J	Li, S; Hartemink, N; Speybroeck, N; Vanwambeke, SO				Li, Sen; Hartemink, Nienke; Speybroeck, Niko; Vanwambeke, Sophie O.			Consequences of Landscape Fragmentation on Lyme Disease Risk: A Cellular Automata Approach	PLOS ONE			English	Article							IXODES-RICINUS TICKS; BURGDORFERI SENSU-LATO; CO-FEEDING TRANSMISSION; ROE DEER; BORNE ENCEPHALITIS; ANAPLASMA-PHAGOCYTOPHILUM; HABITAT ASSOCIATIONS; FOREST FRAGMENTATION; HOST MOVEMENT; IXODIDAE	The abundance of infected Ixodid ticks is an important component of human risk of Lyme disease, and various empirical studies have shown that this is associated, at least in part, to landscape fragmentation. In this study, we aimed at exploring how varying woodland fragmentation patterns affect the risk of Lyme disease, through infected tick abundance. A cellular automata model was developed, incorporating a heterogeneous landscape with three interactive components: an age-structured tick population, a classical disease transmission function, and hosts. A set of simplifying assumptions were adopted with respect to the study objective and field data limitations. In the model, the landscape influences both tick survival and host movement. The validation of the model was performed with an empirical study. Scenarios of various landscape configurations (focusing on woodland fragmentation) were simulated and compared. Lyme disease risk indices (density and infection prevalence of nymphs) differed considerably between scenarios: (i) the risk could be higher in highly fragmented woodlands, which is supported by a number of recently published empirical studies, and (ii) grassland could reduce the risk in adjacent woodland, which suggests landscape fragmentation studies of zoonotic diseases should not focus on the patch-level woodland patterns only, but also on landscape-level adjacent land cover patterns. Further analysis of the simulation results indicated strong correlations between Lyme disease risk indices and the density, shape and aggregation level of woodland patches. These findings highlight the strong effect of the spatial patterns of local host population and movement on the spatial dynamics of Lyme disease risks, which can be shaped by woodland fragmentation. In conclusion, using a cellular automata approach is beneficial for modelling complex zoonotic transmission systems as it can be combined with either real world landscapes for exploring direct spatial effects or artificial representations for outlining possible empirical investigations.	[Li, Sen; Hartemink, Nienke; Vanwambeke, Sophie O.] Catholic Univ Louvain, Georges Lemaitre Ctr Earth & Climate Res, Earth & Life Inst, B-1348 Louvain, Belgium; [Speybroeck, Niko] Catholic Univ Louvain, Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Li, S (corresponding author), Catholic Univ Louvain, Georges Lemaitre Ctr Earth & Climate Res, Earth & Life Inst, B-1348 Louvain, Belgium.	sen.li@uclouvain.be		hartemink, nienke/0000-0001-9820-7699; Li, Sen/0000-0002-1177-7339; Vanwambeke, Sophie/0000-0001-6620-6173; Speybroeck, Niko/0000-0003-3322-3502	EU [FP7-261504 EDENext]; French Community of Belgium	EU(European Commission); French Community of Belgium	Sen Li is a research fellow (aspirant) in F.R.S-FNRS. This study was partially funded by EU grant FP7-261504 EDENext and is catalogued by the EDENext Steering Committee as EDENext012 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and don't necessarily reflect the views of the European Commission. This study was also partially funded by the Special Research Fund (FSR) of the French Community of Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Bian L, 2003, ECOL MODEL, V159, P279, DOI 10.1016/S0304-3800(02)00298-3; Boswell GP, 1998, P ROY SOC B-BIOL SCI, V265, P1921, DOI 10.1098/rspb.1998.0521; Bown KJ, 2008, APPL ENVIRON MICROB, V74, P7118, DOI 10.1128/AEM.00625-08; Boyard C, 2007, PARASITOLOGY, V134, P987, DOI 10.1017/S0031182007002351; Brownstein JS, 2005, OECOLOGIA, V146, P469, DOI 10.1007/s00442-005-0251-9; Brunner JL, 2008, ECOLOGY, V89, P2259, DOI 10.1890/07-0665.1; Carpi G, 2008, EPIDEMIOL INFECT, V136, P1416, DOI 10.1017/S0950268807000039; Carpi G, 2009, VECTOR-BORNE ZOONOT, V9, P179, DOI 10.1089/vbz.2008.0068; Cross PC, 2005, ECOL LETT, V8, P587, DOI 10.1111/j.1461-0248.2005.00760.x; DANIEL M, 1976, Folia Parasitologica (Ceske Budejovice), V23, P327; Danielova V, 2002, FOLIA PARASIT, V49, P323, DOI 10.14411/fp.2002.060; Daniels TJ, 2000, J MED ENTOMOL, V37, P357, DOI 10.1603/0022-2585(2000)037[0357:EPSADS]2.0.CO;2; De Dobbelaere I, 2010, PLANT PATHOL, V59, P301, DOI 10.1111/j.1365-3059.2009.02212.x; Delbeuck C, 2008, CELLULE ETAT ENV WAL; DGRNE, OFFH OBS FAUN FLOR H; Diuk-Wasser MA, 2010, GLOBAL ECOL BIOGEOGR, V19, P504, DOI 10.1111/j.1466-8238.2010.00526.x; Dobson ADM, 2011, J APPL ECOL, V48, P1017, DOI 10.1111/j.1365-2664.2011.02003.x; Escutenaire S, 2000, VIRUS RES, V67, P91, DOI 10.1016/S0168-1702(00)00136-2; Estrada-Pena A, 2005, EXP APPL ACAROL, V37, P257, DOI 10.1007/s10493-005-3271-6; Estrada-Pena A, 2003, ECOGRAPHY, V26, P661, DOI 10.1034/j.1600-0587.2003.03530.x; Estrada-Pena A, 2005, LANDSCAPE ECOL, V20, P529, DOI 10.1007/s10980-004-3318-9; Estrada-Pena A, 2011, FOR ECOL MANAGE AEM, P00067; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Frank DH, 1998, LANDSCAPE ECOL, V13, P27, DOI 10.1023/A:1007965600166; Fryxell JM, 2008, P NATL ACAD SCI USA, V105, P19114, DOI 10.1073/pnas.0801737105; Gaff HD, 2007, B MATH BIOL, V69, P265, DOI 10.1007/s11538-006-9125-5; GRAY JS, 1981, B ENTOMOL RES, V71, P533, DOI 10.1017/S0007485300008543; Guerra M, 2002, EMERG INFECT DIS, V8, P289, DOI 10.3201/eid0803.010166; Halos L, 2010, APPL ENVIRON MICROB, V76, P4413, DOI 10.1128/AEM.00610-10; Hancock PA, 2011, INT J PARASITOL, V41, P513, DOI 10.1016/j.ijpara.2010.12.012; Hartemink NA, 2008, AM NAT, V171, P743, DOI 10.1086/587530; Hemami MR, 2005, FOREST ECOL MANAG, V215, P224, DOI 10.1016/j.foreco.2005.05.013; Hewison AJM, 2001, CAN J ZOOL, V79, P679, DOI 10.1139/cjz-79-4-679; Hoch T, 2010, ECOL MODEL, V221, P1798, DOI 10.1016/j.ecolmodel.2010.04.008; Hubalek Z, 1998, PARASITOL RES, V84, P167, DOI 10.1007/s004360050378; Hudson PJ, 2001, MED VET ENTOMOL, V15, P304, DOI 10.1046/j.0269-283x.2001.00317.x; JONES LD, 1987, SCIENCE, V237, P775, DOI 10.1126/science.3616608; Keeling MJ, 2000, P ROY SOC B-BIOL SCI, V267, P2219, DOI 10.1098/rspb.2000.1272; Keeling MJ, 2002, ECOL LETT, V5, P20, DOI 10.1046/j.1461-0248.2002.00268.x; KIKKAWA J, 1964, J ANIM ECOL, V33, P259, DOI 10.2307/2631; Killilea ME, 2008, ECOHEALTH, V5, P167, DOI 10.1007/s10393-008-0171-3; KURTENBACH K, 1995, J MED ENTOMOL, V32, P807, DOI 10.1093/jmedent/32.6.807; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Lubelczyk CB, 2004, ENVIRON ENTOMOL, V33, P900, DOI 10.1603/0046-225X-33.4.900; MACLEOD J., 1932, PARASITOLOGY, V24, P382, DOI 10.1017/S0031182000020795; MATUSCHKA FR, 1992, J INFECT DIS, V165, P479, DOI 10.1093/infdis/165.3.479; McLane AJ, 2011, ECOL MODEL, V222, P1544, DOI 10.1016/j.ecolmodel.2011.01.020; MINSHULL JI, 1982, J PARASITOL, V68, P484, DOI 10.2307/3280962; Misonne MC, 1998, J CLIN MICROBIOL, V36, P3352, DOI 10.1128/JCM.36.11.3352-3354.1998; Mount GA, 1997, J MED ENTOMOL, V34, P461, DOI 10.1093/jmedent/34.4.461; Ogden NH, 2005, INT J PARASITOL, V35, P375, DOI 10.1016/j.ijpara.2004.12.013; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Perkins SE, 2006, ECOLOGY, V87, P1981, DOI 10.1890/0012-9658(2006)87[1981:LDALTT]2.0.CO;2; Putman R., 1988, NATURAL HIST DEER; PUTMAN RJ, 1986, J APPL ECOL, V23, P91, DOI 10.2307/2403083; Radeloff VC, 1999, ECOL MODEL, V114, P287, DOI 10.1016/S0304-3800(98)00164-1; Randolph S, 2003, EMERG INFECT DIS, V9, P893; RANDOLPH SE, 1995, J MED ENTOMOL, V32, P765, DOI 10.1093/jmedent/32.6.765; Randolph SE, 2001, PHILOS T R SOC B, V356, P1045, DOI 10.1098/rstb.2001.0893; Randolph SE, 1996, PARASITOL TODAY, V12, P472, DOI 10.1016/S0169-4758(96)10072-7; Randolph SE, 2004, INT J MED MICROBIOL, V293, P5, DOI 10.1016/S1433-1128(04)80004-4; Randolph SE, 1999, PARASITOLOGY, V118, P177, DOI 10.1017/S0031182098003643; Rauter C, 2005, APPL ENVIRON MICROB, V71, P7203, DOI 10.1128/AEM.71.11.7203-7216.2005; Richter D, 2002, EMERG INFECT DIS, V8, P1421, DOI 10.3201/eid0812.010519; Robertson JN, 2000, EUR J EPIDEMIOL, V16, P647, DOI 10.1023/A:1007615109273; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Rosicova K, 2011, HEALTH PLACE, V17, P701, DOI 10.1016/j.healthplace.2011.01.004; Ruiz-Fons F, 2010, INT J PARASITOL, V40, P1013, DOI 10.1016/j.ijpara.2010.02.006; Sauvage F, 2003, J ANIM ECOL, V72, P1, DOI 10.1046/j.1365-2656.2003.00675.x; Speybroeck N, 2006, ENVIRON ECOL STAT, V13, P69, DOI 10.1007/s10651-005-5691-1; Tack W, 2012, FOREST ECOL MANAG, V265, P30, DOI 10.1016/j.foreco.2011.10.028; Talleklint L, 1997, EXP APPL ACAROL, V21, P755, DOI 10.1023/A:1018473122070; Vanwambeke SO, 2010, VECTOR-BORNE ZOONOT, V10, P497, DOI 10.1089/vbz.2009.0116; Vor Torsten, 2010, Experimental and Applied Acarology, V51, P405, DOI 10.1007/s10493-010-9337-0; Watts EJ, 2009, PARASITOLOGY, V136, P1221, DOI 10.1017/S0031182009990424	77	20	20	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39612	10.1371/journal.pone.0039612	http://dx.doi.org/10.1371/journal.pone.0039612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761842	Green Published, gold, Green Submitted			2022-12-27	WOS:000305781700052
J	Barzegar, A				Barzegar, Abolfazl			Proton-Coupled Electron-Transfer Mechanism for the Radical Scavenging Activity of Cardiovascular Drug Dipyridamole	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; LIPID-PEROXIDATION; THEORETICAL CALCULATION; IONIZATION-POTENTIALS; ANTIOXIDANT ACTIVITY; GAS-PHASE; VITAMIN-E; DERIVATIVES; MODELS	Dipyridamole (DIP) is a well-known pharmaceutical drug used as a coronary vasodilator and anti-platelet agent in clinics for treating several cardiovascular diseases. Primarily, the therapeutic effects of the drug are attributed to its antioxidant potency. In this research, we aim to declare the unknown antioxidant mechanism of DIP as well as its potent chain-breaking antioxidant activity in polar aqueous medium inside the cells, using different experimental methods and theoretical quantum calculations. Data demonstrated the higher antioxidant capacity of DIP against ROS and free radicals in polar cell's interior. DIP is capable of generating long living and noninvasive DIP center dot radicals in oxidant condition that leads to an effective "chain-breaking antioxidant" activity. Quantum computational data indicated that DIP antioxidant has more favorable ionization potential than trolox which means DIP has higher antioxidant activity. Also, data showed that the direct hydrogen-transfer is not a favorable process to construct DIP center dot because of high barrier energy, though electron-transfer process can more easily to produce DIP center dot+ with the lowest barrier energy. Altogether, the electron donating potency of DIP to reduce ferric ion, having the low anodic oxidation peak potential, producing long lived stable DIP center dot radicals and protecting myoblast cells from oxidation, proposed the excellent "chain-breaking antioxidant'' potency via electron-transfer mechanism of this vasodilator DIP drug in polar aqueous medium.	[Barzegar, Abolfazl] Univ Tabriz, RIFS, Tabriz, Iran; [Barzegar, Abolfazl] Tabriz Univ Med Sci, SABS, Tabriz, Iran	University of Tabriz; Tabriz University of Medical Science	Barzegar, A (corresponding author), Univ Tabriz, RIFS, Tabriz, Iran.	barzegar@tabrizu.ac.ir		Barzegar, Abolfazl/0000-0002-1237-0848	Research Institute for Fundamental Sciences (RIFS)-University of Tabriz; Iran National Science Foundation (INSF)	Research Institute for Fundamental Sciences (RIFS)-University of Tabriz; Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF))	The author gratefully acknowledges the financial support provided by Research Institute for Fundamental Sciences (RIFS)-University of Tabriz and Iran National Science Foundation (INSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzegar A, 2012, FOOD CHEM; Barzegar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026012; Barzegar A, 2011, BIOCHIMIE, V93, P1880, DOI 10.1016/j.biochi.2011.07.019; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Borges RS, 2011, J COMPUT THEOR NANOS, V8, P69, DOI 10.1166/jctn.2011.1660; Borissevitch GP, 1996, BBA-BIOMEMBRANES, V1278, P12, DOI 10.1016/0005-2736(95)00208-1; Chakrabarti S, 2005, J PHARMACOL EXP THER, V315, P494, DOI 10.1124/jpet.105.089987; Chakrabarti S, 2007, J CARDIOVASC PHARM, V50, P449, DOI 10.1097/FJC.0b013e31813542db; DELACRUZ JP, 1992, LIPIDS, V27, P192, DOI 10.1007/BF02536177; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; DiLabio GA, 1999, CHEM PHYS LETT, V311, P215, DOI 10.1016/S0009-2614(99)00786-1; DiLabio GA, 2000, J ORG CHEM, V65, P2195, DOI 10.1021/jo991833e; Frisch M. J., 1998, GAUSSIAN 98; Ghaffari T, 2011, BIOIMPACTS, V1, P121, DOI 10.5681/bi.2011.016; Gomaa A, 2010, INT IMMUNOPHARMACOL, V10, P1406, DOI 10.1016/j.intimp.2010.08.006; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Gomes A, 2008, BIOORGAN MED CHEM, V16, P7939, DOI 10.1016/j.bmc.2008.07.072; IULIANO L, 1989, LIPIDS, V24, P430, DOI 10.1007/BF02535151; Iuliano L, 1996, BRIT J PHARMACOL, V119, P1438, DOI 10.1111/j.1476-5381.1996.tb16056.x; Iuliano L, 2000, BBA-GEN SUBJECTS, V1474, P177, DOI 10.1016/S0304-4165(00)00017-9; Khodaie L, 2012, BIOIMPACTS, V2, P47, DOI 10.5681/bi.2012.006; Kim HH, 2008, ARTERIOSCL THROM VAS, V28, pS39, DOI 10.1161/ATVBAHA.107.160226; Kusmic C, 2000, CARDIOVASC RES, V47, P510, DOI 10.1016/S0008-6363(00)00058-4; LUGER P, 1983, ACTA CRYSTALLOGR C, V39, P1454, DOI 10.1107/S0108270183008859; LULIANO L, 1992, LIPIDS, V27, P349, DOI 10.1007/BF02536149; Mollaamin F, 2011, PHYS CHEM LIQ, V49, P318, DOI 10.1080/00319100903456121; Nepomuceno MF, 1997, FREE RADICAL BIO MED, V23, P1046, DOI 10.1016/S0891-5849(97)00135-4; Onsager L, 1936, J AM CHEM SOC, V58, P1486, DOI 10.1021/ja01299a050; Pattillo CB, 2011, FREE RADICAL BIO MED, V50, P262, DOI 10.1016/j.freeradbiomed.2010.10.714; Sadigh-Eteghad S, 2011, BIOIMPACTS, V1, P219, DOI 10.5681/bi.2011.031; SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4; Soliman M, 2011, J SAUDI HEART ASSOC, V23, P75, DOI 10.1016/j.jsha.2011.01.004; Tye JW, 2006, J COMPUT CHEM, V27, P1454, DOI 10.1002/jcc.20456; Vargas F, 2001, INT J TOXICOL, V20, P363, DOI 10.1080/109158101753333640; Wright JS, 2001, J AM CHEM SOC, V123, P1173, DOI 10.1021/ja002455u	35	16	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39660	10.1371/journal.pone.0039660	http://dx.doi.org/10.1371/journal.pone.0039660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745807	gold, Green Submitted, Green Published			2022-12-27	WOS:000305730900096
J	Cowan, NJ; Chastain, EJ; Vilhena, DA; Freudenberg, JS; Bergstrom, CT				Cowan, Noah J.; Chastain, Erick J.; Vilhena, Daril A.; Freudenberg, James S.; Bergstrom, Carl T.			Nodal Dynamics, Not Degree Distributions, Determine the Structural Controllability of Complex Networks	PLOS ONE			English	Article							PINNING CONTROL; SYNCHRONIZATION; SYSTEMS	Structural controllability has been proposed as an analytical framework for making predictions regarding the control of complex networks across myriad disciplines in the physical and life sciences (Liu et al., Nature: 473(7346):167-173, 2011). Although the integration of control theory and network analysis is important, we argue that the application of the structural controllability framework to most if not all real-world networks leads to the conclusion that a single control input, applied to the power dominating set, is all that is needed for structural controllability. This result is consistent with the well-known fact that controllability and its dual observability are generic properties of systems. We argue that more important than issues of structural controllability are the questions of whether a system is almost uncontrollable, whether it is almost unobservable, and whether it possesses almost pole-zero cancellations.	[Cowan, Noah J.] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Chastain, Erick J.] Rutgers State Univ, Dept Comp Sci, New Brunswick, NJ 08903 USA; [Vilhena, Daril A.; Bergstrom, Carl T.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Freudenberg, James S.] Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA; [Bergstrom, Carl T.] Santa Fe Inst, Santa Fe, NM 87501 USA	Johns Hopkins University; Rutgers State University New Brunswick; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; The Santa Fe Institute	Cowan, NJ (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.	ncowan@jhu.edu	Bergstrom, Carl T./H-2299-2011; Cowan, Noah/D-3614-2009	Bergstrom, Carl T./0000-0002-2070-385X; Cowan, Noah/0000-0003-2502-3770	National Science Foundation [0845749, SBE-0915005]; United States National Institute of General Medical Sciences Models of Infectious Disease Agent Study Center for Communicable Disease Dynamics at Harvard University [1U54GM088588]; Div Of Information & Intelligent Systems [0845749] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); United States National Institute of General Medical Sciences Models of Infectious Disease Agent Study Center for Communicable Disease Dynamics at Harvard University; Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This material is based upon work supported by the National Science Foundation under Grants 0845749 (NJC) and SBE-0915005 (CTB), and by United States National Institute of General Medical Sciences Models of Infectious Disease Agent Study Center for Communicable Disease Dynamics 1U54GM088588 (CTB) at Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aazami A, 2007, LECT NOTES COMPUT SC, V4627, P1; BERRYMAN AA, 1995, ECOLOGY, V76, P1980, DOI 10.2307/1940728; Commault C, 2002, KYBERNETIKA, V38, P503; Duan ZS, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056103; FREUDENBERG JS, 1985, IEEE T AUTOMAT CONTR, V30, P555, DOI 10.1109/TAC.1985.1104004; Kwakernaak H., 1972, LINEAR OPTIMAL CONTR; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; LIN CT, 1974, IEEE T AUTOMAT CONTR, VAC19, P201, DOI 10.1109/TAC.1974.1100557; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Liu YY, 2011, COMMUNICATON; Looze DP, 2010, CONTORL SYSTEMS HDB, P1; Lotka AJ, 1920, P NATL ACAD SCI USA, V6, P410, DOI 10.1073/pnas.6.7.410; Lozovanu D, 2010, CTW 10, P115; Lozovanu D, 2010, PROCEDIA COMPUT SCI, V1, P1411, DOI 10.1016/j.procs.2010.04.157; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; MOORE BC, 1981, IEEE T AUTOMAT CONTR, V26, P17, DOI 10.1109/TAC.1981.1102568; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Rugh W.J., 1996, LINEAR SYSTEM THEORY; Sorrentino F, 2007, CHAOS, V17, DOI 10.1063/1.2743098; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Sundaram S, 2008, IEEE J SEL AREA COMM, V26, P650, DOI 10.1109/JSAC.2008.080507; Sundaram S, 2010, P AMER CONTR CONF, P1003; Wang XF, 2002, PHYSICA A, V310, P521, DOI 10.1016/S0378-4371(02)00772-0; Xiang LY, 2007, PHYSICA A, V379, P298, DOI 10.1016/j.physa.2006.12.037	29	195	198	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38398	10.1371/journal.pone.0038398	http://dx.doi.org/10.1371/journal.pone.0038398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761682	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900011
J	Ghag, SB; Shekhawat, UKS; Ganapathi, TR				Ghag, Siddhesh B.; Shekhawat, Upendra K. Singh; Ganapathi, Thumballi R.			Petunia Floral Defensins with Unique Prodomains as Novel Candidates for Development of Fusarium Wilt Resistance in Transgenic Banana Plants	PLOS ONE			English	Article							EMBRYOGENIC-CELL SUSPENSIONS; RICE CONFERS RESISTANCE; MEDIATED TRANSFORMATION; GENE; EXPRESSION; OXYSPORUM; TOBACCO	Antimicrobial peptides are a potent group of defense active molecules that have been utilized in developing resistance against a multitude of plant pathogens. Floral defensins constitute a group of cysteine-rich peptides showing potent growth inhibition of pathogenic filamentous fungi especially Fusarium oxysporum in vitro. Full length genes coding for two Petunia floral defensins, PhDef1 and PhDef2 having unique C-terminal 31 and 27 amino acid long predicted prodomains, were overexpressed in transgenic banana plants using embryogenic cells as explants for Agrobacterium-mediated genetic transformation. High level constitutive expression of these defensins in elite banana cv. Rasthali led to significant resistance against infection of Fusarium oxysporum f. sp. cubense as shown by in vitro and ex vivo bioassay studies. Transgenic banana lines expressing either of the two defensins were clearly less chlorotic and had significantly less infestation and discoloration in the vital corm region of the plant as compared to untransformed controls. Transgenic banana plants expressing high level of full-length PhDef1 and PhDef2 were phenotypically normal and no stunting was observed. In conclusion, our results suggest that high-level constitutive expression of floral defensins having distinctive prodomains is an efficient strategy for development of fungal resistance in economically important fruit crops like banana.	[Ghag, Siddhesh B.; Shekhawat, Upendra K. Singh; Ganapathi, Thumballi R.] Bhabha Atom Res Ctr, Plant Cell Culture Technol Sect, Nucl Agr & Biotechnol Div, Mumbai 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Ghag, SB (corresponding author), Bhabha Atom Res Ctr, Plant Cell Culture Technol Sect, Nucl Agr & Biotechnol Div, Mumbai 400085, Maharashtra, India.	trgana@barc.gov.in		Shekhawat, Upendra/0000-0002-4012-2614				Bakry Frederic, 2009, P3, DOI 10.1007/978-0-387-71201-7_1; BUDDENHAGEN IW, 1990, FUSARIUM WILT OF BANANA, P107; Chakrabarti A, 2003, PLANTA, V216, P587, DOI 10.1007/s00425-002-0918-y; Cote FX, 1996, PHYSIOL PLANTARUM, V97, P285, DOI 10.1034/j.1399-3054.1996.970211.x; FAO, 2010, FAOSTAT AGR; Fravel D, 2003, NEW PHYTOL, V157, P493, DOI 10.1046/j.1469-8137.2003.00700.x; Ganapathi TR, 2008, INT J FRUIT SCI, V8, P147, DOI 10.1080/15538360802526423; Ganapathi TR, 2001, PLANT CELL REP, V20, P157, DOI 10.1007/s002990000287; Gao AG, 2000, NAT BIOTECHNOL, V18, P1307, DOI 10.1038/82436; Halpin C, 2005, PLANT BIOTECHNOL J, V3, P141, DOI 10.1111/j.1467-7652.2004.00113.x; Hermann SR, 2001, PLANT CELL REP, V20, P525, DOI 10.1007/s002990100352; Heslop-Harrison JS, 2007, ANN BOT-LONDON, V100, P1073, DOI 10.1093/aob/mcm191; Janssen BJC, 2003, BIOCHEMISTRY-US, V42, P8214, DOI 10.1021/bi034379o; Jha S, 2009, TRANSGENIC RES, V18, P59, DOI 10.1007/s11248-008-9196-1; Jha S, 2010, TRANSGENIC RES, V19, P373, DOI 10.1007/s11248-009-9315-7; Kant P, 2011, COMPREHENSIVE BIOTECHNOLOGY, VOL 4: AGRICULTURAL AND RELATED BIOTECHNOLOGIES, 2ND EDITION, P729; Kanzaki H, 2002, THEOR APPL GENET, V105, P809, DOI 10.1007/s00122-001-0817-9; Keymanesh K, 2009, WORLD J MICROB BIOT, V25, P933, DOI 10.1007/s11274-009-9984-7; Lay FT, 2003, PLANT PHYSIOL, V131, P1283, DOI 10.1104/pp.102.016626; Li CY, 2011, EUR J PLANT PATHOL, V131, P327, DOI 10.1007/s10658-011-9811-5; Ntui VO, 2010, PLANT CELL REP, V29, P943, DOI 10.1007/s00299-010-0880-2; Paul JY, 2011, PLANT BIOTECHNOL J, V9, P1141, DOI 10.1111/j.1467-7652.2011.00639.x; Pegg KG, 1996, AUST J AGR RES, V47, P637, DOI 10.1071/AR9960637; Pei XW, 2005, J INTEGR PLANT BIOL, V47, P971, DOI 10.1111/j.1744-7909.2005.00141.x; Ploetz RC, 2006, PHYTOPATHOLOGY, V96, P653, DOI 10.1094/PHYTO-96-0653; Portieles R, 2010, PLANT BIOTECHNOL J, V8, P678, DOI 10.1111/j.1467-7652.2010.00501.x; Shekhawat UKS, 2008, PLANT CELL TISS ORG, V92, P261, DOI 10.1007/s11240-007-9330-4; Shekhawat UKS, 2011, PLANTA, V234, P915, DOI 10.1007/s00425-011-1455-3; Stotz HU, 2009, PLANT SIGNAL BEHAV, V4, P1010, DOI 10.4161/psb.4.11.9755; Stover R.H., 1962, FUSARIAL WILT PANAMA; Tavares LS, 2008, PEPTIDES, V29, P1842, DOI 10.1016/j.peptides.2008.06.003; Tendulkar SR, 2003, BIOTECHNOL LETT, V25, P1941, DOI 10.1023/B:BILE.0000003990.27624.04; Thangavelu R, 2010, PLANT DIS, V94, P1379, DOI 10.1094/PDIS-05-10-0330; Thevissen K, 1996, J BIOL CHEM, V271, P15018, DOI 10.1074/jbc.271.25.15018; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; van der Weerden NL, 2010, J BIOL CHEM, V285, P37513, DOI 10.1074/jbc.M110.134882; Vishnevetsky J, 2011, TRANSGENIC RES, V20, P61, DOI 10.1007/s11248-010-9392-7; Wagiran A, 2010, AUST J CROP SCI, V4, P421; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wu YL, 2010, EUR J PLANT PATHOL, V128, P409, DOI 10.1007/s10658-010-9669-y; Zainal Z., 2009, American Journal of Plant Physiology, V4, P70, DOI 10.3923/ajpp.2009.70.79	41	69	75	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39557	10.1371/journal.pone.0039557	http://dx.doi.org/10.1371/journal.pone.0039557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745785	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900078
J	Lang, SM; Kazi, AA; Hong-Brown, L; Lang, CH				Lang, Susan M.; Kazi, Abid A.; Hong-Brown, Ly; Lang, Charles H.			Delayed Recovery of Skeletal Muscle Mass following Hindlimb Immobilization in mTOR Heterozygous Mice	PLOS ONE			English	Article							MAJOR PHYSIOLOGICAL REGULATOR; PROTEIN-SYNTHESIS RATES; I GENE-TRANSFER; IGF-I; GROWTH-FACTOR; UBIQUITIN-PROTEASOME; LIMB IMMOBILIZATION; APOPTOTIC PATHWAYS; ADULT RATS; ATROPHY	The present study addressed the hypothesis that reducing mTOR, as seen in mTOR heterozygous (+/-) mice, would exaggerate the changes in protein synthesis and degradation observed during hindlimb immobilization as well as impair normal muscle regrowth during the recovery period. Atrophy was produced by unilateral hindlimb immobilization and data compared to the contralateral gastrocnemius. In wild-type (WT) mice, the gradual loss of muscle mass plateaued by day 7. This response was associated with a reduction in basal protein synthesis and development of leucine resistance. Proteasome activity was consistently elevated, but atrogin-1 and MuRF1 mRNAs were only transiently increased returning to basal values by day 7. When assessed 7 days after immobilization, the decreased muscle mass and protein synthesis and increased proteasome activity did not differ between WT and mTOR(+/-) mice. Moreover, the muscle inflammatory cytokine response did not differ between groups. After 10 days of recovery, WT mice showed no decrement in muscle mass, and this accretion resulted from a sustained increase in protein synthesis and a normalization of proteasome activity. In contrast, mTOR(+/-) mice failed to fully replete muscle mass at this time, a defect caused by the lack of a compensatory increase in protein synthesis. The delayed muscle regrowth of the previously immobilized muscle in the mTOR(+/-) mice was associated with a decreased raptor.4EBP1 and increased raptor.Deptor binding. Slowed regrowth was also associated with a sustained inflammatory response (e. g., increased TNF alpha and CD45 mRNA) during the recovery period and a failure of IGF-I to increase as in WT mice. These data suggest mTOR is relatively more important in regulating the accretion of muscle mass during recovery than the loss of muscle during the atrophy phase, and that protein synthesis is more sensitive than degradation to the reduction in mTOR during muscle regrowth.	[Lang, Susan M.; Kazi, Abid A.; Hong-Brown, Ly; Lang, Charles H.] Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Lang, SM (corresponding author), Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA 17033 USA.	clang@psu.edu			National Institutes of Health [GM38032]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038032, R29GM038032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding from National Institutes of Health GM38032 supported the current research project (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006518; Bajotto G, 2011, EUR J APPL PHYSIOL, V111, P1815, DOI 10.1007/s00421-010-1825-8; Barton ER, 2006, APPL PHYSIOL NUTR ME, V31, P791, DOI 10.1139/h06-054; Bialek P, 2011, PHYSIOL GENOMICS, V43, P1075, DOI 10.1152/physiolgenomics.00247.2010; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bondesen BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1651, DOI 10.1152/ajpcell.00518.2005; BOOTH FW, 1979, J APPL PHYSIOL, V47, P974, DOI 10.1152/jappl.1979.47.5.974; BOOTH FW, 1978, J APPL PHYSIOL, V44, P225, DOI 10.1152/jappl.1978.44.2.225; Burks TN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002227; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Caron AZ, 2009, J APPL PHYSIOL, V106, P2049, DOI 10.1152/japplphysiol.91505.2008; Childs TE, 2003, AM J PHYSIOL-CELL PH, V285, pC391, DOI 10.1152/ajpcell.00478.2002; Criswell DS, 1998, AM J PHYSIOL-ENDOC M, V275, pE373; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A; Fitts RH, 2007, AM J PHYSIOL-CELL PH, V293, pC313, DOI 10.1152/ajpcell.00573.2006; Flueck M, 2010, J APPL PHYSIOL, V108, P1821, DOI 10.1152/japplphysiol.01246.2009a; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; Frost R A, 2003, Minerva Endocrinol, V28, P53; Frost RA, 2005, CURR OPIN CLIN NUTR, V8, P255, DOI 10.1097/01.mco.0000165003.16578.2d; Frost RA, 2007, J APPL PHYSIOL, V103, P378, DOI 10.1152/japplphysiol.00089.2007; Frost RA, 2007, AM J PHYSIOL-ENDOC M, V292, pE501, DOI 10.1152/ajpendo.00359.2006; Frost RA, 2011, PHYSIOLOGY, V26, P83, DOI 10.1152/physiol.00044.2010; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; GARLICK PJ, 1994, AM J PHYSIOL, V266, pE287, DOI 10.1152/ajpendo.1994.266.3.E287; GIBSON JNA, 1987, CLIN SCI, V72, P503, DOI 10.1042/cs0720503; Glover EI, 2008, J PHYSIOL-LONDON, V586, P6049, DOI 10.1113/jphysiol.2008.160333; Goldspink G, 2005, PHYSIOLOGY, V20, P232, DOI 10.1152/physiol.00004.2005; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gustafsson T, 2010, J APPL PHYSIOL, V109, P721, DOI 10.1152/japplphysiol.00110.2009; Haddad F, 2003, J APPL PHYSIOL, V95, P791, DOI 10.1152/japplphysiol.01113.2002; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hood DA, 2006, J EXP BIOL, V209, P2265, DOI 10.1242/jeb.02182; Kazi AA, 2011, MOL MED, V17, P925, DOI 10.2119/molmed.2011.00070; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim SJ, 2007, J APPL PHYSIOL, V103, P195, DOI 10.1152/japplphysiol.01427.2006; Krawiec BJ, 2005, AM J PHYSIOL-ENDOC M, V289, pE969, DOI 10.1152/ajpendo.00126.2005; Labeit S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/693741; Lang CH, 2002, AM J PHYSIOL-ENDOC M, V282, pE336, DOI 10.1152/ajpendo.00366.2001; Lang CH, 2007, AM J PHYSIOL-ENDOC M, V293, pE453, DOI 10.1152/ajpendo.00204.2007; Lang CH, 2010, AM J PHYSIOL-REG I, V299, pR935, DOI 10.1152/ajpregu.00297.2010; Lang CH, 2010, AM J PHYSIOL-ENDOC M, V298, pE1283, DOI 10.1152/ajpendo.00676.2009; Lemoine JK, 2009, MUSCLE NERVE, V39, P463, DOI 10.1002/mus.21189; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machida S, 2004, MED SCI SPORT EXER, V36, P52, DOI 10.1249/01.MSS.0000106175.24978.84; Magne H, 2011, J PHYSIOL-LONDON, V589, P511, DOI 10.1113/jphysiol.2010.201707; Matheny RW, 2010, ENDOCRINOLOGY, V151, P865, DOI 10.1210/en.2009-1217; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Morris RT, 2004, J APPL PHYSIOL, V96, P398, DOI 10.1152/japplphysiol.00454.2003; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Murphy KT, 2011, J APPL PHYSIOL, V110, P1065, DOI 10.1152/japplphysiol.01183.2010; Murton AJ, 2008, BBA-MOL BASIS DIS, V1782, P730, DOI 10.1016/j.bbadis.2008.10.011; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Nystrom G, 2009, METABOLISM, V58, P787, DOI 10.1016/j.metabol.2009.01.015; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Peterson JM, 2006, J APPL PHYSIOL, V101, P1394, DOI 10.1152/japplphysiol.01453.2005; Rabinovsky ED, 2002, FASEB J, V16, P53, DOI 10.1096/fj.02-0183fje; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Schakman O, 2005, ENDOCRINOLOGY, V146, P1789, DOI 10.1210/en.2004-1594; Smith IJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE762, DOI 10.1152/ajpendo.90226.2008; Stelzer JE, 2003, J APPL PHYSIOL, V95, P2425, DOI 10.1152/japplphysiol.01091.2002; Stevens-Lapsley JE, 2010, AM J PHYSIOL-ENDOC M, V299, pE730, DOI 10.1152/ajpendo.00230.2010; Stewart CE, 2010, J APPL PHYSIOL, V108, P1820, DOI 10.1152/japplphysiol.01246.2009; Sugiura T, 2005, AM J PHYSIOL-REG I, V288, pR1273, DOI 10.1152/ajpregu.00688.2004; Temmerman L, 2010, GROWTH HORM IGF RES, V20, P255, DOI 10.1016/j.ghir.2010.03.002; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; TUCKER KR, 1981, J APPL PHYSIOL, V51, P73, DOI 10.1152/jappl.1981.51.1.73; Vargas R, 2008, ALCOHOL CLIN EXP RES, V32, P128, DOI 10.1111/j.1530-0277.2007.00548.x; Vary Thomas C., 2008, V447, P343, DOI 10.1007/978-1-59745-242-7_22; Vary TC, 2008, AM J PHYSIOL-REG I, V294, pR1777, DOI 10.1152/ajpregu.00056.2008; Vazeille E, 2008, AM J PHYSIOL-ENDOC M, V295, pE1181, DOI 10.1152/ajpendo.90532.2008; Washington TA, 2011, ACTA PHYSIOL, V202, P657, DOI 10.1111/j.1748-1716.2011.02281.x; Weichhart T, 2008, ANN RHEUM DIS, V67, P70, DOI 10.1136/ard.2008.098459; Yamamoto D, 2010, MUSCLE NERVE, V41, P819, DOI 10.1002/mus.21621; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	80	55	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38910	10.1371/journal.pone.0038910	http://dx.doi.org/10.1371/journal.pone.0038910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745686	gold, Green Published			2022-12-27	WOS:000305730900023
J	Sangare, LR; Weiss, NS; Brentlinger, PE; Richardson, BA; Staedke, SG; Kiwuwa, MS; Stergachis, A				Sangare, Laura R.; Weiss, Noel S.; Brentlinger, Paula E.; Richardson, Barbra A.; Staedke, Sarah G.; Kiwuwa, Mpungu S.; Stergachis, Andy			Determinants of Use of Insecticide Treated Nets for the Prevention of Malaria in Pregnancy: Jinja, Uganda	PLOS ONE			English	Article							INTERMITTENT PRESUMPTIVE TREATMENT; BED NETS; MOSQUITO NETS; POLICY IMPLICATIONS; COST-EFFECTIVENESS; WESTERN KENYA; WOMEN; OWNERSHIP; PERCEPTIONS; TANZANIA	Background: One established means of preventing the adverse consequences of malaria during pregnancy is sleeping under an insecticide treated net (ITN) throughout pregnancy. Despite increased access to this intervention over time, consistent ITN use during pregnancy remains relatively uncommon in sub-Saharan Africa. Methodology/Principal Findings: We sought to identify determinants of ITN use during pregnancy. Utilizing a population-based random sample, we interviewed 500 women living in Jinja, Uganda, who had been pregnant in the past year. ITN ownership at the start of pregnancy was reported by 359 women (72%) and 28 women (20%) acquired an ITN after the first trimester of pregnancy. Among 387 ITN owners, 73% reported either always sleeping under the ITN during all trimesters of pregnancy, or after acquiring their net. Owning more than 1 net was slightly associated with always sleeping under an ITN during pregnancy (RR: 1.13; 95% CI: 1.00, 1.28). Women who always slept under an ITN during pregnancy were more likely to be influenced by an advertisement on the radio/poster than being given an ITN free of charge (RR: 1.48; 95% CI: 1.24, 1.76). No differences were found between other socio-demographic factors, pregnancy history, ANC use or socio-cultural factors. Conclusions/Significance: While self-reported ITN ownership and use was common throughout pregnancy, we were unable to pinpoint why a sizable fraction of Ugandan women did not always adhere to recommendations for use of an ITN during pregnancy. More data are needed on the capacity of individual households to support the installation of ITNs which may provide insight into interventions targeted at improving the convenience and adherence of daily ITN use.	[Stergachis, Andy] Univ Washington, Dept Global Hlth, Global Med Program, Seattle, WA 98195 USA; [Stergachis, Andy] Univ Washington, Dept Epidemiol, Global Med Program, Seattle, WA 98195 USA; [Richardson, Barbra A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Staedke, Sarah G.] Makerere Univ, London Sch Hyg & Trop Med, Sch Med, Kampala, Uganda; [Kiwuwa, Mpungu S.] Makerere Univ, Sch Med, Kampala, Uganda	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Makerere University; Makerere University	Sangare, LR (corresponding author), Univ Washington, Dept Global Hlth, Global Med Program, Seattle, WA 98195 USA.	lsangare@u.washington.edu		Brentlinger, Paula/0000-0002-4865-8915	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000422] Funding Source: NIH RePORTER; NCATS NIH HHS [TL1 TR000422] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Agha S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-13; Ahmed SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012660; Alaii JA, 2003, AM J TROP MED HYG, V68, P142, DOI 10.4269/ajtmh.2003.68.142; [Anonymous], 2010, UG MAL IND SURV 2009; [Anonymous], 2011, WHOHTMGMP20111; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-113; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Baume CA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-153; Binka FN, 1997, TROP MED INT HEALTH, V2, P499, DOI 10.1046/j.1365-3156.1997.d01-299.x; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; Erlanger TE, 2004, MED VET ENTOMOL, V18, P153, DOI 10.1111/j.0269-283X.2004.00491.x; de Oliveira MRF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-277; Gamble C, 2007, PLOS MED, V4, P506, DOI 10.1371/journal.pmed.0040107; Gerstl S, 2010, TROP MED INT HEALTH, V15, P480, DOI 10.1111/j.1365-3156.2010.02478.x; Gikandi PW, 2008, TROP MED INT HEALTH, V13, P208, DOI 10.1111/j.1365-3156.2007.01992.x; Grabowsky M, 2007, TROP MED INT HEALTH, V12, P815, DOI 10.1111/j.1365-3156.2007.01862.x; Greenwood B, 2007, LANCET INFECT DIS, V7, P169, DOI 10.1016/S1473-3099(07)70028-2; Guyatt HL, 2004, TROP MED INT HEALTH, V9, P255, DOI 10.1046/j.1365-3156.2003.01193.x; Hanson K, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2434; Human Research Affairs/Research Management, 2007, PAYM HUM SUBJ PART R; Lumley T, 2006, 293 UW BIOST; Maxwell CA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-44; Mbonye AK, 2006, HEALTH POLICY PLANN, V21, P17, DOI 10.1093/heapol/czj002; Mbonye AK, 2006, HEALTH POLICY, V77, P279, DOI 10.1016/j.healthpol.2005.07.020; Menendez C, 2006, CURR MOL MED, V6, P269, DOI 10.2174/156652406776055186; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Nganda RY, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-42; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Okrah J, 2002, TROP MED INT HEALTH, V7, P240, DOI 10.1046/j.1365-3156.2002.00856.x; Pettifor A, 2009, TROP MED INT HEALTH, V14, P20, DOI 10.1111/j.1365-3156.2008.02179.x; Pettifor A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-331; Ribera JM, 2007, PLOS MED, V4, P631, DOI 10.1371/journal.pmed.0040092; Roll Back Malaria Monitoring and Evaluation Reference Group, 2005, MAL IND SURV BAS DOC; Rutstein SO, 2004, 6 DHS COMP ORC; Sangare LR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-152; Sangare LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015066; Steketee RW, 2008, AM J TROP MED HYG, V79, P45, DOI 10.4269/ajtmh.2008.79.45; Uganda Bureau of Statistics Macro International Inc, 2007, UG DEM HLTH SURV 200; van Eijk AM, 2011, LANCET INFECT DIS, V11, P190, DOI 10.1016/S1473-3099(10)70295-4; Winch PJ, 1997, TROP MED INT HEALTH, V2, P760, DOI 10.1046/j.1365-3156.1997.d01-376.x; Yates A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-52; Yukich JO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-51	43	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39712	10.1371/journal.pone.0039712	http://dx.doi.org/10.1371/journal.pone.0039712			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745817	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000305730900105
J	Seidl, K; Solis, NV; Bayer, AS; Hady, WA; Ellison, S; Klashman, MC; Xiong, YQ; Filler, SG				Seidl, Kati; Solis, Norma V.; Bayer, Arnold S.; Hady, Wessam Abdel; Ellison, Steven; Klashman, Meredith C.; Xiong, Yan Q.; Filler, Scott G.			Divergent Responses of Different Endothelial Cell Types to Infection with Candida albicans and Staphylococcus aureus	PLOS ONE			English	Article							ADHESION MOLECULE EXPRESSION; SMALL-COLONY VARIANTS; EXPERIMENTAL ENDOCARDITIS; PROINFLAMMATORY RESPONSE; PHENOTYPIC HETEROGENEITY; ASPERGILLUS-FUMIGATUS; CYTOKINE PRODUCTION; GENE-EXPRESSION; IN-VITRO; VIRULENCE	Endothelial cells are important in the pathogenesis of bloodstream infections caused by Candida albicans and Staphylococcus aureus. Numerous investigations have used human umbilical vein endothelial cells (HUVECs) to study microbial-endothelial cell interactions in vitro. However, the use of HUVECs requires a constant supply of umbilical cords, and there are significant donor-to-donor variations in these endothelial cells. The use of an immortalized endothelial cell line would obviate such difficulties. One candidate in this regard is HMEC-1, an immortalized human dermal microvascular endothelial cell line. To determine if HMEC-1 cells are suitable for studying the interactions of C. albicans and S. aureus with endothelial cells in vitro, we compared the interactions of these organisms with HMEC-1 cells and HUVECs. We found that wild-type C. albicans had significantly reduced adherence to and invasion of HMEC-1 cells as compared to HUVECs. Although wild-type S. aureus adhered to and invaded HMEC-1 cells similarly to HUVECs, an agr mutant strain had significantly reduced invasion of HMEC-1 cells, but not HUVECs. Furthermore, HMEC-1 cells were less susceptible to damage induced by C. albicans, but more susceptible to damage caused by S. aureus. In addition, HMEC-1 cells secreted very little IL-8 in response to infection with either organism, whereas infection of HUVECs induced substantial IL-8 secretion. This weak IL-8 response was likely due to the anatomic site from which HMEC-1 cells were obtained because infection of primary human dermal microvascular endothelial cells with C. albicans and S. aureus also induced little increase in IL-8 production above basal levels. Thus, C. albicans and S. aureus interact with HMEC-1 cells in a substantially different manner than with HUVECs, and data obtained with one type of endothelial cell cannot necessarily be extrapolated to other types.	[Seidl, Kati; Solis, Norma V.; Bayer, Arnold S.; Hady, Wessam Abdel; Ellison, Steven; Klashman, Meredith C.; Xiong, Yan Q.; Filler, Scott G.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Seidl, Kati] Univ Zurich, Univ Zurich Hosp, Zurich, Switzerland; [Bayer, Arnold S.; Xiong, Yan Q.; Filler, Scott G.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Ellison, Steven] Calif State Univ Dominguez Hills, Dept Biol, Carson, CA 90747 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of Zurich; University Zurich Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California State University System; California State University Dominguez Hills	Seidl, K (corresponding author), Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA.	sfiller@ucla.edu	Xiong, Yan Q/AAC-6362-2021	Xiong, Yan Q/0000-0002-8732-6948	Foundation for Research at the Medical Faculty, University of Zurich, Switzerland; Clinical Trials Center, University Hospital Zurich, Switzerland; American Heart Association [SDG 0630219N, GIA 09GRNT2180065]; U.S. National Institutes of Health [R01AI39108, R01AI054928]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054928, R01AI039108] Funding Source: NIH RePORTER	Foundation for Research at the Medical Faculty, University of Zurich, Switzerland; Clinical Trials Center, University Hospital Zurich, Switzerland; American Heart Association(American Heart Association); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants of the Foundation for Research at the Medical Faculty, University of Zurich, Switzerland and Matching Funds of the Clinical Trials Center, University Hospital Zurich, Switzerland to K. S., the American Heart Association grants SDG 0630219N and GIA 09GRNT2180065 to Y.Q.X., and the U.S. National Institutes of Health grants (R01AI39108 to A. S. B., and R01AI054928 to S. G. F.). The endothelial cells used in these studies were isolated from human umbilical cords, which were collected by the pediatric, perinatal and mobile unit of the UCLA Clinical and Translational Science Institute at LA BioMed/Harbor-UCLA Medical Center (UL1TR000124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Aird WC, 2008, PHARMACOL REP, V60, P139; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Atalla H, 2008, FOODBORNE PATHOG DIS, V5, P785, DOI 10.1089/fpd.2008.0110; BALWIT JM, 1994, J INFECT DIS, V170, P1033, DOI 10.1093/infdis/170.4.1033; Bezerra LML, 2004, BLOOD, V103, P2143, DOI 10.1182/blood-2003-06-2186; Cheung AL, 2007, CURR PROTOC MICROBIO, p9C41; Chiang LY, 2008, INFECT IMMUN, V76, P3429, DOI 10.1128/IAI.01510-07; Cho NH, 2001, INFECT IMMUN, V69, P1265, DOI 10.1128/IAI.69.3.1265-1272.2001; Chorianopoulos E, 2009, CELL TISSUE RES, V335, P153, DOI 10.1007/s00441-008-0687-4; Cleary IA, 2011, MICROBIOL-SGM, V157, P1806, DOI 10.1099/mic.0.046326-0; Coombes BK, 2001, INFECT IMMUN, V69, P1420, DOI 10.1128/IAI.69.3.1420-1427.2001; Davis D, 2000, MOL CELL BIOL, V20, P971, DOI 10.1128/MCB.20.3.971-978.2000; Esen M, 2001, APOPTOSIS, V6, P431, DOI 10.1023/A:1012445925628; Ferrero MC, 2011, MICROBES INFECT, V13, P852, DOI 10.1016/j.micinf.2011.04.010; FILLER SG, 1995, INFECT IMMUN, V63, P976, DOI 10.1128/IAI.63.3.976-983.1995; Filler SG, 1996, INFECT IMMUN, V64, P2609, DOI 10.1128/IAI.64.7.2609-2617.1996; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Grubb SEW, 2009, INFECT IMMUN, V77, P3872, DOI 10.1128/IAI.00518-09; Grundmeier M, 2010, J INFECT DIS, V201, P871, DOI 10.1086/651023; Haslinger-Loffler B, 2005, CELL MICROBIOL, V7, P1087, DOI 10.1111/j.1462-5822.2005.00533.x; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kamai Y, 2006, MED MYCOL, V44, pS115, DOI 10.1080/13693780600897989; Krishnaswamy G, 1999, J INTERF CYTOK RES, V19, P91, DOI 10.1089/107999099314234; Lidington EA, 1999, TRANSPL IMMUNOL, V7, P239, DOI 10.1016/S0966-3274(99)80008-2; Mehta PK, 2006, MICROB PATHOGENESIS, V41, P119, DOI 10.1016/j.micpath.2006.05.002; Mitchell G, 2008, MOL MICROBIOL, V70, P1540, DOI 10.1111/j.1365-2958.2008.06511.x; Nanobashvili J., 2003, EUR SURG, V35, P214, DOI 10.1007/s10353-003-0012-0; Oostingh GJ, 2007, J INVEST DERMATOL, V127, P2253, DOI 10.1038/sj.jid.5700828; Orozco AS, 2000, INFECT IMMUN, V68, P1134, DOI 10.1128/IAI.68.3.1134-1141.2000; Pang YY, 2010, J INNATE IMMUN, V2, P546, DOI 10.1159/000319855; Park H, 2009, EUKARYOT CELL, V8, P1498, DOI 10.1128/EC.00165-09; Phan QT, 2005, J BIOL CHEM, V280, P10455, DOI 10.1074/jbc.M412592200; Phan QT, 2000, INFECT IMMUN, V68, P3485, DOI 10.1128/IAI.68.6.3485-3490.2000; Phan Quynh T., 2009, V470, P313, DOI 10.1007/978-1-59745-204-5_22; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Pohlmann-Dietze P, 2000, INFECT IMMUN, V68, P4865, DOI 10.1128/IAI.68.9.4865-4871.2000; Resto-Ruiz SI, 2002, INFECT IMMUN, V70, P4564, DOI 10.1128/IAI.70.8.4564-4570.2002; Rydkina E, 2010, INFECT IMMUN, V78, P2599, DOI 10.1128/IAI.01335-09; Sanchez AA, 2004, INFECT IMMUN, V72, P598, DOI 10.1128/IAI.72.1.598-601.2004; SCHEGLOVITOVA O, 1995, ARCH VIROL, V140, P951, DOI 10.1007/BF01314971; Seidl K, 2011, ANTIMICROB AGENTS CH, V55, P5631, DOI 10.1128/AAC.05251-11; Seidl K, 2011, CELL MICROBIOL, V13, P1530, DOI 10.1111/j.1462-5822.2011.01639.x; Shenkman B, 2002, J MED MICROBIOL, P51; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Sinha B, 2000, INFECT IMMUN, V68, P6871, DOI 10.1128/IAI.68.12.6871-6878.2000; Strindhall J, 2005, SCAND J IMMUNOL, V61, P57, DOI 10.1111/j.0300-9475.2005.01526.x; Sun JN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001181; Suzuki T, 2011, ANTIMICROB AGENTS CH, V55, P767, DOI 10.1128/AAC.00879-10; Tajima A, 2009, INFECT IMMUN, V77, P327, DOI 10.1128/IAI.00748-08; Tuchscherr L, 2010, J INFECT DIS, V202, P1031, DOI 10.1086/656047; VANN JM, 1987, INFECT IMMUN, V55, P2155, DOI 10.1128/IAI.55.9.2155-2163.1987; Wilson D, 2010, EUKARYOT CELL, V9, P278, DOI 10.1128/EC.00307-09; Yao L, 1996, INFECT IMMUN, V64, P3407, DOI 10.1128/IAI.64.8.3407-3409.1996	55	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39633	10.1371/journal.pone.0039633	http://dx.doi.org/10.1371/journal.pone.0039633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745797	gold, Green Submitted, Green Published			2022-12-27	WOS:000305730900087
J	Yang, IV; Luna, LG; Cotter, J; Talbert, J; Leach, SM; Kidd, R; Turner, J; Kummer, N; Kervitsky, D; Brown, KK; Boon, K; Schwarz, MI; Schwartz, DA; Steele, MP				Yang, Ivana V.; Luna, Leah G.; Cotter, Jennifer; Talbert, Janet; Leach, Sonia M.; Kidd, Raven; Turner, Julia; Kummer, Nathan; Kervitsky, Dolly; Brown, Kevin K.; Boon, Kathy; Schwarz, Marvin I.; Schwartz, David A.; Steele, Mark P.			The Peripheral Blood Transcriptome Identifies the Presence and Extent of Disease in Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							PROGNOSTIC VALUE; ACUTE EXACERBATIONS; ALPHA-DEFENSINS; GENE; SURVIVAL; PHYSIOLOGY; DIAGNOSIS; SYSTEM; GROWTH	Rationale: Peripheral blood biomarkers are needed to identify and determine the extent of idiopathic pulmonary fibrosis (IPF). Current physiologic and radiographic prognostic indicators diagnose IPF too late in the course of disease. We hypothesize that peripheral blood biomarkers will identify disease in its early stages, and facilitate monitoring for disease progression. Methods: Gene expression profiles of peripheral blood RNA from 130 IPF patients were collected on Agilent microarrays. Significance analysis of microarrays (SAM) with a false discovery rate (FDR) of 1% was utilized to identify genes that were differentially-expressed in samples categorized based on percent predicted DLCO and FVC. Main Measurements and Results: At 1% FDR, 1428 genes were differentially-expressed in mild IPF (DLCO>65%) compared to controls and 2790 transcripts were differentially-expressed in severe IPF (DLCO>35%) compared to controls. When categorized by percent predicted DLCO, SAM demonstrated 13 differentially-expressed transcripts between mild and severe IPF (<5% FDR). These include CAMP, CEACAM6, CTSG, DEFA3 and A4, OLFM4, HLTF, PACSIN1, GABBR1, IGHM, and 3 unknown genes. Principal component analysis (PCA) was performed to determine outliers based on severity of disease, and demonstrated 1 mild case to be clinically misclassified as a severe case of IPF. No differentially-expressed transcripts were identified between mild and severe IPF when categorized by percent predicted FVC. Conclusions: These results demonstrate that the peripheral blood transcriptome has the potential to distinguish normal individuals from patients with IPF, as well as extent of disease when samples were classified by percent predicted DLCO, but not FVC.	[Yang, Ivana V.; Luna, Leah G.; Cotter, Jennifer; Talbert, Janet; Leach, Sonia M.; Turner, Julia; Kummer, Nathan; Kervitsky, Dolly; Schwarz, Marvin I.; Schwartz, David A.] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO USA; [Kidd, Raven] Duke Univ, Med Ctr, Durham, NC USA; [Kervitsky, Dolly; Brown, Kevin K.] Natl Jewish Hlth, Interstitial Lung Dis Lab, Denver, CO USA; [Yang, Ivana V.; Schwarz, Marvin I.; Schwartz, David A.] Univ Colorado, Dept Med, Aurora, CO USA; [Boon, Kathy; Steele, Mark P.] Excerpta Med, Amsterdam, Netherlands; [Steele, Mark P.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	National Jewish Health; Duke University; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Vanderbilt University	Yang, IV (corresponding author), Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO USA.	mark.p.steele@vanderbilt.edu	Kidd, Raven N/H-4081-2013; Brown, Kevin/ABF-2544-2020; Yang, Ivana V/P-3059-2018	Kidd, Raven N/0000-0002-1101-7639; Yang, Ivana V/0000-0002-1018-489X	National Heart Lung Blood Institute [5R01HL095393, RC1HL09957]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095393] Funding Source: NIH RePORTER	National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Heart Lung Blood Institute 5R01HL095393 and RC1HL09957. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenomori M, 2010, EXP LUNG RES, V36, P411, DOI 10.3109/01902141003714049; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; [Anonymous], 1987, Am Rev Respir Dis, V136, P1285; Bevins CL, 2006, ANTIMICROBIAL PEPTID, V34, P253; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Collard Harold R, 2008, Curr Opin Support Palliat Care, V2, P100, DOI 10.1097/SPC.0b013e3282ff6336; Collard HR, 2003, AM J RESP CRIT CARE, V168, P538, DOI 10.1164/rccm.200211-1311OC; Flaherty KR, 2006, AM J RESP CRIT CARE, V174, P803, DOI 10.1164/rccm.200604-488OC; Flaherty KR, 2003, AM J RESP CRIT CARE, V168, P543, DOI 10.1164/rccm.200209-1112OC; Ganz T, 2002, J CLIN INVEST, V109, P693, DOI 10.1172/JCI200215218; Greene KE, 2002, EUR RESPIR J, V19, P439, DOI 10.1183/09031936.02.00081102; Han WH, 2009, FEBS J, V276, P6603, DOI 10.1111/j.1742-4658.2009.07370.x; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Jegal Y, 2005, AM J RESP CRIT CARE, V171, P639, DOI 10.1164/rccm.200403-331OC; King TE, 2005, CHEST, V127, P171, DOI 10.1378/chest.127.1.171; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; Konishi K, 2009, AM J RESP CRIT CARE, V180, P167, DOI 10.1164/rccm.200810-1596OC; Koshida S, 2007, CANCER SCI, V98, P315, DOI 10.1111/j.1349-7006.2006.00383.x; Latsi PI, 2003, AM J RESP CRIT CARE, V168, P531, DOI 10.1164/rccm.200210-1245OC; Liu WL, 2010, BLOOD, V116, P4938, DOI 10.1182/blood-2009-10-246439; Lynch DA, 2005, AM J RESP CRIT CARE, V172, P488, DOI 10.1164/rccm.200412-1756OC; Mukae H, 2002, THORAX, V57, P623, DOI 10.1136/thorax.57.7.623; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Prassel A, 2009, AM J RESP CRIT CARE, V179, P717, DOI 10.1164/rccm.200808-1201OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richards TJ, 2012, AM J RESP CRIT CARE, V185, P67, DOI 10.1164/rccm.201101-0058OC; Rosas IO, 2007, AM J RESP CRIT CARE, V176, P698, DOI 10.1164/rccm.200702-254OC; Rosas IO, 2008, PLOS MED, V5, P623, DOI 10.1371/journal.pmed.0050093; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Tzilas V, 2009, AM J MED SCI, V338, P481, DOI 10.1097/MAJ.0b013e3181ad5984; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Wetering S, 2005, J LEUKOCYTE BIOL, V77, P444, DOI 10.1189/jlb.0604367; Venkatadri K, 2009, PHYSL LUNG CELL MOL, V296, pL1019; Wilson CL, 2009, J BIOL CHEM, V284, P8301, DOI 10.1074/jbc.M809744200; Yang IV, 2007, AM J RESP CRIT CARE, V175, P45, DOI 10.1164/rccm.200601-062OC; Yokoyama A, 2006, RESPIROLOGY, V11, P164, DOI 10.1111/j.1440-1843.2006.00834.x; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	41	60	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e37708	10.1371/journal.pone.0037708	http://dx.doi.org/10.1371/journal.pone.0037708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761659	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900004
J	Angot, E; Steiner, JA; Tome, CML; Ekstrom, P; Mattsson, B; Bjorklund, A; Brundin, P				Angot, Elodie; Steiner, Jennifer A.; Tome, Carla M. Lema; Ekstrom, Peter; Mattsson, Bengt; Bjorklund, Anders; Brundin, Patrik			Alpha-Synuclein Cell-to-Cell Transfer and Seeding in Grafted Dopaminergic Neurons In Vivo	PLOS ONE			English	Article							SPORADIC PARKINSONS-DISEASE; LEWY BODY PATHOLOGY; DEATH; INCLUSIONS; MUTATION; TRIPLICATION; DUPLICATION; ENDOCYTOSIS; CLEARANCE; RESPONSES	Several people with Parkinson's disease have been treated with intrastriatal grafts of fetal dopaminergic neurons. Following autopsy, 10-22 years after surgery, some of the grafted neurons contained Lewy bodies similar to those observed in the host brain. Numerous studies have attempted to explain these findings in cell and animal models. In cell culture, alpha-synuclein has been found to transfer from one cell to another, via mechanisms that include exosomal transport and endocytosis, and in certain cases seed aggregation in the recipient cell. In animal models, transfer of alpha-synuclein from host brain cells to grafted neurons has been shown, but the reported frequency of the event has been relatively low and little is known about the underlying mechanisms as well as the fate of the transferred alpha-synuclein. We now demonstrate frequent transfer of alpha-synuclein from a rat brain engineered to overexpress human alpha-synuclein to grafted dopaminergic neurons. Further, we show that this model can be used to explore mechanisms underlying cell-to-cell transfer of alpha-synuclein. Thus, we present evidence both for the involvement of endocytosis in alpha-synuclein uptake in vivo, and for seeding of aggregation of endogenous alpha-synuclein in the recipient neuron by the transferred alpha-synuclein. Finally, we show that, at least in a subset of the studied cells, the transmitted alpha-synuclein is sensitive to proteinase K. Our new model system could be used to test compounds that inhibit cell-to-cell transfer of alpha-synuclein and therefore might retard progression of Parkinson neuropathology.	[Angot, Elodie; Steiner, Jennifer A.; Tome, Carla M. Lema; Brundin, Patrik] Lund Univ, Neuronal Survival Unit, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden; [Steiner, Jennifer A.; Brundin, Patrik] Van Andel Res Inst, Ctr Neurodegenerat Sci, Grand Rapids, MI USA; [Ekstrom, Peter] ImaGene iT, Lund, Sweden; [Mattsson, Bengt; Bjorklund, Anders] Lund Univ, Neurobiol Unit, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden	Lund University; Van Andel Institute; Lund University	Angot, E (corresponding author), Lund Univ, Neuronal Survival Unit, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden.	Elodie.Angot@med.lu.se	Björklund, Anders/ABA-1326-2020	Bjorklund, Anders/0000-0002-5676-6203; Angot, Elodie/0000-0002-5041-4485	Michael J. Fox Foundation for Parkinson's Research; Swedish Brain Foundation; Swedish Parkinson Foundation; Soderberg's Foundation; Swedish Research Council; Anna-Lisa Rosenberg Foundation; European Research Area Network of European Funding for Neuroscience Research Program MIPROTRAN; Human Frontier Science Program; European Research Council; Strong Research Environment Multipark (Multidisciplinary research in Parkinson's disease at Lund University)	Michael J. Fox Foundation for Parkinson's Research; Swedish Brain Foundation; Swedish Parkinson Foundation; Soderberg's Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Anna-Lisa Rosenberg Foundation; European Research Area Network of European Funding for Neuroscience Research Program MIPROTRAN; Human Frontier Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); Strong Research Environment Multipark (Multidisciplinary research in Parkinson's disease at Lund University)	This work was supported by the Michael J. Fox Foundation for Parkinson's Research; Swedish Brain Foundation; Swedish Parkinson Foundation; Soderberg's Foundation; Swedish Research Council, including the Linnaeus grant Bagadilico; Anna-Lisa Rosenberg Foundation; European Research Area Network of European Funding for Neuroscience Research Program MIPROTRAN; Human Frontier Science Program; a European Research Council Advanced Award and a private donation from Mr. Sven Astell. All authors are active in the Strong Research Environment Multipark (Multidisciplinary research in Parkinson's disease at Lund University), and EA and JAS are both recipients of personal fellowships from this program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angot E, 2010, LANCET NEUROL, V9, P1128, DOI 10.1016/S1474-4422(10)70213-1; Barker RA, 1996, EXP NEUROL, V141, P79, DOI 10.1006/exnr.1996.0141; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2007, ACTA NEUROPATHOL, V114, P231, DOI 10.1007/s00401-007-0244-3; BRUNDIN P, 1986, DEV BRAIN RES, V24, P77, DOI 10.1016/0165-3806(86)90174-4; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chu YP, 2010, ANN NY ACAD SCI, V1184, P55, DOI 10.1111/j.1749-6632.2009.05229.x; Croisier E, 2006, ACTA NEUROPATHOL, V112, P517, DOI 10.1007/s00401-006-0119-z; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Danzer KM, 2009, J NEUROCHEM, V111, P192, DOI 10.1111/j.1471-4159.2009.06324.x; Decressac M, 2011, NEUROBIOL D IN PRESS; Decressac M, 2011, BRAIN, V134, P2302, DOI 10.1093/brain/awr149; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; DUAN WM, 1995, EXP BRAIN RES, V104, P227; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Emgard M, 1999, EXP NEUROL, V160, P279, DOI 10.1006/exnr.1999.7198; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; Grimm D, 2002, METHODS, V28, P146, DOI 10.1016/S1046-2023(02)00219-0; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hawkes CH, 2009, ANN NY ACAD SCI, V1170, P615, DOI 10.1111/j.1749-6632.2009.04365.x; Jang A, 2010, J NEUROCHEM, V113, P1263, DOI 10.1111/j.1471-4159.2010.06695.x; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kordower JH, 2011, NEUROBIOL DIS, V43, P552, DOI 10.1016/j.nbd.2011.05.001; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kurowska Z, 2011, J PARKINSON DIS, V1, P83, DOI 10.3233/JPD-2011-11004; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Li JY, 2010, MOVEMENT DISORD, V25, P1091, DOI 10.1002/mds.23012; Luk KC, 2012, J EXPT MED; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Mougenot A. L., 2011, NEUROBIOL AGING; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Terada S, 2003, ACTA NEUROPATHOL, V105, P163, DOI 10.1007/s00401-002-0622-9; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Waxman EA, 2010, J NEUROCHEM, V113, P374, DOI 10.1111/j.1471-4159.2010.06592.x; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	45	186	189	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39465	10.1371/journal.pone.0039465	http://dx.doi.org/10.1371/journal.pone.0039465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737239	Green Submitted, Green Published, gold			2022-12-27	WOS:000305695100038
J	Storebo, OJ; Gluud, C; Winkel, P; Simonsen, E				Storebo, Ole Jakob; Gluud, Christian; Winkel, Per; Simonsen, Erik			Social-Skills and Parental Training plus Standard Treatment versus Standard Treatment for Children with ADHD - The Randomised SOSTRA Trial	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; METHYLPHENIDATE; ATTACHMENT; RELIABILITY; THERAPY	Objective: To investigate the effects of social-skills training and parental training programme for children with attention deficit hyperactivity disorder (ADHD). Methods: We conducted a randomized two-armed, parallel group, assessor-blinded superiority trial consisting of social-skills training plus parental training and standard treatment versus standard treatment alone. A sample size calculation showed at least 52 children should be included for the trial with follow up three and six months after randomization. The primary outcome measure was ADHD symptoms and secondary outcomes were social skills and emotional competences. Results 56: children (39 boys, 17 girls, mean age 10.4 years, SD 1.31) with ADHD were randomized, 28 to the experimental group and 27 to the control group. Mixed-model analyses with repeated measures showed that the time course (y = a + bt + ct(2)) of ADHD symptoms (p = 0.40), social skills (p = 0.80), and emotional competences (p = 0.14) were not significantly influenced by the intervention. Conclusions: Social skills training plus parental training did not show any significant benefit for children with attention deficit hyperactivity disorder when compared with standard treatment. More and larger randomized trials are needed.	[Storebo, Ole Jakob] Child & Adolescent Psychiat Dept, Child Psychiat Clin, Region Zealand, Denmark; [Storebo, Ole Jakob; Simonsen, Erik] Psychiat Res Unit, Roskilde, Denmark; [Storebo, Ole Jakob; Gluud, Christian; Winkel, Per] Copenhagen Univ Hosp, Rigshosp, Dept 3344, Ctr Clin Intervent Res,Copenhagen Trial Unit, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Storebo, OJ (corresponding author), Child & Adolescent Psychiat Dept, Child Psychiat Clin, Region Zealand, Denmark.	ojst@regionsjaelland.dk	Simonsen, Erik/N-6615-2014; Gluud, Christian/AAY-1027-2021; Gluud, Christian/HGB-3191-2022	Simonsen, Erik/0000-0002-6134-2392; Gluud, Christian/0000-0002-8861-0799; 	Region's Zealand University Hospital (RESUS); Region Zealand Research Foundation; Psychiatric Research Unit, Region Zealand; Fru C. Hermansens Foundation; Slagtermester Max Worzner and Inger Wozners Foundation; TrygFonden	Region's Zealand University Hospital (RESUS); Region Zealand Research Foundation; Psychiatric Research Unit, Region Zealand; Fru C. Hermansens Foundation; Slagtermester Max Worzner and Inger Wozners Foundation; TrygFonden	The SOSTRA trial was financially supported by Region's Zealand University Hospital (RESUS), Region Zealand Research Foundation, and Psychiatric Research Unit, Region Zealand. Funding was also received from the Fru C. Hermansens Foundation, Slagtermester Max Worzner and Inger Wozners Foundation, and TrygFonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler Lenard A, 2006, Ann Clin Psychiatry, V18, P145, DOI 10.1080/10401230600801077; Antshel KM, 2003, J CLIN CHILD ADOLESC, V32, P153, DOI 10.1207/S15374424JCCP3201_14; Atkinson M, 2010, ARCH DIS CHILDHOOD-E, V95, P24, DOI 10.1136/adc.2009.175943; Barkley R.A, 2006, ATTENTION DEFICIT HY, V3rd; Clarke L., 2002, CLIN CHILD PSYCHOL P, V7, P179, DOI [10.1177/1359104502007002006, DOI 10.1177/1359104502007002006]; Conners C. K., 2008, CONNERS 3 EDITION CO, V3rd; Conners C. K., 2008, CONNERS; Corkum PV, 2005, CHILD FAM BEHAV THER, V27, P29, DOI 10.1300/J019v27n04_02; Cyr M, 1998, DRUGS, V56, P215, DOI 10.2165/00003495-199856020-00005; de Boo GM, 2007, CLIN PSYCHOL REV, V27, P78, DOI 10.1016/j.cpr.2006.03.006; ELLIOTT SN, 1993, BEHAV MODIF, V17, P287, DOI 10.1177/01454455930173004; Fohlmann AH, 2009, PSYKOSE HOS UNGE; GADOW KD, 1990, J AM ACAD CHILD PSY, V29, P710, DOI 10.1097/00004583-199009000-00006; Gillberg C, 1997, ARCH GEN PSYCHIAT, V54, P857; Goldman LS, 1998, JAMA-J AM MED ASSOC, V279, P1100, DOI 10.1001/jama.279.14.1100; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; HORN WF, 1991, J AM ACAD CHILD PSY, V30, P233, DOI 10.1097/00004583-199103000-00011; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kavale KA., 1997, ADV LEARN BEHAV DISA, V11, P1; Keus F, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-90; Kissgen R, 2009, PSYCHOPATHOLOGY, V42, P201, DOI 10.1159/000209333; LANDAU S, 1991, SCHOOL PSYCHOL REV, V20, P235; Liberman RP, 1988, PSYCHIATR REHABIL J, P147; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Majewicz-Hefley Amy, 2007, J Atten Disord, V10, P239, DOI 10.1177/1087054706289934; MALONE MA, 1993, J CHILD NEUROL, V8, P157, DOI 10.1177/088307389300800209; Niederhofer H, 2009, PSYCHOL REP, V104, P645, DOI 10.2466/PR0.104.2.645-648; Nigg JT, 2005, DEV PSYCHOPATHOL, V17, P785, DOI 10.1017/S0954579405050376; Pasini A, 2007, BRAIN DEV-JPN, V29, P400, DOI 10.1016/j.braindev.2006.11.010; Petersen Dorthe Janne, 2002, Ugeskr Laeger, V164, P3433; Pfiffner LJ, 1997, J CONSULT CLIN PSYCH, V65, P749, DOI 10.1037/0022-006X.65.5.749; Pinto Carmen, 2006, J Atten Disord, V10, P83, DOI 10.1177/1087054705286058; Polanczyk G, 2007, CURR OPIN PSYCHIATR, V20, P386, DOI 10.1097/YCO.0b013e3281568d7a; Rutter M., 2003, SOCIAL COMMUNICATION; Schmidt S, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-58; Sergeant JA, 2003, NEUROSCI BIOBEHAV R, V27, P583, DOI 10.1016/j.neubiorev.2003.08.004; Shmueli-Goetz Y, 2008, DEV PSYCHOL, V44, P939, DOI 10.1037/0012-1649.44.4.939; Storebo O, 2012, COCHRANE DATABASE SY; Storebo OJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008223.pub2; Storebo OJ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-18; SWANSON JM, 1993, EXCEPT CHILDREN, V60, P154, DOI 10.1177/001440299306000209; Target M., 2003, J CHILD PSYCH, V29, P171, DOI [10.1080/0075417031000138433, DOI 10.1080/0075417031000138433]; Taylor E, 2004, EUR CHILD ADOLES PSY, V13, P7, DOI 10.1007/s00787-004-1002-x; Van der Oord S, 2008, CLIN PSYCHOL REV, V28, P783, DOI 10.1016/j.cpr.2007.10.007; Weschler D., 1991, WECHSLER INTELLIGENC; WHALEN CK, 1985, CLIN PSYCHOL REV, V5, P447, DOI 10.1016/0272-7358(85)90004-2; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	48	27	27	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e37280	10.1371/journal.pone.0037280	http://dx.doi.org/10.1371/journal.pone.0037280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	964KK	22745657	gold, Green Submitted, Green Published			2022-12-27	WOS:000305693200005
J	Adhikari, D; Gorre, N; Risal, S; Zhao, ZY; Zhang, H; Shen, Y; Liu, K				Adhikari, Deepak; Gorre, Nagaraju; Risal, Sanjiv; Zhao, Zhiyi; Zhang, Hua; Shen, Yan; Liu, Kui			The Safe Use of a PTEN Inhibitor for the Activation of Dormant Mouse Primordial Follicles and Generation of Fertilizable Eggs	PLOS ONE			English	Article							OOCYTE-SPECIFIC DELETION; OVARIAN; CRYOPRESERVATION; PRESERVATION; TISSUE; WOMEN	Background: Primordial ovarian follicles, which are often present in the ovaries of premature ovarian failure (POF) patients or are cryopreserved from the ovaries of young cancer patients who are undergoing gonadotoxic anticancer therapies, cannot be used to generate mature oocytes for in vitro fertilization (IVF). There has been very little success in triggering growth of primordial follicles to obtain fertilizable oocytes due to the poor understanding of the biology of primordial follicle activation. Methodology/Principal Findings: We have recently reported that PTEN (phosphatase and tensin homolog deleted on chromosome ten) prevents primordial follicle activation in mice, and deletion of Pten from the oocytes of primordial follicles leads to follicular activation. Consequently, the PTEN inhibitor has been successfully used in vitro to activate primordial follicles in both mouse and human ovaries. These results suggest that PTEN inhibitors could be used in ovarian culture medium to trigger the activation of primordial follicle. To study the safety and efficacy of the use of such inhibitors, we activated primordial follicles from neonatal mouse ovaries by transient treatment with a PTEN inhibitor bpV(HOpic). These ovaries were then transplanted under the kidney capsules of recipient mice to generate mature oocytes. The mature oocytes were fertilized in vitro and progeny mice were obtained after embryo transfer. Results and Conclusions: Long-term monitoring up to the second generation of progeny mice showed that the mice were reproductively active and were free from any overt signs or symptoms of chronic illnesses. Our results indicate that the use of PTEN inhibitors could be a safe and effective way of generating mature human oocytes for use in novel IVF techniques.	[Adhikari, Deepak; Gorre, Nagaraju; Risal, Sanjiv; Zhao, Zhiyi; Zhang, Hua; Shen, Yan; Liu, Kui] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Gothenburg	Adhikari, D (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden.	yan.shen@vgregion.se; kui.liu@gu.se	Risal, Sanjiv/P-5758-2019; Risal, Sanjiv/K-9883-2017; Adhikari, Deepak/H-6176-2013	Risal, Sanjiv/0000-0003-1723-5431; Risal, Sanjiv/0000-0003-1723-5431; Adhikari, Deepak/0000-0003-0656-9858; Adhikari, Deepak/0000-0002-3404-8753				Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Anderson RA, 2008, REPRODUCTION, V136, P681, DOI 10.1530/REP-08-0097; Beck-Peccoz P, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-9; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; Fan HY, 2008, MOL ENDOCRINOL, V22, P2128, DOI 10.1210/me.2008-0095; GOUGEON A, 1987, J REPROD FERTIL, V81, P433; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43, DOI 10.1016/s0074-7696(08)61524-7; Hovatta O, 2004, EUR J OBSTET GYN R B, V113, pS50, DOI 10.1016/j.ejogrb.2003.11.012; Jagarlamudi K, 2010, MOL CELL ENDOCRINOL, V315, P1, DOI 10.1016/j.mce.2009.07.016; Jagarlamudi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006186; Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454; Kim SS, 2012, J ASSIST REPROD GEN, V29, P489, DOI 10.1007/s10815-012-9757-3; Li J, 2010, P NATL ACAD SCI USA, V107, P10280, DOI 10.1073/pnas.1001198107; Marhhom E, 2007, OBSTET GYNECOL SURV, V62, P58, DOI 10.1097/01.ogx.0000251029.93792.5d; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Oktay K, 1997, FERTIL STERIL, V67, P481, DOI 10.1016/S0015-0282(97)80073-8; Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001; Poirot C, 2002, HUM REPROD, V17, P1447, DOI 10.1093/humrep/17.6.1447; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Reddy P, 2010, TRENDS ENDOCRIN MET, V21, P96, DOI 10.1016/j.tem.2009.10.001; Rosendahl M, 2011, REPROD BIOMED ONLINE, V22, P162, DOI 10.1016/j.rbmo.2010.10.015; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013	23	68	71	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39034	10.1371/journal.pone.0039034	http://dx.doi.org/10.1371/journal.pone.0039034			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761722	Green Submitted, Green Published, gold			2022-12-27	WOS:000305825800018
J	Birkett, PJ; Vanak, AT; Muggeo, VMR; Ferreira, SM; Slotow, R				Birkett, Patricia J.; Vanak, Abi T.; Muggeo, Vito M. R.; Ferreira, Salamon M.; Slotow, Rob			Animal Perception of Seasonal Thresholds: Changes in Elephant Movement in Relation to Rainfall Patterns	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; HABITAT SELECTION; HOME-RANGE; GAME RESERVE; POPULATION; REGRESSION; LANDSCAPE; PHENOLOGY; HERBIVORE; RESPONSES	Background: The identification of temporal thresholds or shifts in animal movement informs ecologists of changes in an animal's behaviour, which contributes to an understanding of species' responses in different environments. In African savannas, rainfall, temperature and primary productivity influence the movements of large herbivores and drive changes at different scales. Here, we developed a novel approach to define seasonal shifts in movement behaviour by examining the movements of a highly mobile herbivore (elephant; Loxodonta africana), in relation to local and regional rainfall patterns. Methodology/Principal Findings: We used speed to determine movement changes of between 8 and 14 GPS-collared elephant cows, grouped into five spatial clusters, in Kruger National Park, South Africa. To detect broad-scale patterns of movement, we ran a three-year daily time-series model for each individual (2007-2009). Piecewise regression models provided the best fit for elephant movement, which exhibited a segmented, waveform pattern over time. Major breakpoints in speed occurred at the end of the dry and wet seasons of each year. During the dry season, female elephant are constrained by limited forage and thus the distances they cover are shorter and less variable. Despite the inter-annual variability of rainfall, speed breakpoints were strongly correlated with both local and regional rainfall breakpoints across all three years. Thus, at a multi-year scale, rainfall patterns significantly affect the movements of elephant. The variability of both speed and rainfall breakpoints across different years highlights the need for an objective definition of seasonal boundaries. Conclusions/Significance: By using objective criteria to determine behavioural shifts, we identified a biologically meaningful indicator of major changes in animal behaviour in different years. We recommend the use of such criteria, from an animal's perspective, for delineating seasons or other extrinsic shifts in ecological studies, rather than arbitrarily fixed definitions based on convention or common practice.	[Birkett, Patricia J.; Vanak, Abi T.; Ferreira, Salamon M.; Slotow, Rob] Univ Kwazulu Natal, Sch Life Sci, Amarula Elephant Res Programme, Durban, South Africa; [Muggeo, Vito M. R.] Univ Palermo, Dipartimento Sci Stat & Matemat Vianelli, Palermo, Italy; [Ferreira, Salamon M.] Kruger Natl Pk, Sci Serv, Skukuza, South Africa	University of Kwazulu Natal; University of Palermo	Birkett, PJ (corresponding author), Univ Kwazulu Natal, Sch Life Sci, Amarula Elephant Res Programme, Durban, South Africa.	birkett.patricia@gmail.com	Muggeo, Vito M. R./P-4864-2015; Slotow, Rob/AAM-9053-2020; Vanak, Abi/F-8519-2010	Muggeo, Vito M. R./0000-0002-3386-4054; Vanak, Abi/0000-0003-2435-4260; Slotow, Rob/0000-0001-9469-1508	Amarula Trust; UKZN; National Research Foundation, South Africa [GUN: 61470]	Amarula Trust; UKZN; National Research Foundation, South Africa(National Research Foundation - South AfricaSouth African Medical Research Council)	Funding for this study was received through a donation from the Amarula Trust (http://www.amarulatrust.com/). UKZN and The National Research Foundation, South Africa, provided funding for PJB (GUN: 61470 to RS) (http://www.nrf.ac.za/) and a post-doctoral fellowship to ATV. There are no constraints from the funders on use or dissemination of the data, or influence on the results or conclusions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], KRUGER EXPERIENCE EC; Apps CD, 2001, J WILDLIFE MANAGE, V65, P65, DOI 10.2307/3803278; Archibald S, 2007, J VEG SCI, V18, P583, DOI 10.1111/j.1654-1103.2007.tb02572.x; Beyer H, 2006, HAWTHS ANAL TOOLS AR; Codron J, 2006, J MAMMAL, V87, P27, DOI 10.1644/05-MAMM-A-017R1.1; Cushman SA, 2005, OIKOS, V109, P331, DOI 10.1111/j.0030-1299.2005.13538.x; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; de Knegt HJ, 2007, BEHAV ECOL, V18, P1065, DOI 10.1093/beheco/arm080; de Knegt HJ, 2011, J ANIM ECOL, V80, P270, DOI 10.1111/j.1365-2656.2010.01764.x; De Villiers PA, 1997, AFR J ECOL, V35, P224, DOI 10.1111/j.1365-2028.1997.079-89079.x; Demarchi Nike W., 2003, Northwestern Naturalist, V84, P135; Druce HC, 2008, BIOL CONSERV, V141, P3127, DOI 10.1016/j.biocon.2008.09.024; Fryxell JM, 2008, P NATL ACAD SCI USA, V105, P19114, DOI 10.1073/pnas.0801737105; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Kerley Graham I.H., 2008, P146; Leggett KEA, 2006, AFR ZOOL, V41, P17, DOI 10.3377/1562-7020(2006)41[17:HRASMO]2.0.CO;2; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; MILTON SJ, 1987, S AFR J WILDL RES, V17, P1; Mucina Ladislav, 2006, V19, P2; Muggeo V.M., 2008, R NEWS, V8, P20; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Muggeo VMR, 2010, R PACKAGE SEGMENTED; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; OTTICHILO WK, 1986, AFR J ECOL, V24, P53, DOI 10.1111/j.1365-2028.1986.tb00342.x; Owen-Smith N, 2006, S AFR J SCI, V102, P389; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Owen-Smith RN, 1982, ECOLOGY TROPICAL SAV, P360; Owen-Smith RN., 2002, CAMB ST ECO, DOI 10.1017/CBO9780511525605; Pinaud D, 2008, J APPL ECOL, V45, P91, DOI 10.1111/j.1365-2664.2007.01370.x; Polansky L, 2011, J R SOC INTERFACE, V8, P322, DOI 10.1098/rsif.2010.0389; PRINS HHT, 1988, J BIOGEOGR, V15, P451, DOI 10.2307/2845275; R Core Team, 2021, R LANGUAGE ENV STAT; Roux C, 2009, AFR J ECOL, V47, P146, DOI 10.1111/j.1365-2028.2007.00896.x; SENFT RL, 1987, BIOSCIENCE, V37, P789, DOI 10.2307/1310545; Shackleton CM, 1999, GLOBAL ECOL BIOGEOGR, V8, P125, DOI 10.1046/j.1365-2699.1999.00128.x; Shannon G, 2006, AFR ZOOL, V41, P37, DOI 10.3377/1562-7020(2006)41[37:AEHRAH]2.0.CO;2; Shannon G, 2011, ECOSYSTEMS, V14, P1372, DOI 10.1007/s10021-011-9485-z; Shannon G, 2010, AUSTRAL ECOL, V35, P731, DOI 10.1111/j.1442-9993.2009.02080.x; Smit IPJ, 2007, DIVERS DISTRIB, V13, P225, DOI 10.1111/j.1472-4642.2007.00318.x; Tiwari RC, 2005, J R STAT SOC C-APPL, V54, P919, DOI 10.1111/j.1467-9876.2005.00518.x; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; van aarde Rudi, 2008, P84; Vanak AT, 2012, ECOGRAPHY, V35, P315, DOI 10.1111/j.1600-0587.2011.07213.x; Vanak AT, 2010, BIOL CONSERV, V143, P2631, DOI 10.1016/j.biocon.2010.07.005; Venter F.J., 2003, KRUGER EXPERIENCE EC, P83, DOI DOI 10.2989/10220110409485835; VILJOEN PJ, 1989, AFR J ECOL, V27, P227, DOI 10.1111/j.1365-2028.1989.tb01016.x; Wal EV, 2009, J WILDLIFE MANAGE, V73, P1189, DOI 10.2193/2008-137; Whitehouse AM, 2003, AFR ZOOL, V38, P95; Wittemyer G, 2008, P NATL ACAD SCI USA, V105, P19108, DOI 10.1073/pnas.0801744105; Woolley LA, 2011, BIOTROPICA, V43, P489, DOI 10.1111/j.1744-7429.2010.00733.x; Woolley LA, 2009, J WILDLIFE MANAGE, V73, P827, DOI 10.2193/2008-412	52	48	50	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e38363	10.1371/journal.pone.0038363	http://dx.doi.org/10.1371/journal.pone.0038363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761680	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800012
J	Carney, DR; Banaji, MR				Carney, Dana R.; Banaji, Mahzarin R.			First Is Best	PLOS ONE			English	Article							SERIAL POSITION; LAST DANCE; PRIMACY; CHOICE; ORDER; JUDGMENTS; DIRECTION; RECENCY; MODELS; SAVE	We experience the world serially rather than simultaneously. A century of research on human and nonhuman animals has suggested that the first experience in a series of two or more is cognitively privileged. We report three experiments designed to test the effect of first position on implicit preference and choice using targets that range from individual humans and social groups to consumer goods. Experiment 1 demonstrated an implicit preference to buy goods from the first salesperson encountered and to join teams encountered first, even when the difference in encounter is mere seconds. In Experiment 2 the first of two consumer items presented in quick succession was more likely to be chosen. In Experiment 3 an alternative hypothesis that first position merely accentuates the valence of options was ruled out by demonstrating that first position enhances preference for the first even when it is evaluatively negative in meaning (a criminal). Together, these experiments demonstrate a "first is best" effect and we offer possible interpretations based on evolutionary mechanisms of this "bound" on rational behavior and suggest that automaticity of judgment may be a helpful principle in clarifying previous inconsistencies in the empirical record on the effects of order on preference and choice.	[Carney, Dana R.] Univ Calif Berkeley, Management Org, Berkeley, CA 94720 USA; [Banaji, Mahzarin R.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	University of California System; University of California Berkeley; Harvard University	Carney, DR (corresponding author), Univ Calif Berkeley, Management Org, Berkeley, CA 94720 USA.	dcarney@berkeley.edu			Harvard's Mind, Brain, and Behavior Initiative; Third Millennium Foundation; National Institutes of Mental Health; Mind Science Institute	Harvard's Mind, Brain, and Behavior Initiative; Third Millennium Foundation; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Mind Science Institute	Research was supported by Harvard's Mind, Brain, and Behavior Initiative (D.R.C. and M.R.B.), and grants from the Third Millennium Foundation, the National Institutes of Mental Health and Mind Science Institute to M. R. Banaji. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, JUDGMENT UNCERTAINTY; ASCH SE, 1946, J ABNORM SOC PSYCH, V41, P258, DOI 10.1037/h0055756; BOLHUIS JJ, 1990, ANIM BEHAV, V40, P472, DOI 10.1016/S0003-3472(05)80527-5; de Bruin WB, 2006, ACTA PSYCHOL, V123, P299, DOI 10.1016/j.actpsy.2006.01.009; de Bruin WB, 2005, ACTA PSYCHOL, V118, P245, DOI 10.1016/j.actpsy.2004.08.005; Ebbinghaus H., 1885, MEMORY CONTRIBUTION; Gilovich T., 2002, HEURISTICS BIASES PS, DOI [DOI 10.1017/CBO9780511808098.004, DOI 10.1017/CBO9780511808098]; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2002, J PERS SOC PSYCHOL, V83, P367, DOI 10.1037//0022-3514.83.2.367; Hovland C., 1957, EXPT ATTEMPTS MINIMI; Insko CA, 1954, J ABNORMAL SOCIAL PS, V69, P381; JAYNES J, 1957, J COMP PHYSIOL PSYCH, V50, P6, DOI 10.1037/h0044716; Jersild A, 1928, J APPL PSYCHOL, V12, P611, DOI 10.1037/h0075226; Johnson M. H., 1992, CURRENT DIRECTIONS P, V1, P52; JONES EE, 1968, J PERS SOC PSYCHOL, V10, P317, DOI 10.1037/h0026818; Knower FH, 1936, J ABNORMAL SOCIAL PS, V30, P522; KROSNICK JA, 1987, PUBLIC OPIN QUART, V51, P201, DOI 10.1086/269029; Li Y, 2009, J BEHAV DECIS MAKING, V22, P378, DOI 10.1002/bdm.638; Lund F.H., 1925, J ABNORMAL SOCIAL PS, P183; Mantonakis A, 2009, PSYCHOL SCI, V20, P1309, DOI 10.1111/j.1467-9280.2009.02453.x; MILLER N, 1959, J ABNORM SOC PSYCH, V59, P1, DOI 10.1037/h0049330; Nisbett R. E., 1980, HUMAN INFERENCE STRA; Pineno O, 2005, BEHAV PROCESS, V69, P223, DOI 10.1016/j.beproc.2005.02.006; SIMON HA, 1979, ANNU REV PSYCHOL, V30, P363, DOI 10.1146/annurev.ps.30.020179.002051; SIMON HA, 1959, AM ECON REV, V49, P253; THALER R, 1980, J ECON BEHAV ORGAN, V1, P39, DOI 10.1016/0167-2681(80)90051-7; TVERSKY A, 1977, PSYCHOL REV, V84, P327, DOI 10.1037/h0026750; Tversky A, 1978, COGNITION CATEGORIZA, P81; Wanke M, 1996, PUBLIC OPIN QUART, V60, P400, DOI 10.1086/297761; WANKE M, 1995, PUBLIC OPIN QUART, V59, P347, DOI 10.1086/269481	30	49	50	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e35088	10.1371/journal.pone.0035088	http://dx.doi.org/10.1371/journal.pone.0035088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966GL	22761650	Green Submitted, Green Published, gold			2022-12-27	WOS:000305825800002
J	Nastasijevic, B; Wright, BR; Smestad, J; Warrington, AE; Rodriguez, M; Maher, LJ				Nastasijevic, Branislav; Wright, Brent R.; Smestad, John; Warrington, Arthur E.; Rodriguez, Moses; Maher, L. James, III			Remyelination Induced by a DNA Aptamer in a Mouse Model of Multiple Sclerosis	PLOS ONE			English	Article							INDUCED DEMYELINATION; ANTIVIRAL ACTIVITY; OLMSTED COUNTY; MYELIN REPAIR; RNA; SELECTION; OLIGODENDROCYTES; MINNESOTA; THERAPIES; LIGANDS	Multiple sclerosis (MS) is a debilitating inflammatory disease of the central nervous system (CNS) characterized by local destruction of the insulating myelin surrounding neuronal axons. With more than 200 million MS patients worldwide, the absence of treatments that prevent progression or induce repair poses a major challenge. Anti-inflammatory therapies have met with limited success only in preventing relapses. Previous screening of human serum samples revealed natural IgM antibodies that bind oligodendrocytes and promote both cell signaling and remyelination of CNS lesions in an MS model involving chronic infection of susceptible mice by Theiler's encephalomyelitis virus and in the lysolecithin model of focal demyelination. This intriguing result raises the possibility that molecules with binding specificity for oligodendrocytes or myelin components may promote therapeutic remyelination in MS. Because of the size and complexity of IgM antibodies, it is of interest to identify smaller myelin-specific molecules with the ability to promote remyelination in vivo. Here we show that a 40-nucleotide single-stranded DNA aptamer selected for affinity to murine myelin shows this property. This aptamer binds multiple myelin components in vitro. Peritoneal injection of this aptamer results in distribution to CNS tissues and promotes remyelination of CNS lesions in mice infected by Theiler's virus. Interestingly, the selected DNA aptamer contains guanosine-rich sequences predicted to induce folding involving guanosine quartet structures. Relative to monoclonal antibodies, DNA aptamers are small, stable, and non-immunogenic, suggesting new possibilities for MS treatment.	[Nastasijevic, Branislav; Smestad, John; Maher, L. James, III] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA; [Wright, Brent R.; Warrington, Arthur E.; Rodriguez, Moses] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN USA; [Wright, Brent R.; Warrington, Arthur E.; Rodriguez, Moses] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Nastasijevic, B (corresponding author), Univ Belgrade, Vinca Inst Nucl Sci, Belgrade, Serbia.	rodriguez.moses@mayo.edu; maher@mayo.edu	Nastasijevic, Branislav/AAV-1763-2021	Nastasijevic, Branislav/0000-0002-4529-1599; Rodriguez, Moses/0000-0001-6328-6497; Smestad, John/0000-0001-7922-3319	Mayo Foundation; Collaborative MS Center from the National MS Society; National Institutes of Health [NS R01 24180, NS R01 32129]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024180, R01NS032129] Funding Source: NIH RePORTER	Mayo Foundation; Collaborative MS Center from the National MS Society; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Mayo Foundation, by a Collaborative MS Center Grant from the National MS Society and by grants NS R01 24180 and NS R01 32129 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreola ML, 2001, BIOCHEMISTRY-US, V40, P10087, DOI 10.1021/bi0108599; Bates D, 2011, NEUROLOGY, V76, pS14, DOI 10.1212/WNL.0b013e3182050388; Bieber AJ, 2002, GLIA, V37, P241, DOI 10.1002/glia.10033; CAMPAGNONI AT, 1988, J NEUROCHEM, V51, P1, DOI 10.1111/j.1471-4159.1988.tb04827.x; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Dougan H, 2000, NUCL MED BIOL, V27, P289, DOI 10.1016/S0969-8051(99)00103-1; ELLINGTON AD, 1994, CURR BIOL, V4, P427, DOI 10.1016/S0960-9822(00)00093-2; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Freedman MS, 2011, NEUROLOGY, V76, pS26, DOI 10.1212/WNL.0b013e318205051d; GRIFFIN LC, 1993, GENE, V137, P25, DOI 10.1016/0378-1119(93)90247-Z; Lee JF, 2006, CURR OPIN CHEM BIOL, V10, P282, DOI 10.1016/j.cbpa.2006.03.015; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Mayr WT, 2003, NEUROLOGY, V61, P1373, DOI 10.1212/01.WNL.0000094316.90240.EB; Mitsunaga Y, 2002, FASEB J, V16, P1325, DOI 10.1096/fj.01-0994fje; Nastasijevic B, 2008, BIOCHEM BIOPH RES CO, V366, P420, DOI 10.1016/j.bbrc.2007.11.169; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; RODRIGUEZ M, 1994, NEUROLOGY, V44, P28, DOI 10.1212/WNL.44.1.28; RODRIGUEZ M, 1987, CRIT REV IMMUNOL, V7, P325; Rodriguez M, 1996, NEUROLOGY, V46, P538, DOI 10.1212/WNL.46.2.538; RODRIGUEZ M, 1987, J IMMUNOL, V138, P3438; Soldan MMP, 2003, MOL CELL NEUROSCI, V22, P14, DOI 10.1016/S1044-7431(02)00018-0; Somasunderam A, 2005, BIOCHEMISTRY-US, V44, P10388, DOI 10.1021/bi0507074; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Warrington AE, 2000, P NATL ACAD SCI USA, V97, P6820, DOI 10.1073/pnas.97.12.6820	24	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39595	10.1371/journal.pone.0039595	http://dx.doi.org/10.1371/journal.pone.0039595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761835	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800049
J	Standley, S; Petralia, RS; Gravell, M; Hamilton, R; Wang, YX; Schubert, M; Wenthold, RJ				Standley, Steve; Petralia, Ronald S.; Gravell, Manneth; Hamilton, Rebecca; Wang, Ya-Xian; Schubert, Manfred; Wenthold, Robert J.			Trafficking of the NMDAR2B Receptor Subunit Distal Cytoplasmic Tail from Endoplasmic Reticulum to the Synapse	PLOS ONE			English	Article							DENSITY PROTEIN PSD-95; ER RETENTION SIGNAL; TRANS-GOLGI NETWORK; VESICULAR STOMATITIS-VIRUS; PRESYNAPTIC ACTIVE ZONES; HIPPOCAMPAL-NEURONS; SECRETORY PATHWAY; CELL-SURFACE; PDZ PROTEINS; CORTICAL-NEURONS	NMDA receptor NR2A/B subunits have PDZ-binding domains on their extreme C-termini that are known to interact with the PSD-95 family and other PDZ proteins. We explore the interactions between PSD-95 family proteins and the NR2A/B cytoplasmic tails, and the consequences of these interactions, from the endoplasmic reticulum (ER) through delivery to the synapse in primary rat hippocampal and cortical cultured neurons. We find that the NR2A/B cytoplasmic tails cluster very early in the secretory pathway and interact serially with SAP102 beginning at the intermediate compartment, and then PSD-95. We further establish that colocalization of the distal C-terminus of NR2B and PSD-95 begins at the trans-Golgi Network (TGN). Formation of NR2B/PSD-95/SAP102 complexes is dependent on the PDZ binding domain of NR2B subunits, but association with SAP102 and PSD-95 plays no distinguishable role in cluster pre-formation or initial targeting to the vicinity of the synapse. Instead the PDZ binding domain plays a role in restricting cell-surface clusters to postsynaptic targets.	[Standley, Steve] Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA USA; [Petralia, Ronald S.; Wang, Ya-Xian; Wenthold, Robert J.] Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bethesda, MD USA; [Gravell, Manneth; Hamilton, Rebecca; Schubert, Manfred] NINDS, Mol Virol & Neurogenet Sect, NIH, Bethesda, MD 20892 USA	Western University of Health Sciences; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Standley, S (corresponding author), Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA USA.	sstandley@westernu.edu			National Institute on Deafness and Other Communication Disorders (NIDCD); National Institutes on Neurological Diseases and Stroke (NINDS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZICDC000081, ZIADC000003] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institutes on Neurological Diseases and Stroke (NINDS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was funded by the Intramural programs of the National Institute on Deafness and Other Communication Disorders (NIDCD) and the National Institutes on Neurological Diseases and Stroke (NINDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Bard L, 2011, MOL CELL NEUROSCI, V48, P298, DOI 10.1016/j.mcn.2011.05.009; Bard L, 2010, P NATL ACAD SCI USA, V107, P19561, DOI 10.1073/pnas.1002690107; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; BOS K, 1993, EMBO J, V12, P2219, DOI 10.1002/j.1460-2075.1993.tb05870.x; Cousins SL, 2009, NEUROSCIENCE, V158, P89, DOI 10.1016/j.neuroscience.2007.12.051; Cousins SL, 2012, J BIOL CHEM, V287, P13465, DOI 10.1074/jbc.M111.292862; Craven SE, 2000, J BIOL CHEM, V275, P20045, DOI 10.1074/jbc.M910153199; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Cui-Wang TT, 2012, CELL, V148, P309, DOI 10.1016/j.cell.2011.11.056; DURAND GM, 1992, P NATL ACAD SCI USA, V89, P9359, DOI 10.1073/pnas.89.19.9359; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; El-Husseini AE, 2000, J BIOL CHEM, V275, P23904, DOI 10.1074/jbc.M909919199; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; Forder JP, 2009, NEUROSCIENCE, V158, P293, DOI 10.1016/j.neuroscience.2008.10.021; GALLIONE CJ, 1985, J VIROL, V54, P374, DOI 10.1128/JVI.54.2.374-382.1985; GRIFFITHS G, 1989, J CELL BIOL, V108, P277, DOI 10.1083/jcb.108.2.277; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; Guillaud L, 2003, J NEUROSCI, V23, P131; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; Horstmann H, 2002, J CELL SCI, V115, P4263, DOI 10.1242/jcs.00115; Horton AC, 2003, J NEUROSCI, V23, P6188; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jeyifous O, 2009, NAT NEUROSCI, V12, P1011, DOI 10.1038/nn.2362; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Kennedy MJ, 2010, CELL, V141, P524, DOI 10.1016/j.cell.2010.02.042; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kurschner C, 1998, MOL CELL NEUROSCI, V11, P161, DOI 10.1006/mcne.1998.0679; Ladinsky MS, 2002, MOL BIOL CELL, V13, P2810, DOI 10.1091/mbc.01-12-0593; LEFRANCOIS L, 1982, VIROLOGY, V121, P157, DOI 10.1016/0042-6822(82)90125-8; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Mentis GZ, 2006, J NEUROSCI METH, V157, P208, DOI 10.1016/j.jneumeth.2006.04.011; MILLER SG, 1991, J CELL BIOL, V112, P39, DOI 10.1083/jcb.112.1.39; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Mok H, 2002, J NEUROSCI, V22, P5253; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Pierce JP, 2001, CURR BIOL, V11, P351, DOI 10.1016/S0960-9822(01)00077-X; Prange O, 2001, J NEUROSCI, V21, P9325, DOI 10.1523/JNEUROSCI.21-23-09325.2001; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Prybylowski K, 2002, J NEUROSCI, V22, P8902; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rao A, 1998, J NEUROSCI, V18, P1217; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Ryan TJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-6; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; SCHAFER W, 1995, EMBO J, V14, P2424, DOI 10.1002/j.1460-2075.1995.tb07240.x; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Storey GP, 2011, J NEUROSCI, V31, P6311, DOI 10.1523/JNEUROSCI.5553-10.2011; Tovar KR, 1999, J NEUROSCI, V19, P4180; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Xia H, 2001, NEUROPHARMACOLOGY, V41, P714, DOI 10.1016/S0028-3908(01)00103-4; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zheng CY, 2010, J NEUROSCI, V30, P4757, DOI 10.1523/JNEUROSCI.6108-09.2010	76	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39585	10.1371/journal.pone.0039585	http://dx.doi.org/10.1371/journal.pone.0039585			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761831	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800046
J	Tong, CCL; Ko, EC; Sung, MW; Cesaretti, JA; Stock, RG; Packer, SH; Forsythe, K; Genden, EM; Schwartz, M; Lau, KHV; Galsky, M; Ozao-Choy, J; Chen, SH; Kao, J				Tong, Charles C. L.; Ko, Eric C.; Sung, Max W.; Cesaretti, Jamie A.; Stock, Richard G.; Packer, Stuart H.; Forsythe, Kevin; Genden, Eric M.; Schwartz, Myron; Lau, K. H. Vincent; Galsky, Matthew; Ozao-Choy, Junko; Chen, Shu-hsia; Kao, Johnny			Phase II Trial of Concurrent Sunitinib and Image-Guided Radiotherapy for Oligometastases	PLOS ONE			English	Article							STEREOTACTIC BODY RADIATION; METASTATIC COLORECTAL-CANCER; RENAL-CELL CARCINOMA; BREAST-CANCER; LUNG-CANCER; LIVER METASTASES; PLUS IRINOTECAN; PROSTATE-CANCER; I/II TRIAL; THERAPY	Background: Preclinical data suggest that sunitinib enhances the efficacy of radiotherapy. We tested the combination of sunitinib and hypofractionated image-guided radiotherapy (IGRT) in a cohort of patients with historically incurable distant metastases. Methods: Twenty five patients with oligometastases, defined as 1-5 sites of active disease on whole body imaging, were enrolled in a phase II trial from 2/08 to 9/10. The most common tumor types treated were head and neck, liver, lung, kidney and prostate cancers. Patients were treated with the recommended phase II dose of 37.5 mg daily sunitinib (days 1-28) and IGRT 50 Gy (days 8-12 and 15-19). Maintenance sunitinib was used in 33% of patients. Median follow up was 17.5 months (range, 0.7 to 37.4 months). Results: The 18-month local control, distant control, progression-free survival (PFS) and overall survival (OS) were 75%, 52%, 56% and 71%, respectively. At last follow-up, 11 (44%) patients were alive without evidence of disease, 7 (28%) were alive with distant metastases, 3 (12%) were dead from distant metastases, 3 (12%) were dead from comorbid illness, and 1 (4%) was dead from treatment-related toxicities. The incidence of acute grade >= 3 toxicities was 28%, most commonly myelosuppression, bleeding and abnormal liver function tests. Conclusions: Concurrent sunitinib and IGRT achieves major clinical responses in a subset of patients with oligometastases.	[Tong, Charles C. L.; Ko, Eric C.; Stock, Richard G.; Forsythe, Kevin; Lau, K. H. Vincent] Mt Sinai Med Ctr, Dept Radiat Oncol, New York, NY 10029 USA; [Tong, Charles C. L.; Genden, Eric M.] Mt Sinai Med Ctr, Dept Otolaryngol Head & Neck Surg, New York, NY 10029 USA; [Sung, Max W.; Packer, Stuart H.; Galsky, Matthew] Mt Sinai Med Ctr, Dept Med Oncol, New York, NY 10029 USA; [Cesaretti, Jamie A.] Florida Radiat Oncol Grp, Jacksonville, FL USA; [Ozao-Choy, Junko; Chen, Shu-hsia] Mt Sinai Med Ctr, Dept Oncol Sci, New York, NY 10029 USA; [Kao, Johnny] Good Samaritan Hosp, Med Ctr, Dept Radiat Oncol, W Islip, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Tong, CCL (corresponding author), Mt Sinai Med Ctr, Dept Radiat Oncol, New York, NY 10029 USA.	johnnykaomd@gmail.com	Ko, Eric/AAB-7870-2019	Ko, Eric/0000-0003-2308-115X; Tong, Charles/0000-0002-4471-5134; Cesaretti, Jamie/0000-0001-6294-0047	Pfizer [2005-1082]; Ellen Katz Foundation; NATIONAL CANCER INSTITUTE [R01CA109322] Funding Source: NIH RePORTER	Pfizer(Pfizer); Ellen Katz Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Pfizer and the Ellen Katz Foundation Award. Sunitinib was provided by Pfizer. Financial disclosure: JK received the Pfizer investigator initiated award #2005-1082 and the Ellen Katz Foundation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chow LQM, 2007, J CLIN ONCOL, V25, P884, DOI 10.1200/JCO.2006.06.3602; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; HELLMAN S, 1995, J CLIN ONCOL, V13, P8, DOI 10.1200/JCO.1995.13.1.8; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Je YJ, 2009, LANCET ONCOL, V10, P967, DOI 10.1016/S1470-2045(09)70222-0; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Kao J, 2010, CRIT REV ONCOL HEMAT; Kao J, 2009, CANCER-AM CANCER SOC, V115, P3571, DOI 10.1002/cncr.24412; Ko JS, 2009, CLIN CANCER RES, V15, P2148, DOI 10.1158/1078-0432.CCR-08-1332; Lee MT, 2009, J CLIN ONCOL, V27, P1585, DOI 10.1200/JCO.2008.20.0600; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; MacDermed DM, 2008, J SURG ONCOL, V98, P202, DOI 10.1002/jso.21102; Marks LB, 2000, INT J RADIAT ONCOL, V48, P625, DOI 10.1016/S0360-3016(00)00697-0; Mauceri HJ, 1998, NATURE, V394, P287, DOI 10.1038/28412; Metha N, 2004, INT J ONCOL, V25, P1677; Milano MT, 2008, CANCER-AM CANCER SOC, V112, P650, DOI 10.1002/cncr.23209; Milano MT, 2008, RADIAT ONCOL, V3, DOI 10.1186/1748-717X-3-36; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Ozao-Choy J, 2009, CANCER RES, V69, P2514, DOI 10.1158/0008-5472.CAN-08-4709; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Rusthoven KE, 2009, J CLIN ONCOL, V27, P1572, DOI 10.1200/JCO.2008.19.6329; Rusthoven KE, 2009, J CLIN ONCOL, V27, P1579, DOI 10.1200/JCO.2008.19.6386; Salama JK, 2008, CLIN CANCER RES, V14, P5255, DOI 10.1158/1078-0432.CCR-08-0358; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Schueneman AJ, 2003, CANCER RES, V63, P4009; Seiwert TY, 2007, NAT CLIN PRACT ONCOL, V4, P86, DOI 10.1038/ncponc0714; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Vu HL, 2010, CANCER LETT, V288, P149, DOI 10.1016/j.canlet.2009.06.026; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307	33	55	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e36979	10.1371/journal.pone.0036979	http://dx.doi.org/10.1371/journal.pone.0036979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761653	gold, Green Published, Green Submitted			2022-12-27	WOS:000305825800004
J	Andor-Ardo, D; Keen, EC; Hudspeth, AJ; Magnasco, MO				Andor-Ardo, Daniel; Keen, Erica C.; Hudspeth, A. J.; Magnasco, Marcelo O.			Fast, Automated Implementation of Temporally Precise Blind Deconvolution of Multiphasic Excitatory Postsynaptic Currents	PLOS ONE			English	Article							HAIR-CELLS; TRANSMITTER; SYNAPSE; RELEASE	Records of excitatory postsynaptic currents (EPSCs) are often complex, with overlapping signals that display a large range of amplitudes. Statistical analysis of the kinetics and amplitudes of such complex EPSCs is nonetheless essential to the understanding of transmitter release. We therefore developed a maximum-likelihood blind deconvolution algorithm to detect exocytotic events in complex EPSC records. The algorithm is capable of characterizing the kinetics of the prototypical EPSC as well as delineating individual release events at higher temporal resolution than other extant methods. The approach also accommodates data with low signal-to-noise ratios and those with substantial overlaps between events. We demonstrated the algorithm's efficacy on paired whole-cell electrode recordings and synthetic data of high complexity. Using the algorithm to align EPSCs, we characterized their kinetics in a parameter-free way. Combining this approach with maximum-entropy deconvolution, we were able to identify independent release events in complex records at a temporal resolution of less than 250 ms. We determined that the increase in total postsynaptic current associated with depolarization of the presynaptic cell stems primarily from an increase in the rate of EPSCs rather than an increase in their amplitude. Finally, we found that fluctuations owing to postsynaptic receptor kinetics and experimental noise, as well as the model dependence of the deconvolution process, explain our inability to observe quantized peaks in histograms of EPSC amplitudes from physiological recordings.	[Andor-Ardo, Daniel; Keen, Erica C.; Hudspeth, A. J.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Andor-Ardo, Daniel; Keen, Erica C.; Hudspeth, A. J.] Rockefeller Univ, Lab Sensory Neurosci, New York, NY 10021 USA; [Andor-Ardo, Daniel; Magnasco, Marcelo O.] Rockefeller Univ, Phys Math Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Rockefeller University	Andor-Ardo, D (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	daa@cantab.net			National Institutes of Health [DC000241, DC007294]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH094612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC000241, R01DC007294, R01DC000241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by grants DC000241 and DC007294 from the National Institutes of Health (http://nih.gov). A.J.H. is an Investigator of Howard Hughes Medical Institute (http://hmmi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andor-Ardo D, 2010, P NATL ACAD SCI USA, V107, P2019, DOI 10.1073/pnas.0914372107; Bishop C. M, 2006, PATTERN RECOGNITION; COHEN I, 1981, BRAIN RES, V223, P185, DOI 10.1016/0006-8993(81)90821-0; Gull SF, 1999, QUANTIFIED MAXUMUM E; Keen EC, 2006, P NATL ACAD SCI USA, V103, P5537, DOI 10.1073/pnas.0601103103; Li GL, 2009, J NEUROSCI, V29, P7558, DOI 10.1523/JNEUROSCI.0514-09.2009; MacKay D, 1991, NEURAL COMPUT, V4, P415; Neher E, 2001, J NEUROSCI, V21, P444, DOI 10.1523/JNEUROSCI.21-02-00444.2001; ROSSI ML, 1994, J PHYSIOL-LONDON, V478, P17, DOI 10.1113/jphysiol.1994.sp020227; Sivia Devinderjit, 2006, DATA ANAL BAYESIAN T, DOI DOI 10.1007/10201161_90; Synaptosoft Inc, MIN PROGR; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wiener N., 1931, SEM BER PREUSS AKAD, VXXXI, P696	13	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e38198	10.1371/journal.pone.0038198	http://dx.doi.org/10.1371/journal.pone.0038198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761670	Green Published, gold			2022-12-27	WOS:000305808700003
J	Zhang, JL; Zheng, QC; Li, ZQ; Zhang, HX				Zhang, Ji-Long; Zheng, Qing-Chuan; Li, Zheng-Qiang; Zhang, Hong-Xing			Molecular Dynamics Simulations Suggest Ligand's Binding to Nicotinamidase/Pyrazinamidase	PLOS ONE			English	Article							RESISTANT MYCOBACTERIUM-TUBERCULOSIS; FREE-ENERGY DIFFERENCES; PNCA MUTATIONS; NICOTINAMIDASE PNCA; PYRAZINAMIDE; MECHANISM; INFECTIVITY; INHIBITION; METABOLISM; NAD(+)	The research on the binding process of ligand to pyrazinamidase (PncA) is crucial for elucidating the inherent relationship between resistance of Mycobacterium tuberculosis and PncA's activity. In the present study, molecular dynamics (MD) simulation methods were performed to investigate the unbinding process of nicotinamide (NAM) from two PncA enzymes, which is the reverse of the corresponding binding process. The calculated potential of mean force (PMF) based on the steered molecular dynamics (SMD) simulations sheds light on an optimal binding/unbinding pathway of the ligand. The comparative analyses between two PncAs clearly exhibit the consistency of the binding/unbinding pathway in the two enzymes, implying the universality of the pathway in all kinds of PncAs. Several important residues dominating the pathway were also determined by the calculation of interaction energies. The structural change of the proteins induced by NAM's unbinding or binding shows the great extent interior motion in some homologous region adjacent to the active sites of the two PncAs. The structure comparison substantiates that this region should be very important for the ligand's binding in all PncAs. Additionally, MD simulations also show that the coordination position of the ligand is displaced by one water molecule in the unliganded enzymes. These results could provide the more penetrating understanding of drug resistance of M. tuberculosis and be helpful for the development of new antituberculosis drugs.	[Zhang, Ji-Long; Zheng, Qing-Chuan; Zhang, Hong-Xing] Jilin Univ, Inst Theoret Chem, State Key Lab Theoret & Computat Chem, Changchun, Peoples R China; [Li, Zheng-Qiang] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China	Jilin University; Jilin University	Zhang, JL (corresponding author), Jilin Univ, Inst Theoret Chem, State Key Lab Theoret & Computat Chem, Changchun, Peoples R China.	zhanghx@mail.jlu.edu.cn			Natural Science Foundation of China [21173096, 20903045, 20973076]; Specialized Research Fund for the Doctoral Program of Higher Education [20110061110018]; Jilin University [201003044]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Jilin University(Jilin University)	This work is supported by the Natural Science Foundation of China (Grant Nos. 21173096, 20903045, and 20973076), Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20110061110018), and the Specialized Fund for the Basic Research of Jilin University (Grant No. 201003044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, DISC STUD 2 5; Barco P, 2006, J ANTIMICROB CHEMOTH, V58, P930, DOI 10.1093/jac/dkl363; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Du XL, 2001, BIOCHEMISTRY-US, V40, P14166, DOI 10.1021/bi0115479; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; French JB, 2010, BIOCHEMISTRY-US, V49, P10421, DOI 10.1021/bi1012518; French JB, 2010, BIOCHEMISTRY-US, V49, P8803, DOI 10.1021/bi1012436; Fyfe PK, 2009, ANGEW CHEM INT EDIT, V48, P9176, DOI 10.1002/anie.200903407; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Henin J, 2004, J CHEM PHYS, V121, P2904, DOI 10.1063/1.1773132; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hou L, 2000, EPIDEMIOL INFECT, V124, P227, DOI 10.1017/S0950268899003635; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jarzynski C, 1997, PHYS REV E, V56, P5018, DOI 10.1103/PhysRevE.56.5018; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim S, 2004, FEMS MICROBIOL LETT, V234, P289, DOI [10.1111/j.1574-6968.2004.tb09546.x, 10.1016/j.femsle.2004.03.038]; KONNO K, 1967, AM REV RESPIR DIS, V95, P461; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Magni G, 1999, ADV ENZYMOL RELAT AR, V73, P35; Mestdagh M, 1999, ANTIMICROB AGENTS CH, V43, P2317, DOI 10.1128/AAC.43.9.2317; Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473; Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311; Petrella S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015785; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Portugal I, 2004, ANTIMICROB AGENTS CH, V48, P2736, DOI 10.1128/AAC.48.7.2736-2738.2004; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; Rodrigues VDFS, 2005, ANTIMICROB AGENTS CH, V49, P444, DOI 10.1128/AAC.49.1.444-446.2005; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Sheen P, 2009, TUBERCULOSIS, V89, P109, DOI 10.1016/j.tube.2009.01.004; Shi R, 2007, MINI-REV MED CHEM, V7, P1177, DOI 10.2174/138955707782331740; Shi WL, 2011, SCIENCE, V333, P1630, DOI 10.1126/science.1208813; Singh Pushpendra, 2006, J Commun Dis, V38, P288; Speck T, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066112; STEELE MA, 1988, CHEST, V94, P845, DOI 10.1378/chest.94.4.845; Toukmaji AY, 1996, COMPUT PHYS COMMUN, V95, P73, DOI 10.1016/0010-4655(96)00016-1; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; World Health Organization, 1995, WHO REP TUB EP STOP, P270; Ytreberg FM, 2004, J COMPUT CHEM, V25, P1749, DOI 10.1002/jcc.20103; Zhang H, 2008, FEBS J, V275, P753, DOI 10.1111/j.1742-4658.2007.06241.x; Zhang JL, 2011, COMPUT BIOL CHEM, V35, P50, DOI 10.1016/j.compbiolchem.2011.01.001; Zhang JL, 2010, CHEM PHYS LETT, V484, P338, DOI 10.1016/j.cplett.2009.12.022; Zhang JL, 2010, J PHYS CHEM B, V114, P7383, DOI 10.1021/jp9113078; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6	48	25	25	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39546	10.1371/journal.pone.0039546	http://dx.doi.org/10.1371/journal.pone.0039546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761821	Green Published, Green Submitted, gold			2022-12-27	WOS:000305808700034
J	Deng, W; Pang, PS; Tsang, CM; Hau, PM; Yip, YL; Cheung, ALM; Tsao, SW				Deng, Wen; Pang, Pei Shin; Tsang, Chi Man; Hau, Pok Man; Yip, Yim Ling; Cheung, Annie L. M.; Tsao, Sai Wah			Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Impairs G2 Checkpoint in Human Nasopharyngeal Epithelial Cells through Defective Chk1 Activation	PLOS ONE			English	Article							GENOMIC INSTABILITY; DNA-DAMAGE; HUMAN-LYMPHOCYTES; CARCINOMA; G(2); EXPRESSION; PHOSPHORYLATION; CANCER; LMP1; IRRADIATION	Nasopharyngeal carcinoma (NPC) is a common cancer in Southeast Asia, particularly in southern regions of China. EBV infection is closely associated with NPC and has long been postulated to play an etiological role in the development of NPC. However, the role of EBV in malignant transformation of nasopharyngeal epithelial cells remains enigmatic. The current hypothesis of NPC development is that premalignant nasopharyngeal epithelial cells harboring genetic alterations support EBV infection and expression of EBV genes induces further genomic instability to facilitate the development of NPC. The latent membrane protein 1 (LMP1) is a well-documented EBV-encoded oncogene. The involvement of LMP1 in human epithelial malignancies has been implicated, but the mechanisms of oncogenic actions of LMP1, particularly in nasopharyngeal cells, are unclear. Here we observed that LMP1 expression in nasopharyngeal epithelial cells impaired G2 checkpoint, leading to formation of unrepaired chromatid breaks in metaphases after c-ray irradiation. We further found that defective Chk1 activation was involved in the induction of G2 checkpoint defect in LMP1-expressing nasopharyngeal epithelial cells. Impairment of G2 checkpoint could result in loss of the acentrically broken chromatids and propagation of broken centric chromatids in daughter cells exiting mitosis, which facilitates chromosome instability. Our findings suggest that LMP1 expression facilitates genomic instability in cells under genotoxic stress. Elucidation of the mechanisms involved in LMP1-induced genomic instability in nasopharyngeal epithelial cells will shed lights on the understanding of role of EBV infection in NPC development.	[Deng, Wen; Pang, Pei Shin; Tsang, Chi Man; Hau, Pok Man; Yip, Yim Ling; Cheung, Annie L. M.; Tsao, Sai Wah] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Deng, W (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China.	gswtsao@hkucc.hku.hk	Deng, Wen/M-5208-2019; Deng, Wen/C-4154-2009; /C-4230-2009	/0000-0003-3217-1456	Hong Kong General Research Fund [HKU 7770/07M]; AoE NPC [AoE/M-06/08]; University of Hong Kong CRCG [200807176131]	Hong Kong General Research Fund; AoE NPC; University of Hong Kong CRCG(University of Hong Kong)	This work was supported by the Hong Kong General Research Fund (HKU 7770/07M), the AoE NPC grant (AoE/M-06/08), and The University of Hong Kong CRCG Grant (200807176131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bose S, 2009, J PATHOL, V217, P345, DOI 10.1002/path.2487; Busson P, 2004, TRENDS MICROBIOL, V12, P356, DOI 10.1016/j.tim.2004.06.005; Chan ASC, 2002, INT J CANCER, V102, P300, DOI 10.1002/ijc.10689; Chen P, 1999, ONCOGENE, V18, P249, DOI 10.1038/sj.onc.1202257; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Cheung ST, 1996, INT J CANCER, V66, P711, DOI 10.1002/(SICI)1097-0215(19960529)66:5<711::AID-IJC21>3.0.CO;2-5; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; Deng W, 2003, CYTOM PART A, V51A, P46, DOI 10.1002/cyto.a.10004; Deng W, 1999, INT J RADIAT BIOL, V75, P1107, DOI 10.1080/095530099139575; Gagos S, 2008, CANCER RES, V68, P8146, DOI 10.1158/0008-5472.CAN-08-0945; GLASER R, 1989, P NATL ACAD SCI USA, V86, P9524, DOI 10.1073/pnas.86.23.9524; Gruhne B, 2009, ONCOGENE, V28, P3997, DOI 10.1038/onc.2009.258; Krempler A, 2007, CELL CYCLE, V6, P1682, DOI 10.4161/cc.6.14.4480; Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963; Kuntz K, 2009, CANCER BIOL THER, V8, P1433, DOI 10.4161/cbt.8.15.9081; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Li HM, 2006, INT J CANCER, V119, P1567, DOI 10.1002/ijc.22032; LIAO H, 1995, J CELL BIOL, V130, P507, DOI 10.1083/jcb.130.3.507; Liu MT, 2004, ONCOGENE, V23, P2531, DOI 10.1038/sj.onc.1207375; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Ma XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024647; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; PATHMANATHAN R, 1995, NEW ENGL J MED, V333, P693, DOI 10.1056/NEJM199509143331103; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; PINCHEIRA J, 1991, MUTAT RES, V251, P71, DOI 10.1016/0027-5107(91)90216-B; Shinohara M, 2006, MOL BIOL CELL, V17, P5227, DOI 10.1091/mbc.E06-04-0284; Syljuasen RG, 2006, CANCER RES, V66, P10253, DOI 10.1158/0008-5472.CAN-06-2144; Tsao SW, 2002, SEMIN CANCER BIOL, V12, P473, DOI 10.1016/S1044579X02000901; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Yip YL, 2008, INT J ONCOL, V33, P713, DOI 10.3892/ijo_00000057; Yip YL, 2010, J MED VIROL, V82, P1711, DOI 10.1002/jmv.21875; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	36	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39095	10.1371/journal.pone.0039095	http://dx.doi.org/10.1371/journal.pone.0039095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761726	Green Published, gold, Green Submitted			2022-12-27	WOS:000305781700017
J	Lee, AS; Chen, WP; Kuo, YL; Ho, YJ; Lee, SS; Su, MJ				Lee, A. S.; Chen, W. P.; Kuo, Y. L.; Ho, Y. J.; Lee, S. S.; Su, M. J.			Thaliporphine Preserves Cardiac Function of Endotoxemic Rabbits by Both Directly and Indirectly Attenuating NF kappa B Signaling Pathway	PLOS ONE			English	Article							VENTRICULAR CONTRACTILITY; CANINE MODEL; TNF-ALPHA; SEPSIS; DYSFUNCTION; ACTIVATION; EXPRESSION; MECHANISMS; DEPRESSION; INHIBITION	Cardiac depression in sepsis is associated with the increased morbidity and mortality. Although myofilaments damage, autonomic dysfunction, and apoptosis play roles in sepsis-induced myocardial dysfunction, the underlying mechanism is not clear. All of these possible factors are related to NF kappa B signaling, which plays the main role in sepsis signaling. Thaliporphine was determined to possess anti-inflammatory and cardioprotective activity by suppressing NF kappa B signaling in rodents. The purpose of this study is to further prove this protective effect in larger septic animals, and try to find the underlying mechanisms. The systolic and diastolic functions were evaluated in vivo by pressure-volume analysis at different preloads. Both preload-dependent and - independent hemodynamic parameters were performed. Inflammatory factors of whole blood and serum samples were analyzed. Several sepsis-related signaling pathways were also determined at protein level. Changes detected by conductance catheter showed Thaliporphine could recover impaired left ventricular systolic function after 4 hours LPS injection. It could also reverse the LPS induced steeper EDPVR and gentler ESPVR, thus improve Ees, Ea, and PRSW. Thaliporphine may exert this protective effect by decreasing TNF alpha and caspase3 dependent cell apoptosis, which was consistent with the decreased serum cTnI and LDH concentration. Thaliporphine could protect sepsis-associated myocardial dysfunction in both preload-dependent and - independent ways. It may exert these protective effects by both increase of "good"-PI3K/Akt/mTOR and decrease of "bad"-p38/NF kappa B pathways, which followed by diminishing TNF alpha and caspase3 dependent cell apoptosis.	[Lee, A. S.] China Med Univ Hosp, Div Cardiol, Taichung, Taiwan; [Lee, A. S.] China Med Univ Hosp, Res Ctr L5, Taichung, Taiwan; [Lee, A. S.] China Med Univ, Taichung, Taiwan; [Chen, W. P.; Kuo, Y. L.; Ho, Y. J.; Su, M. J.] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan; [Lee, S. S.] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei 10764, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Taiwan University; National Taiwan University	Lee, AS (corresponding author), China Med Univ Hosp, Div Cardiol, Taichung, Taiwan.	mingja@ntu.edu.tw		SU, MING-JAI/0000-0001-8887-6899; Lee, An-sheng/0000-0001-8176-3269; Chen, Wen-Pin/0000-0002-0143-5642	National Science Council [NSC96-3114-P-002-002-Y]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH100-TD-B-111-004]; China Medical University Hospital [DMR-99-172]	National Science Council(Ministry of Science and Technology, Taiwan); Taiwan Department of Health Clinical Trial and Research Center of Excellence; China Medical University Hospital	This study was supported by a research of grant of National Science Council (NSC96-3114-P-002-002-Y), Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004), and China Medical University Hospital (DMR-99-172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JE, 1993, CIRCULATION, V88, P101, DOI 10.1161/01.CIR.88.1.101; Amadou A, 2002, AM J PHYSIOL-CELL PH, V282, pC1339, DOI 10.1152/ajpcell.00471.2001; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Balija TM, 2011, CURR OPIN INFECT DIS, V24, P248, DOI 10.1097/QCO.0b013e32834536ce; Barraud D, 2007, CRIT CARE MED, V35, P1376, DOI 10.1097/01.CCM.0000261889.18102.84; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; Bryant D, 1998, CIRCULATION, V97, P1375, DOI 10.1161/01.CIR.97.14.1375; CAPASSO JM, 1989, CIRC RES, V65, P1499, DOI 10.1161/01.RES.65.6.1499; Chen WP, 2010, N-S ARCH PHARMACOL, V382, P441, DOI 10.1007/s00210-010-0562-1; Chiao CW, 2005, N-S ARCH PHARMACOL, V371, P34, DOI 10.1007/s00210-004-1014-6; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; CUNNION RE, 1986, CIRCULATION, V73, P637, DOI 10.1161/01.CIR.73.4.637; Davani EY, 2006, CARDIOVASC RES, V72, P134, DOI 10.1016/j.cardiores.2006.06.029; Estes J E, 1980, Adv Shock Res, V3, P229; Fernandes A, 2007, EUR J NEUROSCI, V25, P1058, DOI 10.1111/j.1460-9568.2007.05340.x; Fernandes CJ, 1999, INTENS CARE MED, V25, P1165, DOI 10.1007/s001340051030; GUINAUDEAU H, 1975, LLOYDIA, V38, P275; Heumann D, 2002, CLIN CHIM ACTA, V323, P59, DOI 10.1016/S0009-8981(02)00180-8; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; HUNG J, 1993, CIRC RES, V73, P125, DOI 10.1161/01.RES.73.1.125; Issa R, 2007, J IMMUNOL, V178, P7366, DOI 10.4049/jimmunol.178.11.7366; KASS DA, 1987, CIRCULATION, V76, P1422, DOI 10.1161/01.CIR.76.6.1422; Klintman D, 2005, ANN SURG, V242, P830, DOI 10.1097/01.sla.0000189132.86878.f7; KUTSKY P, 1990, CIRC SHOCK, V30, P349; LEFER AM, 1970, AM J PHYSIOL, V218, P1423, DOI 10.1152/ajplegacy.1970.218.5.1423; Li MX, 2005, CIRCULATION, V111, P2494, DOI 10.1161/01.CIR.0000165117.71483.0C; Liaudet L, 2000, CRIT CARE MED, V28, pN37, DOI 10.1097/00003246-200004001-00005; LIU MS, 1991, BIOCHEM BIOPH RES CO, V174, P1248, DOI 10.1016/0006-291X(91)91555-Q; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; MCDONOUGH KH, 1988, CIRC SHOCK, V25, P291; Mebazaa A, 2001, CIRCULATION, V104, P3137, DOI 10.1161/hc5001.100662; Mendes SD, 2009, CELL SIGNAL, V21, P1109, DOI 10.1016/j.cellsig.2009.02.025; Merx MW, 2007, CIRCULATION, V116, P793, DOI 10.1161/CIRCULATIONAHA.106.678359; Munt B, 1998, CRIT CARE MED, V26, P1829, DOI 10.1097/00003246-199811000-00023; NATANSON C, 1989, J CLIN INVEST, V83, P243, DOI 10.1172/JCI113866; Neviere RR, 1999, AM J PHYSIOL-HEART C, V277, pH885, DOI 10.1152/ajpheart.1999.277.3.H885; ORCHARD CH, 1990, AM J PHYSIOL, V258, pC967, DOI 10.1152/ajpcell.1990.258.6.C967; Pathan N, 2004, LANCET, V363, P203, DOI 10.1016/S0140-6736(03)15326-3; PAWLUSH DG, 1990, CIRC SHOCK, V31, P269; Peng TQ, 2003, CARDIOVASC RES, V59, P893, DOI 10.1016/S0008-6363(03)00509-1; PETROS A, 1994, CARDIOVASC RES, V28, P34, DOI 10.1093/cvr/28.1.34; Poelaert J, 1997, INTENS CARE MED, V23, P553, DOI 10.1007/s001340050372; Seybold J, 2005, BLOOD, V105, P3569, DOI 10.1182/blood-2004-07-2729; SHAPIRO JI, 1990, AM J PHYSIOL, V258, pH1835, DOI 10.1152/ajpheart.1990.258.6.H1835; Sharma AC, 2007, SHOCK, V28, P265, DOI 10.1097/01.shk.0000235090.30550.fb; SOLOMON MA, 1994, AM J PHYSIOL, V266, pH757, DOI 10.1152/ajpheart.1994.266.2.H757; Tao WK, 2004, SHOCK, V21, P31, DOI 10.1097/01.shk.0000101673.49265.5d; Tavener SA, 2006, AM J PHYSIOL-HEART C, V290, pH800, DOI 10.1152/ajpheart.00701.2005; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Vieillard-Baron A, 2003, AM J RESP CRIT CARE, V168, P1270, DOI 10.1164/rccm.200306-816CC; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Yang M, 2008, AM J PHYSIOL-HEART C, V294, pH994, DOI 10.1152/ajpheart.01044.2007; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	54	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39174	10.1371/journal.pone.0039174	http://dx.doi.org/10.1371/journal.pone.0039174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761733	gold, Green Published, Green Submitted			2022-12-27	WOS:000305781700020
J	Tse, HTK; Weaver, WM; Di Carlo, D				Tse, Henry Tat Kwong; Weaver, Westbrook McConnell; Di Carlo, Dino			Increased Asymmetric and Multi-Daughter Cell Division in Mechanically Confined Microenvironments	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; EXTRA CENTROSOMES; CANCER-CELLS; MITOSIS; ORIENTATION; CHECKPOINT; ANEUPLOIDY; RIGIDITY; TENSION; CYCLE	As the microenvironment of a cell changes, associated mechanical cues may lead to changes in biochemical signaling and inherently mechanical processes such as mitosis. Here we explore the effects of confined mechanical environments on cellular responses during mitosis. Previously, effects of mechanical confinement have been difficult to optically observe in three-dimensional and in vivo systems. To address this challenge, we present a novel microfluidic perfusion culture system that allows controllable variation in the level of confinement in a single axis allowing observation of cell growth and division at the single-cell level. The device is capable of creating precise confinement conditions in the vertical direction varying from high (3 mm) to low (7 mm) confinement while also varying the substrate stiffness (E = 130 kPa and 1 MPa). The Human cervical carcinoma (HeLa) model with a known 3N+ karyotype was used for this study. For this cell line, we observe that mechanically confined cell cycles resulted in stressed cell divisions: (i) delayed mitosis, (ii) multi-daughter mitosis events (from 3 up to 5 daughter cells), (iii) unevenly sized daughter cells, and (iv) induction of cell death. In the highest confined conditions, the frequency of divisions producing more than two progeny was increased an astounding 50-fold from unconfined environments, representing about one half of all successful mitotic events. Notably, the majority of daughter cells resulting from multipolar divisions were viable after cytokinesis and, perhaps suggesting another regulatory checkpoint in the cell cycle, were in some cases observed to re-fuse with neighboring cells post-cytokinesis. The higher instances of abnormal mitosis that we report in confined mechanically stiff spaces, may lead to increased rates of abnormal, viable, cells in the population. This work provides support to a hypothesis that environmental mechanical cues influences structural mechanisms of mitosis such as geometric orientation of the mitotic plane or planes.	[Tse, Henry Tat Kwong; Weaver, Westbrook McConnell; Di Carlo, Dino] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90024 USA; [Di Carlo, Dino] Calif NanoSyst Inst, Los Angeles, CA USA	University of California System; University of California Los Angeles	Tse, HTK (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90024 USA.	dicarlo@seas.ucla.edu						Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; Assoian RK, 2008, TRENDS CELL BIOL, V18, P347, DOI 10.1016/j.tcb.2008.05.002; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Erenpreisa J, 2010, ONCOGENE, V29, P5447, DOI 10.1038/onc.2010.310; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Ingber DE, 2008, SEMIN CANCER BIOL, V18, P356, DOI 10.1016/j.semcancer.2008.03.016; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lelievre SA, 1998, P NATL ACAD SCI USA, V95, P14711, DOI 10.1073/pnas.95.25.14711; Maresca TJ, 2010, J CELL SCI, V123, P825, DOI 10.1242/jcs.064790; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Ochsner M, 2007, LAB CHIP, V7, P1074, DOI 10.1039/b704449f; Park AYJ, 2009, J BIOL CHEM, V284, P9418, DOI 10.1074/jbc.M809040200; PELC SR, 1956, EXP CELL RES, V11, P128, DOI 10.1016/0014-4827(56)90197-5; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; STEIN GS, 1972, J CELL BIOL, V52, P292, DOI 10.1083/jcb.52.2.292; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2008, HFSP J, V2, P65, DOI 10.2976/1.2895661; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Vilmos P, 2009, EUR J CELL BIOL, V88, P609, DOI 10.1016/j.ejcb.2009.05.006; Vitale I, 2010, EMBO J, V29, P1272, DOI 10.1038/emboj.2010.11	26	51	52	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e38986	10.1371/journal.pone.0038986	http://dx.doi.org/10.1371/journal.pone.0038986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761717	Green Published, gold, Green Submitted			2022-12-27	WOS:000305781700014
J	Kassa, MT; Penmetsa, RV; Carrasquilla-Garcia, N; Sarma, BK; Datta, S; Upadhyaya, HD; Varshney, RK; von Wettberg, EJB; Cook, DR				Kassa, Mulualem T.; Penmetsa, R. Varma; Carrasquilla-Garcia, Noelia; Sarma, Birinchi K.; Datta, Subhojit; Upadhyaya, Hari D.; Varshney, Rajeev K.; von Wettberg, Eric J. B.; Cook, Douglas R.			Genetic Patterns of Domestication in Pigeonpea (Cajanus cajan (L.) Millsp.) and Wild Cajanus Relatives	PLOS ONE			English	Article							SOYBEAN GLYCINE-MAX; DIVERSITY; SINGLE; BOTTLENECK; COLLECTION; PHYLOGENY; AUSTRALIA; GERMPLASM; INFERENCE; ORIGINS	Pigeonpea (Cajanus cajan) is an annual or short-lived perennial food legume of acute regional importance, providing significant protein to the human diet in less developed regions of Asia and Africa. Due to its narrow genetic base, pigeonpea improvement is increasingly reliant on introgression of valuable traits from wild forms, a practice that would benefit from knowledge of its domestication history and relationships to wild species. Here we use 752 single nucleotide polymorphisms (SNPs) derived from 670 low copy orthologous genes to clarify the evolutionary history of pigeonpea (79 accessions) and its wild relatives (31 accessions). We identified three well-supported lineages that are geographically clustered and congruent with previous nuclear and plastid sequence-based phylogenies. Among all species analyzed Cajanus cajanifolius is the most probable progenitor of cultivated pigeonpea. Multiple lines of evidence suggest recent gene flow between cultivated and non-cultivated forms, as well as historical gene flow between diverged but sympatric species. Evidence supports that primary domestication occurred in India, with a second and more recent nested population bottleneck focused in tropical regions that is the likely consequence of pigeonpea breeding. We find abundant allelic variation and genetic diversity among the wild relatives, with the exception of wild species from Australia for which we report a third bottleneck unrelated to domestication within India. Domesticated C. cajan possess 75% less allelic diversity than the progenitor clade of wild Indian species, indicating a severe "domestication bottleneck" during pigeonpea domestication.	[Kassa, Mulualem T.; Penmetsa, R. Varma; Carrasquilla-Garcia, Noelia; Sarma, Birinchi K.; Datta, Subhojit; Cook, Douglas R.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Sarma, Birinchi K.] Banaras Hindu Univ, Dept Mycol & Plant Pathol, Varanasi 221005, Uttar Pradesh, India; [Upadhyaya, Hari D.; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Patancheru 502324, Andhra Pradesh, India; [von Wettberg, Eric J. B.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [von Wettberg, Eric J. B.] Fairchild Trop Bot Garden, Ctr Trop Plant Conservat, Coral Gables, FL USA	University of California System; University of California Davis; Banaras Hindu University (BHU); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); State University System of Florida; Florida International University	Kassa, MT (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	drcook@ucdavis.edu	Updhayaya, Hari/C-4858-2014; Datta, Subhojit/AAR-8209-2021; Varshney, Rajeev K/C-5295-2014; von Wettberg, Eric/C-1115-2016; Sarma, Birinchi Kumar/ABE-5555-2020; Sarma, Birinchi Kumar/GPX-1633-2022	Updhayaya, Hari/0000-0002-5166-6844; Datta, Subhojit/0000-0002-5924-4355; Varshney, Rajeev K/0000-0002-4562-9131; von Wettberg, Eric/0000-0002-2724-0317; Sarma, Birinchi Kumar/0000-0002-1041-8422; Sarma, Birinchi Kumar/0000-0002-1041-8422	Indian Council of Agricultural Research under Indo-US Agricultural Knowledge Initiative; Indian Department of Science and Technology	Indian Council of Agricultural Research under Indo-US Agricultural Knowledge Initiative; Indian Department of Science and Technology(Department of Science & Technology (India))	This work was supported by the Indian Council of Agricultural Research under the Indo-US Agricultural Knowledge Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge BOYSCAST fellowships from the Indian Department of Science and Technology to BKS and SD. This paper is contribution number 231 from the Tropical Biology Program of Florida International University, associated with EJBvW. We are grateful to Professor Nigel Barker of Rhodes University Professor Jos van der Maesen of Wageningen University The Netherlands, and Associate Professor David Remington of the University of North Carolina at Greensboro for their helpful comments during preparation of the manuscript, and to Dr Reyazul Rouf Mir and Dr Rachit K Saxena for their valuable assistance with germplasm selection. We also acknowledge the important contributions of certain DNA samples used in this study from Dr Pawan Kulwal of Dr. Panjabrao Deshmukh Agricultural University (PDAU), Akola (India), Dr B Fakrudin University of Agricultural Sciences (UAS)-Bangalore (India), and Dr M Byregowda of UAS-Dharwad (India).	Allaby RG, 2008, P NATL ACAD SCI USA, V105, P13982, DOI 10.1073/pnas.0803780105; Bagavathiannan MV, 2008, AGR ECOSYST ENVIRON, V127, P1, DOI 10.1016/j.agee.2008.03.009; Bhatia G. K., 1981, Proceedings, International Workshop on Pigeonpeas, Vol. 2, P129; Bohra A., 2010, J PLANT BIOL, V37, P83; Bruno WJ, 2000, MOL BIOL EVOL, V17, P189, DOI 10.1093/oxfordjournals.molbev.a026231; Buckler ES, 2001, GENET RES, V77, P213, DOI 10.1017/S0016672301005158; De D. N., 1974, Evolutionary Studies in World Crops., P79; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Falush D, 2003, GENETICS, V164, P1567; FAOSTAT, 2008, ONL AGR STAT; Fortunato RH, 2000, HERENDEEN PS, P339; Guo JA, 2010, ANN BOT-LONDON, V106, P505, DOI 10.1093/aob/mcq125; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; HAUSER LA, 1982, SYST BOT, V7, P249, DOI 10.2307/2418387; He ZW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002100; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Kajale M.D., 1974, EXCAVATIONS BHOKARDA, P7; Kenicer G, 2005, ENDINB J BOT, V62, P195; Kilian B, 2006, MOL GENET GENOMICS, V276, P230, DOI 10.1007/s00438-006-0136-6; Li YH, 2010, NEW PHYTOL, V188, P242, DOI 10.1111/j.1469-8137.2010.03344.x; Liu AZ, 2006, GENETICS, V173, P321, DOI 10.1534/genetics.105.051110; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Maesen L. J. G. van der, 1990, The pigeonpea., P15; Maesen L. J. G. van der, 1980, Miscellaneous Papers, Landbouwhogeschool Wageningen, P257; Mallikarjuna N, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: LEGUME CROPS AND FORAGES, P21, DOI 10.1007/978-3-642-14387-8_2; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Morrell PL, 2007, P NATL ACAD SCI USA, V104, P3289, DOI 10.1073/pnas.0611377104; Motta-Aldana JR, 2010, CROP SCI, V50, P1773, DOI 10.2135/cropsci2009.12.0706; Nene Y. L., 1990, The pigeonpea., P1; Odeny DA, 2007, PLANT BREEDING, V126, P130, DOI 10.1111/j.1439-0523.2007.01324.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perrier X., 2006, DARWIN; Pritchard JK, 2000, GENETICS, V155, P945; Purseglove JW, 1968, TROPICAL CROPS DICOT; RATNAPARKHE MB, 1995, THEOR APPL GENET, V91, P893, DOI 10.1007/BF00223897; Redd AJ, 2002, CURR BIOL, V12, P673, DOI 10.1016/S0960-9822(02)00789-3; Reddy LJ, 2005, GENET RESOUR CROP EV, V52, P1049, DOI 10.1007/s10722-004-6152-7; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saxena K. B., 2003, Indian Journal of Genetics & Plant Breeding, V63, P225; Saxena KB, 2010, EUPHYTICA, V173, P329, DOI 10.1007/s10681-009-0088-0; Saxena K. B., 2008, Tropical Plant Biology, V1, P159, DOI 10.1007/s12042-008-9014-1; Saxena KB, 2005, EUPHYTICA, V145, P289, DOI 10.1007/s10681-005-1647-7; Souframanien J, 2003, EUPHYTICA, V129, P293, DOI 10.1023/A:1022212127025; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tenaillon MI, 2004, MOL BIOL EVOL, V21, P1214, DOI 10.1093/molbev/msh102; Tindall HD, 1988, VEGETABLES TROPICS; Upadhyaya HD, 2011, PLANT GENET RESOUR-C, V9, P97, DOI 10.1017/S1479262110000419; Upadhyaya HD, 2006, CROP SCI, V46, P2127, DOI 10.2135/cropsci2006.01.0032; van der Maesen LJG, 2003, AUST SYST BOT, V16, P219, DOI 10.1071/SB01047; Van der Maesen LJG, 1986, WAGENINGEN PAPERS AG; Yang SY, 2006, THEOR APPL GENET, V113, P585, DOI 10.1007/s00122-006-0317-z; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005	57	62	62	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39563	10.1371/journal.pone.0039563	http://dx.doi.org/10.1371/journal.pone.0039563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745789	Green Published, gold, Green Accepted			2022-12-27	WOS:000305730900081
J	Loftus, JC; Ross, JTD; Paquette, KM; Paulino, VM; Nasser, S; Yang, ZB; Kloss, J; Kim, S; Berens, ME; Tran, NL				Loftus, Joseph C.; Ross, Julianna T. D.; Paquette, Kimberly M.; Paulino, Vincent M.; Nasser, Sara; Yang, Zhongbo; Kloss, Jean; Kim, Seungchan; Berens, Michael E.; Tran, Nhan L.			miRNA Expression Profiling in Migrating Glioblastoma Cells: Regulation of Cell Migration and Invasion by miR-23b via Targeting of Pyk2	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; GLIOMA-CELLS; GENE-EXPRESSION; PROLIFERATION; MULTIFORME; MODULATION; MICRORNAS; APOPTOSIS; SUBTYPES; SURVIVAL	Background: Glioblastoma (GB) is the most common and lethal type of primary brain tumor. Clinical outcome remains poor and is essentially palliative due to the highly invasive nature of the disease. A more thorough understanding of the molecular mechanisms that drive glioma invasion is required to limit dispersion of malignant glioma cells. Methodology/Principal Findings: We investigated the potential role of differential expression of microRNAs (miRNA) in glioma invasion by comparing the matched large-scale, genome-wide miRNA expression profiles of migrating and migration-restricted human glioma cells. Migratory and migration-restricted cell populations from seven glioma cell lines were isolated and profiled for miRNA expression. Statistical analyses revealed a set of miRNAs common to all seven glioma cell lines that were significantly down regulated in the migrating cell population relative to cells in the migration-restricted population. Among the down-regulated miRNAs, miR-23b has been reported to target potential drivers of cell migration and invasion in other cell types. Over-expression of miR-23b significantly inhibited glioma cell migration and invasion. A bioinformatics search revealed a conserved target site within the 39 untranslated region (UTR) of Pyk2, a non-receptor tyrosine kinase previously implicated in the regulation of glioma cell migration and invasion. Increased expression of miR-23b reduced the protein expression level of Pyk2 in glioma cells but did not significantly alter the protein expression level of the related focal adhesion kinase FAK. Expression of Pyk2 via a transcript variant missing the 39UTR in miR-23b-expressing cells partially rescued cell migration, whereas expression of Pyk2 via a transcript containing an intact 39UTR failed to rescue cell migration. Conclusions/Significance: Reduced expression of miR-23b enhances glioma cell migration in vitro and invasion ex vivo via modulation of Pyk2 protein expression. The data suggest that specific miRNAs may regulate glioma migration and invasion to influence the progression of this disease.	[Loftus, Joseph C.; Yang, Zhongbo; Kloss, Jean] Mayo Clin Arizona, Dept Biochem & Mol Biol, Scottsdale, AZ USA; [Ross, Julianna T. D.; Paquette, Kimberly M.; Paulino, Vincent M.; Berens, Michael E.; Tran, Nhan L.] Translat Genom Res Inst, Canc & Cell Biol Div, Phoenix, AZ USA; [Nasser, Sara; Kim, Seungchan] Translat Genom Res Inst, Computat Biol Div, Phoenix, AZ USA	Mayo Clinic; Mayo Clinic Phoenix; Translational Genomics Research Institute; Translational Genomics Research Institute	Loftus, JC (corresponding author), Mayo Clin Arizona, Dept Biochem & Mol Biol, Scottsdale, AZ USA.	loftus.joseph@mayo.edu; ntran@tgen.org	Yang, Zhongbo/O-3979-2019	Kim, Seungchan/0000-0003-4183-4338	Science Foundation Arizona [CAA0244-08]; NIH [R01 CA130940, R01 CA103956]; NATIONAL CANCER INSTITUTE [R01CA130940, R01CA103956] Funding Source: NIH RePORTER	Science Foundation Arizona; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Science Foundation Arizona CAA0244-08 (NLT) and NIH grants R01 CA130940 (NLT) and R01 CA103956 (JCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asadi-Moghaddam K, 2010, EXPERT REV ANTICANC, V10, P1753, DOI [10.1586/era.10.168, 10.1586/ERA.10.168]; BERENS ME, 1994, CLIN EXP METASTAS, V12, P405, DOI 10.1007/BF01755884; Berens ME, 2004, METH MOLEC MED, V88, P219; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Conti A, 2009, J NEURO-ONCOL, V93, P325, DOI 10.1007/s11060-009-9797-4; Demuth T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-54; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gutenberg A, 2004, ACTA NEUROPATHOL, V108, P224, DOI 10.1007/s00401-004-0886-3; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Joy AM, 2003, J CELL SCI, V116, P4409, DOI 10.1242/jcs.00712; Kislin KL, 2009, NEOPLASIA, V11, P377, DOI 10.1593/neo.81572; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lawler S, 2009, J NEURO-ONCOL, V92, P297, DOI 10.1007/s11060-009-9843-2; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Lefranc F, 2009, ADV TECH STAND NEURO, V34, P3, DOI 10.1007/978-3-211-78741-0_1; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lipinski CA, 2005, NEOPLASIA, V7, P435, DOI 10.1593/neo.04712; Lipinski CA, 2003, MOL CANCER RES, V1, P323; Lipinski CA, 2008, J NEURO-ONCOL, V90, P181, DOI 10.1007/s11060-008-9656-8; Liu N, 2008, CELL RES, V18, P985, DOI 10.1038/cr.2008.278; Mariani L, 2001, J NEURO-ONCOL, V53, P161, DOI 10.1023/A:1012253317934; McDonough W, 1998, J NEUROPATH EXP NEUR, V57, P449, DOI 10.1097/00005072-199805000-00008; Melo SA, 2011, FEBS LETT, V585, P2087, DOI 10.1016/j.febslet.2010.08.009; Mischel PS, 2003, ONCOGENE, V22, P2361, DOI 10.1038/sj.onc.1206344; Moriarty CH, 2010, J BIOL CHEM, V285, P20541, DOI 10.1074/jbc.M110.121012; Nakada M, 2005, AM J PATHOL, V167, P565, DOI 10.1016/S0002-9440(10)62998-7; Nakada M, 2004, CANCER RES, V64, P3179, DOI 10.1158/0008-5472.CAN-03-3667; Novakova J, 2009, BIOCHEM BIOPH RES CO, V386, P1, DOI 10.1016/j.bbrc.2009.06.034; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Purow B, 2011, J NEURO-ONCOL, V103, P429, DOI 10.1007/s11060-010-0449-5; Salvi A, 2009, FEBS J, V276, P2966, DOI 10.1111/j.1742-4658.2009.07014.x; Song LB, 2010, BIOCHEM BIOPH RES CO, V402, P135, DOI 10.1016/j.bbrc.2010.10.003; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun T, 2011, ALTERED EXPRESSION M; Teodorczyk M, 2010, J CELL PHYSIOL, V222, P1, DOI 10.1002/jcp.21901; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Tran NL, 2003, AM J PATHOL, V162, P1313, DOI 10.1016/S0002-9440(10)63927-2; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555	47	52	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39818	10.1371/journal.pone.0039818	http://dx.doi.org/10.1371/journal.pone.0039818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745829	Green Submitted, Green Published, gold			2022-12-27	WOS:000305730900115
J	Pucciarelli, S; Ballarini, P; Sparvoli, D; Barchetta, S; Yu, T; Detrich, HW; Miceli, C				Pucciarelli, Sandra; Ballarini, Patrizia; Sparvoli, Daniela; Barchetta, Sabrina; Yu, Ting; Detrich, H. William, III; Miceli, Cristina			Distinct Functional Roles of beta-Tubulin Isotypes in Microtubule Arrays of Tetrahymena thermophila, a Model Single-Celled Organism	PLOS ONE			English	Article							CILIATE EUPLOTES-FOCARDII; GAMMA-TUBULIN; ALPHA-TUBULIN; III-TUBULIN; POSTTRANSLATIONAL MODIFICATIONS; PACLITAXEL RESISTANCE; NUCLEAR DIVISION; BINDING AGENTS; GENE; EVOLUTION	Background: The multi-tubulin hypothesis proposes that each tubulin isotype performs a unique role, or subset of roles, in the universe of microtubule function(s). To test this hypothesis, we are investigating the functions of the recently discovered, noncanonical beta-like tubulins (BLTs) of the ciliate, Tetrahymena thermophila. Tetrahymena forms 17 distinct microtubular structures whose assembly had been thought to be based on single alpha- and beta-isotypes. However, completion of the macronuclear genome sequence of Tetrahymena demonstrated that this ciliate possessed a beta-tubulin multigene family: two synonymous genes (BTU1 and BTU2) encode the canonical beta-tubulin, BTU2, and six genes (BLT1-6) yield five divergent beta-tubulin isotypes. In this report, we examine the structural features and functions of two of the BLTs (BLT1 and BLT4) and compare them to those of BTU2. Methodology/Principal Findings: With respect to BTU2, BLT1 and BLT4 had multiple sequence substitutions in their GTP-binding sites, in their interaction surfaces, and in their microtubule-targeting motifs, which together suggest that they have specialized functions. To assess the roles of these tubulins in vivo, we transformed Tetrahymena with expression vectors that direct the synthesis of GFP-tagged versions of the isotypes. We show that GFP-BLT1 and GFP-BLT4 were not detectable in somatic cilia and basal bodies, whereas GFP-BTU2 strongly labeled these structures. During cell division, GFP-BLT1 and GFP-BLT4, but not GFP-BTU2, were incorporated into the microtubule arrays of the macronucleus and into the mitotic apparatus of the micronucleus. GFP-BLT1 also participated in formation of the microtubules of the meiotic apparatus of the micronucleus during conjugation. Partitioning of the isotypes between nuclear and ciliary microtubules was confirmed biochemically. Conclusion/Significance: We conclude that Tetrahymena uses a family of distinct beta-tubulin isotypes to construct subsets of functionally different microtubules, a result that provides strong support for the multi-tubulin hypothesis.	[Pucciarelli, Sandra; Ballarini, Patrizia; Sparvoli, Daniela; Barchetta, Sabrina; Yu, Ting; Miceli, Cristina] Univ Camerino, Sch Biosci & Biotechnol, I-62032 Camerino, MC, Italy; [Detrich, H. William, III] Northeastern Univ, Ctr Marine Sci, Dept Earth & Environm Sci, Nahant, MA 01908 USA; [Detrich, H. William, III] Northeastern Univ, Ctr Marine Sci, Dept Biol, Nahant, MA 01908 USA	University of Camerino; Northeastern University; Northeastern University	Pucciarelli, S (corresponding author), Univ Camerino, Sch Biosci & Biotechnol, I-62032 Camerino, MC, Italy.	sandra.pucciarelli@unicam.it	Yu, Ting/A-3674-2013	Miceli, Cristina/0000-0002-7829-8471; Sparvoli, Daniela/0000-0002-5992-3753; Pucciarelli, Sandra/0000-0003-4178-2689	Italian "Programma Nazionale di Ricerche in Antartide" (PNRA); Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca'' (MIUR); U.S. National Science Foundation [ANT-0944517]; COST action [BM1102]; Office of Polar Programs (OPP) [0944517] Funding Source: National Science Foundation	Italian "Programma Nazionale di Ricerche in Antartide" (PNRA); Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca'' (MIUR)(Ministry of Education, Universities and Research (MIUR)); U.S. National Science Foundation(National Science Foundation (NSF)); COST action(European Cooperation in Science and Technology (COST)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by grants from the Italian "Programma Nazionale di Ricerche in Antartide" (PNRA) and from the Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca'' (MIUR) (PRIN 2008) to CM and by U.S. National Science Foundation grant ANT-0944517 to HWD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the COST (action BM1102) for supporting part of this work.	Akoumianaki T, 2009, J CELL SCI, V122, P1111, DOI 10.1242/jcs.043034; ALLEN RD, 1967, J PROTOZOOL, V14, P553, DOI 10.1111/j.1550-7408.1967.tb02042.x; Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Barchetta S, 2008, EUKARYOT CELL, V7, P379, DOI 10.1128/EC.00221-07; Bhattacharya R, 2011, MOL BIOL CELL, V22, P1025, DOI 10.1091/mbc.E10-10-0822; Bhattacharya R, 2009, J BIOL CHEM, V284, P13023, DOI 10.1074/jbc.M900167200; Chiappori F, 2012, PROTEINS, V80, P1154, DOI 10.1002/prot.24016; Cole ES, 2008, J EUKARYOT MICROBIOL, V55, P245, DOI 10.1111/j.1550-7408.2008.00337.x; Coyne RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-562; Dingwall C, 1998, CURR BIOL, V8, pR922, DOI 10.1016/S0960-9822(98)00010-4; Duan JM, 2002, CURR BIOL, V12, P313, DOI 10.1016/S0960-9822(02)00651-6; EICHENLAUBRITTER U, 1984, NATURE, V307, P60, DOI 10.1038/307060a0; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Ferris AM, 2009, J NEUROSCI METH, V182, P157, DOI 10.1016/j.jneumeth.2009.06.002; Fujiu K, 1999, CELL STRUCT FUNCT, V24, P401, DOI 10.1247/csf.24.401; Fujiu K, 2000, CELL MOTIL CYTOSKEL, V46, P17, DOI 10.1002/(SICI)1097-0169(200005)46:1<17::AID-CM3>3.0.CO;2-C; Fulton C., 1976, CELL MOTIL CYTOSKEL, V3, P987; GAERTIG J, 1992, PROTOPLASMA, V167, P74, DOI 10.1007/BF01353583; GAERTIG J, 1992, P NATL ACAD SCI USA, V89, P9196, DOI 10.1073/pnas.89.19.9196; Gaertig J, 2000, J EUKARYOT MICROBIOL, V47, P185, DOI 10.1111/j.1550-7408.2000.tb00037.x; GAERTIG J, 1993, CELL MOTIL CYTOSKEL, V25, P243, DOI 10.1002/cm.970250305; Gaertig J, 2005, BIOCHEMIST, V27, P15; Gan PP, 2010, MOL CANCER THER, V9, P1339, DOI 10.1158/1535-7163.MCT-09-0679; Goodson Holly V, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5480; Goodson HV, 2010, COLD SPRING HARB PRO, P85, DOI [10.1101/pdb.top85, DOI 10.1101/PDB.T0P85]; Inclan YF, 2001, J CELL SCI, V114, P413; Iwamoto M, 2009, CURR BIOL, V19, P843, DOI 10.1016/j.cub.2009.03.055; Joachimiak E, 2007, PROTIST, V158, P39, DOI 10.1016/j.protis.2006.08.001; Joe PA, 2008, CELL MOTIL CYTOSKEL, V65, P476, DOI 10.1002/cm.20274; Kamath K, 2005, J BIOL CHEM, V280, P12902, DOI 10.1074/jbc.M414477200; Karrer KM, 2000, METHOD CELL BIOL, V62, P127; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAFOUNTAIN JR, 1979, CHROMOSOMA, V75, P293, DOI 10.1007/BF00293473; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Luduena RF, 1998, INT REV CYTOL, V178, P207; Maddox P, 1999, J CELL BIOL, V144, P977, DOI 10.1083/jcb.144.5.977; Malone CD, 2008, EUKARYOT CELL, V7, P1487, DOI 10.1128/EC.00193-08; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Marziale F, 2008, FEBS J, V275, P5367, DOI 10.1111/j.1742-4658.2008.06666.x; MCGRATH KE, 1994, CELL MOTIL CYTOSKEL, V27, P272, DOI 10.1002/cm.970270308; McKean PG, 2001, J CELL SCI, V114, P2723; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Nielsen MG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-113; Nielsen MG, 2002, EVOL DEV, V4, P303, DOI 10.1046/j.1525-142X.2002.02015.x; Nielsen MG, 2001, CURR BIOL, V11, P529, DOI 10.1016/S0960-9822(01)00150-6; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Orias E, 2011, RES MICROBIOL, V162, P578, DOI 10.1016/j.resmic.2011.05.001; Pucciarelli S, 1997, CELL MOTIL CYTOSKEL, V38, P329, DOI 10.1002/(SICI)1097-0169(1997)38:4<329::AID-CM3>3.0.CO;2-Z; Pucciarelli S, 2009, MAR GENOM, V2, P57, DOI 10.1016/j.margen.2009.03.008; RAFF EC, 1984, J CELL BIOL, V99, P1, DOI 10.1083/jcb.99.1.1; Raff EC, 2008, CURR BIOL, V18, P911, DOI 10.1016/j.cub.2008.05.031; Seve P, 2008, LANCET ONCOL, V9, P168, DOI 10.1016/S1470-2045(08)70029-9; Shang YH, 2005, J CELL BIOL, V171, P1035, DOI 10.1083/jcb.200508184; Smith JJ, 2004, EUKARYOT CELL, V3, P1217, DOI 10.1128/EC.3.5.1217-1226.2004; Snaith HA, 2010, METHOD CELL BIOL, V97, P147, DOI 10.1016/S0091-679X(10)97009-X; Thazhath R, 2002, NAT CELL BIOL, V4, P256, DOI 10.1038/ncb764; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tischfield MA, 2010, BIOSCIENCE REP, V30, P319, DOI 10.1042/BSR20100025; TUCKER JB, 1985, J CELL BIOL, V101, P1966, DOI 10.1083/jcb.101.5.1966; Tyler KM, 2010, J MOL EVOL, V70, P395, DOI 10.1007/s00239-010-9338-y; Walss-Bass C, 2001, CELL MOTIL CYTOSKEL, V49, P208, DOI 10.1002/cm.1034; WILLIAMS NE, 1984, J PROTOZOOL, V31, P492, DOI 10.1111/j.1550-7408.1984.tb03002.x; Wloga D, 2008, EUKARYOT CELL, V7, P1362, DOI 10.1128/EC.00084-08; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; WOLFE J, 1976, CHROMOSOMA, V55, P289, DOI 10.1007/BF00292827; Xia L, 2000, J CELL BIOL, V149, P1097, DOI 10.1083/jcb.149.5.1097; YAO MC, 1989, MOL CELL BIOL, V9, P1092, DOI 10.1128/MCB.9.3.1092; YAO MC, 1991, P NATL ACAD SCI USA, V88, P9493, DOI 10.1073/pnas.88.21.9493; Yao MC, 2007, J CELL SCI, V120, P1978, DOI 10.1242/jcs.006502	72	12	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39694	10.1371/journal.pone.0039694	http://dx.doi.org/10.1371/journal.pone.0039694			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745812	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900100
J	Nieto, JD; Fisher, M; Cook, S; Laderach, P; Lundy, M				Nieto, Jacqueline Diaz; Fisher, Myles; Cook, Simon; Laederach, Peter; Lundy, Mark			Weather Indices for Designing Micro-Insurance Products for Small-Holder Farmers in the Tropics	PLOS ONE			English	Article							DROUGHT; RISK; AMERICA; DEMAND	Agriculture is inherently risky. Drought is a particularly troublesome hazard that has a documented adverse impact on agricultural development. A long history of decision-support tools have been developed to try and help farmers or policy makers manage risk. We offer site-specific drought insurance methodology as a significant addition to this process. Drought insurance works by encapsulating the best available scientific estimate of drought probability and severity at a site within a single number-the insurance premium, which is offered by insurers to insurable parties in a transparent risk-sharing agreement. The proposed method is demonstrated in a case study for dry beans in Nicaragua.	[Nieto, Jacqueline Diaz] Univ Sheffield, Kroto Res Inst, Catchment Sci Ctr, Sheffield, S Yorkshire, England; [Fisher, Myles; Cook, Simon; Laederach, Peter; Lundy, Mark] Ctr Int Agr Trop, Cali, Colombia	University of Sheffield; Alliance; International Center for Tropical Agriculture - CIAT	Nieto, JD (corresponding author), Univ Sheffield, Kroto Res Inst, Catchment Sci Ctr, North Campus, Sheffield, S Yorkshire, England.	p.laderach@cgiar.org	Cook, Simon/R-7762-2017	Cook, Simon/0000-0003-0902-1476; Laderach, Peter/0000-0001-8708-6318	German Federal Ministry for Economic Cooperation and Development (BMZ); Climate Change, Agriculture and Food Security Program (CCAFS)	German Federal Ministry for Economic Cooperation and Development (BMZ); Climate Change, Agriculture and Food Security Program (CCAFS)	The authors acknowledge partial funding from the German Federal Ministry for Economic Cooperation and Development (BMZ) and support from the Climate Change, Agriculture and Food Security Program (CCAFS/ http://ccafs.cgiar.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltodano ME, 2001, LINEA BASE SITIO REF; Barrett CB, 2001, NONFARM INCOME DIVER; Binswanger-Mkhize HP, 2011, J DEV STUDIES; Bird K, 2002, 13 CPD U BITM; Brown W., 1999, PROVIDING INSURANC 1; Bryla E, 2003, RISK MANAGEMENT PRIC; Cohen M., 2006, PROTECTING POOR MICR, VProtecting the poor: A microinsurance compendium, P25; Collier B., 2010, STATE KNOWLEDGE REPO; Davidson B. R., 1965, NO MYTH STUDY PHYS E; Dercon S, 2001, INCOME RISK COPING S; Dercon S., 2008, LIT REV MICROINSURAN; Em-dat, 2004, INT DIS DAT; Giannini A, 2009, 0901 IRI ARD WORD BA; Hazell P, 2000, WEATHER INSURANCE PR; Hess U, 2003, 9 WORLD BANK AGR RUR; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jaramillo PM, 1989, CULTIVO FRIOL; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; Jones PG, 2000, AGRON J, V92, P445, DOI 10.2134/agronj2000.923445x; Jones PG, 2002, MARKSIM COMPUTER BAS; Laderach P., 2011, EC SOCIAL POLITICAL; Liu BC, 2010, AGRIC AGRIC SCI PROC, V1, P179, DOI 10.1016/j.aaspro.2010.09.022; Magana V, 1999, J CLIMATE, V12, P1577, DOI 10.1175/1520-0442(1999)012<1577:TMDOMA>2.0.CO;2; Ministerio Agropecuario y Forestal, 2001, ATL RUR NIC; Miranda M, 2001, AM J AGR ECON, V83, P650, DOI 10.1111/0002-9092.00185; Miranda MJ, 1997, AM J AGR ECON, V79, P206, DOI 10.2307/1243954; Morduch J, 1999, WORLD BANK RES OBSER, V14, P187, DOI 10.1093/wbro/14.2.187; MORDUCH J, 1995, J ECON PERSPECT, V9, P103, DOI 10.1257/jep.9.3.103; MOSLEY P, 1995, J DEV STUD, V31, P428, DOI 10.1080/00220389508422371; Nieto JD, 2010, CLIM DEV, V2, P233, DOI 10.3763/cdev.2010.0050; Osgood D, 2007, 0702 IRI ARD WORK BA; Pandey S, 2001, RICE RES FOOD SECURI, P67; Patt A, 2010, GLOBAL ENVIRON CHANG, V20, P153, DOI 10.1016/j.gloenvcha.2009.10.007; Quintana JO, 1983, SUELOS FERTILIZACION; Rios MJ, 2002, FRIJOL PHASEOLUS VUL; ROSENZWEIG MR, 1993, ECON J, V103, P56, DOI 10.2307/2234337; Sakurai T, 1997, AM J AGR ECON, V79, P1193, DOI 10.2307/1244277; Skees J.R., 2001, 2577 WPS WORLD BANK; Skees JR, 2008, POTENTIAL WEATHER IN; Skees JR, 2003, RISK MANAGEMENT CHAL; Stoppa A., 2003, INT C AGR POL REF WT; Turvey C. G., 2001, Review of Agricultural Economics, V23, P333, DOI 10.1111/1467-9353.00065; van Oppen C, 2001, J INSUR RES PRAC; Varangis P, 2003, WEATHER INDEXES DEV; Voysest O., 1991, Common beans: research for crop improvement., P119; Webb P., 1992, Quarterly Journal of International Agriculture, V31, P230; Wenner M, 2003, PAV WAY FORW RUR FIN; World Bank, 2001, INN MAN CAT RISKS CA; World Bank, 2000, 20448LAC WORLD BANK	49	7	7	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38281	10.1371/journal.pone.0038281	http://dx.doi.org/10.1371/journal.pone.0038281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	964KY	22737210	Green Submitted, Green Published, gold			2022-12-27	WOS:000305695100007
J	Persson, LJP; Aanerud, M; Hiemstra, PS; Hardie, JA; Bakke, PS; Eagan, TML				Persson, Louise Jeanette Pauline; Aanerud, Marianne; Hiemstra, Pieter Sicco; Hardie, Jon Andrew; Bakke, Per Sigvald; Eagan, Tomas Mikal Lind			Chronic Obstructive Pulmonary Disease Is Associated with Low Levels of Vitamin D	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; 3RD NATIONAL-HEALTH; D DEFICIENCY; DEPRESSIVE SYMPTOMS; LUNG-FUNCTION; SMOKING; INDUCER; MARKERS; COPD; D-3	Introduction: COPD patients may be at increased risk for vitamin D (25(OH)D) deficiency, but risk factors for deficiency among COPD patients have not been extensively reported. Methods: Serum 25(OH)D levels were measured by liquid chromatography double mass spectrometry in subjects aged 4076 years from Western Norway, including 433 COPD patients (GOLD stage II-IV) and 325 controls. Levels <20 ng/mL defined deficiency. Season, sex, age, body mass index (BMI), smoking, GOLD stage, exacerbation frequency, arterial oxygen tension (PaO2), respiratory symptoms, depression (CES-D score >= 16), comorbidities (Charlson score), treatment for osteoporosis, use of inhaled steroids, and total white blood count were examined for associations with 25(OH)D in both linear and logistic regression models. Results: COPD patients had an increased risk for vitamin D deficiency compared to controls after adjustment for seasonality, age, smoking and BMI. Variables associated with lower 25(OH)D levels in COPD patients were obesity (=-6.63), current smoking (=-4.02), GOLD stage III-IV (=-4.71, =-5.64), and depression (=-3.29). Summertime decreased the risk of vitamin D deficiency (OR = 0.22). Conclusion: COPD was associated with an increased risk of vitamin D deficiency, and important disease characteristics were significantly related to 25(OH)D levels.	[Persson, Louise Jeanette Pauline; Aanerud, Marianne; Hardie, Jon Andrew; Eagan, Tomas Mikal Lind] Haukeland Hosp, Dept Thorac Med, N-5021 Bergen, Norway; [Hardie, Jon Andrew; Bakke, Per Sigvald; Eagan, Tomas Mikal Lind] Univ Bergen, Inst Med, Bergen, Norway; [Hiemstra, Pieter Sicco] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands	University of Bergen; Haukeland University Hospital; University of Bergen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Persson, LJP (corresponding author), Haukeland Hosp, Dept Thorac Med, N-5021 Bergen, Norway.	louise.persson@med.uib.no	Eagan, Tomas ML/P-3554-2014; Eagan, Tomas Mikal/AHC-9127-2022; Hiemstra, Pieter S/K-8587-2018; /V-8478-2019	Eagan, Tomas ML/0000-0001-8725-9960; Hiemstra, Pieter S/0000-0002-0238-5982; 	Foundation for Respiratory Research, University of Bergen, Bergen, Norway; Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway; Norwegian ExtraFoundation for Health and Rehabilitation [2007/2/0039]; Bergen medical research foundation	Foundation for Respiratory Research, University of Bergen, Bergen, Norway; Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway; Norwegian ExtraFoundation for Health and Rehabilitation; Bergen medical research foundation	The sampling of the cohort study was funded by unrestricted grants from The Foundation for Respiratory Research, University of Bergen, Bergen, Norway and by grants from the Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway. This manuscript takes part of a PhD project (grant number 2007/2/0039), funded by the Norwegian ExtraFoundation for Health and Rehabilitation (www.extrastiftelsen.no). An additional grant from the Bergen medical research foundation (www.bmfstiftelse.no) was used to fund the Vitamin D analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Bjerk S, 2011, AM J RESP CRIT CARE, V183; Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; Brehm JM, 2009, AM J RESP CRIT CARE, V179, P765, DOI 10.1164/rccm.200808-1361OC; Brot C, 1999, EUR J CLIN NUTR, V53, P920, DOI 10.1038/sj.ejcn.1600870; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cosio BG, 2010, AM J RESP CRIT CARE, V181, P655, DOI 10.1164/rccm.201001-0111UP; Devereux G, 2007, AM J CLIN NUTR, V85, P853, DOI 10.1093/ajcn/85.3.853; Dobak John, 1994, Journal of Dermatological Science, V8, P18, DOI 10.1016/0923-1811(94)90316-6; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Eagan TML, 2010, EUR RESPIR J, V35, P540, DOI 10.1183/09031936.00088209; Forli L, 2004, J INTERN MED, V256, P56, DOI 10.1111/j.1365-2796.2004.01337.x; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Grimnes G, 2010, EUR J ENDOCRINOL, V163, P339, DOI 10.1530/EJE-10-0150; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; Jorde R, 2008, J INTERN MED, V264, P599, DOI 10.1111/j.1365-2796.2008.02008.x; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; LEMIRE JM, 1985, J IMMUNOL, V134, P3032; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Milaneschi Y, 2010, J CLIN ENDOCR METAB, V95, P3225, DOI 10.1210/jc.2010-0347; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Saure EW, 2011, CLIN RESP J; Schlaich C, 1998, OSTEOPOROSIS INT, V8, P261, DOI 10.1007/s001980050063; Stewart R, 2010, PSYCHOSOM MED, V72, P608, DOI 10.1097/PSY.0b013e3181e9bf15; Sutherland ER, 2010, AM J RESP CRIT CARE, V181, P699, DOI 10.1164/rccm.200911-1710OC; Timms PM, 2002, QJM-INT J MED, V95, P787, DOI 10.1093/qjmed/95.12.787; VANDERWIELEN RPJ, 1995, LANCET, V346, P207, DOI 10.1016/S0140-6736(95)91266-5; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Williams AF, 2007, UPDATE VITAMIN D POS; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690	34	107	109	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38934	10.1371/journal.pone.0038934	http://dx.doi.org/10.1371/journal.pone.0038934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737223	Green Submitted, Green Published, gold			2022-12-27	WOS:000305695100022
J	Bazzi, A; Zargarian, L; Chaminade, F; De Rocquigny, H; Rene, B; Mely, Y; Fosse, P; Mauffret, O				Bazzi, Ali; Zargarian, Loussine; Chaminade, Francoise; De Rocquigny, Hugues; Rene, Brigitte; Mely, Yves; Fosse, Philippe; Mauffret, Olivier			Intrinsic Nucleic Acid Dynamics Modulates HIV-1 Nucleocapsid Protein Binding to Its Targets	PLOS ONE			English	Article							CHEMICAL-SHIFT TENSORS; RNA PACKAGING SIGNAL; STEM-LOOP SL2; CTAR DNA; TAR RNA; STRUCTURAL DETERMINANTS; COMPLEMENTARY SEQUENCES; DESTABILIZING ACTIVITY; NMR RELAXATION; ZINC FINGERS	HIV-1 nucleocapsid protein (NC) is involved in the rearrangement of nucleic acids occurring in key steps of reverse transcription. The protein, through its two zinc fingers, interacts preferentially with unpaired guanines in single-stranded sequences. In mini-cTAR stem-loop, which corresponds to the top half of the cDNA copy of the transactivation response element of the HIV-1 genome, NC was found to exhibit a clear preference for the TGG sequence at the bottom of mini-cTAR stem. To further understand how this site was selected among several potential binding sites containing unpaired guanines, we probed the intrinsic dynamics of mini-cTAR using C-13 relaxation measurements. Results of spin relaxation time measurements have been analyzed using the model-free formalism and completed by dispersion relaxation measurements. Our data indicate that the preferentially recognized guanine in the lower part of the stem is exempt of conformational exchange and highly mobile. In contrast, the unrecognized unpaired guanines of mini-cTAR are involved in conformational exchange, probably related to transient base-pairs. These findings support the notion that NC preferentially recognizes unpaired guanines exhibiting a high degree of mobility. The ability of NC to discriminate between close sequences through their dynamic properties contributes to understanding how NC recognizes specific sites within the HIV genome.	[Bazzi, Ali; Zargarian, Loussine; Chaminade, Francoise; Rene, Brigitte; Fosse, Philippe; Mauffret, Olivier] Ecole Normale Super, CNRS, Lab Biol & Pharmacol Appl, Cachan, France; [De Rocquigny, Hugues; Mely, Yves] Univ Strasbourg, Lab Biophoton & Pharmacol, CNRS, UMR 7213,Fac Pharm, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bazzi, A (corresponding author), Ecole Normale Super, CNRS, Lab Biol & Pharmacol Appl, Cachan, France.	olivier.mauffret@lbpa.ens-cachan.fr			Agence Nationale de Recherche sur le Sida; Agence Nationale de la Recherche (ANR); Centre National de la Recherche Scientifique [CNRS LBPA UMR 8113]	Agence Nationale de Recherche sur le Sida(ANRSFrench National Research Agency (ANR)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Agence Nationale de Recherche sur le Sida (to P.F., O.M. and A.B.) and by Agence Nationale de la Recherche (ANR) project "Femtostack" (to YM). Funding for open access charge came from Centre National de la Recherche Scientifique (CNRS LBPA UMR 8113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOULELA F, 1995, J MOL BIOL, V253, P313, DOI 10.1006/jmbi.1995.0555; Al-Hashimi HM, 2002, J MOL BIOL, V315, P95, DOI 10.1006/jmbi.2001.5235; Amarasinghe GK, 2000, J MOL BIOL, V299, P145, DOI 10.1006/jmbi.2000.3710; Amarasinghe GK, 2000, J MOL BIOL, V301, P491, DOI 10.1006/jmbi.2000.3979; Avilov SV, 2008, NUCLEIC ACIDS RES, V36, P885, DOI 10.1093/nar/gkm1109; Avilov SV, 2009, BIOCHEMISTRY-US, V48, P2422, DOI 10.1021/bi8022366; Basu VP, 2008, VIRUS RES, V134, P19, DOI 10.1016/j.virusres.2007.12.017; Bazzi A, 2011, NUCL ACIDS RES; Beltz H, 2005, J MOL BIOL, V348, P1113, DOI 10.1016/j.jmb.2005.02.042; Beltz H, 2004, J MOL BIOL, V338, P711, DOI 10.1016/j.jmb.2004.03.019; Beltz H, 2003, J MOL BIOL, V328, P95, DOI 10.1016/S0022-2836(03)00244-4; Boisbouvier J, 2003, J BIOMOL NMR, V27, P133, DOI 10.1023/A:1024931619957; Bothe JR, 2011, NAT METHODS, V8, P919, DOI [10.1038/NMETH.1735, 10.1038/nmeth.1735]; Bourbigot S, 2008, J MOL BIOL, V383, P1112, DOI 10.1016/j.jmb.2008.08.046; Bryce DL, 2005, J AM CHEM SOC, V127, P7387, DOI 10.1021/ja051039c; Darlix JL, 2007, ADV PHARMACOL, V55, P299, DOI 10.1016/S1054-3589(07)55009-X; Darlix JL, 2011, J MOL BIOL, V410, P565, DOI 10.1016/j.jmb.2011.03.037; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; Dethoff EA, 2008, BIOPHYS J, V95, P3906, DOI 10.1529/biophysj.108.140285; Duchardt E, 2005, J BIOMOL NMR, V32, P295, DOI 10.1007/s10858-005-0659-x; Fisher RJ, 1998, J VIROL, V72, P1902, DOI 10.1128/JVI.72.3.1902-1909.1998; Gherghe C, 2010, P NATL ACAD SCI USA, V107, P19248, DOI 10.1073/pnas.1006897107; Godet J, 2006, J MOL BIOL, V356, P1180, DOI 10.1016/j.jmb.2005.12.038; Godet J, 2011, NUCLEIC ACIDS RES, V39, P6633, DOI 10.1093/nar/gkr274; Godet J, 2010, RNA BIOL, V7, P687, DOI 10.4161/rna.7.6.13616; Hansen AL, 2007, J AM CHEM SOC, V129, P16072, DOI 10.1021/ja0757982; Kanevsky I, 2005, J MOL BIOL, V348, P1059, DOI 10.1016/j.jmb.2005.03.046; Kanevsky I, 2011, NUCLEIC ACIDS RES, V39, P8148, DOI 10.1093/nar/gkr526; LAPADATTAPOLSKY M, 1993, NUCLEIC ACIDS RES, V21, P831, DOI 10.1093/nar/21.4.831; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Levin JG, 2010, RNA BIOL, V7, P754, DOI 10.4161/rna.7.6.14115; Lu K, 2011, J MOL BIOL, V410, P609, DOI 10.1016/j.jmb.2011.04.029; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MELY Y, 1993, BIOPHYS J, V65, P1513, DOI 10.1016/S0006-3495(93)81222-0; Mirambeau G, 2010, RNA BIOL, V7, P724, DOI 10.4161/rna.7.6.13777; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; Morellet N, 1998, J MOL BIOL, V283, P419, DOI 10.1006/jmbi.1998.2098; Muriaux D, 2010, RNA BIOL, V7, P744, DOI 10.4161/rna.7.6.14065; Oberstrass FC, 2008, J AM CHEM SOC, V130, P12007, DOI 10.1021/ja8023115; Olsen GL, 2008, J AM CHEM SOC, V130, P2896, DOI 10.1021/ja0778803; Olsen GL, 2010, J AM CHEM SOC, V132, P303, DOI 10.1021/ja907515s; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Palmer AG, 2006, CHEM REV, V106, P1700, DOI 10.1021/cr0404287; Palmer RF, 2005, AM J PUBLIC HEALTH, V95, P125, DOI 10.2105/AJPH.2003.023077; Pappalardo L, 1998, J MOL BIOL, V282, P801, DOI 10.1006/jmbi.1998.2046; PUGLISI JD, 1992, SCIENCE, V257, P76, DOI 10.1126/science.1621097; Rule GS, 2006, FUNDAMENTALS PROTEIN; Schroeder SJ, 2000, BIOCHEMISTRY-US, V39, P9257, DOI 10.1021/bi000229r; Shajani Z, 2005, J MOL BIOL, V349, P699, DOI 10.1016/j.jmb.2005.04.012; Shajani Z, 2008, BIOCHEMISTRY-US, V47, P7617, DOI 10.1021/bi7020469; Shvadchak VV, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1083; Spriggs S, 2008, BIOCHEMISTRY-US, V47, P13064, DOI 10.1021/bi8014373; Sun XY, 2007, NUCLEIC ACIDS RES, V35, P1698, DOI 10.1093/nar/gkm020; Thomas JA, 2008, VIRUS RES, V134, P39, DOI 10.1016/j.virusres.2007.12.006; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Vo MN, 2006, J MOL BIOL, V363, P244, DOI 10.1016/j.jmb.2006.08.039; Vo MN, 2009, J MOL BIOL, V386, P773, DOI 10.1016/j.jmb.2008.12.073; Vuilleumier C, 1999, BIOCHEMISTRY-US, V38, P16816, DOI 10.1021/bi991145p; Wang H, 2009, J AM CHEM SOC, V131, P15534, DOI 10.1021/ja9070046; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P8266, DOI 10.1021/ja00097a037; Ying JF, 2006, J AM CHEM SOC, V128, P11443, DOI 10.1021/ja061984g; Zargarian L, 2009, NUCLEIC ACIDS RES, V37, P4043, DOI 10.1093/nar/gkp297; Zhang Q, 2006, SCIENCE, V311, P653, DOI 10.1126/science.1119488	66	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38905	10.1371/journal.pone.0038905	http://dx.doi.org/10.1371/journal.pone.0038905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745685	Green Submitted, Green Published, gold			2022-12-27	WOS:000305693200026
J	Moriya, K; Suzuki, M; Watanabe, Y; Takahashi, T; Aoki, Y; Uchiyama, T; Kumaki, S; Sasahara, Y; Minegishi, M; Kure, S; Tsuchiya, S; Sugamura, K; Ishii, N				Moriya, Kunihiko; Suzuki, Makiko; Watanabe, Yohei; Takahashi, Takeshi; Aoki, Yoko; Uchiyama, Toru; Kumaki, Satoru; Sasahara, Yoji; Minegishi, Masayoshi; Kure, Shigeo; Tsuchiya, Shigeru; Sugamura, Kazuo; Ishii, Naoto			Development of a Multi-Step Leukemogenesis Model of MLL-Rearranged Leukemia Using Humanized Mice	PLOS ONE			English	Article							MYELOID PROGENITORS; FLUORESCENT PROTEIN; STEM-CELLS; NOG MICE; HUMAN B; MOUSE; TRANSLOCATIONS; TRANSFORMATION; PROGRESSION; EXPRESSION	Mixed-lineage-leukemia (MLL) fusion oncogenes are intimately involved in acute leukemia and secondary therapy-related acute leukemia. To understand MLL-rearranged leukemia, several murine models for this disease have been established. However, the mouse leukemia derived from mouse hematopoietic stem cells (HSCs) may not be fully comparable with human leukemia. Here we developed a humanized mouse model for human leukemia by transplanting human cord blood-derived HSCs transduced with an MLL-AF10 oncogene into a supra-immunodeficient mouse strain, NOD/Shi-scid, IL-2R gamma(-/-) (NOG) mice. Injection of the MLL-AF10-transduced HSCs into the liver of NOG mice enhanced multilineage hematopoiesis, but did not induce leukemia. Because active mutations in ras genes are often found in MLL-related leukemia, we next transduced the gene for a constitutively active form of K-ras along with the MLL-AF10 oncogene. Eight weeks after transplantation, all the recipient mice had developed acute monoblastic leukemia (the M5 phenotype in French-American-British classification). We thus successfully established a human MLL-rearranged leukemia that was derived in vivo from human HSCs. In addition, since the enforced expression of the mutant K-ras alone was insufficient to induce leukemia, the present model may also be a useful experimental platform for the multi-step leukemogenesis model of human leukemia.	[Moriya, Kunihiko; Suzuki, Makiko; Takahashi, Takeshi; Sugamura, Kazuo; Ishii, Naoto] Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 980, Japan; [Moriya, Kunihiko; Watanabe, Yohei; Uchiyama, Toru; Kumaki, Satoru; Sasahara, Yoji; Kure, Shigeo; Tsuchiya, Shigeru] Tohoku Univ, Grad Sch Med, Dept Pediat, Sendai, Miyagi 980, Japan; [Aoki, Yoko] Tohoku Univ, Grad Sch Med, Dept Med Genet, Sendai, Miyagi 980, Japan; [Takahashi, Takeshi] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan; [Minegishi, Masayoshi] Tohoku Univ Hosp, Div Blood Transfus, Sendai, Miyagi, Japan; [Sugamura, Kazuo] Miyagi Canc Ctr, Natori, Miyagi 9811293, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Miyagi Cancer Center	Moriya, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 980, Japan.	ishiin@med.tohoku.ac.jp		UCHIYAMA, TORU/0000-0001-9610-0900; Ishii, Naoto/0000-0002-0549-8245	Japan Society and Technology Agency [111020001010004100]; Japan Science and Technology Agency; Kato Memorial Bioscience Foundation	Japan Society and Technology Agency; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Kato Memorial Bioscience Foundation	This work was supported in part by a grant-in-aid (#111020001010004100) for scientific research from the Japan Society and Technology Agency, by a grant from Japan Science and Technology Agency, and by a grant from Kato Memorial Bioscience Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Balgobind BV, 2011, LEUKEMIA, V25, P1239, DOI 10.1038/leu.2011.90; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; DiMartino JF, 2002, BLOOD, V99, P3780, DOI 10.1182/blood.V99.10.3780; Forster A, 2003, CANCER CELL, V3, P449, DOI 10.1016/S1535-6108(03)00106-5; Fu JF, 2010, INT J CANCER, V126, P1621, DOI 10.1002/ijc.24867; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Hiramatsu H, 2003, BLOOD, V102, P873, DOI 10.1182/blood-2002-09-2755; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ito M, 2008, CURR TOP MICROBIOL, V324, P53; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Johnson JJ, 2003, BLOOD, V101, P3229, DOI 10.1182/blood-2002-05-1515; Kambe N, 2004, BLOOD, V103, P860, DOI 10.1182/blood-2003-04-1160; Kaneko S, 2001, HUM GENE THER, V12, P35, DOI 10.1089/104303401450942; Kelly LM, 2002, ANNU REV GENOM HUM G, V3, P179, DOI 10.1146/annurev.genom.3.032802.115046; Kennedy JA, 2008, LEUKEMIA, V22, P2029, DOI 10.1038/leu.2008.206; Komeno Y, 2009, J CELL PHYSIOL, V219, P529, DOI 10.1002/jcp.21739; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Liedtke M, 2009, BLOOD, V113, P6061, DOI 10.1182/blood-2008-12-197061; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; McCubrey JA, 2008, LEUKEMIA, V22, P708, DOI 10.1038/leu.2008.27; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; Montes R, 2011, BLOOD, V117, P4746, DOI 10.1182/blood-2010-12-322230; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Ono R, 2009, LEUKEMIA, V23, P2197, DOI 10.1038/leu.2009.177; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rizo A, 2010, BLOOD, V116, P4621, DOI 10.1182/blood-2010-02-270660; Saito Y, 2010, NATURE BIOTECHNOLOGY; Sekine R, 2008, INT J HEMATOL, V87, P351, DOI 10.1007/s12185-008-0082-7; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Stubbs MC, 2008, LEUKEMIA, V22, P66, DOI 10.1038/sj.leu.2404951; Tamai H, 2011, LEUKEMIA, V25, P888, DOI 10.1038/leu.2011.15; Tomizawa D, 2007, LEUKEMIA, V21, P2258, DOI 10.1038/sj.leu.2404903; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020	36	64	65	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e37892	10.1371/journal.pone.0037892	http://dx.doi.org/10.1371/journal.pone.0037892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745659	gold, Green Published, Green Submitted			2022-12-27	WOS:000305693200007
J	Gunton, JE; Sisavanh, M; Stokes, RA; Satin, J; Satin, LS; Zhang, M; Liu, SM; Cai, WK; Cheng, K; Cooney, GJ; Laybutt, DR; So, T; Molero, JC; Grey, ST; Andres, DA; Rolph, MS; Mackay, CR				Gunton, Jenny E.; Sisavanh, Mary; Stokes, Rebecca A.; Satin, Jon; Satin, Leslie S.; Zhang, Min; Liu, Sue M.; Cai, Weikang; Cheng, Kim; Cooney, Gregory J.; Laybutt, D. Ross; So, Trina; Molero, Juan-Carlos; Grey, Shane T.; Andres, Douglas A.; Rolph, Michael S.; Mackay, Charles R.			Mice Deficient in GEM GTPase Show Abnormal Glucose Homeostasis Due to Defects in Beta-Cell Calcium Handling	PLOS ONE			English	Article							INSULIN-SECRETION; CHANNEL ACTIVITY; FUNCTIONAL EXPRESSION; POTASSIUM CHANNEL; BINDING PROTEINS; RAD; DYNAMICS; CLONING; SUBUNIT; ISLETS	Aims and Hypothesis: Glucose-stimulated insulin secretion from beta-cells is a tightly regulated process that requires calcium flux to trigger exocytosis of insulin-containing vesicles. Regulation of calcium handling in beta-cells remains incompletely understood. Gem, a member of the RGK (Rad/Gem/Kir) family regulates calcium channel handling in other cell types, and Gem over-expression inhibits insulin release in insulin-secreting Min6 cells. The aim of this study was to explore the role of Gem in insulin secretion. We hypothesised that Gem may regulate insulin secretion and thus affect glucose tolerance in vivo. Methods: Gem-deficient mice were generated and their metabolic phenotype characterised by in vivo testing of glucose tolerance, insulin tolerance and insulin secretion. Calcium flux was measured in isolated islets. Results: Gem-deficient mice were glucose intolerant and had impaired glucose stimulated insulin secretion. Furthermore, the islets of Gem-deficient mice exhibited decreased free calcium responses to glucose and the calcium oscillations seen upon glucose stimulation were smaller in amplitude and had a reduced frequency. Conclusions: These results suggest that Gem plays an important role in normal beta-cell function by regulation of calcium signalling.	[Gunton, Jenny E.; Stokes, Rebecca A.; Cheng, Kim] Garvan Inst Med Res, Diabet & Transcript Factors Grp, Sydney, NSW, Australia; [Gunton, Jenny E.; Stokes, Rebecca A.; Cheng, Kim] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Gunton, Jenny E.] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia; [Gunton, Jenny E.] Westmead Hosp, Dept Endocrinol & Diabet, Sydney, NSW, Australia; [Sisavanh, Mary; Liu, Sue M.; So, Trina; Grey, Shane T.] Garvan Inst Med Res, Div Immunol, Sydney, NSW, Australia; [Satin, Jon] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY USA; [Satin, Leslie S.; Zhang, Min] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA USA; [Cai, Weikang; Andres, Douglas A.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY USA; [Cooney, Gregory J.; Laybutt, D. Ross; Molero, Juan-Carlos] Garvan Inst Med Res, Div Diabet, Sydney, NSW, Australia; [Rolph, Michael S.] Griffith Univ, Inst Glyc, Brisbane, Qld 4111, Australia; [Mackay, Charles R.] Monash Univ, Dept Immunol, Sch Biomed Sci, Fac Med Nursing & Hlth Serv, Clayton, Vic, Australia; [Satin, Leslie S.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Satin, Leslie S.] Univ Michigan, Sch Med, Brehm Diabet Ctr, Ann Arbor, MI USA	Garvan Institute of Medical Research; University of New South Wales Sydney; University of Sydney; University of Sydney; Garvan Institute of Medical Research; University of Kentucky; Virginia Commonwealth University; University of Kentucky; Garvan Institute of Medical Research; Griffith University; Monash University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gunton, JE (corresponding author), Garvan Inst Med Res, Diabet & Transcript Factors Grp, Sydney, NSW, Australia.	j.gunton@garvan.org.au	Mackay, Charles R/A-9673-2008; Cai, Weikang/K-2394-2019; Grey, Shane T/B-3020-2008; Gunton, Jenny E/AAH-7719-2021	Mackay, Charles R/0000-0002-6338-7340; Grey, Shane T/0000-0003-2160-1625; Liu, Sue Min/0000-0003-1504-1115; Cai, Weikang/0000-0001-5638-0805	Cooperative Research Centre for Asthma (CRC); National Institutes of Health (NIH) [R01 DK46409, R01 HL072936, R01 HL074091]; National Health and Medical Research Council (NHMRC); National Health and Medical Research Council (NHMRC)/Diabetes Australia Research Trust (DART); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072936, R01HL074091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK046409] Funding Source: NIH RePORTER	Cooperative Research Centre for Asthma (CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC)/Diabetes Australia Research Trust (DART)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Cooperative Research Centre for Asthma (CRC) (to CRM), National Institutes of Health (NIH) R01 DK46409 (to LS), R01 HL072936 (to DA and JS), R01 HL074091 (to JS). MR is the recipient of a National Health and Medical Research Council (NHMRC) RD Wright Fellowship. JEG is the recipient of a National Health and Medical Research Council (NHMRC)/The Diabetes Australia Research Trust (DART) Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader MF, 2004, BBA-MOL CELL RES, V1742, P37, DOI 10.1016/j.bbamcr.2004.09.028; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; Chang L, 2007, CIRCULATION, V116, P2976, DOI 10.1161/CIRCULATIONAHA.107.707257; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; Correll RN, 2008, CELL SIGNAL, V20, P292, DOI 10.1016/j.cellsig.2007.10.028; Crump SM, 2006, AM J PHYSIOL-HEART C, V291, pH1959, DOI 10.1152/ajpheart.00956.2005; CURRY DL, 1968, AM J PHYSIOL, V214, P174, DOI 10.1152/ajplegacy.1968.214.1.174; EFRAT S, 1994, TRENDS BIOCHEM SCI, V19, P535, DOI 10.1016/0968-0004(94)90056-6; Finlin BS, 2005, J BIOL CHEM, V280, P41864, DOI 10.1074/jbc.M414261200; Finlin BS, 1997, J BIOL CHEM, V272, P21982, DOI 10.1074/jbc.272.35.21982; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; GERMAN MS, 1993, P NATL ACAD SCI USA, V90, P1781, DOI 10.1073/pnas.90.5.1781; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Jing XJ, 2005, J CLIN INVEST, V115, P146, DOI 10.1172/JCI200522518; Lau SM, 2011, DIABETOLOGIA, V54, P910, DOI 10.1007/s00125-010-1998-z; Leone A, 2001, ONCOGENE, V20, P3217, DOI 10.1038/sj.onc.1204420; Liuwantara D, 2006, DIABETES, V55, P2491, DOI 10.2337/db06-0142; MAGUIRE J, 1994, SCIENCE, V265, P241, DOI 10.1126/science.7912851; Mears D, 2004, J MEMBRANE BIOL, V200, P57, DOI 10.1007/s00232-004-0692-9; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; MISLER S, 1986, P NATL ACAD SCI USA, V83, P7119, DOI 10.1073/pnas.83.18.7119; Nichols CG, 2007, DIABETES OBES METAB, V9, P81, DOI 10.1111/j.1463-1326.2007.00778.x; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Pratley RE, 2001, DIABETOLOGIA, V44, P929, DOI 10.1007/s001250100580; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Safayhi H, 1997, MOL ENDOCRINOL, V11, P619, DOI 10.1210/me.11.5.619; Sakura H, 1995, FEBS LETT, V377, P338, DOI 10.1016/0014-5793(95)01369-5; Sasson Y, 2011, J MOL BIOL; Schuit FC, 2001, DIABETES, V50, P1, DOI 10.2337/diabetes.50.1.1; Schulla V, 2003, EMBO J, V22, P3844, DOI 10.1093/emboj/cdg389; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SEINO S, 1992, P NATL ACAD SCI USA, V89, P584, DOI 10.1073/pnas.89.2.584; Tarasov A, 2004, DIABETES, V53, pS113, DOI 10.2337/diabetes.53.suppl_3.S113; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; THORENS B, 1990, P NATL ACAD SCI USA, V87, P6492, DOI 10.1073/pnas.87.17.6492; Wang G, 2010, CIRC RES, V106, P317, DOI 10.1161/CIRCRESAHA.109.208272; Wang HG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025741; Ward Y, 2004, MOL CELL BIOL, V24, P651, DOI 10.1128/MCB.24.2.651-661.2004; Ward Y, 2002, J CELL BIOL, V157, P291, DOI 10.1083/jcb.200111026; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Zhang M, 2003, BIOPHYS J, V84, P2852, DOI 10.1016/S0006-3495(03)70014-9; Zhang M, 2005, J GEN PHYSIOL, V126, P353, DOI 10.1085/jgp.200509312; Zhang M, 2008, BIOPHYS J, V95, P4676, DOI 10.1529/biophysj.107.125088	45	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39462	10.1371/journal.pone.0039462	http://dx.doi.org/10.1371/journal.pone.0039462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761801	gold, Green Published			2022-12-27	WOS:000305826400016
J	Ma, N; Li, N; He, XS; Sun, DL; Zhang, XC; Zhang, DR				Ma, Ning; Li, Nan; He, Xiao-Song; Sun, De-Lin; Zhang, Xiaochu; Zhang, Da-Ren			Rejection of Unfair Offers Can Be Driven by Negative Emotions, Evidence from Modified Ultimatum Games with Anonymity	PLOS ONE			English	Article							SOCIAL DECISION-MAKING; NEURAL BASIS; COOPERATION; PUNISHMENT; NEUROSCIENCE; FAIRNESS; BEHAVIOR; TRUST; PREFERENCES; COGNITION	The rejection of unfair offers can be affected by both negative emotions (e. g. anger and moral disgust) and deliberate cognitive processing of behavioral consequences (e. g. concerns of maintaining social fairness and protecting personal reputation). However, whether negative emotions are sufficient to motivate this behavior is still controversial. With modified ultimatum games, a recent study (Yamagishi T, et al. (2009) Proc Natl Acad Sci USA 106:11520-11523) found that people reject unfair offers even when this behavior increases inequity, and even when they could not communicate to the proposers. Yamagishi suggested that rejection of unfair offers could occurr without people's concerning of maintaining social fairness, and could be driven by negative emotions. However, as anonymity was not sufficiently guaranteed in Yamagishi's study, the rejection rates in their experiments may have been influenced by people's concerns of protecting personal reputation (reputational concerns) in addition to negative emotions; thus, it was unclear whether the rejection was driven by negative emotions, or by reputational concerns, or both. In the present study, with specific methods to ensure anonymity, the effect of reputational concerns was successfully ruled out. We found that in a private situation in which rejection could not be driven by reputational concerns, the rejection rates of unfair offers were significantly larger than zero, and in public situations in which rejection rates could be influenced by both negative emotions and reputational concerns, rejection rates were significantly higher than that in the private situation. These results, together with Yamagishi's findings, provided more complete evidence suggesting (a) that the rejection of unfair offers can be driven by negative emotions and (b) that deliberate cognitive processing of the consequences of the behavior can increase the rejection rate, which may benefit social cooperation.	[Ma, Ning] Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei 230026, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Ma, N (corresponding author), Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei 230026, Anhui, Peoples R China.	man@ustc.edu.cn; drzhang@ustc.edu.cn	Sun, Delin/A-4154-2010; Sun, Delin/H-8070-2019; Zhang, Xiaochu/AEW-0582-2022; Zhang, Xiaochu/AAG-8768-2022; He, Xiaosong/J-5580-2019; Zhang, Xiaochu/O-9592-2014	Sun, Delin/0000-0003-3283-423X; Sun, Delin/0000-0003-3283-423X; He, Xiaosong/0000-0002-7941-2918; Zhang, Xiaochu/0000-0002-7541-0130	National Nature Science Foundation of China [31000458, 30870764, 91024025]; Fundamental Research Funds for Central Universities of China [WK2070000007]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities of China	This research is supported by the National Nature Science Foundation of China (31000458, 30870764 and 91024025) and the Fundamental Research Funds for the Central Universities of China (WK2070000007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bault N, 2011, P NATL ACAD SCI USA, V108, P16044, DOI 10.1073/pnas.1100892108; Branas-Garza P, 2010, GAME ECON BEHAV, V69, P249, DOI 10.1016/j.geb.2009.10.014; Brosnan SF, 2010, PHILOS T R SOC B, V365, P2699, DOI 10.1098/rstb.2010.0154; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Charness G, 2008, J ECON BEHAV ORGAN, V68, P29, DOI 10.1016/j.jebo.2008.03.001; Clavien C, 2010, ECON PHILOS, V26, P267, DOI 10.1017/S0266267110000374; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Frith CD, 2008, PHILOS T R SOC B, V363, P3875, DOI 10.1098/rstb.2008.0156; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Hashimoto H, 2011, ASIAN J SOC PSYCHOL, V14, P140, DOI 10.1111/j.1467-839X.2010.01337.x; Hoffman E, 1996, AM ECON REV, V86, P653; Jensen K, 2010, PHILOS T R SOC B, V365, P2635, DOI 10.1098/rstb.2010.0146; Klein C, 2010, NEUROETHICS; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Kurzban R, 2007, EVOL HUM BEHAV, V28, P75, DOI 10.1016/j.evolhumbehav.2006.06.001; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; Tabibnia G, 2007, ANN NY ACAD SCI, V1118, P90, DOI 10.1196/annals.1412.001; Tennie C, 2012, BEHAV BRAIN SCI, V35, DOI 10.1017/S0140525X11001336; Xiao E, 2005, P NATL ACAD SCI USA, V102, P7398, DOI 10.1073/pnas.0502399102; Yamagishi T, 2008, PSYCHOL SCI, V19, P579, DOI 10.1111/j.1467-9280.2008.02126.x; Yamagishi T, 2009, P NATL ACAD SCI USA, V106, P11520, DOI 10.1073/pnas.0900636106; Zak PJ, 2006, ECON HUM BIOL, V4, P412, DOI 10.1016/j.ehb.2006.06.004; Zak PJ, 2004, ANN NY ACAD SCI, V1032, P224, DOI 10.1196/annals.1314.025; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009	30	8	9	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39619	10.1371/journal.pone.0039619	http://dx.doi.org/10.1371/journal.pone.0039619			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966GR	22761845	Green Published, Green Submitted, gold			2022-12-27	WOS:000305826400023
J	Yue-Chun, L; Teng, Z; Na-Dan, Z; Li-Sha, G; Qin, L; Xue-Qiang, G; Jia-Feng, L				Yue-Chun, Li; Teng, Zhang; Na-Dan, Zhou; Li-Sha, Ge; Qin, Luo; Xue-Qiang, Guan; Jia-Feng, Lin			Comparison of Effects of Ivabradine versus Carvedilol in Murine Model with the Coxsackievirus B3-Induced Viral Myocarditis	PLOS ONE			English	Article							HEART-RATE REDUCTION; LEFT-VENTRICULAR FUNCTION; NECROSIS-FACTOR-ALPHA; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; BRADYCARDIAC AGENT; BLOOD-FLOW; EXPRESSION; FAILURE; IMPROVES	Background: Elevated heart rate is associated with increased cardiovascular morbidity. The selective I-f current inhibitor ivabradine reduces heart rate without affecting cardiac contractility, and has been shown to be cardioprotective in the failing heart. Ivabradine also exerts some of its beneficial effects by decreasing cardiac proinflammatory cytokines and inhibiting peroxidants and collagen accumulation in atherosclerosis or congestive heart failure. However, the effects of ivabradine in the setting of acute viral myocarditis and on the cytokines, oxidative stress and cardiomyocyte apoptosis have not been investigated. Methodology/Principal Findings: The study was designed to compare the effects of ivabradine and carvedilol in acute viral myocarditis. In a coxsackievirus B3 murine myocarditis model (Balb/c), effects of ivabradine and carvedilol (a nonselective beta-renoceptor antagonist) on myocardial histopathological changes, cardiac function, plasma noradrenaline, cytokine levels, cardiomyocyte apoptosis, malondialdehyde and superoxide dismutase contents were studied. Both ivabradine and carvedilol similarly and significantly reduced heart rate, attenuated myocardial lesions and improved the impairment of left ventricular function. In addition, ivabradine treatment as well as carvedilol treatment showed significant effects on altered myocardial cytokines with a decrease in the amount of plasma noradrenaline. The increased myocardial MCP-1, IL-6, and TNF-alpha. in the infected mice was significantly attenuated in the ivabradine treatment group. Only carvedilol had significant anti-oxidative and anti-apoptoic effects in coxsackievirus B3-infected mice. Conclusions/Significance: These results show that the protective effects of heart rate reduction with ivabradine and carvedilol observed in the acute phase of coxsackievirus B3 murine myocarditis may be due not only to the heart rate reduction itself but also to the downregulation of inflammatory cytokines.	[Yue-Chun, Li; Teng, Zhang; Na-Dan, Zhou; Qin, Luo; Xue-Qiang, Guan; Jia-Feng, Lin] Wenzhou Med Coll, Affiliated Hosp 2, Dept Cardiol, Wenzhou, Peoples R China; [Li-Sha, Ge] Wenzhou Med Coll, Affiliated Hosp 2, Dept Pediat, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Yue-Chun, L (corresponding author), Wenzhou Med Coll, Affiliated Hosp 2, Dept Cardiol, Wenzhou, Peoples R China.	liyuechun1980@sina.com.cn; linjiafeng_wzmcfey@163.com			Nature Science Foundation of Zhejiang Province [Y2100551]; Wenzhou Municipal Science and Technology Commission, China [2008F80011]	Nature Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Wenzhou Municipal Science and Technology Commission, China	This study is supported by Nature Science Foundation of Zhejiang Province (Grant No. Y2100551) and Wenzhou Municipal Science and Technology Commission (Grant No. 2008F80011), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bois P, 1996, BRIT J PHARMACOL, V118, P1051, DOI 10.1111/j.1476-5381.1996.tb15505.x; Busseuil D, 2010, CARDIOLOGY, V117, P234, DOI 10.1159/000322905; Ceconi C, 2011, AM J PHYSIOL-HEART C, V300, pH366, DOI 10.1152/ajpheart.01117.2009; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Colston JT, 1998, CARDIOVASC RES, V38, P158, DOI 10.1016/S0008-6363(97)00323-4; Couvreur N, 2010, EUR HEART J, V31, P1529, DOI 10.1093/eurheartj/ehp554; Custodis F, 2008, CIRCULATION, V117, P2377, DOI 10.1161/CIRCULATIONAHA.107.746537; Custodis F, 2010, J AM COLL CARDIOL, V56, P1973, DOI 10.1016/j.jacc.2010.09.014; Dawson J, 2003, EXPERT OPIN THER TAR, V7, P35; Drouin A, 2008, BRIT J PHARMACOL, V154, P749, DOI 10.1038/bjp.2008.116; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Feuerstein GZ, 1997, DRUG TODAY, V33, P453, DOI 10.1358/dot.1997.33.7.442004; HARRIS TJ, 1995, J AM COLL CARDIOL, V26, P102, DOI 10.1016/0735-1097(95)00123-H; Heusch G, 2008, BRIT J PHARMACOL, V153, P1589, DOI 10.1038/sj.bjp.0707673; Heusch G, 2008, BRIT J PHARMACOL, V155, P970, DOI 10.1038/bjp.2008.347; Heusch G, 2008, EUR HEART J, V29, P2265, DOI 10.1093/eurheartj/ehn337; Kapadia S R, 1999, Cardiol Rev, V7, P196, DOI 10.1097/00045415-199907000-00011; Kaya Z, 2011, CARDIOVASC RES, V91, P116, DOI 10.1093/cvr/cvr063; Kolattukudy PE, 1998, AM J PATHOL, V152, P101; Kroller-Schon S, 2011, BASIC RES CARDIOL, V106, P1147, DOI 10.1007/s00395-011-0227-3; Li YC, 2008, J CARDIOVASC PHARM, V51, P92, DOI 10.1097/FJC.0b013e31815c6624; Li YC, 2012, CURR PHARM DESIGN, V18, P1620; Metra M, 2005, EUR HEART J, V26, P2259, DOI 10.1093/eurheartj/ehi386; Mulder P, 2004, CIRCULATION, V109, P1674, DOI 10.1161/01.CIR.0000118464.48959.1C; Muller-Werdan U, 1999, EUR HEART J SUPPL, V20, pP1721; Nishio R, 2003, J AM COLL CARDIOL, V41, P340, DOI 10.1016/S0735-1097(02)02711-0; Opasich C, 2001, AM J CARDIOL, V88, P382, DOI 10.1016/S0002-9149(01)01683-6; Pauschinger M, 2005, EUR J HEART FAIL, V7, P444, DOI 10.1016/j.ejheart.2004.07.002; Pauschinger M, 1999, CIRCULATION, V99, P889, DOI 10.1161/01.CIR.99.7.889; Sajadieh A, 2004, EUR HEART J, V25, P363, DOI 10.1016/j.ehj.2003.12.003; Saraste A, 2003, CARDIOVASC PATHOL, V12, P255, DOI 10.1016/S1054-8807(03)00077-2; Satoh M, 2000, J AM COLL CARDIOL, V36, P1288, DOI 10.1016/S0735-1097(00)00827-5; Schirmer SH, 2012, EUR HEART J, V33, P1223, DOI 10.1093/eurheartj/ehr255; Seko Y, 1997, J PATHOL, V183, P105; Shioi T, 1996, CIRCULATION, V94, P2930, DOI 10.1161/01.CIR.94.11.2930; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Tanaka T, 2001, J MOL CELL CARDIOL, V33, P1627, DOI 10.1006/jmcc.2001.1428; Tardif JC, 2011, EUR HEART J, V32, P2507, DOI 10.1093/eurheartj/ehr311; Ulu N, 2009, J CARDIOVASC PHARM, V53, P9, DOI 10.1097/FJC.0b013e318193dfce; vanderPoll T, 1996, J CLIN INVEST, V97, P713, DOI 10.1172/JCI118469; WRIGHT AJA, 1981, CIRC RES, V49, P469, DOI 10.1161/01.RES.49.2.469; Yue-chun L, 2010, EUR J PHARMACOL, V640, P112; Zheng W, 1999, CIRC RES, V85, P192, DOI 10.1161/01.RES.85.2.192	43	54	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39394	10.1371/journal.pone.0039394	http://dx.doi.org/10.1371/journal.pone.0039394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761780	Green Published, gold, Green Submitted			2022-12-27	WOS:000305826400015
J	Ahmed, EA; Agay, D; Schrock, G; Drouet, M; Meineke, V; Scherthan, H				Ahmed, Emad A.; Agay, Diane; Schrock, Gerrit; Drouet, Michel; Meineke, Viktor; Scherthan, Harry			Persistent DNA Damage after High Dose In Vivo Gamma Exposure of Minipig Skin	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; NORMAL-TISSUES; HUMAN-CELLS; X-RAYS; H2AX PHOSPHORYLATION; IONIZING-RADIATION; HISTONE H2AX; REPAIR; APOPTOSIS; SINGLE	Background: Exposure to high doses of ionizing radiation (IR) can lead to localized radiation injury of the skin and exposed cells suffer dsDNA breaks that may elicit cell death or stochastic changes. Little is known about the DNA damage response after high-dose exposure of the skin. Here, we investigate the cellular and DNA damage response in acutely irradiated minipig skin. Methods and Findings: IR-induced DNA damage, repair and cellular survival were studied in 15 cm(2) of minipig skin exposed in vivo to similar to 50 Co-60 gamma rays. Skin biopsies of control and 4 h up to 96 days post exposure were investigated for radiation-induced foci (RIF) formation using gamma-H2AX, 53BP1, and active ATM-p immunofluorescence. High-dose IR induced massive gamma-H2AX phosphorylation and high 53BP1 RIF numbers 4 h, 20 h after IR. As time progressed RIF numbers dropped to a low of <1% of keratinocytes at 28-70 days. The latter contained large RIFs that included ATM-p, indicating the accumulation of complex DNA damage. At 96 days most of the cells with RIFs had disappeared. The frequency of active-caspase-3-positive apoptotic cells was 17-fold increased 3 days after IR and remained >3-fold elevated at all subsequent time points. Replicating basal cells (Ki67+) were reduced 3 days post IR followed by increased proliferation and recovery of epidermal cellularity after 28 days. Conclusions: Acute high dose irradiation of minipig epidermis impaired stem cell replication and induced elevated apoptosis from 3 days onward. DNA repair cleared the high numbers of DBSs in skin cells, while RIFs that persisted in <1% cells marked complex and potentially lethal DNA damage up to several weeks after exposure. An elevated frequency of keratinocytes with persistent RIFs may thus serve as indicator of previous acute radiation exposure, which may be useful in the follow up of nuclear or radiological accident scenarios.	[Ahmed, Emad A.; Schrock, Gerrit; Meineke, Viktor; Scherthan, Harry] Univ Ulm, Inst Radiobiol Bundeswehr Verbindung, Munich, Germany; [Agay, Diane; Drouet, Michel] IRBA Antenne La Tronche CRSSA, La Tronche, France	Ulm University	Ahmed, EA (corresponding author), Univ Ulm, Inst Radiobiol Bundeswehr Verbindung, Munich, Germany.	scherth@web.de	Ahmed, Emad A/ABD-6691-2021; Ahmed, Emad/O-9188-2016	Ahmed, Emad A/0000-0002-5289-2966; Ahmed, Emad/0000-0002-5289-2966	Alexander-von-Humboldt Foundation; European Union [241536]	Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation); European Union(European Commission)	Alexander-von-Humboldt Foundation supported E. A. Ahmed with a stipend. H. Scherthan acknowledges partial support from the European Union's Seventh Framework Programme (FP7/2007-2013)under grant agreement nu 241536. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agay D, 2010, EXP HEMATOL, V38, P945, DOI 10.1016/j.exphem.2010.06.008; ALBARWARI SE, 1976, INT J RADIAT BIOL, V30, P201, DOI 10.1080/09553007614550981; ARCHAMBEAU JO, 1979, RADIAT RES, V79, P298, DOI 10.2307/3575099; Asaithamby A, 2011, P NATL ACAD SCI USA, V108, P8293, DOI 10.1073/pnas.1016045108; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Balter S, 2010, RADIOLOGY, V254, P326, DOI 10.1148/radiol.2542082312; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bhogal N, 2010, RADIAT RES, V173, P1, DOI 10.1667/RR1851.1; Bhogal N, 2009, INT J RADIAT BIOL, V85, P732, DOI 10.1080/09553000902785791; Bolderston A, 2006, SUPPORT CARE CANCER, V14, P802, DOI 10.1007/s00520-006-0063-4; Bouquet F, 2006, CELL CYCLE, V5, P1116, DOI 10.4161/cc.5.10.2799; BRENNER DJ, 1992, INT J RADIAT BIOL, V61, P737, DOI 10.1080/09553009214551591; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Chua MLK, 2011, RADIOTHER ONCOL, V99, P225, DOI 10.1016/j.radonc.2011.04.009; Costes SV, 2010, MUTAT RES-REV MUTAT, V704, P78, DOI 10.1016/j.mrrev.2009.12.006; Costes SV, 2006, RADIAT RES, V165, P505, DOI 10.1667/RR3538.1; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; Foray N, 1999, INT J RADIAT BIOL, V75, P1589, DOI 10.1080/095530099139197; Forcheron F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031694; Forrester HB, 2000, RADIAT RES, V154, P625, DOI 10.1667/0033-7587(2000)154[0625:CVTLAO]2.0.CO;2; Gagou ME, 2010, MOL BIOL CELL, V21, P739, DOI 10.1091/mbc.E09-07-0618; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GOLD R, 1994, LAB INVEST, V71, P219; Greubel C, 2008, RADIAT ENVIRON BIOPH, V47, P423, DOI 10.1007/s00411-008-0182-z; Grigaitiene J, 2007, MED LITH, V43, P301, DOI 10.3390/medicina43040037; Harding SM, 2011, RADIOTHER ONCOL, V99, P307, DOI 10.1016/j.radonc.2011.05.039; HENDRY JH, 1980, RADIAT RES, V84, P87, DOI 10.2307/3575220; Jeggo P, 2006, RADIAT PROT DOSIM, V122, P124, DOI 10.1093/rpd/ncl495; Lataillade JJ, 2007, REGEN MED, V2, P785, DOI 10.2217/17460751.2.5.785; Lippens S, 2005, CELL DEATH DIFFER, V12, P1497, DOI 10.1038/sj.cdd.4401722; Lippens S, 2000, CELL DEATH DIFFER, V7, P1218, DOI 10.1038/sj.cdd.4400785; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Liu SK, 2008, CANCER METAST REV, V27, P445, DOI 10.1007/s10555-008-9137-8; Mahl JA, 2006, EXP TOXICOL PATHOL, V57, P341, DOI 10.1016/j.etp.2006.03.004; Meineke V, 2005, BJR S, V27, P85; Moon SH, 2010, CELL CYCLE, V9, P2092, DOI 10.4161/cc.9.11.11810; MORRIS GM, 1988, BRIT J RADIOL, V61, P205, DOI 10.1259/0007-1285-61-723-205; MORRIS GM, 1989, BRIT J RADIOL, V62, P41, DOI 10.1259/0007-1285-62-733-41; Nakamura K, 2006, DNA REPAIR, V5, P741, DOI 10.1016/j.dnarep.2006.03.008; Nenot JC, 2009, J RADIOL PROT, V29, P301, DOI 10.1088/0952-4746/29/3/R01; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Olive PL, 2011, RADIOTHER ONCOL, V101, P18, DOI 10.1016/j.radonc.2011.05.055; Qvarnstrom OF, 2004, RADIOTHER ONCOL, V72, P311, DOI 10.1016/j.radonc.2004.07.009; Redon CE, 2009, ADV SPACE RES, V43, P1171, DOI 10.1016/j.asr.2008.10.011; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roos WP, 2012, CANC LETT; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rovee D.T., 1972, EPIDERMAL WOUND HEAL, P71; Rube CE, 2008, INT J RADIAT ONCOL, V72, P1180, DOI 10.1016/j.ijrobp.2008.07.017; Rube CE, 2010, INT J RADIAT ONCOL, V76, P1206, DOI 10.1016/j.ijrobp.2009.10.009; Scherthan H, 2008, BIOCHEM BIOPH RES CO, V371, P694, DOI 10.1016/j.bbrc.2008.04.127; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Simonsson M, 2008, RADIOTHER ONCOL, V88, P388, DOI 10.1016/j.radonc.2008.04.017; Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059; Suzuki K, 2010, RADIAT RES, V174, P415, DOI 10.1667/RR2007.1; Svetlova MP, 2010, MUTAT RES-FUND MOL M, V685, P54, DOI 10.1016/j.mrfmmm.2009.08.001; VANDENAARDWEG GJMJ, 1990, RADIAT RES, V124, P283, DOI 10.2307/3577840; WARD JF, 1991, BASIC LIFE SCI, V58, P403	61	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39521	10.1371/journal.pone.0039521	http://dx.doi.org/10.1371/journal.pone.0039521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761813	gold, Green Submitted, Green Published			2022-12-27	WOS:000305825800041
J	Li, L; Gu, Y; Liu, T; Bai, YP; Hou, LB; Cheng, Z; Hu, LQ; Gao, B				Li, Lun; Gu, Ye; Liu, Tao; Bai, Yupeng; Hou, Lingbo; Cheng, Zhong; Hu, Liqun; Gao, Bo			A Randomized, Single-Center Double-Blinded Trial on the Effects of Diltiazem Sustained-Release Capsules in Patients with Coronary Slow Flow Phenomenon at 6-Month Follow-Up	PLOS ONE			English	Article							BLOOD-FLOW; RESERVE; ARTERIES; ANGINA	Objective: The aim of this study is to observe the chronic effects of diltiazem release capsules on patients with coronary slow flow (CSF) phenomenon. Methods: From 2004 to 2009, 80 consecutive patients with chest pain and normal coronary arteries evidenced by coronary angiography and CSF were included in this randomized, double-blind, placebo-controlled trial. CSF patterns were evaluated by the corrected TIMI frame count. Patients were randomly assigned at 1:1 ratio to diltiazem sustained-release capsules treatment group (Dil, 90 mg twice daily) or placebo control group. Holter, liver and kidney function, treadmill exercise test, coronary angiography and left ventricular angiography were measured at baseline and after 6 months. The incidence of cardiovascular events (re-admission or progress in coronary heart disease, myocardial infarction, malignant arrhythmia or cardiac death) was evaluated during the 6 months follow up. Results: Thirty-nine patients in control and 40 patients in Dil group completed the 6 months follow-up. There was no medication induced drug withdraw during follow up. Left ventricular ejection fraction was similar between the 2 groups at baseline and during follow up. Heart rate was significantly lower in Dil group than in control group and there was no symptomatic bradycardia and II and III degree atrioventricular conduction block in both groups. Significant improvement was observed in the onset of chest pain, treadmill exercise test and coronary blood flow in Dil group while these parameters remained unchanged in control group at the end of 6 months follow up. The incidence of cardiovascular events was similar between the two groups. Conclusion: Diltiazem slow-release capsules improved coronary blood flow and alleviated angina in patients with CSF.	[Li, Lun; Gu, Ye; Liu, Tao; Bai, Yupeng; Hou, Lingbo; Cheng, Zhong; Hu, Liqun; Gao, Bo] Huazhong Univ Sci & Technol, Wuhan Puai Hosp, Dept Cardiol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Li, L (corresponding author), Huazhong Univ Sci & Technol, Wuhan Puai Hosp, Dept Cardiol, Wuhan 430074, Peoples R China.	yegu2003cn@163.com		Li, Mingzhou/0000-0001-8681-7684	Puai Hospital, Huazhong University of Science and Technology	Puai Hospital, Huazhong University of Science and Technology	The funding was provided by Puai Hospital, Huazhong University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltrame JF, 2004, J AM COLL CARDIOL, V44, P57, DOI 10.1016/j.jacc.2004.03.055; Beltrame JF, 2003, AM HEART J, V146, P84, DOI 10.1016/S0002-8703(03)00124-8; Beltrame JF, 2002, CARDIOLOGY, V97, P197, DOI 10.1159/000063121; Ellestad M.H., 1986, J OCCUP ENVIRON MED, V28, P1142; Fineschi M, 2008, INT J CARDIOL, V127, P358, DOI 10.1016/j.ijcard.2007.06.010; Gibson CM, 1996, CIRCULATION, V93, P879, DOI 10.1161/01.CIR.93.5.879; Konidala S, 2004, PROG CARDIOVASC DIS, V46, P349, DOI 10.1016/j.pcad.2003.10.001; Mangieri E, 1996, CATHETER CARDIO DIAG, V37, P375, DOI 10.1002/(SICI)1097-0304(199604)37:4<375::AID-CCD7>3.0.CO;2-8; Mangieri E, 2006, J CARDIOVASC MED, V7, P322, DOI 10.2459/01.JCM.0000223253.16686.4d; MCIVOR ME, 1995, CATHETER CARDIO DIAG, V35, P287; Rim SJ, 2001, CIRCULATION, V104, P2704, DOI 10.1161/hc4701.099580; Sadamatsu K, 2007, INTERNAL MED, V46, P1991, DOI 10.2169/internalmedicine.46.0355; Shirani S, 2009, CARDIOL J, V16, P146; Sutsch G, 1995, INT J CARDIOL, V52, P135, DOI 10.1016/0167-5273(95)02458-9; TAMBE AA, 1972, AM HEART J, V84, P66, DOI 10.1016/0002-8703(72)90307-9; Wang X, 2010, MED HYPOTHESES, V75, P334, DOI 10.1016/j.mehy.2010.03.016; Werner GS, 2002, CATHETER CARDIO INTE, V57, P444, DOI 10.1002/ccd.10375; Zheng Zhao-fen, 2006, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V31, P917	18	30	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e38851	10.1371/journal.pone.0038851	http://dx.doi.org/10.1371/journal.pone.0038851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761709	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800015
J	Lingua, G; Bona, E; Todeschini, V; Cattaneo, C; Marsano, F; Berta, G; Cavaletto, M				Lingua, Guido; Bona, Elisa; Todeschini, Valeria; Cattaneo, Chiara; Marsano, Francesco; Berta, Graziella; Cavaletto, Maria			Effects of Heavy Metals and Arbuscular Mycorrhiza on the Leaf Proteome of a Selected Poplar Clone: A Time Course Analysis	PLOS ONE			English	Article							POPULUS-ALBA; MOLECULAR-PROPERTIES; CONTAMINATED SOILS; MASS-SPECTROMETRY; PLANT-RESPONSES; STRESS-RESPONSE; ZINC; PROTEINS; RICE; CADMIUM	Arbuscular mycorrhizal (AM) fungi establish a mutualistic symbiosis with the roots of most plant species. While receiving photosynthates, they improve the mineral nutrition of the plant and can also increase its tolerance towards some pollutants, like heavy metals. Although the fungal symbionts exclusively colonize the plant roots, some plant responses can be systemic. Therefore, in this work a clone of Populus alba L., previously selected for its tolerance to copper and zinc, was used to investigate the effects of the symbiosis with the AM fungus Glomus intraradices on the leaf protein expression. Poplar leaf samples were collected from plants maintained in a glasshouse on polluted (copper and zinc contaminated) or unpolluted soil, after four, six and sixteen months of growth. For each harvest, about 450 proteins were reproducibly separated on 2DE maps. At the first harvest the most relevant effect on protein modulation was exerted by the AM fungi, at the second one by the metals, and at the last one by both treatments. This work demonstrates how importantly the time of sampling affects the proteome responses in perennial plants. In addition, it underlines the ability of a proteomic approach, targeted on protein identification, to depict changes in a specific pattern of protein expression, while being still far from elucidating the biological function of each protein.	[Lingua, Guido; Bona, Elisa; Todeschini, Valeria; Cattaneo, Chiara; Marsano, Francesco; Berta, Graziella; Cavaletto, Maria] Univ Piemonte Orientale, Dipartimento Sci & Innovaz Tecnol, Alessandria, Italy	University of Eastern Piedmont Amedeo Avogadro	Lingua, G (corresponding author), Univ Piemonte Orientale, Dipartimento Sci & Innovaz Tecnol, Alessandria, Italy.	guido.lingua@mfn.unipmn.it	Bona, Elisa/K-2073-2019; Cavaletto, Maria/K-3500-2018; Lingua, Guido/H-9324-2019; Todeschini, Valeria/I-8437-2019; Marsano, Francesco/E-6144-2010	Bona, Elisa/0000-0002-4320-1203; Cavaletto, Maria/0000-0002-8511-161X; Lingua, Guido/0000-0003-3157-4376; Marsano, Francesco/0000-0001-9471-4693; cattaneo, chiara/0000-0001-5637-8967; TODESCHINI, Valeria/0000-0002-4202-9050	Italian Ministry for Education, University and Research [PRIN 2005055337]	Italian Ministry for Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by funds from the Italian Ministry for Education, University and Research (PRIN 2005055337). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn IP, 2005, PLANT PHYSIOL, V138, P1505, DOI 10.1104/pp.104.058693; Ahsan N, 2009, PROTEOMICS, V9, P2602, DOI 10.1002/pmic.200800935; Anicic M, 2011, ECOL INDIC, V11, P824, DOI 10.1016/j.ecolind.2010.10.009; Balestrazzi A, 2009, PLANT CELL REP, V28, P1179, DOI 10.1007/s00299-009-0719-x; BAO W, 1993, SCIENCE, V260, P672, DOI 10.1126/science.260.5108.672; Bohler S, 2007, PROTEOMICS, V7, P1584, DOI 10.1002/pmic.200600822; Bona E, 2007, PROTEOMICS, V7, P1121, DOI 10.1002/pmic.200600712; Bona E, 2011, J PROTEOMICS, V74, P1338, DOI 10.1016/j.jprot.2011.03.027; Bona E, 2010, PROTEOMICS, V10, P3811, DOI 10.1002/pmic.200900436; Bonhomme L, 2009, PROTEOMICS, V9, P4121, DOI 10.1002/pmic.200900047; Borghi M, 2008, ENVIRON EXP BOT, V62, P290, DOI 10.1016/j.envexpbot.2007.10.001; Bothe H, 2010, MYCORRHIZA, V20, P445, DOI 10.1007/s00572-010-0332-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briat JF, 1999, CELL MOL LIFE SCI, V56, P155, DOI 10.1007/s000180050014; BROWN MS, 1993, NATURE, V366, P14, DOI 10.1038/366014a0; Camara B, 2008, BIOCHEM BIOPH RES CO, V376, P423, DOI 10.1016/j.bbrc.2008.09.006; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Castiglione S, 2009, ENVIRON POLLUT, V157, P2108, DOI 10.1016/j.envpol.2009.02.011; Castiglione S, 2007, CHEMOSPHERE, V67, P1117, DOI 10.1016/j.chemosphere.2006.11.039; Chien HF, 2001, PLANT GROWTH REGUL, V33, P205, DOI 10.1023/A:1017539616793; Cicatelli A, 2012, ENVIRON EXP BOT, V75, P25, DOI 10.1016/j.envexpbot.2011.08.012; Cicatelli A, 2010, ANN BOT-LONDON, V106, P791, DOI 10.1093/aob/mcq170; Clijsters H, 2000, STRUCTURE FUNCTION P, P299; Cornish-Bowden A, 2007, PROTEOMICS, V7, P839, DOI 10.1002/pmic.200600431; Cosio C, 2004, PLANT PHYSIOL, V134, P716, DOI 10.1104/pp.103.031948; Cui SX, 2005, PROTEOMICS, V5, P3162, DOI 10.1002/pmic.200401148; Davies FT, 2001, J PLANT PHYSIOL, V158, P777, DOI 10.1078/0176-1617-00311; Di Baccio D, 2003, NEW PHYTOL, V159, P443, DOI 10.1046/j.1469-8137.2003.00818.x; Di Baccio D, 2009, ENVIRON EXP BOT, V67, P153, DOI 10.1016/j.envexpbot.2009.05.014; Durand TC, 2010, PROTEOMICS, V10, P349, DOI 10.1002/pmic.200900484; Faison BD, 2004, SOIL BIOL, V1, P81; Ferreira S, 2006, ANN BOT-LONDON, V98, P361, DOI 10.1093/aob/mcl106; Franchin C, 2007, PHYSIOL PLANTARUM, V130, P77, DOI 10.1111/j.1399-3054.2007.00886.x; Gamalero E, 2009, CAN J MICROBIOL, V55, P501, DOI [10.1139/W09-010, 10.1139/w09-010]; GRAY JC, 1987, ADV BOT RES, V14, P25; Guerra F, 2009, ENVIRON EXP BOT, V67, P335, DOI 10.1016/j.envexpbot.2009.08.004; Hajduch M, 2001, ELECTROPHORESIS, V22, P2824, DOI 10.1002/1522-2683(200108)22:13&lt;2824::AID-ELPS2824&gt;3.0.CO;2-C; Hanson AD, 2000, TRENDS PLANT SCI, V5, P206, DOI 10.1016/S1360-1385(00)01599-5; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hohmann S, 1998, BBA-PROTEIN STRUCT M, V1385, P201, DOI 10.1016/S0167-4838(98)00069-7; Jamal A, 2002, INT J PHYTOREMEDIAT, V4, P205, DOI 10.1080/15226510208500083; Ke YQ, 2009, BIOCHEM BIOPH RES CO, V379, P133, DOI 10.1016/j.bbrc.2008.12.067; Ker K, 2010, MYCORRHIZA, V20, P399, DOI 10.1007/s00572-009-0293-7; Khan AG, 2001, ENVIRON INT, V26, P417, DOI 10.1016/S0160-4120(01)00022-8; Kieffer P, 2008, PROTEOMICS, V8, P2514, DOI 10.1002/pmic.200701110; Kieffer P, 2009, J PROTEOME RES, V8, P400, DOI 10.1021/pr800561r; Kieffer P, 2009, J PROTEOMICS, V72, P379, DOI 10.1016/j.jprot.2009.01.014; Kohler A, 2004, NEW PHYTOL, V164, P83, DOI 10.1111/j.1469-8137.2004.01168.x; Latef AAHA, 2011, MYCORRHIZA, V21, P495, DOI 10.1007/s00572-010-0360-0; Laureysens I, 2004, ENVIRON POLLUT, V131, P485, DOI 10.1016/j.envpol.2004.02.009; Lebeau T, 2008, ENVIRON POLLUT, V153, P497, DOI 10.1016/j.envpol.2007.09.015; Lequeux H, 2010, PLANT PHYSIOL BIOCH, V48, P673, DOI 10.1016/j.plaphy.2010.05.005; Lingua G, 2008, ENVIRON POLLUT, V153, P137, DOI 10.1016/j.envpol.2007.07.012; Macek T, 2004, SOIL BIOL, V1, P135; Malerba M, 2010, PROTOPLASMA, V239, P23, DOI 10.1007/s00709-009-0078-z; Marri L, 2009, MOL PLANT, V2, P259, DOI 10.1093/mp/ssn061; Martinez MC, 1996, EUR J BIOCHEM, V241, P849, DOI 10.1111/j.1432-1033.1996.00849.x; McDougall GJ, 1996, HOLZFORSCHUNG, V50, P549, DOI 10.1515/hfsg.1996.50.6.549; Mohanty S, 2006, PLANTA, V224, P692, DOI 10.1007/s00425-006-0248-6; Okada K, 2000, PLANT PHYSIOL, V122, P1045, DOI 10.1104/pp.122.4.1045; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pilon-Smits E, 2005, ANNU REV PLANT BIOL, V56, P15, DOI 10.1146/annurev.arplant.56.032604.144214; Plomion C, 2006, PROTEOMICS, V6, P6509, DOI 10.1002/pmic.200600362; Pulford ID, 2003, ENVIRON INT, V29, P529, DOI 10.1016/S0160-4120(02)00152-6; Punamiya P, 2010, J HAZARD MATER, V177, P465, DOI 10.1016/j.jhazmat.2009.12.056; Quemeneur M, 2010, APPL ENVIRON MICROB, V76, P4566, DOI 10.1128/AEM.03104-09; Quoreshi AM, 2008, BIOMASS BIOENERG, V32, P381, DOI 10.1016/j.biombioe.2007.10.010; R Development Core Team, R LANG ENV STAT COMP; Ranocha P, 2002, PLANT PHYSIOL, V129, P145, DOI 10.1104/pp.010988; Redon PO, 2009, MYCORRHIZA, V19, P187, DOI 10.1007/s00572-009-0230-9; Ribeiro DT, 2005, J EXP BOT, V56, P1797, DOI 10.1093/jxb/eri168; Sayed SA, 2002, PLANT GROWTH REGUL, V36, P71, DOI 10.1023/A:1014784831387; Scafaro AP, 2010, J EXP BOT, V61, P191, DOI 10.1093/jxb/erp294; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Singh S, 2010, ECOTOX ENVIRON SAFE, V73, P1975, DOI 10.1016/j.ecoenv.2010.08.020; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Song J, 2006, PLANT CELL, V18, P2258, DOI 10.1105/tpc.105.039123; Sparvoli R, 2000, PLANT J, V24, P825, DOI 10.1046/j.1365-313x.2000.00933.x; Srividhya J, 2007, PROTEOMICS, V7, P828, DOI 10.1002/pmic.200600428; Takacs D, 2005, Z NATURFORSCH C, V60, P357; THURSTON CF, 1994, MICROBIOL-SGM, V140, P19, DOI 10.1099/13500872-140-1-19; Timperio AM, 2008, J PROTEOMICS, V71, P391, DOI 10.1016/j.jprot.2008.07.005; Todeschini V, 2011, ENVIRON EXP BOT, V71, P50, DOI 10.1016/j.envexpbot.2010.10.018; Trotta A, 1996, PLANT SOIL, V185, P199, DOI 10.1007/BF02257525; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; Turnau K, 2008, PLANT SOIL, V305, P267, DOI 10.1007/s11104-008-9563-y; Turnau K, 2005, TRACE ELEMENTS ENV B, P235, DOI DOI 10.1201/9781420032048.CH13; UOTILA L, 1979, ARCH BIOCHEM BIOPHYS, V196, P33, DOI 10.1016/0003-9861(79)90548-4; Valcu CM, 2006, PROTEOMICS, V6, P4166, DOI 10.1002/pmic.200500660; Valente MAS, 2009, J EXP BOT, V60, P533, DOI 10.1093/jxb/ern296; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Wang GN, 2006, PLANT MOL BIOL, V60, P437, DOI 10.1007/s11103-005-4770-x; Wang ZW, 2011, J SCI FOOD AGR, V91, P377, DOI 10.1002/jsfa.4196; Yan SP, 2005, PROTEOMICS, V5, P235, DOI 10.1002/pmic.200400853; Zancani M, 2004, EUR J BIOCHEM, V271, P3657, DOI 10.1111/j.1432-1033.2004.04300.x; Zhang DH, 2005, MOL CELL PROTEOMICS, V4, P1686, DOI 10.1074/mcp.M400221-MCP200; Zhang O, 2004, PROTEOMICS, V4, P2058, DOI 10.1002/pmic.200300733; Zhao FJ, 2000, PLANT CELL ENVIRON, V23, P507, DOI 10.1046/j.1365-3040.2000.00569.x	99	54	58	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e38662	10.1371/journal.pone.0038662	http://dx.doi.org/10.1371/journal.pone.0038662			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761694	Green Submitted, Green Published, gold			2022-12-27	WOS:000305808700008
J	Wane, J; Nyatanyi, T; Nkunda, R; Rukelibuga, J; Ahmed, Z; Biedron, C; Kabeja, A; Muhimpundu, MA; Kabanda, A; Antara, S; Briet, O; Koama, JB; Rusanganwa, A; Mukabayire, O; Karema, C; Raghunathan, P; Lowrance, D				Wane, Justin; Nyatanyi, Thierry; Nkunda, Richard; Rukelibuga, Joseph; Ahmed, Zara; Biedron, Caitlin; Kabeja, Adeline; Muhimpundu, Marie Aimee; Kabanda, Alice; Antara, Simon; Briet, Olivier; Koama, Jean Baptiste; Rusanganwa, Andre; Mukabayire, Odette; Karema, Corine; Raghunathan, Pratima; Lowrance, David			2009 Pandemic Influenza A (H1N1) Virus Outbreak and Response - Rwanda, October, 2009-May, 2010	PLOS ONE			English	Article							INFECTIONS; AFRICA; APRIL	Background: In October 2009, the first case of pandemic influenza A(H1N1) pdm09 (pH1N1) was confirmed in Kigali, Rwanda and countrywide dissemination occurred within several weeks. We describe clinical and epidemiological characteristics of this epidemic. Methods: From October 2009 through May 2010, we undertook epidemiologic investigations and response to pH1N1. Respiratory specimens were collected from all patients meeting the WHO case definition for pH1N1, which were tested using CDC's real time RT-PCR protocol at the Rwandan National Reference Laboratory (NRL). Following documented viral transmission in the community, testing focused on clinically severe and high-risk group suspect cases. Results: From October 9, 2009 through May 31, 2010, NRL tested 2,045 specimens. In total, 26% (n = 532) of specimens tested influenza positive; of these 96% (n = 510) were influenza A and 4% (n = 22) were influenza B. Of cases testing influenza A positive, 96.8% (n = 494), 3% (n = 15), and 0.2% (n = 1) were A(H1N1) pdm09, Seasonal A(H3) and Seasonal A(non-subtyped), respectively. Among laboratory-confirmed cases, 263 (53.2%) were children <15 years and 275 (52%) were female. In total, 58 (12%) cases were hospitalized with mean duration of hospitalization of 5 days (Range: 2-15 days). All cases recovered and there were no deaths. Overall, 339 (68%) confirmed cases received oseltamivir in any setting. Among all positive cases, 26.9% (143/532) were among groups known to be at high risk of influenza-associated complications, including age <5 years 23% (122/532), asthma 0.8% (4/532), cardiac disease 1.5% (8/532), pregnancy 0.6% (3/532), diabetes mellitus 0.4% (2/532), and chronic malnutrition 0.8% (4/532). Conclusions: Rwanda experienced a PH1N1 outbreak which was epidemiologically similar to PH1N1 outbreaks in the region. Unlike seasonal influenza, children <15 years were the most affected by pH1N1. Lessons learned from the outbreak response included the need to strengthen integrated disease surveillance, develop laboratory contingency plans, and evaluate the influenza sentinel surveillance system.	[Wane, Justin] King Faisal Hosp, Kigali, Rwanda; [Nyatanyi, Thierry; Kabeja, Adeline; Muhimpundu, Marie Aimee; Briet, Olivier; Karema, Corine] Minist Hlth, Ctr Treatment & Res HIV AIDS Malaria TB & Other E, Kigali, Rwanda; [Nkunda, Richard; Kabanda, Alice; Mukabayire, Odette] Natl Reference Lab, Kigali, Rwanda; [Rukelibuga, Joseph] Ctr Dis Control & Prevent CDC, Influenza Div, Kigali, Rwanda; [Ahmed, Zara; Biedron, Caitlin; Koama, Jean Baptiste; Raghunathan, Pratima; Lowrance, David] Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Kigali, Rwanda; [Antara, Simon] African Field Epidemiol Network, Kigali, Rwanda; [Rusanganwa, Andre] WHO, Kigali, Rwanda	World Health Organization	Wane, J (corresponding author), King Faisal Hosp, Kigali, Rwanda.	lowranced@na.cdc.gov	; Briet, Olivier/K-1917-2015	NYATANYI, Thierry/0000-0003-2300-0479; Briet, Olivier/0000-0003-1186-2688				[Anonymous], 2010, PAND H1N1 2009 UPDAT; Archer BN, 2009, EUROSURVEILLANCE, V14, P11; Breiman RF, 2007, EMERG INFECT DIS, V13, P1453, DOI 10.3201/eid1310.070400; CDC, 2008, INFL DIS; Han K, 2009, EMERG INFECT DIS, V15, P1578, DOI 10.3201/eid1510.091013; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Mogoka Osoro E, 2009, HOSP PATIENTS PANDEM, V17; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; National Institute of Statistics of Rwanda, 2002, RWAND GEN POP HOUS C; Ritger K. A., 2009, Morbidity and Mortality Weekly Report, V58, P913; Rwanda Ministry of Health National Institute of Statistics of Rwanda ICF Macro, 2009, RWAND INT DEM HLTH S; Tabu C., 2009, Morbidity and Mortality Weekly Report, V58, P1143; Tinoco Y, 2009, INFLUENZA OTHER RESP, V3, P253, DOI 10.1111/j.1750-2659.2009.00111.x; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P249; World Health Organization, 2009, CDC REAL TIM RTPCR R; World Health Organization (WHO), 2009, INFL LIK ILLN US MEX; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740	17	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e31572	10.1371/journal.pone.0031572	http://dx.doi.org/10.1371/journal.pone.0031572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22745652	Green Published, gold, Green Submitted			2022-12-27	WOS:000305808700001
J	Hu, ZH; Yu, DN; Almeida-Suhett, C; Tu, K; Marini, AM; Eiden, L; Braga, MF; Zhu, J; Li, Z				Hu, Zhonghua; Yu, Danni; Almeida-Suhett, Camila; Tu, Kang; Marini, Ann M.; Eiden, Lee; Braga, Maria F.; Zhu, Jun; Li, Zheng			Expression of miRNAs and Their Cooperative Regulation of the Pathophysiology in Traumatic Brain Injury	PLOS ONE			English	Article							GENE-EXPRESSION; MICRORNA; IMPACT; RAT; NEUROPROTECTION; MECHANISMS; GENOME; MEMORY	Traumatic brain injury (TBI) is a leading cause of injury-related death and disability worldwide. Effective treatment for TBI is limited and many TBI patients suffer from neuropsychiatric sequelae. The molecular and cellular mechanisms underlying the neuronal damage and impairment of mental abilities following TBI are largely unknown. Here we used the next generation sequencing platform to delineate miRNA transcriptome changes in the hippocampus at 24 hours and 7 days following TBI in the rat controlled cortical impact injury (CCI) model, and developed a bioinformatic analysis to identify cellular activities that are regulated by miRNAs differentially expressed in the CCI brains. The results of our study indicate that distinct sets of miRNAs are regulated at different post-traumatic times, and suggest that multiple miRNA species cooperatively regulate cellular pathways for the pathological changes and management of brain injury. The distinctive miRNAs expression profiles at different post-CCI times may be used as molecular signatures to assess TBI progression. In addition to known pathophysiological changes, our study identifies many other cellular pathways that are subjected to modification by differentially expressed miRNAs in TBI brains. These pathways can potentially be targeted for development of novel TBI treatment.	[Hu, Zhonghua; Li, Zheng] NIMH, Unit Synapse Dev & Plast, NIH, Bethesda, MD 20892 USA; [Eiden, Lee] NIMH, Lab Cellular & Mol Regulat, NIH, Bethesda, MD 20892 USA; [Tu, Kang; Zhu, Jun] NHLBI, Genet & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA; [Yu, Danni] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Almeida-Suhett, Camila; Braga, Maria F.] Uniformed Serv Univ Hlth Sci, Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Marini, Ann M.] Uniformed Serv Univ Hlth Sci, Sch Med, Dept Neurol, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Hu, ZH (corresponding author), NIMH, Unit Synapse Dev & Plast, NIH, Bethesda, MD 20892 USA.	lizheng2@mail.nih.gov	Li, Zheng/I-8016-2014; Hu, Zhonghua/F-9493-2014; Hu, Zhonghua/J-1169-2016; Almeida-Suhett, Camila/I-8045-2016	Li, Zheng/0000-0002-2978-2531; Hu, Zhonghua/0000-0002-0117-7081; Almeida-Suhett, Camila/0000-0002-7588-9487; Eiden, Lee/0000-0001-7524-944X	NIMH; Department of Defense in the Center for Neuroscience and Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002386, ZIAMH002882] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Defense in the Center for Neuroscience and Regenerative Medicine(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this work includes funding from the Intramural Research Program of the NIMH and Department of Defense in the Center for Neuroscience and Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr TL, 2011, BIOL RES NURS, V13, P140, DOI 10.1177/1099800410385671; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dash PK, 2004, NEUROCHEM RES, V29, P1275, DOI 10.1023/B:NERE.0000023614.30084.eb; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Fenelon K, 2011, P NATL ACAD SCI USA, V108, P4447, DOI 10.1073/pnas.1101219108; Graham SH, 2000, J NEUROTRAUM, V17, P831, DOI 10.1089/neu.2000.17.831; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jennekens N, 2010, J CLIN NURS, V19, P1198, DOI 10.1111/j.1365-2702.2009.03114.x; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; Ling KH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-176; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shao NY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-409; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Twigger SN, 2008, NAT GENET, V40, P523, DOI 10.1038/ng0508-523; Wu H, 2010, MOL CELL, V38, P67, DOI 10.1016/j.molcel.2010.02.021	35	46	51	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39357	10.1371/journal.pone.0039357	http://dx.doi.org/10.1371/journal.pone.0039357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761770	gold, Green Published, Green Submitted			2022-12-27	WOS:000305730900050
J	Kamdem, C; Fossog, BT; Simard, F; Etouna, J; Ndo, C; Kengne, P; Bousses, P; Etoa, FX; Awono-Ambene, P; Fontenille, D; Antonio-Nkondjio, C; Besansky, NJ; Costantini, C				Kamdem, Colince; Fossog, Billy Tene; Simard, Frederic; Etouna, Joachim; Ndo, Cyrille; Kengne, Pierre; Bousses, Philippe; Etoa, Francois-Xavier; Awono-Ambene, Parfait; Fontenille, Didier; Antonio-Nkondjio, Christophe; Besansky, Nora J.; Costantini, Carlo			Anthropogenic Habitat Disturbance and Ecological Divergence between Incipient Species of the Malaria Mosquito Anopheles gambiae	PLOS ONE			English	Article							MOLECULAR-FORMS; GENETIC DIFFERENTIATION; SPECIATION; TRANSMISSION; S.S.; SELECTION; ISLANDS; COMPLEX; FLOW; URBANIZATION	Background: Anthropogenic habitat disturbance is a prime cause in the current trend of the Earth's reduction in biodiversity. Here we show that the human footprint on the Central African rainforest, which is resulting in deforestation and growth of densely populated urban agglomerates, is associated to ecological divergence and cryptic speciation leading to adaptive radiation within the major malaria mosquito Anopheles gambiae. Methodology/Principal Findings: In southern Cameroon, the frequency of two molecular forms-M and S-among which reproductive isolation is strong but still incomplete, was correlated to an index of urbanisation extracted from remotely sensed data, expressed as the proportion of built-up surface in each sampling unit. The two forms markedly segregated along an urbanisation gradient forming a bimodal cline of similar to 6-km width: the S form was exclusive to the rural habitat, whereas only the M form was present in the core of densely urbanised settings, co-occurring at times in the same polluted larval habitats of the southern house mosquito Culex quinquefasciatus-a species association that was not historically recorded before. Conclusions/Significance: Our results indicate that when humans create novel habitats and ecological heterogeneities, they can provide evolutionary opportunities for rapid adaptive niche shifts associated with lineage divergence, whose consequences upon malaria transmission might be significant.	[Kamdem, Colince; Fossog, Billy Tene; Simard, Frederic; Ndo, Cyrille; Kengne, Pierre; Bousses, Philippe; Fontenille, Didier; Costantini, Carlo] IRD, IRD 224, CNRS 5290, UMR MIVEGEC,UM1,UM2, Montpellier, France; [Kamdem, Colince; Fossog, Billy Tene; Ndo, Cyrille; Kengne, Pierre; Awono-Ambene, Parfait; Antonio-Nkondjio, Christophe; Costantini, Carlo] Org Coordinat Lutte Endemies Afrique Cent OCEAC, Lab Rech Paludisme, Yaounde, Cameroon; [Kamdem, Colince; Fossog, Billy Tene; Ndo, Cyrille; Etoa, Francois-Xavier] Univ Yaounde I, Dept Biochem, Yaounde, Cameroon; [Etouna, Joachim] INC, Dept Geog Res, Yaounde, Cameroon; [Besansky, Nora J.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Yaounde I; University of Notre Dame	Kamdem, C (corresponding author), IRD, IRD 224, CNRS 5290, UMR MIVEGEC,UM1,UM2, Montpellier, France.	carlo.costantini@ird.fr	Frederic, SIMARD/AFV-5001-2022; FONTENILLE, didier/G-4091-2013; Costantini, Carlo/F-3470-2012; SIMARD, Frederic/J-9489-2016	Frederic, SIMARD/0000-0002-2871-5329; Costantini, Carlo/0000-0003-1016-129X; SIMARD, Frederic/0000-0002-2871-5329; TENE, Billy/0000-0003-0010-0450; FONTENILLE, didier/0000-0002-0544-3885; KENGNE, Pierre/0000-0002-3069-3202; Antonio Nkondjio, Christophe/0000-0003-0073-1578	Institut de Recherche pour le Developpement (IRD); NIH [RO1 AI63508]; Wellcome Trust [WT086423MA]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063508] Funding Source: NIH RePORTER	Institut de Recherche pour le Developpement (IRD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support was provided by Institut de Recherche pour le Developpement (IRD), NIH grant No RO1 AI63508 to NJB, and Wellcome Trust Intermediate Fellowship in Public Health and Topical Medicine No WT086423MA to CAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, MOSQUITO ECOLOGY FIE; Antonio-Nkondjio C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-154; Augustin NH, 1996, J APPL ECOL, V33, P339, DOI 10.2307/2404755; Awolola T. S., 2007, Journal of Vector Borne Diseases, V44, P241; Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102; Bivand RS, 2008, USE R, P1; Blower JG, 1981, ESTIMATING SIZE ANIM; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Costantini C, 1996, MED VET ENTOMOL, V10, P203, DOI 10.1111/j.1365-2915.1996.tb00733.x; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Diabate A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-5; Doby J. M., 1957, Bulletin de la Societe de Pathologie Exotique Paris, V50, P945; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Filchak KE, 2000, NATURE, V407, P739, DOI 10.1038/35037578; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Franqueville A., 1984, YAOUNDE CONSTRUIRE C; Gillies M, 1987, ANOPHELINAE AFRICA S; Gimonneau G, 2012, MED VET ENTOMOL, V26, P9, DOI 10.1111/j.1365-2915.2011.00957.x; Gimonneau G, 2010, BEHAV ECOL, V21, P1087, DOI 10.1093/beheco/arq114; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Hendry AP, 2000, SCIENCE, V290, P516, DOI 10.1126/science.290.5491.516; HURLBERT SH, 1969, ECOLOGY, V50, P1, DOI 10.2307/1934657; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Lee Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-75; Legendre P., 2012, NUMERICAL ECOLOGY; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; MALLET J, 1990, GENETICS, V124, P921; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Noor MAF, 2009, HEREDITY, V103, P439, DOI 10.1038/hdy.2009.151; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Omlin FX, 2007, AM J TROP MED HYG, V77, P264, DOI 10.4269/ajtmh.2007.77.264; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Rageau J., 1953, Annales de Parasitologie Humaine et Comparee, V28, P425; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Slotman MA, 2007, MOL ECOL, V16, P639, DOI 10.1111/j.1365-294X.2006.03172.x; Smith T, 2004, AM J TROP MED HYG, V71, P80, DOI 10.4269/ajtmh.2004.71.80; Smith TA, 2001, TRENDS PARASITOL, V17, P145, DOI 10.1016/S1471-4922(00)01814-6; Smith TB, 2008, MOL ECOL, V17, P1, DOI 10.1111/j.1365-294X.2007.03607.x; Tilman D, 2001, P NATL ACAD SCI USA, V98, P5433, DOI 10.1073/pnas.091093198; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P10, DOI 10.1016/0035-9203(87)90472-X; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; Turner TL, 2010, MOL ECOL, V19, P848, DOI 10.1111/j.1365-294X.2010.04532.x; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Via S, 2009, P NATL ACAD SCI US; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; Wondji C, 2002, INSECT MOL BIOL, V11, P11, DOI 10.1046/j.0962-1075.2001.00306.x; Yawson AE, 2007, GENETICS, V175, P751, DOI 10.1534/genetics.106.065888; Zhang QF, 2005, ENVIRON MONIT ASSESS, V101, P69	60	95	98	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39453	10.1371/journal.pone.0039453	http://dx.doi.org/10.1371/journal.pone.0039453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745756	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900061
J	Starrett, J; Garb, JE; Kuelbs, A; Azubuike, UO; Hayashi, CY				Starrett, James; Garb, Jessica E.; Kuelbs, Amanda; Azubuike, Ugochi O.; Hayashi, Cheryl Y.			Early Events in the Evolution of Spider Silk Genes	PLOS ONE			English	Article							EGG CASE SILK; SPINNING APPARATUS; DRAGLINE SILK; FIBROIN; TARANTULAS; ARANEAE; FIBERS; SYSTEM; ARCHITECTURE; PERFORMANCE	Silk spinning is essential to spider ecology and has had a key role in the expansive diversification of spiders. Silk is composed primarily of proteins called spidroins, which are encoded by a multi-gene family. Spidroins have been studied extensively in the derived clade, Orbiculariae (orb-weavers), from the suborder Araneomorphae ('true spiders'). Orbicularians produce a suite of different silks, and underlying this repertoire is a history of duplication and spidroin gene divergence. A second class of silk proteins, Egg Case Proteins (ECPs), is known only from the orbicularian species, Lactrodectus hesperus (Western black widow). In L. hesperus, ECPs bond with tubuliform spidroins to form egg case silk fibers. Because most of the phylogenetic diversity of spiders has not been sampled for their silk genes, there is limited understanding of spidroin gene family history and the prevalence of ECPs. Silk genes have not been reported from the suborder Mesothelae (segmented spiders), which diverged from all other spiders >380 million years ago, and sampling from Mygalomorphae (tarantulas, trapdoor spiders) and basal araneomorph lineages is sparse. In comparison to orbicularians, mesotheles and mygalomorphs have a simpler silk biology and thus are hypothesized to have less diversity of silk genes. Here, we present cDNAs synthesized from the silk glands of six mygalomorph species, a mesothele, and a non-orbicularian araneomorph, and uncover a surprisingly rich silk gene diversity. In particular, we find ECP homologs in the mesothele, suggesting that ECPs were present in the common ancestor of extant spiders, and originally were not specialized to complex with tubuliform spidroins. Furthermore, gene-tree/species-tree reconciliation analysis reveals that numerous spidroin gene duplications occurred after the split between Mesothelae and Opisthothelae (Mygalomorphae plus Araneomorphae). We use the spidroin gene tree to reconstruct the evolution of amino acid compositions of spidroins that perform different ecological functions.	[Starrett, James; Kuelbs, Amanda; Azubuike, Ugochi O.; Hayashi, Cheryl Y.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Garb, Jessica E.] Univ Massachusetts, Dept Biol Sci, Lowell, MA USA	University of California System; University of California Riverside; University of Massachusetts System; University of Massachusetts Lowell	Starrett, J (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	James.Starrett@email.ucr.edu	Garb, Jessica E/J-4566-2015		National Science Foundation (NSF) [DEB-0236020]; NSF [DEB-0910365]; Army Research Office [W911NF0610455]	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Army Research Office	This work was funded by National Science Foundation (NSF) DEB-0236020 to CYH, NSF DEB-0910365 to JS and CYH, and Army Research Office W911NF0610455 to CYH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; An B, 2011, BIOMACROMOLECULES, V12, P2375, DOI 10.1021/bm200463e; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Ayoub NA, 2007, MOL PHYLOGENET EVOL, V42, P394, DOI 10.1016/j.ympev.2006.07.018; Ayoub Nadia A., 2009, P255; Bahlcke J., 2005, ENZYKLOP DIE NEUZEIT, V1; Beuken E, 1998, BIOTECHNIQUES, V24, P748, DOI 10.2144/98245bm10; Bittencourt D, 2010, COMP BIOCHEM PHYS B, V155, P419, DOI 10.1016/j.cbpb.2010.01.005; Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275; Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106; Blasingame E, 2009, J BIOL CHEM, V284, P29097, DOI 10.1074/jbc.M109.021378; Boutry C, 2010, J EXP BIOL, V213, P3505, DOI 10.1242/jeb.046110; Brooks AE, 2008, BIOMACROMOLECULES, V9, P1506, DOI 10.1021/bm701124p; CODDINGTON JA, 1989, J ARACHNOL, V17, P71; Coddington JA, 2004, ASSEMBLING THE TREE OF LIFE, P296; CODDINGTON JA, 1991, ANNU REV ECOL SYST, V22, P565, DOI 10.1146/annurev.es.22.110191.003025; Coyle FA, 1986, SPIDERS WEBS BEHAV E, P310; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Foelix R., 2011, BIOL SPIDERS, V3; Foelix RF, 2012, J EXP BIOL, V215, P1084, DOI 10.1242/jeb.066811; Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102; Garb JE, 2007, MOL BIOL EVOL, V24, P2454, DOI 10.1093/molbev/msm179; Garb JE, 2006, SCIENCE, V312, P1762, DOI 10.1126/science.1127946; Garb JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-243; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; GLATZ L, 1972, Z MORPHOL TIERE, V72, P1; GLATZ L, 1973, Z MORPHOL TIERE, V75, P1, DOI 10.1007/BF00723667; Gorb SN, 2006, NATURE, V443, P407, DOI 10.1038/443407a; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; GRIFFITHS JR, 1980, J MATER SCI, V15, P491, DOI 10.1007/BF02396800; Griswold CE, 1999, J ARACHNOL, V27, P53; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; HAUPT J, 1993, ANN SCI NAT ZOOL, V14, P35; Haupt J., 2003, ZOOLOGICA STUTTGART, V154, P1; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477; Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478; Hedin M, 2006, MOL PHYLOGENET EVOL, V41, P454, DOI 10.1016/j.ympev.2006.05.017; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y; Hu XY, 2006, BIOCHEMISTRY-US, V45, P3506, DOI 10.1021/bi052105q; Hu XY, 2005, BIOCHEMISTRY-US, V44, P10020, DOI 10.1021/bi050494i; Hu XY, 2005, J BIOL CHEM, V280, P21220, DOI 10.1074/jbc.M412316200; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kovoor J., 1987, P160; Lee Chunghau, 2006, Evolutionary Bioinformatics Online, V2, P193; Maddison W., 2018, MESQUITE MODULAR SYS; Miller M.A., 2010, P GAT COMP ENV WORKS; Newman AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-382; Nicholas KB., 1997, GENEDOC TOOL EDITING; Nylander JAA., 2004, BIOINFORMATICS; Oakley TH, 2005, MOL BIOL EVOL, V22, P40, DOI 10.1093/molbev/msh257; Page RDM, 1998, BIOINFORMATICS, V14, P819, DOI 10.1093/bioinformatics/14.9.819; PALMER JM, 1985, J MORPHOL, V186, P195, DOI 10.1002/jmor.1051860205; PALMER JM, 1982, J MORPHOL, V174, P269, DOI 10.1002/jmor.1051740303; Peattie AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020485; Perez-Miles F, 2009, NATURE, V461, pE9, DOI 10.1038/nature08404; Perry DJ, 2010, BIOMACROMOLECULES, V11, P3000, DOI 10.1021/bm1007585; Platnick N. I., 1991, AM MUS NOVIT, V3016, P1; Platnick N.I., 2013, WORLD SPIDER CATALOG, DOI [10.5531/db.iz.0001, DOI 10.5531/DB.IZ.0001]; Prosdocimi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021634; Rind FC, 2011, J EXP BIOL, V214, P1874, DOI 10.1242/jeb.055657; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Savage KN, 2008, J EXP BIOL, V211, P1948, DOI 10.1242/jeb.014225; SHEAR WA, 1989, SCIENCE, V246, P479, DOI 10.1126/science.246.4929.479; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SHULTZ JW, 1987, BIOL REV, V62, P89, DOI 10.1111/j.1469-185X.1987.tb01263.x; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; STAMATAKIS A., 2006, P 20 IEEE INT PAR DI, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sutherland TD, 2010, ANNU REV ENTOMOL, V55, P171, DOI 10.1146/annurev-ento-112408-085401; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Swanson BO, 2006, EVOLUTION, V60, P2539; Swanson BO, 2009, INTEGR COMP BIOL, V49, P21, DOI 10.1093/icb/icp013; Ubick D, 2005, SPIDERS N AM IDENTIF; Vollrath F, 2007, ANNU REV ECOL EVOL S, V38, P819, DOI 10.1146/annurev.ecolsys.37.091305.110221; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120	80	42	42	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38084	10.1371/journal.pone.0038084	http://dx.doi.org/10.1371/journal.pone.0038084			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761664	gold, Green Published, Green Submitted			2022-12-27	WOS:000305730900006
J	Byun, HM; Nordio, F; Coull, BA; Tarantini, L; Hou, LF; Bonzini, M; Apostoli, P; Bertazzi, PA; Baccarelli, A				Byun, Hyang-Min; Nordio, Francesco; Coull, Brent A.; Tarantini, Letizia; Hou, Lifang; Bonzini, Matteo; Apostoli, Pietro; Bertazzi, Pier Alberto; Baccarelli, Andrea			Temporal Stability of Epigenetic Markers: Sequence Characteristics and Predictors of Short-Term DNA Methylation Variations	PLOS ONE			English	Article							CPG ISLAND SHORES; PARTICULATE MATTER; GENE-EXPRESSION; HUMAN COLON; DISEASE; EXPOSURE; RISK; TRANSCRIPTION; PATTERNS; PROMOTER	Background: DNA methylation is an epigenetic mechanism that has been increasingly investigated in observational human studies, particularly on blood leukocyte DNA. Characterizing the degree and determinants of DNA methylation stability can provide critical information for the design and conduction of human epigenetic studies. Methods: We measured DNA methylation in 12 gene-promoter regions (APC, p16, p53, RASSF1A, CDH13, eNOS, ET-1, IFN gamma, IL-6, TNF alpha, iNOS, and hTERT) and 2 of non-long terminal repeat elements, i.e., L1 and Alu in blood samples obtained from 63 healthy individuals at baseline (Day 1) and after three days (Day 4). DNA methylation was measured by bisulfite-PCR-Pyrosequencing. We calculated intraclass correlation coefficients (ICCs) to measure the within-individual stability of DNA methylation between Day 1 and 4, subtracted of pyrosequencing error and adjusted for multiple covariates. Results: Methylation markers showed different temporal behaviors ranging from high (IL-6, ICC = 0.89) to low stability (APC, ICC = 0.08) between Day 1 and 4. Multiple sequence and marker characteristics were associated with the degree of variation. Density of CpG dinucleotides nearby the sequence analyzed (measured as CpG(o/e) or G+C content within +/- 200bp) was positively associated with DNA methylation stability. The 39 proximity to repeat elements and range of DNA methylation on Day 1 were also positively associated with methylation stability. An inverted U-shaped correlation was observed between mean DNA methylation on Day 1 and stability. Conclusions: The degree of short-term DNA methylation stability is marker-dependent and associated with sequence characteristics and methylation levels.	[Byun, Hyang-Min; Nordio, Francesco; Baccarelli, Andrea] Harvard Univ, Sch Publ Hlth, Lab Environm Epigenet, Exposure Epidemiol & Risk Program, Boston, MA 02115 USA; [Nordio, Francesco; Tarantini, Letizia; Bertazzi, Pier Alberto] Univ Milan, Dept Environm & Occupat Hlth, Milan, Italy; [Nordio, Francesco; Tarantini, Letizia; Bertazzi, Pier Alberto] IRCCS Ca Granda Maggiore Policlin Hosp, Milan, Italy; [Coull, Brent A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Hou, Lifang] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Bonzini, Matteo] Univ Insubria, Epidemiol & Prevent Med Res Ctr, Varese, Italy; [Apostoli, Pietro] Univ Brescia, Dept Expt & Appl Med Occupat Med & Ind Hyg, Brescia, Italy	Harvard University; Harvard T.H. Chan School of Public Health; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Harvard University; Harvard T.H. Chan School of Public Health; Northwestern University; Feinberg School of Medicine; University of Insubria; University of Brescia	Byun, HM (corresponding author), Harvard Univ, Sch Publ Hlth, Lab Environm Epigenet, Exposure Epidemiol & Risk Program, 665 Huntington Ave, Boston, MA 02115 USA.	hmbyun@hsph.harvard.edu	bertazzi, pietro alberto/D-5039-2017; Byun, Hyang-Min/X-2843-2018; Bonzini, Matteo/K-7540-2016	bertazzi, pietro alberto/0000-0003-3475-2449; Byun, Hyang-Min/0000-0002-6278-3165; Bonzini, Matteo/0000-0002-6405-7554; Baccarelli, Andrea/0000-0002-3436-0640	United States National Institutes of Health [R01ES020268, R21ES019773, R21ES020010, P30ES000002]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002, R01ES020268, R21ES019773, R21ES020010] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding support was provided by the United States National Institutes of Health grants R01ES020268, R21ES019773, R21ES020010, and P30ES000002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2010, NATURE, V463, P596, DOI 10.1038/463596b; Arnaud P, 2000, MOL CELL BIOL, V20, P3434, DOI 10.1128/MCB.20.10.3434-3441.2000; Baccarelli A, 2011, LANCET, V377, P694, DOI 10.1016/S0140-6736(10)62348-3; Baccarelli A, 2010, EPIDEMIOLOGY, V21, P819, DOI 10.1097/EDE.0b013e3181f20457; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bollati V, 2011, BRAIN BEHAV IMMUN, V25, P1078, DOI 10.1016/j.bbi.2011.01.017; Bollati V, 2010, ENVIRON HEALTH PERSP, V118, P763, DOI 10.1289/ehp.0901300; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Cantone L, 2011, ENVIRON HEALTH PERSP, V119, P964, DOI 10.1289/ehp.1002955; Cedar H, 1999, NATURE, V397, P568, DOI 10.1038/17492; Choi SH, 2011, NUCLEIC ACIDS RES, V39, P104, DOI 10.1093/nar/gkq774; Dioni L, 2011, ENVIRON HEALTH PERSP, V119, P622, DOI 10.1289/ehp.1002486; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Hervouet Eric, 2010, Genes Cancer, V1, P434, DOI 10.1177/1947601910373794; Hou LF, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-48; Hoyo C, 2009, J EPIDEMIOL COMMUN H, V63, P683, DOI 10.1136/jech.2009.090803; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Lechner M, 2010, ADV GENET, V70, P247, DOI [10.1016/S0065-2660(10)70009-2, 10.1016/B978-0-12-380866-0.60009-5]; Lunyak VV, 2007, SCIENCE, V317, P248, DOI 10.1126/science.1140871; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Nawrot TS, 2011, LANCET, V377, P732, DOI 10.1016/S0140-6736(10)62296-9; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Relton CL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000356; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; Tarantini L, 2009, ENVIRON HEALTH PERSP, V117, P217, DOI 10.1289/ehp.11898; Terry MB, 2011, EPIGENETICS-US, V6, P828, DOI 10.4161/epi.6.7.16500; Tost J, 2003, BIOTECHNIQUES, V35, P152, DOI 10.2144/03351md02; Turker MS, 1997, MUTAT RES-REV MUTAT, V386, P119, DOI 10.1016/S1383-5742(96)00048-8; Wang XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025913; Zhu XH, 2011, INT J DERMATOL, V50, P697, DOI 10.1111/j.1365-4632.2010.04804.x	40	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39220	10.1371/journal.pone.0039220	http://dx.doi.org/10.1371/journal.pone.0039220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745719	Green Submitted, Green Published, gold			2022-12-27	WOS:000305693200051
J	Van Remoortel, H; Raste, Y; Louvaris, Z; Giavedoni, S; Burtin, C; Langer, D; Wilson, F; Rabinovich, R; Vogiatzis, I; Hopkinson, NS; Troosters, T				Van Remoortel, Hans; Raste, Yogini; Louvaris, Zafeiris; Giavedoni, Santiago; Burtin, Chris; Langer, Daniel; Wilson, Frederick; Rabinovich, Roberto; Vogiatzis, Ioannis; Hopkinson, Nicholas S.; Troosters, Thierry		PROactive Consortium	Validity of Six Activity Monitors in Chronic Obstructive Pulmonary Disease: A Comparison with Indirect Calorimetry	PLOS ONE			English	Article							CLINICALLY STABLE PATIENTS; PHYSICAL-ACTIVITY; ENERGY-EXPENDITURE; LIFECORDER EX; COPD; ACTIGRAPH; RELIABILITY; VALIDATION; STANDARDIZATION; ACCELEROMETERS	Reduced physical activity is an important feature of Chronic Obstructive Pulmonary Disease (COPD). Various activity monitors are available but their validity is poorly established. The aim was to evaluate the validity of six monitors in patients with COPD. We hypothesized triaxial monitors to be more valid compared to uniaxial monitors. Thirty-nine patients (age 68 +/- 7years, FEV1 54 +/- 18%predicted) performed a one-hour standardized activity protocol. Patients wore 6 monitors (Kenz Lifecorder (Kenz), Actiwatch, RT3, Actigraph GT3X (Actigraph), Dynaport MiniMod (MiniMod), and SenseWear Armband (SenseWear)) as well as a portable metabolic system (Oxycon Mobile). Validity was evaluated by correlation analysis between indirect calorimetry (VO2) and the monitor outputs: Metabolic Equivalent of Task [METs] (SenseWear, MiniMod), activity counts (Actiwatch), vector magnitude units (Actigraph, RT3) and arbitrary units (Kenz) over the whole protocol and slow versus fast walking. Minute-by-minute correlations were highest for the MiniMod (r = 0.82), Actigraph (r = 0.79), SenseWear (r = 0.73) and RT3 (r = 0.73). Over the whole protocol, the mean correlations were best for the SenseWear (r = 0.76), Kenz (r = 0.52), Actigraph (r = 0.49) and MiniMod (r = 0.45). The MiniMod (r = 0.94) and Actigraph (r = 0.88) performed better in detecting different walking speeds. The Dynaport MiniMod, Actigraph GT3X and SenseWear Armband (all triaxial monitors) are the most valid monitors during standardized physical activities. The Dynaport MiniMod and Actigraph GT3X discriminate best between different walking speeds.	[Van Remoortel, Hans; Burtin, Chris; Langer, Daniel; Troosters, Thierry] Katholieke Univ Leuven, Dept Rehabil Sci, Fac Kinesiol & Rehabil Sci, Louvain, Belgium; [Van Remoortel, Hans; Burtin, Chris; Langer, Daniel; Troosters, Thierry] Univ Hosp Gasthuisberg, Div Resp, Louvain, Belgium; [Raste, Yogini; Hopkinson, Nicholas S.] Univ London Imperial Coll Sci Technol & Med, London, England; [Raste, Yogini; Hopkinson, Nicholas S.] Royal Brompton & Harefield NHS Fdn Trust, NIHR Resp Biomed Res Unit, London, England; [Louvaris, Zafeiris; Vogiatzis, Ioannis] Univ Athens, Dept Phys Educ & Sports Sci, Athens 11528, Greece; [Louvaris, Zafeiris; Vogiatzis, Ioannis] Univ Athens, Res Ctr Intens & Emergency Thorac Med, Thorax Fdn, Athens 11528, Greece; [Giavedoni, Santiago; Rabinovich, Roberto] Univ Edinburgh, Ctr Inflammat Res, ELEGI Colt Lab, Edinburgh, Midlothian, Scotland; [Wilson, Frederick] Pfizer Worldwide Res & Dev, Precis Med, Sandwich, Kent, England	KU Leuven; KU Leuven; University Hospital Leuven; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; University of Edinburgh; Pfizer	Van Remoortel, H (corresponding author), Katholieke Univ Leuven, Dept Rehabil Sci, Fac Kinesiol & Rehabil Sci, Louvain, Belgium.	thierry.troosters@med.kuleuven.be	burtin, chris/F-8813-2013; burtin, chris/B-3343-2015; Van Remoortel, Hans/AAH-2425-2019; J, Garcia-Aymerich/G-6867-2014; Puhan, Milo/ABE-6298-2020; Langer, Daniel/B-7307-2014	J, Garcia-Aymerich/0000-0002-7097-4586; Puhan, Milo/0000-0003-4721-1879; Langer, Daniel/0000-0001-8738-9482; Frei, Anja/0000-0002-7134-1000; Hopkinson, Nicholas/0000-0003-3235-0454; Louvaris, Zafeiris/0000-0001-8661-8546; Dobbels, Fabienne/0000-0002-9502-7374	Innovative Medicines Initiative Joint Undertaking (IMU JU) [115011]; NIHR Respiratory Biomedical Research Unit at Royal Brompton and Harefield NHS Foundation Trust; Imperial College, London, United Kingdom	Innovative Medicines Initiative Joint Undertaking (IMU JU); NIHR Respiratory Biomedical Research Unit at Royal Brompton and Harefield NHS Foundation Trust; Imperial College, London, United Kingdom	The Proactive project is funded by the Innovative Medicines Initiative Joint Undertaking (IMU JU) # 115011 and additional funds at each institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Laura Jacobs (Respiratory Division, UZ Gasthuisberg, Leuven, Belgium) was involved in patient recruitment and data collection, Y.R. (NIHR Respiratory Biomedical Research Unit, Royal Brompton, London, United Kingdom) was involved in patient recruitment, data collection, data analysis and manuscript preparation. Both were funded by IMI JU.; N.S.H. is supported by the NIHR Respiratory Biomedical Research Unit at Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom.	Abel MG, 2008, APPL PHYSIOL NUTR ME, V33, P1155, DOI [10.1139/H08-103, 10.1139/h08-103]; Annegarn J, 2012, J AM MED DIR ASSOC, V13, P284, DOI 10.1016/j.jamda.2011.01.002; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Baarends EM, 1997, THORAX, V52, P780, DOI 10.1136/thx.52.9.780; Baarends EM, 1997, THORAX, V52, P981, DOI 10.1136/thx.52.11.981; Behnke M, 2000, RESP MED, V94, P1184, DOI 10.1053/rmed.2000.0949; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122; Bossenbroek L, 2011, COPD, V8, P306, DOI 10.3109/15412555.2011.578601; BOUTEN CV, 1994, MED SCI SPORT EXER, V26, P1516; Brazeau AS, 2011, APPL PHYSIOL NUTR ME, V36, P339, DOI [10.1139/H11-016, 10.1139/h11-016]; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Cavalheri V, 2011, RESP MED, V105, P922, DOI 10.1016/j.rmed.2011.01.004; Chen Kong Y, 2003, Diabetes Technol Ther, V5, P1023, DOI 10.1089/152091503322641088; Coronado Marcos, 2003, J Cardiopulm Rehabil, V23, P357, DOI 10.1097/00008483-200309000-00006; COTES JE, 1993, EUR RESPIR J, V6, P41, DOI 10.1183/09041950.041s1693; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Crouter SE, 2006, EUR J APPL PHYSIOL, V98, P601, DOI 10.1007/s00421-006-0307-5; Decramer M, 2008, COPD, V5, P235, DOI 10.1080/15412550802237531; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; Garcia-Aymerich J, 2007, AM J RESP CRIT CARE, V175, P458, DOI 10.1164/rccm.200607-896OC; Gironda RJ, 2007, J REHABIL RES DEV, V44, P223, DOI 10.1682/JRRD.2006.06.0058; Hartmann A, 2009, GAIT POSTURE, V29, P444, DOI 10.1016/j.gaitpost.2008.11.003; Hernandes NA, 2009, J BRAS PNEUMOL, V35, P949, DOI 10.1590/S1806-37132009001000002; Hill K, 2010, THORAX, V65, P486, DOI 10.1136/thx.2009.128702; Hoydal KL, 2007, SCAND CARDIOVASC J, V41, P405, DOI 10.1080/14017430701601636; JONES NL, 1985, AM REV RESPIR DIS, V131, P700; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Langer D, 2009, THORAX, V64, P641, DOI 10.1136/thx.2008.112102; McArdle WD, 2005, ESSENTIALS EXERCISE, P262; McClain JJ, 2007, APPL PHYSIOL NUTR ME, V32, P753, DOI 10.1139/H07-060; Mcclain JJ, 2007, MED SCI SPORT EXER, V39, P1509, DOI 10.1249/mss.0b013e3180dc9954; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Patel Sanjay A, 2007, COPD, V4, P107, DOI 10.1080/15412550701246658; Pitta F, 2008, CHEST, V134, P273, DOI 10.1378/chest.07-2655; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Reneman M, 2010, INT J REHABIL RES, V33, P178, DOI 10.1097/MRR.0b013e32832c1e73; Rothney MP, 2008, OBESITY, V16, P1946, DOI 10.1038/oby.2008.279; Troosters T, 1999, EUR RESPIR J, V14, P270, DOI 10.1034/j.1399-3003.1999.14b06.x; Troosters Thierry, 2011, Open Respir Med J, V5, P1, DOI 10.2174/1874306401105010001; Troosters T, 2010, RESP MED, V104, P1005, DOI 10.1016/j.rmed.2010.01.012; Waschki B, 2011, CHEST, V140, P331, DOI 10.1378/chest.10-2521; Watz H, 2009, EUR RESPIR J, V33, P262, DOI 10.1183/09031936.00024608	45	219	225	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39198	10.1371/journal.pone.0039198	http://dx.doi.org/10.1371/journal.pone.0039198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745715	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693200047
J	Bradham, WS; Bian, AH; Oeser, A; Gebretsadik, T; Shintani, A; Solus, J; Estis, J; Lu, QA; Todd, J; Raggi, P; Stein, CM				Bradham, William S.; Bian, Aihua; Oeser, Annette; Gebretsadik, Tebeb; Shintani, Ayumi; Solus, Joseph; Estis, Joel; Quynh Anh Lu; Todd, John; Raggi, Paolo; Stein, C. Michael			High-Sensitivity Cardiac Troponin-I Is Elevated in Patients with Rheumatoid Arthritis, Independent of Cardiovascular Risk Factors and Inflammation	PLOS ONE			English	Article							HEART-FAILURE; MYOCARDIAL-INFARCTION; MORTALITY; DISEASE; ATHEROSCLEROSIS; METAANALYSIS; BIOMARKERS; APOPTOSIS; ASSAY	Objectives: We examined the hypothesis that cardiac-specific troponin-I (cTn-I), a biomarker of myocardial injury, is elevated in patients with rheumatoid arthritis (RA). Background: RA patients have an increased incidence of heart failure (HF). Chronic myocardial injury in RA may be a mechanism for the development of HF. Methods: We compared cTn-I concentrations measured by high-sensitivity immunoassay in 164 patients with RA and 90 controls, excluding prior or active heart failure. We examined the relationship between cTn-I concentrations and cardiovascular risk factors, inflammation, and coronary artery calcium score (CACS), a measure of coronary atherosclerosis. Results: cTn-I concentrations were 49% higher in patients with RA (median 1.15 pg/mL [IQR 0.73-1.92] than controls (0.77 pg/mL [0.49-1.28](P < 0.001). The difference remained statistically significant after adjustment for demographic characteristics (P = 0.002), further adjustment for cardiovascular (CV) risk factors (P = 0.004), inflammatory markers (P = 0.008), and in a comprehensive model of CV risk factors and inflammatory markers (P = 0.03). In patients with RA, cTn-I concentrations were positively correlated with age (rho = 0.359), Framingham risk score (FRS) (rho = 0.366), and systolic blood pressure (rho = 0.248 (all P values <= 0.001)), but not with measures of inflammation or RA drug therapies. cTn-I was significantly correlated with CACS in RA in univariate analysis, but not after adjustment for age, race, sex and FRS (P = 0.79). Further model adjustments for renal function and coronary artery disease confirmed the significance of the findings. Conclusion: High-sensitivity cTn-I concentrations are elevated in patients with RA without heart failure, independent of cardiovascular risk profile and inflammatory markers. Elevated troponin concentrations in RA may indicate subclinical, indolent myocardial injury.	[Bradham, William S.] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiol, Nashville, TN 37240 USA; [Oeser, Annette; Stein, C. Michael] Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN USA; [Bian, Aihua; Gebretsadik, Tebeb; Shintani, Ayumi] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Solus, Joseph] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN USA; [Raggi, Paolo] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA; [Estis, Joel; Quynh Anh Lu; Todd, John] Singulex Inc, Alameda, CA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Emory University	Bradham, WS (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiol, Nashville, TN 37240 USA.	william.bradham@vanderbilt.edu			National Institutes of Health from NCRR/NIH [HL65082, HL67964, UL1RR024975, P60 AR056116]; Dan May Chair in Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024978, UL1RR024975, KL2RR024977] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065082, R01HL067964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR056116] Funding Source: NIH RePORTER	National Institutes of Health from NCRR/NIH; Dan May Chair in Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants from the National Institutes of Health HL65082, HL67964, UL1RR024975 from NCRR/NIH, P60 AR056116, and the Dan May Chair in Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Blankenberg S, 2010, CIRCULATION, V121, P2388, DOI 10.1161/CIRCULATIONAHA.109.901413; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Chung CP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2098; Chung CP, 2005, ARTHRITIS RHEUM-US, V52, P3045, DOI 10.1002/art.21288; D'Errico Maria P, 2012, Int J Radiat Oncol Biol Phys, V82, pe239, DOI 10.1016/j.ijrobp.2011.03.058; Giles JT, 2010, ARTHRITIS RHEUM-US, V62, P940, DOI 10.1002/art.27349; Gupta S, 2007, PROG CARDIOVASC DIS, V50, P151, DOI 10.1016/j.pcad.2007.01.002; HAMM CW, 1992, NEW ENGL J MED, V327, P146, DOI 10.1056/NEJM199207163270302; Hessel MHM, 2008, PFLUG ARCH EUR J PHY, V455, P979, DOI 10.1007/s00424-007-0354-8; Januzzi JL, 2010, CIRCULATION, V121, P1227, DOI 10.1161/CIRCULATIONAHA.109.893826; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Levy L, 2008, CLIN EXP RHEUMATOL, V26, P673; Logeart D, 2001, AM HEART J, V141, P247, DOI 10.1067/mhj.2001.111767; Meune C, 2009, RHEUMATOLOGY, V48, P1309, DOI 10.1093/rheumatology/kep252; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Nicola PJ, 2006, ARTHRITIS RHEUM-US, V54, P60, DOI 10.1002/art.21560; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; PINCUS T, 1984, ARTHRITIS RHEUM-US, V27, P864, DOI 10.1002/art.1780270805; Saunders JT, 2011, CIRCULATION, V123, P1367, DOI 10.1161/CIRCULATIONAHA.110.005264; Semb AG, 2010, ANN RHEUM DIS, V69, P1996, DOI 10.1136/ard.2009.126128; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Solus J, 2008, ARTHRITIS RHEUM-US, V58, P2662, DOI 10.1002/art.23796; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408	29	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e38930	10.1371/journal.pone.0038930	http://dx.doi.org/10.1371/journal.pone.0038930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761714	gold, Green Published, Green Submitted			2022-12-27	WOS:000305826400007
J	Sivaprasad, S; Gupta, B; Gulliford, MC; Dodhia, H; Mann, S; Nagi, D; Evans, J				Sivaprasad, Sobha; Gupta, Bhaskar; Gulliford, Martin C.; Dodhia, Hiten; Mann, Samantha; Nagi, Dinesh; Evans, Jennifer			Ethnic Variation in the Prevalence of Visual Impairment in People Attending Diabetic Retinopathy Screening in the United Kingdom (DRIVE UK)	PLOS ONE			English	Article							SIGHT-THREATENING RETINOPATHY; OLDER-ADULTS; EYE DISEASE; POPULATION; BLINDNESS; HEALTH; RISK; INEQUALITIES; COMMUNITY; MELLITUS	Purpose: To provide estimates of visual impairment in people with diabetes attending screening in a multi-ethnic population in England (United Kingdom). Methods: The Diabetic Retinopathy In Various Ethnic groups in UK (DRIVE UK) Study is a cross-sectional study on the ethnic variations of the prevalence of DR and visual impairment in two multi-racial cohorts in the UK. People on the diabetes register in West Yorkshire and South East London who were screened, treated or monitored between April 2008 to July 2009 (London) or August 2009 (West Yorkshire) were included in the study. Data on age, gender, ethnic group, visual acuity and diabetic retinopathy were collected. Ethnic group was defined according to the 2011 census classification. The two main ethnic minority groups represented here are Blacks ("Black/African/Caribbean/Black British'') and South Asians ("Asians originating from the Indian subcontinent''). We examined the prevalence of visual impairment in the better eye using three cut-off points (a) loss of vision sufficient for driving (approximately <6/9) (b) visual impairment (<6/12) and (c) severe visual impairment (<6/60), standardising the prevalence of visual impairment in the minority ethnic groups to the age-structure of the white population. Results: Data on visual acuity and were available on 50,331 individuals 3.4% of people diagnosed with diabetes and attending screening were visually impaired (95% confidence intervals (CI) 3.2% to 3.5%) and 0.39% severely visually impaired (0.33% to 0.44%). Blacks and South Asians had a higher prevalence of visual impairment (directly age standardised prevalence 4.6%, 95% CI 4.0% to 5.1% and 6.9%, 95% CI 5.8% to 8.0% respectively) compared to white people (3.3%, 95% CI 3.1% to 3.5%). Visual loss was also more prevalent with increasing age, type 1 diabetes and in people living in Yorkshire. Conclusions: Visual impairment remains an important public health problem in people with diabetes, and is more prevalent in the minority ethnic groups in the UK.	[Sivaprasad, Sobha; Gupta, Bhaskar] Kings Coll Hosp NHS Fdn Trust, Laser & Retinal Res Unit, London, England; [Gulliford, Martin C.] Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England; [Dodhia, Hiten] Lambeth NHS Primary Care Trust, Dept Publ Hlth, London, England; [Mann, Samantha] St Thomas Hosp NHS Fdn Trust, Dept Ophthalmol, London, England; [Nagi, Dinesh] Mid Yorkshire NHS Trust, Wakefield, Yorks, England; [Evans, Jennifer] London Sch Hyg & Trop Med, Dept Epidemiol, London WC1, England	King's College Hospital NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine	Sivaprasad, S (corresponding author), Kings Coll Hosp NHS Fdn Trust, Laser & Retinal Res Unit, London, England.	senswathi@aol.com	Gulliford, Martin C/I-8606-2018; Sivaprasad, S./D-6876-2015; Evans, Jennifer/F-4672-2012	Gulliford, Martin C/0000-0003-1898-9075; Sivaprasad, S./0000-0001-8952-0659; Evans, Jennifer/0000-0002-6137-2030	Guide Dogs For the Blind Association	Guide Dogs For the Blind Association	This work was supported by Guide Dogs For the Blind Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARDH E, 1993, DIABETIC MED, V10, P555, DOI 10.1111/j.1464-5491.1993.tb00120.x; Arun CS, 2009, DIABETIC MED, V26, P489, DOI 10.1111/j.1464-5491.2009.02718.x; Broadbent DM, 1999, EYE, V13, P160, DOI 10.1038/eye.1999.43; Bunce C, 2010, EYE, V24, P1692, DOI 10.1038/eye.2010.122; Canavan YM, 1997, ULSTER MED J, V66, P92; Collerton J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4904; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Cormack TGM, 2001, BRIT J OPHTHALMOL, V85, P354, DOI 10.1136/bjo.85.3.354; Diabetes UK, DIAB UK 2010 KEY STA; Evans JR, 2002, BRIT J OPHTHALMOL, V86, P795, DOI 10.1136/bjo.86.7.795; Garvican L, 2003, QUALITY ASSURANCE NA; Gordon-Bennett P, 2009, CLIN OPHTHALMOL, V3, P75; Gulliford MC, 2010, DIABETIC MED, V27, P282, DOI 10.1111/j.1464-5491.2010.02946.x; Gulliford MC, 2004, DIABETIC MED, V21, P45, DOI 10.1046/j.1464-5491.2003.01061.x; HARRIS EL, 1993, DIABETES CARE, V16, P748, DOI 10.2337/diacare.16.5.748; Hayward LM, 2002, DIABETIC MED, V19, P27, DOI 10.1046/j.0742-3071.2001.00603.x; Hirai FE, 2011, OPHTHALMOLOGY, V118, P353, DOI 10.1016/j.ophtha.2010.06.022; Jones GC, 2010, OPHTHAL EPIDEMIOL, V17, P400, DOI 10.3109/09286586.2010.528137; KLEIN R, 1994, OPHTHALMOLOGY, V101, P68; Klein R, 2009, OPHTHALMOLOGY, V116, P1937, DOI 10.1016/j.ophtha.2009.03.012; Kumar N, 2006, EYE, V20, P455, DOI 10.1038/sj.eye.6701908; Leske MC, 2010, REV PANAM SALUD PUBL, V27, P259, DOI 10.1590/S1020-49892010000400004; Nwosu S N, 2000, Ophthalmic Epidemiol, V7, P41, DOI 10.1076/0928-6586(200003)7:1;1-2;FT041; Olafsdottir E, 2007, ACTA OPHTHALMOL SCAN, V85, P40, DOI 10.1111/j.1600-0420.2006.00753.x; Olivarius ND, 2001, GRAEF ARCH CLIN EXP, V239, P664, DOI 10.1007/s004170100324; Pardhan S, 2004, EYE, V18, P233, DOI 10.1038/sj.eye.6700629; Prasad S, 2001, EYE, V15, P640, DOI 10.1038/eye.2001.200; Raymond NT, 2009, DIABETES CARE, V32, P410, DOI 10.2337/dc08-1422; Scanlon PH, 2008, J MED SCREEN, V15, P1, DOI 10.1258/jms.2008.008015; Sinclair AJ, 2000, AGE AGEING, V29, P335, DOI 10.1093/ageing/29.4.335; Sivaprasad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032182; Stefansson E, 2000, ACTA OPHTHALMOL SCAN, V78, P374, DOI 10.1034/j.1600-0420.2000.078004374.x; TIELSCH JM, 1990, ARCH OPHTHALMOL-CHIC, V108, P286, DOI 10.1001/archopht.1990.01070040138048; UK National Screening Committee, 2009, ESS EL DEV DIAB RET; Yorkshire and the Humber Quality Observatory (YHQO), 2011, APHO DIAB PREV MOD E; Younis N, 2003, DIABETIC MED, V20, P758, DOI 10.1046/j.1464-5491.2003.01035.x; Younis N, 2003, LANCET, V361, P195, DOI 10.1016/S0140-6736(03)12267-2; Zhang X., 2006, Morbidity and Mortality Weekly Report, V55, P1169	38	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39608	10.1371/journal.pone.0039608	http://dx.doi.org/10.1371/journal.pone.0039608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761840	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305825800050
J	Smith, GC; McDonald, RA; Wilkinson, D				Smith, Graham C.; McDonald, Robbie A.; Wilkinson, David			Comparing Badger (Meles meles) Management Strategies for Reducing Tuberculosis Incidence in Cattle	PLOS ONE			English	Article							COST-BENEFIT-ANALYSIS; BOVINE TUBERCULOSIS; MYCOBACTERIUM-BOVIS; CULLING TRIAL; ENGLAND; MODEL; POPULATION; VACCINATION; PERTURBATION; BREAKDOWNS	Bovine tuberculosis (bTB), caused by Mycobacterium bovis, continues to be a serious economic problem for the British cattle industry. The Eurasian badger (Meles meles) is partly responsible for maintenance of the disease and its transmission to cattle. Previous attempts to manage the disease by culling badgers have been hampered by social perturbation, which in some situations is associated with increases in the cattle herd incidence of bTB. Following the licensing of an injectable vaccine, we consider the relative merits of management strategies to reduce bTB in badgers, and thereby reduce cattle herd incidence. We used an established simulation model of the badger-cattle-TB system and investigated four proposed strategies: business as usual with no badger management, large-scale proactive badger culling, badger vaccination, and culling with a ring of vaccination around it. For ease of comparison with empirical data, model treatments were applied over 150 km(2) and were evaluated over the whole of a 300 km(2) area, comprising the core treatment area and a ring of approximately 2 km. The effects of treatment were evaluated over a 10-year period comprising treatment for five years and the subsequent five year period without treatment. Against a background of existing disease control measures, where 144 cattle herd incidents might be expected over 10 years, badger culling prevented 26 cattle herd incidents while vaccination prevented 16. Culling in the core 150 km(2) plus vaccination in a ring around it prevented about 40 cattle herd breakdowns by partly mitigating the negative effects of culling, although this approach clearly required greater effort. While model outcomes were robust to uncertainty in parameter estimates, the outcomes of culling were sensitive to low rates of land access for culling, low culling efficacy, and the early cessation of a culling strategy, all of which were likely to lead to an overall increase in cattle disease.	[Smith, Graham C.; Wilkinson, David] Food & Environm Res Agcy, York, N Yorkshire, England; [McDonald, Robbie A.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	Food & Environment Research Agency; University of Exeter	Smith, GC (corresponding author), Food & Environm Res Agcy, York, N Yorkshire, England.	graham.smith@fera.gsi.gov.uk	McDonald, Robbie/AAK-2718-2020; Smith, Graham C/J-2593-2013; McDonald, Robbie A/A-2931-2012	McDonald, Robbie/0000-0002-6922-3195; Smith, Graham C/0000-0002-9897-6794; McDonald, Robbie A/0000-0002-6922-3195	UK Department for Environment, Food and Rural Affairs (Defra)	UK Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA))	The UK Department for Environment, Food and Rural Affairs (Defra, http://ww2.defra.gov.uk/) funded this work. Defra designed the three strategies to investigate, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Carter SP, 2007, P ROY SOC B-BIOL SCI, V274, P2769, DOI 10.1098/rspb.2007.0998; Chambers MA, 2011, P ROY SOC B-BIOL SCI, V278, P1913, DOI 10.1098/rspb.2010.1953; CHEESEMAN C, 1979, APPL ANIM ETHOL, V5, P193, DOI 10.1016/0304-3762(79)90092-0; CHEESEMAN CL, 1988, MAMMAL REV, V18, P51, DOI 10.1111/j.1365-2907.1988.tb00071.x; Crawshaw TR, 2008, VET REC, V163, P473, DOI 10.1136/vr.163.16.473; Defra, 2010, BOV TUB GOV APPR TAC; Delahay RJ, 2000, J ANIM ECOL, V69, P428, DOI 10.1046/j.1365-2656.2000.00406.x; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Green LE, 2005, PREV VET MED, V70, P293, DOI 10.1016/j.prevetmed.2005.05.005; Holland EP, 2007, PLOS COMPUT BIOL, V3, P1979, DOI 10.1371/journal.pcbi.0030200; Independent Scientific Group, 2007, BOV TB SCI EV; Jenkins HE, 2008, INT J INFECT DIS, V12, P457, DOI 10.1016/j.ijid.2008.04.001; Jenkins HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009090; Krebs J., 1997, PB3423 HMSO; LEPPER AWD, 1977, AUST VET J, V53, P214, DOI 10.1111/j.1751-0813.1977.tb00188.x; Mill AC, 2012, EPIDEMIOL INFECT, V140, P219, DOI 10.1017/S0950268811000434; Neal E., 1996, BADGERS; Pope LC, 2007, MOL ECOL, V16, P4919, DOI 10.1111/j.1365-294X.2007.03553.x; Rogers LM, 1998, P ROY SOC B-BIOL SCI, V265, P1269, DOI 10.1098/rspb.1998.0429; Rogers LM, 1997, J ZOOL, V242, P705, DOI 10.1111/j.1469-7998.1997.tb05821.x; Smith GC, 2007, VET REC, V160, P723, DOI 10.1136/vr.160.21.723; Smith GC, 2007, VET J, V173, P302, DOI 10.1016/j.tvjl.2005.11.017; Smith GC, 1995, MAMMALIA, V59, P639, DOI 10.1515/mamm.1995.59.4.639; Smith GC, 1997, J APPL ECOL, V34, P1375, DOI 10.2307/2405255; Smith GC, 2002, ECOL MODEL, V150, P45, DOI 10.1016/S0304-3800(01)00471-9; Smith GC, 2001, J APPL ECOL, V38, P509, DOI 10.1046/j.1365-2664.2001.00609.x; Smith GC, 2001, J APPL ECOL, V38, P520, DOI 10.1046/j.1365-2664.2001.00610.x; VMD, 2010, CURR AUTH PROD; Wilkinson D, 2004, J APPL ECOL, V41, P492, DOI 10.1111/j.0021-8901.2004.00898.x; Wilkinson D, 2009, J WILDLIFE DIS, V45, P1062, DOI 10.7589/0090-3558-45.4.1062; Wilkinson D, 2000, J ZOOL, V250, P389, DOI 10.1111/j.1469-7998.2000.tb00782.x; Woodroffe R, 2008, J ZOOL, V274, P28, DOI 10.1111/j.1469-7998.2007.00353.x; Woodroffe R, 2006, J APPL ECOL, V43, P1, DOI 10.1111/j.1365-2664.2005.01144.x; Woodroffe R, 2006, P NATL ACAD SCI USA, V103, P14713, DOI 10.1073/pnas.0606251103	34	23	23	1	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39250	10.1371/journal.pone.0039250	http://dx.doi.org/10.1371/journal.pone.0039250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761746	gold, Green Published, Green Submitted			2022-12-27	WOS:000305825800026
J	Phillips, D; Nibau, C; Wnetrzak, J; Jenkins, G				Phillips, Dylan; Nibau, Candida; Wnetrzak, Joanna; Jenkins, Glyn			High Resolution Analysis of Meiotic Chromosome Structure and Behaviour in Barley (Hordeum vulgare L.)	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; RYE SECALE-CEREALE; ARABIDOPSIS-THALIANA; CROSSOVER DISTRIBUTION; RECOMBINATION NODULES; ZMM PROTEINS; PROPHASE-I; MEIOSIS-I; SYNAPSIS; GENOME	Reciprocal crossing over and independent assortment of chromosomes during meiosis generate most of the genetic variation in sexually reproducing organisms. In barley, crossovers are confined primarily to distal regions of the chromosomes, which means that a substantial proportion of the genes of this crop rarely, if ever, engage in recombination events. There is potentially much to be gained by redistributing crossovers to more proximal regions, but our ability to achieve this is dependent upon a far better understanding of meiosis in this species. This study explores the meiotic process by describing with unprecedented resolution the early behaviour of chromosomal domains, the progression of synapsis and the structure of the synaptonemal complex (SC). Using a combination of molecular cytogenetics and advanced fluorescence imaging, we show for the first time in this species that non-homologous centromeres are coupled prior to synapsis. We demonstrate that at early meiotic prophase the loading of the SC-associated structural protein ASY1, the cluster of telomeres, and distal synaptic initiation sites occupy the same polarised region of the nucleus. Through the use of advanced 3D image analysis, we show that synapsis is driven predominantly from the telomeres, and that new synaptic initiation sites arise during zygotene. In addition, we identified two different SC configurations through the use of super-resolution 3D structured illumination microscopy (3D-SIM).	[Phillips, Dylan; Nibau, Candida; Wnetrzak, Joanna; Jenkins, Glyn] Aberystwyth Univ, Inst Biol Environm & Rural Sci IBERS, Aberystwyth, Dyfed, Wales	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Phillips, D (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci IBERS, Aberystwyth, Dyfed, Wales.	gmj@aber.ac.uk		Nibau, Candida/0000-0002-0877-6001; Phillips, Dylan/0000-0002-9139-5727	Biotechnology and Biological Sciences Research Council [BB/F018754/1]; BBSRC [BB/F018754/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors acknowledge with gratitude financial support from the Biotechnology and Biological Sciences Research Council (grant ref. BB/F018754/1) (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIRACHED-DARMENCY M, 1983, CHROMOSOMA, V88, P299, DOI 10.1007/BF00292907; Abranches R, 1998, J CELL BIOL, V143, P5, DOI 10.1083/jcb.143.1.5; Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Anderson LK, 2003, GENETICS, V165, P849; Armstrong SJ, 2002, J CELL SCI, V115, P3645, DOI 10.1242/jcs.00048; Bardhan A, 2010, J BIOSCIENCES, V35, P485, DOI 10.1007/s12038-010-0053-z; Bass HW, 1997, J CELL BIOL, V137, P5, DOI 10.1083/jcb.137.1.5; Boden SA, 2009, PLANT J, V57, P487, DOI 10.1111/j.1365-313X.2008.03701.x; Chelysheva L, 2007, PLOS GENET, V3, P802, DOI 10.1371/journal.pgen.0030083; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; Crismani W, 2011, INT J PLANT GENOMICS, V2011; Cuadrado A, 2007, CYTOGENET GENOME RES, V119, P91, DOI 10.1159/000109624; Erayman M, 2004, NUCLEIC ACIDS RES, V32, P3546, DOI 10.1093/nar/gkh639; GILLIES CB, 1984, CRC CR REV PLANT SCI, V2, P81, DOI 10.1080/07352688409382191; GILLIES CB, 1985, CHROMOSOMA, V92, P165, DOI 10.1007/BF00348690; Golubovskaya IN, 2006, J CELL SCI, V119, P3306, DOI 10.1242/jcs.03054; Golubovskaya IN, 2011, J EXP BOT, V62, P1533, DOI 10.1093/jxb/erq292; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Gustafsson MGL, 2008, NAT METHODS, V5, P385, DOI 10.1038/nmeth0508-385; Hamant O, 2006, ANNU REV PLANT BIOL, V57, P267, DOI 10.1146/annurev.arplant.57.032905.105255; HASENKAMPF CA, 1984, CHROMOSOMA, V90, P285, DOI 10.1007/BF00287036; HASENKAMPF CA, 1984, CHROMOSOMA, V90, P275, DOI 10.1007/BF00287035; HASENKAMPF CA, 1989, J HERED, V80, P197, DOI 10.1093/oxfordjournals.jhered.a110835; Higgins JD, 2005, GENE DEV, V19, P2488, DOI 10.1101/gad.354705; Holm PB, 1977, CARLSBERG RES COMMUN, V42; Hudakova S, 2001, NUCLEIC ACIDS RES, V29, P5029, DOI 10.1093/nar/29.24.5029; Idziak D, 2011, CHROMOSOMA, V120, P469, DOI 10.1007/s00412-011-0326-9; Jasencakova Z, 2001, CHROMOSOMA, V110, P83, DOI 10.1007/s004120100132; Jenkins G, 2007, NAT PROTOC, V2, P88, DOI 10.1038/nprot.2006.490; Jones GH, 2003, CHROMOSOME RES, V11, P205, DOI 10.1023/A:1022831724990; Khoo Kelvin H P, 2012, BMC Res Notes, V5, P106, DOI 10.1186/1756-0500-5-106; King J, 2002, GENETICS, V161, P315; King J, 2007, GENETICS, V177, P597, DOI 10.1534/genetics.107.075515; Koehler KE, 1996, HUM MOL GENET, V5, P1495, DOI 10.1093/hmg/5.Supplement_1.1495; Kunzel G, 2000, GENETICS, V154, P397; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Martinez-Perez E, 2003, PLANT J, V36, P21, DOI 10.1046/j.1365-313X.2003.01853.x; Martinez-Perez E, 1999, J CELL SCI, V112, P1761; Martinez-Perez E, 2000, J CELL BIOL, V148, P233, DOI 10.1083/jcb.148.2.233; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Mayer KFX, 2009, PLANT PHYSIOL, V151, P496, DOI 10.1104/pp.109.142612; Mikhailova EI, 2006, GENETICS, V174, P1247, DOI 10.1534/genetics.106.064105; Mikhailova EI, 2001, J CELL SCI, V114, P1875; Moses M. J., 1968, Annual Review of Genetics, V2, P363, DOI 10.1146/annurev.ge.02.120168.002051; Naranjo T, 2004, TRENDS PLANT SCI, V9, P214, DOI 10.1016/j.tplants.2004.03.001; Nonomura KI, 2006, J CELL SCI, V119, P217, DOI 10.1242/jcs.02736; Noor MAF, 2009, HEREDITY, V103, P439, DOI 10.1038/hdy.2009.151; Obeso D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010336; Osman K, 2011, NEW PHYTOL, V190, P523, DOI 10.1111/j.1469-8137.2011.03665.x; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Phillips D, 2008, ANN BOT-LONDON, V101, P873, DOI 10.1093/aob/mcm202; Phillips D, 2010, CYTOGENET GENOME RES, V129, P154, DOI 10.1159/000314335; Qi LL, 2010, FUNCT INTEGR GENOMIC, V10, P477, DOI 10.1007/s10142-010-0190-3; Rabl C, 1885, MORPHOL JB, V10, P214; RICHARDS EJ, 1988, CELL, V53, P127, DOI 10.1016/0092-8674(88)90494-1; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; Rockmill B, 2006, GENETICS, V174, P1745, DOI 10.1534/genetics.106.058933; Saintenac C, 2011, CHROMOSOMA, V120, P185, DOI 10.1007/s00412-010-0302-9; Saintenac C, 2009, GENETICS, V181, P393, DOI 10.1534/genetics.108.097469; Sanchez-Moran E, 2008, CYTOGENET GENOME RES, V120, P302, DOI 10.1159/000121079; Sanchez-Moran E, 2007, GENE DEV, V21, P2220, DOI 10.1101/gad.439007; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; SCHMEKEL K, 1995, TRENDS CELL BIOL, V5, P239, DOI 10.1016/S0962-8924(00)89017-0; SEN SK, 1970, NATURE, V228, P79, DOI 10.1038/228079a0; Shinohara M, 2008, NAT GENET, V40, P299, DOI 10.1038/ng.83; Stewart MN, 2008, TRENDS GENET, V24, P564, DOI 10.1016/j.tig.2008.08.006; STOCKERT J C, 1970, Cytobiologie, V2, P235; Trelles-Sticken E, 1999, J CELL SCI, V112, P651; Tsubouchi T, 2006, DEV CELL, V10, P809, DOI 10.1016/j.devcel.2006.04.003; UNFRIED I, 1990, NUCLEIC ACIDS RES, V18, P4011, DOI 10.1093/nar/18.13.4011; Wang CJR, 2009, GENETICS, V183, P905, DOI 10.1534/genetics.109.108688; WESTERGAARD M, 1972, ANNU REV GENET, V6, P71, DOI 10.1146/annurev.ge.06.120172.000443; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	75	44	46	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39539	10.1371/journal.pone.0039539	http://dx.doi.org/10.1371/journal.pone.0039539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761818	Green Submitted, Green Published, gold			2022-12-27	WOS:000305781700045
J	Appukuttan, B; McFarland, TJ; Stempel, A; Kassem, JB; Hartzell, M; Zhang, Y; Bond, D; West, K; Wilson, R; Stout, A; Pan, YZ; Ilias, H; Robertson, K; Klein, ML; Wilson, D; Smith, JR; Stout, JT				Appukuttan, Binoy; McFarland, Trevor J.; Stempel, Andrew; Kassem, Jean B.; Hartzell, Matthew; Zhang, Yi; Bond, Derek; West, Kelsey; Wilson, Reid; Stout, Andrew; Pan, Yuzhen; Ilias, Hoda; Robertson, Kathryn; Klein, Michael L.; Wilson, David; Smith, Justine R.; Stout, J. Timothy			The Related Transcriptional Enhancer Factor-1 Isoform, TEAD4(216), Can Repress Vascular Endothelial Growth Factor Expression in Mammalian Cells	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; PERMEABILITY FACTOR; GENE-EXPRESSION; SPLICE VARIANTS; TRANSGENIC MICE; SURVIVAL FACTOR; NERVOUS-SYSTEM; HIPPO PATHWAY; FACTOR ACTS; VEGF	Increased cellular production of vascular endothelial growth factor (VEGF) is responsible for the development and progression of multiple cancers and other neovascular conditions, and therapies targeting post-translational VEGF products are used in the treatment of these diseases. Development of methods to control and modify the transcription of the VEGF gene is an alternative approach that may have therapeutic potential. We have previously shown that isoforms of the transcriptional enhancer factor 1-related (TEAD4) protein can enhance the production of VEGF. In this study we describe a new TEAD4 isoform, TEAD4(216), which represses VEGF promoter activity. The TEAD4(216) isoform inhibits human VEGF promoter activity and does not require the presence of the hypoxia responsive element (HRE), which is the sequence critical to hypoxia inducible factor (HIF)-mediated effects. The TEAD4(216) protein is localized to the cytoplasm, whereas the enhancer isoforms are found within the nucleus. The TEAD4(216) isoform can competitively repress the stimulatory activity of the TEAD4(434) and TEAD4(148) enhancers. Synthesis of the native VEGF(165) protein and cellular proliferation is suppressed by the TEAD4(216) isoform. Mutational analysis indicates that nuclear or cytoplasmic localization of any isoform determines whether it acts as an enhancer or repressor, respectively. The TEAD4(216) isoform appears to inhibit VEGF production independently of the HRE required activity by HIF, suggesting that this alternatively spliced isoform of TEAD4 may provide a novel approach to treat VEGF-dependent diseases.	[Appukuttan, Binoy; McFarland, Trevor J.; Stempel, Andrew; Kassem, Jean B.; Hartzell, Matthew; Zhang, Yi; Bond, Derek; West, Kelsey; Wilson, Reid; Stout, Andrew; Pan, Yuzhen; Ilias, Hoda; Robertson, Kathryn; Klein, Michael L.; Wilson, David; Smith, Justine R.; Stout, J. Timothy] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA	Oregon Health & Science University	Appukuttan, B (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	appukutt@ohsu.edu	Smith, Justine/Y-9044-2019; Pan, YZ/GVS-2269-2022	Smith, Justine/0000-0002-4756-5493; Stout, Andrew/0000-0001-9470-1032; Wilson, Reid/0000-0002-4240-2361	National Institutes of Health [R01 EY019042]; Clayton Foundation for Research; Research to Prevent Blindness; Collins Medical Trust; American Health Assistance Foundation; NATIONAL EYE INSTITUTE [R01EY019042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Foundation for Research; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Collins Medical Trust; American Health Assistance Foundation(BrightFocus Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding for this work was provided by: National Institutes of Health (R01 EY019042); Clayton Foundation for Research; Research to Prevent Blindness; Collins Medical Trust; and the American Health Assistance Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; ANDREADIS A, 1987, ANNU REV CELL BIOL, V3, P207, DOI 10.1146/annurev.cellbio.3.1.207; Appukuttan B, 2007, INVEST OPHTH VIS SCI, V48, P3775, DOI 10.1167/iovs.06-1172; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Banerjee S, 2008, BIOCHEMISTRY-US, V47, P3345, DOI 10.1021/bi8000352; Benhaddou A, 2011, CELL DEATH DIFFER; Boyd SR, 2002, ARCH OPHTHALMOL-CHIC, V120, P1644; Chen LM, 2010, GENE DEV, V24, P290, DOI 10.1101/gad.1865310; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; CONNOLLY DT, 1989, J BIOL CHEM, V264, P20017; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; DUKER JS, 1989, OPHTHALMOLOGY, V96, P87; Farrance IKG, 1996, J BIOL CHEM, V271, P8266, DOI 10.1074/jbc.271.14.8266; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Guerrin M, 1997, ONCOGENE, V14, P463, DOI 10.1038/sj.onc.1200846; Gunther JB, 2009, SURV OPHTHALMOL, V54, P372, DOI 10.1016/j.survophthal.2009.02.004; Gupta M, 2001, J BIOL CHEM, V276, P10413, DOI 10.1074/jbc.M008625200; Gupta MP, 1997, MOL CELL BIOL, V17, P3924, DOI 10.1128/MCB.17.7.3924; Huh JI, 2005, ONCOGENE, V24, P790, DOI 10.1038/sj.onc.1208221; Husain Deeba, 2002, Ophthalmol Clin North Am, V15, P87, DOI 10.1016/S0896-1549(01)00009-8; Ishida A, 2001, J CELL PHYSIOL, V188, P359, DOI 10.1002/jcp.1121; Jiang SW, 2000, DNA CELL BIOL, V19, P507, DOI 10.1089/10445490050128430; Jin Y, 2011, J BIOL CHEM, V286, P22699, DOI 10.1074/jbc.M111.237024; Kallio PJ, 1997, P NATL ACAD SCI USA, V94, P5667, DOI 10.1073/pnas.94.11.5667; Kaneko KJ, 1998, DEV GENET, V22, P43, DOI 10.1002/(SICI)1520-6408(1998)22:1&lt;43::AID-DVG5&gt;3.0.CO;2-7; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; Kim I, 1999, INVEST OPHTH VIS SCI, V40, P2115; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Lu Ming, 2006, Ophthalmol Clin North Am, V19, P323; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; MILLER JW, 1994, AM J PATHOL, V145, P574; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Ozaki H, 1999, INVEST OPHTH VIS SCI, V40, P182; Pourgholami Mohammad H., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P343, DOI 10.2174/187152508785909528; Robinson CJ, 2001, J CELL SCI, V114, P853; Ryan SJ, 2006, RETINA; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Schoeffner DJ, 2005, LAB INVEST, V85, P608, DOI 10.1038/labinvest.3700258; Sheridan CM, 2009, GRAEF ARCH CLIN EXP, V247, P1361, DOI 10.1007/s00417-009-1133-3; Shie JL, 2004, J BIOL CHEM, V279, P25010, DOI 10.1074/jbc.M403103200; Shima DT, 1996, INVEST OPHTH VIS SCI, V37, P1334; Smith JR, 2007, AM J CLIN PATHOL, V127, P633, DOI 10.1309/NUQHJ79BHWYD9TAF; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Stewart AFR, 1996, GENOMICS, V37, P68, DOI 10.1006/geno.1996.0522; STREULI M, 1989, EMBO J, V8, P787, DOI 10.1002/j.1460-2075.1989.tb03439.x; Teng ACT, 2010, FASEB J, V24, P4825, DOI 10.1096/fj.10-167049; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wittko IM, 2009, J NEUROSCI, V29, P8704, DOI 10.1523/JNEUROSCI.5527-08.2009; Yamagishi S, 1999, LAB INVEST, V79, P501; Yasunami M, 1996, BIOCHEM BIOPH RES CO, V228, P365, DOI 10.1006/bbrc.1996.1667; Yockey CE, 1996, J BIOL CHEM, V271, P3727, DOI 10.1074/jbc.271.7.3727; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zuzarte PC, 2000, BBA-GENE STRUCT EXPR, V1517, P82, DOI 10.1016/S0167-4781(00)00261-X	58	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e31260	10.1371/journal.pone.0031260	http://dx.doi.org/10.1371/journal.pone.0031260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761647	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900001
J	Bedell, RA; Anderson, STB; van Lettow, M; Akesson, A; Corbett, EL; Kumwenda, M; Chan, AK; Heyderman, RS; Zachariah, R; Harries, AD; Ramsay, AR				Bedell, Richard A.; Anderson, Suzanne T. B.; van Lettow, Monique; Akesson, Ann; Corbett, Elizabeth L.; Kumwenda, Moses; Chan, Adrienne K.; Heyderman, Robert S.; Zachariah, Rony; Harries, Anthony D.; Ramsay, Andrew R.			High Prevalence of Tuberculosis and Serious Bloodstream Infections in Ambulatory Individuals Presenting for Antiretroviral Therapy in Malawi	PLOS ONE			English	Article							NEGATIVE PULMONARY TUBERCULOSIS; SUB-SAHARAN AFRICA; EARLY MORTALITY; CRYPTOCOCCAL ANTIGENEMIA; SPUTUM INDUCTION; SCALE-UP; HIV; ADULTS; DIAGNOSIS; SMEAR	Background: Tuberculosis (TB) and serious bloodstream infections (BSI) may contribute to the high early mortality observed among patients qualifying for antiretroviral therapy (ART) with unexplained weight loss, chronic fever or chronic diarrhea. Methods and Findings: A prospective cohort study determined the prevalence of undiagnosed TB or BSI among ambulatory HIV-infected adults with unexplained weight loss and/or chronic fever, or diarrhea in two routine program settings in Malawi. Subjects with positive expectorated sputum smears for AFB were excluded. Investigations Bacterial and mycobacterial blood cultures, cryptococcal antigen test (CrAg), induced sputum (IS) for TB microscopy and solid culture, full blood count and CD4 lymphocyte count. Among 469 subjects, 52 (11%) had microbiological evidence of TB; 50 (11%) had a positive (non-TB) blood culture and/or positive CrAg. Sixty-five additional TB cases were diagnosed on clinical and radiological grounds. Nontyphoidal Salmonellae (NTS) were the most common blood culture pathogens (29 cases; 6% of participants and 52% of bloodstream isolates). Multivariate analysis of baseline clinical and hematological characteristics found significant independent associations between oral candidiasis or lymphadenopathy and TB, marked CD4 lymphopenia and NTS infection, and severe anemia and either infection, but low positive likelihood ratios (<2 for all combinations). Conclusions: We observed a high prevalence of TB and serious BSI, particularly NTS, in a program cohort of chronically ill HIV-infected outpatients. Baseline clinical and hematological characteristics were inadequate predictors of infection. HIV clinics need better rapid screening tools for TB and BSI. Clinical trials to evaluate empiric TB or NTS treatment are required in similar populations.	[Bedell, Richard A.; van Lettow, Monique; Kumwenda, Moses; Chan, Adrienne K.] Dignitas Int, Zomba, Malawi; [Bedell, Richard A.] Univ British Columbia, Div Global Hlth, Vancouver, BC V5Z 1M9, Canada; [Anderson, Suzanne T. B.; Corbett, Elizabeth L.; Heyderman, Robert S.] Malawi Liverpool Wellcome Trust, Clin Res Programme, Blantyre, Malawi; [Anderson, Suzanne T. B.] Brighton & Sussex Med Sch, Dept Med, Falmer, Sussex, England; [van Lettow, Monique] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Akesson, Ann] Med Sans Frontieres Operat Ctr Brussels, Thyolo, Malawi; [Corbett, Elizabeth L.; Harries, Anthony D.] London Sch Hyg & Trop Med, London WC1, England; [Chan, Adrienne K.] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Zachariah, Rony] Med Sans Frontieres Operat Ctr Brussels, Brussels, Belgium; [Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Ramsay, Andrew R.] World Hlth Org, Geneva, Switzerland; [Ramsay, Andrew R.] Univ St Andrews, Sch Med, St Andrews KY16 9AJ, Fife, Scotland	University of British Columbia; University of Malawi; University of Brighton; University of Sussex; University of Toronto; University of London; London School of Hygiene & Tropical Medicine; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; World Health Organization; University of St Andrews	Bedell, RA (corresponding author), Dignitas Int, Zomba, Malawi.	r.bedell@dignitasinternational.org	Bedell, Richard/AAC-2595-2020	Bedell, Richard/0000-0002-5687-8053; Kumwenda, Moses Kelly/0000-0003-3091-7330; zachariah, rony/0000-0002-2915-9328; Corbett, Elizabeth/0000-0002-3552-3181	TREAT TB - An initiative; USAID (United States Agency for International Development); MSF-OCB	TREAT TB - An initiative; USAID (United States Agency for International Development)(United States Agency for International Development (USAID)); MSF-OCB	This study was funded through TREAT TB - An initiative led by the International Union Against Tuberculosis and Lung Disease (the Union) and supported by a USAID Cooperative Agreement (United States Agency for International Development). MSF-OCB self-funded their involvement in this study and did not receive funds from USAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Zahrani K, 2001, INT J TUBERC LUNG D, V5, P855; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P29, DOI 10.1093/jac/48.suppl_1.29; Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Archibald LK, 2000, J INFECT DIS, V181, P1414, DOI 10.1086/315367; Attia A, 2001, J ACQ IMMUN DEF SYND, V28, P478, DOI 10.1097/00042560-200112150-00012; Bell M, 2001, Int J Infect Dis, V5, P63, DOI 10.1016/S1201-9712(01)90027-X; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brown M, 2007, CLIN INFECT DIS, V44, P1415, DOI 10.1086/516782; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Cox JA, 2010, AIDS REV, V12, P183; Feltham R.K.A., 2003, COWAN STEELS MANUAL; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; GILKS CF, 1990, LANCET, V336, P545, DOI 10.1016/0140-6736(90)92096-Z; Gordon MA, 2001, J INFECTION, V42, P44, DOI 10.1053/jinf.2000.0779; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Kassa-Kelembho E, 2003, ACTA TROP, V89, P67, DOI 10.1016/j.actatropica.2003.09.004; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P287; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; LUCAS SB, 1994, BRIT MED J, V308, P1531, DOI 10.1136/bmj.308.6943.1531; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC; Mtunthama N, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-137; Murray J, 2007, AIDS, V21, pS97, DOI 10.1097/01.aids.0000299416.61808.24; Ngoma D, 2008, TROP DOCT, V38, P159, DOI 10.1258/td.2007.070244; Payongayong E., 2006, SIMPLE HOUSEHOLD POV; Peters RPH, 2004, TROP MED INT HEALTH, V9, P928, DOI 10.1111/j.1365-3156.2004.01288.x; Saathoff E, 2011, INT J TUBERC LUNG D, V15, P925, DOI 10.5588/ijtld.10.0477; Saranchuk P, 2007, SAMJ S AFR MED J, V97, P517; Ssali FN, 1998, J ACQ IMMUN DEF SYND, V19, P484, DOI 10.1097/00042560-199812150-00007; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Were W, 2009, INT J TUBERC LUNG D, V13, P47; WHO, 2011, POL STAT AUT REAL TI; Wilson D, 2006, INT J TUBERC LUNG D, V10, P31	41	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39347	10.1371/journal.pone.0039347	http://dx.doi.org/10.1371/journal.pone.0039347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761767	Green Published, Green Accepted, gold			2022-12-27	WOS:000305730900047
J	Hedman, AK; Li, MS; Langford, PR; Kroll, JS				Hedman, Asa K.; Li, Ming-Shi; Langford, Paul R.; Kroll, J. Simon			Transcriptional Profiling of Serogroup B Neisseria meningitidis Growing in Human Blood: An Approach to Vaccine Antigen Discovery	PLOS ONE			English	Article							BACTERICIDAL ACTIVITY; STRAIN; EXPRESSION; DNA; IDENTIFICATION; MICROARRAY; SEQUENCE; SURFACE; GROWTH; GENES	Neisseria meningitidis is a nasopharyngeal commensal of humans which occasionally invades the blood to cause septicaemia. The transcriptome of N. meningitidis strain MC58 grown in human blood for up to 4 hours was determined and around 10% of the genome was found to be differentially regulated. The nuo, pet and atp operons, involved in energy metabolism, were up-regulated, while many house-keeping genes were down-regulated. Genes encoding protein chaperones and proteases, involved in the stress response; complement resistant genes encoding enzymes for LOS sialylation and biosynthesis; and fHbp (NMB1870) and nspA (NMB0663), encoding vaccine candidates, were all up-regulated. Genes for glutamate uptake and metabolism, and biosynthesis of purine and pyrimidine were also up-regulated. Blood grown meningococci are under stress and undergo a metabolic adaptation and energy conservation strategy. The localisation of four putative outer membrane proteins encoded by genes found to be up-regulated in blood was assessed by FACS using polyclonal mouse antisera, and one (NMB0390) showed evidence of surface expression, supporting its vaccine candidacy.	[Hedman, Asa K.; Li, Ming-Shi; Langford, Paul R.; Kroll, J. Simon] Univ London Imperial Coll Sci Technol & Med, Paediat Sect, Dept Med, London, England	Imperial College London	Hedman, AK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Paediat Sect, Dept Med, St Marys Campus, London, England.	ming-shi.li@imperial.ac.uk	Langford, Paul/AAU-4189-2020; Langford, Paul R/B-9092-2008	Langford, Paul/0000-0002-6368-4724; Langford, Paul R/0000-0002-6368-4724; Hedman, Asa/0000-0001-5413-204X	Sanofi Pasteur; George John and Sheilah Livanos Charitable Trust	Sanofi Pasteur; George John and Sheilah Livanos Charitable Trust	This study was funded by Sanofi Pasteur and the George John and Sheilah Livanos Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolini E, 2006, MOL MICROBIOL, V60, P963, DOI 10.1111/j.1365-2958.2006.05163.x; Ben-Zvi AP, 2001, J STRUCT BIOL, V135, P84, DOI 10.1006/jsbi.2001.4352; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Chen CY, 1999, MICROBIOL-SGM, V145, P2967, DOI 10.1099/00221287-145-10-2967; Derrick JP, 1999, INFECT IMMUN, V67, P2406, DOI 10.1128/IAI.67.5.2406-2413.1999; Echenique-Rivera H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002027; Friedrich T, 2004, BBA-BIOENERGETICS, V1608, P1, DOI 10.1016/j.bbabio.2003.10.002; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; Grifantini R, 2004, MOL MICROBIOL, V54, P962, DOI 10.1111/j.1365-2958.2004.04315.x; Grifantini R, 2002, NAT BIOTECHNOL, V20, P914, DOI 10.1038/nbt728; Gupta S, 1996, NAT MED, V2, P437, DOI 10.1038/nm0496-437; Heist GD, 1922, J IMMUNOL, V7, P1; Hung MC, 2011, INFECT IMMUN, V79, P3784, DOI 10.1128/IAI.05019-11; Ison CA, 1999, MICROB PATHOGENESIS, V27, P207, DOI 10.1006/mpat.1999.0296; Joosten KFM, 2000, J CLIN ENDOCR METAB, V85, P3746, DOI 10.1210/jc.85.10.3746; Uria MJ, 2008, J EXP MED, V205, P1423, DOI 10.1084/jem.20072577; Joseph B, 2010, J BACTERIOL, V192, P5363, DOI 10.1128/JB.00883-10; Kahler CM, 1998, INFECT IMMUN, V66, P5939, DOI 10.1128/IAI.66.12.5939-5947.1998; Keiser PB, 2010, VACCINE, V28, P6970, DOI 10.1016/j.vaccine.2010.08.048; Kerkhoven RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001980; Kurz S, 2003, VACCINE, V21, P768, DOI 10.1016/S0264-410X(02)00596-0; Leuzzi R, 2005, MOL MICROBIOL, V58, P669, DOI 10.1111/j.1365-2958.2005.04859.x; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Li MS, 2009, MED MICROBIOL IMMUN, V198, P57, DOI 10.1007/s00430-008-0105-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Monaco C, 2006, INFECT IMMUN, V74, P1725, DOI 10.1128/IAI.74.3.1725-1740.2006; O'Dwyer CA, 2009, MICROBIOL-SGM, V155, P1940, DOI 10.1099/mic.0.026559-0; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ovstebo R, 2004, J CLIN MICROBIOL, V42, P2980, DOI 10.1128/JCM.42.7.2980-2987.2004; Pagliarulo C, 2004, MOL MICROBIOL, V51, P1757, DOI 10.1111/j.1365-2958.2003.03947.x; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Peng JP, 2008, GENOMICS, V91, P78, DOI 10.1016/j.ygeno.2007.10.004; Picard F, 2009, CR BIOL, V332, P958, DOI 10.1016/j.crvi.2009.09.005; Plested JS, 2009, CLIN VACCINE IMMUNOL, V16, P785, DOI 10.1128/CVI.00007-09; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Seib KL, 2007, MOL MICROBIOL, V63, P54, DOI 10.1111/j.1365-2958.2006.05478.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stabler RA, 2005, MICROBIOL-SGM, V151, P2907, DOI 10.1099/mic.0.28099-0; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun YH, 2000, NAT MED, V6, P1269, DOI 10.1038/81380; Tala A, 2011, MOL MICROBIOL, V81, P1330, DOI 10.1111/j.1365-2958.2011.07766.x; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Vogel U, 1999, MOL MICROBIOL, V32, P1133, DOI 10.1046/j.1365-2958.1999.01469.x; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	51	20	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39718	10.1371/journal.pone.0039718	http://dx.doi.org/10.1371/journal.pone.0039718			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745818	Green Published, gold			2022-12-27	WOS:000305730900106
J	Hubler, D; Rankovic, M; Richter, K; Lazarevic, V; Altrock, WD; Fischer, KD; Gundelfinger, ED; Fejtova, A				Huebler, Diana; Rankovic, Marija; Richter, Karin; Lazarevic, Vesna; Altrock, Wilko D.; Fischer, Klaus-Dieter; Gundelfinger, Eckart D.; Fejtova, Anna			Differential Spatial Expression and Subcellular Localization of CtBP Family Members in Rodent Brain	PLOS ONE			English	Article							SYNAPTIC RIBBONS; MOLECULAR-CLONING; MEMBRANE FISSION; PROTEIN BASSOON; GOLGI MEMBRANE; ROLES; CTBP/BARS; CTBP3/BARS; REPRESSION; INTERACTS	C-terminal binding proteins (CtBPs) are well-characterized nuclear transcriptional co-regulators. In addition, cytoplasmic functions were discovered for these ubiquitously expressed proteins. These include the involvement of the isoform CtBP1-S/BARS50 in cellular membrane-trafficking processes and a role of the isoform RIBEYE as molecular scaffolds in ribbons, the presynaptic specializations of sensory synapses. CtBPs were suggested to regulate neuronal differentiation and they were implied in the control of gene expression during epileptogenesis. However, the expression patterns of CtBP family members in specific brain areas and their subcellular localizations in neurons in situ are largely unknown. Here, we performed comprehensive assessment of the expression of CtBP1 and CtBP2 in mouse brain at the microscopic and the ultra-structural levels using specific antibodies. We quantified and compared expression levels of both CtBPs in biochemically isolated brain fractions containing cellular nuclei or synaptic compartment. Our study demonstrates differential regional and subcellular expression patterns for the two CtBP family members in brain and reveals a previously unknown synaptic localization for CtBP2 in particular brain regions. Finally, we propose a mechanism of differential synapto-nuclear targeting of its splice variants CtBP2-S and CtBP2-L in neurons.	[Huebler, Diana; Rankovic, Marija; Lazarevic, Vesna; Altrock, Wilko D.; Gundelfinger, Eckart D.; Fejtova, Anna] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Magdeburg, Germany; [Richter, Karin; Fischer, Klaus-Dieter] Univ Magdeburg, Inst Biochem & Cell Biol, D-39106 Magdeburg, Germany; [Lazarevic, Vesna] German Ctr Neurodegenerat Disorders DZNE, Magdeburg Branch, Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Hubler, D (corresponding author), Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Magdeburg, Germany.	afejtova@lin-magdeburg.de	Fejtova, Anna/AAZ-1024-2020; Fejtova, Anna/E-6343-2015	Fejtova, Anna/0000-0002-1815-4409	DFG [AL1115/1-1]; State of Saxony-Anhalt; European Commission;  [DFG-SFB 854]	DFG(German Research Foundation (DFG)); State of Saxony-Anhalt; European Commission(European CommissionEuropean Commission Joint Research Centre); 	This study was sponsored by DFG AL1115/1-1 to WDA, DFG-SFB 854 to KDF and EDG, and by the State of Saxony-Anhalt and the European Commission, EFRE 2007-2013 (ZVOH) to AF and MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; Brannon M, 1999, DEVELOPMENT, V126, P3159; Carcedo CH, 2004, SCIENCE, V305, P93, DOI 10.1126/science.1097775; Ch'ng TH, 2011, CURR OPIN NEUROBIOL, V21, P345, DOI 10.1016/j.conb.2011.01.011; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Corda D, 2006, TRENDS CELL BIOL, V16, P167, DOI 10.1016/j.tcb.2006.01.007; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Furusawa T, 1999, MOL CELL BIOL, V19, P8581; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Goslin K., 1998, CULTURING NERVE CELL, P339; Gundelfinger ED, 2011, CURR OPIN NEUROBIOL; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Izutsu K, 2001, BLOOD, V97, P2815, DOI 10.1182/blood.V97.9.2815; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; Katsanis N, 1998, GENOMICS, V47, P294, DOI 10.1006/geno.1997.5115; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Krieglstein K, 2011, TRENDS NEUROSCI, V34, P421, DOI 10.1016/j.tins.2011.06.002; Magupalli VG, 2008, J NEUROSCI, V28, P7954, DOI 10.1523/JNEUROSCI.1964-08.2008; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Poortinga G, 1998, EMBO J, V17, P2067, DOI 10.1093/emboj/17.7.2067; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Spanfo S, 1999, J BIOL CHEM, V274, P17705, DOI 10.1074/jbc.274.25.17705; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Verger A, 2006, MOL CELL BIOL, V26, P4882, DOI 10.1128/MCB.02402-05; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; West AE, 2011, COLD SPRING HARB PER, V3; Yang JS, 2005, EMBO J, V24, P4133, DOI 10.1038/sj.emboj.7600873; Zenisek D, 2003, J NEUROSCI, V23, P2538	35	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39710	10.1371/journal.pone.0039710	http://dx.doi.org/10.1371/journal.pone.0039710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745816	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900104
J	Yamasaki, S; Hasegawa, A; Hojyo, S; Ohashi, W; Fukada, T; Nishida, K; Hirano, T				Yamasaki, Satoru; Hasegawa, Aiko; Hojyo, Shintaro; Ohashi, Wakana; Fukada, Toshiyuki; Nishida, Keigo; Hirano, Toshio			A Novel Role of the L-Type Calcium Channel alpha(1D) Subunit as a Gatekeeper for Intracellular Zinc Signaling: Zinc Wave	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; MAST-CELLS; CYTOKINE PRODUCTION; MICE LACKING; ACTIVATION; HYPERSENSITIVITY; HOMEOSTASIS; RETENTION	Recent studies have shown that zinc ion (Zn) can behave as an intracellular signaling molecule. We previously demonstrated that mast cells stimulated through the high-affinity IgE receptor (Fc epsilon RI) rapidly release intracellular Zn from the endoplasmic reticulum (ER), and we named this phenomenon the "Zn wave". However, the molecules responsible for releasing Zn and the roles of the Zn wave were elusive. Here we identified the pore-forming alpha(1) subunit of the Cav1.3 (alpha(1D)) L-type calcium channel (LTCC) as the gatekeeper for the Zn wave. LTCC antagonists inhibited the Zn wave, and an agonist was sufficient to induce it. Notably, alpha(1D) was mainly localized to the ER rather than the plasma membrane in mast cells, and the Zn wave was impaired by alpha(1D) knockdown. We further found that the LTCC-mediated Zn wave positively controlled cytokine gene induction by enhancing the DNA-binding activity of NF-kappa B. Consistent with this finding, LTCC antagonists inhibited the cytokine-mediated delayed-type allergic reaction in mice without affecting the immediate-type allergic reaction. These findings indicated that the LTCC alpha(1D) subunit located on the ER membrane has a novel function as a gatekeeper for the Zn wave, which is involved in regulating NF-kappa B signaling and the delayed-type allergic reaction.	[Yamasaki, Satoru; Hasegawa, Aiko; Hojyo, Shintaro; Ohashi, Wakana; Fukada, Toshiyuki; Nishida, Keigo; Hirano, Toshio] Res Ctr Allergy & Immunol RCAI, RIKEN, Lab Cytokine Signaling, Yokohama, Kanagawa, Japan; [Nishida, Keigo] Osaka Univ, Grad Sch Frontier Biosci, Lab Immune Syst, Cooperat Program, Suita, Osaka, Japan; [Fukada, Toshiyuki] Osaka Univ, Grad Sch Med, Dept Allergy & Immunol, Suita, Osaka, Japan; [Hirano, Toshio] Osaka Univ, Japan Sci & Technol Agcy, JST CREST Program, Suita, Osaka, Japan	RIKEN; Osaka University; Osaka University; Japan Science & Technology Agency (JST); Osaka University	Yamasaki, S (corresponding author), Res Ctr Allergy & Immunol RCAI, RIKEN, Lab Cytokine Signaling, Yokohama, Kanagawa, Japan.	hirano@molonc.med.osaka-u.ac.jp		Hasegawa, Aiko/0000-0003-2887-444X	KAKENHI [23590576]; JST-CREST; Suzuken Memorial Foundation; Naito Foundation; Kanagawa Nanbyo Study Foundation;  [24249028]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Suzuken Memorial Foundation; Naito Foundation(Naito Memorial Foundation); Kanagawa Nanbyo Study Foundation; 	This work was supported by Grant-in-Aid for Scientific Research (KAKENHI #23590576), the JST-CREST program (http://www.jst.go.jp/kisoken/crest/en/area03/2-05.html), Grant-in-Aid for Scientific Research (A) (#24249028), the Suzuken Memorial Foundation (KN), the Naito Foundation (TF), and Kanagawa Nanbyo Study Foundation (TF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; ATAR D, 1995, J BIOL CHEM, V270, P2473, DOI 10.1074/jbc.270.6.2473; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Biedermann T, 2000, J EXP MED, V192, P1441, DOI 10.1084/jem.192.10.1441; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cornet V, 2002, EUR J NEUROSCI, V16, P883, DOI 10.1046/j.1460-9568.2002.02168.x; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Frederickson CJ, 2001, BIOMETALS, V14, P353, DOI 10.1023/A:1012934207456; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Gyulkhandanyan AV, 2006, J BIOL CHEM, V281, P9361, DOI 10.1074/jbc.M508542200; Haase H, 2008, J IMMUNOL, V181, P6491, DOI 10.4049/jimmunol.181.9.6491; Haase H, 2006, ANAL BIOCHEM, V352, P222, DOI 10.1016/j.ab.2006.02.009; Hambidge M, 2000, J NUTR, V130, p1344S, DOI 10.1093/jn/130.5.1344S; Hirano T, 2008, ADV IMMUNOL, V97, P149, DOI 10.1016/S0065-2776(08)00003-5; Hojyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018059; Kabu K, 2006, J IMMUNOL, V177, P1296, DOI 10.4049/jimmunol.177.2.1296; Kakurai M, 2006, AM J PATHOL, V169, P1713, DOI 10.2353/ajpath.2006.060602; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2000, ANN REV IMMUNOL, V18; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982; Kotturi MF, 2006, TRENDS PHARMACOL SCI, V27, P360, DOI 10.1016/j.tips.2006.05.007; Levy S, 2009, J BIOL CHEM, V284, P32434, DOI 10.1074/jbc.M109.058842; Maret W, 2011, BIOMETALS, V24, P411, DOI 10.1007/s10534-010-9406-1; Marquardt DL, 2000, J ALLERGY CLIN IMMUN, V105, P500, DOI 10.1067/mai.2000.104942; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Murakami M, 2008, CANCER SCI, V99, P1515, DOI 10.1111/j.1349-7006.2008.00854.x; Nishida K, 2002, BLOOD, V99, P1866, DOI 10.1182/blood.V99.5.1866; Nishida K, 2009, J EXP MED, V206, P1351, DOI 10.1084/jem.20082533; OKAMOTO T, 1992, INT IMMUNOL, V4, P811, DOI 10.1093/intimm/4.7.811; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Prasad AS, 2001, NUTRITION, V17, P67, DOI 10.1016/S0899-9007(00)00469-X; Ramadan O, 2009, J BIOL CHEM, V284, P5042, DOI 10.1074/jbc.M809132200; Sensi SL, 1997, J NEUROSCI, V17, P9554; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Shumilina E, 2008, J IMMUNOL, V180, P8040, DOI 10.4049/jimmunol.180.12.8040; Suto H, 2006, J IMMUNOL, V176, P4102, DOI 10.4049/jimmunol.176.7.4102; TOLEDANO MB, 1993, MOL CELL BIOL, V13, P852, DOI 10.1128/MCB.13.2.852; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; YANG JP, 1995, FEBS LETT, V361, P89, DOI 10.1016/0014-5793(95)00157-5; Yu MC, 2011, J EXP MED, V208, P775, DOI 10.1084/jem.20100031	47	48	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39654	10.1371/journal.pone.0039654	http://dx.doi.org/10.1371/journal.pone.0039654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745805	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900095
J	Aldrich, MC; Kumar, R; Colangelo, LA; Williams, LK; Sen, S; Kritchevsky, SB; Meibohm, B; Galanter, J; Hu, DL; Gignoux, CR; Liu, YM; Harris, TB; Ziv, E; Zmuda, J; Garcia, M; Leak, TS; Foreman, MG; Smith, LJ; Fornage, M; Liu, K; Burchard, EG				Aldrich, Melinda C.; Kumar, Rajesh; Colangelo, Laura A.; Williams, L. Keoki; Sen, Saunak; Kritchevsky, Stephen B.; Meibohm, Bernd; Galanter, Joshua; Hu, Donglei; Gignoux, Christopher R.; Liu, Yongmei; Harris, Tamara B.; Ziv, Elad; Zmuda, Joseph; Garcia, Melissa; Leak, Tennille S.; Foreman, Marilyn G.; Smith, Lewis J.; Fornage, Myriam; Liu, Kiang; Burchard, Esteban G.		Hlth ABC CARDIA Studies	Genetic Ancestry-Smoking Interactions and Lung Function in African Americans: A Cohort Study	PLOS ONE			English	Article							FORCED EXPIRATORY VOLUME; PULMONARY-FUNCTION; CARDIOVASCULAR-DISEASE; LONGITUDINAL CHANGE; GENDER-DIFFERENCES; POPULATION; SCAN; RISK; HERITABILITY; LIMITATION	Background: Smoking tobacco reduces lung function. African Americans have both lower lung function and decreased metabolism of tobacco smoke compared to European Americans. African ancestry is also associated with lower pulmonary function in African Americans. We aimed to determine whether African ancestry modifies the association between smoking and lung function and its rate of decline in African Americans. Methodology/Principal Findings: We evaluated a prospective ongoing cohort of 1,281 African Americans participating in the Health, Aging, and Body Composition (Health ABC) Study initiated in 1997. We also examined an ongoing prospective cohort initiated in 1985 of 1,223 African Americans in the Coronary Artery Disease in Young Adults (CARDIA) Study. Pulmonary function and tobacco smoking exposure were measured at baseline and repeatedly over the follow-up period. Individual genetic ancestry proportions were estimated using ancestry informative markers selected to distinguish European and West African ancestry. African Americans with a high proportion of African ancestry had lower baseline forced expiratory volume in one second (FEV1) per pack-year of smoking (-5.7 ml FEV1/smoking pack-year) compared with smokers with lower African ancestry (-4.6 ml in FEV1/smoking pack-year) (interaction P value = 0.17). Longitudinal analyses revealed a suggestive interaction between smoking, and African ancestry on the rate of FEV1 decline in Health ABC and independently replicated in CARDIA. Conclusions/Significance: African American individuals with a high proportion of African ancestry are at greater risk for losing lung function while smoking.	[Aldrich, Melinda C.] Vanderbilt Univ, Div Epidemiol, Dept Thorac Surg, Nashville, TN USA; [Aldrich, Melinda C.; Galanter, Joshua; Hu, Donglei; Gignoux, Christopher R.; Ziv, Elad; Burchard, Esteban G.] Univ Calif San Francisco, Dept Med Sci, San Francisco, CA 94143 USA; [Aldrich, Melinda C.; Galanter, Joshua; Hu, Donglei; Gignoux, Christopher R.; Ziv, Elad; Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Kumar, Rajesh] Northwestern Univ, Childrens Mem Hosp, Dept Pediat, Feinberg Sch Med, Chicago, IL 60614 USA; [Colangelo, Laura A.; Liu, Kiang] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Williams, L. Keoki] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI USA; [Williams, L. Keoki] Henry Ford Hlth Syst, Ctr Hlth Policy & Hlth Serv Res, Detroit, MI USA; [Sen, Saunak] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Kritchevsky, Stephen B.] Wake Forest Univ, Bowman Gray Sch Med, Sticht Ctr Aging, Winston Salem, NC USA; [Meibohm, Bernd] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Memphis, TN 38163 USA; [Liu, Yongmei] Wake Forest Univ, Dept Epidemiol & Prevent, Winston Salem, NC 27109 USA; [Harris, Tamara B.; Garcia, Melissa] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, Bethesda, MD 20892 USA; [Zmuda, Joseph; Leak, Tennille S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Foreman, Marilyn G.] Morehouse Sch Med, Div Pulm & Crit Care Med, Atlanta, GA 30310 USA; [Smith, Lewis J.] Northwestern Univ, Dept Med, Div Pulm & Crit Care, Feinberg Sch Med, Chicago, IL 60611 USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Div Epidemiol, Houston, TX USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Inst Mol Med, Houston, TX USA	Vanderbilt University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; University of California System; University of California San Francisco; Wake Forest University; Wake Forest Baptist Medical Center; University of Tennessee System; University of Tennessee Health Science Center; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Morehouse School of Medicine; Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Aldrich, MC (corresponding author), Vanderbilt Univ, Div Epidemiol, Dept Thorac Surg, Nashville, TN USA.	melinda.aldrich@vanderbilt.edu	Ziv, Elad/L-5396-2014	Foreman, Marilyn/0000-0002-9405-7475; Smith, Lewis J/0000-0002-4728-1562; Kumar, Rajesh/0000-0002-1962-7108; Meibohm, Bernd/0000-0003-3923-3648; Kritchevsky, Stephen/0000-0003-3336-6781; Galanter, Joshua/0000-0002-2561-6384	National Institutes of Health [HL078885, AI077439, HL088133, R01 HL74104, AI079139, AI061774, HL079055, DK064695, K23HL093023, HL092601, N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106, N01-HC-48047, 48050, N01-HC-95095]; Vanderbilt Clinical and Translational Research Scholars Program; Flight Attendant Medical Research Institute (FAMRI); American Asthma Foundation; Sandler Foundation; National Heart, Lung, and Blood Institute (NHLBI); Karmel-Sonix; Merck Co; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095095, N01HC048049, N01HC048048, N01HC048050, N01HC048047] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL092601, R01HL074104, K23HL093023, R01HL079055, R01HL078885, R01HL088133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439, R01AI079139, R01AI061774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062101, ZIAAG006000, ZIAAG007390, N01AG062103, N01AG062106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Clinical and Translational Research Scholars Program; Flight Attendant Medical Research Institute (FAMRI); American Asthma Foundation; Sandler Foundation; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Karmel-Sonix; Merck Co(Merck & Company); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the National Institutes of Health (HL078885, AI077439, HL088133, R01 HL74104, AI079139, AI061774, HL079055, DK064695, K23HL093023, HL092601, contracts N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106, N01-HC-48047 through 48050, and N01-HC-95095), the Vanderbilt Clinical and Translational Research Scholars Program, the Flight Attendant Medical Research Institute (FAMRI), the American Asthma Foundation and the Sandler Foundation. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The NIA had final responsibility for the decision to submit for publication for Health ABC. The Coronary Artery Risk Development in Young Adults Study (CARDIA) is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the University of Alabama at Birmingham, University of Minnesota, Northwestern University, and Kaiser Foundation Research Institute. This manuscript has been reviewed by CARDIA for scientific content and consistency of data interpretation with previous CARDIA publications.; The authors have read the journal's policy and have the following conflicts: Dr. Aldrich has served as a Guest Editor for PLoS ONE. Christopher R. Gignoux holds stock with 23andMe, Inc. Dr. Smith received consultancy funds from Karmel-Sonix. Dr. Williams has received funding from Merck & Co for speaking engagements and travel. No other disclosures were reported. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; BEATY TH, 1984, AM REV RESPIR DIS, V129, P660, DOI 10.1164/arrd.1984.129.5.660; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry OF, 2008, CHEST, V134, P1231, DOI 10.1378/chest.08-0257; Centers For Disease Control (Usa), 1998, Morbidity and Mortality Weekly Report, V47, P1; Chanock SJ, 2011, NAT GENET, V43, P178, DOI 10.1038/ng0311-178; Chatila WM, 2004, CHEST, V125, P15, DOI 10.1378/chest.125.1.15; Cutter G R, 1991, Control Clin Trials, V12, p1S, DOI 10.1016/0197-2456(91)90002-4; Dransfield MT, 2006, RESP MED, V100, P1110, DOI 10.1016/j.rmed.2005.09.019; Foreman MG, 2011, AM J RESP CRIT CARE; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; GIBSON KF, 1995, CHEST, V108, P1380; Gottlieb DJ, 2001, AM J RESP CRIT CARE, V164, P1655, DOI 10.1164/ajrccm.164.9.2010122; Gravel S, 2011, P NATL ACAD SCI; Griffith KA, 2001, AM J RESP CRIT CARE, V163, P61, DOI 10.1164/ajrccm.163.1.9906089; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Harik-Khan RI, 2004, AM J EPIDEMIOL, V160, P893, DOI 10.1093/aje/kwh297; James AL, 2005, AM J RESP CRIT CARE, V171, P109, DOI 10.1164/rccm.200402-230OC; Joost O, 2002, AM J RESP CRIT CARE, V165, P795, DOI 10.1164/ajrccm.165.6.2102057; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Kumar R, 2010, NEW ENGL J MED, V363, P321, DOI 10.1056/NEJMoa0907897; Kwan ML, 2004, AM J EPIDEMIOL, V160, P1098, DOI 10.1093/aje/kwh317; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; Perez-Stable EJ, 1998, JAMA-J AM MED ASSOC, V280, P152, DOI 10.1001/jama.280.2.152; Pritchard JK, 2000, GENETICS, V155, P945; REDLINE S, 1987, AM REV RESPIR DIS, V135, P217; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Reich D, 2007, AM J HUM GENET, V80, P716, DOI 10.1086/513206; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Reiner AP, 2007, HUM GENET, V121, P565, DOI 10.1007/s00439-007-0350-2; RYBICKI BA, 1990, J CLIN EPIDEMIOL, V43, P667, DOI 10.1016/0895-4356(90)90037-P; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Selvin S., 1996, STAT ANAL EPIDEMIOLO; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Trinidad DR, 2009, NICOTINE TOB RES, V11, P203, DOI 10.1093/ntr/ntn018; US Surgeon General, 1998, MMWR RECOMM REP, V47, pv; Vollmer WM, 2000, CHEST, V117, P764, DOI 10.1378/chest.117.3.764; Waterer GW, 2001, J AM GERIATR SOC, V49, P1032, DOI 10.1046/j.1532-5415.2001.49205.x; Whitfield KE, 2004, ETHNIC DIS, V14, P206; Wilk JB, 2003, AM J RESP CRIT CARE, V167, P1528, DOI 10.1164/rccm.200207-755OC; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Winkler CA, 2010, ANNU REV GENOM HUM G, V11, P65, DOI 10.1146/annurev-genom-082509-141523; Yang JJ, 2011, NAT GENET, V43, P237, DOI 10.1038/ng.763; Young RP, 2007, EUR RESPIR J, V30, P616, DOI 10.1183/09031936.00021707	46	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39541	10.1371/journal.pone.0039541	http://dx.doi.org/10.1371/journal.pone.0039541			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737244	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000305695100043
J	Tisato, V; Zauli, G; Voltan, R; Gianesini, S; di Iasio, MG; Volpi, I; Fiorentini, G; Zamboni, P; Secchiero, P				Tisato, Veronica; Zauli, Giorgio; Voltan, Rebecca; Gianesini, Sergio; di Iasio, Maria Grazia; Volpi, Ilaria; Fiorentini, Guido; Zamboni, Paolo; Secchiero, Paola			Endothelial Cells Obtained from Patients Affected by Chronic Venous Disease Exhibit a Pro-Inflammatory Phenotype	PLOS ONE			English	Article							RISK-FACTORS; OSTEOPROTEGERIN; ADHESION; ASSOCIATION; DIFFERENCE; PREDICTOR; MORTALITY; LEUKOCYTE; NUTLIN-3; PROTEIN	Background: The inflammatory properties of vein endothelium in relation to chronic venous disease (CVD) have been poorly investigated. Therefore, new insights on the characteristics of large vein endothelium would increase our knowledge of large vessel physiopathology. Methodology/Principal Findings: Surgical specimens of veins were obtained from the tertiary venous network (R3) and/or saphenous vein (SF) of patients affected by CVD and from control individuals. Highly purified venous endothelial cell (VEC) cultures obtained from CVD patients were characterized for morphological, phenotypic and functional properties compared to control VEC. An increase of CD31/PECAM-1, CD146 and ICAM-1 surface levels was documented at flow cytometry in pathological VEC with respect to normal controls. Of note, the strongest expression of these pro-inflammatory markers was observed in VEC obtained from patients with more advanced disease. Similarly, spontaneous cell proliferation and resistance to starvation was higher in pathological than in normal VEC, while the migratory response of VEC showed an opposite trend, being significantly lower in VEC obtained from pathological specimens. In addition, in keeping with a higher baseline transcriptional activity of NF-kB, the release of the pro-inflammatory cytokines osteoprotegerin (OPG) and vascular endothelial growth factor (VEGF) was higher in pathological VEC cultures with respect to control VEC. Interestingly, there was a systemic correlation to these in vitro data, as demonstrated by higher serum OPG and VEGF levels in CVD patients with respect to normal healthy controls. Conclusion/Significance: Taken together, these data indicate that large vein endothelial cells obtained from CVD patients exhibit a pro-inflammatory phenotype, which might significantly contribute to systemic inflammation in CVD patients.	[Tisato, Veronica; Voltan, Rebecca; di Iasio, Maria Grazia; Volpi, Ilaria; Secchiero, Paola] Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy; [Tisato, Veronica; Voltan, Rebecca; di Iasio, Maria Grazia; Volpi, Ilaria; Secchiero, Paola] Univ Ferrara, LTTA Ctr, I-44100 Ferrara, Italy; [Zauli, Giorgio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Gianesini, Sergio; Fiorentini, Guido; Zamboni, Paolo] Univ Ferrara, Vasc Dis Ctr, I-44100 Ferrara, Italy	University of Ferrara; University of Ferrara; IRCCS Burlo Garofolo; University of Ferrara	Tisato, V (corresponding author), Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy.	paola.secchiero@unife.it	secchiero, paola/G-9689-2015; Tisato, Veronica/K-4525-2016; Zauli, Giorgio/ABE-8001-2020; GIANESINI, SERGIO/K-9992-2016	secchiero, paola/0000-0003-4101-7987; Zauli, Giorgio/0000-0002-3750-8698; Fiorentini, Guido/0000-0002-1186-1979; Tisato, Veronica/0000-0001-8448-066X	FoRST-Fondazione per la Ricerca Scientifica Termale	FoRST-Fondazione per la Ricerca Scientifica Termale	This work was supported by a grant from FoRST-Fondazione per la Ricerca Scientifica Termale (to GZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide P, 2012, J IMMUNOL, V188, P1421, DOI 10.4049/jimmunol.1101647; Auzky O, 2011, INT ANGIOL, V30, P335; Bardin N, 2009, ARTERIOSCL THROM VAS, V29, P746, DOI 10.1161/ATVBAHA.108.183251; Beidler SK, 2009, J VASC SURG, V49, P1013, DOI 10.1016/j.jvs.2008.11.049; CAMPIONI D, 1995, AIDS RES HUM RETROV, V11, P1039, DOI 10.1089/aid.1995.11.1039; Carrasco OF, 2009, ANGIOLOGY, V60, P763, DOI 10.1177/0003319709332108; Eberhardt RT, 2005, CIRCULATION, V111, P2398, DOI 10.1161/01.CIR.0000164199.72440.08; Eriksson EE, 2005, ARTERIOSCL THROM VAS, V25, P723, DOI 10.1161/01.ATV.0000157578.51417.6f; Eriksson Einar E., 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P309, DOI 10.2174/1568006033481357; Gimbrone MA, 2000, ANN NY ACAD SCI, V902, P230; Glen K, 2012, J CELL PHYSIOL, V227, P2710, DOI 10.1002/jcp.23015; Harhouri K, 2010, BLOOD, V115, P3843, DOI 10.1182/blood-2009-06-229591; Hong C, 2005, ATHEROSCLEROSIS, V183, P169, DOI 10.1016/j.atherosclerosis.2005.03.047; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Levi M, 2003, CARDIOVASC RES, V60, P26, DOI 10.1016/S0008-6363(02)00857-X; Ley K, 2002, IMMUNOL REV, V186, P8, DOI 10.1034/j.1600-065X.2002.18602.x; Leychenko A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029055; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Malyankar UM, 2000, J BIOL CHEM, V275, P20959, DOI 10.1074/jbc.C000290200; Mogelvang R, 2012, AM J CARDIOL, V109, P515, DOI 10.1016/j.amjcard.2011.09.043; Naskret D, 2010, MICROVASC RES, V80, P440, DOI 10.1016/j.mvr.2010.07.009; Parkington HC, 2004, PHARMACOL RES, V49, P509, DOI 10.1016/j.phrs.2003.11.012; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Privratsky JR, 2010, LIFE SCI, V87, P69, DOI 10.1016/j.lfs.2010.06.001; Schmid-Schonbein GW, 2001, ANGIOLOGY, V52, pS27, DOI 10.1177/0003319701052001S04; Secchiero P, 2007, CURR DRUG METAB, V8, P395, DOI 10.2174/138920007780655432; Secchiero P, 2010, ATHEROSCLEROSIS, V210, P274, DOI 10.1016/j.atherosclerosis.2009.11.005; Sumpio BE, 2002, INT J BIOCHEM CELL B, V34, P1508, DOI 10.1016/S1357-2725(02)00075-4; Ulbrich H, 2003, TRENDS PHARMACOL SCI, V24, P640, DOI 10.1016/j.tips.2003.10.004; Venuraju SM, 2010, J AM COLL CARDIOL, V55, P2049, DOI 10.1016/j.jacc.2010.03.013; Vik A, 2011, J THROMB HAEMOST, V9, P638, DOI 10.1111/j.1538-7836.2011.04222.x; Voltan R, 2011, CLIN CANCER RES, V17, P5649, DOI 10.1158/1078-0432.CCR-11-1064; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wakefield T W, 1997, Cardiovasc Surg, V5, P6, DOI 10.1016/S0967-2109(96)00083-X; Westra J, 2011, RHEUMATOLOGY, V50, P665, DOI 10.1093/rheumatology/keq378; Zauli G, 2009, CELL MOL LIFE SCI, V66, P841, DOI 10.1007/s00018-008-8536-x; Zauli G, 2007, BLOOD, V110, P536, DOI 10.1182/blood-2007-01-068395	38	38	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39543	10.1371/journal.pone.0039543	http://dx.doi.org/10.1371/journal.pone.0039543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737245	Green Published, Green Submitted, gold			2022-12-27	WOS:000305695100044
J	Breda, A; Martinelli, LKB; Bizarro, CV; Rosado, LA; Borges, CB; Santos, DS; Basso, LA				Breda, Ardala; Martinelli, Leonardo K. B.; Bizarro, Cristiano V.; Rosado, Leonardo A.; Borges, Caroline B.; Santos, Diogenes S.; Basso, Luiz A.			Wild-Type Phosphoribosylpyrophosphate Synthase (PRS) from Mycobacterium tuberculosis: A Bacterial Class II PRS?	PLOS ONE			English	Article							DIPHOSPHATE SYNTHASE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; SYNTHETASE; PROTEIN; ENZYME; STATE; PURIFICATION; HISTIDINE; PATHWAY	The 5-phospho-alpha-D-ribose 1-diphosphate (PRPP) metabolite plays essential roles in several biosynthetic pathways, including histidine, tryptophan, nucleotides, and, in mycobacteria, cell wall precursors. PRPP is synthesized from alpha-D-ribose 5-phosphate (R5P) and ATP by the Mycobacterium tuberculosis prsA gene product, phosphoribosylpyrophosphate synthase (MtPRS). Here, we report amplification, cloning, expression and purification of wild-type MtPRS. Glutaraldehyde cross-linking results suggest that MtPRS predominates as a hexamer, presenting varied oligomeric states due to distinct ligand binding. MtPRS activity measurements were carried out by a novel coupled continuous spectrophotometric assay. MtPRS enzyme activity could be detected in the absence of Pi. ADP, GDP and UMP inhibit MtPRS activity. Steady-state kinetics results indicate that MtPRS has broad substrate specificity, being able to accept ATP, GTP, CTP, and UTP as diphosphoryl group donors. Fluorescence spectroscopy data suggest that the enzyme mechanism for purine diphosphoryl donors follows a random order of substrate addition, and for pyrimidine diphosphoryl donors follows an ordered mechanism of substrate addition in which R5P binds first to free enzyme. An ordered mechanism for product dissociation is followed by MtPRS, in which PRPP is the first product to be released followed by the nucleoside monophosphate products to yield free enzyme for the next round of catalysis. The broad specificity for diphosphoryl group donors and detection of enzyme activity in the absence of Pi would suggest that MtPRS belongs to Class II PRS proteins. On the other hand, the hexameric quaternary structure and allosteric ADP inhibition would place MtPRS in Class I PRSs. Further data are needed to classify MtPRS as belonging to a particular family of PRS proteins. The data here presented should help augment our understanding of MtPRS mode of action. Current efforts are toward experimental structure determination of MtPRS to provide a solid foundation for the rational design of specific inhibitors of this enzyme.	[Breda, Ardala; Martinelli, Leonardo K. B.; Bizarro, Cristiano V.; Rosado, Leonardo A.; Borges, Caroline B.; Santos, Diogenes S.; Basso, Luiz A.] Pontificia Univ Catolica Rio Grande Sul PUCRS, Programa Posgrad Biol Celular & Mol, CPBMF, INCT TB, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul	Breda, A (corresponding author), Pontificia Univ Catolica Rio Grande Sul PUCRS, Programa Posgrad Biol Celular & Mol, CPBMF, INCT TB, Porto Alegre, RS, Brazil.	diogenes@pucrs.br; luiz.basso@pucrs.br	Bizarro, Cristiano/I-5643-2013; Basso, Luiz Augusto/T-9308-2019; Tuberculose, Inct/K-2302-2013	Bizarro, Cristiano/0000-0002-2609-8996; Basso, Luiz Augusto/0000-0003-0903-2407; Katzfuss, Ardala/0000-0002-7177-9600; Astolfi Rosado, Leonardo/0000-0002-4349-0244	Decit/SCTIE/MS-MCT-CNPq-FNDCT-CAPES; FAPERGS-PRONEXCNPq; National Council for Scientific and Technological Development (CNPq); Higher Education Co-ordination Agency (CAPES)	Decit/SCTIE/MS-MCT-CNPq-FNDCT-CAPES; FAPERGS-PRONEXCNPq; National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Higher Education Co-ordination Agency (CAPES)	This work was supported by funds of Decit/SCTIE/MS-MCT-CNPq-FNDCT-CAPES to National Institute of Science and Technology on Tuberculosis (INCT-TB) to Diogenes S. Santos and Luiz Basso. Luiz Basso and Diogenes S. Santos also acknowledge financial support awarded by FAPERGS-PRONEXCNPq-2009. (Fundacao de Amparo A Pesquisa do Estado do Rio Grande do Sul - The National Council for Scientific and Technological Development.) Luiz Basso (CNPq, 520182/99-5) and Diogenes S. Santos (CNPq, 304051/1975-06) are Research Career Awardees of The National Council for Scientific and Technological Development (CNPq). Ardala Breda, Leonardo K. B. Martinelli, Cristiano V. Bizarro, Leonardo A. Rosado and Caroline B. Borges acknowledge scholarships awarded by The National Council for Scientific and Technological Development (CNPq) and The Higher Education Co-ordination Agency (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderwick LJ, 2011, GLYCOBIOLOGY, V21, P410, DOI 10.1093/glycob/cwq173; AMES BN, 1961, J BIOL CHEM, V236, P2019; ARNVIG K, 1990, EUR J BIOCHEM, V192, P195, DOI 10.1111/j.1432-1033.1990.tb19214.x; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Martinelli LKB, 2011, MOL BIOSYST, V7, P1289, DOI 10.1039/c0mb00245c; BRAVEN J, 1984, ANN CLIN BIOCHEM, V21, P366, DOI 10.1177/000456328402100505; Breda A, 2012, MOL BIOSYST, V8, P572, DOI 10.1039/c1mb05402c; Chant A, 2005, PROTEIN EXPRES PURIF, V39, P152, DOI 10.1016/j.pep.2004.10.017; Cook PF, 2007, GARLAND SCI, P19; Copeland R. A., 2004, ENZYMES PRACTICAL IN; DA Harris, SPECTROPHOTOMETRY SP; Dawson RMC, 1989, DATA BIOCH RES, P408; Ducati RG, 2007, CURR DRUG TARGETS, V8, P423, DOI 10.2174/138945007780059004; Eriksen TA, 2000, NAT STRUCT BIOL, V7, P303; Fadoulogiou VE, 2008, ANAL BIOCHEM, V373, P404, DOI 10.1016/j.ab.2007.10.027; Fonda Irena, 2002, ScientificWorldJournal, V2, P1312; Harris D.A., 1987, SPECTROPHOTOMETRY SP, P49; Hill AV, 1913, BIOCHEM J, V7, P471, DOI 10.1042/bj0070471; Hove-Jensen B, 2004, J BIOL CHEM, V279, P40345, DOI 10.1074/jbc.M405480200; HOVEJENSEN B, 1986, J BIOL CHEM, V261, P6765; HOVEJENSEN B, 1988, J BACTERIOL, V170, P1148, DOI 10.1128/jb.170.3.1148-1152.1988; Kadziola A, 2005, J MOL BIOL, V354, P815, DOI 10.1016/j.jmb.2005.10.001; KHORANA HG, 1958, J BIOL CHEM, V230, P941; Klammer AA, 2006, J PROTEOME RES, V5, P695, DOI 10.1021/pr050315j; Krath BN, 1999, BBA-PROTEIN STRUCT M, V1430, P403, DOI 10.1016/S0167-4838(99)00022-9; Krath BN, 2001, J BIOL CHEM, V276, P17851, DOI 10.1074/jbc.M010172200; Krath BN, 2001, PROTEIN SCI, V10, P2317, DOI 10.1110/ps.11801; Krungkrai SR, 2005, BIOCHEMISTRY-US, V44, P1643, DOI 10.1021/bi048439h; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li S, 2007, BIOCHEM J, V401, P39, DOI 10.1042/BJ20061066; Lucarelli AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015494; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; NOSAL JM, 1993, J BIOL CHEM, V268, P10168; OZTURK DH, 1995, BIOCHEMISTRY-US, V34, P10755, DOI 10.1021/bi00034a007; Roth D G, 1978, Methods Enzymol, V51, P12; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Scherman MS, 1996, J BIOL CHEM, V271, P29652, DOI 10.1074/jbc.271.47.29652; Schneiter R, 2000, MICROBIOL-SGM, V146, P3269, DOI 10.1099/00221287-146-12-3269; SCHUBERT KR, 1975, J BIOL CHEM, V250, P7492; Segel IH., 1993, ENZYME KINETICS BEHA; Sinha SC, 2001, CURR OPIN STRUC BIOL, V11, P733, DOI 10.1016/S0959-440X(01)00274-3; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Svenson S, 2010, HUM VACCINES, V6, P309, DOI 10.4161/hv.6.4.10711; Switzer R L, 1978, Methods Enzymol, V51, P3; SWITZER RL, 1969, J BIOL CHEM, V244, P2854; TATIBANA M, 1995, ADV ENZYME REGUL, V35, P229, DOI 10.1016/0065-2571(94)00017-W; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; WHO, 2010, GLOB TUB CONTR 2010; *WHO, 2009, MIN M HIGH M XDR TB; Willemoes M, 2000, J BIOL CHEM, V275, P35408, DOI 10.1074/jbc.M006346200; Wolucka BA, 2008, FEBS J, V275, P2691, DOI 10.1111/j.1742-4658.2008.06395.x; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5; ZOREF E, 1975, J CLIN INVEST, V56, P1093, DOI 10.1172/JCI108183	54	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39245	10.1371/journal.pone.0039245	http://dx.doi.org/10.1371/journal.pone.0039245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745722	Green Submitted, gold, Green Published			2022-12-27	WOS:000305693200052
J	Patil, KR; Roune, L; McHardy, AC				Patil, Kaustubh Raosaheb; Roune, Linus; McHardy, Alice Carolyn			The PhyloPythiaS Web Server for Taxonomic Assignment of Metagenome Sequences	PLOS ONE			English	Article							PHYLOGENETIC CLASSIFICATION; FUNCTIONAL-ANALYSIS; GENOMES	Metagenome sequencing is becoming common and there is an increasing need for easily accessible tools for data analysis. An essential step is the taxonomic classification of sequence fragments. We describe a web server for the taxonomic assignment of metagenome sequences with PhyloPythiaS. PhyloPythiaS is a fast and accurate sequence composition-based classifier that utilizes the hierarchical relationships between clades. Taxonomic assignments with the web server can be made with a generic model, or with sample-specific models that users can specify and create. Several interactive visualization modes and multiple download formats allow quick and convenient analysis and downstream processing of taxonomic assignments. Here, we demonstrate usage of our web server by taxonomic assignment of metagenome samples from an acidophilic biofilm community of an acid mine and of a microbial community from cow rumen.	[Patil, Kaustubh Raosaheb; Roune, Linus; McHardy, Alice Carolyn] Max Planck Inst Informat, Max Planck Res Grp Computat Genom & Epidemiol, Saarbrucken, Germany; [McHardy, Alice Carolyn] Univ Dusseldorf, Dept Algorithm Bioinformat, D-40225 Dusseldorf, Germany	Max Planck Society; Heinrich Heine University Dusseldorf	Patil, KR (corresponding author), Max Planck Inst Informat, Max Planck Res Grp Computat Genom & Epidemiol, Saarbrucken, Germany.	alice.mchardy@uni-duesseldorf.de	McHardy, Alice/ABF-2322-2020; McHardy, Alice C/K-9377-2018	McHardy, Alice/0000-0003-2370-3430; McHardy, Alice C/0000-0003-2370-3430	Max-Planck society; Heinrich-Heine University	Max-Planck society(Max Planck Society); Heinrich-Heine University	KRP, LR and ACM were supported by the Max-Planck society. ACM was also supported by the Heinrich-Heine University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams N, 2010, J R STAT SOC A STAT, V173, P274, DOI 10.1111/j.1467-985X.2009.00624_10.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Foerstner KU, 2005, EMBO REP, V6, P1208, DOI 10.1038/sj.embor.7400538; Gerlach W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-430; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hugenholtz P, 2002, GENOME BIOL, V3; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; KARLIN S, 1995, TRENDS GENET, V11, P283; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; McHardy AC, 2007, CURR OPIN MICROBIOL, V10, P499, DOI 10.1016/j.mib.2007.08.004; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Rosen GL, 2011, BIOINFORMATICS, V27, P127, DOI 10.1093/bioinformatics/btq619; Sandberg R, 2001, GENOME RES, V11, P1404, DOI 10.1101/gr.186401; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Tsochantaridis I, 2005, J MACH LEARN RES, V6, P1453; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269	29	82	84	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38581	10.1371/journal.pone.0038581	http://dx.doi.org/10.1371/journal.pone.0038581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745671	Green Submitted, Green Published, gold			2022-12-27	WOS:000305693200017
J	Ratert, N; Meyer, HA; Jung, M; Mollenkopf, HJ; Wagner, I; Miller, K; Kilic, E; Erbersdobler, A; Weikert, S; Jung, K				Ratert, Nadine; Meyer, Hellmuth-Alexander; Jung, Monika; Mollenkopf, Hans-Joachim; Wagner, Ina; Miller, Kurt; Kilic, Ergin; Erbersdobler, Andreas; Weikert, Steffen; Jung, Klaus			Reference miRNAs for miRNAome Analysis of Urothelial Carcinomas	PLOS ONE			English	Article							ENDOGENOUS CONTROL GENES; TRANSCRIPTION-PCR DATA; RELATIVE QUANTIFICATION; RT-PCR; MICRORNA SIGNATURES; HOUSEKEEPING GENES; TUMOR-SUPPRESSOR; HUMAN TISSUE; CELL-DEATH; BLADDER	Background/Objective: Reverse transcription quantitative real-time PCR (RT-qPCR) is widely used in microRNA (miRNA) expression studies on cancer. To compensate for the analytical variability produced by the multiple steps of the method, relative quantification of the measured miRNAs is required, which is based on normalization to endogenous reference genes. No study has been performed so far on reference miRNAs for normalization of miRNA expression in urothelial carcinoma. The aim of this study was to identify suitable reference miRNAs for miRNA expression studies by RT-qPCR in urothelial carcinoma. Methods: Candidate reference miRNAs were selected from 24 urothelial carcinoma and normal bladder tissue samples by miRNA microarrays. The usefulness of these candidate reference miRNAs together with the commonly for normalization purposes used small nuclear RNAs RNU6B, RNU48, and Z30 were thereafter validated by RT-qPCR in 58 tissue samples and analyzed by the algorithms geNorm, NormFinder, and BestKeeper. Principal Findings: Based on the miRNA microarray data, a total of 16 miRNAs were identified as putative reference genes. After validation by RT-qPCR, miR-101, miR-125a-5p, miR-148b, miR-151-5p, miR-181a, miR-181b, miR-29c, miR-324-3p, miR-424, miR-874, RNU6B, RNU48, and Z30 were used for geNorm, NormFinder, and BestKeeper analyses that gave different combinations of recommended reference genes for normalization. Conclusions: The present study provided the first systematic analysis for identifying suitable reference miRNAs for miRNA expression studies of urothelial carcinoma by RT-qPCR. Different combinations of reference genes resulted in reliable expression data for both strongly and less strongly altered miRNAs. Notably, RNU6B, which is the most frequently used reference gene for miRNA studies, gave inaccurate normalization. The combination of four (miR-101, miR-125a-5p, miR-148b, and miR-151-5p) or three (miR-148b, miR-181b, and miR-874,) reference miRNAs is recommended for normalization.	[Ratert, Nadine; Meyer, Hellmuth-Alexander; Jung, Monika; Miller, Kurt; Weikert, Steffen; Jung, Klaus] Univ Hosp Charite, Dept Urol, Berlin, Germany; [Ratert, Nadine; Jung, Klaus] Berlin Inst Urol Res, Berlin, Germany; [Meyer, Hellmuth-Alexander] Univ Hosp Charite, Inst Physiol, Berlin, Germany; [Mollenkopf, Hans-Joachim; Wagner, Ina] Max Planck Inst Infect Biol, Berlin, Germany; [Kilic, Ergin] Univ Hosp Charite, Inst Pathol, Berlin, Germany; [Erbersdobler, Andreas] Univ Rostock, Inst Pathol, Rostock, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Rostock	Ratert, N (corresponding author), Univ Hosp Charite, Dept Urol, Berlin, Germany.	klaus.jung@charite.de	Jung, Klaus/Z-2122-2018; Mollenkopf, Hans-Joachim/AAH-2500-2019	Jung, Klaus/0000-0001-9797-5362; Mollenkopf, Hans-Joachim/0000-0003-1167-4783	Foundation for Urological Research [BFIU_2010]; SONNENFELD-Stiftung [89838210]; Federal Ministry of Education and Research (MedSys)	Foundation for Urological Research; SONNENFELD-Stiftung; Federal Ministry of Education and Research (MedSys)(Federal Ministry of Education & Research (BMBF))	This study was partly supported by grants from the Foundation for Urological Research (BFIU_2010), the SONNENFELD-Stiftung (89838210), and the Federal Ministry of Education and Research (MedSys). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cao Y, 2011, TUMOR BIOL, V32, P179, DOI 10.1007/s13277-010-0111-z; Carlsson J, 2010, CANCER GENET CYTOGEN, V202, P71, DOI 10.1016/j.cancergencyto.2010.06.009; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Fendler A, 2011, CLIN CHEM, V57, P954, DOI 10.1373/clinchem.2010.157727; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hirata H, 2012, CARCINOGENESIS, V33, P41, DOI 10.1093/carcin/bgr239; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Jung M, 2010, CLIN CHEM, V56, P998, DOI 10.1373/clinchem.2009.141580; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Kessler Y, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-106; Latham GJ, 2010, METHODS MOL BIOL, V667, P19, DOI 10.1007/978-1-60761-811-9_2; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lin TX, 2009, J UROLOGY, V181, P1372, DOI 10.1016/j.juro.2008.10.149; Lin YW, 2012, FEBS LETT, V586, P442, DOI 10.1016/j.febslet.2012.01.027; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Magi-Galluzzi C, 2007, GENITOURINARY PATHOL, P154; Masotti A, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/659028; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Neely LA, 2010, UROL ONCOL-SEMIN ORI, V28, P39, DOI 10.1016/j.urolonc.2008.06.006; Ohl F, 2005, J MOL MED, V83, P1014, DOI 10.1007/s00109-005-0703-z; Ostenfeld MS, 2010, ONCOGENE, V29, P1073, DOI 10.1038/onc.2009.395; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Schaefer A, 2010, EXP MOL MED, V42, P749, DOI 10.3858/emm.2010.42.11.076; Schaefer A, 2010, NAT REV UROL, V7, P286, DOI 10.1038/nrurol.2010.45; Shen YM, 2011, EXP MOL MED, V43, P358, DOI 10.3858/emm.2011.43.6.039; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sobin, 2009, UICC TNM CLASSIFICAT; Song T, 2010, ASIAN PAC J CANCER P, V11, P905; Tatarano S, 2011, INT J ONCOL, V39, P13, DOI 10.3892/ijo.2011.1012; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; van der Kwast TH, 2009, CURR OPIN UROL, V19, P516, DOI 10.1097/MOU.0b013e32832eb45f; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Villadsen SB, 2012, BRIT J CANCER, V106, P366, DOI 10.1038/bjc.2011.520; Wang G, 2010, INT UROL NEPHROL, V42, P95, DOI 10.1007/s11255-009-9584-3; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Wotschofsky Z, 2011, ANAL BIOCHEM, V417, P233, DOI 10.1016/j.ab.2011.06.009; Wszolek MF, 2011, UROL ONCOL-SEMIN ORI, V29, P794, DOI 10.1016/j.urolonc.2009.08.024; Yamada Y, 2011, CANCER SCI, V102, P522, DOI 10.1111/j.1349-7006.2010.01816.x; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	58	64	71	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39309	10.1371/journal.pone.0039309	http://dx.doi.org/10.1371/journal.pone.0039309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745731	Green Submitted, gold, Green Published			2022-12-27	WOS:000305693200061
J	Phithakkitnukoon, S; Smoreda, Z; Olivier, P				Phithakkitnukoon, Santi; Smoreda, Zbigniew; Olivier, Patrick			Socio-Geography of Human Mobility: A Study Using Longitudinal Mobile Phone Data	PLOS ONE			English	Article								A relationship between people's mobility and their social networks is presented based on an analysis of calling and mobility traces for one year of anonymized call detail records of over one million mobile phone users in Portugal. We find that about 80% of places visited are within just 20 km of their nearest (geographical) social ties' locations. This figure rises to 90% at a 'geo-social radius' of 45 km. In terms of their travel scope, people are geographically closer to their weak ties than strong ties. Specifically, they are 15% more likely to be at some distance away from their weak ties than strong ties. The likelihood of being at some distance from social ties increases with the population density, and the rates of increase are higher for shorter geo-social radii. In addition, we find that area population density is indicative of geo-social radius where denser areas imply shorter radii. For example, in urban areas such as Lisbon and Porto, the geo-social radius is approximately 7 km and this increases to approximately 15 km for less densely populated areas such as Parades and Santa Maria da Feira.	[Phithakkitnukoon, Santi; Olivier, Patrick] Newcastle Univ, Culture Lab, Sch Comp Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Smoreda, Zbigniew] Orange Labs, Sociol & Econ Networks & Serv Dept, Issy Les Moulineaux, France	Newcastle University - UK; Orange SA	Phithakkitnukoon, S (corresponding author), Newcastle Univ, Culture Lab, Sch Comp Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	santi@newcastle.ac.uk	OLIVIER, PATRICK/V-5367-2019; Smoręda, Zbigniew/D-9265-2011; Phithakkitnukoon, Santi/E-4204-2015; Olivier, Patrick/B-2909-2011	Smoręda, Zbigniew/0000-0002-4047-7597; Phithakkitnukoon, Santi/0000-0002-5716-9363; Olivier, Patrick/0000-0003-2841-7580	School of Computing of Newcastle University	School of Computing of Newcastle University	The work has been funded by the School of Computing of Newcastle University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calabrese F., 2010, 2010 13th International IEEE Conference on Intelligent Transportation Systems (ITSC 2010), P312, DOI 10.1109/ITSC.2010.5625119; Calabrese F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020814; Calabrese F, 2010, LECT NOTES COMPUT SC, V6030, P22, DOI 10.1007/978-3-642-12654-3_2; Chiswick BR, 2010, ECONOMICA, V77, P201, DOI 10.1111/j.1468-0335.2009.00634.x; Eagle Nathan, 2009, 2009 International Conference on Computational Science and Engineering (CSE), P144, DOI 10.1109/CSE.2009.91; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Edwards C, 2010, NEW ELECTRON, V43, P19; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Eurofound, 2000, WORK COND PORT 2000; Eurostat, 2006, IS TIM WOM MEN DISTR; Ewing R, 2001, TRANSPORT RES REC, P87, DOI 10.3141/1780-10; Glaeser E.L., 2004, HDB REG URBAN EC, V4, P2481, DOI [DOI 10.1016/S1574-0080(04)80013-0, 10.1016/S1574-0080(04)80013-0]; Gonzalez MC, 2009, NATURE, V458, DOI 10.1038/nature07850; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hidalgo CA, 2008, PHYSICA A, V387, P3017, DOI 10.1016/j.physa.2008.01.073; Instituto Nacional de Estatistica, 2007, DEM STAT 2007; Instituto Nacional de Estatistica, 2001, 2001 CENS; Ioannides YM, 2003, REG SCI URBAN ECON, V33, P127, DOI 10.1016/S0166-0462(02)00006-6; Isaacman S, 2011, LECT NOTES COMPUT SC, V6696, P133, DOI 10.1007/978-3-642-21726-5_9; Krings Gautier, 2009, 2009 International Conference on Computational Science and Engineering (CSE), P936, DOI 10.1109/CSE.2009.272; Leighton T, 2009, COMMUN ACM, V52, P44, DOI 10.1145/1461928.1461944; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Onnela JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016939; Phithakkitnukoon S., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P515, DOI 10.1109/PASSAT/SocialCom.2011.11; Phithakkitnukoon S, 2011, AI SOC, V26, P71, DOI 10.1007/s00146-009-0230-5; Qiang Hao, 2010, P 19 INT C WORLD WID, P401, DOI DOI 10.1145/1772690.1772732; Quercia Daniele, 2010, Proceedings 2010 10th IEEE International Conference on Data Mining (ICDM 2010), P971, DOI 10.1109/ICDM.2010.152; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Traag V. A., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P625, DOI 10.1109/PASSAT/SocialCom.2011.133; United States Department of Labor, 2011, AM TIM US SURV SUMM; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053; Zheng V.W., 2010, P 19 INT C WORLD WID, DOI DOI 10.1145/1772690.1772795; Zheng Y., 2009, P 18 INT C WORLD WID, P791, DOI DOI 10.1145/1526709.1526816	34	112	112	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39253	10.1371/journal.pone.0039253	http://dx.doi.org/10.1371/journal.pone.0039253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761748	Green Submitted, gold, Green Published			2022-12-27	WOS:000305826400009
J	Ding, D; Wang, YJ; Han, MS; Fu, ZY; Li, WH; Liu, ZH; Hu, YM; Tang, JH				Ding, Dong; Wang, Yinju; Han, Mingshui; Fu, Zhiyuan; Li, Weihua; Liu, Zonghua; Hu, Yanmin; Tang, Jihua			MicroRNA Transcriptomic Analysis of Heterosis during Maize Seed Germination	PLOS ONE			English	Article							GENE-EXPRESSION; ALLELIC VARIATION; LEAF; PATTERNS; MIRNAS; FAMILY; GROWTH; LINES; NACL; B73	Heterosis has been utilized widely in the breeding of maize and other crops, and plays an important role in increasing yield, improving quality and enhancing stresses resistance, but the molecular mechanism responsible for heterosis is far from clear. To illustrate whether miRNA-dependent gene regulation is responsible for heterosis during maize germination, a deep-sequencing technique was applied to germinating embryos of a maize hybrid, Yuyu22, which is cultivated widely in China and its parental inbred lines, Yu87-1 and Zong3. The target genes of several miRNAs showing significant expression in the hybrid and parental lines were predicted and tested using real-time PCR. A total of 107 conserved maize miRNAs were co-detected in the hybrid and parental lines. Most of these miRNAs were expressed non-additively in the hybrid compared to its parental lines. These results indicated that miRNAs might participate in heterosis during maize germination and exert an influence via the decay of their target genes. Novel miRNAs were predicted follow a rigorous criterion and only the miRNAs detected in all three samples were treated as a novel maize miRNA. In total, 34 miRNAs belonged to 20 miRNA families were predicted in germinating maize seeds. Global repression of miRNAs in the hybrid, which might result in enhanced gene expression, might be one reason why the hybrid showed higher embryo germination vigor compared to its parental lines.	[Ding, Dong; Wang, Yinju; Han, Mingshui; Fu, Zhiyuan; Li, Weihua; Liu, Zonghua; Hu, Yanmin; Tang, Jihua] Henan Agr Univ, Coll Agron, Zhengzhou, Peoples R China	Henan Agricultural University	Ding, D (corresponding author), Henan Agr Univ, Coll Agron, Zhengzhou, Peoples R China.	Tangjihua1@163.com		fu, zhiyuan/0000-0002-9078-5133	National Nature Foundation of China [31000714]; National High Technology Research and Development Program of China [2012AA 10A 305]	National Nature Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by a grant from the National Nature Foundation of China (no. 31000714; http://www.nsfc.gov.cn/) and a grant from the National High Technology Research and Development Program of China (no. 2012AA 10A 305; http://www.863.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Bowman JL, 2004, BIOESSAYS, V26, P938, DOI 10.1002/bies.20103; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Christianson JA, 2009, PLANT PHYSIOL, V149, P1724, DOI 10.1104/pp.108.131912; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Chuck G, 2010, DEVELOPMENT, V137, P1243, DOI 10.1242/dev.048348; Frisch M, 2010, THEOR APPL GENET, V120, P441, DOI 10.1007/s00122-009-1204-1; Fu ZY, 2011, PROTEOMICS, V11, P1462, DOI 10.1002/pmic.201000481; Gao P, 2010, PLANTA, V231, P991, DOI 10.1007/s00425-010-1104-2; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Guo M, 2004, PLANT CELL, V16, P1707, DOI 10.1105/tpc.022087; Guo M, 2003, PLANT J, V36, P30, DOI 10.1046/j.1365-313X.2003.01852.x; Guo M, 2006, THEOR APPL GENET, V113, P831, DOI 10.1007/s00122-006-0335-x; Hoecker N, 2008, PROTEOMICS, V8, P3882, DOI 10.1002/pmic.200800023; Jahnke S, 2010, THEOR APPL GENET, V120, P389, DOI 10.1007/s00122-009-1207-y; Jones DF, 1917, GENETICS, V2, P466; Kim JH, 2003, PLANT J, V36, P94, DOI 10.1046/j.1365-313X.2003.01862.x; Kim SG, 2008, PLANT J, V55, P77, DOI 10.1111/j.1365-313X.2008.03493.x; LEONARDI A, 1991, THEOR APPL GENET, V82, P552, DOI 10.1007/BF00226790; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liu DM, 2009, PHYSIOL PLANTARUM, V136, P223, DOI 10.1111/j.1399-3054.2009.01229.x; Ma J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r22; Meyer S, 2007, PLANT MOL BIOL, V63, P381, DOI 10.1007/s11103-006-9095-x; Mica E, 2006, J EXP BOT, V57, P2601, DOI 10.1093/jxb/erl013; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Ogo Y, 2008, J BIOL CHEM, V283, P13407, DOI 10.1074/jbc.M708732200; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; POWERS L, 1945, BOT GAZ, V106, P247, DOI 10.1086/335297; Romisch-Margl L, 2010, THEOR APPL GENET, V120, P369, DOI 10.1007/s00122-009-1190-3; ROMAGNOLI S, 1990, THEOR APPL GENET, V80, P769, DOI 10.1007/BF00224190; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shull G. H., 1952, Heterosis., P14; SHULL G.H., 1908, J HERED, V4, P296; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; Song RT, 2003, P NATL ACAD SCI USA, V100, P9055, DOI 10.1073/pnas.1032999100; Stupar RM, 2006, GENETICS, V173, P2199, DOI 10.1534/genetics.106.060699; Swanson-Wagner RA, 2009, SCIENCE, V326, P1118, DOI 10.1126/science.1178294; Tang JH, 2007, CHINESE SCI BULL, V52, P477, DOI 10.1007/s11434-007-0098-z; Tang JH, 2010, THEOR APPL GENET, V120, P333, DOI 10.1007/s00122-009-1213-0; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Wang L, 2011, J EXP BOT, V62, P761, DOI 10.1093/jxb/erq307; Wang Y, 2009, INT J MOL SCI, V10, P116, DOI 10.3390/ijms10010116; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Yamamoto A, 2009, PLANT J, V58, P843, DOI 10.1111/j.1365-313X.2009.03817.x; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang Y, 2007, PLANT MOL BIOL, V63, P429, DOI 10.1007/s11103-006-9099-6	53	52	60	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39578	10.1371/journal.pone.0039578	http://dx.doi.org/10.1371/journal.pone.0039578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761829	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800045
J	Puglis, HJ; Boone, MD				Puglis, Holly J.; Boone, Michelle D.			Effects of Terrestrial Buffer Zones on Amphibians on Golf Courses	PLOS ONE			English	Article							POND-BREEDING SALAMANDERS; VEGETATIVE FILTER STRIPS; NORTHERN CRICKET FROGS; ACRIS-CREPITANS; AMBYSTOMA-TALPOIDEUM; GREEN FROGS; TADPOLES; DECLINE; LARVAL; METAMORPHOSIS	A major cause of amphibian declines worldwide is habitat destruction or alteration. Public green spaces, such as golf courses and parks, could serve as safe havens to curb the effects of habitat loss if managed in ways to bolster local amphibian communities. We reared larval Blanchard's cricket frogs (Acris blanchardi) and green frogs (Rana clamitans) in golf course ponds with and without 1 m terrestrial buffer zones, and released marked cricket frog metamorphs at the golf course ponds they were reared in. Larval survival of both species was affected by the presence of a buffer zone, with increased survival for cricket frogs and decreased survival for green frogs when reared in ponds with buffer zones. No marked cricket frog juveniles were recovered at any golf course pond in the following year, suggesting that most animals died or migrated. In a separate study, we released cricket frogs in a terrestrial pen and allowed them to choose between mown and unmown grass. Cricket frogs had a greater probability of using unmown versus mown grass. Our results suggest that incorporating buffer zones around ponds can offer suitable habitat for some amphibian species and can improve the quality of the aquatic environment for some sensitive local amphibians.	[Puglis, Holly J.; Boone, Michelle D.] Miami Univ, Dept Zool, Oxford, OH 45056 USA	University System of Ohio; Miami University	Puglis, HJ (corresponding author), Miami Univ, Dept Zool, Oxford, OH 45056 USA.	hpuglis@usgs.gov		Puglis, Holly/0000-0002-3090-6597	National Fish and Wildlife Foundation [2007-0070-003]; Miami University	National Fish and Wildlife Foundation; Miami University	Funding for this project came from a National Fish and Wildlife Foundation Wildlife Links Grant (2007-0070-003) and Miami University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade CM, 2010, J HERPETOL, V44, P591, DOI 10.1670/09-140.1; Altig R, 2007, FRESHWATER BIOL, V52, P386, DOI 10.1111/j.1365-2427.2006.01694.x; BARFIELD BJ, 1979, T ASAE, V22, P540, DOI 10.13031/2013.35057; Beard JB., 2002, TURF MANAGEMENT GOLF, V2nd ed; Beard KH, 2002, OECOLOGIA, V133, P583, DOI 10.1007/s00442-002-1071-9; BERVEN KA, 1990, ECOLOGY, V71, P1599, DOI 10.2307/1938295; Biek R, 2002, CONSERV BIOL, V16, P728, DOI 10.1046/j.1523-1739.2002.00433.x; Birchfield GL, 2005, SOUTHEAST NAT, V4, P63, DOI 10.1656/1528-7092(2005)004[0063:MPODNG]2.0.CO;2; BOBKA MS, 1981, COPEIA, P417; Boone MD, 2004, ECOL APPL, V14, P685, DOI 10.1890/02-5308; Boone MD, 2008, CONSERV BIOL, V22, P172, DOI 10.1111/j.1523-1739.2007.00817.x; Bridges CM, 2000, CONSERV BIOL, V14, P1490, DOI 10.1046/j.1523-1739.2000.99343.x; Bridges CM, 2002, B ENVIRON CONTAM TOX, V69, P562, DOI 10.1007/s00128-002-0098-2; Brodman R, 2006, J FRESHWATER ECOL, V21, P467, DOI 10.1080/02705060.2006.9665024; Brodman Robert, 1998, P125; BURKETT RD, 1984, VERTEBRATE ECOLOGY S, P89; BURTON TM, 1975, COPEIA, P541; CHAUBEY I, 1994, T ASAE, V37, P845, DOI 10.13031/2013.28149; Colding J, 2009, ECOSYSTEMS, V12, P191, DOI 10.1007/s10021-008-9217-1; Conroy SDS, 2003, POPUL ECOL, V45, P105, DOI 10.1007/s10144-003-0145-9; Garcia-Munoz E, 2009, ARCH ENVIRON CON TOX, V56, P557, DOI 10.1007/s00244-008-9201-y; Gosner N, 1960, HERPETOLOGICA, V16, P183; GRAY RH, 1983, COPEIA, P300; Gray RH, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P441; Harper EB, 2007, OECOLOGIA, V153, P879, DOI 10.1007/s00442-007-0796-x; Hay Robert, 1998, P79; Hoff KV, 1999, TADPOLES, P215; HORNE MT, 1995, ARCH ENVIRON CON TOX, V29, P500; Johnson JR, 2008, HERPETOLOGICA, V64, P259, DOI 10.1655/07-064.1; Kenna MP, 2002, USGA TURFGRASS ENV R, V1, P1; KERBY JL, 2009, ECOL LETT, V12, P1; Krutz LJ, 2005, WEED SCI, V53, P353, DOI 10.1614/WS-03-079R2; Lehtinen RM, 2006, COPEIA, P159, DOI 10.1643/0045-8511(2006)6[159:TEDOBC]2.0.CO;2; LUBOWSKI RN, 2006, EC INFORM B USDA, V14; McCarthy MA, 2004, J APPL ECOL, V41, P780, DOI 10.1111/j.0021-8901.2004.00919.x; Mierzwa Kenneth S., 1998, P115; MORIN PJ, 1983, ECOL MONOGR, V53, P119, DOI 10.2307/1942491; Morris KM, 2007, J WILDLIFE MANAGE, V71, P1034, DOI 10.2193/2005-469; Patty L, 1997, PESTIC SCI, V49, P243, DOI 10.1002/(SICI)1096-9063(199703)49:3&lt;243::AID-PS510&gt;3.0.CO;2-8; Porej D, 2004, WETL ECOL MANAG, V12, P1; Rankins A, 2001, WEED SCI, V49, P647, DOI 10.1614/0043-1745(2001)049[0647:PGFSFR]2.0.CO;2; Ranvestel AW, 2004, FRESHWATER BIOL, V49, P274, DOI 10.1111/j.1365-2427.2004.01184.x; Relyea RA, 2004, ENVIRON TOXICOL CHEM, V23, P1080, DOI 10.1897/03-259; Scott D. E., 2002, USGA TURFGRASS ENV R, V1, P1; SEMLITSCH RD, 1987, COPEIA, P61, DOI 10.2307/1446038; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; Semlitsch RD, 1998, CONSERV BIOL, V12, P1113, DOI 10.1046/j.1523-1739.1998.97274.x; Semlitsch RD, 2003, CONSERV BIOL, V17, P1219, DOI 10.1046/j.1523-1739.2003.02177.x; Semlitsch RD, 1996, LONG TERM STUDIES VE, P17; Sin H, 2008, BIOL INVASIONS, V10, P335, DOI 10.1007/s10530-007-9133-x; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; SMITH GC, 1976, ECOLOGY, V57, P252, DOI 10.2307/1934814; Smith GR, 2003, J HERPETOL, V37, P383, DOI 10.1670/0022-1511(2003)037[0383:MSBNCF]2.0.CO;2; Srivastava P, 1998, T ASAE, V41, P89, DOI 10.13031/2013.17161; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; U.S. Environmental Protection Agency, 1999, EPA600R99098; Vredenburg VT, 2004, P NATL ACAD SCI USA, V101, P7646, DOI 10.1073/pnas.0402321101; Waddle JH, 2008, J HERPETOL, V42, P467, DOI 10.1670/07-265.1; Welsh HH, 1998, ECOL APPL, V8, P1118; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; WRIGHT AH, 1995, HDB FROGS TOADS	61	10	11	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39590	10.1371/journal.pone.0039590	http://dx.doi.org/10.1371/journal.pone.0039590			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761833	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800047
J	Arbellay, E; Corona, C; Stoffel, M; Fonti, P; Decaulne, A				Arbellay, Estelle; Corona, Christophe; Stoffel, Markus; Fonti, Patrick; Decaulne, Armelle			Defining an Adequate Sample of Earlywood Vessels for Retrospective Injury Detection in Diffuse-Porous Species	PLOS ONE			English	Article							TREE-RINGS; WOOD; POPLAR; BETULA; FAGUS; XYLEM; SIZE; OAK; CO2	Vessels of broad-leaved trees have been analyzed to study how trees deal with various environmental factors. Cambial injury, in particular, has been reported to induce the formation of narrower conduits. Yet, little or no effort has been devoted to the elaboration of vessel sampling strategies for retrospective injury detection based on vessel lumen size reduction. To fill this methodological gap, four wounded individuals each of grey alder (Alnus incana (L.) Moench) and downy birch (Betula pubescens Ehrh.) were harvested in an avalanche path. Earlywood vessel lumina were measured and compared for each tree between the injury ring built during the growing season following wounding and the control ring laid down the previous year. Measurements were performed along a 10 mm wide radial strip, located directly next to the injury. Specifically, this study aimed at (i) investigating the intra-annual duration and local extension of vessel narrowing close to the wound margin and (ii) identifying an adequate sample of earlywood vessels (number and intra-ring location of cells) attesting to cambial injury. Based on the results of this study, we recommend analyzing at least 30 vessels in each ring. Within the 10 mm wide segment of the injury ring, wound-induced reduction in vessel lumen size did not fade with increasing radial and tangential distances, but we nevertheless advise favoring early earlywood vessels located closest to the injury. These findings, derived from two species widespread across subarctic, mountainous, and temperate regions, will assist retrospective injury detection in Alnus, Betula, and other diffuse-porous species as well as future related research on hydraulic implications after wounding.	[Arbellay, Estelle; Corona, Christophe; Stoffel, Markus] Univ Bern, Inst Geol Sci, Lab Dendrogeomorphol, Bern, Switzerland; [Arbellay, Estelle; Stoffel, Markus] Univ Geneva, Inst Environm Sci, Carouge, Switzerland; [Fonti, Patrick] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Decaulne, Armelle] Univ Clermont Ferrand, CNRS Geolab, Clermont Ferrand, France	University of Bern; University of Geneva; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universite de Limoges	Arbellay, E (corresponding author), Univ Bern, Inst Geol Sci, Lab Dendrogeomorphol, Bern, Switzerland.	estelle.arbellay@dendrolab.ch	Fonti, Patrick/B-7400-2011; Stoffel, Markus/A-1793-2017; CORONA, Christophe/I-2095-2012	Fonti, Patrick/0000-0002-7070-3292; Stoffel, Markus/0000-0003-0816-1303; CORONA, Christophe/0000-0002-7645-6157	Service des Forets et du Paysage (SFP); Service des Routes et des Cours d'Eau (SRCE), Canton of Valais	Service des Forets et du Paysage (SFP); Service des Routes et des Cours d'Eau (SRCE), Canton of Valais	The authors are indebted to the Service des Forets et du Paysage (SFP) and the Service des Routes et des Cours d'Eau (SRCE), Canton of Valais, for their financial support of this study as part of the RUFINE project. They are also grateful to Achim A. Beylich (Geological Survey of Norway, Trondheim) for providing accommodation and transportation during fieldwork through the ESF sedyMONT Norway project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles F, 1992, ETHYLENE PLANT BIOL; ALONI R, 1983, DIFFERENTIATION, V24, P203, DOI 10.1111/j.1432-0436.1983.tb01320.x; ALONI R, 1984, BOT GAZ, V145, P50, DOI 10.1086/337425; Arbellay E, 2012, BOREAS UNPUB; Arbellay E, 2012, J EXP BOT, V63, P3271, DOI 10.1093/jxb/ers050; Arbellay E, 2010, TREE PHYSIOL, V30, P1290, DOI 10.1093/treephys/tpq065; Baas P., 2004, EVOLUTION PLANT PHYS, DOI DOI 10.1016/B978-012339552-8/50016-0; Ballesteros JA, 2010, TREE PHYSIOL, V30, P773, DOI 10.1093/treephys/tpq031; Battipaglia G, 2010, NEW PHYTOL, V188, P1099, DOI 10.1111/j.1469-8137.2010.03443.x; Blanchette RA., 1992, DEFENSE MECH WOODY P, P76, DOI DOI 10.1007/978-3-662-01642-8_5; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Eckstein D, 2004, NEW PHYTOL, V163, P1, DOI 10.1111/j.1469-8137.2004.01117.x; Fink S., 1999, ENCY PLANT ANATOMY 6, V14; Fonti P, 2007, NEW PHYTOL, V173, P562, DOI 10.1111/j.1469-8137.2006.01945.x; Fonti P, 2010, NEW PHYTOL, V185, P42, DOI 10.1111/j.1469-8137.2009.03030.x; Garcia-Gonzalez I, 2003, TREE PHYSIOL, V23, P497, DOI 10.1093/treephys/23.7.497; Garcia-Gonzalez I, 2008, TREES-STRUCT FUNCT, V22, P237, DOI 10.1007/s00468-007-0180-9; Kames S, 2011, DENDROCHRONOLOGIA, V29, P109, DOI 10.1016/j.dendro.2009.10.004; Kostiainen K, 2008, TREE PHYSIOL, V28, P805, DOI 10.1093/treephys/28.5.805; KURODA K, 1985, IAWA BULL, V6, P107, DOI 10.1163/22941932-90000922; LEVYADUN S, 1993, NEW PHYTOL, V124, P339, DOI 10.1111/j.1469-8137.1993.tb03824.x; Liese W, 1996, FOREST TREES PALMS D, P20; LOWERTS G, 1986, WOOD FIBER SCI, V18, P537; RADEMACHER P, 1984, IAWA BULL, V5, P141, DOI 10.1163/22941932-90000879; SASS U, 1995, TREES-STRUCT FUNCT, V9, P247, DOI 10.1007/BF00202014; Schoch W., 2004, WOOD ANATOMY CENTRAL; Schume H, 2004, TREES-STRUCT FUNCT, V18, P184, DOI 10.1007/s00468-003-0294-7; St George S., 2002, TREE-RING RES, V58, P3; Sutton A, 2005, IAWA J, V26, P221; Tardif JC, 2006, CAN J FOREST RES, V36, P2317, DOI 10.1139/X06-133; Watanabe Y, 2010, PLANT CELL ENVIRON, V33, P1101, DOI 10.1111/j.1365-3040.2010.02132.x; White F. M., 2006, VISCOUS FLUID FLOW	32	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e38824	10.1371/journal.pone.0038824	http://dx.doi.org/10.1371/journal.pone.0038824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761707	Green Published, gold			2022-12-27	WOS:000305808700012
J	Craddock, TJA; George, MS; Freedman, H; Barakat, KH; Damaraju, S; Hameroff, S; Tuszynski, JA				Craddock, Travis J. A.; George, Marc St.; Freedman, Holly; Barakat, Khaled H.; Damaraju, Sambasivarao; Hameroff, Stuart; Tuszynski, Jack A.			Computational Predictions of Volatile Anesthetic Interactions with the Microtubule Cytoskeleton: Implications for Side Effects of General Anesthesia	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ALPHA-BETA-TUBULIN; RAT-BRAIN PROTEINS; MOLECULAR-DYNAMICS; SEVOFLURANE ANESTHESIA; HIPPOCAMPAL-NEURONS; INHALED ANESTHETICS; COGNITIVE DECLINE; HALOTHANE BINDING; KINASE-C	The cytoskeleton is essential to cell morphology, cargo trafficking, and cell division. As the neuronal cytoskeleton is extremely complex, it is no wonder that a startling number of neurodegenerative disorders (including but not limited to Alzheimer's disease, Parkinson's disease and Huntington's disease) share the common feature of a dysfunctional neuronal cytoskeleton. Recently, concern has been raised about a possible link between anesthesia, post-operative cognitive dysfunction, and the exacerbation of neurodegenerative disorders. Experimental investigations suggest that anesthetics bind to and affect cytoskeletal microtubules, and that anesthesia-related cognitive dysfunction involves microtubule instability, hyper-phosphorylation of the microtubule-associated protein tau, and tau separation from microtubules. However, exact mechanisms are yet to be identified. In this paper the interaction of anesthetics with the microtubule subunit protein tubulin is investigated using computer-modeling methods. Homology modeling, molecular dynamics simulations and surface geometry techniques were used to determine putative binding sites for volatile anesthetics on tubulin. This was followed by free energy based docking calculations for halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) on the tubulin body, and C-terminal regions for specific tubulin isotypes. Locations of the putative binding sites, halothane binding energies and the relation to cytoskeleton function are reported in this paper.	[Craddock, Travis J. A.; Barakat, Khaled H.; Tuszynski, Jack A.] Univ Alberta, Dept Phys, Edmonton, AB, Canada; [George, Marc St.; Damaraju, Sambasivarao] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Freedman, Holly] Univ Algarve, Fdn Sci & Technol, Ctr Marine Sci, Faro, Portugal; [Hameroff, Stuart] Univ Arizona, Hlth Sci Ctr, Dept Anesthesiol, Ctr Consciousness Studies, Tucson, AZ USA; [Hameroff, Stuart] Univ Arizona, Hlth Sci Ctr, Dept Psychol, Ctr Consciousness Studies, Tucson, AZ USA; [Damaraju, Sambasivarao; Tuszynski, Jack A.] Univ Alberta, Dept Oncol, Cross Canc Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta; Universidade do Algarve; University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Arizona Health Sciences; University of Alberta	Craddock, TJA (corresponding author), Univ Alberta, Dept Phys, Edmonton, AB, Canada.	travisc@ualberta.ca; jackt@ualberta.ca	Tuszynski, Jack/AAA-2073-2020	Tuszynski, Jack/0000-0001-9976-0429; Barakat, Khaled/0000-0002-3567-7279; Craddock, Travis/0000-0001-7244-6317	NSERC (Natural Sciences and Engineering Research Council); Alberta Cancer Foundation [23783]; Alberta Advanced Education and Technology [TC-LSI-08-09]; Allard Foundation [23676]; Portuguese Foundation for Science and Technology (FCT)	NSERC (Natural Sciences and Engineering Research Council)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Cancer Foundation; Alberta Advanced Education and Technology; Allard Foundation; Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	T.J.A.C. gratefully acknowledges funding support from NSERC (Natural Sciences and Engineering Research Council) (www.nserc-crsng.gc.ca). J.A.T. acknowledges support for this research from the Alberta Cancer Foundation (Grant #: 23783) (albertacancer.ca), Alberta Advanced Education and Technology (Grant #: TC-LSI-08-09) (www.advancededucation.gov.ab.ca), the Allard Foundation (Grant #: 23676), and NSERC (www.nserc-crsng.gc.ca). H. F. is grateful for postdoctoral fellowship funding from the Portuguese Foundation for Science and Technology (FCT) (www.fct.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON AC, 1968, LANCET, V2, P1326; ALLISON AC, 1970, J CELL SCI, V7, P483; ANTHONY BL, 1989, NEUROSCI LETT, V99, P191, DOI 10.1016/0304-3940(89)90288-7; Avidan MS, 2011, J ALZHEIMERS DIS, V24, P201, DOI 10.3233/JAD-2011-101680; Bai RL, 1996, CANCER RES, V56, P4398; Bennett MJ, 2010, CHEM BIOL, V17, P725, DOI 10.1016/j.chembiol.2010.05.019; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BHATTACHARYYA B, 1985, J BIOL CHEM, V260, P208; Brady GP, 2000, J COMPUT AID MOL DES, V14, P383, DOI 10.1023/A:1008124202956; Bush AI, 2008, NEUROTHERAPEUTICS, V5, P421, DOI 10.1016/j.nurt.2008.05.001; Byrem WC, 2006, BBA-PROTEINS PROTEOM, V1764, P1320, DOI 10.1016/j.bbapap.2006.06.009; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Carpenter EJ, 2006, EUR BIOPHYS J BIOPHY, V36, P35, DOI 10.1007/s00249-006-0088-0; Case D.A., 2006, AMBER, V9; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; COVARRUBIAS M, 1995, J BIOL CHEM, V270, P19408, DOI 10.1074/jbc.270.33.19408; Craddock TJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033552; Craddock TJA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002421; DAIGLE I, 1993, BIOCHEM CELL BIOL, V71, P57, DOI 10.1139/o93-009; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Durieux ME, 1996, ANESTHESIOLOGY, V84, P173, DOI 10.1097/00000542-199601000-00020; Eckenhoff ME, 2002, J PHARMACOL EXP THER, V300, P172, DOI 10.1124/jpet.300.1.172; Eckenhoff MF, 1998, J PHARMACOL EXP THER, V285, P371; Eckenhoff RG, 2012, ANESTHESIOLOGY, V116, P751, DOI 10.1097/ALN.0b013e31824be8e1; ELMAGHRABI EA, 1993, ANESTHESIOLOGY, V78, P750, DOI 10.1097/00000542-199304000-00019; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Fodale V, 2010, J ALZHEIMERS DIS, V22, pS1, DOI 10.3233/JAD-2010-100809; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; FRANKS NP, 1984, NATURE, V310, P599, DOI 10.1038/310599a0; Freedman H, 2011, PROTEINS, V79, P2968, DOI 10.1002/prot.23155; Furukawa K, 2003, J NEUROCHEM, V87, P427, DOI 10.1046/j.1471-4159.2003.02020.x; FURUKAWA K, 1995, BRAIN RES, V689, P141, DOI 10.1016/0006-8993(95)00537-Z; Futterer CD, 2004, ANESTHESIOLOGY, V100, P302; GASKIN F, 1977, J BIOL CHEM, V252, P6918; Ghersi D, 2009, PROTEINS, V74, P417, DOI 10.1002/prot.22154; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Greenberger Lee M., 2008, P227, DOI 10.1007/978-1-59745-336-3_10; Hameroff S, 2002, BIOSYSTEMS, V64, P149, DOI 10.1016/S0303-2647(01)00183-6; Hameroff SR, 2010, J INTEGR NEUROSCI, V9, P253, DOI 10.1142/S0219635210002482; Hemmings HC, 1996, ANESTHESIOLOGY, V84, P652, DOI 10.1097/00000542-199603000-00021; Hetenyi C, 2006, FEBS LETT, V580, P1447, DOI 10.1016/j.febslet.2006.01.074; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; HINKLEY R E JR, 1971, Journal of Neurobiology, V2, P97, DOI 10.1002/neu.480020202; HINKLEY RE, 1972, J CELL BIOL, V53, P258, DOI 10.1083/jcb.53.1.258; HINKLEY RE, 1976, J ULTRA MOL STRUCT R, V57, P237, DOI 10.1016/S0022-5320(76)80113-X; HINKLEY RE, 1978, J CELL SCI, V32, P99; Huzil JT, 2008, J MOL BIOL, V378, P1016, DOI 10.1016/j.jmb.2008.03.026; Huzil JT, 2006, NANOTECHNOLOGY, V17, pS90, DOI 10.1088/0957-4484/17/4/014; Joe PA, 2009, J BIOL CHEM, V284, P4283, DOI 10.1074/jbc.M807491200; JOHNSON BD, 1994, PFLUG ARCH EUR J PHY, V429, P14, DOI 10.1007/BF02584025; JOHNSON BD, 1993, NEURON, V10, P797, DOI 10.1016/0896-6273(93)90196-X; Kaech S, 1999, P NATL ACAD SCI USA, V96, P10433, DOI 10.1073/pnas.96.18.10433; Kalenka A, 2007, ANESTH ANALG, V104, P1129, DOI 10.1213/01.ane.0000260799.37107.e6; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; KARON BS, 1995, BIOPHYS J, V68, P936, DOI 10.1016/S0006-3495(95)80269-9; Khan IA, 2003, INVEST NEW DRUG, V21, P3, DOI 10.1023/A:1022946305242; KINGSTON DGI, 1994, TRENDS BIOTECHNOL, V12, P222, DOI 10.1016/0167-7799(94)90120-1; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V297, P1760, DOI 10.1001/jama.297.16.1760; Le Freche H, 2012, ANESTHESIOLOGY, V116, P779, DOI 10.1097/ALN.0b013e31824be8c7; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; LIVINGSTON A, 1979, CELL TISSUE RES, V198, P137; Livingston A, 1979, BR J PHARM, V67, p453P; Lobert S, 2000, BIOCHEMISTRY-US, V39, P12053, DOI 10.1021/bi001038r; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Luduena Richard E., 2008, P123, DOI 10.1007/978-1-59745-336-3_6; Luduena Richard F., 2008, P105, DOI 10.1007/978-1-59745-336-3_5; MEJILLANO MR, 1992, BIOCHEMISTRY-US, V31, P3478, DOI 10.1021/bi00128a023; Meyer DK, 2000, J NEUROSCI, V20, P6743, DOI 10.1523/JNEUROSCI.20-18-06743.2000; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Minami K, 1998, J BIOL CHEM, V273, P8248, DOI 10.1074/jbc.273.14.8248; Mironov SL, 1999, EUR J NEUROSCI, V11, P1831, DOI 10.1046/j.1460-9568.1999.00584.x; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Okuda C, 1976, JAP J ANESTH, V35, p78S; Pan JZ, 2008, PROTEOMICS, V8, P2983, DOI 10.1002/pmic.200800057; Pan JZ, 2007, J PROTEOME RES, V6, P582, DOI 10.1021/pr060311u; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Pentyala SN, 1999, EUR J PHARMACOL, V384, P213, DOI 10.1016/S0014-2999(99)00625-1; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Raines DE, 1996, ANESTHESIOLOGY, V84, P663, DOI 10.1097/00000542-199603000-00022; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rehberg B, 1996, ANESTHESIOLOGY, V84, P1223, DOI 10.1097/00000542-199605000-00025; RICHARDS CD, 1976, BRIT J PHARMACOL, V58, P347, DOI 10.1111/j.1476-5381.1976.tb07711.x; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SACKETT DL, 1985, J BIOL CHEM, V260, P43; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez-Pedregal VM, 2009, TOP CURR CHEM, V286, P151, DOI 10.1007/128_2008_22; Santamaria LB, 2010, SURG ONCOL, V19, P63, DOI 10.1016/j.suronc.2009.03.007; SEGAL IS, 1988, ANESTHESIOLOGY, V69, P818, DOI 10.1097/00000542-198812000-00004; SERRANO L, 1984, P NATL ACAD SCI-BIOL, V81, P5989, DOI 10.1073/pnas.81.19.5989; SERRANO L, 1988, BIOCHEM J, V252, P683, DOI 10.1042/bj2520683; Shu NJ, 2008, BIOINFORMATICS, V24, P775, DOI 10.1093/bioinformatics/btm618; SLATER SJ, 1993, NATURE, V364, P82, DOI 10.1038/364082a0; Smith CD, 1996, J BIOL CHEM, V271, P6192, DOI 10.1074/jbc.271.11.6192; Streiff JH, 2006, BIOPHYS J, V91, P3405, DOI 10.1529/biophysj.106.082586; Tang JX, 2010, ANESTH ANALG, V110, P421, DOI 10.1213/ANE.0b013e3181b80939; Tang P, 2001, J COMPUT CHEM, V22, P436, DOI 10.1002/1096-987X(200103)22:4<436::AID-JCC1014>3.0.CO;2-U; Tesler A, 1977, EXP CELL RES, V107, P247; TYSON GE, 1973, Z ZELLFORSCH MIK ANA, V141, P443, DOI 10.1007/BF00307116; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VERGARA GA, 1981, PHARMACOLOGY, V23, P264, DOI 10.1159/000137559; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; WANDOSELL F, 1986, J BIOL CHEM, V261, P332; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; WARFIELD RK, 1974, SCIENCE, V186, P1219, DOI 10.1126/science.186.4170.1219; WEST RR, 1991, J BIOL CHEM, V266, P21886; Wolff J, 1996, PROTEIN SCI, V5, P2020, DOI 10.1002/pro.5560051008; Woolf NJ, 2009, BIOL MED PHYS BIOMED, P177, DOI 10.1007/978-3-642-03584-5_5; Xi J, 2004, J BIOL CHEM, V279, P19628, DOI 10.1074/jbc.M313864200	112	49	50	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e37251	10.1371/journal.pone.0037251	http://dx.doi.org/10.1371/journal.pone.0037251			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761654	Green Published, gold, Green Submitted			2022-12-27	WOS:000305781700002
J	Kuykendall, LD; Shao, JY; Hartung, JS				Kuykendall, L. David; Shao, Jonathan Y.; Hartung, John S.			'Ca. Liberibacter asiaticus' Proteins Orthologous with pSymA-Encoded Proteins of Sinorhizobium meliloti: Hypothetical Roles in Plant Host Interaction	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENOME SEQUENCE; LYSR HOMOLOG; BACTERIA; EFFLUX; ANTIPORTER; EXPRESSION; MECHANISM; MOTILITY; FAMILY	Sinorhizobium meliloti strain 1021, a nitrogen-fixing, root-nodulating bacterial microsymbiont of alfalfa, has a 3.5 Mbp circular chromosome and two megaplasmids including 1.3 Mbp pSymA carrying nonessential 'accessory' genes for nitrogen fixation (nif), nodulation and host specificity (nod). A related bacterium, psyllid-vectored 'Ca. Liberibacter asiaticus,' is an obligate phytopathogen with a reduced genome that was previously analyzed for genes orthologous to genes on the S. meliloti circular chromosome. In general, proteins encoded by pSymA genes are more similar in sequence alignment to those encoded by S. meliloti chromosomal orthologs than to orthologous proteins encoded by genes carried on the 'Ca. Liberibacter asiaticus' genome. Only two 'Ca. Liberibacter asiaticus' proteins were identified as having orthologous proteins encoded on pSymA but not also encoded on the chromosome of S. meliloti. These two orthologous gene pairs encode a Na+/K+ antiporter (shared with intracellular pathogens of the family Bartonellacea) and a Co++, Zn++ and Cd++ cation efflux protein that is shared with the phytopathogen Agrobacterium. Another shared protein, a redox-regulated K+ efflux pump may regulate cytoplasmic pH and homeostasis. The pSymA and 'Ca. Liberibacter asiaticus' orthologs of the latter protein are more highly similar in amino acid alignment compared with the alignment of the pSymA-encoded protein with its S. meliloti chromosomal homolog. About 182 pSymA encoded proteins have sequence similarity (<= E-10) with 'Ca. Liberibacter asiaticus' proteins, often present as multiple orthologs of single 'Ca. Liberibacter asiaticus' proteins. These proteins are involved with amino acid uptake, cell surface structure, chaperonins, electron transport, export of bioactive molecules, cellular homeostasis, regulation of gene expression, signal transduction and synthesis of amino acids and metabolic cofactors. The presence of multiple orthologs defies mutational analysis and is consistent with the hypothesis that these proteins may be of particular importance in host/microbe interaction and their duplication likely facilitates their ongoing evolution.	[Kuykendall, L. David; Shao, Jonathan Y.; Hartung, John S.] ARS, USDA, Mol Plant Pathol Lab, Beltsville, MD USA	United States Department of Agriculture (USDA)	Kuykendall, LD (corresponding author), ARS, USDA, Mol Plant Pathol Lab, Beltsville, MD USA.	John.Hartung@ars.usda.gov						Ammar ED, 2011, J PHYTOPATHOL, V159, P726, DOI 10.1111/j.1439-0434.2011.01836.x; Barnett MJ, 2001, P NATL ACAD SCI USA, V98, P9883, DOI 10.1073/pnas.161294798; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Coletta HD, 2004, PLANT DIS, V88, P1382, DOI 10.1094/PDIS.2004.88.12.1382C; Cordwell SJ, 1997, GENE, V195, P113, DOI 10.1016/S0378-1119(97)00063-2; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Goldberg M, 1999, J BIOL CHEM, V274, P26065, DOI 10.1074/jbc.274.37.26065; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Guffanti AA, 2002, MOL MICROBIOL, V45, P145, DOI 10.1046/j.1365-2958.2002.02998.x; Harris SJ, 1998, MOL MICROBIOL, V28, P705, DOI 10.1046/j.1365-2958.1998.00825.x; Hartung JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023289; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Kovacikova G, 1999, J BACTERIOL, V181, P4250, DOI 10.1128/JB.181.14.4250-4256.1999; Kuykendall L., 2006, INT J SYST EVOL MICR, V56, P1; Kuykendall L. D., 2005, BERGEYS MANUAL SYSTE, V2, P324; Kuykendall LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034673; Layer G, 2002, J BIOL CHEM, V277, P34136, DOI 10.1074/jbc.M205247200; Li WB, 2009, PHYTOPATHOLOGY, V99, P139, DOI 10.1094/PHYTO-99-2-0139; Li YX, 2007, MICROBIOL-SGM, V153, P719, DOI 10.1099/mic.0.2006/002311-0; Mueller K, 2011, J BACTERIOL, V193, P485, DOI 10.1128/JB.01129-10; Ness LS, 1999, J BIOL CHEM, V274, P9524, DOI 10.1074/jbc.274.14.9524; Pollack J. Dennis, 2002, OMICS A Journal of Integrative Biology, V6, P247, DOI 10.1089/15362310260256909; Rego AT, 2010, BIOCHEM J, V425, P475, DOI 10.1042/BJ20091518; Rogel MA, 2001, APPL ENVIRON MICROB, V67, P3264, DOI 10.1128/AEM.67.7.3264-3268.2001; Roosild TP, 2010, P NATL ACAD SCI USA, V107, P19784, DOI 10.1073/pnas.1012716107; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; SALIBE A. A., 1966, Plant Protection Bulletin, F.A.O., V14, P141; Slater SC, 2009, J BACTERIOL, V191, P2501, DOI 10.1128/JB.01779-08; Soto MJ, 2006, MICROBIOL-SGM, V152, P3167, DOI 10.1099/mic.0.29112-0; SWANSON JA, 1993, GENETICS, V134, P435; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Tischler AD, 2005, INFECT IMMUNITY, V73; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Williams KA, 2000, NATURE, V403, P112, DOI 10.1038/47534; Young JM, 2001, INT J SYST EVOL MICR, V51, P89, DOI 10.1099/00207713-51-1-89	39	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e38725	10.1371/journal.pone.0038725	http://dx.doi.org/10.1371/journal.pone.0038725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761700	Green Submitted, Green Published, gold			2022-12-27	WOS:000305781700010
J	Joseph, AP; Valadie, H; Srinivasan, N; de Brevern, AG				Joseph, Agnel Praveen; Valadie, Helene; Srinivasan, Narayanaswamy; de Brevern, Alexandre G.			Local Structural Differences in Homologous Proteins: Specificities in Different SCOP Classes	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; STRUCTURE PREDICTION; SECONDARY STRUCTURE; BETA-TURNS; CONFORMATIONAL PROPENSITIES; SOLVENT ACCESSIBILITY; STRUCTURE ALIGNMENT; ALIGNED SEQUENCES; MOTIFS; INSERTIONS	The constant increase in the number of solved protein structures is of great help in understanding the basic principles behind protein folding and evolution. 3-D structural knowledge is valuable in designing and developing methods for comparison, modelling and prediction of protein structures. These approaches for structure analysis can be directly implicated in studying protein function and for drug design. The backbone of a protein structure favours certain local conformations which include alpha-helices, beta-strands and turns. Libraries of limited number of local conformations (Structural Alphabets) were developed in the past to obtain a useful categorization of backbone conformation. Protein Block (PB) is one such Structural Alphabet that gave a reasonable structure approximation of 0.42 angstrom. In this study, we use PB description of local structures to analyse conformations that are preferred sites for structural variations and insertions, among group of related folds. This knowledge can be utilized in improving tools for structure comparison that work by analysing local structure similarities. Conformational differences between homologous proteins are known to occur often in the regions comprising turns and loops. Interestingly, these differences are found to have specific preferences depending upon the structural classes of proteins. Such class-specific preferences are mainly seen in the all-beta class with changes involving short helical conformations and hairpin turns. A test carried out on a benchmark dataset also indicates that the use of knowledge on the class specific variations can improve the performance of a PB based structure comparison approach. The preference for the indel sites also seem to be confined to a few backbone conformations involving beta-turns and helix C-caps. These are mainly associated with short loops joining the regular secondary structures that mediate a reversal in the chain direction. Rare beta-turns of type I' and II' are also identified as preferred sites for insertions.	[Joseph, Agnel Praveen; de Brevern, Alexandre G.] INSERM, UMR S 665, Paris, France; [Joseph, Agnel Praveen; de Brevern, Alexandre G.] Univ Paris Diderot, UMR 665, Paris, France; [Joseph, Agnel Praveen; de Brevern, Alexandre G.] INTS, Paris, France; [Valadie, Helene] Univ Paris 07, INSERM, UMR S 726, DSIMB, Paris, France; [Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Indian Institute of Science (IISC) - Bangalore	Joseph, AP (corresponding author), INSERM, UMR S 665, Paris, France.	alexandre.debrevern@univ-paris-diderot.fr	de Brevern, Alexandre G./B-4788-2009	de Brevern, Alexandre G./0000-0001-7112-5626	Ministere de la Recherche, Universite Paris Diderot - Paris 7; Institute for Health and Medical Research (INSERM); Indian Department of Biotechnology; CEFIPRA [3903-E]; National Institute for Blood Transfusion (INTS)	Ministere de la Recherche, Universite Paris Diderot - Paris 7(Ministry of Research, France); Institute for Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Indian Department of Biotechnology; CEFIPRA; National Institute for Blood Transfusion (INTS)	This work was supported by grants from the Ministere de la Recherche, Universite Paris Diderot - Paris 7, National Institute for Blood Transfusion (INTS) and the Institute for Health and Medical Research (INSERM) and Indian Department of Biotechnology. APJ has a grant from CEFIPRA number 3903-E. NS and AdB acknowledge the support from CEFIPRA collaborative grant (number 3903-E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; [Anonymous], PYMOL MOL GRAPH SYST; Aravind L, 2002, CURR OPIN STRUC BIOL, V12, P392, DOI 10.1016/S0959-440X(02)00334-2; Aurora R, 1997, J BIOL CHEM, V272, P1413, DOI 10.1074/jbc.272.3.1413; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Balaji S, 2001, NUCLEIC ACIDS RES, V29, P61, DOI 10.1093/nar/29.1.61; Benros C, 2009, J THEOR BIOL, V256, P215, DOI 10.1016/j.jtbi.2008.08.032; Bornot A, 2006, BIOINFORMATION, V1, P153, DOI 10.6026/97320630001153; Brick K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-236; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Castillo-Davis CI, 2004, GENOME RES, V14, P802, DOI 10.1101/gr.2195604; CHAKRABARTTY A, 1993, P NATL ACAD SCI USA, V90, P11332, DOI 10.1073/pnas.90.23.11332; Chang MSS, 2004, J MOL BIOL, V341, P617, DOI 10.1016/j.jmb.2004.05.045; Chen B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S15; Choi IG, 2006, P NATL ACAD SCI USA, V103, P14056, DOI 10.1073/pnas.0606239103; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; CHOU PY, 1977, J MOL BIOL, V115, P135, DOI 10.1016/0022-2836(77)90094-8; Coronado JE, 2006, EUKARYOT CELL, V5, P628, DOI 10.1128/EC.5.4.628-637.2006; Cubellis MV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S8; DAYHOFF MO, 1972, MODEL EVOLUTIONARY C; De Brevern AG, 2007, J BIOSCIENCES, V32, P51, DOI 10.1007/s12038-007-0006-3; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; de Brevern Alexandre G., 2005, In Silico Biology, V5, P283; de Brevern Alexandre G, 2004, In Silico Biol, V4, P381; Dong QW, 2008, PROTEINS, V72, P163, DOI 10.1002/prot.21904; Dudev M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-106; Ellrott Kyle, 2007, Comput Syst Bioinformatics Conf, V6, P335, DOI 10.1142/9781860948732_0034; Engel DE, 2005, PROTEINS, V61, P325, DOI 10.1002/prot.20522; Etchebest C, 2005, PROTEINS, V59, P810, DOI 10.1002/prot.20458; Faure G, 2009, BIOCHIMIE, V91, P876, DOI 10.1016/j.biochi.2009.04.008; FLORES TP, 1993, PROTEIN SCI, V2, P1811, DOI 10.1002/pro.5560021104; Fu HL, 2009, PROTEINS, V77, P491, DOI 10.1002/prot.22509; Gelly JC, 2011, NUCLEIC ACIDS RES, V39, pW18, DOI 10.1093/nar/gkr333; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Goldman N, 1998, GENETICS, V149, P445; Goldstein RA, 2008, CURR OPIN STRUC BIOL, V18, P170, DOI 10.1016/j.sbi.2008.01.006; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Gowri VS, 2003, NUCLEIC ACIDS RES, V31, P486, DOI 10.1093/nar/gkg063; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Guerler A, 2008, PROTEIN SCI, V17, P1374, DOI 10.1110/ps.035469.108; Gunasekaran K, 1998, J MOL BIOL, V284, P1505, DOI 10.1006/jmbi.1998.2154; Hayward S, 2001, PROTEIN SCI, V10, P2219, DOI 10.1110/ps.23101; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hubbard S. J., 1993, NACCESS; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Jiang H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-444; JOHNSON MS, 1993, J MOL BIOL, V233, P716, DOI 10.1006/jmbi.1993.1548; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; JONES TA, 1986, EMBO J, V5, P819, DOI 10.1002/j.1460-2075.1986.tb04287.x; Joseph AP, 2011, BIOCHIMIE, V93, P1434, DOI 10.1016/j.biochi.2011.04.010; Joseph Agnel Praveen, 2010, Biophys Rev, V2, P137, DOI 10.1007/s12551-010-0036-1; Joseph AP, 2010, PROTEIN STRUCTURE PR; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kapp GT, 2004, BIOCHEMISTRY-US, V43, P3814, DOI 10.1021/bi035683k; Kim R, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-24; KOHONEN T, 2001, INF SCI, V3, P501; Kolodny R, 2002, J MOL BIOL, V323, P297, DOI 10.1016/S0022-2836(02)00942-7; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kountouris P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-407; Kruus E, 2005, NUCLEIC ACIDS RES, V33, P5343, DOI 10.1093/nar/gki842; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; LEWIS PN, 1971, P NATL ACAD SCI USA, V68, P2293, DOI 10.1073/pnas.68.9.2293; Li Q, 2009, PROTEINS, V74, P820, DOI 10.1002/prot.22191; LUTHY R, 1991, PROTEINS, V10, P229, DOI 10.1002/prot.340100307; Martinez JC, 1998, NAT STRUCT BIOL, V5, P721, DOI 10.1038/1418; Micheletti C, 2000, PROTEINS, V40, P662, DOI 10.1002/1097-0134(20000901)40:4<662::AID-PROT90>3.0.CO;2-F; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NICHOLSON LK, 1995, NAT STRUCT BIOL, V2, P274, DOI 10.1038/nsb0495-274; Offmann B, 2007, CURR BIOINFORM, V2, P165, DOI 10.2174/157489307781662105; OVERINGTON J, 1990, P ROY SOC B-BIOL SCI, V241, P132, DOI 10.1098/rspb.1990.0077; Paila U, 2008, NUCLEIC ACIDS RES, V36, P6664, DOI 10.1093/nar/gkn635; Panchenko AR, 2005, PROTEINS, V61, P535, DOI 10.1002/prot.20644; PASCARELLA S, 1992, J MOL BIOL, V224, P461, DOI 10.1016/0022-2836(92)91008-D; Petrov DA, 2002, THEOR POPUL BIOL, V61, P531, DOI 10.1006/tpbi.2002.1605; Przytycka T, 1999, NAT STRUCT BIOL, V6, P672; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; ROOMAN MJ, 1990, J MOL BIOL, V213, P327, DOI 10.1016/S0022-2836(05)80194-9; Rose GD, 2006, NAT CHEM BIOL, V2, P123, DOI 10.1038/nchembio0306-123; Sagermann M, 2002, PROTEIN SCI, V11, P516, DOI 10.1110/ps.39802; SALEMME FR, 1977, P NATL ACAD SCI USA, V74, P2820, DOI 10.1073/pnas.74.7.2820; Sander O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-14; Sandhya S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004981; Schuchhardt J, 1996, PROTEIN ENG, V9, P833, DOI 10.1093/protein/9.10.833; Shepherd AJ, 1999, PROTEIN SCI, V8, P1045, DOI 10.1110/ps.8.5.1045; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; SHORTLE D, 1995, CURR OPIN BIOTECH, V6, P387, DOI 10.1016/0958-1669(95)80067-0; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; SONDEK J, 1990, PROTEINS, V7, P299, DOI 10.1002/prot.340070402; SRINIVASAN R, 1994, P NATL ACAD SCI USA, V91, P11113, DOI 10.1073/pnas.91.23.11113; Sujatha S, 2001, BIOINFORMATICS, V17, P375, DOI 10.1093/bioinformatics/17.4.375; Taylor MS, 2004, GENOME RES, V14, P555, DOI 10.1101/gr.1977804; Thangudu RR, 2007, PROTEINS, V67, P255, DOI 10.1002/prot.21318; Thomas A, 2006, PROTEINS, V65, P889, DOI 10.1002/prot.21151; Thorne JL, 1996, MOL BIOL EVOL, V13, P666, DOI 10.1093/oxfordjournals.molbev.a025627; Thornton JM, 1999, J MOL BIOL, V293, P333, DOI 10.1006/jmbi.1999.3054; TOPHAM CM, 1993, J MOL BIOL, V229, P194, DOI 10.1006/jmbi.1993.1018; Tyagi M, 2008, PROTEINS, V71, P920, DOI 10.1002/prot.21776; Tyagi M, 2006, NUCLEIC ACIDS RES, V34, pW119, DOI 10.1093/nar/gkl199; Tyagi M, 2006, PROTEINS, V65, P32, DOI 10.1002/prot.21087; Tyagi M, 2009, COMPUT BIOL CHEM, V33, P329, DOI 10.1016/j.compbiolchem.2009.06.002; UNGER R, 1989, PROTEINS, V5, P355, DOI 10.1002/prot.340050410; WAKO H, 1994, J MOL BIOL, V238, P682, DOI 10.1006/jmbi.1994.1329; WAKO H, 1994, J MOL BIOL, V238, P693, DOI 10.1006/jmbi.1994.1330; Wu CY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq478; Yang AS, 1996, J MOL BIOL, V259, P873, DOI 10.1006/jmbi.1996.0364; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Yu YK, 2005, BIOINFORMATICS, V21, P902, DOI 10.1093/bioinformatics/bti070; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Z, 2011, MOL BIOL EVOL, V28, P291, DOI 10.1093/molbev/msq196; Zimmermann O, 2008, J CHEM INF MODEL, V48, P1903, DOI 10.1021/ci800178a; Zuo YC, 2009, PEPTIDES, V30, P1788, DOI 10.1016/j.peptides.2009.06.032	114	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38805	10.1371/journal.pone.0038805	http://dx.doi.org/10.1371/journal.pone.0038805			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745680	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305730900020
J	Schroten, M; Hanisch, FG; Quednau, N; Stump, C; Riebe, R; Lenk, M; Wolburg, H; Tenenbaum, T; Schwerk, C				Schroten, Mira; Hanisch, Franz-Georg; Quednau, Natascha; Stump, Carolin; Riebe, Roland; Lenk, Matthias; Wolburg, Hartwig; Tenenbaum, Tobias; Schwerk, Christian			A Novel Porcine In Vitro Model of the Blood-Cerebrospinal Fluid Barrier with Strong Barrier Function	PLOS ONE			English	Article							PLEXUS EPITHELIAL-CELLS; CHOROID-PLEXUS; STREPTOCOCCUS-SUIS; TRANSPORT; TIGHT; SYSTEM; ESTABLISHMENT; EXPRESSION; CLAUDIN-2; JUNCTIONS	Epithelial cells of the plexus choroideus form the structural basis of the blood-cerebrospinal fluid barrier (BCSFB). In vitro models of the BCSFB presenting characteristics of a functional barrier are of significant scientific interest as tools for examination of BCSFB function. Due to a lack of suitable cell lines as in vitro models, primary porcine plexus epithelial cells were subjected to a series of selective cultivation steps until a stable continuous subcultivatable epithelial cell line (PCP-R) was established. PCP-R cells grow in a regular polygonal pattern with a doubling time of 28-36 h. At a cell number of 1.5x10(5) in a 24-well plate confluence is reached in 56-72 h. Cells are cytokeratin positive and chromosomal analysis revealed 56 chromosomes at peak (84th subculture). Employing reverse transcription PCR mRNA expression of several transporters and components of cell junctions could be detected. The latter includes tight junction components like Claudin-1 and -3, ZO-1, and Occludin, and the adherens junction protein E-cadherin. Cellular localization studies of ZO-1, Occludin and Claudin-1 by immunofluorescence and morphological analysis by electron microscopy demonstrated formation of a dense tight junction structure. Importantly, when grown on cell culture inserts PCP-R developed typical characteristics of a functional BCSFB including high transepithelial electrical resistance above 600 Omega xcm(2) as well as low permeability for macromolecules. In summary, our data suggest the PCP-R cell line as a suitable in vitro model of the porcine BCSFB.	[Schroten, Mira; Quednau, Natascha; Stump, Carolin; Tenenbaum, Tobias; Schwerk, Christian] Univ Heidelberg, Med Fac Mannheim, Dept Pediat, D-6800 Mannheim, Germany; [Schroten, Mira; Hanisch, Franz-Georg] Univ Cologne, Fac Med, Inst Biochem 2, D-50931 Cologne, Germany; [Riebe, Roland; Lenk, Matthias] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Infectol, Greifswald, Germany; [Wolburg, Hartwig] Univ Tubingen, Inst Pathol, D-7400 Tubingen, Germany	Ruprecht Karls University Heidelberg; University of Cologne; Friedrich Loeffler Institute; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schroten, M (corresponding author), Univ Heidelberg, Med Fac Mannheim, Dept Pediat, D-6800 Mannheim, Germany.	christian.schwerk@medma.uni-heidelberg.de	Schwerk, Christian/GNP-5375-2022		Deutsche Forschungsgemeinschaft [TE 653/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (TE 653/2-2) to T.T. and H.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Engelhardt B, 2001, MICROSC RES TECHNIQ, V52, P112, DOI 10.1002/1097-0029(20010101)52:1<112::AID-JEMT13>3.0.CO;2-5; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Gath U, 1997, EUR J CELL BIOL, V74, P68; Ghersi-Egea JF, 2002, J DRUG TARGET, V10, P353, DOI 10.1080/10611860290031859; Haselbach M, 2001, MICROSC RES TECHNIQ, V52, P137, DOI 10.1002/1097-0029(20010101)52:1<137::AID-JEMT15>3.3.CO;2-A; HULL RN, 1976, IN VITRO CELL DEV B, V12, P670, DOI 10.1007/BF02797469; Ishiwata Isamu, 2005, Hum Cell, V18, P67; Kitazawa T, 2001, PHARMACEUT RES, V18, P16, DOI 10.1023/A:1011014424212; Klas J, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-11; Kumabe Toshihiro, 1996, Neurologia Medico-Chirurgica, V36, P179, DOI 10.2176/nmc.36.179; Schwerk C, 2011, MICROBES INFECT, V13, P953, DOI 10.1016/j.micinf.2011.05.012; Shi LZ, 2008, TOXICOL IN VITRO, V22, P190, DOI 10.1016/j.tiv.2007.07.007; Shi LZC, 2005, BRAIN RES, V1057, P37, DOI 10.1016/j.brainres.2005.07.046; SPECTOR R, 1989, SCI AM, V261, P68, DOI 10.1038/scientificamerican1189-68; Spector R, 2010, PHARM RES-DORDR, V27, P2054, DOI 10.1007/s11095-010-0162-2; Strazielle N, 2011, NEUROMETHODS, V56, P161, DOI 10.1007/978-1-61779-077-5_8; Szmydynger-Chodobska Joanna, 2007, Cerebrospinal Fluid Res, V4, P11, DOI 10.1186/1743-8454-4-11; Tenenbaum T, 2009, CELL MICROBIOL, V11, P323, DOI 10.1111/j.1462-5822.2008.01255.x; Tenenbauma T, 2008, BRAIN RES, V1229, P1, DOI 10.1016/j.brainres.2008.06.118; Vorbrodt AW, 2003, BRAIN RES REV, V42, P221, DOI 10.1016/S0165-0173(03)00177-2; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; Wang XQ, 2006, BRAIN RES, V1097, P1, DOI 10.1016/j.brainres.2006.04.046; Wolburg H, 2001, NEUROSCI LETT, V307, P77, DOI 10.1016/S0304-3940(01)01927-9; Wolburg H, 2010, ACTA NEUROPATHOL, V119, P75, DOI 10.1007/s00401-009-0627-8; WOOD PM, 1976, BRAIN RES, V115, P361, DOI 10.1016/0006-8993(76)90355-3; Zeni P, 2007, AM J PHYSIOL-CELL PH, V293, pC855, DOI 10.1152/ajpcell.00470.2006; Zheng W, 2002, BRAIN RES, V958, P371, DOI 10.1016/S0006-8993(02)03683-1	28	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39835	10.1371/journal.pone.0039835	http://dx.doi.org/10.1371/journal.pone.0039835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745832	Green Submitted, Green Published, gold			2022-12-27	WOS:000305730900118
J	Andreote, FD; Jimenez, DJ; Chaves, D; Dias, ACF; Luvizotto, DM; Dini-Andreote, F; Fasanella, CC; Lopez, MV; Baena, S; Taketani, RG; de Melo, IS				Andreote, Fernando Dini; Javier Jimenez, Diego; Chaves, Diego; Franco Dias, Armando Cavalcante; Luvizotto, Danice Mazzer; Dini-Andreote, Francisco; Fasanella, Cristiane Cipola; Lopez, Maryeimy Varon; Baena, Sandra; Taketani, Rodrigo Gouvea; de Melo, Itamar Soares			The Microbiome of Brazilian Mangrove Sediments as Revealed by Metagenomics	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; ARCHAEAL COMMUNITIES; DIVERSITY; PRODUCTIVITY; GENERATION; REDUCTION; RESOURCE; GENOMICS; ECOLOGY; SERVER	Here we embark in a deep metagenomic survey that revealed the taxonomic and potential metabolic pathways aspects of mangrove sediment microbiology. The extraction of DNA from sediment samples and the direct application of pyrosequencing resulted in approximately 215 Mb of data from four distinct mangrove areas (BrMgv01 to 04) in Brazil. The taxonomic approaches applied revealed the dominance of Deltaproteobacteria and Gammaproteobacteria in the samples. Paired statistical analysis showed higher proportions of specific taxonomic groups in each dataset. The metabolic reconstruction indicated the possible occurrence of processes modulated by the prevailing conditions found in mangrove sediments. In terms of carbon cycling, the sequences indicated the prevalence of genes involved in the metabolism of methane, formaldehyde, and carbon dioxide. With respect to the nitrogen cycle, evidence for sequences associated with dissimilatory reduction of nitrate, nitrogen immobilization, and denitrification was detected. Sequences related to the production of adenylsulfate, sulfite, and H2S were relevant to the sulphur cycle. These data indicate that the microbial core involved in methane, nitrogen, and sulphur metabolism consists mainly of Burkholderiaceae, Planctomycetaceae, Rhodobacteraceae, and Desulfobacteraceae. Comparison of our data to datasets from soil and sea samples resulted in the allotment of the mangrove sediments between those samples. The results of this study add valuable data about the composition of microbial communities in mangroves and also shed light on possible transformations promoted by microbial organisms in mangrove sediments.	[Andreote, Fernando Dini; Franco Dias, Armando Cavalcante; Luvizotto, Danice Mazzer; Dini-Andreote, Francisco; Fasanella, Cristiane Cipola; Lopez, Maryeimy Varon] Univ Sao Paulo, Dept Soil Sci, Luiz de Queiroz Coll Agr, Sao Paulo, Brazil; [Javier Jimenez, Diego; Baena, Sandra] Pontificia Univ Javeriana, Dept Biol, Bogota, Distrito Capita, Colombia; [Javier Jimenez, Diego] Colombian Corp Agr Res CORPO, Ctr Biotechnol & Bioind, Bogota, Distrito Capita, Colombia; [Javier Jimenez, Diego; Chaves, Diego; Baena, Sandra] Colombian Ctr Genom & Bioinformat Extreme Environ, Bogota, Distrito Capita, Colombia; [Taketani, Rodrigo Gouvea; de Melo, Itamar Soares] EMBRAPA Environm, Lab Environm Microbiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Pontificia Universidad Javeriana; Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Andreote, FD (corresponding author), Univ Sao Paulo, Dept Soil Sci, Luiz de Queiroz Coll Agr, Sao Paulo, Brazil.	fdandreo@gmail.com	Dias, Armando Cavalcante Franco/O-1477-2019; Taketani, Rodrigo Gouvêa/D-1145-2011; Dini-Andreote, Francisco/M-6176-2017; Jimenez, Diego/GNW-3973-2022; Dias, Armando Cavalcante Franco/F-5878-2012; Baena, Sandra/AAF-8165-2019; Andreote, Fernando Dini/B-8499-2012; Melo, Itamar S/I-8516-2012	Dias, Armando Cavalcante Franco/0000-0002-2651-6270; Taketani, Rodrigo Gouvêa/0000-0002-5999-8704; Dini-Andreote, Francisco/0000-0002-6654-0769; Dias, Armando Cavalcante Franco/0000-0002-2651-6270; Andreote, Fernando Dini/0000-0002-9883-9968; Baena, Sandra/0000-0001-5377-9079; Jimenez Avella, Diego Javier/0000-0002-9339-6520	Sao Paulo Research Foundation (FAPESP) [2004/13910-6]; FAPESP [Proc. 2008/54013-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported financially by the Sao Paulo Research Foundation (FAPESP, proc. number 2004/13910-6), and A.C.F. Dias received a graduate fellowship from FAPESP (Proc. 2008/54013-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONGI DM, 1988, MICROBIAL ECOL, V15, P59, DOI 10.1007/BF02012952; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaral-Zettler LA, 2011, ISME J, V5, P42, DOI 10.1038/ismej.2010.101; Andreote FD, 2009, BRAZ J MICROBIOL, V40, P417, DOI 10.1590/S1517-83822009000300001; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Biddle JF, 2011, ISME J, V5, P1038, DOI 10.1038/ismej.2010.199; Bodaker I, 2010, ISME J, V4, P399, DOI 10.1038/ismej.2009.141; Clark MW, 1998, CHEM GEOL, V149, P147, DOI 10.1016/S0009-2541(98)00034-5; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dar SA, 2008, APPL MICROBIOL BIOT, V78, P1045, DOI 10.1007/s00253-008-1391-8; DeAngelis KM, 2010, BIOENERG RES, V3, P146, DOI 10.1007/s12155-010-9089-z; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dias ACF, 2010, ANTON LEEUW INT J G, V98, P541, DOI 10.1007/s10482-010-9471-z; Dias ACF, 2009, WORLD J MICROB BIOT, V25, P1305, DOI 10.1007/s11274-009-0013-7; dos Santos HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016943; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Ferreira TO, 2010, J SOIL SEDIMENT, V10, P995, DOI 10.1007/s11368-010-0224-4; Flores-Mireles AL, 2007, APPL ENVIRON MICROB, V73, P7308, DOI 10.1128/AEM.01892-06; Dias ACF, 2011, J SOIL SEDIMENT, V11, P1466, DOI 10.1007/s11368-011-0423-7; Gerlach W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-430; Ghai R, 2010, ISME J, V4, P1154, DOI 10.1038/ismej.2010.44; Ghosh Abhrajyoti, 2010, Saline Syst, V6, P1, DOI 10.1186/1746-1448-6-1; Gilbert JA, 2011, ISME J, V5, P777, DOI 10.1038/ismej.2010.178; Gomes NCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014065; Gomes NCM, 2010, FEMS MICROBIOL ECOL, V74, P276, DOI 10.1111/j.1574-6941.2010.00962.x; Gomes NCM, 2008, FEMS MICROBIOL ECOL, V66, P96, DOI 10.1111/j.1574-6941.2008.00519.x; Holguin G, 2001, BIOL FERT SOILS, V33, P265, DOI 10.1007/s003740000319; Huang Y, 2009, HDB MOL MICROBIAL EC, P784; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Inskeep WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009773; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kathiresan K, 2001, ADV MAR BIOL, V40, P81, DOI 10.1016/S0065-2881(01)40003-4; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Li M, 2011, APPL MICROBIOL BIOT, V89, P1243, DOI 10.1007/s00253-010-2929-0; Lyimo TJ, 2002, AMBIO, V31, P614, DOI 10.1639/0044-7447(2002)031[0614:SRAMIS]2.0.CO;2; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; OREMLAND RS, 1982, NATURE, V296, P143, DOI 10.1038/296143a0; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Sahoo K, 2009, INDIAN J MAR SCI, V38, P249; Saunders DL, 2001, WATER RES, V35, P1897, DOI 10.1016/S0043-1354(00)00479-6; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shi YM, 2011, ISME J, V5, P999, DOI 10.1038/ismej.2010.189; Simon C, 2009, APPL ENVIRON MICROB, V75, P7519, DOI 10.1128/AEM.00946-09; Simon C, 2009, APPL MICROBIOL BIOT, V85, P265, DOI 10.1007/s00253-009-2233-z; Sousa OV, 2006, MAR POLLUT BULL, V52, P1725, DOI 10.1016/j.marpolbul.2006.07.006; Steele HL, 2005, FEMS MICROBIOL LETT, V247, P105, DOI 10.1016/j.femsle.2005.05.011; Taketani RG, 2010, ANTON LEEUW INT J G, V97, P401, DOI 10.1007/s10482-010-9422-8; Taketani RG, 2010, J MICROBIOL, V48, P7, DOI 10.1007/s12275-009-0147-1; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Tian Y, 2008, MAR POLLUT BULL, V57, P707, DOI 10.1016/j.marpolbul.2008.03.011; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yan B, 2006, J MICROBIOL, V44, P566	59	150	166	5	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38600	10.1371/journal.pone.0038600	http://dx.doi.org/10.1371/journal.pone.0038600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737213	Green Published, Green Submitted, gold			2022-12-27	WOS:000305695100010
J	Nanni, P; Nicoletti, G; Palladini, A; Croci, S; Murgo, A; Ianzano, ML; Grosso, V; Stivani, V; Antognoli, A; Lamolinara, A; Landuzzi, L; di Tomaso, E; Iezzi, M; De Giovanni, C; Lollini, PL				Nanni, Patrizia; Nicoletti, Giordano; Palladini, Arianna; Croci, Stefania; Murgo, Annalisa; Ianzano, Marianna L.; Grosso, Valentina; Stivani, Valeria; Antognoli, Agnese; Lamolinara, Alessia; Landuzzi, Lorena; di Tomaso, Emmanuelle; Iezzi, Manuela; De Giovanni, Carla; Lollini, Pier-Luigi			Multiorgan Metastasis of Human HER-2(+) Breast Cancer in Rag2(-/-);Il2rg(-/-) Mice and Treatment with PI3K Inhibitor	PLOS ONE			English	Article							BRAIN METASTASES; CELL-LINES; MOUSE MODELS; TRASTUZUMAB; CARCINOMA; TUMORS	In vivo studies of the metastatic process are severely hampered by the fact that most human tumor cell lines derived from highly metastatic tumors fail to consistently metastasize in immunodeficient mice like nude mice. We describe a model system based on a highly immunodeficient double knockout mouse, Rag2(-/-);Il2rg(-/-), which lacks T, B and NK cell activity. In this model human metastatic HER-2(+) breast cancer cells displayed their full multiorgan metastatic potential, without the need for selections or additional manipulations of the system. Human HER-2(+) breast cancer cell lines MDA-MB-453 and BT-474 injected into Rag2(-/-);Il2rg(-/-) mice faithfully reproduced human cancer dissemination, with multiple metastatic sites that included lungs, bones, brain, liver, ovaries, and others. Multiorgan metastatic spread was obtained both from local tumors, growing orthotopically or subcutaneously, and from cells injected intravenously. The problem of brain recurrencies is acutely felt in HER-2(+) breast cancer, because monoclonal antibodies against HER-2 penetrate poorly the blood-brain barrier. We studied whether a novel oral small molecule inhibitor of downstream PI3K, selected for its penetration of the blood-brain barrier, could affect multiorgan metastatic spread in Rag2(-/-);Il2rg(-/-) mice. NVP-BKM120 effectively controlled metastatic growth in multiple organs, and resulted in a significant proportion of mice free from brain and bone metastases. Human HER-2(+) human breast cancer cells in Rag2(-/-);Il2rg(-/-) mice faithfully reproduced the multiorgan metastatic pattern observed in patients, thus allowing the investigation of metastatic mechanisms and the preclinical study of novel antimetastatic agents.	[Nanni, Patrizia; Palladini, Arianna; Croci, Stefania; Murgo, Annalisa; Ianzano, Marianna L.; Grosso, Valentina; Stivani, Valeria; Antognoli, Agnese; De Giovanni, Carla] Univ Bologna, Dept Expt Pathol, Sect Canc Res, I-40126 Bologna, Italy; [Nicoletti, Giordano; Landuzzi, Lorena] Rizzoli Orthoped Inst, Bologna, Italy; [Lamolinara, Alessia; Iezzi, Manuela] Univ G DAnnunzio, Aging Res Ctr, Chieti, Italy; [di Tomaso, Emmanuelle] Novartis Inst BioMed Res Inc, Cambridge, MA USA; [Lollini, Pier-Luigi] Univ Bologna, Dept Hematol & Oncol Sci, Bologna, Italy	University of Bologna; IRCCS Istituto Ortopedico Rizzoli; G d'Annunzio University of Chieti-Pescara; Novartis; University of Bologna	Nanni, P (corresponding author), Univ Bologna, Dept Expt Pathol, Sect Canc Res, I-40126 Bologna, Italy.	carla.degiovanni@unibo.it	Palladini, Arianna/A-8994-2013; Landuzzi, Lorena/J-6511-2016; Iezzi, Manuela/AAB-7939-2019; Lollini, Pier Luigi/A-7644-2008; lamolinara, alessia/AAB-8833-2019; Croci, Stefania/K-2899-2016	Iezzi, Manuela/0000-0002-6296-6498; Lollini, Pier Luigi/0000-0003-1702-4108; lamolinara, alessia/0000-0002-7421-4509; Croci, Stefania/0000-0002-8622-0439; Nanni, Patrizia/0000-0001-5319-0803; Landuzzi, Lorena/0000-0001-9879-8118	Italian Association for Cancer Research (AIRC), Milan, Italy [10353]; Department of Experimental Pathology, University of Bologna; Italian Ministry for University and Research; Italian Ministry of Health	Italian Association for Cancer Research (AIRC), Milan, Italy(Fondazione AIRC per la ricerca sul cancro); Department of Experimental Pathology, University of Bologna; Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Italian Association for Cancer Research (AIRC), Milan, Italy (project n. 10353); the Department of Experimental Pathology, University of Bologna (Pallotti funds); the Italian Ministry for University and Research (PRIN 2008); and the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxevanis CN, 2010, IMMUNOTHERAPY-UK, V2, P213, DOI 10.2217/IMT.09.89; Becker M, 2002, BRIT J CANCER, V87, P1328, DOI 10.1038/sj.bjc.6600573; Bos PD, 2010, CURR OPIN PHARMACOL, V10, P571, DOI 10.1016/j.coph.2010.06.003; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bria E, 2008, BREAST CANCER RES TR, V109, P231, DOI 10.1007/s10549-007-9663-z; Cavallo F, 2011, CANCER IMMUNOL IMMUN, V60, P319, DOI 10.1007/s00262-010-0968-0; Ciravolo V, 2012, J CELL PHYSIOL, V227, P658, DOI 10.1002/jcp.22773; Clinchy B, 2000, BREAST CANCER RES TR, V61, P217, DOI 10.1023/A:1006494001861; Cruz-Munoz W, 2011, SEMIN CANCER BIOL, V21, P123, DOI 10.1016/j.semcancer.2010.12.001; Fidler IJ, 2011, SEMIN CANCER BIOL, V21, P107, DOI 10.1016/j.semcancer.2010.12.009; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; GAROFALO A, 1993, INVAS METAST, V13, P82; HANNA N, 1981, J IMMUNOL, V127, P1754; Jonkers J, 2007, J MAMMARY GLAND BIOL, V12, P191, DOI 10.1007/s10911-007-9050-8; Kim IS, 2010, BIOCHEM BIOPH RES CO, V394, P443, DOI 10.1016/j.bbrc.2010.03.070; Kuperwasser C, 2005, CANCER RES, V65, P6130, DOI 10.1158/0008-5472.CAN-04-1408; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Le Devedec SE, 2009, CLIN EXP METASTAS, V26, P673, DOI 10.1007/s10585-009-9267-6; LEE YTNM, 1983, J SURG ONCOL, V23, P175, DOI 10.1002/jso.2930230311; Lin NU, 2007, CLIN CANCER RES, V13, P1648, DOI 10.1158/1078-0432.CCR-06-2478; Lollini PL, 2006, NAT REV CANCER, V6, P204, DOI 10.1038/nrc1815; Lorger M, 2011, J NEUROONCOL; Lucci MA, 2010, CELL ONCOL, V32, P361, DOI 10.3233/CLO-2010-0520; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Nanni P, 2010, EUR J CANCER, V46, P659, DOI 10.1016/j.ejca.2009.11.018; Narayan M, 2009, CANCER RES, V69, P2191, DOI 10.1158/0008-5472.CAN-08-1056; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ocana A, 2011, NAT REV CLIN ONCOL, V8, P200, DOI 10.1038/nrclinonc.2010.194; Palmieri D, 2007, CLIN CANCER RES, V13, P1656, DOI 10.1158/1078-0432.CCR-06-2659; Price JE, 1996, BREAST CANCER RES TR, V39, P93, DOI 10.1007/BF01806081; Sanchez CG, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2833; Steeg PS, 2011, NAT REV CANCER, V11, P352, DOI 10.1038/nrc3053; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Welch D. R., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P30; ZHANG RD, 1991, INVAS METAST, V11, P204	38	66	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39626	10.1371/journal.pone.0039626	http://dx.doi.org/10.1371/journal.pone.0039626			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737248	Green Submitted, Green Published, gold			2022-12-27	WOS:000305695100047
J	Kim, HJ; Hwang, SH; Han, ME; Baek, S; Sim, HE; Yoon, S; Baek, SY; Kim, BS; Kim, JH; Kim, SY; Oh, SO				Kim, Hyun-Jung; Hwang, Sun-Hwi; Han, Myoung-Eun; Baek, Sungmin; Sim, Hey-Eun; Yoon, Sik; Baek, Sun-Yong; Kim, Bong-Seon; Kim, Jeong-Hwan; Kim, Seon-Young; Oh, Sae-Ock			LAP2 Is Widely Overexpressed in Diverse Digestive Tract Cancers and Regulates Motility of Cancer Cells	PLOS ONE			English	Article							NUCLEAR-MEMBRANE PROTEIN; C-KINASE SUBSTRATE; POLYPEPTIDE 2; HEPATOCELLULAR-CARCINOMA; AUTOCRINE LOOP; LEM-DOMAIN; IN-VIVO; EXPRESSION; THYMOPOIETIN; ACTIVATION	Background: Lamina-associated polypeptides 2 (LAP2) is a nuclear protein that connects the nuclear lamina with chromatin. Although its critical roles in genetic disorders and hematopoietic malignancies have been described, its expression and roles in digestive tract cancers have been poorly characterized. Methods: To examine the expression of LAP2 in patient tissues, we performed immunohistochemistry and real-time PCR. To examine motility of cancer cells, we employed Boyden chamber, wound healing and Matrigel invasion assays. To reveal its roles in metastasis in vivo, we used a liver metastasis xenograft model. To investigate the underlying mechanism, a cDNA microarray was conducted. Results: Immunohistochemistry in patient tissues showed widespread expression of LAP2 in diverse digestive tract cancers including stomach, pancreas, liver, and bile duct cancers. Real-time PCR confirmed that LAP2 beta is over-expressed in gastric cancer tissues. Knockdown of LAP2 beta did not affect proliferation of most digestive tract cancer cells except pancreatic cancer cells. However, knockdown of LAP2 beta decreased motility of all tested cancer cells. Moreover, overexpression of LAP2 beta increased motility of gastric and pancreatic cancer cells. In the liver metastasis xenograft model, LAP2 beta increased metastatic efficacy of gastric cancer cells and mortality in tested mice. cDNA microarrays showed the possibility that myristoylated alanine-rich C kinase substrate (MARCKS) and interleukin6 (IL6) may mediate LAP2 beta-regulated motility of cancer cells. Conclusions: From the above results, we conclude that LAP2 is widely overexpressed in diverse digestive tract cancers and LAP2 beta regulates motility of cancer cells and suggest that LAP2 beta may have utility for diagnostics and therapeutics in digestive tract cancers.	[Kim, Hyun-Jung; Han, Myoung-Eun; Baek, Sungmin; Sim, Hey-Eun; Yoon, Sik; Baek, Sun-Yong; Kim, Bong-Seon; Oh, Sae-Ock] Pusan Natl Univ, Sch Med, Dept Anat, Pusan 609735, South Korea; [Kim, Hyun-Jung; Han, Myoung-Eun; Baek, Sungmin; Sim, Hey-Eun; Oh, Sae-Ock] Pusan Natl Univ, Med Res Ctr Ischem Tissue Regenerat, Pusan 609735, South Korea; [Hwang, Sun-Hwi] Pusan Natl Univ, Sch Med, Dept Surg, Pusan 609735, South Korea; [Kim, Jeong-Hwan; Kim, Seon-Young] KRIBB, Med Genom Res Ctr, Taejon, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University; Pusan National University Hospital; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, HJ (corresponding author), Pusan Natl Univ, Sch Med, Dept Anat, Pusan 609735, South Korea.	hedgehog@pusan.ac.kr	Baek, Sungmin/D-2034-2017	Baek, Sungmin/0000-0002-3163-0617	Medical Research Institute [2010-25]; Pusan National University Hospital; medical research centre program of Ministry of Education, Science and Technology/Korea Science and Engineering Foundation [2011-0006190]; National Core Research Center Program from Ministry of Education, Science and Technology [R15-2006-022-01001-0]	Medical Research Institute; Pusan National University Hospital(Pusan National University); medical research centre program of Ministry of Education, Science and Technology/Korea Science and Engineering Foundation; National Core Research Center Program from Ministry of Education, Science and Technology	This work was supported by Medical Research Institute Grant (2010-25), Pusan National University Hospital, the medical research centre program of Ministry of Education, Science and Technology/Korea Science and Engineering Foundation (2011-0006190) and the National Core Research Center Program from Ministry of Education, Science and Technology (No. R15-2006-022-01001-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Badache A, 2001, CANCER RES, V61, P383; Berger R, 1996, GENOME RES, V6, P361, DOI 10.1101/gr.6.5.361; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Brachner A, 2005, J CELL SCI, V118, P5797, DOI 10.1242/jcs.02701; Cavarretta IT, 2007, ONCOGENE, V26, P2822, DOI 10.1038/sj.onc.1210097; Chang KT, 2005, AM J PHYSIOL-LUNG C, V289, pL446, DOI 10.1152/ajplung.00089.2005; Dechat T, 2000, J STRUCT BIOL, V129, P335, DOI 10.1006/jsbi.2000.4212; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; FURUKAWA K, 1995, EMBO J, V14, P1626, DOI 10.1002/j.1460-2075.1995.tb07151.x; Gant TM, 1999, J CELL BIOL, V144, P1083, DOI 10.1083/jcb.144.6.1083; Gardner-Thorpe J, 2002, BIOCHEM BIOPH RES CO, V293, P391, DOI 10.1016/S0006-291X(02)00237-1; HARRIS CA, 1994, P NATL ACAD SCI USA, V91, P6283, DOI 10.1073/pnas.91.14.6283; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Hellemans J, 2004, NAT GENET, V36, P1213, DOI 10.1038/ng1453; Ishijima Y, 1996, BIOCHEM BIOPH RES CO, V226, P431, DOI 10.1006/bbrc.1996.1373; Ishimura A, 2006, DEVELOPMENT, V133, P3919, DOI 10.1242/DEV.02538; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lee KK, 2000, MOL BIOL CELL, V11, P3089, DOI 10.1091/mbc.11.9.3089; Lin F, 2000, J BIOL CHEM, V275, P4840, DOI 10.1074/jbc.275.7.4840; Liu QL, 2010, J NEURO-ONCOL, V100, P165, DOI 10.1007/s11060-010-0158-0; Manilal S, 1996, HUM MOL GENET, V5, P801, DOI 10.1093/hmg/5.6.801; Markiewicz E, 2006, EMBO J, V25, P3275, DOI 10.1038/sj.emboj.7601230; Martins S, 2003, J CELL BIOL, V160, P177, DOI 10.1083/jcb.200210026; Masaki T, 2005, INT J ONCOL, V26, P661; Micallef J, 2009, CANCER RES, V69, P7548, DOI 10.1158/0008-5472.CAN-08-4783; Nagano A, 1996, NAT GENET, V12, P254, DOI 10.1038/ng0396-254; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nili E, 2001, J CELL SCI, V114, P3297; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Opdam FJM, 2004, ONCOGENE, V23, P6647, DOI 10.1038/sj.onc.1207887; Palmer TD, 2011, ADV DRUG DELIVER REV, V63, P568, DOI 10.1016/j.addr.2011.04.008; Parise P, 2006, CELL CYCLE, V5, P1331, DOI 10.4161/cc.5.12.2833; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Schoft VK, 2003, J CELL SCI, V116, P2505, DOI 10.1242/jcs.00450; Selander KS, 2004, CANCER RES, V64, P6924, DOI 10.1158/0008-5472.CAN-03-2516; Somech R, 2005, J CELL SCI, V118, P4017, DOI 10.1242/jcs.02521; Somech R, 2007, ANN HEMATOL, V86, P393, DOI 10.1007/s00277-007-0275-9; Taylor MRG, 2005, HUM MUTAT, V26, P566, DOI 10.1002/humu.20250; Techasen A, 2010, CANCER SCI, V101, P658, DOI 10.1111/j.1349-7006.2009.01427.x; VAN MEIR E, 1990, CANCER RES, V50, P6683; Vlcek S, 2007, CURR OPIN CELL BIOL, V19, P298, DOI 10.1016/j.ceb.2007.04.001; Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8; Weber PJA, 1999, BIOL CHEM, V380, P653, DOI 10.1515/BC.1999.081; Worman HJ, 2006, BBA-MOL CELL BIOL L, V1761, P626, DOI 10.1016/j.bbalip.2006.02.010; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464	48	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39482	10.1371/journal.pone.0039482	http://dx.doi.org/10.1371/journal.pone.0039482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745766	gold, Green Published, Green Submitted			2022-12-27	WOS:000305693200080
J	Kunkel, SD; Elmore, CJ; Bongers, KS; Ebert, SM; Fox, DK; Dyle, MC; Bullard, SA; Adams, CM				Kunkel, Steven D.; Elmore, Christopher J.; Bongers, Kale S.; Ebert, Scott M.; Fox, Daniel K.; Dyle, Michael C.; Bullard, Steven A.; Adams, Christopher M.			Ursolic Acid Increases Skeletal Muscle and Brown Fat and Decreases Diet-Induced Obesity, Glucose Intolerance and Fatty Liver Disease	PLOS ONE			English	Article							EXPRESSION SIGNATURES; INSULIN-RESISTANCE; GROWTH; PATHWAY; MICE; TRANSCRIPTION; HYPERTROPHY; PROTEIN; MASS; AKT	Skeletal muscle Akt activity stimulates muscle growth and imparts resistance to obesity, glucose intolerance and fatty liver disease. We recently found that ursolic acid increases skeletal muscle Akt activity and stimulates muscle growth in non-obese mice. Here, we tested the hypothesis that ursolic acid might increase skeletal muscle Akt activity in a mouse model of diet-induced obesity. We studied mice that consumed a high fat diet lacking or containing ursolic acid. In skeletal muscle, ursolic acid increased Akt activity, as well as downstream mRNAs that promote glucose utilization (hexokinase-II), blood vessel recruitment (Vegfa) and autocrine/paracrine IGF-I signaling (Igf1). As a result, ursolic acid increased skeletal muscle mass, fast and slow muscle fiber size, grip strength and exercise capacity. Interestingly, ursolic acid also increased brown fat, a tissue that shares developmental origins with skeletal muscle. Consistent with increased skeletal muscle and brown fat, ursolic acid increased energy expenditure, leading to reduced obesity, improved glucose tolerance and decreased hepatic steatosis. These data support a model in which ursolic acid reduces obesity, glucose intolerance and fatty liver disease by increasing skeletal muscle and brown fat, and suggest ursolic acid as a potential therapeutic approach for obesity and obesity-related illness.	[Kunkel, Steven D.; Elmore, Christopher J.; Bongers, Kale S.; Ebert, Scott M.; Fox, Daniel K.; Dyle, Michael C.; Bullard, Steven A.; Adams, Christopher M.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Kunkel, Steven D.; Elmore, Christopher J.; Bongers, Kale S.; Ebert, Scott M.; Fox, Daniel K.; Dyle, Michael C.; Bullard, Steven A.; Adams, Christopher M.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA; [Kunkel, Steven D.; Elmore, Christopher J.; Bongers, Kale S.; Ebert, Scott M.; Fox, Daniel K.; Dyle, Michael C.; Bullard, Steven A.; Adams, Christopher M.] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA; [Kunkel, Steven D.; Adams, Christopher M.] Iowa City Vet Affairs Med Ctr, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Kunkel, SD (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	christopher-adams@uiowa.edu		Adams, Christopher/0000-0002-5795-7212; Bongers, Kale/0000-0002-9297-9185	National Institutes of Health [1R01AR059115, GM07361, HL007121, KL2RR024980]; Department of Veterans Affairs [IBX000976A]; Fraternal Order of Eagles Diabetes Research Center at the University of Iowa; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024980] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Fraternal Order of Eagles Diabetes Research Center at the University of Iowa; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was funded by grants from the National Institutes of Health (1R01AR059115, GM07361, HL007121 and KL2RR024980), Department of Veterans Affairs (IBX000976A) and the Fraternal Order of Eagles Diabetes Research Center at the University of Iowa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603; Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; Blaauw B, 2009, FASEB J, V23, P3896, DOI 10.1096/fj.09-131870; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bozulic L, 2009, CURR OPIN CELL BIOL, V21, P256, DOI 10.1016/j.ceb.2009.02.002; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frighetto RTS, 2008, FOOD CHEM, V106, P767, DOI 10.1016/j.foodchem.2007.06.003; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jager S, 2009, MOLECULES, V14, P2016, DOI 10.3390/molecules14062016; Jayaprakasam B, 2006, J AGR FOOD CHEM, V54, P243, DOI 10.1021/jf0520342; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liu H, 2005, J ETHNOPHARMACOL, V100, P92, DOI 10.1016/j.jep.2005.05.024; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Mark AL, 2009, HYPERTENSION, V53, P375, DOI 10.1161/HYPERTENSIONAHA.108.124255; Morrison SF, 2001, AM J PHYSIOL-REG I, V281, pR683, DOI 10.1152/ajpregu.2001.281.3.R683; MORRISON WR, 1964, J LIPID RES, V5, P600; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Osawa H, 1996, J BIOL CHEM, V271, P16690, DOI 10.1074/jbc.271.28.16690; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Rao VS, 2011, J MED FOOD; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Shavlakadze T, 2005, NEUROMUSCULAR DISORD, V15, P139, DOI 10.1016/j.nmd.2004.10.013; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Takahashi A, 2002, MOL CELL BIOL, V22, P4803, DOI 10.1128/MCB.22.13.4803-4814.2002; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Wijers SLJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001777; Yore MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022862; Zhang DY, 2010, CELL METAB, V11, P402, DOI 10.1016/j.cmet.2010.03.012	38	141	154	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39332	10.1371/journal.pone.0039332	http://dx.doi.org/10.1371/journal.pone.0039332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745735	Green Submitted, Green Published, gold			2022-12-27	WOS:000305693200063
J	Moura, DS; Sultan, S; Georgin-Lavialle, S; Barete, S; Lortholary, O; Gaillard, R; Hermine, O				Moura, Daniela Silva; Sultan, Serge; Georgin-Lavialle, Sophie; Barete, Stephane; Lortholary, Olivier; Gaillard, Raphael; Hermine, Olivier			Evidence for Cognitive Impairment in Mastocytosis: Prevalence, Features and Correlations to Depression	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; MAST-CELL DEGRANULATION; BLOOD-BRAIN-BARRIER; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; DISORDERS; DYSREGULATION; PERMEABILITY; METAANALYSIS; PERFORMANCE	Mastocytosis is a heterogeneous disease characterized by mast cells accumulation in one or more organs. We have reported that depression is frequent in mastocytosis, but although it was already described, little is known about the prevalence and features of cognitive impairment. Our objective was to describe the prevalence and features of cognitive impairment in a large cohort of patients with this rare disease (n = 57; mean age = 45) and to explore the relations between memory impairment and depression. Objective memory impairment was evaluated using the 3rd edition of the Clinical Memory scale of Wechsler. Depression symptoms were evaluated using the Hamilton Depression Rating Scale. Age and education levels were controlled for all patients. Patients with mastocytosis presented high levels of cognitive impairment (memory and/or attention) (n = 22; 38.6%). Cognitive impairment was moderate in 59% of the cases, concerned immediate auditory (41%) and working memory (73%) and was not associated to depression (p >= 0.717). In conclusion, immediate auditory memory and attention impairment in mastocytosis are frequent, even in young individuals, and are not consecutive to depression. In mastocytosis, cognitive complaints call for complex neuropsychological assessment. Mild-moderate cognitive impairment and depression constitute two specific but somewhat independent syndromes in mastocytosis. These results suggest differential effects of mast-cell activity in the brain, on systems involved in emotionality and in cognition.	[Moura, Daniela Silva; Georgin-Lavialle, Sophie; Barete, Stephane; Lortholary, Olivier; Hermine, Olivier] Univ Paris 05, Fdn Imagine Paris, Hop Necker Enfants Malad, Ctr Reference Mastocytoses, Paris, France; [Moura, Daniela Silva] Univ Paris 05, IUPDP Inst Psychol, Lab Psychopathol & Proc Sante EA 4057, Paris, France; [Georgin-Lavialle, Sophie; Barete, Stephane; Hermine, Olivier] Hop Necker Enfants Malad, CNRS UMR 8147, Paris, France; [Georgin-Lavialle, Sophie] Univ Paris 05, Hop Europeen Georges Pompidou, Serv Med Interne, Paris, France; [Barete, Stephane] Univ Paris 06, Hop Tenon, Dept Dermatol, Paris, France; [Lortholary, Olivier] Univ Paris 05, Hop Necker Enfants Malad, Serv Malad Infect & Trop, Paris, France; [Sultan, Serge] Univ Montreal, Quebec City, PQ, Canada; [Sultan, Serge] CHU St Justine, Ctr Rech, Montreal, PQ, Canada; [Gaillard, Raphael] Univ Paris 05, INSERM, Ctr Psychiat & Neurosci U894, Lab Physiopathol Malad Psychiat, Paris, France; [Gaillard, Raphael] Univ Paris 05, Fac Med Paris Descartes, Serv Hosp Univ, Ctr Hosp St Anne, Paris, France; [Hermine, Olivier] Univ Paris 05, Hop Necker Enfants Malad, Serv Hematol Adulte, Paris, France; [Hermine, Olivier] IHU Hop Necker Enfants Malad, Fdn Imagine, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Moura, DS (corresponding author), Univ Paris 05, Fdn Imagine Paris, Hop Necker Enfants Malad, Ctr Reference Mastocytoses, Paris, France.	d.moura.nck@gmail.com; ohermine@gmail.com	Hermine, Olivier/Q-7072-2018; Gaillard, Raphael/J-6527-2015	Hermine, Olivier/0000-0003-2574-3874; Gaillard, Raphael/0000-0002-1297-4369	Canceropole Ile-de-France (Appel d'offre SHS); French Institut National du Cancer (SHS)	Canceropole Ile-de-France (Appel d'offre SHS); French Institut National du Cancer (SHS)	DSM is recipient from a grant from Canceropole Ile-de-France (Appel d'offre SHS 2009). SS is a recipient of grants from the French Institut National du Cancer (SHS 2010, 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobholz JA, 2003, CURR OPIN NEUROL, V16, P283, DOI 10.1097/00019052-200306000-00006; Bruehl H, 2007, J CLIN ENDOCR METAB, V92, P2439, DOI 10.1210/jc.2006-2540; Buckner RL, 2003, J NEUROSCI, V23, P3999; Caceres F, 2011, J CLIN EXP NEUROPSYC, V33, P1094, DOI 10.1080/13803395.2011.603690; Carroll JC, 2011, J NEUROSCI, V31, P14436, DOI 10.1523/JNEUROSCI.3836-11.2011; Castaneda AE, 2008, J AFFECT DISORDERS, V106, P1, DOI 10.1016/j.jad.2007.06.006; Craig MC, 2010, PSYCHONEUROENDOCRINO, V35, P987, DOI 10.1016/j.psyneuen.2009.12.012; Creavin ST, 2011, J ALZHEIMERS DIS; DeCarli C, 2003, LANCET NEUROL, V2, P15, DOI 10.1016/S1474-4422(03)00262-X; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Esposito P, 2001, BRAIN RES, V888, P117, DOI 10.1016/S0006-8993(00)03026-2; Fossati P, 2004, J PSYCHIATR RES, V38, P137, DOI 10.1016/j.jpsychires.2003.08.002; Godard JGS, 2011, PSYCHIAT RES     JUL; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Haroon E, 2012, NEUROPSYCHOPHARMACOL, V37, P137, DOI 10.1038/npp.2011.205; Harrison NA, 2009, BIOL PSYCHIAT, V66, P407, DOI 10.1016/j.biopsych.2009.03.015; Heesen C, 2002, PSYCHONEUROENDOCRINO, V27, P505, DOI 10.1016/S0306-4530(01)00071-3; Hermine O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002266; Kohler CA, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/328602; Lanternier F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001906; Larrabee G J, 1994, Int Psychogeriatr, V6, P95, DOI 10.1017/S1041610294001663; LENNERT K, 1979, HISTOPATHOLOGY, V3, P349, DOI 10.1111/j.1365-2559.1979.tb03017.x; Lescheid DW, 1997, ENDOCRINOLOGY, V138, P5618, DOI 10.1210/en.138.12.5618; Mair RG, 2008, J NEUROSCI, V28, P14293, DOI 10.1523/JNEUROSCI.3301-08.2008; Matsumoto I, 2001, J EXP MED, V194, P71, DOI 10.1084/jem.194.1.71; McClintock SA, 2010, NEUROPSYCHOLOGY, V24, P9, DOI 10.1037/a0017336; Metcalfe DD, 1991, J INVEST DERMATOL, V96, p2S; Monastero R, 2009, J ALZHEIMERS DIS, V18, P11, DOI 10.3233/JAD-2009-1120; Moura DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026375; Nautiyal KM, 2008, P NATL ACAD SCI USA, V105, P18053, DOI 10.1073/pnas.0809479105; Pang X, 1996, NEUROSCIENCE, V73, P889, DOI 10.1016/0306-4522(95)00606-0; Paul C, 2010, AM J HEMATOL, V85, P921, DOI 10.1002/ajh.21894; Peltz CB, 2012, ALZHEIMERS DEMENT, V8, P87, DOI 10.1016/j.jalz.2011.02.008; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Piette F, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt75; Plangar I, 2011, J ALZHEIMERS DIS, V24, P199, DOI 10.3233/JAD-2011-110131; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Rodriguez-Sanchez E, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-147; ROGERS MP, 1986, PSYCHOSOM MED, V48, P437, DOI 10.1097/00006842-198607000-00006; Silverman AJ, 2002, PROG BRAIN RES, V141, P315; SILVERMAN AJ, 1994, P NATL ACAD SCI USA, V91, P3695, DOI 10.1073/pnas.91.9.3695; Theoharides TC, 1998, ENDOCRINOLOGY, V139, P403, DOI 10.1210/en.139.1.403; THEOHARIDES TC, 1995, ENDOCRINOLOGY, V136, P5745, DOI 10.1210/en.136.12.5745; Theoharides TC, 2008, J CLIN PSYCHOPHARM, V28, P479, DOI 10.1097/JCP.0b013e3181845f48; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P34, DOI 10.1016/j.bbadis.2010.12.017; Theoharides TC, 2009, INT J IMMUNOPATH PH, V22, P859, DOI 10.1177/039463200902200401; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; Valent P, 2003, HEMATOL ONCOL CLIN N, V17, P1227, DOI 10.1016/S0889-8588(03)00089-3; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wilhelm M, 2010, GEN COMP ENDOCR, V172, P173; Yaffe K, 2011, ARCH NEUROL-CHICAGO, V68, P631, DOI 10.1001/archneurol.2011.82; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	52	46	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39468	10.1371/journal.pone.0039468	http://dx.doi.org/10.1371/journal.pone.0039468			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745762	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200078
J	Jimenez, JN; Ocampo, AM; Vanegas, JM; Rodriguez, EA; Mediavilla, JR; Chen, L; Muskus, CE; Velez, LA; Rojas, C; Restrepo, AV; Ospina, S; Garces, C; Franco, L; Bifani, P; Kreiswirth, BN; Correa, MM				Natalia Jimenez, J.; Ocampo, Ana M.; Vanegas, Johanna M.; Rodriguez, Erika A.; Mediavilla, Jose R.; Chen, Liang; Muskus, Carlos E.; Velez, Lazaro A.; Rojas, Carlos; Restrepo, Andrea V.; Ospina, Sigifredo; Garces, Carlos; Franco, Liliana; Bifani, Pablo; Kreiswirth, Barry N.; Correa, Margarita M.			CC8 MRSA Strains Harboring SCCmec Type IVc are Predominant in Colombian Hospitals	PLOS ONE			English	Article							RESISTANT-STAPHYLOCOCCUS-AUREUS; CASSETTE CHROMOSOME MEC; METHICILLIN-RESISTANT; MULTIPLEX PCR; SEQUENCE; INFECTIONS; EMERGENCE; CLONES; EPIDEMIOLOGY; EVOLUTION	Background: Recent reports highlight the incursion of community-associated MRSA within healthcare settings. However, knowledge of this phenomenon remains limited in Latin America. The aim of this study was to evaluate the molecular epidemiology of MRSA in three tertiary-care hospitals in Medellin, Colombia. Methods: An observational cross-sectional study was conducted from 2008-2010. MRSA infections were classified as either community-associated (CA-MRSA) or healthcare-associated (HA-MRSA), with HA-MRSA further classified as hospital-onset (HAHO-MRSA) or community-onset (HACO-MRSA) according to standard epidemiological definitions established by the U. S. Centers for Disease Control and Prevention (CDC). Genotypic analysis included SCCmec typing, spa typing, PFGE and MLST. Results: Out of 538 total MRSA isolates, 68 (12.6%) were defined as CA-MRSA, 243 (45.2%) as HACO-MRSA and 227 (42.2%) as HAHO-MRSA. The majority harbored SCCmec type IVc (306, 58.7%), followed by SCCmec type I (174, 33.4%). The prevalence of type IVc among CA-, HACO- and HAHO-MRSA isolates was 92.4%, 65.1% and 43.6%, respectively. From 2008 to 2010, the prevalence of type IVc-bearing strains increased significantly, from 50.0% to 68.2% (p=0.004). Strains harboring SCCmec IVc were mainly associated with spa types t1610, t008 and t024 (MLST clonal complex 8), while PFGE confirmed that the t008 and t1610 strains were closely related to the USA300-0114 CA-MRSA clone. Notably, strains belonging to these three spa types exhibited high levels of tetracycline resistance (45.9%). Conclusion: CC8 MRSA strains harboring SCCmec type IVc are becoming predominant in Medellin hospitals, displacing previously reported CC5 HA-MRSA clones. Based on shared characteristics including SCCmec IVc, absence of the ACME element and tetracycline resistance, the USA300-related isolates in this study are most likely related to USA300-LV, the recently-described 'Latin American variant' of USA300.	[Natalia Jimenez, J.; Ocampo, Ana M.; Vanegas, Johanna M.; Rodriguez, Erika A.; Correa, Margarita M.] Univ Antioquia, Grp Microbiol Mol, Escuela Microbiol, Medellin, Colombia; [Mediavilla, Jose R.; Chen, Liang; Kreiswirth, Barry N.] Univ Med & Dent New Jersey, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Muskus, Carlos E.] Univ Antioquia, Programa Estudio & Control Enfermedades Trop PECE, Medellin, Colombia; [Velez, Lazaro A.] Univ Antioquia, Grp Investigador Problemas Enfermedades Infeccios, Medellin, Colombia; [Rojas, Carlos] Univ Antioquia, Grp Epidemiol, Medellin, Colombia; [Restrepo, Andrea V.; Garces, Carlos] Hosp Pablo Tobon Uribe, Medellin, Colombia; [Ospina, Sigifredo; Garces, Carlos] Hosp Univ San Vicente Fdn, Medellin, Colombia; [Garces, Carlos; Franco, Liliana] Congregac Mariana, Clin Cardiovasc, Medellin, Colombia; [Bifani, Pablo] Sci Inst Publ Hlth, Brussels, Belgium	Universidad de Antioquia; Rutgers State University New Brunswick; Rutgers State University Medical Center; Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia	Jimenez, JN (corresponding author), Univ Antioquia, Grp Microbiol Mol, Escuela Microbiol, Medellin, Colombia.	judynatalia@yahoo.com	Muskus, Carlos Enrique/AFJ-8423-2022; Muskus, Carlos Enrique/AAF-5247-2022; Rodríguez, Erika A./T-4200-2017; Rojas Cruz, Carlos Alberto/GZM-2307-2022	Rodríguez, Erika A./0000-0002-8582-8776; Rojas Cruz, Carlos Alberto/0000-0003-0915-6653; Bifani, Pablo/0000-0001-9651-6439; Chen, Liang/0000-0001-5845-2235; Jimenez, J Natalia/0000-0002-9183-1912; Vanegas, Johanna/0000-0003-0649-6660	Departamento Administrativo de Ciencia, Tecnologia e Innovacion-COLCIENCIAS [1115-459-21442]; Comite para el Desarrollo de la Investigacion -CODI, Universidad de Antioquia [CIMB-032-11]; COLCIENCIAS	Departamento Administrativo de Ciencia, Tecnologia e Innovacion-COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Comite para el Desarrollo de la Investigacion -CODI, Universidad de Antioquia; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This research was supported by the Departamento Administrativo de Ciencia, Tecnologia e Innovacion-COLCIENCIAS, Project: 1115-459-21442 and Comite para el Desarrollo de la Investigacion -CODI, Universidad de Antioquia, Project: CIMB-032-11. JNJ received financial support for doctoral training from COLCIENCIAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CA, 2010, AM J INFECT CONTROL, V38, P315, DOI 10.1016/j.ajic.2009.05.013; [Anonymous], 2009, PERFORMANCE STANDARD, V19; Arias CA, 2008, NEW ENGL J MED, V359, P2177, DOI 10.1056/NEJMc0804021; Becker AP, 2011, EPIDEMIOL INFECT, P1; Benoit SR, 2008, EMERG INFECT DIS, V14, P1216, DOI 10.3201/eid1408.071183; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Cruz C, 2005, INT J ANTIMICROB AG, V26, P457, DOI 10.1016/j.ijantimicag.2005.08.013; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Denis O, 2003, MICROB DRUG RESIST, V9, P61, DOI 10.1089/107662903764736355; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Donnio PY, 2004, J ANTIMICROB CHEMOTH, V53, P808, DOI 10.1093/jac/dkh185; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gardella N, 2008, DIAGN MICR INFEC DIS, V62, P343, DOI 10.1016/j.diagmicrobio.2008.07.008; Gomes AR, 2001, MICROB DRUG RESIST, V7, P23, DOI 10.1089/107662901750152729; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Larsen AR, 2009, J CLIN MICROBIOL, V47, P3765, DOI 10.1128/JCM.00934-09; Li SS, 2011, ANTIMICROB AGENTS CH, V55, P3046, DOI 10.1128/AAC.01475-10; Ma XX, 2005, EMERG INFECT DIS, V11, P973; Maree CL, 2007, EMERG INFECT DIS, V13, P236, DOI 10.3201/eid1302.060781; Mathema Barun, 2008, V431, P285; Mayor L, 2007, J CLIN MICROBIOL, V45, P2298, DOI 10.1128/JCM.00040-07; McClure JA, 2006, J CLIN MICROBIOL, V44, P1141, DOI 10.1128/JCM.44.3.1141-1144.2006; Mehrotra M, 2000, J CLIN MICROBIOL, V38, P1032, DOI 10.1128/JCM.38.3.1032-1035.2000; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Mulvey MR, 2001, J CLIN MICROBIOL, V39, P3481, DOI 10.1128/JCM.39.10.3481-3485.2001; Nimmo GR, 2012, CLIN MICROBIOL  0324; Oliveira DC, 2006, ANTIMICROB AGENTS CH, V50, P3457, DOI 10.1128/AAC.00629-06; Popovich KJ, 2008, CLIN INFECT DIS, V46, P787, DOI 10.1086/528716; Reyes J, 2009, CLIN INFECT DIS, V49, P1861, DOI 10.1086/648426; Ribeiro A, 2005, J CLIN MICROBIOL, V43, P1985, DOI 10.1128/JCM.43.4.1985-1988.2005; Ribeiro A, 2007, DIAGN MICR INFEC DIS, V59, P339, DOI 10.1016/j.diagmicrobio.2007.05.007; Robinson DA, 2005, LANCET, V365, P1256, DOI 10.1016/S0140-6736(05)74814-5; Rodriguez-Noriega E, 2010, REV CHIL INFECTOL, V27, P59; Rodriguez-Noriega E, 2010, INT J INFECT DIS, V14, pE560, DOI 10.1016/j.ijid.2009.08.018; Saiman L, 2003, CLIN INFECT DIS, V37, P1313, DOI 10.1086/379022; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Shopsin B, 2000, MICROB DRUG RESIST, V6, P239, DOI 10.1089/mdr.2000.6.239; Sola C, 2008, J CLIN MICROBIOL, V46, P1826, DOI 10.1128/JCM.01949-07; Sola C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030487; Stranden AM, 2009, INFECTION, V37, P44, DOI 10.1007/s15010-008-7430-7	47	40	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38576	10.1371/journal.pone.0038576	http://dx.doi.org/10.1371/journal.pone.0038576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745670	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200016
J	Clotault, J; Peltier, D; Soufflet-Freslon, V; Briard, M; Geoffriau, E				Clotault, Jeremy; Peltier, Didier; Soufflet-Freslon, Vanessa; Briard, Mathilde; Geoffriau, Emmanuel			Differential Selection on Carotenoid Biosynthesis Genes as a Function of Gene Position in the Metabolic Pathway: A Study on the Carrot and Dicots	PLOS ONE			English	Article							EVOLUTIONARY RATE VARIATION; MOLECULAR EVOLUTION; NUCLEOTIDE DIVERSITY; DAUCUS-CAROTA; DNA-SEQUENCE; ARABIDOPSIS; PATTERNS; SITES; L.; LIKELIHOOD	Background: Selection of genes involved in metabolic pathways could target them differently depending on the position of genes in the pathway and on their role in controlling metabolic fluxes. This hypothesis was tested in the carotenoid biosynthesis pathway using population genetics and phylogenetics. Methodology/Principal Findings: Evolutionary rates of seven genes distributed along the carotenoid biosynthesis pathway, IPI, PDS, CRTISO, LCYB, LCYE, CHXE and ZEP, were compared in seven dicot taxa. A survey of deviations from neutrality expectations at these genes was also undertaken in cultivated carrot (Daucus carota subsp. sativus), a species that has been intensely bred for carotenoid pattern diversification in its root during its cultivation history. Parts of sequences of these genes were obtained from 46 individuals representing a wide diversity of cultivated carrots. Downstream genes exhibited higher deviations from neutral expectations than upstream genes. Comparisons of synonymous and nonsynonymous substitution rates between genes among dicots revealed greater constraints on upstream genes than on downstream genes. An excess of intermediate frequency polymorphisms, high nucleotide diversity and/or high differentiation of CRTISO, LCYB1 and LCYE in cultivated carrot suggest that balancing selection may have targeted genes acting centrally in the pathway. Conclusions/Significance: Our results are consistent with relaxed constraints on downstream genes and selection targeting the central enzymes of the carotenoid biosynthesis pathway during carrot breeding history.	[Clotault, Jeremy; Peltier, Didier; Soufflet-Freslon, Vanessa; Briard, Mathilde; Geoffriau, Emmanuel] Univ Angers, PRES LUNAM, Inst Rech Hort & Semences, UMR1345, Angers, France; [Clotault, Jeremy; Peltier, Didier; Soufflet-Freslon, Vanessa; Briard, Mathilde; Geoffriau, Emmanuel] Inst Rech Hort & Semences, Agrocampus Ouest, UMR1345, Angers, France; [Clotault, Jeremy; Peltier, Didier; Soufflet-Freslon, Vanessa; Briard, Mathilde; Geoffriau, Emmanuel] Inst Rech Hort & Semences, UMR1345, INRA, Beaucouze, France	Universite d'Angers; Institut Agro; Agrocampus Ouest; Universite d'Angers; INRAE	Clotault, J (corresponding author), Univ Angers, PRES LUNAM, Inst Rech Hort & Semences, UMR1345, Angers, France.	jeremy.clotault@univ-angers.fr	martel, celine/O-6651-2016	martel, celine/0000-0002-1800-4558; Clotault, Jeremy/0000-0002-7678-1929	Pays de la Loire region; French Ministry of Research	Pays de la Loire region(Region Pays de la Loire); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This study was supported by grants from the Pays de la Loire region. Jeremy Clotault was a PhD student funded by the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BANGA O., 1957, EUPHYTICA, V6, P54; Banga O., 1963, MAIN TYPES W CAROTEN; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; BARTLEY GE, 1995, PLANT CELL, V7, P1027, DOI 10.1105/tpc.7.7.1027; Baudry E, 2003, GENETICS, V165, P1619; Beaumont MA, 2002, GENETICS, V162, P2025; Bouvier F, 2005, PROG LIPID RES, V44, P357, DOI 10.1016/j.plipres.2005.09.003; CHAKRABORTY R, 1993, EXS, V67, P153; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Clotault J, 2012, MOL BIOL EVOL, V29, P1199, DOI 10.1093/molbev/msr287; Clotault J, 2010, THEOR APPL GENET, V121, P659, DOI 10.1007/s00122-010-1338-1; Cork JM, 2004, BIOESSAYS, V26, P479, DOI 10.1002/bies.20026; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; De Mita S, 2007, GENETICS, V177, P2123, DOI 10.1534/genetics.107.076943; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Flowers JM, 2007, MOL BIOL EVOL, V24, P1347, DOI 10.1093/molbev/msm057; Fu ZY, 2010, THEOR APPL GENET, V120, P709, DOI 10.1007/s00122-009-1188-x; Galpaz N, 2006, PLANT CELL, V18, P1947, DOI 10.1105/tpc.105.039966; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Howitt CA, 2006, PLANT CELL ENVIRON, V29, P435, DOI 10.1111/j.1365-3040.2005.01492.x; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1992, GENETICS, V132, P583; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Just BJ, 2007, THEOR APPL GENET, V114, P693, DOI 10.1007/s00122-006-0469-x; Just BJ, 2009, THEOR APPL GENET, V119, P1155, DOI 10.1007/s00122-009-1117-z; Kreitman M, 2000, ANNU REV GENOM HUM G, V1, P539, DOI 10.1146/annurev.genom.1.1.539; Kronholm I, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-33; Laufer B, 1919, SINO IRANICA CHINESE, V15, P451; LI WH, 1985, MOL BIOL EVOL, V2, P150; Livingstone K, 2009, J HERED, V100, P754, DOI 10.1093/jhered/esp026; Lu S, 2008, J INTEGR PLANT BIOL, V50, P778, DOI 10.1111/j.1744-7909.2008.00708.x; Lu YQ, 2003, MOL BIOL EVOL, V20, P1844, DOI 10.1093/molbev/msg197; Ma YZ, 2003, P NATL ACAD SCI USA, V100, P4377, DOI 10.1073/pnas.0736959100; Maass D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006373; MACKEVIC VI, 1929, B APPL BOT GENET PL, V20, P517; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 1987, MOL EVOLUTIONARY GEN; Nicolle C, 2004, J AM SOC HORTIC SCI, V129, P523, DOI 10.21273/JASHS.129.4.0523; Nordborg M, 2003, GENETICS, V163, P1201; Palaisa KA, 2003, PLANT CELL, V15, P1795, DOI 10.1105/tpc.012526; Pavlidis P, 2010, MOL ECOL RESOUR, V10, P723, DOI 10.1111/j.1755-0998.2010.02832.x; R Core Team, 2020, R LANG ENV STAT COMP; Ramos-Onsins SE, 2008, MOL ECOL, V17, P1211, DOI 10.1111/j.1365-294X.2007.03633.x; Ramsay H, 2009, MOL BIOL EVOL, V26, P1045, DOI 10.1093/molbev/msp021; Rausher MD, 2008, J MOL EVOL, V67, P137, DOI 10.1007/s00239-008-9105-5; Rausher MD, 1999, MOL BIOL EVOL, V16, P266, DOI 10.1093/oxfordjournals.molbev.a026108; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shinohara S, 1984, VEGETABLE SEED PRODU, P273; Surles RL, 2004, J AGR FOOD CHEM, V52, P3417, DOI 10.1021/jf035472m; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Wright KM, 2010, GENETICS, V184, P483, DOI 10.1534/genetics.109.110411; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Wright SI, 2004, GENETICS, V168, P1071, DOI 10.1534/genetics.104.026500; Yang YH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-206; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu GQ, 2011, MOL BIOL EVOL, V28, P659, DOI 10.1093/molbev/msq243; Yu HS, 2011, MOL BIOL EVOL, V28, P1785, DOI 10.1093/molbev/msr002; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432	65	36	37	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38724	10.1371/journal.pone.0038724	http://dx.doi.org/10.1371/journal.pone.0038724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22737218	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300042
J	Wilson, BJ; Nicholas, FW; James, JW; Wade, CM; Tammen, I; Raadsma, HW; Castle, K; Thomson, PC				Wilson, Bethany J.; Nicholas, Frank W.; James, John W.; Wade, Claire M.; Tammen, Imke; Raadsma, Herman W.; Castle, Kao; Thomson, Peter C.			Heritability and Phenotypic Variation of Canine Hip Dysplasia Radiographic Traits in a Cohort of Australian German Shepherd Dogs	PLOS ONE			English	Article							GENETIC-PARAMETERS; ELBOW DYSPLASIA; UNITED-KINGDOM; SCORE; EPIDEMIOLOGY; NEWFOUNDLAND; POPULATION; RETRIEVERS; COMPONENTS	Canine Hip Dysplasia (CHD) is a common, painful and debilitating orthopaedic disorder of dogs with a partly genetic, multifactorial aetiology. Worldwide, potential breeding dogs are evaluated for CHD using radiographically based screening schemes such as the nine ordinally-scored British Veterinary Association Hip Traits (BVAHTs). The effectiveness of selective breeding based on screening results requires that a significant proportion of the phenotypic variation is caused by the presence of favourable alleles segregating in the population. This proportion, heritability, was measured in a cohort of 13,124 Australian German Shepherd Dogs born between 1976 and 2005, displaying phenotypic variation for BVAHTs, using ordinal, linear and binary mixed models fitted by a Restricted Maximum Likelihood method. Heritability estimates for the nine BVAHTs ranged from 0.14-0.24 (ordinal models), 0.14-0.25 (linear models) and 0.12-0.40 (binary models). Heritability for the summed BVAHT phenotype was 0.30 +/- 0.02. The presence of heritable variation demonstrates that selection based on BVAHTs has the potential to improve BVAHT scores in the population. Assuming a genetic correlation between BVAHT scores and CHD-related pain and dysfunction, the welfare of Australian German Shepherds can be improved by continuing to consider BVAHT scores in the selection of breeding dogs, but that as heritability values are only moderate in magnitude the accuracy, and effectiveness, of selection could be improved by the use of Estimated Breeding Values in preference to solely phenotype based selection of breeding animals.	[Wilson, Bethany J.; Nicholas, Frank W.; James, John W.; Wade, Claire M.; Tammen, Imke; Raadsma, Herman W.; Castle, Kao; Thomson, Peter C.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Sydney	Wilson, BJ (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	bethany.wilson@sydney.edu.au	Nicholas, Frank/AGY-8318-2022; Nicholas, Frank William/AAE-5566-2022; Tammen, Imke/AFF-7998-2022; Thomson, Peter/V-7290-2019	Nicholas, Frank/0000-0002-9178-3965; Nicholas, Frank William/0000-0002-9178-3965; Tammen, Imke/0000-0002-5520-6597; Thomson, Peter/0000-0003-4428-444X; Wade, Claire/0000-0003-3413-4771				Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Demko J, 2005, VET CLIN N AM-SMALL, V35, P1111, DOI 10.1016/j.cvsm.2005.05.002; Dietschi E, 2003, J ANIM BREED GENET, V120, P150, DOI 10.1046/j.1439-0388.2003.00390.x; Everts RE, 2000, VET QUART, V22, P63, DOI 10.1080/01652176.2000.9695027; Fluckiger M., 2007, EUROPEAN J COMPANION, V17, P135; Gibbs C, 1997, VET REC, V141, P275; Ginja MMD, 2010, VET J, V184, P269, DOI 10.1016/j.tvjl.2009.04.009; Hamann H, 2003, J ANIM BREED GENET, V120, P258, DOI 10.1046/j.1439-0388.2003.00395.x; HEDHAMMAR A, 1979, J AM VET MED ASSOC, V174, P1012; Janutta V, 2006, J HERED, V97, P13, DOI 10.1093/jhered/esi128; Karsada R, 2007, FOLIA VET, V51, P142; Lawson DD, 2000, HEREDITARY BONE JOIN, P267; Leighton EA, 1997, J AM VET MED ASSOC, V210, P1474; Leppanen M, 2000, J ANIM BREED GENET, V117, P97, DOI 10.1111/j.1439-0388.2000x.00229.x; Lewis TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013610; Lewis TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012797; Maki K, 2004, HEREDITY, V92, P402, DOI 10.1038/sj.hdy.6800434; Malm S, 2007, PREV VET MED, V78, P196, DOI 10.1016/j.prevetmed.2006.10.005; Malm S, 2010, PREV VET MED, V93, P222, DOI 10.1016/j.prevetmed.2009.09.017; Marschall Y, 2007, MAMM GENOME, V18, P861, DOI 10.1007/s00335-007-9071-z; Sewell MD, 2009, BRIT MED J, V339, P12; Silvestre AM, 2007, J ANIM SCI, V85, P1880, DOI 10.2527/jas.2007-0166; Steinetz BG, 2008, AM J VET RES, V69, P59, DOI 10.2460/ajvr.69.1.59; Stock KF, 2011, J ANIM BREED GENET, V128, P219, DOI 10.1111/j.1439-0388.2010.00901.x; Sturaro E, 2006, ITAL J ANIM SCI, V5, P107; Todhunter RJ, 2003, J HERED, V94, P39, DOI 10.1093/jhered/esg006; Wilson BJ, 2011, J ANIM BREED GENET, V128, P230, DOI 10.1111/j.1439-0388.2010.00903.x; Wilson B, 2011, VET J, V189, P160, DOI 10.1016/j.tvjl.2011.06.014; Wood JLN, 2000, PREV VET MED, V46, P75, DOI 10.1016/S0167-5877(00)00140-9; Wood JLN, 2000, PREV VET MED, V46, P87, DOI 10.1016/S0167-5877(00)00141-0; Wood JLN, 2002, PREV VET MED, V55, P95, DOI 10.1016/S0167-5877(02)00090-9; Woolliams JA, 2011, VET J IN PRESS	32	25	26	7	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39620	10.1371/journal.pone.0039620	http://dx.doi.org/10.1371/journal.pone.0039620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761846	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800051
J	Scheele, C; Nielsen, S; Kelly, M; Broholm, C; Nielsen, AR; Taudorf, S; Pedersen, M; Fischer, CP; Pedersen, BK				Scheele, Camilla; Nielsen, Soren; Kelly, Meghan; Broholm, Christa; Nielsen, Anders Rinnov; Taudorf, Sarah; Pedersen, Maria; Fischer, Christian P.; Pedersen, Bente Klarlund			Satellite Cells Derived from Obese Humans with Type 2 Diabetes and Differentiated into Myocytes In Vitro Exhibit Abnormal Response to IL-6	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HUMAN SKELETAL-MUSCLE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; GLUCOSE-UPTAKE; CHRONIC EXPOSURE; FACTOR-ALPHA; INTERLEUKIN-6; PROTEIN; ACTIVATION	Obesity and type 2 diabetes are associated with chronically elevated systemic levels of IL-6, a pro-inflammatory cytokine with a role in skeletal muscle metabolism that signals through the IL-6 receptor (IL-6R alpha). We hypothesized that skeletal muscle in obesity-associated type 2 diabetes develops a resistance to IL-6. By utilizing western blot analysis, we demonstrate that IL-6R alpha protein was down regulated in skeletal muscle biopsies from obese persons with and without type 2 diabetes. To further investigate the status of IL-6 signaling in skeletal muscle in obesity-associated type 2 diabetes, we isolated satellite cells from skeletal muscle of people that were healthy (He), obese (Ob) or were obese and had type 2 diabetes (DM), and differentiated them in vitro into myocytes. Down-regulation of IL-6R alpha was conserved in Ob myocytes. In addition, acute IL-6 administration for 30, 60 and 120 minutes, resulted in a down-regulation of IL-6R alpha protein in Ob myocytes compared to both He myocytes (P<0.05) and DM myocytes (P<0.05). Interestingly, there was a strong time-dependent regulation of IL-6R alpha protein in response to IL-6 (P<0.001) in He myocytes, not present in the other groups. Assessing downstream signaling, DM, but not Ob myocytes demonstrated a trend towards an increased protein phosphorylation of STAT3 in DM myocytes (P=0.067) accompanied by a reduced SOCS3 protein induction (P<0.05), in response to IL-6 administration. Despite this loss of negative control, IL-6 failed to increase AMPK alpha 2 activity and IL-6 mRNA expression in DM myocytes. There was no difference in fusion capacity of myocytes between cell groups. Our data suggest that negative control of IL-6 signaling is increased in myocytes in obesity, whereas a dysfunctional IL-6 signaling is established further downstream of IL-6R alpha in DM myocytes, possibly representing a novel mechanism by which skeletal muscle function is compromised in type 2 diabetes.	[Scheele, Camilla] Univ Copenhagen, Rigshosp, Fac Hlth Sci, Ctr Inflammat & Metab,Dept Infect Dis, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Rigshosp, Fac Hlth Sci, Copenhagen Muscle Res Ctr, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Scheele, C (corresponding author), Univ Copenhagen, Rigshosp, Fac Hlth Sci, Ctr Inflammat & Metab,Dept Infect Dis, DK-2100 Copenhagen, Denmark.	camilla.scheele@gmail.com	Nielsen, Søren/AAC-2325-2020; Scheele, Camilla/AAA-3599-2020; Pedersen, Bente Klarlund/AGR-3217-2022; Kelly, Meghan/ABD-6727-2021; Scheele, Camilla/S-6401-2017	Nielsen, Søren/0000-0002-3119-750X; Scheele, Camilla/0000-0002-6055-9709; Pedersen, Bente Klarlund/0000-0001-6508-6288; Kelly, Meghan/0000-0002-8541-5533; Scheele, Camilla/0000-0002-6055-9709; Rinnov, Anders Rasmussen/0000-0003-3859-3289; Fischer, Christian/0000-0002-0657-9143	Danish National Research Foundation [02-512-55]; Danish Council for Independent Research -Medical Sciences; Commission of the European Communities [223576 - MYOAGE]; Swedish Research Council; Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research [09-067009, 09-075724]; Capital Region of Denmark	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Council for Independent Research -Medical Sciences(Det Frie Forskningsrad (DFF)); Commission of the European Communities(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Capital Region of Denmark	The Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (# 02-512-55)(http://www.dg.dk/en/). This study was further supported by the Danish Council for Independent Research -Medical Sciences (http://en.fi.dk/councils-commissions/the-danish-council-for-independent-research/scientific-research-councils/medical-sciences), the Commission of the European Communities (Grant Agreement no. 223576 - MYOAGE)(http://www.myoage.eu/), and by a grant from the Swedish Research Council (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). CIM is part of the UNIK Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology, and Innovation (http://foodfitnesspharma.ku.dk/). CIM is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09-067009 and 09-075724)(http://en.fi.dk/councils-commissions/the-danish-council-for-strategic-research). The Copenhagen Muscle Research Centre is supported by a grant from the Capital Region of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalili L, 2006, MOL ENDOCRINOL, V20, P3364, DOI 10.1210/me.2005-0490; Bastard JP, 2002, J CLIN ENDOCR METAB, V87, P2084, DOI 10.1210/jc.87.5.2084; Bodell PW, 2009, J APPL PHYSIOL, V106, P443, DOI 10.1152/japplphysiol.90831.2008; Bruce CR, 2004, AM J PHYSIOL-ENDOC M, V287, pE616, DOI 10.1152/ajpendo.00150.2004; Carey AL, 2004, DIABETOLOGIA, V47, P1029, DOI 10.1007/s00125-004-1403-x; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Dey BR, 2000, BIOCHEM BIOPH RES CO, V278, P38, DOI 10.1006/bbrc.2000.3762; Diao YR, 2009, MOL CELL BIOL, V29, P5084, DOI 10.1128/MCB.00267-09; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Fernandez-Real JM, 2001, J CLIN ENDOCR METAB, V86, P1154, DOI 10.1210/jc.86.3.1154; Gallagher IJ, 2010, GENOME MED, V2, DOI 10.1186/gm130; Gaster M, 2004, DIABETES, V53, P542, DOI 10.2337/diabetes.53.3.542; Gaster M, 2002, DIABETES, V51, P921, DOI 10.2337/diabetes.51.4.921; Glund S, 2007, DIABETES, V56, P1630, DOI 10.2337/db06-1733; Green CJ, 2011, DIABETES, V60, P2810, DOI 10.2337/db11-0263; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; Jackson S, 2000, DIABETES, V49, P1169, DOI 10.2337/diabetes.49.7.1169; Kawazoe Y, 2001, J EXP MED, V193, P263, DOI 10.1084/jem.193.2.263; Keller C, 2005, J APPL PHYSIOL, V99, P2075, DOI 10.1152/japplphysiol.00590.2005; Keller P, 2003, BIOCHEM BIOPH RES CO, V310, P550, DOI 10.1016/j.bbrc.2003.09.048; Kelly M, 2004, BIOCHEM BIOPH RES CO, V320, P449, DOI 10.1016/j.bbrc.2004.05.188; Kelly M, 2009, DIABETES, V58, P1953, DOI 10.2337/db08-1293; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Liu L, 2008, CURR ISSUES MOL BIOL, V10, P25, DOI 10.21775/cimb.010.025; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Mooney RA, 2001, J BIOL CHEM, V276, P25889, DOI 10.1074/jbc.M010579200; Mortensen OH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007419; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; Nielsen AR, 2008, DIABETES, V57, P3078, DOI 10.2337/db08-0182; Ostrowski K, 1998, J PHYSIOL-LONDON, V508, P949, DOI 10.1111/j.1469-7793.1998.949bp.x; Petersen EW, 2005, AM J PHYSIOL-ENDOC M, V288, pE155, DOI 10.1152/ajpendo.00257.2004; Plomgaard P, 2007, DIABETOLOGIA, V50, P2562, DOI 10.1007/s00125-007-0834-6; RICHTER EA, 1989, J APPL PHYSIOL, V66, P876; Rieusset J, 2004, DIABETES, V53, P2232, DOI 10.2337/diabetes.53.9.2232; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; Steinberg GR, 2006, J CLIN ENDOCR METAB, V91, P3592, DOI 10.1210/jc.2006-0638; Thompson DB, 1996, J CLIN INVEST, V98, P2346, DOI 10.1172/JCI119046; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weigert C, 2007, AM J PHYSIOL-CELL PH, V293, pC1139, DOI 10.1152/ajpcell.00142.2007	48	46	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39657	10.1371/journal.pone.0039657	http://dx.doi.org/10.1371/journal.pone.0039657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761857	Green Submitted, Green Published, gold			2022-12-27	WOS:000305808700041
J	Essaghir, A; Demoulin, JB				Essaghir, Ahmed; Demoulin, Jean-Baptiste			A Minimal Connected Network of Transcription Factors Regulated in Human Tumors and Its Application to the Quest for Universal Cancer Biomarkers	PLOS ONE			English	Article							CELL CARCINOMA; GENOMIC DATA; EXPRESSION; RECEPTOR; HYPOXIA; MYC; BIOINFORMATICS; INFLAMMATION; METABOLISM; ACTIVATION	A universal cancer biomarker candidate for diagnosis is supposed to distinguish, within a broad range of tumors, between healthy and diseased patients. Recently published studies have explored the universal usefulness of some biomarkers in human tumors. In this study, we present an integrative approach to search for potential common cancer biomarkers. Using the TFactS web-tool with a catalogue of experimentally established gene regulations, we could predict transcription factors (TFs) regulated in 305 different human cancer cell lines covering a large panel of tumor types. We also identified chromosomal regions having significant copy number variation (CNV) in these cell lines. Within the scope of TFactS catalogue, 88 TFs whose activity status were explained by their gene expressions and CNVs were identified. Their minimal connected network (MCN) of protein-protein interactions forms a significant module within the human curated TF proteome. Functional analysis of the proteins included in this MCN revealed enrichment in cancer pathways as well as inflammation. The ten most central proteins in MCN are TFs that trans-regulate 157 known genes encoding secreted and transmembrane proteins. In publicly available collections of gene expression data from 8,525 patient tissues, 86 genes were differentially regulated in cancer compared to inflammatory diseases and controls. From TCGA cancer gene expression data sets, 50 genes were significantly associated to patient survival in at least one tumor type. Enrichment analysis shows that these genes mechanistically interact in common cancer pathways. Among these cancer biomarker candidates, TFRC, MET and VEGFA are commonly amplified genes in tumors and their encoded proteins stained positive in more than 80% of malignancies from public databases. They are linked to angiogenesis and hypoxia, which are common in cancer. They could be interesting for further investigations in cancer diagnostic strategies.	[Essaghir, Ahmed; Demoulin, Jean-Baptiste] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium	Universite Catholique Louvain	Essaghir, A (corresponding author), Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium.	ahmed.essaghir@uclouvain.be		Demoulin, Jean-Baptiste/0000-0002-8016-6689	Universite Catholique de Louvain	Universite Catholique de Louvain	This work was funded by FSR Fellowship from Universite Catholique de Louvain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel Ethan V, 2011, Front Biosci (Schol Ed), V3, P937; Aggarwal BB, 2011, ONCOLOGY-NY, V25, P414; Basak SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005884; Basil CF, 2006, CANCER RES, V66, P2953, DOI 10.1158/0008-5472.CAN-05-3433; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Bengtsson H., 2008, AROMA AFFYMETRIX GEN; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Buseman C. M., 2011, MUTAT RES, V730, P90; Chang YF, 2011, ANAL CHEM, V83, P5324, DOI 10.1021/ac200754x; Chechlinska M, 2010, NAT REV CANCER, V10, P2, DOI 10.1038/nrc2782; Chen L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-416; Cho-Chung YS, 2006, BBA-MOL BASIS DIS, V1762, P587, DOI 10.1016/j.bbadis.2006.04.001; Clements J, 1997, CLIN CANCER RES, V3, P1427; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Cui T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016010; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Dawany NB, 2011, INT J CANCER, V128, P2881, DOI 10.1002/ijc.25854; Demoulin JB, 2006, GROWTH FACTORS, V24, P184, DOI 10.1080/08977190600696430; Deshmukh H, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-57; Essaghir A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq149; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gioeli D, 2011, MOL TRANSL MED, P33, DOI 10.1007/978-1-60761-478-4_2; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Guberman JM, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar041; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Javelaud D, 2011, CANCER RES, V71, P5606, DOI 10.1158/0008-5472.CAN-11-1194; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kuiper RP, 2010, CURR OPIN GENET DEV, V20, P282, DOI 10.1016/j.gde.2010.03.005; Laurenti G, 2011, J CELL BIOCHEM, V112, P3891, DOI 10.1002/jcb.23323; Lefebvre C, 2012, WILEY INTERDISCIPLIN; Levenson VV, 2011, EXPERT REV MOL DIAGN, V11, P807, DOI [10.1586/erm.11.74, 10.1586/ERM.11.74]; Levenson VV, 2010, EXPERT REV MOL DIAGN, V10, P481, DOI 10.1586/ERM.10.17; Li YQ, 2011, P NATL ACAD SCI USA, V108, P9951, DOI 10.1073/pnas.1016912108; Little JL, 2008, MOL CANCER THER, V7, P3816, DOI 10.1158/1535-7163.MCT-08-0558; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Mehta Sunali, 2010, Ther Adv Med Oncol, V2, P125, DOI 10.1177/1758834009360519; Milne ANA, 2007, HUM PATHOL, V38, P903, DOI 10.1016/j.humpath.2006.12.010; Minguez P, 2009, NUCLEIC ACIDS RES, V37, pW109, DOI 10.1093/nar/gkp402; Montano-Almendras CP, 2012, HAEMATOLOGICA; Murray GI, 1997, CANCER RES, V57, P3026; Nesterova M, 2006, BBA-MOL BASIS DIS, V1762, P398, DOI 10.1016/j.bbadis.2005.12.010; Noguchi K, 2004, ANTICANCER RES, V24, P3387; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; Pachikian BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023365; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; Radu A, 2010, NEW ENGL J MED, V363, P1621, DOI 10.1056/NEJMoa1001283; Rodriguez-Caso C, 2005, FEBS J, V272, P6423, DOI 10.1111/j.1742-4658.2005.05041.x; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Sethi G, 2012, BIOSCIENCE REP, V32, P1, DOI 10.1042/BSR20100136; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Steidl C, 2011, BLOOD, V118, P2659, DOI 10.1182/blood-2011-05-326538; Sun SY, 2011, INT J CANCER, V129, P2337, DOI 10.1002/ijc.25927; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; Therneau T, 2011, SURVIVAL SURVIVAL AN; Tran LM, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-121; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; van Leenders GJLH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026753; Wilson BJ, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-49; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Xu T, 2010, CANCER RES, V70, P6420, DOI 10.1158/0008-5472.CAN-10-0686; Xu Y, 2012, MOL BIOL REP, V39, P1627, DOI 10.1007/s11033-011-0902-3; Yang YL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003661; You HN, 2011, HEPATOLOGY, V54, P879, DOI 10.1002/hep.24450; You WK, 2011, CANCER RES, V71, P4758, DOI 10.1158/0008-5472.CAN-10-2527; Zavoral M, 2011, WORLD J GASTROENTERO, V17, P2897, DOI 10.3748/wjg.v17.i24.2897	71	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39666	10.1371/journal.pone.0039666	http://dx.doi.org/10.1371/journal.pone.0039666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761861	Green Published, gold			2022-12-27	WOS:000305781700057
J	Shiheido, H; Terada, F; Tabata, N; Hayakawa, I; Matsumura, N; Takashima, H; Ogawa, Y; Du, WL; Yamada, T; Shoji, M; Sugai, T; Doi, N; Iijima, S; Hattori, Y; Yanagawa, H				Shiheido, Hirokazu; Terada, Fukiko; Tabata, Noriko; Hayakawa, Ichigo; Matsumura, Nobutaka; Takashima, Hideaki; Ogawa, Yoko; Du, Wenlin; Yamada, Taketo; Shoji, Mitsuru; Sugai, Takeshi; Doi, Nobuhide; Iijima, Shiro; Hattori, Yutaka; Yanagawa, Hiroshi			A Phthalimide Derivative That Inhibits Centrosomal Clustering Is Effective on Multiple Myeloma	PLOS ONE			English	Article							MESSENGER-RNA DISPLAY; SPINDLE MULTIPOLARITY; GROWTH-FACTOR; CANCER-CELLS; HELA-CELLS; NUCLEOPHOSMIN; THALIDOMIDE; EXPRESSION; PROTEIN; P53	Despite the introduction of newly developed drugs such as lenalidomide and bortezomib, patients with multiple myeloma are still difficult to treat and have a poor prognosis. In order to find novel drugs that are effective for multiple myeloma, we tested the antitumor activity of 29 phthalimide derivatives against several multiple myeloma cell lines. Among these derivatives, 2-(2,6-diisopropylphenyl)-5-amino-1H-isoindole-1,3-dione (TC11) was found to be a potent inhibitor of tumor cell proliferation and an inducer of apoptosis via activation of caspase-3, 8 and 9. This compound also showed in vivo activity against multiple myeloma cell line KMS34 tumor xenografts in ICR/SCID mice. By means of mRNA display selection on a microfluidic chip, the target protein of TC11 was identified as nucleophosmin 1 (NPM). Binding of TC11 and NPM monomer was confirmed by surface plasmon resonance. Immunofluorescence and NPM knockdown studies in HeLa cells suggested that TC11 inhibits centrosomal clustering by inhibiting the centrosomal-regulatory function of NPM, thereby inducing multipolar mitotic cells, which undergo apoptosis. NPM may become a novel target for development of antitumor drugs active against multiple myeloma.	[Shiheido, Hirokazu; Tabata, Noriko; Hayakawa, Ichigo; Matsumura, Nobutaka; Takashima, Hideaki; Ogawa, Yoko; Doi, Nobuhide; Yanagawa, Hiroshi] Keio Univ, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 223, Japan; [Terada, Fukiko; Shoji, Mitsuru; Sugai, Takeshi; Iijima, Shiro; Hattori, Yutaka] Keio Univ, Fac Pharm, Minato Ku, Tokyo, Japan; [Du, Wenlin; Yamada, Taketo] Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 160, Japan	Keio University; Keio University; Keio University	Shiheido, H (corresponding author), Keio Univ, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 223, Japan.	hyana@bio.keio.ac.jp	Doi, Nobuhide/C-4481-2014	Doi, Nobuhide/0000-0002-2402-6390; Hattori, Yutaka/0000-0003-1080-9738; Shiheido, Hirokazu/0000-0002-1415-2019	basic research program (CREST) of the Japan Science and Technology Agency; Ministry of Education, Culture, Sport, Science, and Technology (MEXT), Japan [22310121]; Strategic Research Foundation from Ministry of Education, Culture, Sport, Science, and Technology (MEXT), Japan [S0801008, S0901009]	basic research program (CREST) of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sport, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Research Foundation from Ministry of Education, Culture, Sport, Science, and Technology (MEXT), Japan	This work was supported by grants for a basic research program (CREST) of the Japan Science and Technology Agency, and a Grant-in-Aid for Scientific Research (22310121) and Strategic Research Foundation Grant-aided Projects for Private Universities (S0801008 and S0901009) from Ministry of Education, Culture, Sport, Science, and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANIAN R, 1969, J AMER MED ASSOC, V208, P1680, DOI 10.1001/jama.208.9.1680; Amin MA, 2008, FEBS LETT, V582, P3839, DOI 10.1016/j.febslet.2008.10.023; Avet-Loiseau H, 2010, LEUKEMIA, V24, P623, DOI 10.1038/leu.2009.273; Avet-Loiseau H, 2007, BLOOD, V109, P3489, DOI 10.1182/blood-2006-08-040410; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; CHAN PK, 1995, BBA-GENE STRUCT EXPR, V1262, P37, DOI 10.1016/0167-4781(95)00044-H; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Debes-Marun CS, 2003, LEUKEMIA, V17, P427, DOI 10.1038/sj.leu.2402797; Delforge M, 2010, LANCET ONCOL, V11, P1086, DOI 10.1016/S1470-2045(10)70068-1; Dispenzieri A, 2007, BLOOD, V109, P465, DOI 10.1182/blood-2006-07-032987; Du WL, 2007, BLOOD, V109, P3042, DOI 10.1182/blood-2006-02-003103; Fassas ABT, 2002, BRIT J HAEMATOL, V118, P1041, DOI 10.1046/j.1365-2141.2002.03757.x; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hideshima T, 2000, BLOOD, V96, P2943, DOI 10.1182/blood.V96.9.2943; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Horisawa K, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh167; Inatsuki S, 2005, BIOORG MED CHEM LETT, V15, P321, DOI 10.1016/j.bmcl.2004.10.072; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Leber B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000915; Li ZL, 2008, P NATL ACAD SCI USA, V105, P18794, DOI 10.1073/pnas.0806879105; Magedov IV, 2007, BIOORG MED CHEM LETT, V17, P3872, DOI 10.1016/j.bmcl.2007.05.004; Mitsiades N, 2002, BLOOD, V99, P4525, DOI 10.1182/blood.V99.12.4525; Miyamoto-Sato E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng078; Okuda M, 2002, ONCOGENE, V21, P6170, DOI 10.1038/sj.onc.1205708; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Otsuki T, 1999, INT J ONCOL, V15, P1205; Palumbo A, 2010, LEUKEMIA, V24, P1037, DOI 10.1038/leu.2010.58; Qi W, 2008, ONCOGENE, V27, P4210, DOI 10.1038/onc.2008.54; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Rebacz B, 2007, CANCER RES, V67, P6342, DOI 10.1158/0008-5472.CAN-07-0663; Rousselet A, 2009, BIOL CELL, V101, P679, DOI 10.1042/BC20080218; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Saunders W, 2005, SEMIN CANCER BIOL, V15, P25, DOI 10.1016/j.semcancer.2004.09.003; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Smadja NV, 2001, BLOOD, V98, P2229, DOI 10.1182/blood.V98.7.2229; Sohyris N, 2005, ONCOGENE, V24, P2184; Stewart AK, 2005, J CLIN ONCOL, V23, P6339, DOI 10.1200/JCO.2005.05.023; Tabata N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp184; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Zatsepina OV, 1999, J CELL SCI, V112, P455	41	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e38878	10.1371/journal.pone.0038878	http://dx.doi.org/10.1371/journal.pone.0038878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761710	Green Submitted, gold, Green Published			2022-12-27	WOS:000305781700012
J	Levi, H; Schoknecht, K; Prager, O; Chassidim, Y; Weissberg, I; Serlin, Y; Friedman, A				Levi, Haviv; Schoknecht, Karl; Prager, Ofer; Chassidim, Yoash; Weissberg, Itai; Serlin, Yonatan; Friedman, Alon			Stimulation of the Sphenopalatine Ganglion Induces Reperfusion and Blood-Brain Barrier Protection in the Photothrombotic Stroke Model	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; SPREADING DEPOLARIZATION; SUBARACHNOID HEMORRHAGE; RAT; FLOW; EPILEPTOGENESIS; NERVE; DISRUPTION; PERMEABILITY; ISOFLURANE	Purpose: The treatment of stroke remains a challenge. Animal studies showing that electrical stimulation of the sphenopalatine ganglion (SPG) exerts beneficial effects in the treatment of stroke have led to the initiation of clinical studies. However, the detailed effects of SPG stimulation on the injured brain are not known. Methods: The effect of acute SPG stimulation was studied by direct vascular imaging, fluorescent angiography and laser Doppler flowmetry in the sensory motor cortex of the anaesthetized rat. Focal cerebral ischemia was induced by the rose bengal (RB) photothrombosis method. In chronic experiments, SPG stimulation, starting 15 min or 24 h after photothrombosis, was given for 3 h per day on four consecutive days. Structural damage was assessed using histological and immunohistochemical methods. Cortical functions were assessed by quantitative analysis of epidural electrocorticographic (ECoG) activity continuously recorded in behaving animals. Results: Stimulation induced intensity-and duration-dependent vasodilation and increased cerebral blood flow in both healthy and photothrombotic brains. In SPG-stimulated rats both blood brain-barrier (BBB) opening, pathological brain activity and lesion volume were attenuated compared to untreated stroke animals, with no apparent difference in the glial response surrounding the necrotic lesion. Conclusion: SPG-stimulation in rats induces vasodilation of cortical arterioles, partial reperfusion of the ischemic lesion, and normalization of brain functions with reduced BBB dysfunction and stroke volume. These findings support the potential therapeutic effect of SPG stimulation in focal cerebral ischemia even when applied 24 h after stroke onset and thus may extend the therapeutic window of currently administered stroke medications.	[Levi, Haviv; Prager, Ofer; Chassidim, Yoash; Weissberg, Itai; Serlin, Yonatan; Friedman, Alon] Ben Gurion Univ Negev, Dept Physiol & Neurobiol, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Schoknecht, Karl; Friedman, Alon] Charite, Inst Neurophysiol, Neurocure Res Ctr, D-13353 Berlin, Germany	Ben Gurion University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Levi, H (corresponding author), Ben Gurion Univ Negev, Dept Physiol & Neurobiol, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel.	alonf@bgu.ac.il	Weissberg, Itai/AGU-9930-2022	Prager, Ofer/0000-0002-0172-0849	BrainsGate Ltd.	BrainsGate Ltd.	This study was partially funded by BrainsGate Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Arora S, 2005, STROKE, V36, P1232, DOI 10.1161/01.STR.0000165902.18021.5b; Ayajiki K, 2005, J APPL PHYSIOL, V98, P1792, DOI 10.1152/japplphysiol.00690.2004; Bang OY, 2007, ANN NEUROL, V62, P170, DOI 10.1002/ana.21174; Bar-Shir A, 2010, J MAGN RESON IMAGING, V31, P1355, DOI 10.1002/jmri.22110; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; David Y, 2009, J NEUROSCI, V29, P10588, DOI 10.1523/JNEUROSCI.2323-09.2009; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Drenckhahn C, 2012, BRAIN, V135, P853, DOI 10.1093/brain/aws010; Friedman A, 2009, BLOOD BRAIN BARRIER; Ginsberg MD, 1997, AM J NEURORADIOL, V18, P1435; Henninger N, 2007, STROKE, V38, P2779, DOI 10.1161/STROKEAHA.107.485581; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Kastrup A, 1999, J NEUROL SCI, V166, P91, DOI 10.1016/S0022-510X(99)00121-5; Khurana D, 2009, INT J STROKE, V4, P480, DOI 10.1111/j.1747-4949.2009.00385.x; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Matta BF, 1999, ANESTHESIOLOGY, V91, P677, DOI 10.1097/00000542-199909000-00019; O'Donnell ME, 2004, ADV EXP MED BIOL, V559, P67; Prager O, 2010, NEUROIMAGE, V49, P337, DOI 10.1016/j.neuroimage.2009.08.009; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; SEYLAZ J, 1988, J CEREBR BLOOD F MET, V8, P875, DOI 10.1038/jcbfm.1988.145; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Smith WS, 2005, STROKE, V36, P1432, DOI 10.1161/01.STR.0000171066.25248.1d; Stoll G, 2009, J CEREBR BLOOD F MET, V29, P331, DOI 10.1038/jcbfm.2008.129; Su DS, 2010, NEUROL SCI, V31, P431, DOI 10.1007/s10072-010-0238-0; SUZUKI N, 1990, J CEREBR BLOOD F MET, V10, P383, DOI 10.1038/jcbfm.1990.68; Takahashi M, 2011, J NEUROSURG, V114, P1104, DOI 10.3171/2010.6.JNS091525; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; Toda N, 2000, NEUROSCIENCE, V96, P393, DOI 10.1016/S0306-4522(99)00557-6; Tomkins O, 2007, NEUROBIOL DIS, V25, P367, DOI 10.1016/j.nbd.2006.10.006; VASQUEZ J, 1979, PFLUG ARCH EUR J PHY, V379, P157, DOI 10.1007/BF00586942; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Williams P, 2006, J NEUROSCI METH, V155, P39, DOI 10.1016/j.jneumeth.2005.12.035; Yarnitsky D, 2005, SURG NEUROL, V64, P5, DOI 10.1016/j.surneu.2004.09.029; Yarnitsky D, 2004, BRAIN RES, V1018, P236, DOI 10.1016/j.brainres.2004.05.103; Yarnitsky D, 2004, J NEUROSURG, V101, P303, DOI 10.3171/jns.2004.101.2.0303; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	41	41	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39636	10.1371/journal.pone.0039636	http://dx.doi.org/10.1371/journal.pone.0039636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745798	Green Submitted, gold, Green Published			2022-12-27	WOS:000305730900088
J	Liu, JQ; Manouchehri, N; Lee, TF; Yao, MZ; Bigam, DL; Cheung, PY				Liu, Jiang-Qin; Manouchehri, Namdar; Lee, Tze-Fun; Yao, Mingzhu; Bigam, David L.; Cheung, Po-Yin			Infusing Sodium Bicarbonate Suppresses Hydrogen Peroxide Accumulation and Superoxide Dismutase Activity in Hypoxic-Reoxygenated Newborn Piglets	PLOS ONE			English	Article							CARBONATE RADICAL-ANION; BLOOD-FLOW; CEREBRAL-ISCHEMIA; N-ACETYLCYSTEINE; REACTIVE OXYGEN; NITRIC-OXIDE; PEROXYNITRITE; NEUROPROTECTION; RESUSCITATION; HEMODYNAMICS	Background: The effectiveness of sodium bicarbonate (SB) has recently been questioned although it is often used to correct metabolic acidosis of neonates. The aim of the present study was to examine its effect on hemodynamic changes and hydrogen peroxide (H2O2) generation in the resuscitation of hypoxic newborn animals with severe acidosis. Methods: Newborn piglets were block-randomized into a sham-operated control group without hypoxia (n = 6) and two hypoxia-reoxygenation groups (2 h normocapnic alveolar hypoxia followed by 4 h room-air reoxygenation, n = 8/group). At 10 min after reoxygenation, piglets were given either i.v. SB (2 mEq/kg), or saline (hypoxia-reoxygenation controls) in a blinded, randomized fashion. Hemodynamic data and blood gas were collected at specific time points and cerebral cortical H2O2 production was continuously monitored throughout experimental period. Plasma superoxide dismutase and catalase and brain tissue glutathione, superoxide dismutase, catalase, nitrotyrosine and lactate levels were assayed. Results: Two hours of normocapnic alveolar hypoxia caused cardiogenic shock with metabolic acidosis (pH: 6.99+/-0.07, HCO3-: 8.5+/-1.6 mmol/L). Upon resuscitation, systemic hemodynamics immediately recovered and then gradually deteriorated with normalization of acid-base imbalance over 4 h of reoxygenation. SB administration significantly enhanced the recovery of both pH and HCO3- recovery within the first hour of reoxygenation but did not cause any significant effect in the acid-base at 4 h of reoxygenation and the temporal hemodynamic changes. SB administration significantly suppressed the increase in H2O2 accumulation in the brain with inhibition of superoxide dismutase, but not catalase, activity during hypoxia-reoxygenation as compared to those of saline-treated controls. Conclusions: Despite enhancing the normalization of acid-base imbalance, SB administration during resuscitation did not provide any beneficial effects on hemodynamic recovery in asphyxiated newborn piglets. SB treatment also reduced the H2O2 accumulation in the cerebral cortex without significant effects on oxidative stress markers presumably by suppressing superoxide dismutase but not catalase activity.	[Liu, Jiang-Qin; Yao, Mingzhu] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Neonatol, Shanghai 200092, Peoples R China; [Liu, Jiang-Qin; Lee, Tze-Fun; Cheung, Po-Yin] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Manouchehri, Namdar; Bigam, David L.; Cheung, Po-Yin] Univ Alberta, Dept Surg, Edmonton, AB, Canada	Tongji University; University of Alberta; University of Alberta	Liu, JQ (corresponding author), Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Neonatol, Shanghai 200092, Peoples R China.	poyin@ualberta.ca	Cheung, Po-Yin/C-2804-2013	Cheung, Po-Yin/0000-0002-7141-1523	Canadian Institutes of Health Research [MOP 53116]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding from an operating grant (MOP 53116) from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammari AN, 2002, CURR OPIN PEDIATR, V14, P151, DOI 10.1097/00008480-200204000-00002; Anderson RE, 2002, NEUROSURGERY, V51, P1256, DOI 10.1097/00006123-200211000-00022; Aschner JL, 2008, PEDIATRICS, V122, P831, DOI 10.1542/peds.2007-2400; Augusto O, 2002, FREE RADICAL BIO MED, V32, P841, DOI 10.1016/S0891-5849(02)00786-4; Barbosa LF, 2009, DALTON T, P1450, DOI 10.1039/b813235f; Berg CS, 2010, J PEDIATR-US, V157, P684, DOI 10.1016/j.jpeds.2010.05.019; Bonini MG, 2009, J BIOL CHEM, V284, P14618, DOI 10.1074/jbc.M804644200; Cardenas VJ, 1996, CRIT CARE MED, V24, P827, DOI 10.1097/00003246-199605000-00017; Cheung PY, 2011, JOVE-J VIS EXP, DOI 10.3791/3166; COOPER DJ, 1993, AM REV RESPIR DIS, V148, P317, DOI 10.1164/ajrccm/148.2.317; Dickey EJ, 2011, J VET INTERN MED, V25, P1231, DOI 10.1111/j.1939-1676.2011.00818.x; Epperlein MM, 1998, J AM SOC NEPHROL, V9, P457; Guo MF, 2011, FOLIA NEUROPATHOL, V49, P79; Halliwell B, 1997, FEBS LETT, V411, P157, DOI 10.1016/S0014-5793(97)00469-9; Hurn PD, 1997, AM J PHYSIOL-HEART C, V272, pH2557, DOI 10.1152/ajpheart.1997.272.6.H2557; Johnson PJ, 2011, NEONATAL NETW, V30, P199, DOI 10.1891/0730-0832.30.3.199; Jung JE, 2009, J NEUROSCI, V29, P7003, DOI 10.1523/JNEUROSCI.1110-09.2009; Kalyanaraman B, 2001, ADV EXP MED BIOL, V500, P175; KETTE F, 1991, JAMA-J AM MED ASSOC, V266, P2121, DOI 10.1001/jama.266.15.2121; KETTE F, 1990, CIRCULATION, V81, P1660, DOI 10.1161/01.CIR.81.5.1660; Khan AU, 2000, P NATL ACAD SCI USA, V97, P2984, DOI 10.1073/pnas.050587297; Kolla VA, 2007, PLANTA, V225, P1421, DOI 10.1007/s00425-006-0450-6; LAPTOOK AR, 1985, PEDIATR RES, V19, P815, DOI 10.1203/00006450-198508000-00007; Lee TF, 2008, INTENS CARE MED, V34, P190, DOI 10.1007/s00134-007-0880-z; Lokesh L, 2004, RESUSCITATION, V60, P219, DOI 10.1016/j.resuscitation.2003.10.004; LOU HC, 1978, ACTA NEUROL SCAND, V57, P239, DOI 10.1111/j.1600-0404.1978.tb05871.x; Ma SK, 2008, CLIN EXP PHARMACOL P, V35, P262, DOI 10.1111/j.1440-1681.2007.04837.x; Martin RJ, 2006, FANAROFF MARTINS NEO, P505; Medinas DB, 2007, IUBMB LIFE, V59, P255, DOI 10.1080/15216540701230511; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Peng YW, 2011, PEDIATR RES, V70, P61, DOI 10.1203/PDR.0b013e31821b1a92; Rees S, 2011, INT J DEV NEUROSCI, V29, P551, DOI 10.1016/j.ijdevneu.2011.04.004; Reiter RJ, 2002, MECH AGEING DEV, V123, P1007, DOI 10.1016/S0047-6374(01)00384-0; Saenz P, 2011, NEONATOLOGY, V99, P170, DOI 10.1159/000313780; Saugstad OD, 2005, BIOL NEONATE, V88, P228, DOI 10.1159/000087586; Squadrito GL, 2002, CHEM RES TOXICOL, V15, P885, DOI 10.1021/tx020004c; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Szabo C, 2010, SHOCK, V34, P4, DOI 10.1097/SHK.0b013e3181e7e9ba; Uppu RM, 2007, CLIN EXP PHARMACOL P, V34, P933, DOI 10.1111/j.1440-1681.2007.04641.x; van Alfen-van der Velden AAEM, 2006, BIOL NEONATE, V90, P122, DOI 10.1159/000092411; Wang SY, 2012, ARTIF CELL BLOOD SUB, V40, P142, DOI 10.3109/10731199.2011.611474; Weis SN, 2011, INT J DEV NEUROSCI, V29, P115, DOI 10.1016/j.ijdevneu.2010.12.005; Ypsilantis P, 2006, J SURG RES, V134, P278, DOI 10.1016/j.jss.2005.12.031; Zhang H, 2004, FREE RADICAL BIO MED, V36, P1355, DOI 10.1016/j.freeradbiomed.2004.02.038	44	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39081	10.1371/journal.pone.0039081	http://dx.doi.org/10.1371/journal.pone.0039081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761724	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900031
J	Huang, JH; Lu, L; Zhang, JB; Hu, XY; Zhang, YG; Liang, W; Wu, SY; Luo, ZJ				Huang, Jinghui; Lu, Lei; Zhang, Jianbin; Hu, Xueyu; Zhang, Yongguang; Liang, Wei; Wu, Siyu; Luo, Zhuojing			Electrical Stimulation to Conductive Scaffold Promotes Axonal Regeneration and Remyelination in a Rat Model of Large Nerve Defect	PLOS ONE			English	Article							POOR FUNCTIONAL RECOVERY; SCHWANN-CELLS; NEURITE OUTGROWTH; CONTRIBUTING FACTORS; CEREBRAL-ISCHEMIA; REPAIR; POLYMER; GROWTH; GUIDANCE; FIELDS	Background: Electrical stimulation (ES) has been shown to promote nerve regeneration when it was applied to the proximal nerve stump. However, the possible beneficial effect of establishing a local electrical environment between a large nerve defect on nerve regeneration has not been reported in previous studies. The present study attempted to establish a local electrical environment between a large nerve defect, and examined its effect on nerve regeneration and functional recovery. Methodology/Findings: In the present study, a conductive scaffold was constructed and used to bridge a 15 mm sciatic nerve defect in rats, and intermittent ES (3 V, 20 Hz) was applied to the conductive scaffold to establish an electrical environment at the site of nerve defect. Nerve regeneration and functional recovery were examined after nerve injury repair and ES. We found that axonal regeneration and remyelination of the regenerated axons were significantly enhanced by ES which was applied to conductive scaffold. In addition, both motor and sensory functional recovery was significantly improved and muscle atrophy was partially reversed by ES localized at the conductive scaffold. Further investigations showed that the expression of S-100, BDNF (brain-derived neurotrophic factor), P0 and Par-3 was significantly up-regulated by ES at the conductive scaffold. Conclusions/Significance: Establishing an electrical environment with ES localized at the conductive scaffold is capable of accelerating nerve regeneration and promoting functional recovery in a 15 mm nerve defect in rats. The findings provide new directions for exploring regenerative approaches to achieve better functional recovery in the treatment of large nerve defect.	[Huang, Jinghui; Hu, Xueyu; Zhang, Yongguang; Liang, Wei; Luo, Zhuojing] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, Xian 710032, Peoples R China; [Lu, Lei] Fourth Mil Med Univ, Sch Stomatol, Dept Oral Anat & Physiol, Xian 710032, Peoples R China; [Zhang, Jianbin] Fourth Mil Med Univ, Sch Publ Hlth, Key Lab Hazard Assessment & Control Special Opera, Minist Educ, Xian 710032, Peoples R China; [Zhang, Jianbin] Fourth Mil Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Xian 710032, Peoples R China; [Zhang, Yongguang] Fuzhou Gen Hosp, Fuzhou, Peoples R China; [Wu, Siyu] Third Mil Med Univ, Daping Hosp, Dept Orthopaed, Chongqing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Army Medical University	Huang, JH (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, Xian 710032, Peoples R China.	zjluo@fmmu.edu.cn		Huang, Jinghui/0000-0002-0991-0591	National Natural Science Foundation of China [30770571, 30973052]; National Hi-Tech Research and Development Program of China (863 Program) [2002AA216101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (No. 30770571 and No. 30973052) and the National Hi-Tech Research and Development Program of China (863 Program) (No. 2002AA216101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlborn P, 2007, EXP NEUROL, V208, P137, DOI 10.1016/j.expneurol.2007.08.005; Al-Majed AA, 2000, J NEUROSCI, V20, P2602; Bloch J, 2001, EXP NEUROL, V172, P425, DOI 10.1006/exnr.2001.7778; Brushart TM, 2002, J NEUROSCI, V22, P6631; Chan JR, 2006, SCIENCE, V314, P832, DOI 10.1126/science.1134069; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; FU SY, 1995, J NEUROSCI, V15, P3876; FU SY, 1995, J NEUROSCI, V15, P3886; Gordon T, 2003, J PERIPHER NERV SYST, V8, P236, DOI 10.1111/j.1085-9489.2003.03029.x; Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748; HARE GMT, 1992, PLAST RECONSTR SURG, V89, P251, DOI 10.1097/00006534-199202000-00009; Hendriks WTJ, 2004, PROG BRAIN RES, V146, P451; Hood B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E4; Hu XY, 2009, TISSUE ENG PT A, V15, P3297, DOI [10.1089/ten.tea.2009.0017, 10.1089/ten.TEA.2009.0017]; Huang JH, 2010, NEUROREHAB NEURAL RE, V24, P736, DOI 10.1177/1545968310368686; Huang JH, 2010, J BIOMED MATER RES A, V93A, P164, DOI 10.1002/jbm.a.32511; Huang JH, 2010, GLIA, V58, P622, DOI 10.1002/glia.20951; Huang JH, 2009, J NEUROTRAUM, V26, P1805, DOI [10.1089/neu.2008.0732, 10.1089/neu.2008-0732]; Komotar RJ, 2007, NAT PROTOC, V2, P2345, DOI 10.1038/nprot.2007.359; Li BC, 2010, J BIOMED MATER RES A, V94A, P769, DOI 10.1002/jbm.a.32727; Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073; MARTINI R, 1995, NAT GENET, V11, P281, DOI 10.1038/ng1195-281; Martini R, 2008, GLIA, V56, P1566, DOI 10.1002/glia.20766; McKasson MJ, 2008, EXP NEUROL, V211, P585, DOI 10.1016/j.expneurol.2008.02.015; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Moroder P, 2011, ACTA BIOMATER, V7, P944, DOI 10.1016/j.actbio.2010.10.013; PATEL N, 1982, J NEUROSCI, V2, P483; Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948; Sughrue ME, 2006, J NEUROSCI METH, V151, P83, DOI 10.1016/j.jneumeth.2005.04.023; Tseng CY, 2003, J RECONSTR MICROSURG, V19, P331; Wood M, 2006, BIOELECTROMAGNETICS, V27, P328, DOI 10.1002/bem.20214; Zhang Z, 2007, ARTIF ORGANS, V31, P13, DOI 10.1111/j.1525-1594.2007.00335.x	32	79	87	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39526	10.1371/journal.pone.0039526	http://dx.doi.org/10.1371/journal.pone.0039526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737243	Green Submitted, Green Published, gold			2022-12-27	WOS:000305695100042
J	Loong, CKP; Zhou, HX; Chase, PB				Loong, Campion K. P.; Zhou, Huan-Xiang; Chase, P. Bryant			Persistence Length of Human Cardiac alpha-Tropomyosin Measured by Single Molecule Direct Probe Microscopy	PLOS ONE			English	Article							REGULATORY UNIT INTERACTIONS; MECHANICAL-PROPERTIES; THERMAL FLUCTUATIONS; FLEXURAL RIGIDITY; FORCE MICROSCOPY; BINDING-SITES; MUSCLE; ACTIN; FLEXIBILITY; ACTOMYOSIN	alpha-Tropomyosin (alpha Tm) is the predominant tropomyosin isoform in adult human heart and constitutes a major component in Ca2+-regulated systolic contraction of cardiac muscle. We present here the first direct probe images of WT human cardiac alpha Tm by atomic force microscopy, and quantify its mechanical flexibility with three independent analysis methods. Single molecules of bacterially-expressed human cardiac alpha Tm were imaged on poly-lysine coated mica and their contours were analyzed. Analysis of tangent-angle (theta(s)) correlation along molecular contours, second moment of tangent angles (<theta(2)(s)>), and end-to-end length (Le-e) distributions respectively yielded values of persistence length (L-p) of 41-46 nm, 40-45 nm, and 42-52 nm, corresponding to 1-1.3 molecular contour lengths (L-c). We also demonstrate that a sufficiently large population, with at least 100 molecules, is required for a reliable L-p measurement of alpha Tm in single molecule studies. Our estimate that L-p for alpha Tm is only slightly longer than L-c is consistent with a previous study showing there is little spread of cooperative activation into near-neighbor regulatory units of cardiac thin filaments. The L-p determined here for human cardiac alpha Tm perhaps represents an evolutionarily tuned optimum between Ca2+ sensitivity and cooperativity in cardiac thin filaments and likely constitutes an essential parameter for normal function in the human heart.	[Loong, Campion K. P.; Chase, P. Bryant] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Loong, Campion K. P.; Zhou, Huan-Xiang] Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA; [Zhou, Huan-Xiang] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Loong, CKP (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	campion.loong@gmail.com; chase@bio.fsu.edu	zhou, huan/GYJ-4398-2022; Zhou, Huan-Xiang/M-5170-2016; Chase, P. Bryant/M-6322-2019	Zhou, Huan-Xiang/0000-0001-9020-0302; Chase, P. Bryant/0000-0001-9701-561X	United States National Institutes of Health [GM88187]; American Heart Association Predoctoral Fellowship [0815127E]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088187] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Huan-Xiang Zhou was supported in part by United States National Institutes of Health Grant GM88187. Campion K. P. Loong was supported in part by American Heart Association Predoctoral Fellowship 0815127E. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abels JA, 2005, BIOPHYS J, V88, P2737, DOI 10.1529/biophysj.104.052811; Albet-Torres N, 2007, LANGMUIR, V23, P11147, DOI 10.1021/la7008682; Bai F, 2011, BIOPHYS J, V100, P1014, DOI 10.1016/j.bpj.2011.01.001; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; Bozec L, 2005, BIOPHYS J, V88, P4223, DOI 10.1529/biophysj.104.055228; Brangwynne CP, 2007, BIOPHYS J, V93, P346, DOI 10.1529/biophysj.106.096966; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; Brunet NM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/657523; Byun KE, 2007, LANGMUIR, V23, P9535, DOI 10.1021/la7019318; Cantor C.R., 1980, BIOPHYSICAL CHEM 2; Chase PB, 2004, ANN BIOMED ENG, V32, P1559, DOI 10.1114/B:ABME.0000049039.89173.08; Cheng Y, 2011, BIOSENS BIOELECTRON, V26, P4538, DOI 10.1016/j.bios.2011.05.019; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Daniel TL, 1998, BIOPHYS J, V74, P1611, DOI 10.1016/S0006-3495(98)77875-0; FRONTALI C, 1979, BIOPOLYMERS, V18, P1353, DOI 10.1002/bip.1979.360180604; Gillis TE, 2007, J PHYSIOL-LONDON, V580, P561, DOI 10.1113/jphysiol.2007.128975; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Harris DC, 1998, J CHEM EDUC, V75, P119, DOI 10.1021/ed075p119; Howard J, 1996, Proc Natl Acad Sci U S A, V93, P4462; Howard J., 2001, MECH MOTOR PROTEINS; Howe N, 2007, BETTER SKELETONIZATI; HVIDT S, 1982, BIOCHEMISTRY-US, V21, P4064, DOI 10.1021/bi00260a024; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Jaber JA, 2003, NANO LETT, V3, P1505, DOI 10.1021/nl034539h; Kataoka A, 2007, J BIOMECH, V40, P2044, DOI 10.1016/j.jbiomech.2006.09.026; LANG D, 1968, J MOL BIOL, V36, P137, DOI 10.1016/0022-2836(68)90225-8; LEHMAN W, 1995, J MOL BIOL, V251, P191, DOI 10.1006/jmbi.1995.0425; Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080; LEHRER SS, 1975, P NATL ACAD SCI USA, V72, P3377, DOI 10.1073/pnas.72.9.3377; Li XC, 2010, J MOL BIOL, V395, P327, DOI 10.1016/j.jmb.2009.10.060; Loong CKP, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00080; Manandhar P, 2005, LANGMUIR, V21, P3213, DOI 10.1021/la047227i; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Martyn DA, 2002, BIOPHYS J, V83, P3425, DOI 10.1016/S0006-3495(02)75342-3; Mathur MC, 2011, BIOCHEM BIOPH RES CO, V406, P74, DOI 10.1016/j.bbrc.2011.01.112; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038; Mucke N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007756; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; OTT A, 1993, PHYS REV E, V48, pR1642, DOI 10.1103/PhysRevE.48.R1642; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; Phillips GN, 1996, BIOPOLYMERS, V38, P89, DOI 10.1002/(SICI)1097-0282(199601)38:1<89::AID-BIP7>3.3.CO;2-X; PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7; Regnier M, 2002, J PHYSIOL-LONDON, V540, P485, DOI 10.1113/jphysiol.2001.013179; Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687; Schoffstall B, 2011, DNA CELL BIOL, V30, P653, DOI 10.1089/dna.2010.1163; Schoffstall B, 2006, J PHYSIOL-LONDON, V577, P935, DOI 10.1113/jphysiol.2006.120105; Smillie L, 1996, BIOCH SMOOTH MUSCLE, P63; Sousa D, 2010, BIOPHYS J, V99, P862, DOI 10.1016/j.bpj.2010.05.004; STEWART M, 1975, FEBS LETT, V53, P5, DOI 10.1016/0014-5793(75)80668-5; TRIFONOV EN, 1985, CRC CR REV BIOCH MOL, V19, P89, DOI 10.3109/10409238509082540; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Wang F, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/435271; Wilhelm J, 1996, PHYS REV LETT, V77, P2581, DOI 10.1103/PhysRevLett.77.2581	55	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39676	10.1371/journal.pone.0039676	http://dx.doi.org/10.1371/journal.pone.0039676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737252	Green Published, gold, Green Submitted			2022-12-27	WOS:000305695100051
J	Chen, Y; Huang, W; Constantini, S				Chen, Yun; Huang, Wei; Constantini, Shlomi			Blast Shock Wave Mitigation Using the Hydraulic Energy Redirection and Release Technology	PLOS ONE			English	Article							INJURY; TSUNAMIS; PRESSURE; PHYSICS	A hydraulic energy redirection and release technology has been developed for mitigating the effects of blast shock waves on protected objects. The technology employs a liquid-filled plastic tubing as a blast overpressure transformer to transfer kinetic energy of blast shock waves into hydraulic energy in the plastic tubings. The hydraulic energy is redirected through the plastic tubings to the openings at the lower ends, and then is quickly released with the liquid flowing out through the openings. The samples of the specifically designed body armor in which the liquid-filled plastic tubings were installed vertically as the outer layer of the body armor were tested. The blast test results demonstrated that blast overpressure behind the body armor samples was remarkably reduced by 97% in 0.2 msec after the liquid flowed out of its appropriate volume through the openings. The results also suggested that a volumetric liquid surge might be created when kinetic energy of blast shock wave was transferred into hydraulic energy to cause a rapid physical movement or displacement of the liquid. The volumetric liquid surge has a strong destructive power, and can cause a noncontact, remote injury in humans (such as blast-induced traumatic brain injury and post-traumatic stress disorder) if it is created in cardiovascular system. The hydraulic energy redirection and release technology can successfully mitigate blast shock waves from the outer surface of the body armor. It should be further explored as an innovative approach to effectively protect against blast threats to civilian and military personnel.	[Chen, Yun] BrightstarTech Inc, Clarksburg, MD USA; [Huang, Wei] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Constantini, Shlomi] Tel Aviv Univ, Tel Aviv Med Ctr, Dana Childrens Hosp, Dept Pediat Neurosurg, IL-69978 Tel Aviv, Israel	Uniformed Services University of the Health Sciences - USA; Tel Aviv University; Sackler Faculty of Medicine	Chen, Y (corresponding author), BrightstarTech Inc, Clarksburg, MD USA.	yun.chen@brightstartechinc.com			BrightstarTech, Inc.	BrightstarTech, Inc.	This work was supported in part by BrightstarTech, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 1977, EFFECTS NUCL WEAPONS; Azenkot A, 2004, IRRIGATION SYSTEM DE; Bailey JL, 2006, ADA443885 DTIC; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Cannon L, 2001, J R Army Med Corps, V147, P87; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chen HX, 2011, US patent, Patent No. [13/285049, 13285049]; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Choe S-H., 2010, NY TIMES; Courtney AC, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3702803; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Haugen KB, 2005, MAR PETROL GEOL, V22, P209, DOI 10.1016/j.marpetgeo.2004.10.016; HIRSCH AE, 1972, J NEUROSURG, V37, P95, DOI 10.3171/jns.1972.37.1.0095; Kailasanath K, 2002, ADA400620 DTIC; Krehl POK, 2011, EUR PHYS J H, V36, P85, DOI 10.1140/epjh/e2011-10037-x; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Margaritondo G, 2005, EUR J PHYS, V26, P401, DOI 10.1088/0143-0807/26/3/007; Pudasaini SP, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041308; Reid WD, 1996, DSTOGD0109 DEP DEF S; Rice D, 2000, TACTICAL EDGE J  SUM, P53; Rinehart SA, 2010, DESIGN CONSIDERATION; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Schwer D, 2006, ADA452669 DTIC; Stuhmiller JH, 2008, BIQPJHSCH10 ARM MED; VOIT SS, 1987, ANNU REV FLUID MECH, V19, P217, DOI 10.1146/annurev.fl.19.010187.001245; Willauer HD, 2009, J HAZARD MATER, V165, P1068, DOI 10.1016/j.jhazmat.2008.10.130	26	18	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39353	10.1371/journal.pone.0039353	http://dx.doi.org/10.1371/journal.pone.0039353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745740	gold, Green Published			2022-12-27	WOS:000305693200067
J	Sorensen, M; Andersen, ZJ; Nordsborg, RB; Jensen, SS; Lillelund, KG; Beelen, R; Schmidt, EB; Tjonneland, A; Overvad, K; Raaschou-Nielsen, O				Sorensen, Mette; Andersen, Zorana J.; Nordsborg, Rikke B.; Jensen, Steen S.; Lillelund, Kenneth G.; Beelen, Rob; Schmidt, Erik B.; Tjonneland, Anne; Overvad, Kim; Raaschou-Nielsen, Ole			Road Traffic Noise and Incident Myocardial Infarction: A Prospective Cohort Study	PLOS ONE			English	Article							AIR-POLLUTION; GLUCOSE-METABOLISM; HUMAN EXPOSURE; SLEEP; OBESITY; STREET; MODEL; POOR	Background: Both road traffic noise and ambient air pollution have been associated with risk for ischemic heart disease, but only few inconsistent studies include both exposures. Methods: In a population-based cohort of 57 053 people aged 50 to 64 years at enrolment in 1993-1997, we identified 1600 cases of first-ever MI between enrolment and 2006. The mean follow-up time was 9.8 years. Exposure to road traffic noise and air pollution from 1988 to 2006 was estimated for all cohort members from residential address history. Associations between exposure to road traffic noise and incident MI were analysed in a Cox regression model with adjustment for air pollution (NOx) and other potential confounders: age, sex, education, lifestyle confounders, railway and airport noise. Results: We found that residential exposure to road traffic noise (L-den) was significantly associated with MI, with an incidence rate ratio IRR of 1.12 per 10 dB for both of the two exposure windows: yearly exposure at the time of diagnosis (95% confidence interval (CI): 1.02-1.22) and 5-years time-weighted mean (95% CI: 1.02-1.23) preceding the diagnosis. Visualizing of the results using restricted cubic splines showed a linear dose-response relationship. Conclusions: Exposure to long-term residential road traffic noise was associated with a higher risk for MI, in a dose-dependent manner.	[Sorensen, Mette; Andersen, Zorana J.; Nordsborg, Rikke B.; Tjonneland, Anne; Raaschou-Nielsen, Ole] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Andersen, Zorana J.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Jensen, Steen S.] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Lillelund, Kenneth G.] Ramboll Danmark AS, Aarhus, Denmark; [Beelen, Rob] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Schmidt, Erik B.; Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Ctr Cardiovasc Res, Dept Cardiol, Aalborg, Denmark; [Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark	Danish Cancer Society; University of Copenhagen; Aarhus University; Utrecht University; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University	Sorensen, M (corresponding author), Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark.	mettes@cancer.dk	Raaschou-Nielsen, Ole/GOK-0338-2022; Jensen, Steen Solvang/AAM-2945-2021; Andersen, Zorana Jovanovic/P-4983-2014	Raaschou-Nielsen, Ole/0000-0002-1223-0909; Andersen, Zorana Jovanovic/0000-0003-4138-9828; Sorensen, Mette/0000-0002-7302-4789; Baastrup Nordsborg, Rikke/0000-0003-4374-8230; Jensen, Steen Solvang/0000-0001-5923-8441; Overvad, Kim/0000-0001-6429-7921; Tjonneland, Anne/0000-0003-4385-2097	Danish Environmental Protection Agency; Research Centre for Environmental Health, Danish Ministry of the Interior and Health; Danish Cancer Society	Danish Environmental Protection Agency; Research Centre for Environmental Health, Danish Ministry of the Interior and Health; Danish Cancer Society(Danish Cancer Society)	This work was supported by funding from the Danish Environmental Protection Agency, the Research Centre for Environmental Health, Danish Ministry of the Interior and Health, and the Danish Cancer Society. The Danish Environmental Protection Agency participated in collecting information on railway and airport noise. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, OFF J EUR COMMUNITIE, V45, P12; Babisch WF, 2005, EPIDEMIOLOGY, V16, P33, DOI 10.1097/01.ede.0000147104.84424.24; Babisch Wolfgang, 2006, Noise Health, V8, P1; Babisch W, 2008, NOISE HEALTH, V10, P27, DOI 10.4103/1463-1741.39005; Beelen R, 2009, OCCUP ENVIRON MED, V66, P243, DOI 10.1136/oem.2008.042358; Bendtsen H, 1999, SCI TOTAL ENVIRON, V235, P331, DOI 10.1016/S0048-9697(99)00216-8; Berkowicz R, 2008, ENVIRON MODELL SOFTW, V23, P296, DOI 10.1016/j.envsoft.2007.04.007; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Buxton OM, 2010, DIABETES, V59, P2126, DOI 10.2337/db09-0699; Portela PC, 2009, CEREBROVASC DIS, V27, P104, DOI 10.1159/000200447; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Hertel O, 2001, PURE APPL CHEM, V73, P137, DOI 10.1351/pac200173010137; Hui L, 2007, BRAIN BEHAV IMMUN, V21, P308, DOI 10.1016/j.bbi.2006.09.005; Huss A, 2010, EPIDEMIOLOGY, V21, P829, DOI 10.1097/EDE.0b013e3181f4e634; Jarup L, 2008, ENVIRON HEALTH PERSP, V116, P329, DOI 10.1289/ehp.10775; Jensen SS, 2001, TRANSPORT RES D-TR E, V6, P229, DOI 10.1016/S1361-9209(00)00026-2; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; Ketzel M, 2003, ATMOS ENVIRON, V37, P2735, DOI 10.1016/S1352-2310(03)00245-0; Ketzel M, 2011, INT J ENVIRON POLLUT, V47, P226, DOI 10.1504/IJEP.2011.047337; Leger D, 2000, J SLEEP RES, V9, P35, DOI 10.1046/j.1365-2869.2000.00178.x; Lusk SL, 2004, ARCH ENVIRON HEALTH, V59, P392, DOI 10.3200/AEOH.59.8.392-399; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Miedema Henk M E, 2007, Behav Sleep Med, V5, P1, DOI 10.1207/s15402010bsm0501_1; Miller MA, 2007, CURR VASC PHARMACOL, V5, P93, DOI 10.2174/157016107780368280; Raaschou-Nielsen O, 2000, J EXPO ANAL ENV EPID, V10, P4, DOI 10.1038/sj.jea.7500070; Raaschou-Nielsen O, 2011, ENVIRON HEALTH PERSP, V119, P860, DOI 10.1289/ehp.1002353; Sateia MJ, 2000, SLEEP, V23, P243; Selander J, 2009, EPIDEMIOLOGY, V20, P272, DOI 10.1097/EDE.0b013e31819463bd; Sorensen M, 2011, EUR HEART J, V32, P737, DOI 10.1093/eurheartj/ehq466; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Wagner J, 2010, INT J HYG ENVIR HEAL, V213, P153, DOI 10.1016/j.ijheh.2009.08.004; Wright CE, 2007, BRAIN BEHAV IMMUN, V21, P358, DOI 10.1016/j.bbi.2006.08.007	37	143	148	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39283	10.1371/journal.pone.0039283	http://dx.doi.org/10.1371/journal.pone.0039283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745727	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693200057
J	Wang, XL; Yang, L; Chan, KP; Chiu, SS; Chan, KH; Peiris, JSM; Wong, CM				Wang, Xi-Ling; Yang, Lin; Chan, King-Pan; Chiu, Susan S.; Chan, Kwok-Hung; Peiris, J. S. Malik; Wong, Chit-Ming			Model Selection in Time Series Studies of Influenza-Associated Mortality	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; SUBTROPICAL CITY; YOUNG-CHILDREN; AIR-POLLUTION; UNITED-STATES; HONG-KONG; HOSPITALIZATION; DISEASE; BURDEN; BACTERIAL	Background: Poisson regression modeling has been widely used to estimate influenza-associated disease burden, as it has the advantage of adjusting for multiple seasonal confounders. However, few studies have discussed how to judge the adequacy of confounding adjustment. This study aims to compare the performance of commonly adopted model selection criteria in terms of providing a reliable and valid estimate for the health impact of influenza. Methods: We assessed four model selection criteria: quasi Akaike information criterion (QAIC), quasi Bayesian information criterion (QBIC), partial autocorrelation functions of residuals (PACF), and generalized cross-validation (GCV), by separately applying them to select the Poisson model best fitted to the mortality datasets that were simulated under the different assumptions of seasonal confounding. The performance of these criteria was evaluated by the bias and root-mean-square error (RMSE) of estimates from the pre-determined coefficients of influenza proxy variable. These four criteria were subsequently applied to an empirical hospitalization dataset to confirm the findings of simulation study. Results: GCV consistently provided smaller biases and RMSEs for the influenza coefficient estimates than QAIC, QBIC and PACF, under the different simulation scenarios. Sensitivity analysis of different pre-determined influenza coefficients, study periods and lag weeks showed that GCV consistently outperformed the other criteria. Similar results were found in applying these selection criteria to estimate influenza-associated hospitalization. Conclusions: GCV criterion is recommended for selection of Poisson models to estimate influenza-associated mortality and morbidity burden with proper adjustment for confounding. These findings shall help standardize the Poisson modeling approach for influenza disease burden studies.	[Wang, Xi-Ling; Yang, Lin; Chan, King-Pan; Peiris, J. S. Malik; Wong, Chit-Ming] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Chiu, Susan S.] Univ Hong Kong, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Kwok-Hung] Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Peiris, J. S. Malik] Univ Hong Kong, Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Wang, XL (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	linyang@hku.hk	YANG, Lin/F-9601-2014; Chan, Kwok Hung/ABD-5399-2021	YANG, Lin/0000-0002-5964-3233; 	Research Fund for the Control of Infectious Diseases [11100582]; Area of Excellence Scheme of the University Grants Committee of the Hong Kong Special Administrative Region Government [AoE/M-12/-06]	Research Fund for the Control of Infectious Diseases; Area of Excellence Scheme of the University Grants Committee of the Hong Kong Special Administrative Region Government	This study was supported by the Research Fund for the Control of Infectious Diseases (11100582) and the Area of Excellence Scheme of the University Grants Committee (AoE/M-12/-06) of the Hong Kong Special Administrative Region Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auget J-L, 2007, ADV STAT METHODS HLT; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; DeForest L.B., 2008, GROWERS AGRICULURAL; Gilca R, 2009, AM J EPIDEMIOL, V170, P925, DOI 10.1093/aje/kwp195; Griffin MR, 2002, ARCH INTERN MED, V162, P1229, DOI 10.1001/archinte.162.11.1229; Hardelid P, 2011, EPIDEMIOL INFECT, V139, P1431, DOI 10.1017/S0950268811000410; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Healthy Hong Kong Department of Health The Government of the Hong Kong Special Administrative Region, 2012, DEATH STAT SEX AG CA; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Jackson ML, 2009, ANN EPIDEMIOL, V19, P681, DOI 10.1016/j.annepidem.2009.06.009; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; McCullagh P., 1989, GEN LINEAR MODELS, V(2nd), DOI [10.1007/978-1-4899-3242-6, https://doi.org/10.1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6]; MCNENEY B, 1994, CAN J STAT, V22, P421, DOI 10.2307/3315402; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Newall AT, 2010, EPIDEMIOL INFECT, V138, P836, DOI 10.1017/S095026880999118X; Nunes B, 2010, STAT METHODS MED RES, V00, P1; Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Short KR, 2011, J INFECT DIS, V204, P1857, DOI 10.1093/infdis/jir618; Simmerman JM, 2008, INFLUENZA OTHER RESP, V2, P81, DOI 10.1111/j.1750-2659.2008.00045.x; Tasher D, 2011, CLIN INFECT DIS, V53, P1199, DOI 10.1093/cid/cir726; Thach TQ, 2010, ATMOS ENVIRON, V44, P1437, DOI 10.1016/j.atmosenv.2010.01.036; Thompson WW, 2009, AM J PUBLIC HEALTH, V99, pS225, DOI 10.2105/AJPH.2008.151944; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Warren-Gash C, 2011, J INFECT DIS, V203, P1710, DOI 10.1093/infdis/jir171; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121; Wong Chit-Ming, 2010, Res Rep Health Eff Inst, P283; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Yang L, 2011, VACCINE, V29, P8909, DOI 10.1016/j.vaccine.2011.09.071; Yang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017882; Yang L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-133; Zeileis A., 2007, REGRESSION MODELS CO	36	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39423	10.1371/journal.pone.0039423	http://dx.doi.org/10.1371/journal.pone.0039423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745751	gold, Green Published, Green Submitted			2022-12-27	WOS:000305693200075
J	Yang, ZR; Grant, M				Yang, Zheng Rong; Grant, Murray			An Ultra-Fast Metabolite Prediction Algorithm	PLOS ONE			English	Article							MASS-SPECTROMETRY DATA; RETENTION TIME ALIGNMENT; FUNCTIONAL GENOMICS; SYSTEMS BIOLOGY; LIQUID-CHROMATOGRAPHY; DIFFERENTIAL ANALYSIS; ACCURATE MASS; METABOLOMICS; IDENTIFICATION; PROTEOMICS	Small molecules are central to all biological processes and metabolomics becoming an increasingly important discovery tool. Robust, accurate and efficient experimental approaches are critical to supporting and validating predictions from post-genomic studies. To accurately predict metabolic changes and dynamics, experimental design requires multiple biological replicates and usually multiple treatments. Mass spectra from each run are processed and metabolite features are extracted. Because of machine resolution and variation in replicates, one metabolite may have different implementations (values) of retention time and mass in different spectra. A major impediment to effectively utilizing untargeted metabolomics data is ensuring accurate spectral alignment, enabling precise recognition of features (metabolites) across spectra. Existing alignment algorithms use either a global merge strategy or a local merge strategy. The former delivers an accurate alignment, but lacks efficiency. The latter is fast, but often inaccurate. Here we document a new algorithm employing a technique known as quicksort. The results on both simulated data and real data show that this algorithm provides a dramatic increase in alignment speed and also improves alignment accuracy.	[Yang, Zheng Rong; Grant, Murray] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England	University of Exeter	Yang, ZR (corresponding author), Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England.	z.r.yang@ex.ac.uk	yang, zheng/HGC-7753-2022		British Biotechnology and Science Research Council [BB/C514115/1, BB/E010334/1, BB/F005903/1]; BBSRC [BB/F005903/1, BB/E010334/1, BB/I014691/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E010334/1, BB/F005903/1, BB/I014691/1, BB/C514115/1] Funding Source: researchfish	British Biotechnology and Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Data set 2 was generated from British Biotechnology and Science Research Council funding (Grants BB/C514115/1, BB/E010334/1 and BB/F005903/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Baran R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-530; Biedendieck R, 2011, METHOD ENZYMOL, V500, P165, DOI 10.1016/B978-0-12-385118-5.00010-4; Broeckling CD, 2006, ANAL CHEM, V78, P4334, DOI 10.1021/ac0521596; Chae M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S15; Conrads TP, 2000, ANAL CHEM, V72, P3349, DOI 10.1021/ac0002386; de Groot JCW, 2008, PROTEOMICS, V8, P32, DOI 10.1002/pmic.200700707; De Souza DP, 2006, BIOINFORMATICS, V22, P1391, DOI 10.1093/bioinformatics/btl085; DiMaggio PA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-458; Duran AL, 2003, BIOINFORMATICS, V19, P2283, DOI 10.1093/bioinformatics/btg315; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; Fischer B, 2006, BIOINFORMATICS, V22, pE132, DOI 10.1093/bioinformatics/btl219; Garey M.R., 1979, COMPUTERS INTRACTABI; Hoffmann N, 2009, BIOINFORMATICS, V25, P2080, DOI 10.1093/bioinformatics/btp343; Johnson KJ, 2003, J CHROMATOGR A, V996, P141, DOI 10.1016/S0021-9673(03)00616-2; Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179; Lange E, 2007, BIOINFORMATICS, V23, pI273, DOI 10.1093/bioinformatics/btm209; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Ma Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026108; Mapelli V, 2008, TRENDS BIOTECHNOL, V26, P490, DOI 10.1016/j.tibtech.2008.05.008; Matthaus F, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000049; Norbeck AD, 2005, J AM SOC MASS SPECTR, V16, P1239, DOI 10.1016/j.jasms.2005.05.009; Okada T, 2010, CURR COMPUT-AID DRUG, V6, P179, DOI 10.2174/157340910791760055; Oksman-Caldentey KM, 2005, CURR OPIN BIOTECH, V16, P174, DOI 10.1016/j.copbio.2005.02.007; Perera V, 2012, METABOLOMICS, V8, pS175, DOI 10.1007/s11306-011-0389-x; Powers R, 2007, COMB CHEM HIGH T SCR, V10, P676, DOI 10.2174/138620707782507331; Robinson AR, 2007, NEW PHYTOL, V174, P762, DOI 10.1111/j.1469-8137.2007.02046.x; Robinson MD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-419; Saito K, 2008, ANN REV PLANT BIOL, V16; Saito K, 2008, TRENDS PLANT SCI, V13, P36, DOI 10.1016/j.tplants.2007.10.006; Schulz-Trieglaff O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-423; Sedgewick C, 1997, ALGORITHMS C 1 4; Skiena S. S., 2008, ALGORITHM DESIGN MAN; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; Tibshirani R, 2004, BIOINFORMATICS, V20, P3034, DOI 10.1093/bioinformatics/bth357; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; von Roepenack-Lahaye E, 2004, PLANT PHYSIOL, V134, P548, DOI 10.1104/pp.103.032714; Voss B, 2011, BIOINFORMATICS, V27, P987, DOI 10.1093/bioinformatics/btr051; Westergaard SL, 2007, BIOTECHNOL BIOENG, V96, P134, DOI 10.1002/bit.21135; Wong JWH, 2005, BIOINFORMATICS, V21, P2088, DOI 10.1093/bioinformatics/bti300; Wu LA, 2005, METAB ENG, V7, P302, DOI 10.1016/j.ymben.2005.05.003	43	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39158	10.1371/journal.pone.0039158	http://dx.doi.org/10.1371/journal.pone.0039158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745711	gold, Green Submitted, Green Published			2022-12-27	WOS:000305693200045
J	Wang, SP; Yin, TQ; Zeng, SH; Che, HL; Yang, FF; Chen, XC; Shen, GL; Wu, ZY				Wang, Shiping; Yin, Tieqiu; Zeng, Shaohua; Che, Hongli; Yang, Feifei; Chen, Xiuchun; Shen, Guoli; Wu, Zhaoyang			A Piezoelectric Immunosensor Using Hybrid Self-Assembled Monolayers for Detection of Schistosoma japonicum	PLOS ONE			English	Article							QUARTZ-CRYSTAL MICROBALANCE; IMMUNOASSAY; BIOSENSOR; SERUM; BINDING; THIOLS; GOLD; MASS	Background: The parasite Schistosoma japonicum causes schistosomiasis disease, which threatens human life and hampers economic and social development in some Asian countries. An important lesson learned from efforts to reduce the occurrence of schistosomiasis is that the diagnostic approach must be altered as further progress is made towards the control and ultimate elimination of the disease. Methodology/Principal Findings: Using mixed self-assembled monolayer membrane (mixed SAM) technology, a mixture of mercaptopropionic acid (MPA) and mercaptoethanol (ME) was self-assembled on the surface of quartz crystals by gold-sulphur-bonds. Soluble egg antigens (SEA) of S. japonicum were then cross-linked to the quartz crystal using a special coupling agent. As compared with the traditional single self-assembled monolayer immobilization method, S. japonicum antigen (SjAg) immobilization using mixed self-assembled monolayers exhibits much greater immunoreactivity. Under optimal experimental conditions, the detection range is 1:1500 to 1:60 (infected rabbit serum dilution ratios). We measured several infected rabbit serum samples with varying S. japonicum antibody (SjAb) concentrations using both immunosensor and ELISA techniques and then produced a correlation analysis. The correlation coefficients reached 0.973. Conclusions/Significance: We have developed a new, simple, sensitive, and reusable piezoelectric immunosensor that directly detects SjAb in the serum. This method may represent an alternative to the current diagnostic methods for S. japonicum infection in the clinical laboratory or for analysis outside the laboratory.	[Wang, Shiping; Yin, Tieqiu; Zeng, Shaohua; Che, Hongli; Yang, Feifei; Chen, Xiuchun] Cent S Univ, Dept Parasitol, Xiangya Med Coll, Key Lab Schistosomiasis Hunan, Changsha, Hunan, Peoples R China; [Yin, Tieqiu] Second Peoples Hosp Hunan Prov, Changsha, Hunan, Peoples R China; [Yin, Tieqiu] Brains Hosp Hunan Prov, Dept Clin Lab, Changsha, Hunan, Peoples R China; [Shen, Guoli; Wu, Zhaoyang] Hunan Univ, Coll Chem & Chem Engn, State Key Lab Chemo Biosensing & Chemometr, Changsha 410082, Hunan, Peoples R China	Central South University; Hunan University	Wang, SP (corresponding author), Cent S Univ, Dept Parasitol, Xiangya Med Coll, Key Lab Schistosomiasis Hunan, Changsha, Hunan, Peoples R China.	spwang@126.com	尹, 铁球/GRY-2326-2022		Key Basic Research and Development Program (973 plan) of China [2007CB513108]; Deutsche Forschungsgemeinschaft (DFG, Germany) [KO4136/1-1]; National "Eleventh Five-Year'' Support Plan of China [2009BAI78B05]; Key Laboratory of Immune and Control Schistosomiasis; Key Subject Development Special Program of Hunan Province [2008-985-2]	Key Basic Research and Development Program (973 plan) of China; Deutsche Forschungsgemeinschaft (DFG, Germany)(German Research Foundation (DFG)); National "Eleventh Five-Year'' Support Plan of China; Key Laboratory of Immune and Control Schistosomiasis; Key Subject Development Special Program of Hunan Province	The work was supported by grants from the Key Basic Research and Development Program (973 plan) of China (Grant No. 2007CB513108), Deutsche Forschungsgemeinschaft (DFG, Germany) (Grant No. KO4136/1-1) and the National "Eleventh Five-Year'' Support Plan of China (Grant No. 2009BAI78B05), and the Key Laboratory of Immune and Control Schistosomiasis and the Key Subject Development Special Program of Hunan Province (2008-985-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atassi MZ, 1984, MOL IMMUNOL, P16; BAIN CD, 1989, J AM CHEM SOC, V111, P7164, DOI 10.1021/ja00200a040; Balen J, 2007, B WORLD HEALTH ORGAN, V85, P519, DOI 10.2471/BLT.06.034033; Bergquist R, 2009, TRENDS PARASITOL, V25, P151, DOI 10.1016/j.pt.2009.01.004; Briand E, 2007, BIOSENS BIOELECTRON, V22, P2884, DOI 10.1016/j.bios.2006.12.009; Chapman RG, 2000, LANGMUIR, V16, P6927, DOI 10.1021/la991579l; Chen ZZ, 2002, CHEM J CHINESE U, V23, P1044; Cheng CW, 2008, BIOSENS BIOELECTRON, V24, P136, DOI 10.1016/j.bios.2008.03.029; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Chou YH, 2003, AM J TROP MED HYG, V68, P18, DOI 10.4269/ajtmh.2003.68.18; Chu X, 2005, J IMMUNOL METHODS, V301, P77, DOI 10.1016/j.jim.2005.03.005; Deng T, 2004, SENSOR ACTUAT B-CHEM, V99, P123, DOI 10.1016/j.snb.2003.11.005; Dubrovsky TB, 1999, ANAL CHEM, V71, P327, DOI 10.1021/ac9804745; Frederix F, 2003, LANGMUIR, V19, P4351, DOI 10.1021/la026908f; GHOURCHIAN HO, 1994, TALANTA, V41, P401, DOI 10.1016/0039-9140(94)80145-2; GUI M, 1991, ANN TROP MED PARASIT, V85, P599, DOI 10.1080/00034983.1991.11812615; Hirose Yoshinori, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P445; Jung LS, 2000, LANGMUIR, V16, P9421, DOI 10.1021/la000144r; KING WH, 1964, ANAL CHEM, V36, P1735, DOI 10.1021/ac60215a012; KONIG B, 1995, ANAL CHIM ACTA, V309, P19, DOI 10.1016/0003-2670(94)00640-8; Li YS, 2005, SE ASIAN J TROPICAL, V36, P79; Liang S, 2007, P NATL ACAD SCI USA, V104, P7110, DOI 10.1073/pnas.0701878104; Liou MH, 2001, THESIS 3 MILITARY ME, P39; Lu HC, 2000, BIOTECHNOL PROGR, V16, P116, DOI 10.1021/bp9901320; Monica A, 2007, TALANTA, V72, P1362; MURATSUGU M, 1993, ANAL CHEM, V65, P2933, DOI 10.1021/ac00068a036; Niikura K, 1998, J AM CHEM SOC, V120, P8537, DOI 10.1021/ja980967r; Satjapipat M, 2001, LANGMUIR, V17, P7637, DOI 10.1021/la010989i; Shen GY, 2007, ANAL BIOCHEM, V365, P1, DOI 10.1016/j.ab.2006.11.038; Shen GY, 2010, THIN SOLID FILMS, V518, P5010, DOI 10.1016/j.tsf.2010.03.077; Shen GX, 1998, MODERN EXPT TECHNOLO, P133; SHONS A, 1972, J BIOMED MATER RES, V6, P565, DOI 10.1002/jbm.820060608; Steegborn C, 1997, BIOSENS BIOELECTRON, V12, P19, DOI 10.1016/0956-5663(96)89086-5; Su XD, 2004, ANAL CHEM, V76, P489, DOI 10.1021/ac035175g; TIU WU, 1989, ACTA TROP, V46, P75, DOI 10.1016/0001-706X(89)90001-6; Wang CC, 2002, ANAL BIOANAL CHEM, V373, P803, DOI 10.1007/s00216-002-1389-5; Wang H, 2001, CHEM J CHINESE U, V22, P1305; Wang Shiping, 1995, Chinese Journal of Parasitology & Parasitic Diseases, V13, P25; Wu VCH, 2007, BIOSENS BIOELECTRON, V22, P2967, DOI 10.1016/j.bios.2006.12.016; Wu ZY, 2006, BIOSENS BIOELECTRON, V22, P207, DOI 10.1016/j.bios.2005.12.016; Wu ZY, 1999, ANAL CHIM ACTA, V398, P57, DOI 10.1016/S0003-2670(99)00379-7; Wu ZY, 1997, CHEM J CHINESE U, V18, P1774; Wu ZY, 2001, CHEM J CHINESE U, V22, P542; Zhang B, 2008, J IMMUNOL METHODS, V338, P7, DOI 10.1016/j.jim.2008.06.003; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423; Zhou XN, 2010, ADV PARASIT, V72, P145, DOI 10.1016/S0065-308X(10)72006-6; 温志立, 2001, 生物医学工程学杂志, V18, P642	47	10	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30779	10.1371/journal.pone.0030779	http://dx.doi.org/10.1371/journal.pone.0030779			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22745651	gold, Green Published, Green Submitted			2022-12-27	WOS:000301704200033
J	Fureix, C; Jego, P; Henry, S; Lansade, L; Hausberger, M				Fureix, Carole; Jego, Patrick; Henry, Severine; Lansade, Lea; Hausberger, Martine			Towards an Ethological Animal Model of Depression? A Study on Horses	PLOS ONE			English	Article							PITUITARY-ADRENOCORTICAL AXIS; CHRONIC STRESS; CORTISOL; BEHAVIOR; TEMPERAMENT; INDICATORS; DISORDERS; RESPONSES; TRAITS; HUMANS	Background: Recent reviews question current animal models of depression and emphasise the need for ethological models of mood disorders based on animals living under natural conditions. Domestic horses encounter chronic stress, including potential stress at work, which can induce behavioural disorders (e. g. "apathy"). Our pioneering study evaluated the potential of domestic horses in their usual environment to become an ethological model of depression by testing this models' face validity (i.e. behavioural similarity with descriptions of human depressive states). Methodology/Principal Findings: We observed the spontaneous behaviour of 59 working horses in their home environment, focusing on immobility bouts of apparent unresponsiveness when horses displayed an atypical posture (termed withdrawn hereafter), evaluated their responsiveness to their environment and their anxiety levels, and analysed cortisol levels. Twenty-four percent of the horses presented the withdrawn posture, also characterized by gaze, head and ears fixity, a profile that suggests a spontaneous expression of "behavioural despair". When compared with control "non-withdrawn" horses from the same stable, withdrawn horses appeared more indifferent to environmental stimuli in their home environment but reacted more emotionally in more challenging situations. They exhibited lower plasma cortisol levels. Withdrawn horses all belonged to the same breed and females were over-represented. Conclusions/Significance: Horse might be a useful potential candidate for an animal model of depression. Face validity of this model appeared good, and potential genetic input and high prevalence of these disorders in females add to the convergence. At a time when current animal models of depression are questioned and the need for novel models is expressed, this study suggests that novel models and biomarkers could emerge from ethological approaches in home environments.	[Fureix, Carole; Jego, Patrick; Henry, Severine; Hausberger, Martine] Univ Rennes 1, UMR CNRS Ethol Anim & Humaine 6552, Rennes, France; [Lansade, Lea] Univ Tours, Inst Francais Cheval & Equitat, UMR INRA CNRS Physiol Reprod & Comportements 6175, Nouzilly, France	Universite de Rennes; INRAE; Universite de Tours	Fureix, C (corresponding author), Univ Rennes 1, UMR CNRS Ethol Anim & Humaine 6552, Rennes, France.	fureix.carole@gmail.com			"Caisse Centrale de la Mutualite Sociale Agricole" (French Agricultural Social Insurance)	"Caisse Centrale de la Mutualite Sociale Agricole" (French Agricultural Social Insurance)	This work has been supported by the "Caisse Centrale de la Mutualite Sociale Agricole" (French Agricultural Social Insurance). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Beerda B, 1999, PHYSIOL BEHAV, V66, P233, DOI 10.1016/S0031-9384(98)00289-3; Broom DM, 1987, BIOL STRESS FARM ANI; Burn CC, 2010, APPL ANIM BEHAV SCI, V126, P109, DOI 10.1016/j.applanim.2010.06.007; Christensen JW, 2005, APPL ANIM BEHAV SCI, V93, P53, DOI 10.1016/j.applanim.2005.06.017; Deussing J.M., 2006, DRUG DISCO TODAY DIS, V3, P375, DOI [DOI 10.1016/J.DDM0D.2006.11.003, 10.1016/J.DDMOD.2006.11.003, DOI 10.1016/J.DDMOD.2006.11.003]; Flint J, 1996, J MOL MED-JMM, V74, P515; FORDHAM DP, 1991, ANIM PROD, V52, P287, DOI 10.1017/S0003356100012794; Fureix C, 2011, NATURWISSENSCHAFTEN, V98, P583, DOI 10.1007/s00114-011-0803-2; Fureix C, 2009, ANIM COGN, V12, P643, DOI 10.1007/s10071-009-0223-2; Hall C, 2008, J APPL ANIM WELF SCI, V11, P249, DOI 10.1080/10888700802101130; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; HARLOW HF, 1973, J AUTISM CHILD SCHIZ, V3, P299, DOI 10.1007/BF01538539; HARLOW HF, 1974, BEHAV BIOL, V12, P273, DOI 10.1016/S0091-6773(74)91475-8; Hausberger M, 2004, J COMP PSYCHOL, V118, P434, DOI 10.1037/0735-7036.118.4.434; Hausberger M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014659; Hausberger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007625; HUTSON GD, 1993, APPL ANIM BEHAV SCI, V35, P255, DOI 10.1016/0168-1591(93)90141-B; Hutson GD, 2000, APPL ANIM BEHAV SCI, V66, P187, DOI 10.1016/S0168-1591(99)00084-2; Jensen KH, 1996, PHYSIOL BEHAV, V59, P741, DOI 10.1016/0031-9384(95)02159-0; Lansade L, 2008, APPL ANIM BEHAV SCI, V114, P534, DOI 10.1016/j.applanim.2008.02.012; Lansade L, 2008, APPL ANIM BEHAV SCI, V115, P182, DOI 10.1016/j.applanim.2008.06.011; LeScolan N, 1997, BEHAV PROCESS, V41, P257, DOI 10.1016/S0376-6357(97)00052-1; MAES M, 1994, BIOL PSYCHIAT, V36, P498, DOI 10.1016/0006-3223(94)90652-1; Matthews K, 2005, NEUROSCI BIOBEHAV R, V29, P503, DOI 10.1016/j.neubiorev.2005.03.005; McArthur R, 2006, PHARMACOL BIOCHEM BE, V84, P436, DOI 10.1016/j.pbb.2006.06.005; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; Michaud K, 2008, STRESS, V11, P177, DOI 10.1080/10253890701727874; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Mills DS, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P212; Moore B, 2002, BRIT J PSYCHIAT, V181, P348, DOI 10.1192/bjp.181.4.348; Mormede P, 2007, PHYSIOL BEHAV, V92, P317, DOI 10.1016/j.physbeh.2006.12.003; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; O'Brien A, 2008, ANXIETY STRESS COPIN, V21, P55, DOI 10.1080/10615800701529504; O'Neil MF, 2003, HUM PSYCHOPHARM CLIN, V18, P239, DOI 10.1002/hup.496; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Pritchett LC, 2003, APPL ANIM BEHAV SCI, V80, P31, DOI 10.1016/S0168-1591(02)00205-8; Redua MA, 2002, VET ANAESTH ANALG, V29, P200, DOI 10.1046/j.1467-2995.2002.00083.x; Reefmann N, 2009, APPL ANIM BEHAV SCI, V118, P199, DOI 10.1016/j.applanim.2009.02.013; Romero LM, 2009, HORM BEHAV, V55, P375, DOI 10.1016/j.yhbeh.2008.12.009; Saslow CA, 2002, APPL ANIM BEHAV SCI, V78, P209, DOI 10.1016/S0168-1591(02)00092-8; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Strickland PL, 2002, BRIT J PSYCHIAT, V180, P168, DOI 10.1192/bjp.180.2.168; Sufka KJ, 2006, BEHAV PHARMACOL, V17, P681, DOI 10.1097/FBP.0b013e3280115fac; Visser EK, 2008, APPL ANIM BEHAV SCI, V114, P521, DOI 10.1016/j.applanim.2008.03.003; Visser EK, 2002, PHYSIOL BEHAV, V76, P289, DOI 10.1016/S0031-9384(02)00698-4; Visser EK, 2001, APPL ANIM BEHAV SCI, V74, P241, DOI 10.1016/S0168-1591(01)00177-0; von Borstel UU, 2009, APPL ANIM BEHAV SCI, V116, P228, DOI 10.1016/j.applanim.2008.10.001; Wallbott HG, 1998, EUR J SOC PSYCHOL, V28, P879, DOI 10.1002/(SICI)1099-0992(1998110)28:6<879::AID-EJSP901>3.0.CO;2-W; Waring G.H., 2003, HORSE BEHAV, V2; Wolff A, 1997, BEHAV PROCESS, V40, P209, DOI 10.1016/S0376-6357(97)00784-5; [No title captured]; [No title captured]	54	81	82	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39280	10.1371/journal.pone.0039280	http://dx.doi.org/10.1371/journal.pone.0039280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761752	Green Published, Green Submitted, gold			2022-12-27	WOS:000305826400010
J	Murtola, TJ; Syvala, H; Pennanen, P; Blauer, M; Solakivi, T; Ylikomi, T; Tammela, TLJ				Murtola, Teemu J.; Syvala, Heimo; Pennanen, Pasi; Blauer, Merja; Solakivi, Tiina; Ylikomi, Timo; Tammela, Teuvo L. J.			The Importance of LDL and Cholesterol Metabolism for Prostate Epithelial Cell Growth	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; CANCER-CELLS; PROLIFERATION; RISK; PHYTOSTEROLS; SIMVASTATIN; PROGRESSION; PREVENTION; PATHWAYS; SURVIVAL	Cholesterol-lowering treatment has been suggested to delay progression of prostate cancer by decreasing serum LDL. We studied in vitro the effect of extracellular LDL-cholesterol on the number of prostate epithelial cells and on the expression of key regulators of cholesterol metabolism. Two normal prostatic epithelial cell lines (P96E, P97E), two in vitro immortalized epithelial cell lines (PWR-1E, RWPE-1) and two cancer cell lines (LNCaP and VCaP) were grown in cholesterol-deficient conditions. Cells were treated with 1-50 mu g/ml LDL-cholesterol and/or 100 nM simvastatin for seven days. Cell number relative to control was measured with crystal violet staining. Changes in mRNA and protein expression of key effectors in cholesterol metabolism (HMGCR, LDLR, SREBP2 and ABCA1) were measured with RT-PCR and immunoblotting, respectively. LDL increased the relative cell number of prostate cancer cell lines, but reduced the number of normal epithelial cells at high concentrations. Treatment with cholesterol-lowering simvastatin induced up to 90% reduction in relative cell number of normal cell lines but a 15-20% reduction in relative number of cancer cells, an effect accompanied by sharp upregulation of HMGCR and LDLR. These effects were prevented by LDL. Compared to the normal cells, prostate cancer cells showed high expression of cholesterol-producing HMGCR but failed to express the major cholesterol exporter ABCA1. LDL increased relative cell number of cancer cell lines, and these cells were less vulnerable than normal cells to cholesterol-lowering simvastatin treatment. Our study supports the importance of LDL for prostate cancer cells, and suggests that cholesterol metabolism in prostate cancer has been reprogrammed to increased production in order to support rapid cell growth.	[Murtola, Teemu J.; Syvala, Heimo] Univ Tampere, Sch Med, Dept Anat, FIN-33101 Tampere, Finland; [Murtola, Teemu J.; Tammela, Teuvo L. J.] Tampere Univ Hosp, Dept Urol, Tampere, Finland; [Pennanen, Pasi; Ylikomi, Timo] Univ Tampere, Sch Med, Dept Cell Biol, FIN-33101 Tampere, Finland; [Blauer, Merja] Tampere Univ Hosp, Dept Gastroenterol & Alimentary Tract Surg, Tampere, Finland; [Blauer, Merja] Tampere Univ Hosp, Tampere Pancreas Lab, Tampere, Finland; [Solakivi, Tiina] Univ Tampere, Sch Med, Dept Med Biochem, FIN-33101 Tampere, Finland	Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Tampere University	Murtola, TJ (corresponding author), Univ Tampere, Sch Med, Dept Anat, FIN-33101 Tampere, Finland.	teemu.murtola@uta.fi		Murtola, Teemu/0000-0003-2932-9590	Finnish Cancer Organisation; Orion Pharma Research Foundation	Finnish Cancer Organisation; Orion Pharma Research Foundation	This study was supported by grants from the competitive research funding from the Finnish Cancer Organisation and by a non-restrictive grant from Orion Pharma Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2009, CANCER EPIDEM BIOMAR, V18, P2814, DOI 10.1158/1055-9965.EPI-08-1248; Awad AB, 2001, EUR J CANCER PREV, V10, P507, DOI 10.1097/00008469-200112000-00005; Brown AJ, 2007, CLIN EXP PHARMACOL P, V34, P135, DOI 10.1111/j.1440-1681.2007.04565.x; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Brown MS, 1985, NOB LECT 9 DEC; Chen YF, 2001, INT J CANCER, V91, P41, DOI 10.1002/1097-0215(20010101)91:1<41::AID-IJC1009>3.0.CO;2-2; Connolly JM, 1997, NUTR CANCER, V29, P114, DOI 10.1080/01635589709514611; Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hamilton Robert J, 2008, J Natl Cancer Inst, V100, P1511, DOI 10.1093/jnci/djn362; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayashi N, 2011, BJU INT IN PRESS; Haylett AK, 2002, J PHOTOCH PHOTOBIO B, V66, P171, DOI 10.1016/S1011-1344(02)00241-5; Ifere GO, 2009, CANCER DETECT PREV, V32, P319, DOI 10.1016/j.cdp.2008.12.002; JAAKKOLA O, 1988, ATHEROSCLEROSIS, V69, P257, DOI 10.1016/0021-9150(88)90022-6; Kitahara CM, 2011, J CLIN ONCOL, V29, P1592, DOI 10.1200/JCO.2010.31.5200; Krycer JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008496; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Leon CG, 2010, PROSTATE, V70, P390, DOI 10.1002/pros.21072; Mondul AM, 2010, CANCER CAUSE CONTROL, V21, P61, DOI 10.1007/s10552-009-9434-8; Moses KA, 2009, J UROLOGY, V182, P2219, DOI 10.1016/j.juro.2009.07.039; Murtola TJ, 2008, NAT CLIN PRACT UROL, V5, P376, DOI 10.1038/ncpuro1146; Murtola TJ, 2011, EUR J PHARMACOL, V673, P96, DOI 10.1016/j.ejphar.2011.10.022; Murtola TJ, 2010, EXPERT REV ANTICANC, V10, P1563, DOI [10.1586/era.10.137, 10.1586/ERA.10.137]; Murtola TJ, 2009, PROSTATE, V69, P1017, DOI 10.1002/pros.20951; Platz EA, 2009, CANCER EPIDEM BIOMAR, V18, P2807, DOI 10.1158/1055-9965.EPI-09-0472; Ploumidou K, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.07.515; Sekine Y, 2010, MOL CANCER RES, V8, P1284, DOI 10.1158/1541-7786.MCR-10-0008; Sekine Y, 2009, CANCER EPIDEMIOL, V33, P16, DOI 10.1016/j.canep.2009.04.004; Solomon KR, 2009, AM J PATHOL, V174, P1017, DOI 10.2353/ajpath.2009.080551; Twiddy AL, 2011, PROSTATE; Van Hemelrijck M, 2011, CANCER-AM CANCER SOC, V117, P2086, DOI 10.1002/cncr.25758; VITOLS S, 1991, CANCER CELL-MON REV, V3, P488; WANG Y, 1995, J NATL CANCER I, V87, P1456, DOI 10.1093/jnci/87.19.1456; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD; Zhuang LY, 2005, J CLIN INVEST, V115, P959	37	59	59	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39445	10.1371/journal.pone.0039445	http://dx.doi.org/10.1371/journal.pone.0039445			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761797	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800035
J	Jannie, KM; Stipp, CS; Weiner, JA				Jannie, Karry M.; Stipp, Christopher S.; Weiner, Joshua A.			ALCAM Regulates Motility, Invasiveness, and Adherens Junction Formation in Uveal Melanoma Cells	PLOS ONE			English	Article							ADHESION MOLECULE; IMMUNOGLOBULIN SUPERFAMILY; BREAST-CANCER; N-CADHERIN; TUMOR PROGRESSION; PROSTATE-CANCER; MATRIX METALLOPROTEINASE-2; PATIENT SURVIVAL; ALPHA-CATENIN; FGF-RECEPTOR	ALCAM, a member of the immunoglobulin superfamily, has been implicated in numerous developmental events and has been repeatedly identified as a marker for cancer metastasis. Previous studies addressing ALCAM's role in cancer have, however, yielded conflicting results. Depending on the tumor cell type, ALCAM expression has been reported to be both positively and negatively correlated with cancer progression and metastasis in the literature. To better understand how ALCAM might regulate cancer cell behavior, we utilized a panel of defined uveal melanoma cell lines with high or low ALCAM levels, and directly tested the effects of manipulating these levels on cell motility, invasiveness, and adhesion using multiple assays. ALCAM expression was stably silenced by shRNA knockdown in a high-ALCAM cell line (MUM-2B); the resulting cells displayed reduced motility in gap-closure assays and a reduction in invasiveness as measured by a transwell migration assay. Immunostaining revealed that the silenced cells were defective in the formation of adherens junctions, at which ALCAM colocalizes with N-cadherin and beta-catenin in native cells. Additionally, we stably overexpressed ALCAM in a low-ALCAM cell line (MUM-2C); intriguingly, these cells did not exhibit any increase in motility or invasiveness, indicating that ALCAM is necessary but not sufficient to promote metastasis-associated cell behaviors. In these ALCAM-overexpressing cells, however, recruitment of beta-catenin and N-cadherin to adherens junctions was enhanced. These data confirm a previously suggested role for ALCAM in the regulation of adherens junctions, and also suggest a mechanism by which ALCAM might differentially enhance or decrease invasiveness, depending on the type of cadherin adhesion complexes present in tissues surrounding the primary tumor, and on the cadherin status of the tumor cells themselves.	[Jannie, Karry M.; Stipp, Christopher S.; Weiner, Joshua A.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa	Jannie, KM (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	joshua-weiner@uiowa.edu	Weiner, Joshua/AAA-6532-2021	Weiner, Joshua/0000-0002-3352-2847	E. Matilda Ziegler Foundation for the Blind; NATIONAL CANCER INSTITUTE [R01CA136664] Funding Source: NIH RePORTER	E. Matilda Ziegler Foundation for the Blind; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the E. Matilda Ziegler Foundation for the Blind to J.A.W. We thank Afshin Varzavand and Kristin Long Beltz for generous technical assistance and members of the Weiner laboratory for helpful discussions.	Avci HX, 2004, DEV BIOL, V271, P291, DOI 10.1016/j.ydbio.2004.03.035; Baker EA, 2000, BRIT J SURG, V87, P1215, DOI 10.1046/j.1365-2168.2000.01531.x; Bech-Serra JJ, 2006, MOL CELL BIOL, V26, P5086, DOI 10.1128/MCB.02380-05; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Bruder SP, 1998, J BONE MINER RES, V13, P655, DOI 10.1359/jbmr.1998.13.4.655; Buhusi M, 2009, J NEUROSCI, V29, P15630, DOI 10.1523/JNEUROSCI.2215-09.2009; Cavallaro U, 2001, NAT CELL BIOL, V3, P650, DOI 10.1038/35083041; Cortes F, 1999, BLOOD, V93, P826, DOI 10.1182/blood.V93.3.826.403k28_826_837; Daniels KJ, 1996, LAB INVEST, V75, P55; Davies SR, 2008, ONCOL REP, V19, P555; Degen WGJ, 1998, AM J PATHOL, V152, P805; Diekmann H, 2009, J COMP NEUROL, V513, P38, DOI 10.1002/cne.21928; Edwards JG, 2003, BRIT J CANCER, V88, P1553, DOI 10.1038/sj.bjc.6600920; Fashena D, 1999, J COMP NEUROL, V406, P415, DOI 10.1002/(SICI)1096-9861(19990412)406:3<415::AID-CNE9>3.0.CO;2-2; Folberg R, 2008, INVEST OPHTH VIS SCI, V49, P4697, DOI 10.1167/iovs.08-2324; Hassan NJ, 2004, EUR J IMMUNOL, V34, P930, DOI 10.1002/eji.200424856; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Jezierska A, 2006, MED SCI MONITOR, V12, pBR245; Katidou Markella, 2008, Biotechnology Journal, V3, P1564, DOI 10.1002/biot.200800281; Kato Y, 2006, J IMMUNOL, V177, P877, DOI 10.4049/jimmunol.177.2.877; Kincaid, 1998, Cancer Control, V5, P299; King JA, 2004, BREAST CANCER RES, V6, pR478, DOI 10.1186/bcr815; Koshiba T, 1998, CANCER, V82, P642, DOI 10.1002/(SICI)1097-0142(19980215)82:4<642::AID-CNCR5>3.0.CO;2-N; Kristiansen G, 2005, J PATHOL, V205, P359, DOI 10.1002/path.1676; Kristiansen G, 2003, PROSTATE, V54, P34, DOI 10.1002/pros.10161; LAESSING U, 1994, DIFFERENTIATION, V56, P21, DOI 10.1007/s002580050017; Laessing U, 1996, J NEUROBIOL, V29, P65, DOI 10.1002/(SICI)1097-4695(199601)29:1<65::AID-NEU5>3.0.CO;2-5; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li G, 2000, MOL MED TODAY, V6, P163, DOI 10.1016/S1357-4310(00)01692-0; Li G, 2001, CANCER RES, V61, P3819; Liang SM, 2011, INT J GYNECOL CANCER, V21, P523, DOI 10.1097/IGC.0b013e31820e135a; Lunter PC, 2005, CANCER RES, V65, P8801, DOI 10.1158/0008-5472.CAN-05-0378; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Martinez-Rico C, 2005, J BIOL CHEM, V280, P4753, DOI 10.1074/jbc.M412544200; Minner S, 2011, HUM PATHOL; Nelissen JMDT, 2000, MOL BIOL CELL, V11, P2057, DOI 10.1091/mbc.11.6.2057; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Ofori-Acquah SF, 2008, MICROVASC RES, V75, P391, DOI 10.1016/j.mvr.2007.10.006; Ofori-Acquah SF, 2008, TRANSL RES, V151, P122, DOI 10.1016/j.trsl.2007.09.006; Ohneda O, 2001, BLOOD, V98, P2134, DOI 10.1182/blood.V98.7.2134; Ott H, 2001, DEV BIOL, V235, P86, DOI 10.1006/dbio.2001.0278; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; POLLERBERG GE, 1994, DEV BIOL, V165, P670, DOI 10.1006/dbio.1994.1284; Reymond N, 2001, J BIOL CHEM, V276, P43205, DOI 10.1074/jbc.M103810200; Rosso O, 2007, MOL CANCER RES, V5, P1246, DOI 10.1158/1541-7786.MCR-07-0060; Rougon G, 2003, ANNU REV NEUROSCI, V26, P207, DOI 10.1146/annurev.neuro.26.041002.131014; Saint-Geniez M, 2004, INT J DEV BIOL, V48, P1045, DOI 10.1387/ijdb.041895ms; Sakisaka T, 2004, CURR OPIN CELL BIOL, V16, P513, DOI 10.1016/j.ceb.2004.07.007; Sandig M, 1997, CELL MOTIL CYTOSKEL, V38, P351, DOI 10.1002/(SICI)1097-0169(1997)38:4<351::AID-CM5>3.3.CO;2-Z; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; Sayner SL, 2011, AM J PHYSIOL-LUNG C, V301, pL117, DOI 10.1152/ajplung.00417.2009; Schubert W, 2001, J COMP NEUROL, V439, P368, DOI 10.1002/cne.1356; Seftor EA, 2002, CLIN EXP METASTAS, V19, P233, DOI 10.1023/A:1015591624171; Sekine-Aizawa Y, 1998, EUR J NEUROSCI, V10, P2810, DOI 10.1111/j.1460-9568.1998.00288.x; Skonier JE, 1997, PROTEIN SCI, V6, P1768, DOI 10.1002/pro.5560060818; Stamey TA, 2001, J UROLOGY, V166, P2171, DOI 10.1016/S0022-5347(05)65528-0; Stemmler MP, 2008, MOL BIOSYST, V4, P835, DOI 10.1039/b719215k; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Tomita K, 2000, BIOCHEM BIOPH RES CO, V267, P870, DOI 10.1006/bbrc.1999.2040; Tomita K, 2000, CANCER RES, V60, P3650; Uhlenbrock K, 2004, J CELL SCI, V117, P4863, DOI 10.1242/jcs.01367; van Kempen LCLT, 2004, J INVEST DERMATOL, V122, P1293, DOI 10.1111/j.0022-202X.2004.22531.x; van Kempen LCLT, 2001, J BIOL CHEM, V276, P25783, DOI 10.1074/jbc.M011272200; van Kempen LCLT, 2000, AM J PATHOL, V156, P769, DOI 10.1016/S0002-9440(10)64943-7; Van Marck V, 2005, CANCER RES, V65, P8774, DOI 10.1158/0008-5472.CAN-04-4414; Verma A, 2005, ONCOLOGY-BASEL, V68, P462, DOI 10.1159/000086989; Weichert W, 2004, J CLIN PATHOL, V57, P1160, DOI 10.1136/jcp.2004.016238; Weiner JA, 2004, MOL CELL NEUROSCI, V27, P59, DOI 10.1016/j.mcn.2004.06.005	72	25	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39330	10.1371/journal.pone.0039330	http://dx.doi.org/10.1371/journal.pone.0039330			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22745734	Green Submitted, Green Published, gold			2022-12-27	WOS:000305808700022
J	Kim, TN; Goodwill, PW; Chen, Y; Conolly, SM; Schaffer, CB; Liepmann, D; Wang, RA				Kim, Tyson N.; Goodwill, Patrick W.; Chen, Yeni; Conolly, Steven M.; Schaffer, Chris B.; Liepmann, Dorian; Wang, Rong A.			Line-Scanning Particle Image Velocimetry: An Optical Approach for Quantifying a Wide Range of Blood Flow Speeds in Live Animals	PLOS ONE			English	Article							RED-CELL VELOCITY; ARTERIOVENOUS-MALFORMATIONS; MULTIPHOTON MICROSCOPY; MOLECULAR REGULATION; 2-PHOTON MICROSCOPY; SHEAR; ANGIOGENESIS; VESSELS; TISSUE; BRAIN	Background: The ability to measure blood velocities is critical for studying vascular development, physiology, and pathology. A key challenge is to quantify a wide range of blood velocities in vessels deep within living specimens with concurrent diffraction-limited resolution imaging of vascular cells. Two-photon laser scanning microscopy (TPLSM) has shown tremendous promise in analyzing blood velocities hundreds of micrometers deep in animals with cellular resolution. However, current analysis of TPLSM-based data is limited to the lower range of blood velocities and is not adequate to study faster velocities in many normal or disease conditions. Methodology/Principal Findings: We developed line-scanning particle image velocimetry (LS-PIV), which used TPLSM data to quantify peak blood velocities up to 84 mm/s in live mice harboring brain arteriovenous malformation, a disease characterized by high flow. With this method, we were able to accurately detect the elevated blood velocities and exaggerated pulsatility along the abnormal vascular network in these animals. LS-PIV robustly analyzed noisy data from vessels as deep as 850 mm below the brain surface. In addition to analyzing in vivo data, we validated the accuracy of LS-PIV up to 800 mm/s using simulations with known velocity and noise parameters. Conclusions/Significance: To our knowledge, these blood velocity measurements are the fastest recorded with TPLSM. Partnered with transgenic mice carrying cell-specific fluorescent reporters, LS-PIV will also enable the direct in vivo correlation of cellular, biochemical, and hemodynamic parameters in high flow vascular development and diseases such as atherogenesis, arteriogenesis, and vascular anomalies.	[Kim, Tyson N.; Chen, Yeni; Wang, Rong A.] Univ Calif San Francisco, Dept Surg, Div Vasc Surg, Lab Accelerated Vasc Res, San Francisco, CA 94143 USA; [Goodwill, Patrick W.; Conolly, Steven M.; Liepmann, Dorian] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Schaffer, Chris B.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; Cornell University	Kim, TN (corresponding author), Univ Calif San Francisco, Dept Surg, Div Vasc Surg, Lab Accelerated Vasc Res, San Francisco, CA 94143 USA.	rong.wang@ucsfmedctr.org	Goodwill, Patrick/AAB-8825-2022; Schaffer, Chris B./A-7409-2008	Goodwill, Patrick/0000-0003-4240-1956; Schaffer, Chris B./0000-0002-7800-9596; Kim, Tyson/0000-0002-5275-6614; Conolly, Steven/0000-0002-3310-6085	Vascular Cures; National Institutes of Health [R01 NS067420, R01 HL075033, T32 GM07618, F30 1F30HL099005]; American Heart Association [10GRNT4170146]; Frank A. Campini Foundation; Mildred V. Strouss Trust; Tobacco-Related Disease Research Program Fellowship [19DT-0007]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL099005, R01HL075033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067420] Funding Source: NIH RePORTER	Vascular Cures; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Frank A. Campini Foundation; Mildred V. Strouss Trust; Tobacco-Related Disease Research Program Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Vascular Cures (formerly the Pacific Vascular Research Foundation), National Institutes of Health R01 NS067420, American Heart Association Grant in Aid 10GRNT4170146, National Institutes of Health R01 HL075033, the Frank A. Campini Foundation, and the Mildred V. Strouss Trust (to R.A.W.); National Institutes of Health T32 GM07618 (to UCSF MSTP); and Tobacco-Related Disease Research Program Fellowship 19DT-0007 and National Institutes of Health F30 1F30HL099005 (to T.N.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Amirbekian S, 2009, AM J PHYSIOL-HEART C, V297, pH1290, DOI 10.1152/ajpheart.00889.2008; Brown EB, 2001, NAT MED, V7, P864, DOI 10.1038/89997; Buschmann I, 2010, DEVELOPMENT, V137, P2187, DOI 10.1242/dev.045351; Carlson TR, 2005, P NATL ACAD SCI USA, V102, P9884, DOI 10.1073/pnas.0504391102; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Conway SJ, 2003, GENESIS, V35, P1, DOI 10.1002/gene.10152; Corti P, 2011, DEVELOPMENT, V138, P1573, DOI 10.1242/dev.060467; Dai GH, 2004, P NATL ACAD SCI USA, V101, P14871, DOI 10.1073/pnas.0406073101; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; del Alamo JC, 2008, P NATL ACAD SCI USA, V105, P15411, DOI 10.1073/pnas.0804573105; Drew PJ, 2010, J COMPUT NEUROSCI, V29, P5, DOI 10.1007/s10827-009-0159-1; ELLIS CG, 1992, MICROVASC RES, V44, P214, DOI 10.1016/0026-2862(92)90081-Y; Farrar MJ, 2012, NAT METHODS, V9, P297, DOI [10.1038/NMETH.1856, 10.1038/nmeth.1856]; Gulati S, 2008, J NON-NEWTON FLUID, V155, P51, DOI 10.1016/j.jnnfm.2008.05.005; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577; Hornig S, 2008, SOFT MATTER, V4, P1169, DOI 10.1039/b800276b; Huang CQ, 2003, DEVELOPMENT, V130, P6111, DOI 10.1242/dev.00831; Huo YL, 2008, ANN BIOMED ENG, V36, P685, DOI 10.1007/s10439-008-9473-4; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Japee SA, 2005, MICROCIRCULATION, V12, P507, DOI 10.1080/10739680591003341; Jones EAV, 2004, AM J PHYSIOL-HEART C, V287, pH1561, DOI 10.1152/ajpheart.00081.2004; Kamoun WS, 2010, NAT METHODS, V7, P655, DOI [10.1038/NMETH.1475, 10.1038/nmeth.1475]; Kang JJ, 2006, AM J PHYSIOL-RENAL, V291, pF495, DOI 10.1152/ajprenal.00521.2005; Kashiwagi S, 2008, NAT MED, V14, P255, DOI 10.1038/nm1730; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Kleinfeld David, 2000; Kobat D, 2009, OPT EXPRESS, V17, P13354, DOI 10.1364/OE.17.013354; Kurz H, 2000, J NEURO-ONCOL, V50, P17, DOI 10.1023/A:1006485716743; le Noble F, 2004, DEVELOPMENT, V131, P361, DOI 10.1242/dev.00929; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; Looney MR, 2011, NAT METHODS, V8, P91, DOI 10.1038/NMETH.1543; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Megens RTA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3281672; Morgan M, 2001, J CLIN NEUROSCI, V8, P216, DOI 10.1054/jocn.2000.0795; Murphy PA, 2008, P NATL ACAD SCI USA, V105, P10901, DOI 10.1073/pnas.0802743105; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Murray CD, 1926, J GEN PHYSIOL, V9, P835, DOI 10.1085/jgp.9.6.835; Nguyen QT, 2006, J NEUROSCI METH, V156, P351, DOI 10.1016/j.jneumeth.2006.03.001; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Nishimura N, 2010, J CEREBR BLOOD F MET, V30, P1914, DOI 10.1038/jcbfm.2010.157; Oheim M, 2001, J NEUROSCI METH, V111, P29, DOI 10.1016/S0165-0270(01)00438-1; OPPENHEIM AV, 1981, P IEEE, V69, P529, DOI 10.1109/PROC.1981.12022; Parzy E, 2009, NMR BIOMED, V22, P532, DOI 10.1002/nbm.1365; Reddy GD, 2008, NAT NEUROSCI, V11, P713, DOI 10.1038/nn.2116; ROSENBLUM WI, 1981, MICROVASC RES, V22, P225, DOI 10.1016/0026-2862(81)90092-3; Rubart M, 2004, CIRC RES, V95, P1154, DOI 10.1161/01.RES.0000150593.30324.42; Santisakultarm TP, 2012, AM J PHYSIOL-HEART C, V302, pH1367, DOI 10.1152/ajpheart.00417.2011; Santisakultarm TP, 2011, J CEREBR BLOOD F MET, V31, P1337, DOI 10.1038/jcbfm.2011.18; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; Shih AY, 2009, J CEREBR BLOOD F MET, V29, P738, DOI 10.1038/jcbfm.2008.166; Srinivasan VJ, 2011, J CEREBR BLOOD F MET, V31, P1339, DOI 10.1038/jcbfm.2011.19; Theer P, 2003, OPT LETT, V28, P1022, DOI 10.1364/OL.28.001022; TYML K, 1980, MICROVASC RES, V20, P1, DOI 10.1016/0026-2862(80)90014-X; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; WAYLAND H, 1967, J APPL PHYSIOL, V22, P333, DOI 10.1152/jappl.1967.22.2.333; Wernet MP, 2005, MEAS SCI TECHNOL, V16, P601, DOI 10.1088/0957-0233/16/3/001; WILLERT CE, 1991, EXP FLUIDS, V10, P181; Williams RM, 2010, TRANSL ONCOL, V3, P181, DOI 10.1593/tlo.09310; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	64	77	79	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e38590	10.1371/journal.pone.0038590	http://dx.doi.org/10.1371/journal.pone.0038590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22761686	Green Submitted, gold, Green Published			2022-12-27	WOS:000305808700006
J	Zhu, F; Shen, BR				Zhu, Fei; Shen, Bairong			Combined SVM-CRFs for Biological Named Entity Recognition with Maximal Bidirectional Squeezing	PLOS ONE			English	Article							CORPUS; GENE	Biological named entity recognition, the identification of biological terms in text, is essential for biomedical information extraction. Machine learning-based approaches have been widely applied in this area. However, the recognition performance of current approaches could still be improved. Our novel approach is to combine support vector machines (SVMs) and conditional random fields (CRFs), which can complement and facilitate each other. During the hybrid process, we use SVM to separate biological terms from non-biological terms, before we use CRFs to determine the types of biological terms, which makes full use of the power of SVM as a binary-class classifier and the data-labeling capacity of CRFs. We then merge the results of SVM and CRFs. To remove any inconsistencies that might result from the merging, we develop a useful algorithm and apply two rules. To ensure biological terms with a maximum length are identified, we propose a maximal bidirectional squeezing approach that finds the longest term. We also add a positive gain to rare events to reinforce their probability and avoid bias. Our approach will also gradually extend the context so more contextual information can be included. We examined the performance of four approaches with GENIA corpus and JNLPBA04 data. The combination of SVM and CRFs improved performance. The macro-precision, macro-recall, and macro-F-1 of the SVM-CRFs hybrid approach surpassed conventional SVM and CRFs. After applying the new algorithms, the macro-F1 reached 91.67% with the GENIA corpus and 84.04% with the JNLPBA04 data.	[Zhu, Fei; Shen, Bairong] Soochow Univ, Ctr Syst Biol, Suzhou, Jiangsu, Peoples R China; [Zhu, Fei] Soochow Univ, Sch Comp Sci & Technol, Suzhou, Jiangsu, Peoples R China; [Shen, Bairong] Soochow Univ, Inst Biomed Informat Engn, Suzhou, Jiangsu, Peoples R China; [Shen, Bairong] Soochow Univ, Dept Bioinformat, Coll Med, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Zhu, F (corresponding author), Soochow Univ, Ctr Syst Biol, Suzhou, Jiangsu, Peoples R China.	bairong.shen@suda.edu.cn	Shen, Bairong/E-6431-2012; Shen, Bairong/W-1254-2019	Shen, Bairong/0000-0003-2899-1531; Shen, Bairong/0000-0003-2899-1531	National Nature Science Foundation of China [31170795, 91029703]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20113201110015]; International S&T Cooperation Program of Suzhou [SH201120]; National 973 Programs of China [2010CB945600]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); International S&T Cooperation Program of Suzhou; National 973 Programs of China(National Basic Research Program of China)	This work was supported by the National Nature Science Foundation of China (31170795, 91029703), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20113201110015), the International S&T Cooperation Program of Suzhou (SH201120), and the National 973 Programs of China (2010CB945600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananiadou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014780; Bishop CM, 2007, PATTERN RECOGN, P393; Chung C, 2011, ACM T INTEL SYST TEC, V2, p[21, 27]; Cohen AM, 2005, BRIEF BIOINFORM, V6, P57, DOI 10.1093/bib/6.1.57; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dagar A, 2011, PEDIATR NEUROSURG, V47, P186, DOI 10.1159/000334257; Dai HJ, 2010, J COMPUT SCI TECH-CH, V25, P169, DOI 10.1007/s11390-010-9313-5; Ephraim Y, 2002, IEEE T INFORM THEORY, V48, P1518, DOI 10.1109/TIT.2002.1003838; Finkel Jenny Rose, 2005, P 43 ANN M ASS COMP, P363; Habib Mona Soliman, 2010, Int J Bioinform Res Appl, V6, P191, DOI 10.1504/IJBRA.2010.032121; He Ying, 2008, AMIA Annu Symp Proc, P293; Hjorland B, 2010, J AM SOC INF SCI TEC, V61, P217, DOI 10.1002/asi.21261; Hsu C.-W., 2002, IEEE T NEURAL NETWOR; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; JAYNES ET, 1968, IEEE T SYST SCI CYB, VSSC4, P227, DOI 10.1109/TSSC.1968.300117; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Ju ZF, 2011, C IND ELECT APPL, P455, DOI 10.1109/ICIEA.2011.5975627; Kim JD, 2003, BIOINFORMATICS, V19, pi180, DOI 10.1093/bioinformatics/btg1023; Kim J-D, 2004, P INT JOINT WORKSH N, P70; Kuo CJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S7; Lafferty J, 2001, P 18 INT C MACH LEAR, P282, DOI DOI 10.1038/NPROT.2006.61; Li LS, 2009, COMPUT BIOL CHEM, V33, P334, DOI 10.1016/j.compbiolchem.2009.07.004; Li Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-188; Lin YF, 2004, P 4 ACM SIGKDD WORKS, P56; Makino T, 2002, TUNING SUPPORT VECTO; Rebholz-Schuhman D., 2011, J BIOMED SEMANT, V2, P1; Tanabe L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S3; Tanabe L, 2002, BIOINFORMATICS, V18, P1124, DOI 10.1093/bioinformatics/18.8.1124; Tsai RTH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S9; Tsai TH, 2006, EXPERT SYST APPL, V30, P117, DOI 10.1016/j.eswa.2005.09.072; Tsochantaridis I., 2004, P 21 INT C MACH LEAR, P104; Wallach H. M., 2004, MSCIS0421 U PENNS; Winnenburg R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S3; Zhou GD, 2004, BIOINFORMATICS, V20, P1178, DOI 10.1093/bioinformatics/bth060	34	7	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39230	10.1371/journal.pone.0039230	http://dx.doi.org/10.1371/journal.pone.0039230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22745720	gold, Green Submitted, Green Published			2022-12-27	WOS:000305808700020
J	Hu, LL; Cui, WR; He, ZS; Shi, XH; Feng, KY; Ma, BY; Cai, YD				Hu, Lele; Cui, Weiren; He, Zhisong; Shi, Xiaohe; Feng, Kaiyan; Ma, Buyong; Cai, Yu-Dong			Cooperativity among Short Amyloid Stretches in Long Amyloidogenic Sequences	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; AGGREGATION; PREDICTION; FIBRILS; SEGMENTS; IDENTIFICATION; DETERMINANTS; POLYPEPTIDE; SELECTION; REGIONS	Amyloid fibrillar aggregates of polypeptides are associated with many neurodegenerative diseases. Short peptide segments in protein sequences may trigger aggregation. Identifying these stretches and examining their behavior in longer protein segments is critical for understanding these diseases and obtaining potential therapies. In this study, we combined machine learning and structure-based energy evaluation to examine and predict amyloidogenic segments. Our feature selection method discovered that windows consisting of long amino acid segments of similar to 30 residues, instead of the commonly used short hexapeptides, provided the highest accuracy. Weighted contributions of an amino acid at each position in a 27 residue window revealed three cooperative regions of short stretch, resemble the beta-strand-turn-beta-strand motif in A-beta peptide amyloid and beta-solenoid structure of HET-s(218-289) prion (C). Using an in-house energy evaluation algorithm, the interaction energy between two short stretches in long segment is computed and incorporated as an additional feature. The algorithm successfully predicted and classified amyloid segments with an overall accuracy of 75%. Our study revealed that genome-wide amyloid segments are not only dependent on short high propensity stretches, but also on nearby residues.	[Hu, Lele; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Cui, Weiren; He, Zhisong] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Hu, Lele] Shanghai Univ, Coll Sci, Dept Chem, Shanghai, Peoples R China; [Shi, Xiaohe] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Shi, Xiaohe] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Feng, Kaiyan] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Ma, Buyong] NCI, Basic Sci Program, SAIC Frederick, Ctr Canc Res Nanobiol Program,NIH, Frederick, MD 21701 USA	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Hu, LL (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	mabuyong@mail.nih.gov; cai_yud@yahoo.com.cn	Ma, Buyong/F-9491-2011	Ma, Buyong/0000-0002-7383-719X; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; Shanghai Municipal Education Commission [12ZZ087]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with funds from the National Basic Research Program of China (2011CB510102, 2011CB510101), Innovation Program of Shanghai Municipal Education Commission (12ZZ087), and Federal funds from National Cancer Institute, National Institutes of Health, under contract number HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bahar I, 1997, J MOL BIOL, V266, P195, DOI 10.1006/jmbi.1996.0758; Benvenga S, 2008, AMYLOID, V15, P269, DOI 10.1080/13506120802524866; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buttstedt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015436; Cai YD, 2008, MOL DIVERS, V12, P131, DOI 10.1007/s11030-008-9085-9; Cai YD, 2009, J PROTEOME RES, V8, P999, DOI 10.1021/pr800717y; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen FE, 1999, J MOL BIOL, V293, P313, DOI 10.1006/jmbi.1999.2990; Colombo G, 2008, PROTEINS, V70, P863, DOI 10.1002/prot.21648; de Groot NS, 2006, FEBS J, V273, P658, DOI 10.1111/j.1742-4658.2005.05102.x; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Dobson CM, 2002, NATURE, V418, P729, DOI 10.1038/418729a; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Esteras-Chopo A, 2005, P NATL ACAD SCI USA, V102, P16672, DOI 10.1073/pnas.0505905102; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Frith MC, 2002, NUCLEIC ACIDS RES, V30, P3214, DOI 10.1093/nar/gkf438; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Guo Z, 2008, PROTEIN SCI, V17, P1617, DOI 10.1110/ps.036368.108; Hamodrakas SJ, 2007, INT J BIOL MACROMOL, V41, P295, DOI 10.1016/j.ijbiomac.2007.03.008; Jia SC, 2011, PROTEIN PEPTIDE LETT, V18, P609, DOI 10.2174/092986611795222777; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jordan IK, 2005, NATURE, V433, P633, DOI 10.1038/nature03306; Kandaswamy KK, 2011, J THEOR BIOL, V270, P56, DOI 10.1016/j.jtbi.2010.10.037; Kelly JW, 2002, NAT STRUCT BIOL, V9, P323, DOI 10.1038/nsb0502-323; Kinjo AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001963; Koo BW, 2008, PROTEIN ENG DES SEL, V21, P147, DOI 10.1093/protein/gzm076; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; LU L, 2009, MOL DIVERS; Ma B, 2007, CURR TOP MED CHEM, V7, P999, DOI 10.2174/156802607780906717; Ma BY, 2006, CURR OPIN CHEM BIOL, V10, P445, DOI 10.1016/j.cbpa.2006.08.018; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Maji SK, 2009, J BIOL CHEM, V284, P23580, DOI 10.1074/jbc.M109.038133; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Murphy RM, 2007, BIOTECHNOL PROGR, V23, P548, DOI 10.1021/bp060374h; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Padrick SB, 2001, J MOL BIOL, V308, P783, DOI 10.1006/jmbi.2001.4608; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Perczel A, 2007, J AM CHEM SOC, V129, P14959, DOI 10.1021/ja0747122; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Soldi G, 2005, BIOPHYS J, V89, P4234, DOI 10.1529/biophysj.105.067538; Tartaglia GG, 2005, PROTEIN SCI, V14, P2723, DOI 10.1110/ps.051471205; Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Pastor MT, 2007, PRION, V1, P9, DOI 10.4161/pri.1.1.4100; Tian J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S45; Toombs JA, 2010, MOL CELL BIOL, V30, P319, DOI 10.1128/MCB.01140-09; Trojanowski JQ, 2003, NEUROMOL MED, V4, P1, DOI 10.1385/NMM:4:1-2:1; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Xu SH, 2007, AMYLOID, V14, P119, DOI 10.1080/13506120701260059; Zhang ZQ, 2007, BIOINFORMATICS, V23, P2218, DOI 10.1093/bioinformatics/btm325; Zheng J, 2007, BIOPHYS J, V93, P3046, DOI 10.1529/biophysj.107.110700	58	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39369	10.1371/journal.pone.0039369	http://dx.doi.org/10.1371/journal.pone.0039369			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761773	Green Submitted, Green Published, gold			2022-12-27	WOS:000305730900052
J	Ivkovic, M; Kuceyeski, A; Raj, A				Ivkovic, Milos; Kuceyeski, Amy; Raj, Ashish			Statistics of Weighted Brain Networks Reveal Hierarchical Organization and Gaussian Degree Distribution	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; SMALL-WORLD; SCALE-FREE; MRI	Whole brain weighted connectivity networks were extracted from high resolution diffusion MRI data of 14 healthy volunteers. A statistically robust technique was proposed for the removal of questionable connections. Unlike most previous studies our methods are completely adapted for networks with arbitrary weights. Conventional statistics of these weighted networks were computed and found to be comparable to existing reports. After a robust fitting procedure using multiple parametric distributions it was found that the weighted node degree of our networks is best described by the normal distribution, in contrast to previous reports which have proposed heavy tailed distributions. We show that post-processing of the connectivity weights, such as thresholding, can influence the weighted degree asymptotics. The clustering coefficients were found to be distributed either as gamma or power-law distribution, depending on the formula used. We proposed a new hierarchical graph clustering approach, which revealed that the brain network is divided into a regular base-2 hierarchical tree. Connections within and across this hierarchy were found to be uncommonly ordered. The combined weight of our results supports a hierarchically ordered view of the brain, whose connections have heavy tails, but whose weighted node degrees are comparable.	[Ivkovic, Milos; Kuceyeski, Amy; Raj, Ashish] Weill Cornell Med Coll, New York, NY USA	Cornell University	Ivkovic, M (corresponding author), Weill Cornell Med Coll, New York, NY USA.	mii2004@med.cornell.edu			National Science Foundation (NSF) [0844032]; Purdue University; Dell; The MathWorks; Microsoft	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Purdue University; Dell; The MathWorks; Microsoft(Microsoft)	The authors acknowledge the use of the Cornell Center for Advanced Computing's 'MATLAB on the TeraGrid' experimental computing resource funded by National Science Foundation (NSF) grant 0844032 in partnership with Purdue University, Dell, The MathWorks, and Microsoft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman-Gomez Y., 2006, 12 ANN M ORG HUM BRA; ALPERT CJ, 1995, DES AUT CON, P195; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; CLAUSET A, 2007, POWER LAW DISTRIBUTI; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Fanti C, 2004, ADV NEUR IN, V16, P1603; Friston K. J., 2003, STAT PARAMETRIC MAPP; Friston KJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000081; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; HOLM S, 1979, SCAND J STAT, V6, P65; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; JOHNSON DB, 1977, J ACM, V24, P1, DOI 10.1145/321992.321993; Kalna G, 2007, AI COMMUN, V20, P263; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Ng AY, 2002, ADV NEUR IN, V14, P849; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Saramaki J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.027105; SCANNELL JW, 1995, J NEUROSCI, V15, P1463; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Sommer FT, 2003, THEOR BIOSCI, V122, P55, DOI 10.1078/1431-7613-00074; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2010, EXPLORING B IN PRESS; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1; Yu SX, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P313, DOI 10.1109/iccv.2003.1238361	33	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e35029	10.1371/journal.pone.0035029	http://dx.doi.org/10.1371/journal.pone.0035029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761649	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900002
J	Lee, NV; Lira, ME; Pavlicek, A; Ye, JJ; Buckman, D; Bagrodia, S; Srinivasa, SP; Zhao, YJ; Aparicio, S; Rejto, PA; Christensen, JG; Ching, KA				Lee, Nathan V.; Lira, Maruja E.; Pavlicek, Adam; Ye, Jingjing; Buckman, Dana; Bagrodia, Shubha; Srinivasa, Sreesha P.; Zhao, Yongjun; Aparicio, Samuel; Rejto, Paul A.; Christensen, James G.; Ching, Keith A.			A Novel SND1-BRAF Fusion Confers Resistance to c-Met Inhibitor PF-04217903 in GTL16 Cells though MAPK Activation	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; ACQUIRED-RESISTANCE; CANCER-CELLS; LUNG-CANCER; GENE AMPLIFICATION; PROSTATE-CANCER; GASTRIC-CANCER; RAF INHIBITION; B-RAF; BRAF	Targeting cancers with amplified or abnormally activated c-Met (hepatocyte growth factor receptor) may have therapeutic benefit based on nonclinical and emerging clinical findings. However, the eventual emergence of drug resistant tumors motivates the pre-emptive identification of potential mechanisms of clinical resistance. We rendered a MET amplified gastric cancer cell line, GTL16, resistant to c-Met inhibition with prolonged exposure to a c-Met inhibitor, PF-04217903 (METi). Characterization of surviving cells identified an amplified chromosomal rearrangement between 7q32 and 7q34 which overexpresses a constitutively active SND1-BRAF fusion protein. In the resistant clones, hyperactivation of the downstream MAPK pathway via SND1-BRAF conferred resistance to c-Met receptor tyrosine kinase inhibition. Combination treatment with METi and a RAF inhibitor, PF-04880594 (RAFi) inhibited ERK activation and circumvented resistance to either single agent. Alternatively, treatment with a MEK inhibitor, PD-0325901 (MEKi) alone effectively blocked ERK phosphorylation and inhibited cell growth. Our results suggest that combination of a c-Met tyrosine kinase inhibitor with a BRAF or a MEK inhibitor may be effective in treating resistant tumors that use activated BRAF to escape suppression of c-Met signaling.	[Lee, Nathan V.; Lira, Maruja E.; Pavlicek, Adam; Buckman, Dana; Bagrodia, Shubha; Srinivasa, Sreesha P.; Rejto, Paul A.; Christensen, James G.; Ching, Keith A.] Pfizer Global Res & Dev, Oncol Res Unit, San Diego, CA USA; [Ye, Jingjing] Pfizer Global Res & Dev, Global Preclin Stat, San Diego, CA USA; [Zhao, Yongjun] BC Canc Res Ctr, Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Aparicio, Samuel] BC Canc Agcy, Mol Oncol, Vancouver, BC, Canada; [Aparicio, Samuel] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada	Pfizer; Pfizer; British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia	Lee, NV (corresponding author), Pfizer Global Res & Dev, Oncol Res Unit, San Diego, CA USA.	keith.ching@pfizer.com	Rejto, Paul/M-4782-2019	Aparicio, Samuel/0000-0002-0487-9599	Pfizer Inc.; Pfizer	Pfizer Inc.(Pfizer); Pfizer(Pfizer)	Work described in the manuscript was funded by Pfizer Inc. (www.pfizer.com). Employees of the funder actively contributed to study design, data collection and analysis, decision to publish, and preparation of the manuscript.; Nathan Lee, Maruja Lira, Adam Pavlicek, Jingjing Ye, Dana Buckman, Shubha Bagrodia, Sreesha Srinivasa, Paul Rejto, James Christensen, and Keith Ching were paid employees of Pfizer. Yongjun Zhao and Samuel Aparicio were funded by Pfizer. Pfizer maintains the patents and marketing rights to the compounds PF-04217903, PF-04880594, and Xalkori used in this study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bachleitner-Hofmann T, 2008, MOL CANCER THER, V7, P3499, DOI 10.1158/1535-7163.MCT-08-0374; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Bertotti A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000643; Bertotti A, 2010, CLIN CANCER RES, V16, P3933, DOI 10.1158/1078-0432.CCR-10-0106; Brown AP, 2007, CANCER CHEMOTH PHARM, V59, P671, DOI 10.1007/s00280-006-0323-5; Buck E, 2006, MOL CANCER THER, V5, P2676, DOI 10.1158/1535-7163.MCT-06-0166; Cepero V, 2010, CANCER RES, V70, P7580, DOI 10.1158/0008-5472.CAN-10-0436; Ciampi R, 2005, J CLIN INVEST, V115, P94, DOI 10.1172/JCI200523237; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Corso S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-121; Dessars B, 2007, J INVEST DERMATOL, V127, P1468, DOI 10.1038/sj.jid.5700725; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P3943, DOI 10.1210/jc.2008-0607; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ercan D, 2010, ONCOGENE, V29, P2346, DOI 10.1038/onc.2009.526; Gear J, 2004, INVEST OPHTH VIS SCI, V45, P2484, DOI 10.1167/iovs.04-0093; Goodall J, 2004, MOL CELL BIOL, V24, P2923, DOI 10.1128/MCB.24.7.2923-2931.2004; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Herrick J, 2000, P NATL ACAD SCI USA, V97, P222, DOI 10.1073/pnas.97.1.222; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Kuruma H, 2009, AM J PATHOL, V174, P2044, DOI 10.2353/ajpath.2009.080776; Li CL, 2008, NUCLEIC ACIDS RES, V36, P3579, DOI 10.1093/nar/gkn236; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WQ, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-2; LONGATI P, 1994, ONCOGENE, V9, P49; Lutterbach B, 2007, CANCER RES, V67, P2081, DOI 10.1158/0008-5472.CAN-06-3495; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; McDermott U, 2010, CANCER RES, V70, P1625, DOI 10.1158/0008-5472.CAN-09-3620; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Ritz C, 2005, J STAT SOFTW, V12, P1; Santhekadur PK, 2012, J BIOL CHEM; Sarkar D, 2008, USE R, P1; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Sebolt-Leopold JS, 2006, NATURE, V441, P457, DOI 10.1038/nature04874; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Tiedt R, 2011, CANCER RES, V71, P5255, DOI 10.1158/0008-5472.CAN-10-4433; Tsuchiya N, 2007, CANCER RES, V67, P9568, DOI 10.1158/0008-5472.CAN-06-2707; Tsuchiya N, 2010, MUTAT RES-FUND MOL M, V693, P94, DOI 10.1016/j.mrfmmm.2010.09.001; Vergani E, 2011, NEOPLASIA, V13, P1132, DOI 10.1593/neo.111102; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yip L, 2011, ANN SURG ONCOL, V18, P2035, DOI 10.1245/s10434-011-1733-0; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhong S, 1999, NAT GENET, V23, P287, DOI 10.1038/15463	57	39	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39653	10.1371/journal.pone.0039653	http://dx.doi.org/10.1371/journal.pone.0039653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745804	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900094
J	Liu, B; Chen, J; Wang, JH; Liu, X; Duan, XH; Shang, XJ; Long, Y; Chen, ZG; Li, XF; Huang, Y; He, Y				Liu, Bo; Chen, Jun; Wang, Jinhui; Liu, Xian; Duan, Xiaohui; Shang, Xiaojing; Long, Yu; Chen, Zhiguang; Li, Xiaofang; Huang, Yan; He, Yong			Altered Small-World Efficiency of Brain Functional Networks in Acupuncture at ST36: A Functional MRI Study	PLOS ONE			English	Article							RESTING-STATE CONNECTIVITY; CONCURRENT TMS-FMRI; VISUAL-CORTEX; ACUPOINT STIMULATION; ALZHEIMERS-DISEASE; CEREBRAL-CORTEX; CORTICAL HUBS; FOLLOW-UP; ELECTROACUPUNCTURE; MODULATION	Background: Acupuncture in humans can produce clinical effects via the central nervous system. However, the neural substrates of acupuncture's effects remain largely unknown. Results: We utilized functional MRI to investigate the topological efficiency of brain functional networks in eighteen healthy young adults who were scanned before and after acupuncture at the ST36 acupoints (ACUP) and its sham point (SHAM). Whole-brain functional networks were constructed by thresholding temporal correlations matrices of ninety brain regions, followed by a graph theory-based analysis. We showed that brain functional networks exhibited small-world attributes (high local and global efficiency) regardless of the order of acupuncture and stimulus points, a finding compatible with previous studies of brain functional networks. Furthermore, the brain networks had increased local efficiency after ACUP stimulation but there were no significant differences after SHAM, indicating a specificity of acupuncture point in coordinating local information flow over the whole brain. Moreover, significant (P<0.05, corrected by false discovery rate approach) effects of only acupuncture point were detected on nodal degree of the left hippocampus (higher nodal degree at ACUP as compared to SHAM). Using an uncorrected P<0.05, point-related effects were also observed in the anterior cingulate cortex, frontal and occipital regions while stimulation-related effects in various brain regions of frontal, parietal and occipital cortex regions. In addition, we found that several limbic and subcortical brain regions exhibited point-and stimulation-related alterations in their regional homogeneity (P<0.05, uncorrected). Conclusions: Our results suggest that acupuncture modulates topological organization of whole-brain functional brain networks and the modulation has point specificity. These findings provide new insights into neuronal mechanism of acupuncture from the perspective of functional integration. Further studies would be interesting to apply network analysis approaches to study the effects of acupuncture treatments on brain disorders.	[Liu, Bo; Chen, Jun; Liu, Xian; Duan, Xiaohui; Shang, Xiaojing; Long, Yu; Chen, Zhiguang; Li, Xiaofang; Huang, Yan] Guangdong Prov Hosp Tradit Chinese Med, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Wang, Jinhui; He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Guangzhou University of Chinese Medicine; Beijing Normal University	Liu, B (corresponding author), Guangdong Prov Hosp Tradit Chinese Med, Dept Radiol, Guangzhou, Guangdong, Peoples R China.	lbgdhtcm@163.com	Chen, Jun/AAD-7667-2020; He, Yong/Q-5756-2018; Duan, Xiaohui/R-5693-2019; He, Yong/C-2161-2009; Wang, jinhui/AAF-8668-2019	CHEN, JUN/0000-0001-5049-5759; He, Yong/0000-0002-7039-2850; chen, jun/0000-0002-1936-9954	Guangdong Science and Technology Department [2008B080703041, 2010B080701025]; Natural Science Foundation of China [81030028, 30870667]; Beijing Natural Science Foundation [7102090]; Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry)	Guangdong Science and Technology Department; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry)(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was partly supported by the Guangdong Science and Technology Department (No. 2008B080703041 and 2010B080701025), the Natural Science Foundation of China (Grant Nos. 81030028 and 30870667), the Beijing Natural Science Foundation (Grant No. 7102090) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry, YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Beijing University of Chinese Medicine Shanghai University of T.C.M Nanjing University Of Chinese Medicine, 2005, ESS CHIN AC; Biella G, 2001, NEUROIMAGE, V14, P60, DOI 10.1006/nimg.2001.0798; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Campbell Anthony, 2006, Acupunct Med, V24, P118; Chen K, 1995, J Tradit Chin Med, V15, P203; Cheng TO, 2000, HEART, V83, P256, DOI 10.1136/heart.83.3.256; Cho ZH, 1998, P NATL ACAD SCI USA, V95, P2670, DOI 10.1073/pnas.95.5.2670; Chung S C, 2000, J Physiol Anthropol Appl Human Sci, V19, P93, DOI 10.2114/jpa.19.93; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Fang JL, 2009, HUM BRAIN MAPP, V30, P1196, DOI 10.1002/hbm.20583; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gareus IK, 2002, J MAGN RESON IMAGING, V15, P227, DOI 10.1002/jmri.10059; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hsieh CW, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/951258; Hui KKS, 2005, NEUROIMAGE, V27, P479, DOI 10.1016/j.neuroimage.2005.04.037; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; Kong JA, 2002, J ALTERN COMPLEM MED, V8, P411, DOI 10.1089/107555302760253603; Kong J, 2007, J ALTERN COMPLEM MED, V13, P1059, DOI 10.1089/acm.2007.0524; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li G, 2003, HUM BRAIN MAPP, V18, P233, DOI 10.1002/hbm.10098; Luo F, 2008, NEUROCHEM RES, V33, P1950, DOI 10.1007/s11064-008-9692-y; Makris N, 2007, CEREB CORTEX, V17, P1364, DOI 10.1093/cercor/bhl047; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mayer DJ, 2000, ANNU REV MED, V51, P49, DOI 10.1146/annurev.med.51.1.49; Molsberger AF, 2002, PAIN, V99, P579, DOI 10.1016/S0304-3959(02)00269-5; Napadow V, 2005, HUM BRAIN MAPP, V24, P193, DOI 10.1002/hbm.20081; Qin W, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-55; RICHARDSON PH, 1986, PAIN, V24, P15, DOI 10.1016/0304-3959(86)90023-0; Ruff CC, 2008, CEREB CORTEX, V18, P817, DOI 10.1093/cercor/bhm128; Ruff CC, 2006, CURR BIOL, V16, P1479, DOI 10.1016/j.cub.2006.06.057; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang SM, 2008, ANESTH ANALG, V106, P611, DOI 10.1213/ane.0b013e318160644d; Wang SM, 2007, ANESTH ANALG, V105, P499, DOI 10.1213/01.ane.0000270216.71234.f5; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Witt C, 2005, LANCET, V366, P136, DOI 10.1016/S0140-6736(05)66871-7; Wu MT, 1999, RADIOLOGY, V212, P133, DOI 10.1148/radiology.212.1.r99jl04133; Wu MT, 2002, NEUROIMAGE, V16, P1028, DOI 10.1006/nimg.2002.1145; Yan B, 2005, NEUROSCI LETT, V383, P236, DOI 10.1016/j.neulet.2005.04.021; Yeo S, 2010, J ALTERN COMPLEM MED, V16, P481, DOI 10.1089/acm.2009.0606; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang TJ, 2011, J PSYCHIATR NEUROSCI, V36, P23, DOI 10.1503/jpn.100006; Zhang WT, 2003, BRAIN RES, V982, P168, DOI 10.1016/S0006-8993(03)02983-4; Zuo XN, 2011, CEREB CORTE IN PRESS	64	19	27	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39342	10.1371/journal.pone.0039342	http://dx.doi.org/10.1371/journal.pone.0039342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761766	gold, Green Published, Green Submitted			2022-12-27	WOS:000305730900046
J	Panagopoulos, I; Micci, F; Thorsen, J; Gorunova, L; Eibak, AM; Bjerkehagen, B; Davidson, B; Heim, S				Panagopoulos, Ioannis; Micci, Francesca; Thorsen, Jim; Gorunova, Ludmila; Eibak, Anne Mette; Bjerkehagen, Bodil; Davidson, Ben; Heim, Sverre			Novel Fusion of MYST/Esa1-Associated Factor 6 and PHF1 in Endometrial Stromal Sarcoma	PLOS ONE			English	Article							JAZF1-JJAZ1 GENE FUSION; HISTONE ACETYLTRANSFERASE COMPLEXES; MOLECULAR ANALYSIS; UTERINE SARCOMAS; TUMORS; IDENTIFICATION; METHYLATION; ABERRATIONS; JAZF1/PHF1; NEOPLASMS	Rearrangement of chromosome band 6p21 is recurrent in endometrial stromal sarcoma (ESS) and targets the PHF1 gene. So far, PHF1 was found to be the 39 partner in the JAZF1-PHF1 and EPC1-PHF1 chimeras but since the 6p21 rearrangements involve also other chromosomal translocation partners, other PHF1-fusions seem likely. Here, we show that PHF1 is recombined with a novel fusion partner, MEAF6 from 1p34, in an ESS carrying a t(1;6)(p34;p21) translocation as the sole karyotypic anomaly. 59-RACE, RT-PCR, and sequencing showed the presence of an MEAF6-PHF1 chimera in the tumor with exon 5 of MEAF6 being fused in-frame to exon 2 of PHF1 so that the entire PHF1 coding region becomes the 39 terminal part of the MEAF6-PHF1 fusion. The predicted fusion protein is composed of 750 amino acids and contains the histone acetyltransferase subunit NuA4 domain of MEAF6 and the tudor, PHD zinc finger, and MTF2 domains of PHF1. Although the specific functions of the MEAF6 and PHF1 proteins and why they are targeted by a neoplasia-specific gene fusion are not directly apparent, it seems that rearrangement of genes involved in acetylation (EPC1, MEAF6) and methylation (PHF1), resulting in aberrant gene expression, is a common theme in ESS pathogenesis.	[Panagopoulos, Ioannis; Micci, Francesca; Thorsen, Jim; Gorunova, Ludmila; Eibak, Anne Mette; Heim, Sverre] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Med Informat, Sect Canc Cytogenet, Oslo, Norway; [Panagopoulos, Ioannis; Micci, Francesca; Thorsen, Jim; Gorunova, Ludmila; Eibak, Anne Mette; Heim, Sverre] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Bjerkehagen, Bodil; Davidson, Ben] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Panagopoulos, I (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Med Informat, Sect Canc Cytogenet, Oslo, Norway.	ioannis.panagopoulos@rr-research.no		Panagopoulos, Ioannis/0000-0003-2159-5341	Norwegian Cancer Society; Helse Sor-Ost (the South-East Regional Health Authority)	Norwegian Cancer Society(Norwegian Cancer Society); Helse Sor-Ost (the South-East Regional Health Authority)	This work was supported by grants from the Norwegian Cancer Society and Helse Sor-Ost (the South-East Regional Health Authority). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Avvakumov N, 2007, ONCOGENE, V26, P5395, DOI 10.1038/sj.onc.1210608; Baker P, 2007, J CLIN PATHOL, V60, P235, DOI 10.1136/jcp.2005.031203; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Chiang S, 2011, AM J SURG PATHOL, V35, P1364, DOI 10.1097/PAS.0b013e3182262743; Chiang S, 2011, HUM PATHOL, V42, P609, DOI 10.1016/j.humpath.2010.12.005; CIN PD, 1988, CANCER GENET CYTOGEN, V36, P1, DOI 10.1016/0165-4608(88)90068-4; Coulson M, 1998, GENOMICS, V48, P381, DOI 10.1006/geno.1997.5201; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Gil-Benso R, 1999, VIRCHOWS ARCH, V434, P307, DOI 10.1007/s004280050346; Hennig Y, 1996, CANCER GENET CYTOGEN, V87, P148, DOI 10.1016/0165-4608(95)00311-8; Hong ZH, 2008, NUCLEIC ACIDS RES, V36, P2939, DOI 10.1093/nar/gkn146; Hrzenjak A, 2005, J MOL DIAGN, V7, P388, DOI 10.1016/S1525-1578(10)60568-5; Huang HY, 2004, AM J SURG PATHOL, V28, P224, DOI 10.1097/00000478-200402000-00010; Iliszko M, 1998, GYNECOL ONCOL, V71, P172, DOI 10.1006/gyno.1998.5165; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; LAXMAN R, 1993, CANCER, V71, P1283, DOI 10.1002/1097-0142(19930215)71:4<1283::AID-CNCR2820710419>3.0.CO;2-I; Lee CH, 2012, P NATL ACAD SCI USA, V109, P929, DOI 10.1073/pnas.1115528109; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li XZ, 2011, MOL CELL BIOL, V31, P351, DOI 10.1128/MCB.00259-10; Mandahl N, 2001, HUMAN CYTOGENETICS M, P165; Micci F, 2006, CANCER RES, V66, P107, DOI 10.1158/0008-5472.CAN-05-2485; Micci F, 2009, CANCER LETT, V277, P205, DOI 10.1016/j.canlet.2008.12.016; Nucci MR, 2007, AM J SURG PATHOL, V31, P65, DOI 10.1097/01.pas.0000213327.86992.d1; Oliva E, 2007, AM J SURG PATHOL, V31, P1277, DOI 10.1097/PAS.0b013e318031f012; Panagopoulos I, 2008, CANCER GENET CYTOGEN, V185, P74, DOI 10.1016/J.cancergencyto.2008.04.020; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Schaffer LG, 2009, ISCN 2009 INT SYSTEM; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; World Health Organization, 2003, TUMOURS BREAST FEMAL	32	66	72	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39354	10.1371/journal.pone.0039354	http://dx.doi.org/10.1371/journal.pone.0039354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761769	Green Submitted, Green Published, gold			2022-12-27	WOS:000305730900049
J	Cramer, EP; Glenthoj, A; Hager, M; Juncker-Jensen, A; Engelholm, LH; Santoni-Rugiu, E; Lund, LR; Laerum, OD; Cowland, JB; Borregaard, N				Cramer, Elisabeth P.; Glenthoj, Andreas; Hager, Mattias; Juncker-Jensen, Anna; Engelholm, Lars H.; Santoni-Rugiu, Eric; Lund, Leif R.; Laerum, Ole D.; Cowland, Jack B.; Borregaard, Niels			No Effect of NGAL/lipocalin-2 on Aggressiveness of Cancer in the MMTV-PyMT/FVB/N Mouse Model for Breast Cancer	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ACUTE RENAL INJURY; NEUTROPHIL-GELATINASE; CATHEPSIN-B; SUBCELLULAR-LOCALIZATION; EPITHELIAL-CELLS; LUNG METASTASIS; NGAL; IDENTIFICATION; EXPRESSION	NGAL/lipocalin-2 is a siderophore-binding protein that is highly expressed in several cancers. It is suggested to confer a proliferative advantage to cancer cells. Its expression has been correlated with aggressiveness of breast cancer as determined both in patients and in mouse breast cancer models. This was recently confirmed in two mouse models of spontaneous breast cancer in wild-type and lipocalin-2-deficient mice. We used a similar strategy using a different mouse strain. Lipocalin-2-deficient mice and mouse mammary tumor virus-polyoma middle T antigen (MMTV-PyMT) mice were crossed into the same FVB/N background. All mice developed tumors by week 8. The mice were sacrificed on week 13 and tissue was processed for biochemical and histological analysis. The total tumor volume and number of metastases were quantitated in 26 lipocalin-2-deficient mice and 34 wild-type controls. Lipocalin-2 expression in tumors of MMTV-PyMT-positive and wild-type mice was assessed by quantitative real-time PCR and by immunohistochemistry. The expression of the lipocalin-2 receptors 24p3R and megalin and of Mmp-9, transferrin receptor, and Bdh2 (a producer of a mammalian siderophore) were quantitated by real-time PCR. No significant difference was observed between wild-type and lipocalin-2-deficient mice. Lipocalin-2 was highly expressed in tumors from wild-type mice, but the expression did not correlate with tumor size. No effect of lipocalin-2 was observed with respect to time to tumor appearance, total tumor volume, or to the number of metastases. Histology and gelatinolytic activity of the mammary tumors did not differ between wild-type and lipocalin-2-deficient mice. We conclude that NGAL/lipocalin-2 does not invariably affect the aggressiveness of breast cancers as assessed in mouse models, thus questioning the role of lipocalin-2 in cancer development.	[Cramer, Elisabeth P.; Glenthoj, Andreas; Hager, Mattias; Cowland, Jack B.; Borregaard, Niels] Copenhagen Univ Hosp, Dept Hematol, Granulocyte Res Lab, Copenhagen, Denmark; [Juncker-Jensen, Anna; Engelholm, Lars H.; Laerum, Ole D.] Univ Copenhagen, Rigshosp, Natl Univ Hosp, Finsen Lab, DK-1168 Copenhagen, Denmark; [Santoni-Rugiu, Eric] Univ Copenhagen, Rigshosp, Natl Univ Hosp, Dept Pathol, DK-1168 Copenhagen, Denmark; [Lund, Leif R.] Univ Copenhagen, Dept Cellular & Mol Med, DK-1168 Copenhagen, Denmark; [Laerum, Ole D.] Univ Bergen, Gade Inst, Sect Pathol, N-5020 Bergen, Norway	University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Bergen	Cramer, EP (corresponding author), Copenhagen Univ Hosp, Dept Hematol, Granulocyte Res Lab, Copenhagen, Denmark.	jcowland@rh.dk; borregaard@rh.dk	Santoni-Rugiu, Eric/AAH-3368-2020; Glenthøj, Andreas/ABD-5948-2021; Santoni-Rugiu, Eric/H-4913-2019	Santoni-Rugiu, Eric/0000-0002-2283-3535; Glenthøj, Andreas/0000-0003-2082-0738; Cowland, Jack Bernard/0000-0002-7429-5388; Engelholm, Lars/0000-0002-6616-1232	Lundbeck Foundation [139/05]; Danish Cancer Research Foundation [13-07]; Novo Nordisk Foundation [4292-80]; Danish Medical Research Council [22-04-0399, 09-061617]	Lundbeck Foundation(Lundbeckfonden); Danish Cancer Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Lundbeck Foundation (http://www.lundbeckfonden.dk, 139/05), the Danish Cancer Research Foundation (http://www.dansk-kraeftforsknings-fond.dk, 13-07), The Novo Nordisk Foundation (http://www.novonordiskfonden.dk, 4292-80), and the Danish Medical Research Council (http://www.fi.dk/raad-og-udvalg/det-frie-forskningsraad, 22-04-0399 and 09-061617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almholt K, 2005, INT J CANCER, V113, P525, DOI 10.1002/ijc.20631; Almholt K, 2008, MOL CANCER THER, V7, P2758, DOI 10.1158/1535-7163.MCT-08-0251; Almholt K, 2007, J MAMMARY GLAND BIOL, V12, P83, DOI 10.1007/s10911-007-9040-x; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Bauer M, 2008, BREAST CANCER RES TR, V108, P389, DOI 10.1007/s10549-007-9619-3; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Berger T, 2010, P NATL ACAD SCI USA, V107, P2995, DOI 10.1073/pnas.1000101107; Beynon RJ, 2003, BIOCHEM SOC T, V31, P142, DOI 10.1042/bst0310142; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; Cancedda FD, 1996, J BIOL CHEM, V271, P20163, DOI 10.1074/jbc.271.33.20163; Chan YR, 2009, J IMMUNOL, V182, P4947, DOI 10.4049/jimmunol.0803282; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; Davie SA, 2007, TRANSGENIC RES, V16, P193, DOI 10.1007/s11248-006-9056-9; Devarajan P, 2010, NEPHROLOGY, V15, P419, DOI 10.1111/j.1440-1797.2010.01317.x; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; FLOWER DR, 1991, BIOCHEM BIOPH RES CO, V180, P69, DOI 10.1016/S0006-291X(05)81256-2; Friedl A, 1999, HISTOCHEM J, V31, P433, DOI 10.1023/A:1003708808934; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Goetz DH, 2000, BIOCHEMISTRY-US, V39, P1935, DOI 10.1021/bi992215v; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Johnson EE, 2010, FEMS IMMUNOL MED MIC, V58, P138, DOI 10.1111/j.1574-695X.2009.00622.x; Juncker-Jensen A, 2009, MOL CARCINOGEN, V48, P618, DOI 10.1002/mc.20503; Karlsen JR, 2010, J BIOL CHEM, V285, P14088, DOI 10.1074/jbc.M109.017129; KJELDSEN L, 1992, BIOCHEM J, V287, P603, DOI 10.1042/bj2870603; Kjeldsen L, 1996, J IMMUNOL METHODS, V198, P155, DOI 10.1016/S0022-1759(96)00153-6; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; KJELDSEN L, 1994, BLOOD, V83, P799; Klausen P, 2005, EUR J HAEMATOL, V75, P332, DOI 10.1111/j.1600-0609.2005.00511.x; Kubben FJGM, 2007, EUR J CANCER, V43, P1869, DOI 10.1016/j.ejca.2007.05.013; Leng XH, 2009, CANCER RES, V69, P8579, DOI 10.1158/0008-5472.CAN-09-1934; Lifsted T, 1998, INT J CANCER, V77, P640, DOI 10.1002/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; Mallbris L, 2002, EXP DERMATOL, V11, P584, DOI 10.1034/j.1600-0625.2002.110611.x; Martin MD, 2008, CANCER RES, V68, P6251, DOI 10.1158/0008-5472.CAN-08-0537; Mazzoni A, 2007, J DENT RES, V86, P436, DOI 10.1177/154405910708600509; Mishra J, 2004, J AM SOC NEPHROL, V15, P3073, DOI 10.1097/01.ASN.0000145013.44578.45; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Nielsen BS, 2001, AM J PATHOL, V158, P1997, DOI 10.1016/S0002-9440(10)64671-8; Saiga H, 2008, J IMMUNOL, V181, P8521, DOI 10.4049/jimmunol.181.12.8521; Sevenich L, 2011, ONCOGENE, V30, P54, DOI 10.1038/onc.2010.387; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Stoesz SP, 1998, INT J CANCER, V79, P565, DOI 10.1002/(SICI)1097-0215(19981218)79:6<565::AID-IJC3>3.3.CO;2-6; Stoesz SP, 1995, ONCOGENE, V11, P2233; Tschesche H, 2001, EUR J BIOCHEM, V268, P1918, DOI 10.1046/j.1432-1327.2001.02066.x; Vasiljeva O, 2008, ONCOGENE, V27, P4191, DOI 10.1038/onc.2008.59; Wu H, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-96; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106	57	22	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39646	10.1371/journal.pone.0039646	http://dx.doi.org/10.1371/journal.pone.0039646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737251	gold, Green Published, Green Submitted			2022-12-27	WOS:000305695100050
J	Ibrahim, GM; Akiyama, T; Ochi, A; Otsubo, H; Smith, ML; Taylor, MJ; Donner, E; Rutka, JT; Snead, OC; Doesburg, SM				Ibrahim, George M.; Akiyama, Tomoyuki; Ochi, Ayako; Otsubo, Hiroshi; Smith, Mary Lou; Taylor, Margot J.; Donner, Elizabeth; Rutka, James T.; Snead, O. Carter, III; Doesburg, Sam M.			Disruption of Rolandic Gamma-Band Functional Connectivity by Seizures is Associated with Motor Impairments in Children with Epilepsy	PLOS ONE			English	Article							HIGH-FREQUENCY OSCILLATIONS; TEMPORAL-LOBE EPILEPSY; EPILEPTOGENIC NETWORKS; MEMORY FORMATION; EEG ACTIVITY; BRAIN; SYNCHRONIZATION; COHERENCE; RESPONSES; RESECTION	Although children with epilepsy exhibit numerous neurological and cognitive deficits, the mechanisms underlying these impairments remain unclear. Synchronization of oscillatory neural activity in the gamma frequency range (>30 Hz) is purported to be a mechanism mediating functional integration within neuronal networks supporting cognition, perception and action. Here, we tested the hypothesis that seizure-induced alterations in gamma synchronization are associated with functional deficits. By calculating synchrony among electrodes and performing graph theoretical analysis, we assessed functional connectivity and local network structure of the hand motor area of children with focal epilepsy from intracranial electroencephalographic recordings. A local decrease in inter-electrode phase synchrony in the gamma bands during ictal periods, relative to interictal periods, within the motor cortex was strongly associated with clinical motor weakness. Gamma-band ictal desychronization was a stronger predictor of deficits than the presence of the seizure-onset zone or lesion within the motor cortex. There was a positive correlation between the magnitude of ictal desychronization and impairment of motor dexterity in the contralateral, but not ipsilateral hand. There was no association between ictal desynchronization within the hand motor area and non-motor deficits. This study uniquely demonstrates that seizure-induced disturbances in cortical functional connectivity are associated with network-specific neurological deficits.	[Ibrahim, George M.; Rutka, James T.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Akiyama, Tomoyuki; Ochi, Ayako; Otsubo, Hiroshi; Smith, Mary Lou; Donner, Elizabeth; Snead, O. Carter, III] Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada; [Ibrahim, George M.; Taylor, Margot J.; Snead, O. Carter, III] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Taylor, Margot J.; Doesburg, Sam M.] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Taylor, Margot J.; Snead, O. Carter, III; Doesburg, Sam M.] Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; [Smith, Mary Lou] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Taylor, Margot J.; Doesburg, Sam M.] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ibrahim, GM (corresponding author), Hosp Sick Children, Div Neurosurg, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sam.doesburg@sickkids.ca	Donner, Elizabeth/AAW-4773-2021		Hospital for Sick Children, Foundation Student Scholarship Program; Hospital for Sick Children Centre for Brain and Behavior; Ontario Brain Institute; Wiley Family and Jack Beqaj Funds for epilepsy surgery research; University of Toronto; Royal College of Physicians and Surgeons of Canada	Hospital for Sick Children, Foundation Student Scholarship Program; Hospital for Sick Children Centre for Brain and Behavior; Ontario Brain Institute; Wiley Family and Jack Beqaj Funds for epilepsy surgery research; University of Toronto(University of Toronto); Royal College of Physicians and Surgeons of Canada	This work was supported by the Hospital for Sick Children, Foundation Student Scholarship Program, the Hospital for Sick Children Centre for Brain and Behavior, the Ontario Brain Institute, the Wiley Family and Jack Beqaj Funds for epilepsy surgery research, the University of Toronto Surgeon-Scientist Program, and the Royal College of Physicians and Surgeons of Canada Clinician-Investigator Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2011, EPILEPSIA, V52, P1802, DOI 10.1111/j.1528-1167.2011.03199.x; Bartolomei F, 2005, CLIN NEUROPHYSIOL, V116, P2473, DOI 10.1016/j.clinph.2005.05.013; Benasich AA, 2008, BEHAV BRAIN RES, V195, P215, DOI 10.1016/j.bbr.2008.08.049; Benifla M, 2009, J NEUROSURG-PEDIATR, V4, P199, DOI 10.3171/2009.3.PEDS08459; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Burgess AP, 2002, INT J PSYCHOPHYSIOL, V46, P91, DOI 10.1016/S0167-8760(02)00108-3; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fell J, 2006, NEUROSCI LETT, V407, P37, DOI 10.1016/j.neulet.2006.07.074; Fisher RA, 1935, DESIGN EXPT; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Helmstaedter C, 2009, BRAIN, V132, P2822, DOI 10.1093/brain/awp182; Holmes GL, 1998, NEURON, V21, P1231, DOI 10.1016/S0896-6273(00)80642-X; Horstmann MT, 2010, CLIN NEUROPHYSIOL, V121, P172, DOI 10.1016/j.clinph.2009.10.013; Jonas R, 2004, NEUROLOGY, V62, P1712, DOI 10.1212/01.WNL.0000127109.14569.C3; Kemp B, 2003, CLIN NEUROPHYSIOL, V114, P1755, DOI 10.1016/S1388-2457(03)00123-8; Kulandaivel K, 2011, EPILEPSY BEHAV, V20, P700, DOI 10.1016/j.yebeh.2011.02.021; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; Masquelier T, 2009, J NEUROSCI, V29, P13484, DOI 10.1523/JNEUROSCI.2207-09.2009; Matthew C.G., 1964, GROOVED PEGBOARD INS; Mazaheri A, 2010, BIOL PSYCHIAT, V67, P617, DOI 10.1016/j.biopsych.2009.11.022; Meador KJ, 2002, NEUROLOGY, V58, pS21, DOI 10.1212/WNL.58.8_suppl_5.S21; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; Nariai H, 2011, EPILEPSIA, V52, P63, DOI 10.1111/j.1528-1167.2010.02786.x; Newman M.E.J., 2010, NETWORKS INTRO; Ochi A, 2007, EPILEPSIA, V48, P286, DOI 10.1111/j.1528-1167.2007.00923.x; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Ortega GJ, 2008, EPILEPSIA, V49, P269, DOI 10.1111/j.1528-1167.2007.01266.x; Reitan RM., 1969, MANUAL ADM NEUROPSYC; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rose M, 2006, CEREB CORTEX, V16, P1522, DOI 10.1093/cercor/bhj089; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Schindler K, 2007, BRAIN, V130, P65, DOI 10.1093/brain/awl304; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Supp GG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000684; Uhlhaas PJ, 2009, P NATL ACAD SCI USA, V106, P9866, DOI 10.1073/pnas.0900390106; van Wingerden M, 2010, J NEUROSCI, V30, P10025, DOI 10.1523/JNEUROSCI.0222-10.2010; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang Y, 2011, J NEUROSCI, V31, P13204, DOI 10.1523/JNEUROSCI.6227-10.2011; Warren CP, 2010, J NEUROPHYSIOL, V104, P3530, DOI 10.1152/jn.00368.2010; Wendling F, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00154; Weschler D, 2003, WISC 4 ADM MANUAL MA; Wilke C, 2011, EPILEPSIA, V52, P84, DOI 10.1111/j.1528-1167.2010.02785.x; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047; Zhang ZQ, 2009, J NEUROL, V256, P1705, DOI 10.1007/s00415-009-5187-2; Zhang ZQ, 2009, NEUROSCI LETT, V458, P97, DOI 10.1016/j.neulet.2009.04.040	51	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39326	10.1371/journal.pone.0039326	http://dx.doi.org/10.1371/journal.pone.0039326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737233	Green Submitted, Green Published, gold			2022-12-27	WOS:000305695100031
J	Nassiri, I; Masoudi-Nejad, A; Jalili, M; Moeini, A				Nassiri, Isar; Masoudi-Nejad, Ali; Jalili, Mahdi; Moeini, Ali			Nonparametric Simulation of Signal Transduction Networks with Semi-Synchronized Update	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; MODEL; CONSEQUENCES; PATHWAYS; TOPOLOGY; DYNAMICS	Simulating signal transduction in cellular signaling networks provides predictions of network dynamics by quantifying the changes in concentration and activity-level of the individual proteins. Since numerical values of kinetic parameters might be difficult to obtain, it is imperative to develop non-parametric approaches that combine the connectivity of a network with the response of individual proteins to signals which travel through the network. The activity levels of signaling proteins computed through existing non-parametric modeling tools do not show significant correlations with the observed values in experimental results. In this work we developed a non-parametric computational framework to describe the profile of the evolving process and the time course of the proportion of active form of molecules in the signal transduction networks. The model is also capable of incorporating perturbations. The model was validated on four signaling networks showing that it can effectively uncover the activity levels and trends of response during signal transduction process.	[Nassiri, Isar; Masoudi-Nejad, Ali] Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran; [Jalili, Mahdi] Sharif Univ Technol, Dept Comp Engn, Tehran, Iran; [Moeini, Ali] Univ Tehran, Coll Engn, Dept Algorithms & Computat, Tehran, Iran	University of Tehran; Sharif University of Technology; University of Tehran	Nassiri, I (corresponding author), Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran.	amasoudin@ibb.ut.ac.ir	Masoudi-Nejad, Ali/E-7922-2010; Masoudi-Nejad, Ali/ABH-2078-2021	Masoudi-Nejad, Ali/0000-0003-0659-5183; Jalili, Mahdi/0000-0002-0517-9420				Abhishek Garg KM, 2008, BIOINFORMATICS, V25, P101; Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Albert R, 2009, METHOD ENZYMOL, V467, P281, DOI 10.1016/S0076-6879(09)67011-7; Aldridge BB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000340; Alexopoulos LG, 2010, MOL CELL PROTEOMICS, V9, P1849, DOI 10.1074/mcp.M110.000406; Apgar JF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040030; Assmann SM, 2009, METHODS MOL BIOL, V553, P207, DOI 10.1007/978-1-60327-563-7_10; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Breitling R, 2005, FEBS LETT, V579, P6289, DOI 10.1016/j.febslet.2005.10.034; Brun C, 2004, GENOME BIOL, V5; Cevikbas F, 2012, J INVEST DERMATOL, V132, P1326, DOI 10.1038/jid.2012.66; Chaouiya C, 2007, BRIEF BIOINFORM, V8, P210, DOI 10.1093/bib/bbm029; Chen L, 2009, BIOMOLECULAR NETWORK; Chen LN, 2002, IEEE T CIRCUITS-I, V49, P602, DOI 10.1109/TCSI.2002.1001949; Cope AP, 2004, ARTHRITIS RES THER, V6, P112, DOI 10.1186/ar1185; Cosgrove BD, 2009, TOXICOL APPL PHARM, V237, P317, DOI 10.1016/j.taap.2009.04.002; Costa LD, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-16; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Doherty DG, 1999, J IMMUNOL, V163, P2314; Fu C, 2009, MOL BIOSYST, V5, P1809, DOI [10.1039/b905382d, 10.1039/B905382D]; Garg A, 2008, BIOINFORMATICS, V24, P1917, DOI 10.1093/bioinformatics/btn336; Gaudet S, 2005, MOL CELL PROTEOMICS, V4, P1569, DOI 10.1074/mcp.M500158-MCP200; Jack J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-109; Janes KA, 2003, MOL CELL PROTEOMICS, V2, P463, DOI 10.1074/mcp.M300045-MCP200; Jenkins DJ, 2010, J MOL EVOL, V70, P215, DOI 10.1007/s00239-010-9323-5; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Kaiser M, 2004, BIOL CYBERN, V90, P311, DOI 10.1007/s00422-004-0479-1; Kampen V, 1992, STOCHASTIC PROCESSES, V1; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Klann MT, 2009, BIOPHYS J, V96, P5122, DOI 10.1016/j.bpj.2009.03.049; Krall JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015945; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Leydesdorff L, 2006, J AM SOC INF SCI TEC, V57, P1616, DOI 10.1002/asi.20335; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Li A, 2007, BIOINFORMATICS, V23, P222, DOI 10.1093/bioinformatics/btl581; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Melas IN, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-107; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Muller M, 2008, FASEB J, V22, P1393, DOI 10.1096/fj.07-9100com; Nees J, 2009, SCIENTOMETRICS, V5, P14; Nisbach F, 2007, EUR PHYS J B, V58, P185, DOI 10.1140/epjb/e2007-00214-4; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pavlopoulos GA, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-10; Pritchard JR, 2009, MOL CANCER THER, V8, P2183, DOI 10.1158/1535-7163.MCT-08-1203; Ruths D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000005; Saadatpour A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002267; Saez-Rodriguez J, 2008, BIOINFORMATICS, V24, P840, DOI 10.1093/bioinformatics/btn018; Saez-Rodriguez J, 2011, CANCER RES, V71, P5400, DOI 10.1158/0008-5472.CAN-10-4453; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Samanta MP, 2003, P NATL ACAD SCI USA, V100, P12579, DOI 10.1073/pnas.2132527100; Schnapp BJ, 2003, J CELL SCI, V116, P2125, DOI 10.1242/jcs.00488; Tyers M, 2003, NATURE, V422, P193, DOI 10.1038/nature01510; Valitutti S, 1997, IMMUNOL TODAY, V18, P299, DOI 10.1016/S0167-5699(97)01075-X; Van Den Berg HA, 2001, J THEOR BIOL, V209, P465, DOI 10.1006/jtbi.2001.2281; van Riel NAW, 2006, BRIEF BIOINFORM, V7, P364, DOI 10.1093/bib/bbl040; vSun J, 2007, J CHEM PHYS, V127; Wallner B, 2005, PROTEIN SCI, V14, P1315, DOI 10.1110/ps.041253405; Wang RS, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-44; Wedagedara J, 2011, J NATL SCI FOUND SRI, V39, P03; White FM, 2008, CURR OPIN BIOTECH, V19, P404, DOI 10.1016/j.copbio.2008.06.006; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhang RR, 2008, P NATL ACAD SCI USA, V105, P16308, DOI 10.1073/pnas.0806447105; Zielinski R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-88	65	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39643	10.1371/journal.pone.0039643	http://dx.doi.org/10.1371/journal.pone.0039643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737250	Green Published, Green Submitted, gold			2022-12-27	WOS:000305695100049
J	Villalobos-Comparan, M; Villamil-Ramirez, H; Villarreal-Molina, T; Larrieta-Carrasco, E; Leon-Mimila, P; Romero-Hidalgo, S; Jacobo-Albavera, L; Liceaga-Fuentes, AE; Campos-Perez, FJ; Lopez-Contreras, BE; Tusie-Luna, T; del Rio-Navarro, BE; Aguilar-Salinas, CA; Canizales-Quinteros, S				Villalobos-Comparan, Marisela; Villamil-Ramirez, Hugo; Villarreal-Molina, Teresa; Larrieta-Carrasco, Elena; Leon-Mimila, Paola; Romero-Hidalgo, Sandra; Jacobo-Albavera, Leonor; Liceaga-Fuentes, Adriana E.; Campos-Perez, Francisco J.; Lopez-Contreras, Blanca E.; Tusie-Luna, Teresa; del Rio-Navarro, Blanca E.; Aguilar-Salinas, Carlos A.; Canizales-Quinteros, Samuel			PCSK1 rs6232 Is Associated with Childhood and Adult Class III Obesity in the Mexican Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; VARIANTS; MUTATIONS; RISK; GENE	Background: Common variants rs6232 and rs6235 in the PCSK1 gene have been associated with obesity in European populations. We aimed to evaluate the contribution of these variants to obesity and related traits in Mexican children and adults. Methodology/Principal Findings: Rs6232 and rs6235 were genotyped in 2382 individuals, 1206 children and 1176 adults. Minor allele frequencies were 0.78% for rs6232 and 19.99% for rs6235. Rs6232 was significantly associated with childhood obesity and adult class III obesity (OR = 3.01 95% CI 1.64-5.53; P = 4 x 10(-4) in the combined analysis). In addition, this SNP was significantly associated with lower fasting glucose levels (P = 0.01) and with increased insulin levels and HOMA-B (P = 0.05 and 0.01, respectively) only in non-obese children. In contrast, rs6235 showed no significant association with obesity or with glucose homeostasis parameters in any group. Conclusion/Significance: Although rs6232 is rare in the Mexican population, it should be considered as an important risk factor for extreme forms of obesity.	[Villalobos-Comparan, Marisela; Villamil-Ramirez, Hugo; Leon-Mimila, Paola; Jacobo-Albavera, Leonor; Canizales-Quinteros, Samuel] Univ Nacl Autonoma Mexico, Fac Quim, Dept Biol, Mexico City 04510, DF, Mexico; [Villalobos-Comparan, Marisela; Villamil-Ramirez, Hugo; Larrieta-Carrasco, Elena; Leon-Mimila, Paola; Jacobo-Albavera, Leonor; Lopez-Contreras, Blanca E.; Tusie-Luna, Teresa; Canizales-Quinteros, Samuel] INCMNSZ, Unidad Biol Mol & Med Genom, Mexico City, DF, Mexico; [Villarreal-Molina, Teresa; Romero-Hidalgo, Sandra; Lopez-Contreras, Blanca E.] Inst Nacl Med Genom INMEGEN, Mexico City, DF, Mexico; [Liceaga-Fuentes, Adriana E.; Campos-Perez, Francisco J.] Hosp Ruben Lenero, Clin Obesidad, Mexico City, DF, Mexico; [Tusie-Luna, Teresa] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [del Rio-Navarro, Blanca E.] Hosp Infantil Mexico Dr Federico Gomez, Dept Alergia & Inmunol Clin, Mexico City, DF, Mexico; [Aguilar-Salinas, Carlos A.] INCMNSZ, Dept Endocrinol & Metab, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico; Hospital Infantil de Mexico Federico Gomez	Villalobos-Comparan, M (corresponding author), Univ Nacl Autonoma Mexico, Fac Quim, Dept Biol, Mexico City 04510, DF, Mexico.	cani@servidor.unam.mx	Salinas, Carlos A Aguilar/AAL-4491-2020; Leon-Mimila, Paola/U-2375-2019	Romero-Hidalgo, Sandra/0000-0003-3077-7825; Jacobo-Albavera, Leonor/0000-0001-5129-8108; VILLARREAL MOLINA, TERESA/0000-0003-4450-7690; Leon, Paola/0000-0001-6334-1492	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [113861, 210322, 244112, 234714, 195399]; Ciencias Biomedicas at Universidad Nacional Autonoma de Mexico (UNAM)	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ciencias Biomedicas at Universidad Nacional Autonoma de Mexico (UNAM)	This research was supported by grant 113861 from the Consejo Nacional de Ciencia y Tecnologia (CONACyT, http://www.conacyt.mx/Paginas/default.aspx). MVC is in the PhD program from Ciencias Biomedicas at Universidad Nacional Autonoma de Mexico (UNAM). MVC, HVR, PLM and LJA are recipients of the CONACyT scholarship number 210322, 244112, 234714 and 195399, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Canizales-Quinteros S, 2007, HUM BIOL, V79, P111, DOI 10.1353/hub.2007.0022; Chang YC, 2010, OBESITY, V18, P1404, DOI 10.1038/oby.2009.390; Creemers JWM, 2012, DIABETES, V61, P383, DOI 10.2337/db11-0305; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gjesing AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023907; Heni M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-86; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Kilpelainen TO, 2009, HUM MOL GENET, V18, P3496, DOI 10.1093/hmg/ddp280; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Qi QB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010590; Ramachandrappa S, 2011, J CLIN INVEST, V121, P2080, DOI 10.1172/JCI46044; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Sandholt CH, 2010, DIABETES, V59, P1667, DOI 10.2337/db09-1042; Secretaria de Salud Instituto Nacional de Salud Publica, 2006, ENC NAC SAL NUTR ENS; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Villalobos-Comparan M, 2008, OBESITY, V16, P2296, DOI 10.1038/oby.2008.367; Villarreal-Molina MT, 2007, DIABETES, V56, P1881, DOI 10.2337/db06-0905; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087	27	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39037	10.1371/journal.pone.0039037	http://dx.doi.org/10.1371/journal.pone.0039037			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737226	Green Published, Green Submitted, gold			2022-12-27	WOS:000305695100025
J	Kessler, DA; Maruvka, YE; Ouren, J; Shnerb, NM				Kessler, David A.; Maruvka, Yosi E.; Ouren, Joergen; Shnerb, Nadav M.			You Name It - How Memory and Delay Govern First Name Dynamics	PLOS ONE			English	Article							DRIFT	The adoption and abandonment of first names through time is a fascinating phenomenon that may shed light on social dynamics and the forces that determine cultural taste in general. Here we show that baby name dynamics is governed almost solely by deterministic forces, even though the emerging abundance statistics resembles the one obtained from a pure drift model. Exogenous events are shown to affect the name dynamics very rarely, and most of the year-to-year fluctuations around the deterministic trend may be attributed solely to demographic noise. We suggest that the rise and fall of a name reflect an "infection" process with delay and memory. The symmetry between adoption and abandonment speed emerges from our model without further assumptions.	[Kessler, David A.; Shnerb, Nadav M.] Bar Ilan Univ, Dept Phys, Ramat Gan, Israel; [Maruvka, Yosi E.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Maruvka, Yosi E.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Ouren, Joergen] Stat Norway, Res Dept, Oslo, Norway	Bar Ilan University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Statistics Norway	Kessler, DA (corresponding author), Bar Ilan Univ, Dept Phys, Ramat Gan, Israel.	nadav.shnerb@gmail.com	Kessler, David/B-1391-2008	Kessler, David/0000-0002-5279-1655; Maruvka, Yosef/0000-0002-8918-9887	Israeli Science Foundation BIKURA [1026/11]	Israeli Science Foundation BIKURA	The work was supported by Israeli Science Foundation BIKURA grant no. 1026/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley RA, 2004, P ROY SOC B-BIOL SCI, V271, P1443, DOI 10.1098/rspb.2004.2746; Berger J, 2009, P NATL ACAD SCI USA, V106, P8146, DOI 10.1073/pnas.0812647106; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Connell JH, 1970, GRADWELL PJDBAGR; Galbi Douglas A., 2002, LONG TERM TRENDS PER; Hahn MW, 2003, P ROY SOC B-BIOL SCI, V270, pS120, DOI 10.1098/rsbl.2003.0045; Hubbell S.P., 2001, MG POP BIOL, V32; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Kimura M, 1982, MOL EVOLUTION PROTEI, pxiv; Lieberson S, 2000, MATTER TASTE NAMES F, pxvi; Manrubia SC, 2002, J THEOR BIOL, V216, P461, DOI 10.1006/jtbi.2002.3002; Maruvka YE, 2010, J THEOR BIOL, V262, P245, DOI 10.1016/j.jtbi.2009.09.022; Mommsen T, 1905, HIST ROME; Murray, 2002, MATH BIOL I INTRO IN; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883	16	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38790	10.1371/journal.pone.0038790	http://dx.doi.org/10.1371/journal.pone.0038790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745679	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200023
J	Lee, J; Lim, S; Kang, SM; Min, S; Son, K; Lee, HS; Park, EM; Ngo, HTT; Tran, HTL; Lim, YS; Hwang, SB				Lee, Jihye; Lim, Seri; Kang, Sang-Min; Min, Saehong; Son, Kidong; Lee, Han Sol; Park, Eun Mee; Ngo, Huong T. T.; Tran, Huong T. L.; Lim, Yun-Sook; Hwang, Soon B.			Saponin Inhibits Hepatitis C Virus Propagation by Up-regulating Suppressor of Cytokine Signaling 2	PLOS ONE			English	Article							TRITERPENOID SAPONINS; BIOLOGICAL-ACTIVITIES; INFECTION; SOCS3; GLYCYRRHIZIN; REPLICATION; EXPRESSION; PROTEASE; THERAPY; HCV	Saponins are a group of naturally occurring plant glycosides which possess a wide range of pharmacological properties, including anti-tumorigenic and antiviral activities. To investigate whether saponin has anti-hepatitis C virus (HCV) activity, we examined the effect of saponin on HCV replication. HCV replication was efficiently inhibited at a concentration of 10 mu g/ml of saponin in cell culture grown HCV (HCVcc)-infected cells. Inhibitory effect of saponin on HCV replication was verified by quantitative real-time PCR, reporter assay, and immunoblot analysis. In addition, saponin potentiated IFN-alpha-induced anti-HCV activity. Moreover, saponin exerted antiviral activity even in IFN-alpha resistant mutant HCVcc-infected cells. To investigate how cellular genes were regulated by saponin, we performed microarray analysis using HCVcc-infected cells. We demonstrated that suppressor of cytokine signaling 2 (SOCS2) protein level was distinctively increased by saponin, which in turn resulted in inhibition of HCV replication. We further showed that silencing of SOCS2 resurrected HCV replication and overexpression of SOCS2 suppressed HCV replication. These data imply that saponin inhibits HCV replication via SOCS2 signaling pathway. These findings suggest that saponin may be a potent therapeutic agent for HCV patients.	[Lee, Jihye; Lim, Seri; Kang, Sang-Min; Min, Saehong; Son, Kidong; Lee, Han Sol; Park, Eun Mee; Ngo, Huong T. T.; Tran, Huong T. L.; Lim, Yun-Sook; Hwang, Soon B.] Hallym Univ, Ilsong Inst Life Sci, Natl Res Lab Hepatitis Virus C, Anyang, South Korea	Hallym University	Lee, J (corresponding author), Hallym Univ, Ilsong Inst Life Sci, Natl Res Lab Hepatitis Virus C, Anyang, South Korea.	sbhwang@hallym.ac.kr			National R&D Program for Cancer Control, Ministry for Health and Welfare, Korea [1020290]; National Research Laboratory Grant program [ROA-2007-0056700]; Ministry of Education, Science and Technology, Korea [2008-2004100]	National R&D Program for Cancer Control, Ministry for Health and Welfare, Korea; National Research Laboratory Grant program; Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National R&D Program for Cancer Control, Ministry for Health and Welfare, Korea (1020290), and by the National Research Laboratory Grant program (ROA-2007-0056700) and Biotechnology Development (2008-2004100) from the Ministry of Education, Science and Technology, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arase Y, 1997, CANCER, V79, P1494, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B; Choi SH, 2006, J BIOL CHEM, V281, P7468, DOI 10.1074/jbc.M512438200; Dehmlow C, 1996, HEPATOLOGY, V23, P749, DOI 10.1002/hep.510230415; El-Fakharany EM, 2010, PROTEIN PEPTIDE LETT, V17, P1031; Giannini C, 2003, CELL DEATH DIFFER, V10, pS27, DOI 10.1038/sj.cdd.4401121; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hussein G, 2000, PHYTOTHER RES, V14, P510, DOI 10.1002/1099-1573(200011)14:7&lt;510::AID-PTR646&gt;3.0.CO;2-B; Ikeda T, 2005, BIOL PHARM BULL, V28, P1779, DOI 10.1248/bpb.28.1779; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kelantari H, 2011, J RES MED SCI, V16, P287; Kim KA, 2009, J HEPATOL, V50, P705, DOI 10.1016/j.jhep.2008.12.021; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; Lim YS, 2011, J VIROL, V85, P8777, DOI 10.1128/JVI.02533-10; Lim YS, 2011, J BIOL CHEM, V286, P11290, DOI 10.1074/jbc.M110.194472; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Mengoni F, 2002, PLANTA MED, V68, P111, DOI 10.1055/s-2002-20256; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Ott M, 1997, EUR J CLIN INVEST, V27, P908, DOI 10.1046/j.1365-2362.1997.2020749.x; Patrick L, 1999, Altern Med Rev, V4, P220; Riguera R, 1997, J MAR BIOTECHNOL, V5, P187; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sindambiwe JB, 1998, J NAT PROD, V61, P585, DOI 10.1021/np9705165; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; TAKAHARA T, 1994, J HEPATOL, V21, P601, DOI 10.1016/S0168-8278(94)80108-8; Takeshita M, 2009, J BIOL CHEM, V284, P21165, DOI 10.1074/jbc.M109.004945; Tannahill GM, 2005, MOL CELL BIOL, V25, P9115, DOI 10.1128/MCB.25.20.9115-9126.2005; Tran HTL, 2011, FEBS LETT, V585, P409, DOI 10.1016/j.febslet.2010.12.028; VENKATESWARAN PS, 1987, P NATL ACAD SCI USA, V84, P274, DOI 10.1073/pnas.84.1.274; Yoshiki Y, 1998, BIOSCI BIOTECH BIOCH, V62, P2291, DOI 10.1271/bbb.62.2291; Zuo GY, 2007, ANTIVIR RES, V76, P86, DOI 10.1016/j.antiviral.2007.06.001	31	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39366	10.1371/journal.pone.0039366	http://dx.doi.org/10.1371/journal.pone.0039366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745742	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200068
J	Ali, JG; Alborn, HT; Campos-Herrera, R; Kaplan, F; Duncan, LW; Rodriguez-Saona, C; Koppenhofer, AM; Stelinski, LL				Ali, Jared G.; Alborn, Hans T.; Campos-Herrera, Raquel; Kaplan, Fatma; Duncan, Larry W.; Rodriguez-Saona, Cesar; Koppenhoefer, Albrecht M.; Stelinski, Lukasz L.			Subterranean, Herbivore-Induced Plant Volatile Increases Biological Control Activity of Multiple Beneficial Nematode Species in Distinct Habitats	PLOS ONE			English	Article							DIAPREPES-ABBREVIATUS COLEOPTERA; ENTOMOPATHOGENIC NEMATODES; FLORIDA CITRUS; SOIL; ROOTS; PCR; CURCULIONIDAE; RESPONSES; DEFENSE; ENEMIES	While the role of herbivore-induced volatiles in plant-herbivore-natural enemy interactions is well documented aboveground, new evidence suggests that belowground volatile emissions can protect plants by attracting entomopathogenic nematodes (EPNs). However, due to methodological limitations, no study has previously detected belowground herbivore-induced volatiles in the field or quantified their impact on attraction of diverse EPN species. Here we show how a belowground herbivore-induced volatile can enhance mortality of agriculturally significant root pests. First, in real time, we identified pregeijerene (1,5-dimethylcyclodeca-1,5,7-triene) from citrus roots 9-12 hours after initiation of larval Diaprepes abbreviatus feeding. This compound was also detected in the root zone of mature citrus trees in the field. Application of collected volatiles from weevil-damaged citrus roots attracted native EPNs and increased mortality of beetle larvae (D. abbreviatus) compared to controls in a citrus orchard. In addition, field applications of isolated pregeijerene caused similar results. Quantitative real-time PCR revealed that pregeijerene increased pest mortality by attracting four species of naturally occurring EPNs in the field. Finally, we tested the generality of this root-zone signal by application of pregeijerene in blueberry fields; mortality of larvae (Galleria mellonella and Anomala orientalis) again increased by attracting naturally occurring populations of an EPN. Thus, this specific belowground signal attracts natural enemies of widespread root pests in distinct agricultural systems and may have broad potential in biological control of root pests.	[Ali, Jared G.; Campos-Herrera, Raquel; Duncan, Larry W.; Stelinski, Lukasz L.] Univ Florida, Ctr Citrus Res & Educ, Dept Entomol & Nematol, Lake Alfred, FL USA; [Alborn, Hans T.; Kaplan, Fatma] ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL USA; [Campos-Herrera, Raquel] Ctr Ciencias Medioambientales, Inst Ciencias Agr, Dept Contaminac Ambiental, Madrid, Spain; [Rodriguez-Saona, Cesar; Koppenhoefer, Albrecht M.] Rutgers State Univ, Dept Entomol, New Brunswick, NJ 08903 USA	State University System of Florida; University of Florida; United States Department of Agriculture (USDA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Ciencias Medioambientales (CCMA); CSIC - Instituto de Ciencias Agrarias (ICA); Rutgers State University New Brunswick	Ali, JG (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	stelinski@ufl.edu	Campos-Herrera, Raquel/A-5299-2017; Kaplan, Fatma/AAJ-7666-2020; Raquel, Campos Herrera/G-5285-2012; Campos-Herrera, Raquel/Z-2427-2019	Campos-Herrera, Raquel/0000-0003-0852-5269; Kaplan, Fatma/0000-0002-9565-0211; Campos-Herrera, Raquel/0000-0003-0852-5269; Ali, Jareg/0000-0002-5794-9554; Ali, Jared/0000-0001-9870-0299	USDA-CSREES; Citrus Research and Development Foundation; University of Florida; European Union [FP7-PEOLE-2009-10F-252980]	USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Citrus Research and Development Foundation; University of Florida(University of Florida); European Union(European Commission)	This research was partially supported by grants from the USDA-CSREES, Citrus Research and Development Foundation and start up funding provided by the University of Florida to LLS. RCH was supported by the Seventh Framework Programme of the European Union (FP7-PEOLE-2009-10F-252980). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JG, 2011, J ECOL, V99, P26, DOI 10.1111/j.1365-2745.2010.01758.x; Ali JG, 2010, J CHEM ECOL, V36, P361, DOI 10.1007/s10886-010-9773-7; BEAVERS JB, 1982, FLA ENTOMOL, V65, P263, DOI 10.2307/3494286; Birkett MA, 2000, P NATL ACAD SCI USA, V97, P9329, DOI 10.1073/pnas.160241697; Boff MIC, 2001, ENTOMOL EXP APPL, V98, P329, DOI 10.1023/A:1018907812376; Bruce TJA, 2010, SIGNAL COMMUN PLANTS, P215, DOI 10.1007/978-3-642-12162-3_12; Bullock RC, 1999, FLA ENTOMOL, V82, P1, DOI 10.2307/3495831; Campos-Herrera R, 2011, ANN APPL BIOL, V158, P55, DOI 10.1111/j.1744-7348.2010.00433.x; Campos-Herrera R, 2011, J INVERTEBR PATHOL, V108, P30, DOI 10.1016/j.jip.2011.06.005; De Deyn GB, 2007, OIKOS, V116, P923, DOI [10.1111/j.2007.0030-1299.15761.x, 10.1111/j.0030-1299.2007.15761.x]; Degenhardt J, 2003, CURR OPIN BIOTECH, V14, P169, DOI 10.1016/S0958-1669(03)00025-9; Degenhardt J, 2009, P NATL ACAD SCI USA, V106, P13213, DOI 10.1073/pnas.0906365106; Denno RF, 2008, J NEMATOL, V40, P61; Duncan LW, 2007, J NEMATOL, V39, P176; El-Borai FE, 2007, J NEMATOL, V39, P203; El-Borai FE, 2011, J INVERTEBR PATHOL, V106, P347, DOI 10.1016/j.jip.2010.12.001; Gaugler R., 2002, ENTOMOPATHOGENIC NEM; Georgis R, 2006, BIOL CONTROL, V38, P103, DOI 10.1016/j.biocontrol.2005.11.005; Graham JH, 2003, PLANT DIS, V87, P85, DOI 10.1094/PDIS.2003.87.1.85; GREEN TR, 1972, SCIENCE, V175, P776, DOI 10.1126/science.175.4023.776; Hallem EA, 2011, CURR BIOL, V21, P377, DOI 10.1016/j.cub.2011.01.048; Hare JD, 2011, ANNU REV ENTOMOL, V56, P161, DOI 10.1146/annurev-ento-120709-144753; HAUKIOJA E, 1975, REP KEVO SUBARCTIC R, V12, P1; Hiltpold I, 2010, CHEMOECOLOGY, V20, P155, DOI 10.1007/s00049-009-0034-6; Holeva R, 2006, MOL CELL PROBE, V20, P203, DOI 10.1016/j.mcp.2005.12.004; Hunter MD, 2002, AGR FOREST ENTOMOL, V4, P81, DOI 10.1046/j.1461-9563.2002.00138.x; Hunter MD, 2001, AGR FOREST ENTOMOL, V3, P153, DOI 10.1046/j.1461-9555.2001.00108.x; James DG, 2005, BIOCONTROL, V50, P871, DOI 10.1007/s10526-005-3313-3; JENKINS W. R., 1964, PLANT DIS REP, V48, P692; Johnson SN, 2008, ROOT FEEDERS; Kant MR, 2009, ADV BOT RES, V51, P613, DOI 10.1016/S0065-2296(09)51014-2; Kaplan I, 2012, BIOL CONTROL, V60, P77, DOI 10.1016/j.biocontrol.2011.10.017; Kaya Harry K., 1997, P281, DOI 10.1016/B978-012432555-5/50016-6; KAYA HK, 1993, ANNU REV ENTOMOL, V38, P181, DOI 10.1146/annurev.en.38.010193.001145; Khan ZR, 1997, NATURE, V388, P631, DOI 10.1038/41681; Kolb S, 2003, APPL ENVIRON MICROB, V69, P2423, DOI 10.1128/AEM.69.5.2423-2429.2003; Koppenhofer AM, 2004, J ECON ENTOMOL, V97, P1842, DOI 10.1603/0022-0493-97.6.1842; KUBECZKA KH, 1980, BIOCHEM SYST ECOL, V8, P39, DOI 10.1016/0305-1978(80)90023-X; Kuzovkina IN, 2009, RUSS J PLANT PHYSL+, V56, P846, DOI 10.1134/S1021443709060156; Lapointe SL, 1999, FLA ENTOMOL, V82, P291, DOI 10.2307/3496582; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; McCoy CW, 2000, BIOL CONTROL, V19, P182, DOI 10.1006/bcon.2000.0852; Ockroy MLB, 2001, AGR FOREST ENTOMOL, V3, P201, DOI 10.1046/j.1461-9555.2001.00107.x; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Rasmann S, 2012, J CHEM ECOL IN PRESS; Rasmann S, 2008, PLANT PHYSIOL, V146, P875, DOI 10.1104/pp.107.112045; SCHROEDER WJ, 1994, J NEMATOL, V26, P360; Simpson SE, 1996, ENVIRON ENTOMOL, V25, P333, DOI 10.1093/ee/25.2.333; Stover E, 2002, HORTTECHNOLOGY, V12, P143, DOI 10.21273/HORTTECH.12.1.143; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7; Thaler JS, 1996, J CHEM ECOL, V22, P1767, DOI 10.1007/BF02028503; Torr P, 2007, J ANIM ECOL, V76, P238, DOI 10.1111/j.1365-2656.2006.01196.x; TUMLINSON JH, 1993, ARCH INSECT BIOCHEM, V22, P385, DOI 10.1002/arch.940220307; Turlings TCJ, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P21, DOI 10.1017/CBO9780511542664.003; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Turlings TCJ, 2006, CURR OPIN PLANT BIOL, V9, P421, DOI 10.1016/j.pbi.2006.05.010; van Dam NM, 2011, J ECOL, V99, P77, DOI 10.1111/j.1365-2745.2010.01761.x; van Dam NM, 2009, ANNU REV ECOL EVOL S, V40, P373, DOI 10.1146/annurev.ecolsys.110308.120314; van Tol RWHM, 2001, ECOL LETT, V4, P292, DOI 10.1046/j.1461-0248.2001.00227.x	59	83	85	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e38146	10.1371/journal.pone.0038146	http://dx.doi.org/10.1371/journal.pone.0038146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761668	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800009
J	Liu, KW; Xie, GC; Chen, LJ; Xiao, XJ; Zheng, YY; Cai, J; Zhai, JW; Zhang, GQ; Liu, ZJ				Liu, Ke-Wei; Xie, Gao-Chang; Chen, Li-Jun; Xiao, Xin-Ju; Zheng, Yu-Yun; Cai, Jing; Zhai, Jun-Wen; Zhang, Guo-Qiang; Liu, Zhong-Jian			Sinocurculigo, a New Genus of Hypoxidaceae from China Based on Molecular and Morphological Evidence	PLOS ONE			English	Article							AMPLIFICATION; PHYLOGENETICS; ORCHIDACEAE; HYPOXIS; REGIONS	Background: The monocot family Hypoxidaceae consists of nine genera with nearly 200 species. They occur mostly in the Southern Hemisphere with only a few species in the Northern Hemisphere, of which three genera, Hypoxis, Molineria, and Curculigo, with eight species are distributed in China. Recently, we have found a hypoxid-like plant in China that is quite different in floral structure from any of the three genera and even of the known taxa in Hypoxidaceae. Methodology/Principal Findings: In addition to morphological analysis, we performed maximum parsimony, maximum likelihood, and Bayesian inference analyses based on fragments of the chloroplast matK and rbcL genes of 60 taxa in 12 families representing all major clades of the Hypoxidaceae alliance. Results showed that Hypoxidaceae is monophyletic and and that the new plant belongs to it, forming a distinct clade within the family Hypoxidaceae as a sister of Molineria. Phylogeny of the Hypoxidaceae family was constructed based on a combined matrix of the chloroplast rbcL, trnS-G, and trnL-F regions of 59 taxa in Hypoxidaceae and its alliance. Findings of the molecular investigation is consistent with those of the morphological analysis. Conclusions/Significance: Based on the results of our molecular and morphological analyses in the present study, we propose a new genus, Sinocurculigo.	[Liu, Ke-Wei; Xie, Gao-Chang; Chen, Li-Jun; Xiao, Xin-Ju; Zheng, Yu-Yun; Cai, Jing; Zhai, Jun-Wen; Zhang, Guo-Qiang; Liu, Zhong-Jian] Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China; [Liu, Ke-Wei; Xie, Gao-Chang; Chen, Li-Jun; Xiao, Xin-Ju; Zheng, Yu-Yun; Cai, Jing; Zhai, Jun-Wen; Zhang, Guo-Qiang; Liu, Zhong-Jian] Orchid Conservat & Res Ctr Shenzhen, Shenzhen, Peoples R China; [Liu, Ke-Wei; Cai, Jing; Liu, Zhong-Jian] Tsinghua Univ, Ctr Biotechnol & BioMed, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China; [Zhai, Jun-Wen] Chinese Acad Sci, S China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Liu, Zhong-Jian] S China Agr Univ, Coll Forestry, Guangzhou, Guangdong, Peoples R China	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Chinese Academy of Sciences; South China Botanical Garden, CAS; South China Agricultural University	Liu, KW (corresponding author), Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China.	zhang2384539@163.com; liuzj@sinicaorchid.org	Zhang, Guo-Qiang/AAG-6817-2019	Zhang, Guo-Qiang/0000-0001-6439-019X; Cai, Jing/0000-0002-2496-4731; Liu, Zhong-Jian/0000-0003-4390-3878	Forestry Construction of State Forestry Administration of China [2010-240]; Forestry Construction of Guangdong Province, China [2010-317]	Forestry Construction of State Forestry Administration of China; Forestry Construction of Guangdong Province, China	This work was supported by fellowships of the Forestry Construction of State Forestry Administration of China (No. 2010-240) and the Forestry Construction of Guangdong Province, China (No. 2010-317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT CF, 1995, S AFR MED J, V85, P853; Carlsward BS, 2006, AM J BOT, V93, P770, DOI 10.3732/ajb.93.5.770; Chen Li-Jun, 2011, Plant Science Journal, V29, P38, DOI 10.3724/SP.J.1142.2011.10038; Chen SC, 1966, ACT PHYT SIN, V11, P129; Chen SC., 2009, FLORA CHINA, V25; Drewes SE, 2004, S AFR J SCI, V100, P425; Fay Michael F., 1997, Kew Bulletin, V52, P111, DOI 10.2307/4117844; GARAY L. A., 1960, BOT MUS LEAFLETS HARVARD UNIV, V19, P57; GARAY LA, 1972, J ARNOLD ARBORETUM, V53, P202; Hamilton MB, 1999, MOL ECOL, V8, P521; Hidayat T, 2005, J PLANT RES, V118, P271, DOI 10.1007/s10265-005-0217-3; Hutchinson J., 1973, FAMILIES FLOWERING P; Ji Z.H., 2000, FLORA CHINA, P264; Judd Walter S., 2000, Harvard Papers in Botany, V5, P79; Kocyan A, 2011, MOL PHYLOGENET EVOL, V60, P122, DOI 10.1016/j.ympev.2011.02.021; Liu Z.J., 2006, GENUS CYMBIDIUM CHIN; Madhavan V, 2007, PHARM BIOL, V45, P18, DOI 10.1080/13880200601026259; Mills E, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-19; Nodall I, 1998, FAMILIES GENERA VASC, V3, P286, DOI DOI 10.1007/978-3-662-03533-7_; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Remizowa MV, 2010, ANN MO BOT GARD, V97, P617, DOI 10.3417/2009142; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rudall PJ, 1998, BOT J LINN SOC, V127, P1; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiv M, 1999, PLANT SYST EVOL, V218, P299, DOI 10.1007/BF01089233; THOMPSON M F, 1978, Bothalia, V12, P429; Wiland-Szymanska J, 2002, NOVON, V12, P142, DOI 10.2307/3393254; Wiland-Szymanska J, 2006, FLORA TROPICAL E AFR	31	8	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e38880	10.1371/journal.pone.0038880	http://dx.doi.org/10.1371/journal.pone.0038880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761711	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800016
J	Wang, Z; Huang, H; Zhang, HS; Sun, CH; Hao, Y; Yang, JY; Fan, Y; Xi, JJ				Wang, Zhao; Huang, Huang; Zhang, Hanshuo; Sun, Changhong; Hao, Yang; Yang, Junyu; Fan, Yu; Xi, Jianzhong Jeff			A Magnetic Bead-Integrated Chip for the Large Scale Manufacture of Normalized esiRNAs	PLOS ONE			English	Article							ENDORIBONUCLEASE-PREPARED SIRNA; RNA INTERFERENCE; CELL-DIVISION; SCREEN	The chemically-synthesized siRNA duplex has become a powerful and widely used tool for RNAi loss-of-function studies, but suffers from a high off-target effect problem. Recently, endoribonulease-prepared siRNA (esiRNA) has been shown to be an attractive alternative due to its lower off-target effect and cost effectiveness. However, the current manufacturing method for esiRNA is complicated, mainly in regards to purification and normalization on a large-scale level. In this study, we present a magnetic bead-integrated chip that can immobilize amplification or transcription products on beads and accomplish transcription, digestion, normalization and purification in a robust and convenient manner. This chip is equipped to manufacture ready-to-use esiRNAs on a large-scale level. Silencing specificity and efficiency of these esiRNAs were validated at the transcriptional, translational and functional levels. Manufacture of several normalized esiRNAs in a single well, including those silencing PARP1 and BRCA1, was successfully achieved, and the esiRNAs were subsequently utilized to effectively investigate their synergistic effect on cell viability. A small esiRNA library targeting 68 tyrosine kinase genes was constructed for a loss-of-function study, and four genes were identified in regulating the migration capability of Hela cells. We believe that this approach provides a more robust and cost-effective choice for manufacturing esiRNAs than current approaches, and therefore these heterogeneous RNA strands may have utility in most intensive and extensive applications.	[Wang, Zhao; Huang, Huang; Zhang, Hanshuo; Sun, Changhong; Hao, Yang; Yang, Junyu; Fan, Yu; Xi, Jianzhong Jeff] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China; [Xi, Jianzhong Jeff] Chinese Acad Sci, State Key Lab Transducer Technol, Shanghai, Peoples R China	Peking University; Chinese Academy of Sciences	Wang, Z (corresponding author), Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China.	jzxi@pku.edu.cn	Yang, Junyu/AAL-8904-2020	Yang, Junyu/0000-0002-5964-5335	MOST - Ministry of Science and Technology [2011CB809106, 2008ZX09401-002]; NSFC - National Science Foundation of China [30600142, 81030040]; Coulter Foundation; State Key Laboratory of Transducer Technology	MOST - Ministry of Science and Technology; NSFC - National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Coulter Foundation; State Key Laboratory of Transducer Technology	This work was supported by the MOST - Ministry of Science and Technology (Grant No. 2011CB809106, 2008ZX09401-002,), NSFC - National Science Foundation of China (Grant No. 30600142, 81030040), Coulter Foundation Seed Grant, and State Key Laboratory of Transducer Technology Seed Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Huang HA, 2011, LAB CHIP, V11, P1036, DOI [10.1039/c0lc00564a, 10.1039/c01c00564a]; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Tan C, 2007, VIRUS RES, V126, P172, DOI 10.1016/j.virusres.2007.02.013; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555	13	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39419	10.1371/journal.pone.0039419	http://dx.doi.org/10.1371/journal.pone.0039419			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761791	gold, Green Published, Green Submitted			2022-12-27	WOS:000305825800032
J	Kliewer, A; Mann, A; Petrich, A; Poll, F; Schulz, S				Kliewer, Andrea; Mann, Anika; Petrich, Aline; Poell, Florian; Schulz, Stefan			A Transplantable Phosphorylation Probe for Direct Assessment of G Protein-Coupled Receptor Activation	PLOS ONE			English	Article							OCTREOTIDE; PASIREOTIDE; SUBTYPES; SST(2A); EXPRESSION; ADENOMAS; BINDING; SOM230; ANALOG	The newly developed multireceptor somatostatin analogs pasireotide (SOM230), octreotide and somatoprim (DG3173) have primarily been characterized according to their binding profiles. However, their ability to activate individual somatostatin receptor subtypes (sst) has not been directly assessed so far. Here, we transplanted the carboxyl-terminal phosphorylation motif of the sst(2) receptor to other somatostatin receptors and assessed receptor activation using a set of three phosphosite-specific antibodies. Our comparative analysis revealed unexpected efficacy profiles for pasireotide, octreotide and somatoprim. Pasireotide was able to activate sst(3) and sst(5) receptors but was only a partial agonist at the sst(2) receptor. Octreotide exhibited potent agonistic properties at the sst(2) receptor but produced very little sst(5) receptor activation. Like octreotide, somatoprim was a full agonist at the sst(2) receptor. Unlike octreotide, somatoprim was also a potent agonist at the sst(5) receptor. Together, we propose the application of a phosphorylation probe for direct assessment of G protein-coupled receptor activation and demonstrate its utility in the pharmacological characterization of novel somatostatin analogs.	[Kliewer, Andrea; Mann, Anika; Petrich, Aline; Poell, Florian; Schulz, Stefan] Univ Jena, Jena Univ Hosp, Dept Pharmacol & Toxicol, Jena, Germany	Friedrich Schiller University of Jena	Kliewer, A (corresponding author), Univ Jena, Jena Univ Hosp, Dept Pharmacol & Toxicol, Jena, Germany.	Stefan.Schulz@mti.uni-jena.de	Schulz, Stefan/A-6928-2017	Schulz, Stefan/0000-0002-5997-8885	Deutsche Forschungsgemeinschaft [SCHU924/10-3]; Deutsche Krebshilfe [109952]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the Deutsche Forschungsgemeinschaft grant SCHU924/10-3 and the Deutsche Krebshilfe grant 109952. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosio M, 2011, NEUROPHARMACOLOGY, V60, P45, DOI 10.1016/j.neuropharm.2010.08.006; Boscaro M, 2009, J CLIN ENDOCR METAB, V94, P115, DOI 10.1210/jc.2008-1008; Bruns C, 2002, EUR J ENDOCRINOL, V146, P707, DOI 10.1530/eje.0.1460707; Donangelo I, 2005, ENDOCRINE, V28, P131, DOI 10.1385/ENDO:28:2:131; Fischer T, 2008, J CLIN ENDOCR METAB, V93, P4519, DOI 10.1210/jc.2008-1063; Ghosh M, 2011, J BIOL CHEM, V286, P13561, DOI 10.1074/jbc.M110.215723; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Lesche S, 2009, J CLIN ENDOCR METAB, V94, P654, DOI 10.1210/jc.2008-1919; Lewis I, 2003, J MED CHEM, V46, P2334, DOI 10.1021/jm021093t; Liu QS, 2009, MOL PHARMACOL, V76, P68, DOI 10.1124/mol.108.054262; Ma PM, 2005, CLIN PHARMACOL THER, V78, P69, DOI 10.1016/j.clpt.2005.04.003; Mundschenk J, 2003, J CLIN ENDOCR METAB, V88, P5150, DOI 10.1210/jc.2003-030262; Oberg KE, 2010, GASTROENTEROLOGY, V139, P742, DOI 10.1053/j.gastro.2010.07.002; Pedroncelli AM, 2010, NEUROENDOCRINOLOGY, V92, P120, DOI 10.1159/000314352; Petersenn S, 2010, J CLIN ENDOCR METAB, V95, P2781, DOI 10.1210/jc.2009-2272; Pfeiffer M, 2001, J BIOL CHEM, V276, P14027, DOI 10.1074/jbc.M006084200; Plockinger U, 2012, EUR J ENDOCRINOL, V166, P223, DOI 10.1530/EJE-11-0737; Plockinger U, 2008, J CLIN ENDOCR METAB, V93, P1203, DOI 10.1210/jc.2007-1986; Poll F, 2010, MOL ENDOCRINOL, V24, P436, DOI 10.1210/me.2009-0315; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reiter E., 2011, ANN REV PHARM TOXICO; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Schulz S, 2000, CLIN CANCER RES, V6, P1865; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006	25	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e39458	10.1371/journal.pone.0039458	http://dx.doi.org/10.1371/journal.pone.0039458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966AK	22745760	Green Submitted, Green Published, gold			2022-12-27	WOS:000305808700031
J	Brocklehurst, N; Upchurch, P; Mannion, PD; O'Connor, J				Brocklehurst, Neil; Upchurch, Paul; Mannion, Philip D.; O'Connor, Jingmai			The Completeness of the Fossil Record of Mesozoic Birds: Implications for Early Avian Evolution	PLOS ONE			English	Article							ORNITHURINE BIRD; AVES ORNITHOTHORACES; DINOSAUR DIVERSITY; SAMPLING BIASES; MASS EXTINCTION; ROCK RECORD; SEA-LEVEL; RADIATION; DIVERSIFICATION; PRESERVATION	Many palaeobiological analyses have concluded that modern birds (Neornithes) radiated no earlier than the Maastrichtian, whereas molecular clock studies have argued for a much earlier origination. Here, we assess the quality of the fossil record of Mesozoic avian species, using a recently proposed character completeness metric which calculates the percentage of phylogenetic characters that can be scored for each taxon. Estimates of fossil record quality are plotted against geological time and compared to estimates of species level diversity, sea level, and depositional environment. Geographical controls on the avian fossil record are investigated by comparing the completeness scores of species in different continental regions and latitudinal bins. Avian fossil record quality varies greatly with peaks during the Tithonian-early Berriasian, Aptian, and Coniacian-Santonian, and troughs during the Albian-Turonian and the Maastrichtian. The completeness metric correlates more strongly with a 'sampling corrected' residual diversity curve of avian species than with the raw taxic diversity curve, suggesting that the abundance and diversity of birds might influence the probability of high quality specimens being preserved. There is no correlation between avian completeness and sea level, the number of fluviolacustrine localities or a recently constructed character completeness metric of sauropodomorph dinosaurs. Comparisons between the completeness of Mesozoic birds and sauropodomorphs suggest that small delicate vertebrate skeletons are more easily destroyed by taphonomic processes, but more easily preserved whole. Lagerstatten deposits might therefore have a stronger impact on reconstructions of diversity of smaller organisms relative to more robust forms. The relatively poor quality of the avian fossil record in the Late Cretaceous combined with very patchy regional sampling means that it is possible neornithine lineages were present throughout this interval but have not yet been sampled or are difficult to identify because of the fragmentary nature of the specimens.	[Brocklehurst, Neil; Mannion, Philip D.] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Naturkunde, Berlin, Germany; [Upchurch, Paul] UCL, Dept Earth Sci, London, England; [Mannion, Philip D.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London, England; [O'Connor, Jingmai] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China; [O'Connor, Jingmai] Nat Hist Museum LA Cty, Dinosaur Inst, Los Angeles, CA USA	Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of London; University College London; Imperial College London; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Brocklehurst, N (corresponding author), Leibniz Inst Evolut & Biodiversitatsforsch, Museum Naturkunde, Berlin, Germany.	neil.brocklehurst@mfn-berlin.de	Upchurch, Paul/C-1654-2008	Mannion, Philip/0000-0002-9361-6941				Agnolin FL, 2012, PALAEONTOL Z, V86, P85, DOI 10.1007/s12542-011-0112-2; Agnolin FL, 2006, AMEGHINIANA, V43, P245; ALLISON PA, 1993, GEOLOGY, V21, P527, DOI 10.1130/0091-7613(1993)021<0527:EFRDOS>2.3.CO;2; Alroy J, 2010, SCIENCE, V329, P1191, DOI 10.1126/science.1189910; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Bakker R.T., 1977, PATTERNS EVOLUTION I, P439; Barale G, 1973, CR HEBD ACAD SCI, V227, P1340; Barrett PM, 2009, P ROY SOC B-BIOL SCI, V276, P2667, DOI 10.1098/rspb.2009.0352; Benson RBJ, 2011, GEOL SOC SPEC PUBL, V358, P191, DOI 10.1144/SP358.13; Benson RBJ, 2010, P ROY SOC B-BIOL SCI, V277, P829, DOI 10.1098/rspb.2009.1845; Benton MJ, 2008, PALEOBIOLOGY, V34, P516, DOI 10.1666/06077.1; Benton MJ, 2007, PALAEONTOLOGY, V50, P23, DOI 10.1111/j.1475-4983.2006.00612.x; Benton MJ, 2012, GEOLOGY, V40, P339, DOI 10.1130/G32669.1; Benton MJ, 2011, GEOL SOC SPEC PUBL, V358, P63, DOI 10.1144/SP358.6; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Benton MJ, 1999, BIOESSAYS, V21, P1043; Benton MJ, 2004, NATURE, V432, P97, DOI 10.1038/nature02950; Bleiweiss R, 1998, GEOLOGY, V26, P323, DOI 10.1130/0091-7613(1998)026<0323:FGASET>2.3.CO;2; Brand Leonard R., 2003, Journal of Taphonomy, V1, P69; Brodkorb P., 1963, P 13 INT ORN C AM OR, VVol. 1, P55; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Brown JW, 2007, BIOL LETTERS, V3, P257, DOI 10.1098/rsbl.2006.0611; Bush AM, 2004, PALEOBIOLOGY, V30, P666, DOI 10.1666/0094-8373(2004)030<0666:RBFDCT>2.0.CO;2; Butler RJ, 2011, P ROY SOC B-BIOL SCI, V278, P1165, DOI 10.1098/rspb.2010.1754; Butler RJ, 2009, PALEOBIOLOGY, V35, P432, DOI 10.1666/0094-8373-35.3.432; Chang SC, 2009, PALAEOGEOGR PALAEOCL, V280, P94, DOI 10.1016/j.palaeo.2009.06.021; Chatterjee S., 1997, THE RISE OF BIRDS; Chatterjee S, 1989, J VERTEBR PALEONTOL, V8, p11A; Chatterjee Sankar, 2002, P125; Chiappe LM, 2002, ANNU REV ECOL SYST, V33, P91, DOI 10.1146/annurev.ecolsys.33.010802.150517; Chiappe LM, 1995, NATURE, V391, P147; Chiappe Luis M., 2002, P230; Chiappe Luis M., 1995, Courier Forschungsinstitut Senckenberg, V181, P55; Clarke J, 2004, B AM MUS NAT HIST, P1; Clarke JA, 2005, NATURE, V433, P305, DOI 10.1038/nature03150; Clarke JA, 2002, AM MUS NOVIT, V3447, P1; Connor JKO, 2009, J VERTEBR PALEONTOL, V29, P188; Cooper A, 1997, SCIENCE, V275, P1109, DOI 10.1126/science.275.5303.1109; CRACRAFT J, 1974, IBIS, V116, P494, DOI 10.1111/j.1474-919X.1974.tb07648.x; Cracraft J, 2001, P ROY SOC B-BIOL SCI, V268, P459, DOI 10.1098/rspb.2000.1368; CRACRAFT J, 1982, SYST ZOOL, V31, P35, DOI 10.2307/2413412; Crampton JS, 2003, SCIENCE, V301, P358, DOI 10.1126/science.1085075; Davis PG, 1998, PALAIOS, V13, P3, DOI 10.2307/3515277; DODSON P, 1990, P NATL ACAD SCI USA, V87, P7608, DOI 10.1073/pnas.87.19.7608; Dyke GJ, 2004, ZOOL J LINN SOC-LOND, V141, P153, DOI 10.1111/j.1096-3642.2004.00118.x; Dyke GJ, 2001, GEOL J, V36, P305; Elzanowski A, 2001, ACTA PALAEONTOL POL, V46, P519; Elzanowski A, 2011, AUK, V128, P138, DOI 10.1525/auk.2011.10113; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Fara E, 2000, PALAIOS, V15, P161, DOI 10.2307/3515502; Fastovsky DE, 2004, GEOLOGY, V32, P877, DOI 10.1130/G20695.1; Feduccia A, 2003, TRENDS ECOL EVOL, V18, P172, DOI 10.1016/S0169-5347(03)00017-X; FEDUCCIA A, 1995, SCIENCE, V267, P637, DOI 10.1126/science.267.5198.637; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Fountaine TMR, 2005, P ROY SOC B-BIOL SCI, V272, P289, DOI 10.1098/rspb.2004.2923; Galton Peter M., 2002, P317; Gill F. B., 1990, ORNITHOLOGY; Goswami A, 2011, P NATL ACAD SCI USA, V108, P16333, DOI 10.1073/pnas.1108723108; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hannisdal B, 2011, SCIENCE, V334, P1121, DOI 10.1126/science.1210695; Haubold H., 1990, Historical Biology, V4, P75; Hope Sylvia, 2002, P339; Hou L., 1997, MESOZOIC BIRDS CHINA; Hou Lian-Hai, 1999, Vertebrata Palasiatica, V37, P228; [Ji Qiang 季强], 2005, [地质通报, Geological Bulletin of China], V24, P197; Krause DW, 2003, ACTA PALAEONTOL POL, V48, P321; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kurochkin EN, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)386<0001:ANPBAA>2.0.CO;2; Lee MSY, 2012, BIOL LETTERS, V8, P299, DOI 10.1098/rsbl.2011.0884; Lloyd GT, 2012, BIOL LETTERS, V8, P123, DOI 10.1098/rsbl.2011.0210; Longrich NR, 2011, P NATL ACAD SCI USA, V108, P15253, DOI 10.1073/pnas.1110395108; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Mannion PD, 2011, GLOBAL ECOL IN PRESS, DOI [10.1111/j1466-8238.2011.00735, DOI 10.1111/J1466-8238.2011.00735]; Mannion PD, 2011, BIOL REV, V86, P157, DOI 10.1111/j.1469-185X.2010.00139.x; Mannion PD, 2010, PALEOBIOLOGY, V36, P283, DOI 10.1666/09008.1; Mannion PD, 2010, PALEOBIOLOGY, V36, P253, DOI 10.1666/08085.1; Marsh O.C., 1880, ODONTORNITHES MONOGR, DOI [10.5962/bhl.title.61298, DOI 10.5962/BHL.TITLE.61298]; Martin L.D., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P35; MARTIN L D, 1984, Transactions of the Kansas Academy of Science, V87, P141, DOI 10.2307/3627850; Martin-Closas C., 1995, MONTSEC MONTRAL ALCO, P29; Mayr G., 2009, PALEOGENE FOSSIL BIR, DOI DOI 10.1007/978-3-540-89628-9; Mayr G, 2006, PALAEONTOL Z, V80, P390, DOI 10.1007/BF02990211; McGowan AJ, 2008, PALEOBIOLOGY, V34, P80, DOI 10.1666/07019.1; McKinney M.L., 1990, P28; Meyer H.von., 1861, NEUES JB MINERALOGIE, V1861, P678; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Norell MA, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3545[1:ANDTFU]2.0.CO;2; Norell Mark A., 1992, P89; O'Connor JK, 2010, J VERTEBR PALEONTOL, V30, P311, DOI 10.1080/02724631003617498; Olson S.L., 1985, Avian Biology, V8, P79; Paton T, 2002, P ROY SOC B-BIOL SCI, V269, P839, DOI 10.1098/rspb.2002.1961; Peybernes B, 1972, CR HEBD ACAD SCI, V276, P2501; RAUP DM, 1972, SCIENCE, V177, P1065, DOI 10.1126/science.177.4054.1065; RICHARDS HG, 1974, NOTULAE NATURAE, V449, P1; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; Smith AB, 2007, PALAEONTOLOGY, V50, P765, DOI 10.1111/j.1475-4983.2007.00693.x; Smith AB, 2007, PALEOBIOLOGY, V33, P310, DOI 10.1666/06073.1; Tokaryk TT, 1997, J VERTEBR PALEONTOL, V17, P172, DOI 10.1080/02724634.1997.10010961; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Upchurch P, 2011, GEOL SOC SPEC PUBL, V358, P209, DOI 10.1144/SP358.14; Upchurch P, 2008, TRENDS ECOL EVOL, V23, P229, DOI 10.1016/j.tree.2007.11.006; Upchurch P, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P104; Wang XR, 2010, ACTA GEOL SIN-ENGL, V84, P247, DOI 10.1111/j.1755-6724.2010.00156.x; Weishampel D, 1987, 4 S MES TERR EC ROYA, P224; WELLNHOFER P, 1988, SCIENCE, V240, P1790, DOI 10.1126/science.240.4860.1790; Wilson LE, 2011, J SYST PALAEONTOL, V9, P9, DOI 10.1080/14772019.2010.502910; Witmer Lawrence M., 2002, P3; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Zhang FC, 2008, SCI CHINA SER D, V51, P625, DOI 10.1007/s11430-008-0050-3; Zhou ZH, 2005, P NATL ACAD SCI USA, V102, P18998, DOI 10.1073/pnas.0507106102; Zhou ZH, 2008, J ANAT, V212, P565, DOI 10.1111/j.1469-7580.2008.00880.x; Zhou ZH, 2006, ZOOL SCR, V35, P363, DOI 10.1111/j.1463-6409.2006.00234.x	116	74	75	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39056	10.1371/journal.pone.0039056	http://dx.doi.org/10.1371/journal.pone.0039056			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761723	Green Submitted, gold, Green Published			2022-12-27	WOS:000305781700016
J	Baena, ML; Macias-Ordonez, R				Lucia Baena, Martha; Macias-Ordonez, Rogelio			Phenology of Scramble Polygyny in a Wild Population of Chrysolemid Beetles: The Opportunity for and the Strength of Sexual Selection	PLOS ONE			English	Article							MATING SYSTEM; EVOLUTION; DENSITY; ECOLOGY; ADVANTAGE; INTENSITY; VARIANCE; DYNAMICS; COLORADO; SUCCESS	Recent debate has highlighted the importance of estimating both the strength of sexual selection on phenotypic traits, and the opportunity for sexual selection. We describe seasonal fluctuations in mating dynamics of Leptinotarsa undecimlineata (Coleoptera: Chrysomelidae). We compared several estimates of the opportunity for, and the strength of, sexual selection and male precopulatory competition over the reproductive season. First, using a null model, we suggest that the ratio between observed values of the opportunity for sexual selections and their expected value under random mating results in unbiased estimates of the actual nonrandom mating behavior of the population. Second, we found that estimates for the whole reproductive season often misrepresent the actual value at any given time period. Third, mating differentials on male size and mobility, frequency of male fighting and three estimates of the opportunity for sexual selection provide contrasting but complementary information. More intense sexual selection associated to male mobility, but not to male size, was observed in periods with high opportunity for sexual selection and high frequency of male fights. Fourth, based on parameters of spatial and temporal aggregation of female receptivity, we describe the mating system of L. undecimlineata as a scramble mating polygyny in which the opportunity for sexual selection varies widely throughout the season, but the strength of sexual selection on male size remains fairly weak, while male mobility inversely covaries with mating success. We suggest that different estimates for the opportunity for, and intensity of, sexual selection should be applied in order to discriminate how different behavioral and demographic factors shape the reproductive dynamic of populations.	[Lucia Baena, Martha; Macias-Ordonez, Rogelio] Inst Ecol AC, Red Biol Evolut, Xalapa, Veracruz, Mexico	Instituto de Ecologia - Mexico	Baena, ML (corresponding author), Inst Ecol AC, Red Biol Evolut, Xalapa, Veracruz, Mexico.	marthalucia.baena@gmail.com	Macías-Ordóñez, Rogelio/E-8286-2010; Hurtado, Martha L. Baena/AAE-4998-2020; Macías-Ordóñez, Rogelio/AAO-3447-2020	Macías-Ordóñez, Rogelio/0000-0003-1101-6289; Hurtado, Martha L. Baena/0000-0002-5684-2771; 				Andersson Malte, 1994; ARNOLD SJ, 1984, EVOLUTION, V38, P720, DOI 10.1111/j.1558-5646.1984.tb00345.x; ARNOLD SJ, 1984, EVOLUTION, V38, P709, DOI [10.2307/2408383, 10.1111/j.1558-5646.1984.tb00344.x]; Barry KL, 2011, EVOL ECOL, V25, P107, DOI 10.1007/s10682-010-9384-3; Boiteau G, 1998, ENTOMOL EXP APPL, V89, P147, DOI 10.1023/A:1003543419535; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; BORGIA G, 1982, EVOLUTION, V36, P307, DOI [10.2307/2408049, 10.1111/j.1558-5646.1982.tb05046.x]; Canas LA, 2002, BIOL CONTROL, V24, P50, DOI 10.1016/S1049-9644(02)00005-1; CLUTTONBROCK TH, 1992, Q REV BIOL, V67, P437, DOI 10.1086/417793; Cockburn A, 2008, P R SOC B, V275, P605, DOI 10.1098/rspb.2007.0916; Crawley M.J., 2007, R BOOK; Croshaw DA, 2010, BIOL J LINN SOC, V99, P73; CROW JF, 1958, AM ANTHROPOL, V60, P1; CROWLEY PH, 1991, AM NAT, V137, P567, DOI 10.1086/285184; DICKINSON JL, 1995, BEHAV ECOL, V6, P280, DOI 10.1093/beheco/6.3.280; DICKINSON JL, 1992, BEHAV ECOL, V3, P32, DOI 10.1093/beheco/3.1.32; Dunn SJ, 2012, AM NAT, V179, P451, DOI 10.1086/664626; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Fairbairn DJ, 2001, EVOL ECOL RES, V3, P667; Gosden TP, 2008, EVOLUTION, V62, P845, DOI 10.1111/j.1558-5646.2008.00323.x; Hersch EI, 2004, EVOLUTION, V58, P479, DOI 10.1111/j.0014-3820.2004.tb01671.x; Hoekstra HE, 2001, P NATL ACAD SCI USA, V98, P9157, DOI 10.1073/pnas.161281098; Holwerda F, 2010, J HYDROL, V384, P84, DOI 10.1016/j.jhydrol.2010.01.012; Jennions MD, 2012, J EVOLUTION BIOL, V25, P591, DOI 10.1111/j.1420-9101.2011.02451.x; Jones AG, 2009, EVOLUTION, V63, P1673, DOI 10.1111/j.1558-5646.2009.00664.x; Jones AG, 2004, AM NAT, V164, P444, DOI 10.1086/423826; Kasumovic MM, 2008, EVOLUTION, V62, P2316, DOI 10.1111/j.1558-5646.2008.00446.x; Kelly CD, 2005, BEHAV ECOL, V16, P145, DOI 10.1093/beheco/arh141; Kelly CD, 2008, BEHAV ECOL, V19, P184, DOI 10.1093/beheco/arm121; Klug H, 2010, J EVOLUTION BIOL, V23, P447, DOI 10.1111/j.1420-9101.2009.01921.x; Klug H, 2010, ECOL LETT, V13, P1094, DOI 10.1111/j.1461-0248.2010.01495.x; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Kokko H, 2007, ECOL LETT, V10, P773, DOI 10.1111/j.1461-0248.2007.01086.x; Krakauer AH, 2011, J EVOL BIOL COMMENTA, P1; Krakauer AH, 2008, CONDOR, V110, P1, DOI 10.1525/cond.2008.110.1.1; Lopez-Carretero A, 2005, ENTOMOL EXP APPL, V115, P27, DOI 10.1111/j.1570-7458.2005.00279.x; Macias-Ordonez R, 2005, MAR FRESHW BEHAV PHY, V38, P159, DOI 10.1080/10236240500222101; Mills SC, 2007, P ROY SOC B-BIOL SCI, V274, P143, DOI 10.1098/rspb.2006.3639; Mobley KB, 2007, MOL ECOL, V16, P2596, DOI 10.1111/j.1365-294X.2007.03337.x; Pavkovic-Lucic S, 2009, ETHOL ECOL EVOL, V21, P155, DOI 10.1080/08927014.2009.9522504; R Core Team, 2018, R LANG ENV STAT COMP; Rank NE, 2006, J INSECT BEHAV, V19, P699, DOI 10.1007/s10905-006-9051-2; Rankin DJ, 2007, OIKOS, V116, P335, DOI [10.1111/j.2006.0030-1299.15451.x, 10.1111/j.0030-1299.2007.15451.x]; SHUSTER SM, 2003, MG BEH ECOL, pR7; Shuster SM, 2009, P NATL ACAD SCI USA, V106, P10009, DOI 10.1073/pnas.0901132106; Soto EM, 1990, ATLAS CLIMATICO MUNI; SUTHERLAND WJ, 1985, ANIM BEHAV, V33, P1349, DOI 10.1016/S0003-3472(85)80197-4; Thornhill R., 1983, pi; Vanpe C, 2008, BEHAV ECOL, V19, P309, DOI 10.1093/beheco/arm132; WADE MJ, 1979, AM NAT, V114, P742, DOI 10.1086/283520; WADE MJ, 1980, ANIM BEHAV, V28, P446, DOI 10.1016/S0003-3472(80)80052-2; WADE MJ, 1995, EVOL ECOL, V9, P118, DOI 10.1007/BF01237701	52	11	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e38315	10.1371/journal.pone.0038315	http://dx.doi.org/10.1371/journal.pone.0038315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761675	Green Published, gold, Green Submitted			2022-12-27	WOS:000305781700006
J	Martin, J; Edwards, HH; Burgess, MA; Percival, HF; Fagan, DE; Gardner, BE; Ortega-Ortiz, JG; Ifju, PG; Evers, BS; Rambo, TJ				Martin, Julien; Edwards, Holly H.; Burgess, Matthew A.; Percival, H. Franklin; Fagan, Daniel E.; Gardner, Beth E.; Ortega-Ortiz, Joel G.; Ifju, Peter G.; Evers, Brandon S.; Rambo, Thomas J.			Estimating Distribution of Hidden Objects with Drones: From Tennis Balls to Manatees	PLOS ONE			English	Article							AERIAL SURVEYS	Unmanned aerial vehicles (UAV), or drones, have been used widely in military applications, but more recently civilian applications have emerged (e. g., wildlife population monitoring, traffic monitoring, law enforcement, oil and gas pipeline threat detection). UAV can have several advantages over manned aircraft for wildlife surveys, including reduced ecological footprint, increased safety, and the ability to collect high-resolution geo-referenced imagery that can document the presence of species without the use of a human observer. We illustrate how geo-referenced data collected with UAV technology in combination with recently developed statistical models can improve our ability to estimate the distribution of organisms. To demonstrate the efficacy of this methodology, we conducted an experiment in which tennis balls were used as surrogates of organisms to be surveyed. We used a UAV to collect images of an experimental field with a known number of tennis balls, each of which had a certain probability of being hidden. We then applied spatially explicit occupancy models to estimate the number of balls and created precise distribution maps. We conducted three consecutive surveys over the experimental field and estimated the total number of balls to be 328 (95% CI: 312, 348). The true number was 329 balls, but simple counts based on the UAV pictures would have led to a total maximum count of 284. The distribution of the balls in the field followed a simulated environmental gradient. We also were able to accurately estimate the relationship between the gradient and the distribution of balls. Our experiment demonstrates how this technology can be used to create precise distribution maps in which discrete regions of the study area are assigned a probability of presence of an object. Finally, we discuss the applicability and relevance of this experimental study to the case study of Florida manatee distribution at power plants.	[Martin, Julien; Edwards, Holly H.; Fagan, Daniel E.; Ortega-Ortiz, Joel G.] Fish & Wildlife Res Inst, Florida Fish & Wildlife Conservat Commiss, St Petersburg, FL USA; [Burgess, Matthew A.; Percival, H. Franklin] Univ Florida, Florida Cooperat Fish & Wildlife Res Unit, US Geol Survey, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Gardner, Beth E.] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Ifju, Peter G.; Evers, Brandon S.; Rambo, Thomas J.] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL USA	Florida Fish & Wildlife Conservation Commission; State University System of Florida; University of Florida; United States Department of the Interior; United States Geological Survey; University of North Carolina; North Carolina State University; State University System of Florida; University of Florida	Martin, J (corresponding author), Fish & Wildlife Res Inst, Florida Fish & Wildlife Conservat Commiss, St Petersburg, FL USA.	Julien.Martin@myfwc.com		Martin, Julien/0000-0002-7375-129X	Save the Manatee Trust Fund; US Army Corps of Engineers; US Geological Survey; Florida Fish and Wildlife Conservation Commission; University of Florida	Save the Manatee Trust Fund; US Army Corps of Engineers(United States Department of DefenseUnited States Army); US Geological Survey(United States Geological Survey); Florida Fish and Wildlife Conservation Commission; University of Florida(University of Florida)	This work was funded by Save the Manatee Trust Fund, US Army Corps of Engineers, US Geological Survey, Florida Fish and Wildlife Conservation Commission, and University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnell ML, 2004, J WILDLIFE MANAGE, V20, P63; Eberhardt L, 1982, WILDLIFE MONOGR, V63, P46; Edwards HH, 2007, J WILDLIFE MANAGE, V71, P2052, DOI 10.2193/2005-645; Jones GP, 2006, WILDLIFE SOC B, V34, P750, DOI 10.2193/0091-7648(2006)34[750:AAOSUA]2.0.CO;2; Kery M., 2010, INTRO WINBUGS ECOLOG; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MARSH H, 1989, J WILDLIFE MANAGE, V53, P1017, DOI 10.2307/3809604; Pollock KH, 2006, J WILDLIFE MANAGE, V70, P255, DOI 10.2193/0022-541X(2006)70[255:EAAIHE]2.0.CO;2; Rango A, 2006, ENVIRON PRAC, V8, P159, DOI 10.1017/S1466046606060224; Royle J. A., 2008, HIERARCHICAL MODELIN; Unblinking eyes in the sky, 2012, ECONOMIST US    0303, P12	11	61	62	5	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e38882	10.1371/journal.pone.0038882	http://dx.doi.org/10.1371/journal.pone.0038882			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761712	Green Published, gold, Green Submitted			2022-12-27	WOS:000305781700013
J	Reynolds, LK; McGlathery, KJ; Waycott, M				Reynolds, Laura K.; McGlathery, Karen J.; Waycott, Michelle			Genetic Diversity Enhances Restoration Success by Augmenting Ecosystem Services	PLOS ONE			English	Article							ZOSTERA-MARINA; GENOTYPIC DIVERSITY; EELGRASS; DISTURBANCE; RECOVERY; SIZE; FITNESS; BAY	Disturbance and habitat destruction due to human activities is a pervasive problem in near-shore marine ecosystems, and restoration is often used to mitigate losses. A common metric used to evaluate the success of restoration is the return of ecosystem services. Previous research has shown that biodiversity, including genetic diversity, is positively associated with the provision of ecosystem services. We conducted a restoration experiment using sources, techniques, and sites similar to actual large-scale seagrass restoration projects and demonstrated that a small increase in genetic diversity enhanced ecosystem services (invertebrate habitat, increased primary productivity, and nutrient retention). In our experiment, plots with elevated genetic diversity had plants that survived longer, increased in density more quickly, and provided more ecosystem services (invertebrate habitat, increased primary productivity, and nutrient retention). We used the number of alleles per locus as a measure of genetic diversity, which, unlike clonal diversity used in earlier research, can be applied to any organism. Additionally, unlike previous studies where positive impacts of diversity occurred only after a large disturbance, this study assessed the importance of diversity in response to potential environmental stresses (high temperature, low light) along a water-depth gradient. We found a positive impact of diversity along the entire depth gradient. Taken together, these results suggest that ecosystem restoration will significantly benefit from obtaining sources (transplants or seeds) with high genetic diversity and from restoration techniques that can maintain that genetic diversity.	[Reynolds, Laura K.; McGlathery, Karen J.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Waycott, Michelle] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia	University of Virginia; University of Adelaide	Reynolds, LK (corresponding author), Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA.	lkreynolds@virginia.edu	Waycott, Michelle/AAR-8809-2021	Waycott, Michelle/0000-0002-0822-0564; Reynolds, Laura K/0000-0002-4498-4641	National Science Foundation [DEB-0621014]; Jones Environmental Research Endowment	National Science Foundation(National Science Foundation (NSF)); Jones Environmental Research Endowment	Financial support for this study was provided by the National Science Foundation grant DEB-0621014 to the Virginia Coast Reserve LTER project and from the Jones Environmental Research Endowment to the Department of Environmental Sciences at the University of Virginia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, HDB SEAGRASS BIOL EC; Arnaud-Haond S, 2010, ESTUAR COAST, V33, P878, DOI 10.1007/s12237-009-9238-9; Brown LR, 1985, CONSERVING BIOL DIVE; CANTELO WW, 1984, ENVIRON ENTOMOL, V13, P1443, DOI 10.1093/ee/13.5.1443; Carr JA, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001744; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Davis RC, 1998, RESTOR ECOL, V6, P297, DOI 10.1046/j.1526-100X.1998.00634.x; Green E.P., 2003, WORLD ATLAS SEAGRASS; Hammerli A, 2003, MOL ECOL, V12, P619, DOI 10.1046/j.1365-294X.2003.01766.x; Hauxwell J, 2004, J AQUAT PLANT MANAGE, V42, P49; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes AR, 2011, J ECOL, V99, P445, DOI 10.1111/j.1365-2745.2010.01767.x; Hughes AR, 2009, ECOLOGY, V90, P1412, DOI 10.1890/07-2030.1; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; KINZIG AP, 2001, FUNCTIONAL CONSEQUEN; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; Marion SR, 2010, RESTOR ECOL, V18, P514, DOI 10.1111/j.1526-100X.2010.00692.x; McGlathery KJ, 2012, MAR ECOL PROG SER, V448, P209, DOI 10.3354/meps09574; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Olsen JL, 2004, MOL ECOL, V13, P1923, DOI 10.1111/j.1365-294X.2004.02205.x; Orth RJ, 2006, AQUAT BOT, V84, P26, DOI 10.1016/j.aquabot.2005.07.007; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Procaccini G, 2007, J EXP MAR BIOL ECOL, V350, P234, DOI 10.1016/j.jembe.2007.05.035; Ramage DL, 1999, MAR ECOL PROG SER, V189, P275, DOI 10.3354/meps189275; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Reusch TBH, 2006, ESTUARIES COASTS, V29, P159, DOI 10.1007/BF02784707; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Reusch TBH, 1999, MAR BIOL, V133, P519, DOI 10.1007/s002270050492; Reusch TBH, 2001, MAR ECOL PROG SER, V211, P261, DOI 10.3354/meps211261; Reynolds LK, 2012, MAR ECOL PROG SER, V448, P223, DOI 10.3354/meps09386; Ruiz-Jaen MC, 2005, RESTOR ECOL, V13, P569, DOI 10.1111/j.1526-100X.2005.00072.x; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Society for Ecological Restoration International Science & Policy Working Group (SER), 2004, SER INT PRIM EC REST; van Katwijk MM, 2009, MAR POLLUT BULL, V58, P179, DOI 10.1016/j.marpolbul.2008.09.028; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williams SL, 2001, ECOL APPL, V11, P1472, DOI 10.1890/1051-0761(2001)011[1472:RGDIET]2.0.CO;2	37	112	115	1	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e38397	10.1371/journal.pone.0038397	http://dx.doi.org/10.1371/journal.pone.0038397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761681	Green Published, Green Submitted, gold			2022-12-27	WOS:000305781700008
J	Ciampa, PJ; Vaz, LME; Blevins, M; Sidat, M; Rothman, RL; Vermund, SH; Vergara, AE				Ciampa, Philip J.; Vaz, Lara M. E.; Blevins, Meridith; Sidat, Moshin; Rothman, Russell L.; Vermund, Sten H.; Vergara, Alfredo E.			The Association among Literacy, Numeracy, HIV Knowledge and Health-Seeking Behavior: A Population-Based Survey of Women in Rural Mozambique	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; ADHERENCE; CARE; PERSPECTIVE; INSTRUMENTS; HIV/AIDS; ERRORS; ADULTS	Background: Limited literacy skills are common in the United States (US) and are related to lower HIV knowledge and worse health behaviors and outcomes. The extent of these associations is unknown in countries like Mozambique, where no rigorously validated literacy and numeracy measures exist. Methods: A validated measure of literacy and numeracy, the Wide Range Achievement Test, version 3 (WRAT-3) was translated into Portuguese, adapted for a Mozambican context, and administered to a cross-section of female heads-of-household during a provincially representative survey conducted from August 8 to September 25, 2010. Construct validity of each subscale was examined by testing associations with education, income, and possession of socioeconomic assets, stratified by Portuguese speaking ability. Multivariable regression models estimated the association among literacy/numeracy and HIV knowledge, self-reported HIV testing, and utilization of prenatal care. Results: Data from 3,557 women were analyzed; 1,110 (37.9%) reported speaking Portuguese. Respondents' mean age was 31.2; 44.6% lacked formal education, and 34.3% reported no income. Illiteracy was common (50.4% of Portuguese speakers, 93.7% of non-Portuguese speakers) and the mean numeracy score (10.4) corresponded to US kindergarten-level skills. Literacy or numeracy was associated (p<0.01) with education, income, age, and other socioeconomic assets. Literacy and numeracy skills were associated with HIV knowledge in adjusted models, but not with HIV testing or receipt of clinic-based prenatal care. Conclusion: The adapted literacy and numeracy subscales are valid for use with rural Mozambican women. Limited literacy and numeracy skills were common and associated with lower HIV knowledge. Further study is needed to determine the extent to which addressing literacy/numeracy will lead to improved health outcomes.	[Ciampa, Philip J.; Vaz, Lara M. E.; Blevins, Meridith; Vermund, Sten H.; Vergara, Alfredo E.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Vaz, Lara M. E.] Friends Global Hlth LLC, Maputo, Mozambique; [Sidat, Moshin] Univ Eduardo Mondlane, Dept Community Hlth, Maputo, Mozambique; [Ciampa, Philip J.; Rothman, Russell L.] Vanderbilt Univ, Div Gen Internal Med & Publ Hlth, Nashville, TN USA	Vanderbilt University; Eduardo Mondlane University; Vanderbilt University	Ciampa, PJ (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA.	Philip.Ciampa@vanderbilt.edu	Vermund, Sten/AAD-3592-2020; Sidat, Mohsin/AAS-1894-2021	Vermund, Sten/0000-0001-7289-8698; Rothman, Russsell/0000-0002-1506-3990; Blevins, Meridith/0000-0002-3861-9859; Sidat, Mohsin/0000-0002-8378-2014	United States Agency for International Development (USAID)-Mozambique through World Vision, Inc. [656-A-00-09-00141-00]; Vanderbilt University	United States Agency for International Development (USAID)-Mozambique through World Vision, Inc.(United States Agency for International Development (USAID)); Vanderbilt University	This manuscript was supported by the United States Agency for International Development (USAID)-Mozambique (Award No. 656-A-00-09-00141-00) through a sub-grant from World Vision, Inc. and by Vanderbilt University through the endowment of the Amos Christie Chair in Global Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID, the United States Government, or World Vision, Inc.	[Anonymous], 2010, HUM DEV REP 2010 20; Audet CM, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-15; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Ciampa PJ, 2011, JAIDS-J ACQ IMM DEF, V58, P115, DOI 10.1097/QAI.0b013e31822149bf; Cook RE, 2011, JAIDS-J ACQ IMM DEF, V56, pE104, DOI 10.1097/QAI.0b013e318207a535; Davis TC, 1998, HEALTH EDUC BEHAV, V25, P613, DOI 10.1177/109019819802500508; Doak CC, 1996, TEACHING PATIENTS LO; Dowse R, 2010, PHARM WORLD SCI, V32, P464, DOI 10.1007/s11096-010-9392-y; Groh K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-650; Hegazi A, 2010, AIDS CARE, V22, P1340, DOI 10.1080/09540121003693514; *I MED, 2004, HLTH LIT PRESCR END; Kalichman SC, 1999, J GEN INTERN MED, V14, P267, DOI 10.1046/j.1525-1497.1999.00334.x; Kalichman SC, 2000, AM J PREV MED, V18, P325, DOI 10.1016/S0749-3797(00)00121-5; Kalichman SC, 2000, J ACQ IMMUN DEF SYND, V25, P337, DOI 10.1097/00126334-200012010-00007; Kripalani S, 2006, J GEN INTERN MED, V21, P852, DOI 10.1111/j.1525-1497.2006.00536.x; Kutner M, 2006, HLTH LITERACY AM ADU; Kutner M., 2005, 1 LOOK LITERACY AM A; Lee SYD, 2006, HEALTH SERV RES, V41, P1392, DOI 10.1111/j.1475-6773.2006.00532.x; McTavish S, 2010, SOC SCI MED, V71, P1958, DOI 10.1016/j.socscimed.2010.09.007; Miller LG, 2003, CLIN INFECT DIS, V36, P514, DOI 10.1086/367857; Moon Troy D, 2010, Retrovirology (Auckl), V3, P1; NURSS JR, 1995, J READING, V38, P632; ORCMacro, 2006, MEAS DHS MOD QUEST C; Osborn CY, 2011, AM J HEALTH BEHAV, V35, P118; Rothman RL, 2008, J HEALTH COMMUN, V13, P583, DOI 10.1080/10810730802281791; Stuebing K W, 1997, Health Transit Rev, V7, P151; UNAIDS, 2010, GLOB REP UNAIDS REP; Underwood C, 2007, J HEALTH COMMUN, V12, P317, DOI 10.1080/10810730701325962; Vergara AE, 2011, BASELINE SURVEY REPO; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME; Wolf MS, 2005, AIDS CARE, V17, P863, DOI 10.1080/09540120500038660; Wolf MS, 2004, INT J STD AIDS, V15, P747, DOI 10.1258/0956462042395131; World Health Organisation (WHO) regional office for Africa, 2011, HIV WHO AFR REG PROG; Yin HS, 2007, AMBUL PEDIATR, V7, P292, DOI 10.1016/j.ambp.2007.04.004; Yin HS, 2011, ACAD PEDIATR, V11, P50, DOI 10.1016/j.acap.2010.12.007; Yin HS, 2010, ARCH PEDIAT ADOL MED, V164, P181, DOI 10.1001/archpediatrics.2009.269	36	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39391	10.1371/journal.pone.0039391	http://dx.doi.org/10.1371/journal.pone.0039391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	964XV	22745747	Green Submitted, Green Published, gold			2022-12-27	WOS:000305730900055
J	Erim, DO; Kolapo, UM; Resch, SC				Erim, Daniel O.; Kolapo, Usman M.; Resch, Stephen C.			A Rapid Assessment of the Availability and Use of Obstetric Care in Nigerian Healthcare Facilities	PLOS ONE			English	Article							INDUCED-ABORTION	Background: As part of efforts to reduce maternal deaths in Nigeria, pregnant women are being encouraged to give birth in healthcare facilities. However, little is known about whether or not available healthcare facilities can cope with an increasing demand for obstetric care. We thus carried out this survey as a rapid and tactical assessment of facility quality. We visited 121 healthcare facilities, and used the opportunity to interview over 700 women seeking care at these facilities. Findings: Most of the primary healthcare facilities we visited were unable to provide all basic Emergency Obstetric Care (bEmOC) services. In general, they lack clinical staff needed to dispense maternal and neonatal care services, ambulances and uninterrupted electricity supply whenever there were obstetric emergencies. Secondary healthcare facilities fared better, but, like their primary counterparts, lack neonatal care infrastructure. Among patients, most lived within 30 minutes of the visited facilities and still reported some difficulty getting there. Of those who had had two or more childbirths, the conditional probability of a delivery occurring in a healthcare facility was 0.91 if the previous delivery occurred in a healthcare facility, and 0.24 if it occurred at home. The crude risk of an adverse neonatal outcome did not significantly vary by delivery site or birth attendant, and the occurrence of such an outcome during an in-facility delivery may influence the mother to have her next delivery outside. Such an outcome during a home delivery may not prompt a subsequent in-facility delivery. Conclusions: In conclusion, reducing maternal deaths in Nigeria will require attention to both increasing the number of facilities with high-quality EmOC capability and also assuring Nigerian women have access to these facilities regardless of where they live.	[Erim, Daniel O.; Resch, Stephen C.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, Boston, MA 02115 USA; [Kolapo, Usman M.] Indepth Precis Consult, Abuja, Nigeria; [Erim, Daniel O.] Harvard Univ, Ctr Geog Anal, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Erim, DO (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, Boston, MA 02115 USA.	derim@hsph.harvard.edu		Erim, Daniel/0000-0002-6604-7640	John D. and Catherine T. MacArthur Foundation [07-8900-00GSS, 10-97002-000-INP]	John D. and Catherine T. MacArthur Foundation	This work was funded by the John D. and Catherine T. MacArthur Foundation grants (#07-8900-00GSS and #10-97002-000-INP). URL: http://www.macfound.org. The funder had no role in the study, design, data collections analysis, decision to publish or preparation of the manuscript.	Adeyi O, 2006, HARVARD CTR POPULATI; Ajala O. A., 2005, Journal of Human Ecology, V18, P121; Amanyeiwe U, 2009, NIGERIA HIV AIDS SER, V20, P20; [Anonymous], VANGUARD NEWSPAPER; Asuzu M.C., 2004, J COMMUNITY MED PRIM, V16, P1; British Council, 2012, GEND NIG REP 2012; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Government of Nigeria Federal Ministry of Health, 2005, NAT HIV SYPH SER SEN; Government of Nigeria Federal Ministry of Health, 2007, HIV STI INT BIOL BEH; Government of Nigeria National Agency for the Control of AIDS, 2009, NAT POL HIV AIDS; Government of Nigeria National Bureau of Statiscits, 2009, ANN ABSTR STAT; Government of Nigeria National Bureau of Statistics, 2007, DIR HLTH EST NIG; Government of Nigeria National Primary Healthcare Development Agency, 2010, MIDW SERV SCHEM MSS; Henshaw SK, 1998, INT FAM PLAN PERSPEC, V24, P156, DOI 10.2307/2991973; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Hope for health in Nigeria, 2011, LANCET, V377, P1891; Imam N, 2011, DAILY TRUST NEWSPAPE; Kale O, 2006, NIGERIAN HLTH REV 20; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Maine D, 1997, GUIDELINES MONITORIN, V1997; Monday N, 2012, DAILY TRUST NEWSPAPE; National Population Commission (NPC) (Nigeria) and ICF Macro, 2009, NIG DEM HLTH SURV; Okonofua F, 2010, INT J GYNECOL OBSTET, V111, P122, DOI 10.1016/j.ijgo.2010.05.020; Olekanma J, 2011, CHAMPION NEWSPAPERS; Oluwarotimi A, 2011, LEADERSHIP NEWSPAPER; World Bank, 2008, MAT HLTH IND NIG; World Bank, 2008, LIF RISK MAT DEATH N	28	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39555	10.1371/journal.pone.0039555	http://dx.doi.org/10.1371/journal.pone.0039555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745784	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900077
J	Fan, LH; Dang, XQ; Wang, KZ				Fan, Lihong; Dang, Xiaoqian; Wang, Kunzheng			Comparison between Bipolar Hemiarthroplasty and Total Hip Arthroplasty for Unstable Intertrochanteric Fractures in Elderly Osteoporotic Patients	PLOS ONE			English	Article							INTERNAL-FIXATION; FEMORAL FRACTURES; PROSTHETIC REPLACEMENT; TROCHANTERIC FRACTURES; SCREW; INTRAMEDULLARY; COMPLICATIONS; FEMUR; NECK; NAIL	The present study was conducted to compare bipolar hemiarthroplasty (BA) with total hip arthroplasty (THA) in treatment of unstable intertrochanteric fractures in elderly osteoporotic patients. The THA group included 14 males and 26 females with a mean age of 73.4 years, and the BA group included 27 males and 45 females with a mean age of 76.5 years. Significant difference existed between the two groups in operation time, blood loss, transfusion volume and cost of hospitalization, while no remarkable difference was identified in hospitalization period, general complications, joint function, pain, rate of revision and mortality. No dislocation was observed in BA group while 3 occurred in THA group. The results indicated that for unstable intertrochanteric fractures in elderly osteoporotic patients, BA seems to be a better or more reasonable choice compared with THA for the reason of less blood loss, shorter operation time, lower cost and no dislocation.	[Fan, Lihong; Dang, Xiaoqian; Wang, Kunzheng] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Orthopaed Surg, Xian 710049, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University	Fan, LH (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Orthopaed Surg, Xian 710049, Shaanxi Provinc, Peoples R China.	drwangkz@eyou.com		Dang, Xiaoqian/0000-0002-5498-6800; Wang, Kunzheng/0000-0002-1981-4237	National Natural Science Foundation of China [81101363]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 81101363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CI, 2001, J ORTHOP TRAUMA, V15, P394, DOI 10.1097/00005131-200108000-00003; Albareda J, 1996, INT ORTHOP, V20, P47, DOI 10.1007/s002640050026; APRIN H, 1980, J TRAUMA, V20, P32, DOI 10.1097/00005373-198020010-00004; BAUMGAERTNER MR, 1998, CLIN ORTHOP RELAT R, V348, P87; Boldin C, 2003, ACTA ORTHOP SCAND, V74, P53, DOI 10.1080/00016470310013662; BROSTROM LA, 1992, ANN CHIR GYNAECOL FE, V81, P66; Chan KC, 2000, CLIN ORTHOP RELAT R, P206, DOI 10.1097/00003086-200002000-00025; Cho CH, 2010, ORTHOPEDICS, V33, P11; DAVIS TRC, 1990, J BONE JOINT SURG BR, V72, P26, DOI 10.1302/0301-620X.72B1.2298790; Faldini C, 2006, J ORTHOP TRAUMATOL, V7, P117, DOI 10.1007/s10195-006-0133-x; GEBHARD JS, 1992, CLIN ORTHOP RELAT R, P123; GREEN S, 1987, CLIN ORTHOP RELAT R, P169; Gulati Parvjeet Singh, 2009, PB J ORTHOPAEDICS, VXI; Habernek H, 2000, ORTHOPEDICS, V23, P121; Haentjens P, 2005, DISABIL REHABIL, V27, P1167, DOI 10.1080/09638280500055966; HAENTJENS P, 1989, J BONE JOINT SURG AM, V71A, P1214, DOI 10.2106/00004623-198971080-00015; Haentjens P, 1994, Acta Orthop Belg, V60 Suppl 1, P124; Haidukewych GJ, 2003, J BONE JOINT SURG AM, V85A, P899, DOI 10.2106/00004623-200305000-00019; HARWIN SF, 1990, ORTHOPEDICS, V13, P1131; Hummel MT, 2009, J ARTHROPLASTY, V24, P73, DOI 10.1016/j.arth.2009.04.026; KENZORA JE, 1984, CLIN ORTHOP RELAT R, P45; Kim SY, 2005, J BONE JOINT SURG AM, V87A, P2186, DOI 10.2106/JBJS.D.02768; Kim WY, 2001, INT ORTHOP, V25, P360, DOI 10.1007/s002640100287; Koval KJ, 1998, CLIN ORTHOP RELAT R, P2; Larsson S, 2002, Scand J Surg, V91, P140; Lindskog DM, 2004, J AM ACAD ORTHOP SUR, V12, P179, DOI 10.5435/00124635-200405000-00006; MARIANI EM, 1987, CLIN ORTHOP RELAT R, P81; Marsh JL, 2007, J ORTHOP TRAUMA, V21, pS1, DOI 10.1097/00005131-200711101-00001; Narayan KK, 2006, ARCH ORTHOP TRAUM SU, V126, P545, DOI 10.1007/s00402-006-0182-x; Papasimos S, 2005, ARCH ORTHOP TRAUM SU, V125, P462, DOI 10.1007/s00402-005-0021-5; PHILLIPS TW, 1989, J BONE JOINT SURG AM, V71A, P913, DOI 10.2106/00004623-198971060-00016; Rodop O, 2002, INT ORTHOP, V26, P233, DOI 10.1007/s00264-002-0358-0; Sancheti KH, 2010, INDIAN J ORTHOP, V44, P428, DOI 10.4103/0019-5413.67122; Sepah YJ, 2010, INT ORTHOP, V34, P431, DOI 10.1007/s00264-009-0803-4; Sidhu AS, 2010, INT ORTHOP, V34, P789, DOI 10.1007/s00264-009-0826-x; Sierra RJ, 2002, CLIN ORTHOP RELAT R, V399, P129; STAPPAERTS KH, 1995, J ORTHOP TRAUMA, V9, P292, DOI 10.1097/00005131-199509040-00004; STERN MB, 1987, CLIN ORTHOP RELAT R, P75; Watson JT, 1998, CLIN ORTHOP RELAT R, P79; Zuckerman JD, 1996, NEW ENGL J MED, V334, P1519, DOI 10.1056/NEJM199606063342307	40	14	20	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39531	10.1371/journal.pone.0039531	http://dx.doi.org/10.1371/journal.pone.0039531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745778	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900071
J	Messina, V; Meikar, O; Paronetto, MP; Calabretta, S; Geremia, R; Kotaja, N; Sette, C				Messina, Valeria; Meikar, Oliver; Paronetto, Maria Paola; Calabretta, Sara; Geremia, Raffaele; Kotaja, Noora; Sette, Claudio			The RNA Binding Protein SAM68 Transiently Localizes in the Chromatoid Body of Male Germ Cells and Influences Expression of Select MicroRNAs	PLOS ONE			English	Article							SPLICING REGULATOR SAM68; MOUSE SPERMATOGENESIS; PROSTATE-CANCER; MESSENGER-RNAS; HNRNP A1; BODIES; SPERMATOCYTES; PROTOONCOGENE; ACCUMULATION; TRANSLATION	The chromatoid body (CB) is a unique structure of male germ cells composed of thin filaments that condense into a perinuclear organelle after meiosis. Due to the presence of proteins involved in different steps of RNA metabolism and of different classes of RNAs, including microRNAs (miRNAs), the CB has been recently suggested to function as an RNA processing centre. Herein, we show that the RNA binding protein SAM68 transiently localizes in the CB, in concomitance with the meiotic divisions of mouse spermatocytes. Precise staging of the seminiferous tubules and co-localization studies with MVH and MILI, two well recognized CB markers, documented that SAM68 transiently associates with the CB in secondary spermatocytes and early round spermatids. Furthermore, although SAM68 co-immunoprecipitated with MVH in secondary spermatocytes, its ablation did not affect the proper localization of MVH in the CB. On the other hand, ablation of the CB constitutive component MIWI did not impair association of SAM68 with the CB. Isolation of CBs from Sam68 wild type and knockout mouse testes and comparison of their protein content by mass spectrometry indicated that Sam68 ablation did not cause overall alterations in the CB proteome. Lastly, we found that SAM68 interacts with DROSHA and DICER in secondary spermatocytes and early round spermatids and that a subset of miRNAs were altered in Sam68(-/-) germ cells. These results suggest a novel role for SAM68 in the miRNA pathway during spermatogenesis.	[Messina, Valeria; Calabretta, Sara; Geremia, Raffaele; Sette, Claudio] Univ Roma Tor Vergata, Sect Anat, Dept Publ Hlth & Cell Biol, Rome, Italy; [Messina, Valeria; Paronetto, Maria Paola; Sette, Claudio] Fdn Santa Lucia IRCCS, Lab Neuroembryol, Rome, Italy; [Meikar, Oliver; Kotaja, Noora] Univ Turku, Dept Physiol, Inst Biomed, Turku, Finland; [Paronetto, Maria Paola] Univ Rome Foro Ital, Dept Hlth Sci, Rome, Italy; [Calabretta, Sara] Univ Roma La Sapienza, Digest & Liver Dis Unit, Med Sch 2, S Andrea Hosp, Rome, Italy	University of Rome Tor Vergata; IRCCS Santa Lucia; University of Turku; Foro Italico University of Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Messina, V (corresponding author), Univ Roma Tor Vergata, Sect Anat, Dept Publ Hlth & Cell Biol, Rome, Italy.	claudio.sette@uniroma2.it	Messina, Valeria/J-4912-2016; Sette, Claudio/S-4307-2019; Paronetto, Maria Paola/A-9578-2012	Sette, Claudio/0000-0003-2864-8266; GEREMIA, Raffaele/0000-0001-9056-6603; Kotaja, Noora/0000-0003-1503-9170; Paronetto, Maria Paola/0000-0001-5324-0903	Telethon [GGP09154]; Associazione Italiana Ricerca sul Cancro (AIRC) [IG 10348, MFAG 11658]; Italian Ministry of Education	Telethon(Fondazione Telethon); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education	This work was supported by Grants from Telethon to C.S. (GGP09154), The Associazione Italiana Ricerca sul Cancro (AIRC) to C.S. (IG 10348) and to M.P.P. (MFAG 11658) and the Italian Ministry of Education (PRIN 2008) to R. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benda C, 1891, ARCH ANAT PHYSL, P549; Bielli P, 2011, ENDOCR-RELAT CANCER, V18, pR91, DOI 10.1530/ERC-11-0041; Busa R, 2007, ONCOGENE, V26, P4372, DOI 10.1038/sj.onc.1210224; Busa R, 2010, NUCLEIC ACIDS RES, V38, P3005, DOI 10.1093/nar/gkq004; Chi MN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004900; Chuma S, 2009, MOL CELL ENDOCRINOL, V306, P17, DOI 10.1016/j.mce.2008.11.009; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Ginter-Matuszewska B, 2011, HISTOCHEM CELL BIOL, V136, P279, DOI 10.1007/s00418-011-0842-y; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Henao-Mejia J, 2009, EXP CELL RES, V315, P3381, DOI 10.1016/j.yexcr.2009.07.011; Henao-Mejia J, 2009, MOL CELL, V33, P87, DOI 10.1016/j.molcel.2008.11.024; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Kotaja N, 2006, J CELL SCI, V119, P2819, DOI 10.1242/jcs.03022; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Meikar O, 2011, REPRODUCTION, V142, P195, DOI 10.1530/REP-11-0057; Meikar O, 2010, EXP CELL RES, V316, P1567, DOI 10.1016/j.yexcr.2010.02.023; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Onohara Y, 2010, HISTOCHEM CELL BIOL, V133, P627, DOI 10.1007/s00418-010-0699-5; PANIAGUA R, 1986, ANAT EMBRYOL, V174, P301, DOI 10.1007/BF00698780; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Paronetto MP, 2011, NUCLEIC ACIDS RES, V39, P4961, DOI 10.1093/nar/gkr085; Paronetto MP, 2010, CANCER RES, V70, P229, DOI 10.1158/0008-5472.CAN-09-2788; Paronetto MP, 2010, INT J ANDROL, V33, P2, DOI 10.1111/j.1365-2605.2009.00959.x; Paronetto MP, 2009, J CELL BIOL, V185, P235, DOI 10.1083/jcb.200811138; Paronetto MP, 2006, MOL BIOL CELL, V17, P14, DOI 10.1091/mbc.e05-06-0548; Paronetto MP, 2004, EMBO J, V23, P4649, DOI 10.1038/sj.emboj.7600448; Parvinen M, 2005, INT J ANDROL, V28, P189, DOI 10.1111/j.1365-2605.2005.00542.x; Pedrotti S, 2010, EMBO J, V29, P1235, DOI 10.1038/emboj.2010.19; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Richard S, 2005, PLOS GENET, V1, P676, DOI 10.1371/journal.pgen.0010074; Ru P, 2012, MOL CANCER THER, V11, P1166, DOI 10.1158/1535-7163.MCT-12-0100; Sette C, 1999, J BIOL CHEM, V274, P33571, DOI 10.1074/jbc.274.47.33571; Sette C, 2010, J ANDROL, V31, P66, DOI 10.2164/jandrol.109.008136; Subramanyam D, 2011, CURR OPIN GENET DEV, V21, P498, DOI 10.1016/j.gde.2011.04.011; SUD BN, 1961, Q J MICROSC SCI, V102, P273; Takada S, 2009, RNA, V15, P1507, DOI 10.1261/rna.1418309; Tanaka T, 2011, P NATL ACAD SCI USA, V108, P10579, DOI 10.1073/pnas.1015447108; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Tsai-Morris CH, 2004, P NATL ACAD SCI USA, V101, P6373, DOI 10.1073/pnas.0401855101; Valacca C, 2010, J CELL BIOL, V191, P87, DOI 10.1083/jcb.201001073; Vasileva A, 2009, CURR BIOL, V19, P630, DOI 10.1016/j.cub.2009.02.047; Ventela S, 2003, MOL BIOL CELL, V14, P2768, DOI 10.1091/mbc.E02-10-0647; Wu H, 2010, MOL CELL, V38, P67, DOI 10.1016/j.molcel.2010.02.021; Yokota S, 2008, ACTA HISTOCHEM CYTOC, V41, P65, DOI 10.1267/ahc.08010	47	14	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39729	10.1371/journal.pone.0039729	http://dx.doi.org/10.1371/journal.pone.0039729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745822	gold, Green Published, Green Submitted			2022-12-27	WOS:000305730900109
J	Shi, YC; Yu, CW; Liao, VHC; Pan, TM				Shi, Yeu-Ching; Yu, Chan-Wei; Liao, Vivian Hsiu-Chuan; Pan, Tzu-Ming			Monascus-Fermented Dioscorea Enhances Oxidative Stress Resistance via DAF-16/FOXO in Caenorhabditis elegans	PLOS ONE			English	Article							INDUCED DIABETIC-RATS; RED MOLD DIOSCOREA; PURPUREUS NTU 568; LIFE-SPAN; SUPEROXIDE DISMUTASES; HYDROGEN-PEROXIDE; MODEL ORGANISM; CANCER-CELLS; C-ELEGANS; DISEASE	Background: Monascus-fermented products are mentioned in an ancient Chinese pharmacopoeia of medicinal food and herbs. Monascus-fermented products offer valuable therapeutic benefits and have been extensively used in East Asia for several centuries. Several biological activities of Monascus-fermented products were recently described, and the extract of Monascus-fermented products showed strong antioxidant activity of scavenging DPPH radicals. To evaluate whether Monascus-fermented dioscorea products have potential as nutritional supplements, Monascus-fermented dioscorea's modulation of oxidative-stress resistance and associated regulatory mechanisms in Caenorhabditis elegans were investigated. Principal Findings: We examined oxidative stress resistance of the ethanol extract of red mold dioscorea (RMDE) in C. elegans, and found that RMDE-treated wild-type C. elegans showed an increased survival during juglone-induced oxidative stress compared to untreated controls, whereas the antioxidant phenotype was absent from a daf-16 mutant. In addition, the RMDE reduced the level of intracellular reactive oxygen species in C. elegans. Finally, the RMDE affected the subcellular distribution of the FOXO transcription factor, DAF-16, in C. elegans and induced the expression of the sod-3 antioxidative gene. Conclusions: These findings suggest that the RMDE acts as an antioxidative stress agent and thus may have potential as a nutritional supplement. Further studies in C. elegans suggest that the antioxidant effect of RMDE is mediated via regulation of the DAF-16/FOXO-dependent pathway.	[Shi, Yeu-Ching; Yu, Chan-Wei; Liao, Vivian Hsiu-Chuan] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan; [Pan, Tzu-Ming] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Shi, YC (corresponding author), Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan.	vivianliao@ntu.edu.tw; tmpan@ntu.edu.tw	Yu, Chan-Wei/H-4885-2016; Hsiao, Wei-Hung/B-9931-2013	Yu, Chan-Wei/0000-0001-6903-0871; PAN, TZU-MING/0000-0002-9865-1893; Liao, Vivian/0000-0002-4676-9953	NIH National Center for Research Resources	NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Caenorhabditis elegans strains were provided by the Caenorhabditis Genetics Center funded by the NIH National Center for Research Resources.	Aniya Y, 2000, FREE RADICAL BIO MED, V28, P999, DOI 10.1016/S0891-5849(00)00188-X; Ayyadevara S, 2008, AGING CELL, V7, P13, DOI 10.1111/j.1474-9726.2007.00348.x; Bartz RR, 2010, CRIT CARE, V14, DOI 10.1186/cc9185; BLUM J, 1983, ARCH BIOCHEM BIOPHYS, V222, P35, DOI 10.1016/0003-9861(83)90499-X; BRENNER S, 1974, GENETICS, V77, P71; Brown NS, 2001, BREAST CANCER RES, V3, P323, DOI 10.1186/bcr315; Calabrese EJ, 2007, TOXICOL APPL PHARM, V222, P122, DOI 10.1016/j.taap.2007.02.015; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; FOX RB, 1984, J CLIN INVEST, V74, P1456, DOI 10.1172/JCI111558; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Heidler T, 2010, BIOGERONTOLOGY, V11, P183, DOI 10.1007/s10522-009-9239-x; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hileman EO, 2004, CANCER CHEMOTH PHARM, V53, P209, DOI 10.1007/s00280-003-0726-5; Hsu WH, 2010, J SCI FOOD AGR, V90, P2709, DOI 10.1002/jsfa.4144; Hsu YW, 2010, J AGR FOOD CHEM, V58, P8211, DOI 10.1021/jf100930j; Hudson AL, 2011, MOL BIOCHEM PARASIT, V176, P17, DOI 10.1016/j.molbiopara.2010.11.006; Ishii N, 2000, FREE RADICAL RES, V33, P857, DOI 10.1080/10715760000301371; Jansen WTM, 2002, INFECT IMMUN, V70, P5202, DOI 10.1128/IAI.70.9.5202-5207.2002; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; Johnstone IL, 1996, EMBO J, V15, P3633, DOI 10.1002/j.1460-2075.1996.tb00732.x; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kampkotter A, 2007, TOXICOLOGY, V234, P113, DOI 10.1016/j.tox.2007.02.006; Keowkase R, 2010, NEUROPHARMACOLOGY, V59, P358, DOI 10.1016/j.neuropharm.2010.04.008; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Kuningas M, 2007, EUR J HUM GENET, V15, P294, DOI 10.1038/sj.ejhg.5201766; Kuo CF, 2009, J AGR FOOD CHEM, V57, P11397, DOI 10.1021/jf9027798; Larminie CGC, 1996, DNA CELL BIOL, V15, P75, DOI 10.1089/dna.1996.15.75; Lee CL, 2007, J AGR FOOD CHEM, V55, P7162, DOI 10.1021/jf071293j; Lee CL, 2006, APPL MICROBIOL BIOT, V72, P1254, DOI 10.1007/s00253-006-0404-8; Lee CL, 2010, J AGR FOOD CHEM, V58, P2230, DOI 10.1021/jf904027y; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Luo Y, 2006, LIFE SCI, V78, P2066, DOI 10.1016/j.lfs.2005.12.004; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Perry George, 2002, Journal of Biomedicine & Biotechnology, V2, P120, DOI 10.1155/S1110724302203010; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Sarmann J, 2009, J BIOL CHEM, V284, P16482, DOI 10.1074/jbc.M808255200; Schlotterer A, 2009, DIABETES, V58, P2450, DOI 10.2337/db09-0567; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shi YC, 2010, J SCI FOOD AGR, V90, P2519, DOI 10.1002/jsfa.4115; Shi YC, 2010, J AGR FOOD CHEM, V58, P7634, DOI 10.1021/jf101194f; Singh Uma, 2006, Pathophysiology, V13, P129, DOI 10.1016/j.pathophys.2006.05.002; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Wolf M, 2008, J CELL PHYSIOL, V214, P721, DOI 10.1002/jcp.21269; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006	58	20	21	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39515	10.1371/journal.pone.0039515	http://dx.doi.org/10.1371/journal.pone.0039515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745774	gold, Green Submitted, Green Published			2022-12-27	WOS:000305730900068
J	Unlu, S; Tang, SW; Wang, EN; Martinez, I; Tang, DL; Bianchi, ME; Zeh, HJ; Lotze, MT				Unlu, Sebnem; Tang, Siuwah; Wang, E. Na; Martinez, Ivan; Tang, Daolin; Bianchi, Marco E.; Zeh, Herbert J., III; Lotze, Michael T.			Damage Associated Molecular Pattern Molecule-Induced microRNAs (DAMPmiRs) in Human Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							EXPRESSION; CANCER; METASTASIS; SIGNATURE; PATHWAY; DEATH	Endogenous damage associated molecular pattern molecules (DAMPs) released from necrotic, damaged or stressed cells are associated with an inflammatory response. Whether the microRNA (miR) expression signature of this response is different from that of a pathogen associated molecular pattern (PAMP)-stimulated inflammatory response is unknown. We report here that miR-34c and miR-214 are significantly expressed in fresh human peripheral blood mononuclear cells (PBMCs) exposed to DAMP-containing freeze-thaw lysates, or to conditioned media from serum-starved and glucose-deprived cells (p<6x10(-4) and p<3.7x10(-3)), respectively. Interestingly, only miR-34c expression was differentially expressed in PBMCs exposed to freeze-thaw lysates or conditioned media from wildtype High Mobility Group B1 (HMGB1(+/+)) mouse embryonic fibroblast (MEF) cells, when compared to cultures exposed to lysates or conditioned media from HMGB1(-/-) MEFs. miR-155 expression in these cultures was negligible, but was significantly expressed in PBMCs stimulated with Lipopolysaccahride (LPS) or most other Toll-like receptor (TLR) ligands, making it the prototypic "PAMPmiR". Exposure to a damaged human colorectal carcinoma cell line lysate (HCT116) similarly resulted in increased miR-34c and miR-214 levels. When PBMCs were pre-transfected with anti-miR-34c and then exposed to lysate, expression levels of IKK gamma mRNA, a putative target of miR-34c, increased, while protein levels of IKK gamma in cultures transfected with a pre-miR-34c were abrogated. Levels of miR-34c expression (as well as pro-inflammatory cytokines, IL-1 beta and TNF alpha) decreased when PBMC cultures were briefly pre-incubated with the K+ channel (inflammasome) inhibitor, glybenclamide, suggesting that inflammasome activation is upstream of miR-34c expression in response to DAMPs. Our findings demonstrate that a specific microRNA expression signature is associated with the inflammatory response to damaged/injured cells and carries implications for many acute and chronic inflammatory disorders.	[Unlu, Sebnem; Tang, Siuwah; Tang, Daolin; Zeh, Herbert J., III; Lotze, Michael T.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA; [Wang, E. Na] NIH, Dept Transfus Med, Infect Dis & Immunogenet Lab, Bethesda, MD 20892 USA; [Bianchi, Marco E.] San Raffaele Univ, Dept Mol Biol & Funct Genom, Milan, Italy; [Bianchi, Marco E.] Ist Sci San Raffaele, I-20132 Milan, Italy; [Martinez, Ivan] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Yale University	Unlu, S (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA.	unlus@upmc.edu; lotzemt@upmc.edu	Tang, Daolin/B-2905-2010; Tang, Daolin/ABD-5062-2021	Tang, Daolin/0000-0002-1903-6180; Bianchi, Marco Emilio/0000-0002-5329-6445	National Institutes of Health [P01 CA 101944-04]; National Cancer Institute; Clinical and Translational Research award [1U54RR023506-01-PI]; NATIONAL CANCER INSTITUTE [P01CA101944] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Clinical and Translational Research award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This project was funded by the National Institutes of Health (P01 CA 101944-04, PI: Michael T. Lotze, MD), the National Cancer Institute ("Integrating NK and DC into Cancer Therapy") and a Clinical and Translational Research award to Herbert J. Zeh and Bino John. (from 1U54RR023506-01-PI: Steven Reis, MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Buchser WJ, 2012, CANCER RES, V72, P2970, DOI 10.1158/0008-5472.CAN-11-3396; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Krynetskaia N, 2008, MOL PHARMACOL, V73, P260, DOI 10.1124/mol.107.041764; Liang XY, 2012, CANCER RES, V72, P2791, DOI 10.1158/0008-5472.CAN-12-0320; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin SY, 2012, SCIENCE, V336, P477, DOI 10.1126/science.1217032; Lodish HF, 2008, NAT REV IMMUNOL, V8, P238, DOI 10.1038/nri2280; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weiner LM, 2012, NEW ENGL J MED, V366, P1156, DOI 10.1056/NEJMcibr1114526; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Yang H, 2008, CANCER RES, V68, P1609; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488	33	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38899	10.1371/journal.pone.0038899	http://dx.doi.org/10.1371/journal.pone.0038899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745684	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000305730900022
J	Vaulot, D; Lepere, C; Toulza, E; De la Iglesia, R; Poulain, J; Gaboyer, F; Moreau, H; Vandepoele, K; Ulloa, O; Gavory, F; Piganeau, G				Vaulot, Daniel; Lepere, Cecile; Toulza, Eve; De la Iglesia, Rodrigo; Poulain, Julie; Gaboyer, Frederic; Moreau, Herve; Vandepoele, Klaas; Ulloa, Osvaldo; Gavory, Frederick; Piganeau, Gwenael			Metagenomes of the Picoalga Bathycoccus from the Chile Coastal Upwelling	PLOS ONE			English	Article							SOUTH EAST PACIFIC; MEDITERRANEAN SEA; GENETIC DIVERSITY; EUKARYOTIC PICOPHYTOPLANKTON; OSTREOCOCCUS CHLOROPHYTA; MARINE PICOEUKARYOTES; PHYTOPLANKTON; PRASINOPHYCEAE; PICOPLANKTON; GENOMES	Among small photosynthetic eukaryotes that play a key role in oceanic food webs, picoplanktonic Mamiellophyceae such as Bathycoccus, Micromonas, and Ostreococcus are particularly important in coastal regions. By using a combination of cell sorting by flow cytometry, whole genome amplification (WGA), and 454 pyrosequencing, we obtained metagenomic data for two natural picophytoplankton populations from the coastal upwelling waters off central Chile. About 60% of the reads of each sample could be mapped to the genome of Bathycoccus strain from the Mediterranean Sea (RCC1105), representing a total of 9 Mbp (sample T142) and 13 Mbp (sample T149) of non-redundant Bathycoccus genome sequences. WGA did not amplify all regions uniformly, resulting in unequal coverage along a given chromosome and between chromosomes. The identity at the DNA level between the metagenomes and the cultured genome was very high (96.3% identical bases for the three larger chromosomes over a 360 kbp alignment). At least two to three different genotypes seemed to be present in each natural sample based on read mapping to Bathycoccus RCC1105 genome.	[Vaulot, Daniel; Lepere, Cecile; Gaboyer, Frederic] Univ Paris 06, UPMC, Roscoff, France; [Vaulot, Daniel; Lepere, Cecile; Gaboyer, Frederic] CNRS, Biol Stn, UMR 7144, Roscoff, France; [Toulza, Eve; Moreau, Herve; Piganeau, Gwenael] CNRS, Banyuls Sur Mer, France; [Toulza, Eve; Moreau, Herve; Piganeau, Gwenael] Univ Paris 06, UPMC, OOB, UMR 7232, Banyuls Sur Mer, France; [De la Iglesia, Rodrigo; Ulloa, Osvaldo] Univ Concepcion, Dept Oceanog, Concepcion, Chile; [De la Iglesia, Rodrigo; Ulloa, Osvaldo] Univ Concepcion, Ctr Invest Oceanog Pacifico Sur Oriental, Concepcion, Chile; [Poulain, Julie; Gavory, Frederick] CEA, Inst Genom, Genoscope, Evry, France; [Vandepoele, Klaas] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Vandepoele, Klaas] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universidad de Concepcion; Universidad de Concepcion; CEA; Flanders Institute for Biotechnology (VIB); Ghent University	Vaulot, D (corresponding author), Univ Paris 06, UPMC, Pl G Tessier, Roscoff, France.	vaulot@sb-roscoff.fr	Vaulot, Daniel/T-6649-2019; Piganeau, Gwenael V/C-7600-2011; Vandepoele, Klaas/E-7514-2010; Ulloa, Osvaldo/E-1821-2011; Toulza, Eve/A-9919-2012	Vaulot, Daniel/0000-0002-0717-5685; Piganeau, Gwenael V/0000-0002-9992-4187; Vandepoele, Klaas/0000-0003-4790-2725; Ulloa, Osvaldo/0000-0002-9501-5576; Toulza, Eve/0000-0003-2049-2279; Poulain, Julie/0000-0002-8744-3116; Gavory, Frederick/0000-0003-1534-5725	program BIOSOPE cruise; Centre National de la Recherche Scientifique; program PICOFUNPAC; Agence Nationale de la Recherche, Biodiversite [06-BDIV-013]; program PHYTOMETAGENE; Japan Science and Technology; program METAPICO; Genoscope; program Micro B3; European Union [287589]; program FONDAP COPAS; Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile; Ghent University; Interuniversity Attraction Poles Programme [IUAP P6/25]; Belgian State, Science Policy Office (BioMaGNet)	program BIOSOPE cruise; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); program PICOFUNPAC; Agence Nationale de la Recherche, Biodiversite(French National Research Agency (ANR)); program PHYTOMETAGENE; Japan Science and Technology(Japan Science & Technology Agency (JST)); program METAPICO; Genoscope; program Micro B3; European Union(European Commission); program FONDAP COPAS(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile; Ghent University(Ghent University); Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian State, Science Policy Office (BioMaGNet)	This research was supported by the following programs: BIOSOPE cruise (Funded by the Centre National de la Recherche Scientifique), PICOFUNPAC (funded by the Agence Nationale de la Recherche, Biodiversite 06-BDIV-013), PHYTOMETAGENE (jointly funded by Japan Science and Technology and Centre National de la Recherche Scientifique), METAPICO (funded by Genoscope), Micro B3 (funded by the European Union, contract 287589) and FONDAP COPAS (funded by Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile). KV acknowledges the support of Ghent University (Multidisciplinary Research Partnership "Bioinformatics: from nucleotides to networks") and the Interuniversity Attraction Poles Programme [IUAP P6/25], initiated by the Belgian State, Science Policy Office (BioMaGNet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Claustre H, 2008, BIOGEOSCIENCES, V5, P679, DOI 10.5194/bg-5-679-2008; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Collado-Fabbri S, 2011, LIMNOL OCEANOGR, V56, P2334, DOI 10.4319/lo.2011.56.6.2334; Countway PD, 2006, APPL ENVIRON MICROB, V72, P2496, DOI 10.1128/AEM.72.4.2496-2506.2006; Coyne J.A., 2004, SPECIATION; Cuvelier ML, 2010, P NATL ACAD SCI USA, V107, P14679, DOI 10.1073/pnas.1001665107; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Drummond A., 2011, GENEIOUS V 5 4; Frias-Lopez J, 2009, ENVIRON MICROBIOL, V11, P512, DOI 10.1111/j.1462-2920.2008.01793.x; Fuller NJ, 2006, AQUAT MICROB ECOL, V43, P79, DOI 10.3354/ame043079; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Grimsley N, 2010, MOL BIOL EVOL, V27, P47, DOI 10.1093/molbev/msp203; Grob C, 2007, BIOGEOSCIENCES, V4, P837, DOI 10.5194/bg-4-837-2007; Heywood JL, 2011, ISME J, V5, P674, DOI 10.1038/ismej.2010.155; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jancek S, 2008, MOL BIOL EVOL, V25, P2293, DOI 10.1093/molbev/msn168; Jardillier L, 2010, ISME J, V4, P1180, DOI 10.1038/ismej.2010.36; Lepere C, 2011, FEMS MICROBIOL ECOL, V76, P513, DOI 10.1111/j.1574-6941.2011.01072.x; Liu H, 2009, P NATL ACAD SCI USA, V106, P12803, DOI 10.1073/pnas.0905841106; LIWKW, 1994, LIMNOL OCEANOGR, V39, P169; Lovejoy C, 2007, J PHYCOL, V43, P78, DOI 10.1111/j.1529-8817.2006.00310.x; Man-Aharonovich D, 2010, ISME J, V4, P1044, DOI 10.1038/ismej.2010.25; Marie D, 2006, FEMS MICROBIOL ECOL, V55, P403, DOI 10.1111/j.1574-6941.2005.00058.x; Marin B, 2010, PROTIST, V161, P304, DOI 10.1016/j.protis.2009.10.002; Massana R, 2008, ENVIRON MICROBIOL, V10, P1335, DOI 10.1111/j.1462-2920.2007.01549.x; McDonald SM, 2007, AQUAT MICROB ECOL, V50, P75, DOI 10.3354/ame01148; McDonald SM, 2010, MOL BIOL EVOL, V27, P2268, DOI 10.1093/molbev/msq113; Monier A, 2012, ENVIRON MICROBIOL, V14, P162, DOI 10.1111/j.1462-2920.2011.02576.x; Moreau H, GENOME BIOL; Moreau H, 2010, J VIROL, V84, P12555, DOI 10.1128/JVI.01123-10; Not F, 2004, APPL ENVIRON MICROB, V70, P4064, DOI 10.1128/AEM.70.7.4064-4072.2004; Not F, 2007, SCIENCE, V315, P253, DOI 10.1126/science.1136264; O'Kelly CJ, 2003, J PHYCOL, V39, P850, DOI 10.1046/j.1529-8817.2003.02201.x; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Piganeau G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r5; Piganeau G, 2007, GENE, V406, P184, DOI 10.1016/j.gene.2007.09.015; Piganeau G, 2009, J MOL EVOL, V69, P249, DOI 10.1007/s00239-009-9271-0; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Rodriguez F, 2005, ENVIRON MICROBIOL, V7, P853, DOI 10.1111/j.1462-2920.2005.00758.x; Schoenfeld T, 2010, TRENDS MICROBIOL, V18, P20, DOI 10.1016/j.tim.2009.10.001; Shi XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018979; Shi XL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007657; Slapeta J, 2006, MOL BIOL EVOL, V23, P23, DOI 10.1093/molbev/msj001; Tai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024249; Treusch AH, 2012, ISME J, V6, P481, DOI 10.1038/ismej.2011.117; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Viprey M, 2008, ENVIRON MICROBIOL, V10, P1804, DOI 10.1111/j.1462-2920.2008.01602.x; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Worden AZ, 2004, LIMNOL OCEANOGR, V49, P168, DOI 10.4319/lo.2004.49.1.0168; Yoon HS, 2011, SCIENCE, V332, P714, DOI 10.1126/science.1203163; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214; Zubkov MV, 2008, NATURE, V455, P224, DOI 10.1038/nature07236	58	46	47	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39648	10.1371/journal.pone.0039648	http://dx.doi.org/10.1371/journal.pone.0039648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745802	Green Published, gold, Green Submitted			2022-12-27	WOS:000305730900092
J	Campbell, EY; Merritt, RW; Cummins, KW; Benbow, ME				Campbell, Emily Y.; Merritt, Richard W.; Cummins, Kenneth W.; Benbow, M. Eric			Spatial and Temporal Variability of Macroinvertebrates in Spawning and Non-Spawning Habitats during a Salmon Run in Southeast Alaska	PLOS ONE			English	Article							MARINE-DERIVED NUTRIENTS; PACIFIC SALMON; BENTHIC INVERTEBRATES; ANADROMOUS SALMON; REDD EXCAVATION; STREAM HABITAT; FLOW REFUGIA; DISTURBANCE; COMMUNITIES; ECOSYSTEMS	Spawning salmon create patches of disturbance through redd digging which can reduce macroinvertebrate abundance and biomass in spawning habitat. We asked whether displaced invertebrates use non-spawning habitats as refugia in streams. Our study explored how the spatial and temporal distribution of macroinvertebrates changed during a pink salmon (Oncorhynchus gorbuscha) spawning run and compared macroinvertebrates in spawning (riffle) and non-spawning (refugia) habitats in an Alaskan stream. Potential refugia included: pools, stream margins and the hyporheic zone, and we also sampled invertebrate drift. We predicted that macroinvertebrates would decline in riffles and increase in drift and refugia habitats during salmon spawning. We observed a reduction in the density, biomass and taxonomic richness of macroinvertebrates in riffles during spawning. There was no change in pool and margin invertebrate communities, except insect biomass declined in pools during the spawning period. Macroinvertebrate density was greater in the hyporheic zone and macroinvertebrate density and richness increased in the drift during spawning. We observed significant invertebrate declines within spawning habitat; however in non-spawning habitat, there were less pronounced changes in invertebrate density and richness. The results observed may be due to spawning-related disturbances, insect phenology, or other variables. We propose that certain in-stream habitats could be important for the persistence of macroinvertebrates during salmon spawning in a Southeast Alaskan stream.	[Campbell, Emily Y.; Merritt, Richard W.; Benbow, M. Eric] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Cummins, Kenneth W.] Humboldt State Univ, Dept Fisheries Biol, Arcata, CA 95521 USA; [Benbow, M. Eric] Univ Dayton, Dept Biol, Dayton, OH 45469 USA	Michigan State University; California State University System; California State Polytechnic University, Humboldt; University of Dayton	Campbell, EY (corresponding author), Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA.	campb613@msu.edu	Benbow, Mark/V-5895-2019		USDA-CSREES National Research Initiative Competitive Grants Program (Ecosystems Program) [2006-35101-16566]; USDA Forest Service Pacific Northwest Research Station (Aquatic-Land Interactions Program)	USDA-CSREES National Research Initiative Competitive Grants Program (Ecosystems Program); USDA Forest Service Pacific Northwest Research Station (Aquatic-Land Interactions Program)	This research was supported by the USDA-CSREES National Research Initiative Competitive Grants Program (Ecosystems Program 2006-35101-16566) and the USDA Forest Service Pacific Northwest Research Station (Aquatic-Land Interactions Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benke AC, 1999, J N AM BENTHOL SOC, V18, P308, DOI 10.2307/1468447; Berryman AA, 2006, OIKOS, V115, P192, DOI 10.1111/j.0030-1299.2006.15188.x; Campbell EY, 2011, J N AM BENTHOL SOC, V30, P49, DOI 10.1899/10-040.1; Chaloner DT, 2004, FRESHWATER BIOL, V49, P587, DOI 10.1111/j.1365-2427.2004.01213.x; FIELDDODGSON MS, 1987, HYDROBIOLOGIA, V154, P3, DOI 10.1007/BF00026826; Gende SM, 2002, BIOSCIENCE, V52, P917, DOI 10.1641/0006-3568(2002)052[0917:PSIAAT]2.0.CO;2; Gjerlov C, 2003, J N AM BENTHOL SOC, V22, P207, DOI 10.2307/1467993; Hauer F.R., 2007, METHODS STREAM ECOLO; HILDEBRAND SG, 1971, T AM FISH SOC, V100, P61, DOI 10.1577/1548-8659(1971)100<61:TEOCSO>2.0.CO;2; Hynes HBN, 1975, FRESHWATER BIOL, V5, P515; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; KERANS BL, 1992, J N AM BENTHOL SOC, V11, P377, DOI 10.2307/1467559; LANCASTER J, 1993, J N AM BENTHOL SOC, V12, P385, DOI 10.2307/1467619; Lessard JL, 2006, OIKOS, V113, P334, DOI 10.1111/j.2006.0030-1299.14512.x; Lessard JL, 2009, J N AM BENTHOL SOC, V28, P683, DOI 10.1899/08-141.1; Levi PS, 2011, CAN J FISH AQUAT SCI, V68, P1316, DOI [10.1139/F2011-067, 10.1139/f2011-067]; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Merritt R. W., 2008, INTRO AQUATIC INSECT; Minakawa N, 2003, T AM FISH SOC, V132, P598, DOI 10.1577/1548-8659(2003)132<0598:EOCSRE>2.0.CO;2; Monaghan KA, 2009, J N AM BENTHOL SOC, V28, P153, DOI 10.1899/08-071.1; Moore JW, 2008, J ANIM ECOL, V77, P275, DOI 10.1111/j.1365-2656.2007.01336.x; Moore JW, 2010, P ROY SOC B-BIOL SCI, V277, P1695, DOI 10.1098/rspb.2009.2342; Moore JW, 2004, OECOLOGIA, V139, P298, DOI 10.1007/s00442-004-1509-3; Negishi JN, 2002, FRESHWATER BIOL, V47, P1515, DOI 10.1046/j.1365-2427.2002.00877.x; Oliver MJ, 1997, FRESHWATER BIOL, V37, P257; PALMER MA, 1992, OECOLOGIA, V89, P182, DOI 10.1007/BF00317217; Peterson DP, 2000, T AM FISH SOC, V129, P924, DOI 10.1577/1548-8659(2000)129<0924:DOSSHB>2.3.CO;2; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; RESH VH, 1988, J N AM BENTHOL SOC, V7, P433, DOI 10.2307/1467300; Rosario RBD, 2000, J N AM BENTHOL SOC, V50, P839; Ruegg J, 2011, CAN J FISH AQUAT SCI, V68, P277, DOI 10.1139/F10-145; SEDELL JR, 1990, ENVIRON MANAGE, V14, P711, DOI 10.1007/BF02394720; Tiegs SD, 2008, ECOL APPL, V18, P4, DOI 10.1890/07-0655.1; Tiegs SD, 2009, FRESHWATER BIOL, V54, P1864, DOI 10.1111/j.1365-2427.2009.02232.x; White P.S., 1985, ECOLOGY NATURAL DIST; Winterbottom JH, 1997, FRESHWATER BIOL, V38, P37, DOI 10.1046/j.1365-2427.1997.00191.x	36	6	6	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39254	10.1371/journal.pone.0039254	http://dx.doi.org/10.1371/journal.pone.0039254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745724	Green Published, gold			2022-12-27	WOS:000305693200054
J	Kempf, M; Rolain, JM; Diatta, G; Azza, S; Samb, B; Mediannikov, O; Sow, AG; Diene, SM; Fenollar, F; Raoult, D				Kempf, Marie; Rolain, Jean-Marc; Diatta, Georges; Azza, Said; Samb, Bissoum; Mediannikov, Oleg; Sow, Amy Gassama; Diene, Seydina M.; Fenollar, Florence; Raoult, Didier			Carbapenem Resistance and Acinetobacter baumannii in Senegal: The Paradigm of a Common Phenomenon in Natural Reservoirs	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; TROPHERYMA-WHIPPLEI; FECAL SAMPLES; IDENTIFICATION; GENES; PREVALENCE; EMERGENCE; EUROPE; SPP.; SKIN	Incidence of carbapenem-resistant Acinetobacter baumannii is rising in several parts of the world. In Africa, data concerning this species and its resistance to carbapenems are limited. The objective of the present study was to identify the presence of A. baumannii carbapenem-resistant encoding genes in natural reservoirs in Senegal, where antibiotic pressure is believed to be low. From October 2010 to January 2011, 354 human head lice, 717 human fecal samples and 118 animal fecal samples were screened for the presence of A. baumannii by real time PCR targeting bla(OXA51-like) gene. For all samples positive for A. baumannii, the carbapenemase-hydrolysing oxacillinases bla(OXA23-like) and bla(OXA24-like) were searched for and sequenced, and the isolates harbouring an oxacillinase were genotyped using PCR amplification and sequencing of recA gene. The presence of A. baumannii was detected in 4.0% of the head lice, in 5.4% of the human stool samples and in 5.1% of the animal stool samples tested. No bla(OXA24) gene was detected but six fecal samples and three lice were positive for bla(OXA23-like) gene. The bla(OXA23-like) gene isolated in lice was likely a new oxacillinase sequence. Finally, the A. baumannii detected in stools were all of recA genotype 3 and those detected in lice, of recA genotype 4. This study shows for the first time a reservoir of bla(OXA23-like)-positive gene in human head lice and stool samples in Senegal.	[Kempf, Marie; Rolain, Jean-Marc; Azza, Said; Mediannikov, Oleg; Diene, Seydina M.; Fenollar, Florence; Raoult, Didier] Aix Marseille Univ, UMR CNRS 6236, URMITE, Marseille, France; [Diatta, Georges] Inst Rech Dev, URMITE, Dakar, Senegal; [Samb, Bissoum; Sow, Amy Gassama] Inst Pasteur, Unite Bacteriol Expt, Dakar, Senegal	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Kempf, M (corresponding author), Aix Marseille Univ, UMR CNRS 6236, URMITE, Marseille, France.	didier.raoult@gmail.com	DIENE, Seydina/E-9839-2014; Rolain, Jean-Marc/Y-3788-2019; DIENE, Seydina/AAC-3576-2019; RAOULT, Didier/A-8434-2008; Mediannikov, Oleg/H-4018-2015	DIENE, Seydina/0000-0002-6466-2324; Rolain, Jean-Marc/0000-0002-2402-4467; RAOULT, Didier/0000-0002-0633-5974; Mediannikov, Oleg/0000-0001-6039-2008; KEMPF, Marie/0000-0002-2943-7500				Bakour S, 2012, J MED MICRO IN PRESS; Berlau J, 1999, EUR J CLIN MICROBIOL, V18, P179, DOI 10.1007/s100960050254; Berlau J, 1999, J HOSP INFECT, V42, P201, DOI 10.1053/jhin.1999.0602; Bertrand X, 2012, CLIN THER, V34, P124, DOI 10.1016/j.clinthera.2011.11.023; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dijkshoorn L, 2005, CLIN MICROBIOL INFEC, V11, P329, DOI 10.1111/j.1469-0691.2005.01093.x; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Drissi M, 2010, EUR J CLIN MICROBIOL, V29, P1457, DOI 10.1007/s10096-010-1011-2; Fenollar F, 2010, CLIN INFECT DIS, V51, P515, DOI 10.1086/655677; Fenollar F, 2009, EMERG INFECT DIS, V15, P922, DOI 10.3201/eid1506.090182; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Kempf M, 2012, INT J ANTIMICROB AG, V39, P105, DOI 10.1016/j.ijantimicag.2011.10.004; Kim BN, 2009, LANCET INFECT DIS, V9, P245, DOI 10.1016/S1473-3099(09)70055-6; Kusradze I, 2011, INT J ANTIMICROB AG, V38, P164, DOI 10.1016/j.ijantimicag.2011.03.021; La Scola B, 2004, EMERG INFECT DIS, V10, P1671, DOI 10.3201/eid1009.040242; Luna CM, 2007, RESPIROLOGY, V12, P787, DOI 10.1111/j.1440-1843.2007.01147.x; Mansour W, 2008, MICROB DRUG RESIST, V14, P289, DOI 10.1089/mdr.2008.0838; Meyer E, 2010, CRIT CARE, V14, DOI 10.1186/cc9062; Ogata H, 2000, SCIENCE, V290, P347, DOI 10.1126/science.290.5490.347; Oteo J, 2007, J INFECTION, V55, P260, DOI 10.1016/j.jinf.2007.04.009; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Poirel L, 2008, ANTIMICROB AGENTS CH, V52, P1252, DOI 10.1128/AAC.01304-07; Poirel L, 2012, EMERG INFECT DIS, V18, P523, DOI 10.3201/eid1803.111330; Raoult D, 2010, LANCET, V375, P104, DOI 10.1016/S0140-6736(09)61958-9; Rolain JM, 2011, J INFECT DIS, V204, P1146, DOI 10.1093/infdis/jir475; Rolain JM, 2012, CLIN MICROB IN PRESS; Ruiz M, 2007, CLIN MICROBIOL INFEC, V13, P1192, DOI 10.1111/j.1469-0691.2007.01825.x; Seifert H, 1997, J CLIN MICROBIOL, V35, P2819, DOI 10.1128/JCM.35.11.2819-2825.1997; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Tanaka Y, 2012, J WATER HEALTH, V10, P170, DOI 10.2166/wh.2011.086; Touati M, 2012, INT J ANTIM IN PRESS; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004	36	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39495	10.1371/journal.pone.0039495	http://dx.doi.org/10.1371/journal.pone.0039495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745768	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200082
J	Bishop, FL; Adams, AEM; Kaptchuk, TJ; Lewith, GT				Bishop, Felicity L.; Adams, Alison E. M.; Kaptchuk, Ted J.; Lewith, George T.			Informed Consent and Placebo Effects: A Content Analysis of Information Leaflets to Identify What Clinical Trial Participants Are Told about Placebos	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; INTERVIEWS EXAMINING ATTITUDES; DOUBLE-BLIND; SYSTEMATIC REVIEWS; METAANALYSIS; INTERVENTIONS; ALLOCATION; MEDICINE; QUALITY; ARM	Background: Placebo groups are used in randomised clinical trials (RCTs) to control for placebo effects, which can be large. Participants in trials can misunderstand written information particularly regarding technical aspects of trial design such as randomisation; the adequacy of written information about placebos has not been explored. We aimed to identify what participants in major RCTs in the UK are told about placebos and their effects. Methods and Findings: We conducted a content analysis of 45 Participant Information Leaflets (PILs) using quantitative and qualitative methodologies. PILs were obtained from trials on a major registry of current UK clinical trials (the UKCRN database). Eligible leaflets were received from 44 non-commercial trials but only 1 commercial trial. The main limitation is the low response rate (13.5%), but characteristics of included trials were broadly representative of all non-commercial trials on the database. 84% of PILs were for trials with 50:50 randomisation ratios yet in almost every comparison the target treatments were prioritized over the placebos. Placebos were referred to significantly less frequently than target treatments (7 vs. 27 mentions, p<001) and were significantly less likely than target treatments to be described as triggering either beneficial effects (1 vs. 45, p<001) or adverse effects (4 vs. 39, p<001). 8 PILs (18%) explicitly stated that the placebo treatment was either undesirable or ineffective. Conclusions: PILs from recent high quality clinical trials emphasise the benefits and adverse effects of the target treatment, while largely ignoring the possible effects of the placebo. Thus they provide incomplete and at times inaccurate information about placebos. Trial participants should be more fully informed about the health changes that they might experience from a placebo. To do otherwise jeopardises informed consent and is inconsistent with not only the science of placebos but also the fundamental rationale underpinning placebo controlled trials.	[Bishop, Felicity L.; Lewith, George T.] Univ Southampton, Southampton, Hants, England; [Adams, Alison E. M.] No Arizona Univ, Dept Biol, Flagstaff, AZ 86011 USA; [Kaptchuk, Ted J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Program Placebo Studies, Sch Med, Boston, MA 02215 USA	University of Southampton; Northern Arizona University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Bishop, FL (corresponding author), Univ Southampton, Southampton, Hants, England.	F.L.Bishop@southampton.ac.uk		Bishop, Felicity/0000-0002-8737-6662; Lewith, George/0000-0002-2364-3960	Arthritis Research UK Fellowship [18099]; Rufford Maurice Laing Foundation; Primary Care and Population Sciences Unit, University of Southampton; NIH-NCCAM [K24 AT004095, P01 AT006663, R01 AT004662]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004662] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT004095, P01AT006663] Funding Source: NIH RePORTER; Versus Arthritis [18099] Funding Source: researchfish	Arthritis Research UK Fellowship(Versus Arthritis); Rufford Maurice Laing Foundation; Primary Care and Population Sciences Unit, University of Southampton; NIH-NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Versus Arthritis(Versus Arthritis)	FLB's post at the time of this project was supported by an Arthritis Research UK Fellowship (18099). GTL's post is supported by a grant from the Rufford Maurice Laing Foundation. This study was funded by the Primary Care and Population Sciences Unit, University of Southampton. TJK acknowledges NIH-NCCAM grants: #K24 AT004095, #P01 AT006663 and #R01 AT004662. The study sponsor and funder had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Amanzio M, 2009, PAIN, V146, P261, DOI 10.1016/j.pain.2009.07.010; APPELBAUM PS, 1987, HASTINGS CENT REP, V17, P20, DOI 10.2307/3562038; Asai A, 2004, BIOETHICS, V18, P448, DOI 10.1111/j.1467-8519.2004.00409.x; Avins AL, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-16; Benedetti F, 2008, ANNU REV PHARMACOL, V48, P33, DOI 10.1146/annurev.pharmtox.48.113006.094711; BERGMANN JF, 1994, CLIN TRIAL META-ANAL, V29, P41; Bishop FL, 2012, SOC SCI MED, V74, P767, DOI 10.1016/j.socscimed.2011.11.020; Bishop FL, 2012, QUAL HLTH R IN PRESS; Brody H, 2000, J FAM PRACTICE, V49, P649; Criscione LG, 2003, ARTHRIT RHEUM-ARTHR, V49, P361, DOI 10.1002/art.11057; DAHAN R, 1986, BRIT MED J, V293, P363, DOI 10.1136/bmj.293.6543.363; de Groot FM, 2011, J MANIP PHYSIOL THER, V34, P297, DOI 10.1016/j.jmpt.2011.04.007; Di Blasi Z, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-30; Diener HC, 1999, CEPHALALGIA, V19, P699, DOI 10.1046/j.1468-2982.1999.019008699.x; Dinnett EM, 2005, CLIN TRIALS, V2, P254, DOI 10.1191/1740774505cn089oa; Ellis PM, 1998, AUST NZ J PUBL HEAL, V22, P528, DOI 10.1111/j.1467-842X.1998.tb01432.x; Featherstone K, 1998, BRIT MED J, V317, P1177, DOI 10.1136/bmj.317.7167.1177; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Goetz CG, 2003, MOVEMENT DISORD, V18, P1146, DOI 10.1002/mds.10504; HOWARD J, 1982, CLIN PHARMACOL THER, V32, P543, DOI 10.1038/clpt.1982.201; Hummer M, 2003, J CLIN PSYCHIAT, V64, P277, DOI 10.4088/JCP.v64n0308; Joffe H, 2004, RES METHODS CLIN HLT, P56, DOI DOI 10.4135/9781849209793; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Kaptchuk TJ, 2009, CULT MED PSYCHIAT, V33, P382, DOI 10.1007/s11013-009-9141-7; Kaptchuk TJ, 2001, J CLIN EPIDEMIOL, V54, P541, DOI 10.1016/S0895-4356(00)00347-4; KIRSCH I, 1988, BEHAV NEUROSCI, V102, P319, DOI 10.1037/0735-7044.102.2.319; Kirsch I., 1998, PREVENTION TREATMENT, V1, DOI 10.1037/1522-3736.1.1.12a; Loftus Elizabeth F, 2008, Mcgill J Med, V11, P217; Miller FG, 2009, PERSPECT BIOL MED, V52, P518, DOI 10.1353/pbm.0.0115; Moerman DE, 2002, ANN INTERN MED, V136, P471, DOI 10.7326/0003-4819-136-6-200203190-00011; NEY PG, 1986, MED HYPOTHESES, V21, P119, DOI 10.1016/0306-9877(86)90001-0; NIHR Clinical Research Network, 2011, EL INCL STUD NIHR CL; Papakostas GI, 2009, EUR NEUROPSYCHOPHARM, V19, P34, DOI 10.1016/j.euroneuro.2008.08.009; Patel SM, 2005, NEUROGASTROENT MOTIL, V17, P332, DOI 10.1111/j.1365-2982.2005.00650.x; Pope JE, 2003, J RHEUMATOL, V30, P815; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Rief W, 2009, DRUG SAFETY, V32, P1041, DOI 10.2165/11316580-000000000-00000; Robinson EJ, 2005, HLTH TECHNOLOGY ASSE, P9; Sinyor M, 2010, J CLIN PSYCHIAT, V71, P270, DOI 10.4088/JCP.08r04516blu; UK Clinical Research Collaboration, 2006, UND CLIN TRIALS; Wampold BE, 2005, J CLIN PSYCHOL, V61, P835, DOI 10.1002/jclp.20129; Wechsler ME, 2011, NEW ENGL J MED, V365, P119, DOI 10.1056/NEJMoa1103319; Welton AJ, 1999, BRIT MED J, V318, P1114, DOI 10.1136/bmj.318.7191.1114; WMA, 2008, 59 WMA GEN ASS SEOUL; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Zhang W, 2008, ANN RHEUM DIS, V67, P1716, DOI 10.1136/ard.2008.092015; ZIFFERBLATT SM, 1978, CLIN PHARMACOL THER, V23, P1	50	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39661	10.1371/journal.pone.0039661	http://dx.doi.org/10.1371/journal.pone.0039661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	966GL	22761859	Green Published, gold, Green Accepted			2022-12-27	WOS:000305825800057
J	Saldias, MC; Sassarini, FV; Poblete, CM; Vasquez, AV; Butler, IM				Curilem Saldias, Millaray; Villarroel Sassarini, Felipe; Munoz Poblete, Carlos; Vargas Vasquez, Asticio; Maureira Butler, Ivan			Image Correlation Method for DNA Sequence Alignment	PLOS ONE			English	Article							INVARIANT PATTERN-RECOGNITION; GRAPHICAL REPRESENTATION; FILTER DESIGN; SIMILARITY; SEARCH	The complexity of searches and the volume of genomic data make sequence alignment one of bioinformatics most active research areas. New alignment approaches have incorporated digital signal processing techniques. Among these, correlation methods are highly sensitive. This paper proposes a novel sequence alignment method based on 2-dimensional images, where each nucleic acid base is represented as a fixed gray intensity pixel. Query and known database sequences are coded to their pixel representation and sequence alignment is handled as object recognition in a scene problem. Query and database become object and scene, respectively. An image correlation process is carried out in order to search for the best match between them. Given that this procedure can be implemented in an optical correlator, the correlation could eventually be accomplished at light speed. This paper shows an initial research stage where results were "digitally" obtained by simulating an optical correlation of DNA sequences represented as images. A total of 303 queries (variable lengths from 50 to 4500 base pairs) and 100 scenes represented by 100 x 100 images each (in total, one million base pair database) were considered for the image correlation analysis. The results showed that correlations reached very high sensitivity (99.01%), specificity (98.99%) and outperformed BLAST when mutation numbers increased. However, digital correlation processes were hundred times slower than BLAST. We are currently starting an initiative to evaluate the correlation speed process of a real experimental optical correlator. By doing this, we expect to fully exploit optical correlation light properties. As the optical correlator works jointly with the computer, digital algorithms should also be optimized. The results presented in this paper are encouraging and support the study of image correlation methods on sequence alignment.	[Curilem Saldias, Millaray; Villarroel Sassarini, Felipe; Munoz Poblete, Carlos] Univ La Frontera, Dept Ingn Elect, Temuco, Chile; [Curilem Saldias, Millaray; Munoz Poblete, Carlos; Maureira Butler, Ivan] Comis Nacl Invest Cient & Tecnol Gobierno Reg, Agriaquaculture Nutr Genom Ctr CGNA, Genom & Bioinformat Unit, Temuco, Chile; [Vargas Vasquez, Asticio] Univ La Frontera, Dept Ciencias Fis, Ctr Opt & Photon, Temuco, Chile	Universidad de La Frontera; Universidad de La Frontera	Saldias, MC (corresponding author), Univ La Frontera, Dept Ingn Elect, Temuco, Chile.	millaray@ufro.cl	Vargas, Asticio/H-9123-2015; Maureira-Butler, Ivan J/U-3130-2017; muñoz, carlos/AAN-9317-2020	Maureira-Butler, Ivan J/0000-0001-7360-3580; muñoz, carlos/0000-0001-7737-3102; Curilem, Millaray/0000-0001-8685-221X	Research Direction of the La Frontera University; Genomic and Bioinformatics Unit of the Agriaquaculture Nutritional Genomic Center (CGNA), CONICYT-Regional, GORE La Araucania [R10C1001]	Research Direction of the La Frontera University; Genomic and Bioinformatics Unit of the Agriaquaculture Nutritional Genomic Center (CGNA), CONICYT-Regional, GORE La Araucania(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT Regional/CGNA)	The Research Direction of the La Frontera University and the Genomic and Bioinformatics Unit of the Agriaquaculture Nutritional Genomic Center (CGNA), CONICYT-Regional, GORE La Araucania, R10C1001 financed the work presented in the paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anastassiou D, 2001, IEEE SIGNAL PROC MAG, V18, P8, DOI 10.1109/79.939833; Bi CP, 2010, NEUROCOMPUTING, V73, P2394, DOI 10.1016/j.neucom.2010.01.023; Brodzik AK, 2006, IEEE T SIGNAL PROCES, V54, P2456, DOI 10.1109/TSP.2006.873717; Butt JA, 2006, OPT COMMUN, V262, P17, DOI 10.1016/j.optcom.2005.12.046; Davis JA, 1999, APPL OPTICS, V38, P5004, DOI 10.1364/AO.38.005004; Didelot X, 2010, GENETICS, V186, P1435, DOI 10.1534/genetics.110.120121; Domazet-Loso M, 2011, BIOINFORMATICS, V27, P1466, DOI 10.1093/bioinformatics/btr176; Dougherty ER, 2006, IEEE T SIGNAL P, V54; Goodman J. W., 1996, INTRO FOURIER OPTICS; Guo XF, 2001, CHEM PHYS LETT, V350, P106, DOI 10.1016/S0009-2614(01)01246-5; HORNER JL, 1984, APPL OPTICS, V23, P812, DOI 10.1364/AO.23.000812; JUDAY RD, 1993, APPL OPTICS, V32, P5100, DOI 10.1364/AO.32.005100; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Liew AWC, 2005, PATTERN RECOGN, V38, P2055, DOI 10.1016/j.patcog.2005.02.019; Liu DR, 2006, IEEE T NEURAL NETWOR, V17, P919, DOI 10.1109/TNN.2006.875987; Mount DV, 2010, SEQUENCE GENOME ANAL; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pedroso I, 2008, NUCLEIC ACIDS RES, V36, pD517, DOI 10.1093/nar/gkm886; Pham TD, 2007, PATTERN RECOGN, V40, P516, DOI 10.1016/j.patcog.2006.02.026; Qi ZH, 2010, J THEOR BIOL, V263, P227, DOI 10.1016/j.jtbi.2009.12.012; Randic M, 2000, J CHEM INF COMP SCI, V40, P1235, DOI 10.1021/ci000034q; REFREGIER P, 1990, OPT LETT, V15, P854, DOI 10.1364/OL.15.000854; Rockwood Alan L, 2005, J Biomol Tech, V16, P453; Rosenberg MS, 2009, SEQUENCE ALIGNMENT: METHODS, MODELS, CONCEPTS, AND STRATEGIES, P1; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; San Martin C, 2005, 7 ACIVS ANTW BELG 20, V3708, P162; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; VanderLugt, 1992, OPTICAL SIGNAL PROCE; Vargas A, 2003, OPT LASER ENG, V40, P67, DOI 10.1016/S0143-8166(02)00059-3; Wen ZN, 2005, COMPUT BIOL CHEM, V29, P220, DOI 10.1016/j.compbiolchem.2005.04.007; Wu XM, 2007, BIOINFORMATICS, V23, P1744, DOI 10.1093/bioinformatics/btm248; Wu YH, 2003, CHEM PHYS LETT, V367, P170, DOI 10.1016/S0009-2614(02)01684-6	33	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39221	10.1371/journal.pone.0039221	http://dx.doi.org/10.1371/journal.pone.0039221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22761742	Green Published, gold			2022-12-27	WOS:000305825800024
J	Santini-Oliveira, M; Camacho, LAB; Souza, TML; Luz, PM; Vasconcellos, MTL; Giacoia-Gripp, CBW; Morgado, MG; Nunes, EP; Lemos, AS; Ferreira, ACG; Moreira, RI; Veloso, VG; Siqueira, MM; Grinsztejn, B				Santini-Oliveira, Marilia; Camacho, Luiz A. B.; Souza, Thiago M. L.; Luz, Paula M.; Vasconcellos, Mauricio T. L.; Giacoia-Gripp, Carmem B. W.; Morgado, Mariza G.; Nunes, Estevao P.; Lemos, Alberto S.; Ferreira, Ana C. G.; Moreira, Ronaldo I.; Veloso, Valdilea G.; Siqueira, Marilda M.; Grinsztejn, Beatriz			H1N1pdm09 Adjuvanted Vaccination in HIV-Infected Adults: A Randomized Trial of Two Single versus Two Double Doses	PLOS ONE			English	Article							CLINICAL-TRIALS; SPLIT VIRION; INFLUENZA; IMMUNOGENICITY; WOMEN; REPRESENTATION; IMMUNIZATION; IMMUNITY; VIRUS	Background: Since human immunodeficiency virus (HIV)-infected individuals are at increased risk of severe disease from pandemic influenza A (H1N1pdm09), vaccination was recommended as a prevention strategy. The aim of the present study was to evaluate the safety, immunogenicity and persistence of the immune response after vaccination against pandemic influenza A (H1N1pdm09) with an adjuvanted vaccine in human immunodeficiency virus (HIV)-infected adults using two single and two double doses. Methodology/Principal Findings: Open label, randomized trial to evaluate the immune response following H1N1pdm09 vaccination in HIV-infected participants compared to HIV-negative controls (NCT01155037). HIV-infected participants were randomized to receive 2 single (3.75 mu g hemagglutinin) or 2 double (7.5 mu g hemagglutinin) doses of the vaccine, 21 days apart. Controls received one dose of the vaccine. The primary endpoint was seroconversion as measured by hemagglutination inhibition assay. Two hundred fifty six HIV-infected participants (129 and 127 randomized to single and double doses, respectively) and 71 HIV-negative controls were enrolled. Among HIV-infected participants, seroconversion increased from 46.7% and 51.7% after the first dose to 77.2% and 83.8% after the second dose of the vaccine using single and double doses, respectively. Participants aged.40 years showed higher seroconversion compared to younger participants. Seroconversion among HIV-infected women and those with nadir CD4,200 cells/mm(3) was significantly higher with double doses. Persistence of protective antibodies six months after vaccination was achieved by 80% and 89.9% of the HIV-infected participants who received single and double doses, respectively. Conclusions/Significance: Our results support the recommendation of two double doses of adjuvanted H1N1pdm09 vaccine for HIV-infected individuals, particularly women, and those aged.40 years or with nadir CD4,200 cells/mm(3), to achieve antibody levels that are both higher and more sustained.	[Santini-Oliveira, Marilia; Luz, Paula M.; Vasconcellos, Mauricio T. L.; Nunes, Estevao P.; Lemos, Alberto S.; Ferreira, Ana C. G.; Moreira, Ronaldo I.; Veloso, Valdilea G.; Grinsztejn, Beatriz] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Camacho, Luiz A. B.] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil; [Souza, Thiago M. L.; Siqueira, Marilda M.] Fundacao Oswaldo Cruz, Lab Viroses Resp, NIC WHO, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Giacoia-Gripp, Carmem B. W.; Morgado, Mariza G.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Santini-Oliveira, M (corresponding author), Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil.	gbeatriz@ipec.fiocruz.br	de Lemos, Alberto dos Santos/M-4246-2013; LEMOS, ALBERTO/G-6198-2012; Souza, Thiago Moreno L./G-2900-2012; Veloso, Valdilea Gonçalves/J-6189-2012	de Lemos, Alberto dos Santos/0000-0003-0138-6577; Souza, Thiago Moreno L./0000-0003-2212-3899; Luz, Paula/0000-0001-9746-719X	Departamento Nacional de DST e AIDS	Departamento Nacional de DST e AIDS	This study was supported by Departamento Nacional de DST e AIDS (funding) and Programa Nacional de Imunizacoes (vaccines donation), Ministry of Health, Brazil (www.saude.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Beck James M., 2001, American Journal of Respiratory and Critical Care Medicine, V164, P2120; Bickel M, 2011, CLIN INFECT DIS, V52, P122, DOI 10.1093/cid/ciq003; Bickel M, 2010, AIDS, V24, pF31, DOI 10.1097/QAD.0b013e3283398da1; CDC, 2011, UPD CDC EST 2009 H1N; CDC, 2011, IN INFL VACC WHAT YO; CDC, 2011, UPD INT REC HIV INF; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; Crum-Cianflone NF, 2011, VACCINE, V29, P3183, DOI 10.1016/j.vaccine.2011.02.040; Crum-Cianflone NF, 2011, CLIN INFECT DIS, V52, P138, DOI 10.1093/cid/ciq019; Dolin R, 2011, CLIN INFECT DIS, V52, P147, DOI 10.1093/cid/ciq017; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Harris DJ, 2000, NEW ENGL J MED, V343, P475, DOI 10.1056/NEJM200008173430706; Jagsi R, 2009, CANCER-AM CANCER SOC, V115, P3293, DOI 10.1002/cncr.24366; Klein MB, 2007, CLIN INFECT DIS, V45, P234, DOI 10.1086/518986; Launay O, 2011, J INFECT DIS, V204, P124, DOI 10.1093/infdis/jir211; Melloni C, 2010, CIRC-CARDIOVASC QUAL, V3, P135, DOI 10.1161/CIRCOUTCOMES.110.868307; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; MS, 2010, 672010 MS DEP DST AI; OLIVEIRA WK, 2009, EURO SURVEILL, V14; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Settembre EC, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000948; Soonawala D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016496; SVS, 2009, INF EP INFL H1N1 SIT; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Tebas P, 2010, AIDS, V24, P2187, DOI 10.1097/QAD.0b013e32833c6d5c; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; WHO, 2011, FLUNET; World Health Organization, 2009, CDC PROT REALT RTPCR; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430	32	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39310	10.1371/journal.pone.0039310	http://dx.doi.org/10.1371/journal.pone.0039310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22761759	gold, Green Submitted, Green Published			2022-12-27	WOS:000305781700028
J	Hu, YT; Ming, F; Chen, WW; Yan, JY; Xu, ZY; Li, GX; Xu, CY; Yang, JL; Zheng, SJ				Hu, Yi Ting; Ming, Feng; Chen, Wei Wei; Yan, Jing Ying; Xu, Zheng Yu; Li, Gui Xin; Xu, Chun Yan; Yang, Jian Li; Zheng, Shao Jian			TcOPT3, a Member of Oligopeptide Transporters from the Hyperaccumulator Thlaspi caerulescens, Is a Novel Fe/Zn/Cd/Cu Transporter	PLOS ONE			English	Article							HEAVY-METAL HYPERACCUMULATION; ARABIDOPSIS-THALIANA; SACCHAROMYCES-CEREVISIAE; ZINC TRANSPORTER; UPTAKE SYSTEM; GENE ENCODES; PLANTS; NICOTIANAMINE; EXPRESSION; TOLERANCE	Background: Thlaspi caerulescens is a natural selected heavy metal hyperaccumulator that can not only tolerate but also accumulate extremely high levels of heavy metals in the shoots. Thus, to identify the transportors involved in metal long-distance transportation is very important for understanding the mechanism of heavy metal accumulation in this hyperaccumulator. Methodology/Principal Findings: We cloned and characterized a novel gene TcOPT3 of OPT family from T. caerulescens. TcOPT3 was pronouncedly expressed in aerial parts, including stem and leaf. Moreover, in situ hybridization analyses showed that TcOPT3 expressed in the plant vascular systems, especially in the pericycle cells that may be involved in the long-distance transportation. The expression of TcOPT3 was highly induced by iron (Fe) and zinc (Zn) deficiency, especially in the stem and leaf. Sub-cellular localization showed that TcOPT3 was a plasma membrane-localized protein. Furthermore, heterogonous expression of TcOPT3 by mutant yeast (Saccharomyces cerevisiae) complementation experiments demonstrated that TcOPT3 could transport Fe2+ and Zn2+. Moreover, expression of TcOPT3 in yeast increased metal (Fe, Zn, Cu and Cd) accumulation and resulted in an increased sensitivity to cadmium (Cd) and copper (Cu). Conclusions: Our data demonstrated that TcOPT3 might encode an Fe/Zn/Cd/Cu influx transporter with broad-substrate. This is the first report showing that TcOPT3 may be involved in metal long-distance transportation and contribute to the heavy metal hyperaccumulation.	[Hu, Yi Ting; Zheng, Shao Jian] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou, Peoples R China; [Hu, Yi Ting; Chen, Wei Wei; Yan, Jing Ying; Yang, Jian Li; Zheng, Shao Jian] Zhejiang Univ, Coll Life Sci, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou, Peoples R China; [Ming, Feng] Fudan Univ, Inst Plant Biol, Sch Life Sci, Shanghai 200433, Peoples R China; [Xu, Zheng Yu] Anhui Acad Agr Sci, Anhui Prov Lab Nutrient Cycling Resources & Envir, Inst Soil & Fertilizer, Hefei, Peoples R China; [Li, Gui Xin] Zhejiang Univ, Coll Agron & Biotechnol, Hangzhou, Peoples R China; [Xu, Chun Yan] Radiat Environm Monitoring Technol Ctr, State Environm Protect Adm, Hanghzou, Peoples R China	Zhejiang University; Zhejiang University; Fudan University; Anhui Academy of Agricultural Sciences; Zhejiang University	Hu, YT (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou, Peoples R China.	sjzheng@zju.edu.cn	Zheng, Shao Jian/A-3552-2009	Zheng, Shao Jian/0000-0002-3336-8165	NSFC [30625026]; Fundamental Research Funds for Central Universities; Changjiang Scholarship	NSFC(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); Changjiang Scholarship	This work was supported by Changjiang Scholarship, NSFC(30625026) and the Fundamental Research Funds for Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDEREGG G, 1989, J CHEM SOC CHEM COMM, P647, DOI 10.1039/c39890000647; Bovet L, 2003, PLANT CELL ENVIRON, V26, P371, DOI 10.1046/j.1365-3040.2003.00968.x; Cagnac O, 2004, PLANT PHYSIOL, V135, P1378, DOI 10.1104/pp.104.039859; Chu HH, 2010, PLANT PHYSIOL, V154, P197, DOI 10.1104/pp.110.159103; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Courbot M, 2007, PLANT PHYSIOL, V144, P1052, DOI 10.1104/pp.106.095133; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Gendre D, 2007, PLANT J, V49, P1, DOI 10.1111/j.1365-313X.2006.02937.x; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Harada E, 2007, FEBS LETT, V581, P4298, DOI 10.1016/j.febslet.2007.08.011; Hauser M, 2000, J BIOL CHEM, V275, P3037, DOI 10.1074/jbc.275.5.3037; INGROUILLE MJ, 1986, NEW PHYTOL, V102, P219, DOI 10.1111/j.1469-8137.1986.tb00812.x; Kim DY, 2007, PLANT J, V50, P207, DOI 10.1111/j.1365-313X.2007.03044.x; Kim DY, 2006, PLANT PHYSIOL, V140, P922, DOI 10.1104/pp.105.074146; Koh S, 2002, PLANT PHYSIOL, V128, P21, DOI 10.1104/pp.010332; Komminoth P, 1992, Diagn Mol Pathol, V1, P85, DOI 10.1097/00019606-199203000-00014; Kramer U, 2007, FEBS LETT, V581, P2263, DOI 10.1016/j.febslet.2007.04.010; Kumar V, 2009, WORLD C ENG, VIi, P1895; Kumar V, 2009, LECT NOTES ENG COMP, P1863; Lombi E, 2000, NEW PHYTOL, V145, P11, DOI 10.1046/j.1469-8137.2000.00560.x; Lubkowitz MA, 1998, MOL MICROBIOL, V28, P729, DOI 10.1046/j.1365-2958.1998.00827.x; Lubkowitz MA, 1997, MICROBIOL-UK, V143, P387, DOI 10.1099/00221287-143-2-387; Lubkowitz Mark, 2006, Genet Eng (N Y), V27, P35, DOI 10.1007/0-387-25856-6_3; Lubkowitz M, 2011, MOL PLANT, V4, P407, DOI 10.1093/mp/ssr004; Macnair MR, 2003, ADV BOT RES, V40, P63, DOI 10.1016/S0065-2296(05)40002-6; Milner MJ, 2008, ANN BOT-LONDON, V102, P3, DOI 10.1093/aob/mcn063; MINET M, 1992, PLANT J, V2, P417; Morrissey J, 2009, CHEM REV, V109, P4553, DOI 10.1021/cr900112r; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Oomen RJFJ, 2009, NEW PHYTOL, V181, P637, DOI 10.1111/j.1469-8137.2008.02694.x; Papoyan A, 2004, PLANT PHYSIOL, V136, P3814, DOI 10.1104/pp.104.044503; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pike S, 2009, PLANT CELL PHYSIOL, V50, P1923, DOI 10.1093/pcp/pcp136; Pilon M, 2009, CURR OPIN PLANT BIOL, V12, P347, DOI 10.1016/j.pbi.2009.04.011; Plaza S, 2007, J EXP BOT, V58, P1717, DOI 10.1093/jxb/erm025; Puig S, 2009, CURR OPIN PLANT BIOL, V12, P299, DOI 10.1016/j.pbi.2009.04.008; Roosens NH, 2005, PLANTA, V222, P716, DOI 10.1007/s00425-005-0006-1; Salt DE, 1998, ANNU REV PLANT PHYS, V49, P643, DOI 10.1146/annurev.arplant.49.1.643; Stacey G, 2002, TRENDS PLANT SCI, V7, P257, DOI 10.1016/S1360-1385(02)02249-5; Stacey MG, 2006, PLANTA, V223, P291, DOI 10.1007/s00425-005-0087-x; Stacey MG, 2002, PLANT CELL, V14, P2799, DOI 10.1105/tpc.005629; Stacey MG, 2008, PLANT PHYSIOL, V146, P589, DOI 10.1104/pp.107.108183; STEPHAN UW, 1993, PHYSIOL PLANTARUM, V88, P522, DOI 10.1111/j.1399-3054.1993.tb01367.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ueno D, 2011, PLANT J, V66, P852, DOI 10.1111/j.1365-313X.2011.04548.x; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107; Weber M, 2004, PLANT J, V37, P269, DOI 10.1046/j.1365-313X.2003.01960.x; Wintz H, 2003, J BIOL CHEM, V278, P47644, DOI 10.1074/jbc.M309338200; Zhai Z, 2010, NOVEL FUNCTIONS OLD; Zhao H, 1996, J BIOL CHEM, V271, P23203, DOI 10.1074/jbc.271.38.23203; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	54	17	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38535	10.1371/journal.pone.0038535	http://dx.doi.org/10.1371/journal.pone.0038535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22761683	Green Submitted, Green Published, gold			2022-12-27	WOS:000305730900012
J	Liu, YB; Tang, ZX; Darmency, H; Stewart, CN; Di, K; Wei, W; Ma, KP				Liu, Yong-bo; Tang, Zhi-xi; Darmency, Henri; Stewart, C. Neal, Jr.; Di, Kun; Wei, Wei; Ma, Ke-ping			The Effects of Seed Size on Hybrids Formed Rape (Brassica Napus) and Wild Brown Mustard (B. Juncea)	PLOS ONE			English	Article							OILSEED RAPE; SPONTANEOUS HYBRIDIZATION; GROWTH-RATE; BT TRANSGENES; GENE FLOW; RELATIVES; INTROGRESSION; POPULATIONS; RESISTANCE; PLANTS	Background: Seed size has significant implications in ecology, because of its effects on plant fitness. The hybrid seeds that result from crosses between crops and their wild relatives are often small, and the consequences of this have been poorly investigated. Here we report on plant performance of hybrid and its parental transgenic oilseed rape (Brassica napus) and wild B. juncea, all grown from seeds sorted into three seed-size categories. Methodology/Principal Findings: Three seed-size categories were sorted by seed diameter for transgenic B. napus, wild B. juncea and their transgenic and non-transgenic hybrids. The seeds were sown in a field at various plant densities. Globally, small-seeded plants had delayed flowering, lower biomass, fewer flowers and seeds, and a lower thousand-seed weight. The seed-size effect varied among plant types but was not affected by plant density. There was no negative effect of seed size in hybrids, but it was correlated with reduced growth for both parents. Conclusions: Our results imply that the risk of further gene flow would probably not be mitigated by the small size of transgenic hybrid seeds. No fitness cost was detected to be associated with the Bt-transgene in this study.	[Liu, Yong-bo; Tang, Zhi-xi; Di, Kun; Wei, Wei; Ma, Ke-ping] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Liu, Yong-bo; Darmency, Henri] Inst Natl Rech Agron, Agroecol UMR1347, Dijon, France; [Stewart, C. Neal, Jr.] Univ Tennessee, Dept Plant Sci, Knoxville, TN USA; [Liu, Yong-bo] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China; [Di, Kun] PetroChina Tarim Oilfield Co, Korler, Xinjiang, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Chinese Research Academy of Environmental Sciences; China National Petroleum Corporation	Liu, YB (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	weiwei@ibcas.ac.cn	Liu, Yongbo/H-3984-2015; , Weiwei/B-2681-2008; Stewart, Neal/B-4709-2009	Liu, Yongbo/0000-0003-1618-8813; , Weiwei/0000-0002-1815-9314; Stewart, Neal/0000-0003-3026-9193	Natural Science Foundation of China [30970432, 30670316]; United States Department of Agriculture Biotechnology Risk Assessment Grant; PhD joint fellowship between China and France [20072315]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); United States Department of Agriculture Biotechnology Risk Assessment Grant; PhD joint fellowship between China and France	This work was supported by two projects of the Natural Science Foundation of China (grant numbers 30970432, 30670316) and enabled by a United States Department of Agriculture Biotechnology Risk Assessment Grant. This study was also supported by a PhD joint fellowship between China and France (grant number 20072315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SU, 1973, CROP SCI, V13, P119, DOI 10.2135/cropsci1973.0011183X001300010039x; Aparicio N, 2002, J AGR SCI-CAMBRIDGE, V139, P143, DOI 10.1017/S0021859602002411; BARANGER A, 1995, THEOR APPL GENET, V91, P956, DOI 10.1007/BF00223906; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; Bing DJ, 1996, PLANT BREEDING, V115, P470, DOI 10.1111/j.1439-0523.1996.tb00959.x; CHOE HS, 1988, OECOLOGIA, V76, P158, DOI 10.1007/BF00379615; DARMENCY H, 1994, MOL ECOL, V3, P37, DOI 10.1111/j.1365-294X.1994.tb00040.x; Di K, 2009, PEST MANAG SCI, V65, P753, DOI 10.1002/ps.1749; EBER F, 1994, THEOR APPL GENET, V88, P362, DOI 10.1007/BF00223646; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; FRELLO S, 1995, THEOR APPL GENET, V91, P236, DOI 10.1007/BF00220883; GARDNER J C, 1989, Transactions of the Kansas Academy of Science, V92, P49, DOI 10.2307/3628189; Ghersa CM, 2000, FIELD CROP RES, V67, P141, DOI 10.1016/S0378-4290(00)00089-7; Halfhill MD, 2001, THEOR APPL GENET, V103, P659, DOI 10.1007/s001220100613; Harbur MM, 2004, WEED SCI, V52, P578, DOI 10.1614/WS-03-115R1; HARPER J. L., 1970, Annual review of ecology and systematics., V1, P327, DOI 10.1146/annurev.es.01.110170.001551; Harper J. L, 1977, POPULATION BIOL PLAN; JORGENSEN RB, 1994, AM J BOT, V81, P1620, DOI 10.2307/2445340; K Di, 2008, THESIS I BOT; Liu YB, 2010, PLANT SCI, V179, P459, DOI 10.1016/j.plantsci.2010.07.005; MAJOR DJ, 1977, AGRON J, V69, P541, DOI 10.2134/agronj1977.00021962006900040004x; Mason Peter, 2003, Environmental Biosafety Research, V2, P263, DOI 10.1051/ebr:2003016; PETERSON CM, 1989, AGRON J, V81, P245, DOI 10.2134/agronj1989.00021962008100020022x; Pilson D, 2004, ANNU REV ECOL EVOL S, V35, P149, DOI 10.1146/annurev.ecolsys.34.011802.132406; R Core Team, 2018, R LANG ENV STAT COMP; Ramachandran S, 2000, AGRON J, V92, P368, DOI 10.1007/s100870050046; Schafer MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025736; SHANMUGANATHAN V, 1992, ANN BOT-LONDON, V69, P273, DOI 10.1093/oxfordjournals.aob.a088340; Snow AA, 2003, ECOL APPL, V13, P279, DOI 10.1890/1051-0761(2003)013[0279:ABTRHA]2.0.CO;2; Stanton ML, 1985, OECOLOGIA, P67; Stewart CN, 2003, NAT REV GENET, V4, P806, DOI 10.1038/nrg1179; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Vacher C, 2004, THEOR APPL GENET, V109, P806, DOI 10.1007/s00122-004-1696-7; Verdu M, 2005, ECOLOGY, V86, P1385, DOI 10.1890/04-1647; Warwick SI, 2008, MOL ECOL, V17, P1387, DOI 10.1111/j.1365-294X.2007.03567.x; Wei W, 2008, SEED SCI RES, V18, P115, DOI 10.1017/S096025850897433X; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452	37	6	8	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39705	10.1371/journal.pone.0039705	http://dx.doi.org/10.1371/journal.pone.0039705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745814	Green Published, Green Submitted, gold			2022-12-27	WOS:000305730900102
J	Schaub, P; Yu, QJ; Gemmecker, S; Poussin-Courmontagne, P; Mailliot, J; McEwen, AG; Ghisla, S; Al-Babili, S; Cavarelli, J; Beyer, P				Schaub, Patrick; Yu, Qiuju; Gemmecker, Sandra; Poussin-Courmontagne, Pierre; Mailliot, Justine; McEwen, Alastair G.; Ghisla, Sandro; Al-Babili, Salim; Cavarelli, Jean; Beyer, Peter			On the Structure and Function of the Phytoene Desaturase CRTI from Pantoea ananatis, a Membrane-Peripheral and FAD-Dependent Oxidase/Isomerase	PLOS ONE			English	Article							ACYL-COA DEHYDROGENASES; NARCISSUS-PSEUDONARCISSUS; CAROTENOID BIOSYNTHESIS; BETA-CAROTENE; PROTOPORPHYRINOGEN OXIDASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MOLECULAR-OXYGEN; REDOX PATHWAY; CHROMOPLASTS	CRTI-type phytoene desaturases prevailing in bacteria and fungi can form lycopene directly from phytoene while plants employ two distinct desaturases and two cis-tans isomerases for the same purpose. This property renders CRTI a valuable gene to engineer provitamin A-formation to help combat vitamin A malnutrition, such as with Golden Rice. To understand the biochemical processes involved, recombinant CRTI was produced and obtained in homogeneous form that shows high enzymatic activity with the lipophilic substrate phytoene contained in phosphatidyl-choline (PC) liposome membranes. The first crystal structure of apo-CRTI reveals that CRTI belongs to the flavoprotein superfamily comprising protoporphyrinogen IX oxidoreductase and monoamine oxidase. CRTI is a membrane-peripheral oxidoreductase which utilizes FAD as the sole redox-active cofactor. Oxygen, replaceable by quinones in its absence, is needed as the terminal electron acceptor. FAD, besides its catalytic role also displays a structural function by enabling the formation of enzymatically active CRTI membrane associates. Under anaerobic conditions the enzyme can act as a carotene cis-trans isomerase. In silico-docking experiments yielded information on substrate binding sites, potential catalytic residues and is in favor of single half-site recognition of the symmetrical C-40 hydrocarbon substrate.	[Schaub, Patrick; Yu, Qiuju; Gemmecker, Sandra; Al-Babili, Salim; Beyer, Peter] Univ Freiburg, Fac Biol, Ctr Biol Signaling Studies, D-79106 Freiburg, Germany; [Poussin-Courmontagne, Pierre; Mailliot, Justine; McEwen, Alastair G.; Cavarelli, Jean] INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, Dept Biol Struct Integrat,UDS, Illkirch Graffenstaden, France; [Ghisla, Sandro] Univ Konstanz, Dept Biol, Constance, Germany	University of Freiburg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Konstanz	Schaub, P (corresponding author), Univ Freiburg, Fac Biol, Ctr Biol Signaling Studies, Hugstetter Str 55, D-79106 Freiburg, Germany.	peter.beyer@biologie.uni-freiburg.de	Cavarelli, Jean/P-3566-2016; Schaub, Patrick/C-8358-2018	Cavarelli, Jean/0000-0001-8620-8723; Poussin-Courmontagne, Pierre/0000-0003-4813-6882; McEwen, Alastair G./0000-0003-4484-3512; Mailliot, Justine/0000-0002-1026-542X; Al-Babili, Salim/0000-0003-4823-2882	HarvestPlus research consortium; International Rice Research Institute; Bill and Melinda Gates Foundation	HarvestPlus research consortium; International Rice Research Institute(CGIAR); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the HarvestPlus research consortium (www.harvestplus.org) and the International Rice Research Institute (http://irri.org/goldenrice) who received grants from the Bill and Melinda Gates Foundation. The contribution of the German-Israeli Foundation for Scientific Research and Development (www.gif.org) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AlBabili S, 1996, PLANT J, V9, P601, DOI 10.1046/j.1365-313X.1996.9050601.x; Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Arnoux P, 2009, PLANT CELL, V21, P2036, DOI 10.1105/tpc.109.068007; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartley GE, 1999, EUR J BIOCHEM, V259, P396, DOI 10.1046/j.1432-1327.1999.00051.x; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; BEYER P, 1989, EUR J BIOCHEM, V184, P141, DOI 10.1111/j.1432-1033.1989.tb15000.x; Bonk M, 1996, PLANT PHYSIOL, V111, P931, DOI 10.1104/pp.111.3.931; Bonk M, 1997, EUR J BIOCHEM, V247, P942, DOI 10.1111/j.1432-1033.1997.00942.x; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bricogne G, BUSTER 2 9; Carol P, 2001, TRENDS PLANT SCI, V6, P31, DOI 10.1016/S1360-1385(00)01811-2; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 2010, PLANT PHYSIOL, V153, P66, DOI 10.1104/pp.110.153916; Corradi HR, 2006, J BIOL CHEM, V281, P38625, DOI 10.1074/jbc.M606640200; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dailey TA, 1998, J BIOL CHEM, V273, P13658, DOI 10.1074/jbc.273.22.13658; Diretto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000350; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faust A, 2007, J MOL BIOL, V367, P234, DOI 10.1016/j.jmb.2006.11.071; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; FRASER PD, 1992, J BIOL CHEM, V267, P19891; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; HAMILTON RL, 1980, J LIPID RES, V21, P981; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; HENGARTNER U, 1992, HELV CHIM ACTA, V75, P1848, DOI 10.1002/hlca.19920750611; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Kim JJP, 2004, EUR J BIOCHEM, V271, P483, DOI 10.1046/j.1432-1033.2003.03948.x; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Koch M, 2004, EMBO J, V23, P1720, DOI 10.1038/sj.emboj.7600189; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li FQ, 2007, PLANT PHYSIOL, V144, P1181, DOI 10.1104/PP.107.098996; MAYER MP, 1990, EUR J BIOCHEM, V191, P359, DOI 10.1111/j.1432-1033.1990.tb19130.x; MISAWA N, 1993, PLANT J, V4, P833, DOI 10.1046/j.1365-313X.1993.04050833.x; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Morstadt L, 2002, PLANTA, V215, P134, DOI 10.1007/s00425-001-0724-y; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NIEVELSTEIN V, 1995, EUR J BIOCHEM, V233, P864, DOI 10.1111/j.1432-1033.1995.864_3.x; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; Qin XH, 2010, J STRUCT BIOL, V170, P76, DOI 10.1016/j.jsb.2009.11.012; Romer S, 2000, NAT BIOTECHNOL, V18, P666, DOI 10.1038/76523; Rudik I, 2001, ARCH BIOCHEM BIOPHYS, V392, P341, DOI 10.1006/abbi.2001.2467; Saga G, 2010, J BIOL CHEM, V285, P23763, DOI 10.1074/jbc.M110.115097; Sandmann G, 2009, ARCH BIOCHEM BIOPHYS, V483, P169, DOI 10.1016/j.abb.2008.10.004; SPENCER R, 1977, BIOCHEMISTRY-US, V16, P3586, DOI 10.1021/bi00635a014; Stickforth P, 2011, ARCH BIOCHEM BIOPHYS, V505, P118, DOI 10.1016/j.abb.2010.09.021; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Yoneyama K, 2010, PLANT CELL PHYSIOL, V51, P1095, DOI 10.1093/pcp/pcq055; Yu QJ, 2011, J BIOL CHEM, V286, P8666, DOI 10.1074/jbc.M110.208017; Yu QJ, 2010, J BIOL CHEM, V285, P12109, DOI 10.1074/jbc.M109.091843; Zhu CF, 2008, P NATL ACAD SCI USA, V105, P18232, DOI 10.1073/pnas.0809737105	60	54	60	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e39550	10.1371/journal.pone.0039550	http://dx.doi.org/10.1371/journal.pone.0039550			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22745782	gold, Green Published, Green Submitted			2022-12-27	WOS:000305730900075
J	Jarosz, M; Robbez-Masson, L; Chioni, AM; Cross, B; Rosewell, I; Grose, R				Jarosz, Monika; Robbez-Masson, Luisa; Chioni, Athina-Myrto; Cross, Barbara; Rosewell, Ian; Grose, Richard			Fibroblast Growth Factor 22 Is Not Essential for Skin Development and Repair but Plays a Role in Tumorigenesis	PLOS ONE			English	Article							GENE-EXPRESSION; RECEPTOR SPECIFICITY; DIFFERENTIATION; KERATINOCYTES; FGF10; LIMB; MORPHOGENESIS; INDUCTION	Fibroblast Growth Factors play critical roles during development, tissue homeostasis and repair by controlling cell proliferation, survival, migration and differentiation. Of the 22 mammalian FGFs, FGF22, a member of the FGF7/10/22 subfamily, has been shown to have a clear role in synaptogenesis, but its roles in other tissues have not been studied. We have investigated the in vivo functions of FGF22 in mice. Fgf22 null animals were viable, fertile and did not display any obvious abnormalities. Despite the known expression profile of FGF22 in the skin, no differences in either skin or pelage were observed, demonstrating that FGF22 is dispensable during embryogenesis and in unchallenged adult skin. Mice lacking FGF22 were able to heal acute wounds just as efficiently as wild type mice. However, classical two-step skin carcinogenesis challenge revealed that FGF22 null mice developed fewer papillomas than wild type controls, suggesting a potential pro-oncogenic role for FGF22 in the skin.	[Jarosz, Monika; Robbez-Masson, Luisa; Chioni, Athina-Myrto; Grose, Richard] Queen Mary Univ London, Ctr Tumour Biol, Barts Canc Inst, London, England; [Cross, Barbara; Rosewell, Ian] Canc Res UK London Res Inst, Clare Hall Labs, Biol Serv, S Mimms, Herts, England	University of London; Queen Mary University London; Cancer Research UK	Jarosz, M (corresponding author), Queen Mary Univ London, Ctr Tumour Biol, Barts Canc Inst, London, England.	r.p.grose@qmul.ac.uk		Grose, Richard/0000-0002-4738-0173; Robbez-Masson, Luisa/0000-0002-6060-8080	Cancer Research UK; Wellcome Trust [076678/Z/05/Z]; Trustees of St Barts; London Charitable Foundation	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Trustees of St Barts; London Charitable Foundation	This research was funded by Cancer Research UK, The Wellcome Trust (076678/Z/05/Z) and the Trustees of St Barts and The London Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer TA, 2003, EXP CELL RES, V287, P228, DOI 10.1016/S0014-4827(03)00139-3; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Braun S, 2004, PHILOS T R SOC B, V359, P753, DOI 10.1098/rstb.2004.1464; Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002; Chioni AM, 2009, EUR J CELL BIOL, V88, P371, DOI 10.1016/j.ejcb.2009.01.004; DANILENKO DM, 1995, AM J PATHOL, V147, P145; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Grose R, 2007, EMBO J, V26, P1268, DOI 10.1038/sj.emboj.7601583; Guo LF, 1996, GENE DEV, V10, P165, DOI 10.1101/gad.10.2.165; GUO LF, 1993, EMBO J, V12, P973, DOI 10.1002/j.1460-2075.1993.tb05738.x; Hamada K, 1999, Exp Dermatol, V8, P347; Igarashi M, 1998, J BIOL CHEM, V273, P13230, DOI 10.1074/jbc.273.21.13230; Itoh N., 2010, J BIOCH; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Keller UAD, 2006, MOL CELL BIOL, V26, P3773, DOI 10.1128/MCB.26.10.3773-3784.2006; Komi-Kuramochi A, 2005, J ENDOCRINOL, V186, P273, DOI 10.1677/joe.1.06055; Kumin A, 2006, AM J PATHOL, V169, P1194, DOI 10.2353/ajpath.2006.060119; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Nakatake Y, 2001, BBA-GENE STRUCT EXPR, V1517, P460, DOI 10.1016/S0167-4781(00)00302-X; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Petiot A, 2003, DEVELOPMENT, V130, P5493, DOI 10.1242/dev.00788; Revest JM, 2001, DEV BIOL, V231, P47, DOI 10.1006/dbio.2000.0144; Schlake T, 2005, DEVELOPMENT, V132, P2981, DOI 10.1242/dev.01873; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Spielberger R, 2004, NEW ENGL J MED, V351, P2590, DOI 10.1056/NEJMoa040125; Sundberg JP., 1994, HDB MOUSE MUTATIONS, P57; Tagashira S, 1997, GENE, V197, P399, DOI 10.1016/S0378-1119(97)00187-X; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896; Yang JX, 2010, J CELL BIOL, V188, P935, DOI 10.1083/jcb.200910126; Zhang HB, 2004, EUR J CELL BIOL, V83, P3, DOI 10.1078/0171-9335-00355; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	36	24	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39436	10.1371/journal.pone.0039436	http://dx.doi.org/10.1371/journal.pone.0039436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737238	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000305695100037
J	Hou, YX; Guo, YY; Wu, CY; Shen, N; Jiang, YP; Wang, JF				Hou, Yanxia; Guo, Yingying; Wu, Chunyan; Shen, Nan; Jiang, Yongping; Wang, Jingfei			Prediction and Identification of T Cell Epitopes in the H5N1 Influenza Virus Nucleoprotein in Chicken	PLOS ONE			English	Article							MHC-CLASS-I; MAJOR HISTOCOMPATIBILITY COMPLEX; TERMINAL PROCESSING MOTIF; AVIAN INFLUENZA; PEPTIDE BINDING; MOLECULE; LIGANDS; PROTEIN; CRYSTALLIZATION; DIVERSITY	T cell epitopes can be used for the accurate monitoring of avian influenza virus (AIV) immune responses and the rational design of vaccines. No T cell epitopes have been previously identified in the H5N1 AIV virus nucleoprotein (NP) in chickens. For the first time, this study used homology modelling techniques to construct three-dimensional structures of the peptide-binding domains of chicken MHC class I molecules for four commonly encountered unique haplotypes, i.e., B4, B12, B15, and B19. H5N1 AIV NP was computationally parsed into octapeptides or nonapeptides according to the peptide-binding motifs of MHC class I molecules of the B4, B12, B15 and B19 haplotypes. Seventy-five peptide sequences were modelled and their MHC class I molecule-binding abilities were analysed by molecular docking. Twenty-five peptides (Ten for B4, six for B12, two for B15, and seven for B19) were predicted to be potential T cell epitopes in chicken. Nine of these peptides and one unrelated peptide were manually synthesized and their T cell responses were tested in vitro. Spleen lymphocytes were collected from SPF chickens that had been immunised with a NP-expression plasmid, pCAGGS-NP, and they were stimulated using the synthesized peptides. The secretion of chicken IFN-gamma and the proliferation of CD8(+) T cells were tested using an ELISA kit and flow cytometry, respectively. The significant secretion of chicken IFN-gamma and proliferation of CD8(+) T lymphocytes increased by 13.7% and 11.9% were monitored in cells stimulated with peptides NP89-97 and NP198-206, respectively. The results indicate that peptides NP89-97 (PKKTGGPIY) and NP198-206 (KRGINDRNF) are NP T cell epitopes in chicken of certain haplotypes. The method used in this investigation is applicable to predicting T cell epitopes for other antigens in chicken, while this study also extends our understanding of the mechanisms of the immune response to AIV in chicken.	[Hou, Yanxia; Guo, Yingying; Wu, Chunyan; Shen, Nan; Jiang, Yongping; Wang, Jingfei] Chinese Acad Agr Sci, Ctr Anim Infect Dis Diag & Tech Serv, Harbin, Heilongjiang, Peoples R China; [Hou, Yanxia; Guo, Yingying; Wu, Chunyan; Shen, Nan; Jiang, Yongping; Wang, Jingfei] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Heilongjiang, Peoples R China; [Jiang, Yongping] Chinese Acad Agr Sci, Minist Agr, Anim Influenza Lab, Harbin, Heilongjiang, Peoples R China	Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Hou, YX (corresponding author), Chinese Acad Agr Sci, Ctr Anim Infect Dis Diag & Tech Serv, Harbin, Heilongjiang, Peoples R China.	ypjiang99@163.com; jingfei_wang@hotmail.com			State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, CAAS, China [SKLVBP201016]; Director Foundation of Harbin Veterinary Research Institute, CAAS, China [ZGKJ201019]	State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, CAAS, China; Director Foundation of Harbin Veterinary Research Institute, CAAS, China	This research was supported by grants from the State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, CAAS, China (grant no. SKLVBP201016) and the Director Foundation of Harbin Veterinary Research Institute, CAAS, China (grant no. ZGKJ201019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOOTS AMH, 1991, IMMUNOLOGY, V74, P8; Brooks BR, 1993, J COMPUT CHEM, P187; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Cavasotto CN, 2009, DRUG DISCOV TODAY, V14, P676, DOI 10.1016/j.drudis.2009.04.006; Chappell P, 2012, COMPLEX B21 IN PRESS; Colaco CALS, 2008, J IMMUNOL, V181, P3731, DOI 10.4049/jimmunol.181.6.3731; Enserink M, 2006, SCIENCE, V311, P932; Falk K, 1993, Semin Immunol, V5, P81, DOI 10.1006/smim.1993.1012; Fauci AS, 2006, CELL, V124, P665, DOI 10.1016/j.cell.2006.02.010; Fauci AS, 2006, EMERG INFECT DIS, V12, P73; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Hassan MI, 2011, ADV PROTEIN CHEM STR, V83, P223, DOI 10.1016/B978-0-12-381262-9.00006-9; Hofmann A, 2003, VACCINE, V21, P4694, DOI 10.1016/S0264-410X(03)00516-4; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Jiang Y, 2007, ANTIVIR RES, V75, P234, DOI 10.1016/j.antiviral.2007.03.009; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; Kellenberger E, 2004, PROTEINS, V57, P225, DOI 10.1002/prot.20149; Kherraz K, 2011, BIOINFORMATION, V6, P115, DOI 10.6026/97320630006115; Koch M, 2007, IMMUNITY, V27, P885, DOI 10.1016/j.immuni.2007.11.007; La Gruta NL, 2008, P NATL ACAD SCI USA, V105, P2034, DOI 10.1073/pnas.0711682102; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; Miller MM, 2004, IMMUNOGENETICS, V56, P261, DOI 10.1007/s00251-004-0682-1; Miteva MA, 2005, J MED CHEM, V48, P6012, DOI 10.1021/jm050262h; Pan XC, 2011, ACTA CRYSTALLOGR F, V67, P568, DOI 10.1107/S174430911100741X; RAMMENSEE HG, 1995, CURR OPIN IMMUNOL, V7, P85, DOI 10.1016/0952-7915(95)80033-6; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reche PA, 2004, IMMUNOGENETICS, V56, P405, DOI 10.1007/s00251-004-0709-7; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; Schatz MM, 2008, J IMMUNOL, V180, P3210, DOI 10.4049/jimmunol.180.5.3210; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Van Kerkhove MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014582; Wallny HJ, 2006, P NATL ACAD SCI USA, V103, P1434, DOI 10.1073/pnas.0507386103; Wang Qun, 2009, Journal of Agricultural Biotechnology, V17, P7; Zhang JH, 2010, ACTA CRYSTALLOGR F, V66, P99, DOI 10.1107/S174430910905088X; Zheng YS, 2007, J VET MED SCI, V69, P213, DOI 10.1292/jvms.69.213	38	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39344	10.1371/journal.pone.0039344	http://dx.doi.org/10.1371/journal.pone.0039344			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745738	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200065
J	Jones, A; McMillan, MR; Jones, RW; Kowalik, GT; Steeden, JA; Deanfield, JE; Pruessner, JC; Taylor, AM; Muthurangu, V				Jones, Alexander; McMillan, Merlin R.; Jones, Russell W.; Kowalik, Grzegorz T.; Steeden, Jennifer A.; Deanfield, John E.; Pruessner, Jens C.; Taylor, Andrew M.; Muthurangu, Vivek			Adiposity Is Associated with Blunted Cardiovascular, Neuroendocrine and Cognitive Responses to Acute Mental Stress	PLOS ONE			English	Article							BODY-MASS INDEX; PITUITARY-ADRENAL AXIS; PHYSICAL-ACTIVITY; OBESITY; FAT; ATHEROSCLEROSIS; METAANALYSIS; PRESSURE; FATNESS	Obesity and mental stress are potent risk factors for cardiovascular disease but their relationship with each other is unclear. Resilience to stress may differ according to adiposity. Early studies that addressed this are difficult to interpret due to conflicting findings and limited methods. Recent advances in assessment of cardiovascular stress responses and of fat distribution allow accurate assessment of associations between adiposity and stress responsiveness. We measured responses to the Montreal Imaging Stress Task in healthy men (N = 43) and women (N = 45) with a wide range of BMIs. Heart rate (HR) and blood pressure (BP) measures were used with novel magnetic resonance measures of stroke volume (SV), cardiac output (CO), total peripheral resistance (TPR) and arterial compliance to assess cardiovascular responses. Salivary cortisol and the number and speed of answers to mathematics problems in the task were used to assess neuroendocrine and cognitive responses, respectively. Visceral and subcutaneous fat was measured using T-2*-IDEAL. Greater BMI was associated with generalised blunting of cardiovascular (HR:beta = -0.50 bpm.unit(-1), P = 0.009; SV:beta = -0.33 mL.unit(-1), P = 0.01; CO:beta = -61 mL.min(-1).unit(-1), P = 0.002; systolic BP:beta = -0.41 mmHg.unit(-1), P = 0.01; TPR: beta = 0.11 WU.unit(-1), P = 0.02), cognitive (correct answers: r = -0.28, P = 0.01; time to answer: r = 0.26, P = 0.02) and endocrine responses (cortisol: r = 20.25, P = 0.04) to stress. These associations were largely determined by visceral adiposity except for those related to cognitive performance, which were determined by both visceral and subcutaneous adiposity. Our findings suggest that adiposity is associated with centrally reduced stress responsiveness. Although this may mitigate some long-term health risks of stress responsiveness, reduced performance under stress may be a more immediate negative consequence.	[Jones, Alexander; McMillan, Merlin R.; Kowalik, Grzegorz T.; Steeden, Jennifer A.; Taylor, Andrew M.; Muthurangu, Vivek] UCL Inst Cardiovasc Sci, Ctr Cardiovasc Imaging, London, England; [Jones, Russell W.] Chorleywood Hlth Ctr, Chorleywood, England; [Jones, Russell W.] Brunel Univ, Dept Informat Syst & Comp, Uxbridge UB8 3PH, Middx, England; [Deanfield, John E.] UCL Inst Cardiovasc Sci, Ctr Cardiovasc Prevent & Outcomes, London, England; [Pruessner, Jens C.] McGill Univ, Dept Psychiat, Douglas Inst, Montreal, PQ, Canada	University of London; University College London; Brunel University; University of London; University College London; McGill University	Jones, A (corresponding author), UCL Inst Cardiovasc Sci, Ctr Cardiovasc Imaging, London, England.	alex.jones@ucl.ac.uk	Kowalik, Grzegorz/GXN-3387-2022	Taylor, Andrew/0000-0003-4194-7113; Pruessner, Jens/0000-0002-8582-2980; Deanfield, John/0000-0001-8806-6052; Kowalik, Grzegorz/0000-0003-3267-8652; Steeden, Jennifer/0000-0002-9792-2022; Muthurangu, Vivek/0000-0002-4292-6456	UK National Institute of Health Research (NIHR) via the Great Ormond Street Hospital/Institute of Child Health Biomedical Research Centre; Siemens Medical Systems; British Heart Foundation (BHF) Chair of Cardiology; NIHR; Fondation Leducq; BHF; British Heart Foundation [FS/08/012/24454] Funding Source: researchfish	UK National Institute of Health Research (NIHR) via the Great Ormond Street Hospital/Institute of Child Health Biomedical Research Centre; Siemens Medical Systems(Siemens AG); British Heart Foundation (BHF) Chair of Cardiology; NIHR(National Institute for Health Research (NIHR)); Fondation Leducq(Leducq Foundation); BHF(British Heart Foundation); British Heart Foundation(British Heart Foundation)	The Centre for Cardiovascular MR and AJ are funded by the UK National Institute of Health Research (NIHR) via the Great Ormond Street Hospital/Institute of Child Health Biomedical Research Centre. GK is funded by an educational research grant from Siemens Medical Systems. JD is funded by a British Heart Foundation (BHF) Chair of Cardiology. AMT is funded by an NIHR Senior Research Fellowship & The Fondation Leducq. VM is funded by a BHF Intermediate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Boersma GJ, 2010, PHYSIOL BEHAV, V100, P401, DOI 10.1016/j.physbeh.2010.04.007; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Carroll D, 2008, PSYCHOSOM MED, V70, P653, DOI 10.1097/PSY.0b013e31817b9382; Chida Y, 2010, HYPERTENSION, V55, P1026, DOI 10.1161/HYPERTENSIONAHA.109.146621; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Dallman MF, 2010, TRENDS ENDOCRIN MET, V21, P159, DOI 10.1016/j.tem.2009.10.004; Despres J P, 1998, Obes Res, V6 Suppl 1, p8S; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Flaa A, 2008, AM J CLIN NUTR, V87, P1596, DOI 10.1093/ajcn/87.6.1596; Georgescu A, 2011, CLIN SCI, V120, P463, DOI 10.1042/CS20100355; Groesz LM, 2012, APPETITE, V58, P717, DOI 10.1016/j.appet.2011.11.028; Hamer M, 2007, INT J PSYCHOPHYSIOL, V63, P251, DOI 10.1016/j.ijpsycho.2006.11.002; Heiman ML, 1997, ENDOCRINOLOGY, V138, P3859, DOI 10.1210/en.138.9.3859; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; Jones A, 2011, J MAGN RESON IMAGING, V33, P448, DOI 10.1002/jmri.22438; Juster RP, 2011, PSYCHONEUROENDOCRINO, V36, P797, DOI 10.1016/j.psyneuen.2010.11.001; Kouvonen A, 2005, PSYCHOSOM MED, V67, P577, DOI 10.1097/01.psy.0000170330.08704.62; Kowalik G, 2011, P 19 ANN M ISMRM; Lakka TA, 2001, ATHEROSCLEROSIS, V154, P497, DOI 10.1016/S0021-9150(00)00514-1; Lupien SJ, 2002, PSYCHONEUROENDOCRINO, V27, P401, DOI 10.1016/S0306-4530(01)00061-0; Molarius A, 1998, INT J OBESITY, V22, P719, DOI 10.1038/sj.ijo.0800660; Nakamura T, 1997, INT J OBESITY, V21, P580, DOI 10.1038/sj.ijo.0800445; Office for National Statistics, NAT STAT SOC CLASS; Pasquali R, 1996, METABOLISM, V45, P351, DOI 10.1016/S0026-0495(96)90290-5; POULIOT MC, 1992, DIABETES, V41, P826, DOI 10.2337/diabetes.41.7.826; Steeden JA, 2011, RADIOLOGY, V260, P79, DOI 10.1148/radiol.11101844; Steptoe A, 2005, INT J OBESITY, V29, P1329, DOI 10.1038/sj.ijo.0803011; STERGIOPULOS N, 1994, ANN BIOMED ENG, V22, P392, DOI 10.1007/BF02368245; Tabara Y, 2008, HYPERTENS RES, V31, P1219, DOI 10.1291/hypres.31.1219; Waldstein SR, 1999, HEALTH PSYCHOL, V18, P221; Wardle J, 2011, OBESITY, V19, P771, DOI 10.1038/oby.2010.241; Yu HZ, 2007, J MAGN RESON IMAGING, V26, P1153, DOI 10.1002/jmri.21090; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	35	49	50	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39143	10.1371/journal.pone.0039143	http://dx.doi.org/10.1371/journal.pone.0039143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	964KK	22745709	Green Published, Green Submitted, gold			2022-12-27	WOS:000305693200044
J	Shi, GQ; He, J; Shen, T; Fontaine, RE; Yang, L; Zhou, ZY; Gao, H; Xu, YF; Qin, C; Yang, ZL; Liu, JK; Huang, WL; Zeng, G				Shi, GuoQing; He, Jun; Shen, Tao; Fontaine, Robert E.; Yang, Lin; Zhou, ZhongYu; Gao, Hong; Xu, YanFeng; Qin, Chuan; Yang, ZhuLiang; Liu, JiKai; Huang, WenLi; Zeng, Guang			Hypoglycemia and Death in Mice Following Experimental Exposure to an Extract of Trogia venenata Mushrooms	PLOS ONE			English	Article								Background: Clusters of sudden unexplained death (SUD) in Yunnan Province, China, have been linked to eating Trogia venenata mushrooms. We evaluated the toxic effect of this mushroom on mice. Methods: We prepared extracts of fresh T. venenata and Laccaria vinaceoavellanea mushrooms collected from the environs of a village that had SUD. We randomly allocated mice into treatment groups and administered mushroom extracts at doses ranging from 500 to 3500 mg/kg and water (control) via a gavage needle. We observed mice for mortality for 7 days after a 3500 mg/kg dose and for 24 hours after doses from 500 to 3000 mg/kg. We determined biochemical markers from serum two hours after a 2000 mg/kg dose. Results: Ten mice fed T. venenata extract (3500 mg/kg) died by five hours whereas all control mice (L. vinaceoavellanea extract and water) survived the seven-day observation period. All mice died by five hours after exposure to single doses of T. venenata extract ranging from 1500 to 3000 mg/kg, while the four mice exposed to a 500 mg/kg dose all survived. Mice fed 2000 mg/kg of T. venenata extract developed profound hypoglycemia (median = 0.66 mmol/L) two hours after exposure. Discussion: Hypoglycemia and death within hours of exposure, a pattern unique among mushroom toxicity, characterize T. venenata poisoning.	[Shi, GuoQing; Shen, Tao; Fontaine, Robert E.; Zeng, Guang] Chinese Ctr Dis Control & Prevent, Chinese Field Epidemiol Training Program, Beijing, Peoples R China; [He, Jun; Gao, Hong; Xu, YanFeng; Qin, Chuan] Peking Union Med Coll, Beijing 100021, Peoples R China; [He, Jun; Gao, Hong; Xu, YanFeng; Qin, Chuan] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100730, Peoples R China; [Fontaine, Robert E.] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Yang, Lin; Huang, WenLi] Yunnan Inst Endem Dis Control & Prevent, Dali, Yunnan Province, Peoples R China; [Zhou, ZhongYu; Yang, ZhuLiang; Liu, JiKai] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W China, Kunming, Yunnan Province, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Centers for Disease Control & Prevention - USA; Yunnan Institute for Endemic Disease Control & Prevention; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Shi, GQ (corresponding author), Chinese Ctr Dis Control & Prevent, Chinese Field Epidemiol Training Program, Beijing, Peoples R China.	hwenli63@163.com; zeng4605@vip.sina.com			Ministry of Health, China [200802002]; National Basic Research Program of China (973 Program) [2009CB522300]	Ministry of Health, China; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	Funding came from Scientific Research Special Funds (200802002) of the Ministry of Health, China, and National Basic Research Program of China (973 Program, 2009CB522300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Ami H, 1999, ARCH INTERN MED, V159, P281, DOI 10.1001/archinte.159.3.281; Cryer PE, 2007, J CLIN INVEST, V117, P868, DOI 10.1172/JCI31669; de Courten-Myers GM, 2000, J CEREBR BLOOD F MET, V20, P82, DOI 10.1097/00004647-200001000-00012; [黄文丽 Huang Wenli], 2007, [中华流行病学杂志, Chinese Journal of Epidemiology], V28, P233; Joskow R, 2006, CLIN TOXICOL, V44, P267, DOI 10.1080/15563650600584410; Kahn KJ, 1971, BRAIN HYPOXIA, P184; Karlson-Stiber C, 2003, TOXICON, V42, P339, DOI 10.1016/S0041-0101(03)00238-1; [施国庆 SHI Guoqing], 2006, [中华流行病学杂志, Chinese Journal of Epidemiology], V27, P96; Shi GQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035894; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Yang L, 2008, J PREVENTIVE MED INF, V21, P110; Yang ZL, 2012, MYCOL PROG, V11, P937, DOI 10.1007/s11557-012-0809-y; Zhou ZY, 2012, ANGEW CHEM INT EDIT, V51, P2368, DOI 10.1002/anie.201106502	13	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38712	10.1371/journal.pone.0038712	http://dx.doi.org/10.1371/journal.pone.0038712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745677	Green Published, gold			2022-12-27	WOS:000305693200021
J	Zahar, Y; Wagner, H; Gutfreund, Y				Zahar, Yael; Wagner, Hermann; Gutfreund, Yoram			Responses of Tectal Neurons to Contrasting Stimuli: An Electrophysiological Study in the Barn Owl	PLOS ONE			English	Article							PRIMATE SUPERIOR COLLICULUS; CHOLINERGIC NUCLEUS ISTHMI; OPTIC TECTUM; LOOMING OBJECTS; VISUAL-CORTEX; MIDBRAIN NETWORK; RELATIVE MOTION; ATTENTION; PIGEON; SELECTION	The saliency of visual objects is based on the center to background contrast. Particularly objects differing in one feature from the background may be perceived as more salient. It is not clear to what extent this so called "pop-out" effect observed in humans and primates governs saliency perception in non-primates as well. In this study we searched for neural-correlates of pop-out perception in neurons located in the optic tectum of the barn owl. We measured the responses of tectal neurons to stimuli appearing within the visual receptive field, embedded in a large array of additional stimuli (the background). Responses were compared between contrasting and uniform conditions. In a contrasting condition the center was different from the background while in the uniform condition it was identical to the background. Most tectal neurons responded better to stimuli in the contrsating condition compared to the uniform condition when the contrast between center and background was the direction of motion but not when it was the orientation of a bar. Tectal neurons also preferred contrasting over uniform stimuli when the center was looming and the background receding but not when the center was receding and the background looming. Therefore, our results do not support the hypothesis that tectal neurons are sensitive to pop-out per-se. The specific sensitivity to the motion contrasting stimulus is consistent with the idea that object motion and not large field motion (e.g., self-induced motion) is coded in the neural responses of tectal neurons.	[Zahar, Yael; Gutfreund, Yoram] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Dept Physiol & Biophys, Haifa, Israel; [Wagner, Hermann] Rhein Westfal TH Aachen, Inst Biol 2, Aachen, Germany	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; RWTH Aachen University	Zahar, Y (corresponding author), Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Dept Physiol & Biophys, Haifa, Israel.	yoramg@tx.technion.ac.il	Wagner, Hermann/G-5454-2012		German-Israel Foundation (GIF)	German-Israel Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development)	This work was supported by a German-Israel Foundation (GIF) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asadollahi A, 2011, J NEUROSCI, V31, P6088, DOI 10.1523/JNEUROSCI.0023-11.2011; BLOUGH DS, 1977, SCIENCE, V196, P1013, DOI 10.1126/science.860129; Boehnke SE, 2008, CURR OPIN NEUROBIOL, V18, P544, DOI 10.1016/j.conb.2008.11.004; Burrows BE, 2009, J NEUROSCI, V29, P15169, DOI 10.1523/JNEUROSCI.3710-09.2009; Cappe C, 2012, J NEUROSCI, V32, P1171, DOI 10.1523/JNEUROSCI.5517-11.2012; Cohen YE, 1998, J NEUROPHYSIOL, V79, P891, DOI 10.1152/jn.1998.79.2.891; DAVIDSON RM, 1992, EXP BRAIN RES, V92, P246; DAVIDSON RM, 1991, J NEUROPHYSIOL, V65, P1115, DOI 10.1152/jn.1991.65.5.1115; Dorris MC, 2002, J COGNITIVE NEUROSCI, V14, P1256, DOI 10.1162/089892902760807249; Dorris MC, 2007, J NEUROSCI, V27, P5053, DOI 10.1523/JNEUROSCI.4212-06.2007; DULAC S, 1990, J NEUROPHYSIOL, V63, P131, DOI 10.1152/jn.1990.63.1.131; Fecteau JH, 2005, J COGNITIVE NEUROSCI, V17, P1714, DOI 10.1162/089892905774589235; FROST BJ, 1988, J COMP PHYSIOL A, V162, P639, DOI 10.1007/BF01342639; FROST BJ, 1981, EXP BRAIN RES, V43, P173; FROST BJ, 1990, VISION RES, V30, P1677, DOI 10.1016/0042-6989(90)90152-B; FROST BJ, 1983, SCIENCE, V220, P744, DOI 10.1126/science.6836313; Harmening WM, 2011, P NATL ACAD SCI USA, V108, P8461, DOI 10.1073/pnas.1101582108; Hegde J, 2003, J NEUROSCI, V23, P9968; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Knudsen E. I., 2007, ANNU REV NEUROSCI, V6, P6; KNUDSEN EI, 1995, J NEUROSCI, V15, P5139; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; Knudsen EI, 2011, EUR J NEUROSCI, V33, P1961, DOI 10.1111/j.1460-9568.2011.07696.x; Lai DH, 2011, J NEUROPHYSIOL, V105, P793, DOI 10.1152/jn.00673.2010; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lee TS, 2002, NAT NEUROSCI, V5, P589, DOI 10.1038/nn860; Li B, 1996, SCI CHINA SER C, V39, P123; Liu GB, 2003, BRAIN RES, V961, P153, DOI 10.1016/S0006-8993(02)03747-2; Liu YJ, 2011, BRAIN BEHAV EVOLUT, V77, P193, DOI 10.1159/000327045; Maczko KA, 2006, J NEUROSCI, V26, P12799, DOI 10.1523/JNEUROSCI.3946-06.2006; Marin G, 2007, J NEUROSCI, V27, P8112, DOI 10.1523/JNEUROSCI.1420-07.2007; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; Medina L, 2000, TRENDS NEUROSCI, V23, P1, DOI 10.1016/S0166-2236(99)01486-1; MIZE RR, 1976, J COMP NEUROL, V168, P393, DOI 10.1002/cne.901680306; Mysore SP, 2011, CURR OPIN NEUROBIOL, V21, P653, DOI 10.1016/j.conb.2011.05.024; Mysore SP, 2011, J NEUROSCI, V31, P5186, DOI 10.1523/JNEUROSCI.4592-10.2011; Mysore SP, 2010, J NEUROSCI, V30, P1727, DOI 10.1523/JNEUROSCI.3740-09.2010; Netser S, 2011, J NEUROSCI, V31, P17811, DOI 10.1523/JNEUROSCI.4790-11.2011; Netser S, 2010, J NEUROPHYSIOL, V104, P108, DOI 10.1152/jn.01142.2009; Nieder A, 1999, NAT NEUROSCI, V2, P660, DOI 10.1038/10217; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PETTIGREW JD, 1976, SCIENCE, V193, P675, DOI 10.1126/science.948741; POSNER MI, 1984, COMPONENTS VISUAL OR; Raizada RDS, 2001, VIS COGN, V8, P431, DOI 10.1080/13506280143000070; Reches A, 2008, J NEUROSCI, V28, P1523, DOI 10.1523/JNEUROSCI.3785-07.2008; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; TREISMAN A, 1982, J EXP PSYCHOL HUMAN, V8, P194, DOI 10.1037/0096-1523.8.2.194; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Troscianko T, 2009, PHILOS T R SOC B, V364, P449, DOI 10.1098/rstb.2008.0218; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; Wang Y, 2006, J COMP NEUROL, V494, P7, DOI 10.1002/cne.20821; Winkowski DE, 2007, J NEUROSCI, V27, P13279, DOI 10.1523/JNEUROSCI.3937-07.2007; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; WOODS EJ, 1977, EXP BRAIN RES, V27, P347; Wu LQ, 2005, EUR J NEUROSCI, V22, P2325, DOI 10.1111/j.1460-9568.2005.04397.x; Zahar Y, 2009, J NEUROPHYSIOL, V101, P2380, DOI 10.1152/jn.91193.2008; Zar, 2011, BIOSTAT ANAL	58	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39559	10.1371/journal.pone.0039559	http://dx.doi.org/10.1371/journal.pone.0039559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745787	Green Published, gold, Green Submitted			2022-12-27	WOS:000305693200089
J	Gamble, T; Greenbaum, E; Jackman, TR; Russell, AP; Bauer, AM				Gamble, Tony; Greenbaum, Eli; Jackman, Todd R.; Russell, Anthony P.; Bauer, Aaron M.			Repeated Origin and Loss of Adhesive Toepads in Geckos	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENETICS; EVOLUTION; LIKELIHOOD; GEKKOTA; GEKKONIDAE; ECOLOGY; LIZARDS; SYSTEM; CLADE	Geckos are well known for their extraordinary clinging abilities and many species easily scale vertical or even inverted surfaces. This ability is enabled by a complex digital adhesive mechanism (adhesive toepads) that employs van der Waals based adhesion, augmented by frictional forces. Numerous morphological traits and behaviors have evolved to facilitate deployment of the adhesive mechanism, maximize adhesive force and enable release from the substrate. The complex digital morphologies that result allow geckos to interact with their environment in a novel fashion quite differently from most other lizards. Details of toepad morphology suggest multiple gains and losses of the adhesive mechanism, but lack of a comprehensive phylogeny has hindered efforts to determine how frequently adhesive toepads have been gained and lost. Here we present a multigene phylogeny of geckos, including 107 of 118 recognized genera, and determine that adhesive toepads have been gained and lost multiple times, and remarkably, with approximately equal frequency. The most likely hypothesis suggests that adhesive toepads evolved 11 times and were lost nine times. The overall external morphology of the toepad is strikingly similar in many lineages in which it is independently derived, but lineage-specific differences are evident, particularly regarding internal anatomy, with unique morphological patterns defining each independent derivation.	[Gamble, Tony] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Gamble, Tony] Univ Minnesota, Bell Museum Nat Hist, St Paul, MN 55108 USA; [Greenbaum, Eli; Jackman, Todd R.; Bauer, Aaron M.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA; [Russell, Anthony P.] Univ Dept Calgary, Dept Biol Sci, Calgary, AB, Canada	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Villanova University	Gamble, T (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	aaron.bauer@villanova.edu	Gamble, Tony/AAT-4463-2020; Gamble, Carrol/AAE-9895-2019; Williamson, Paula R/B-6425-2016; Young, Bridget/A-2184-2014	Gamble, Tony/0000-0002-0204-8003; Gamble, Carrol/0000-0002-3021-1955; Williamson, Paula R/0000-0001-9802-6636; Snowdon, Claire/0000-0002-9133-5476; Young, Bridget/0000-0001-6041-9901; Jackman, Todd/0000-0002-5391-8136	National science Foundation [DEB 0515909, DEB 0844523]; Natural Sciences and Engineering Research Council of Canada [9745-2008]; Medical Research Council [G0800792] Funding Source: researchfish; National Institute for Health Research [05/516/08] Funding Source: researchfish	National science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by grants DEB 0515909 and DEB 0844523 from the National science Foundation (www.nsf.gov) and by Discovery Grant 9745-2008 from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibardi L, 2003, J MORPHOL, V256, P134, DOI 10.1002/jmor.10076; Aristotle, 1910, HIST ANIMALS; Arnold EN, 2008, ZOOTAXA, P62, DOI 10.11646/zootaxa.1847.1.5; Autumn K, 2006, J EXP BIOL, V209, P3569, DOI 10.1242/jeb.02486; Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Bauer Aaron M., 1999, African Journal of Herpetology, V48, P53, DOI 10.1080/21564574.1999.9651072; Bauer Aaron M., 1997, Proceedings of the California Academy of Sciences, V49, P447; Bauer AM, 2005, J ZOOL, V265, P327, DOI 10.1017/S0952836904006259; Bauer AM, 1987, CAN J ZOOL, V66, P1583; FITZINGER L. J., 1843, SYSTEMA REPTILIUM AM; FitzJohn RG, 2009, SYST BIOL, V58, P595, DOI 10.1093/sysbio/syp067; Fujita MK, 2011, MOL PHYLOGENET EVOL, V58, P71, DOI 10.1016/j.ympev.2010.10.014; Gamble T, 2011, J EVOLUTION BIOL, V24, P231, DOI 10.1111/j.1420-9101.2010.02184.x; Gamble T, 2008, ZOOL SCR, V37, P355, DOI 10.1111/j.1463-6409.2008.00330.x; Gamble T, 2008, J BIOGEOGR, V35, P88, DOI 10.1111/j.1365-2699.2007.01770.x; Gamble T, 2011, ZOOL J LINN SOC-LOND, V163, P1244, DOI 10.1111/j.1096-3642.2011.00741.x; Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917; Goldberg EE, 2008, EVOLUTION, V62, P2727, DOI 10.1111/j.1558-5646.2008.00505.x; Gompel N, 2009, DEV BIOL, V332, P36, DOI 10.1016/j.ydbio.2009.04.040; GOULD S J, 1970, Journal of the History of Biology, V3, P189, DOI 10.1007/BF00137351; Gould SJ, 2002, STRUCTURE EVOLUTIONA; GREEN DM, 1981, COPEIA, P790, DOI 10.2307/1444179; Haldane JB., 1990, CAUSES EVOLUTION; Han D, 2004, BIOL J LINN SOC, V83, P353, DOI 10.1111/j.1095-8312.2004.00393.x; Higham TE, 2010, BIOL J LINN SOC, V101, P860, DOI 10.1111/j.1095-8312.2010.01539.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Irschick DJ, 1996, BIOL J LINN SOC, V59, P21, DOI 10.1111/j.1095-8312.1996.tb01451.x; Jackman TR, 2008, MOL PHYLOGENET EVOL, V46, P74, DOI 10.1016/j.ympev.2007.10.018; Johnson MK, 2009, J ANAT, V214, P937, DOI 10.1111/j.1469-7580.2009.01075.x; Johnson MK, 2005, CAN J ZOOL, V83, P1511, DOI 10.1139/Z05-112; Kim S, 2008, IEEE T ROBOT, V24, P65, DOI 10.1109/TRO.2007.909786; KLUGE AG, 1983, COPEIA, P465, DOI 10.2307/1444392; Kopp A, 2009, EVOLUTION, V63, P2771, DOI 10.1111/j.1558-5646.2009.00761.x; Lamb T, 2006, P ROY SOC B-BIOL SCI, V273, P855, DOI 10.1098/rspb.2005.3390; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Losos JB, 2011, EVOLUTION, V65, P1827, DOI 10.1111/j.1558-5646.2011.01289.x; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Loveridge Arthur, 1947, BULL MUS CAMP ZOOL HARVARD UNIV, V98, P1; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Maddison W.P., 2008, MESQUITE MODULAR SYS; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; Maderson P. F. A., 1970, Forma Functio, V1970, P179; MADERSON PF, 1964, NATURE, V203, P780, DOI 10.1038/203780a0; Mahdavi A, 2008, P NATL ACAD SCI USA, V105, P2307, DOI 10.1073/pnas.0712117105; MAHENDRA BENI CHARAN, 1941, PROC INDIAN ACAD SCI SECT B, V13, P288; Nielsen SV, 2011, MOL PHYLOGENET EVOL, V59, P1, DOI 10.1016/j.ympev.2010.12.007; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Oliver PM, 2012, MOL PHYLOGENET EVOL, V63, P255, DOI 10.1016/j.ympev.2011.12.013; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peattie AM, 2008, ANAT REC, V291, P869, DOI 10.1002/ar.20706; Pianka E.R., 2003, LIZARDS WINDOWS EVOL; Pianka ER, 2005, BIOESSAYS, V27, P647, DOI 10.1002/bies.20237; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2013, TRACER VERSION 1 6; Russell AP, 2007, CAN J ZOOL, V85, P1228, DOI 10.1139/Z07-103; Russell A.P., 1976, Linnean Soc Symp Ser, V3, P217; Russell Anthony P., 2009, Functional Properties of Bio-Inspired Surfaces Characterization and Technological Applications, P103, DOI 10.1142/9789812837028_0005; Russell AP, 2007, J ADHES SCI TECHNOL, V21, P1119, DOI 10.1163/156856107782328371; Russell Anthony P., 2002, Bulletin of the Natural History Museum Zoology Series, V68, P113; Russell AP, 2009, P R SOC B, V276, P3705, DOI 10.1098/rspb.2009.0946; RUSSELL AP, 1975, J ZOOL, V176, P437, DOI 10.1111/j.1469-7998.1975.tb03215.x; Russell AP, 2002, INTEGR COMP BIOL, V42, P1154, DOI 10.1093/icb/42.6.1154; RUSSELL AP, 1979, COPEIA, P1, DOI 10.2307/1443723; RUSSELL AP, 1988, J MORPHOL, V197, P221, DOI 10.1002/jmor.1051970208; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sullivan J, 1999, MOL BIOL EVOL, V16, P1347, DOI 10.1093/oxfordjournals.molbev.a026045; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Uetz P, 2010, ZOOTAXA, P59, DOI 10.11646/zootaxa.2334.1.3; UNDERWOOD GARTH, 1954, PROC ZOOL SOC LONDON, V124, P469; VANZOLINI P E, 1968, Arquivos de Zoologia do Estado de Sao Paulo, V17, P85; Vermeij GJ, 2006, P NATL ACAD SCI USA, V103, P1804, DOI 10.1073/pnas.0508724103; Vidal N, 2009, CR BIOL, V332, P129, DOI 10.1016/j.crvi.2008.07.010; Vitt LJ, 2003, AM NAT, V162, P44, DOI 10.1086/375172; Vitt LJ, 2005, P NATL ACAD SCI USA, V102, P7877, DOI 10.1073/pnas.0501104102; von Dassow G, 1999, J EXP ZOOL, V285, P307, DOI 10.1002/(SICI)1097-010X(19991215)285:4<307::AID-JEZ2>3.3.CO;2-M; Wagner GP, 1996, AM ZOOL, V36, P36; Wake DB, 2011, SCIENCE, V331, P1032, DOI 10.1126/science.1188545; Webster NB, 2009, ACTA ZOOL-STOCKHOLM, V90, P18, DOI 10.1111/j.1463-6395.2008.00324.x; Wiens JJ, 2006, EVOLUTION, V60, P123, DOI 10.1111/j.0014-3820.2006.tb01088.x; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001	88	258	266	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39429	10.1371/journal.pone.0039429	http://dx.doi.org/10.1371/journal.pone.0039429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22586456	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800033
J	Liao, MZ; Nie, XJ; Pan, RJ; Wang, CX; Ruan, SM; Zhang, CQ; Kang, DM; Fu, JH; Qian, YS; Tao, XR; Zhao, JK				Liao, Meizhen; Nie, Xijuan; Pan, Rongjian; Wang, Chuangxin; Ruan, Shiman; Zhang, Changqing; Kang, Dianming; Fu, Jihua; Qian, Yuesheng; Tao, Xiaorun; Zhao, Jinkou			Consistently Low Prevalence of Syphilis among Female Sex Workers in Jinan, China: Findings from Two Consecutive Respondent Driven Sampling Surveys	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; HUMAN-IMMUNODEFICIENCY-VIRUS; METHAMPHETAMINE USE; HIV PREVALENCE; RISK; MEN; INFECTION; PROVINCE; TRIAL	Background: Routine surveillance using convenient sampling found low prevalence of HIV and syphilis among female sex workers in China. Two consecutive surveys using respondent driven sampling were conducted in 2008 and 2009 to examine the prevalence of HIV and syphilis among female sex workers in Jinan, China. Methods: A face-to-face interview was conducted to collect demographic, behavioral and service utilization information using a structured questionnaire. Blood samples were drawn for serological tests of HIV-1 antibody and syphilis antibody. Respondent Driven Sampling Analysis Tool was used to generate population level estimates. Results: In 2008 and in 2009, 363 and 432 subjects were recruited and surveyed respectively. Prevalence of syphilis was 2.8% in 2008 and 2.2% in 2009, while no HIV case was found in both years. Results are comparable to those from routine sentinel surveillance system in the city. Only 60.8% subjects in 2008 and 48.3% in 2009 reported a consistent condom use with clients during the past month. Over 50% subjects had not been covered by any HIV-related services in the past year, with only 15.6% subjects in 2008 and 13.1% in 2009 ever tested for HIV. Conclusions: Despite the low prevalence of syphilis and HIV, risk behaviors are common. Targeted interventions to promote the safe sex and utilization of existing intervention services are still needed to keep the epidemic from growing.	[Liao, Meizhen; Kang, Dianming; Fu, Jihua; Qian, Yuesheng; Tao, Xiaorun] Shandong Prov Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Jinan, Shandong Provin, Peoples R China; [Nie, Xijuan; Pan, Rongjian; Wang, Chuangxin] Licheng Dist Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Jinan, Shandong Provin, Peoples R China; [Ruan, Shiman; Zhang, Changqing] Jinan Municipal Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Jinan, Shandong Provin, Peoples R China; [Zhao, Jinkou] Global Fund Fight AIDS TB & Malaria, Monitoring & Evaluat Unit, Geneva, Switzerland		Liao, MZ (corresponding author), Shandong Prov Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Jinan, Shandong Provin, Peoples R China.	jinkou.zhao@theglobalfund.org	Yang, Xiaobo/G-3854-2016; Zhang, Youjie/F-7346-2016	Zhang, Youjie/0000-0002-6035-8536; mo, zengnan/0000-0002-3047-3138; Zhao, Jinkou/0000-0001-9184-3385	China-US cooperation on HIV prevention and care	China-US cooperation on HIV prevention and care	This work was supported by the China-US cooperation on HIV prevention and care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, 2011 EST HIV AIDS EP; Brown T, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010165; Chapman J, 2008, SEX HEALTH, V5, P291, DOI 10.1071/SH07057; China CDC, 2011, NAT BEH BIOL SURV RE; China-CDC, 2009, NAT GUID DET HIV AID; Chow EPF, 2011, SEX TRANSM DIS, V38, P845, DOI 10.1097/OLQ.0b013e31821a4f43; Cohen J, 2004, SCIENCE, V304, P1934, DOI 10.1126/science.304.5679.1934; Colfax G, 2006, CLIN INFECT DIS, V42, P1463, DOI 10.1086/503259; Fu JH, 2009, CHIN J PUBLIC HLTH, V25, P1004; Goel S, 2009, STAT MED, V28, P2202, DOI 10.1002/sim.3613; Heimer R, 2005, AIDS BEHAV, V9, P403, DOI 10.1007/s10461-005-9030-1; Johnston LG, 2006, J URBAN HEALTH, V83, pI16, DOI 10.1007/s11524-006-9099-5; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Kang DM, 2011, AIDS CARE, V23, P26, DOI 10.1080/09540121.2011.560930; Li Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS48, DOI 10.1097/QAI.0b013e3181c7d72f; Liao MZ, 2011, SEX TRANSM DIS, V38, P57, DOI 10.1097/OLQ.0b013e3181ebb475; Liu HJ, 2009, AIDS BEHAV, V13, P652, DOI 10.1007/s10461-008-9475-0; Ma X, 2007, J ACQ IMMUN DEF SYND, V45, P581; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Pascom AR, 2010, BRAZ J INFECT DIS, V14, P385, DOI 10.1590/S1413-86702010000400014; Potula R, 2008, AM J PATHOL, V172, P1467, DOI 10.2353/ajpath.2008.080130; Rou KM, 2007, AIDS, V21, pS95, DOI 10.1097/01.aids.0000304703.77755.c7; Ruan SM, 2008, AIDS BEHAV, V12, P469, DOI 10.1007/s10461-008-9361-9; Ruan SM, 2009, AIDS BEHAV, V13, P671, DOI 10.1007/s10461-009-9567-5; Scorgie F, 2011, AIDS BEHAV IN PRESS; Shandong Provincial CDC, 2010, COMPR REP HIV AIDS S; Shandong Provincial CDC, 2011, COMPR REP HIV AIDS S; Stormer A, 2006, J URBAN HEALTH, V83, pI73, DOI 10.1007/s11524-006-9105-y; Tabet S, 2002, AIDS, V16, P1271, DOI 10.1097/00002030-200206140-00010; UNODC, 2008, 2008 WORLD DRUG REP; van den Hoek A, 2001, AIDS, V15, P753, DOI 10.1097/00002030-200104130-00011; Wang Lan, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P1009; Wang Y, 2009, AIDS BEHAV, V13, P866, DOI 10.1007/s10461-008-9446-5; World Health Organization, 2000, 2 GEN SURV HIV NEXT; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; Yang HM, 2005, SEX TRANSM DIS, V32, P270, DOI 10.1097/01.olq.0000162360.11910.5a; Yang XS, 2006, AIDS EDUC PREV, V18, P333, DOI 10.1521/aeap.2006.18.4.333	37	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34085	10.1371/journal.pone.0034085	http://dx.doi.org/10.1371/journal.pone.0034085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UP	22737230	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000007
J	Liao, M; Huang, XH; Gao, Y; Tan, AH; Lu, Z; Wu, CL; Zhang, YJ; Yang, XB; Zhang, HY; Qin, X; Mo, ZN				Liao, Ming; Huang, Xianghua; Gao, Yong; Tan, Aihua; Lu, Zheng; Wu, Chunlei; Zhang, Youjie; Yang, Xiaobo; Zhang, Haiying; Qin, Xue; Mo, Zengnan			Testosterone Is Associated with Erectile Dysfunction: A Cross-Sectional Study in Chinese Men	PLOS ONE			English	Article							AGE-RELATED DECLINE; SEX-HORMONE LEVELS; AREA MALE HEALTH; RISK-FACTORS; INTERNATIONAL INDEX; ANDROGEN DEFICIENCY; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; PREVALENCE; SYMPTOMS	Background: Testosterone is essential for the regulation of erectile physiology, but the relationship between low testosterone and erectile dysfunction (ED) has not been firmly established. Purpose: To examine the association between serum total, free and bio-available testosterone and ED in a population-based sample. Methods: A consecutive series of 1776 men aged 20-77 participated in the routine physical examination from September 2009 to December 2009 in Guangxi, China. ED was assessed using the five-item International Index of Erectile Function (IIEF-5) questionnaire. Total testosterone (TT), sex hormone binding globulin (SHBG) and other biochemical profiles were measured. Free testosterone (FT) and bio-available testosterone (BT) were calculated based on Vermeulen's formula. Data were collected with regard to smoking, alcoholic drinking, physical activity and metabolic syndrome. Results: The prevalence of ED (IIEF-5<22) was 47.6%. Men with ED were significantly older, and more prone to smoke cigarettes (>= 20 cigarettes/day) or drink alcohol (>= 3 drinks/week), and more likely to have elevated blood pressure (P = 0.036) or hyperglycemia (P < 0.001) compared with those without ED. The significant increase in SHBG with age was parallel to its increase with increasing severity of ED (P < 0.001). The obscure increase in TT across the ED status was detected without significance (P = 0.418), but TT was positively associated with ED after adjustment for age [odds ratio (OR) = 1.02, 95% CI (confidence internal): 1.00-1.04]. FT and BT were inversely associated with ED (OR = 0.14, 95% CI: 0.06-0.33; OR = 0.92 (95% CI: 0.89-0.96, respectively) in the univariate analysis, and this inverse association appeared to be independent of smoking status, alcoholic drinking, physical activity, hyper-triglyceridemia and hyperglycemia. Conclusions: FT and BT are inversely related to worsening ED, whereas the positive association between TT and ED is most likely due to the increase in SHBG.	[Liao, Ming; Gao, Yong; Lu, Zheng; Wu, Chunlei; Zhang, Youjie; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi Zhuang, Peoples R China; [Liao, Ming; Huang, Xianghua; Gao, Yong; Tan, Aihua; Lu, Zheng; Wu, Chunlei; Zhang, Youjie; Yang, Xiaobo; Zhang, Haiying; Qin, Xue; Mo, Zengnan] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China; [Tan, Aihua] Guangxi Med Univ, Affiliated Hosp 1, Ctr Metab Dis & Diabet, Nanning, Guangxi Zhuang, Peoples R China; [Yang, Xiaobo; Zhang, Haiying] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi Zhuang, Peoples R China; [Qin, Xue] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi Zhuang, Peoples R China; [Gao, Yong] Fudan Univ, Sch Life Sci, Fudan VARI Ctr Genet Epidemiol, Shanghai 200433, Peoples R China; [Huang, Xianghua] Guigang Peoples Hosp, Dept Urol, Guigang, Guangxi Zhuang, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Fudan University	Liao, M (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi Zhuang, Peoples R China.	zengnanmo@hotmail.com	Yang, Xiaobo/G-3854-2016; Zhang, Youjie/F-7346-2016	Zhang, Youjie/0000-0002-6035-8536; mo, zengnan/0000-0002-3047-3138; Zhao, Jinkou/0000-0001-9184-3385	National Natural Science Foundation of China [30945204]; Provincial departments of Finance and Education, Guangxi Zhuang Autonomous Region, China [2009GJCJ150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial departments of Finance and Education, Guangxi Zhuang Autonomous Region, China	The work described in this article is supported by grants from the National Natural Science Foundation of China (Grant No. 30945204) and the Provincial departments of Finance and Education, Guangxi Zhuang Autonomous Region, China (Grant No. 2009GJCJ150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2002, BJU INT, V89, P526, DOI 10.1046/j.1464-410X.2002.02650.x; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Araujo AB, 2007, J CLIN ENDOCR METAB, V92, P4241, DOI 10.1210/jc.2007-1245; Armagan A, 2006, J ANDROL, V27, P517, DOI 10.2164/jandrol.05157; Bai Q, 2004, ASIAN J ANDROL, V6, P343; Basar MM, 2005, UROLOGY, V66, P597, DOI 10.1016/j.urology.2005.03.060; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Christensen BS, 2011, J SEX MED, V8, P1903, DOI 10.1111/j.1743-6109.2011.02291.x; Chughtai B, 2011, CURR OPIN UROL, V21, P514, DOI 10.1097/MOU.0b013e32834b8681; Corona G, 2004, INT J IMPOT RES, V16, P395, DOI 10.1038/sj.ijir.3901225; Corona G, 2009, INT J ANDROL, V32, P720, DOI 10.1111/j.1365-2605.2009.00952.x; Corona G, 2010, J SEX MED, V7, P1362, DOI 10.1111/j.1743-6109.2009.01601.x; Corona G, 2010, J SEX MED, V7, P182, DOI 10.1111/j.1743-6109.2009.01497.x; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; DAMASSA DA, 1977, HORM BEHAV, V8, P275, DOI 10.1016/0018-506X(77)90002-2; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Fisher AD, 2009, J SEX MED, V6, P866, DOI 10.1111/j.1743-6109.2008.01140.x; Gades NM, 2008, J SEX MED, V5, P2209, DOI 10.1111/j.1743-6109.2008.00924.x; Golden SH, 2009, J CLIN ENDOCR METAB, V94, P1853, DOI 10.1210/jc.2008-2291; Gooren LJG, 1996, BRIT J UROL, V78, P763, DOI 10.1046/j.1464-410X.1996.05918.x; Grover SA, 2006, ARCH INTERN MED, V166, P213, DOI 10.1001/archinte.166.2.213; Hao ZY, 2011, J ANDROL, V32, P496, DOI 10.2164/jandrol.110.012138; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P381, DOI 10.1111/j.1365-2265.2005.02350.x; Kocoglu H, 2011, AGING MALE, V14, P207, DOI 10.3109/13685538.2011.617798; Kupelian V, 2007, EUR UROL, V52, P416, DOI 10.1016/j.eururo.2007.03.015; Kupelian V, 2010, PREV MED, V50, P19, DOI 10.1016/j.ypmed.2009.11.006; Lee ACK, 2010, INT J IMPOT RES, V22, P272, DOI 10.1038/ijir.2010.15; Lee JC, 2011, BJU INT, V107, P956, DOI 10.1111/j.1464-410X.2010.09691.x; Lu Z, 2012, PROSTATE, V72, P193, DOI 10.1002/pros.21421; Ly LP, 2010, CLIN ENDOCRINOL, V73, P382, DOI 10.1111/j.1365-2265.2010.03804.x; Muezzinoglu T, 2007, YONSEI MED J, V48, P1015, DOI 10.3349/ymj.2007.48.6.1015; O'Connor DB, 2011, J CLIN ENDOCR METAB, V96, pE1577, DOI 10.1210/jc.2010-2216; Ohlsson C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002313; Rhoden EL, 2002, INT J IMPOT RES, V14, P167, DOI 10.1038/sj.ijir.3900852; Rhoden EL, 2002, J UROLOGY, V167, P1745, DOI 10.1016/S0022-5347(05)65191-9; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; Shiels MS, 2009, CANCER CAUSE CONTROL, V20, P877, DOI 10.1007/s10552-009-9318-y; Tan AH, 2011, METABOLISM, V60, P1186, DOI 10.1016/j.metabol.2011.01.002; Traish AM, 2007, EUR UROL, V52, P54, DOI 10.1016/j.eururo.2007.02.034; Traish AM, 2006, J SEX MED, V3, P382, DOI 10.1111/j.1743-6109.2006.00245.x; Tsujimura A, 2003, J UROLOGY, V170, P2345, DOI 10.1097/01.ju.0000089768.17091.c0; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; VERMEULEN A, 1993, ANN MED, V25, P531; Wu CL, 2011, J ANDROL, V33, P59, DOI 10.2164/jandrol.110.012542; Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101	46	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39234	10.1371/journal.pone.0039234	http://dx.doi.org/10.1371/journal.pone.0039234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737230	Green Published, gold, Green Submitted			2022-12-27	WOS:000305695100028
J	Yueh, MF; Li, T; Evans, RM; Hammock, B; Tukey, RH				Yueh, Mei-Fei; Li, Tao; Evans, Ronald M.; Hammock, Bruce; Tukey, Robert H.			Triclocarban Mediates Induction of Xenobiotic Metabolism through Activation of the Constitutive Androstane Receptor and the Estrogen Receptor Alpha	PLOS ONE			English	Article							WASTE-WATER TREATMENT; UDP-GLUCURONOSYLTRANSFERASE-1 UGT1 LOCUS; INHIBITORY CROSS-TALK; NUCLEAR RECEPTOR; IN-VITRO; ANTIMICROBIAL TRICLOCARBAN; SIGNALING PATHWAY; GENE-EXPRESSION; TRANSGENIC MICE; HUMAN LIVER	Triclocarban (3,4,4'-trichlorocarbanilide, TCC) is used as a broad-based antimicrobial agent that is commonly added to personal hygiene products. Because of its extensive use in the health care industry and resistance to degradation in sewage treatment processes, TCC has become a significant waste product that is found in numerous environmental compartments where humans and wildlife can be exposed. While TCC has been linked to a range of health and environmental effects, few studies have been conducted linking exposure to TCC and induction of xenobiotic metabolism through regulation by environmental sensors such as the nuclear xenobiotic receptors (XenoRs). To identify the ability of TCC to activate xenobiotic sensors, we monitored XenoR activities in response to TCC treatment using luciferase-based reporter assays. Among the XenoRs in the reporter screening assay, TCC promotes both constitutive androstane receptor (CAR) and estrogen receptor alpha (ER alpha) activities. TCC treatment to hUGT1 mice resulted in induction of the UGT1A genes in liver. This induction was dependent upon the constitutive active/androstane receptor (CAR) because no induction occurred in hUGT1Car(-/-) mice. Induction of the UGT1A genes by TCC corresponded with induction of Cyp2b10, another CAR target gene. TCC was demonstrated to be a phenobarbital-like activator of CAR in receptor-based assays. While it has been suggested that TCC be classified as an endocrine disruptor, it activates ER alpha leading to induction of Cyp1b1 in female ovaries as well as in promoter activity. Activation of ER alpha by TCC in receptor-based assays also promotes induction of human CYP2B6. These observations demonstrate that TCC activates nuclear xenobiotic receptors CAR and ER alpha both in vivo and in vitro and might have the potential to alter normal physiological homeostasis. Activation of these xenobiotic-sensing receptors amplifies gene expression profiles that might represent a mechanistic base for potential human health effects from exposure to TCC.	[Tukey, Robert H.] Salk Inst Biol Studies, Howard Hughes Med Inst, Dept Chem, Lab Environm Toxicol, La Jolla, CA 92037 USA; [Li, Tao; Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA; [Hammock, Bruce] Univ Calif Davis, Ctr Canc, Dept Entomol, Davis, CA 95616 USA; [Tukey, Robert H.] Salk Inst Biol Studies, Howard Hughes Med Inst, Dept Biochem, Lab Environm Toxicol, La Jolla, CA 92037 USA; [Yueh, Mei-Fei; Tukey, Robert H.] Salk Inst Biol Studies, Howard Hughes Med Inst, Dept Pharmacol, Lab Environm Toxicol, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California Davis; Howard Hughes Medical Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute	Yueh, MF (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Dept Pharmacol, Lab Environm Toxicol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rtukey@ucsd.edu	Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965; Evans, Richard/0000-0002-8651-6889	United States Public Health Service [P42ES010337]; ARRA Supplement [P42ES010337, P42ES004699, GM086713]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699, P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100481, R01GM086713] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); ARRA Supplement; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was provided by United States Public Health Service Grants P42ES010337 (RE and RHT), a 2009 ARRA Supplement to Superfund grant P42ES010337 (RHT and MFY) and P42ES004699 (BDH), and GM086713 (RHT). BDH is a George and Judy Marcus Senior Fellow of the American Asthma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KC, 2008, ENVIRON HEALTH PERSP, V116, P1203, DOI 10.1289/ehp.11200; Cai HL, 2010, DRUG METAB DISPOS, V38, P879, DOI 10.1124/dmd.109.030130; Carthew P, 1998, TOXICOL SCI, V44, P46, DOI 10.1093/toxsci/44.1.46; Chen F, 2011, ENVIRON POLLUT, V159, P1490, DOI 10.1016/j.envpol.2011.03.016; Chen JG, 2008, ENDOCRINOLOGY, V149, P1173, DOI 10.1210/en.2007-1057; Chen SJ, 2005, J BIOL CHEM, V280, P37547, DOI 10.1074/jbc.M506683200; Chen XS, 2011, LAB INVEST, V91, P1136, DOI 10.1038/labinvest.2011.68; Christen V, 2010, CHEMOSPHERE, V81, P1245, DOI 10.1016/j.chemosphere.2010.09.031; Downes M, 2003, MOL CELL, V11, P1079, DOI 10.1016/S1097-2765(03)00104-7; Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996; Fujiwara R, 2010, P NATL ACAD SCI USA, V107, P5024, DOI 10.1073/pnas.0913290107; Giudice BD, 2010, ENVIRON TOXICOL CHEM, V29, P966, DOI 10.1002/etc.105; Halden RU, 2005, ENVIRON SCI TECHNOL, V39, P1420, DOI 10.1021/es049071e; Heidler J, 2008, ENVIRON SCI TECHNOL, V42, P6324, DOI 10.1021/es703008y; Heidler J, 2006, ENVIRON SCI TECHNOL, V40, P3634, DOI 10.1021/es052245n; Higgins CP, 2009, ENVIRON TOXICOL CHEM, V28, P2580, DOI 10.1897/09-013.1; HILES RA, 1978, DRUG METAB DISPOS, V6, P177; Kawamoto T, 2000, MOL ENDOCRINOL, V14, P1897, DOI 10.1210/me.14.11.1897; Kumar KS, 2010, ARCH ENVIRON CON TOX, V58, P275, DOI 10.1007/s00244-009-9383-y; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Liu JY, 2011, TOXICOL APPL PHARM, V255, P200, DOI 10.1016/j.taap.2011.06.017; Lo R, 2010, BBA-GENE REGUL MECH, V1799, P469, DOI 10.1016/j.bbagrm.2010.01.005; Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M510713200; Min GS, 2002, J BIOL CHEM, V277, P34626, DOI 10.1074/jbc.M205239200; Nguyen N, 2008, J BIOL CHEM, V283, P7901, DOI 10.1074/jbc.M709244200; Perencevich EN, 2001, AM J INFECT CONTROL, V29, P281, DOI 10.1067/mic.2001.115469; Saez E, 2004, GENE DEV, V18, P528, DOI 10.1101/gad.1167804; Schebb NH, 2011, ENVIRON SCI TECHNOL, V45, P3109, DOI 10.1021/es103650m; Scientific Commitee on Consumer Products (2005) SCCP, 2005, SCCP085104; Senekeo-Effenberger K, 2007, DRUG METAB DISPOS, V35, P419, DOI 10.1124/dmd.106.013243d; Strassburg CP, 1997, MOL PHARMACOL, V52, P212, DOI 10.1124/mol.52.2.212; Strassburg CP, 1998, MOL PHARMACOL, V54, P647; Strassburg CP, 1997, CANCER RES, V57, P2979; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Tsuchiya Y, 2004, CANCER RES, V64, P3119, DOI 10.1158/0008-5472.CAN-04-0166; Tukey RH, 2001, MOL PHARMACOL, V59, P405, DOI 10.1124/mol.59.3.405; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; Walsh SE, 2003, J APPL MICROBIOL, V94, P240, DOI 10.1046/j.1365-2672.2003.01825.x; Wang HB, 2008, CURR DRUG METAB, V9, P598, DOI 10.2174/138920008785821710; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Xie W, 2003, P NATL ACAD SCI USA, V100, P4150, DOI 10.1073/pnas.0438010100; Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yueh MF, 2011, MOL PHARMACOL, V79, P1053, DOI 10.1124/mol.110.070649; Yueh MF, 2007, J BIOL CHEM, V282, P8749, DOI 10.1074/jbc.M610790200	51	59	61	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e37705	10.1371/journal.pone.0037705	http://dx.doi.org/10.1371/journal.pone.0037705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22912892	Green Published, gold			2022-12-27	WOS:000305350000007
J	Gamble, C; Nadel, S; Snape, D; McKay, A; Hickey, H; Williamson, P; Glennie, L; Snowdon, C; Young, B				Gamble, Carrol; Nadel, Simon; Snape, Dee; McKay, Andrew; Hickey, Helen; Williamson, Paula; Glennie, Linda; Snowdon, Claire; Young, Bridget			What Parents of Children Who Have Received Emergency Care Think about Deferring Consent in Randomised Trials of Emergency Treatments: Postal Survey	PLOS ONE			English	Article								Objective: To investigate parents' views about deferred consent to inform management of trial disclosure after a child's death. Methods: A postal questionnaire survey was sent to members of the Meningitis Research Foundation UK charity, whose child had suffered from bacterial meningitis or meningococcal septicaemia within the previous 5 years. Main outcome measures were acceptability of deferred consent; timing of requesting consent; and the management of disclosure of the trial after a child's death. Results: 220 families were sent questionnaires of whom 63 (29%) were bereaved. 68 families responded (31%), of whom 19 (28%) were bereaved. The majority (67%) was willing for their child to be involved in the trial without the trial being explained to them beforehand; 70% wanted to be informed about the trial as soon as their child's condition had stabilised. In the event of a child's death before the trial could be discussed the majority of bereaved parents (66% 12/18) anticipated wanting to be told about the trial at some time. This compared with 37% (18/49) of non-bereaved families (p = 0.06). Parents' free text responses indicated that the word 'trial' held strongly negative connotations. A few parents regarded gaps in the evidence base about emergency treatments as indicating staff lacked expertise to care for a critically ill child. Bereaved parents' free text responses indicated the importance of individualised management of disclosure about a trial following a child's death. Discussion: Deferred consent is acceptable to the majority of respondents. Parents whose children had recovered differed in their views compared to bereaved parents. Most bereaved parents would want to be informed about the trial in the aftermath of a child's death, although a minority strongly opposed such disclosure. Distinction should be drawn between the views of bereaved and non-bereaved parents when considering the acceptability of different consent processes.	[Gamble, Carrol; McKay, Andrew; Hickey, Helen; Williamson, Paula] Univ Liverpool, Clin Trials Res Ctr, Liverpool L69 3BX, Merseyside, England; [Nadel, Simon] Imperial Coll Healthcare NHS Trust, St Marys Hosp, London, England; [Glennie, Linda] Meningitis Res Fdn, Bristol, Avon, England; [Snowdon, Claire] London Sch Hyg & Trop Med, London WC1, England	University of Liverpool; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Gamble, C (corresponding author), Univ Liverpool, Clin Trials Res Ctr, Liverpool L69 3BX, Merseyside, England.	c.gamble@liv.ac.uk	Gamble, Tony/AAT-4463-2020; Gamble, Carrol/AAE-9895-2019; Williamson, Paula R/B-6425-2016; Young, Bridget/A-2184-2014	Gamble, Tony/0000-0002-0204-8003; Gamble, Carrol/0000-0002-3021-1955; Williamson, Paula R/0000-0001-9802-6636; Snowdon, Claire/0000-0002-9133-5476; Young, Bridget/0000-0001-6041-9901; Jackman, Todd/0000-0002-5391-8136	MRC North West Hub Trials Methodology Research; Imperial College Healthcare Trust BRC (Biomedical Research Centre); Medical Research Council [G0800792] Funding Source: researchfish; National Institute for Health Research [05/516/08] Funding Source: researchfish	MRC North West Hub Trials Methodology Research; Imperial College Healthcare Trust BRC (Biomedical Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors acknowledge MRC North West Hub Trials Methodology Research for supporting contributions from Paula Williamson, Bridget Young, and Carrol Gamble, and the Imperial College Healthcare Trust BRC (Biomedical Research Centre) for support of Simon Nadel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, OFFICIAL J EUROPEA L, VL 121, P0034; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Culbert A, 2005, J MED ETHICS, V31, P721, DOI 10.1136/jme.2004.011247; Fereday J., 2006, INT J QUAL METH, V5, P80, DOI [DOI 10.1177/160940690600500107, 10.1177/160940690600500107]; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; Jansen TC, 2007, INTENS CARE MED, V33, P894, DOI 10.1007/s00134-007-0580-8; Jansen TC, 2010, INTENS CARE MED, V36, P1962, DOI 10.1007/s00134-010-1988-0; Maitland K, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-90; Morrison CA, 2009, J SURG RES, V157, P115, DOI 10.1016/j.jss.2009.03.051; National Collaborating Centre for Women's and Children's Health (UK), 2010, NICE CLIN GUID; Nichol G, 2006, RESUSCITATION, V70, P360, DOI 10.1016/j.resuscitation.2006.01.020; Shilling V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021604; Smyth RL, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6756; Spencer L., 2003, QUALITY QUALITATIVE; Stephenson T, 2006, BRIT J CLIN PHARMACO, V61, P716, DOI 10.1111/j.1365-2125.2006.02676.x; 1996, FED REG, V61, P51498	16	258	266	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35982	10.1371/journal.pone.0035982	http://dx.doi.org/10.1371/journal.pone.0035982			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586456	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000305335000018
J	Yasseri, T; Sumi, R; Kertesz, J				Yasseri, Taha; Sumi, Robert; Kertesz, Janos			Circadian Patterns of Wikipedia Editorial Activity: A Demographic Analysis	PLOS ONE			English	Article							INTERNET	Wikipedia (WP) as a collaborative, dynamical system of humans is an appropriate subject of social studies. Each single action of the members of this society, i.e., editors, is well recorded and accessible. Using the cumulative data of 34 Wikipedias in different languages, we try to characterize and find the universalities and differences in temporal activity patterns of editors. Based on this data, we estimate the geographical distribution of editors for each WP in the globe. Furthermore we also clarify the differences among different groups of WPs, which originate in the variance of cultural and social features of the communities of editors.	[Yasseri, Taha; Sumi, Robert; Kertesz, Janos] Budapest Univ Technol & Econ, Dept Theoret Phys, Budapest, Hungary; [Kertesz, Janos] Aalto Univ, Dept Biomed Engn & Computat Sci, Espoo, Finland	Budapest University of Technology & Economics; Aalto University	Yasseri, T (corresponding author), Budapest Univ Technol & Econ, Dept Theoret Phys, Budapest, Hungary.	yasseri@phy.bme.hu	Yasseri, Taha/AAK-9213-2021; Yasseri, Taha/B-9863-2014; Kornai, Andras/H-6815-2012	Yasseri, Taha/0000-0002-1800-6094; Kornai, Andras/0000-0001-6078-6840	European Commission under FET-Open [238597]; TEKES	European Commission under FET-Open(European CommissionEuropean Commission Joint Research Centre); TEKES(Finnish Funding Agency for Technology & Innovation (TEKES))	The project ICTeCollective acknowledges the financial support of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open grant number: 238597. JK and TY thank the FiDiPro program of TEKES for partial support. http://www.becs.tkk.fi/ictecollective/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Holloway T, 2007, COMPLEXITY, V12, P30, DOI 10.1002/cplx.20164; Huberman B.A., 2009, 1 MONDAY, V14; Huberman BA, 1999, NATURE, V401, P131, DOI 10.1038/43604; Javanmardi Sara, 2010, Statistical Analysis and Data Mining, V3, P126, DOI 10.1002/sam.10070; Jo HH, 2011, ARXIV11010377; Jonathan C, 2010, E RES, V1, P67; Karsai M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.025102; Ortega Felipe, 2008, P 41 ANN HAW INT C S, P304, DOI DOI 10.1109/HICSS.2008.333; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Park T. K., 2011, 1 MONDAY, V16; Pozdnoukhov A, 2010, P ACM SIGSPATIAL INT; Ratkiewicz J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158701; Spennemann DHR, 2006, INFORM SOC, V22, P101, DOI 10.1080/01972240600567204; Spennemann DHR, 2007, COMPUT EDUC, V49, P726, DOI 10.1016/j.compedu.2005.11.006; Sumi R, 2011, P 3 IEEE INT C SOC C; Sumi R., 2011, P ACM WEBSCI 11 KOBL, P1; Szabo G, 2010, COMMUNICATIONS ACM, V53; Voss J., 2005, P 10 INT C INT SOC S; West A. G., 2010, P 3 EUR WORKSH SYST, P22, DOI DOI 10.1145/1752046.1752050; Wilkinson Dennis M., 2007, 1 MONDAY, V12; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104; Wu Ye, 2010, P NATL ACAD SCI; Yasseri T, DYNAMICS CONFL UNPUB	24	116	122	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30091	10.1371/journal.pone.0030091	http://dx.doi.org/10.1371/journal.pone.0030091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22745683	gold, Green Published, Green Submitted			2022-12-27	WOS:000301454400057
J	Zhou, BY; Buckley, ST; Patel, V; Liu, YX; Luo, J; Krishnaveni, MS; Ivan, M; DeMaio, L; Kim, KJ; Ehrhardt, C; Crandall, ED; Borok, Z				Zhou, Beiyun; Buckley, Stephen T.; Patel, Vipul; Liu, Yixin; Luo, Jiao; Krishnaveni, Manda Sai; Ivan, Mihaela; DeMaio, Lucas; Kim, Kwang-Jin; Ehrhardt, Carsten; Crandall, Edward D.; Borok, Zea			Troglitazone Attenuates TGF-beta 1-Induced EMT in Alveolar Epithelial Cells via a PPAR gamma-Independent Mechanism	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; IDIOPATHIC PULMONARY-FIBROSIS; GLYCOGEN-SYNTHASE KINASE-3; ACUTE LUNG INJURY; MESENCHYMAL TRANSITION; BETA-CATENIN; CARCINOMA-CELLS; IN-VIVO; EXPRESSION; AGONISTS	Peroxisome proliferator activated receptor gamma (PPAR gamma) agonists are effective antifibrotic agents in a number of tissues. Effects of these agents on epithelial-mesenchymal transition (EMT) of primary alveolar epithelial cells (AEC) and potential mechanisms underlying effects on EMT have not been well delineated. We examined effects of troglitazone, a synthetic PPAR gamma agonist, on transforming growth factor (TGF)-beta 1-induced EMT in primary rat AEC and an alveolar epithelial type II (AT2) cell line (RLE-6TN). TGF-beta 1 (2.5 ng/mL) induced EMT in both cell types, as evidenced by acquisition of spindle-like morphology, increased expression of the mesenchymal marker a-smooth muscle actin (alpha-SMA) and downregulation of the tight junctional protein zonula occludens-1 (ZO-1). Concurrent treatment with troglitazone (or rosiglitazone), ameliorated effects of TGF-beta 1. Furthermore, following stimulation with TGF-beta 1 for 6 days, troglitazone reversed EMT-related morphological changes and restored both epithelial and mesenchymal markers to control levels. Treatment with GW9662 (an irreversible PPAR gamma antagonist), or overexpression of a PPAR gamma dominant negative construct, failed to inhibit these effects of troglitazone in AEC. Troglitazone not only attenuated TGF-beta 1-induced phosphorylation of Akt and glycogen synthase kinase (GSK)-3 beta, but also inhibited nuclear translocation of beta-catenin, phosphorylation of Smad2 and Smad3 and upregulation of the EMT-associated transcription factor SNAI1. These results demonstrate inhibitory actions of troglitazone on TGF-beta 1-induced EMT in AEC via a PPAR gamma-independent mechanism likely through inhibition of beta-catenin-dependent signaling downstream of TGF-beta 1, supporting a role for interactions between TGF-beta and Wnt/beta-catenin signaling pathways in EMT.	[Zhou, Beiyun; Patel, Vipul; Liu, Yixin; Luo, Jiao; Krishnaveni, Manda Sai; Ivan, Mihaela; DeMaio, Lucas; Kim, Kwang-Jin; Crandall, Edward D.; Borok, Zea] Univ So Calif, Dept Med, Will Rogers Inst Pulm Res Ctr, Div Pulm Crit Care & Sleep Med, Los Angeles, CA 90089 USA; [Buckley, Stephen T.; Ehrhardt, Carsten] Trinity Coll Dublin, Sch Pharm & Pharmaceut Sci, Dublin, Ireland; [Borok, Zea] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA USA	University of Southern California; Trinity College Dublin; University of Southern California	Zhou, BY (corresponding author), Univ So Calif, Dept Med, Will Rogers Inst Pulm Res Ctr, Div Pulm Crit Care & Sleep Med, Los Angeles, CA 90089 USA.	boro@usc.edu	Borok, Zea/J-9015-2013; Ehrhardt, Carsten/B-1259-2010; CRANDALL, EDWARD/AAD-8382-2020	Ehrhardt, Carsten/0000-0003-0730-1829; Tanaka, Yasuhito/0000-0002-2473-6966; sun, jian/0000-0001-5320-227X; Borok, Zea/0000-0001-8673-8177	United States National Institutes of Health [HL038578, HL062569, HL089445, ES017034, ES018782, HL038621]; Whittier Foundation; Hastings Foundation; American Thoracic Society/Coalition for Pulmonary Fibrosis/Pulmonary Fibrosis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038578, R37HL062569, R01HL038621, R37HL038578, R01HL089445, R01HL062569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017034, RC2ES018782] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whittier Foundation; Hastings Foundation; American Thoracic Society/Coalition for Pulmonary Fibrosis/Pulmonary Fibrosis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by research grants HL038578 (ZB), HL062569 (ZB), HL089445 (ZB), ES017034 (EDC), ES018782 (EDC) and HL038621 (EDC) from the United States National Institutes of Health, as well as the Whittier Foundation and the Hastings Foundation. B. Zhou is supported by an American Thoracic Society/Coalition for Pulmonary Fibrosis/Pulmonary Fibrosis Foundation Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2009, RESPIRATION, V77, P311, DOI 10.1159/000168676; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Belvisi MG, 2006, EUR J PHARMACOL, V533, P101, DOI 10.1016/j.ejphar.2005.12.048; BOROK Z, 1994, IN VITRO CELL DEV-AN, V30A, P99; Bowley E, 2007, J SURG RES, V138, P141, DOI 10.1016/j.jss.2006.07.026; Burgess HA, 2005, AM J PHYSIOL-LUNG C, V288, pL1146, DOI 10.1152/ajplung.00383.2004; Cao LQ, 2007, ACTA PHARMACOL SIN, V28, P879, DOI 10.1111/j.1745-7254.2007.00571.x; Cheng HC, 2008, MOL VIS, V14, P95; Chojkier M, 2005, HEPATOLOGY, V41, P237, DOI 10.1002/hep.20567; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; DRISCOLL KE, 1995, IN VITRO CELL DEV-AN, V31, P516; Ferguson HE, 2009, AM J RESP CELL MOL, V41, P722, DOI 10.1165/rcmb.2009-0006OC; Frankel SK, 2009, CURR OPIN PULM MED, V15, P463, DOI 10.1097/MCP.0b013e32832ea4b3; Genovese T, 2005, EUR RESPIR J, V25, P225, DOI 10.1183/09031936.05.00049704; Giri S, 2004, J IMMUNOL, V173, P5196, DOI 10.4049/jimmunol.173.8.5196; Goetze S, 2002, BIOCHEM BIOPH RES CO, V293, P1431, DOI 10.1016/S0006-291X(02)00385-6; Guarino M, 2009, HUM PATHOL, V40, P1365, DOI 10.1016/j.humpath.2009.02.020; Honda K, 2004, J ALLERGY CLIN IMMUN, V113, P882, DOI 10.1016/j.jaci.2004.02.036; Hong KO, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-28; KAO WWY, 1977, NATURE, V266, P63, DOI 10.1038/266063a0; Kattla JJ, 2008, AM J PHYSIOL-RENAL, V295, pF215, DOI 10.1152/ajprenal.00548.2007; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim Robert, 2008, Ther Adv Respir Dis, V2, P319, DOI 10.1177/1753465808096948; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kulkarni AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015909; Lakatos HF, 2007, PPAR RES, V2007, DOI 10.1155/2007/71323; Lee YJ, 2010, AM J PHYSIOL-RENAL, V298, pF1263, DOI 10.1152/ajprenal.00475.2009; Liu D, 2006, PHYSIOL RES, V55, P291, DOI 10.33549/physiolres.930822; Lu DS, 2010, EUR J PHARMACOL, V636, P198, DOI 10.1016/j.ejphar.2010.03.010; Milam JE, 2008, AM J PHYSIOL-LUNG C, V294, pL891, DOI 10.1152/ajplung.00333.2007; Mughal RS, 2009, CLIN EXP PHARMACOL P, V36, P478, DOI 10.1111/j.1440-1681.2008.05088.x; Nicolas FJ, 2003, J BIOL CHEM, V278, P3251, DOI 10.1074/jbc.M209019200; Reka AK, 2010, MOL CANCER THER, V9, P3221, DOI 10.1158/1535-7163.MCT-10-0570; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Sime PJ, 2008, J INVEST MED, V56, P534, DOI 10.2310/JIM.0b013e31816464e9; Simon DM, 2006, FASEB J, V20, P1507, DOI 10.1096/fj.05-5410fje; Tan XH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-21; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	44	120	123	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e38827	10.1371/journal.pone.0038827	http://dx.doi.org/10.1371/journal.pone.0038827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	22745681	Green Submitted, Green Published, gold			2022-12-27	WOS:000305693200024
J	Chen, F; Zhang, W; Liang, Y; Huang, JL; Li, K; Green, CD; Liu, JC; Zhang, GJ; Zhou, B; Yi, X; Wang, W; Liu, H; Xu, XH; Shen, F; Qu, N; Wang, YD; Gao, GY; San, A; JiangBai, LS; Sang, H; Fang, XD; Kristiansen, K; Yang, HM; Wang, J; Han, JDJ; Wang, J				Chen, Fang; Zhang, Wei; Liang, Yu; Huang, Jialiang; Li, Kui; Green, Christopher D.; Liu, Jiancheng; Zhang, Guojie; Zhou, Bing; Yi, Xin; Wang, Wei; Liu, Hang; Xu, Xiaohong; Shen, Feng; Qu, Ning; Wang, Yading; Gao, Guoyi; San, A.; JiangBai, LuoSang; Sang, Hua; Fang, Xiangdong; Kristiansen, Karsten; Yang, Huanming; Wang, Jun; Han, Jing-Dong J.; Wang, Jian			Transcriptome and Network Changes in Climbers at Extreme Altitudes	PLOS ONE			English	Article							EXPRESSION DATA; STEM-CELLS; HYPOXIA; ADAPTATION; EVEREST; ILLNESS; PROTEIN; OCT4	Extreme altitude can induce a range of cellular and systemic responses. Although it is known that hypoxia underlies the major changes and that the physiological responses include hemodynamic changes and erythropoiesis, the molecular mechanisms and signaling pathways mediating such changes are largely unknown. To obtain a more complete picture of the transcriptional regulatory landscape and networks involved in extreme altitude response, we followed four climbers on an expedition up Mount Xixiabangma (8,012 m), and collected blood samples at four stages during the climb for mRNA and miRNA expression assays. By analyzing dynamic changes of gene networks in response to extreme altitudes, we uncovered a highly modular network with 7 modules of various functions that changed in response to extreme altitudes. The erythrocyte differentiation module is the most prominently up-regulated, reflecting increased erythrocyte differentiation from hematopoietic stem cells, probably at the expense of differentiation into other cell lineages. These changes are accompanied by coordinated down-regulation of general translation. Network topology and flow analyses also uncovered regulators known to modulate hypoxia responses and erythrocyte development, as well as unknown regulators, such as the OCT4 gene, an important regulator in stem cells and assumed to only function in stem cells. We predicted computationally and validated experimentally that increased OCT4 expression at extreme altitude can directly elevate the expression of hemoglobin genes. Our approach established a new framework for analyzing the transcriptional regulatory network from a very limited number of samples.	[Chen, Fang; Zhang, Guojie; Yi, Xin; Wang, Wei; Liu, Hang; Xu, Xiaohong; Shen, Feng; Qu, Ning; Wang, Yading; San, A.; JiangBai, LuoSang; Sang, Hua; Yang, Huanming; Wang, Jun; Wang, Jian] BGI Shenzhen, Shenzhen, Peoples R China; [Zhang, Wei; Huang, Jialiang; Green, Christopher D.; Liu, Jiancheng; Zhou, Bing; Han, Jing-Dong J.] Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai, Peoples R China; [Chen, Fang; Liang, Yu; Li, Kui; Yi, Xin; San, A.; Fang, Xiangdong] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Zhang, Wei; Huang, Jialiang; Liu, Jiancheng; Zhou, Bing] Chinese Acad Sci, Ctr Mol Syst Biol, Inst Genet & Dev Biol, Beijing, Peoples R China; [Chen, Fang; Zhang, Wei; Liang, Yu; Huang, Jialiang; Li, Kui; Liu, Jiancheng; Zhou, Bing; Yi, Xin; San, A.] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Gao, Guoyi] Hosp XiShuangBanNa Dai Nationalities Autonomous, Jinghong, Peoples R China; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Copenhagen	Chen, F (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	wangj@genomics.org.cn; jdhan@picb.ac.cn; wangjian@genomics.org.cn	Zhou, Bing/J-3281-2015; Kristiansen, Karsten/J-5148-2014; Zhang, Guojie/B-6188-2014; Zhang, Guojie/J-7273-2019; Wang, Jun/A-7261-2013; Zhang, Wei/K-4276-2016; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Kristiansen, Karsten/0000-0002-6024-0917; Zhang, Guojie/0000-0001-6860-1521; Zhang, Guojie/0000-0001-6860-1521; Zhang, Wei/0000-0002-0942-1245; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Wang, Dao Wen/0000-0002-9774-3980; , Chen/0000-0001-5080-9383	China National Science Foundation [30890033, 30588001, 30620120433]; Chinese Ministry of Science and Technology [2006CB910700, 2006CB504103]; Chinese Academy of Sciences [KSCX1-YW-R-40, KSCX2-YW-R-76]; Science and Technology Plan of the Tibet Autonomous Region [2007-2-18]	China National Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Plan of the Tibet Autonomous Region	This work was supported by grants from the China National Science Foundation (Grant # 30890033, # 30588001 and # 30620120433), Chinese Ministry of Science and Technology (973 program, Grant # 2006CB910700, # 2006CB504103) and Chinese Academy of Sciences (# KSCX1-YW-R-40, # KSCX2-YW-R-76), Science and Technology Plan of the Tibet Autonomous Region (# 2007-2-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; BERGLUND B, 1992, SPORTS MED, V14, P289, DOI 10.2165/00007256-199214050-00002; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Clerici C, 2009, AM J PHYSIOL-LUNG C, V296, pL267, DOI 10.1152/ajplung.90528.2008; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Grocott MPW, 2009, NEW ENGL J MED, V360, P140, DOI 10.1056/NEJMoa0801581; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Hartmann G, 2000, CYTOKINE, V12, P246, DOI 10.1006/cyto.1999.0533; Hochachka PW, 2003, BIOESSAYS, V25, P515, DOI 10.1002/bies.10261; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Koeppen M, 2011, CURR OPIN ANESTHESIO, V24, P363, DOI 10.1097/ACO.0b013e32834873fd; Lengner CJ, 2008, CELL CYCLE, V7, P725, DOI 10.4161/cc.7.6.5573; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEEHAN RT, 1987, ANN EMERG MED, V16, P974, DOI 10.1016/S0196-0644(87)80743-6; Michael P, 2000, HIGH ALTITUDE MED PH; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Reverter A, 2010, BIOINFORMATICS, V26, P896, DOI 10.1093/bioinformatics/btq051; Richalet JP, 1999, ADV EXP MED BIOL, V474, P297; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUTTON JR, 1988, J APPL PHYSIOL, V64, P1309, DOI 10.1152/jappl.1988.64.4.1309; Torkamani A, 2009, BIOINFORMATICS, V25, P2222, DOI 10.1093/bioinformatics/btp388; Wang X, 2009, STEM CELLS, V27, P1265, DOI 10.1002/stem.58; Xia K, 2006, PLOS COMPUT BIOL, V2, P1482, DOI 10.1371/journal.pcbi.0020145; Xia K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-508; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	32	127	132	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31645	10.1371/journal.pone.0031645	http://dx.doi.org/10.1371/journal.pone.0031645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393366	gold, Green Published, Green Submitted			2022-12-27	WOS:000303003500019
